<SEC-DOCUMENT>0001493152-21-006096.txt : 20210316
<SEC-HEADER>0001493152-21-006096.hdr.sgml : 20210316
<ACCEPTANCE-DATETIME>20210316143933
ACCESSION NUMBER:		0001493152-21-006096
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		141
FILED AS OF DATE:		20210316
DATE AS OF CHANGE:		20210316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Save Foods Inc.
		CENTRAL INDEX KEY:			0001789192
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				264684680
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-254327
		FILM NUMBER:		21745198

	BUSINESS ADDRESS:	
		STREET 1:		156 FIFTH AVENUE 10TH FLOOR
		STREET 2:		CO EARTHBOUND LLC
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010-7751
		BUSINESS PHONE:		972544561349

	MAIL ADDRESS:	
		STREET 1:		156 FIFTH AVENUE 10TH FLOOR
		STREET 2:		CO EARTHBOUND LLC
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010-7751
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>forms-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
filed with the Securities and Exchange Commission on March 16, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
Statement No. 333-</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt; text-transform: uppercase"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt; text-transform: uppercase"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; text-transform: uppercase"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2870</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>26-468460</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State
    or other jurisdiction of<BR>
    incorporation or organization)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary
        Standard Industrial</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classification
        Code Number)</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S.
        Employer</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Identification
        Number)</I></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Save
Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5pt; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kibbutz
Alonim, Israel, 3657700</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5pt; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(347) 468 9583</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address,
including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
Palach</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Save
Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5pt; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kibbutz
Alonim, Israel, 3657700</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5pt; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tel:
(347) 468 9583</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Copies
to:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Oded
        Har-Even, Esq.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
        A. Huberman, Esq.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
        Ben-Bassat, Esq.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sullivan
        &amp; Worcester LLP</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1633
        Broadway</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
        York, NY 10019</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
        660-3060</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leslie
        Marlow, Esq.<BR>
        Hank Gracin, Esq.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patrick
        J. Egan, Esq.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gracin
        &amp; Marlow, LLP</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
        Chrysler Building</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>405
        Lexington Avenue, 26<SUP>th</SUP> Floor</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
        York, NY 10174</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
        907- 6457</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public: </B>As soon as practicable after the effective date of this registration
statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box: [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 19.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 23%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">filer [&nbsp;&nbsp;]</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 18%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[&nbsp;&nbsp;]</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 18%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
filer</FONT></P>
                                                                                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[X]</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 15%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">company [X]</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 18%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Company [&nbsp;&nbsp;]</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of Securities Being Registered</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate
        Offering<BR>
        Price</B><SUP>(1) (2)</SUP></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    of <BR>
    Registration Fee</B><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 62%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $0.0001 per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,800,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,505.58</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter&rsquo;s
    warrants to purchase Common Stock <SUP>(4)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock issuable upon exercise of the Underwriter&rsquo;s warrants <SUP>(5)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">750,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">81.83</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Registration Fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,550,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,587.41</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for purposes of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of
    1933, as amended (the &ldquo;Securities Act&rdquo;). Includes the offering price of shares of Common Stock that the Underwriter
    have the option to purchase to cover over-allotments, if any.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares
    of Common Stock as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other
    similar transactions. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required pursuant to Rule 457(g).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The underwriter&rsquo;s
    warrants are exercisable at a per share exercise price equal to 125% of the public offering price. As estimated solely for
    the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate
    offering price of the underwriter&rsquo;s warrants is equal to 125% of $600,000 (which is 5% of $12,000,000).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment that specifically states that this Registration Statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act, or until the Registration Statement shall become effective on
such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration
statement related to these securities filed with the Securities and Exchange Commission is declared effective. This prospectus
is not an offer to sell or a solicitation of an offer to buy these securities and we are not soliciting offers to buy these securities
in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>PRELIMINARY
    PROSPECTUS </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT
    TO COMPLETION </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>DATED
    MARCH 16, 2021</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares</B></FONT></P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="formdrs_001.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Save
Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering up to shares of our Common Stock par value $0.0001 per share (&ldquo;Common Stock&rdquo;). We anticipate that the
initial public offering price will be between $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
We have applied to list our Common Stock on the Nasdaq Capital Market under the symbol &ldquo;SVFD.&rdquo; No assurance can be
given that our application will be approved or that a trading market will develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently traded on the OTC Markets, Pink Open Market, under the symbol &ldquo;SAFO.&rdquo; On March 9, 2021,
the last reported sale price of our Common Stock was $24 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves risks. See &ldquo;Risk Factors&rdquo; beginning on page 14 of this prospectus for a discussion of the
risks that you should consider in connection with an investment in our securities. Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 68%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    public offering price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discounts and commissions<SUP>(1) </SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds,
    before expenses, to us</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discounts and commissions do not include a non-accountable expense allowance equal to 1.0% of the initial public offering
    price payable to the underwriter. We have agreed to reimburse the underwriters for certain expenses and the underwriters will
    receive compensation in addition to underwriting discounts and commissions. We have also agreed to issue warrants to the representative
    of the underwriters as a portion of the underwriting compensation payable to the underwriters in connection with this offering.
    See the section titled &ldquo;Underwriting&rdquo; beginning on page 92 of this prospectus for additional disclosure regarding
    underwriter compensation and offering expenses.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the underwriters an option for a period of 45 days to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional
shares of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate the expenses of this offering, excluding underwriting discounts and commissions, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
underwriters expect to deliver the Company&rsquo;s securities to the purchasers on or about</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="background-color: white">,
2021.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>ThinkEquity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>a
division of Fordham Financial Management, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="logo_001.jpg" ALT="" STYLE="height: 868px; width: 670px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="logo_002.jpg" ALT="" STYLE="height: 868px; width: 670px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B>&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary Note Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Policy </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#g_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#man_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#man_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive and Director Compensation</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#man_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationships and Related Party Transactions</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#man_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#man_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Our Securities </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pi_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares Eligible for Future Sale</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pi_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material U.S. Federal Income Tax Considerations for Non-U.S. Holders</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pi_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pi_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pi_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pi_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where You Can Find Additional Information </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#kk_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Index to Financial Statements </FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
should rely only on the information contained in this prospectus and any free writing prospectus that we have authorized for use
in connection with this offering. Neither we nor the underwriters have authorized anyone to provide you with information that
is different. We are offering to sell, and seeking offers to buy, the securities covered hereby only in jurisdictions where offers
and sales are permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of
the time of delivery of this prospectus or any sale of the securities covered hereby. Our business, financial condition, results
of operations and prospects may have changed since that date. We are not, and the underwriters are not, making an offer of these
securities in any jurisdiction where the offer is not permitted. You should also read and consider the information in the documents
to which we have referred you under the caption &ldquo;Where You Can Find Additional Information&rdquo; in the prospectus. In
addition, this prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference
is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents.
Copies of some of the documents referred to herein have been filed or will be filed as exhibits to the registration statement
of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &ldquo;Where
You Can Find Additional Information.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
investors outside the United States: Neither we nor any of the underwriters have taken any action that would permit this offering
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in
the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of the securities covered hereby and the distribution of this prospectus
outside of the United States.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
prospectus includes statistical and other industry and market data that we obtained from industry publications and research, surveys
and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate
that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or
completeness of such information. We believe that the data obtained from these industry publications and third-party research,
surveys and studies are reliable. We are ultimately responsible for all disclosure included in this prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Except
where the context requires otherwise, in this prospectus the &ldquo;Company,&rdquo; &ldquo;Save Foods,&rdquo; &ldquo;we,&rdquo;
&ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Save Foods, Inc., a Delaware corporation and, where appropriate, its subsidiary,
Save Foods Ltd.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>In
June 2019, <FONT STYLE="background-color: white">we implemented a one-for-fifteen reverse stock split of our common stock pursuant
to which holders of our Common Stock received one share of our Common Stock for every fifteen shares of Common Stock held.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>On
February 23, 2021, <FONT STYLE="background-color: white">we implemented a one-for-seven reverse stock split of our common stock
pursuant to which holders of our Common Stock received one share of our Common Stock for every seven shares of Common Stock held.
Unless the context expressly dictates otherwise, all references to share and per share amounts referred to herein reflect the
reverse stock split.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="g_001"></A>Cautionary
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements, including statements regarding the progress and timing of our product development,
the goals of our development activities, estimates of the potential markets for our products, estimates of the capacity of manufacturing
and other facilities to support our products, our expected future revenues, operations and expenditures and projected cash needs.
The forward-looking statements are contained principally in the sections of this prospectus entitled &ldquo;Prospectus Summary&rdquo;
&ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;
and &ldquo;Business.&rdquo; These statements relate to future events of our financial performance and involve known and unknown
risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to
differ materially from those expressed or implied by these forward-looking statements. Those risks and uncertainties include,
among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expectations regarding our short and long-term capital requirements;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to raise additional capital to meet our liquidity needs;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to meet the initial listing requirements of the Nasdaq Capital Market and to comply with the continued listing standards
    of the Nasdaq Capital Market; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to generate sufficient proceeds from this offering to affect our business plan;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expected use of proceeds from this offering;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    size and growth of our product market;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    marketing plans;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    activity in the civilian market;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain market acceptance of our technology and products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to satisfy U.S. (including the U.S. Food and Drug Administration, the United States Environmental Protection Agency
    and the California Department of Pesticide Regulation), and international regulatory requirements and obtain required approvals
    for sales or exports of our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to compete in our respective markets;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    plans to continue to invest in research and development;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to gain acceptance of packing house community and other industries for use of our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to establish and maintain strategic partnerships with third parties, including for the distribution of products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain sufficient, qualified personnel;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain or maintain patents or other appropriate protection for the intellectual property;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to grow both domestically and internationally;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to adequately support future growth; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    product liability or intellectual property infringement claims;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effect of COVID-19 on our business; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    with respect to any other plans and strategies for our business.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by
terms such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;expects,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;projects,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;potential,&rdquo; or the negative of those terms, and similar expressions and comparable terminology intended to identify
forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions
and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking
statements. These forward-looking statements represent our estimates and assumptions only as of the date of this prospectus and,
except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as
a result of new information, future events or otherwise after the date of this prospectus. You should read this prospectus, the
documents incorporated by reference in this prospectus, the documents referenced in this prospectus and the documents filed as
exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual
future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="g_002"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information about us, this offering and selected information contained elsewhere in and does not contain all
of the information that you should consider in making your investment decision. Before investing in our securities, you should
carefully read this entire prospectus and <FONT STYLE="background-color: white">the documents incorporated by reference herein</FONT>,
including our financial statements and the related notes and the information set forth under the sections titled &ldquo;Risk Factors&rdquo;
and &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo; Unless otherwise indicated, all share amounts and per
share amounts in this prospectus have been presented on a retrospective and pro forma basis to reflect the reverse stock split
of our outstanding shares of common stock at a ratio of 1-for-7 which we effected on February 23, 2021.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
develop eco-friendly &ldquo;green&rdquo; solutions for the food industry. Our solutions are developed to improve the food safety
and shelf life of fresh produce. We do this by controlling human and plant pathogens, thereby reducing spoilage, and in turn,
reducing food loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of oxidizing
agent-based sanitizers and fungicides at low concentrations. Our &ldquo;green&rdquo; products are capable of cleaning, sanitizing
and controlling pathogens on fresh produce with the goal of making them safer for human consumption and extending their shelf
life by reducing their decay. One of the main advantages of our products is that our active ingredients do not leave any toxicological
residues on the fresh produce we treat. In contrary, by forming a temporary protective shield around the fresh produce we treat,
our products make it difficult for pathogens to develop and potentially provide protection which also reduces cross-contamination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. Food and Drug Administration (the &ldquo;FDA&rdquo;) Food Safety Modernization Act (the &ldquo;FSMA&rdquo;) is transforming
the United States&rsquo; food safety system by shifting the focus from responding to foodborne illness to preventing it. According
to the recent data from the Centers for Disease Control and Prevention, approximately 48 million people in the United States get
sick each year from foodborne diseases. We believe this is a significant public health burden that is largely preventable. Since
2018, the FDA has a legislative mandate to require comprehensive, science-based preventive controls across the food supply such
as the implementation of sanitizers into fresh produce at packing houses to ensure they are cleaned from human pathogens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, most conventional chemical pesticides (fungicides), which are currently used to protect fresh produce from microbial
spoilage and reduce food waste, are toxic, they remain on fruit peel and present health concerns, while also polluting the environment.
Therefore, the use of these products is strictly regulated and their residue on food and on the environment are carefully monitored.
Today&rsquo;s trends led by both consumers and regulatory bodies are to significantly reduce the use of fungicides and switch
to greener solutions. In a series of studies conducted in collaboration with a large post-harvest service company during the second
quarter of 2020, our products have shown to extend the shelf life of fresh produce in &ldquo;organic&rdquo; (where no fungicides
are used at the post-harvest stage) and conventional (where fungicides are being used at the post-harvest stage) settings. On
average, our products may reduce the rotten fruits at the retail level by 50%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a unique opportunity to make a positive difference throughout the food value chain from field to fork and address two of
the major&rsquo;s challenges in the food industry today &mdash; safety and waste. We target major markets that use conventional
chemical pesticides and sanitizers, including the pre- and post-harvest market, the greenhouse market and the fresh-cut market,
where our &ldquo;green&rdquo; products are used as alternatives for, or mixed with, conventional products in order to reduce (i)
health and environmental concerns, and/or (ii) microbial resistance that has reduced the efficacy of conventional chemical pesticides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Core Products</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
innovative products address two of the most significant challenges in the food industry: increase food safety and reduce food
loss. Our main product lines consist of a proprietary blend of organic food acids applied in post-harvest applications designed
to ensure food safety and increase fruit and vegetable&rsquo; shelf life by reducing microbial spoilage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main steps in post-harvest applications are cleaning, sanitization, and coating (wax). Our products address the cleaning and sanitization
application points which are the critical first steps for preserving the quality of fresh produce by controlling microbial contamination
related to food safety (e.g., Listeria, Salmonella, E. coli) and food loss due to microbial spoilage (e.g., fungi, mold and yeast).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the main advantages of our food acid blend is its non-toxic and safe residues that are providing protection to the treated
produce. All the blend ingredients are recognized by the FDA as Generally Recognized as Safe (the &ldquo;GRAS&rdquo;). Moreover,
they significantly reduce or eliminate the need for additional post-harvest applications with conventional fungicide by at least
50%, and in some cases entirely, and can reduce food waste due to spoilage by up to 50% (see results below on easy peelers and
mango).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
main products are currently being used as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.7pt; text-align: justify; text-indent: -17.85pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Processing
    Aids &ndash; SavePROTECT or PeroStar</I>: post-harvest treatment added to fruit and vegetable wash water as a processing
    aid to increase the efficiency of the oxidizing agent present in the water tank against plant pathogens to reduce produce
    loss; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Sanitizers
    - SF3HS and SF3H: </I>post-harvest cleaning and sanitizing solution to control both plant and foodborne pathogens to ensure
    both food safety as well as increase produce&rsquo;s shelf life.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
product portfolio also includes our <I>SpuDefender</I>, which targets and is designed to control the post-harvest potato sprout,
and our <I>FreshProtect</I>, which targets and is designed to control spoilage-creating microorganisms on post-harvest citrus
fruit and has a potential to reduce the bacterial load entering the packing house in pre-harvest applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strengths</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our main strengths include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Strong
    Management Team with Commitment to Green Products</I></B>. Led by a team with over 30 years of experience in developing sanitization
    products and solutions for the agriculture industry, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    plan on becoming a significant player in providing consumers with healthy and green fresh produce from farm to fork while
    endeavoring to ensure food safety and reducing food waste. <FONT STYLE="background-color: white">We believe that our proprietary
    blend of food acids </FONT>provides protection to the treated produce <FONT STYLE="background-color: white">and works in synergy
    with well-known fungicides and sanitizers. This synergy allows us to significantly reduce the concentration of the fungicides
    that are heavily regulated in several countries and, in certain countries, outright banned and meet the food trends of sustainable
    and green produce. </FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Multi-Purpose
    Products that Simplify <FONT STYLE="background-color: white">Crop Treatment Routine and Save Money</FONT></I></B><I><FONT STYLE="background-color: white">.
    </FONT></I><FONT STYLE="background-color: white">While most chemicals marketed in the industry address either food safety
    or food waste, our multi-purpose products are intended to provide a solution for both problems, while simplifying crop treatment
    and achieving cost saving. </FONT>Our products are capable of cleaning and controlling pathogens that would otherwise render
    fresh produce as unsafe for human consumption. Our proprietary blend of food acids combined with well-known sanitizers are
    very efficient against foodborne pathogens like E. coli, Salmonella and Listeria as well as plant pathogens in short contact
    time (99.999% reduction within 30 seconds of contact). <FONT STYLE="background-color: white">In addition, with multipurpose
    products, there is no need to order, ship or dispose of bottles of product, resulting in less energy consumed, less CO2, less
    fuel, and less waste. Our focus on natural product chemistries allows us to continually drive lower costs, higher product
    gross margins and efficacy through longer shelf life and reduction of food waste.</FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Strong
    Intellectual Property Portfolio</I></B>. We believe that we have built a strong intellectual property position throughout
    the food chain (from field to fork) as our patents claim compositions and methods that can be used to protect food and agricultural
    products from decay. We rely on a combination of important intellectual property assets, to protect our innovation. Our employees,
    consultants, customers, and vendors are subject to confidentiality agreements that protect our proprietary manufacturing processes.
    Our patent portfolio includes granted patents in the United States, Europe, and Israel, as well as several priority applications,
    across several patent families, including composition-of-matter claims, methods of use claims, including for treating edible
    matter, for improving the appearance of edible plant matter, and sterilization methods, as well as for articles for implementing
    these methods. These patents directly protect a proprietary method for extending life shelf and reducing edible matter from
    microbial decay</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Commercially
    Available Products and Seamless Implementation</I></B>. One of the oxidizers being used with our products is peracetic acid
    (&ldquo;PAA&rdquo;), a well-known and widely used sanitizer. Following the enforcement of the FSMA in connection with the
    use of sanitizers, more and more packers have been choosing this healthy and eco-friendly sanitizer over chlorine, and this
    choice facilitates implementation of our products. In addition, the application of our products does not require special equipment
    as they are used in combination with or replace existing products applied on the packing line or in the mix tank in the field.
    This allows a relatively cheap, seamless and fast implementation. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Significant
    Reduction of Hazardous Chemicals Food Residue</I></B><I>.</I> Our blend of food acids is recognized by the FDA as GRAS, while
    oxidizers we use rapidly decompose into water and oxygen (or oxygen and acetic acid). The absence of toxicological residues
    not only improves food quality but also promotes occupational safety for the employees of packing houses, contributing to
    a friendlier and safer working environment. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
September 2018, the Company changed its organizational structure and management team. After reviewing the Company&rsquo;s then
existing strategy and results of operation, as well as examining the market opportunities, the new management team decided to
update the Company&rsquo;s strategy, reduce the marketing and sales of its existing products, and focus the Company&rsquo;s efforts
and financial resources in developing its next generation products. During the years 2019 and 2020, we developed, validated and
tested the efficacy of our next generation product &ndash; a blend of food acids &ndash; on a variety of crops in small and large
scale commercial pilots.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
strategy is to develop and commercialize our products through strategic partnerships with global post-harvest service companies
and with large food distributors and retailers with the intent of: (i) extending the shelf life of fresh produce while reducing
(and even eliminating) the use of harmful chemicals (fungicides); (ii) ensuring food safety and shelf life by controlling foodborne
pathogens and allow our customers to meet FSMA regulatory requirements; (iii) reducing food loss and the associated carbon &ldquo;footprint.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
order to achieve our goals, we intend to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Advance
    our Breakthrough Technologies and Commercialization Efforts</I></B>. During the first half of 2021, we plan to run a series
    of additional pilot studies in various commercial collaborations with post-harvest service vendors packing houses and food
    retailers. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Develop
    a Strong Marketing Message Around Promoting Safe Food While Avoiding Food Waste</I></B>. We plan to brand our fresh produce
    with a &ldquo;chemical residues free&rdquo; or &ldquo;naturally protected&rdquo; seal of approval and we believe that like-minded
    fruit packers around the globe will seek to differentiate themselves from their competitors by obtaining this seals.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Acquire
    or License Complementary Products and Technologies</I></B>. We actively search for products and technologies that can enhance
    our portfolio and grow our business to address all the post-harvest treatments such as fruit coating products or technologies.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Expand
    to Additional Produce and Geographies</I></B>. Our plan is to focus first on key countries and regions with the largest markets
    for our crops, including Mexico, Spain, Italy, Israel and key markets in the United States such as California, Florida and
    Texas. We also plan to increase the variety of crops that can be treated with our products, to include produce such as apples,
    bell peppers, tomatoes and papayas.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Leverage
    Our Products Through Collaborations</I></B>. Our focus and expertise in the development of green products for the agritech
    industry and in post-harvest treatments allow us to be a partner of choice for other businesses looking for development partners
    and for larger companies wanting to leverage their product such as PAA into new combination products. For example, companies
    selling or owning fungicides, the maximum residue level (&ldquo;MRL&rdquo;) of which is being reduced, and that are working
    in synergy with our products are good partners. This type of collaboration could allow them to continue selling their product.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
selling and marketing strategy is twofold:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>establish
    collaborations with food retailers</I>; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>partner
    with service vendors to fruit and vegetable packing houses. </I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks, including risks that may prevent us from achieving our business objectives or may adversely
affect our business, financial condition, results of operations, cash flows and prospects that you should consider before making
a decision to invest in our Common Stock. These risks are discussed more fully in the section titled &ldquo;Risk Factors&rdquo;
beginning on page 14 of this prospectus, and include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    have a history of operating losses and expect to incur additional losses in the future;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    have not generated significant revenue from the sale of our products and do not believe that our current cash on hand will
    be sufficient to fund our growth plans or our projected operating requirements. This raises substantial doubt about our ability
    to continue as a going concern. In addition, the report of our independent registered public accounting firm contains an explanatory
    paragraph regarding substantial doubt about our ability to continue as a going concern;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">even
    if this offering is successful, we expect that we will need to raise significant additional capital, which we may be unable
    to obtain;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">because
    of our limited operating history, we may not be able to successfully operate our business or execute our business plan;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our
    products and technology require additional trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    commercial success of our new generation products, as well as any future products, depends upon the degree of market acceptance
    by the packing house community as well as by other prospect markets and industries;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    COVID-19 pandemic, or any other pandemic, epidemic or outbreak of an infectious disease, may materially and adversely affect
    our business and operations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    may face significant competition from other companies looking to develop or acquire new alternative environmentally friendly
    solutions for the treatment of fruits and vegetables, and other edible matter;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our
    success is dependent upon the acceptance of our environmentally friendly solutions for fruits and vegetable;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    may be unable to respond effectively to technological changes in our industry, which could reduce the demand for our products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    currently rely on a limited number of suppliers to produce certain key components of our products.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we are unable to establish sales, marketing and distribution capabilities or enter into successful relationships with third
    parties to perform these services, we may not be successful in commercializing our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    rely on rapidly establishing global distributorship network in order to effectively market our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    results of our early tests may not be indicative of results in future tests and we cannot assure you that any planned or future
    tests will lead to results sufficient for the necessary regulatory approvals;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    products are highly regulated by governmental agencies in the countries where we conduct business and into which we plan to
    expand. Our failure to obtain regulatory approvals and registration, to comply with registration and regulatory requirements
    or to maintain regulatory approvals would have an adverse impact on our ability to market and sell our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    success is dependent upon our ability to achieve regulatory approvals and registration in the United States and abroad (Mexico,
    Israel, Spain and Italy), which might take longer periods than expected;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inherent dangers in production and transportation of hydrogen peroxide and highly concentrated organic acids could cause disruptions
    and could expose us to potentially significant losses, costs or other liabilities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    business and operations may be affected by climate change conditions, which could materially harm our financial results;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions
    in the global economy may adversely affect our business, financial condition and results of operation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    relationship with our employees could deteriorate, and certain key employees could leave, which could adversely affect our
    business and results of operations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are subject to risks relating to portfolio concentration;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    operating results may fluctuate, which makes our results difficult to predict and could cause our results to fall short of
    expectations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">international
    expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated
    with doing business outside of the United States, Mexico or Israel;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    business depends to some extent on international transactions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we are unable to secure and maintain patent or other intellectual property protection for the intellectual property used in
    our products, our ability to compete will be harmed;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we are unable to prevent unauthorized use or disclosure of our proprietary trade secrets and unprotected know-how, our ability
    to compete will be harmed;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    could become subject to patent and other intellectual property litigation that could be costly, result in the diversion of
    management&rsquo;s attention, require us to pay damages and force us to discontinue selling our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may experience claims that our products infringe the intellectual property rights of others, which may cause us to incur unexpected
    costs or prevent us from selling our products or services;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we or our contractors or service providers fail to comply with laws and regulations, we or they could be subject to regulatory
    actions, which could affect our ability to develop, market and sell our products or future products that we may develop and
    may harm our reputation in our industry;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    reforms may adversely affect our ability to sell our products profitably;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions
    in Israel may limit our ability to manage and market our products, which would lead to a decrease in revenues;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may not be able to enforce covenants not-to-compete under current Israeli law that might result in added competition for our
    products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    may be difficult to acquire jurisdiction and enforce liabilities against our officers and directors who are based in Israel;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">even
    if we meet the initial listing requirements of the Nasdaq Capital Market, there can be no assurance that we will be able to
    comply with the continued listing standards of the Nasdaq Capital Market. Our failure to meet the continued listing requirements
    of the Nasdaq Capital Market could result in a de-listing of our Common Stock.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated in the State of Delaware on April 1, 2009. Our principal executive offices are located at Kibbutz Alonim, Israel,
3657700 and our telephone number is (347) 468 9583. Our website address is <I>www.savefoods.co</I>. The information contained
on, or that can be accessed through, our websites is not incorporated by reference into this prospectus and is intended for informational
purposes only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC also maintains an Internet website that contains reports, proxy and information statements and other information regarding
issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through the SEC&rsquo;s
website at <I>http://www.sec.gov</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains trademarks, trade names and service marks of other companies, which are the property of their respective owners.
Solely for convenience, trademarks, trade names and service marks referred to in this prospectus may appear without the &reg;,
&trade; or SM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent
permitted under applicable law, our rights or the right of the applicable licensor to these trademarks, trade names and service
marks. We do not intend our use or display of other parties&rsquo; trademarks, trade names or service marks to imply, and such
use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>The
Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock offered <BR>
by us</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock issued and outstanding</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">1,606,760
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares (as of March 10, 2021)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
shares of Common Stock to be outstanding after this offering</B></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
    (or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters exercise in full their option to purchase additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
    to cover over-allotments, if any)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Over-allotment
    option</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
have granted the underwriters an option for a period of 45 days from the date of this prospectus to purchase up to an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of Common Stock at the public offering price, less the underwriting discount</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 73%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of proceeds</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
        estimate that we will receive gross proceeds of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
        assuming a public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        per share, before deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
        currently expect to use the net proceeds from this offering for the following purposes:</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million for product research and development
    (which may include acquisition of technology to complement our product portfolio) and purchase of lab equipment;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million for gaining regulatory approvals
    and commercialization; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million for selling and marketing; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    remainder for working capital and general corporate purposes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 63%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &ldquo;Use of Proceeds&rdquo; for additional information.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    factors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 73%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &ldquo;Risk Factors&rdquo; beginning on page 14 and the other information included in this prospectus for a discussion of
    factors you should carefully consider before deciding to invest in our Common Stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed
    Nasdaq Capital Market symbol</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have applied to list the Common Stock to be issued in this offering on the Nasdaq Capital Market under the symbol &ldquo;SVFD.&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
number of Common Stock that will be outstanding after this offering as shown above is based on 1,606,760 shares of Common
Stock issued and outstanding as of the date of this prospectus, and the issuance and sale of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our Common Stock in this offering at a public
offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. This number excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,984
    shares of Common Stock issuable upon the exercise of warrants outstanding as of the date of this prospectus, with an exercise
    price of $8.40 per share;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,862
    shares of Common Stock issuable upon the exercise of options to directors, employees and consultants under our 2018 equity
    incentive plan (the &ldquo;Equity Incentive Plan&rdquo;) at a weighted average exercise price of $3.37, of which 119,042 vested
    as of the date of this prospectus; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,730
    shares of Common Stock reserved for future issuance under our Equity Incentive Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all information in this prospectus assumes and gives effect to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of the underwriter&rsquo;s over-allotment option; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of the representative&rsquo;s warrants; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">automatic
    conversion of convertible promissory notes issued in a series of convertible loan agreements into an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
    of Common Stock, assuming an offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
    which is the midpoint of the price range set forth on the cover page of this prospectus, which will occur immediately prior
    to the closing of this offering; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    one-for-seven reverse stock split effected on February 23, 2021.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Summary
Consolidated Financial Data</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
following table summarizes our consolidated financial data as of, and for the periods ended on, the dates indicated. We have derived
the following consolidated statements of operations data for the years ended December 31, 2020 and 2019 from our audited consolidated
financial statements included elsewhere in this prospectus. Our historical results are not necessarily indicative of the results
that may be expected in the future. The following summary consolidated financial data should be read in conjunction with our consolidated
financial statements and related notes and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations&rdquo; appearing elsewhere in this prospectus. Our consolidated financial statements are prepared and presented
in accordance with U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Year ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">U.S. dollars, except share and per share data</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Revenues from sales of products </TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">232,274</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">175,823</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of sales </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(43,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(144,548</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left">Gross profit </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research and development expenses </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(417,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(615,623</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Selling and marketing expenses </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(51,105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(342,058</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">General and administrative expenses </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,070,109</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,004,899</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left">Operating loss </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,349,345</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,931,305</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Financing expenses, net </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(270,393</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,408</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other expenses, net </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,532</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share in losses of affiliated company </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,690</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gain on disposal of affiliated company </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-weight: bold; text-align: left">Net loss </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,606,580</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,990,403</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: Net loss attributable to non-controlling interests </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,441</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,986</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net loss attributable to the Company </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,593,139</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,971,417</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Loss per share (basic and diluted) </TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.38</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of shares of Common Stock outstanding </TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,519,122</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,424,045</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-style: italic; border-bottom: Black 1.5pt solid">U.S. dollars</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro Forma <SUP>(1)</SUP> &nbsp;</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro Forma As<BR> Adjusted <SUP>(2) </SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-weight: bold; text-align: justify">Consolidated Balance Sheet Data:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">687,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">687,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,867,585</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,070,764</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,277,647</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,222,677</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Total stockholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(465,453</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(207,304</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    pro forma data gives effect to the automatic conversion of convertible promissory notes issued in a series of convertible
    loan agreements into an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of Common Stock, assuming an offering price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which
    is the midpoint of the price range set forth on the cover page of this prospectus, which will occur immediately prior to the
    closing of this offering.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    pro forma as adjusted balance sheet data give additional effect to the sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of Common Stock in this offering
    at the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the price range set
    forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated
    offering expenses payable by us.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="g_003"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our securities involves a high degree of risk. You should consider carefully the risks and uncertainties described below, together
with all of the other information in this prospectus, including our financial statements and related notes, before deciding whether
to purchase shares of our securities. If any of the following risks is realized, our business, operating results, financial condition
and prospects could be materially and adversely affected. In that event, the price of our Common Stock could decline, and you
could lose part or all of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Financial Condition and Capital Requirements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have a history of operating losses and expect to incur additional losses in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have sustained losses in recent years, which as of December 31, 2020, accumulated to $12.3 million, including an operating net
loss of $1.3 million and $1.9 million for the years ended December 31, 2020 and 2019, respectively. We are likely to continue
to incur significant net losses for at least the next several years as we continue to pursue our strategy, which is currently
focused on research and development. Our losses have had, and will continue to have, an adverse effect on our stockholders&rsquo;
equity and working capital. Any failure to achieve and maintain profitability would continue to have an adverse effect on our
stockholders&rsquo; equity and working capital and could result in a decline in our share price or cause us to cease operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have not generated significant revenue from the sale of our products and do not believe that our current cash on hand will be
sufficient to fund our growth plans or our projected operating requirements. This raises substantial doubt about our ability to
continue as a going concern. In addition, the report of our independent registered public accounting firm contains an explanatory
paragraph regarding substantial doubt about our ability to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to become profitable depends upon our ability to generate revenue. We have not yet generated any material revenues and
we do not know when, or if, we will generate any such revenue. We currently have no sources of recurring revenue and are therefore
dependent upon external sources for financing our operations. There can be no assurance that we will succeed in obtaining the
necessary financing to continue our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
raises substantial doubt about our ability to continue as a going concern. In addition, the report of our independent registered
public accounting firm contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going
concern. Our audited financial statements do not include any adjustments that might result from the outcome of the uncertainty
regarding our ability to continue as a going concern. This going concern opinion could materially limit our ability to raise additional
funds through the issuance of equity or debt securities or otherwise. Further reports on our financial statements may include
an explanatory paragraph with respect to our ability to continue as a going concern. If we cannot continue as a going concern,
our investors may lose their entire investment in our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if this offering is successful, we expect that we will need to raise significant additional capital, which we may be unable to
obtain.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
capital requirements in connection with our research and development activities and transition to commercial operations have been,
and will continue to be significant. We will require additional funds to continue research, development and testing of our technologies
and products, to obtain intellectual property protection relating to our technologies when appropriate, and to market our products.
There can be no assurance that financing will be available in amounts or on terms acceptable to us, if at all. In either of the
aforementioned situations, we may not be able to fully implement its growth plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
financings that we may require in the future will dilute the percentage ownership interests of our stockholders and may adversely
affect our earnings and net book value per share. In addition, we may not be able to secure any such additional financing on terms
acceptable to us, if at all. Moreover, if we are unable to obtain such additional capital as discussed above, we will be required
to stop our operations, and will resume our activities, only after capital is raised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Business, Industry and Business Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
of our limited operating history, we may not be able to successfully operate our business or execute our business plan.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
September 2018, the Company changed its organizational structure and management team. After reviewing the Company&rsquo;s then
existing strategy and results of operation, as well as examining the market opportunities, the new management team decided to
update the Company&rsquo;s strategy, reduce the marketing and sales of its existing products, and focus the Company&rsquo;s efforts
and financial resources in developing its next generation products. During the years 2019 and 2020, we developed, validated and
tested the efficacy of our next generation product &ndash; a blend of food acids &ndash; on a variety of crops in small and large
scale commercial pilots.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
our limited operating history, it is hard to evaluate our proposed business and prospects. Our proposed business operations will
be subject to numerous risks, uncertainties, expenses and difficulties associated with early-stage enterprises. Such risks include,
but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    absence of a lengthy operating history;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient
    capital to fully realize our operating plan;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expected
    continual losses for the foreseeable future;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    in multiple currencies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to anticipate and adapt to a developing market(s);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
    of our products by the pre- and post-harvest industry players and consumers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    marketing experience;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    competitive environment characterized by well-established and well-capitalized competitors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to identify, attract and retain qualified personnel; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    in an environment that is highly regulated by a number of agencies.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 46.2pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are subject to these risks, evaluating our business may be difficult, our business strategy may be unsuccessful and we may
be unable to address such risks in a cost-effective manner, if at all. If we are unable to successfully address these risks our
business could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
products and technology require additional trials.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
efficacy of our products has only been shown in the limited number of pathogens tested on certain produce and aforementioned climates,
and therefore our products have yet to be proven against certain additional and relevant pathogens, produce and market climates
to validate the efficacy and benefits of our products. <FONT STYLE="background-color: white">However, due to COVID-19, and the
current restrictions on travels, we may delay or postpone certain of our planned trials.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
commercial success of our new generation products, as well as any future products, depends upon the degree of market acceptance
by the packing house community as well as by other prospect markets and industries.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to achieve high volume sales and attain a leading market share and become the new standard of treatment, our products must
not only be approved by the regulators, but also endorsed by the major packing houses and service providers, retailers of fruits
and vegetables as well as environmental organizations. Our success depends on our ability to create significant value to the growers,
the packing houses and the food retailers. We are aware of this key factor and are focusing on conducting large scale trials with
major fruits and vegetables packers and retail suppliers of fresh consumed goods in several countries, in order to show the efficacy
of the products and our technology, and to receive the recognition of packers and retailers. However, there can be no assurances
that we will succeed in such an endeavor, nor is it clear how long it will take until we receive market recognition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that any product that we bring to the market will gain market acceptance by prospective customers. The commercial
success of our new generation products and any future product depends in part on the packing house community as well as other
industries for various use cases, depending on the acceptance by such industries of our technology as a useful and cost-effective
solution compared to current solutions. If our new generation products or any future product does not achieve an adequate level
of acceptance, we may not generate significant product revenue and may not become profitable. The degree of market acceptance
of our products will depend on a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    results of our large-scale trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost, safety, efficacy, and convenience of our new generation products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    acceptance of our products as a superior solution in the fresh produce industry;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability of third parties to enter into relationships with us without violating their existing agreements;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effectiveness of our selling and marketing efforts;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    strength of marketing and distribution support for, and timing of market introduction of, competing products; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">publicity
    concerning our products or competing products.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
efforts to penetrate the packing house industry and educate the marketplace on the benefits of our products may require significant
resources and may never be successful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
COVID-19 pandemic, or any other pandemic, epidemic or outbreak of an infectious disease, may materially and adversely affect our
business and operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
outbreak of COVID-19, which originated in Wuhan, China, in late 2019, has since spread across the globe, including the United
States, Israel and many European countries in which we operate. On March 11, 2020, the World Health Organization declared the
outbreak a pandemic. While COVID-19 is still spreading and the final implications of the pandemic are difficult to estimate at
this stage, it is clear that it has affected the lives of a large portion of the global population. At this time, the pandemic
has caused states of emergency to be declared in various countries, travel restrictions imposed globally, quarantines established
in certain jurisdictions and various institutions and companies being closed. We are actively monitoring the pandemic and we are
taking all necessary measures to respond to the situation in cooperation with the various stakeholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
COVID-19 infection outbreak among our workforce could result in a temporary or long-term disruption in our business activities,
including manufacturing and other functions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on guidelines provided by the Israeli Government, employers (including us) are required to prepare and increase as much as possible
the capacity and arrangement for employees to work remotely. In that regard, and in compliance with all applicable Israeli rules
and guidelines, our offices have remained closed since the middle of March 2020, and all of our employees currently work remotely.
In addition, some of our employees, including our Chief Technology Officer, are currently on a temporary leave without pay (furlough)
and we have postpend some of our planned field tests due to the current restriction on international travels.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may face significant competition from other companies looking to develop or acquire new alternative environmentally friendly solutions
for the treatment of fruits and vegetables, and other edible matter.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to face significant competition in every aspect of our business, and particularly from other companies that seek to enter
our focal market. As regulators continue to move away from current residue chemical solutions, such as chlorpropham or CIPC, existing
suppliers of these solutions are continually looking to develop or acquire new alternative environment-friendly solutions that
can sustain their market share and revenue streams, or to enable the continuance of CIPC at current levels in new ways of treatment.
Additionally, as market opportunity becomes eminent, competitors and new players will most likely attempt to develop similar or
comparable solutions. It is possible that superior or more cost-effective alternative technology will emerge that will achieve
greater market acceptance and render our products less competitive. Furthermore, existing vendors can cooperate to combat new
players by reducing market prices and margins or other competitive initiatives. Our future success will therefore depend, to a
large extent, upon our ability to achieve market acceptance of our innovative solutions as well as develop and introduce new products
and enhancements to existing products. No assurance can be given that we will be able to compete in such a marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for post-harvest solutions is fragmented with various regional suppliers. The market of post-harvest treatments for fruits
and vegetables is dominated by five large players with wide reach across the globe. We believe that the principal factors of competition
in our industry include reputation, product quality, customer service and customer intimacy, product innovation, technical service
and value creation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
success is dependent upon the acceptance of our environmentally friendly solutions for fruits and vegetables.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success is dependent upon the acceptance of our environmentally friendly, non-toxicresidual treatment solutions for fruits
and vegetables. While the market is signaling that such a direction is likely, certain trends as well as the future size of this
market, and other potential markets for our products, rely upon a number of factors, many of which are beyond our control. For
example, both the failure to convince retailers to bear additional costs for &ldquo;green&rdquo; fruit and vegetables as well
as the failure to persuade consumers to purchase &ldquo;green&rdquo; fruits and vegetables for higher prices may adversely affect
our business, financial condition, operating results and cash flow going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be unable to respond effectively to technological changes in our industry, which could reduce the demand for our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future business success will depend upon our ability to maintain and enhance our technological capabilities and develop and market
products, services and applications that meet changing customer needs and market conditions in a cost-effective and timely manner.
Maintaining and enhancing technological capabilities and developing new products may also require significant investments in research
and development. We may not be successful in developing new products, services and technology that successfully compete or be
able to anticipate changing customer needs and preferences, and our customers may not accept one or more of our new products or
services. If we fail to keep pace with evolving technological innovations or fail to modify our products and services in response
to customers&rsquo; needs or preferences, then our business, financial condition and results of operations could be adversely
affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
currently rely on a limited number of suppliers to produce certain key components of our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on unaffiliated contract manufacturers to produce certain key components of our products. In Israel, we are working with
a well-known producer of chemicals, SasaTech, who is responsible for the production of our products. SasaTech is well known for
its knowledge and handling of hydrogen peroxide. In the United States, we have worked for the past few years with Seeler Industries,
a national leader in the marketing and handling of hydrogen peroxide. There is limited available manufacturing capacity that meets
our quality standards and regulatory requirements, especially for the manufacturing of the SF3H and SF3HS with one of their active
ingredient &ndash; hydrogen peroxide &ndash; as well as for FreshProtect with one of its active ingredient &ndash; PO3. If we
are unable to arrange for sufficient production capacity among our contract manufacturers or if our contract manufacturers encounter
production, quality, financial, or other difficulties, including labor or geopolitical disturbances, we may encounter difficulty
in meeting customer demands as we seek alternative sources of supply, or we may have to make financial accommodations to such
contract manufacturers or otherwise take steps to mitigate supply disruption. We may be unable to locate an additional or alternate
contract manufacturer that meets our quality controls and standards and regulatory requirements in a timely manner or on commercially
reasonable terms. Any such difficulties could have an adverse effect on our business, financial condition and results of operations,
which could be material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to establish sales, marketing and distribution capabilities or enter into successful relationships with third parties
to perform these services, we may not be successful in commercializing our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a limited selling and marketing infrastructure and have limited experience in the sale, marketing or distribution of products.
To achieve commercial success for any product for which we have obtained marketing approval, we will need to enter into collaborations
with third parties like post-harvest service companies and establish a selling and marketing infrastructure or to out-license
our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we may consider building a focused selling and marketing infrastructure to market our products in the United States
or elsewhere in the world. There are risks involved with establishing our own sales, marketing and distribution capabilities.
For example, recruiting and training a sales force could be expensive and time consuming and could delay any product launch. This
may be costly, and our investment would be lost if we cannot retain or reposition our selling and marketing personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors
that may inhibit our efforts to commercialize our products on our own include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to recruit, train and retain adequate numbers of effective selling and marketing personnel;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability of sales personnel to obtain access to potential customers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to
    companies with more extensive product lines; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unforeseen
    costs and expenses associated with creating an independent selling and marketing organization.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 46.2pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to establish our own sales, marketing and distribution capabilities or enter into successful arrangements with third
parties to perform these services, our revenues and our profitability may be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may not be successful in entering into arrangements with third parties to sell, market and distribute our products
in our target markets, <FONT STYLE="background-color: white">including first the United States, Mexico, Spain, Italy and Israel</FONT>,
or may be unable to do so on terms that are favorable to us. We likely will have little control over such third parties, and any
of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish
sales, marketing and distribution capabilities successfully, either on our own or in collaboration with third parties, we will
not be successful in commercializing our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely on rapidly establishing global distributorship network in order to effectively market our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed initial partnerships with local partners. In order to expand selling and marketing globally, and capture leading
market share before any potential reaction from the competitors, we will need to rapidly expand geographically and establish a
global distribution network. This is likely to put pressure on our management, financial and operational resources. In order to
mitigate this factor, once we establish a significant presence in the market, we will proceed to establish strategic partnerships
with some of the leading players in the market; however, there are no assurances that we will succeed in establishing such partnerships,
which may harm the marketing of our products and the development of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





































<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
results of our early tests may not be indicative of results in future tests and we cannot assure you that any planned or future
tests will lead to results sufficient for the necessary regulatory approvals.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products have been tested in multiple commercial and small-scale pilots on certain types of produce and during specific time of
the year. We are currently in the development and optimization phases of these products. Results from our later-stage commercial
tests may show lower efficacy than our early-tests conducted previously and we cannot guarantee that when commercialized, our
products will be effective and stable and product improvements as well as possible changes in the application and usage protocol
may be required. These factors may significantly delay receipts of regulatory approvals, and the introduction of our products
into the market. Likewise, we cannot be sure these products will be commercially viable, and have no assurances that we will be
able to expand upon our current product offerings or that any such expansion will generate revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
products are highly regulated by governmental agencies in the countries where we conduct business and into which we plan to expand.
Our failure to obtain regulatory approvals and registration, to comply with registration and regulatory requirements or to maintain
regulatory approvals would have an adverse impact on our ability to market and sell our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our products are subject to technical review and approval by government authorities in each country where we currently conduct
our business and where we intend to sell our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulatory requirements to which we are subject are complex and vary from country to country. To obtain new registrations, it
is necessary to have a local registrant, and to understand the country&rsquo;s regulatory requirements, both at the time an application
for registration is submitted and when the registration decision is made, which may be several years later. A significant investment
in registration data is required (covering all aspects from manufacturing specifications through storage and transport, use, and,
finally, disposal of unwanted product and used containers) to ensure that product performance (e.g. bio efficacy), intrinsic hazards
and use patterns are fully characterized. Risk assessments are conducted by government regulatory authorities who make the final
decision on whether the documented risk associated with a product and active ingredient is acceptable prior to granting approval
for sale. This process may be prolonged due to requirements for additional data or internal administrative processes. There is
a risk that registration of a new product may not be obtained or that a product label may be severely reduced, restricting the
use of the product. If these circumstances arise, there is a risk that the substantial investments made in product development
will generate the projected sales that justified the investment, and our business, financial condition and results of operations
may be adversely affected by failure to obtain new registrations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products
that are already approved may be subject to periodic review by regulatory authorities in many countries. Such reviews frequently
require the provision of new data and more complex risk assessments. The outcome of such reviews of existing registrations cannot
be guaranteed and registrations may be modified or canceled. Since all government regulatory authorities have the right to review
existing registrations at any time, the sustainability of the existing portfolio cannot be guaranteed. Existing registrations
may be lost at any time, resulting in an immediate impact on sales. Furthermore, prior to expiration, it is necessary to renew
registrations. The renewal period and processes vary by country and may require additional studies to support the renewal process.
Failure to comply could result in cancellation of the registration, resulting in an impact on sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, new laws and regulations may be introduced, or existing laws and regulations may be changed or may become subject to
new interpretations, which could result in additional compliance costs, seizures, confiscations, recalls, monetary fines or delays
that could affect us or our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
success is dependent upon our ability to achieve regulatory approvals and registration in the United States and abroad (Mexico,
Israel, Spain and Italy), which might take longer periods than expected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to extensive national, state and local government regulation. A critical key to our success and ability to expand
our business is our ability to obtain regulatory approvals and registration in the United States and in other countries for the
use of our products. The regulatory approvals of some of our products are dependent on trials to show the efficacy and the non-toxicity
of our products, and are time and cost consuming. We do not anticipate any significant problems in obtaining future required licenses,
permits or approvals that are necessary to expand our business, however such registration filling might take longer period than
expected due to various factors including the recent disruptions in regular services as a result of COVID-19, and it might delay
obtaining such regulatory approvals, or might cause delays in starting operations on a large scale in these countries and other
jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
inherent dangers in production and transportation of hydrogen peroxide and highly concentrated organic acids could cause disruptions
and could expose us to potentially significant losses, costs or other liabilities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to significant hazards and risks inherent to the transportation of the active ingredient of one of our
products &ndash; hydrogen peroxide. In high concentrations, our blend of acids has a very low pH which may lead to skin burn and
hydrogen peroxide is an aggressive oxidizer and both can corrode many materials. We are working with limited low concentration
of the material, however in high concentrations of H<SUB>2</SUB>O<SUB>2</SUB> it will react violently. Hydrogen peroxide should
be stored in a cool, dry, well-ventilated area and away from any flammable or combustible substances. It should be transported
in special tanks and vehicles and should be stored in a container composed of non-reactive materials. These hazards and risks
include, but are not limited to fires, explosions, third-party interference (including terrorism) and mechanical failure of equipment
at our or third-party facilities. The occurrence of any of these events could result in production and distribution difficulties
and disruptions, personal injury or wrongful death claims and other damage to properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business and operations may be affected by climate change conditions, which could materially harm our financial results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business may be affected from changes in climate conditions as such events would affect the crops and their storability in those
cases where there is unusually warm, dry, humid or cold weather before cropping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such instances, we may suffer a decrease in revenues as a result of a smaller storage volume of rooms or shorter storage period.
We anticipate that once we increase our operations, and enter certain markets which experience or will experience significant
climate change, such as above-common rain fall, heat waves, dry air conditions, and unusually cold or prolonged cold weather conditions,
such events may materially impact our financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Conditions
in the global economy may adversely affect our business, financial condition and results of operation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
demand for fresh horticultural products is considered inelastic in developed economies, the fresh produce and citrus industries
that we sell to may be affected by material changes in supply, market prices, exchange rates and general economic conditions.
Delays or reductions in our customers&rsquo; purchasing or shifts to lower-cost alternatives that result from tighter economic
market conditions would reduce demand for our products and services and could, consequently, have a material adverse effect on
our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
relationship with our employees could deteriorate, and certain key employees could leave, which could adversely affect our business
and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business involves complex operations and demands a management team to determine and implement our strategy and workforce that
is knowledgeable and has expertise in many areas necessary for our operations. As a company focused on research and development
in the highly-specialized horticultural post-harvest field, we rely on our ability to attract and retain skilled employees, consultants
and contractors, including our specialized research and development. As of March 10, 2021, we employed two full-time employees
and four part-time employees, including the employees employed by our subsidiary, Save Foods Ltd. The departure of highly skilled
employees, consultants or contractors or one or more employees who hold key regional management positions could have an adverse
impact on our operations, including customers choosing to follow a such regional manager to one of our competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, to execute our growth plan we must attract and retain highly qualified personnel. Competition for these employees exists;
new members of management must have significant industry expertise when they join us or engage in significant training which,
in many cases, requires significant time before they achieve full productivity. If we fail to attract, train, retain, and motivate
our key personnel, our business and growth prospects could be severely harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
we are dependent upon the managers to oversee our operations. Thus, there can be no assurance that the managers&rsquo; experience
will be sufficient to successfully achieve our business objectives. All decisions regarding the management of our affairs will
be made exclusively by our officers and directors. In the event these persons are ineffective, our business and results of operation
would likely be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to risks relating to portfolio concentration.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is highly dependent on a small number of products, which are based on our main active ingredients. Our core post-harvest
business includes solutions designed to improve the yields of the packing house but mainly ensure food safety and assisting packing
houses to meet the new FSMA requirements. Our ability to market and sell products containing our active ingredient to key service
providers for treatment in post-harvest food safety industry in order to utilize their market position is important to our future
success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
operating results may fluctuate, which makes our results difficult to predict and could cause our results to fall short of expectations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating results may fluctuate as a result of a number of factors, many of which are outside of our control. As a result, comparing
our operating results on a period-to-period basis may not be meaningful, and you should not rely on our past results as an indication
of our future performance. Our quarterly, year-to-date and annual expenses as a percentage of our revenues may differ significantly
from our historical or projected rates. Our operating results in future quarters may fall below expectations. Any of these events
could cause our stock price to fall. Each of the following factors, among the other risks described herein, may affect our operating
results:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to penetrate the packing house industry with our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to generate revenue from our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount and timing, of operating costs and capital expenditures related to the maintenance and expansion of our businesses,
    and operations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    focus on long-term goals over short-term results;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    global economic situation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in weather conditions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>International
expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated
with doing business outside of the United States, Mexico or Israel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than our headquarters and other operations which are located in Israel (as further described below), we currently have limited
international operations, but our business strategy incorporates potentially significant international expansion, particularly
in anticipation of approval of our product candidates. We also plan to retain sales representatives and third-party distributors,
outside of the United States and Israel at a later date. Doing business internationally involves a number of risks, including
but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">multiple,
    conflicting and changing laws and regulations such as privacy regulations, tax laws, export and import restrictions, employment
    laws, regulatory requirements and other governmental approvals, permits, and licenses;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    by us to obtain regulatory approvals for the use of our product candidates in various countries;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional
    potentially relevant third-party patent or other intellectual property rights;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">complexities
    and difficulties in obtaining protection and enforcing our intellectual property;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limits
    in our ability to penetrate international markets;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
    risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial
    crises on demand and payment for our products and exposure to foreign currency exchange rate fluctuations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural
    disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts,
    curtailment of trade, and other business restrictions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
    expenses including, among others, expenses for travel, translation and insurance; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    and compliance risks that relate to maintaining accurate information and control over sales and activities that may fall within
    the purview of the U.S. Foreign Corrupt Practices Act, as amended (the &ldquo;FCPA&rdquo;) its books and records provisions,
    or its anti-bribery provisions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these factors could significantly harm our future international expansion and operations and, consequently, our results of
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business depends to some extent on international transactions.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the international nature of our business, we are exposed to risks associated with changes in foreign currency exchange
rates. A majority of our revenues and substantially all of our cost of sales are in USD, whilst our management, marketing, sales
and R&amp;D costs are in NIS. We are therefore exposed to foreign currency risk due to fluctuations in exchange rates. This may
result in gains or losses with respect to movements in exchange rates, which may be significant and may also cause fluctuations
in reported financial information that are not necessarily related to our operating results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to secure and maintain patent or other intellectual property protection for the intellectual property used in our
products, our ability to compete will be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success depends, in part, on obtaining and maintaining patent and other intellectual property protection for the proprietary
blend used in our products and our manufacturing process, as well as continuing to develop and secure trade secrets. We might
in the future opt to license intellectual property from other parties. If we, or the other parties from whom we may license intellectual
property, fail to obtain and maintain adequate patent or other intellectual property protection for intellectual property used
in our products, or if any protection is reduced or eliminated, others could use the intellectual property used in our products,
resulting in harm to our competitive business position. In addition, patent and other intellectual property protection may not
provide us with a competitive advantage against competitors that devise ways of making competitive products without infringing
any patents that we own or have rights to.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
patents and patent applications may be subject to interference proceedings, and U.S. patents may be subject to re-examination
proceedings in the U.S. Patent and Trademark Office. Foreign patents may be subject to opposition or comparable proceedings in
the corresponding foreign patent offices. Any of these proceedings could result in loss of the patent or denial of the patent
application, or loss or reduction in the scope of one or more of the claims of the patent or patent application. Changes in either
patent laws or in interpretations of patent laws may also diminish the value of our intellectual property or narrow the scope
of our protection. Interference, re-examination and opposition proceedings may be costly and time consuming, and we, or the other
parties from whom we might potentially license intellectual property, may be unsuccessful in defending against such proceedings.
Thus, any patents that we own or might license may provide limited or no protection against competitors. In addition, our pending
patent applications and those we may file in the future may have claims narrowed during prosecution or may not result in patents
being issued. Even if any of our pending or future applications are issued, they may not provide us with adequate protection or
any competitive advantages. Our ability to develop additional patentable technology is also uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-payment
or delay in payment of patent fees or annuities, whether intentional or unintentional, may also result in the loss of patents
or patent rights important to our business. Many countries, including certain countries in Europe, have compulsory licensing laws
under which a patent owner may be compelled to grant licenses to other parties. In addition, many countries limit the enforceability
of patents against other parties, including government agencies or government contractors. In these countries, the patent owner
may have limited remedies, which could materially diminish the value of the patent. In addition, the laws of some foreign countries
do not protect intellectual property rights to the same extent as do the laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to prevent unauthorized use or disclosure of our proprietary trade secrets and unprotected know-how, our ability
to compete will be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary
trade secrets, copyrights, trademarks and unprotected know-how are also very important to our business. We rely on a combination
of trade secrets, copyrights, trademarks, confidentiality agreements and other contractual provisions and technical security measures
to protect certain aspects of our technology, especially where we do not believe that patent protection is appropriate or obtainable.
We require our office holders, employees, consultants and distributers of our products and most third parties to execute confidentiality
agreements in connection with their relationships with us. However, these measures may not be adequate to safeguard our proprietary
intellectual property and conflicts may, nonetheless, arise regarding ownership of inventions. Such conflicts may lead to the
loss or impairment of our intellectual property or to expensive litigation to defend our rights against competitors who may be
better funded and have superior resources. Our office holders, employees, consultants and other advisors may unintentionally or
willfully disclose our confidential information to competitors. In addition, confidentiality agreements may be unenforceable or
may not provide an adequate remedy in the event of unauthorized disclosure. Enforcing a claim that a third party illegally obtained
and is using our trade secrets is expensive and time consuming, and the outcome is unpredictable. Moreover, our competitors may
independently develop equivalent knowledge, methods and know-how. Unauthorized parties may also attempt to copy or reverse engineer
certain aspects of our products that we consider proprietary. As a result, other parties may be able to use our proprietary technology
or information, and our ability to compete in the market would be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
could become subject to patent and other intellectual property litigation that could be costly, result in the diversion of management&rsquo;s
attention, require us to pay damages and force us to discontinue selling our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
whether a product infringes a patent involves complex legal and factual issues, and the outcome of a patent litigation action
is often uncertain. No assurance can be given that patents containing claims covering our products, parts of our products, technology
or methods do not exist, have not been filed or could not be filed or issued. Furthermore, our competitors or other parties may
assert that our products and the methods we employ in the use of our products are covered by U.S. or foreign patents held by them.
In addition, because patent applications can take many years to issue and because publication schedules for pending applications
vary by jurisdiction, there may be applications now pending of which we are unaware and which may result in issued patents which
our current or future products infringe. Also, because the claims of published patent applications can change between publication
and patent grant, there may be published patent applications with claims that we infringe. There could also be existing patents
that one or more of our products or parts may infringe and of which we are unaware. As the number of competitors in the post-harvest
market grows, and as the number of patents issued grows, the possibility of patent infringement claims against us increases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Infringement
actions and other intellectual property claims and proceedings brought against or by us, whether with or without merit, may cause
us to incur substantial costs and could place a significant strain on our financial resources, divert the attention of management
from our business and harm our reputation. Some of our competitors may be able to sustain the costs of complex patent or intellectual
property litigation more effectively than we can because they have substantially greater resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot be certain that we will successfully defend against allegations of infringement of patents and intellectual property rights
of others. In the event that we become subject to a patent infringement or other intellectual property lawsuit and if the other
party&rsquo;s patents or other intellectual property were upheld as valid and enforceable and we were found to infringe the other
party&rsquo;s patents or violate the terms of a license to which we are a party, we could be required to pay damages. We could
also be prevented from selling our products unless we could obtain a license to use technology or processes covered by such patents
or will be able to redesign the product to avoid infringement. A license may not be available at all or on commercially reasonable
terms or we may not be able to redesign our products to avoid infringement. Modification of our products or development of new
products could require us to conduct clinical trials and to revise our filings with the applicable regulatory bodies, which would
be time consuming and expensive. In these circumstances, we may be unable to sell our products at competitive prices or at all,
our business and operating results could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to claims that former employees, collaborators, or other third parties have an ownership interest in our patents
or other intellectual property. Ownership disputes may arise in the future, for example, from conflicting obligations of consultants
or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other
claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages,
we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property.
Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims,
litigation could result in substantial costs and be a distraction to management and other employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may experience claims that our products infringe the intellectual property rights of others, which may cause us to incur unexpected
costs or prevent us from selling our products or services.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continually seek to improve our business processes and develop new products and applications in a crowded patent space that we
must continually monitor to avoid infringement. We cannot guarantee that we will not experience claims that our processes and
products infringe issued patents (whether present or future) or other intellectual property rights belonging to others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we oppose patent applications that we consider overbroad or otherwise invalid in order to maintain the ability to
operate freely in our various business lines without the risk of being sued for patent infringement. If, however, patents are
subsequently issued on any such applications by other parties, or if patents belonging to others already exist that cover our
products, processes or technologies, we could experience claims for infringement or have to take other remedial or curative actions
to continue our manufacturing and sales activities with respect to one or more products. Likewise, our competitors may also already
hold or have applied for patents in the United States or abroad that, if enforced or issued, could prevail over our patent rights
or otherwise limit our ability to manufacture or sell one or more of our products in the United States or abroad. Any actions
asserted against us could include payment of damages for infringement, stopping the use, require that we obtain licenses from
these parties or substantially re-engineer our products or processes in order to avoid infringement. We may not be able to obtain
the necessary licenses on acceptable terms, or at all, or be able to re-engineer our products successfully. Further, intellectual
property litigation is expensive and time-consuming, regardless of the merits of any claim, and could divert our management&rsquo;s
attention from operating our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Regulatory Compliance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we or our contractors or service providers fail to comply with laws and regulations, we or they could be subject to regulatory
actions, which could affect our ability to develop, market and sell our products or future products that we may develop and may
harm our reputation in our industry.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or our manufacturers or other third-party contractors fail to comply with applicable federal, state or foreign laws or regulations,
including with respect to food treatment, we could be subject to regulatory actions, which could affect our ability to develop,
market and sell our current products or any future products which we may develop in the future and could harm our reputation and
lead to reduced demand for or non-acceptance of our proposed products by the market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Regulatory
reforms may adversely affect our ability to sell our products profitably.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, legislation is drafted and introduced in the United States, Mexico, Israel or other countries in which we operate,
that could significantly change the statutory provisions governing the clearance or approval, manufacture and marketing of our
products, including in the food health industry. In addition, regulations and guidance may often be revised or reinterpreted by
the regulatory authorities in ways that may significantly affect our business and our products. It is impossible to predict whether
legislative changes will be enacted, or interpretations changed, and what the impact of such changes, if any, may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Operations in Israel</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Conditions
in Israel may limit our ability to manage and market our products, which would lead to a decrease in revenues.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
most of our operations is conducted in Israel and our management is located in Israel, our operations are directly affected by
economic, political, geopolitical and military conditions affecting Israel. Accordingly, political, economic and military conditions
in Israel directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have
occurred between Israel and its neighboring countries. These conflicts involved missile strikes against civilian targets in various
parts of Israel including most recently, central Israel, and negatively affected business conditions in Israel as well as home
starts and the building industry in Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
facilities are in range of rockets that may be fired from Lebanon, Syria or the Gaza Strip into Israel. In the event that our
facilities are damaged as a result of hostile action or hostilities otherwise disrupt the ongoing operation of our facilities,
our ability to deliver products to customers could be materially and adversely affected. Our commercial insurance in Israel does
not cover losses that may occur as a result of acts of war; however, losses as a result of terrorist attacks to our facilities
and disruption to the ongoing operations, are covered by our insurance for damages of up to $40 million, if such damages are not
covered by the Israeli government. Although the Israeli government currently covers the reinstatement value of direct damages
that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained and
will be adequate in the event we submit a claim. Even if insurance is maintained and adequate, we cannot assure you that it will
reduce or prevent any losses that may occur as a result of such actions or will be exercised in a timely manner to meet our contractual
obligations with customers and vendors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, popular uprisings in various countries in the Middle East and North Africa have affected the political stability of
those countries. Such instability may lead to deterioration in the political and trade relationships that exist between the State
of Israel and these countries, such as Turkey, from which we import a significant amount of our raw materials. Moreover, some
countries around the world restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions
on doing business with Israel and Israeli companies if hostilities in Israel or political instability in the region continues
or increases. These restrictions may limit materially our ability to obtain raw materials from these countries or sell our products
to companies and customers in these countries. In addition, there have been increased efforts by activists to cause companies
and consumers to boycott Israeli goods. Such efforts, particularly if they become more widespread, may materially and adversely
impact our ability to sell our products out of Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
employees in Israel, generally males, including executive officers, may be called upon to perform military service on an annual
basis until they reach the age of 40 (and in some cases, up to 45 or 49). In emergency circumstances, they could be called to
immediate and prolonged active duty. Our operations could be disrupted by the absence of a significant number of our employees
related to military service or the absence for extended periods of one or more of our key employees for military service. Such
a disruption could materially and adversely affect our business and results of operations. Additionally, the absence of a significant
number of the employees of our Israeli suppliers and contract manufacturers related to military service may disrupt their operations,
in which event our ability to deliver products to customers may be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
hostilities involving Israel or the interruption or curtailment of trade between Israel and its present trading partners, or a
significant downturn in the economic or financial condition of Israel, could materially and adversely affect our operations and
product development, cause our revenues to decrease and materially harm the share price of publicly traded companies with operations
in Israel, such as us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
early January 2020, certain events contributed to an increase in hostilities between the United States and Iran, and as a result
Iran issued multiple public statements threatening to attack Israel and the United States. These events, coupled with the already
mounting tensions between Israel and Iran, may threaten to destabilize the Middle East, the result of which may impact our ability
to conduct our business effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Israeli Parliament (the &ldquo;Knesset&rdquo;), for reasons related to political instability, has failed to pass a budget for
the year 2020, and certain government ministries, which may be critical to the operation of our business, are without necessary
resources and may not receive sufficient funding moving forward. Given the likelihood that the current political stalemate might
not be resolved during the next calendar year, our ability to conduct our business effectively may be adversely materially affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to enforce covenants not-to-compete under current Israeli law that might result in added competition for our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have non-competition agreements with all of our employees, all of which are governed by Israeli law. These agreements prohibit
our employees from competing with or working for our competitors, generally during their employment and for up to 12 months after
termination of their employment. However, Israeli courts are reluctant to enforce non-compete undertakings of former employees
and tend, if at all, to enforce those provisions for relatively brief periods of time in restricted geographical areas, and only
when the employee has obtained unique value to the employer specific to that employer&rsquo;s business and not just regarding
the professional development of the employee. If we are not able to enforce non-compete covenants, we may be faced with added
competition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>It
may be difficult to acquire jurisdiction and enforce liabilities against our officers and directors who are based in Israel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
majority of our officers and present directors reside outside of the United States and most of our operations at the date of this
prospectus are located outside the United States. As a result, it may not be possible for United States investors to enforce their
legal rights, to effect service of process upon our directors or officers or to enforce judgments of United States courts predicated
upon civil liabilities and criminal penalties of our directors and officers under federal securities laws. Moreover, we have been
advised that Israel does not have treaties providing for the reciprocal recognition and enforcement of judgments of courts with
the United States. Further, it is unclear if extradition treaties now in effect between the United States and Israel would permit
effective enforcement of criminal penalties of the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to this Offering and Ownership of Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if we meet the initial listing requirements of the Nasdaq Capital Market, there can be no assurance that we will be able to comply
with the continued listing standards of the Nasdaq Capital Market. Our failure to meet the continued listing requirements of the
Nasdaq Capital Market could result in a de-listing of our Common Stock</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we meet the initial listing requirements of the Nasdaq Capital Market, we cannot assure you that we will be able to comply
with the other standards that we are required to meet in order to maintain a listing of our common stock on the Nasdaq Capital
Market. If after listing we fail to satisfy the continued listing requirements of the Nasdaq Capital Market, such as the corporate
governance requirements or the minimum stockholder&rsquo;s equity requirement, the Nasdaq Capital Market may take steps to de-list
our common stock. Such a de-listing would likely have a negative effect on the price of our Common Stock and would impair our
shareholders&rsquo; ability to sell or purchase our Common Stock when they wish to do so. In the event of a de-listing, we would
take actions to restore our compliance with the Nasdaq Capital Market&rsquo;s listing requirements, but we can provide no assurance
that any action taken by us would result in our common stock becoming listed again, or that any such action would stabilize the
market price or improve the liquidity of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
you purchase shares of our Common Stock in this offering You will experience immediate and substantial dilution in the book value
per share of the common stock you purchase.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
public offering price per share of our Common Stock will be substantially higher than the net tangible book value per share of
our Common Stock immediately prior to the offering. After giving effect to the sale of shares of our Common Stock at a public
offering price of $ per share and after deducting the estimated underwriting discount and estimated offering expenses payable
by us, purchasers of our Common Stock in this offering will incur immediate dilution of $ per share in the net tangible book value
of the Common Stock they acquire. For a further description of the dilution that investors in this offering will experience, see
&ldquo;Dilution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, to the extent that outstanding stock options have been or may be exercised or other shares issued, you may experience
further dilution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of our Common Stock may be highly volatile.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our Common Stock is likely to be volatile. Our Common Stock price could be subject to wide fluctuations in response
to a variety of factors, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reports
    of adverse events with respect to the commercialization and distribution of our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to obtain additional funding;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    delay in filing a regulatory submission for any of our products and any adverse development or perceived adverse development
    with respect to the review of that regulatory submission by the EPA, FDA or other regulatory authority;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to successfully develop and commercialize our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to enter into strategic collaborations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    by us or strategic collaboration partners to prosecute, maintain or enforce our intellectual property rights;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in laws or regulations applicable to future products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to scale up our manufacturing capabilities through third-party manufacturers, inability to obtain adequate product supply
    for our products or the inability to do so at acceptable prices;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">introduction
    of new products or technologies by our competitors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to meet or exceed financial projections we may provide to the public;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to meet or exceed the financial expectations of the investment community;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of significant acquisitions, strategic partnerships, joint ventures or capital commitments by our competitors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
    or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent
    protection for our platform technologies, technologies, products or product candidates;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key scientific or management personnel;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    lawsuits, including patent or stockholder litigation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the market valuations of similar companies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our securities by us or our stockholders in the future; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading
    volumes of our securities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, companies trading in the stock market have experienced extreme price and volume fluctuations that have often been unrelated
or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the
market price of our Common Stock, regardless of our actual operating performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sales
of a substantial number of shares of our Common Stock in the public market by our existing stockholders could cause our share
price to fall.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of shares of our Common Stock in the public market, or the perception that these sales might occur, could
depress the market price of our Common Stock and could impair our ability to raise capital through the sale of additional equity
securities. We are unable to predict the effect that sales may have on the prevailing market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
principal stockholders, officers and directors beneficially own approximately 39.5% of our outstanding shares of Common Stock.
They will therefore be able to exert significant control over matters submitted to our stockholders for approval.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 10, 2021, our principal stockholders, officers and directors beneficially own approximately 39.5% of our outstanding
Common Stock. This significant concentration of share ownership may adversely affect the trading price for our Common Stock because
investors often perceive disadvantages in owning shares in companies with controlling stockholders. As a result, these stockholders,
if they acted together, could significantly influence matters requiring approval by our stockholders, including the election of
directors and the approval of mergers or other business combination transactions. The interests of these stockholders may not
always coincide with our interests or the interests of other stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delaware
law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger,
tender offer or proxy contest difficult, thereby depressing the market price of our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay
or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a
period of three years after the date of the transaction in which the person became an interested stockholder, even if a change
of control would be beneficial to our existing stockholders. In addition, our amended and restated certificate of incorporation
and amended and restated bylaws contain provisions that may make the acquisition of the Company more difficult, including the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    stockholders will only be able to take action at a meeting of stockholders and will not be able to take action by written
    consent for any matter;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    board of directors is classified into three classes of directors with staggered three-year terms;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    special meeting of our stockholders may only be called by a majority of our board of directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">advance
    notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual
    meeting of stockholders; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
    litigation against us can only be brought in Delaware.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions, alone or together, could discourage, delay or prevent a transaction involving a change in control of the Company.
These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their
choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could limit the
opportunity for our stockholders to receive a premium for their shares of our Common Stock, and could also affect the price that
some investors are willing to pay for our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to securities litigation, which is expensive and could divert management attention.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, companies that have experienced volatility in the market price of their stock have been subject to securities class
action litigation. We may be the target of this type of litigation in the future. Litigation of this type could result in substantial
costs and diversion of management&rsquo;s attention and resources, which could seriously hurt our business. Any adverse determination
in litigation could also subject us to significant liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or
if they adversely change their recommendations or publish negative reports regarding our business or our Common Stock, our stock
price and trading volume could decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our Common Stock will be influenced by the research and reports that industry or securities analysts may publish
about us, our business, our market or our competitors. We do not have any control over these analysts and we cannot provide any
assurance that analysts will cover us or provide favorable coverage. If any of the analysts who may cover us adversely change
their recommendation regarding our shares, or provide more favorable relative recommendations about our competitors, our stock
price would likely decline. If any analysts who may cover us were to cease coverage of the Company or fail to regularly publish
reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume
to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Shares
of our Common Stock are an illiquid investment as there is presently a limited market for our Common Stock. We do not know whether
a market for our Common Stock will be sustained or what the trading price of our Common Stock will be and as a result it may be
difficult for you to sell your shares of Common Stock</I></B>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
is presently a limited market for our Common Stock. Although we intend to list our Common Stock on the Nasdaq Stock Market, an
active trading market for our Common Stock may not be sustained. It may be difficult for you to sell your shares of Common Stock
without depressing the market price for our Common Stock or at all. As a result of these and other factors, you may not be able
to sell your shares of Common Stock at or above the offering price or at all. Further, an inactive market may also impair our
ability to raise capital by selling our Common Stock and may impair our ability to enter into strategic partnerships or acquire
companies, products, or services by using our equity securities as consideration. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not anticipate paying any cash dividends in the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends, and we do not anticipate paying cash dividends in the foreseeable future. Therefore,
you should not rely on an investment in our Common Stock as a source for any future dividend income. Our board of directors has
complete discretion as to whether to distribute dividends. Even if our board of directors decides to declare and pay dividends,
the timing, amount and form of future dividends, if any, will depend on our future results of operations and cash flow, our capital
requirements and surplus, the amount of distributions, if any, received by us from our subsidiary, our financial condition, contractual
restrictions and other factors deemed relevant by our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may need additional capital, and the sale of additional shares or equity or debt securities could result in additional dilution
to our stockholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our current cash and cash used in operations, together with the net proceeds from this offering, will be sufficient
to meet our anticipated cash needs for the next 24 months . We may, however, require additional cash resources due to changed
business conditions or other future developments, including further adverse effects to our business from COVID-19 related issues.
If these resources are insufficient to satisfy our cash requirements, we may seek to sell additional equity or debt securities
or obtain one or more credit facilities. The sale of additional equity securities could result in additional dilution to our stockholders.
The incurrence of indebtedness would result in increased debt service obligations and could result in operating and financing
covenants that would restrict our operations. It is uncertain whether financing will be available in amounts or on terms acceptable
to us, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Management
will have broad discretion as to the use of the proceeds from this offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management will have broad discretion in the allocation of the net proceeds and could use them for purposes other than those contemplated
at the time of this offering and as described in the section titled &ldquo;Use of Proceeds.&rdquo; You will be relying on the
judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your
investment decision, to assess whether the net proceeds are being used appropriately. The failure by our management to apply these
funds effectively could result in financial losses that could have a material adverse effect on our business, cause the price
of our securities to decline and delay the development of our product candidates. Pending the application of these funds, we may
invest the net proceeds from this offering in a manner that does not produce income or that loses value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Disruptions
to our information technology systems due to cyber-attacks or our failure to upgrade and adjust our information technology systems,
may materially impair our operations, hinder our growth and materially and adversely affect our business and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that an appropriate information technology (&ldquo;IT&rdquo;), infrastructure is important in order to support our daily
operations and the growth of our business. If we experience difficulties in implementing new or upgraded information systems or
experience significant system failures, or if we are unable to successfully modify our management information systems or respond
to changes in our business needs, we may not be able to effectively manage our business, and we may fail to meet our reporting
obligations. Additionally, if our current back-up storage arrangements and our disaster recovery plan are not operated as planned,
we may not be able to effectively recover our information system in the event of a crisis, which may materially and adversely
affect our business and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the current environment, there are numerous and evolving risks to cybersecurity and privacy, including criminal hackers, hacktivists,
state-sponsored intrusions, industrial espionage, employee malfeasance and human or technological error. High-profile security
breaches at other companies and in government agencies have increased in recent years, and security industry experts and government
officials have warned about the risks of hackers and cyber-attacks targeting businesses such as ours. Computer hackers and others
routinely attempt to breach the security of technology products, services and systems, and to fraudulently induce employees, customers,
or others to disclose information or unwittingly provide access to systems or data. We can provide no assurance that our current
IT system or any updates or upgrades thereto and the current or future IT systems of our distributors use or may use in the future,
are fully protected against third-party intrusions, viruses, hacker attacks, information or data theft or other similar threats.
Legislative or regulatory action in these areas is also evolving, and we may be unable to adapt our IT systems or to manage the
IT systems of third parties to accommodate these changes. We have experienced and expect to continue to experience actual or attempted
cyber-attacks of our IT networks. Although none of these actual or attempted cyber-attacks has had a material adverse impact on
our operations or financial condition, we cannot guarantee that any such incidents will not have such an impact in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to comply with anti-bribery, anti-corruption and anti-money laundering laws could subject us to penalties and other adverse consequences.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the FCPA and other anticorruption, anti-bribery and anti-money laundering laws in the jurisdictions in which we
do business, both domestic and abroad. These laws generally prohibit us and our employees from improperly influencing government
officials or commercial parties in order to obtain or retain business, direct business to any person or gain any advantage. The
FCPA and other applicable anti-bribery and anti-corruption laws also may hold us liable for acts of corruption and bribery committed
by our third-party business partners, representatives and agents. In addition, we leverage third parties to sell our products
and conduct our business abroad. We and our third-party business partners, representatives and agents may have direct or indirect
interactions with officials and employees of government agencies or state-owned or affiliated entities and we may be held liable
for the corrupt or other illegal activities of these third-party business partners and intermediaries, our employees, representatives,
contractors, channel partners and agents, even if we do not explicitly authorize such activities. These laws also require that
we keep accurate books and records and maintain internal controls and compliance procedures designed to prevent any such actions.
While we have policies and procedures to address compliance with such laws, we cannot assure you that our employees and agents
will not take actions in violation of our policies or applicable law, for which we may be ultimately held responsible and our
exposure for violating these laws increases as our international presence is established and as we increase sales and operations
in foreign jurisdictions. Any violation of the FCPA or other applicable anti-bribery, anti-corruption laws and anti-money laundering
laws could result in whistleblower complaints, adverse media coverage, investigations, imposition of significant legal fees, loss
of export privileges, severe criminal or civil sanctions or suspension or debarment from U.S. government contracts, substantial
diversion of management&rsquo;s attention, a decline in the market price of our Common Stock or overall adverse consequences to
our reputation and business, all of which may have an adverse effect on our results of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will incur significant increased costs as a result of the listing of our securities for trading on Nasdaq and our management will
be required to devote substantial time to new compliance initiatives as well as compliance with ongoing U.S. requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the listing of securities on Nasdaq, we will become a publicly traded company in the United States. We anticipate that we will
incur costs associated with corporate governance requirements of the SEC and Nasdaq, as well as requirements under Section 404
and other provisions of the Sarbanes-Oxley Act. We expect these rules and regulations to increase our legal and financial compliance
costs, introduce new costs such as investor relations, stock exchange listing fees and shareholder reporting, and to make some
activities more time consuming and costly. The implementation and testing of such processes and systems may require us to hire
outside consultants and incur other significant costs and resources, particularly a greater percentage of the time and efforts
of our management team will be diverted to these new requirements. Any future changes in the laws and regulations affecting public
companies in the United States, including Section 404 and other provisions of the Sarbanes-Oxley Act, and the rules and regulations
adopted by the SEC and Nasdaq, for so long as they apply to us, will result in increased costs to us as we respond to such changes.
These laws, rules and regulations could make it more difficult or more costly for us to obtain certain types of insurance, including
director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially
higher costs to obtain the same or similar coverage. The impact of these requirements could also make it more difficult for us
to attract and retain qualified persons to serve on our board of directors, our board committees, or as executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
face risks related to compliance with corporate governance laws and financial reporting standards.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sarbanes-Oxley Act of 2002, as well as related new rules and regulations implemented by the SEC and the Public Company Accounting
Oversight Board, require changes in the corporate governance practices and financial reporting standards for public companies.
These new laws, rules and regulations, including compliance with Section 404 of the Sarbanes-Oxley Act of 2002 relating to internal
control over financial reporting, have materially increased the legal and financial compliance costs of small companies and have
made some activities more time-consuming and more burdensome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not have effective internal controls. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Section 404 of the Sarbanes-Oxley Act of 2002, we need to assess the adequacy of our internal controls, remedy
any weaknesses that may be identified, validate that controls are functioning as documented and implement a continuous reporting
and improvement process for internal controls. We may discover deficiencies that require us to improve our procedures, processes
and systems in order to ensure that our internal controls are adequate and effective and that we are in compliance with the requirements
of Section 404 of the Sarbanes-Oxley Act. If the deficiencies are not adequately addressed, or if we are unable to complete all
of our testing and any remediation in time for compliance with the requirements of Section 404 of the Sarbanes-Oxley Act and the
SEC rules under it, we would be unable to conclude that our internal controls over financial reporting are designed and operating
effectively, which could adversely affect investor confidence in our internal controls over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="g_004"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the net proceeds from our issuance and sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of our Common Stock in this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if the underwriter will exercise its
over-allotment option in full), based upon an assumed public offering price of $ per share, the midpoint of the estimated
price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and
offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$1.00 increase or decrease in the assumed public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share would increase or decrease the net proceeds from this offering by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming that the number of shares of Common Stock offered by us, as set
forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and
commissions and estimated offering expenses payable by us. An increase or decrease of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in the number of shares of Common Stock offered by us would
increase or decrease our proceeds by approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the assumed public offering price remains the same,
and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by
us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently expect to use the net proceeds from this offering for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million for product research and development (which may include acquisition of technology to complement our product portfolio)
    and purchase of lab equipment;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million for gaining regulatory approvals and commercialization;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million for selling and marketing; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    remainder for working capital and general corporate purposes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changing
circumstances may cause us to consume capital significantly faster than we currently anticipate. The amounts and timing of our
actual expenditures will depend upon numerous factors, including the progress of our global marketing and sales efforts, with
development efforts, economic and political effects of COVID-19 and government responses to it, and the overall economic environment.
Therefore, our management will retain broad discretion over the use of the proceeds from this offering. We may ultimately use
the proceeds for different purposes than what we currently intend. Pending any ultimate use of any portion of the proceeds from
this offering, if the anticipated proceeds will not be sufficient to fund all the proposed purposes, our management will determine
the order of priority for using the proceeds, as well as the amount and sources of other funds needed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending
our use of the net proceeds from this offering, we may invest the net proceeds in a variety of capital preservation investments,
including short-term, investment grade, interest bearing instruments and U.S. government securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="g_005"></A>DIVIDEND
POLICY </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
have never declared or paid any dividends on our Common Stock. We currently intend to retain all available funds and any future
earnings, if any, to fund the development and expansion of our business and we do not anticipate paying any cash dividends in
the foreseeable future. Any future determination to pay dividends will be made at the discretion of our board of directors and
will depend on various factors, including applicable laws, our results of operations, financial condition, future prospects and
any other factors deemed relevant by our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="g_006"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our cash and cash equivalents and capitalization as of December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis as of December 31, 2020;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    a pro forma basis to give effect to the automatic conversion of convertible promissory notes issued in a series of convertible
    loan agreements into an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of Common Stock, assuming an offering price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is the midpoint of the
    price range set forth on the cover page of this prospectus, which will occur immediately prior to the closing of this offering;
    and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as adjusted basis to give further effect to the issuance and sale of shares of our Common Stock in this offering
    at an assumed public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the estimated price range set forth on the cover page
    of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable
    by us, as if the sale of the Common Stock had occurred on December 31, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma as adjusted information set forth in the table below is illustrative only and will be adjusted based on the actual public
offering price and other terms of this offering determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this table in conjunction with the section titled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations&rdquo; and our financial statements and related notes included elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
as adjusted information set forth in the table below is illustrative only and will be adjusted based on the actual public offering
price and other terms of this offering determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this table in conjunction with the section titled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations&rdquo; and our financial statements and related notes included elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="9" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2020</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">U.S. dollars, except
    share and per share data</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro
    Forma<BR> As&nbsp;Adjusted<BR> <SUP>(1)</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Assets</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 54%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">242,900</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">242,900</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: right"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65,579</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65,579</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total Current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">495,171</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">495,171</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Right-of-Use Asset Arising from Operating Lease</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,700</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,700</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Property and Equipment, Net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">55,194</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">55,194</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Funds in Respect of Employee Rights Upon Retirement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">122,584</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">122,584</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total Assets</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">687,649</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">687,649</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Liabilities and Shareholders&rsquo; Deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Short-term loan from banking institution</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Current maturities of convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">203,323</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">203,323</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other accounts liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">517,711</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">517,711</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total Current Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">785,233</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">728,983</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Fair Value of Convertible Component in Convertible
    Loans</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,970</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Convertible Loans</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">146,929</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Long term from Banking Institution</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,115</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,115</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Liability for Employee Rights Upon Retirement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">157,855</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">157,855</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total Liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,153,102</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">894,953</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Stockholders&rsquo; Deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt">Common stock par value $0.0001 per share: <BR> 495,000,000 shares authorized as of December
    31, 2020 and 2019; issued and outstanding 1,606,760 and 1,458,567 shares as of December 31, 2020 and 2019, respectively.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt">Preferred stock par value $ 0.0001 per share: <BR> 5,000,000 shares authorized as of December
    31, 2020 and 2019; issued and outstanding 0 shares as December 31, 2020 and 2019.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,867,585</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,070,764</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Foreign currency translation adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,275</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,275</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,277,647</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,222,677</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(436,176</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(178,027</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Non-Controlling Interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(29,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(29,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total Stockholders&rsquo; Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(465,453</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(207,304</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total Capitalization</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">687,649</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">687,649</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    $1.00 increase or decrease in the assumed public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock would increase or decrease
    the amount of each of cash and cash equivalents and total stockholders&rsquo; equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming
    that the number of shares of Common Stock offered by us, as set forth on the cover page of this prospectus, remains the same
    and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. An increase
    or decrease of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the number of shares of Common Stock offered by us would increase or decrease each of cash and cash equivalents
    and total stockholders&rsquo; equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming the assumed public offering price remains the same,
    after deducting estimated underwriting discounts and commissions and any estimated offering expenses payable by us.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
number of shares presented in the table above does not include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,984
    shares of Common Stock issuable upon the exercise of warrants outstanding as of December 31, 2020, with an exercise price
    of $8.40 per share;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,862
    shares of Common Stock issuable upon the exercise of options to directors, employees and consultants under our 2018 equity
    incentive plan (the &ldquo;Equity Incentive Plan&rdquo;) at a weighted average exercise price of $3.27, of which 97,351 vested
    as of December 31, 2020; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,730
    shares of Common Stock reserved for future issuance under our Equity Incentive Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 36; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="g_007"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our Common Stock, you will experience immediate and substantial dilution to the extent of the difference between
the public offering price of our Common Stock and the as adjusted net tangible book value per share of Common Stock immediately
after the offering. On December 31, 2020, we had negative net tangible book value of ($465,453), representing a net tangible book
value of $0.29 per share of Common Stock. Net tangible book value per share of Common Stock represents the amount of our total
tangible assets less our total liabilities, divided by 1,606,760, the total number of Common Stock outstanding on December 31,
2020.</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
pro forma negative net tangible book value as of December 31, 2020 was
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , representing approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
forma net tangible book value per share of common stock represents the amount of our total tangible assets less our total
liabilities, divided by 1,815,663, the total number of common stock outstanding on December 31, 2020, and gives effect to the
automatic conversion of convertible promissory notes issued in a series of convertible loan agreements into an aggregate of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of Common Stock, assuming an offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
which is the midpoint of the price range set forth on the cover page of this prospectus, which will occur immediately prior
to the closing of this offering.</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the sale of the Common Stock offered by us in this offering and after deducting the estimated underwriting discounts
and commissions and estimated offering expenses payable by us, assuming no exercise of the Underwriter&rsquo;s over-allotment
option, our pro forma as adjusted net tangible book value estimated at December 31, 2020 would have been approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , representing
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock. At the assumed public offering price for this offering of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock, the midpoint
of the estimated price range set forth on the cover page of this prospectus, this represents an immediate increase in historical
net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock to existing stockholders and an immediate dilution in net tangible book
value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock to purchasers of Common Stock in this offering. Dilution for this purpose represents the
difference between the price per share of Common Stock paid by these purchasers and as adjusted net tangible book value per share
of Common Stock immediately after the completion of this offering.</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates this dilution on a per share basis to new investors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; text-align: left">Assumed public offering price per share, the midpoint of the estimated price range set forth on the cover page of this prospectus</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Historical adjusted net tangible book value per share as of December 31, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Increase in net tangible book value per share attributable to new investors in this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">As adjusted net tangible book value per share after offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dilution in tangible book value per share to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
dilution information discussed above is illustrative only and will change based on the actual public offering price and other
terms of this offering to be determined at pricing. A $1.00 increase or decrease in the assumed initial public offering price
of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock would increase or decrease our as adjusted net tangible book value per share of Common Stock after
this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and the dilution per share of Common Stock to new investors by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming the number of Common Stock offered
by us, as set forth on the cover page of this prospectus, remains the same, after deducting the estimated underwriting discounts
and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of Common Stock we
are offering. </FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">An
increase or decrease of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the number of Common Stock offered by us would increase or decrease our as adjusted net tangible book
value after this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million and the as adjusted net tangible book value per share of Common Stock after
this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock and would increase or decrease the dilution per share of Common Stock to new investors
by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming the assumed public offering price remains the same, after deducting estimated underwriting discounts and estimated
offering expenses payable by us. </FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
following table summarizes, on an as adjusted basis as of December 31, 2020, the differences between the number of Common Stock
acquired from us, the total amount paid and the average price per share of Common Stock paid by the existing holders of our Common
Stock and by investors in this offering and based upon an assumed public offering price of $ per share of Common Stock, the midpoint
of the estimated price range set forth on the cover page of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Shares</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Consideration</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Average Price Per Share of Common</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Number</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>Percent</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>Amount</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>Percent</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>Stock</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Existing stockholders</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt"></FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">New investors</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;<FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; text-align: justify; padding-bottom: 2.5pt">Total</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">100.0</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">%</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">100</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">%</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of Common Stock that will be outstanding after this offering is based on 1,606,760 shares of Common Stock issued
and outstanding as of December 31, 2020, and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,984
    shares of Common Stock issuable upon the exercise of warrants outstanding as of December 31, 2020, with an exercise price
    of $8.40 per share;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,862
    shares of Common Stock issuable upon the exercise of options to directors, employees and consultants under our 2018 equity
    incentive plan (the &ldquo;Equity Incentive Plan&rdquo;) at a weighted average exercise price of $3.27, of which 97,351 vested
    as of December 31, 2020; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,730
    shares of Common Stock reserved for future issuance under our Equity Incentive Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that new options are granted under our equity benefit plans, there will be further dilution to investors purchasing
Common Stock in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
all of such issued and outstanding options, warrants and performance rights had been exercised as of December 31, 2020, the number
of Common Stock held by existing stockholders would increase to 1,834,069, or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares of Common Stock
outstanding after this offering, and the average price per share of Common Stock paid by the existing stockholders would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the underwriter exercises its option to purchase additional shares of Common Stock in full in this offering, the number of shares
of Common Stock held by new investors will increase to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of Common Stock outstanding after this offering
and the percentage of Common Stock held by existing stockholders will decrease to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total Common Stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="g_008"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AND
RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our
consolidated financial statements </I>and <I>the related notes included elsewhere in this prospectus. The discussion below contains
forward-looking statements that are based upon our current expectations and are subject to uncertainty and changes in circumstances.
Actual results may differ materially from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties,
including those identified in &ldquo;Cautionary Note Regarding Forward-Looking Statements&rdquo; and under &ldquo;Risk Factors&rdquo;
elsewhere in this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following financial data in this narrative are expressed in thousands, except for share and share data or as otherwise noted.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
develop eco-friendly &ldquo;green&rdquo; solutions for the food industry. Our solutions are developed to improve the food safety
and shelf life of fresh produce. We do this by controlling human and plant pathogens, thereby reducing spoilage, and in turn,
reducing food loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of oxidizing
agent-based sanitizers and fungicides at low concentrations. Our green products are capable of cleaning, sanitizing and controlling
pathogens on fresh produce with the goal of making them safer for human consumption and extending their shelf life by reducing
their decay. One of the main advantages of our products is that our active ingredients do not leave any toxicological residues
on the fresh produce we treat. In contrary, by forming a temporary protective shield around the fresh produce we treat, our products
make it difficult for pathogens to develop and potentially provide protection which also reduces cross-contamination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Components
of Results of Operation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenues
and Cost of Revenues</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total revenue consists of products and our cost of revenues consists of cost of products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the breakdown of revenues and costs of revenues:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Revenues from sale of products</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">232,274</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">175,823</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(43,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(144,548</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">188,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current operating expenses consist of three components &mdash; research and development expenses, selling and marketing expenses
and general and administrative expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development Expenses, net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses consist primarily of salaries and related personnel expenses, share base compensation, professional
fees and other related research and development expenses such as field tests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the breakdown of research and development expenses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Salaries and related expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">39,021</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">177,712</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">91,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,592</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,854</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Laboratory and field tests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,593</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,968</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,319</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Other expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,285</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">88,547</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">417,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">615,623</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that our research and development expenses will increase as we continue to develop our products and services, field trials
and recruit additional research and development employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Selling
and Marketing Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist primarily of salaries and related expenses, share based compensation and other expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the breakdown of selling and marketing expenses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Salaries and related expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">30,450</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">148,221</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,971</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Other expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">41,626</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">129,609</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">51,105</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">342,059</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that our selling and marketing expenses will increase as we continue to increase our selling and marketing efforts including
commercial validation pilots and recruit additional employees or contractor to support our selling and marketing efforts in our
targeted geographical areas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of professional services, share based compensation and other non-personnel related
expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the breakdown of general and administrative expenses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Professional services</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">443,883</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">461,840</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">416,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">283,910</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,492</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Other expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">141,738</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">133,396</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,070,109</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,004,899</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of the Year Ended December 31, 2020 to the Year Ended December 31, 2019</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our results of operations for the years ended December 31, 2020 and 2019, together with the changes
in those items in dollars:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Revenues from sales of products</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">232,274</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">175,823</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(43,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(144,548</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(417,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(615,623</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(51,105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(342,058</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">General and administrative expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,070,109</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,004,899</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,349,345</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,931,305</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Finance income (expenses), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(270,393</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,408</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,532</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share in losses of affiliated company</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,690</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain on disposal of affiliated company</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,690</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,606,580</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,990,403</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Less: Net loss attributable to non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,441</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,986</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Net loss attributable to the Company</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,593,139</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,971,417</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">Loss per share</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1.05</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1.38</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Weighted average number of shares of Common Stock outstanding attributable to shareholders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,519,122</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,424,045</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenues</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the year ended December 31, 2020 were $232,274, an increase of $56,451, or 32%, compared to total revenues of $175,823 for
the year ended December 31, 2019. The increase is mainly a result of the Company&rsquo;s sales of its new products, which the
Company commenced in the fourth quarter of 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have backlogs or firm commitments from our customers for our products. Our sales might deteriorate if we fail to achieve
commercial success or obtain regulatory approval of any of our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
of Sales</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of sales consists primarily of salaries, materials, transportation and overhead costs of manufacturing our products. Cost of revenues
for the year ended December 31, 2020 was $43,405, a decrease of $101,143, or 70%, compared to total cost of revenues of $144,548
for the year ended December 31, 2019. The decrease is mainly a result of the decrease in salaries and related expenses, due to
the fact that some of our employee are currently on a temporary leave without pay (furlough), due to the effects of COVID-19 on
our business, and a decrease in the overall cost of materials, mainly as a result of inventory elimination made in 2019, due to
our efforts to deploy our new solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Gross
Profit</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
loss for the year ended December 31, 2020 was $188,869, an increase of $157,594, or 504%, compared to gross profit of $31,275
for the year ended December 31, 2019. The increase is mainly a result of the increase in revenues and the decrease in cost of
revenues, as detailed above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses consist of salaries and related expenses, share base compensation, consulting fees, service providers&rsquo;
costs, related materials and overhead expenses. Research and development expenses for the year ended December 31, 2020 were $417,000,
a decrease of $198,623, or 32%, compared to total research and development expenses of $615,623 for the year ended December 31,
2019. The decrease is mainly attributable to: (1) the decrease in professional fees, share based compensation and in payroll;
and (2) the decrease in expenses associated with international travel and field trials which have been postponed due to COVID-19.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Selling
and Marketing Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist primarily of salaries and related costs for selling and marketing personnel, travel related expenses
and services providers. Selling and marketing expenses for the year ended December 31, 2020 were $51,105, a decrease of $290,954,
or 85%, compared to total selling and marketing expenses of $342,058 for the year ended December 31, 2019. The decrease is mainly
attributable to the decrease in payroll expenses and service providers used in relation to selling and marketing activities mainly
associated with the termination of the employment of our former Vice President of Sales in February 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General
and Administrative Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of salaries and related expenses including share based compensation and other non-personnel
related expenses such as legal expenses and directors and insurance costs. General and administrative expenses for the year ended
December 31, 2020 were $1,070,109, an increase of $65,210, or 6%, compared to total general and administrative expenses of $1,004,899
for the year ended December 31, 2019. The increase is mainly a result of the increase in share-based compensation to our service
providers and directors offset partially by a decrease in professional fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financing
Expenses, Net</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
expenses, net for the year ended December 31, 2020 were $270,393, an increase of $226,985, or 523%, compared to total financing
expenses of $43,408 for the year ended December 31, 2019. The increase is mainly a result of compensation expenses related to
the exchange of our convertible loans as well as accrued interest and amortization expenses related to such convertible loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Total
Comprehensive Loss</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, our total comprehensive loss for the year ended December 31, 2020 was $1,593,139, compared to $1,971,417
for the year ended December 31, 2019, a decrease of $378,278, or 19%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impact
of COVID-19</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global spread of COVID-19 led many countries, including the United States, Europe and Israel (where we maintain material operations),
to impose stringent limitations on movement, gatherings, transit of passengers and goods and to close the borders between countries.
The responses of governments have notably impacted many economies as well as capital markets worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on guidelines provided by the Israeli Government, employers (including us) are required to prepare and increase as much as possible
the capacity and arrangement for employees to work remotely. In that regard, and in compliance with all applicable Israeli rules
and guidelines, our offices have remained closed since the middle of March 2020, and all of our employees currently work remotely.
In addition, as of the date of this prospectus, some of our employees are on a temporary leave without pay (furlough), including
our Chief Technology Officer, and we have postponed some of our planned field tests due to the current restriction on international
travels. However, we did experience any material impact on our financial condition and results of operations due to COVID-19,
and we do not expect to experience any material impact on our overall liquidity positions and outlook as a result of the outbreak.
Nevertheless, it is not possible at this time to estimate the full impact that the COVID-19 pandemic, the continued spread of
COVID-19, and any additional measures taken by governments, health officials or by us in response to such spread, could have on
our business results of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies and Estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
describe our significant accounting policies more fully in Note 2 to our consolidated financial statements included elsewhere
in this prospectus. We believe that the accounting policy described in Note 2 is critical in order to fully understand and evaluate
our financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
prepare our financial statements in accordance with U.S. GAAP. At the time of the preparation of the financial statements, our
management is required to use estimates, evaluations and assumptions which affect the application of the accounting policy and
the amounts reported for assets, obligations, income and expenses. Any estimates and assumptions are continually reviewed. The
changes to the accounting estimates are credited during the period in which the change to the estimate is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern Uncertainty</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development and commercialization of our product will require substantial expenditures. We have not yet generated any material
revenues and have incurred substantial accumulated deficit and negative operating cash flows. We currently have no sources of
recurring revenue and are therefore dependent upon external sources for financing our operations. There can be no assurance that
we will succeed in obtaining the necessary financing to continue our operations. As a result, our independent registered public
accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do
not include any adjustments that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
and other service providers of the Company may receive benefits by way of stock-based compensation settled with company options
exercised for shares of our Common Stock. The cost of transactions with employees settled with capital instruments is measured
based on the fair value of the capital instruments on the granting date. The fair value is determined using an accepted options
pricing model. The model is based on share price, grant date and on assumptions regarding expected volatility, expected lifespan,
expected dividend, and a no risk interest rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of the transactions settled with capital instruments is recognized in profit or loss together with a corresponding increase
in the equity over the period in which the performance and/or service takes place, and ending on the date on which the relevant
employees are entitled to the benefits (the &ldquo;Vesting Period&rdquo;). The aggregate expense recognized for transactions settled
with capital instruments at the end of each reporting date and until the Vesting Period reflects the degree to which the Vesting
Period has expired and our best estimate regarding the number of warrants that have ultimately vested. The expense or income in
profit or loss reflects the change of the aggregate expense recognized as of the end of the reported period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Loans</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a series of convertible loan agreements with certain lenders to sell convertible promissory notes containing
conversion feature. The conversion feature is considered embedded derivative instruments, and is to be recorded at their fair
value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying note value.
The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess amount of
the convertible component fair value over the face loan amount. The conversion liability is then marked to market each reporting
period with the resulting gains or losses shown in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was using a third-party appraiser to estimate the fair value of the convertible component.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
selected the Black-Scholes-Merton (&ldquo;Black-Scholes&rdquo;), as our option pricing model to estimate the fair value of our
options awards. The option-pricing model requires a number of assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
dividend yield</I> &mdash; The expected dividend yield assumption is based on our historical experience and expectation of no
future dividend payouts. We have historically not paid cash dividends and have no foreseeable plans to pay cash dividends in the
future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Volatility
</I>&mdash; Since the Company is not traded on any stock exchange market, quoted prices of our shares are unavailable. In case
of insufficient historical data for a company, the expected volatility is based on similar companies&rsquo; stock volatility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risk
free interest rate</I> &mdash; The risk-free interest rate is based on the yield of governmental bonds with equivalent terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Contractual
term</I> &mdash; An option&rsquo;s contractual term is the amount of time the holder has to exercise the option, per the contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Share
price</I> &mdash; The share price is determined according to the last known closing price of the share of our Common Stock at
the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise
operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts
receivable and accounts payable and capital expenditures. Since our inception through December 31, 2020, we have funded our operations
principally with approximately $11,867,746 (net of issuance expenses) from the issuance of shares of shares of our Common Stock,
options and loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents our cash flows for the periods indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
Ended December 31</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Net cash used in operating activities</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(798,740</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(1,244,772</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net cash provided by (used in) investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,065</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(81,655</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">741,760</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,177,436</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Decrease in cash and cash equivalents</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(47,915</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(148,991</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had cash of $242,900, as compared to $290,815 as of December 31, 2019. As of December 31, 2020, we had
a negative working capital of $290,062, as compared to a negative working capital of $199,212 as of December 31, 2019. The decrease
in our cash balance is mainly attributable to our net loss described above and payments to account payables offset by our equity
financing and convertible loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $798,740 for the year ended December 31, 2020, as compared to $1,244,772 for the year ended
December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investing
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by investing activities was $9,065 for the year ended December 31, 2020, as compared to net cash used in investing
activities of $81,655 for the year ended December 31, 2019. The increase is mainly attributable to the decrease in short term
bank deposits in banking institutions and proceeds from investment in unconsolidated entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financing
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $741,760 for the year ended December 31, 2020, as compared to $1,177,436 for the year
ended December 31, 2019. The decrease is mainly the result of a decrease in equity financing and proceeds from convertible loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financial
Arrangements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have financed our operation primarily through proceeds from sales of our shares of Common Stock, convertible
loan agreements and grants from the IAA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2019, January 2020 and March 2020 we entered into a series of convertible loan agreements (the &ldquo;December 2019 CLAs,&rdquo;
and each a &ldquo;December 2019 CLA&rdquo;) with third parties and certain existing shareholders (the &ldquo;December 2019 Lenders&rdquo;),
pursuant to which the December 2019 Lenders agreed to provide the Company loans in the aggregate amount of $514,000 and in exchange
the Company issued to the December 2019 Lenders (i) convertible promissory notes (the &ldquo;December 2019 Notes&rdquo;) and (ii)
warrants with an exercise price of $8.40.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the terms of the December 2019 CLA, the December 2019 Notes bear interest at a rate of 5% per annum and the loan amount represented
by the December 2019 Notes will be repaid to the December 2019 Lenders according to the following schedule: (i) the principal
amount represented by the December 2019 Notes to be repaid in twenty four equal monthly installments, commencing on the twenty
fifth month following the closing of each December 2019 CLA and (ii) the interest accrued on the loan amount to be paid in two
bi-annual installments, commencing on the first anniversary of the first payment of the principal amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the terms of the December 2019 CLA, the outstanding loan amount matures on the earlier of (i) the third anniversary of each
December 2019 CLA or (ii) a deemed liquidation event (as defined therein), and the December 2019 Lenders may convert all or any
portion of the December 2019 Notes at any time prior to the one-year anniversary of each issuance into shares of Common Stock
at a conversion price of $8.40 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2020, we entered into a Securities Purchase Agreement (the &ldquo;June 2020 SPA&rdquo;) with the December 2019 Lenders
in connection with the sale and issuance of 67,369 units, at a purchase price of $7.63 per unit. Each unit consists of: (i) one
share of the Company&rsquo;s Common Stock; and (ii) one warrant to purchase one share of Common Stock with an exercise price of
$8.40. In connection with the June 2020 SPA, the Company issued to the December 2019 Lenders an aggregate of 67,369 shares of
Common Stock and warrants to purchase an aggregate of 67,369 shares of Common Stock. The shares of Common Stock were issued on
July 2, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneous
with and conditioned upon the execution of the June 2020 SPA, the Company and each of the December 2019 Lenders, agreed to effectively
cancel the December 2019 CLA and the equity securities issued thereunder. In connection therewith, each of the December 2019 Lenders,
voluntarily waived any right to receive interest that accrued thereupon pursuant to the December 2019 CLAs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2020, we entered into a Securities Purchase Agreement (the &ldquo;September 2020 SPA&rdquo;) with Medigus Ltd. (&ldquo;Medigus&rdquo;)
in connection with the sale and issuance of 13,107 units, at a purchase price of $7.63 per unit, and for an aggregate purchase
price of $100,000. Each unit consists of: (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock
with an exercise price of $1.20. In connection with the September 2020 SPA, the Company issued to Medigus an aggregate of 13,107
shares of Common Stock and warrants to purchase an aggregate of 13,107 shares of Common Stock. Furthermore, the September 2020
SPA contemplates an additional investment by Medigus not to exceed $25,000 (the &ldquo;Additional Investment&rdquo;), which investment
shall be triggered following the parties&rsquo; initiation of a proof of concept procedure to test the effectiveness of the Company&rsquo;s
sanitizers and its residual effects against different pathogens. In consideration for the Additional Investment, the Company has
agreed to issue an additional 3,277 units at a purchase price of $7.63, which units shall contain the same composition of securities
as described in the aforementioned description of the September 2020 SPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
September 2020, we entered into a series of convertible loan agreements (each a &ldquo;September 2020 CLA&rdquo;) with certain
lenders (the &ldquo;September 2020 Lenders&rdquo;), to sell convertible promissory notes with an aggregate principal amount of
$125,000 (the &ldquo;September 2020 Notes&rdquo;). The September 2020 Notes will bear interest at a rate of 5% per annum. The
outstanding loan amount will mature on the earlier of (i) the third anniversary of each September 2020 CLA or (ii) a deemed liquidation
event (as defined therein). The loan amount represented by the September 2020 Notes will be repaid to the September 2020 Lenders
according to the following schedule: (i) the principal amount represented by the September 2020 Notes will be repaid in four bi-annual
installments, commencing on the first anniversary following the closing of each September 2020 CLA, and (ii) the interest accrued
on the loan amount will be paid in two bi-annual installments, commencing on the first anniversary of the first payment of that
principal amount. The September 2020 Lenders may convert all or any portion of the September 2020 Notes into shares of Common
Stock at any time prior to the closing of an underwritten public offering (the &ldquo;Mandatory Conversion Event&rdquo;), at a
conversion price of $7.63 per share. In addition, the September 2020 Notes will be automatically converted into shares of Common
stock immediately prior to a Mandatory Conversion Event, at a conversion price as shall be determined in connection with the Mandatory
Conversion Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
October 2020, we entered into a series of convertible loan agreements (each a &ldquo;October 2020 CLA&rdquo;) with certain lenders
(the &ldquo;October 2020 Lenders&rdquo;), to sell convertible promissory notes with an aggregate principal amount of $100,000
(the &ldquo;October 2020 Notes&rdquo;). The October 2020 Notes will bear interest at a rate of 5% per annum. The outstanding loan
amount will mature on the earlier of (i) the third anniversary of each October 2020 CLA or (ii) a deemed liquidation event (as
defined therein). The loan amount represented by the October 2020 Notes will be repaid to the October 2020Lenders according to
the following schedule: (i) the principal amount represented by the notes will be repaid in four bi-annual installments, commencing
on the first anniversary following the closing of each October 2020 CLA, and (ii) the interest accrued on the loan amount will
be paid in two bi-annual installments, commencing on the first anniversary of the first payment of that principal amount. The
October 2020 Notes will be automatically converted into shares of Common stock immediately prior to a Mandatory Conversion Event,
at a conversion price as shall be determined in connection with the Mandatory Conversion Event. In addition, the October 2020
Lenders may convert all or any portion of the notes into shares of Common Stock at any time prior to a Mandatory Conversion Event,
at a conversion price of $7.63 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January 2021, we entered into a series of convertible loan agreements (each a &ldquo;January 2021 CLA&rdquo;) with certain lenders
(the &ldquo;January 2021 Lenders&rdquo;), to sell convertible promissory notes with an aggregate principal amount of $274,000
(the &ldquo;January 2021 Notes&rdquo;). The January 2021 Notes bear interest at a rate of 5% per annum. The outstanding loan amount
matures on the earlier of (i) the third anniversary of each January 2021 CLA or (ii) a deemed liquidation event (as defined therein).
The loan amount represented by the January 2021 Notes will be repaid to the January 2021 Lenders according to the following schedule:
(i) the principal amount represented by the notes will be repaid in four bi-annual installments, commencing on the first anniversary
following the closing of each January 2021 CLA, and (ii) the interest accrued on the loan amount will be paid in two bi-annual
installments, commencing on the first anniversary of the first payment of that principal amount. The January 2021 Notes will be
automatically converted into shares of Common stock immediately prior to a Mandatory Conversion Event, at a conversion price as
shall be determined in connection with the Mandatory Conversion Event. In addition, the January 2021 Lenders may convert all or
any portion of the notes into shares of Common Stock at any time prior to a Mandatory Conversion Event, at a conversion price
of $7.63 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the September 2020 CLAs, the October 2020 CLAs and the January 2021 CLAs, we entered into a registration rights agreement
with each of the September 2020 Lenders, October 2020 Lenders and the January 2021 Lenders, whereby each of such lenders received
piggyback registration rights for the shares issuable upon conversion of the September 2020 Notes, October 2020 Notes and the
January 2021 Notes to shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
Outlook</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have financed our operations to date primarily through proceeds from sales of our shares of Common Stock. We have incurred losses
and generated negative cash flows from operations since inception in 2009. Most of our revenues are currently generated in U.S.
dollars from the sale of our products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, our cash and cash equivalents were $242,900. We expect that our existing cash and cash equivalents will
be sufficient to fund our current operations until June 2021, without using the net proceeds from this offering. In addition,
our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional
funds sooner than planned. Our future capital requirements will depend on many factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    progress and costs of our studies and other research and development activities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs of manufacturing our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs and timing of obtaining regulatory approval for our products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential costs of contracting with third parties to provide marketing and distribution services for us or for building such
    capacities internally; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    magnitude of our general and administrative expenses.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
we can generate significant recurring revenues and profit, we expect to satisfy our future cash needs through debt or equity financings.
We cannot be certain that additional funding will be available to us when needed, on acceptable terms, if at all. If funds are
not available, we may be required to delay, reduce the scope of, or eliminate research or development plans for, or commercialization
efforts with respect to our products and services. This may raise substantial doubts about our ability to continue as a going
concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its report on our financial statements for the year ended December 31, 2020, our independent registered public accounting firm
included an explanatory paragraph stating that our recurring losses from operations since inception and our need for additional
funding to finance our operations raises substantial doubt about our ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently have any off-balance sheet arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual
Obligations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our contractual obligations at December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Less than</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1 year</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">1-3 years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3-5 years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>More than</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5 years</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,049</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,049</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quantitative
and Qualitative Disclosures about Market Risk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our
financial position due to adverse changes in financial market prices and rates. Our current investment policy is to invest available
cash in bank deposits with banks that have a credit rating of at least A-minus. Accordingly, some of our cash and cash equivalents
is held in deposits that bear interest. Given the current low rates of interest we receive, we will not be adversely affected
if such rates are reduced. Our market risk exposure is primarily a result of foreign currency exchange rates, which is discussed
in detail in the following paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
of Inflation and Currency Fluctuations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency and reporting currency is the U.S. dollar. We incur some of our expenses in other currencies. As a result,
we are exposed to the risk that the rate of inflation in countries in which we are active other than the United States will exceed
the rate of devaluation of such countries&rsquo; currencies in relation to the dollar or that the timing of any such devaluation
will lag behind inflation in such countries. To date, we have been affected by changes in the rate of inflation or the exchange
rates of other countries&rsquo; currencies compared to the dollar, and we cannot assure you that we will not be adversely affected
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
annual rate of inflation in Israel decreased by 0.7% in 2020 and 0.6% in 2019. The New Israeli Shekel (NIS) revaluated against
the U.S. dollar and decreased by approximately 7% in 2020 and 8% in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="g_009"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
develop eco-friendly &ldquo;green&rdquo; solutions for the food industry. Our solutions are developed to improve the food safety
and shelf life of fresh produce. We do this by controlling human and plant pathogens, thereby reducing spoilage, and in turn,
reducing food loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of oxidizing
agent-based sanitizers and fungicides at low concentrations. Our &ldquo;green&rdquo; products are capable of cleaning, sanitizing
and controlling pathogens on fresh produce with the goal of making them safer for human consumption and extending their shelf
life by reducing their decay. One of the main advantages of our products is that our active ingredients do not leave any toxicological
residues on the fresh produce we treat. In contrary, by forming a temporary protective shield around the fresh produce we treat,
our products make it difficult for pathogens to develop and potentially provide protection which also reduces cross-contamination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. Food and Drug Administration (the &ldquo;FDA&rdquo;) Food Safety Modernization Act (the &ldquo;FSMA&rdquo;) is transforming
the United States&rsquo; food safety system by shifting the focus from responding to foodborne illness to preventing it. According
to the recent data from the Centers for Disease Control and Prevention, approximately 48 million people in the United States get
sick each year from foodborne diseases. We believe this is a significant public health burden that is largely preventable. Since
2018, the FDA has had a legislative mandate to require comprehensive, science-based preventive controls across the food supply
such as the implementation of sanitizers into fresh produce at packing houses to ensure they are cleaned from human pathogens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, most conventional chemical pesticides (fungicides), which are currently used to protect fresh produce from microbial
spoilage and reduce food waste, are potentially toxic, they remain on fruit peel and present health concerns, while also polluting
the environment. Therefore, the use of these products is strictly regulated and their residue on food and on the environment are
carefully monitored. Today&rsquo;s trends led by both consumers and regulatory bodies are to significantly reduce the use of fungicides
and switch to greener solutions. In a series of studies conducted in collaboration with a large post-harvest service company
during the second quarter of 2020, our products have shown impressive results in extending the shelf life of fresh produce in
&ldquo;organic&rdquo; (where no fungicides are used at the post-harvest stage) and conventional (where fungicides are being used
at the post-harvest stage) settings. On average, our products may reduce the rotten fruits at the retail level by 50%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a unique opportunity to make a positive difference throughout the food value chain from field to fork and address two of
the major&rsquo;s challenges in the food industry today &mdash; safety and waste. We target major markets that use conventional
chemical pesticides and sanitizers, including the pre- and post-harvest market, the greenhouse market and the fresh-cut market,
where our &ldquo;green&rdquo; products are used as alternatives for, or mixed with, conventional products in order to reduce (i)
health and environmental concerns, and/or (ii) microbial resistance that has reduced the efficacy of conventional chemical pesticides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Industry
Overview and Market Opportunity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Background</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
world&rsquo;s population is expected to grow to almost 10 billion people by 2050, boosting agricultural demand by some 50%. Providing
healthy and safe food to feed the world&rsquo;s population is one of the biggest challenges of the twenty first century, accentuated
with the backdrop of a of a fragile global economy. Globally, around one-third of the food produced (estimated at circa 1.3 billion
tons), is lost or wasted along the food chain &ndash; from production to consumption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="img_1.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fruits
and vegetables are considered essential food commodities and demonstrate their best benefits especially when consumed fresh. Consumption
as well as production of fresh fruit and vegetables is growing globally; in 2018, the global production of fresh fruit amounted
to about 868 million tons, while the production of fresh vegetable amounted to about 1.09 billion tons. According to a report
published by technavio in October 2020, the fresh food market size has the potential to grow by 337.76 million tons from 2020
to 2024, growing at a CAGR of almost 3% during the forecast period, and the market&rsquo;s growth momentum will accelerate during
the forecast period due to the steady increase in year-over-year growth. In the United States, according to a report by Grand
View Research, increasing health awareness among the U.S population and potential development of secondary diseases due to obesity
and unhealthy eating habits are propelling the market of fruit and vegetables to reach an estimated $1.1 billion by 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Food
Safety and Food Loss</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Food
Safety</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe foodborne diseases are a significant public health concern globally. Hundreds of diseases are caused by eating contaminated
food. Many diseases are spread through unwashed or untreated produce. With </FONT>approximately 48 million people
in the United States (one in six) getting sick, 128,000 hospitalized, and 3,000 die each year from foodborne diseases,
according to recent data published by the FDA, and 23 million in the European region getting sick due to food borne disease,
food safety is another major concern and source of waste, placing a material burden on public health and significant healthcare
cost. The economic burden of foodborne illness has been estimated to be as high as $90 billion annually.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
considering the farm-to-fork chain, microbial contamination of fresh produce can occur at multiple steps. Contamination can take
place during the cultivation of fresh produce, at harvest, during preparation/washing, within distribution chains and transport
to shops, and even at the final step in the consumers&rsquo; kitchen. We believe this is a significant public health burden that
is largely preventable. The FSMA is transforming the United States food safety system by shifting the focus from responding to
foodborne illness to preventing it. The Produce Safety rule of the FSMA establishes, for the first time, science-based minimum
standards for the safe growing, harvesting, packing, and holding of fruits and vegetables grown for human consumption. The final
rule went into effect on January 26, 2016. Sanitization is a cornerstone of FSMA compliance, which requires preventing or eliminating
food safety hazards or reducing such hazards to a minimal level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets
require many types of produce to be washed prior to sale in order to remove dirt and other debris. Produce can be contaminated
with foodborne pathogens before it enters the packing house, and these pathogens cannot be seen with the naked eye. Inability
to visually spot pathogens makes the washing step one of the most important steps in packing because, if washing process is not
controlled, it can become a source of cross-contamination (when foodborne pathogens fall off contaminated produce into the water
where they can contaminate more produce). These washing steps are defined by the packing house safety managers as critical point
because water mixed with organic materials are good conditions for pathogens to develop. Therefore, the use of sanitizers should
be introduced during the washing step because they are, most of the time, one of the last treatments applied before the produce
meets with the consumer. Sanitizers are designed to inactivate/kill any bacteria in the water, drastically reducing the possibility
of cross-contamination. We believe this represents a significant opportunity for us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Food
Loss</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Food and Agriculture Organization of United Nations predicts that about third of the food produced globally are wasted or lost
every year. Approximately 644 million tons of fruits and vegetables are thrown away each year (representing 42% of the total food
wasted every year). A report published in April 2020, generated by the European Innovation Partnership Agricultural Productivity
and Sustainability, estimates that in Europe an estimated 9 million tons of food is lost at the production stage (farm), while
up to 16.9 million tons are lost at the processing stage (packing houses, etc.).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_2.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Much
of this loss is caused by spoilage, which can be caused by microorganisms &ndash; primarily bacteria and mold. In addition, bacteria
and fungi represent the highest numbers of incidents of post-harvest microbial diseases in fresh produce worldwide. Taken together,
it is estimated that nearly a third of all food grown is lost between the time that it is grown and harvested and the time that
it is packaged for retail sale. Such waste equates to roughly $680 billion in industrialized countries and $310 billion in developing
countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-harvest
losses due to spoilage represent a significant problem along the supply chain and lead to profit losses in the millions. The main
causes of these losses are pest or disease infestation and incorrect storage conditions, which lead to rotting or loss of fresh
mass due to respiration and evaporation. Fruits and vegetables are largely damaged after harvest by fungi and bacteria . It is
estimated that an average of 45% of harvested fruit and vegetables are lost globally. Post-harvest diseases have been identified
as the greatest cause of post-harvest losses in fruits and vegetables, causing significant economic losses. It is estimated that
approximately 20 to 25% of the fruit and vegetables harvested are lost due to microbial spoilage during post-harvest handling
in developed countries. Furthermore, the demand for fresh fruits and vegetables, especially exotic tropical fruit has contributed
to the demand for post-harvest treatments to increase shelf life and maintain quality, resulting in more efficient export trade.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
most common way to protect fresh produce and prevent loss is the use of hazardous chemicals such as fungicides in post-harvest
applications. Post-harvest diseases are generally controlled by fungicides. Systemic (non-organic) fungicides, are one of the
most commonly used fungicides, for example, citrus fruits in California are completely covered by the fungicides, and the residue
is persistent for the life of the fruit providing protection. However, as they tend to affect a single biochemical pathway within
the pathogen, fungi may readily develop resistance to systemic fungicides. To avoid potential issues with resistance, maximum
concentration of fungicides will be generally used to ensure highly efficient eradication of the targeted pathogen which leaves
high residue level on the treated produce.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
these chemical agents have been applied for many years with few or limited success due to the development of resistance. Further
they have severe negative effects on human health, and the environment mainly due to the carcinogenic and/or teratogenic properties
of the compounds, and by their cumulative toxic effects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effects of exposure to these hazardous chemicals on humans and the environment are a continuing concern as they are intrinsically
toxic and pollute the environment through wastewater discharge from the packing house or a discarded fruit. Therefore, the agricultural
use of certain pesticides (in the field or in the packing house) has been abandoned in some countries leaving the growers with
significant challenges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
control and monitor the potential negative impacts pesticides might have over time, regulatory agencies that regulate pesticides
&ndash; for example, the United States Environmental Protection Agency (the &ldquo;EPA&rdquo;), the Pest Management Authority
Agency in Canada, and the European Food Safety Authority (&ldquo;EFSA&rdquo;) in Europe, have defined a maximum residue level
(the &ldquo;MRL&rdquo;) that can be present on the treated produce. Additionally, more countries require an MRL for the commodity
to be imported into their country. As there is increased awareness regarding compliance with MRLs, MRLs have become a much greater
concern. These changes have also impacted the market and we believe that consumers spearheaded this change by demanding organic
or pesticide-free foods. Consumers have recently increasingly want to understand where and how their food is grown. Retailers
and processors have capitalized on what they view as an opportunity to offer more information to consumers. It is more common
now for retailers and processors to ask which products have been used on the commodities they are purchasing. There are also retailers
and processors banning the use of certain products, requiring any residues to be below the established MRLs. The reduction in
MRLs results in lower efficacy of fungicide and increased loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the rising demand for healthy food among the global population will trigger the market&rsquo;s growth in the forthcoming
years. Over the last decade, the organic market in Europe continued to grow and reached &euro;40.7 billion in 2018 with 15.6 million
hectares (approximately 38,548,439 acres) (including 2.2 million hectares in Spain, the largest organic area in Europe, followed
by 2.0 million hectares in France and 2.0 million hectares in Italy), providing farmers with further added value on their production.
The strong growth rates in both production and consumption indicate that the organic market has not yet reached its peak and further
growth can still be expected. Organic farming is already responding to further emerging consumer trends such as veganism and demand
for locally produced food products, turning these challenges into opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    consumer demand for organic fruits and vegetables is increasing globally and there is an increasing promotion by government
    organizations for the adoption of environmentally friendly pesticides, the biorational pesticides market estimated at $2.78
    billion in 2017 is projected to reach a value of $5.02 billion by 2022, at a compound annual growth rate (the &ldquo;CAGR&rdquo;)
    of 12.5% from 2017. A biorational pesticide is a term used to define any pesticide material that causes relatively no harm
    to humans or animals and does little or no damage to the environment. We believe that our products could be defined as biorational
    products.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 28%"><IMG SRC="img_4.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analysts
    have predicted that the organic fresh food market will reach a CAGR of almost 15% by 2023. The market size will increase by
    $62.23 billion during the forecast period from 2019 to 2023. In addition, strict regulations have been imposed on the usage
    of pesticides and GMO-produced crops worldwide. This, in turn, has influenced consumer demand for organic fruits and vegetables.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Case
Study &ndash; Citrus Fruit</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Citrus
fruit, which represent one of the main fruit produce worldwide with more than 100 million tons produced worldwide, can be infected
by many fungal pathogens, and these pathogens can cause considerable losses during storage and transportation. Losses are mainly
caused by Penicillium digitatum, P. italicum, Aspergillus flavus and Alternaria alternata for citrus fruit. Post-harvest treatments
such as thiabendazole, imazalil, sodium ortho-phenil phenate or other active ingredients have been used for many years. They are
currently the most commonly used fungicides effective for controlling post-harvest fungal pathogens in citrus and they are used
in citrus packing houses to maintain fresh fruit, control post-harvest decay, and extend fruit shelf life. However, significant
problems such as environmental issues and health concerns have risen in the citrus industry due to chemical residues or the occurrence
of pathogenic resistant strains which require the use of even higher concentration of these post-harvest treatments. However,
currently, the residues of imazalil on citrus fruits is being revised by the European Commission. The EFSA put forward a proposal
in 2018 to cut the MRL for imazalil from 5 milligrams per kilogram to 0.01 milligrams per kilogram, causing worry among Europe&rsquo;s
main citrus producing countries and packers exporting their produce to European countries. Due to the significant impact this
proposal could have on the citrus industry, the European Council has decided, in the meantime, to start reducing imazalil residues
to four milligrams per kilogram for citrus fruit for a limited period of time to allow the citrus industry an extra time to find
green and safe alternatives. Our product PeroStar/SaveProtect has already shown its benefits in reducing significantly the residues
of imazalil while maintaining the produce shelf life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Current
Market Drivers and Trends</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to food safety and food waste concerns, the following market drivers are also shaping the food industry by setting standards
and conditions on the main actors in the industry:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Focus
    of consumers on health characteristics</I></B>: consumers are more aware and conscious of the health characteristics of the
    food they consume. Consumers pay more attention to the qualities of the fresh produce they buy. Particularly in the United
    States and Europe, products such as berries, avocados, mangoes, pomegranates, papayas and sweet potatoes are gaining popularity
    and considered &ldquo;super foods,&rdquo; and these products are showing a strong annual import growth of 10% to 20%. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Increasing
    demand for organic produce</I></B>: the demand for organic products is growing rapidly particularly in Europe and North America,
    and is closely related to consumer interest in healthy and pure eating. While the increasing demand created potential for
    oversees supply, it can be challenging and expansive for exporters in tropical climates to comply with the increasingly demanding
    organic standards.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Success
    of retailers determined by quality of produce</I></B>: a recent report by Fruit Logistica published in 2019, based on consumer
    surveys that involved almost 7,000 consumers in 14 different markets across Europe and North America, demonstrated the increased
    importance of fresh produce for the profitability of food retailers. According to the report, when choosing the place to buy
    their groceries, consumers focus on the quality of the stores&rsquo; fresh food, with freshness of fruits and vegetable being
    their top priority. The report also showed that customers who are satisfied with the store&rsquo;s fresh food quality, would
    visit the store more frequently than those who are not. In addition, consumers are also willing to pay more for better-quality
    produce and their basked will be 4% larger.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Promoting
sustainability</I></B>: a large range of sustainability aspects are directly related and affected by the fresh produce industry.
Food waste accounts for 8% of global greenhouse gas emissions. Both consumers and businesses, are becoming more aware of the growing
importance of sustainability issues. As consumers increasingly embrace social causes, they seek products and brands that align
with their values. According to a recent analysis published by Research Insights, nearly six in 10 consumers surveyed are willing
to change their shopping habits to reduce environmental impact, nearly eight in 10 respondents indicated sustainability is important
for them, and among those respondents that indicated that sustainability is very or extremely important, over 70% indicated that
they would pay a premium of 35%, on average, for brands that are sustainable and environmentally responsible. Increasing number
of companies in the fresh food sector are investing in sustainability. Survey conducted by Champions 12.3 in 2017 showed that
99% of businesses that invested in reduction of food loss and waste, received a net positive financial return. Primary production
companies are investing in aspects of food losses, energy efficiency and carbon footprint, through innovations such as drying
produce, on-farm and off-grid cold rooms and post-harvest treatments.</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Food
    retailers seek to reduce their waste and maximize their revenues</I></B>: more than eight million tons of food are wasted
    every year in the United States in the retail sector alone, which translates into $18 billion in lost value (cost of waste)
    every year. Some retailers, including Walmart, have already committed to implement a zero-waste policy by 2025. Prevention
    solutions across the retail value chain offer the highest returns to retailers and are growing the fastest. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Regulators
    are promoting the use of safer chemical-based product</I></B>: for example, the EPA offers a &ldquo;Safer Choice&rdquo; label
    that product manufacturers may use on qualifying products to help consumers and commercial buyers identify products with safer
    chemical ingredients. The EPA requires that every chemical, regardless of percentage, in a Safer Choice-certified product
    is evaluated and only the safest ingredients are allowed. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Increasing
    investment in foodtech and agritech companies</I></B><I>:</I> according to a recent report published by AgFunder, a venture
    capital firm active in the foodtech and agritech, startups developing agrifoodtech solutions and products, raised approximately
    $26.1 billion in 2020, a 15.5% year-over-year increase. Reduction of food waste, extension of the shelf life of fresh produce
    and reduction of the use of pesticides are main focus of the industry and many companies are addressing these objectives,
    including:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apeel
    Sciences, a company developing an edible coating to extend the shelf life of fruit and vegetables, secured in May 2020 a $250
    million investment from a leading venture capital, based on a firm valuation of more than $1 billion;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lineage
    Logistics, an expert in cold chain management for food, raised $1.6 billion in September 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zymergen,
    an expert in biofacturing with applications also for the agricultures with the goal to develop safer crop protection and pest
    control using their natural products, secured in September 2020 an investment in a total amount of $300 million.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GreenLight
    Biosciences, an RNA based pest control reducing the use of toxic pesticides, secured in June 2020 an investment of $102 million.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provivi,
    a company developing sustainable and safer pest control based on pheromones, closed a $45.5 million financing round in December
    2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enko
    Chem, a company using AI to develop green insecticides, fungicides, and herbicides, announced in June an investment of $45
    million.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroxyChem,
    a manufacturer of hydrogen peroxide and peracetic acid and a well-positioned in high-margin specialty applications and applications
    for environmentally friendly disinfectants, was successfully acquired by Evonik for $640 million.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increased consumption of fruits and vegetables in combination with the current regulation and consumers&rsquo; demand for healthier
food has placed a greater burden on the fresh produce industry to provide food products that are fresher in quality, demonstrate
an extended shelf life and are safer to consume.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aforementioned changes provide a unique opportunity for us to introduce our products. We are aiming to become a significant player
in post-harvest green produce treatment, fully responsive to the world&rsquo;s ongoing change in fruit and vegetables consumption,
food safety requirements as well as regulations and consumer demand to eliminate the use of hazardous chemicals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Core Products</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
innovative products address what we believe to be two of the most significant challenges in the food industry: increase food safety
and reduce food loss. Our main product lines consist of a proprietary blend of organic food acids applied in post-harvest applications
designed to ensure food safety and increase fruit and vegetable&rsquo; shelf life by reducing microbial spoilage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main steps in post-harvest applications are cleaning, sanitization, and coating (wax). Our products address the cleaning and sanitization
application points which are the critical first steps for preserving the quality of fresh produce by controlling microbial contamination
related to food safety (e.g., Listeria, Salmonella, E. coli) and food loss due to microbial spoilage (e.g., fungi, mold and yeast).
In general, the current process includes an initial washing step to remove soil and other debris, which improves the product appearance
and lowers the product temperature. The next step includes sanitation or disinfection methods combined with fungicides that can
further reduce the presence and prevent the transfer of spoilage and pathogenic microorganisms on fresh produce surfaces. The
last step usually includes application of wax sometimes combined with an additional application of fungicides to prevent or reduce
physiological changes and risks of spoilage. Our main products are applied at the cleaning and sanitization steps.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the main advantages of our food acid blend is its non-toxic residues that are providing protection to the treated produce.
And we believe that all the blend ingredients are recognized by the FDA as GRAS. Moreover, they significantly reduce or eliminate
the need for additional post-harvest applications with conventional fungicide by at least 50%, and in some cases entirely, and
can reduce food waste due to spoilage by up to 50% (see results below on easy peelers and mango). Our main products are currently
being used as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Processing
    Aids &ndash; SavePROTECT or PeroStar</I>: post-harvest treatment added to fruit and vegetable wash water as a processing
    aid to increase the efficiency of the oxidizing agent present in the water tank against plant pathogens to reduce produce
    loss; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sanitizers
    - SF3HS and SF3H: </I>post-harvest cleaning and sanitizing solution to control both plant and foodborne pathogens to ensure
    both food safety as well as increase produce&rsquo;s shelf life.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Processing
Aids &ndash; SavePROTECT or PeroStar </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Processing aids are products
that are intended to be used with other products to aid the application or enhance the effect of that product. Save Foods processing
aids, which are marketed as SavePROTECT in the United States and PeroStar in Spain, Israel and Italy, are based on our
proprietary blend of food acids and are added to the wash water at the cleaning and sanitization stages simultaneously with a
low concentration of peracetic acid (&ldquo;PAA&rdquo;), a sanitizing agent. This food acid blend serves several functions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SavePROTECT/PeroStar keeps the process wash waters at a relatively low stable pH level. We have observed that low pH levels strengthen the effectiveness
    of the PAA and the fungicide used which result in increased sanitation and biocide activity;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PAA-based
    products are used as disinfectant in wash water. When used with PAA-based products, SavePROTECT/PeroStar may optimize
    the efficacy of PAA and eliminates the strong odor of PAA, creating a more friendly and safe working environment;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    used with fungicides, including imidazole, imazillil, thiabendazole, etc. &ndash; most commonly used fungicides &ndash;
    SavePROTECT/PeroStar may optimize the efficacy of the fungicides used and prevent resistance buildup;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SavePROTECT/PeroStar helps to clean the fruit surface and can improve the performance of the wax applied leading to an improved appearance of treated
    fruit by leaving a glossy finish on the outer skin of the fruit; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SavePROTECT/PeroStar helps to extend shelf life.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, we ran a series of proof of concept and small trials in collaboration with commercial partners on pears, avocado, easy peelers,
lime, mango, bell pepper, lemons, fresh cut vegetables and figs. In February 2021, we initiated a proof of concept in bananas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Results
on Easy Peelers</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Easy
peelers are citrus fruits that are easier to peel, such as tangerines, mandarins, satsumas, and clementines. As previously described,
imazalil is currently one the most commonly used fungicide that is effective in controlling post-harvest fungal pathogens in citrus.
Currently, the residues of imazalil on citrus fruit is being revised by the European Commission and have already been reduced,
and this reduction poses challenges, especially to packing houses exporting to Europe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
February and June 2020, we collaborated with the Israeli branch of one of the largest worldwide post-harvest service companies
to demonstrate the safety and ability of PeroStar to meet the new requirement of reduced residue level of imazalil and efficiently
control decay against the most common pathogens attacking citrus fruit such as Green mold (Penecillium digitatum) and sour rot
(Geotrichum candidum). The experiment simulated the applications in a packing house which tested the use of imazalil with and
without our products. The reference used in the trials to compare the results was the maximum amount of imazalil allowed and the
current treatment in the packing house which is a combination of PAA and imazalil as well as PAA alone to simulate treatment in
organic settings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
ensure the efficacy of the products, it is customary to deliberately infect the fruit with the target pathogen at a concentration
of around 10<SUP>5</SUP> and to inoculate it for 16 to 24 hours before treatment. Following the treatments, the fruit was stored
in cold storage for between 9 to 21 days and then stored in room temperature for shelf-life evaluation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
these months, we ran a series of trials from small scale/lab test (between 350 to 500 fruits per trial) to semi-commercial application
(more than 1000 fruits per trial). The semi-commercial pilots were run in Ashkelon, Israel on the packing line of Mehadrin in
Israel, a well-know and recognized citrus packer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of the trials have shown that PeroStar significantly reduced the need for additional post-harvest applications with imazalil
by at least 50%, and in some cases entirely while improving the fruit shelf life, reducing waste). In addition, the use of PeroStar
allows the packing house to meet the new limitations of imazalil utilization as well as meet its goal to apply greener and safer
products (see graph below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_001.jpg" ALT="" STYLE="height: 255px; width: 670px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, over the 2018 to 2019 and 2019 to 2020 citrus fruit seasons in the State of California, the safety of our products was
demonstrated on more than 100,000 tons of fresh produce in the aggregate, which, according to the biannual report &ldquo;Citrus:
World Markets and Trade&rdquo; published in July 2020 by the United States Department of Agriculture, represent more than 12%
of the total production in the United States of mandarins/tangerines. The United States is ranked as the number six producer worldwide
with around 800,000 tons, while Israel is ranked number ten with around 200,000 tons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Results
on Mangos</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have recently tested our PeroStar on mangos in collaboration with the Israeli-based Volcani Center for Agricultural Research.
The goal of the test was to evaluate the effectiveness of PeroStar in preventing decay in harvested mangos in comparison with
fludioxonil. Fludioxonil is a fungicide that is commercially available in Israel at a level of 250 to 300 parts per million. Fludioxonil
is deemed to be an effective fungicide against fungi that attack the mango post-harvest, yet there is a growing need for &ldquo;greener&rdquo;
solutions, given Fludioxonil&rsquo;s level of toxicity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mangos
was stored for three weeks after treatment at 12&deg;C and an additional week of shelf life at 20&deg;C in what would typically
simulate a mango crate shipment to Europe and retailers in similarly distanced markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
after evaluation have shown us that the treatment with PeroStar, improved the biocide activity of the PAA, which resulted in a
reduction in both side decay and stem-end rot (common pathogens in mango) leading to an extended shelf life with no use of fungicide
(as demonstrated in the picture below). In addition, the results also showed that the combination of PeroStar with a low concentration
of fludioxonil reduced the post-harvest decay to zero. The results (as presented in the graph below) demonstrate that applying
PeroStar enables mango producers to achieve an improved shelf life of produce compared to the current treatment while reducing
the use of conventional chemical pesticides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_7.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="img_002.jpg" ALT="" STYLE="height: 346px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Commercialization
Stage</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
a successful pilot in Mexico on Persian lime (where SavePROTECT has reduced to zero the fruit decay after 21 days as shown in
the graph below), the packing house has bought a first batch to start the utilization of our product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on these results, food retailers may benefit from additional income of up to $126 per ton of limes assuming a conservative
average price of $3,000 per ton lime (based on an average price per pound lime of $1.49 in 2019), as presented in the graph
below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
European Union is a significant target market for our organic food acid blends because of strict regulations that are being imposed
on the use of pesticides and GMO-produced crops, as well as health conscious consumers who represent a growing demand for organic
fruits and vegetables. In August 2020, we submitted a regulatory dossier for our PeroStar as a processing aid to be used with
PAA in Spain and Italy, two of the largest fruit and vegetables producers in Europe. See <B>&ldquo;</B>Government Regulation and
Product Approval&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In Israel, with the start
of the citrus season, Safe-Pack (Decco Israel) is using our product under a white label name in one of the largest
packing house in Israel.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sanitizer
&ndash; SF3HS or SF3H</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-harvest
sanitizers are considered a pesticide and regulated by the EPA in the United States. The EPA will review toxicity data and results
from tests to show how well the product kills bacteria to determine if the product should be approved. See <B>&ldquo;</B>Government
Regulation and Product Approval&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
sub-category of products is based on our proprietary blend of food acids combined with hydrogen peroxide as the oxizider and includes
SF3HS and SF3H. We believe that this category of products will be an improved sanitizer as compared to traditional sanitizers.
SF3HS and SF3H are public health antimicrobial pesticide products that bear a claim to control by at least a 3 log10 reduction
(99.9%) pest microorganisms that pose a threat to human health (foodborne pathogens), and whose presence cannot readily be observed
by the consumer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
we have finalized our toxicological studies, we conducted a series of microbial trials in laboratories in both the United States
and Israel in non-Good Laboratory Practice (&ldquo;non-GLP&rdquo;) settings in order to evaluate the efficacy of SF3H as an antimicrobial
agent to reduce foodborne pathogenic bacteria in &ldquo;processing water&rdquo; for fruit and vegetables. We used a modification
of the Association of Official Agricultural Chemists Germicidal and Detergent Sanitizing Action of Disinfectants method and test
protocol EN1276 (European standard for the evaluation of chemical disinfectant or antiseptic for bactericidal activity). The tested
organisms are Listeria monocytogenes, Salmonella enterica and Escherichia coli O157:H7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
last test was performed by Analytical Lab Group on a mix culture of Listeria monocytogenes with an exposure time of 30 seconds.
The results showed more than 99.99999% (&gt;7.51 Log10) reduction. In Israel, the tests were performed by the Institute for Food
Microbiology and Consumer Good Health on a single strain for each pathogen (Listeria monocytogenes, Salmonella typhimurium and
E. coli) with exposure time of 30 seconds and the results have shown between 99.99% to 99.9999% reduction. Exposure time is a
key parameter in sanitization process, therefore allowing a short contact time is a significant advantage over the competition
where the current minimum contact time available is 45 seconds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to conduct GLP efficacy studies during the first half of 2021 to complete our regulatory dossier for the EPA and the
FDA to obtain the appropriate regulatory approvals for our products to be marketed and used as &ldquo;sanitizers&rdquo; to claim
control of foodborne pathogens (food safety) as well as plant pathogens (food loss reduction). We plan to submit our regulatory
dossier during the second half of 2021. It is planned that SF3HS/SF3H will be used in post-harvest to control both plant
and foodborne pathogens for fruit and vegetables (including microgreens). For additional information regarding the regulatory
approval process see &ldquo;Government Regulation and Product Approval&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Results
on Avocados</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have tested the efficacy of our SF3H and SF3HS products against Listeria on 40 avocados of which 10 avocados were treated with
our SF3H and SF3HS products. The peel of the avocado was punctured and infected with high level of Listeria. The results have
shown a 99.99% reduction within fifteen seconds of exposure time. In addition, we have also tested the efficacy of SF3H on avocado&rsquo;s
shelf life compared to current treatments (12 avocados per treatment). The results (demonstrated below) show that after 18 days
in room temperature the treated avocados display material reduction in microbial spoilage as compared to avocados treated with
water and chlorine, a well-known sanitizer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_8.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Results
on Microgreens</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
increasing number of studies point to the growing demand for locally sourced, organic vegetables. Various types of &ldquo;young
vegetables,&rdquo; such as sprouts, microgreens and baby greens, are becoming increasingly popular due to their high nutritional
value. Microgreens are deemed premium products and command higher retail value. They also belong to a group of &ldquo;functional
foods&rdquo; and have high levels of bioactive compounds, while requiring less water and energy to grow, which they do year-round.
Currently, microgreens are largely being cultivated in major greenhouses across the United States. According to Agrilyst, an agro-intelligence
platform, greenhouse cultivation of microgreens was the highest in South and North East regions, each accounting for 71% and 59%
in 2017. While consumers in the United States are more focused on growing leafy greens and microgreens than any other vegetables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have tested the efficacy of our SF3H products to control and prevent potential pathogen contamination on microherbs (pea and sorrel)
produced by Israeli-based microgreens exporter 2BFresh. Our treatment combined a post-harvest spray application and a fogging
treatment to be used in the cooldown storage room. In order to determine the efficacy of the product, 25 swabs were taken across
18 trays (nine of each microgreen species). The results (as presented herein) show more than a 90% reduction of the total bacterial
load post-treatment (see table).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our SF3HS and SF3H provide improved sanitization of bacteria (including E. coli, Salmonella and Listeria) while leaving
no toxic residues on fruits and vegetables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect the first commercialization of SF3H and SF3HS at the earliest by the end of the first half of 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Products</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product portfolio also includes the <I>SpuDefender</I> and <I>FreshProtect</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>SpuDefender</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SpuDefender
is one of our EPA-registered products which targets and is designed to control the post-harvest potato sprout. Due to the European
Commission&rsquo;s decision on January 1, 2020 to no longer allow the use of the herbicide chlorpropham (the &ldquo;CIPC&rdquo;),
the post-harvest potato industry is looking for new solutions. For over 50 years, CIPC was widely used as a sprout suppressing
agrochemical agent applied to potatoes that were stored in processing facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
recent discussions with post-harvest experts and potential customers, we believe our SpuDefender product may offer a successful
alternative to CIPC. During 2021, we plan to initiate pilot tests with potential customers to treat potatoes pre-storage (three
to six months storage in average).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>FreshProtect</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FreshProtect
is our second EPA registered product, which targets and is designed to control spoilage-creating microorganisms on post-harvest
citrus fruit. The registered label of the product only allows us to market and sell our FreshProtect in the United States (excluding
California). However, we believe our FreshProtect has a significant potential in reducing the bacterial load entering the packing
house in the pre-harvest market. The non-toxicity of our FreshProtect allows its application up to the day of harvest (0-day pre-harvest
interval), which is critical to prolong crop protection and reduce microbial spoilage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recently ran a proof of concept study under a controlled group environment of different plant fungi responsible for decay which
showed promising initial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also conducted a series of smaller studies, consisting of laboratory tests and tests on a limited number of lemon trees whereby
we demonstrated significant reduction of decay in treated fruit and reduction in bacterial populations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main conclusions of the trials were that FreshProtect with concentration of 1% and 2% applied at 400 gallons per acre materially
reduced sour-rot on inoculated fruit. While both rates were also effective against fruit inoculated with <I>P. digitatum</I>,
(i.e. fungus found in the soil of citrus-producing areas and major source of post-harvest decay), the 2% concentration of FreshProtect
demonstrated significantly more efficacy at reducing sour-rot. Natural incidence of <I>Penicillium spp.</I> (a family of fungi)
was also reduced on fruit inoculated with <I>G. candidum</I>, fungus that is a member of the human microbiome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
FreshProtect can be used in combination with several different kinds of pesticides and fertilizers which allows the application
of more than one pesticide at once. This in turn reduces cost and facilitates implementation. The graph below summarize these
results:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_9.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulation for pre-harvest (in the field) application especially in California as well as in Israel may take more time than post-harvest
application due the potential impact on the environment. Therefore, we expect the product to reach the market during 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strengths</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our main strengths include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Strong
    Management Team with Commitment to Green Products</I></B>. Led by a team with over 30 years of experience in developing sanitization
    products and solutions for the agriculture industry, we plan on becoming a significant player in providing consumers with
    healthy and green fresh produce from farm to fork while endeavoring to ensure food safety and reducing food waste. We believe
    that our proprietary blend of food acids provides protection to the treated produce and works in synergy with well-known fungicides
    and sanitizers. This synergy allows us to significantly reduce the concentration of the fungicides that are heavily regulated
    in several countries and, in certain countries, outright banned and meet the food trends of sustainable and green produce.
    </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Multi-Purpose
    Products that Simplify Crop Treatment Routine and Save Money</I></B><I>. </I>While most chemicals marketed in the industry
    address either food safety or food waste, our multi-purpose products are intended to provide a solution for both problems,
    while simplifying crop treatment and achieving cost saving. Our products are capable of cleaning and controlling pathogens
    that would otherwise render fresh produce as unsafe for human consumption. Our proprietary blend of food acids combined with
    well-known sanitizers are very efficient against foodborne pathogens like E. coli, Salmonella and Listeria as well as plant
    pathogens in short contact time (99.999% reduction within 30 seconds of contact). In addition, with multipurpose products,
    there is no need to order, ship or dispose of bottles of product, resulting in less energy consumed, less CO2, less fuel,
    and less waste. We believe our focus on natural product chemistries will allow us to continually drive lower costs, higher
    product gross margins and efficacy through longer shelf life and reduction of food waste.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Strong
    Intellectual Property Portfolio</I>. </B>We believe that we have built a strong intellectual property position throughout
    the food chain (from field to fork) as our patents claim compositions and methods that can be used to protect food and agricultural
    products from decay. We rely on a combination of important intellectual property assets, to protect our innovation. Our employees,
    consultants, customers, and vendors are subject to confidentiality agreements that protect our proprietary manufacturing processes.
    Our patent portfolio includes granted patents in the United States, Europe, and Israel, as well as several priority applications,
    across several patent families, including composition-of-matter claims, methods of use claims, including for treating edible
    matter, for improving the appearance of edible plant matter, and sterilization methods, as well as for articles for implementing
    these methods. These patents directly protect a proprietary method for extending life shelf and reducing edible matter from
    microbial decay.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Commercially
    Available Products and Seamless Implementation</I></B>. One of the oxidizers being used with our products is PAA, a well-known
    and widely used sanitizer. Following the enforcement of the FSMA in connection with the use of sanitizers, more and more packers
    have been choosing this healthy and eco-friendly sanitizer over chlorine, and this choice facilitates implementation of our
    products. In addition, the application of our products does not require special equipment as they are used in combination
    with or replace existing products applied on the packing line or in the mix tank in the field. This allows a relatively cheap,
    seamless and fast implementation. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Significant
    Reduction of Hazardous Chemicals Food Residue</I></B><I>.</I> Our blend of food acids is recognized by the FDA as GRAS, while
    oxidizers we use rapidly decompose into water and oxygen (or oxygen and acetic acid). The absence of toxicological residues
    not only improves food quality but also promotes occupational safety for the employees of packing houses, contributing to
    a friendlier and safer working environment. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
September 2018, the Company changed its organizational structure and management team. After reviewing the Company&rsquo;s then
existing strategy and results of operation, as well as examining the market opportunities, the new management team decided to
update the Company&rsquo;s strategy, reduce the marketing and sales of its existing products, and focus the Company&rsquo;s efforts
and financial resources in developing its next generation products. During the years 2019 and 2020, we developed, validated and
tested the efficacy of our next generation product &ndash; a blend of food acids &ndash; on a variety of crops in small and large
scale commercial pilots. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
strategy is to develop and commercialize our products through strategic partnerships with global post-harvest service companies
and with large food distributors and retailers with the intent of: (i) extending the shelf life of fresh produce while reducing
(and even eliminating) the use of harmful chemicals (fungicides); (ii) ensuring food safety and shelf life by controlling foodborne
pathogens and allow our customers to meet FSMA regulatory requirements; (iii) reducing food loss and the associated carbon &ldquo;footprint.&rdquo;
Our ultimate goal is to eventually gain presence in a variety of businesses compromising the food industry, including pre-harvest,
post-harvest, retail and consumer businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
order to achieve our goals, we intend to: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Advance
    our Breakthrough Technologies and Commercialization Efforts</I></B>. During the first half of 2021, we plan to run a series
    of additional pilot studies in various commercial collaborations with post-harvest service vendors packing houses and food
    retailers. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Develop
    a Strong Marketing Message Around Promoting Safe Food While Avoiding Food Waste</I></B>. We plan to brand our fresh produce
    with a &ldquo;chemical residues free&rdquo; seal of approval and we believe that like-minded fruit packers around the globe
    will seek to differentiate themselves from their competitors by obtaining this seal.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Acquire
    or License Complementary Products and Technologies</I></B>. We actively search for products and technologies that can enhance
    our portfolio and grow our business to address all the post-harvest treatments such as fruit coating products or technologies.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Expand
    to Additional Produce and Geographies</I></B>. Our plan is to focus first on key countries and regions with the largest markets
    for our crops, including Mexico, Spain, Italy, Israel and key markets in the United States such as California, Florida and
    Texas. We are also plan to increase the variety of crops that can be treated with our products, to include produce such as
    apples, bell peppers, tomatoes and papayas.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Leverage
    Our Products Through Collaborations</I></B>. Our focus and expertise in the development of green products for the agritech
    industry and in post-harvest treatments allow us to be a partner of choice for other businesses looking for development partners
    and for larger companies wanting to leverage their product such as PAA into new combination products. For example, companies
    selling or owning fungicides, the MRL of which is being reduced, and that are working in synergy with our products are good
    partners. This type of collaboration could allow them to continue selling their product.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    selling and marketing strategy is twofold: </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Establish
    Collaborations with Food Retailers</I></B><I>.</I> Large food retailers play an important role in influencing the decisions
    of key suppliers down the food chain (i.e. they can dictate to their suppliers which cleaning solutions they will use when
    treating the fresh produce at their packing house).  Food retailers must ensure food safety as well as reducing food loss occurring during distribution,
    storage and retail. In the United States alone, 4.65 million tons of fresh produce were thrown away at the retail level. This
    waste cost $8.9 billion and amounted to 12% of the U.S. fresh fruit supply and 10% of the fresh vegetable supply. With an
    average percentage of 5% of all strawberries, apples, avocadoes, tomatoes and broccoli in the United Kingdom and 12% and 10%
    of the fresh fruit supply and fresh vegetable supply in the United States, respectively, wasted at the retail and/or distribution
    level, we believe even a small reduction in fresh produce loss can generate large savings.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Partner
    with Service Vendors to Fruit and Vegetable Packing Houses</I></B><I>.</I> Post-harvest service companies provide packing
    houses with the necessary machinery and products, such as sanitizers and fungicides to enable the packing houses to treat
    the produce. Post-harvest service companies face competition due to the current regulations that dictate specific types of
    treatment products and set tolerable residue levels. In addition, these companies must provide their packing houses with state
    of the art, cost effective and green product to incentivize the packing houses to build long-term business relationship with
    them. Moreover, service vendors are important because they have strong influence on the decision of which cleaners, sanitizers,
    fungicides and waxes that the fruit and vegetable packing houses will use. Additional benefit of partnering with post-harvest
    service company is their strong global market presence in the relevant geography. In addition, both food retailers and post-harvest
    service companies have a significant interest in green and efficient post-harvest solutions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
and Marketing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
concentrate our marketing efforts on high value crops, such as avocado, mango, citrus, apples, pears, bananas, papaya, bell pepper,
lettuce and tomatoes and target large producers of these crops as well as large food distributors and retailers. As of the date
of this prospectus, we are exploring collaboration opportunities for our SavePROTECT or PeroStar with producers
in the United States, Spain, Israel, Italy and Mexico. And we intend during the next 12 months to initiate commercial collaboration
with local packers and retailers in our first targeted location previously mentioned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the market opportunities for selected produce in our target markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bananas</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Apples and Pears</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Avocados</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Citrus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Mangos</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Papayas</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tomatos</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Lettuce and Chicory</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Chilli and Green Peppers</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total (in milion tons)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Global Production of the Crop (in million ton)<SUP>1</SUP></B></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">114.2</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">108.2</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">147.9</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">52.3</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">13.1</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">180.5</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">27.5</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">35.8</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">685.5</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Production of the Crop in the Company&rsquo;s Target Markets <SUP>2</SUP> (in million ton)</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.6</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28.0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84.7</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Production of the Crop in the Company&rsquo;s Target Markets (in %)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1.</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    global production for the years 2016, 2017 and 2018.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2.</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    target markets include Israel, Italy, Mexico, Spain and the United States. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
support our efforts, we will increase our marketing and sales team as well as services in our target location to support all our
efforts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
States</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
first market we target for the sale and distribution of SavePROTECT is the post-harvest citrus industry in <FONT STYLE="background-color: white">the
State of </FONT>California, which alone accounts for approximately 80% of all fruits and vegetables in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the last three years, we have treated more than 180,000 tons of citrus fruit with the different version of our SavePROTECT product.
Under the supervision of a world leading packing house to the citrus fruit industry, we evidenced SavePROTECT utility as having
a good safety profile, ensuring food safety and in controlling microbial spoilage. We plan to leverage this collaboration in order
to further penetrate the citrus based fruit packing industry, both in California and beyond.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Post-harvest treatment market for fruits and vegetables, which is projected to grow from $1.5 billion in 2019 to $2.3 billion
by 2026, growing at a CAGR of 6.5% during the forecast period, is led globally by select companies, including DECCO U.S. Post-Harvest,
Inc., (United States), Pace International, (United States), Xeda International (France), John Bean Technologies (United States),
and Agrofresh (United States).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
we have completed our studies and secured the appropriate regulatory approvals, we plan to further penetrate this market. We currently
focus on post-harvest treatment for the citrus industry (as well as mangos and avocados) but are conducting pilot studies with
leading players in the industry to evaluate and validate our products formulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan on commencing one commercial pilot study with a global food retailer by the end of the first quarter of 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2020, we entered into a non-exclusive commission agreement with Earthbound Technologies, LLC (&ldquo;EBT&rdquo;)
for a period of 12 months, according to which EBT will introduce us to potential clients, pre-approved by us (the &ldquo;Introduced
Parties&rdquo;) and will assist us in finalizing commercial agreements with the Introduced Parties. In consideration for its services,
we agreed to pay EBT 12.5% of the net revenues generated from the Introduced Parties (during the agreement period and within 18
months following the termination of the agreement) up to a total aggregated amount of $2,000,000, provided that the compensation
shall not exceed 25% of our gross profit under the given commercial agreement signed with the Introduced Party. In addition, in
the event that the aggregated net revenues generated from the Introduced Parties exceeds $500,000, and subject to the approval
of our board of directors, we will issue to EBT 7,143 options to purchase 7,143 shares of Common Stock at an exercise price of
$8.4 per share. In the event that certain additional events detailed in the agreement occur, we will also issue to EBT, subject
to the approval of our board of directors, an additional 7,143 options to purchase 7,143 shares of Common Stock at an exercise
price of $8.4 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Israel</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September 11,
2020, we signed a five-year exclusive distribution agreement (the &ldquo;Distribution Agreement&rdquo;) with Safe-Pack
Products Ltd. (&ldquo;Safe-Pack&rdquo;), according to which we granted Safe-Pack an exclusive right to resell, distribute,
advertise, and market ours products in the citrus industry in Israel and Palestine. In addition, we agreed to grant
Safe-Pack a right of first refusal to be designated as an exclusive distributor of ours in certain agreed upon territory
for additional products of ours in the post-harvest market. In consideration for the above rights granted to Safe-Pack,
Safe-Pack will submit to us purchase orders of our products at a price specified in the Distribution Agreement.
Commencing upon the second calendar year of the agreement, Safe-Pack is required to meet a minimum purchase quota, as shall be
mutually agreed upon between the parties. In the event that the parties fail to agree on a quota, the quota shall be equal to
last year quota plus 3%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Spain</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have been collaborating with one of the world&rsquo;s leading post-harvest treatment service vendors in Spain since June 2020,
where we are examining our product on citrus fruit. We believe our product could be an improved alternative to current fungicides
that will soon be significantly reduced in this market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Mexico</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are planning a series of studies in which our SavePROTECT will be applied on tomatoes, bananas, lemons, bell peppers and avocados.
The first study to ensure safety of avocados is planned for the first quarter of 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
August and October of 2020, we have conducted three successful trials in Mexico, on more than 200 kilograms of Persian limes.
The results have shown that the addition of SavePROTECT to current treatments extend shelf life. Shelf life was tested for 25
days and results have shown that SavePROTECT substantially reduces decay. Mexico is the largest producer of Persian limes and
is deemed to be that country&rsquo;s second most important citrus fruit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on patents and trade secret protection laws to protect our proprietary products and intellectual property. We entered into
confidentiality agreements with our employees, consultants, customers, service providers and vendors that cover, inter alia, our
technology and proprietary manufacturing processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we own five issued patents, one allowed patent, and seven pending patent applications, four of
which may be submitted worldwide. Expiration dates of our patents, and any patents which may be granted under our pending patent
applications, are from 2031 through 2041. Our patent family includes patents granted in Israel, the United States and Europe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compositions
and Methods of Treating Edible Matter and Substrates Therefor </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family includes granted patents in the United States, Israel, and an allowed application in Europe and is directed to a
method for protecting edible matter from decay by applying to the edible matter a disinfecting composition containing, among other
things, (1) phosphonic or phosphoric acid, (2) a carboxylic acid, (3) performic acid, (4) a performic acid source (such as formic
acid) and an oxidizer (such as hydrogen peroxide).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application/Patent
    Number</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Priority
    Date</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SVF-P-001-EP</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowed</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11825901.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    14, 2010</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SVF-P-001-IL</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">225247</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    14, 2010</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SVF-P-001-IL1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">254909</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    14, 2010</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SVF-P-001-US1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,212,956</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    14, 2010</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SVF-P-001-US2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/278,108</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    14, 2010</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Methods
for Improving the Appearance of Edible Plant Matter</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family includes a granted patent in Israel and is directed to a method of improving the appearance of edible plant matter
either during the pre-harvest or post-harvest stage. The method includes applying a composition based on phosphonic acid to the
edible plant matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">File Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Application/Patent Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Priority Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%">SVF-P-002-IL</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%">Israel</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Patent</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Issued</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: left">229724</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 24%">May 30, 2011</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Method
and Apparatus for Maintaining Fresh Produce in a Transportation Container</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family includes granted patents in Israel and in the United States. The patent family is related to a method of using thereof
for maintaining fresh produce stored in a transportation container. The apparatus is configured to generate an aerosol of one
or more liquid pesticides, thereby reducing pathogenic contamination within the transportation container. This patent family covers
any liquid pesticide for use in the above-mentioned apparatus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">File Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Application/Patent Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Priority Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%">SVF-P-003-IL</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%">Israel</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Patent</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Issued</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">227328</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%">June 23, 2013</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>SVF-P-003-US</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD>Patent</TD><TD>&nbsp;</TD>
    <TD>Issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9,487,350</TD><TD>&nbsp;</TD>
    <TD>June 23, 2013</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sterilization
Compositions and Methods for Use Thereof</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family is directed to compositions and methods for reducing pathogen load within a container or on a surface, including
inter alia the surface of an edible plant matter. Furthermore, the application is directed to compositions and methods for disinfection
of cooling systems.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">File Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Application/Patent Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Priority Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%">SVF-P-004-USP</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: left">United States</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Patent</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Pending</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">63/111,197</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%">November 9, 2020</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sterilization
Devices and Methods for Use Thereof </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family is directed to a device for controlling pathogen load within a container or on a surface by spraying a disinfecting
composition in response to a trigger, such as increased pathogenic contamination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">File Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Application/Patent Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Priority Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%">SVF-P-005-USP</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: left">United States</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Patent</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Pending</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">63/111,220</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%">November 9, 2020</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compositions
Comprising of Several Organic Acids and Use Thereof </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family is directed to kits and methods for controlling pathogen load within or on the surface of an edible plant matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: center">File Number</TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 20%; font-weight: bold; text-align: center">Country</TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">Type</TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">Status</TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Application/Patent Number</TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 21%; font-weight: bold; text-align: center">Priority Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>SVF-P-006-PCT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">International application</TD><TD>&nbsp;</TD>
    <TD>Patent</TD><TD>&nbsp;</TD>
    <TD>Pending</TD><TD>&nbsp;</TD>
    <TD>PCT/IL2021/050229</TD><TD>&nbsp;</TD>
    <TD>March 1, 2020</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Combined
Fungicidal Preparations and Methods for Use Thereof</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
patent family is directed to compositions and to methods for reducing pathogen load on a substrate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">File Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Application/Patent Number</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Priority Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%">SVF-P-007-USP</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: left">United States</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Patent</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%">Pending</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">63/042,622</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%">June 23, 2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>SVF-P-007-USP1-07931-P0004B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD>Patent</TD><TD>&nbsp;</TD>
    <TD>Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">63/126,649</TD><TD>&nbsp;</TD>
    <TD>December 17, 2020</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot be sure that any patent will be granted with respect to any of our pending patent applications or with respect to any patent
applications filed by us in the future. There is also a significant risk that any issued patents will have substantially narrower
claims than those that are currently sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
that the market for the use of green and &ldquo;residue free&rdquo; solutions is evolving, we are continually facing growing competition.
The market for post-harvest solutions is fragmented and includes various regional suppliers. The market of post-harvest treatments
for fruits and vegetables is dominated by five large players with wide reach across the globe. We believe that a market edge will
be given to a company that can solidify its reputation, product quality, customer service and customer intimacy, product innovation,
technical service and value creation. Based on these variables, we believe that we compete favorably when compared with the global
competition in this market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
our main competitors are companies providing PAA, chlorine and other sanitization solutions, such as Ozone as well as technology
companies developing new biorational fungicides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_10.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also compete with heavily diversified multi-national chemical conglomerates, who produce various biocide formulations designed
to kill or deactivate pathogenic micro-organisms. Of these, two companies are the most significant:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Peroxychem</I>:
    Peroxychem is a subsidiary of Evonik Industries AG (Germany). It is a significant worldwide producer of hydrogen peroxide,
    persulfates and PAA. Peroxychem expected revenue of approximately $300 million in 2018; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Solvay
    (Belgium)</I>: Similar to Evonik Industries, Solvay is a heavily diversified multinational chemical conglomerate. In fiscal
    year 2019, the company had approximately &euro;10.2 billion in net sales, spread across the breadth of their product lines.
    Most relevant to us is their blends of PAA and hydrogen peroxide, sold in two primary formulations &ndash; OXYSTRONG for water
    treatment and PROXITANE for the food industry.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we have several indirect competitors, which are companies with whom we seek to make strategic partnerships &ndash; large
companies specializing in post-harvest solutions for the agricultural industry. Such companies include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Decco
    US Post-Harvest</I>: Decco is a subsidiary of Decco Worldwide, which itself is a division of United Phosphorous Ltd. Decco
    provides a variety of solutions, both mechanical and chemical, for the post-harvest industry. They produce conventional fungicides
    (imazalil, thiabendizole, etc.), as well as produce coatings; and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pace
    International</I>: Pace International is a subsidiary of the Sumitomo Chemical Company. Similar to Decco, it provides a variety
    of solutions &ndash; primarily in the realm of conventional fungicides and carnauba wax coatings for fruit.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consider Xeda International, JBT and Agrofresh as our indirect competitors (and current or potential collaborators).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
organic market offers a huge trade and income potential for producers, processors and trading companies globally. The rising demand
of various organic products has driven the demand of organic post-harvest treatments. Green and organic technologies are increasingly
being developed in a global market and several conventional post-harvest product and equipment suppliers, such as Citrosol, Fomesa
and Peroxychem, have taken the opportunity and are starting to develop natural products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and Development</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the last two years we spent an aggregate of $1,032,623 on research and development. We focus on developing innovative solutions
consisting of new generation, patented products that address immediate and long-term needs. Our research efforts are aimed at
optimizing the application protocols of our existing core products such as PeroStar/SavePROTECT for new crops, developing new
blend of acids and enhancing our SF3H/SF3HS products&rsquo; antimicrobial efficacy while taking into account costs, consumers
trends and preferences, which will give the extra value needed to separate our products from those of our competitors in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Post-Harvest</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently working on the compatibility and synergistic effect of our processing aids products SavePROTECT/PeroStar with additional
post-harvest treatments used in the packing house to provide an efficient, greener and cost-effective solution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also focused on the characterization of our new s<FONT STYLE="background-color: white">anitizers</FONT> including the identification,
improvement and other validations of our formulas. These products are based on a unique stabilization process that blends hydrogen
peroxide and food acids to create a broad-spectrum, safe and eco-friendly solution for killing germs. The synergistic effects
of combining hydrogen peroxide with food acids produce a stable yet environmentally safe and easy to handle sanitizer. We use
a network of experts in related fields, such as microbiology, and food chemistry to obtain all the required regulatory approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we are in the initial stages of development of natural antimicrobial edible coatings for microbial safety and food quality
enhancement comprising our acid blend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
accurately test the strength of a sanitizing solution, we are working on developing quantitative methods. Similarly, we are developing
analytical methods that will enable rapid and effective monitoring of the active ingredients through a novel and improved testing
kit that allows for testing at a faster pace and with greater certainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pre-Harvest
&ndash; FreshProtect</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also focused on developing new eco-friendly pre-harvest products which will improve post-harvest management practices by reduction
of total microbial load, before even entering the packing house. An effective pre-harvest treatment may reduce the need for post-harvest
chemical fungicides while increasing profit through reduced spoilage in supply chains. In addition, the potential of addressing
pre-harvest treatment might offer new opportunities for treating crops, such as rice and wheat, with large market potential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pre-harvest application, one of the main advantages of our products is the non-toxicity of its ingredients, allowing its application
up to the day of harvest (0-day pre-harvest interval), which is critical to prolonged crop protection and reduced microbial spoilage
while reducing the total bacterial load entering the packing house. Field studies are conducted by Dr. James E. Adaskeveg from
University of California, Riverside and the largest grower cooperative in CA in the United States on citrus trees to determine
the effectiveness, optimize use protocol and effect on the environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Production</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Israel, we work with SasaTech, a reputable chemical production company. Based on our formulation and guidance, SasaTech is producing
our PeroStar and any other small-scale formulation that we might need for research and development purposes and trials. SasaTech
is particularly regarded for its deep understanding and experience working with oxidizer like hydrogen peroxide and PAA. We also
work with Zohar Dalia which we engage on a case-by-case basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States we work with Seeler Industries, a national leader in marketing, handling, and in the termination of hydrogen
peroxide. Both Seeler and SasaTech, purchase all raw materials necessary for the production of our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
ingredients and/or raw materials that are used in the creation of our products are commodities and are readily available for purchase
off the shelf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulation and Product Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to national, state and local government regulation. Based on the product claims and classification, different regulatory
and registration requirements will apply per country or state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Regulation
of our Sanitizers &ndash; SF3H and SF3SH</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the Unites States, the federal laws that regulate the sale and distribution of our sanitizers include the Federal Insecticide,
Fungicide and Rodenticide Act (the &ldquo;FIFRA&rdquo;) and the Federal Food, Drug and Cosmetic Act (the &ldquo;FFDCA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIFRA
is the federal law that regulates the sale and distribution of pesticides and is administered by the EPA. Products that claim
to control microorganisms on inanimate surfaces, in water and on raw foods are regulated as pesticides. FIFRA requires the pre-market
registration or licensing of pesticide products. To register a pesticide product, we are required to provide test data and related
information to demonstrate that the product is safe and effective under the conditions of use, as specified on the product label.
The cost and timeframe to achieve EPA product registration depends on the type of product and the claims made for the product.
Registered products are also subject to a number of recordkeeping and reporting obligations which require constant product oversight
by companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FFDCA regulates the sale and distribution of drugs, medical devices, cosmetics and foods and is administered by the FDA. Under
FFDCA, the FDA does not register products that are used on food. However, all substances that are used on food, need to be approved
by the FDA. If all the substances or ingredients in a certain product were approved by the FDA for use on food, then a company
can market a product without obtaining a pre-market clearance if the product uses conforms to the regulations. If the substance
in a product is GRAS, then pre-market clearance is not necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Antimicrobial
products applied to processed food are solely regulated by the FDA, even though the intent of such product is to control a pest
(microorganism). Antimicrobial products applied to raw foods (e.g. fruits and vegetables) are jointly regulated by the EPA and
the FDA if application takes place in a food-processing facility. The federal authority to regulate pesticides is found in FIFRA
and the Code of Federal Regulations (&ldquo;CFR&rdquo;), Title 40, Parts 150 to 189. The EPA is responsible for regulating pesticides
at the federal level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our sanitizers, the focus is directed towards the FIFRA. To complete our registration process, we will be required to submit several
studies in the form of a registration dossier, which has not yet been submitted to either the EPA or the FDA. These studies will
specifically include: (i) six acute toxicity studies (already finalized), (ii) physio-chemical properties testing (already finalized),
(iii) one-year storage stability and corrosion (ongoing), and (iv) an efficacy test to confirm the product activity as a sanitizer
(studies conducted under non-good laboratory practices already performed). We have already identified and engaged with a third-party
company in the United States to perform our good laboratory practices efficacy studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, every state has its own laws that requires registration of pesticide products and, therefore, regulates the sale and
distribution of these products. Accordingly, products must also be registered in the states in which they are distributed prior
to any commercial sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Regulation
of Our Processing Aid &ndash; SavePROTECT or PeroStar</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, our SavePROTECT complies fully with CFR Title 40, Part 180.91, which lists inert ingredients exempt from the
requirements of tolerance, and CFR Title 21, Part 173.315, which lists chemicals used in washing or assisting in the peeling of
fruits and vegetables, and can be marketed in the United States (with exclusion of the State of California).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
California, processing aids labeled solely for manufacturing use or repackaging into end-use spray adjuvants do not require registration.
However, processing aid products, such as SavePROTECT, with labels that include both manufacturing or repackaging and end-use
directions require registration with the California Department of Pesticide Registration (the &ldquo;CDPR&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 31, 2020 we have submitted an &ldquo;Application for Registration of Adjuvant&rdquo; for our SavePROTECT to the CDPR. The
dossier submitted included the following studies: (i) acute oral toxicity study and acute dermal toxicity study, (ii) physio-chemical
properties testing (determination of color, physical state, odor, density, pH, viscosity and oxidation/reduction chemical incompatibility),
(iii) validation of the high-performance liquid chromatography method assay, (iv) stability test, and (iv) efficacy data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, based on the opinion of our U.S. regulatory experts, all SavePROTECT ingredients are GRAS substances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the second half of 2021 we plan to submit an application for certification for our SavePROTECT to the Organic Materials Review
Institute (the &ldquo;OMRI&rdquo;), an international nonprofit organization that determines which input products are allowed for
use in organic production and processing. OMRI Listed&reg; products are allowed for use in certified organic operations under
the Unites States Department of Agriculture (the &ldquo;USDA&rdquo;) National Organic Program. OMRI reviews input products to
verify that they meet the organic standards for use on organic farms or in organic processing. OMRI is recognized by the USDA
National Organic Program as a reputable third-party input reviewer in Interim Instruction 3012 of the NOP Handbook. In addition,
OMRI is accredited under the International Organization for Standardization (ISO) 17065 by the USDA Quality Assessment Division.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Europe, processing aids are defined as substances that are added to exert a technological function during food processing and
which may end up in the finished product. According to Regulation (EC) No. 1333/2008, processing aids means any substance which
(i) is not consumed as food by itself; (ii) is intentionally used in the processing of raw materials, foods or their ingredients,
to fulfil a certain technological purpose during treatment or processing; and (iii) may result in the unintentional but technically
unavoidable presence in the final product as residues of the substance or its derivatives, provided they do not present any health
risk and do not have any technological effect on the final product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
aids are differentiated from food additives, which are substances that are added to food with the intention to exert a technological
function within the final food product. Therefore, processing aids must not follow the European Food Safety Authority (the &ldquo;EFSA&rdquo;)
guideline of &ldquo;Data Requirements for the Evaluation of Food Additive Applications.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Europe, our PeroStar is not considered a processing aids in the enzymatic preparation category and, therefore, PeroStar is only
regulated at the national level. While there are no harmonised requirements regarding the registration of a processing aids, some
data (such as full composition and some toxicological data) must be disclosed and discussed with the competent authorities before
the submission of a registration request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Spain, the guidelines for precise documentation for evaluation of technological adjuvants intended to be used in human food, state
specific conditions for the assessment, authorisation and use of all other types of processing aids, which are not processing
aids in the enzymatic preparation category. We have submitted during the third quarter of 2020 a regulatory dossier as a processing
aid for PeroStar in Spain and Italy with very similar information as the regulatory dossier submitted in California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Mexico, based on the product composition and the legal status of the substances to be used as food additives, our PeroStar/SavePROTECT
can be marketed and used in Mexico as a food additive (processing aid) and no registration is required (pending the final confirmation
from Mexican government).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Israel, the guidelines of the National Food Services, Ministry of Health, define the requirements for cleaning and disinfectant
agents used with food. These guidelines state that such cleaning and disinfectant agents applied to the cleaning equipment which
comes into direct contact with food, must not contain carcinogens. Specifically, List A and List B published by the Inter-ministerial
Committee on Carcinogens, Mutagens and Teratogens of the Ministry of Health identify products and ingredients with carcinogenic,
mutagenic and teratogenic properties. Our regulatory consultant in Israel has confirmed that our PeroStar does not contain carcinogens,
mutagens and/or teratogens, and, therefore, is considered approved in terms of the relevant regulations of the National Food Services,
Ministry of Health, and can be used as an additive to cleaning and disinfectant agents for fresh produce.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Registration
of Our SpuDefender and FrehProtect</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have registrations for our SpuDefender (EPA Reg. No. 86381-1) and our FreshProtect (EPA Reg. No. 86381-2), at both the
federal level and in the individual states where the products are sold for the use in post-harvest settings. To allow the utilization
of our FreshProtect in pre-harvest settings, additional studies will need to be submitted to the EPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Organizational
Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have one 98.94% owned subsidiary: Save Foods Ltd., which is incorporated in the State of Israel. Save Foods Ltd. is
responsible for all of our research and development and sales activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
and Facilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development and manufacturing operations are currently conducted at Kibbutz Alonim (Israel) where we lease approximately
70 square feet of space to run our lab studies. The lease expires on December 31, 2021. Our current monthly rent payment is NIS
4,846 (approximately $1,400) which includes taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
believe that our current office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for
the conduct of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 10, 2021, we employ two full-time employees and four part-time employees. None of our employees are members of a union
or subject to the terms of a collective bargaining agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently subject to any material legal proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
History</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated under the name Pimi Agro Cleantech, Inc. on April 1, 2009, under the laws of the state of Delaware. On April
11, 2016, we changed our name from Pimi Agro Cleantech, Inc. to Save Foods, Inc. Our subsidiary was incorporated on January 14,
2004 under the name Pimi Marion Holdings Ltd., to exploit the knowledge, intellectual property and business assets of Nir Ecology
Ltd., a company founded in September 1989, focused on developing sanitizing solutions for the water and food industry. During
the initial years of its activity and until 2009, Pimi Marion Holdings Ltd. focused on the development of new products and applications
within the potato-growing industry. On October 5, 2008, Pimi Marion Holdings Ltd. changed its name to Pimi Agro Cleantech Ltd.
In September 2018, we changed our organizational structure and leadership team to support our new strategy and objectives. The
goal of the organizational change was to drive the Company towards regulatory approvals for our new generation of products. Our
revamped strategy was developed following research we conducted on the applicable and potential commercial markets for our products.
The results of this research demonstrated a clear and significant market for our new products to be deployed as sanitizers for
the agricultural and food tech industries. On May 2, 2019, Pimi Agro Cleantech Ltd. changed its name to Save Foods Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="man_001"></A>MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Executive
Officers and Directors </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding our executive officers, key employees and directors as of the date of this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 26%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 64%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Prof. Benad Goldwasser <SUP>(1) (11)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">69</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">David Palach</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">55</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dan Sztybel</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">43</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer of Save Foods Ltd. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Shlomo Zakai <SUP>(2)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">51</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Nimrod Ben Yehuda <SUP>(3)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">67</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Technology Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dr. Neta Matis</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">37</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Vice President of Research and Development</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dr. Arthur Dawson</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">78</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Business Manager of U.S. Operations</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Vered Raz-Avayo <SUP>(4) (5) (10)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">49</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Director </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Ronen Rosenbloom <SUP>(5) (6) (7) (8) (9)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">48</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Israel Berenshtein <SUP>(5) (6) (8) (9)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">49</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Amitay Weiss <SUP>(5) (7) (10)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">58</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Eliahou Arbib <SUP>(5) (6) (8) (11)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">54</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Udi Kalifi <SUP>(5) (7)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">42</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Director Nominee</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prof.
    Benad will resign from his position as Chairman of the board of directors of Save Foods, Inc. upon the closing of this offering.
    We expect Prof. Benad to be nominated as Chairman of the board of directors of Save Foods Ltd. following his resignation.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Zakai will resign from his position as Chief Financial Officer of the Company upon the closing of this offering. We expect
    Mr. Zakai to be appointed as Controller of the Company following his resignation. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Ben Yehuda has been on a temporary leave without pay (furlough) since March 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Raz-Avayo will resign from her position as a member of the board of directors of the Company upon the closing of this offering.
    We expect Ms. Raz-Avayo to be appointed as Chief Financial Officer of the Company following the resignation of our current
    Chief Financial Officer. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Compensation Committee</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Audit Committee</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Nominating and Corporate Governance Committee.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Class I with a term ending at the 2021 annual meeting of stockholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Class II with a term ending at the 2022 annual meeting of stockholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Class III with a term ending at 2023 annual meeting of stockholders.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Prof.
Benad Goldwasser, Chairman of the Board of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Prof.
Goldwasser</I> has served as chairman of our board of directors since May 2018. He has also served as chairman of the board of
directors of our subsidiary, Save Foods Ltd., since May 2018. Prof. Goldwasser has served as chairman of the board of directors
of ScoutCam Inc (OTC: SCTC) since March 2019, and as a member of the board of directors of Innoventric Ltd. since September 2017.
Prior to that, Prof. Goldwasser has served as chairman of the board of directors of Medigus Ltd. (Nasdaq and TASE: MDGS) from
September 2018 to December 2019, and as a consultant to Shanghai-Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Investment
Fund from May 2016 to May 2019. In 2016, Prof. Goldwasser launched a venture capital fund partnered with Shanghai Alliance Investment
Ltd (SAIL), a Shanghai Government investment company. Prof. Goldwasser has also served on the board of directors of BioCanCell
Ltd. (TASE: BICL) from 2013 to 2016. Prof. Goldwasser holds an MD and MBA from Tel-Aviv University. We believe that Prof. Goldwasser
is qualified to serve on our board of directors because of his leadership in conceptualizing and developing our brand and business,
his entrepreneurship skills and his 27 years of experience building businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>David
Palach, Chief Executive Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Mr.
David Palach</I> has served as our chief executive officer since January 2021. Mr. Palach has owned and served as chief executive
officer of S.T. Sporting LTD and Sun Light Lightning Solutions LTD, companies operating in the environmental industry since 2009
and 2015, respectively. Mr. Palach holds a BBA in Accounting from Baruch College/City University of New York and completed a Directors
Course at Bar Ilan University in Israel. Mr. Palach previously maintained a certified public accounting license in the State of
Maryland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Dan
Sztybel, Chief Executive Officer of Save Foods Ltd.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mr.
Sztybel </I>has served as the chief executive officer of Save Foods Ltd. since April 2019. Mr. Sztybel previously served as the
chief executive officer of the Company from April 2019 to January 2021. Prior to this, Mr. Sztybel has served as our vice president
of business development from October 2018 to March 2019. Prior to joining us, Mr. Sztybel has served as principal at Goldmed Ltd.,
a consulting firm from September 2016 to September 2018. Mr. Sztybel is the founder of Dan Sztybel Consulting Group, a boutique
firm advising global leaders and emerging startups in the healthcare field on strategy, partnerships, and investments and has
served as its managing director/ since November 2014. Mr. Sztybel is also the co-founder of MyndYou, a digital health-tech company.
Prior to that, Mr. Sztybel led the life sciences and healthcare advisory team at Kost, Forer, Gabbay &amp; Kasierer, a member
firm of Ernst &amp; Young Global from July 2007 to November 2014. Mr. Sztybel received his B.Sc. and M.Sc. in molecular biology
and biotechnology from Bar-Ilan University. Mr. Sztybel also completed a special EY-Kellogg-Recanati business program for employee
excellence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Shlomo
Zakai, Chief Financial Officer </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Mr.
Zakai</I> has served as our chief financial officer since August 2017. Mr. Zakai has served as chief financial officer of UAS
Drone Corp. (OTC: USDR) since May 2020, as chief financial officer of Sonovia Ltd. from October 2014 to August 2020, as chief
financial officer of Blue Sphere Corporation (OTC: BLSP) from January 2012 to May 2016, and as chief financial officer of Todos
Medical Ltd. (OTC: TOMDF) from February 2017 to December 2017. Mr. Zakai has established Shlomo Zakai CPA in in 2004, an accounting
firm providing a range of services to publicly traded and private companies. He also previously worked as an accountant for nine
years at Kost, Forer, Gabbay &amp; Kasierer, an independent registered public accounting firm and a member firm of Ernst &amp;
Young Global, where he last served as a senior manager and worked with technology companies publicly traded on Nasdaq and in Israel.
Mr. Zakai holds a BA in Accounting from the College of Management in Rishon Le&rsquo;Zion, Israel, and is a certified public accountant
in Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nimrod
Ben Yehuda, Chief Technology Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mr.
Ben Yehuda</I> has served as our chief technology officer since our inception in 2009. Mr. Ben Yehuda has also served as our chief
executive officer from March 2014 to May 2017 and from February 2018 to September 2019 and served on our board of directors from
August 2005 to October 2019. Mr. Ben Yehuda has been a leading entrepreneur in the area of environmentally friendly solutions
using hydrogen peroxide in many applications. Mr. Ben Yehuda is the founder of our subsidiary, Save Foods, Inc. (formerly Pimi
Marion Holdings Ltd. and Pimi Agro CleanTech Ltd.), which was established to exploit the knowledge, intellectual property and
business assets of Nir Ecology Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dr.
Neta Matis, Vice President of Research and Development </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dr.
Matis</I> has served as our vice president of research and development since January 2019. Prior to joining us, Dr. Matis has
served in various roles at Virdia Inc. including head of process development from January 2017 to October 2018 and research and
development chemist from January 2012 to December 2017. Dr. Matis has a proven track record of leading innovation and proficiency
in developing refinery-scale agricultural processes. Dr. Matis holds a PhD in Chemistry and an MBA from Tel Aviv University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dr.
Arthur (Art) Dawson, Business Manager of U.S. Operations </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Dr.
Dawson</I> has served as our business manager of U.S. operations since January 2020. Since March 2001, Dr. Dawson has served as
the president of The Dawson Company, a boutique consulting firm with expertise in product commercialization and market development
for shelf-life extension products in the post-harvest market, Previously, Dr. Dawson held several key positions in the post-harvest
industry, including the general manager of Decco Worldwide from December 1989 to June 1999, one of the largest post-harvest service
company worldwide, the vice president postharvest fungicides of Ecogen, Inc. from June 1999 to February 2001, as well as different
managerial position at Sunkist Growers, Inc. from October 1973 to November 1983 and Dole Fresh, Inc. from November 1983 to November
1989. Dr. Dawson holds a master&rsquo;s degree in Plant Science and a Ph.D. in Plant Physiology from the University of California,
Riverside. Dr. Dawson also holds a license as a pest control advisor in California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Vered
Raz-Avayo, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ms.
Raz-Avayo</I> has served as a member of our board of directors since August 2018. Ms. Raz-Avayo is a business strategy and a financial
consultant. She has served on the board of directors of Foresight Autonomous Holdings Ltd. (TASE and Nasdaq: FRSX) since July
2017, Apollo Power Ltd. (TASE: APLP) since December 2017 and Africa Israel Residences Ltd. (TASE: AFRE) since November 2012. Prior
to that, Ms. Raz-Avayo served as chief financial officer at one of the companies under the Levayev group from December 1999 to
April 2010. In addition, during the last 12 years, Ms. Raz-Avayo served on the board of directors of S.R Accord LTD (TASE: SRAC)
since July 2010 until July 2016, Analyst I.M.S mutual funds management (1986) LTD since May 2012 until May 2017, Safe -T group
LTD ( Nasdaq: SFET) since March 2016 until March 2019, Naaman group (n.v) LTD since July 2012 until July 2017, TMDA LTD since
June 2016 until June 2020. Ms. Raz-Avayo holds a BA in Business Administration &ndash; Accounting and Finance, from the College
of Management, and an MFA in Film, TV and Screenwriting from the Faculty of Arts of the Tel-Aviv University. Ms. Raz-Avayo is
also a certified public accountant in Israel. <FONT STYLE="background-color: white">Ms. </FONT>Raz-Avayo <FONT STYLE="background-color: white">was
selected to serve as a member of our board of directors due to her extensive </FONT>managerial and consulting experience in finance
encompassing a wide range of industries in Israel and overseas<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Ronen
Rosenbloom, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mr.
Rosenbloom </I>has served as a member of our board of directors since August 2020. Mr. Rosenbloom is an independent lawyer and
has been working out of a self-owned law firm specializing in white collar offences since 2004. Mr. Rosenbloom has served on the
board of directors of Medigus Ltd. (Nasdaq and TASE: MDGS) since September 2018 and ScoutCam Inc. (OTC: SCTC) since December 2019.
Prior to that, Mr. Rosenbloom served as chairman of the Israeli Money Laundering Prohibition committee and the Prohibition of
Money Laundering Committee of the Tel Aviv District, both of the Israel Bar Association from November 2015 <FONT STYLE="background-color: white">to
December </FONT>2019. Mr. Rosenbloom holds an LL.B. from the Ono Academic College, an Israeli branch of University of Manchester.
<FONT STYLE="background-color: white">We believe that Mr. Rosenbloom is qualified to serve on our board of directors because of
his business experience and expertise and background with regard to legal matters.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Israel
Berenshtein, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mr.
Berenshtein </I>has served as a member of our board of directors since August 2020. Mr. Berenshtein <FONT STYLE="background-color: white">has
also served on the board of directors of Chrion Refineries Ltd. (TASE: CHR) since May 2019 and recently started working as a lawyer
in Ben Yakov, Shvimer , Dolv &ndash; Law Office. He previously served in the legal department of Sonol Israel Ltd. since April
2010 to December 2020. Before that, Mr. Berenshtein worked as a commercial lawyer and </FONT>litigator <FONT STYLE="background-color: white">for
a leading Israeli law firm from </FONT>July 2000 <FONT STYLE="background-color: white">to </FONT>April 2010<FONT STYLE="background-color: white">.
Mr. Berenshtein earned an LL.B. in law and an M.A. in political science from Bar Ilan University, Israel. Mr. Berenshtein was
admitted to the Israel Bar Association in 2000. We believe that Mr. </FONT>Berenshtein is qualified to serve on our board of directors
due to his extensive legal experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Amitay
Weiss, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Mr.
Weiss </I>has served as a member of our board of directors since August 2020. Mr. Weiss has also served as chairman of the board
of directors of P.L.T Financial Services Ltd. (TASE: PLTP) since April 2016 and Matomy Media Group Ltd. (LSE: MTMY, TASE: MTMY.TA)
since May 2020, as a member of the board of directors of Cofix Group Ltd. (TASE: CFCS) since August 2015, Ziron Ltd. since June
2019, Algomizer Ltd. (TASE: GIX) since March 2019, and Cyntar Ventures Inc. since August 2019, and as a member of the board of
directors and chief executive officer of Therapix Biosciences Ltd. (OTC: TRPXY) since August 2020. In April 2016, Mr. Weiss founded
Amitay Wiss Management Ltd., an economic consulting company and now serves as its chief executive officer. Mr. Weiss holds a B.A
in economics from New England College, M.B.A. in business administration from Ono Academic College in Israel, an Israeli branch
of University of Manchester and LL.B from the Ono Academic College. We believe that Mr. Weiss is qualified to serve on our board
of directors because of his diverse business, management and leadership experience. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Eliahou
Arbib, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Mr.
Arbib </I>has served as a member of our board of directors since January 2021. Mr. Arbib has also served as chairman of the board
of directors of </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chiron Refineries Ltd. (TASE:
CHR) since September <FONT STYLE="background-color: white">2016. He has also </FONT>the current owner and manager of Eliahou Arbib
Law Offices, since May 2013. Prior to that, from 1993 until 2000, Mr. Arbib was the managing director of AA Arbib Agriculture
Supply Ltd. Mr. Arbib holds an LLB from the Law and Business Academic Center of Ramat Gan, Israel. Mr. Arbib has been an active
member of the Israeli Bar Association since 2013, and served as deputy chairman of the Security and Defense Committee of the Israeli
Bar Association <FONT STYLE="background-color: white">since 2014. We believe that Mr. Weiss is qualified to serve on our board
of directors because of his legal experience as well as experience in the field of agriculture. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Udi
Kalifi, Director Nominee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mr.
Klifi</I> has agreed to serve on our board of directors subject to the consummation of this offering. Mr. Kalifi is the owner
and manager of Udi Kalifi Law Officer since 2006. He has also served as a member of the board of directors of Matomi Media Group
Ltd. (TASE: MTMY) since May 2020. Mr. Kalifi holds an LLB, BSc in Accounting and LLM from the Tel Aviv University, Israel and
a master&rsquo;s degree in law and economics from the University of Bologna, Humbourg and Roterdam. Mr. Kalifi has been an active
member of the Israeli Bar Association since 2006. <FONT STYLE="background-color: white">Mr. </FONT>Kalifi <FONT STYLE="background-color: white">was
selected to serve as a member of our board of directors due to his legal and finance experience. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Family
Relationships </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among any of our directors or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Composition
of Board of Directors </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
this offering, our board of directors will consist of 6 directors. Our directors are appointed by the board of directors at the
annual general meeting. Each director&rsquo;s term will continue until the annual meeting of the stockholders held following his
or her election and the election and qualification of his or her successor, or his or her earlier death, disqualification, resignation
or removal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
considering whether directors have the experience, qualifications, attributes or skills, taken as a whole, to enable our board
of directors to satisfy its oversight responsibilities effectively in light of our business and structure, the board of directors
focuses primarily on each person&rsquo;s background and experience as reflected in the information discussed in each of the directors&rsquo;
individual biographies set forth above. We believe that our directors provide an appropriate mix of experience and skills relevant
to the size and nature of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Arrangements
for Election of Directors and Members of Management </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no arrangements or understandings with major stockholders, customers, suppliers or others pursuant to which any of our executive
management or our directors were selected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined that Vered Raz-Avayo, Ronen Rosenbloom, Israel Berenshtein, Amitay Weiss, Eliahou Arbib and
Udi Kalifi do not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities
of a director and that each of these directors is &ldquo;independent&rdquo; as that term is defined under the rules of The Nasdaq
Stock Market LLC (the &ldquo;Nasdaq Rules&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees
of the Board of Directors </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors directs the management of our business and affairs, as provided by Delaware law, and conducts its business
through meetings of the board of directors and standing committees. We will have a standing audit committee, nominating and corporate
governance committee and compensation committee following the consummation of this offering. In addition, from time to time, special
committees may be established under the direction of the board of directors when necessary to address specific issues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee will be responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing,
    compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
    with our independent registered public accounting firm their independence from management; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    with our independent registered public accounting firm the scope and results of their audit; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    all audit and permissible non-audit services to be performed by our independent registered public accounting firm; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    the financial reporting process and discussing with management and our independent registered public accounting firm the quarterly
    and annual consolidated financial statements that we file with the SEC; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    our financial and accounting controls and compliance with legal and regulatory requirements; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    our policies on risk assessment and risk management; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    related person transactions; and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing
    matters. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of this offering, our audit committee will consist of Udi Kalifi, Amitay Weiss and Ronen Rosenbloom, with Udi
Kalifi serving as chair. Rule 10A-3 of the Exchange Act and Nasdaq Rules require that our audit committee have at least one independent
member upon the listing of our Common Stock, have a majority of independent members within 90 days of the date of this prospectus
and be composed entirely of independent members within one year of the date of this prospectus. Our board of directors has affirmatively
determined that Udi Kalifi, Amitay Weiss and Ronen Rosenbloom each meet the definition of &ldquo;independent director&rdquo; for
purposes of serving on the audit committee under Rule 10A-3 under the Exchange Act and Nasdaq rules. Each member of our audit
committee also meets the financial literacy requirements of Nasdaq listing standards. In addition, our board of directors has
determined that Udi Kalifi will qualify as an &ldquo;audit committee financial expert,&rdquo; as such term is defined in Item
407(d)(5) of Regulation S-K. Our board of directors will adopt a written charter for the audit committee, which will be available
on our principal corporate website at <I>www.savefoods.co</I>. substantially concurrently with the consummation of this offering.
The information on any of our websites is deemed not to be incorporated in this prospectus or to be part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nominating
and Corporate Governance Committee </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
nominating and corporate governance committee will be responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
    individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors;
    </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    our succession plan for the CEO and other executive officers; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    the evaluation of the effectiveness of our board of directors and its committees; and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
    and recommending to our board of directors a set of corporate governance guidelines. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of this offering, our nominating and corporate governance committee will consist of Ronen Rosenbloom, Israel
Berenshtein and Eliahou Arbib, with Ronen Rosenbloom serving as chair. Our board of directors will adopt a written charter for
the nominating and corporate governance committee, which will be available on our principal corporate website at <I>www.savefoods.co</I>.
substantially concurrently with the consummation of this offering. The information on any of our websites is deemed not to be
incorporated in this prospectus or to be part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation committee will be responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving the compensation of our chief executive officer and other executive officers; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and making recommendations to the board of directors regarding director compensation; and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
    and overseeing any compensation consultants. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of this offering, our compensation committee will consist of Ronen Rosenbloom, Israel Berenshtein and Eliahou
Arbib, with Israel Berenshtein serving as chair. Our board has determined that Ronen Rosenbloom, Israel Berenshtein and Eliahou
Arbib meet the definition of &ldquo;independent director&rdquo; for purposes of serving on the compensation committee under Nasdaq
rules, including the heightened independence standards for members of a compensation committee, and are &ldquo;non-employee directors&rdquo;
as defined in Rule 16b-3 of the Exchange Act. Our board of directors will adopt a written charter for the compensation committee,
which will be available on our principal corporate website at <I>www.savefoods.co</I>. substantially concurrently with the consummation
of this offering. The information on any of our websites is deemed not to be incorporated in this prospectus or to be part of
this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
Oversight </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is responsible for overseeing our risk management process. Our board of directors focuses on our general risk
management strategy, the most significant risks facing us, and oversees the implementation of risk mitigation strategies by management.
Our audit committee is also responsible for discussing our policies with respect to risk assessment and risk management. Our board
of directors believes its administration of its risk oversight function has not negatively affected our board of directors&rsquo;
leadership structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Committee Interlocks and Insider Participation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the members of our compensation committee is or has been an officer or employee of the Company. None of our executive officers
serves as a member of the board of directors or compensation committee (or other committee performing equivalent functions) of
any entity that has one or more of its executive officers serving on our board of directors or compensation committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of this offering, we will adopt a written code of business conduct and ethics that applies to our directors,
officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or
controller, or persons performing similar functions. A copy of the code will be posted on our website, www.savefoods.co. In addition,
we intend to post on our website all disclosures that are required by law or Nasdaq listing standards concerning any amendments
to, or waivers from, any provision of the code. The information on any of our websites is deemed not to be incorporated in this
prospectus or to be part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="man_002"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE
AND DIRECTOR COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Summary
Compensation Table </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the compensation of our named executive officers for the years ended December
31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name and principal position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fiscal Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option awards </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All other compensation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; text-align: left">David Palach</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">2020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">14,667</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">14,667</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief Executive Officer </I><SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dan Sztybel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,282</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,778</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">256,060</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Former co-Chief Executive Officer, Chief Executive Officer of Save Foods Ltd </I><SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124,081</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">261,769</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shlomo Zakai</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,721</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,986</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,707</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,310</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,291</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,601</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nimrod Ben Yehuda</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,304</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,304</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left">Chief Technology Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">117,014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">117,014</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Neta Matis</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,202</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,474</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">169,676</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left">VP Research and Development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,444</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,235</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,679</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 19px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Palach was appointed as the Company&rsquo;s co-Chief Executive Officer on November 5, 2020, and as the Company&rsquo;s Chief
    Executive Officer of the Company on January 11, 2021, upon the resignation of Mr. Sztybel.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Mr.
    Sztybel resigned from his position as co-Chief Executive Officer of the Company effective January 11, 2021 and continue serving
    as the Chief Executive Officer of the subsidiary Save Foods Ltd.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 75; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Outstanding
Equity Awards at Fiscal Year-End </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pt; text-align: justify; text-indent: 33pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about the number of outstanding equity awards held by each of our named executive officers
as of December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pt; text-align: justify; text-indent: 33pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Options<BR> (Exercisable)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Options<BR> (Unexercisable)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<BR> Exercise<BR> Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<BR> Expiration<BR> Date</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity<BR> Incentive<BR> Plan Awards:<BR> Number of<BR> Unearned<BR> Shares That<BR> Have Not<BR> Vested</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity<BR> Incentive<BR> Plan Awards:<BR> Market or<BR> Payout Value of Unearned<BR> Shares That<BR> Have Not<BR> Vested</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">David Palach</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left">Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; text-align: left">Dan Sztybel</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">10,715</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">3,571</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">3.15</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/3/2029</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left">Former co- Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,905</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/2/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,143</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,429</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.78</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shlomo Zakai</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,349</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,175</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/3/2029 </FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nimrod Ben Yehuda</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left">Chief Technology Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Neta Matis</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,976</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/3/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left">VP Research and Development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,976</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/31/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,286</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,857</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/23/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Arthur Dawson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left">Business Manager of U.S. Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 76; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Employment
Agreements with Executive Officers </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
and through our Israeli subsidiary, have entered into written employment agreements with certain of our executive officers. Upon
the closing of this offering, we intend to enter into written employment and service agreement with each of our executive officers.
Such employment and service agreement will contain customary provisions and representations, including confidentiality, non-competition,
non-solicitation and inventions assignment undertakings by the executive officers. However, the enforceability of the noncompetition
provisions may be limited under applicable law. In addition, we entered into agreements with each executive officer and director
pursuant to which we will indemnify each of them up to a certain amount and to the extent that these liabilities are not covered
by directors and officers insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Services
Agreement with Dan Sztybel as Chief Executive Officer of Save Foods Ltd.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 10, 2018, we entered into a service agreement (as amended on March 28, 2019, the &ldquo;Save Foods Ltd. CEO Services Agreement&rdquo;),
with Mr. Sztybel and Dan Sztybel Consulting Group Ltd., a consulting services company owned and controlled by Mr. Sztybel, pursuant
to which Mr. Sztybel provides us with services as the chief executive officer of Save Foods Ltd. Pursuant to the terms of the
Save Foods Ltd. CEO Services Agreement, Mr. Sztybel is currently entitled to a monthly fee in the amount of NIS 47,125 (approximately
$14,500) plus value added tax and car allowance in the amount of NIS 3,250 (approximately $1,000) plus value added tax per month.
In addition, under the Save Foods Ltd. CEO Services Agreement, Mr. Sztybel was granted options to purchase shares of our Common
Stock, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    to purchase up to 14,286 shares of Common Stock, under our Equity Incentive Plan, in the event that we will receive EPA and
    FDA approvals by the end of the second quarter of 2020. Such conditions were not met as of June 30, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    to purchase up to 28,572 shares of Common Stock, under our Equity Incentive Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
parties may terminate the Save Foods Ltd. CEO Services Agreement at any time for any reason upon a 30-day prior written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
April 2020, the Company and Mr. Sztybel agreed to temporarily reduce the monthly fixed fee to $9,000 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consulting
Agreement with David Palach as Chief Executive Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 6, 2020, we entered into a consulting agreement with S.T Sporting (1996) Ltd., for the services of David Pallach (the
&ldquo;CEO Consulting Agreement&rdquo;). Pursuant to the terms of the CEO Consulting Agreement, Mr. Palach provides us services
as chief executive officer. Pursuant to the terms of the CEO Consulting Agreement, Mr. Palach is currently entitled to a monthly
fee in the amount of $8,000 plus value added tax per month and a grant of options to purchase shares of our Common Stock, which
amount shall be determined by good faith negotiations by the board of directors on a future date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Engagement
with Shlomo Zakai for Accounting Services</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Zakai is acting as our chief financial officer and our engagement with him is based on a price offer dated September 28, 2017,
pursuant to which Mr. Zakai provides us accountant services. Pursuant to the terms of such price offer, Mr. Zakai is entitled
to a fixed fee for several services as well as compensation according to an hourly rate. For 2019, the scope of our engagement
with Mr. Zakai was in an amount of approximately $64,310.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
January 2020, the Company and Mr. Zakai agreed on a monthly fixed fee of $6,500 per month. Commencing April 2020, the Company
and Mr. Zakai Agreed to temporarily reduce the monthly fixed fee to $4,000 per month. For the year ended December 31, 2020, the
scope of our engagement with Mr. Zakai was in an amount of approximately $55,721.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Services
Agreement with Neta Matis as Vice President of Research and Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2019, we entered into a service agreement (the &ldquo;VP Research and Development Services Agreement&rdquo;), with
NSNC Consulting Ltd. (the &ldquo;Contractor&rdquo;), pursuant to which Ms. Neta Matis, on behalf of the Contractor, provides us
with services as our VP of research and development. Pursuant to the terms of the VP Research and Development Service Agreement,
Ms. Matis provides the services in a part time position scope of 50% and is entitled to a monthly fee in the amount of NIS 15,000
(approximately $4,615) plus value added tax. In addition, Ms. Matis will be granted options to purchase up to 7,143 shares of
our Common Stock. Such options shall vest over a 36-month period commencing in January 2019 as follows: (i) options to purchase
up to 2,381 shares of Common Stock shall vest following the initial 12-month period as of the date of grant, (ii) options to purchase
up to 4,762 shares of Common Stock shall vest following the lapse of each additional three-month period thereafter. All other
terms and conditions of the options shall be consistent to those applicable under our Equity Incentive Plan. Commencing January
2020, Ms. Matis became a full-time employee and is entitled to a monthly fee in the amount of NIS 30,000 (approximately $9,230)
plus value added tax. Commencing April 2020, the Company and Ms. Matis agreed to temporarily reduce the monthly fixed fee to $6,200
per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Summary
Compensation Table</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
following table sets forth the compensation we paid our non-executive directors during the fiscal year ended December 31, 2020.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees earned</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or paid</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>in cash<BR> ($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All other </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>compensation ($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left">Prof. Benad Goldwasser</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">131,764</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">232,530</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">364,294</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vered Raz-Avayo</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,462</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Israel Berenshtein</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Ronen Rosenbloom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Service
Contracts with Non-Executive Directors </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the following agreements, we do not have any written agreements with any of non-officer directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
Advisory Consulting Agreement with Goldmed Ltd.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2017, we entered into a corporate advisory consulting agreement (the &ldquo;Goldmed Agreement&rdquo;), with Goldmed
Ltd., a company wholly owned by Prof. Benad Goldwasser, who currently serves as our active chairman of the board of directors.
Pursuant to the Goldmed Agreement, Prof. Goldwasser provides us with services since May 1, 2018. Under the terms of the Goldmed
Agreement, Prof. Goldwasser is entitled to a monthly fee in the amount of $5,000, of which $2,000 will acrrue as debt of the Company
to Prof. Goldwasser until the Company raises $1,000,000, and to a monthly fee in the amount of $10,000 after the Company will
raise more than $2,000,000. The Goldmed Agreement will continue to be in effect unless terminated by either party by providing
a 90-day prior written notice. In addition. The Goldmed Agreement provides that for its services as director of the Company&rsquo;s
subsidiary, Save Foods Ltd., the Company will issue to Prof. Goldwasser, under the Equity Incentive Plan, warrants to purchase
up to 14,286 shares of our Common Stock at an exercise price of $2.1. Such warrants will vest quarterly over a period of 36 months
and will be accelerated in full if we terminate the Goldmed Agreement for no cause prior to the end of the vesting period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2019, we updated the terms and conditions of the Goldmed Agreement, which now provides that Prof. Goldwasser is entitled
to a monthly fee in the amount of $10,000 and a monthly car allowance of $2,000, which will be triggered when the Company raises
$1 million, and of which will commence on the date Prof. Goldwasser was elected to serve as a member of the board of directors
of the Company. The fee is included in the fees payable to Prof. Goldwasser as a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Equity
Incentive Plan </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain one equity incentive plan &ndash; the 2018 Equity Incentive Plan. As of <FONT STYLE="background-color: white">December
31, 2020</FONT>, the number of shares of Common Stock reserved for the exercise of options granted under Equity Incentive Plan
was 289,942.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Equity Incentive Plan was adopted by our board of directors in October 2018, and became effective immediately thereafter. The
2018 Equity Incentive Plan permits the grant of incentive stock options to employees of the Company, including officers and directors,
and non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, performance
shares and other stock or cash awards as the administrator of the plan may determine, to the Company&rsquo;s employees and service
providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Equity Incentive Plan may be administered by the board of directors or by different committees that may be established with
respect to different groups of service providers; in that event, the committee established with respect to a group of service
providers shall administer the 2018 Equity Incentive Plan with respect to awards granted to members of such group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of the 2018 Equity Incentive Plan, and in the case of a committee, subject to the specific duties delegated
by the board to such committee, the administrator will have the authority, in its sole discretion to determine subject to Israeli
law and section 16 of the Exchange Act, the grantees of awards and the terms of the grant, including, exercise prices, vesting
schedules, acceleration of vesting and conditions and restrictions applicable to an award, as well other matters necessary in
the administration of the 2018 Equity Incentive Plan. The 2018 Equity Incentive Plan enables us to issue awards under various
tax regimes, including, without limitation, pursuant to Section 102 of the Ordinance, and under Section 3(i) of the Ordinance
and Section 422 of the United States Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Equity Incentive Plan provides that awards granted to our employees, directors and officers who are not controlling shareholders
and who are not considered Israeli residents are intended to qualify for special tax treatment under the &ldquo;capital gain track&rdquo;
provisions of Section 102(b) of the Ordinance as detailed above. Our Israeli non-employee service providers and controlling shareholders
may only be granted awards under Section 3(i) of the Ordinance, which does not provide for similar tax benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
granted under the 2018 Equity Incentive Plan to U.S. residents may qualify as &ldquo;incentive stock options&rdquo; within the
meaning of Section 422 of the Code. The exercise price for &ldquo;incentive stock options&rdquo; must not be less than the fair
market value on the date on which an option is granted, or 110% of the fair market value if the option holder holds more than
10% of our share capital. Notwithstanding the foregoing provisions, options may be granted with a per share exercise price of
less than 100% of the fair market value per share on the date of grant pursuant to the issuance or assumption of an option in
a transaction to which Section 424(a) of the Code applies in a manner consistent with said Section 424(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vesting schedule of options granted under the 2018 Equity Incentive Plan is set forth in each grantee&rsquo;s award agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
terminate upon the date set out in the grantee&rsquo;s specific award agreement or at the end of an extended period following
the termination of the grantee&rsquo;s employment or service. In the event of the death of a grantee while employed by or performing
service for us or an affiliate, or in the event of termination of a grantee&rsquo;s employment or services for reasons of disability,
the grantee or his or her estate or legal successor (in the case of death), may exercise awards that have vested prior to termination
within a period of nine (9) months from the date of disability or death but in any event no later than the expiration date of
the awards. If a participant ceases to be a service provider, other than upon the participants termination as the result of the
participant&rsquo;s death or disability, may exercise his or her option within such period of time as is specified in the award
agreement to the extent that the option is vested on the date of termination (but in no event later than the expiration of the
term of such option as set forth in the award agreement). In the absence of a specified time in the award agreement, the option
will remain exercisable for three (3) months following the participant&rsquo;s termination. Unless otherwise provided by the administrator,
if on the date of termination, the participant is not vested as to his or her entire option, the Common Stock covered by the unvested
portion of the option will revert to the 2018 Equity Incentive Plan. If after termination, the participant does not exercise his
or her option within the time specified by the award agreement or by operation of this paragraph, the option will terminate, and
the Common Stock covered by such option will revert to the 2018 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
options may not be assigned or transferred other than by will or laws of descent, unless otherwise determined by the committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of our proposed dissolution or liquidation, the administrator will notify each participant as soon as practicable prior
to the effective date of such proposed transaction. To the extent it has not been previously exercised, an award will terminate
immediately prior to the consummation of such proposed action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a merger or change in control, each outstanding award will be treated as the administrator determines, including,
without limitation, that each award will be assumed or an equivalent option or right substituted by the successor corporation
or a parent or subsidiary of the successor corporation. The administrator will not be required to treat all awards similarly in
the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the successor corporation does not assume or substitute for the award, the participant will fully vest in and have
the right to exercise all of his or her outstanding options and stock appreciation rights, including Common Stock as to which
such awards would not otherwise be vested or exercisable. All restrictions on restricted stock will lapse, and, with respect to
restricted stock units, performance shares and performance units, all performance goals or other vesting criteria will be deemed
achieved at target levels and all other terms and conditions met. In addition, if an option or stock appreciation right is not
assumed or substituted for in the event of a change in control, the administrator will notify the participant in writing or electronically
that the option or stock appreciation right will be fully vested and exercisable for a period of time determined by the administrator
in its sole discretion, and the option or stock appreciation right will terminate upon the expiration of such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the year ended December 31, 2020, we granted to our directors and officers options to purchase a maximum aggregated number of
92,574 of the Company&rsquo;s Common Stock, under our equity incentive plan. 92,574 options were granted at an exercise price
of $3.15 to $3.78 per share, and the latest expiration date for such options is July 1, 2030.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><A NAME="man_003"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employment
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our executive officers have employment and service agreements with us. Upon the closing of this offering, we intend to enter
into written employment and service agreement with each of our executive officers. Such employment and service agreement will
contain customary provisions and representations, including confidentiality, non-competition, non-solicitation and inventions
assignment undertakings by the executive officers. However, the enforceability of the noncompetition provisions may be limited
under applicable law<FONT STYLE="background-color: white">. See &ldquo;Management&mdash;Employment Agreements with Executive Officers&rdquo;
and &ldquo;&mdash; Service Contracts with Non-Executive Directors.&rdquo;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
Agreements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things,
require us or will require us to indemnify each director and executive officer to the fullest extent permitted by Delaware law,
including indemnification of expenses such as attorneys&rsquo; fees, judgments, fines and settlement amounts incurred by the director
or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising out of the
person&rsquo;s services as a director or executive officer. For further information, see &ldquo;Executive and Director Compensation&mdash;Limitations
of Liability and Indemnification.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consulting
and Service Agreements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consulting
Agreement with Amir Uziel </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 2, 2021, we entered into a consulting agreement with Amir Uziel (the &ldquo;Amir Uziel Consulting Agreement&rdquo;), effective
as of January 1, 2021, pursuant to which, Mr. Amir Uziel, <FONT STYLE="background-color: white">a holder of greater than 5% of
our Common Stock</FONT>, provides us with consulting services. Pursuant to the terms of the Amir Uziel Consulting Agreement, Amir
Uziel is entitled to a fee in the amount of $100 per hour up to a maximum of 60 hours. The Amir Uziel Consulting Agreement will
terminate on December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
Advisory Consulting Agreement with Nir Ecology Ltd.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2017, we entered into a corporate advisory consulting agreement with Nir Ecology Ltd. (the &ldquo;Nir Ecology Agreement&rdquo;),
pursuant to which, Mr. Ben Yehuda, our chief technology officer, provided us with services since September 1, 2017. Pursuant to
the terms of the Nir Ecology Agreement, Nir Ecology Ltd. was entitled to a monthly fee in the amount of $3,000. The Nir Ecology
Agreement remained in effect until August 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loan
Agreements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Loan
Agreement with Nimrod Ben Yehuda</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 26, 2019, we entered into a loan agreement (the &ldquo;Ben Yehuda Loan Agreement&rdquo;), with Mr. Nimrod Ben Yehuda,
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our founder and former director <FONT STYLE="background-color: white">of
Nir Ecology Ltd., a co</FONT>mpany wholly owned by Mr. Ben Yehuda, pursuant to <FONT STYLE="background-color: white">which we
extended Nir Ecology Ltd. with a loan in an aggregate amount of </FONT>NIS 50,000 (<FONT STYLE="background-color: white">approximately
$14,021). The loan amount bears interest at an annual compounded rate of four percent from the date the loan was actually provided
and until the repayment date.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2019, we entered into a settlement agreement (the &ldquo;Settlement Agreement&rdquo;), pursuant to which </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
agreed to repay Mr. Ben Yehuda NIS 263,929 (the &ldquo;Ben Yehuda Debt&rdquo;) that we owed him for his services rendered as chief
executive officer of Nir Ecology Ltd. from 2014 through the date of the Settlement Agreement. Pursuant to the Settlement Agreement,
we agreed to offset an amount of NIS 50,000 from the Ben Yehuda Loan Agreement and to repay the remaining balance of the Ben Yehuda
Debt in 12 monthly payments starting in August 2021. The Ben Yehuda Debt will not bear interest and may be prepaid in whole or
in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2021, our board of directors approved the prepayment of an additional $5,000 to Mr. Ben Yehuda, ahead of the designated
date of August 2021, pursuant to the Company&rsquo;s right under the Settlement Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Convertible
Loan Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2019, we entered into the December 2019 CLAs, with certain lenders, including <FONT STYLE="background-color: white">three
of our holders of greater than 5% of our Common Stock, pursuant to which</FONT> the December 2019 Lenders agreed to provide us
loans in the aggregate amount of $379,000 in exchange for convertible promissory notes and warrants. The following table sets
forth the aggregate amount provided by our related parties in the December 2019 CLAs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Participant</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Loan Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">Amir Uziel / Amir Uziel Economic Consultant Ltd.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">100,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">L.I.A Pure Capital Ltd.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">35,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">YAAD Consulting &amp; Management Services (1995) Ltd</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneous
with and conditioned upon the execution of the June 2020 SPA, the Company and each of the December 2019 Lenders, January 2020
Lender and February agreed to effectively cancel the December 2019 CLA and the equity securities issued thereunder. In connection
therewith, each of the December 2019 Lenders voluntarily waived any right to receive interest that accrued thereupon pursuant
to the December 2019 CLA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lease
Agreement with YAAD Consulting &amp; Management Services (1995) Ltd. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
September 1, 2019, we entered into a lease agreement, through our Israeli subsidiary, with YAAD Consulting &amp; Management Services
(1995) Ltd., a holder of greater than 5% of our Common Stock (the &ldquo;YAAD Lease Agreement&rdquo;). Pursuant to the YAAD Lease
Agreement, we paid YAAD Consulting &amp; Management Services (1995) Ltd. a monthly payment of NIS 5,000 (approximately $1,430)
plus value added tax in consideration for office space located at 20 Raul Wallenberg, Tel Aviv, Israel. The YAAD Lease Agreement
remained in effect until September 1, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Private
Placements of our Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2020, we entered into the June 2020 SPA with certain investors, including <FONT STYLE="background-color: white">three
of our holders </FONT>of greater than 5% of our Common Stock, pursuant to which we issued an aggregate of 67,369 shares of Common
Stock and warrants to purchase an aggregate of 67,369 shares of Common Stock for an aggregate purchase price of $565,868. The
following table sets forth the aggregate number of Common Stock issued to our related parties in the June 2020 SPA:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Participant</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">Amir Uziel / Amir Uziel Economic Consultant Ltd.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">13,106</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">L.I.A Pure Capital Ltd.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,588</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">YAAD Consulting &amp; Management Services (1995) Ltd</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,107</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
July 2020, we entered into securities purchase agreements (the &ldquo;July 2020 SPAs&rdquo;) with certain investors, including
two <FONT STYLE="background-color: white">of our holders of greater than 5% of our Common Stock</FONT>, <FONT STYLE="background-color: white">pursuant
to which we issued an aggregate of </FONT>6,554 shares of Common Stock and warrants to purchase an aggregate of 6,554 shares of
Common Stock for an aggregate purchase price of $55,046. The following table sets forth the aggregate number of Common Stock issued
to our related parties in the July 2020 SPAs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Participant</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">Amir Uziel / Amir Uziel Economic Consultant Ltd.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">3,277</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">YAAD Consulting &amp; Management Services (1995) Ltd.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,277</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nir Reinhold / Buffalo Investments Ltd.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,107</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
August 2020, we entered into securities purchase agreements (the &ldquo;August 2020 SPAs&rdquo;) with certain investors, including
three <FONT STYLE="background-color: white">of our holders of greater than 5% of our Common Stock</FONT>, <FONT STYLE="background-color: white">pursuant
to which we issued an aggregate of 13,108 </FONT>shares of Common Stock and warrants to purchase an aggregate of <FONT STYLE="background-color: white">13,108
</FONT>shares of Common Stock for an aggregate purchase price of $110,093. The following table sets forth the aggregate number
of Common Stock issued to our related parties in the August 2020 SPAs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Participant</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">Amir Uziel / Amir Uziel Economic Consultant Ltd.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">6,554</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">L.I.A Pure Capital Ltd.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,277</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">YAAD Consulting &amp; Management Services (1995) Ltd</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,277</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Options </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Since
our inception, we have granted options to purchase shares of our Common Stock to our officers and certain of our directors. Such
option agreements may contain acceleration provisions upon certain merger, acquisition, or change of control transactions. We
describe our option plans under &ldquo;Executive and Director Compensation&mdash;Equity Incentive Plan.&rdquo; If the relationship
between us and an executive officer or a director is terminated, except for cause (as defined in the various option plan agreements),
options that are vested will generally remain exercisable for three months after such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Policies
and Procedures for Related Person Transactions </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to adopt a written related person transaction policy, to be effective immediately prior to the effectiveness of this registration
statement of which this prospectus forms a part, setting forth the policies and procedures for the review and approval or ratification
of &ldquo;related person transactions.&rdquo; For purposes of this policy, a &ldquo;related person transaction&rdquo; is any transaction,
arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any &ldquo;related
person&rdquo; are participants involving an amount that exceeds $120,000 including, without limitation, purchases of goods or
services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees
of indebtedness and employment by us of a related person. Transactions involving compensation for services provided to us as an
employee, consultant or director will not be considered related-person transactions under this policy. A &ldquo;related person&rdquo;
is any executive officer, director or a holder of more than five percent of our Common Stock, including any of their immediate
family members and any entity owned or controlled by such persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
this policy, where a transaction has been identified as a related person transaction, management must present information regarding
the proposed related-person transaction to our audit committee (or, where review by our audit committee would be inappropriate,
to another independent body of our board of directors) for review. In reviewing and approving any such transactions, our audit
committee or other independent body of our board of directors, is tasked to consider all relevant facts and circumstances, including,
but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&rsquo;s length transaction
and the extent of the related person&rsquo;s interest in the transaction. In the event a director has an interest in the proposed
transaction, the director must recuse himself or herself from the deliberations and approval. All of the transactions described
in this section occurred prior to the adoption of this policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="man_004"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Security
Ownership of Certain Beneficial Owners and Management</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
following table sets forth information regarding beneficial ownership of shares of our Common Stock as of March 10, 2021 by: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our issued and outstanding
    share of Common Stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and executive officers; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our current directors and executive officers as a group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Beneficial
ownership is determined in accordance with the rules of the SEC, and includes voting or investment power with respect to shares
of Common Stock. Shares of Common Stock issuable under share options that are exercisable within 60 days after the date of this
prospectus, are deemed issued and outstanding for the purpose of computing the percentage ownership of the person holding the
options but are not deemed issued and outstanding for the purpose of computing the percentage ownership of any other person. Percentage
of shares beneficially owned before this offering is based on 1,606,734 shares of Common Stock issued and outstanding as of March
10, 2021. The number of shares of Common Stock deemed outstanding after this offering includes the shares of Common Stock being
offered for sale in this offering but assumes no exercise by the underwriter of the over-allotment option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment
power with respect to all shares shown to be beneficially owned by them, based on information provided to us by such stockholders.
Unless otherwise indicated below, the address for each beneficial owner listed in the table below is c/o Save Foods, Inc., Kibbutz
Alonim, Israel, 3657700.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of Shares<BR> Beneficially<BR> Owned<BR> Prior to this<BR> Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage Owned<BR> Before this<BR> Offering<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> Owned After this Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">5% or more shareholders:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amir Uziel / Amir Uziel Economic Consultant Ltd.<SUP>(2)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">115,512</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">7.1</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.I.A Pure Capital Ltd. <SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,938</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nimrod Ben Yehuda / Nir Ecology Ltd.<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,890</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nir Reinhold / Buffalo Investments Ltd.<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111,453</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YAAD Consulting &amp; Management Services (1995) Ltd.<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">115,831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Directors and named executive officers who are not 5% holders:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitay Weiss<SUP>(*)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Arthur Dawson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prof. Benad Goldwasser<SUP>(*)(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,302</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dan Sztybel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">David Palach</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel Berenshtein<SUP>(*)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronen Rosenbloom<SUP>(*)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shlomo Zakai</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,143</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vered Raz-Avayo<SUP>(*)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliahou Arbib<SUP>(*)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">All directors and named executive officers as a group (11 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">244,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    director of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(**)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1%.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    percentages shown are based on <FONT STYLE="background-color: white">1,606,760</FONT> Common Stock issued and outstanding
    as of the date of <FONT STYLE="background-color: white">March 10, 2021</FONT>.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    6,981 shares held by Amir Uziel, and 85,594 shares held by Amir Uziel Economic Consultant Ltd. Amir Uziel is the owner of
    Amir Uziel Economic Consultant Ltd. and has voting and dispositive power over the shares held by Amir Uziel Economic Consultant
    Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kfir
    Zilberman is the Owner of L.I.A Pure Capital Ltd. and has the voting and dispositive power over the shares held by L.I.A Pure
    Capital Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    14,146 shares held by Nimrod Ben Yehuda, and 85,744 shares held by Nir Ecology Ltd. Nimrod Ben Yehuda is the owner of Nir
    Ecology Ltd. and has voting and dispositive power over the shares held by Nir Ecology Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    16,191 shares held by Nir Reinhold, and 82,155 shares held by Buffalo Investments Ltd. Nir Reinhold is the owner of Buffalo
    Investments Ltd. and has voting and dispositive power over the shares held by Buffalo Investments Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    3,175 shares held by Itschak Shrem, and 92,995 shares held by YAAD Consulting &amp; Management Services (1995) Ltd. Itschak
    Shrem&nbsp;&nbsp;is the owner of YAAD Consulting &amp; Management Services (1995) Ltd. and has the voting and dispositive
    power over the shares held by YAAD Consulting &amp; Management Services (1995) Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    30,179 options held by Prof. Benad Goldwasser and 57,143 shares held by Anat Tamir Lotan, a member of Prof. Benad&rsquo;s
    immediate family sharing the same household.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 84; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="man_005"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF OUR SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following description summarizes important terms of our capital stock and the provisions of our certificate of incorporation,
our bylaws and Delaware law are summaries. The following descriptions of our capital stock and provisions of our certificate of
incorporation, as amended, and bylaws are summaries and are qualified by reference to the certificate of incorporation and the
bylaws which are filed as exhibits to our registration statement of which this prospectus forms a part.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently authorized to issue up to 495,000,000 shares of Common Stock, of which <FONT STYLE="background-color: white">1,606,734
</FONT>shares were issued and outstanding as of the date of this prospectus, and 5,000,000 shares of preferred stock, par value
$0.0001 per share, of which none were issued and outstanding as of the date of this prospectus. All of our issued and outstanding
shares have been validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws permit the board of directors to issue the whole or any part of any unissued balance of the authorized capital stock. Our
certificate of incorporation permits us to increase or decrease the number of authorized shares of Common Stock by the affirmative
vote of the holders of a majority of the stock of the Company entitled to vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pt; text-align: justify; text-indent: 33pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the last three years, since January 31, 2018, we issued an aggregate of 856,267 shares of Common Stock of which 467,862 shares
were issued in several private placements for aggregate net proceeds of $2,160,033; 67,369 shares were issued as conversion of
several convertible loans for aggregate net proceeds of $620,627; 11,128 shares were issued as stock based compensation; and 309,908
shares were issued in other equity transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our Common Stock are entitled to one vote for each share held on all matters submitted to a vote of our stockholders. Holders
of our Common Stock have no cumulative voting rights. Further, holders of our Common Stock have no preemptive, conversion, redemption
or subscription rights and there are no sinking fund provisions applicable to our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidation
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of our liquidation, dissolution or winding-up, holders of our Common Stock have the right under Section 281 of the Delaware
General Corporation Law to a ratable portion of assets remaining after satisfaction in full of the prior rights of our creditors,
all liabilities and the total liquidation preferences of any outstanding shares of preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividends</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to preferences that may be applicable to any outstanding shares of preferred stock, holders of our Common Stock are entitled to
receive dividends, if any, as may be declared from time to time by our board of directors, or board, out of our assets which are
legally available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation authorizes 5,000,000 shares of preferred stock, par value $0.0001 per share, of which none were issued
and outstanding as of the date of this registration statement. The board of directors is authorized to provide for the issuance
of these unissued shares of preferred stock in one or more series, and to fix the number of shares and to determine the rights,
preferences and privileges thereof. Accordingly, the board of directors may issue preferred stock which may convert into large
numbers of shares of Common Stock and consequently lead to further dilution of other shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants
and Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the last three years, since January 31, 2018, we issued warrants to purchase an aggregate of 187,128 shares of Common Stock to
investors and service providers, with exercise prices ranging from $2.10 to $8.40 per share, of which 28,572 warrants
were exercised and 28,572 were forfeited, and granted options to purchase an aggregate of 261,625 shares of Common Stock to directors,
officers, employees and service providers with exercise prices ranging from $3.15 to $3.78 per share, of which 6,350 options were
exercised and 43,651 options were forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
Promissory Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the last three years, we issued convertible promissory notes in an aggregate principal amount of $1,013,000 in a series of convertible
loan agreements. As of the date of this prospectus we issued an aggregate of 67,369 shares of Common Stock as a result of conversion
of certain convertible promissory notes, at a conversion price of $7.63 per share. The convertible promissory notes will be converted
into shares of Common Stock immediately prior to the closing of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Provisions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of Delaware law, our Certificate of Incorporation and our Bylaws may have the effect of delaying, deferring or discouraging
another person from acquiring control of the Company. These provisions, which are summarized below, may have the effect of discouraging
takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with
our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly
or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals
could result in an improvement of their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amended
and Restated Certificate of Incorporation and Amended and Restated Bylaw Provisions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated certificate of incorporation and our amended and restated bylaws include a number of provisions that could
deter hostile takeovers or delay or prevent changes in control of our management team, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&#9679;</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Board
    of directors&rsquo; vacancies. </I>Our Certificate of Incorporation provides that vacancies on the board of directors may
    be filled only by the affirmative vote of a majority of the directors then in office, irrespective of whether there is a quorum,
    or by a sole remaining director. Additionally, the number of directors to serve on our board of directors is fixed solely
    and exclusively by resolution duly adopted by our board of directors. This would prevent a stockholder from increasing the
    size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with
    its own nominees. This makes it more difficult to change the composition of our board of directors but promotes continuity
    of management.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Special
    meetings of stockholders. </I>Our Certificate of Incorporation currently provides that special meetings of our stockholders
    may be called by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of
    the directors then in office, and special meetings of stockholders may not be called by any other person or persons.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    cumulative voting</I>. The Delaware General Corporation Law provides that stockholders are not entitled to the right to cumulate
    votes in the election of directors unless a corporation&rsquo;s certificate of incorporation provides otherwise. Our amended
    and restated certificate of incorporation does not provide for cumulative voting.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
    of charter provisions</I>. Any amendment of our Certificate of Incorporation requires the affirmative vote of the majority
    of the outstanding shares of capital stock entitled to vote on such amendment, and the affirmative vote of the majority of
    the outstanding shares of each class entitled to vote thereon as a class. Amendments to the Bylaws may be executed pursuant
    to a resolution by the board of directors pursuant to an affirmative vote of a majority of the directors then in office, or
    by the affirmative vote of at least 75% of the outstanding shares of capital stock entitled to vote.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 86; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Issuance
    of undesignated preferred stock</I>. Our board of directors has the authority, without further action by the stockholders,
    to issue up to 5,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated
    from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock, which may
    be converted into large numbers of shares of Common Stock, would enable our board of directors to render more difficult or
    to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Delaware
    Business Combination Statute</I>. The Company is subject to the &ldquo;business combination&rdquo; provisions of Section 203
    of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging
    in a business combination with an interested stockholder for a period of three years following the date such person becomes
    an interested stockholder, unless the business combination or the transaction in which such person becomes an interested stockholder
    is approved in a prescribed manner. Generally, a &ldquo;business combination&rdquo; includes a merger, asset or stock sale,
    or other transaction resulting in a financial benefit to the interested stockholder. Generally, an &ldquo;interested stockholder&rdquo;
    is a person that, together with affiliates and associates, owns, or within three years prior to the determination of interested
    stockholder status did own, 15% or more of a corporation&rsquo;s voting stock. The existence of this provision may have an
    anti-takeover effect with respect to transactions not approved in advance by our board of directors, and the anti-takeover
    effect includes discouraging attempts that might result in a premium over the market price for the shares of our Common Stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exclusive
    forum</I>. Unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware
    is the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting
    a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders,
    (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our amended
    and restated certificate of incorporation or our amended and restated bylaws, or (iv) any action asserting a claim against
    us governed by the internal affairs doctrine. This choice of forum provision may limit a stockholder&rsquo;s ability to bring
    a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which
    may discourage such lawsuits against us and our directors, officers and other employees.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Action Stock Transfer. The transfer agent and registrar&rsquo;s address is
2469 E. Fort Union Blvd, Suite 214, Salt Lake City, UT 84121. The transfer agent&rsquo;s telephone number is (801) 274-1088.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is quoted on the OTC, Pink Tier under the symbol &ldquo;SAFO.&rdquo; We have applied to list our Common Stock on
the Nasdaq Capital Market under the symbol &ldquo;SVFD.&rdquo; No assurance can be given that our application will be approved
or that a trading market will develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pi_001"></A>SHARES
ELIGIBLE FOR FUTURE SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering our Common Stock was traded only on the OTC Markets, Pink Tier. In connection with this offering, we have applied
to apply to list Our Common Stock on the Nasdaq Capital Market. No assurance can be given that our application will be approved.
Sales of substantial amounts of our Common Stock in the public market, or the perception that such sales could occur, could adversely
affect prevailing market prices of our Common Stock. Upon completion of this offering, we will have an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
Common Stock issued and outstanding, assuming the underwriter does not exercise its over-allotment option. All of the Common Stock
sold in this offering will be freely transferable without restriction or further registration under the Securities Act by persons
other than by our affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock will be held by our existing shareholders. Approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of our issued and outstanding Common Stock will be subject
to such lock-up agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
all of our directors and executive officers and holders of all of our outstanding Common Stock signed lock-up agreements in connection
with this offering, pursuant to which, subject to certain exceptions, they agreed not to sell or otherwise dispose of their shares
of Common Stock or any securities convertible into or exchangeable for Common Stock for a period of at least 180 days after the
date of the pricing of our initial public offering without the prior written consent of the underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
144</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Affiliate
Resales of Restricted Securities </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, beginning 90 days after the effective date of the registration statement of which this prospectus is a part, a person
who is an affiliate of ours, or who was an affiliate at any time during the 90 days before a sale, who has beneficially owned
shares of our Common Stock for at least 180 days would be entitled to sell in &ldquo;broker&rsquo;s transactions&rdquo; or certain
&ldquo;riskless principal transactions&rdquo; or to market makers, a number of shares within any three-month period that does
not exceed the greater of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
    of the number of shares of our Common Stock then outstanding; and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    average weekly trading volume in our Common Stock on the during the four calendar weeks preceding the filing of a notice on
    Form 144 with respect to such sale. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliate
resales under Rule 144 are also subject to the availability of current public information about us. In addition, if the number
of shares being sold under Rule 144 by an affiliate during any three-month period exceeds 5,000 shares or has an aggregate sale
price in excess of $50,000, the seller must file a notice on Form 144 with the SEC and Nasdaq concurrently with either the placing
of a sale order with the broker or the execution directly with a market maker.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Non-Affiliate
Resales of Restricted Securities </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Rule 144, a person who is not an affiliate of ours at the time of sale, and has not been an affiliate at any time during the 90
days preceding a sale, and who has beneficially owned shares of our Common Stock for at least six months but less than a year,
is entitled to sell such shares subject only to the availability of current public information about us. If such person has held
our shares for at least one year, such person can resell without regard to any Rule 144 restrictions, including the 90-day public
company requirement and the current public information requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-affiliate
resales are not subject to the manner of sale, volume limitation or notice filing provisions of Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 701, any of our employees, directors, officers, consultants or advisors who purchases shares from us in connection
with a compensatory stock or option plan or other written agreement before the effective date of the registration statement of
which this prospectus forms a part is entitled to sell such shares 90 days after such effective date in reliance on Rule 144.
Our affiliates can resell shares in reliance on Rule 144 without having to comply with the holding period requirement, and non-affiliates
of the issuer can resell shares in reliance on Rule 144 without having to comply with the current public information and holding
period requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has indicated that Rule 701 will apply to typical stock options granted by an issuer before it becomes subject to the reporting
requirements of the Exchange Act, along with the shares acquired upon exercise of such options, including exercises after an issuer
becomes subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
S-8 Registration Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the completion of this offering, we intend to file one or more registration statements on Form S-8 under the Securities Act to
register up the Common Stock issued or reserved for issuance under our 2018 Equity Incentive Plan. The registration statement
on Form S-8 will become effective automatically upon filing. Common Stock issued upon exercise of a share option and registered
under the Form S-8 registration statement will, subject to vesting and lock-up provisions and Rule 144 volume limitations applicable
to our affiliates, be available for sale in the open market immediately unless they are subject to a lock-up, in which case, immediately
after the term of the lock-up expires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">THE
DISCUSSION ABOVE IS A GENERAL SUMMARY. IT DOES NOT COVER ALL SHARE TRANSFER RESTRICTION MATTERS THAT MAY BE OF IMPORTANCE TO A
PROSPECTIVE INVESTOR. EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN LEGAL ADVISOR REGARDING THE PARTICULAR SECURITIES LAWS
AND TRANSFER RESTRICTION CONSEQUENCES OF PURCHASING, HOLDING, AND DISPOSING OF THE COMMON STOCK INCLUDING THE CONSEQUENCES OF
ANY PROPOSED CHANGE IN APPLICABLE LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pi_002"></A>MATERIAL
U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a general discussion of the material U.S. federal income tax considerations applicable to non-U.S. holders (as defined
herein) with respect to their ownership and disposition of shares of our Common Stock and warrants issued pursuant to this offering.
All prospective non-U.S. holders of our Common Stock should consult their tax advisors with respect to the U.S. federal, state,
local and non-U.S. tax consequences of the purchase, ownership and disposition of our Common Stock. In general, a non-U.S. holder
means a beneficial owner of our Common Stock (other than a partnership or an entity or arrangement treated as a partnership for
U.S. federal income tax purposes) that is not, for U.S. federal income tax purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation, or an entity treated as a corporation for U.S. federal income tax purposes, created or organized in the United
    States or under the laws of the United States or of any state thereof or the District of Columbia; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate, the income of which is subject to U.S. federal income tax regardless of its source; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust if (1) a U.S. court can exercise primary supervision over the trust&rsquo;s administration and one or more U.S. persons
    have the authority to control all of the trust&rsquo;s substantial decisions or (2) the trust has a valid election in effect
    under applicable U.S. Treasury Regulations to be treated as a U.S. person.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), existing
U.S. Treasury Regulations promulgated thereunder, published administrative pronouncements and rulings of the U.S. Internal Revenue
Service (the &ldquo;IRS&rdquo;), and judicial decisions, all as in effect as of the date of this prospectus. These authorities
are subject to change and to differing interpretation, possibly with retroactive effect. Any change or differing interpretation
could alter the tax consequences to non-U.S. holders described in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assume in this discussion that a non-U.S. holder holds shares of our Common Stock and warrants as a capital asset within the meaning
of Section 1221 of the Code (generally, for investment). This discussion does not address all aspects of U.S. federal income taxation
that may be relevant to a particular non-U.S. holder in light of that non-U.S. holder&rsquo;s individual circumstances, nor does
it address any alternative minimum, Medicare contribution, estate or gift tax consequences, or any aspects of U.S. state, local
or non-U.S. taxes. This discussion also does not consider any specific facts or circumstances that may apply to a non-U.S. holder
and does not address the special tax rules applicable to particular non-U.S. holders, such as holders that own, or are deemed
to own, more than 5% of our capital stock (except to the extent specifically set forth below), corporations that accumulate earnings
to avoid U.S. federal income tax, tax-exempt organizations, banks, financial institutions, insurance companies, brokers, dealers
or traders in securities, commodities or currencies, tax-qualified retirement plans, holders who hold or receive our Common Stock
pursuant to the exercise of employee stock options or otherwise as compensation, holders holding our Common Stock as part of a
hedge, straddle or other risk reduction strategy, conversion transaction or other integrated investment, holders deemed to sell
our Common Stock under the constructive sale provisions of the Code, controlled foreign corporations, passive foreign investment
companies and certain former U.S. citizens or former long-term residents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, this discussion does not address the tax treatment of partnerships (or entities or arrangements that are treated as
partnerships for U.S. federal income tax purposes) or persons that hold their Common Stock through such partnerships. If a partnership,
including any entity or arrangement treated as a partnership for U.S. federal income tax purposes, holds shares of our Common
Stock, the U.S. federal income tax treatment of a partner in such partnership will generally depend upon the status of the partner
and the activities of the partnership. Such partners and partnerships should consult their tax advisors regarding the tax consequences
of the purchase, ownership and disposition of our Common Stock or warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that a court or the IRS will not challenge one or more of the tax consequences described herein, and we have
not obtained, nor do we intend to obtain, a ruling with respect to the U.S. federal income tax consequences to a non-U.S. holder
of the purchase, ownership or disposition of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in the section entitled &ldquo;<I>Dividend Policy</I>,&rdquo; we do not anticipate paying any dividends on our Common
Stock in the foreseeable future. If we make distributions on our Common Stock or on the warrants (as described below under &ldquo;Constructive
Dividends on Warrants&rdquo;), those payments will constitute dividends for U.S. federal income tax purposes to the extent we
have current or accumulated earnings and profits, as determined under U.S. federal income tax principles. To the extent those
distributions exceed both our current and our accumulated earnings and profits, they will constitute a return of capital and will
first reduce a Non-U.S. Holder&rsquo;s basis in our Common Stock or the warrants, as applicable, but not below zero. Any excess
will be treated as capital gain and will be treated as described below under &ldquo;Gain on Sale or Other Disposition of Common
Stock or warrants.&rdquo; Any such distributions would be subject to the discussions below regarding back-up withholding and the
Foreign Account Tax Compliance Act (&ldquo;FACTA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below on effectively connected income, any dividend paid to a Non-U.S. Holder generally will be subject to U.S.
withholding tax either at a rate of 30% of the gross amount of the dividend or such lower rate as may be specified by an applicable
income tax treaty. To receive a reduced treaty rate, a Non-U.S. Holder must provide us or our agent with an IRS Form W-8BEN, IRS
Form W-8 BEN-E or another appropriate version of IRS Form W-8 (or a successor form), which must be updated periodically, and which,
in each case, must certify qualification for the reduced rate. Non-U.S. Holders should consult their tax advisors regarding their
entitlement to benefits under any applicable income tax treaty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
paid to a Non-U.S. Holder that are effectively connected with the Non-U.S. Holder&rsquo;s conduct of a trade or business within
the United States and that are not eligible for relief from U.S. (net basis) income tax under an applicable income tax treaty
generally are exempt from the (gross basis) withholding tax described above. To obtain this exemption from withholding tax, the
Non-U.S. Holder must provide the applicable withholding agent with an IRS Form W-8ECI or successor form or other applicable IRS
Form W-8 certifying that the dividends are effectively connected with the Non-U.S. Holder&rsquo;s conduct of a trade or business
within the United States. Such effectively connected dividends, if not eligible for relief under a tax treaty, would not be subject
to a withholding tax, but would be taxed at the same graduated rates applicable to U.S. persons, net of certain deductions and
credits and if, in addition, the Non-U.S. Holder is a corporation, may also be subject to a branch profits tax at a rate of 30%
(or such lower rate as may be specified by an applicable income tax treaty).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are eligible for a reduced rate of withholding tax pursuant to a tax treaty, you may be able to obtain a refund of any excess
amounts withheld if you timely file an appropriate claim for refund with the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Constructive
Dividends on Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 305 of the Code, an adjustment to the number of shares of Common Stock that will be issued on the exercise of the warrants,
or an adjustment to the exercise price of the warrants, may be treated as a constructive distribution to a U.S. Holder of the
warrants if, and to the extent that, such adjustment has the effect of increasing such U.S. Holder&rsquo;s proportionate interest
in our &ldquo;earnings and profits&rdquo; or assets, depending on the circumstances of such adjustment (for example, if such adjustment
is to compensate for a distribution of cash or other property to our stockholders). Adjustments to the exercise price of a warrant
made pursuant to a bona fide reasonable adjustment formula that has the effect of preventing dilution of the interest of the holders
of the warrants should generally not result in a constructive distribution. Any constructive distributions would generally be
subject to the tax treatment described above under &ldquo;Distributions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exercise
or Expiration of Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a Non-U.S. Holder will not be required to recognize income, gain or loss upon the exercise of a Warrant by payment of
the exercise price, except possibly to the extent of cash paid in lieu of a fractional share. However, no discussion is provided
herein regarding the U.S. federal income tax treatment on the exercise of a Warrant on a cashless basis, and Non-U.S. Holders
are urged to consult their tax advisors as to the exercise of a Warrant on a cashless basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Warrant expires without being exercised, a Non-U.S. Holder that is engaged in a U.S. trade or business to which any income from
the Warrant would be effectively connected or who is present in the United States for a period or periods aggregating 183 days
or more during the calendar year in which the expiration occurs (and certain other conditions are met) will recognize a capital
loss in an amount equal to such Non-U.S. Holder&rsquo;s tax basis in the Warrant. The amount paid to purchase our Common Stock
and warrants will be apportioned between them in proportion to the respective fair market values of the Common Stock and warrants,
and the apportioned amount will be the tax basis of the Common Stock and warrants respectively. The fair market value of our Common
Stock for this purpose will generally be its trading value immediately after issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gain
on Sale, Exchange or Other Disposition of Our Common Stock or Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below regarding backup withholding and FATCA, a Non-U.S. Holder generally will not be required to pay U.S. federal
income tax on any gain realized upon the sale or other disposition of our Common Stock or the warrants unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    gain is effectively connected with the Non-U.S. Holder&rsquo;s conduct of a trade or business within the United States and
    not eligible for relief under an applicable income tax treaty, in which case the Non-U.S. Holder will be required to pay tax
    on the net gain derived from the sale under regular graduated U.S. federal income tax rates, and for a Non-U.S. Holder that
    is a corporation, such Non-U.S. Holder may be subject to the branch profits tax at a 30% rate (or such lower rate as may be
    specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Non-U.S. Holder is an individual who is present in the United States for a period or periods aggregating 183 days or more
    during the calendar year in which the sale or disposition occurs and certain other conditions are met, in which case the Non-U.S.
    Holder will be required to pay a flat 30% tax on the gain derived from the sale, which tax may be offset by U.S. source capital
    losses (even though the Non-U.S. Holder is not considered a resident of the United States) (subject to applicable income tax
    or other treaties); or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are a &ldquo;U.S. real property holding corporation&rdquo; for U.S. federal income tax purposes (&ldquo;USRPHC&rdquo;), at
    any time within the shorter of the five-year period preceding the disposition or the Non-U.S. Holder&rsquo;s holding period
    for our Common Stock or the warrants. We believe we are not currently and do not anticipate becoming a USRPHC. However, because
    the determination of whether we are a USRPHC depends on the fair market value of our United States real property interests
    relative to the fair market value of our other business assets, there can be no assurance that we will not become a USRPHC
    in the future. Even if we become a USRPHC, however, gain arising from the sale or other taxable disposition by a Non-U.S.
    Holder of our Common Stock will not be subject to United States federal income tax if (A) in the case of our Common Stock,
    (a) shares of our Common Stock are &ldquo;regularly traded,&rdquo; as defined by applicable Treasury Regulations, on an established
    securities market, such as Nasdaq, and (b) the Non-U.S. Holder owns or owned, actually and constructively, 5% or less of the
    shares of our Common Stock throughout the five-year period ending on the date of the sale or exchange; and (B) in the case
    of the warrants, either (a)(i) shares of our Common Stock are &ldquo;regularly traded,&rdquo; as defined by applicable Treasury
    Regulations, on an established securities market, such as Nasdaq, (ii) the warrants are not considered regularly traded on
    an established securities market and (iii) the Non-U.S. Holder does not own, actually or constructively, warrants with a fair
    market value greater than the fair market value of 5% of the shares of our Common Stock, determined as of the date that such
    Non-U.S. Holder acquired its warrants, or (b)(i) the warrants are considered regularly traded on an established securities
    market, and (ii) the Non-U.S. Holder owns or owned, actually and constructively, 5% or less of the warrants throughout the
    five-year period ending on the date of the sale or exchange. The warrants are not expected to be regularly traded on an established
    securities market. If the foregoing exception does not apply, and we are a USRPHC, such Non-U.S. Holder&rsquo;s proceeds received
    on the disposition of shares will generally be subject to withholding at a rate of 15% and such Non-U.S. Holder will generally
    be taxed on any gain in the same manner as gain that is effectively connected with the conduct of a U.S. trade or business,
    except that the branch profits tax generally will not apply.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Backup
Withholding and Information Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
returns may be filed with the IRS in connection with distributions on our Common Stock or constructive dividends on the warrants,
and the proceeds of a sale or other disposition of the Common Stock or the warrants. A non-exempt U.S. Holder may be subject to
U.S. backup withholding on these payments if it fails to provide its taxpayer identification number to the withholding agent and
comply with certification procedures or otherwise establish an exemption from backup withholding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Non-U.S. Holder may be subject to U.S. information reporting and backup withholding on these payments unless the Non-U.S. Holder
complies with certification procedures to establish that it is not a U.S. person (within the meaning of the Code). The certification
requirements generally will be satisfied if the Non-U.S. Holder provides the applicable withholding agent with a statement on
the applicable IRS Form W-8BEN or IRS Form W-8BEN-E (or suitable substitute or successor form), together with all appropriate
attachments, signed under penalties of perjury, stating, among other things, that such Non-U.S. Holder is not a U.S. Person. Applicable
Treasury Regulations provide alternative methods for satisfying this requirement. In addition, the amount of distributions on
Common Stock or constructive dividends on Common Stock paid to a Non-U.S. Holder, and the amount of any U.S. federal tax withheld
therefrom, must be reported annually to the IRS and the holder. This information may be made available by the IRS under the provisions
of an applicable tax treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder resides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of the proceeds of the sale or other disposition of the Common Stock or the warrants to or through a non-U.S. office of a U.S.
broker or of a non-U.S. broker with certain specified U.S. connections generally will be subject to information reporting requirements,
but not backup withholding, unless the Non-U.S. Holder certifies under penalties of perjury that it is not a U.S. person or an
exemption otherwise applies. Payments of the proceeds of a sale or other disposition of the Common Stock or the warrants to or
through a U.S. office of a broker generally will be subject to information reporting and backup withholding, unless the Non-U.S.
Holder certifies under penalties of perjury that it is not a U.S. person or otherwise establishes an exemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. The amount of any backup withholding from a payment generally will be allowed as a credit
against the holder&rsquo;s U.S. federal income tax liability and may entitle the holder to a refund, provided that the required
information is timely furnished to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Account Tax Compliance Act</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FATCA
imposes withholding tax on certain types of payments made to foreign financial institutions and certain other non-U.S. entities.
The legislation imposes a 30% withholding tax on dividends on, or, subject to the discussion of certain proposed Treasury Regulations
below, gross proceeds from the sale or other disposition of, our Common Stock or the warrants paid to a &ldquo;foreign financial
institution&rdquo; or to certain &ldquo;non-financial foreign entities&rdquo; (each as defined in the Code), unless (i) the foreign
financial institution undertakes certain diligence and reporting obligations, (ii) the non-financial foreign entity either certifies
it does not have any &ldquo;substantial United States owners&rdquo; (as defined in the Code) or furnishes identifying information
regarding each substantial United States owner, or (iii) the foreign financial institution or non-financial foreign entity otherwise
qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence and
reporting requirements in (i) above, it must enter into an agreement with the U.S. Treasury requiring, among other things, that
it undertake to identify accounts held by &ldquo;specified United States persons&rdquo; or &ldquo;United States-owned foreign
entities&rdquo; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on payments
to account holders whose actions prevent it from complying with these reporting and other requirements. If the country in which
a payee is resident has entered into an &ldquo;intergovernmental agreement&rdquo; with the United States regarding FATCA, that
agreement may permit the payee to report to that country rather than to the U.S. Department of the Treasury. The U.S. Treasury
recently released proposed Treasury Regulations which, if finalized in their present form, would eliminate the federal withholding
tax of 30% applicable to the gross proceeds of a sale or other disposition of our Common Stock or the warrants. In its preamble
to such proposed Treasury Regulations, the U.S. Treasury stated that taxpayers may generally rely on the proposed regulations
until final regulations are issued. Prospective investors should consult their own tax advisors regarding the possible impact
of these rules on their investment in our Common Stock or the warrants, and the possible impact of these rules on the entities
through which they hold our Common Stock or the warrants, including, without limitation, the process and deadlines for meeting
the applicable requirements to prevent the imposition of this 30% withholding tax under FATCA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
PRECEDING DISCUSSION IS FOR GENERAL INFORMATION ONLY. EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS TAX ADVISOR REGARDING THE PARTICULAR
U.S. FEDERAL, STATE AND LOCAL AND NON-U.S. TAX CONSEQUENCES OF PURCHASING, HOLDING AND DISPOSING OF OUR COMMON STOCK AND WARRANTS,
INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pi_003"></A>UNDERWRITING
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity,
a division of Fordham Financial Management, Inc., is acting as representative of the underwriters. Subject to the terms and conditions
of an underwriting agreement between us and the representative, we have agreed to sell to each underwriter named below, and each
underwriter named below has severally agreed to purchase, at the public offering price less the underwriting discounts set forth
on the cover page of this prospectus, the number of shares of Common Stock listed next to its name in the following table:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<BR> Shares<BR> of Common<BR> Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; text-align: left">ThinkEquity, a division of Fordham Financial Management, Inc.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the obligations of the underwriters to pay for and accept delivery of the shares of Common
Stock offered by this prospectus are subject to various conditions and representations and warranties, including the approval
of certain legal matters by their counsel and other conditions specified in the underwriting agreement. The shares of Common Stock
are offered by the underwriters, subject to prior sale, when, as and if issued to and accepted by them. The underwriters reserve
the right to withdraw, cancel or modify the offer to the public and to reject orders in whole or in part. The underwriters are
obligated to take and pay for all of the shares of Common Stock offered by this prospectus if any such shares of Common Stock
are taken, other than those shares of Common Stock covered by the over-allotment option described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the underwriters against specified liabilities, including liabilities under the Securities Act, and to
contribute to payments the underwriters may be required to make in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-Allotment
Option</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted a 45-day option to the representative of the underwriters to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares of our Common Stock
at a public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, solely to cover over-allotments, if any. The underwriters may exercise this option
for 45 days from the date of this prospectus solely to cover sales of shares of Common Stock by the underwriters in excess of
the total number of shares of Common Stock set forth in the table above. If any of these additional shares are purchased, the
underwriters will offer the additional shares on the same terms as those on which the shares are being offered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discounts
and Commissions; Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters propose initially to offer the shares of Common Stock to the public at the public offering price set forth on the
cover page of this prospectus and to dealers at those prices less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of Common Stock. If
all of the shares of Common Stock offered by us are not sold at the public offering price, the underwriters may change the offering
price and other selling terms by means of a supplement to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 94; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the public offering price, underwriting discounts and commissions and proceeds before expenses to us. The
information assumes either no exercise or full exercise of the over-allotment option we granted to the representative of the underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Per Share</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Total Without<BR>
 Over-allotment<BR>
 Option</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Total With<BR>
 Over-allotment<BR>
 Option</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Public offering price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Underwriting discount (7%)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds, before expenses, to us</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-accountable expense allowance (1%)(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    non-accountable expense allowance will not payable with respect to representative&rsquo;s exercise of the over-allotment option.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay a non-accountable expense allowance to the representative of the underwriters equal to 1% of the gross proceeds
received at the closing of the offering. The non-accountable expense allowance of 1% is not payable with respect to the shares
sold upon exercise of the underwriters&rsquo; over-allotment option. We have paid an expense deposit of $20,000 to the representative,
which will be applied against the out-of-pocket accountable expenses that will be paid by us to the underwriters in connection
with this offering, and will be reimbursed to us to the extent not actually incurred in compliance with applicable FINRA rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed to pay certain of the representative&rsquo;s expenses relating to the offering, including (a) filing fees associated
with the review of the offering by FINRA; (b) all fees and expenses relating to the listing of the Common Stock on the Nasdaq
Capital Market, including any fees charges by The Depository Trust for new securities; (c) all fees, expenses and disbursements
relating to background checks of our officers and directors in an amount not to exceed $15,000 in the aggregate; (d) all fees,
expenses and disbursements relating to the registration or qualification of the shares of our Common Stock under the &ldquo;blue
sky&rdquo; securities laws of such states and other jurisdictions as the representative may reasonably designate; (e) all fees,
expenses and disbursements relating to the registration, qualification or exemption of the shares of our Common Stock under the
securities laws of such foreign jurisdictions as the representative may reasonably designate; (f) the costs associated with post-closing
advertising the offering in the national editions of the Wall Street Journal and New York Times; (g) the costs associated with
bound volumes of the public offering materials as well as commemorative mementos and Lucite tombstones, each of which the Company
or its designee shall provide within a reasonable time after the closing of this offering in such quantities as the representative
may reasonably request in an amount not to exceed $3,000 in the aggregate; (h) the fees and expenses of the Company&rsquo;s accountants,
transfer agents and public relations firm; (i) fees and expenses of the underwriters&rsquo; legal counsel not to exceed $85,000;
(j) a $29,500 cost associated with the underwriters use of Ipreo&rsquo;s book-building, prospectus tracking and compliance software
for the offering; (k) $10,000 for data services and communications expenses; and (l) up to $20,000 of the underwriters&rsquo;
actual accountable &ldquo;road show&rdquo; expenses for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total estimated expenses of the offering, including registration, filing and listing fees, printing fees and legal and accounting
expenses, but excluding underwriting discounts and commissions, are approximately $ .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representative&rsquo;s
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of this offering, we have agreed to issue to the representative as compensation warrants to purchase up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of Common
Stock (5% of the aggregate number of shares of Common Stock sold in this offering exclusive of the over-allotment option, or the
representative&rsquo;s warrants). The representative&rsquo;s warrants will be exercisable at a per share exercise price equal
to 125% of the public offering price per share in this offering (excluding the over-allotment option). The representative&rsquo;s
warrants are exercisable at any time and from time to time, in whole or in part, during the four and one half year period commencing
180 days from the effective date of the registration statement of which this prospectus is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 95; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representative&rsquo;s warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant
to Rule 5110(e)(1)(A) of FINRA. The representative (or permitted assignees under Rule 5110(e)(1)(A)) will not sell, transfer,
assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging,
short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the
underlying securities for a period of 180 days from the effective date of the registration statement of which this prospectus
is a part. In addition, the warrants provide for registration rights upon request, in certain cases. The sole demand registration
right provided will not be greater than five years from the effective date of the registration statement in compliance with Rule
5110(g) of FINRA. The piggyback registration rights provided will not be greater than seven years from the effective date of the
registration statement in compliance with Rule 5110(g) of FINRA. We will bear all fees and expenses attendant to registering the
shares of Common Stock issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders.
The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise
price or underlying shares will not be adjusted for issuances of shares of Common Stock at a price below the warrant exercise
price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to &ldquo;lock-up&rdquo; agreements, we, our executive officers and directors, and holders of 5% or more of the outstanding shares
of Common Stock, have agreed, without the prior written consent of the representative not to directly or indirectly, offer to
sell, sell, pledge or otherwise transfer or dispose of any of shares of our Common Stock (or enter into any transaction or device
that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of
our Common Stock), enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of
the economic benefits or risks of ownership of shares of our Common Stock, make any demand for or exercise any right or cause
to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common
Stock or securities convertible into or exercisable or exchangeable for Common Stock or any other securities of ours or publicly
disclose the intention to do any of the foregoing, subject to customary exceptions, for a period of six months after the date
of this prospectus in the case of our directors, executive officers, the Company and any successor of the Company and certain
stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
of this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has not been an active market for our Common Stock. The public offering price for our Common Stock will
be determined through negotiations between us and the underwriters. Among the factors to be considered in these negotiations will
be prevailing market conditions, our financial information, market valuations of other companies that we and the underwriters
believe to be comparable to us, estimates of our business potential, the present state of our development and other factors deemed
relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer no assurances that the public offering price of our Common Stock will correspond to the price at which our Common Stock
will trade in the public market subsequent to this offering or that an active trading market for our Common Stock and warrants
will develop and continue after this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
of First Refusal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
eighteen (18) months from the closing date of this offering, the representative will have an irrevocable right of first refusal,
in its sole discretion, to act as sole investment banker, sole book-runner, and/or sole placement agent, at the representative&rsquo;s
sole discretion, for each and every future public and private equity and debt offering, including all equity linked financings,
during such eighteen (18) month period, on terms customary to the representative. The representative will have the sole right
to determine whether or not any other broker-dealer will have the right to participate in any such offering and the economic terms
of any such participation. The representative will not have more than one opportunity to waive or terminate the right of first
refusal in consideration of any payment or fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 96; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discretionary
Accounts </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters do not intend to confirm sales of the shares of Common Stock offered hereby to any accounts over which they have
discretionary authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading;
Nasdaq Capital Market Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is presently quoted on the OTC, Pink Tier under the symbol &ldquo;SAFO.&rdquo; We have applied to list our Common
Stock on the Nasdaq Capital Market under the symbol &ldquo;SVFD.&rdquo; No assurance can be given that our application will be
approved or that a trading market will develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, certain of the underwriters and/or their affiliates may in the future provide, various investment banking and other
financial services for us for which they may receive customary fees. In the course of their businesses, the underwriters and their
affiliates may actively trade our securities or loans for their own account or for the accounts of customers, and, accordingly,
the underwriters and their affiliates may at any time hold long or short positions in such securities or loans. Except for services
provided in connection with this offering, no underwriter has provided any investment banking or other financial services to us
during the 180-day period preceding the date of this prospectus and we do not expect to retain any underwriter to perform any
investment banking or other financial services for at least 90 days after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
Stabilization, Short Positions and Penalty Bids</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price
of our Common Stock. Specifically, the underwriters may over-allot in connection with this offering by selling more shares than
are set forth on the cover page of this prospectus. This creates a short position in our Common Stock for its own account. The
short position may be either a covered short position or a naked short position. In a covered short position, the number of shares
of Common Stock over-allotted by the underwriters is not greater than the number of shares of Common Stock that they may purchase
in the over-allotment option. In a naked short position, the number of shares of Common Stock involved is greater than the number
of shares Common Stock in the over-allotment option. To close out a short position, the underwriters may elect to exercise all
or part of the over-allotment option. The underwriters may also elect to stabilize the price of our Common Stock or reduce any
short position by bidding for, and purchasing, Common Stock in the open market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters may also impose a penalty bid. This occurs when a particular underwriter or dealer repays selling concessions allowed
to it for distributing shares of Common Stock in this offering because the underwriter repurchases the shares of Common Stock
in stabilizing or short covering transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
the underwriters may bid for, and purchase, shares of our Common Stock in market making transactions, including &ldquo;passive&rdquo;
market making transactions as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
activities may stabilize or maintain the market price of our Common Stock at a price that is higher than the price that might
otherwise exist in the absence of these activities. The underwriters are not required to engage in these activities, and may discontinue
any of these activities at any time without notice. These transactions may be effected on the national securities exchange on
which our shares of Common Stock are traded, in the over-the-counter market, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 97; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the underwriters against liabilities relating to this offering arising under the Securities Act and the
Exchange Act, liabilities arising from breaches of some or all of the representations and warranties contained in the underwriting
agreement, and to contribute to payments that the underwriters may be required to make for these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus in electronic format may be made available on websites or through other online services maintained by one or more of
the underwriters, or by their affiliates. Other than this prospectus in electronic format, the information on any underwriter&rsquo;s
website and any information contained in any other website maintained by an underwriter is not part of this prospectus or the
registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or any underwriter in
its capacity as underwriter, and should not be relied upon by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
Restrictions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
action has been taken in any jurisdiction (except in the United States) that would permit a public offering of our Common Stock,
or the possession, circulation or distribution of this prospectus or any other material relating to us or our Common Stock in
any jurisdiction where action for that purpose is required. Accordingly, our Common Stock may not be offered or sold, directly
or indirectly, and this prospectus or any other offering material or advertisements in connection with our Common Stock may be
distributed or published, in or from any country or jurisdiction, except in compliance with any applicable rules and regulations
of any such country or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>European
Economic Area and United Kingdom</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
relation to each Member State of the European Economic Area and the United Kingdom (each a &ldquo;Relevant State&rdquo;), no Common
Stock has been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication
of a prospectus in relation to the Common Stock which has been approved by the competent authority in that Relevant State or,
where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance
with the Prospectus Regulation, except that offers of shares may be made to the public in that Relevant State at any time under
the following exemptions under the Prospectus Regulation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    legal entities which are qualified investors as defined under the Prospectus Regulation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    the underwriters to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Regulation),
    subject to obtaining the prior consent of the representatives of the underwriters for any such offer; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    any other circumstances falling within Article 1(4) of the Prospectus Regulation,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided
that no such offer of Common Stock shall result in a requirement for us or any underwriter to publish a prospectus pursuant to
Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this provision, the expression an &ldquo;offer of Common Stock to the public&rdquo; in relation to any Common
Stock in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the
offer and any Common Stock to be offered so as to enable an investor to decide to purchase or subscribe for our Common Stock,
and the expression &ldquo;Prospectus Regulation&rdquo; means Regulation (EU) 2017/1129.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 98; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
Kingdom</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus has only been communicated or caused to have been communicated and will only be communicated or caused to be communicated
as an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and
Markets Act of 2000, or the FSMA) as received in connection with the issue or sale of our Common Stock in circumstances in which
Section 21(1) of the FSMA does not apply to us. All applicable provisions of the FSMA will be complied with in respect to anything
done in relation to our Common Stock in, from or otherwise involving the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Canada</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited
investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario),
and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant
Obligations. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to,
the prospectus requirements of applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this
prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages
are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province
or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province
or territory for particulars of these rights or consult with a legal advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to section 3A.3 of National Instrument 33-105 Underwriting Conflicts, or NI 33-105, the underwriters are not required to comply
with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 99; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Australia</I></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian
Securities and Investments Commission and does not purport to include the information required of a disclosure document under
Chapter 6D of the Australian Corporations Act. Accordingly, (i)&nbsp;the offer of the securities under this prospectus is only
made to persons to whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations
Act under one or more exemptions set out in section 708 of the Australian Corporations Act, (ii)&nbsp;this prospectus is made
available in Australia only to those persons as set forth in clause (i)&nbsp;above, and (iii)&nbsp;the offeree must be sent a
notice stating in substance that by accepting this offer, the offeree represents that the offeree is such a person as set forth
in clause (i)&nbsp;above, and, unless permitted under the Australian Corporations Act, agrees not to sell or offer for sale within
Australia any of the securities sold to the offeree within 12&nbsp;months after its transfer to the offeree under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>China</I></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in
the People&rsquo;s Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau
Special Administrative Region and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal
or natural persons other than directly to &ldquo;qualified domestic institutional investors.&rdquo;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>France</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers)
in France within the meaning of Article&nbsp;L.411-1 of the French Monetary and Financial Code (Code Mon&eacute;taire et Financier)
and Articles 211-1 et seq. of the General Regulation of the French Autorit&eacute; des march&eacute;s financiers (&ldquo;AMF&rdquo;).
The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval
in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
offers, sales and distributions have been and shall only be made in France to (i)&nbsp;qualified investors (investisseurs qualifi&eacute;s)
acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&deg; and D.411-1 to D.411-3, D.744-1,
D.754-1 ;and D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or (ii)&nbsp;a restricted number
of non-qualified investors (cercle restreint d&rsquo;investisseurs) acting for their own account, as defined in and in accordance
with Articles L.411-2-II-2&deg; and D.411-4, D.744-1, D.754-1; and D.764-1 of the French Monetary and Financial Code and any implementing
regulation.</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article&nbsp;211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed
(directly or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and
L.621-8 to L.621-8-3 of the French Monetary and Financial Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Ireland</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been
filed with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering
of securities in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations&nbsp;2005 (the &ldquo;Prospectus
Regulations&rdquo;). The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly
in Ireland by way of a public offering, except to (i)&nbsp;qualified investors as defined in Regulation&nbsp;2(l) of the Prospectus
Regulations and (ii)&nbsp;fewer than 100 natural or legal persons who are not qualified investors.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 100; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Israel</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or
ISA, nor have such securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly,
to the public in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection
with the offering or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability
or completeness, or rendered an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly,
to the public of the securities offered by this prospectus is subject to restrictions on transferability and must be effected
only in compliance with the Israeli securities laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Italy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission
(Commissione Nazionale per le Societ&thinsp;&mdash;&thinsp;$$&thinsp;&mdash;&thinsp;Aga e la Borsa, &ldquo;CONSOB&rdquo; pursuant
to the Italian securities legislation and, accordingly, no offering material relating to the securities may be distributed in
Italy and such securities may not be offered or sold in Italy in a public offer within the meaning of Article&nbsp;1.1(t) of Legislative
Decree No. 58 of 24 February&nbsp;1998 (&ldquo;Decree No. 58&rdquo;), other than:</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         Italian qualified investors, as defined in Article&nbsp;100 of Decree no.58 by reference
                                         to Article&nbsp;34-ter of CONSOB Regulation no.&nbsp;11971 of 14 May&nbsp;1999 (&ldquo;Regulation
                                         no.&nbsp;1197l&rdquo;) as amended (&ldquo;Qualified Investors&rdquo;); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         other circumstances that are exempt from the rules on public offer pursuant to Article&nbsp;100
                                         of Decree No. 58 and Article&nbsp;34-ter of Regulation&nbsp;No. 11971 as amended.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding
placements where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">made
                                         by investment firms, banks or financial intermediaries permitted to conduct such activities
                                         in Italy in accordance with Legislative Decree No. 385 of 1 September&nbsp;1993 (as amended),
                                         Decree No. 58, CONSOB Regulation&nbsp;No. 16190 of 29 October&nbsp;2007 and any other
                                         applicable laws; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         compliance with all relevant Italian securities, tax and exchange controls and any other
                                         applicable laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement
rules provided under Decree No. 58 and the Regulation&nbsp;No. 11971 as amended, unless an exception from those rules applies.
Failure to comply with such rules may result in the sale of such securities being declared null and void and in the liability
of the entity transferring the securities for any damages suffered by the investors.</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Japan</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities have not been and will not be registered under Article&nbsp;4, paragraph 1 of the Financial Instruments and Exchange
Law of Japan (Law No. 25 of 1948), as amended (the &ldquo;FIEL&rdquo;) pursuant to an exemption from the registration requirements
applicable to a private placement of securities to Qualified Institutional Investors (as defined in and in accordance with Article&nbsp;2,
paragraph 3 of the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly
or indirectly, in Japan or to, or for the benefit of, any resident of Japan other than Qualified Institutional Investors. Any
Qualified Institutional Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional
Investor, and acquisition by any such person of securities is conditional upon the execution of an agreement to that effect.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 101; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Portugal</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offer of financial securities (oferta p&uacute;blica de valores mobili&aacute;rios)
in Portugal, within the meaning of Article&nbsp;109 of the Portuguese Securities Code (C&oacute;digo dos Valores Mobili&aacute;rios).
The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal.
This document and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese
Securities Market Commission (Comiss&abreve;o do Mercado de Valores Mobili&aacute;rios) for approval in Portugal and, accordingly,
may not be distributed or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances
that are deemed not to qualify as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of
securities in Portugal are limited to persons who are &ldquo;qualified investors&rdquo; (as defined in the Portuguese Securities
Code). Only such investors may receive this document and they may not distribute it or the information contained in it to any
other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sweden</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority).
Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances
that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980)
om handel med finansiella instrument). Any offering of securities in Sweden is limited to persons who are &ldquo;qualified investors&rdquo;
(as defined in the Financial Instruments Trading Act). Only such investors may receive this document and they may not distribute
it or the information contained in it to any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Switzerland</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&ldquo;SIX&rdquo;) or
on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the
disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure
standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange
or regulated trading facility in Switzerland. Neither this document nor any other offering material relating to the securities
may be publicly distributed or otherwise made publicly available in Switzerland.</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss
regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised
by, the Swiss Financial Market Supervisory Authority (FINMA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is personal to the recipient only and not for general circulation in Switzerland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
Arab Emirates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab
Emirates or any other governmental authority in the United Arab Emirates, nor has the Company received authorization or licensing
from the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or
sell the securities within the United Arab Emirates. This document does not constitute and may not be used for the purpose of
an offer or invitation. No services relating to the securities, including the receipt of applications and/or the allotment or
redemption of such shares, may be rendered within the United Arab Emirates by the Company.</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 102; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pi_004"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP of New York, New York will pass upon the validity of the securities offered hereby. Certain legal matters
in connection with this offering will be passed upon for the underwriter by Gracin &amp; Marlow, LLP, New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pi_005"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of Save Foods, Inc. as of December 31, 2020 and 2019 and for each of the two years in the period
ended December 31, 2020, included in this prospectus and in the Registration Statement have been so included in reliance on the
report of Halperin CPA, Financial Consulting &amp; Management, an independent registered public accounting firm, given on the
authority of said firm as experts in auditing and accounting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pi_006"></A>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered hereby.
This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in
the registration statement or the exhibits and schedules filed with the registration statement. For further information about
us and the securities offered hereby, we refer you to the registration statement and the exhibits filed with the registration
statement. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed
as an exhibit to the registration statement are not necessarily complete, and each such statement is qualified in all respects
by reference to the full text of such contract or other document filed as an exhibit to the registration statement. The SEC also
maintains an internet website that contains reports, proxy statements and other information about registrants, like us, that file
electronically with the SEC. The address of that website is <I>www.sec.gov</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of this offering, we will be required to file periodic reports, proxy statements, and other information with the SEC
pursuant to the Exchange Act. These reports, proxy statements, and other information will be available on the website of the SEC
referred to above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also maintain a website at <I>www.savefoods.co</I>., through which you may access these materials free of charge as soon as reasonably
practicable after they are electronically filed with, or furnished to, the SEC. <B>However, the information contained in or accessible
through our website is not part of this prospectus or the registration statement of which this prospectus forms a part, and investors
should not rely on such information in making a decision to purchase our Common Stock in this offering.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 103; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kk_001"></A>Save
Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
OF DECEMBER 31, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE DIR="LTR" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><A HREF="#fin_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
    FINANCIAL STATEMENTS:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><A HREF="#fin_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets as of December 31, 2020 and December 31, 2019</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><A HREF="#fin_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Comprehensive Loss for the years ended December 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><A HREF="#fin_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Changes in Shareholders&rsquo; Deficit for the years ended December 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><A HREF="#fin_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><A HREF="#fin_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8
    &ndash; F-27</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 104; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 105.75pt; width: 225pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="fin_002"></A>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
THE BOARD OF DIRECTORS AND STOCKHOLDERS OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Save Foods, Inc (the &ldquo;Company&rdquo;) and its subsidiary, Save
Foods Ltd. as of December 31, 2020 and 2019, the related consolidated statements of operations and comprehensive loss, changes
in stockholders&rsquo; deficit and cash flows for each of the two years in the period ended December 31, 2020, and the related
notes (collectively referred to as the &ldquo;consolidated financial statements&rdquo;). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and
the results of its operations and its cash flows for each of the two years in the period ended December 31, 2020, in conformity
with accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Going
Concern</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
As discussed in Note 1C to the consolidated financial statements, the Company has not yet generated material revenues from its
operations to fund its activities and is therefore dependent upon external sources for financing its operations. As of December
31, 2020, the Company has incurred accumulated deficit of $12,277,647 and negative operating cash flows. These factor among others,
as discussed in Note 1C to the consolidated financial statements raise substantial doubt about the Company&rsquo;s ability to
continue as a going concern. Management&rsquo;s plans concerning these matters are also described in Note 1C to the consolidated
financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome
of&rsquo; these uncertainties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an
opinion on the Company&rsquo;s financial statements based on our audit. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether
due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting
but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Halperin Ilanit.</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified
    Public Accountants (Isr.)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
Aviv, Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
9, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&rsquo;s auditor since 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 27pt; width: 487.5pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="fin_003"></A>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
BALANCE SHEETS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">242,900</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">290,815</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Restricted cash (Note 2D)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,194</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,003</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,302</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other current assets (Note 3)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65,579</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,300</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total Current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">495,171</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">424,614</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Right Of Use asset arising from operating lease</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,700</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">48,982</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Property and Equipment, Net (Note 4)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">55,194</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">81,119</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Funds in Respect of Employee Rights Upon Retirement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">122,584</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">109,955</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">687,649</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">664,670</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Liabilities and Shareholders&rsquo; Deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Short-term loan from banking institution (Note 7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,230</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Current maturities of convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">203,323</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">235,864</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other accounts liabilities (Note 5)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">517,711</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">380,732</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">785,233</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">623,826</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Fair Value of Convertible Component in Convertible Loans (Note 6)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,970</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Convertible Loans (Notes 6)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">146,929</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">285,917</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Long term from banking institution (Note 7)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,115</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,955</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Liability for employee rights upon retirement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">157,855</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">142,091</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,153,102</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,066,789</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Stockholders&rsquo; Deficit (Note 9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Common stocks of US$ 0.0001 par value each (&ldquo;Common Stocks&rdquo;):<BR> 495,000,000 shares authorized as of December 31, 2020 and 2019; issued and outstanding 1,606,760 and 1,458,593 shares as of December 31, 2020 and 2019, respectively.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Preferred stocks of US$ 0.0001 par value (&ldquo;Preferred stocks&rdquo;):<BR> 5,000,000 shares authorized as of December 31, 2020 and 2019; issued and outstanding 0 shares as of December 31, 2020 and 2019.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,867,585</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,329,571</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Foreign currency translation adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,275</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,275</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,277,647</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10,684,508</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(436,176</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(381,066</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(29,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(21,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total stockholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(465,453</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(402,119</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total liabilities and stockholders&rsquo; deficit</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">687,649</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">664,670</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
accompanying notes are an integral part of the consolidated financial statements. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="fin_004"></A>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF COMPREHENSIVE LOSS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Year ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Revenues from sales of products</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">232,274</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">175,823</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cost of sales (Note 11)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(43,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(144,548</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">Gross profit (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research and development expenses (Note 12)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(417,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(615,623</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(51,105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(342,058</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">General and administrative expenses (Note 13)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,070,109</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,004,899</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">Operating loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,349,345</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,931,305</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Financing expenses, net (Note 14)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(270,393</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,408</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other expenses, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,532</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Shares in losses of affiliated company</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,690</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gain on disposal of affiliated company</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-left: 10pt">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,606,580</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,990,403</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: Net loss attributable to non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,441</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,986</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Net loss attributable to the Company</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,593,139</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,971,417</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Loss per share (basic and diluted) (Note 16)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.38</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
accompanying notes are an integral part of the consolidated financial statements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="fin_005"></A>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STATEMENTS
OF CHANGES IN STOCKHOLDERS&rsquo; DEFICIT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Number<BR>

    of Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additional<BR>
    paid-in<BR>
 capital</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated<BR>

    other<BR>
 comprehensive<BR>
 income <BR>
(loss)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Proceeds
    on<BR>
 account of<BR>
 shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated<BR>

    deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    <BR>
Company&rsquo;s<BR>
 stockholders&rsquo; equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Non-<BR>
controlling
    interest</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    <BR>
stockholders&rsquo;<BR>
 deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">BALANCE
    AT JANUARY 1, 2019</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,318,422</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">132</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,852,461</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(26,275</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">105,000</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,713,091</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">218,227</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,712</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">211,515</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">CHANGES
    DURING THE YEAR ENDED DECEMBER 31, 2019:</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance
    of shares for cash</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">140,171</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">14</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">945,679</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(105,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">840,693</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">840,693</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Value
    of warrant issued in convertible loans</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">97,406</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">97,406</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">97,406</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock
    based compensation</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">434,025</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">434,025</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,645</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">438,670</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive
    loss for the year</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,971,417</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,971,417</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(18,986</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,990,403</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">BALANCE
    AT DECEMBER 31, 2019</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,458,593</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">146</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,329,571</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(26,275</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10,684,508</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(381,066</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21,053</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(402,119</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">CHANGES
    DURING THE YEAR ENDED DECEMBER 31, 2020:</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance
    of shares for cash</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">45,876</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">5</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">349,995</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">350,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">350,000</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Value
    of warrant issued in convertible loans</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,696</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,696</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,696</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Conversion
    of convertible loans</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">67,369</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">7</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">585,924</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">585,931</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">585,931</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Exercise
    of warrants</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">28,572</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">59,998</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">60,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">60,000</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Exercise
    of options</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,350</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">19,999</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">20,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">20,000</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock
    based compensation</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">487,402</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">487,402</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,217</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">492,619</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-left: 7.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive
    loss for the year</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,593,139</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,593,139</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13,441</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,606,580</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">BALANCE
    AT DECEMBER 31, 2020</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,606,760</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">161</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,867,585</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(26,275</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,277,647</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(436,176</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(29,277</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(465,453</FONT></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
accompanying notes are an integral part of the consolidated financial statements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="fin_006"></A>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF CASH FLOWS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Year ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; text-align: left; padding-left: 10pt">Loss for the period</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(1,606,580</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(1,990,403</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Adjustments required to reconcile net loss for the period to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,205</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,351</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Loss from sales of Property and Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,382</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Share in losses (gain on disposal) of affiliated company</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,690</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,690</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Increase (decrease) in liability for employee rights upon retirement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,764</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,019</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Stock based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">492,619</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">438,670</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Expenses on convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">176,216</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,147</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Compensation expenses in exchange of instruments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,793</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Decrease (increase) in accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(83,938</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71,294</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Decrease (increase) in inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(54</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Decrease (increase) in other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,575</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,739</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Increase (decrease) in accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,541</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,313</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Increase in other accounts payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">197,659</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">59,625</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(798,740</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,244,772</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from (payments on) investment in unconsolidated entity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,864</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,567</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Decrease (increase) in Short term deposits in banking institutions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,799</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(38,194</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Increase in funds in respect of employee rights upon retirement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,629</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,567</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from sales of Property and Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Purchase of Property and Equipment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(23,327</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Net cash provided by (used in) investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,065</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(81,655</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 20pt">Proceeds from Secured promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 20pt">Proceeds from convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">379,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 20pt">Repayments of long-term loans from banking institutes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,272</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(42,257</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 20pt">Repayments of right of use asset arising from operating lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(40,968</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 20pt">Proceeds from stock issued for cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">840,693</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 20pt">Exercise of options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 20pt">Exercise of warrants</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">60,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">741,760</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,177,436</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCREASE IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,915</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(148,991</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">290,815</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">439,806</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">CASH AND CASH EQUIVALENTS AT END OF YEAR</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">242,900</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">290,815</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF CASH FLOWS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cash paid during the year for:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Interest</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 1.5pt solid; text-align: right">408</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 1.5pt solid; text-align: right">836</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Non cash transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Disposal of affiliated company</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,704</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Termination of lease agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,590</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Issuance of warrants in convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,388</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Conversion of convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">528,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Initial recognition of operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,982</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Initial recognition of operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(48,982</TD><TD STYLE="text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
accompanying notes are an integral part of the consolidated financial statements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="fin_008"></A>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
1 &ndash; GENERAL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operations</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc. (the &ldquo;Company&rdquo;) was incorporated on April 1, 2009, under the laws of the State of Delaware. On April 27,
2009, the Company acquired from its stockholders 98.94% of the issued and outstanding shares of Save Foods Ltd., including preferred
and common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods Ltd. was incorporated in 2004 and commenced its operations in 2005. Save Foods Ltd. develops, produces, and focuses on delivering
innovative solutions for the food industry aimed at improving food safety and prolonging shelf life of fresh produce.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s common stock is quoted on the OTC, Pink Tier, under the symbol &ldquo;SAFO&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reverse
    stock split</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2019, the Company amended and restated its Certificate of Incorporation to effect a 15 to 1 reverse stock split of the
Company&rsquo;s outstanding Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the reverse stock split, which became effective on June 11, 2019, every 15 shares of the Company&rsquo;s outstanding
Common Stock prior to the effect of that amendment was combined and reclassified into one share of the Company&rsquo;s Common
Stock. No fractional shares were issued in connection with or following the reverse split. The number of outstanding shares of
the Company&rsquo;s Common Stock and par value of the shares remained unchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 23, 2021, the Company amended its Certificate of Incorporation to effect a 7 to 1 reverse stock split of the Company&rsquo;s
outstanding Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the reverse stock split, every 7 shares of the Company&rsquo;s outstanding Common Stock prior to the effect of that
amendment was combined and reclassified into one share of the Company&rsquo;s Common Stock. No fractional shares were issued in
connection with or following the reverse split. The number of authorized capital of the Company&rsquo;s Common Stock and par value
of the shares remained unchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
share, stock option and per share information in these condensed consolidated financial statements have been restated to reflect
the stock split on a retroactive basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Going
    concern uncertainty</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
its incorporation (April 1, 2009), the Company has not had any operations other than those carried out by Save Foods Ltd. The
development and commercialization of Save Foods Ltd.&rsquo;s products will require substantial expenditures. Save Foods Ltd. and
the Company have not yet generated sufficient revenues from their operations to fund the Group&rsquo;s (as defined below) activities
and are therefore dependent upon external sources for financing their operations. There can be no assurance that the Company will
succeed in obtaining the necessary financing to continue its operations. As of December 31, 2020, the Company had $242,900 in
cash, a negative working capital of $290,062 and an accumulated deficit of $12,277,647.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will need to secure additional capital in the future in order to meet its anticipated liquidity needs primarily through
the sale of additional Common Stock or other equity securities and/or debt financing. Funds from these sources may not be available
to the Company on acceptable terms, if at all, and the Company cannot give assurance that it will be successful in securing such
additional capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company focuses its solutions towards vegetables and fruits which are considered the largest in terms of worldwide consumption.
Among other things, the Company tries to cooperate with major fruit packing houses in Israel and abroad.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
factors raise substantial doubt about Save Foods Ltd. and the Company&rsquo;s ability to continue as a going concern. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
1 &ndash; GENERAL (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D</B>.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2019, a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. This virus continues to spread globally
    and, has spread to over 180 countries, including the United States and Israel. The spread of COVID-19 from China to other
    countries has resulted in the World Health Organization declaring the outbreak of COVID-19 as a &ldquo;pandemic,&rdquo; or
    a worldwide spread of a new disease, on March 11, 2020. Many countries around the world have imposed quarantines and restrictions
    on travel and mass gatherings to slow the spread of the virus, including in the United States and in Israel. Governments may
    divert spending from other budgeted resources as they seek to reduce and/or stop the spread of an infectious disease, such
    as COVID-19. Such events may result in a period of business and manufacturing disruption, and in reduced operations, any of
    which could materially affect the Company&rsquo;s business, financial condition and results of operations. The extent to which
    COVID-19 impacts the Company&rsquo;s business will depend on future developments, which are highly uncertain and cannot be
    predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19
    or treat its impact, among others. The Company believes it is taking appropriate actions to mitigate the negative impacts.
    However, the full impact of COVID-19 is unknown and cannot be reasonably estimated as these events occurred subsequent to
    year end and are still developing.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    factors</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Save Foods Ltd. (collectively, the &ldquo;Group&rdquo;) face a number of risks, including uncertainties regarding
finalization of the development process, demand and market acceptance of the Group&rsquo;s products, the effects of technological
changes, competition and the development of products by competitors. Additionally, other risk factors also exist, such as the
ability to manage growth and the effect of planned expansion of operations on the Group&rsquo;s future results. In addition, the
Group expects to continue incurring significant operating costs and losses in connection with the development of its products
and increased marketing efforts. As mentioned above, the Group has not yet generated significant revenues from its operations
to fund its activities, and therefore the continuance of its activities as a going concern depends on the receipt of additional
funding from its current stockholders and investors or from third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2&ndash; SIGNIFICANT ACCOUNTING POLICIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements were prepared in accordance with accounting principles generally accepted in the United States of America
(US GAAP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of estimates in the preparation of financial statements</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial
statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.
As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions,
share based compensation and convertible loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Functional
    currency</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of the Group&rsquo;s revenues is generated in U.S. dollars. In addition, most of the Group&rsquo;s costs are denominated
and determined in U.S. dollars and in new Israeli shekels. Management believes that the dollar is the currency in the primary
economic environment in which the Group operates. Thus, the functional and reporting currency of the Group is the U.S. dollar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with Accounting Standards
Codification (ASC) 830, &ldquo;Foreign Currency Matters&rdquo;. All transaction gains and losses of the remeasured monetary balance
sheet items are reflected in the statements of operations as financial income or expenses, as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2&ndash; SIGNIFICANT ACCOUNTING POLICIES (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principles
    of consolidation</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its subsidiary, Save Foods Ltd. All significant intercompany
balances and transactions have been eliminated on consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
    and cash equivalents, and Restricted cash</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
equivalents are short-term highly liquid investments which include short term bank deposits (up to three months from date of deposit),
that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less
as of the date acquired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
cash as of December 31, 2020 and 2019 included a NIS 72,000 ($22,395) and NIS 132,000 ($38,194), respectively collateral account
for the Company&rsquo;s corporate credit cards and a loan and is classified in current assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts
    receivables</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivables are stated at their net realizable value. The allowance against gross accounts receivables reflects the best estimate
of losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known
troubled accounts and other currently available information. As of December 31, 2020, and 2019, an allowance for doubtful debts
in the amount of $26,553 and $24,702, respectively, is reflected in net accounts receivables. Accounts receivables are written
off after all reasonable means to collect the full amount have been exhausted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property,
    plant and equipment, net</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method
    over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated
    depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is
    reflected in the Statements of Operations and Comprehensive Loss.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rates
    of depreciation:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Furniture and office equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Machines</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-15</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Computers</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">33</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vehicle</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impairment
    of long-lived assets</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&rsquo;s long-lived assets are reviewed for impairment in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;)
Topic 360, &ldquo;Property, Plant and Equipment&rdquo;, whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying
amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such assets are considered
to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its
fair value. No impairment expenses were recorded during the years ended December 31, 2020 or 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2&ndash; SIGNIFICANT ACCOUNTING POLICIES (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deferred
    income taxes</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group accounts for income taxes in accordance with ASC Topic 740, &ldquo;Income Taxes&rdquo;. Accordingly, deferred income taxes
are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial
accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using
the enacted tax rates expected to be in effect when these differences reverse. Valuation allowances in respect of deferred tax
assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial
statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise&rsquo;s financial statements.
According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&rsquo;s accounting
policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not
recognize such items in its fiscal 2020 and 2019 financial statements and did not recognize any liability with respect to an unrecognized
tax position in its balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liability
    for employee rights upon retirement</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods Ltd&rsquo;s liability for employee rights upon retirement with respect to its Israeli employees is calculated, pursuant
to Israeli Severance Pay Law, based on the most recent salary of each employee multiplied by the number of years of employment,
as of the balance sheet date. Employees are entitled to one month&rsquo;s salary for each year of employment, or a portion thereof.
Save Foods Ltd. makes monthly deposits to insurance policies and severance pay funds. The liability of the Company is fully provided
for.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposited funds include profits accumulated up to the balance sheet date. The deposited funds may be withdrawn upon the fulfillment
of the obligation pursuant to Israeli severance pay laws or labor agreements. The value of the deposited funds is based on the
cash surrender value of these policies, and includes immaterial profits/losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severance
expenses for the years ended December 31, 2020 and 2019, amounted to $7,419 and $24,000, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>J.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revenue
    recognition</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
are recognized when delivery has occurred and there is persuasive evidence of an agreement, the fee is fixed or determinable and
collection of the related receivables is reasonably assured and no further obligations exist.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of products are recognized when title and risk and rewards for the products are transferred to the customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>K.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
    and development expenses</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses are charged to operations as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2&ndash; SIGNIFICANT ACCOUNTING POLICIES (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>L.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Royalty-bearing
    grants</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty-bearing
grants from the Israeli Innovation Authority (the &ldquo;IIA&rdquo;) for funding approved research and development projects are
recognized at the time Save Foods Ltd. is entitled to such grants (i.e. at the time that there is reasonable assurance that the
Company will comply with the conditions attached to the grant and that there is reasonable assurance that the grant will be received),
on the basis of the costs incurred and reduce research and development costs. The cumulative research and development grants received
by the Company from inception through December 2020 amounted to NIS 484,429 (US$150,678).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, and 2019, the Company did not accrue for or pay any royalties to the IIA since no revenues were recognized
in respect of the funded projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>M.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inventories</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are valued at the lower of cost or net realizable value. Cost of raw and packaging materials, purchased products, manufactured
finished products and products in process are determined on the average costs basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company regularly reviews its inventories for impairment and reserves are established when necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basic
    and diluted loss per common stock</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per common stock is computed by dividing the loss for the period applicable to shareholders, by the weighted average number
of shares of common stock outstanding during the period. Securities that may participate in dividends with the shares of common
stock (such as the convertible preferred) are considered in the computation of basic loss per share under the two-class method.
However, in periods of net loss, only the convertible preferred shares are considered, since such shares have a contractual obligation
to share in the losses of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing diluted loss per share, basic loss per share is adjusted to reflect the potential dilution that could occur upon the
exercise of potential shares. Accordingly, in periods of net loss, no potential shares are considered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>O.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-based
    compensation</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair
values in accordance with ASC 718, &ldquo;Compensation-Stock Compensation&rdquo;. Share-based payments including grants of stock
options are recognized in the statement of comprehensive loss as an operating expense based on the fair value of the award at
the date of grant. The fair value of stock options granted is estimated using the Black-Scholes option-pricing model. The Company
has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the requisite service
period or over the implicit service period when a performance condition affects the vesting, and it is considered probable that
the performance condition will be achieved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
payments awarded to consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, &ldquo;Equity-Based Payments
to Non-Employees&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2&ndash; SIGNIFICANT ACCOUNTING POLICIES (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
    Value Measurements</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of certain of the Company&rsquo;s financial instruments including cash, accounts receivable, account payable, accrued expenses,
notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports
fair value in accordance with ASC 820, &ldquo;Fair Value Measurements and Disclosure&rdquo; defines fair value, establishes a
framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair
value investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best
use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair
value of a liability should reflect the risk of non-performance, which includes, among other things, the Company&rsquo;s credit
risk.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The
selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the
characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair
value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides
fair value hierarchy for inputs and resulting measurement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities
in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that
are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant
to the fair values.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements
in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to
expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes
during the period attributable to the following: total gains or losses for the period (realized and unrealized), segregating those
gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the
statement of income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records a debt discount related to the issuance of convertible debts that have conversion features at adjustable rates.
The debt discount for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase
in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the fair value
of the conversion features. The debt discount will be accreted by recording additional non-cash gains and losses related to the
change in fair values of derivative liabilities over the life of the convertible notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair
value hierarchy are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance as of December 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 44%; text-align: left; padding-bottom: 1.5pt">Fair Value of convertible component in convertible loan</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">54,970</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">54,970</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Total liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,970</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,970</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Fair value of Convertible component</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Outstanding at January 1, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Fair value of issued level 3 liability</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">27,762</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Changes in fair value</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">27,208</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Outstanding at December 31, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">54,970</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Q.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concentrations
    of credit risk</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents
as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily
held in Dollars and New Israeli Shekels, are deposited with major banks in Israel and United States. Management believes that
such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial
instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange
contracts, option contracts or other foreign hedging arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>R.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contingencies</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or
additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2&ndash; SIGNIFICANT ACCOUNTING POLICIES (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    Accounting Pronouncements </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the Financial Accounting Standards Board (the &ldquo;FASB&rdquo;) issued Accounting Standards Update (&ldquo;ASU&rdquo;)
No. 2016-13, &ldquo;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.&rdquo;
In November 2018, FASB issued ASU No. 2018-19, &ldquo;Codification Improvements to Topic 326, Financial Instruments-Credit Losses&rdquo;,
which amends the scope and transition requirements of ASU 2016-13. Topic 326 requires a financial asset (or a group of financial
assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected
credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable
and supportable forecasts that affect the collectability of the reported amount. Topic 326 will originally become effective for
the Company beginning January 1, 2020, with early adoption permitted, on a modified retrospective approach. As a smaller reporting
company, the effective date for the Company has been delayed until fiscal years beginning after December 15, 2022, in accordance
with ASU 2019-10, although early adoption is still permitted. This standard did not have a material impact to the Company&rsquo;s
consolidated financial statements after evaluation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments
in this ASU simplify the accounting for income taxes, eliminates certain exceptions to the general principles in Topic 740 and
clarifies certain aspects of the current guidance to improve consistent application among reporting entities. ASU 2019-12 is effective
for fiscal years beginning after December 15, 2021 and interim periods within annual periods beginning after December 15, 2022,
though early adoption is permitted, including adoption in any interim period for which financial statements have not yet been
issued. This standard is not expected to have a material impact to the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure
Requirements for Fair Value Measurement. This standard will require entities to disclose the amount of total gains or losses for
the period recognized in other comprehensive income that is attributable to fair value changes in assets and liabilities held
as of the balance sheet date and categorized within Level 3 of the fair value hierarchy. This ASU will be effective for the Company
for annual and interim periods beginning after December 31, 2020. Early adoption of this standard is permitted. This standard
did not have a material impact to the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity
s Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models
for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion
features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue
to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to
the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting
and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital.
ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity&rsquo;s own equity to reduce
form-over-substance-based accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning
after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than
fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Management has not yet evaluated
the impact that the adoption of ASU 2020-06 will have on the Company&rsquo;s consolidated financial statement presentation or
disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
new pronouncements issued but not effective as of December 31, 2020 are not expected to have a material impact on the Company&rsquo;s
consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; OTHER CURRENT ASSETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid expenses and
    advances to vendors</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,020</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,811</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Receivables from sale of subsidiary
    (Note 5)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,704</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Government
    Institutions</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,855</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,489</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">65,579</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,300</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 &ndash; PROPERTY AND EQUIPMENT, NET</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Computers</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,328</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,328</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture and office equipment</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Machines</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">130,797</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">134,665</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vehicles</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">85,149</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">85,149</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">231,276</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">235,144</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less - accumulated depreciation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(139,382</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(117,325</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less &ndash;
    Impairment of long lived assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(36,700</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(36,700</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total property
    and equipment, net</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,194</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81,119</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the years ended December 31, 2020 and 2019, depreciation expenses were US$ 22,512 and US$ 27,351 respectively, and additional
property and equipment were purchased in an amount of US$ 23,327 for the years ended December 31, 2019 (none for the year ended
December 31, 2020).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5 &ndash; OTHER ACCOUNTS LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employees and related
    institutions</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">110,220</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">135,901</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">392,442</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">184,616</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Right Of Use liability arising from
    operating lease</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,049</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">52,093</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Affiliated
    company (*)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,122</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">517,711</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">380,732</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 2, 2019,
    the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. (&ldquo;Savescann&rdquo;)
    a newly formed company registered in Canada. Savecann intended to market the Company&rsquo;s solutions to the Cannabis market.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 21, 2020,
    the Company sold its entire holdings in Savecann for total consideration of 10,000 Canadian Dollars ($7,000), of which $2,704
    were not paid yet and are presented as part of other current assets.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6 &ndash; CONVERTIBLE LOANS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2019, the Company entered into a series of Convertible Loan Agreements (each a &ldquo;CLA&rdquo;) with third parties
    and certain existing shareholders (the &ldquo;Lenders&rdquo;), pursuant to which the Lenders agreed to provide the Company
    loans in the aggregate amount of $379,000 and in exchange the Company issued to the Lenders (i) convertible promissory notes
    (the &ldquo;Notes&rdquo;) and (ii) warrants with an exercise price of $8.40. In January and March 2020, the Company entered
    into two additional CLA agreements for an aggregate amount of $135,000, consisting of the same terms.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
    to the terms of the CLA, the Notes bear interest at a rate of 5% per annum and the loan amount represented by the Notes is
    to be repaid to the Lenders according to the following schedule: (i) the principal amount represented by the Notes to be repaid
    in twenty four equal monthly installments, commencing on the twenty fifth month following the closing of each CLA, and (ii)
    the interest accrued on the loan amount to be paid in two bi-annual installments, commencing on the first anniversary of the
    first payment of the principal amount.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition, according to the terms of the CLA, the outstanding loan amount matures on the earlier of (i) the third anniversary
    of each CLA or (ii) a deemed liquidation event (as defined therein), and the Lenders may convert all or any portion of the
    Notes at any time prior to the one-year anniversary of each issuance into shares of the Company&rsquo;s Common Stock at a
    conversion price of $8.40 per share.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with ASC 815-15-25, the conversion feature was considered embedded derivative instruments, and is to be recorded
    at their fair value as its fair value can be separated from the convertible loan and its conversion is independent of the
    underlying note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan
    in the excess amount of the convertible component fair value over the face loan amount. The conversion liability is then marked
    to market each reporting period with the resulting gains or losses shown in the statements of operations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         a result of the above issuances, the Company recorded in the periods ended March 31,
                                         2020 and December 31, 2019, a total amount of $34,696 and $97,406, respectively, in respect
                                         of the detachable warrants, as a credit to stockholders&rsquo; equity (additional paid
                                         in capital). The fair value of the Warrants was determined using the Black-Scholes pricing
                                         model, assuming a risk free rate of 1.6%, a volatility factor of 54.00%, dividend yields
                                         of 0% and an expected life of 3 years.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 24, 2020, the Company entered into a Securities Purchase Agreement (the &ldquo;SPA&rdquo;) with the Lenders in connection
    with the sale and issuance of 69,332 units (&ldquo;Units&rdquo;), at a purchase price of $7.63 per Unit. Each Unit consists
    of: (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.4
    (the &ldquo;Warrant&rdquo;). In connection with the SPA, the Company issued to the Lenders an aggregate of 67,369 shares of
    Common Stock and Warrants to purchase an aggregate of 67,369 shares of Common Stock. The shares of Common Stock were issued
    on July 2, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneous
    with and conditioned upon the execution of the SPA, the Company and each of the Lenders agreed to effectively cancel the CLA
    and the equity securities issued thereunder. In connection therewith, each of the Lenders voluntarily waived any right to
    receive interest that accrued thereupon pursuant to the CLA.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company evaluated the transaction as an exchange of instruments and as a result of the above conversion, recorded a compensation
    expenses in a total amount of $57,793, as of the exchange date, and as a credit to stockholders&rsquo; equity (additional
    paid in capital). The fair value of the additional shares granted in the conversion was calculated based on the Company&rsquo;s
    share price as of the date of the conversion. The fair value of the additional warrants granted in the conversion was determined
    using the Black-Scholes pricing model, assuming a risk-free rate of 0.21%, a volatility factor of 51.96%, dividend yields
    of 0% and an expected life of 2.45-2.71 years.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years ended December 31, 2020 and 2019, the Company recorded net interest and amortization expenses in the amount of $199,709
    and $4,323, respectively, in respect of the discounts recorded on the CLAs.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 21, 2020, the Company entered into a series of additional convertible loan agreements (each a &ldquo;2020 CLA&rdquo;)
    with certain lenders (the &ldquo;2020 Lenders&rdquo;) to sell convertible promissory notes with an aggregate principal amount
    of $125,000 (each a &ldquo;2020 Note&rdquo;). The outstanding loan amount under the 2020 CLA will mature on the earlier of
    (i) the third anniversary of each 2020 CLA or (ii) a deemed liquidation event (as defined therein), and the 2020 Lenders may
    convert all or any portion of the 2020 Notes into shares of Common Stock at any time prior to a mandatory conversion event
    (as defined therein) at a conversion price of $7.63 per share. The 2020 Notes will bear interest at a rate of 5% per annum.
    The loan amount represented by the 2020 Notes will be repaid to the 2020 Lenders according to the following schedule: (i)
    the principal amount represented by the 2020 Notes will be repaid in four bi-annual installments, commencing on the first
    anniversary following the closing of each 2020 CLA, and (ii) the interest accrued on the loan amount will be paid in two bi-annual
    installments, commencing on the first anniversary of the first payment of that principal amount.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6 &ndash; CONVERTIBLE LOANS</B> (continue)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    October 2020, the Company entered into a series of additional 2020 CLAs with additional 2020 Lenders to sell additional 2020
    Notes with an aggregate principal amount of $100,000.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    January 2021, the Company entered into a series of additional 2020 CLAs with additional 2020 Lenders to sell additional 2020
    Notes with an aggregate principal amount of $274,000. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    part of the 2020 CLA, the Company entered into a registration rights agreement with each of the 2020 Lenders, whereby each
    2020 Lender received piggyback registration rights for the shares issuable upon conversion of the 2020 Notes to shares of
    Common Stock.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loans are convertible into common Stock upon (i) a completion of underwritten public offering (&ldquo;Mandatory Conversion&rdquo;)
convert the outstanding loan amount at a share price as shall be determined in the offering, or (ii) at the lender&rsquo;s discretion
(&ldquo;Optional Conversion&rdquo;) convert the outstanding loan amount at a share price per share of $7.63.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 815-15-25, the conversion feature was considered embedded derivative instruments, and is to be recorded at
their fair value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying
note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess
amount of the convertible component fair value over the face loan amount. The conversion liability is then marked to market each
reporting period with the resulting gains or losses shown in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the convertible component was estimated by third party appraiser as weighted average of the two possible scenarios
of the total loan amount conversion: as of September 21, 2020 and October 23, 2020, 70% probability for the Mandatory Conversion
and 30% probability for the Optional Conversion and as of December 31, 2020, 75% probability for the Mandatory Conversion and
25% probability for the Optional Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Mandatory Conversion (scenario 1) was estimated by the appraiser using the Black-Scholes option pricing model, to compute the
fair value of the derivative and to market the fair value of the derivative at each balance sheet date. The following are the
data and assumptions used as of issuance dates and as of the balance sheet date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 78%; font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    21, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>October
                                         23,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend yield</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free interest rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.19</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.11</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.09</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected term (years)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.775</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.685</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.417</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51.96</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51.96</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48.06</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Share price</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.72</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.88</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.61</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,208</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,457</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47,499</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Optional Conversion (scenario 2) was estimated by the appraiser using binomial option pricing model and simulating and waiver
of the lender as an exercise price, to compute the fair value of the derivative and to mark to market the fair value of the derivative
at each balance sheet date. The following are the data and assumptions used as of the issuance dates and as of balance sheet date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 78%; font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    21, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">October
    23, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 42%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend yield</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free interest rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12-0.16</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12-0.2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10-0.14</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51.96</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51.96</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48.06</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Share price</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.72</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.88</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.61</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,824</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,167</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">77,381</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the convertible component was estimated by the third-party appraiser after giving effect to the weighted average
of the two possible scenarios as of issuance dates was $27,762 and as of December 31, 2020 was $54,970.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value allocated to the convertible loan was estimated by third party appraiser as the residual value of the proceeds net
of the convertible component and was estimated at a value of $203,179 as of December 31, 2020 of which $56,250 is presented under
current liabilities and $146,929 is presented under long term liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: left; text-indent: -68.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7 - LONG-TERM LOANS FROM BANKING INSTITUTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: left; text-indent: -68.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Composition</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-align: left; text-indent: -22.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest rate at<BR> December 31</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 51%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term loans</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,064</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,185</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less current
    maturities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,949</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,230</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,115</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,955</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maturity
    dates:</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-align: left; text-indent: -22.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">First year</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,949</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Second year</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,115</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,064</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 &ndash; COMMITMENT AND CONTINGENT LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods Ltd. is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development
    projects in which the IIA participates by way of grants. In the first 3 years of sales the Company shall pay 3% of the sales
    of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales,
    the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount
    of grants received plus interest at LIBOR. Save Foods Ltd. was entitled to the grants only upon incurring research and development
    expenditures. There were no future performance obligations related to the grants received from the IIA. As of December 31,
    2020, the contingent liabilities with respect to grants received from the IIA, subject to repayment under these royalty agreements
    on future sales is NIS 484,429 (US$ 150,678), not including interest.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company and its subsidiary currently lease office space at Kibbutz Alonim under a short-term operating lease agreement ends
    at December 31, 2020 with an option to extend the agreement with additional year ended at December 31, 2021. During the years
    2020 and 2019, the Company paid an annual rent of $14,967 and $10,605, respectively under the above agreement. The agreement
    was automatically renewed (option) until December 31, 2021.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company and Save Foods Ltd. entered into a short term lease agreement for the period ended at May 31, 2019, with
a shareholder for the lease of an office and related services for a monthly fee of NIS 5,000 (approximately $1,400).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 1, 2019 the Company and Save Foods Ltd. entered into a lease agreement for its offices in Tel Aviv for the period ending December
31, 2020, for the lease of an office and management fees for a monthly fee of NIS 11,214 (approximately $3,450). On August 9,
2020, the Company and the lessor agreed that the Company would pay the lessor a one-time NIS10,000 ($3,100) and the agreement
would be terminate as of August 13, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2017, the Company entered into a lease agreement for office space in New York, hereinafter the New York Lease. The
New York Lease will expire on September 30, 2020, unless terminated earlier by either party by providing 30 days prior written
notice to the other party. The New York Lease rent amount, $7,200, was fully paid for through an issuance of 720,000 shares of
our Common Stock on November 5, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 &ndash; COMMITMENT AND CONTINGENT LIABILITIES (continue)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    July 2011, Save Foods, Ltd. filed with the Commissioner of Patent of the Israeli Patent Office (the &ldquo;Commissioner&rdquo;)
    a claim stating its opposition to a patent application made by Xeda International S.A, (&ldquo;Xeda&rdquo;), which would have
    restricted Save Foods Ltd&rsquo;s operations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -21.3pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Commissioner accepted Save Foods Ltd&rsquo;s claims against Xeda&rsquo;s patent application and, accordingly, rejected
Xeda&rsquo;s application. The Commissioner awarded Save Foods Ltd. with expenses and legal fees in the aggregate amount of approximately
NIS 165,000 (approximately $46,000)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2018, Xeda filed an appeal with the District Court in Jerusalem (the &ldquo;Court&rdquo;), with respect to the Commissioner&rsquo;s
decision, and in January 2019, the Court dismissed Xeda&rsquo;s appeal and awarded Save Foods Ltd. expenses and legal fees in
the aggregate amount of approximately NIS 50,000 (approximately $13,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2019, Xeda filed a request to appeal the Court&rsquo;s decision with the Israeli Supreme Court. In May 2019, the Israeli
Supreme Court rejected Xeda&rsquo;s request to appeal and awarded Save Foods Ltd. expenses and legal fees in the aggregate amount
of NIS 8,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 22, 2020, the Company entered into a non-exclusive Commission Agreement with Earthbound Technologies, LLC (&ldquo;EBT&rdquo;)
    for a period of 12 months, according to which EBT shall introduce the Company to potential clients, pre-approved by the Company
    (&ldquo;Introduced Parties&rdquo;) and shall assist the Company in finalizing commercial agreements with the Introduced Parties.
    In consideration for its services, the Company agreed to pay EBT 12.5% of the net revenues generated from Introduced Parties
    (during the agreement period and within 18 months following the termination of the agreement) up to a total aggregated amount
    of $2,000,000, provided that the compensation shall not exceed 25% of the Company&rsquo;s gross profit under the given commercial
    agreement signed with the Introduced Party. In addition, in the event that the aggregated net revenues generated from Introduces
    Parties exceeds $500,000, and subject to the approval of the Board, the Company shall issue to EBT 7,143 options to purchase
    7,143 shares of Common Stock at an exercise price of $8.4 per share. In the event that certain additional events detailed
    in the agreement occur, the Company will also issue to EBT, subject to the approval of the Board, an additional 7,143 options
    to purchase 7,143 shares of Common Stock at an exercise price of $8.4 per share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 22, 2020, the Company entered into a Distribution Agreement (the &ldquo;Distribution Agreement&rdquo;), with Safe-Pack
    Products Ltd (&ldquo;Safe-Pack&rdquo;) according to which the Company granted Safe-Pack an exclusive right to resell, distribute,
    advertise, and market Company&rsquo;s products related to the citrus industry in Israel and other territories, as well as
    additional products as shall be mutually agreed upon in the future. In addition, the Company agreed to grant Safe-Pack a right
    of first refusal to be designated as an exclusive distributor of the Company in certain agreed upon territory for additional
    products of the Company as they relate to the field of post-harvest. In consideration for the above rights granted to Safe-Pack,
    Safe-Pack will submit to the Company purchase orders of its products at a price specified in the Distribution Agreement. Commencing
    upon the second calendar year of the agreement, Safe-Pack is required to meet a minimum purchase quota, as shall be mutually
    agreed upon between the parties. In the event that the parties fail to agree on a quota, the quota shall be equal to last
    year quota plus 3%.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash; SHAREHOLDERS&rsquo; EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Description
of the rights attached to the Shares in the Company:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
stock:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of common stock entitles the holder to one vote, either in person or by proxy, at meetings of stockholders. The holders
are not permitted to vote their shares cumulatively. Accordingly, the stockholders of the Company&rsquo;s common stock who hold,
in the aggregate, more than fifty percent of the total voting rights can elect all of the directors and, in such event, the holders
of the remaining minority shares will not be able to elect any of such directors. The vote of the holders of a majority of the
issued and outstanding shares of common stock entitled to vote thereon is sufficient to authorize, affirm, ratify or consent to
such act or action, except as otherwise provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January 2019 the Company issued total of 19,050 shares of Common Stock of the Company $0.0001 par value, to accredited investors
for total consideration of $120,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
February 2019 the Company issued total of 35,717 shares of Common Stock of the Company $0.0001 par value, to accredited investors
for total consideration of $225,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
March 2019 the Company issued total of 15,874 shares of Common Stock of the Company $0.0001 par value, to accredited investor
for total consideration of $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, during March 2019 the Company issued 7,937 shares of Common Stock of the Company $0.0001 par value, to an accredited
investor for total consideration of $50,000 and at the same time issued him 7,937 shares of Common Stock $0.0001 par value for
total consideration of $66,666 and 7,937 warrants to purchase the company shares of Common Stock at an exercise price of 84 cents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
June 2019, the Company issued total of 31,747 shares of Common Stock of the Company $0.0001 par value, to accredited investors
for total consideration of $200,000. In addition, During June 2019 the Company issued 10,004 shares of Common Stock of the Company
$0.0001 par value, to an accredited investor for total consideration of $84,034 and at the same time issued that accredited investor
10,004 warrants to purchase the company shares of Common Stock at an exercise price of 84 cents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
August 2019, the Company signed a subscription agreement with an investor according to which the Company will issue total of 11,905
shares of Common Stock of the Company $0.0001 par value, to accredited investor for total consideration of $100,000. In addition,
and at the same time issued that accredited investor 11,905 warrants to purchase the company shares of Common Stock at an exercise
price of 84 cents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0.3pt"></P>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash; SHAREHOLDERS&rsquo; EQUITY (continue)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2020, the Company entered into a Securities Purchase Agreement (the &ldquo;May Agreement&rdquo;) with an existing shareholder
(the &ldquo;Investor&rdquo;), pursuant to which the Company sold to the Investor for an aggregated amount of $100,000, 13,107
units at a price per unit of $7.63 (the &ldquo;2019 Units&rdquo;), each 2019 Unit consists of (i) one share of Common Stock and
(ii) one warrant to purchase one share of Common Stock with an exercise price of $8.40 for a period of 36 months following the
issuance date. The shares of Common Stock were issued on July 2, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 2, 2020, the Company issued 67,369 shares of Common Stock in respect of the conversion of convertible loans as detailed in
Note 3A above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
July and August 2020, the Company entered into additional Securities Purchase Agreements with existing shareholders (the &ldquo;Additional
Investors&rdquo;), pursuant to which the Company sold to the Additional Investors for an aggregate amount of $150,000, 19,662
units, based substantially upon the same terms as in the May Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2020, the Company entered into a Securities Purchase Agreement (the &ldquo;Medigus SPA&rdquo;) with Medigus Ltd.
(&ldquo;Medigus&rdquo;) in connection with the sale and issuance of 13,107 units for total consideration of $100,000, based substantially
upon the same terms as in the May Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Medigus SPA contemplates an additional investment by Medigus not to exceed $25,000 (the &ldquo;Additional Medigus Investment&rdquo;),
which shall be triggered following the parties&rsquo; initiation of a proof of concept procedure to test the effectiveness of
the Company&rsquo;s sanitizers and its residual effects on surfaces against different pathogens including COVID-19. In consideration
for the Additional Medigus Investment, the Company has agreed to issue an additional 3,277 units at a purchase price of $7.63,
which units shall contain the same composition of securities as described in the foregoing description of the Medigus SPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2020 and September 24, 2020, the Chairman of the Board of Directors of the Company (the &ldquo;Board&rdquo;), exercised
a warrant to purchase an aggregate of 28,572 shares of Common Stock, which warrants were granted to him on June 15, 2020 by the
Board as a replacement for his recently expired options, which were previously granted to him in April 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, two directors on Save Food Ltd exercised 6,350 options under the 2018 Equity Incentive Plan into 6,350 shares of
common stock of the Company total consideration of $20,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10 &ndash; STOCK OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 18, 2018, the Company adopted the 2018 Share Incentive Plan (the &ldquo;2018 Equity Incentive Plan&rdquo;), pursuant to
which the Company&rsquo;s Board of Directors is authorized to grant up to 190,477 options, exercisable into 190,477 shares of
Common Stock of the Company. The purpose of the 2018 Equity Incentive Plan is to offer attract and retain the best available personnel,
provide incentive to individuals who perform services for the Company and promote the success of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2019, the Company granted of 80,954 options under the 2018 Equity Incentive Plan of which 9,524 options are vested
quarterly over three years commencing May 15, 2018, 35,715 options are vested 1/3 after a year commencing October 1, 2018 and
the remaining 2/3 are vested quarterly over additional two years, 14,286 options are vested quarterly over three years commencing
October 1, 2018 and 21,429 options are vested 1/3 after a year commencing January 1, 2019 and the remaining 2/3 are vested quarterly
over additional two years</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April, 2019, the Board of Directors of the Company approved the issuance of 28,572 options to purchase 28,572 Company&rsquo;s
Common Stock 0.0001 par value, to Mr. Dan Sztybel, under the Company&rsquo;s 2018 Equity Incentive Plan. The options shall vest
quarterly over three years, commencing April 1, 2019, and shall be exercisable for an exercise price of $3.15 per share. In addition,
the Board of Directors of the Company approved the issuance of 14,286 options to purchase 14,286 Company&rsquo;s Common Stock
0.0001 par value, to Mr. Dan Sztybel, subject to Save Foods Ltd&rsquo;s obtainment of certain EPA and FDA approvals by the end
of the second quarter of 2020. Such conditions did not met as of June 30, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2019, the Board of Directors of the Company approved the grant of 45,239 options under the 2018 Equity Incentive
Plan of which 28,572 options are vested quarterly over three years commencing January 3, 2019, 9,524 options are vested 1/3 after
a year commencing January 3, 2019 and the remaining 2/3 are vested quarterly over additional two years, and 7,143 options are
vested 1/3 after a year commencing October 1, 2019 and the remaining 2/3 are vested quarterly over additional two years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Board of Directors approved the agreement with a consultant, according to which the consultant would receive 2,858
fully vested options to purchase Company&rsquo;s shares at exercise price of $6.3 per option for certain &ldquo;closed&rdquo;
introduction made by the consultant in Chile. No options were granted under this agreement as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2020, the Company granted 21,143 options to purchase its Common Stock under the 2018 Equity Incentive Plan (the &ldquo;Plan&rdquo;).
The options shall vest quarterly over two years commencing June 23, 2020, whereby 12.50% of the shares covered by the options
will vest on the three month anniversary of June 23, 2020, and 12.50% of the shares covered by the options will vest at the end
of each subsequent three month period thereafter over the course of the subsequent 21 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2020, the Company granted 71,431 options to purchase its Common Stock under the 2018 Equity Incentive Plan. The options
shall vest quarterly over two years commencing June 1, 2020, whereby 12.50% of the shares covered by the options will vest on
the three month anniversary of June 1, 2020, and 12.50% of the shares covered by the options will vest at the end of each subsequent
three month period thereafter over the course of the subsequent 21 months. The fair value of the options was estimated at a value
of $344,767 at the date of issuance using the Black-Scholes option pricing model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on July 1, 2020, the Board approved an increase to the share option pool under the Plan by 99,466 shares of Common Stock,
such that after the increase the total number of shares of Common Stock issuable under the Plan is 289,942 shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2020, the Board approved an amendment of the terms of the outstanding options granted to certain employees and directors
of the Company. According to the new terms, subject to the consummation of equity financing in excess of $1,000,000 and the completion
of listing of the Company&rsquo;s Common Stock for trade on the Nasdaq, and in the event that the employment or engagement of
such grantee is either terminated (not for cause) or otherwise changed thereby resulting in the conclusion of such engagement
(including voluntary resignation), all outstanding options of such grantee shall vest immediately and shall be exercisable for
a period of three years following the termination date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10 &ndash; STOCK OPTIONS (continue)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&rsquo;s stock option activity for employees and directors of the Company for the year ended
December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
                                         of</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at January
    1, 2019</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">59,525</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted (*)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,526</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,762</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at January 1, 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">164,289</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">92,574</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.64</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,350</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(29,365</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,286</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">206,862</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number of
    options exercisable at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97,351</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.27</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -25.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)
Options that were granted on January 3, 2019 with vesting that commences before December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value of the awards outstanding as of December 31, 2020 is US$1,084,465. These amounts represent the total
intrinsic value, based on the Company&rsquo;s stock price of US$ 8.61 as of December 31, 2020, less the weighted exercise price.
This represents the potential amount received by the option holders had all option holders exercised their options as of that
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of options granted was estimated at the dates of grant using the Black-Scholes option pricing model. The following
are the data and assumptions used:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend yield</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected volatility (%) (*)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">52</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free interest rate (%) (**)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.23</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.56-2.39</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected term of options (years)
    (***)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price (US dollars)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15-3.78</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Share price (US dollars)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value (US dollars)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.83-5.17</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.19</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 53.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to the low trading volume of the Company&rsquo;s Common Stock, the expected volatility was based on the historical volatility
    of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical
    industry).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(**)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    risk-free interest rate represented the risk-free rate of US$ zero &ndash; coupon US Government Loans.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(***)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on
    the &ldquo;simplified method&rdquo; in accordance with SEC Staff Accounting Bulletin No. 110.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 120.5pt; text-align: justify; text-indent: -42.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total fair value estimation of the non-cash compensation of the grant at 2020 and 2019 was approximately $453,976 and $440,848,
respectively. Costs incurred in respect of stock-based compensation for employees and directors, for the year ended December 31,
2020 and 2019 were $492,619 and $438,670, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, there are 76,730 options available for future grants under the 2018 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
11 &ndash; COST OF SALES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Salaries and related expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">8,074</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">35,142</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,402</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,531</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Materials</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,692</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,390</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vehicle maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,063</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,455</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Travel expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">978</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,408</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Transportation and storage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,632</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,299</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,564</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">323</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">43,405</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">144,548</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
12 &ndash; RESEARCH AND DEVELOPMENT EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Salaries and related expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">39,021</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">177,712</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">91,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,592</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,854</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,319</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Travel expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,138</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vehicle maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,657</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,227</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Rent and asset management</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,582</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Laboratory and Field tests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,593</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,968</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">33,438</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">25,600</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">417,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">615,623</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
13 &ndash; GENERAL AND ADMINISTRATIVE EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Professional services</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">443,883</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">461,840</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">416,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">283,910</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,492</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Insurance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,367</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Rent and office maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,135</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,080</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Levies and tolls</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,477</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,601</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Communications</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,910</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,914</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,133</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Travel expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,305</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,310</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,848</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,995</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,070,109</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,004,899</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
14 &ndash; FINANCING EXPENSES, NET</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Interest and amortization expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">202,917</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">4,323</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Currency exchange differences</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,266</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Changes in fair value of convertible loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,208</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Bank charges and other finance expenses, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,231</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,819</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">270,393</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">43,408</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
15 &ndash; INCOME TAX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
                                         resident companies are taxed on their worldwide income for corporate income tax purposes
                                         at a statutory rate of 21% this reflect certain effects of the Act which includes a reduction
                                         in the corporate tax rate from 35% to 21% as well as other changes. No further taxes
                                         are payable on this profit unless that profit is distributed. If certain conditions are
                                         met, income derived from foreign subsidiaries is tax exempt in the US under applicable
                                         tax treaties to avoid double taxation.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                                         of the Israeli company is taxable from 2018 and onwards, at corporate tax rate of 23%.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company and Save Foods Ltd. has not received final tax assessments since its inception.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of December 31, 2020, the Company and Save Foods Ltd. has estimated carry forward losses
                                         for tax purposes of approximately $1,264,000 and $9,412,000, respectively, which can
                                         be offset against future taxable income, if any.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
15 &ndash; INCOME TAX (continue)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following is reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal
    tax rate) and the tax expense reported in the financial statements:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.9in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Pretax loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">1,593,139</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">1,971,417</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Federal tax rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income tax computed at the ordinary tax rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">334,559</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">413,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-deductible expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(63,565</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,278</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(109,772</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(93,970</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Tax in respect of differences in corporate tax rates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,688</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Losses and timing differences in respect of which no deferred taxes were
    generated</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(174,702</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(344,438</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: justify; direction: ltr; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    taxes result primarily from temporary differences in the recognition of certain revenue and expense items for financial and
    income tax reporting purposes. Significant components of the Company&rsquo;s future tax assets are as follows:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.9in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Composition of deferred tax assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: justify">Provision for employee related obligation</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">31,627</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">29,353</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Non capital loss carry forwards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,350,367</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,171,821</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Valuation allowance</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,381,994</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,201,174</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 128; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
16 &ndash; LOSS PER COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share is computed by dividing net loss by the weighted average number of shares outstanding during the year. The weighted
average number of shares of Common Stock used in computing basic and diluted loss per common stock for the years ended December
31, 2020 and 2019, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Weighted average number of shares of Common Stock outstanding attributable to shareholders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,519,122</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,424,045</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share (*)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">206,862</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">164,289</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)
The effect of the inclusion of option and convertible loans in 2020 and 2019 is anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
17 &ndash; RELATED PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
Transactions and balances with related parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">General and administrative expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 64%; text-align: left">Directors compensation</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">380,756</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">295,088</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Salaries and fees to officers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">336,433</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">358,370</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Consultants and other fees</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,331</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(*) 769,520</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(*) 653,458</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">(*) share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">394,756</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">272,077</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Research and development expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Salaries and fees to officers</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">25,301</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">116,692</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
Balances with related parties and officers:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-bottom: 1.5pt">Other accounts payables</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; border-bottom: Black 1.5pt solid; text-align: right">424,515</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; border-bottom: Black 1.5pt solid; text-align: right">199,983</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.
Other information:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         November 5, 2020, the board of directors of the Company appointed Mr. David Palach, to
                                         serve as co-Chief Executive Officer of the Company, effective as of the same date. In
                                         connection with Mr. Palach&rsquo;s appointment, the parties entered into a Consulting
                                         Agreement pursuant to which the Company and Mr. Palach agreed upon, inter alia, the following
                                         engagement terms: (a) a monthly retainer of $8,000, and (b) a grant of options to purchase
                                         shares of the Company&rsquo;s common stock, which amount shall be determined by the Board
                                         on a future date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         October 10, 2018 the Board of directors of Save Foods Ltd. approved to engage in consulting
                                         agreements with Amir Uziel Economic Consultant Ltd (a company controlled by Amir Uziel)
                                         and with L.A Pure Capital Ltd (a company controlled by Kfir Zilberman) at a monthly fee
                                         of $1,500.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         October 10, 2018 the Board of directors of Save Foods Ltd. approved a monthly directors
                                         fee of $1,500 to Itzhak Shrem.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.
dollars, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: left; text-indent: -63.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
17 &ndash; SUBSEQUENT EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         February 23, 2021, the Company amended its Certificate of Incorporation to effect a 7
                                         to 1 reverse stock split of the Company&rsquo;s outstanding Common Stock. As a result
                                         of the reverse stock split, which became effective on February 23, 2021, every 7 shares
                                         of the Company&rsquo;s outstanding Common Stock prior to the effect of that amendment
                                         was combined and reclassified into one share of the Company&rsquo;s Common Stock. No
                                         fractional shares were issued in connection with or following the reverse split. The
                                         number of authorized capital of the Company&rsquo;s Common Stock and par value of the
                                         shares remained unchanged.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
share, stock option and per share information in these condensed consolidated financial statements have been restated to reflect
the stock split on a retroactive basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         January 2021, the Company entered into a series of additional 2020 CLAs (See note 6B
                                         above) with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal
                                         amount of $274,000.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"></P>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Shares
of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT><IMG SRC="formdrs_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Save
Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>ThinkEquity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>a
division of Fordham Financial Management, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
and including, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2021 (25 days after the date of this prospectus), all dealers that effect transactions in our securities, whether
or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealer&rsquo;s obligation
to deliver a prospectus when acting as an underwriter and with respect to unsold allotment or subscription.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 131; Options: NewSection; Value: 99 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
13. Other Expenses of Issuance and Distribution </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable in connection
with the sale and distribution of the securities being registered. All amounts are estimated except the SEC registration fee and
the FINRA filing fee. Except as otherwise noted, all the expenses below will be paid by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; text-align: left">SEC registration fee</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,588</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">FINRA filing fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,183</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Initial listing fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accountants&rsquo; fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Transfer Agent&rsquo;s fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Printing and engraving expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Miscellaneous</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">310,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Indemnification of Directors and Officers </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL (&ldquo;Section 145&rdquo;) provides that a Delaware corporation may indemnify any person who was, is or is threatened
to be made, party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was
an officer, director, employee or agent of such corporation or is or was serving at the request of such corporation as a director,
officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such
action, suit or proceeding, provided such person acted in good faith and in a manner he reasonably believed to be in or not opposed
to the corporation&rsquo;s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe
that his or her conduct was illegal. A Delaware corporation may indemnify any persons who are, were or are a party to any threatened,
pending or completed action or suit by or in the right of the corporation by reason of the fact that such person is or was a director,
officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&rsquo;
fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit, provided
such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the corporation&rsquo;s best
interests, provided that no indemnification is permitted without judicial approval if the officer, director, employee or agent
is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense
of any action referred to above, the corporation must indemnify him against the expenses which such officer or director has actually
and reasonably incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer,
employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or
agent of another corporation or enterprise, against any liability asserted against him and incurred by him in any such capacity,
or arising out of his or her status as such, whether or not the corporation would otherwise have the power to indemnify him under
Section 145.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we must indemnify our directors and officers to the fullest extent permitted by the DGCL and must also pay
expenses incurred in defending any such proceeding in advance of its final disposition upon delivery of an undertaking, by or
on behalf of an indemnified person, to repay all amounts so advanced if it should be determined ultimately that such person is
not entitled to be indemnified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 132; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into indemnification agreements with certain of our executive officers and directors pursuant to which we have agreed
to indemnify such persons against all expenses and liabilities incurred or paid by such person in connection with any proceeding
arising from the fact that such person is or was an officer or director of the Company, and to advance expenses as incurred by
or on behalf of such person in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter
acquire under any statute, provision of our certificate of incorporation, as amended, our bylaws, agreement, vote of stockholders
or disinterested directors or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain standard policies of insurance that provide coverage (1) to our directors and officers against loss rising from claims
made by reason of breach of duty or other wrongful act and (2) to us with respect to indemnification payments that we may make
to such directors and officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
any underwriting agreement we enter into in connection with the sale of Common Stock being registered hereby, the underwriter
will agree to indemnify, under certain conditions, us, our directors, our officers and persons who control us, within the meaning
of the Securities Act, against certain liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Recent Sales of Unregistered Securities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below are the sales of all securities by the Company since March 2018, which were not registered under the Securities Act.
The Company believes that each of such issuances was exempt from registration under the Securities Act in reliance on Section
4(a)(2) of the Securities Act, Rule 701 and/or Regulation S under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 29, 2018, we issued 28,572 shares of Common Stock for total consideration of $30,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
August 2018, we issued: (i) 11,128 shares of Common Stock to several existing shareholders of the Company who were owed a sum
of $35,000; (ii) 274,986 shares of Common Stock to accredited investors who held shares in Save Foods Ltd. in exchange for 7,218,129
shares of Save Foods Ltd., at the rate of 0.038 shares of Common Stock of the Company for each share of Save Foods Ltd; and (iii)
160,643 shares of Common Stock of the Company to several investors, for total consideration of $506,000 reflecting a price of
$3.15 per share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 4, 2018, we issued 25,398 shares of Common Stock to two accredited investors for total consideration of $80,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2018, we issued 36,513 shares of Common Stock to an accredited investor for total consideration of $115,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
November 2018, we issued an aggregate of 30,689 shares of Common Stock to accredited investors for total consideration of $133,333.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
January 2019, we issued an aggregate of 19,050 shares of Common Stock to accredited investors for total consideration of $120,000</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
February 2019, we issued an aggregate of 35,717 shares of Common Stock to accredited investors for total consideration of $225,000.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
March 2019, we issued (i) 31,748 shares of Common Stock to an accredited investors for total consideration of $216,666, and (iii)
warrants to purchase 7,937 shares of Common Stock at an exercise price of $12.60 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 133; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
June 2019, we issued: (i) 31,747 shares of Common Stock to accredited investors for total consideration of $200,000; and (ii)
10,004 shares of Common Stock to an accredited investor for total consideration of $84,034 and at the same time issued that accredited
investor 10,004 warrants to purchase shares of Common Stock at an exercise price of $12.60.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
August 2019, we issued 11,905 shares of Common Stock to an accredited investor for total consideration of $100,000. In addition,
we issued him 11,905 warrants to purchase shares of Common Stock at an exercise price of $12.60.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
July and August 2020, we issued: (i) 67,369 shares of Common Stock in respect of the conversion of convertible loans; (ii) 32,769
units, for an aggregate amount of $250,000, at a price of $7.63 per unit, where each unit consists of one share of Common Stock
and one warrant to purchase one share of Common Stock with an exercise price of $8.40 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
September 2020, we issued 13,107 units, for an aggregate amount of $100,000, at a purchase price of $7.63 per unit to Medigus
Ltd., where each unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock with an exercise
price of $8.40 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, we issued 6,350 shares of Common Stock following the exercise of options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
December 2017, we issued warrants to purchase an aggregate of 187,128 shares of Common Stock to investors and service providers,
with exercise prices ranging from $2.1 to $8.4 per share. As of the date of this prospectus, 28,572 warrants were exercised and
28,572 warrants were forfeited, such that the total outstanding amount of warrants as of the date of this prospectus is 129,984.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
December 2017, we granted to our directors, officers, employees and service providers options to purchase an aggregate of 261,625
shares of Common Stock under our Equity Incentive Plan, with exercise prices ranging from $3.15 to $3.78 per share. As of the
date of this prospectus, 6,350 options were exercised and 43,651 options were forfeited, such that the total outstanding number
of options as of the date of this prospectus is 206,862.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
December 2017, we issued convertible promissory notes in an aggregate principal amount of $1,013,000 in a series of convertible
loan agreements. As of the date of this prospectus, we issued an aggregate of 67,369 shares of Common Stock as a result of conversion
of certain convertible promissory notes, at a conversion price of $7.63 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 134; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Item
16. Exhibits and Financial Statement Schedules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    </B>&nbsp;<B>No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
    of Exhibit</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex1-1.htm">Form of Underwriting Agreement by and between the Company and ThinkEquity, a Division of Fordham Financial Management, Inc., as Representative of the several underwriters named therein.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex3-1_1.htm">Amended and Restated Certificate of Incorporation of Save Foods, Inc.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex3-1_2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of the Certificate of Incorporation of Save Foods, Inc., effective as of June 12, 2019.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.3*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex3-1_3.htm">Certificate of Amendment of the Certificate of Incorporation of Save Foods, Inc., effective as of November 24, 2020.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.4*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex3-1_4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of the Certificate of Incorporation of Save Foods, Inc., effective as of February 23, 2020.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex3-2.htm">Amended and Restated Bylaws of Save Foods, Inc.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex4-2.htm">Form of Underwriter&rsquo;s Warrant.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Sullivan &amp; Worcester LLP, counsel to the Company</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-1.htm">2018 Equity Incentive Plan</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Advisory Consulting Agreement, dated August 30, 2017, by and between Save Foods, Inc. and Goldmed Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3*+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engagement Letter, dated September 28, 2017, related to financial services rendered to Save Foods, Inc. and Save Foods Ltd. by Shlomo Zakai.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4*+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services Agreement, dated October 10, 2018, by and between Pimi Agro Cleantech Ltd., Dan Sztybel and Dan Sztybel Consulting Group Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5*+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-5.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services Agreement, dated January 15, 2019, by and between Pimi Agro Cleantech Ltd. and NSNC Consulting Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6*+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-6.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum No. 1 to Services Agreement, dated March 28, 2019, by and between Pimi Agro Cleantech Ltd., Dan Sztybel and Dan Sztybel Consulting Group Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-7.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement, dated February 26, 2019, by and between Pimi Agro Cleantech Ltd. and Nimrod Ben Yehuda.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-8.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement Agreement, dated March 18, 2019, by and between Pimi Agro Cleantech Ltd. and Nimrod Ben Yehuda.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-9.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, entered as of March 2, 2021, by and between Save Foods, Inc. and Amir Uziel.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10*^</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-10.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Exclusive Commission Agreement, dated September 22, 2020, by and among Save Foods, Inc. and Earthbound Technologies, LLC. </FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11*^</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-11.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution Agreement, dated September 22, 2020, by and among Save Foods Ltd. and Safe-Pack Products Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-12.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated September 23, 2020, by and among Save Foods, Inc. and Medigus Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13*+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-13.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated November 1, 2020, by and between Save Foods, Inc. and S.T. Sporting (1996) Ltd.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex21-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Halperin CPA, Independent Registered Public Accounting Firm.</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Sullivan &amp; Worcester LLP (included in Exhibit 5.1).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#poa_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on the signature page of this registration statement).</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of <FONT>Udi Kalifi</FONT> as Director Nominee.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed by amendment.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    contract or compensatory plan or arrangement.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">^</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">Portions
                                         of this exhibit have been omitted under rules of the U.S. Securities and Exchange Commission
                                         permitting the confidential treatment of select information.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 135; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent
no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo;
table in the effective registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided,
however, that Paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in
a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant
pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), that
are incorporated by reference in the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide</I> offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act to any purchaser: If the registrant is subject to Rule
430C (&sect;230.430C of this chapter), each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating
to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A
(&sect;230.430A of this chapter), shall be deemed to be part of and included in the registration statement as of the date it is
first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such
first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such date of first use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That, for the purpose of determining liability under the Securities Act to any purchaser in the initial distribution of the securities,
the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this
registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller
to the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule 424 (&sect;230.424 of this chapter);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
to by the undersigned registrant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 136; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the undersigned registrant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
of the registrant&rsquo;s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable,
each filing of an employee benefit plan&rsquo;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated
by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The undersigned registrant hereby undertakes to supplement the prospectus, after the expiration of the subscription period, to
set forth the results of the subscription offer, the transactions by the underwriter during the subscription period, the amount
of unsubscribed securities to be purchased by the underwriter, and the terms of any subsequent reoffering thereof. If any public
offering by the underwriter is to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective
amendment will be filed to set forth the terms of such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the Company pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by
the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Securities Act and will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
For the purpose of determining any liability under the Securities Act, the registrant will treat the information omitted from
the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus
filed by the registrant under Rule 424(b)(1), or (4), or 497(h) under the Securities Act as part of this registration statement
as of the time the Commission declared it effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 137; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, we have duly caused this Registration Statement on Form S-1 to
be signed on its behalf by the undersigned, thereunto duly authorized in the City of Rishon L&rsquo;zion State of Israel, on the
day of March 16, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVEFOODS,
    INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
David Palach</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="poa_001"></A>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
the undersigned officers and directors of Save Foods, Inc. hereby severally constitute and appoint David Palach and Shlomo Zakai,
and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with
full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities,
to sign any and all amendments (including post-effective amendments) to this registration statement (or any other registration
statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933),
and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each
and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their
or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities held on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 29%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 38%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 29%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Palach </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
        Executive Officer)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Shlomo Zakai</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief
        Financial Officer</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">March 16, 2021</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shlomo
    Zakai</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Principal
        Financial Officer and Principal Accounting Officer)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Benad Goldwasser</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Chairman of the Board of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Vered Raz-Avayo</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vered
    Raz-Avayo</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronen Rosenbloom</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronen
    Rosenbloom</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Israel Berenshtein </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    Berenshtein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Amitay Weiss </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitay
    Weiss</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Eliahou Arbiv</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    16, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliahou
    Arbib</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 138; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>between</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Save
foods, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ThinkEquity</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>a
division of Fordham Financial Management, Inc.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>as
Representative of the Several Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>UNDERWRITING
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Division of Fordham Financial Management, Inc.<BR>
As Representative of the several Underwriters named on <U>Schedule 1</U> attached hereto<BR>
17 State Street, 22<SUP>nd</SUP> Floor<BR>
New York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Save Foods, Inc., a company incorporated under the laws of the State of Delaware (collectively with its subsidiaries
and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter
defined) as being subsidiaries or affiliates of Save Foods, Inc., the &ldquo;<B>Company</B>&rdquo;), hereby confirms its agreement
(this &ldquo;<B>Agreement</B>&rdquo;) with ThinkEquity, a division of Fordham Financial Management, Inc. (hereinafter referred
to as &ldquo;you&rdquo; (including its correlatives) or the &ldquo;<B>Representative</B>&rdquo;), and with the other underwriters
named on <U>Schedule 1</U> hereto for which the Representative is acting as representative (the Representative and such other
underwriters being collectively called the &ldquo;<B>Underwriters</B>&rdquo; or, individually, an &ldquo;<B>Underwriter</B>&rdquo;)
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Purchase and Sale of Shares.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Firm Shares.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.1
<U>Nature and Purchase of Firm Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 103.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth,
the Company agrees to issue and sell to the several Underwriters, an aggregate of [&#9679;] shares (each, a &ldquo;Firm Share&rdquo;
and collectively, the &ldquo;Firm Shares&rdquo;) of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;Common
Stock&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares set forth opposite their
respective names on Schedule 1 attached hereto and made a part hereof at a purchase price of $[&#9679;] per Firm Share (93% of
the public offering price per Firm Share, before expenses, including the 1% non-accountable expense allowance described in Section
3.10.2). The Firm Shares are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus
(as defined in Section 2.1.1 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.2
<U>Firm Shares Payment and Delivery.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-indent: 135.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on the second (2<SUP>nd</SUP>) Business Day
following the date of this Agreement (or the third (3<SUP>rd</SUP>) Business Day following the date of this Agreement if this
Agreement is executed by all parties after 4:01 p.m., Eastern time) or at such earlier time as shall be agreed upon by the Representative
and the Company, at the offices of Gracin &amp; Marlow, LLP, The Chrysler Building, 405 Lexington Avenue, 26<SUP>th</SUP> Floor,
New York, New York 10174 (&ldquo;<B>Representative&rsquo;s Counsel</B>&rdquo;), or at such other place (or remotely by facsimile
or other electronic transmission) as shall be agreed upon by the Representative and the Company. The hour and date of delivery
and payment for the Firm Shares is called the &ldquo;<B>Closing Date</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order
of the Company upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the Firm
Shares (or through the facilities of the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;)) for the account of the Underwriters.
The Firm Shares shall be registered in such name or names and in such authorized denominations as the Representative may request
in writing at least two (2) full Business Days prior to the Closing Date. The Company shall not be obligated to sell or deliver
the Firm Shares except upon tender of payment by the Representative for all of the Firm Shares. The term &ldquo;<B>Business Day</B>&rdquo;
means <FONT STYLE="background-color: white">any day other than Saturday, Sunday or other day on which commercial banks in The
City of New York are authorized or required by law to remain closed; </FONT><U>provided</U><FONT STYLE="background-color: white">,
</FONT><U>however</U><FONT STYLE="background-color: white">, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New
York are generally are open for use by customers on such day.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Over-allotment Option.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1
<U>Option Shares</U>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm
Shares, the Company hereby grants to the Underwriters an option (the &ldquo;<B>Over-allotment Option</B>&rdquo;) to purchase up
to an additional [&#9679;] shares of Common Stock, representing up to fifteen percent (15%) of the Firm Shares sold in the offering
(the &ldquo;<B>Option Shares</B>&rdquo;) for the purpose of covering over-allotments of such securities, if any. The purchase
price to be paid per Option Share shall be $[&#9679;]. The Firm Shares and the Option Shares are collectively referred to as the
&ldquo;<B>Public Securities</B>.&rdquo; The offering and sale of the Public Securities is herein referred to as the &ldquo;<B>Offering</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.2
<U>Exercise of the Over-allotment Option.</U> The Over-allotment Option granted pursuant to <U>Section 1.2.1</U> hereof may be
exercised by the Representative as to all (at any time) or any part (from time to time) of the Option Shares within 45 days after
the date of this Agreement. The Underwriters shall not be under any obligation to purchase any Option Shares prior to the exercise
of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the giving of oral notice to the Company
from the Representative, which must be confirmed in writing by overnight mail or facsimile or other electronic transmission setting
forth the number and type of Option Shares to be purchased and the date and time for delivery of and payment for the Option Shares
(the &ldquo;<B>Option Closing Date</B>&rdquo;), which shall not be later than one (1) full Business Day after the date of the
notice or such other time as shall be agreed upon by the Company and the Representative, at the offices of Representative&rsquo;s
Counsel or at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the
Company and the Representative. If such delivery and payment for the Option Shares does not occur on the Closing Date, the Option
Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment Option with respect to all or any portion
of the Option Shares, subject to the terms and conditions set forth herein, (i) the Company shall become obligated to sell to
the Underwriters the number and type of Option Shares specified in such notice and (ii) each of the Underwriters, acting severally
and not jointly, shall purchase that portion of the total number of Option Shares then being purchased as set forth in <U>Schedule
1</U> opposite the name of such Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.3
<U>Payment and Delivery</U>. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal
(same day) funds, payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory
to the Representative) representing the Option Shares (or through the facilities of DTC for the account of the Underwriters).
The Option Shares shall be registered in such name or names and in such authorized denominations as the Representative may request
in writing at least one (1) full Business Days prior to the Option Closing Date. The Company shall not be obligated to sell or
deliver the Option Shares except upon tender of payment by the Representative for applicable Option Shares. The Option Closing
Date may be simultaneous with, but not earlier than, the Closing Date; and in the event that such time and date are simultaneous
with the Closing Date, the term &ldquo;<B>Closing Date</B>&rdquo; shall refer to the time and date of delivery of the Firm Shares
and Option Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Representative&rsquo;s Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.1
<U>Purchase Warrants</U>. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing
Date an option (the &ldquo;<B>Representative&rsquo;s Warrant</B>&rdquo;) for the purchase of an aggregate of [&#9679;] shares
of Common Stock (which is equal to an aggregate of 5.0% of the Firm Shares sold in the Offering), for an aggregate purchase price
of $100.00. The Representative&rsquo;s Warrant Agreement, in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Representative&rsquo;s
Warrant Agreement</B>&rdquo;), shall be exercisable, in whole or in part, commencing on a date that is one hundred and eighty
(180) days after the effective date of the Registration Statement (as defined in <U>Section 2.1.1</U> below) (the &ldquo;<B>Effective
Date</B>&rdquo;) and expiring on the five-year anniversary of the Effective Date at an initial exercise price per share of Common
Stock of $[&#9679;], which is equal to 125% of the public offering price of each Firm Share. The Representative&rsquo;s Warrant
Agreement and the shares of Common Stock issuable upon exercise thereof are sometimes hereinafter referred to together as the
&ldquo;<B>Representative&rsquo;s Securities</B>.&rdquo; The Representative understands and agrees that there are significant restrictions
pursuant to FINRA Rule 5110 against transferring the Representative&rsquo;s Warrants and the underlying shares of Common Stock
during the one hundred eighty (180) days immediately following the Effective Date and by its acceptance thereof shall agree that
the Representative&rsquo;s Warrants and the underlying shares of Common Stock shall not be sold during the Offering, or sold,
transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction
that would result in the effective economic disposition of the Representative&rsquo;s Warrants and the underlying shares of Common
Stock by any person for a period of one hundred eighty (180) days immediately following the Effective Date, except as provided
for in FINRA Rule 5110(e)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.2
<U>Delivery</U>. Delivery of the Representative&rsquo;s Warrant Agreement shall be made on the Closing Date and shall be issued
in the name or names and in such authorized denominations as the Representative may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Representations and Warranties of the Company</U>. The Company, represents and warrants to the Underwriters as of the Applicable
Time (as defined below), as of the Closing Date and as of the Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Filing of Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1
<U>Pursuant to the Securities Act</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
a registration statement, and an amendment or amendments thereto, on Form S-1 (File No. 333-[&#9679;]), including any related
prospectus or prospectuses, for the registration of the Public Securities and the Representative&rsquo;s Securities under the
Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), which registration statement and amendment or amendments
have been prepared by the Company in all material respects in conformity with the requirements of the Securities Act and the rules
and regulations of the Commission under the Securities Act (the &ldquo;<B>Securities Act Regulations</B>&rdquo;) and will contain
all material statements that are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations.
Except as the context may otherwise require, such registration statement, as amended, on file with the Commission at the time
the registration statement became effective (including the Preliminary Prospectus included in the registration statement, financial
statements, schedules, exhibits and all other documents filed as a part thereof or incorporated therein and all information deemed
to be a part thereof as of the Effective Date pursuant to paragraph (b) of Rule 430A of the Securities Act Regulations (the &ldquo;<B>Rule
430A Information</B>&rdquo;)), is referred to herein as the &ldquo;Registration Statement.&rdquo; If the Company files any registration
statement pursuant to Rule 462(b) of the Securities Act Regulations, then after such filing, the term &ldquo;Registration Statement&rdquo;
shall include such registration statement filed pursuant to Rule 462(b). The Registration Statement has been declared effective
by the Commission on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information
that was used after such effectiveness and prior to the execution and delivery of this Agreement, is herein called a &ldquo;<B>Preliminary
Prospectus</B>.&rdquo; The Preliminary Prospectus, subject to completion, dated [&bull;], 2021, that was included in the Registration
Statement immediately prior to the Applicable Time is hereinafter called the &ldquo;<B>Pricing Prospectus</B>.&rdquo; The final
prospectus in the form first furnished to the Underwriters for use in the Offering is hereinafter called the &ldquo;<B>Prospectus</B>.&rdquo;
Any reference to the &ldquo;most recent Preliminary Prospectus&rdquo; shall be deemed to refer to the latest Preliminary Prospectus
included in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Time</B>&rdquo; means [TIME] [a.m./p.m.], Eastern time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Free Writing Prospectus</B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities
Act Regulations (&ldquo;<B>Rule 433</B>&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined
in Rule 405 of the Securities Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission
by the Company, (ii) a &ldquo;road show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i), whether
or not required to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i)
because it contains a description of the Public Securities or of the Offering that does not reflect the final terms, in each case
in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s
records pursuant to Rule 433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
General Use Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution
to prospective investors (other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433 (the &ldquo;<B>Bona
Fide Electronic Road Show</B>&rdquo;)), as evidenced by its being specified in <U>Schedule 2-B</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Limited Use Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free
Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Pricing
Disclosure Package</B>&rdquo; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time,
the Pricing Prospectus and the information included on <U>Schedule 2-A</U> hereto, all considered together.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2
<U>Pursuant to the Exchange Act.</U> The Company has filed with the Commission a Form 8-A (Accession No. 001-[&#9679;]) providing
for the registration pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
of the shares of Common Stock; and such Form 8-A has become effective under the Exchange Act. The Company has taken no action
designed to, or likely to have the effect of, terminating the registration of the shares of Common Stock under the Exchange Act,
nor has the Company received any notification that the Commission is contemplating terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3
<U>Testing the Waters Communications</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-indent: 103.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each Written Testing-the-Waters Communications did not, as of the Applicable Time, and at all times through the completion of
the public offer and sale of the Public Securities will not, include any information that conflicted, conflicts or will conflict
with the information contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus. Each Written Testing-the-Waters
Communication did not, as of the Applicable Time, when taken together with the Pricing Disclosure Package, contain an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <I>provided</I> that no representation or warranty is made as to the Underwriters&rsquo;
Information (as defined in Section 2.4.1 below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-indent: 103.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Company (a) has not engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with the
consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule 144A under the
Securities Act or institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and (b) has
not authorized any third party to engage in Testing-the-Waters Communications. The Company reconfirms that the Representative
has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed any
Written Testing-the-Waters Communications other than those listed on Schedule 2-C hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-indent: 103.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Stock Exchange Listing</U>. The shares of Common Stock and the shares of Common Stock underlying the Representative&rsquo;s
Warrants have been approved for listing on the Nasdaq Capital Market (the &ldquo;<B>Exchange</B>&rdquo;), and the Company has
taken no action designed to, or likely to have the effect of, delisting the shares of Common Stock or the shares of Common Stock
underlying the Representative&rsquo;s Warrants from the Exchange, nor has the Company received any notification that the Exchange
is contemplating terminating such listing except as described in the Registration Statement, the Pricing Disclosure Package and
the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>No Stop Orders, etc.</U> Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued
any order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has
instituted or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company
has complied with each request (if any) from the Commission for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>Disclosures in Registration Statement.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1
<U>Compliance with Securities Act and 10b-5 Representation.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.7pt; text-indent: 103.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all
material respects with the requirements of the Securities Act and the rules and regulations of the Commission thereunder (the
&ldquo;<B>Securities Act Regulations</B>&rdquo;). Each Preliminary Prospectus, the Prospectus and any amendment or supplement
thereto, at the time each was filed with the Commission, complied in all material respects with the requirements of the Securities
Act and the Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection with this
offering and the Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission
pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.7pt; text-indent: 103.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Registration Statement, when it became effective, did not contain and, as amended or supplemented, if applicable, will not
contain, as of the date of such amendment or supplement, an untrue statement of a material fact or omitted or will omit to state
a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that
this representation and warranty shall not apply to any information contained in or omitted from the Registration Statement or
any amendment thereto in reliance upon and in conformity with information furnished in writing to the Company by or on behalf
of any Underwriter through the Representative specifically for use therein. The parties acknowledge and agree that such information
provided by or on behalf of any Underwriter consists solely of the following disclosure contained in the &ldquo;Underwriting&rdquo;
section of the Prospectus: (a) the first sentence of the first paragraph under the heading &ldquo;Discounts and Commissions; Expenses&rdquo;,
and (b) the third paragraph under the heading &ldquo;Price Stabilization, Short Positions and Penalty Bids&rdquo; and (collectively,
the &ldquo;<B>Underwriters&rsquo; Information</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-indent: 103.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Pricing Disclosure Package, as of the Applicable Time, did not contain an untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The Prospectus will not, as of its date, as of the Closing Date or as of any Option Closing Date, contain an untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading. Each Issuer Free Writing Prospectus complies in all material
respects with the applicable provisions of the Securities Act and the Securities Act Regulations, and does not conflict with the
information contained in the Registration Statement, the Pricing Prospectus or the Prospectus, and each Issuer Free Writing Prospectus
listed in <U>Schedule 2-B</U> hereto, as supplemented by and taken together with the Pricing Disclosure Package did not, as of
the Applicable Time, contain an untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. No representation and warranty
is made in this Section 1(d) with respect to the Underwriters&rsquo; Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2
<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements
or other documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement,
that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the
Company or its Subsidiary is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, or (ii) is material to the Company&rsquo;s or its Subsidiary&rsquo;s
business, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and
is enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms,
except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo;
rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and
state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may
be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. None
of such agreements or instruments has been assigned by the Company or its Subsidiary, and none of the Company, its Subsidiary
nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge, no event
has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. To the Company&rsquo;s
knowledge, performance by the Company or its Subsidiary of the material provisions of such agreements or instruments will not
result in a violation of any existing applicable law, rule, regulation, ordinance, judgment, order or decree of any governmental
or regulatory agency, body, authority or court, domestic or foreign, having jurisdiction over the Company or its Subsidiary or
any of its assets or businesses (each, a &ldquo;<B>Governmental Entity</B>&rdquo;), including, without limitation, those relating
to environmental laws and regulations. The Company owns or controls, directly or indirectly, only Save Foods, Ltd. (the &ldquo;<B>Subsidiary</B>&rdquo;)
and has no other interest, nominal or beneficial, direct or indirect, in any other corporation, joint venture or other business
entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3
<U>Prior Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for
the benefit of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed
in the Registration Statement, the Pricing Disclosure Package and the Preliminary Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4
<U>Regulations</U>. The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning
the effects of federal, state, local and all foreign regulation on the Offering and the Company&rsquo;s business as currently
contemplated are accurate, correct and complete in all material respects and no other such regulations are required to be disclosed
in the Registration Statement, the Pricing Disclosure Package and the Prospectus which are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5
<U>No Other Distribution of Offering Materials.</U> The Company has not, directly or indirectly, distributed and will not distribute
any offering material in connection with the Offering other than any Preliminary Prospectus, the Disclosure Package, the Prospectus
and other materials, if any, permitted under the Securities Act and consistent with Section 3.2 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<U>Changes After Dates in Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.1.
<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material
adverse change (including in the financial position or results of operations of the Company) or development in the business of
the Company which, singularly or in the aggregate) would involve a material adverse change or prospective material adverse change,
whether or not arising from transactions in the ordinary course of business, in or affecting the business, general affairs, management,
condition (financial or otherwise), results of operations, stockholders&rsquo; equity, business, assets, properties or prospects
of the Company and the Subsidiary, taken as a whole (a &ldquo;<B>Material Adverse Change</B>&rdquo;); (ii) there have been no
material transactions entered into by the Company, other than as contemplated pursuant to this Agreement; (iii) no officer or
director of the Company has resigned from any position with the Company; and (iv) neither the Company nor its Subsidiary has sustained
any material loss or interference with its business or properties from fire, explosion, flood, earthquake, hurricane, accident
or other calamity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.2.
<U>Recent Securities Transactions, etc</U>. Subsequent to the respective dates as of which information is given in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein
or disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i) issued
any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any
dividend or made any other distribution on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<U>Independent Accountants</U>. To the knowledge of the Company, Halperin Ilanit, Certified Public Accountants (Israel) (the &ldquo;<B>Auditor</B>&rdquo;),
who has certified the financial statements and supporting schedules and information of the Company that are included in the Registration
Statement, the Pricing Disclosure Package or the Prospectus are independent public accountants as required by the Securities Act,
the Securities Act Regulations and the rules of the Public Company Accounting Oversight Board (&ldquo;<B>PCAOB</B>&rdquo;). The
Auditor has not, during the periods covered by the financial statements included in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<U>Financial Statements, etc</U>. The financial statements, including the notes thereto and supporting schedules included in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, fairly present in all material respects the financial
position and the results of operations of the Company at the dates and for the periods to which they apply; and such financial
statements have been prepared in conformity with U.S. generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;), consistently
applied throughout the periods involved (provided that unaudited interim financial statements are subject to year-end audit adjustments
that are not expected to be material in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules
included in the Registration Statement present fairly the information required to be stated therein. Except as included therein,
no historical or pro forma financial statements are required to be included in the Registration Statement, the Pricing Disclosure
Package or the Prospectus under the Securities Act or the Securities Act Regulations. The pro forma and pro forma as adjusted
financial information and the related notes, if any, included in the Registration Statement, the Pricing Disclosure Package and
the Prospectus have been properly compiled and prepared in accordance with the applicable requirements of the Securities Act and
the Securities Act Regulations and present fairly the information shown therein, and the assumptions used in the preparation thereof
are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred
to therein. All disclosures contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus regarding
&ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules and regulations of the Commission), if any, comply,
in all material respects, with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent
applicable. Each of the Registration Statement, the Pricing Disclosure Package and the Prospectus discloses all material off-balance
sheet transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company with
unconsolidated entities or other persons that may have a material current or future effect on the Company&rsquo;s financial condition,
changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components
of revenues or expenses. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
(a) neither the Company nor any of its direct and indirect subsidiaries, including each entity disclosed or described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus as being a subsidiary of the Company has incurred any material liabilities
or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of business,
(b) the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock,
(c) there has not been any change in the capital stock of the Company or its Subsidiary, or, other than in the course of business,
any grants under any stock compensation plan, and (d) there has not been any material adverse change in the Company&rsquo;s long-term
or short-term debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
<U>Authorized Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based
on the assumptions stated in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will have
on the Closing Date the adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration
Statement, the Pricing Disclosure Package and the Prospectus, on the Effective Date, as of the Applicable Time and on the Closing
Date and any Option Closing Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any
authorized, but unissued shares of Common Stock of the Company or any security convertible or exercisable into shares of Common
Stock of the Company, or any contracts or commitments to issue or sell shares of Common Stock or any such options, warrants, rights
or convertible securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<U>Valid Issuance of Securities, etc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9.1
<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated
by this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have
no rights of rescission or similar rights with respect thereto or put rights, and are not subject to personal liability by reason
of being such holders; and none of such securities were issued in violation of the preemptive rights, rights of first refusal
or rights of participation of any holders of any security of the Company or similar contractual rights granted by the Company.
The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common Stock were
at all relevant times either registered under the Securities Act and the applicable state securities or &ldquo;blue sky&rdquo;
laws or, based in part on the representations and warranties of the purchasers of such Shares, exempt from such registration requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9.2
<U>Securities Sold Pursuant to this Agreement</U>. The Public Securities and Representative&rsquo;s Securities have been duly
authorized for issuance and sale and, when issued and paid for pursuant to the terms of this Agreement, and the Representative&rsquo;s
Warrant Agreement for the Representative&rsquo;s Securities, will be validly issued, fully paid and non-assessable; the holders
thereof are not and will not be subject to personal liability by reason of being such holders; the Public Securities and Representative&rsquo;s
Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual
rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public
Securities and Representative&rsquo;s Securities has been duly and validly taken. The Public Securities and Representative&rsquo;s
Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement, the
Pricing Disclosure Package and the Prospectus. All corporate action required to be taken for the authorization, issuance and sale
of the Representative&rsquo;s Warrant Agreement has been duly and validly taken; the shares of Common Stock issuable upon exercise
of the Representative&rsquo;s Warrant have been duly authorized and reserved for issuance by all necessary corporate action on
the part of the Company and when paid for and issued in accordance with the Representative&rsquo;s Warrant and the Representative&rsquo;s
Warrant Agreement, such shares of Common Stock will be validly issued, fully paid and non-assessable; the holders thereof are
not and will not be subject to personal liability by reason of being such holders; and such shares of Common Stock are not and
will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
<U>Registration Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into
securities of the Company have the right to require the Company to register any such securities of the Company under the Securities
Act or to include any such securities in a registration statement to be filed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
<U>Validity and Binding Effect of Agreements</U>. This Agreement and the Representative&rsquo;s Warrant Agreement have been duly
and validly authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreements of
the Company, enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may
be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii) as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws; and (iii) that the
remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and
to the discretion of the court before which any proceeding therefor may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
<U>No Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement, the Representative&rsquo;s
Warrant and the Representative&rsquo;s Warrant Agreement and all ancillary documents, the consummation by the Company of the transactions
herein and therein contemplated and the compliance by the Company with the terms hereof and thereof, as the case may be, do not
and will not, with or without the giving of notice or the lapse of time or both: (i) result in a material breach of, or conflict
with any of the terms and provisions of, or constitute a material default under, or result in the creation, modification, termination
or imposition of any lien, charge, mortgage, pledge, security interest, claim, equity, trust or other encumbrance, preferential
arrangement, defect or restriction of any kind whatsoever (any &ldquo;<B>Lien</B>&rdquo;) upon any property or assets of the Company
pursuant to the terms of any indenture, mortgage, deed of trust, note, lease, loan agreement or any other agreement or instrument,
franchise, license or permit to which the Company is a party or as to which any property of the Company is a party; (ii) result
in any violation of the provisions of the Company&rsquo;s Certificate of Incorporation (as the same have been amended or restated
from time to time, the &ldquo;<B>Charter</B>&rdquo;), the by-laws of the Company (as the same may be amended or restated from
time to time) or (iii) violate any existing applicable law, rule, regulation, ordinance, directive, judgment, writ, order or decree
of any Governmental Entity as of the date hereof (including, without limitation, those promulgated by the U.S. Environmental Protection
Agency, Food and Drug Administration of the U.S. Department of Health and Human Services (the &ldquo;<B>FDA</B>&rdquo;), the California
Department of Pesticide Regulation or by any foreign, state or local Governmental Entity performing functions similar to those
performed by the FDA), except in the cases of clauses (i) and (iii) for such breaches, conflicts or violations which could not
reasonably be expected to have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
<U>No Defaults; Violations</U>. The Company is not (i) in violation of its Charter, by-laws, or other organizational documents,
(ii) in default under, and no event has occurred which, with notice or lapse of time or both, would constitute a default under
or result in the creation or imposition of any Lien upon any property or assets of the Company pursuant to any indenture, mortgage,
deed of trust, note, lease, loan agreement or other agreement or instrument to which it is a party or by which it is bound or
to which any of its property or assets is subject, or (iii) in violation of any statute, law, rule, regulation, ordinance, directive,
judgment, writ, decree or order of any court or judicial, regulatory or other legal or Governmental Entity, except (in the case
of clauses (ii) and (iii) above) for violations or defaults that could not (individually or in the aggregate) reasonably be expected
to have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
<U>Corporate Power; Licenses; Authorizations.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14.1
<U>Conduct of Business</U>. The Company has all requisite power and authority, and all necessary consents, approvals, authorizations,
orders, registrations, qualifications, licenses, filings and permits of, with and from all Governmental Entities and all third
parties, foreign and domestic (collectively, the &ldquo;<B>Authorizations</B>&rdquo;), to own, lease and operate its properties
and conduct its business as it is now being conducted and as disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, and each such Authorization is valid and in full force and effect, except in each case as could not reasonably
be expected to have a Material Adverse Change. The Company has not received notice of any investigation or proceedings which,
if decided adversely to the Company, could reasonably be expected to result in, the revocation of, or imposition of a materially
burdensome restriction on, any such Authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14.2
<U>Transactions Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement, and the
Representative&rsquo;s Warrant Agreement and to carry out the provisions and conditions hereof and thereof, and all Authorizations
required in connection therewith have been obtained. No Authorization of, and no filing with, Governmental Entity is required
for the valid issuance, sale and delivery of the Public Securities and the consummation of the transactions and agreements contemplated
by this Agreement and the Representative&rsquo;s Warrant Agreement and as contemplated by the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as may be required under state securities or blue sky laws or the by-laws the rules
and regulations of the Financial Industry Regulatory Authority, Inc. (&ldquo;<B>FINRA</B>&rdquo;) in connection with the purchase
and distribution of the Public Securities by the Underwriters, each of which has been obtained and is in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires (the &ldquo;<B>Questionnaires</B>&rdquo;)
completed by each of the Company&rsquo;s directors, officers and principal stockholders immediately prior to the Offering (the
&ldquo;<B>Insiders</B>&rdquo;) as supplemented by all information concerning the Company&rsquo;s directors, officers and principal
stockholders as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, provided to the Underwriters
is true and correct in all material respects and the Company has not become aware of any information which would cause the information
disclosed in the Questionnaires to become inaccurate and incorrect in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16
<U>Litigation; Governmental Proceedings</U>. There is no material action, suit, proceeding, inquiry, arbitration, investigation,
litigation or governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company,
its Subsidiary or, to the Company&rsquo;s knowledge, any executive officer or director which has not been disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus or in connection with the Company&rsquo;s listing application for
the listing of the Public Securities on the Exchange, and which if resolved adversely to the Company or to its Subsidiary would
result in a Material Adverse Change or otherwise affect the Company&rsquo;s ability to consummate the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17
<U>Good Standing</U>. Each of the Company and its Subsidiary has been duly incorporated and validly existing as a corporation
and is in good standing under the laws of the state of its organization as of the date hereof, and is duly qualified to do business
and is in good standing in each other jurisdiction in which its ownership or lease of property or the conduct of business requires
such qualification, except where the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected
to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18
<U>Insurance</U>. The Company maintains insurance in such amounts and covering such risks as the Company reasonably considers
adequate for the conduct of its business and the value of its properties and as is customary for companies engaged in similar
businesses in similar industries, all of which insurance is in full force and effect, except where the failure to maintain such
insurance could not reasonably be expected to have a Material Adverse Change. There are no material claims by the Company under
any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights
clause. The Company reasonably believes that it will be able to renew its existing insurance as and when such coverage expires
or will be able to obtain replacement insurance adequate for the conduct of the business and the value of its properties at a
cost that would not have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19
<U>Transactions Affecting Disclosure to FINRA.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.1
<U>Finder&rsquo;s Fees</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
there are no claims, payments, contracts, arrangements, agreements or understandings between the Company and any person that would
give rise to a valid claim against the Company or any Underwriter for a brokerage commission, finder&rsquo;s fee or other like
payment in connection with the transactions contemplated by this Agreement or, to the Company&rsquo;s knowledge, any arrangements,
agreements, understandings, payments or issuance with respect to the Company or any of its officers, directors, stockholders,
partners, employees or affiliates that may affect the Underwriters&rsquo; compensation as determined by FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.2
<U>Payments Within Six (6) Months</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as
a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing
to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that
has any direct or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the Effective
Date, other than the payment to the Underwriters as provided hereunder in connection with the Offering..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.3
<U>Use of Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent with
the application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure
Package and the Prospectus. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member
or its affiliates, except as specifically described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.4
<U>FINRA Affiliation</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
there is no (i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class of the Company&rsquo;s securities
or (iii) beneficial owner of the Company&rsquo;s unregistered equity securities which were acquired during the 180-day period
immediately preceding the filing of the Registration Statement that is an affiliate or associated person of a FINRA member participating
in the Offering (as determined in accordance with the rules and regulations of FINRA). Except as disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, the Company (i) does not have any material lending or other relationship
with any bank or lending affiliate of any Underwriter and (ii) does not intend to use any of the proceeds from the sale of the
Public Securities to repay any outstanding debt owed to any affiliate of any Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.5
<U>Information</U>. All information provided by the Company in the FINRA questionnaire to Representative&rsquo;s Counsel specifically
for use by Representative&rsquo;s Counsel in connection with its Public Offering System filings (and related disclosure) with
FINRA is true, correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20
<U>Foreign Corrupt Practices Act</U>. None of the Company and its Subsidiary or, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company and its Subsidiary or any other person acting on behalf of the Company and
its Subsidiary, has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price
concessions to customers in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier,
or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political
party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder the
business of the Company (or assist it in connection with any actual or proposed transaction) that (i) might subject the Company
to any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii) if not given in the past, might
have had a Material Adverse Change or (iii) if not continued in the future, might adversely affect the assets, business, operations
or prospects of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are
sufficient to cause the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended,
and the rules and regulations thereunder (collectively, the &ldquo;<B>FCPA</B>&rdquo;); (iv) violated or is in violation of any
provision of the FCPA or any applicable non-U.S. anti-bribery statute or regulation; (v) made any bribe, rebate, payoff, influence
payment, kickback or other unlawful payment; or (vi) received notice of any investigation, proceeding or inquiry by any Governmental
Entity regarding any of the matters in clauses (i)-(v) above; and the Company and, to the knowledge of the Company, the Company&rsquo;s
affiliates have conducted their respective businesses in compliance with the FCPA and have instituted and maintain policies and
procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21
<U>Compliance with OFAC</U>. None of the Company and its Subsidiary or, to the Company&rsquo;s knowledge, any director or officer
of the Company and any agent, employee, affiliate or other person acting on behalf of the Company, is currently the subject or
target of any sanctions administered or enforced by the United States Government, including, without limitation, the U.S. Department
of the Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;<B>OFAC</B>&rdquo;), the U.S. Department of State, the United
Nations Security Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant sanctions authority (collectively,
&ldquo;<B>Sanctions</B>&rdquo;), nor is the Company located, organized or resident in a country or territory that is the subject
of Sanctions; and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise
make available such proceeds to any joint venture partner or other person or entity, for the purpose of financing the activities
of or business with any person, or in any country or territory, that currently is the subject or target of any U.S. sanctions
administered by OFAC or in any other manner that will result in a violation by any person (including any person participating
in the transaction whether as underwriter, advisor, investor or otherwise) of Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22
<U>Money Laundering Laws</U>. The operations of the Company and its Subsidiary are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;<B>Money
Laundering Laws</B>&rdquo;); and no action, suit or proceeding by or before any Governmental Entity involving the Company with
respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23
<U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in either the Registration Statement, Pricing Disclosure Package or the Prospectus has been
made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to you
or to Representative&rsquo;s Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the
matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25
<U>Lock-Up Agreements</U>. <U>Schedule 3</U> hereto contains a complete and accurate list of each of the Company&rsquo;s officers,
directors and each owner of 5% or more of the Company&rsquo;s outstanding shares of Common Stock (or securities convertible into
or exercisable for shares of Common Stock) (collectively, the &ldquo;<B>Lock-Up Parties</B>&rdquo;). The Company has caused each
of the Lock-Up Parties to deliver to the Representative an executed Lock-Up Agreement, in the form attached hereto as <U>Exhibit
B</U> (the &ldquo;<B>Lock-Up Agreement</B>&rdquo;), prior to the execution of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26
<U>RESERVED</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27
<U>Related Party Transactions.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.1
<U>Business Relationships</U>. There are no business relationships or related party transactions involving the Company or any
other person required to be described in the Pricing Disclosure Package and the Prospectus that have not been described. Without
limiting the generality of the immediately preceding sentence, no relationship, direct or indirect, exists between or among the
Company on the one hand, and the directors, officers, or 5% or greater stockholders of the Company on the other hand, that is
required to be described in the Pricing Disclosure Package and the Prospectus and that is not so described. Except as described
in the Registration Statement, Pricing Disclosure Package and the Prospectus, since inception, the Company has not, directly or
indirectly, extended or maintained credit, arranged to extend credit, or renewed any extension of credit, in the form of a personal
loan, to or for any director or executive officer of the Company, or to or for any family member or affiliate of any director
or executive officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.2
<U>No Unconsolidated Entities</U>. There are no transactions, arrangements or other relationships between and/or among the Company,
its Subsidiary, any of their affiliates (as such term is defined in Rule 405 of the Securities Act) and any unconsolidated entity,
including, but not limited to, any structure finance, special purpose or limited purpose entity that could reasonably be expected
to materially affect the Company&rsquo;s or its Subsidiary&rsquo; liquidity or the availability of or requirements for its capital
resources required to be described in the Pricing Disclosure Package and the Prospectus or a document incorporated by reference
therein which have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.28
Board of Directors. The Board of Directors of the Company is, and on the Closing Date, will be comprised of the persons set forth
under the heading of the Pricing Prospectus and the Prospectus captioned &ldquo;Management.&rdquo; The qualifications of the persons
serving as board members and the overall composition of the board comply with the Exchange Act and the rules and regulations of
the Commission promulgated thereunder (the &ldquo;<B>Exchange Act Regulations</B>&rdquo;), the Sarbanes-Oxley Act of 2002 and
the rules promulgated thereunder (the <B>&ldquo;Sarbanes-Oxley Act</B>&rdquo;) applicable to the Company and the listing rules
of the Nasdaq Stock Market LLC. At least one member of the Audit Committee of the Board of Directors of the Company qualifies,
and at the Closing Date, will qualify as an &ldquo;audit committee financial expert,&rdquo; as such term is defined under Regulation
S-K and the listing rules of the Nasdaq Stock Market LLC. In addition, at least a majority of the persons serving on the Board
of Directors qualify as &ldquo;independent,&rdquo; as defined under the listing rules of the Nasdaq Stock Market LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29
<U>Sarbanes-Oxley Compliance.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.1
<U>Disclosure Controls</U>. Except as set forth in the Registration Statement, Pricing Disclosure Package and the Prospectus,
the Company has developed and currently maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e)
under the Exchange Act Regulations) that comply with the requirements of the Exchange Act; such disclosure controls and procedures
have been designed to ensure that material information relating to the Company is made known to the Company&rsquo;s principal
executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures
are effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.2
<U>Compliance</U>. Except as set forth in the Registration Statement, Pricing Disclosure Package and the Prospectus, the Company
has taken all necessary actions to ensure that, upon the effectiveness of the Registration Statement, it will be in compliance
with all provisions of the Sarbanes-Oxley Act with which the Company is required to comply as of the effectiveness of the Registration
Statement, and is taking all steps necessary to ensure that it will at all times be in compliance with other provisions of the
Sarbanes-Oxley Act as and when the same become applicable to the Company after the effectiveness of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30
<U>Accounting Controls</U>. Except as set forth in the Registration Statement, Pricing Disclosure Package and the Prospectus,
the Company maintains a system of &ldquo;internal control over financial reporting&rdquo; (as defined under Rules 13a-15(f) under
the Exchange Act Regulations) that complies with the requirements of the Exchange Act and have been designed by, or under the
supervision of, their respective principal executive and principal financial officers, or persons performing similar functions,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
the Company is not aware of any material weaknesses in its internal controls. The Company&rsquo;s auditors and the Audit Committee
of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the
design or operation of internal controls over financial reporting which are known to the Company&rsquo;s management and that have
adversely affected or are reasonably likely to adversely affect the ability of the Company to record, process, summarize and report
financial information; and (ii) any fraud known to the Company&rsquo;s management, whether or not material, that involves management
or other employees who have a significant role in the Company&rsquo;s internal controls over financial reporting. Since the date
of the latest audited financial statements included in the Pricing Disclosure Package, there has been no change in the Company&rsquo;s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31
<U>No Investment Company Status</U>. The Company is not and, at all times up to and including consummation of the transactions
contemplated by this Agreement, and after giving effect to application of the net proceeds of the Offering as described in the
Pricing Disclosure Package and the Prospectus, will not be, required to register as an &ldquo;investment company&rdquo; under
the Investment Company Act of 1940, as amended, and is not and will not be an entity &ldquo;controlled&rdquo; by an &ldquo;investment
company&rdquo; within the meaning of such act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.32
<U>No Labor Disputes</U>. No labor disturbance by the employees of the Company exists or, to the best of the Company&rsquo;s knowledge,
is imminent and the Company is not aware of any existing or imminent labor disturbances by the employees of any of its principal
suppliers, manufacturers&rsquo; customers or contractors, which, in either case (individually or in the aggregate), could reasonably
be expected to have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33
<U>Intellectual Property Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company and each of its Subsidiary owns or possesses or has valid rights to use all patents, patent applications, trademarks,
service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets
and similar rights (&ldquo;<B>Intellectual Property Rights</B>&rdquo;) described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus and necessary for the conduct of the business of the Company and its Subsidiary as currently carried
on and as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. To the knowledge of the
Company, no action or use by the Company or any of its Subsidiary necessary for the conduct of its business as currently carried
on and as described in the Registration Statement and the Prospectus will involve or give rise to any infringement of, or license
or similar fees for, any Intellectual Property Rights of others. Neither the Company nor any of its Subsidiary has received any
notice alleging any such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as would not
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company,
there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the
Company; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging
the rights of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would
form a reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims in this
Section 2.33, reasonably be expected to result in a Material Adverse Change; (C) the Intellectual Property Rights owned by the
Company and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged
by a court of competent jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or, to the Company&rsquo;s
knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property
Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim that would, individually
or in the aggregate, together with any other claims in this Section 2.33, reasonably be expected to result in a Material Adverse
Change; (D) there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others that
the Company infringes, misappropriates or otherwise violates any Intellectual Property Rights or other proprietary rights of others,
the Company has not received any written notice of such claim and the Company is unaware of any other facts which would form a
reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this Section
2.33, reasonably be expected to result in a Material Adverse Change; and (E) to the Company&rsquo;s knowledge, no employee of
the Company is in or has ever been in violation in any material respect of any term of any employment contract, patent disclosure
agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any
restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment
with the Company, or actions undertaken by the employee while employed with the Company and could reasonably be expected to result,
individually or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s knowledge, all material technical information
developed by and belonging to the Company which has not been patented has been kept confidential. The Company is not a party to
or bound by any options, licenses or agreements with respect to the Intellectual Property Rights of any other person or entity
that are required to be set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus and are not
described therein. The Registration Statement, the Pricing Disclosure Package and the Prospectus contain in all material respects
the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company has been
obtained or is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company&rsquo;s
knowledge, any of its officers, directors or employees, or otherwise in violation of the rights of any persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
All licenses for the use of the Intellectual Property described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus are in full force and effect in all material respects and are enforceable by the Company that is a party thereto
and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with their terms, except (x) as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the
remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and
to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments has
been assigned by the Company, and neither the Company nor, to the Company&rsquo;s knowledge, any other party is in default thereunder
and, to the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would
constitute a default thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.34
<U>Taxes</U>. Each of the Company and its Subsidiary has filed all returns (as hereinafter defined) required to be filed with
taxing authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof. Each of the Company
and its Subsidiary has paid all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes
imposed on or assessed against the Company or such respective Subsidiary, except as would not be reasonably expected to have a
Material Adverse Change. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of
the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and
including the dates of such consolidated financial statements. Except as disclosed in writing to the Underwriters, (i) no issues
have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as
due from the Company or its Subsidiary, and (ii) no waivers of statutes of limitation with respect to the returns or collection
of taxes have been given by or requested from the Company or its Subsidiary. The term &ldquo;taxes&rdquo; means all federal, state,
local, foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license,
lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall
profits, customs, duties or other taxes, fees, assessments or charges of any kind whatever, together with any interest and any
penalties, additions to tax or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations,
reports, statements and other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35
<U>Compliance with Environmental Laws</U>. Except as would not involve, individually or in the aggregate, a Material Change: (i)
neither the Company nor its Subsidiary is in violation of any Federal, state, local or foreign statute, law, rule, regulation,
ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial
or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including,
without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without
limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes,
toxic substances, hazardous substances, petroleum or petroleum products (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;)
or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials
(collectively, &ldquo;<B>Environmental Laws</B>&rdquo;); (ii) the Company and its Subsidiary have all material permits, authorizations
and approvals required under any applicable Environmental Laws and are each in compliance in all material respects with their
requirements; (iii) there are no pending or, to the Company&rsquo;s actual knowledge, threatened administrative, regulatory or
judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings
relating to any Environmental Law against the Company or any of its subsidiaries; and (iv) there are no events or circumstances
that might reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding
by any private party or governmental body or agency, against or affecting the Company or any of its subsidiaries relating to Hazardous
Materials or any Environmental Laws. There has been no disposal, discharge, emission contamination or other release of any kind
at, onto or from any such property or into the environment surrounding any such property of any Hazardous Substances with respect
to which the Company has knowledge, except as could not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Change. The Company has not agreed to assume, undertake or provide indemnification for any liability of any other person
under any Environmental Law, including any obligation for cleanup or remedial action, except as could not, individually or in
the aggregate, reasonably be expected to have a Material Adverse Change. There is no pending or, to the best of the Company&rsquo;s
knowledge, threatened administrative, regulatory or judicial action, claim or notice of noncompliance or violation, investigation
or proceedings relating to any Environmental Law against the Company. No property of any Company is subject to any Lien under
any Environmental Law. The Company is not subject to any order, decree, agreement or other individualized legal requirement related
to any Environmental Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.36
<U>ERISA Compliance</U>. The Company, its Subsidiary and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee
Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively,
&ldquo;<B>ERISA</B>&rdquo;)) established or maintained by the Company, its Subsidiary or its &ldquo;ERISA Affiliates&rdquo; (as
defined below) are in compliance in all material respects with ERISA. &ldquo;ERISA Affiliate&rdquo; means, with respect to the
Company, any member of any group of organizations described in Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of
1986, as amended, and the regulations and published interpretations thereunder (the &ldquo;Code&rdquo;) of which the Company or
its Subsidiary is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is reasonably expected
to occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company or its Subsidiary or
any of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company or its Subsidiary
or any of its ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded
benefit liabilities&rdquo; (as defined under ERISA). None of the Company, its Subsidiary nor any of its ERISA Affiliates has incurred
or reasonably expects to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal
from, any &ldquo;employee benefit plan&rdquo; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit
plan&rdquo; established or maintained by the Company, its Subsidiary or any of its ERISA Affiliates that is intended to be qualified
under Section 401(a) of the Code is so qualified and, to the knowledge of the Company, nothing has occurred, whether by action
or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.37
<U>Compliance with Laws</U>. Each of the Company and its Subsidiary: (i) is and at all times has been in compliance with all statutes,
rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing use, distribution,
marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed
by Company or its Subsidiary (&ldquo;<B>Applicable Laws</B>&rdquo;), except as could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Change; (ii) has not received any written notices, statements or other correspondence or
notice from the FDA or any foreign, state or local Governmental Entity performing functions similar to the FDA or any other Governmental
Entity alleging or asserting noncompliance with any Applicable Laws or any Authorizations; (iii) possesses all material Authorizations
and such Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations;
(iv) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other
action from any governmental Entity or third party alleging that any product operation or activity is in violation of any applicable
Laws or Authorizations and has no knowledge that any such governmental authority is considering such action; and (v) has filed,
obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims submissions and
supplements or amendments as required by any applicable Laws or Authorizations and that all such reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments were complete and correct in all material respects on
the date filed (or were corrected or supplemented by a subsequent submission).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.38
<U>Smaller Reporting Company</U>. As of the time of filing of the Registration Statement and as of the date of this Agreement,
the Company was a &ldquo;smaller reporting company,&rdquo; as defined in Rule 12b-2 of the Exchange Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.39
<U>Industry Data</U>. The statistical, industry related and market-related data included in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus are based on or derived from sources that the Company reasonably and in good
faith believes are reliable and accurate or represent the Company&rsquo;s good faith estimates that are made on the basis of data
derived from such sources, and such data agree with the sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40
<U>Margin Securities</U>. The Company does not own any &ldquo;margin securities&rdquo; as that term is defined in Regulation U
of the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal Reserve Board</B>&rdquo;), and none of the proceeds
of the Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose
of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for any other
purpose which might cause any of the shares of Common Stock to be considered a &ldquo;purpose credit&rdquo; within the meanings
of Regulation T, U or X of the Federal Reserve Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41
<U>Integration</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require
the registration of any such securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.42
<U>Title to Real and Personal Property</U>. The Company owns or leases all such properties as are necessary to the conduct of
its business as presently operated as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
The Company has good and marketable title in fee simple to all real property and good and marketable title to all personal property
owned by it, in each case free and clear of any and all Liens except such as are described in the Registration Statement, the
Pricing Disclosure Package and the Prospectus or such as do not (individually or in the aggregate) materially affect the value
of such property or materially interfere with the use made or proposed to be made of such property by the Company; and any real
property and buildings held under lease or sublease by the Company are held by them under valid, subsisting and enforceable leases
with such exceptions as are not material to, and do not materially interfere with, the use made and proposed to be made of such
property and buildings by the Company. The Company has not received any notice of any claim adverse to its ownership of any real
or personal property or of any claim against the continued possession of any real property, whether owned or held under lease
or sublease by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.43
<U>Confidentiality and Non-Competitions</U>. To the Company&rsquo;s knowledge, no director, officer, key employee or consultant
of the Company is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with
any employer or prior employer that could materially affect his ability to be and act in his respective capacity of the Company
or be expected to result in a Material Adverse Change. Each officer, key employee or consultant of the Company has entered into
a confidentiality agreement in favor of the Company relating to the protection of the proprietary information and confidential
information of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.44
<U>Corporate Records</U>. The minute books of the Company and its Subsidiary have been made available to the Underwriters and
counsel for the Underwriters, and such books (i) contain minutes of all material meetings and actions of the board of directors
(including each board committee) and stockholders of the Company, and (ii) reflect all material transactions referred to in such
minutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.45
<U>No Stabilization</U>. Neither the Company nor any of its affiliates (within the meaning of Rule 144 under the Securities Act)
has taken, directly or indirectly, any action which constitutes or is designed to cause or result in, or which could reasonably
be expected to constitute, cause or result in, the stabilization or manipulation of the price of any security to facilitate the
sale or resale of the Public Securities or to result in a violation of Regulation M under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46
<U>Electronic Road Show</U>. The Company has made available a Bona Fide Electronic Road Show in compliance with Rule 433(d)(8)(ii)
of the Securities Act Regulations such that no filing of any &ldquo;road show&rdquo; (as defined in Rule 433(h) of the Securities
Act Regulations) is required in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Covenants of the Company</U>. The Company covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Amendments to Registration Statement</U>. The Company shall deliver to the Representative, prior to filing, any amendment or
supplement to the Registration Statement or Prospectus proposed to be filed after the Effective Date and not file any such amendment
or supplement to which the Representative shall reasonably object in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Federal Securities Laws.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1
<U>Compliance</U>. The Company, subject to Section 3.2.2, shall comply with the requirements of Rule 430A of the Securities Act
Regulations, and will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective amendment
to the Registration Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed; (ii)
of the receipt of any comments from the Commission; (iii) of any request by the Commission for any amendment to the Registration
Statement or any amendment or supplement to the Prospectus or for additional information; (iv) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing
or suspending the use of any Preliminary Prospectus or the Prospectus, or of the suspension of the qualification of the Public
Securities and Representative&rsquo;s Securities for offering or sale in any jurisdiction, or of the initiation or threatening
of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of the Securities Act concerning
the Registration Statement; and (v) if the Company becomes the subject of a proceeding under Section 8A of the Securities Act
in connection with the Offering of the Public Securities and Representative&rsquo;s Securities. The Company shall effect all filings
required under Rule 424(b) of the Securities Act Regulations, in the manner and within the time period required by Rule 424(b)
(without reliance on Rule 424(b) (8)), and shall take such steps as it deems necessary to ascertain promptly whether the form
of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was
not, it will promptly file such prospectus. The Company shall use its best efforts to prevent the issuance of any stop order,
prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2
Continued Compliance. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the
Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement,
the Representative&rsquo;s Warrant Agreement and in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
If at any time when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule 172 of the Securities
Act Regulations (&ldquo;Rule 172&rdquo;), would be) required by the Securities Act to be delivered in connection with sales of
the Public Securities, any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of
counsel for the Underwriters or for the Company, to (i) amend the Registration Statement in order that the Registration Statement
will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading; (ii) amend or supplement the Pricing Disclosure Package or the Prospectus in order
that the Pricing Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances
existing at the time it is delivered to a purchaser or (iii) amend the Registration Statement or amend or supplement the Pricing
Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the Securities Act or the
Securities Act Regulations, the Company will promptly (A) give the Representative notice of such event; (B) prepare any amendment
or supplement as may be necessary to correct such statement or omission or to make the Registration Statement, the Pricing Disclosure
Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or use,
furnish the Representative with copies of any such amendment or supplement and (C) file with the Commission any such amendment
or supplement; provided that the Company shall not file or use any such amendment or supplement to which the Representative or
counsel for the Underwriters shall reasonably object. The Company will furnish to the Underwriters such number of copies of such
amendment or supplement as the Underwriters may reasonably request. The Company has given the Representative notice of any filings
made pursuant to the Exchange Act or the Exchange Act Regulations within 48 hours prior to the Applicable Time; the Company will
give the Representative notice of its intention to make any such filing from the Applicable Time to the Closing Date and will
furnish the Representative with copies of any such documents a reasonable amount of time prior to such proposed filing, as the
case may be, and will not file or use any such document to which the Representative or counsel for the Underwriters shall reasonably
object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3
<U>Exchanged Act Registration</U>. For a period of three (3) years after the date of this Agreement, the Company shall use its
reasonable best efforts to maintain the registration of the Common Stock under the Exchange Act. The Company shall not deregister
any of the Common Stock under the Exchange Act for a period of three (3) years after the date of this Agreement, without the prior
written consent of the Representative, which consent shall not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.4
<U>Free Writing Prospectuses.</U> The Company will not, without the prior consent of the Representative, (i) make any offer relating
to the Public Securities that would constitute a &ldquo;free writing prospectus&rdquo; as defined in Rule 405 under the Securities
Act, except for any Issuer Free Writing Prospectus set forth in <U>Schedule 2-B</U> hereto and any electronic road show previously
approved by the Representative, or (ii) file, refer to, approve, use or authorize the use of any &ldquo;free writing prospectus&rdquo;
as defined in Rule 405 under the Securities Act with respect to the Offering or the Public Securities. If at any time any event
shall have occurred as a result of which any Issuer Free Writing Prospectus as then amended or supplemented would, in the judgment
of the Underwriters or the Company, conflict with the information in the Registration Statement, the Pricing Prospectus or the
Prospectus as then amended or supplemented or would, in the judgment of the Underwriters or the Company, include an untrue statement
of a material fact or omit to state any material necessary in order to make the statements therein, in the light of the circumstances
existing at the time of delivery to the purchaser, not misleading, or if to comply with the Securities Act or the Securities Act
Regulations it shall be necessary at any time to amend or supplement any Issuer Free Writing Prospectus, the Company will notify
the Representative promptly and, if requested by the Representative, prepare and furnish without charge to each Underwriter an
appropriate amendment or supplement (in form and substance satisfactory to the Representative) that will correct such statement,
omission or conflict or effect such compliance. The Company has complied and will comply with the requirements of Rule 433 with
respect to each Issuer Free Writing Prospectus including, without limitation, all prospectus delivery, filing, record retention
and legending requirements applicable to each such Issuer Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.5
<U>Testing-the-Waters Communications.</U> If at any time following the distribution of any Written Testing-the-Waters Communication
there occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or
would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company shall
promptly notify the Representative and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters
Communication to eliminate or correct such untrue statement or omission. The Company will promptly notify the Representative of
(i) any distribution by the Company of Written Testing-the-Waters Communications and (ii) any request by the Commission for information
concerning the Written Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Delivery to the Underwriters of Registration Statements</U>. The Company has delivered or made available or shall deliver or
make available to the Representative and counsel for the Representative, without charge, signed copies of the Registration Statement
as originally filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates
of experts, and will also deliver to the Underwriters, without charge, a conformed copy of the Registration Statement as originally
filed and each amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration Statement and
each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed
with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Delivery to the Underwriters of Prospectuses</U>. The Company has delivered or made available or will deliver or make available
to each Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and
the Company hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to
each Underwriter, without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception
afforded by Rule 172 of the Securities Act Regulations, would be) required to be delivered under the Securities Act, such number
of copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request. The Prospectus and any amendments
or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed
with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Effectiveness and Events Requiring Notice to the Representative</U>. The Company shall use its best efforts to cause the Registration
Statement to remain effective with a current prospectus for at least nine (9) months after the Applicable Time, and shall notify
the Representative immediately and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any
amendment thereto; (ii) of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding
for that purpose; (iii) of the issuance by any state securities commission of any proceedings for the suspension of the qualification
of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding
for that purpose; (iv) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration
Statement or Prospectus; (v) of the receipt of any comments or request for any additional information from the Commission; and
(vi) of the happening of any event during the period described in this Section 3.5 that, in the judgment of the Company, makes
any statement of a material fact made in the Registration Statement, the Pricing Disclosure Package or the Prospectus untrue or
that requires the making of any changes in (a) the Registration Statement in order to make the statements therein not misleading,
or (b) in the Pricing Disclosure Package or the Prospectus in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. If the Commission or any state securities commission shall enter a stop order or suspend
such qualification at any time, the Company shall make every reasonable effort to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Review of Financial Statements</U>. For a period of three (3) years after the date of this Agreement, the Company, at its expense,
shall cause its regularly engaged independent registered public accounting firm to review (but not audit) the Company&rsquo;s
financial statements for each of the three (3) fiscal quarters immediately preceding the announcement of any quarterly financial
information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Listing</U>. The Company shall use its reasonable best efforts to maintain the listing of the Common Stock (including the Firm
Shares, Option Shares and shares of Common Stock issuable upon exercise of the Representative&rsquo;s Warrants) on the Exchange
for at least three (3) years from the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<U>Financial Public Relations Firm</U>. As of the date of this Agreement, the Company shall have retained a financial public relations
firm reasonably acceptable to the Representative and the Company, which shall initially be MDM Worldwide Solutions, which firm
shall be experienced in assisting issuers in initial public offerings of securities and in their relations with their security
holders, and shall retain such firm or another firm reasonably acceptable to the Representative for a period of not less than
three (3) years after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<U>Reports to the Representative</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.1
<U>Periodic Reports, etc</U>. For a period of three (3) years after the date of this Agreement, the Company shall furnish to the
Representative copies of such financial statements and other periodic and special reports as the Company from time to time furnishes
generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy of each periodic
report the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii)
a copy of every press release and every news item and article with respect to the Company or its affairs which was released by
the Company; (iii) a copy of each Form 8-K prepared and filed by the Company; (iv) five copies of each registration statement
filed by the Company under the Securities Act; (v) a copy of each report or other communication furnished to stockholders and
(vi) such additional documents and information with respect to the Company and the affairs of any future subsidiaries of the Company
as the Representative may from time to time reasonably request; provided the Representative shall sign, if requested by the Company,
a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative and Representative&rsquo;s
Counsel in connection with the Representative&rsquo;s receipt of such information. Documents filed with the Commission pursuant
to its EDGAR system or otherwise publicly filed or made available shall be deemed to have been delivered to the Representative
pursuant to this Section 3.9.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.2
<U>Transfer Agent; Transfer Sheets</U>. For a period of three (3) years after the date of this Agreement, the Company shall retain
a transfer agent and registrar acceptable to the Representative (the &ldquo;<B>Transfer Agent</B>&rdquo;) and shall furnish to
the Representative at the Company&rsquo;s sole cost and expense such transfer sheets of the Company&rsquo;s securities as the
Representative may reasonably request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and
DTC. Action Stock Transfer Corp. is acceptable to the Representative to act as Transfer Agent for the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.3
<U>Trading Reports</U>. For a period of three (3) years after the date of this Agreement, the Company shall provide to the Representative,
at the Company&rsquo;s expense, such reports published by Exchange relating to price trading of the Public Securities, as the
Representative shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<U>Payment of Expenses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.1
<U>General Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date and the Option Closing
Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company
under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration
of Public Securities to be issued and sold in the Offering with the Commission; (b) all filing fees associated with the review
of the Offering by FINRA; (c) all fees and expenses relating to the listing of such Common Stock on the Exchange; (d) all fees,
expenses and disbursements relating to background checks of the Company&rsquo;s officers and directors in an amount not to exceed
$15,000 in the aggregate; (e) all fees, expenses and disbursements relating to the registration or qualification of the Public
Securities under the &ldquo;blue sky&rdquo; securities laws of such states and other jurisdictions as the Representative may reasonably
designate; (f) all fees, expenses and disbursements relating to the registration, qualification or exemption of the Public Securities
under the securities laws of such foreign jurisdictions as the Representative may reasonably designate; (g) the costs of all mailing
and printing of the underwriting documents (including, without limitation, this Agreement, any blue sky surveys and, if appropriate,
any agreement among underwriters, selected dealers&rsquo; agreement, underwriters&rsquo; questionnaire and power of attorney),
Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses
as the Representative may reasonably deem necessary; (h) the costs and expenses of the public relations firm referred to in Section
3.8 hereof; (i) the costs of preparing, printing and delivering certificates representing the Public Securities; (j) fees and
expenses of the Transfer Agent for the shares of Common Stock; (k) stock transfer and/or stamp taxes, if any, payable upon the
transfer of securities from the Company to the Underwriters; (l) the costs associated with post-Closing advertising of the Offering
in the national editions of <I>The Wall Street Journal</I> and <I>The New York Times</I>; (m) the costs associated with bound
volumes of the public offering materials as well as commemorative mementos and lucite tombstones in an aggregate amount not to
exceed $3,000, each of which the Company or its designee will provide, including to the Representative, within a reasonable time
after the Closing in such quantities as the Representative may reasonably request; (n) the fees and expenses of the Company&rsquo;s
accountants; (o) the fees and expenses of the Company&rsquo;s legal counsel and other agents and representatives; (p) the fees
and expenses of the Underwriter&rsquo;s legal counsel not to exceed $85,000; (q) the $29,500 cost associated with the Underwriters&rsquo;
use of Ipreo&rsquo;s book building, prospectus tracking and compliance software for the Offering; (r) $10,000 for data services
and communications expenses; and (s) up to $20,000 of the Underwriters&rsquo; actual accountable &ldquo;road show&rdquo; expenses
for the Offering. Notwithstanding the foregoing, the total reimbursable amount pursuant to clauses (p),(q),(r) and (s) shall be
$100,000. The Representative may deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or the
Option Closing Date, if any, the expenses set forth herein to be paid by the Company to the Underwriters, provided, however, that
in the event that the Offering is terminated, the Company agrees to reimburse the Underwriters pursuant to Section 8.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.2
<U>Non-accountable Expenses</U>. The Company further agrees that, in addition to the expenses payable pursuant to Section 3.10.1,
on the Closing Date it shall pay to the Representative, by deduction from the net proceeds of the Offering contemplated herein,
a non-accountable expense allowance equal to one percent (1%) of the gross proceeds received by the Company from the sale of the
Firm Shares (excluding the Option Shares), less the Advance (as such term is defined in Section 8.3 hereof), provided, however,
that in the event that the Offering is terminated, the Company agrees to reimburse the Underwriters pursuant to Section 8.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve
and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling
the Company to issue the Public Securities and the shares of Common Stock issuable upon exercise the Representative&rsquo;s Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
<U>Application of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent
with the application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing
Disclosure Package and the Prospectus. None of the net proceeds of the Offering will be paid by the Company to any participating
FINRA member or its affiliates, except as specifically described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<U>Delivery of Earnings Statements to Security Holders</U>. The Company shall make generally available to its security holders
as soon as practicable, but not later than the first day of the fifteenth (15th) full calendar month following the Effective Date,
an earnings statement (which need not be certified by an independent registered public accounting firm unless required by the
Securities Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of
the Securities Act) covering a period of at least twelve (12) consecutive months beginning after the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14
<U>Stabilization</U>. Neither the Company nor, to their knowledge, any of their employees, directors or stockholders (without
the consent of the Representative) has taken or shall take, directly or indirectly, any action designed to or that has constituted
or that might reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15
<U>Internal Controls</U>. The Company shall maintain a system of internal accounting controls sufficient to provide reasonable
assurances that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorization; (ii) transactions
are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability
for assets; (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization;
and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16
<U>Accountants</U>. As of the date of this Agreement, the Company shall have retained an independent registered public accounting
firm, as required by the Securities Act and the Regulations and the PCAOB, reasonably acceptable to the Representative and the
Company shall retain a nationally recognized independent public accounting firm for a period of at least three (3) years after
the date of this Agreement. The Representative acknowledges that the Auditor is acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17
<U>FINRA</U>. For a period of 180 days from the later of the Closing Date or the Option Closing Date, the Company shall advise
the Representative (who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or director
of the Company, (ii) any beneficial owner of 5% or more of any class of the Company&rsquo;s securities or (iii) any beneficial
owner of the Company&rsquo;s unregistered equity securities which were acquired during the 180 days immediately preceding the
filing of the Registration Statement is or becomes an affiliate or associated person of a FINRA member participating in the Offering
(as determined in accordance with the rules and regulations of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company s is
solely contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be
acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of their affiliates in connection with
the Offering and the other transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19
<U>Company Lock-Up Agreements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19.1
<U>Restrictions on Sales of Capital Stock</U>. The Company, on behalf of itself and any successor entity of the Company, agrees
that, without the prior written consent of the Representative, it will not, for a period of six (6) months commencing on the date
of this Agreement (the &ldquo;<B>Lock-Up Period</B>&rdquo;), (i) offer, pledge, sell, contract to sell, sell any option or contract
to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer
or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable
or exchangeable for shares of capital stock of the Company (other than the Option Shares and Common Stock issued pursuant to employee
benefit plans, qualified stock option plans or other employee compensation plans existing on the date hereof or pursuant to currently
outstanding options, warrants or rights) provided that either (a) such shares shall not vest during the Lock-Up Period or (b)
the grantee of such shares will execute a Lock-Up Agreement; (ii) file or cause to be filed any registration statement with the
Commission relating to the offering of any shares of capital stock of the Company or any securities convertible into or exercisable
or exchangeable for shares of capital stock of the Company other than a registration statement on Form S-4 or S-8; (iii) complete
any offering of debt securities of the Company, other than entering into a line of credit with a traditional bank; or (iv) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of capital stock of the Company, whether any such transaction described in clause (i), (ii) or (iv) above is to be settled by
delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
restrictions contained in this <U>Section 3.18</U> shall not apply to (i) the Public Securities to be sold hereunder, (ii) the
issuance by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security
outstanding on the date of this Agreement, which is disclosed in the Registration Statement, Pricing Disclosure Package and Prospectus,
(iii) the issuance by the Company of any security under any equity compensation plan of the Company, (iv) the issuance by the
Company of shares of Common Stock in the connection with mergers, acquisitions or joint ventures, and (v) the issuance by the
Company of shares of Common Stock to consultants in the Company&rsquo;s ordinary course of business and not for capital raising
transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19.2
<U>Restriction on Continuous Offerings</U>. Notwithstanding the restrictions contained in Section 3.19.1, the Company, on behalf
of itself and any successor entity, agrees that, without the prior written consent of the Representative, it will not, for a period
of 12 months after the date of this Agreement, directly or indirectly in any &ldquo;at-the-market&rdquo;, or continuous equity
transaction, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock of
the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20
<U>Release of D&amp;O Lock-up Period</U>. If the Representative, in its sole discretion, agrees to release or waive the restrictions
set forth in the Lock-Up Agreements described in <U>Section 2.25</U> hereof for an officer or director of the Company and provide
the Company with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release
or waiver, the Company agrees if required by applicable law to announce the impending release or waiver by a press release substantially
in the form of <U>Exhibit C</U> hereto through a major news service at least two (2) Business Days before the effective date of
the release or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21
<U>Blue Sky Qualifications</U>. The Company shall use its best efforts, in cooperation with the Underwriters, if necessary, to
qualify the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions
(domestic or foreign) as the Representative may designate and to maintain such qualifications in effect so long as required to
complete the distribution of the Public Securities; provided, however, that the Company shall not be obligated to file any general
consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which
it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise
so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22
<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but
for the exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required
to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange
Act Regulations. Additionally, the Company shall report the use of proceeds from the issuance of the Public Securities as may
be required under Rule 463 under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24
<U>Press Releases</U>. Prior to the Closing Date and any Option Closing Date, the Company shall not issue any press release or
other communication directly or indirectly or hold any press conference with respect to the Company, its condition, financial
or otherwise, or earnings, business affairs or business prospects (except for routine oral marketing communications in the ordinary
course of business and consistent with the past practices of the Company and of which the Representative is notified), without
the prior written consent of the Representative, which consent shall not be unreasonably withheld, unless in the judgment of the
Company and its counsel, and after notification to the Representative, such press release or communication is required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.25
<U>Sarbanes-Oxley</U>. The Company shall at all times comply with all applicable provisions of the Sarbanes-Oxley Act in effect
from time to time and applicable to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26.
<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but
for the exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required
to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange
Act Regulations. Additionally, the Company shall report the use of proceeds from the issuance of the Public Securities as may
be required under Rule 463 under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27.
<U>Pursuant to the Exchange Act</U>. Prior to the Closing Date, the Company will have filed with the Commission the Form 8-A providing
for the registration pursuant to Section 12(b) under the Exchange Act of the Common Stock; and prior to the Closing Date the Form
8-A will have become effective under the Exchange Act. The Company has taken no action designed to, or likely to have the effect
of, terminating the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that
the Commission is contemplating terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Conditions of Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Public Securities,
as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of
the date hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of
officers of the Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder;
and (iv) the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Regulatory Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1
<U>Effectiveness of Registration Statement; Rule 430A Information</U>. The Registration Statement shall have become effective
not later than 5:00 p.m., Eastern time, on the date of this Agreement or such later date and time as shall be consented to in
writing by you, and, at each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the
Registration Statement or any post-effective amendment thereto shall have been issued under the Securities Act, no order preventing
or suspending the use of any Preliminary Prospectus or the Prospectus shall have been issued and no proceedings for any of those
purposes shall have been instituted or are pending or, to the Company&rsquo;s knowledge, contemplated by the Commission. The Company
has complied with each request (if any) from the Commission for additional information. A prospectus containing the Rule 430A
Information shall have been filed with the Commission in the manner and within the time frame required by Rule 424(b) under the
Securities Act Regulations (without reliance on Rule 424(b)(8)) or a post-effective amendment providing such information shall
have been filed with, and declared effective by, the Commission in accordance with the requirements of Rule 430A under the Securities
Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2
<U>FINRA Clearance</U>. On or before the date of this Agreement, the Representative shall have received clearance from FINRA as
to the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3
<U>Exchange Stock Market Clearance</U>. On the Closing Date, the Company&rsquo;s Common Stock (including the Option Shares) shall
have been approved for listing on the Exchange. On the first Option Closing Date (if any), the Company&rsquo;s Common Stock (including
the Option Shares) shall have been approved for listing on the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Company Counsel Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1
<U>Closing Date Opinion of Counsel to the Company</U>. On the Closing Date, the Representative shall have received the favorable
opinions of Sullivan &amp; Worcester LLP, special corporate and securities counsel to the Company, and a written statement providing
certain &ldquo;10b-5&rdquo; negative assurances, dated the Closing Date and addressed to the Representative, substantially in
a form reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2
<U>Closing Date Opinion of Counsel to the Company</U>. On the Closing Date, the Representative shall have received the favorable
opinions of [&#9679;], special Israeli counsel to the Company, and a written statement providing certain &ldquo;10b-5&rdquo; negative
assurances, dated the Closing Date and addressed to the Representative, substantially in a form reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.3
[<U>Closing Date Opinion of Regulatory Counsel to the Company</U>. On the Closing Date, the Representative shall have received
the favorable opinion of [&#9679;], regulatory counsel to the Company, and a written statement providing certain &ldquo;10b-5&rdquo;
negative assurances, dated the Closing Date and addressed to the Representative, substantially in a form acceptable to the Representative.]&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4
<U>Closing Date Opinion of Intellectual Property Counsel to the Company</U>. On the Closing Date, the Representative shall have
received the favorable opinion of [&#9679;], intellectual property counsel to the Company, and a written statement providing certain
&ldquo;10b-5&rdquo; negative assurances, dated the Closing Date and addressed to the Representative, substantially in a form acceptable
to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.5
<U>Option Closing Date Opinions of Counsel</U>. On the Option Closing Date, if any, the Representative shall have received the
favorable opinions of each counsel listed in Sections 4.2.1, 4.2.2, 4.2.3 and 4.2.4, dated the Option Closing Date, addressed
to the Representative and in form and substance reasonably satisfactory to the Representative, confirming as of the Option Closing
Date, the statements made by such counsels in their respective opinions delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.5
<U>Reliance</U>. In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other
than the laws of the United States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to
the extent specified in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to
the Representative) of other counsel reasonably acceptable to the Representative, familiar with the applicable laws; and (ii)
as to matters of fact, to the extent they deem proper, on certificates or other written statements of officers of the Company
and officers of departments of various jurisdictions having custody of documents respecting the corporate existence or good standing
of the Company, provided that copies of any such statements or certificates shall be delivered to Representative&rsquo;s Counsel
if requested. The opinions described in Sections 4.2.1, 4.2.2, 4.2.3 and 4.2.4 and any opinion relied upon by such counsel
shall include a statement to the effect that it may be relied upon by Representative Counsel in its opinion delivered to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Comfort Letters.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1
<U>Cold Comfort Letter</U>. At the time this Agreement is executed you shall have received a cold comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements
and certain financial information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
addressed to the Representative and in form and substance satisfactory in all respects to you and to Representative&rsquo;s Counsel
from the Auditor, dated as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2
<U>Bring-down Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have
received from the Auditor a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that
the Auditor reaffirms the statements made in the letter furnished pursuant to Section 4.3.1, except that the specified date referred
to shall be a date not more than three (3) Business Days prior to the Closing Date or the Option Closing Date, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Officers&rsquo; Certificates.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.1
<U>Officers&rsquo; Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date
and any Option Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial
Officer stating that (i) such officers have carefully examined the Registration Statement, the Pricing Disclosure Package, any
Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the Registration Statement and each amendment thereto,
as of the Applicable Time and as of the date of this Agreement and as of the Closing Date (or any Option Closing Date if such
date is other than the Closing Date) did not include any untrue statement of a material fact and did not omit to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, and the Pricing Disclosure Package,
as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date),
any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date if such date is other
than the Closing Date), the Prospectus and each amendment or supplement thereto, as of the respective date thereof and as of the
Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances in which they were made, not misleading, (ii) since the Effective
Date of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment to the
Registration Statement, the Pricing Disclosure Package or the Prospectus, (iii) to the best of their knowledge, as of the Closing
Date (or any Option Closing Date if such date is other than the Closing Date), the representations and warranties of the Company
in this Agreement are true and correct in all material respects (except for those representations and warranties qualified as
to materiality, which shall be true and correct in all respects and except for those representations and warranties which refer
to facts existing at a specific date, which shall be true and correct as of such date) and the Company has complied with all agreements
and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option
Closing Date if such date is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most recent
audited financial statements included or incorporated by reference in the Pricing Disclosure Package, any material adverse change
in the financial position or results of operations of the Company, or any change or development that, singularly or in the aggregate,
would involve a material adverse change, in or affecting the condition (financial or otherwise), results of operations, business,
assets or prospects of the Company, except as set forth in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.2
<U>Secretary&rsquo;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall
have received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Date,
as the case may be, respectively, certifying: (i) that each of the Charter and by-laws is true and complete, has not been modified
and is in full force and effect; (ii) that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering
are in full force and effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence between
the Company or its counsel and the Commission; and (iv) as to the incumbency of the officers of the Company. The documents referred
to in such certificate shall be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.3.
<U>Chief Financial Officer&rsquo;s Certificate</U>. At each of the date of this Agreement, the Closing Date and the Option Closing
Date, if any, the Representative shall have received a certificate of the Chief Financial Officer of the Company, dated the Closing
Date or the Option Date, as the case may be, respectively, with respect to the accuracy of certain information contained in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, in a form reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>No Material Changes</U>. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have
been no Material Adverse Change and no material change in the capital stock or debt of the Company from the latest dates as of
which such information is set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except as
set forth in the Registration Statement, Pricing Disclosure and the Prospectus; (ii) no action, suit or proceeding, at law or
in equity, shall have been pending or threatened against the Company or any Insider before or by any court or Federal or state
commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may result in a Material Adverse
Change, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus; (iii) no stop order
shall have been issued under the Securities Act and no proceedings therefore shall have been initiated or threatened by the Commission;
(iv) no action shall have been taken and no law, statute, rule, regulation or order shall have been enacted, adopted or issued
by any Governmental Entity which would prevent the issuance or sale of the Public Securities or materially and adversely affect
or potentially materially and adversely affect the business or operations of the Company; (v) no injunction, restraining order
or order of any other nature by any Federal or state court of competent jurisdiction shall have been issued which would prevent
the issuance or sale of the Public Securities or materially and adversely affect or potentially materially and adversely affect
the business or operations of the Company; and (vi) the Registration Statement, the Pricing Disclosure Package and the Prospectus
and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance
with the Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of the
Securities Act and the Securities Act Regulations, and neither the Registration Statement, the Pricing Disclosure Package, the
Prospectus nor any Issuer Free Writing Prospectus nor any amendment or supplement thereto shall contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>No Material Misstatement or Omission</U>. The Underwriters shall not have discovered and disclosed to the Company on or prior
to the Closing Date and any Option Closing Date that the Registration Statement or any amendment or supplement thereto contains
an untrue statement of a fact which, in the opinion of counsel for the Underwriters, is material or omits to state any fact which,
in the opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements therein
not misleading, or that the Registration Statement, Pricing Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus
or any amendment or supplement thereto contains an untrue statement of fact which, in the opinion of such counsel, is material
or omits to state any fact which, in the opinion of such counsel, is material and is necessary in order to make the statements,
in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters incident to the authorization, form and validity
of each of this Agreement, the Representative&rsquo;s Warrant Agreement, the Public Securities, the Registration Statement, the
Pricing Disclosure Package, each Issuer Free Writing Prospectus, if any, and the Prospectus and all other legal matters relating
to this Agreement, the Representative&rsquo;s Warrant Agreement and the transactions contemplated hereby and thereby shall be
reasonably satisfactory in all material respects to counsel for the Underwriters, and the Company shall have furnished to such
counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Delivery of Agreements.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.1
<U>Deliveries on the Date of this Agreement</U>. On or before the date of this Agreement, the Company shall have delivered to
the Representative executed copies of the Lock-Up Agreements from each of the persons listed in <U>Schedule 3</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.2
<U>Closing Date Deliveries</U>. On the Closing Date, the Company shall have delivered to the Representative an executed copy of
the Representative&rsquo;s Warrant Agreements in the names as the Representative shall request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Additional Documents</U>. At the Closing Date and at each Option Closing Date (if any), Representative&rsquo;s Counsel shall
have been furnished with such documents and opinions as they may require for the purpose of enabling Representative&rsquo;s Counsel
to deliver an opinion to the Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or
the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance
and sale of the Public Securities and the Representative&rsquo;s Securities as herein contemplated shall be satisfactory in form
and substance to the Representative and Representative&rsquo;s Counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Indemnification of the Underwriters.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
<U>General</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter,
its affiliates and each of its and their respective directors, officers, members, employees, representatives, partners, shareholders,
affiliates, counsel and agents and each person, if any, who controls any such Underwriter within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;<B>Underwriter Indemnified Parties</B>,&rdquo; and
each an &ldquo;<B>Underwriter Indemnified Party</B>&rdquo;), against any and all loss, liability, claim, damage and expense whatsoever
(including but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing or defending
against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action between any of the
Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any third party, or
otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute or
at common law or otherwise or under the laws of foreign countries (a &ldquo;<B>Claim</B>&rdquo;), arising out of or based upon
any untrue statement or alleged untrue statement of a material fact contained in (i) the Registration Statement, the Pricing Disclosure
Package, the Preliminary Prospectus, the Prospectus, or any Issuer Free Writing Prospectus (as from time to time each may be amended
and supplemented) or this Agreement; (ii) any materials or information provided to investors by, or with the approval of, the
Company in connection with the marketing of the Offering, including any &ldquo;road show&rdquo; or investor presentations made
to investors by the Company (whether in person or electronically); (iii) any application or other document or written communication
(in this <U>Section 5</U>, collectively called &ldquo;<B>application</B>&rdquo;) executed by the Company or based upon written
information furnished by the Company in any jurisdiction in order to qualify the Public Securities under the securities laws thereof
or filed with the Commission, any state securities commission or agency, the Exchange or any other national securities exchange;
or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading, unless such statement or omission was made
in reliance upon, and in conformity with, the Underwriters&rsquo; Information, or (iv) otherwise arising in connection with or
allegedly in connection with the Offering. With respect to any untrue statement or omission or alleged untrue statement or omission
made in the Registration Statement, Pricing Disclosure Package or Prospectus, the indemnity agreement contained in this Section
5.1.1 shall not inure to the benefit of any Underwriter Indemnified Party to the extent that any loss, liability, claim, damage
or expense of such Underwriter Indemnified Party results from the fact that a copy of the Prospectus was not given or sent to
the person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale of the Public Securities
to such person as required by the Securities Act and the Securities Act Regulations, and if the untrue statement or omission has
been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the Company
with its obligations under <U>Section 3.3</U> hereof. The Company also agrees that it will reimburse each Underwriter Indemnified
Party for all fees and expenses (including but not limited to any and all legal or other expenses reasonably incurred in investigating,
preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action
between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any
third party, or otherwise) (collectively, the &ldquo;<B>Expenses</B>&rdquo;), and further agrees wherever and whenever possible
to advance payment of Expenses as they are incurred by an Underwriter Indemnified Party in investigating, preparing, pursuing
or defending any Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
<U>Procedure</U>. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought
against the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing
of the institution of such action and the Company shall assume the defense of such action, including the employment and fees of
counsel (subject to the approval of such Underwriter Indemnified Party) and payment of actual expenses if an Underwriter Indemnified
Party requests that the Company do so. Such Underwriter Indemnified Party shall have the right to employ its or their own counsel
in any such case, but the fees and expenses of such counsel shall be at the expense of the Company, and shall be advanced by the
Company, provided however, that the Company shall not be obligated to bear the reasonable fees and expenses of more than one firm
of attorneys selected by the Underwriter Indemnified Party (in addition to local counsel). The Company shall not be liable for
any settlement of any action effected without its consent (which shall not be unreasonably withheld). In addition, the Company
shall not, without the prior written consent of the Underwriters, settle, compromise or consent to the entry of any judgment in
or otherwise seek to terminate any pending or threatened action in respect of which advancement, reimbursement, indemnification
or contribution may be sought hereunder (whether or not such Underwriter Indemnified Party is a party thereto) unless such settlement,
compromise, consent or termination (i) includes an unconditional release of each Underwriter Indemnified Party, acceptable to
such Underwriter Indemnified Party, from all liabilities, expenses and claims arising out of such action for which indemnification
or contribution may be sought and (ii) does not include a statement as to or an admission of fault, culpability or a failure to
act, by or on behalf of any Underwriter Indemnified Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Indemnification of the Company</U>. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the
Company, its directors, its officers who signed the Registration Statement and persons who control the Company within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense
described in the foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue
statements or omissions, or alleged untrue statements or omissions made in the Registration Statement, any Preliminary Prospectus,
the Pricing Disclosure Package or Prospectus or any amendment or supplement thereto or in any application, in reliance upon, and
in strict conformity with, the Underwriters&rsquo; Information. In case any action shall be brought against the Company or any
other person so indemnified based on any Preliminary Prospectus, the Registration Statement, the Pricing Disclosure Package or
Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity may be sought against
any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each other person
so indemnified shall have the rights and duties given to the several Underwriters by the provisions of <U>Section 5.1.2</U>. The
Company agrees promptly to notify the Representative of the commencement of any litigation or proceedings against the Company
or any of its officers, directors or any person, if any, who controls the Company within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act, in connection with the issuance and sale of the Public Securities or in connection with
the Registration Statement, the Pricing Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
<U>Contribution Rights</U>. If the indemnification provided for in this <U>Section 5</U> shall for any reason be unavailable to
or insufficient to hold harmless an indemnified party under <U>Section 5.1 or 5.2</U> in respect of any loss, claim, damage or
liability, or any action in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying
such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage
or liability, or action in respect thereof, (i) in such proportion as shall be appropriate to reflect the relative benefits received
by the Company, on the one hand, and the Underwriters, on the other, from the Offering of the Public Securities, or (ii) if the
allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not
only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the
Underwriters, on the other, with respect to the statements or omissions that resulted in such loss, claim, damage or liability,
or action in respect thereof, as well as any other relevant equitable considerations. The relative benefits received by the Company,
on the one hand, and the Underwriters, on the other, with respect to such Offering shall be deemed to be in the same proportion
as the total net proceeds from the Offering of the Public Securities purchased under this Agreement (before deducting expenses)
received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand, and the total underwriting
discounts and commissions received by the Underwriters with respect to the securities purchased under this Agreement, as set forth
in the table on the cover page of the Prospectus, on the other hand. The relative fault shall be determined by reference to whether
the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to
information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access to information
and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be
just and equitable if contributions pursuant to this <U>Section 5.3.1</U> were to be determined by pro rata allocation (even if
the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take into account
the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim,
damage or liability, or action in respect thereof, referred to above in this <U>Section 5.3.1</U> shall be deemed to include,
for purposes of this <U>Section 5.3.1</U>, any legal or other expenses reasonably incurred by such indemnified party in connection
with investigating or defending any such action or claim. Notwithstanding the provisions of this <U>Section 5.3.1</U> in no event
shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and
commissions received by such Underwriter with respect to the Offering of the Public Securities exceeds the amount of any damages
that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of
notice of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof
is to be made against another party (&ldquo;contributing party&rdquo;), notify the contributing party of the commencement thereof,
but the failure to so notify the contributing party will not relieve it from any liability which it may have to any other party
other than for contribution hereunder. In case any such action, suit or proceeding is brought against any party, and such party
notifies a contributing party or its representative of the commencement thereof within the aforesaid 15 days, the contributing
party will be entitled to participate therein with the notifying party and any other contributing party similarly notified. Any
such contributing party shall not be liable to any party seeking contribution on account of any settlement of any claim, action
or proceeding affected by such party seeking contribution on account of any settlement of any claim, action or proceeding affected
by such party seeking contribution without the written consent of such contributing party. The contribution provisions contained
in this <U>Section 5.3.2</U> are intended to supersede, to the extent permitted by law, any right to contribution under the Securities
Act, the Exchange Act or otherwise available. Each Underwriter&rsquo;s obligations to contribute pursuant to this <U>Section 5.3
</U>are several and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Default by an Underwriter.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Default Not Exceeding 10% of Firm Shares or Option Shares</U>. If any Underwriter or Underwriters shall default in its or their
obligations to purchase the Firm Shares or the Option Shares, if the Over-allotment Option is exercised hereunder, and if the
number of the Firm Shares or Option Shares with respect to which such default relates does not exceed in the aggregate 10% of
the number of Firm Shares or Option Shares that all Underwriters have agreed to purchase hereunder, then such Firm Shares or Option
Shares to which the default relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Default Exceeding 10% of Firm Shares or Option Shares</U>. In the event that the default addressed in Section 6.1 relates to
more than 10% of the Firm Shares or Option Shares, the Representative may in its discretion arrange for it or for another party
or parties to purchase such Firm Shares or Option Shares to which such default relates on the terms contained herein. If, within
one (1) Business Day after such default relating to more than 10% of the Firm Shares or Option Shares, the Representative does
not arrange for the purchase of such Firm Shares or Option Shares, then the Company shall be entitled to a further period of one
(1) Business Day within which to procure another party or parties satisfactory to the Representative to purchase said Firm Shares
or Option Shares on such terms. In the event that neither the Representative nor the Company arrange for the purchase of the Firm
Shares or Option Shares to which a default relates as provided in this Section 6, this Agreement will automatically be terminated
by the Representative or the Company without liability on the part of the Company (except as provided in Sections 3.10 and 5 hereof)
or the several Underwriters (except as provided in Section 5 hereof); provided, however, that if such default occurs with respect
to the Option Shares, this Agreement will not terminate as to the Firm Shares; and provided, further, that nothing herein shall
relieve a defaulting Underwriter of its liability, if any, to the other Underwriters and to the Company for damages occasioned
by its default hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Postponement of Closing Date</U>. In the event that the Firm Shares or Option Shares to which the default relates are to be
purchased by the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative
or the Company shall have the right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any
event exceeding five (5) Business Days, in order to effect whatever changes may thereby be made necessary in the Registration
Statement, the Pricing Disclosure Package or the Prospectus or in any other documents and arrangements, and the Company agrees
to file promptly any amendment to the Registration Statement, the Pricing Disclosure Package or the Prospectus that in the opinion
of counsel for the Underwriter may thereby be made necessary. The term &ldquo;<B>Underwriter</B>&rdquo; as used in this Agreement
shall include any party substituted under this Section 6 with like effect as if it had originally been a party to this Agreement
with respect to such shares of Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Additional Covenants.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i) the qualifications of the persons serving
as members of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act, the Exchange
Act and the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company
seeks to have any of its securities listed on another exchange or quoted on an automated quotation system, and (ii) if applicable,
at least one member of the Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee financial expert,&rdquo;
as such term is defined under Regulation S-K and the listing rules of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Prohibition on Press Releases and Public Announcements</U>. The Company shall not issue press releases or engage in any other
publicity, without the Representative&rsquo;s prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first
(1<SUP>st</SUP>) Business Day following the fortieth (40<SUP>th</SUP>) day after the Closing Date, other than normal and customary
releases issued in the ordinary course of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Right of First Refusal</U>. Provided that the Firm Shares are sold in accordance with the terms of this Agreement, the Representative
shall have an irrevocable right of first refusal (the &ldquo;<B>Right of First Refusal</B>&rdquo;), for a period of thirty six
(36) months after the date the Offering is completed, to act as sole and exclusive investment banker, sole and exclusive book-runner,
and sole and exclusive underwriter and/or sole and exclusive placement agent, at the Representative&rsquo;s sole and exclusive
discretion, for each and every future public and private equity and debt offering, including all equity linked financings (each,
a &ldquo;<B>Subject Transaction</B>&rdquo;), during such thirty six (36) month period, of the Company, or any successor to or
subsidiary of the Company, on terms and conditions customary to the Representative for such Subject Transactions. For the avoidance
of any doubt, the Company shall not retain, engage or solicit any additional investment banker, book-runner, financial advisor,
underwriter and/or placement agent in a Subject Transaction without the express written consent of the Representative. The Representative
shall have the sole right to determine whether or not any other broker dealer shall have the right to participate in any Subject
Transaction in which it exercises its right of first refusal and the economic terms of any such participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall notify the Representative of its intention to pursue a Subject Transaction, including the material terms thereof,
by providing written notice thereof by registered mail or overnight courier service addressed to the Representative. If the Representative
fails to exercise its Right of First Refusal with respect to any Subject Transaction within ten (10) Business Days after the mailing
of such written notice, then the Representative shall have no further claim or right with respect to the Subject Transaction.
The Representative may elect, in its sole and absolute discretion, not to exercise its Right of First Refusal with respect to
any Subject Transaction; provided that any such election by the Representative shall not adversely affect the Representative&rsquo;s
Right of First Refusal with respect to any other Subject Transaction during the thirty six (36) month period agreed to above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Effectiveness of this Agreement and Termination Thereof.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Effectiveness of the Agreement</U>. This Agreement shall become effective when the Company and the Representative have executed
the same and delivered counterparts of such signatures to the other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Termination</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date,
(i) if any domestic or international event or act or occurrence has materially disrupted, or in your opinion will in the immediate
future materially disrupt, general securities markets in the United States; or (ii) if trading on the New York Stock Exchange
or the Nasdaq Stock Market LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall
have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or
any other Governmental Entity having jurisdiction; or (iii) if the United States shall have become involved in a new war or an
increase in major hostilities; or (iv) if a banking moratorium has been declared by a New York State or Federal authority; or
(v) if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities
markets; or (vi) if the Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage
or other calamity or malicious act which, whether or not such loss shall have been insured, will, in your opinion, make it inadvisable
to proceed with the delivery of the Firm Shares or Option Shares; or (vii) if the Company is in material breach of any of its
representations, warranties or covenants hereunder; or (viii) if the Representative shall have become aware after the date hereof
of a material adverse change in the conditions or prospects of the Company, or a material adverse change in general market conditions
as in the Representative&rsquo;s reasonable judgment would make it impracticable to proceed with the offering, sale and/or delivery
of the Public Securities or to enforce contracts made by the Underwriters for the sale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Expenses</U>. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters,
pursuant to Section 6.2 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the
time specified herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters
their actual and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including
the fees and disbursements of Representative Counsel) up to $100,000, inclusive of the $20,000 advance for accountable expenses
previously paid by the Company to the Representative (the &ldquo;<B>Advance</B>&rdquo;) and upon demand the Company shall pay
the full amount thereof to the Representative on behalf of the Underwriters; provided, however, that such expense cap in no way
limits or impairs the indemnification and contribution provisions of this Agreement. Notwithstanding the foregoing, any advance
received by the Representative will be reimbursed to the Company to the extent not actually incurred in compliance with FINRA
Rule 5110(g)(4)(A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Survival of Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder
or any termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5
shall remain in full force and effect and shall not be in any way affected by, such election or termination or failure to carry
out the terms of this Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Representations, Warranties, Agreements to Survive</U>. All representations, warranties and agreements contained in this Agreement
or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless
of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any
Underwriter, its officers or directors or any person controlling the Company or (ii) delivery of and payment for the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Miscellaneous.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall
be mailed (registered or certified mail, return receipt requested), personally delivered or sent by facsimile transmission or
e-mail and confirmed and shall be deemed given when so delivered, faxed or e-mailed and confirmed or if mailed, two (2) days after
such mailing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Representative:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity,
a division of Fordham Financial Management, Inc.<BR>
17 State Street, 22<SUP>nd</SUP> Floor<BR>
New York, New York 10004<BR>
Attention: Mr. Eric Lord, Head of Investment Banking<BR>
Fax No.: (212) 349-2550</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
el@think-equity.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gracin
&amp; Marlow, LLP<BR>
The Chrysler Building<BR>
405 Lexington Avenue, 26<SUP>th</SUP> Floor<BR>
New York, New York 10174<BR>
Attention: Leslie Marlow, Esq. or Patrick J. Egan, Esq.<BR>
Fax No: (212) 208-4657</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
lmarlow@gracinmarlow.com or pegan@gracinmarlow.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Habarzel
7</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
Aviv, Israel 6971011</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
David Palach, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: +97237175788</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
david@savefoods.co</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">with
a copy (which shall not constitute notice), in each case, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP<BR>
1633 Broadway<BR>
New York, New York 10019<BR>
Attention: Oded Har-Even, Esq.<BR>
Fax No.: (212) 660-3000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
ohareven@sullivanlaw.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way
limit or affect the meaning or interpretation of any of the terms or provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
Absence of Fiduciary Relationship. The Company acknowledges and agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
each Underwriter&rsquo;s responsibility to the Company is solely contractual in nature, each Underwriter has been retained solely
to act as an underwriter in connection with the Offering and no fiduciary, advisory or agency relationship between the Company
and the Underwriters has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether
either the Representative has advised or is advising the Company on other matters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the price of the Public Securities set forth in this Agreement was established by the Company following discussions and arm&rsquo;s-length
negotiations with the Representative, and the Company are capable of evaluating and understanding, and understands and accepts,
the terms, risks and conditions of the transactions contemplated by this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
it has been advised that the Representative and their respective affiliates are engaged in a broad range of transactions which
may involve interests that differ from those of the Company and that the Underwriters have no obligation to disclose such interests
and transactions to the Company by virtue of any fiduciary, advisory or agency relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
<U>Research Analyst Independence</U>. The Company acknowledges that each Underwriter&rsquo;s research analysts and research departments
are required to be independent from its investment banking division and are subject to certain regulations and internal policies,
and that such Underwriter&rsquo;s research analysts may hold views and make statements or investment recommendations and/or publish
research reports with respect to the Company and/or the Offering that differ from the views of their investment banking division.
The Company acknowledges that each Underwriter is a full service securities firm and as such from time to time, subject to applicable
securities laws, rules and regulations, may effect transactions for its own account or the account of its customers and hold long
or short positions in debt or equity securities of the Company; provided, however, that nothing in this Section 9.4 shall relieve
the Underwriter of any responsibility or liability it may otherwise bear in connection with activities in violation of applicable
securities laws, rules or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
<U>Amendment</U>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6
<U>Entire Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof,
and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7
<U>Binding Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters,
the Company, and the controlling persons, directors and officers referred to in Section 5.2 hereof, and their respective successors,
legal representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right,
remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &ldquo;successors
and assigns&rdquo; shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8
<U>Governing Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in
accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby
agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought
and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District
of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to
be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested,
postage prepaid, addressed to it at the address set forth in Section 9.1 hereof. Such mailing shall be deemed personal service
and shall be legal and binding upon the Company in any action, proceeding or claim. The Company agrees that the prevailing party(ies)
in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses
relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on its own behalf
and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each of the Underwriters hereby
irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.9
<U>Execution in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto
in separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one
and the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto
and delivered to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf
transmission shall constitute valid and sufficient delivery thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.10
<U>Waiver, etc</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall
not be deemed or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any
provision hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No
waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set
forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and
no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent
breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[<I>Signature
Page Follows</I>]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space
provided below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SAVE
    FOODS, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed
as of the date first written above<BR>
mentioned, on behalf of itself and as<BR>
Representative of the several Underwriters<BR>
named on <U>Schedule 1</U> hereto:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ThinkEquity,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
Division of Fordham Financial Management, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Eric Lord</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Head of Investment
    Banking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc. &ndash; Underwriting Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>SCHEDULE
1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Number of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Firm Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchased</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be Purchased if</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>the Over-</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Allotment Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>is Fully Exercised</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">ThinkEquity, a division of Fordham Financial Management, Inc.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">TOTAL</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Firm Shares: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Option Shares: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Firm Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Non-accountable expense allowance per Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Share (before expenses): $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->A</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer
General Use Free Writing Prospectuses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free
writing prospectus filed with the SEC on [_____], 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->B</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Written
Testing-the-Waters Communications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->C</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
3</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>List
of Lock-Up Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors
and Officers of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prof.
    Benad Goldwasser, Chairman of the Board of Directors</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach, Chief Executive Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shlomo
    Zakai, Chief Financial Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nimrod
    Ben Yehuda, Chief Technology Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronen
    Rosenblum, Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    Berenshtein, Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vered
    Raz-Avayo, Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitay
    Weiss, Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliahou
    Arbiv, Director</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Greater
Than 5% Stockholders of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nir
    Ecology Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amir
    Uziel / Amir Uziel Economic Consultant Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.I.A
    Pure Capital Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buffalo
    Investment Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YAAD
    Consulting &amp; Management Services (1995) Ltd.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&rsquo;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Options: NewSection; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Division of Fordham Financial Management, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 22<SUP>nd</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on <U>Schedule 1</U> to the Underwriting Agreement referenced below</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that ThinkEquity, a Division of Fordham Financial Management, Inc. (the &ldquo;<B>Representative</B>&rdquo;),
proposes to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting Agreement</B>&rdquo;) with Save Foods, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), providing for the public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of
shares of common stock, par value $0.0001 per share, of the Company (the &ldquo;<B>Common Shares</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
induce the Representative to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that,
without the prior written consent of the Representative, the undersigned will not, during the period commencing on the date hereof
and ending [90/180]<SUP>1</SUP> days after the date of the Underwriting Agreement relating to the Public Offering (the &ldquo;<B>Lock-Up
Period</B>&rdquo;), (1) offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly,
any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares, whether now owned or hereafter
acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively,
the &ldquo;<B>Lock-Up Securities</B>&rdquo;); (2) enter into any swap or other arrangement that transfers to another, in whole
or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in
clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise; (3) make any demand for or exercise
any right with respect to the registration of any Lock-Up Securities; or (4) publicly disclose the intention to make any offer,
sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities.
Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Securities without the
prior written consent of the Representative in connection with (a) transactions relating to Lock-Up Securities acquired in open
market transactions after the completion of the Public Offering; <U>provided</U> that no filing under Section 13 or Section 16(a)
of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), or other public announcement shall
be required or shall be voluntarily made in connection with subsequent sales of Lock-Up Securities acquired in such open market
transactions; (b) transfers of Lock-Up Securities as a <I>bona fide</I> gift, by will or intestacy or to a family member or trust
for the benefit of the undersigned or a family member (for purposes of this lock-up agreement, &ldquo;family member&rdquo; means
any relationship by blood, marriage or adoption, not more remote than first cousin); (c) transfers of Lock-Up Securities to a
charity or educational institution; (d) if the undersigned is a corporation, partnership, limited liability company or other business
entity, (i) any transfers of Lock-Up Securities to another corporation, partnership or other business entity that controls, is
controlled by or is under common control with the undersigned or (ii) distributions of Lock-Up Securities to members, partners,
stockholders, subsidiaries or affiliates (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of
the undersigned; (e) if the undersigned is a trust, to a trustee or beneficiary of the trust; <U>provided</U> that in the case
of any transfer pursuant to the foregoing clauses (b), (c) (d) or (e), (i) any such transfer shall not involve a disposition for
value, (ii) each transferee shall sign and deliver to the Representative a lock-up agreement substantially in the form of this
lock-up agreement and (iii) no filing under Section 13 or Section 16(a) of the Exchange Act or other public announcement shall
be required or shall be voluntarily made; (f) the receipt by the undersigned from the Company of Common Shares upon the vesting
of restricted stock awards or stock units or upon the exercise of options to purchase the Company&rsquo;s Common Shares issued
under an equity incentive plan of the Company or an employment arrangement described in the Pricing Prospectus (as defined in
the Underwriting Agreement) (the &ldquo;<B>Plan Shares</B>&rdquo;) or the transfer of Common Shares or any securities convertible
into Common Shares to the Company upon a vesting event of the Company&rsquo;s securities or upon the exercise of options to purchase
the Company&rsquo;s securities, in each case on a &ldquo;cashless&rdquo; or &ldquo;net exercise&rdquo; basis or to cover tax obligations
of the undersigned in connection with such vesting or exercise, but only to the extent such right expires during the Lock-up Period,
<U>provided</U> that no filing under Section 13 or Section 16(a) of the Exchange Act or other public announcement shall be required
or shall be voluntarily made within 180 days after the date of the Underwriting Agreement, and after such 180<SUP>th</SUP> day,
if the undersigned is required to file a report under Section 13 or Section 16(a) of the Exchange Act reporting a reduction in
beneficial ownership of Common Shares during the Lock-Up Period, the undersigned shall include a statement in such schedule or
report to the effect that the purpose of such transfer was to cover tax withholding obligations of the undersigned in connection
with such vesting or exercise and, <U>provided further</U>, that the Plan Shares shall be subject to the terms of this lock-up
agreement; (g) the transfer of Lock-Up Securities pursuant to agreements described in the Pricing Prospectus under which the Company
has the option to repurchase such securities or a right of first refusal with respect to the transfer of such securities, <U>provided
</U>that if the undersigned is required to file a report under Section 13 or Section 16(a) of the Exchange Act reporting a reduction
in beneficial ownership of Common Shares during the Lock-Up Period, the undersigned shall include a statement in such schedule
or report describing the purpose of the transaction; (h) the establishment of a trading plan pursuant to Rule 10b5-1 under the
Exchange Act for the transfer of Lock-Up Securities, <U>provided</U> that (i) such plan does not provide for the transfer of Lock-Up
Securities during the Lock-Up Period and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is
required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan, such
public announcement or filing shall include a statement to the effect that no transfer of Lock-Up Securities may be made under
such plan during the Lock-Up Period; (i) the transfer of Lock-Up Securities that occurs by operation of law, such as pursuant
to a qualified domestic order or in connection with a divorce settlement, <U>provided</U> that the transferee agrees to sign and
deliver a lock-up agreement substantially in the form of this lock-up agreement for the balance of the Lock-Up Period, and <U>provided
further</U>, that any filing under Section 13 or Section 16(a) of the Exchange Act that is required to be made during the Lock-Up
Period as a result of such transfer shall include a statement that such transfer has occurred by operation of law; and (j) the
transfer of Lock-Up Securities pursuant to a bona fide third party tender offer, merger, consolidation or other similar transaction
made to all holders of the Common Shares involving a &ldquo;change of control&rdquo; (as defined below) of the Company after the
closing of the Public Offering and approved by the Company&rsquo;s board of directors; <U>provided</U> that in the event that
the tender offer, merger, consolidation or other such transaction is not completed, the Lock-Up Securities owned by the undersigned
shall remain subject to the restrictions contained in this lock-up agreement. For purposes of clause (j) above, &ldquo;change
of control&rdquo; shall mean the consummation of any bona fide third party tender offer, merger, amalgamation, consolidation or
other similar transaction the result of which is that any &ldquo;person&rdquo; (as defined in Section 13(d)(3) of the Exchange
Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of a majority
of total voting power of the voting stock of the Company. The undersigned also agrees and consents to the entry of stop transfer
instructions with the Company&rsquo;s transfer agent and registrar against the transfer of the undersigned&rsquo;s Lock-Up Securities
except in compliance with this lock-up agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1
</SUP>90 days for 5% holders and 180 days for officers/directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that, prior to engaging in any transaction or taking any other action that is subject to the terms of this
lock-up agreement during the period from the date hereof to and including the 34<SUP>th</SUP> day following the expiration of
the Lock-Up Period, the undersigned will give notice thereof to the Company and will not consummate any such transaction or take
any such action unless it has received written confirmation from the Company that the Lock-Up Period has expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be
equally applicable to any issuer-directed or &ldquo;friends and family&rdquo; Common Shares that the undersigned may purchase
in the Public Offering; (ii) the Representative agrees that, at least three (3) business days before the effective date of any
release or waiver of the foregoing restrictions in connection with a transfer of Lock-Up Securities, the Representative will notify
the Company of the impending release or waiver; and (iii) the Company has agreed in the Underwriting Agreement to announce the
impending release or waiver by press release through a major news service at least two (2) business days before the effective
date of the release or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall
only be effective two (2) business days after the publication date of such press release. The provisions of this paragraph will
not apply if (a) the release or waiver is effected solely to permit a transfer of Lock-Up Securities not for consideration and
(b) the transferee has agreed in writing to be bound by the same terms described in this lock-up agreement to the extent and for
the duration that such terms remain in effect at the time of such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation
of the Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon
the undersigned&rsquo;s heirs, legal representatives, successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, if the Underwriting Agreement is not executed by April 30, 2021, or if the Underwriting Agreement
(other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery
of the Common Shares to be sold thereunder, then this lock-up agreement shall be void and of no further force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will
only be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the
Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
page follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    - Please Print)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 49; Value: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Press Release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0 1in 0 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Date]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 12.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc., a company incorporated under the laws of Delaware (the &ldquo;<B>Company</B>&rdquo;), announced today that ThinkEquity,
a division of Fordham Financial Management, Inc., acting as representative for the underwriters in the Company&rsquo;s recent
public offering of the Company&rsquo;s shares of common stock and warrants, is [waiving] [releasing] a lock-up restriction with
respect to _________ the Company&rsquo;s shares of common stock held by [certain officers, directors or other security holders]
[an officer, director or security holder] of the Company. The [waiver] [release] will take effect on _________, 20___, and the
shares may be sold on or after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or
sale is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from
registration under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.1
<SEQUENCE>3
<FILENAME>ex3-1_1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 3.1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST
AMENDED AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF INCORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc., a corporation organized and existing under the laws of the State of Delaware (the &ldquo;<U>Corporation</U>&rdquo;),
hereby certifies as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The name of the Corporation is Save Foods, Inc. The date of the filing of its original Certificate of Incorporation with the Secretary
of State of the State of Delaware was April 1, 2009 (the &ldquo;<U>Original Certificate</U>&rdquo;). The name under which the
Corporation filed the Original Certificate was Pimi Agro Cleantech Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
This First Amended and Restated Certificate of Incorporation (the &ldquo;<U>Certificate</U>&rdquo;) amends, restates and integrates
the provisions of the Certificate of Incorporation (the &ldquo;<U>Amended Certificate</U>&rdquo;), and was duly adopted in accordance
with the provisions of Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware (the &ldquo;<B>DGCL</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The text of the Amended Certificate is hereby amended and restated in its entirety to provide as herein set forth in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
name of the Corporation is Save Foods, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
address of the Corporation&rsquo;s registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street,
Wilmington, Country of New Castle, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CAPITAL
STOCK</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of shares of capital stock which the Corporation shall have authority to issue is five hundred million (500,000,000),
of which (i) four hundred and ninety five million (495,000,000) shares shall be a class designated as common stock, par value
$0.0001 per share (the &ldquo;Common Stock&rdquo;), and (ii) five million (5,000,000) shares shall be a class designated as undesignated
preferred stock, par value $.0001 per share (the &ldquo;<U>Undesignated Preferred Stock</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in any certificate of designations of any series of Undesignated Preferred Stock, the number of authorized
shares of the class of Common Stock or Undesignated Preferred Stock may from time to time be increased or decreased (but not below
the number of shares of such class outstanding) by the affirmative vote of the holders of a majority in voting power of the outstanding
shares of capital stock of the Corporation irrespective of the provisions of Section 242(b)(2) of the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
powers, preferences and rights of, and the qualifications, limitations and restrictions upon, each class or series of stock shall
be determined in accordance with, or as set forth below in this Article IV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>COMMON STOCK</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to all the rights, powers and preferences of the Undesignated Preferred Stock and except as provided by law or in this Certificate
(or in any certificate of designations of any series of Undesignated Preferred Stock):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the holders of the Common Stock shall have the exclusive right to vote for the election of directors of the Corporation (the &ldquo;<U>Directors</U>&rdquo;)
and on all other matters requiring stockholder action, each outstanding share entitling the holder thereof to one vote on each
matter properly submitted to the stockholders of the Corporation for their vote; <U>provided</U>, <U>however</U>, that, except
as otherwise required by law, holders of Common Stock, as such, shall not be entitled to vote on any amendment to this Certificate
(or on any amendment to a certificate of designations of any series of Undesignated Preferred Stock) that alters or changes the
powers, preferences, rights or other terms of one or more outstanding series of Undesignated Preferred Stock if the holders of
such affected series of Undesignated Preferred Stock are entitled to vote, either separately or together with the holders of one
or more other such series, on such amendment pursuant to this Certificate (or pursuant to a certificate of designations of any
series of Undesignated Preferred Stock) or pursuant to the DGCL;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
dividends may be declared and paid or set apart for payment upon the Common Stock out of any assets or funds of the Corporation
legally available for the payment of dividends, but only when and as declared by the Corporation&rsquo;s board of directors (&ldquo;<U>Board
of Directors</U>&rdquo;) or any authorized committee thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
upon the voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the net assets of the Corporation
shall be distributed pro rata to the holders of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>UNDESIGNATED PREFERRED STOCK</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors or any authorized committee thereof is expressly authorized, to the fullest extent permitted by law, to provide
by resolution or resolutions for, out of the unissued shares of Undesignated Preferred Stock, the issuance of the shares of Undesignated
Preferred Stock in one or more series of such stock, and by filing a certificate of designations pursuant to applicable law of
the State of Delaware, to establish or change from time to time the number of shares of each such series, and to fix the designations,
powers, including voting powers, full or limited, or no voting powers, preferences and the relative, participating, optional or
other special rights of the shares of each series and any qualifications, limitations and restrictions thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STOCKHOLDER
ACTION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Action without Meeting</U>. Any action required or permitted to be taken at any annual or special meeting of stockholders may
be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action
to be so taken, shall be signed by the holders of outstanding stock having a majority of the number of votes that would be necessary
to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be
delivered to the Corporation by delivery to its registered office in the State of Delaware, its principal place of business or
an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded.
Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall, to the extent
required by applicable law, be given to those stockholders who have not consented in writing, and who, if the action had been
taken at a meeting, would have been entitled to notice of the meeting if the record date for notice of such meeting had been the
date that written consents signed by a sufficient number of holders to take the action were delivered to the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Special Meetings</U>. Except as otherwise required by statute and subject to the rights, if any, of the holders of any series
of Undesignated Preferred Stock, special meetings of the stockholders of the Corporation may be called only by the Board of Directors
acting pursuant to a resolution approved by the affirmative vote of a majority of the Directors then in office, and special meetings
of stockholders may not be called by any other person or persons. Only those matters set forth in the notice of the special meeting
may be considered or acted upon at a special meeting of stockholders of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>General</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors
except as otherwise provided herein or required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Election of Directors</U>. Election of Directors need not be by written ballot unless the By-laws of the Corporation (the &ldquo;<U>By-laws</U>&rdquo;)
shall so provide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Number of Directors; Term of Office</U>. The number of Directors of the Corporation shall be fixed solely and exclusively by
resolution duly adopted from time to time by the Board of Directors. At each annual meeting of stockholders, Directors elected
to succeed those Directors whose terms expire shall be elected for a term of office to expire at the succeeding annual meeting
of stockholders after their election. Notwithstanding the foregoing, the Directors elected shall hold office until their successors
are duly elected and qualified or until their earlier resignation, death or removal. The directors need not be stockholders of
the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, whenever, pursuant to the provisions of Article IV of this Certificate, the holders of any one or more series of
Undesignated Preferred Stock shall have the right, voting separately as a series or together with holders of other such series,
to elect Directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies and other
features of such directorships shall be governed by the terms of this Certificate and any certificate of designations applicable
to such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Vacancies</U>. Subject to the rights, if any, of the holders of any series of Undesignated Preferred Stock to elect Directors
and to fill vacancies in the Board of Directors relating thereto, any and all vacancies in the Board of Directors, however occurring,
including, without limitation, by reason of an increase in the size of the Board of Directors, or the death, resignation, disqualification
or removal of a Director, shall be filled solely and exclusively by the affirmative vote of a majority of the remaining Directors
then in office, even if less than a quorum of the Board of Directors, and not by the stockholders. Any Director appointed in accordance
with the preceding sentence shall hold office until the succeeding annual general meeting of the stockholders of the Corporation
and until such Director&rsquo;s successor shall have been duly elected and qualified or until his or her earlier resignation,
death or removal. In the event of a vacancy in the Board of Directors, the remaining Directors, except as otherwise provided by
law, shall exercise the powers of the full Board of Directors until the vacancy is filled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Removal</U>. Subject to the rights, if any, of any series of Undesignated Preferred Stock to elect Directors and to remove
any Director whom the holders of any such series have the right to elect, any Director (including persons elected by Directors
to fill vacancies in the Board of Directors) may be removed from office with or without cause and only by the affirmative vote
of the holders of the majority of the outstanding shares of capital stock then entitled to vote at an election of Directors. At
least forty-five (45) days prior to any annual or special meeting of stockholders at which it is proposed that any Director be
removed from office, written notice of such proposed removal and the alleged grounds thereof shall be sent to the Director whose
removal will be considered at the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>LIMITATION
OF LIABILITY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach
of fiduciary duty as a Director, except for liability (a) for any breach of the Director&rsquo;s duty of loyalty to the Corporation
or its stockholders, (b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation
of law, (c) under Section 174 of the DGCL or (d) for any transaction from which the Director derived an improper personal benefit.
If the DGCL is amended after the effective date of this Certificate to authorize corporate action further eliminating or limiting
the personal liability of Directors, then the liability of a Director of the Corporation shall be eliminated or limited to the
fullest extent permitted by the DGCL, as so amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
amendment, repeal or modification of this Article VII by either of (i) the stockholders of the Corporation or (ii) an amendment
to the DGCL, shall not adversely affect any right or protection existing at the time of such amendment, repeal or modification
with respect to any acts or omissions occurring before such amendment, repeal or modification of a person serving as a Director
at the time of such amendment, repeal or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AMENDMENT
OF BY-LAWS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Amendment by Directors</U>. Except as otherwise provided by law, the By-laws of the Corporation may be amended or repealed
by the Board of Directors by the affirmative vote of a majority of the Directors then in office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Amendment by Stockholders</U>. The By-laws of the Corporation may be amended or repealed at any annual meeting of stockholders,
or special meeting of stockholders called for such purpose, by the affirmative vote of at least 75% of the outstanding shares
of capital stock entitled to vote on such amendment or repeal, voting together as a single class; <U>provided</U>, <U>however</U>,
that if the Board of Directors recommends that stockholders approve such amendment or repeal at such meeting of stockholders,
such amendment or repeal shall only require the affirmative vote of the majority of the outstanding shares of capital stock entitled
to vote on such amendment or repeal, voting together as a single class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AMENDMENT
OF CERTIFICATE OF INCORPORATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation reserves the right to amend or repeal this Certificate in the manner now or hereafter prescribed by statute and this
Certificate, and all rights conferred upon stockholders herein are granted subject to this reservation. Whenever any vote of the
holders of capital stock of the Corporation is required to amend or repeal any provision of this Certificate, and in addition
to any other vote of holders of capital stock that is required by this Certificate or by law, such amendment or repeal shall require
the affirmative vote of the majority of the outstanding shares of capital stock entitled to vote on such amendment or repeal,
and the affirmative vote of the majority of the outstanding shares of each class entitled to vote thereon as a class, at a duly
constituted meeting of stockholders called expressly for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed by:</FONT></TD>
    <TD STYLE="width: 45%; font: 11pt Calibri, Helvetica, Sans-Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><I>/s/
    Benad Goldwasser</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser, Chairman of the Board</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.2
<SEQUENCE>4
<FILENAME>ex3-1_2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex3-12_001.jpg" ALT="" STYLE="height: 916; width: 670"></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex3-12_002.jpg" ALT="" STYLE="height: 915; width: 670">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.3
<SEQUENCE>5
<FILENAME>ex3-1_3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.1.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex3-11_001.jpg" ALT="" STYLE="height: 969; width: 670">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex3-11_002.jpg" ALT="" STYLE="height: 867; width: 670">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex3-11_003.jpg" ALT="" STYLE="height: 867; width: 670">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.4
<SEQUENCE>6
<FILENAME>ex3-1_4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1.4</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex3-14_001.jpg" ALT="" STYLE="height: 948px; width: 670px"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B><IMG SRC="ex3-14_002.jpg" ALT="" STYLE="height: 948px; width: 670px">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>7
<FILENAME>ex3-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit
3.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>BY-LAWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SAVE FOODS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(the &ldquo;<U>Corporation</U>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ARTICLE I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Stockholders</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>Annual Meeting</U>.
The annual meeting of stockholders (any such meeting being referred to in these By-laws as an &ldquo;<U>Annual Meeting</U>&rdquo;)
shall be held at the hour, date and place within or without the United States which is fixed by the Corporation&rsquo;s board of
directors (&ldquo;<U>Board of Directors</U>&rdquo;), which time, date and place may subsequently be changed at any time by vote
of the Board of Directors. If no Annual Meeting has been held for a period of thirteen (13) months after the Corporation&rsquo;s
last Annual Meeting, a special meeting in lieu thereof may be held, and such special meeting shall have, for the purposes of these
By-laws or otherwise, all the force and effect of an Annual Meeting. Any and all references hereafter in these By-laws to an Annual
Meeting or Annual Meetings also shall be deemed to refer to any special meeting(s) in lieu thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 2. <U>Notice of
Stockholder Business and Nominations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) <U>Annual Meetings
of Stockholders</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(1) Nominations of persons
for election to the Board of Directors of the Corporation and the proposal of other business to be considered by the stockholders
may be brought before an Annual Meeting (i) by or at the direction of the Board of Directors or (ii) by any stockholder of the
Corporation who was a stockholder of record at the time of giving of notice provided for in this By-law, who is entitled to vote
at the meeting, who is present (in person or by proxy) at the meeting and who complies with the notice procedures set forth in
this By-law as to such nomination or business. For the avoidance of doubt, the foregoing clause (ii) shall be the exclusive means
for a stockholder to bring nominations or business properly before an Annual Meeting (other than matters properly brought under
Rule 14a-8 (or any successor rule) under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;)),
and such stockholder must comply with the notice and other procedures set forth in Article I, Section 2(a)(2) and (3) of this By-law
to bring such nominations or business properly before an Annual Meeting. In addition to the other requirements set forth in this
By-law, for any proposal of business to be considered at an Annual Meeting, it must be a proper subject for action by stockholders
of the Corporation under Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(2) For nominations or
other business to be properly brought before an Annual Meeting by a stockholder pursuant to clause (ii) of Article I, Section 2(a)(1)
of this By-law, the stockholder must (i) have given Timely Notice (as defined below) thereof in writing to the Secretary of the
Corporation, (ii) have provided any updates or supplements to such notice at the times and in the forms required by this By-law
and (iii) together with the beneficial owner(s), if any, on whose behalf the nomination or business proposal is made, have acted
in accordance with the representations set forth in the Solicitation Statement (as defined below) required by this By-law. To be
timely, a stockholder&rsquo;s written notice shall be received by the Secretary at the principal executive offices of the Corporation
not later than the close of business on the ninetieth (90th) day nor earlier than the close of business on the one hundred twentieth
(120th) day prior to the one-year anniversary of the preceding year&rsquo;s Annual Meeting; provided, however, that in the event
the Annual Meeting is first convened more than thirty (30) days before or more than sixty (60) days after such anniversary date,
or if no Annual Meeting were held in the preceding year, notice by the stockholder to be timely must be received by the Secretary
of the Corporation not later than the close of business on the later of the ninetieth (90th) day prior to the scheduled date of
such Annual Meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first
made (such notice within such time periods shall be referred to as &ldquo;<U>Timely Notice</U>&rdquo;). Such stockholder&rsquo;s
Timely Notice shall set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(A) as to each
person whom the stockholder proposes to nominate for election or reelection as a director, all information relating to such person
that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise
required, in each case pursuant to Regulation 14A under the Exchange Act (including such person&rsquo;s written consent to being
named in the proxy statement as a nominee and to serving as a director if elected);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(B) as to any other
business that the stockholder proposes to bring before the meeting, a brief description of the business desired to be brought before
the meeting, the reasons for conducting such business at the meeting, and any material interest in such business of each Proposing
Person (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(C) (i) the name
and address of the stockholder giving the notice, as they appear on the Corporation&rsquo;s books, and the names and addresses
of the other Proposing Persons (if any) and (ii) as to each Proposing Person, the following information: (a) the class or series
and number of all shares of capital stock of the Corporation which are, directly or indirectly, owned beneficially or of record
by such Proposing Person or any of its affiliates or associates (as such terms are defined in Rule 12b-2 promulgated under the
Exchange Act), including any shares of any class or series of capital stock of the Corporation as to which such Proposing Person
or any of its affiliates or associates has a right to acquire beneficial ownership at any time in the future, (b) all Synthetic
Equity Interests (as defined below) in which such Proposing Person or any of its affiliates or associates, directly or indirectly,
holds an interest including a description of the material terms of each such Synthetic Equity Interest, including without limitation,
identification of the counterparty to each such Synthetic Equity Interest and disclosure, for each such Synthetic Equity Interest,
as to (x) whether or not such Synthetic Equity Interest conveys any voting rights, directly or indirectly, in such shares to such
Proposing Person, (y) whether or not such Synthetic Equity Interest is required to be, or is capable of being, settled through
delivery of such shares and (z) whether or not such Proposing Person and/or, to the extent known, the counterparty to such Synthetic
Equity Interest has entered into other transactions that hedge or mitigate the economic effect of such Synthetic Equity Interest,
(c) any proxy (other than a revocable proxy given in response to a public proxy solicitation made pursuant to, and in accordance
with, the Exchange Act), agreement, arrangement, understanding or relationship pursuant to which such Proposing Person has or shares
a right to, directly or indirectly, vote any shares of any class or series of capital stock of the Corporation, (d) any rights
to dividends or other distributions on the shares of any class or series of capital stock of the Corporation, directly or indirectly,
owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation, and
(e) any performance-related fees (other than an asset based fee) that such Proposing Person, directly or indirectly, is entitled
to based on any increase or decrease in the value of shares of any class or series of capital stock of the Corporation or any Synthetic
Equity Interests (the disclosures to be made pursuant to the foregoing clauses (a) through (e) are referred to, collectively, as
&ldquo;<U>Material Ownership Interests</U>&rdquo;) and (iii) a description of the material terms of all agreements, arrangements
or understandings (whether or not in writing) entered into by any Proposing Person or any of its affiliates or associates with
any other person for the purpose of acquiring, holding, disposing or voting of any shares of any class or series of capital stock
of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(D) (i) a description
of all agreements, arrangements or understandings by and among any of the Proposing Persons, or by and among any Proposing Persons
and any other person (including with any proposed nominee(s)), pertaining to the nomination(s) or other business proposed to be
brought before the meeting of stockholders (which description shall identify the name of each other person who is party to such
an agreement, arrangement or understanding), and (ii) identification of the names and addresses of other stockholders (including
beneficial owners) known by any of the Proposing Persons to support such nominations or other business proposal(s), and to the
extent known the class and number of all shares of the Corporation&rsquo;s capital stock owned beneficially or of record by such
other stockholder(s) or other beneficial owner(s); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(E) a statement
whether or not the stockholder giving the notice and/or the other Proposing Person(s), if any, will deliver a proxy statement and
form of proxy to holders of, in the case of a business proposal, at least the percentage of voting power of all of the shares of
capital stock of the Corporation required under applicable law to approve the proposal or, in the case of a nomination or nominations,
at least the percentage of voting power of all of the shares of capital stock of the Corporation reasonably believed by such Proposing
Person to be sufficient to elect the nominee or nominees proposed to be nominated by such stockholder (such statement, the &ldquo;<U>Solicitation
Statement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">For purposes
of this Article I of these By-laws, the term &ldquo;<U>Proposing Person</U>&rdquo; shall mean the following persons: (i) the stockholder
of record providing the notice of nominations or business proposed to be brought before a stockholders&rsquo; meeting, and (ii)
the beneficial owner(s), if different, on whose behalf the nominations or business proposed to be brought before a stockholders&rsquo;
meeting is made. For purposes of this Section 2 of Article I of these By-laws, the term &ldquo;<U>Synthetic Equity Interest</U>&rdquo;
shall mean any transaction, agreement or arrangement (or series of transactions, agreements or arrangements), including, without
limitation, any derivative, swap, hedge, repurchase or so-called &ldquo;stock borrowing&rdquo; agreement or arrangement, the purpose
or effect of which is to, directly or indirectly: (a) give a person or entity economic benefit and/or risk similar to ownership
of shares of any class or series of capital stock of the Corporation, in whole or in part, including due to the fact that such
transaction, agreement or arrangement provides, directly or indirectly, the opportunity to profit or avoid a loss from any increase
or decrease in the value of any shares of any class or series of capital stock of the Corporation, (b) mitigate loss to, reduce
the economic risk of or manage the risk of share price changes for, any person or entity with respect to any shares of any class
or series of capital stock of the Corporation, (c) otherwise provide in any manner the opportunity to profit or avoid a loss from
any decrease in the value of any shares of any class or series of capital stock of the Corporation, or (d) increase or decrease
the voting power of any person or entity with respect to any shares of any class or series of capital stock of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(3) A stockholder providing
Timely Notice of nominations or business proposed to be brought before an Annual Meeting shall further update and supplement such
notice, if necessary, so that the information (including, without limitation, the Material Ownership Interests information) provided
or required to be provided in such notice pursuant to this By-law shall be true and correct as of the record date for the meeting
and as of the date that is ten (10) business days prior to such Annual Meeting, and such update and supplement shall be received
by the Secretary at the principal executive offices of the Corporation not later than the close of business on the fifth (5th)
business day after the record date for the Annual Meeting (in the case of the update and supplement required to be made as of the
record date), and not later than the close of business on the eighth (8th) business day prior to the date of the Annual Meeting
(in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(4) Notwithstanding anything
in the second sentence of Article I, Section 2(a)(2) of this By-law to the contrary, in the event that the number of directors
to be elected to the Board of Directors of the Corporation is increased and there is no public announcement naming all of the nominees
for director or specifying the size of the increased Board of Directors made by the Corporation at least ten (10) days before the
last day a stockholder may deliver a notice of nomination in accordance with the second sentence of Article I, Section 2(a)(2),
a stockholder&rsquo;s notice required by this By-law shall also be considered timely, but only with respect to nominees for any
new positions created by such increase, if it shall be received by the Secretary of the Corporation not later than the close of
business on the tenth (10th) day following the day on which such public announcement is first made by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) <U>General</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(1) Only such persons
who are nominated in accordance with the provisions of this By-law shall be eligible for election and to serve as directors and
only such business shall be conducted at an Annual Meeting as shall have been brought before the meeting in accordance with the
provisions of this By-law or in accordance with Rule 14a-8 under the Exchange Act. The Board of Directors or a designated committee
thereof shall have the power to determine whether a nomination or any business proposed to be brought before the meeting was made
in accordance with the provisions of this By-law. If neither the Board of Directors nor such designated committee makes a determination
as to whether any stockholder proposal or nomination was made in accordance with the provisions of this By-law, the presiding officer
of the Annual Meeting shall have the power and duty to determine whether the stockholder proposal or nomination was made in accordance
with the provisions of this By-law. If the Board of Directors or a designated committee thereof or the presiding officer, as applicable,
determines that any stockholder proposal or nomination was not made in accordance with the provisions of this By-law, such proposal
or nomination shall be disregarded and shall not be presented for action at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(2) Except as otherwise
required by law, nothing in this Article I, Section 2 shall obligate the Corporation or the Board of Directors to include in any
proxy statement or other stockholder communication distributed on behalf of the Corporation or the Board of Directors information
with respect to any nominee for director or any other matter of business submitted by a stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(3) Notwithstanding the
foregoing provisions of this Article I, Section 2, if the nominating or proposing stockholder (or a qualified representative of
the stockholder) does not appear at the Annual Meeting to present a nomination or any business, such nomination or business shall
be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of
this Article I, Section 2, to be considered a qualified representative of the proposing stockholder, a person must be authorized
by a written instrument executed by such stockholder or an electronic transmission delivered by such stockholder to act for such
stockholder as proxy at the meeting of stockholders and such person must produce such written instrument or electronic transmission,
or a reliable reproduction of the written instrument or electronic transmission, to the presiding officer at the meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(4) For purposes of this
By-law, &ldquo;<U>public announcement</U>&rdquo; shall mean disclosure in a press release reported by the Dow Jones News Service,
Associated Press or comparable national news service or in a document publicly filed by the Corporation with the Securities and
Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 70.9pt">(5) Notwithstanding the
foregoing provisions of this By-law, a stockholder shall also comply with all applicable requirements of the Exchange Act and the
rules and regulations thereunder with respect to the matters set forth in this By-law. Nothing in this By-law shall be deemed to
affect any rights of (i) stockholders to have proposals included in the Corporation&rsquo;s proxy statement pursuant to Rule 14a-8
(or any successor rule), as applicable, under the Exchange Act and, to the extent required by such rule, have such proposals considered
and voted on at an Annual Meeting or (ii) the holders of any series of Undesignated Preferred Stock to elect directors under specified
circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 3. <U>Special Meetings</U>.
Except as otherwise required by statute and subject to the rights, if any, of the holders of any series of Undesignated Preferred
Stock, special meetings of the stockholders of the Corporation may be called only by the Board of Directors acting pursuant to
a resolution approved by the affirmative vote of a majority of the directors then in office. The Board of Directors may postpone
or reschedule any previously scheduled special meeting of stockholders. Only those matters set forth in the notice of the special
meeting may be considered or acted upon at a special meeting of stockholders of the Corporation. Nominations of persons for election
to the Board of Directors of the Corporation and stockholder proposals of other business shall not be brought before a special
meeting of stockholders to be considered by the stockholders unless such special meeting is held in lieu of an annual meeting of
stockholders in accordance with Article I, Section 1 of these By-laws, in which case such special meeting in lieu thereof shall
be deemed an Annual Meeting for purposes of these By-laws and the provisions of Article I, Section 2 of these By-laws shall govern
such special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 4. <U>Notice of
Meetings; Adjournments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) A notice of each Annual
Meeting stating the hour, date and place, if any, of such Annual Meeting and the means of remote communication, if any, by which
stockholders and proxyholders may be deemed to be present in person and vote at such meeting, shall be given not less than ten
(10) days nor more than sixty (60) days before the Annual Meeting, to each stockholder entitled to vote thereat by delivering such
notice to such stockholder or by mailing it, postage prepaid, addressed to such stockholder at the address of such stockholder
as it appears on the Corporation&rsquo;s stock transfer books. Without limiting the manner by which notice may otherwise be given
to stockholders, any notice to stockholders may be given by electronic transmission in the manner provided in Section 232 of the
Delaware General Corporation Law (&ldquo;<U>DGCL</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) Notice of all special
meetings of stockholders shall be given in the same manner as provided for Annual Meetings, except that the notice of all special
meetings shall state the purpose or purposes for which the meeting has been called.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) Notice of an Annual
Meeting or special meeting of stockholders need not be given to a stockholder if a waiver of notice is executed, or waiver of notice
by electronic transmission is provided, before or after such meeting by such stockholder or if such stockholder attends such meeting,
unless such attendance is for the express purpose of objecting at the beginning of the meeting to the transaction of any business
because the meeting was not lawfully called or convened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) The Board of Directors
may postpone and reschedule any previously scheduled Annual Meeting or special meeting of stockholders and any record date with
respect thereto, regardless of whether any notice or public disclosure with respect to any such meeting has been sent or made pursuant
to Section 2 of this Article I of these By-laws or otherwise. In no event shall the public announcement of an adjournment, postponement
or rescheduling of any previously scheduled meeting of stockholders commence a new time period for the giving of a stockholder&rsquo;s
notice under this Article I of these By-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) When any meeting is
convened, the presiding officer may adjourn the meeting if (i) no quorum is present for the transaction of business, (ii) the Board
of Directors determines that adjournment is necessary or appropriate to enable the stockholders to consider fully information which
the Board of Directors determines has not been made sufficiently or timely available to stockholders, or (iii) the Board of Directors
determines that adjournment is otherwise in the best interests of the Corporation. When any Annual Meeting or special meeting of
stockholders is adjourned to another hour, date or place, notice need not be given of the adjourned meeting other than an announcement
at the meeting at which the adjournment is taken of the hour, date and place, if any, to which the meeting is adjourned and the
means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at
such adjourned meeting; provided, however, that if the adjournment is for more than thirty (30) days from the meeting date, or
if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting and the means of
remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such adjourned
meeting shall be given to each stockholder of record entitled to vote thereat and each stockholder who, by law or under the Certificate
of Incorporation of the Corporation (as the same may hereafter be amended and/or restated, the &ldquo;<U>Certificate</U>&rdquo;)
or these By-laws, is entitled to such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 5. <U>Quorum</U>.
A majority of the shares entitled to vote, present in person or represented by proxy, shall constitute a quorum at any meeting
of stockholders. If less than a quorum is present at a meeting, the holders of voting stock representing a majority of the voting
power present at the meeting or the presiding officer may adjourn the meeting from time to time, and the meeting may be held as
adjourned without further notice, except as provided in Section 4 of this Article I. At such adjourned meeting at which a quorum
is present, any business may be transacted which might have been transacted at the meeting as originally noticed. The stockholders
present at a duly constituted meeting may continue to transact business until adjournment, notwithstanding the withdrawal of enough
stockholders to leave less than a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 6. <U>Voting and
Proxies</U>. Stockholders shall have one vote for each share of stock entitled to vote owned by them of record according to the
stock ledger of the Corporation as of the record date, unless otherwise provided by law or by the Certificate. Stockholders may
vote either (i) in person, (ii) by written proxy or (iii) by a transmission permitted by Section 212(c) of the DGCL. Any copy,
facsimile telecommunication or other reliable reproduction of the writing or transmission permitted by Section 212(c) of the DGCL
may be substituted for or used in lieu of the original writing or transmission for any and all purposes for which the original
writing or transmission could be used, provided that such copy, facsimile telecommunication or other reproduction shall be a complete
reproduction of the entire original writing or transmission. Proxies shall be filed in accordance with the procedures established
for the meeting of stockholders. Except as otherwise limited therein or as otherwise provided by law, proxies authorizing a person
to vote at a specific meeting shall entitle the persons authorized thereby to vote at any adjournment of such meeting, but they
shall not be valid after final adjournment of such meeting. A proxy with respect to stock held in the name of two or more persons
shall be valid if executed by or on behalf of any one of them unless at or prior to the exercise of the proxy the Corporation receives
a specific written notice to the contrary from any one of them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 7. <U>Action at
Meeting</U>. When a quorum is present at any meeting of stockholders, any matter before any such meeting (other than an election
of a director or directors) shall be decided by a majority of the votes properly cast for and against such matter, except where
a larger vote is required by law, by the Certificate or by these By-laws. Any election of directors by stockholders shall be determined
by a plurality of the votes properly cast on the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 8. <U>Stockholder
Lists</U>. The Secretary or an Assistant Secretary (or the Corporation&rsquo;s transfer agent or other person authorized by these
By-laws or by law) shall prepare and make, at least ten (10) days before every Annual Meeting or special meeting of stockholders,
a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of
each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination
of any stockholder, for a period of at least ten (10) days prior to the meeting in the manner provided by law. The list shall also
be open to the examination of any stockholder during the whole time of the meeting as provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 9. <U>Presiding
Officer</U>. The Board of Directors shall designate a representative to preside over all Annual Meetings or special meetings of
stockholders, provide that if the Board of Directors does not so designate such a presiding officer, then the Chairperson of the
Board, if one is elected, shall preside over such meetings. If the Board of Directors does not so designate such a presiding officer
and there is no Chairperson of the Board or the Chairperson of the Board is unable to so preside or is absent, then the Chief Executive
Officer, if one is elected, shall preside over such meetings, provided further that if there is no Chief Executive Officer or the
Chief Executive Officer is unable to so preside or is absent, then the President shall preside over such meetings. The presiding
officer at any Annual Meeting or special meeting of stockholders shall have the power, among other things, to adjourn such meeting
at any time and from time to time, subject to Sections 4 and 5 of this Article I. The order of business and all other matters of
procedure at any meeting of the stockholders shall be determined by the presiding officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 10. <U>Inspectors
of Elections</U>. The Corporation shall, in advance of any meeting of stockholders, appoint one or more inspectors to act at the
meeting and make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace
any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the presiding officer
shall appoint one or more inspectors to act at the meeting. Any inspector may, but need not, be an officer, employee or agent of
the Corporation. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully
to execute the duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors shall
perform such duties as are required by the DGCL, including the counting of all votes and ballots. The inspectors may appoint or
retain other persons or entities to assist the inspectors in the performance of the duties of the inspectors. The presiding officer
may review all determinations made by the inspectors, and in so doing the presiding officer shall be entitled to exercise his or
her sole judgment and discretion and he or she shall not be bound by any determinations made by the inspectors. All determinations
by the inspectors and, if applicable, the presiding officer, shall be subject to further review by any court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ARTICLE II</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>Powers</U>.
The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors except as otherwise
provided by the Certificate or required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 2. <U>Number and
Terms</U>. The number of directors of the Corporation shall be fixed solely and exclusively by resolution duly adopted from time
to time by the Board of Directors. The directors shall hold office in the manner provided in the Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 3. <U>Qualification</U>.
No director need be a stockholder of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 4. <U>Vacancies</U>.
Vacancies in the Board of Directors shall be filled in the manner provided in the Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 5. <U>Removal</U>.
Directors may be removed from office only in the manner provided in the Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 6. <U>Resignation</U>.
A director may resign at any time by giving written notice to the Chairperson of the Board, if one is elected, the President or
the Secretary. A resignation shall be effective upon receipt, unless the resignation otherwise provides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 7. <U>Regular Meetings</U>.
The regular annual meeting of the Board of Directors shall be held, without notice other than under this Section 7, on the same
date and at the same place as the Annual Meeting following the close of such meeting of stockholders. Other regular meetings of
the Board of Directors may be held at such hour, date and place as the Board of Directors may by resolution from time to time determine
and publicize by means of reasonable notice given to any director who is not present at the meeting at which such resolution is
adopted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 8. <U>Special Meetings</U>.
Special meetings of the Board of Directors may be called, orally or in writing, by or at the request of a majority of the directors,
the Chairperson of the Board, if one is elected, or the President. The person calling any such special meeting of the Board of
Directors may fix the hour, date and place thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 9. <U>Notice of
Meetings</U>. Notice of the hour, date and place of all special meetings of the Board of Directors shall be given to each director
by the Secretary or an Assistant Secretary, or in case of the death, absence, incapacity or refusal of such persons, by the Chairperson
of the Board, if one is elected, or the President or such other officer designated by the Chairperson of the Board, if one is elected,
or the President. Notice of any special meeting of the Board of Directors shall be given to each director in person, by telephone,
or by facsimile, electronic mail or other form of electronic communication, sent to his or her business or home address, at least
twenty-four (24) hours in advance of the meeting, or by written notice mailed to his or her business or home address, at least
forty-eight (48) hours in advance of the meeting. Such notice shall be deemed to be delivered when hand-delivered to such address,
read to such director by telephone, deposited in the mail so addressed, with postage thereon prepaid if mailed, dispatched or transmitted
if sent by facsimile transmission or by electronic mail or other form of electronic communications. A written waiver of notice
signed before or after a meeting by a director and filed with the records of the meeting shall be deemed to be equivalent to notice
of the meeting. The attendance of a director at a meeting shall constitute a waiver of notice of such meeting, except where a director
attends a meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because
such meeting is not lawfully called or convened. Except as otherwise required by law, by the Certificate or by these By-laws, neither
the business to be transacted at, nor the purpose of, any meeting of the Board of Directors need be specified in the notice or
waiver of notice of such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;SECTION 10. <U>Quorum</U>.
At any meeting of the Board of Directors, a majority of the total number of directors shall constitute a quorum for the transaction
of business, but if less than a quorum is present at a meeting, a majority of the directors present may adjourn the meeting from
time to time, and the meeting may be held as adjourned without further notice. Any business which might have been transacted at
the meeting as originally noticed may be transacted at such adjourned meeting at which a quorum is present. For purposes of this
section, the total number of directors includes any unfilled vacancies on the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 11. <U>Action at
Meeting</U>. At any meeting of the Board of Directors at which a quorum is present, the vote of a majority of the directors present
shall constitute action by the Board of Directors, unless otherwise required by law, by the Certificate or by these By-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 12. <U>Action by
Consent</U>. Any action required or permitted to be taken at any meeting of the Board of Directors may be taken without a meeting
if all members of the Board of Directors consent thereto in writing or by electronic transmission and the writing or writings or
electronic transmission or transmissions are filed with the records of the meetings of the Board of Directors. Such filing shall
be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic
form. Such consent shall be treated as a resolution of the Board of Directors for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 13. <U>Manner of
Participation</U>. Directors may participate in meetings of the Board of Directors by means of conference telephone or other communications
equipment by means of which all directors participating in the meeting can hear each other, and participation in a meeting in accordance
herewith shall constitute presence in person at such meeting for purposes of these By-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 14. <U>Presiding
Director</U>. The Board of Directors shall designate a representative to preside over all meetings of the Board of Directors, provided
that if the Board of Directors does not so designate such a presiding director or such designated presiding director is unable
to so preside or is absent, then the Chairperson of the Board, if one is elected, shall preside over all meetings of the Board
of Directors. If both the designated presiding director, if one is so designated, and the Chairperson of the Board, if one is elected,
are unable to preside or are absent, the Board of Directors shall designate an alternate representative to preside over a meeting
of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 15. <U>Committees</U>.
The Board of Directors, by vote of a majority of the directors then in office, may elect one or more committees, including, without
limitation, a Compensation Committee, a Nominating &amp; Corporate Governance Committee and an Audit Committee, and may delegate
thereto some or all of its powers except those which by law, by the Certificate or by these By-laws may not be delegated. Except
as the Board of Directors may otherwise determine, any such committee may make rules for the conduct of its business, but unless
otherwise provided by the Board of Directors or in such rules, its business shall be conducted so far as possible in the same manner
as is provided by these By-laws for the Board of Directors. All members of such committees shall hold such offices at the pleasure
of the Board of Directors. The Board of Directors may abolish any such committee at any time. Any committee to which the Board
of Directors delegates any of its powers or duties shall keep records of its meetings and shall report its action to the Board
of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 16. <U>Compensation
of Directors</U>. Directors shall receive such compensation for their services as shall be determined by a majority of the Board
of Directors, or a designated committee thereof, provided that directors who are serving the Corporation as employees and who receive
compensation for their services as such, shall not receive any salary or other compensation for their services as directors of
the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ARTICLE III</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Officers</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>Enumeration</U>.
The officers of the Corporation shall consist of a President, a Treasurer, a Secretary and such other officers, including, without
limitation, a Chairperson of the Board of Directors, a Chief Executive Officer and one or more Vice Presidents (including Executive
Vice Presidents or Senior Vice Presidents), Assistant Vice Presidents, Assistant Treasurers and Assistant Secretaries, as the Board
of Directors may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 2. <U>Election</U>.
At the regular annual meeting of the Board of Directors following the Annual Meeting, the Board of Directors shall elect the President,
the Treasurer and the Secretary. Other officers may be elected by the Board of Directors at such regular annual meeting of the
Board of Directors or at any other regular or special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 3. <U>Qualification</U>.
No officer need be a stockholder or a director. Any person may occupy more than one office of the Corporation at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 4. <U>Tenure</U>.
Except as otherwise provided by the Certificate or by these By-laws each of the officers of the Corporation shall hold office until
the regular annual meeting of the Board of Directors following the next Annual Meeting and until his or her successor is elected
and qualified or until his or her earlier resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 5. <U>Resignation</U>.
Any officer may resign by delivering his or her written resignation to the Corporation addressed to the President or the Secretary,
and such resignation shall be effective upon receipt, unless the resignation otherwise provides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 6. <U>Removal</U>.
Except as otherwise provided by law, the Board of Directors may remove any officer with or without cause by the affirmative vote
of a majority of the directors then in office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 7. <U>Absence or
Disability</U>. In the event of the absence or disability of any officer, the Board of Directors may designate another officer
to act temporarily in place of such absent or disabled officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 8. <U>Vacancies</U>.
Any vacancy in any office may be filled for the unexpired portion of the term by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 9. <U>President</U>.
The President shall, subject to the direction of the Board of Directors, have such powers and shall perform such duties as the
Board of Directors may from time to time designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 10. <U>Chairperson
of the Board</U>. The Chairperson of the Board, if one is elected, shall have such powers and shall perform such duties as the
Board of Directors may from time to time designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 11. <U>Chief Executive
Officer</U>. The Chief Executive Officer, if one is elected, shall have such powers and shall perform such duties as the Board
of Directors may from time to time designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 12. <U>Vice Presidents
and Assistant Vice Presidents</U>. Any Vice President (including any Executive Vice President or Senior Vice President) and any
Assistant Vice President shall have such powers and shall perform such duties as the Board of Directors or the Chief Executive
Officer may from time to time designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 13. <U>Treasurer
and Assistant Treasurers</U>. The Treasurer shall, subject to the direction of the Board of Directors and except as the Board of
Directors or the Chief Executive Officer may otherwise provide, have general charge of the financial affairs of the Corporation
and shall cause to be kept accurate books of account. The Treasurer shall have custody of all funds, securities, and valuable documents
of the Corporation. He or she shall have such other duties and powers as may be designated from time to time by the Board of Directors
or the Chief Executive Officer. Any Assistant Treasurer shall have such powers and perform such duties as the Board of Directors
or the Chief Executive Officer may from time to time designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 14. <U>Secretary
and Assistant Secretaries</U>. The Secretary shall record all the proceedings of the meetings of the stockholders and the Board
of Directors (including committees of the Board of Directors) in books kept for that purpose. In his or her absence from any such
meeting, a temporary secretary chosen at the meeting shall record the proceedings thereof. The Secretary shall have charge of the
stock ledger (which may, however, be kept by any transfer or other agent of the Corporation). The Secretary shall have custody
of the seal of the Corporation, and the Secretary, or an Assistant Secretary shall have authority to affix it to any instrument
requiring it, and, when so affixed, the seal may be attested by his or her signature or that of an Assistant Secretary. The Secretary
shall have such other duties and powers as may be designated from time to time by the Board of Directors or the Chief Executive
Officer. In the absence of the Secretary, any Assistant Secretary may perform his or her duties and responsibilities. Any Assistant
Secretary shall have such powers and perform such duties as the Board of Directors or the Chief Executive Officer may from time
to time designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 15. <U>Other Powers
and Duties</U>. Subject to these By-laws and to such limitations as the Board of Directors may from time to time prescribe, the
officers of the Corporation shall each have such powers and duties as generally pertain to their respective offices, as well as
such powers and duties as from time to time may be conferred by the Board of Directors or the Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ARTICLE IV</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Capital Stock</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>Certificates
of Stock</U>. Each stockholder shall be entitled to a certificate of the capital stock of the Corporation in such form as may from
time to time be prescribed by the Board of Directors. Such certificate shall be signed by the Chairperson of the Board, the President
or a Vice President and by the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant Secretary. The Corporation
seal and the signatures by the Corporation&rsquo;s officers, the transfer agent or the registrar may be facsimiles. In case any
officer, transfer agent or registrar who has signed or whose facsimile signature has been placed on such certificate shall have
ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with
the same effect as if he or she were such officer, transfer agent or registrar at the time of its issue. Every certificate for
shares of stock which are subject to any restriction on transfer and every certificate issued when the Corporation is authorized
to issue more than one class or series of stock shall contain such legend with respect thereto as is required by law. Notwithstanding
anything to the contrary provided in these Bylaws, the Board of Directors of the Corporation may provide by resolution or resolutions
that some or all of any or all classes or series of its stock shall be uncertificated shares (except that the foregoing shall not
apply to shares represented by a certificate until such certificate is surrendered to the Corporation), and by the approval and
adoption of these Bylaws the Board of Directors has determined that all classes or series of the Corporation&rsquo;s stock may
be uncertificated, whether upon original issuance, re-issuance, or subsequent transfer.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 2. <U>Transfers</U>.
Subject to any restrictions on transfer and unless otherwise provided by the Board of Directors, shares of stock that are represented
by a certificate may be transferred on the books of the Corporation by the surrender to the Corporation or its transfer agent of
the certificate theretofore properly endorsed or accompanied by a written assignment or power of attorney properly executed, with
transfer stamps (if necessary) affixed, and with such proof of the authenticity of signature as the Corporation or its transfer
agent may reasonably require. Shares of stock that are not represented by a certificate may be transferred on the books of the
Corporation by submitting to the Corporation or its transfer agent such evidence of transfer and following such other procedures
as the Corporation or its transfer agent may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 3. <U>Record Holders</U>.
Except as may otherwise be required by law, by the Certificate or by these By-laws, the Corporation shall be entitled to treat
the record holder of stock as shown on its books as the owner of such stock for all purposes, including the payment of dividends
and the right to vote with respect thereto, regardless of any transfer, pledge or other disposition of such stock, until the shares
have been transferred on the books of the Corporation in accordance with the requirements of these By-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 4. <U>Record Date</U>.
In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or
any adjournment thereof or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled
to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action,
the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the
record date is adopted by the Board of Directors, and which record date: (a) in the case of determination of stockholders entitled
to vote at any meeting of stockholders, shall, unless otherwise required by law, not be more than sixty (60) nor less than ten
(10) days before the date of such meeting and (b) in the case of any other action, shall not be more than sixty (60) days prior
to such other action. If no record date is fixed: (i) the record date for determining stockholders entitled to notice of or to
vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given,
or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held; and (ii) the
record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board
of Directors adopts the resolution relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 5. <U>Replacement
of Certificates</U>. In case of the alleged loss, destruction or mutilation of a certificate of stock of the Corporation, a duplicate
certificate may be issued in place thereof, upon such terms as the Board of Directors may prescribe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ARTICLE V</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Indemnification</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>Definitions</U>.
For purposes of this Article:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<U>Corporate
Status</U>&rdquo; describes the status of a person who is serving or has served (i) as a Director of the Corporation, (ii) as an
Officer of the Corporation, (iii) as a Non-Officer Employee of the Corporation, or (iv) as a director, partner, trustee, officer,
employee or agent of any other corporation, partnership, limited liability company, joint venture, trust, employee benefit plan,
foundation, association, organization or other legal entity which such person is or was serving at the request of the Corporation.
For purposes of this Section 1(a), a Director, Officer or Non-Officer Employee of the Corporation who is serving or has served
as a director, partner, trustee, officer, employee or agent of a Subsidiary shall be deemed to be serving at the request of the
Corporation. Notwithstanding the foregoing, &ldquo;Corporate Status&rdquo; shall not include the status of a person who is serving
or has served as a director, officer, employee or agent of a constituent corporation absorbed in a merger or consolidation transaction
with the Corporation with respect to such person&rsquo;s activities prior to said transaction, unless specifically authorized by
the Board of Directors or the stockholders of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;<U>Director</U>&rdquo;
means any person who serves or has served the Corporation as a director on the Board of Directors of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) &ldquo;<U>Disinterested
Director</U>&rdquo; means, with respect to each Proceeding in respect of which indemnification is sought hereunder, a Director
of the Corporation who is not and was not a party to such Proceeding;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) &ldquo;<U>Expenses</U>&rdquo;
means all attorneys&rsquo; fees, retainers, court costs, transcript costs, fees of expert witnesses, private investigators and
professional advisors (including, without limitation, accountants and investment bankers), travel expenses, duplicating costs,
printing and binding costs, costs of preparation of demonstrative evidence and other courtroom presentation aids and devices, costs
incurred in connection with document review, organization, imaging and computerization, telephone charges, postage, delivery service
fees, and all other disbursements, costs or expenses of the type customarily incurred in connection with prosecuting, defending,
preparing to prosecute or defend, investigating, being or preparing to be a witness in, settling or otherwise participating in,
a Proceeding;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;<U>Liabilities</U>&rdquo;
means judgments, damages, liabilities, losses, penalties, excise taxes, fines and amounts paid in settlement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;<U>Non-Officer
Employee</U>&rdquo; means any person who serves or has served as an employee or agent of the Corporation, but who is not or was
not a Director or Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;<U>Officer</U>&rdquo;
means any person who serves or has served the Corporation as an officer of the Corporation appointed by the Board of Directors
of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(h) &ldquo;<U>Proceeding</U>&rdquo;
means any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, inquiry, investigation,
administrative hearing or other proceeding, whether civil, criminal, administrative, arbitrative or investigative; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;<U>Subsidiary</U>&rdquo;
shall mean any corporation, partnership, limited liability company, joint venture, trust or other entity of which the Corporation
owns (either directly or through or together with another Subsidiary of the Corporation) either (i) a general partner, managing
member or other similar interest or (ii) (A) fifty percent (50%) or more of the voting power of the voting capital equity interests
of such corporation, partnership, limited liability company, joint venture or other entity, or (B) fifty percent (50%) or more
of the outstanding voting capital stock or other voting equity interests of such corporation, partnership, limited liability company,
joint venture or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;SECTION 2. <U>Indemnification
of Directors and Officers</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) Subject to the operation
of Section 4 of this Article V of these By-laws, each Director and Officer shall be indemnified and held harmless by the Corporation
to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but, in the case of any such amendment,
only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted
the Corporation to provide prior to such amendment), and to the extent authorized in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(1) <U>Actions,
Suits and Proceedings Other than By or In the Right of the Corporation</U>. Each Director and Officer shall be indemnified and
held harmless by the Corporation against any and all Expenses and Liabilities that are incurred or paid by such Director or Officer
or on such Director&rsquo;s or Officer&rsquo;s behalf in connection with any Proceeding or any claim, issue or matter therein (other
than an action by or in the right of the Corporation), which such Director or Officer is, or is threatened to be made, a party
to or participant in by reason of such Director&rsquo;s or Officer&rsquo;s Corporate Status, if such Director or Officer acted
in good faith and in a manner such Director or Officer reasonably believed to be in or not opposed to the best interests of the
Corporation and, with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(2) <U>Actions,
Suits and Proceedings By or In the Right of the Corporation</U>. Each Director and Officer shall be indemnified and held harmless
by the Corporation against any and all Expenses that are incurred by such Director or Officer or on such Director&rsquo;s or Officer&rsquo;s
behalf in connection with any Proceeding or any claim, issue or matter therein by or in the right of the Corporation, which such
Director or Officer is, or is threatened to be made, a party to or participant in by reason of such Director&rsquo;s or Officer&rsquo;s
Corporate Status, if such Director or Officer acted in good faith and in a manner such Director or Officer reasonably believed
to be in or not opposed to the best interests of the Corporation; provided, however, that no indemnification shall be made under
this Section 2(a)(2) in respect of any claim, issue or matter as to which such Director or Officer shall have been finally adjudged
by a court of competent jurisdiction to be liable to the Corporation, unless, and only to the extent that, the Court of Chancery
or another court in which such Proceeding was brought shall determine upon application that, despite adjudication of liability,
but in view of all the circumstances of the case, such Director or Officer is fairly and reasonably entitled to indemnification
for such Expenses that such court deems proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(3) <U>Survival
of Rights</U>. The rights of indemnification provided by this Section 2 shall continue as to a Director or Officer after he or
she has ceased to be a Director or Officer and shall inure to the benefit of his or her heirs, executors, administrators and personal
representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(4) <U>Actions
by Directors or Officers</U>. Notwithstanding the foregoing, the Corporation shall indemnify any Director or Officer seeking indemnification
in connection with a Proceeding initiated by such Director or Officer only if such Proceeding (including any parts of such Proceeding
not initiated by such Director or Officer) was authorized in advance by the Board of Directors of the Corporation, unless such
Proceeding was brought to enforce such Officer&rsquo;s or Director&rsquo;s rights to indemnification or, in the case of Directors,
advancement of Expenses under these By-laws in accordance with the provisions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 3. <U>Indemnification
of Non-Officer Employees</U>. Subject to the operation of Section 4 of this Article V of these By-laws, each Non-Officer Employee
may, in the discretion of the Board of Directors of the Corporation, be indemnified by the Corporation to the fullest extent authorized
by the DGCL, as the same exists or may hereafter be amended, against any or all Expenses and Liabilities that are incurred by such
Non-Officer Employee or on such Non-Officer Employee&rsquo;s behalf in connection with any threatened, pending or completed Proceeding,
or any claim, issue or matter therein, which such Non-Officer Employee is, or is threatened to be made, a party to or participant
in by reason of such Non-Officer Employee&rsquo;s Corporate Status, if such Non-Officer Employee acted in good faith and in a manner
such Non-Officer Employee reasonably believed to be in or not opposed to the best interests of the Corporation and, with respect
to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. The rights of indemnification provided
by this Section 3 shall exist as to a Non-Officer Employee after he or she has ceased to be a Non-Officer Employee and shall inure
to the benefit of his or her heirs, personal representatives, executors and administrators. Notwithstanding the foregoing, the
Corporation may indemnify any Non-Officer Employee seeking indemnification in connection with a Proceeding initiated by such Non-Officer
Employee only if such Proceeding was authorized in advance by the Board of Directors of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 4. <U>Determination</U>.
Unless ordered by a court, no indemnification shall be provided pursuant to this Article V to a Director, to an Officer or to a
Non-Officer Employee unless a determination shall have been made that such person acted in good faith and in a manner such person
reasonably believed to be in or not opposed to the best interests of the Corporation and, with respect to any criminal Proceeding,
such person had no reasonable cause to believe his or her conduct was unlawful. Such determination shall be made by (a) a majority
vote of the Disinterested Directors, even though less than a quorum of the Board of Directors, (b) a committee comprised of Disinterested
Directors, such committee having been designated by a majority vote of the Disinterested Directors (even though less than a quorum),
(c) if there are no such Disinterested Directors, or if a majority of Disinterested Directors so directs, by independent legal
counsel in a written opinion, or (d) by the stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 5. <U>Advancement
of Expenses to Directors Prior to Final Disposition</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The Corporation shall
advance all Expenses incurred by or on behalf of any Director in connection with any Proceeding in which such Director is involved
by reason of such Director&rsquo;s Corporate Status within thirty (30) days after the receipt by the Corporation of a written statement
from such Director requesting such advance or advances from time to time, whether prior to or after final disposition of such Proceeding.
Such statement or statements shall reasonably evidence the Expenses incurred by such Director and shall be preceded or accompanied
by an undertaking by or on behalf of such Director to repay any Expenses so advanced if it shall ultimately be determined that
such Director is not entitled to be indemnified against such Expenses. Notwithstanding the foregoing, the Corporation shall advance
all Expenses incurred by or on behalf of any Director seeking advancement of expenses hereunder in connection with a Proceeding
initiated by such Director only if such Proceeding (including any parts of such Proceeding not initiated by such Director) was
(i) authorized by the Board of Directors of the Corporation, or (ii) brought to enforce such Director&rsquo;s rights to indemnification
or advancement of Expenses under these By-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) If a claim for advancement
of Expenses hereunder by a Director is not paid in full by the Corporation within thirty (30) days after receipt by the Corporation
of documentation of Expenses and the required undertaking, such Director may at any time thereafter bring suit against the Corporation
to recover the unpaid amount of the claim and if successful in whole or in part, such Director shall also be entitled to be paid
the expenses of prosecuting such claim. The failure of the Corporation (including its Board of Directors or any committee thereof,
independent legal counsel, or stockholders) to make a determination concerning the permissibility of such advancement of Expenses
under this Article V shall not be a defense to an action brought by a Director for recovery of the unpaid amount of an advancement
claim and shall not create a presumption that such advancement is not permissible. The burden of proving that a Director is not
entitled to an advancement of expenses shall be on the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) In any suit brought
by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled
to recover such expenses upon a final adjudication that the Director has not met any applicable standard for indemnification set
forth in the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 6. <U>Advancement
of Expenses to Officers and Non-Officer Employees Prior to Final Disposition</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The Corporation may,
at the discretion of the Board of Directors of the Corporation, advance any or all Expenses incurred by or on behalf of any Officer
or any Non-Officer Employee in connection with any Proceeding in which such person is involved by reason of his or her Corporate
Status as an Officer or Non-Officer Employee upon the receipt by the Corporation of a statement or statements from such Officer
or Non-Officer Employee requesting such advance or advances from time to time, whether prior to or after final disposition of such
Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by such Officer or Non-Officer Employee
and shall be preceded or accompanied by an undertaking by or on behalf of such person to repay any Expenses so advanced if it shall
ultimately be determined that such Officer or Non-Officer Employee is not entitled to be indemnified against such Expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) In any suit brought
by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled
to recover such expenses upon a final adjudication that the Officer or Non-Officer Employee has not met any applicable standard
for indemnification set forth in the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 7. <U>Contractual
Nature of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The provisions of this
Article V shall be deemed to be a contract between the Corporation and each Director and Officer entitled to the benefits hereof
at any time while this Article V is in effect, in consideration of such person&rsquo;s past or current and any future performance
of services for the Corporation. Neither amendment, repeal or modification of any provision of this Article V nor the adoption
of any provision of the Certificate of Incorporation inconsistent with this Article V shall eliminate or reduce any right conferred
by this Article V in respect of any act or omission occurring, or any cause of action or claim that accrues or arises or any state
of facts existing, at the time of or before such amendment, repeal, modification or adoption of an inconsistent provision (even
in the case of a proceeding based on such a state of facts that is commenced after such time), and all rights to indemnification
and advancement of Expenses granted herein or arising out of any act or omission shall vest at the time of the act or omission
in question, regardless of when or if any proceeding with respect to such act or omission is commenced. The rights to indemnification
and to advancement of expenses provided by, or granted pursuant to, this Article V shall continue notwithstanding that the person
has ceased to be a director or officer of the Corporation and shall inure to the benefit of the estate, heirs, executors, administrators,
legatees and distributes of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) If a claim for indemnification
hereunder by a Director or Officer is not paid in full by the Corporation within sixty (60) days after receipt by the Corporation
of a written claim for indemnification, such Director or Officer may at any time thereafter bring suit against the Corporation
to recover the unpaid amount of the claim, and if successful in whole or in part, such Director or Officer shall also be entitled
to be paid the expenses of prosecuting such claim. The failure of the Corporation (including its Board of Directors or any committee
thereof, independent legal counsel, or stockholders) to make a determination concerning the permissibility of such indemnification
under this Article V shall not be a defense to an action brought by a Director or Officer for recovery of the unpaid amount of
an indemnification claim and shall not create a presumption that such indemnification is not permissible. The burden of proving
that a Director or Officer is not entitled to indemnification shall be on the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) In any suit brought
by a Director or Officer to enforce a right to indemnification hereunder, it shall be a defense that such Director or Officer has
not met any applicable standard for indemnification set forth in the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 8. <U>Non-Exclusivity
of Rights</U>. The rights to indemnification and to advancement of Expenses set forth in this Article V shall not be exclusive
of any other right which any Director, Officer, or Non-Officer Employee may have or hereafter acquire under any statute, provision
of the Certificate or these By-laws, agreement, vote of stockholders or Disinterested Directors or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 9. <U>Insurance</U>.
The Corporation may maintain insurance, at its expense, to protect itself and any Director, Officer or Non-Officer Employee against
any liability of any character asserted against or incurred by the Corporation or any such Director, Officer or Non-Officer Employee,
or arising out of any such person&rsquo;s Corporate Status, whether or not the Corporation would have the power to indemnify such
person against such liability under the DGCL or the provisions of this Article V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 10. <U>Other Indemnification</U>.
The Corporation&rsquo;s obligation, if any, to indemnify or provide advancement of Expenses to any person under this Article V
as a result of such person serving, at the request of the Corporation, as a director, partner, trustee, officer, employee or agent
of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount
such person may collect as indemnification or advancement of Expenses from such other corporation, partnership, joint venture,
trust, employee benefit plan or enterprise (the &ldquo;<U>Primary Indemnitor</U>&rdquo;). Any indemnification or advancement of
Expenses under this Article V owed by the Corporation as a result of a person serving, at the request of the Corporation, as a
director, partner, trustee, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise shall only be in excess of, and shall be secondary to, the indemnification or advancement of Expenses
available from the applicable Primary Indemnitor(s) and any applicable insurance policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>ARTICLE VI</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Miscellaneous Provisions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>Fiscal Year</U>.
The fiscal year of the Corporation shall be determined by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 2. <U>Seal</U>.
The Board of Directors shall have power to adopt and alter the seal of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 3. <U>Execution
of Instruments</U>. All deeds, leases, transfers, contracts, bonds, notes and other obligations to be entered into by the Corporation
in the ordinary course of its business without director action may be executed on behalf of the Corporation by the Chairperson
of the Board, if one is elected, the President or the Treasurer or any other officer, employee or agent of the Corporation as the
Board of Directors or the executive committee of the Board may authorize.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 4. <U>Voting of
Securities</U>. Unless the Board of Directors otherwise provides, the Chairperson of the Board, if one is elected, the President
or the Treasurer may waive notice of and act on behalf of the Corporation, or appoint another person or persons to act as proxy
or attorney in fact for the Corporation with or without discretionary power and/or power of substitution, at any meeting of stockholders
or shareholders of any other corporation or organization, any of whose securities are held by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 5. <U>Resident
Agent</U>. The Board of Directors may appoint a resident agent upon whom legal process may be served in any action or proceeding
against the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 6. <U>Corporate
Records</U>. The original or attested copies of the Certificate, By-laws and records of all meetings of the incorporators, stockholders
and the Board of Directors and the stock transfer books, which shall contain the names of all stockholders, their record addresses
and the amount of stock held by each, may be kept outside the State of Delaware and shall be kept at the principal office of the
Corporation, at an office of its counsel, at an office of its transfer agent or at such other place or places as may be designated
from time to time by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 7. <U>Certificate</U>.
All references in these By-laws to the Certificate shall be deemed to refer to the First Amended and Restated Certificate of Incorporation
of the Corporation, as amended and/or restated and in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 8. <U>Exclusive
Jurisdiction of Delaware Courts</U>. Unless the Corporation consents in writing to the selection of an alternative forum, the Court
of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought
on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or
other employee of the Corporation to the Corporation or the Corporation&rsquo;s stockholders, (iii) any action asserting a claim
arising pursuant to any provision of the Delaware General Corporation Law or the Certificate or By-laws, or (iv) any action asserting
a claim against the Corporation governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring
any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of
this Section 8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 9. <U>Amendment
of By-laws</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) <U>Amendment by Directors</U>.
Except as provided otherwise by law, these By-laws may be amended or repealed by the Board of Directors by the affirmative vote
of a majority of the directors then in office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) <U>Amendment by Stockholders</U>.
These By-laws may be amended or repealed at any Annual Meeting, or special meeting of stockholders called for such purpose in accordance
with these By-Laws, by the affirmative vote of at least seventy-five percent (75%) of the outstanding shares entitled to vote on
such amendment or repeal, voting together as a single class; provided, however, that if the Board of Directors recommends that
stockholders approve such amendment or repeal at such meeting of stockholders, such amendment or repeal shall only require the
affirmative vote of the majority of the outstanding shares entitled to vote on such amendment or repeal, voting together as a single
class. Notwithstanding the foregoing, stockholder approval shall not be required unless mandated by the Certificate, these By-laws,
or other applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 10. <U>Notices</U>.
If mailed, notice to stockholders shall be deemed given when deposited in the mail, postage prepaid, directed to the stockholder
at such stockholder&rsquo;s address as it appears on the records of the Corporation. Without limiting the manner by which notice
otherwise may be given to stockholders, any notice to stockholders may be given by electronic transmission in the manner provided
in Section 232 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 11. <U>Waivers</U>.
A written waiver of any notice, signed by a stockholder or director, or waiver by electronic transmission by such person, whether
given before or after the time of the event for which notice is to be given, shall be deemed equivalent to the notice required
to be given to such person. Neither the business to be transacted at, nor the purpose of, any meeting need be specified in such
a waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Adopted on August 29, 2019.</P>

<P STYLE="font: 12pt David,sans-serif; margin: 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>8
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&rsquo;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT OR BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION THAT WOULD
RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED FOR A PERIOD OF ONE HUNDRED EIGHTY
DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT,
INC., OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF THINKEQUITY,
A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [<B>DATE THAT IS [180 DAYS] FROM THE EFFECTIVE DATE OF THE OFFERING</B>].
VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [<B>DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING</B>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: _______<SUP>1</SUP></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Initial
    Exercise Date: ______, 2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT TO PURCHASE COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after ____, 2021, which is one hundred eighty (180) days following the Effective Date (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date
that is five (5) years following the Effective Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from Save Foods, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______<SUP>1</SUP> shares
of Common Stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of the Company (the &ldquo;<U>Warrant Shares</U>&rdquo;),
as subject to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings
indicated in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a &ldquo;shelter in place,&rdquo; &ldquo;non-essential employee&rdquo; or similar closure of physical branch locations at the
direction of any governmental authority if such banks&rsquo; electronic funds transfer systems (including for wire transfers)
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP>Total
equals 5% of the aggregate number of Firm Shares issued and sold in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the effective date of the registration statement on Form S-1 (File No. 333-[___]) including any related
prospectus or prospectuses, for the registration of the Company&rsquo;s Common Stock under the Securities Act, that the Company
has filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the New York Stock Exchange is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
or the New York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means that certain Underwriting Agreement, dated as of [____], 2021, by and between, the Company and ThinkEquity,
a division of Fordham Financial Management, Inc., as representatives of the underwriters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the
volume weighted average price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as
applicable, (c) if Common Stock is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock
are then reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases,
the fair market value of the Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after
the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of
the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books
of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within
two (2) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant
has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within five
(5) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder
and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt of such notice. <B>The Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any
given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$_______<SUP>2</SUP></B>,
subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at any time on or after the Initial Exercise Date, there is no effective registration statement registering,
or the prospectus contained therein is not available for the issuance of the Warrant Shares, then in lieu of exercising this Warrant
by delivering the aggregate Exercise Price by wire transfer or cashier&rsquo;s check, at the election of the Holder this Warrant
may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall
be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font: 11pt/107% Calibri, Helvetica, Sans-Serif; width: 1in">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 11pt/107% Calibri, Helvetica, Sans-Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">(A) =</FONT></TD>
    <TD STYLE="text-align: justify; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>125% of the public offering price per share of Common Stock issued and sold in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%; width: 1in">&nbsp;</TD>
    <TD STYLE="line-height: 107%; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">(B) =</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">(X) =</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a &ldquo;cashless exercise,&rdquo; the parties acknowledge and agree that in accordance with
Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised,
and the holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise
pursuant to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by its transfer agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with
The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company
is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the
Warrant Shares to or resale of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without
volume or manner-of-sale limitations pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder
prior to the Warrant Share Delivery Date (as defined below), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is two
(2) Trading Days after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;), provided that the Company shall not be obligated to deliver the Warrant Shares hereunder unless the Company
has received the aggregate Exercise Price on or before the Warrant Shares Delivery Date. If the Warrant Shares can be delivered
via DWAC, the transfer agent shall have received from the Company, at the expense of the Company, any legal opinions or other
documentation required by it to deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back
up documentation from the Holder, including with respect to affiliate status) and, if applicable and requested by the Company
prior to the Warrant Share Delivery Date, the transfer agent shall have received from the Holder a confirmation of sale of the
Warrant Shares (provided the requirement of the Holder to provide a confirmation as to the sale of Warrant Shares shall not be
applicable to the issuance of unlegended Warrant Shares upon a cashless exercise of this Warrant if the Warrant Shares are then
eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be deemed to have been issued, and Holder or any other
person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as
of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted)
and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, having
been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by
the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock
on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following such Warrant Share
Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder
a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which
new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided</U>,
<U>however</U>, that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise
notice concurrently with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and
the restoration of Holder&rsquo;s right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise
on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open
market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price
(including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying
(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored
(in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would
have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder
purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice
indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law
or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto. The Company shall pay all transfer agent fees required for same-day processing of any Notice
of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions)
required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.
<U>Signature</U>. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the
Holder in order to exercise this Purchase Warrant. Without limiting the preceding sentences, no ink-original exercise form shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in
order to exercise this Purchase Warrant. No additional legal opinion, other information or instructions shall be required of the
Holder to exercise this Purchase Warrant. The Company shall honor exercises of this Purchase Warrant and shall deliver Shares
underlying this Purchase Warrant in accordance with the terms, conditions and time periods set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect
to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of
shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of
shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any
other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on
conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged
by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of
the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall
be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and
of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a
Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic
or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a
more recent written notice by the Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common Stock
outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by
the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e)
shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which
may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to
a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.
For the purposes of clarification, the Exercise Price of this Warrant will not be adjusted in the event that the Company or any
Subsidiary thereof, as applicable, sells or grants any option to purchase, or sell or grant any right to reprice, or otherwise
dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common
Stock Equivalents, at an effective price per share less than the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase
Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result
in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase
Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
(other than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common
Stock, by way of return of capital or otherwise (including, without limitation, any distribution of shares or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other
similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such
case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, to
the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the
Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until
the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making
or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable by holders of Common Stock as a result of such Fundamental Transaction
for each share of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate
Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is
exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to
the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being
for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction),
and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
the provisions of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect
as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the
Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a
party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed
a notice to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days
prior to the applicable record or effective date hereinafter specified, stating (x) the date on which a record is to be taken
for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is
expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall
be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect therein
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
hereunder constitutes, or contains, material, non-public information regarding the Company or any of its Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Pursuant to FINRA Rule 5110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of
this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative,
put, or call transaction that would result in the effective economic disposition of the securities by any person for a period
of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant
is being issued, except the transfer of any security:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    operation of law or by reason of reorganization of the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred
    remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities
    being offered;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member
    manages or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10%
    of the equity in the fund; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section
    4(a) for the remainder of the time period.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all
rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender
of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion
of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant
in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date the Holder
delivers an assignment form to the Company assigning this Warrant full. The Warrant, if properly assigned in accordance herewith,
may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable
pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a
view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5. Registration Rights.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.1</U> <U>Demand Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
<U>Grant of Right</U>. The Company, upon written demand (a &ldquo;<U>Demand Notice</U>&rdquo;) of the Holder(s) of at least 51%
of the Warrants and/or the underlying Warrant Shares (&ldquo;<U>Majority Holders</U>&rdquo;), agrees to register, on one occasion,
all or any portion of the Warrant Shares underlying the Warrants (collectively, the &ldquo;<U>Registrable Securities</U>&rdquo;).
On such occasion, the Company will file a registration statement with the Commission covering the Registrable Securities within
thirty (30) days after receipt of a Demand Notice and use its commercially reasonable efforts to have the registration statement
declared effective promptly thereafter, subject to compliance with review by the Commission; provided, however, that the Company
shall not be required to comply with a Demand Notice if the Company has filed a registration statement with respect to which the
Holder is entitled to piggyback registration rights pursuant to Section 5.2 hereof and either: (i) the Holder has elected to participate
in the offering covered by such registration statement or (ii) if such registration statement relates to an underwritten primary
offering of securities of the Company, until the offering covered by such registration statement has been withdrawn or until thirty
(30) days after such offering is consummated. The sole demand for registration may be made at any time beginning on the Initial
Exercise Date and expiring on the fifth anniversary of the Effective Date in accordance with FINRA Rule 5110(g)(8)(C). The Company
covenants and agrees to give written notice of its receipt of any Demand Notice by any Holder(s) to all other registered Holders
of the Warrants and/or the Registrable Securities within ten (10) days after the date of the receipt of any such Demand Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section
5.1.1, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders
to represent them in connection with the sale of the Registrable Securities. The Company agrees to use its commercially reasonable
efforts to cause the filing required herein to become effective promptly and to qualify or register the Registrable Securities
in such States as are reasonably requested by the Holder(s); provided, however, that in no event shall the Company be required
to register the Registrable Securities in a State in which such registration would cause: (i) the Company to be obligated to register
or license to do business in such State or submit to general service of process in such State, or (ii) the principal stockholders
of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall cause any registration
statement filed pursuant to the demand right granted under Section 5.1.1 to remain effective for a period of at least twelve (12)
consecutive months after the date that the Holders of the Registrable Securities covered by such registration statement are first
given the opportunity to sell all of such securities. The Holders shall only use the prospectuses provided by the Company to sell
the Warrant Shares covered by such registration statement, and will immediately cease to use any prospectus furnished by the Company
if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding
the provisions of this Section 5.1.2, the Holder shall be entitled to a demand registration under this Section 5.1.2 on only one
(1) occasion and such demand registration right shall terminate on the fifth anniversary of the date of the Underwriting Agreement
(as defined below) in accordance with FINRA Rule 5110(g)(8)(C).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.2</U>
<U>&ldquo;Piggy-Back&rdquo; Registration.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1
<U>Grant of Right</U>. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have
the right, for a period of no more than five (5) years from the Initial Exercise Date in accordance with FINRA Rule 5110(g)(8)(D),
to include the Registrable Securities as part of any other registration of securities filed by the Company (other than in connection
with a transaction contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent
form); provided, however, that if, solely in connection with any primary underwritten public offering for the account of the Company,
the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of Registrable Securities
that may be included in the Registration Statement because, in such underwriter(s)&rsquo; judgment, marketing or other factors
dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such
Registration Statement only such limited portion of the Registrable Securities with respect to which the Holder requested inclusion
hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable Securities shall be made pro rata among the
Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought to be included
by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company has first
excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such Registration
Statement or are not entitled to pro rata inclusion with the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2
<U>Terms</U>. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section
5.2.1 hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by
the Holders to represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration,
the Company shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice
prior to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for
each registration statement filed by the Company during the five (5) year period following the Initial Exercise Date until such
time as all of the Registrable Securities have been sold by the Holder. The holders of the Registrable Securities shall exercise
the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice within ten (10) days of the receipt of the Company&rsquo;s
notice of its intention to file a registration statement. Except as otherwise provided in this Warrant, there shall be no limit
on the number of times the Holder may request registration under this Section 5.2.2; provided, however, that such registration
rights shall terminate on the third anniversary of the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.3</U>
<U>General Terms</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
<U>Indemnification</U>. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration
statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act
or Section 20 (a) of the Exchange Act against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo;
fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any
of them may become subject under the Securities Act, the Exchange Act or otherwise, arising from such registration statement but
only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters
contained in Section 5.1 of the Underwriting Agreement. The Holder(s) of the Registrable Securities to be sold pursuant to such
registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against all
loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act,
the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns,
in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the provisions
contained in Section 5.2 of the Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.3.2
Exercise of Warrants</U>. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants
prior to or after the initial filing of any registration statement or the effectiveness thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.3
<U>Documents Delivered to Holders</U>. The Company shall furnish to each Holder participating in any of the foregoing offerings
and to each underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an
opinion of counsel to the Company, dated the effective date of such registration statement (and, if such registration includes
an underwritten public offering, an opinion dated the date of the closing under any underwriting agreement related thereto), and
(ii) a &ldquo;cold comfort&rdquo; letter dated the effective date of such registration statement (and, if such registration includes
an underwritten public offering, a letter dated the date of the closing under the underwriting agreement) signed by the independent
registered public accounting firm which has issued a report on the Company&rsquo;s financial statements included in such registration
statement, in each case covering substantially the same matters with respect to such registration statement (and the prospectus
included therein) and, in the case of such accountants&rsquo; letter, with respect to events subsequent to the date of such financial
statements, as are customarily covered in opinions of issuer&rsquo;s counsel and in accountants&rsquo; letters delivered to underwriters
in underwritten public offerings of securities. The Company shall also deliver promptly to each Holder participating in the offering
requesting the correspondence and memoranda described below and to the managing underwriter, if any, copies of all correspondence
between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission
or its staff with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon
reasonable advance notice, with respect to information contained in or omitted from the registration statement as it deems reasonably
necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records
and properties and opportunities to discuss the business of the Company with its officers and independent auditors, all to such
reasonable extent and at such reasonable times as any such Holder shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.4
<U>Underwriting Agreement</U>. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any,
selected by any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter
shall be reasonably satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the
Company, each Holder and such managing underwriters, and shall contain such representations, warranties and covenants by the Company
and such other terms as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall
be parties to any underwriting agreement relating to an underwritten sale of their Registrable Securities and may, at their option,
require that any or all the representations, warranties and covenants of the Company to or for the benefit of such underwriters
shall also be made to and for the benefit of such Holders. Such Holders shall not be required to make any representations or warranties
to or agreements with the Company or the underwriters except as they may relate to such Holders, their Warrant Shares and their
intended methods of distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.5
<U>Documents to be Delivered by Holder(s)</U>. Each of the Holder(s) participating in any of the foregoing offerings shall furnish
to the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling
security holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.6
<U>Damages</U>. Should the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the
Company or the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or
other relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive)
relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving
actual damages and without the necessity of posting bond or other security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other
    rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss,
    Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
    satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant
    Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case
    of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
    if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
    in lieu of such Warrant or stock certificate.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Saturdays,
    Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
    or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding
    Trading Day.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorized
    Shares</U>.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above
the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares
upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be
necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jurisdiction</U>.
    All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in
    accordance with the provisions of the Underwriting Agreement.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restrictions</U>.
    The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder
    does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Nonwaiver
    and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
    operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any
    other provision of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with
    any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such
    amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo;
    fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in
    otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>.
    Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be
    delivered in accordance with the notice provisions of the Underwriting Agreement.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limitation
    of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
    purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
    of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
    by the Company or by creditors of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remedies</U>.
    The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
    to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
    for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
    assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Successors
    and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
    inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
    assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this
    Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment</U>.
    This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability</U>.
    Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
    law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
    ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the
    remaining provisions of this Warrant.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Headings</U>.
    The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part
    of this Warrant.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first
above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SAVE
    FOODS, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:
SAVE FOODS, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">_________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. If the Warrant is being exercised via cash exercise, the undersigned is an &ldquo;accredited investor&rdquo;
as defined in Regulation D promulgated under the Securities Act of 1933, as amended</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing warrant, execute</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
form and supply required information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Do
not use this form to exercise the warrant.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned
to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________
whose address is</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
______________, _______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&nbsp;_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration
or enlargement or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>9
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018
EQUITY INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Purposes of the Plan</U>. The purposes of this Plan are:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    attract and retain the best available personnel for positions of substantial responsibility,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    provide incentives to individuals who perform services for the Company, and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    promote the success of the Company&rsquo;s business.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan permits the grant of Incentive Stock Options, Non-statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted
Stock Units, Performance Units, Performance Shares and other stock or cash awards as the Administrator may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Definitions</U>. As used herein, the following definitions will apply:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Administrator</U>&rdquo; means the Board or any of its Committees as will be administering the Plan, in accordance with
Section 4 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<U>Affiliate</U>&rdquo; means any corporation or any other entity (including, but not limited to, partnerships and joint
ventures) controlling, controlled by, or under common control with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<U>Applicable Laws</U>&rdquo; means the requirements relating to the administration of equity-based awards under U.S. federal
and state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the
Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction where Awards are, or will be,
granted under the Plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<U>Award</U>&rdquo; means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights,
Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares and other stock or cash awards as the Administrator
may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<U>Award Agreement</U>&rdquo; means the written agreement setting forth the terms and provisions applicable to each Award
granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<U>Board</U>&rdquo; means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<U>Change in Control</U>&rdquo; means the occurrence of any of the following events after the Effective Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group
    (&ldquo;<U>Person</U>&rdquo;), acquires ownership of stock in the Company that, together with the stock already held by such
    Person, constitutes more than 50% of the total voting power of the stock of the Company; provided, however, that for purposes
    of this subsection (i), the acquisition of additional stock by any Person who is considered to own more than 50% of the total
    voting power of the stock of the Company before the acquisition will not be considered a Change in Control; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    individuals who constitute the members of the Board cease, by reason of a financing, merger, combination, acquisition, takeover
    or other non-ordinary course transaction affecting the Company, to constitute at least fifty-one percent (51%) of the members
    of the Board; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of any of the following events: (A) a change in the ownership of a substantial portion of the Company&rsquo;s
    assets, which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the
    date of the most recent acquisition by such Person) assets from the Company that have a total gross fair market value equal
    to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition
    or acquisitions, or (B) a merger, consolidation or reorganization involving the Company, where either or both of the events
    described in clauses (i) or (ii) above would be the result. For purposes of this subsection (iii), the following will not
    constitute a change in the ownership of a substantial portion of the Company&rsquo;s assets or a Change in Control: (A) a
    transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (B) a transfer
    of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with
    respect to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly
    or indirectly, by the Company, (3) a Person that owns, directly or indirectly, 50% or more of the total value or voting power
    of all the outstanding stock of the Company, or (4) an entity, at least 50% of the total equity or voting power of which is
    owned, directly or indirectly, by a Person described in subsection (iii)(B)(3) above. For purposes of this subsection (iii),
    gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined
    without regard to any liabilities associated with such assets.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Section 2(g), persons will be considered to be acting as a group if they are owners of a corporation or other
entity that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<U>Code</U>&rdquo; means the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code herein will
be a reference to any successor or amended section of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<U>Committee</U>&rdquo; means a committee of Directors or of other individuals satisfying Applicable Laws appointed by
the Board in accordance with Section 4 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<U>Common Stock</U>&rdquo; means the common stock, par value $0.0001 per share, of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<U>Company</U>&rdquo; means Save Foods Inc., a Delaware corporation, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<U>Consultant</U>&rdquo; means any person, including an advisor, other than an Employee engaged by the Company or a Parent,
Subsidiary or Affiliate to render services to such entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
This section is left intentionally blank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<U>Director</U>&rdquo; means a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<U>Disability</U>&rdquo; means permanent and total disability as defined in Section 22(e)(3) of the Code, provided that
in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent
and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time
to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<U>Effective Date</U>&rdquo; shall have the meaning set forth in Section 18 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<U>Employee</U>&rdquo; means any person, including Officers and Directors, other than a Consultant employed by the Company
or any Parent, Subsidiary or Affiliate of the Company. Neither service as a Director nor payment of a director&rsquo;s fee by
the Company will be sufficient to constitute &ldquo;employment&rdquo; by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<U>Exchange Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<U>Exchange Program</U>&rdquo; means a program under which (i) outstanding Awards are surrendered or cancelled in exchange
for Awards of the same type (which may have lower exercise prices and different terms), Awards of a different type, and/or cash,
and/or (ii) the exercise price of an outstanding Award is reduced. The Administrator will determine the terms and conditions of
any Exchange Program in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&ldquo;<U>Fair Market Value</U>&rdquo; means, as of any date, the value of the Common Stock as the Administrator may determine
in good faith, by reference to the closing price of such stock on any established stock exchange or on a national market system
on the day of determination, if the Common Stock is so listed on any established stock exchange or on a national market system.
If the Common Stock is not listed on any established stock exchange or on a national market system, the value of the Common Stock
will be determined as the Administrator may determine in good faith using (i) a valuation methodology set forth in Treasury Regulation
1.409A-1(b)(5)(iv)(B) or (ii) with respect to valuations applicable to Awards that are not subject to Code Section 409A, such
other valuation methods as the Administrator may select.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<U>Fiscal Year</U>&rdquo; means the fiscal year of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<U>Incentive Stock Option</U>&rdquo; means an Option that by its terms qualifies and is otherwise intended to qualify as
an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<U>Non-statutory Stock Option</U>&rdquo; means an Option that by its terms does not qualify or expressly provides that
it is not intended to qualify as an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<U>Officer</U>&rdquo; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange
Act and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<U>Option</U>&rdquo; means a stock option granted pursuant to Section 6 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<U>Parent</U>&rdquo; means a &ldquo;parent corporation,&rdquo; whether now or hereafter existing, as defined in Section
424(e) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<U>Participant</U>&rdquo; means the holder of an outstanding Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<U>Performance Goals</U>&rdquo; will have the meaning set forth in Section 11 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<U>Performance Period</U>&rdquo; means any Fiscal Year of the Company or such other period as determined by the Administrator
in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<U>Performance Share</U>&rdquo; means an Award denominated in Shares which may be earned in whole or in part upon attainment
of Performance Goals or other vesting criteria as the Administrator may determine pursuant to Section 10 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&ldquo;<U>Performance Unit</U>&rdquo; means an Award which may be earned in whole or in part upon attainment of Performance Goals
or other vesting criteria as the Administrator may determine and which may be settled for cash, Shares or other securities or
a combination of the foregoing pursuant to Section 10 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&ldquo;<U>Period of Restriction</U>&rdquo; means the period during which transfers of Shares of Restricted Stock are subject to
restrictions and, therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the
passage of time, the achievement of target levels of performance, or the occurrence of other events specified in the applicable
Award, as interpreted and construed by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
&ldquo;<U>Plan</U>&rdquo; means this 2018 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<U>Restricted Stock</U>&rdquo; means Shares issued pursuant to an Award of Restricted Stock under Section 8 hereof, or
issued pursuant to the early exercise of an Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&ldquo;<U>Restricted Stock Unit</U>&rdquo; means a bookkeeping entry representing an amount equal to the Fair Market Value of
one Share, granted pursuant to Section 9 hereof. Each Restricted Stock Unit represents an unfunded and unsecured obligation of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&ldquo;<U>Rule 16b-3</U>&rdquo; means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion
is being exercised with respect to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
&ldquo;<U>Section 16(b)</U>&rdquo; means Section 16(b) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&ldquo;<U>Service Provider</U>&rdquo; means an Employee, Director or Consultant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
&ldquo;<U>Share</U>&rdquo; means a share of Common Stock, as adjusted in accordance with Section 14 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
&ldquo;<U>Stock Appreciation Right</U>&rdquo; means an Award, granted alone or in connection with an Option, that pursuant to
Section 7 is designated as a Stock Appreciation Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
&ldquo;<U>Subsidiary</U>&rdquo; means a &ldquo;subsidiary corporation,&rdquo; whether now or hereafter existing, as defined in
Section 424(f) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Stock Subject to the Plan</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Maximum Aggregate Number of Shares</U>. Subject to the provisions of Section 13 hereof, the maximum aggregate number of Shares
that may be awarded and sold under the Plan is 20,000,000. The Shares may be authorized, but unissued, or reacquired Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lapsed Awards</U>. If an Award expires or becomes unexercisable without having been exercised in full, or, with respect to
Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units, is forfeited to or repurchased by the Company,
the unpurchased Shares (or for Awards other than Options and Stock Appreciation Rights, the forfeited or repurchased Shares) which
were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated). Upon exercise
of a Stock Appreciation Right settled in Shares, the gross number of Shares covered by the portion of the Award so settled will
cease to be available under the Plan. Shares that have actually been issued under the Plan under any Award will not be returned
to the Plan and will not become available for future distribution under the Plan; provided, however, that if unvested Shares of
Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units are repurchased by the Company or are forfeited
to the Company, such Shares will become available for future grant under the Plan. Shares subject to an Award that are transferred
to or retained by the Company to pay the tax and/or exercise price of an Award will become available for future grant or sale
under the Plan. To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result
in reducing the number of Shares available for issuance under the Plan and, for the elimination of doubt, the number of Shares
of equal value to such cash payment shall become available for future grant or sale under the Plan. Notwithstanding the foregoing
provisions of this Section 3(b), subject to adjustment provided in Section 13 hereof, the maximum number of Shares that may be
issued upon the exercise of Incentive Stock Options will equal the aggregate Share number stated in Section 3(a) above, plus,
to the extent allowable under Section 422 of the Code, any Shares that become available for issuance under the Plan under this
Section 3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Share Reserve</U>. The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares
as will be sufficient to satisfy the requirements of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Administration of the Plan</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Procedure</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Multiple
    Administrative Bodies</U>. Different Committees may be established with respect to different groups of Service Providers;
    in that event, the Committee established with respect to a group of Service Providers shall administer the Plan with respect
    to Awards granted to members of such group.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rule
    16b-3</U>. To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated
    hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
    Administration</U>. Other than as provided above, the Plan will be administered by (A) the Board or (B) a Committee, which
    committee will be constituted to satisfy Applicable Laws.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Powers of the Administrator</U>. Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific
duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.35in; text-align: justify">(i)</TD>
    <TD STYLE="text-align: justify">to determine Fair Market Value;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(ii)</TD>
    <TD STYLE="text-align: justify">to select the Service Providers to whom Awards may be granted hereunder;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(iii)</TD>
    <TD STYLE="text-align: justify">to determine the terms and condition, not inconsistent with the terms of the Plan, of any Award granted hereunder;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(iv)</TD>
    <TD STYLE="text-align: justify">to institute an Exchange Program and to determine the terms and conditions, not inconsistent with the terms of the Plan, for (1) the surrender or cancellation of outstanding Awards in exchange for Awards of the same type, Awards of a different type, and/or cash, or (2) the reduction of the exercise price of outstanding Awards;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(v)</TD>
    <TD STYLE="text-align: justify">to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(vi)</TD>
    <TD STYLE="text-align: justify">to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of satisfying applicable foreign laws;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(vii)</TD>
    <TD STYLE="text-align: justify">to modify or amend each Award (subject to Section 19(c) hereof);</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(viii)</TD>
    <TD STYLE="text-align: justify">to authorize any person to execute on behalf of the Company any instrument required to reflect or implement the grant of an Award previously granted by the Administrator;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(ix)</TD>
    <TD STYLE="text-align: justify">to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant under an Award pursuant to such procedures as the Administrator may determine consistent with the requirements for compliance with or exemption from the provisions of Code Section 409A; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(x)</TD>
    <TD STYLE="text-align: justify">to make all other determinations deemed necessary or advisable for administering the Plan.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Effect of Administrator&rsquo;s Decision</U>. The Administrator&rsquo;s decisions, determinations, and interpretations will
be final and binding on all Participants and any other holders of Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Eligibility</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>General Rule</U>. Non-statutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance
Units, Performance Shares, and such other cash or stock awards as the Administrator determines may be granted to Service Providers.
Incentive Stock Options may be granted only to Employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Stock Options</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Limitations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Option will be designated in the Award Agreement as either an Incentive Stock Option or a Non-statutory Stock Option. However,
    notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive
    Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company
    and any Parent or Subsidiary) exceeds $100,000 (U.S.), such Options will be treated as Non-statutory Stock Options. For purposes
    of this Section 6(a), Incentive Stock Options will be taken into account in the order in which they were granted. The Fair
    Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the limits set forth in Section 3, the Administrator will have complete discretion to determine the number of Shares subject
    to an Option granted to any Participant.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Term of Option</U>. The Administrator will determine the term of each Option in its sole discretion; provided, however, that
the term will be no more than ten (10) years from the date of grant thereof in the case of Incentive Stock Options. Moreover,
in the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive Stock Option is granted, owns
stock representing more than 10% of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary,
the term of the Incentive Stock Option will be five (5) years from the date of grant or such shorter term as may be provided in
the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Option Exercise Price and Consideration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
    Price</U>. The per share exercise price for the Shares to be issued pursuant to exercise of an Option will be determined by
    the Administrator. In the case of an Incentive Stock Option granted to an Employee who, at the time the Incentive Stock Option
    is granted, owns stock representing more than 10% of the voting power of all classes of stock of the Company or any Parent
    or Subsidiary, the per Share exercise price will be no less than 110% of the Fair Market Value per Share on the date of grant.
    Notwithstanding the foregoing provisions of this Section 6(c), Options may be granted with a per Share exercise price of less
    than 100% of the Fair Market Value per Share on the date of grant pursuant to the issuance or assumption of an Option in a
    transaction to which Section 424(a) of the Code applies in a manner consistent with said Section 424(a).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Waiting
    Period and Exercise Dates</U>. At the time an Option is granted, the Administrator will fix the period within which the Option
    may be exercised and will determine any conditions that must be satisfied before the Option may be exercised.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Form
    of Consideration</U>. The Administrator will determine the acceptable form(s) of consideration for exercising an Option, including
    the method of payment, to the extent permitted by Applicable Laws.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Exercise of Option</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Procedure
    for Exercise; Rights as a Stockholder</U>. Any Option granted hereunder will be exercisable according to the terms of the
    Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement.
    An Option may not be exercised for a fraction of a Share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Option will be deemed exercised when the Company receives: (i) notice of exercise (in such form as the Administrator specifies
from time to time) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which
the Option is exercised (together with any applicable withholding taxes). No adjustment will be made for a dividend or other right
for which the record date is prior to the date the Shares are issued, except as provided in Section 14 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
    of Relationship as a Service Provider</U>. If a Participant ceases to be a Service Provider, other than upon the Participant&rsquo;s
    termination as the result of the Participant&rsquo;s death or Disability, the Participant may exercise his or her Option within
    such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of termination
    (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence
    of a specified time in the Award Agreement, the Option will remain exercisable for three (3) months following the Participant&rsquo;s
    termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as
    to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination
    the Participant does not exercise his or her Option within the time specified by Award Agreement or by operation of this Section
    6(d)(3), the Option will terminate, and the Shares covered by such Option will revert to the Plan.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disability
                                         of Participant</U>. If a Participant ceases to be a Service Provider as a result of the
                                         Participant&rsquo;s Disability, the Participant may exercise his or her Option within
                                         such period of time as is specified in the Award Agreement to the extent the Option is
                                         vested on the date of cessation (but in no event later than the expiration of the term
                                         of such Option as set forth in the Award Agreement). In the absence of a specified time
                                         in the Award Agreement, the Option will remain exercisable for six (6) months following
                                         the date the Participant ceases to be a Service Provider. Unless otherwise provided by
                                         the Administrator, if on the date of cessation the Participant is not vested as to his
                                         or her entire Option, the Shares covered by the unvested portion of the Option will revert
                                         to the Plan. If after cessation the Participant does not exercise his or her Option within
                                         the time specified herein, the Option will terminate, and the Shares covered by such
                                         Option will revert to the Plan.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Death
    of Participant</U>. If a Participant dies while a Service Provider, the Option may be exercised within such period of time
    as is specified in the Award Agreement to the extent that the Option is vested on the date of death (but in no event may the
    option be exercised later than the expiration of the term of such Option as set forth in the Award Agreement), by the Participant&rsquo;s
    beneficiary, provided such beneficiary has been designated prior to Participant&rsquo;s death in a form acceptable to the
    Administrator. If no such beneficiary has been designated by the Participant, then such Option may be exercised by the personal
    representative of the Participant&rsquo;s estate or by the person(s) to whom the Option is transferred pursuant to the Participant&rsquo;s
    will or in accordance with the laws of descent and distribution. In the absence of a specified time in the Award Agreement,
    the Option will remain exercisable for six (6) months following Participant&rsquo;s death. Unless otherwise provided by the
    Administrator, if at the time of death Participant is not vested as to his or her entire Option, the Shares covered by the
    unvested portion of the Option will continue to vest in accordance with the Award Agreement. If the Option is not so exercised
    within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Stock Appreciation Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Grant of Stock Appreciation Rights</U>. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be
granted to Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Number of Shares</U>. The Administrator will have complete discretion to determine the number of Stock Appreciation Rights
granted to any Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exercise Price and Other Terms</U>. The Administrator, subject to the provisions of the Plan, will have complete discretion
to determine the terms and conditions of Stock Appreciation Rights granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Stock Appreciation Rights Agreement</U>. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will
specify the exercise price, the number of Shares with respect to which the Award is granted, the term of the Stock Appreciation
Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Expiration of Stock Appreciation Rights</U>. A Stock Appreciation Right granted under the Plan will expire upon the date determined
by the Administrator, in its sole discretion, and set forth in the Award Agreement; provided, however, that the term will be no
more than ten (10) years from the date of grant thereof. Notwithstanding the foregoing, the rules of Section 6(d) above also will
apply to Stock Appreciation Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Payment of Stock Appreciation Right Amount</U>. Upon exercise of a Stock Appreciation Right, a Participant will be entitled
to receive payment from the Company in an amount determined by multiplying:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -13.2pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.35in">(i)</TD>
    <TD STYLE="text-align: justify">The difference between the Fair Market Value of a Share on the date of exercise over the &ldquo;stock appreciation right exercise price,&rdquo; as defined under Treasury Regulation Section 1.409A-1(b)(i)(B)(2), <U>i.e</U>., the Fair Market Value of a Share on the date of grant of the Stock Appreciation Right; times</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(ii)</TD>
    <TD STYLE="text-align: justify">The number of Shares with respect to which the Stock Appreciation Right is exercised.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent
value, or in some combination thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Restricted Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Grant of Restricted Stock</U>. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time
to time, may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion,
will determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Restricted Stock Agreement</U>. Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the
Period of Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion,
will determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Transferability</U>. Except as provided in this Section 8, Shares of Restricted Stock may not be sold, transferred, pledged,
assigned, or otherwise alienated or hypothecated until such Shares become non-forfeitable at the end of the applicable Period
of Restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Other Restrictions</U>. The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted
Stock as it may deem advisable or appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Removal of Restrictions</U>. Except as otherwise provided in this Section 8, Shares of Restricted Stock covered by each Restricted
Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction.
The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Voting Rights</U>. During the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder
may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise in a manner not prohibited
by the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Dividends and Other Distributions</U>. During the Period of Restriction, Service Providers holding Shares of Restricted Stock
will be entitled to receive all dividends and other distributions paid with respect to such Shares unless otherwise provided in
the Award Agreement. If any such dividends or distributions are paid in Shares, the Shares will be subject to the same restrictions
on transferability and provisions for forfeiture as the Shares of Restricted Stock with respect to which they were paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Return of Restricted Stock to Company</U>. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions
have not lapsed will revert to the Company and again will become available for grant under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Tax
Law Changes</U>. The recently-enacted Tax Cuts and Jobs Act of 2017 (&ldquo;TCJA&rdquo;) repealed the
&ldquo;performance-based compensation&rdquo; exemption for awards granted after November 2, 2017. Accordingly, this Plan does
not include certain grants of awards intended to qualify as &ldquo;performance-based compensation&rdquo; under Section 162(m)
of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;). We cannot exchange outstanding options or stock
appreciation rights for full value awards, such as restricted stock or restricted stock units, at a time when the exercise
price for such options or stock appreciation rights exceed the then current fair market value of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Restricted Stock Units</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Grant</U>. Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator. Each
Restricted Stock Unit grant will be evidenced by an Award Agreement that will specify such other terms and conditions as the Administrator,
in its sole discretion, will determine in accordance with the terms and conditions of the Plan, including all terms, conditions,
and restrictions related to the grant, the number of Restricted Stock Units and the form of payout, which, subject to Section
9(d) hereof, may be left to the discretion of the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Vesting Criteria and Other Terms</U>. The Administrator will set vesting criteria in its discretion, which, depending on the
extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant.
After the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any restrictions for
such Restricted Stock Units. Each Award of Restricted Stock Units will be evidenced by an Award Agreement that will specify the
vesting criteria, and such other terms and conditions as the Administrator, in its sole discretion will determine. The Administrator,
in its discretion, may accelerate the time at which any restrictions will lapse or be removed, subject to the prohibition on acceleration
of the timing of distribution of deferred compensation subject to Section 409A of the Code, to the extent applicable to the Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Earning Restricted Stock Units</U>. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive
a payout as specified in the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Form and Timing of Payment</U>. Payment of earned Restricted Stock Units will be made as soon as practicable after the date(s)
set forth in the Award Agreement, which shall satisfy the requirements of Section 409A of the Code, to the extent applicable to
such Award. The Administrator, in its sole discretion, may pay earned Restricted Stock Units in cash, Shares, or a combination
thereof. Shares represented by Restricted Stock Units that are fully paid in cash again will be available for grant under the
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Cancellation</U>. On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Performance Units and Performance Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Grant of Performance Units/Shares</U>. Performance Units and Performance Shares may be granted to Service Providers at any
time and from time to time, as will be determined by the Administrator, in its sole discretion. The Administrator will have complete
discretion in determining the number of Performance Units/Shares granted to each Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Value of Performance Units/Shares</U>. Each Performance Unit will have an initial value that is established by the Administrator
on or before the date of grant. Each Performance Share will have an initial value equal to the Fair Market Value of a Share on
the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Performance Objectives and Other Terms</U>. The Administrator will set performance objectives or other vesting provisions.
The Administrator may set vesting criteria based upon the achievement of Company-wide, business unit, or individual goals (including,
but not limited to, continued employment), or any other basis determined by the Administrator in its discretion. Each Award of
Performance Units/Shares will be evidenced by an Award Agreement that will specify the Performance Period, and such other terms
and conditions as the Administrator, in its sole discretion, will determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Earning of Performance Units/Shares</U>. After the applicable Performance Period has ended, the holder of Performance Units/Shares
will be entitled to receive a payout of the number of Performance Units/Shares earned by the Participant over the Performance
Period, to be determined as a function of the extent to which the corresponding performance objectives or other vesting provisions
have been achieved. After the grant of a Performance Unit/Share, the Administrator, in its sole discretion, may reduce or waive
any performance objectives or other vesting provisions for such Performance Unit/Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Form and Timing of Payment of Performance Units/Shares</U>. Payment of earned Performance Units/Shares will be made as soon
as practicable after the expiration of the applicable Performance Period or, if earlier, after the date on which a Participant&rsquo;s
interest in such Performance Units/Shares is no longer subject to a substantial risk of forfeiture, provided however, that in
no event shall such payment be made after the later to occur of (i) December 31 of the year in which such risk of forfeiture lapses
or (ii) two and one-half months after such risk of forfeiture lapses. The Administrator, in its sole discretion, may pay earned
Performance Units/Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned
Performance Units/Shares at the close of the applicable Performance Period) or in a combination thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Cancellation of Performance Units/Shares</U>. On the date set forth in the Award Agreement, all unearned or unvested Performance
Units/Shares will be forfeited to the Company, and again will be available for grant under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Leaves of Absence</U>. Unless the Administrator provides otherwise, vesting of Awards granted hereunder will be suspended during
any unpaid leave of absence. A Service Provider will not cease to be an Employee in the case of (i) any leave of absence approved
by the Company, or (ii) transfers between locations of the Company or between the Company, its Parent, or any Subsidiary. For
purposes of Incentive Stock Options, no such leave may exceed three (3) months, unless reemployment upon expiration of such leave
is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so
guaranteed, then six (6) months and one day following the commencement of such leave any Incentive Stock Option held by the Participant
will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Transferability of Awards</U>. Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned,
hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be
exercised, during the lifetime of the Participant, only by the Participant. If the Administrator makes an Award transferable,
such Award may only be transferred (i) by will, (ii) by the laws of descent and distribution, (iii) to a revocable trust, or (iv)
as permitted by Rule 701 of the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Adjustments; Dissolution or Liquidation; Merger or Change in Control</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Adjustments</U>. In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities,
or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off,
combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure
of the Company affecting the Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or
potential benefits intended to be made available under the Plan, will adjust the number and class of Shares that may be delivered
under the Plan and/or the number, class, and price of Shares covered by each outstanding Award, and the numerical Share limits
set forth in Sections 3, 6, 7, 8, 9 and 10 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, the Administrator will
notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has
not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Change in Control</U>. In the event of a merger or Change in Control, each outstanding Award will be treated as the Administrator
determines, including, without limitation, that each Award will be assumed or an equivalent option or right substituted by the
successor corporation or a Parent or Subsidiary of the successor corporation (the &ldquo;<U>Successor Corporation</U>&rdquo;).
The Administrator will not be required to treat all Awards similarly in the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Successor Corporation does not assume or substitute for the Award, the Participant will fully vest in and have
the right to exercise all of his or her outstanding Options and Stock Appreciation Rights, including Shares as to which such Awards
would not otherwise be vested or exercisable, all restrictions on Restricted Stock will lapse, and, with respect to Restricted
Stock Units, Performance Shares and Performance Units, all Performance Goals or other vesting criteria will be deemed achieved
at target levels and all other terms and conditions met. In addition, if an Option or Stock Appreciation Right is not assumed
or substituted for in the event of a Change in Control, the Administrator will notify the Participant in writing or electronically
that the Option or Stock Appreciation Right will be fully vested and exercisable for a period of time determined by the Administrator
in its sole discretion, and the Option or Stock Appreciation Right will terminate upon the expiration of such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this subsection (c), an Award will be considered assumed if, following the Change in Control, the Award confers
the right to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration
(whether stock, cash, or other securities or property) or, in the case of a Stock Appreciation Right upon the exercise of which
the Administrator determines to settle in cash or a Performance Share or Performance Unit which the Administrator can determine
to settle in cash, the fair market value of the consideration received in the merger or Change in Control by holders of Common
Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the
type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration
received in the Change in Control is not solely common stock of the Successor Corporation, the Administrator may, with the consent
of the Successor Corporation, provide for the consideration to be received upon the exercise of an Option or Stock Appreciation
Right or upon the payout of a Performance Share or Performance Unit, for each Share subject to such Award (or in the case of Performance
Units, the number of implied shares determined by dividing the value of the Performance Units by the per share consideration received
by holders of Common Stock in the Change in Control), to be solely common stock of the Successor Corporation equal in fair market
value to the per share consideration received by holders of Common Stock in the Change in Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything in this Section 14(c) to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one or more
Performance Goals will not be considered assumed if the Company or its successor modifies any of such Performance Goals without
the Participant&rsquo;s consent; provided, however, a modification to such Performance Goals only to reflect the Successor Corporation&rsquo;s
post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Tax Withholding</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Withholding Requirements</U>. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof), the Company
will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient
to satisfy federal, state, local, foreign or other taxes (including the Participant&rsquo;s FICA obligation) required to be withheld
with respect to such Award (or exercise thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Withholding Arrangements</U>. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from
time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation)
(i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares having a Fair Market Value equal
to the minimum amount required to be withheld, (iii) delivering to the Company already-owned Shares having a Fair Market Value
equal to the amount required to be withheld, or (iv) selling a sufficient number of Shares otherwise deliverable to the Participant
through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to
the amount required to be withheld. The amount of the withholding requirement will be deemed to include any amount which the Administrator
agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state
or local marginal income tax rates applicable to the Participant with respect to the Award on the date that the amount of tax
to be withheld is to be determined. The Fair Market Value of the Shares to be withheld or delivered will be determined as of the
date that the taxes are required to be withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>No Effect on Employment or Service</U>. Neither the Plan nor any Award will confer upon a Participant any right with respect
to continuing the Participant&rsquo;s relationship as a Service Provider with the Company, nor will they interfere in any way
with the Participant&rsquo;s right or the Company&rsquo;s right to terminate such relationship at any time, with or without cause,
to the extent permitted by Applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>Date of Grant</U>. The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination
granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided
to each Participant within a reasonable time after the date of such grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>Term of Plan</U>. Subject to Section 22 hereof, the Plan will become effective upon its adoption by the Board (the &ldquo;<U>Effective
Date</U>&rdquo;). It will continue in effect for a term of ten (10) years unless terminated earlier under Section 19 hereof; provided,
however, that such expiration shall not affect Awards then outstanding, and the terms and conditions of this Plan shall continue
to apply to such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>Amendment and Termination of the Plan</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Amendment and Termination</U>. The Administrator may at any time amend, alter, suspend or terminate the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Stockholder Approval</U>. The Company will obtain stockholder approval of the Plan and any Plan amendment to the extent necessary
or desirable to comply with Applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Effect of Amendment or Termination</U>. No amendment, alteration, suspension, or termination of the Plan will impair the rights
of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in
writing and signed by the Participant and the Company. Termination of the Plan will not affect the Administrator&rsquo;s ability
to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<U>Conditions Upon Issuance of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Legal Compliance</U>. Shares will not be issued pursuant to the exercise of an Award unless the exercise of such Award and
the issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel
for the Company with respect to such compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Investment Representations</U>. As a condition to the exercise of an Award, the Company may require the person exercising such
Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without
any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is
required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Restrictive Legends</U>. All Award Agreements and all securities of the Company issued pursuant thereto shall bear such legends
regarding restrictions on transfer and such other legends as the appropriate officer of the Company shall determine to be necessary
or advisable to comply with applicable securities and other laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20. <U>Inability
to Obtain Authority</U>. The inability of the Company to obtain authority from any regulatory body having jurisdiction,
which authority is deemed by the Company&rsquo;s counsel to be necessary to the lawful issuance and sale of any Shares
hereunder, will relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such
requisite authority will not have been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<U>Stockholder Approval</U>. The Plan will be subject to approval by the stockholders of the Company within twelve (12) months
after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required
under Applicable Laws, including without limitation Section 422 of the Code. In the event that stockholder approval is not obtained
within twelve (12) months after the date the Plan is adopted by the Board, all Incentive Stock Options granted hereunder shall
be void <I>ab initio </I>and of no effect. Notwithstanding any other provisions of the Plan, no Awards shall be exercisable until
the date of such stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<U>Notification of Election Under Section 83(b) of the Code</U>. If any Service Provider shall, in connection with the acquisition
of Shares under the Plan, make the election permitted under Section 83(b) of the Code, such Service Provider shall notify the
Company of such election within ten (10) days of filing notice of the election with the Internal Revenue Service and provide the
Company with a copy thereof, in addition to any filing and a notification required pursuant to regulations issued under the authority
of Section 83(b) of the Code. A Service Provider shall not be permitted to make a Section 83(b) election with respect to an Award
of a Restricted Stock Unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.
<U>Notification Upon Disqualifying Disposition Under Section 421(b) of the Code</U>. Each Service Provider shall notify the Company
of any disposition of Shares issued pursuant to the exercise of an Incentive Stock Option under the circumstances described in
Section 421(b) of the Code (relating to certain disqualifying dispositions), within ten (10) days of such disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.
<U>409A Timing Rule for Specified Employees</U>. If at the time of a Service Provider&rsquo;s separation from service, such individual
is considered a &ldquo;specified employee&rdquo; within the meaning of Section 409A(a)(2)(B)(i) of the Code, and if any payment
that such Service Provider becomes entitled to under the Plan or any Award is deemed payable on account of such individual&rsquo;s
separation from service, then no such payment shall be made prior to the date that is the earlier of (i) six months and one day
after the individual&rsquo;s separation from service, or (ii) the individual&rsquo;s death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.
<U>Governing Law</U>. The law of the State of Delaware shall govern all questions concerning the construction, validity and interpretation
of this Plan, without regard to such state&rsquo;s conflict of laws rules, subject to the Company&rsquo;s intention that the Plan
satisfy the requirements of jurisdictions outside of the United States of America with respect to Awards subject to such jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.
<U>Rules Particular to Specific Countries</U>. Notwithstanding anything herein to the contrary, the terms and conditions of the
Plan may be adjusted with respect to a particular country by means of an addendum to the Plan in the form of an appendix (the
&ldquo;<B>Appendix</B>&rdquo;), and to the extent that the terms and conditions set forth in the Appendix conflict with any provisions
of the Plan, the provisions of the Appendix shall prevail. Terms and conditions set forth in the Appendix shall apply only to
Options and Shares issued to Optionees under the jurisdiction of the specific country that is subject of the Appendix and shall
not apply to Awards issued to any other Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Remainder
of the page intentionally left blank</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratified
and approved by the Board on October 18, 2018<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPENDIX
&ndash; ISRAEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
THE 2018 EQUITY INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">GENERAL</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Israeli Appendix (the &ldquo;Israeli Appendix&rdquo;) to the Save Foods Inc. 2018 Equity Incentive Plan (as amended from time
    to time) (the &ldquo;Plan&rdquo; and the &ldquo;Company&rdquo;, respectively) shall apply only to participants who are residents
    of the State of Israel or those who are deemed to be residents of the State of Israel for the purpose of payment of tax (the
    &ldquo;Israeli Optionees&rdquo;). The grant of Options to an Israeli Optionee shall be subject to the fulfillment of the conditions
    set forth below and pursuant to and subject to the terms and conditions set forth in the Plan. Capitalized terms used and
    not otherwise defined herein shall have the respective meanings ascribed to them in the Plan.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Israeli Appendix is to be read as a continuation of the Plan and only refers to Options granted to Israeli Optionees so that
    they comply with the requirements set by the Israeli law in general, and in particular with the provisions of Section 102
    (as defined below), and any regulations, rules, orders or procedures promulgated thereunder, as may be amended or replaced
    from time to time. For the avoidance of doubt, this Israeli Appendix does not add to nor modify the Plan in respect of Optionees
    who are non Israeli Optionees.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Plan and this Israeli Appendix are complementary to each other and shall be deemed one document. In any case of contradiction,
    whether explicit or implied, between the provisions of this Israeli Appendix and the Plan, the provisions set out in this
    Israeli Appendix shall prevail with respect to Options granted to Israeli Optionees.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">DEFINITIONS</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
following definitions shall be in effect under the Israeli Appendix:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Affiliate&rdquo;
    means any &ldquo;employing company&rdquo; within the meaning of Section 102(a) of the Ordinance.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Approved
    102 Option&rdquo; means an Option granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the
    benefit of the Optionee.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Controlling
    Shareholder&rdquo; means a &ldquo;controlling shareholder&rdquo; as defined in Section 32(9) of the Ordinance.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Employee&rdquo;
    means an Israeli Optionee who is employed by, or serving as a director or an Office Holder of, the Company or any other employee
    company [&#1495;&#1489;&#1512;&#1492; &#1502;&#1506;&#1489;&#1497;&#1491;&#1492;] as defined in Section 102(a) of the Ordinance;
    provided such employee, director or office holder is not a Controlling Shareholder.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(e)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;ITA&rdquo;
    means the Israeli Tax Authorities.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(f)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Non-Employee&rdquo;
    means an Israeli Optionee that is not an Employee, including an Israeli Optionee that (i) serves as a consultant, adviser,
    or service provider, or (ii) is a Controlling Shareholder.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(g)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Office
    Holder&rdquo; means an &ldquo;office holder&rdquo; as defined under the Israeli Companies Law, 1999.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(h)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;102
    Capital Gain Option&rdquo; means an Approved 102 Option elected and designated by the Company to qualify under the capital
    gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;102
    Option&rdquo; means any Option granted pursuant to Section 102.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(j)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;102
    Ordinary Income Option&rdquo; means an Approved 102 Option elected and designated by the Company to qualify under the ordinary
    income tax treatment in accordance with the provisions of Section 102(b)(1) of the Ordinance.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(k)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Ordinance&rdquo;
    means the Israeli Tax Ordinance (New Version), 1961.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(l)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Section
    102&rdquo; means Section 102 of the Ordinance and any regulations, rules, orders or procedures promulgated thereunder as now
    in effect or as hereafter amended.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(m)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;3(i)
    Option&rdquo; means an Option granted pursuant to Section 3(i) of the Ordinance.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(n)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Trustee&rdquo;
    means any individual or entity appointed by the Company and approved by the ITA to serve as trustee of Approved 102 Options.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(o)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Unapproved
    102 Option&rdquo; means an Option granted pursuant to Section 102(c) of the Ordinance and not held in trust by a Trustee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ISSUANCE
    OF OPTIONS; ELIGIBILITY</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
    persons eligible for participation in the Plan under the Israeli Appendix shall include any Employees or Non-Employees of
    the Company or of any Affiliate; provided, however, that (i) Employees may only be granted 102 Options; and (ii) Non-Employees
    may only be granted 3(i) Options.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 0.5in; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
    Company may designate Options granted to Employees as Approved 102 Options or Unapproved 102 Options.</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
    grant of Approved 102 Options shall be made under this Israeli Appendix and shall be conditioned upon the approval of this
    Israeli Appendix by the ITA.</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Approved
    102 Options may either be classified as 102 Capital Gain Options (&ldquo;CGOs&rdquo;) or 102 Ordinary Income Options (&ldquo;OIOs&rdquo;).</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(e)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">No
    Approved 102 Options may be granted under this Israeli Appendix to any Employee, unless and until the Company elects to classify
    its Approved 102 Options as CGOs or OIOs and appropriately files notice of such election with the ITA (the &ldquo;Election&rdquo;).
    The Election shall become effective beginning the first date of grant of an Approved 102 Option under this Israeli Appendix
    and may not be changed until the end of the year following the year during which the Company first granted Approved 102 Options
    under such Election. The Election shall obligate the Company to grant only the type of Approved 102 Option it has elected,
    and shall apply to all Employees who were granted Approved 102 Options during the time the Election is in effect, all in accordance
    with the provisions of Section 102(g) of the Ordinance. For the avoidance of doubt, such Election shall not prevent the Company
    from granting Unapproved 102 Options and 3(i) Options simultaneously.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(f)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">All
    Approved 102 Options must be held in trust by a Trustee, as described in Section &lrm;4 below.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(g)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
    terms and conditions upon which Options shall be issued and exercised shall be as specified in the Option Agreement to be
    executed pursuant to the Plan and to this Israeli Appendix. Each Option Agreement shall state, inter alia, the type of Option
    granted thereunder (whether a CGO, OIO, Unapproved 102 Option or a 3(i) Option).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">TRUSTEE</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
provisions of this Section shall apply with respect of Approved 102 Options:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Approved
    102 Options, any shares issued upon exercise of such Approved 102 Options and other shares received subsequently following
    any realization of rights, including without limitation, bonus shares, shall be allocated or issued to the Trustee and held
    for the benefit of the Optionee.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Approved
    102 Options and any shares received subsequently following exercise of 102 Options, shall be held by the Trustee for such
    period of time as required by Section 102 (the &ldquo;Holding Period&rdquo;).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
    Optionee shall not be entitled to sell or release from trust the Approved 102 Options or shares issued upon their exercise,
    until the lapse of the Holding Period.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
    the event the requirements of Section 102 are not met, the Optionee shall not be entitled to the tax treatment available for
    Approved 102 Options and the Approved 102 Options may be regarded as Unapproved 102 Options, all in accordance with the provisions
    of Section 102.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(e)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Notwithstanding
    anything to the contrary, the Trustee may hold the release of any Approved 102 Options or shares issued upon exercise of Approved
    102 Options, until the full payment of the Optionee&rsquo;s tax liabilities arising in respect thereof.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(f)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">As
    a condition for issuance of Approved 102 Options, the Israeli Optionee shall execute an undertaking, in form to be provided
    by the Company, acknowledging the terms of issuance under Section 102 and releasing the Trustee from any liability for actions
    or decisions made in good faith by the Trustee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">FAIR
    MARKET VALUE FOR TAX PURPOSES</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Without
derogating from the definition of &ldquo;Fair Market Value&rdquo; included in the Plan, if at the date of grant the Company&rsquo;s
shares are listed on any established stock exchange or a national market system or will be registered for trading within ninety
(90) days following the date of grant, then solely for the purpose of determining the tax liability of CGOs pursuant to Section
102(b)(3) of the Ordinance, the fair market value of the shares shall be determined in accordance with the average value of the
Company&rsquo;s shares on the thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following
the date of registration for trading, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">EXERCISE
    OF OPTIONS</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Options
    shall be exercised by the Optionee in accordance with the terms of the Plan, but in any event, in accordance with the instructions
    of the Trustee and the requirements of Section 102.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">If
    the Optionee ceases to be employed or engaged by the Company or any Affiliate, then at the request of the Company, the Optionee
    shall extend to the Company and/or its Subsidiaries a security or guarantee for the payment of tax due at the time of sale
    of shares, pursuant to the Company&rsquo;s policies and in accordance with any applicable provisions of Section 102.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">RESTRICTIONS
    ON ASSIGNABILITY AND SALE OF OPTIONS</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Without
derogating from any restriction on assignability or transferability specified in the Plan, as long as Options issued under this
Israeli Addendum or Shares purchased upon exercise of such Options and/or any other securities issued with respect thereto, are
held by the Trustee for the benefit of an Israeli Optionee, such Israeli Optionee may not transfer, assign, pledge or mortgage
any rights with respect of the Options and/or the shares to which they are exercisable (as applicable), other than by will or
laws of descent and distribution. The terms of this Israeli Addendum and the Plan shall be binding on the executors, administrators,
heirs, and successors of Options. Notwithstanding the foregoing, if any such sale, assignment, pledge, mortgate or release occurs
during the Holding Period, the sanctions under Section 102 of the Ordinance shall apply to and shall be borne by the Israeli Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">TAX
    CONSEQUENCES</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Without
    derogating from the Plan, the Trustee may withhold taxes according to requirements of applicable laws, rules and regulations,
    including withholding taxes at source, from any payment to the Optionee. Furthermore, the Israeli Optionee shall indemnify
    the Company, its Subsidiaries and the Trustee and hold them harmless from and against any and all liability for any such tax
    or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have
    withheld, any such tax from any payment made to the Optionee.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
    Company and the Trustee shall not be required to release any Options, shares, or share certificate to an Israeli Optionee
    until all required payments have been fully made and satisfactory evidence was provided to the Company and the Trustee.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Neither
    the Corporation and/or Subsidiary nor the Board shall have any liability to any Israeli Optionee, or to any other party, if
    an Option (or any portion thereof) that is intended to be qualified as Capital Gain Option is determined by the Board, ITA
    or the Trustee not to be qualified as Capital Gain Option.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">GOVERNING
    LAW &amp; JURISDICTION</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Israeli Appendix shall be governed by, construed and enforced in accordance with the laws of the State of Israel, without giving
effect to the principles of conflict of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*******</FONT></P>



<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>10
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Advisory Consulting Agreement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Corporate Advisory Consulting Agreement (this &ldquo;Agreement&rdquo;), is made as of August 30, 2017, between Save Foods,
Inc., a Delaware corporation, having its principal place of business located at C.O: Earthbound LLC, 156 Fifth Avenue, Floor
10, New York, NY 10010-7751156 USA (the &ldquo;Company&rdquo;) and Goldmed Ltd. an cornpany organized under the laws of the
state of Israel, having an address Herzl Rosenblum St 6 Tel Aviv, Israel under the control of Prof. Benad Goldwassr (the
&ldquo;Consultant&rdquo;), the Company and the Consultant are sometimes referred to individually, as a &ldquo;Party&rdquo;
and collectively, as the &ldquo;Parties.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Consultant has the professional expertise and is experienced in managing companies and has agreed to the Company&rsquo;s request
to serve as the Company active chairman (&ldquo;the Services&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Consultant will be providing services, within his field of expertise, to the Company commencing on May 1, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Company desires to engage the Consultant as an independent contractor for the Services, set forth in Section 1 below; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">D.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Parties agree that this Agreement reflects
the entire understanding and agreement between the Parties on the subject matter herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>NOW,
THEREFORE, </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration of the premises
and promises, warranties and representations Herein contained, it is agreed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<FONT STYLE="background-color: white">Services: </FONT></B>The Consultant will provide the Company the Service solely by Prof.
Benad Goldwasser, who will serve as the active Chairman of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Compensation:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In consideration for this Services, the Company shall pay the Consultant US$5,000 per month. Until the Company will raise at
least SIMM the Consultant will be paid in cash only $3,000 monthly, and the balance of $2,000 will be accrued as debt of the
company to the Consultant, which will be paid out to the $1MM funding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
After the Company will raise additional $1MM (altogether $2MM) the Consultant compensation will be increased to $ 10,000 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
In addition, for its services as director in the Pimi Agro Cleantech LTD., a subsidiary of the Company, the Company will issue
to Prof. Goldwasser under its ESOP 1,500,000 warrants to purchase shares of Common Stock of the Company at an exercise price of
2 cents <FONT STYLE="background-color: white"><B>(&ldquo;The Warrants&rdquo;). </B></FONT>The Warrants will be vested on a period
of 36 months every 3 months. If the company will terminate the agreement with the Consultant, prior to the end of the vesting
period, for no cause, Prof. Goldwasser will be entitled to acceleration of all the Warrants which have not been vested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<FONT STYLE="background-color: white">Term: </FONT></B>This Agreement shall survive for at least 12 months and could be terminated
thereafter (after 31.5.2018) by each party be giving upon 90 days advanced notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
<FONT STYLE="background-color: white">Independent Contractor: </FONT></B>The Consultant understands and acknowledges that since
the Consultant is an independent contractor of but is not an employee of the Company. As a result, the Company will not withhold
income taxes or pay any employee taxes on its behalf, nor will the Consultant receive any benefits of an employee. The Consultant
does hereby indemnify and hold harmless the Company from and against any and all claims, liabilities, demands, losses or expenses
incurred by the Company if the Consultant fails to pay any applicable income and/or employment taxes (including interest or penalties
of whatever nature), in any amount, relating to the Consultant&rsquo;s past Services to the Company, including any attorney&rsquo;s
fees or costs to the prevailing party to enforce this indemnity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
<FONT STYLE="background-color: white">Representations and Warranties: </FONT></B>For the purposes of this Agreement, the Consultant
represents and warrants as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Consultant is duly organized and validly existing under the laws of it state of organization and has full power and authority
to enter into this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
All information that the Consultant has provided to the Company concerning the Consultant and the Consultant&rsquo;s knowledge
of matters, or, is correct and complete as of the date of this Agreement and may be relied upon by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
In rendering the Services hereunder, the Consultant agrees to comply with all applicable federal and state securities laws, the
rules and regulations thereunder, the rules and regulations of the SEC and of any exchange or quotation service on which the Company&rsquo;s
securities are listed and/or subject to quotation and the rules and regulations of the National Association of Securities Dealers,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
<FONT STYLE="background-color: white">No Third-Party Rights: </FONT></B>The Parties warrant and represent that they are authorized
to enter this Agreement and that no third parties, other than the Parties hereto, have any interest in any of the Services contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7pt; text-align: justify; text-indent: 0.5in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
<FONT STYLE="background-color: white">Governing Law/Arbitration: </FONT></B>This Agreement shall be governed by and construed
in accordance with the laws of the State of New York. Any dispute arising under or related to this Agreement or the construction
or application of this Agreement, any claim arising out of this Agreement or its breach, shall be submitted to arbitration in
New York County, State of New York, before one arbitrator in accordance with the Commercial Arbitration Rules of the American
Arbitration Association, upon the written request of one Party after service of that request on the other Party. The cost of arbitration
shall be borne by the losing Party. The arbitrator is also authorized to award reasonable attorney&rsquo;s fees to the prevailing
Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
<FONT STYLE="background-color: white">Validity: </FONT></B>If any paragraph, sentence, term or provision hereof shall be held
to be invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect Arbitration Association, upon
the written request of one Party after service of that request on the other Party. The cost of arbitration shall be borne by the
losing Party. The arbitrator is also authorized to award reasonable attorney&rsquo;s fees to the prevailing Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
<FONT STYLE="background-color: white">Validity: </FONT></B>If any paragraph, sentence, term or provision hereof shall be held
to be invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect the validity enforceability
of any other paragraph, sentence, term and provision hereof. To the extent required, any paragraph, sentence, term or provision
of this Agreement may be modified by the parties hereto by written amendment to preserve its validity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
<FONT STYLE="background-color: white">Entire Agreement: </FONT></B>This Agreement contains the entire understanding of the Parties
on the subject matter hereof and cannot be altered or amended except by an amendment duly executed by all Parties hereto. This
Agreement shall be binding upon and inure to the benefit of the successors, assigns and personal representatives of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Parties hereto have executed this Agreement effective as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Save Foods, Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consultant</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 43%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 43%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/ Nimrod Ben Yehuda</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/ Benad Goldwasser</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nimrod Ben Yehuda</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CEO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>11
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:
Adv. Eitan Shmueli</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pimi
Agro Cleantech Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Kibbutz
Alonim</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28
September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:
<U>Engagement Letter</U><U> for Accounting Services</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
enjoyed our meeting and am honored to hereby submit an offer of my services for services related to auditing and advisory services
to Pimi Agro Cleantech Ltd. (&ldquo;PIMI&rdquo;) and Save Foods Inc. (&ldquo;SAFO&rdquo;), of which is quoted on the OTCQB Market.
I am certain that our offices is capable of providing the personal, loyal and professional services that you desire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shlomo
Zakai, CPA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shlomo
Zakai, CPA, is a certified accountant since 1998. Mr. Zakai has extensive experience in auditing, preparation of financial statements
and consulting. He is experienced in providing advice to publicly traded companies in Israel and abroad, and is particularly experienced
in matters related to US GAAP and IFRS. Mr. Zakai&rsquo;s offices serve as account managers and financial officers for a number
of companies and provide services in matters of implementing control reports and Sarbanes Oxley, specifically for Israeli public
companies that are traded in Israel and on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Zakai&rsquo;s office was formed in 2000 by Mr. Zakai, and had a stated purpose of providing a variety of financial services to
customers of various sizes through methods and an approach that places an emphasis on availability and accessability, quality
and professionalism, and without compromise. Mr. Zakai&rsquo;s office offers services of managing accounts also to private companies
as well as public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Zakai&rsquo;s office staff includes accountants, interns and account managers with extensive experience in the required areas
of practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Activities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
was discussed during our meeting, the company at issue develop and sell chemicals that are designed to extend the shelf life of
vegetables and fruits. The company is interested in expanding its scope of activity and, to such end, is interested in raising
capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-top: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Required Services and Fees</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    (excluding VAT)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="width: 55%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditing
    financial statements and income tax reports for year-end 2016 per income tax laws in Israel for Pimi.</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIS
    13,000 (pre-approved)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation
    of English report per US GAAP for consolidated statements for SAFO.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation
    of report to be submitted to OTCQB for SAFO per method of Alternative Reporting for December 31, 2016, which will include
    Pimi results for December 31, 2016, as discussed in previous clause.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIS
    6,000</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manage
    monthly accounting services on an ongoing basis in USD and NIS. Includes preparation of and issuance of receipts to customers
    and assistance in managing payments with suppliers.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NIS
    2,500 per month.</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif">&#9675;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 47%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manage
    account with ZOOM, in cloud service that allows users to watch in real time the findings of the accounting staff. The company
    will pay for the monthly fees related to software.</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable for up to five employees.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine
    work structure that will ensure capable work product.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products
    will be passed to the company on a bi-weekly basis.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    System Restoration for 2017 - Bookkeeping material is currently fed to the Accounting System and NIS only. Manually transfer
    all of the bookkeeping operations of 2017 to September 30, 2017.</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIS
    6,000</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bookkeeping
    and account management services include:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supervising
    account management of the company.</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Phase
    A &ndash; fee is per hour with average fee set at NIS 170 NIS per hour.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation
    of financial reports required on a quarterly basis/annual basis to the SEC and assistance in audit reports for the company.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Phase B
    &ndash; Following six months of work, reassessment of scope of services and hours worked, and renegotiated per budget<FONT STYLE="font-size: 10pt">.</FONT></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
    of budget and forecasts as may be required.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-top: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
am confident that our offices can provide you with the personal, quality-driven and dedicated services that will best assist the
company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
would be happy to answer any additional questions or clarify any of the aforementioned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regards,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shlomo
Zakai, CPA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Shlomo Zakai</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>12
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SERVICES
AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Services Agreement (the &ldquo;<B>Agreement</B>&rdquo;) is made and entered into this 10 day of October 2018, by and between <B>Pimi
Agro Cleantech Ltd</B>., registration number 51-349712-3, a company organized and registered under the laws of the State of Israel
with address at POB 360, Yokneam, Israel (the &ldquo;<B>Company</B>&rdquo;), and <B>Mr. Dan Sztybel (&ldquo;Sztybel&rdquo;) on
behalf of a company under his control</B>, Dan Sztybel Consulting Group Ltd., Israeli ID No. 313935561residing at Kazan 2/3, Raanana,
Israel (the &ldquo;<B>Contractor</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Company wishes to retain the services of the Contractor as an independent contractor, and the Contractor agrees to provide
services to the Company, as an independent contractor, as of the Commencement Date of Services (as defined hereunder) and throughout
the Term (as defined hereunder); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the parties desire to state the terms and conditions of the Contractor&rsquo;s engagement by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFOR</B>, in consideration of the mutual premises, covenants and undertakings contained herein, the parties hereto have hereby
agreed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Term</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractor&rsquo;s
Services with Company shall commence as of October, 2018 (&ldquo;<B>Commencement Date of Services</B>&rdquo;) and shall continue
in full force until terminated by either party as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Services</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
As of the Commencement Date of Services, the Contractor, shall provide the Company, personally by Mr. Sztybel and/or by personnel
under his supervision, in the name and on behalf of the Contractor, with VP Business Development services (the &ldquo;<B>Services</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
The Contractor shall provide the Services in a part-time position scope of 80% (eighty percent), on retainer basis, of which at
least one day a week Mr. Sztybel shall work at the Company premises and with respect to the remaining days of the week, Mr. Sztybel
may work from any location unless otherwise mutually determined by the Parties. The Parties further intend to enter into a full-time
position scope relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
The Contractor shall devote time, and efforts necessary to perform the Services under this Agreement, at a professional standard,
well and faithfully, to the Company&rsquo;s full satisfaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
The Contractor shall report to the Company&rsquo;s CEO, on the progress in the services&rsquo; provision on a monthly basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.
Equipment (if any) furnished to the Contractor by the Company for the purpose of the Services&rsquo; provision shall be the exclusive
property of the Company and shall be returned to the Company immediately upon the expiration or termination of this Agreement
for any reason whatsoever. The Contractor represent and warrant that they shall not transfer and/or use any equipment furnished
to him by the Company, other than for the purpose of the Services&rsquo; provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6.
The Contractor represent that there is no contractual or other legal restriction preventing or limiting him from entering into
this Agreement or performing any of his/her obligations hereunder. The Contractor shall immediately notify the Company of any
actual or potential conflict of interest that may arise with respect to their Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7.
The Contractor shall not have the authority to sign contracts on behalf of the Company or to otherwise bind the Company in any
manner whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Consideration</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
As final and total consideration for the Contractor&rsquo;s full performance of this Agreement and for the provision of Services,
the Company shall pay to the Contractor a monthly fee of 30,160 NIS (plus VAT) as of the Commencement Date. All payments shall
be made against issuance of a valid tax invoice by the Contractor at the end of each month. It is hereby agreed that against a
full time position scope, the Contractor&rsquo;s fees will be increased accordingly to a monthly fee of 37,700 NIS (plus VAT).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
<U>Mobile allowance</U>. The Contractor will be entitled to receive 250 NIS per month for cell phone expenses against issuance
of a valid tax invoice by the Contractor at the end of each month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.
<U>Car. </U>The Contractor will be entitled to car expenses reimbursement in the total monthly amount of 3,250 NIS plus VAT. Payments
of the car expenses by the Company under this paragraph are in lieu of traveling expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.
The fees shall be payable within 14 days following receipt of the Contractor&rsquo;s tax invoice by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5.
Withholdings shall be deducted at source from the payments made hereunder to the Contractor according to any applicable law. The
Contractor shall bear any tax imposed in connection with the payments and benefits provided hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.
The Company shall bear and reimburse The Contractor for all expenses incurred by him in rendering the Services under this Agreement
including but not limited to travel expenses, flights expenditures (business class) etc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.
In the event of the Employee&rsquo;s continuous employment with the Company at the date of grant by the Save Foods Inc., the Company&rsquo;s
parent company (hereinafter: &ldquo;<B>Save Foods</B>&rdquo;), to its and/or to Company&rsquo;s employees or service providers
of options to purchase Save Foods&rsquo; shares under employees&rsquo; stock option plan which Save Foods intend to adopt subject
to receipt of all approvals and permits required by the applicable law (the &ldquo;<B>Plan</B>&rdquo;), then the Company shall
recommend to the Board of Directors of Save Foods to grant the Mr. Sztybel 1,500,000 options to purchase up to 1,500,000 of Save
Foods&rsquo; ordinary shares under the Plan, as determined by the Save Foods&rsquo; sole discretion and subject to any approvals
required by the applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8.
Such options shall vest over 36 months period following the Commencement Date of Service, as follows: (a) 500,000 options shall
vest following 12 months as of the date of grant, (b) 125,000 options shall vest following the lapse of each 3 months period thereafter.
All other terms and conditions of the options shall be consistent to those applicable to other options grant to employees of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Proprietary Information</U></B>. As a condition precedent to the coming into force of this Agreement, The Contractor shall
execute the Confidential Information, Invention Assignment and Non-Competition Agreement attached hereto as <B><U>Annex A</U></B>
(the &ldquo;<B>Proprietary Rights Agreement</B>&rdquo;). The Proprietary Rights Agreement shall survive the termination of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Termination</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
Each party may terminate this Agreement at its discretion at any time by providing the other party with a 30 days prior written
notice of termination (the &ldquo;<B>Notice Period</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
During the Notice Period, The Contractor shall be obligated to continue to provide all of their Services and to take all steps,
satisfactory to Company, to ensure the orderly transition to any person or entity designated by the Company of all matters handled
by the Contractor in the framework of the Services provided to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
Notwithstanding the provisions of Section 5.2 above to the contrary, concurrently with, or at any time after a Termination Notice
is delivered by either party hereto, the Company shall be entitled to waive the Contractor&rsquo;s Services for the Company during
the Notice Period or any part thereof and/or terminate the business relationship prior to the completion of the Notice Period.
In such event the Company shall pay to the Contractor an indemnity in lieu of notice in an amount equal to the fees that the Contractor
would have received for the remaining part of the notice period, and payable on the same dates at which such fees would have received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.
Notwithstanding the above, the Company shall be entitled to terminate the Services hereunder with immediate effect and without
paying the Notice Period payments, where said termination is a Termination for Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement, the term &ldquo;<B>Termination for Cause</B>&rdquo; shall mean termination of Services as a result of
the occurrence of any one of the following: (a) a breach of trust or fiduciary duties, including but not limited to theft, embezzlement,
self-dealing, or breach of the provisions of the Proprietary Right Agreement; (b) any willful failure to perform or failure to
perform competently any of the Contractor&rsquo;s fundamental Services hereunder, or other breach of this Agreement, which was
not cured within ten (10) days of receipt by the Contractor of written notice thereof; (c) an event in which the Contractor deliberately
or gross negligently causes harm to the Company&rsquo;s business affairs or reputation; (d) conviction of the Contractor in a
crime or felony involving moral turpitude; or (e) other cause justifying termination of contract under applicable law, (collectively
&ldquo;<B>Cause</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.
Notwithstanding anything herein to the contrary and without derogating from the Company&rsquo;s rights pursuant to any applicable
law, in the event that the Contractor shall terminate his Services with the Company with immediate effect or upon shorter notice
than the Notice Period, the Company shall have the right to offset any payments to which Contractor shall have otherwise been
entitled for his Services hereunder during the Notice Period, or any part thereof, as the case may be, from any other payments
payable to Contractor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6.
No indemnity will be due by reason of expiration, termination, or non-renewal of this Agreement for any reason whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
<U>Relationship of the Parties; Indemnification.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
It is expressed and acknowledged that The Contractor are an independent contractor and that this Agreement does not create any
partnership, authority, agency or employer-employee relations between the Contractor and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
The Contractor alone shall be liable for payment of all the taxes, national insurance and any other compulsory payment applicable
to them in connection with its business, in connection with the Services provided by them to the Company and in connection with
the performance of any of its obligations pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.
Without derogating from the aforesaid, the parties agree that if, notwithstanding the agreement between them, it is in future
determined by any judicial instance that during the period of this Agreement, employer-employee relations existed between the
Contractor and/or anyone on his/her behalf, on the one hand, and the Company, on the other hand, and that she has the rights of
a hired employee vis-&agrave;-vis the Company in respect of the contractual relationship the subject of this Agreement, the following
provisions shall apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Contractor shall indemnify the Company in respect of any claim and/or demand submitted against the Company Mr. Sztybel in
    respect of employer-employee relations, within 14 days of receiving written demand, and including cover for the legal costs
    occasioned to the Company as a result of such demand and/or claim.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    it is determined that if any payment must be made to the Contractor and/or anyone on their behalf in respect of employer-employee
    relations as aforesaid, the remuneration of an &ldquo;employee&rdquo; providing services such as those that the Contractor
    or Mr. Sztybel is supposed to provide to the Company, from the date of commencement of the contractual relations between the
    parties, shall not exceed NIS 75 gross per hour (<B>&ldquo;the wage&rdquo;</B>), for the provision of the Services as defined
    above and for the same number of working hours, as customary in the Company. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is agreed and warranted that the consideration payable to the Contractor and/or anyone on his/her behalf pursuant hereto for
    the provision of the Services is higher than the wage received by the Company&rsquo;s employees who perform work of a similar
    nature.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the avoidance of doubt, the Company shall not pay twice for the provision of the Services pursuant to this Agreement, that
    is to say &ndash; any payment made to the Contractor and/or anyone on his/her behalf shall be instead and/or on account of
    any amount paid as a wage to the Contractor and/or anyone on his/her behalf.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the event of a determination as aforesaid, accounting shall take place between the parties and the Contractor shall pay the
    Company any surplus amount received by him/her or anyone on his/her behalf over and beyond the wage during the period of this
    Agreement, together with full linkage and in accordance with the consumer price index and annual interest as prescribed in
    the Adjudication of Interest Law in respect of debts at the Execution Office, computed from the date on which any payment
    is made to the Contractor until the date on which it is actually returned by the Contractor to the Company, on the basis of
    the index known on the relevant date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Contractor is hereby giving the Company an irrevocable instruction to set off from any amount awarded in his/her favor, in
    consequence of the existence of employer-employee relations, if and insofar as such an award is made, the Contractor&rsquo;s
    entire debt to the Company deriving from the accounting detailed above In addition in case of existence of employer-employee
    relations, the Parties will examine the need to enter into agreement which reflects the intent of the Parties. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.
The Company&rsquo;s failure or delay in enforcing any of the provisions of this Agreement shall not in any way be construed as
a waiver of any such provisions or prevent the Company thereafter from enforcing each and every other provision of this Agreement
which were previously not enforced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.
This Agreement shall be interpreted and construed in accordance with the laws of the State of Israel. The parties submit to the
exclusive jurisdiction of the competent courts of Tel-Aviv in any dispute related to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3.
The Company shall be entitled to set-off any amount that the Contractor owes to the Company according to this Agreement and/or
any applicable law, from any amount that the Contractor is entitled to receive from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4.
Captions and paragraph headings used in this Agreement are for convenience only and shall not be used in the construction or interpretation
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5.
This Agreement (and its Annexes) shall not be amended, modified or varied by any oral agreement or representation other than by
a written instrument executed by both parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6.
The provisions of this Agreement shall, where possible, be interpreted in a manner necessary to sustain their legality and enforceability.
Without derogating from the foregoing, in the event that any one or more of the provisions contained in this Agreement should
be held invalid, illegal or unenforceable in any respect due to the fact that it is over-broad or insufficiently limited in time,
geography or else, the parties hereby authorize, to the maximum extent legally permissible, the tribunal interpreting such provision(s)
to replace the invalid, illegal or unenforceable provision(s) with valid provision(s) the effect of which come as close as possible
to that of the invalid, illegal or unenforceable provision(s). The validity, legality and enforceability of the remaining provisions
contained herein shall in no way be affected or impaired as a result of any provision contained in this Agreement being held invalid,
illegal or unenforceable in any respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have duly executed this Services Agreement on the day and year set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Benad Goldwasser </I></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dan Sztybel</I></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dan Sztybel</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pimi
    Agro Cleantech Ltd.</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    Contractor</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
    Dan Sztybel</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:
    </B></FONT></TD>
    <TD STYLE="width: 27%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser</FONT></TD>
    <TD STYLE="width: 2%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:</B></FONT></TD>
    <TD STYLE="width: 27%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Sztybel </FONT></TD>
    <TD STYLE="width: 2%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="width: 27%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    21, 2018</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    21, 2018</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    21, 2018</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Confidential
Information, Invention Assignment and Non-Competition Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annex C constitutes an integral part of the Services Agreement (the &ldquo;<B>Agreement</B>&rdquo;) entered into on 10 day of
October 2018, by and between <B>Pimi Agro Cleantech Ltd</B>., registration number 51-349712-3, a company organized and registered
under the laws of the State of Israel with address at POB 360, Yokneam, Israel (the &ldquo;<B>Company</B>&rdquo;), and <B>Mr.
Dan Sztybel (&ldquo;Sztybel&rdquo;) on behalf of a company under his control</B>, Dan Sztybel Consulting Group Ltd., Israeli ID
No. 313935561 residing at Kazan 2/3, Raanana (the &ldquo;<B>Contractor</B>&rdquo;). Capitalized terms used and not otherwise defined
herein shall have the respective meaning assigned to them in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
acknowledge that as a result of the Services provided under the terms and provisions of the Agreement, we may develop, receive,
or otherwise have access to confidential or proprietary information which is of value to the Company. We therefore agree, as a
condition of our relationship with the Company, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>Confidential Information</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
<I><U>Company Information</U></I>. We agree at all times during the term of our Services and thereafter, to hold in strictest
confidence, and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written
authorization of the Board of Directors of the Company, any Confidential Information of the Company, except under a non-disclosure
agreement duly authorized and executed by the Company. We understand that &ldquo;<B>Confidential Information</B>&rdquo; means
any non-public information that relates to the actual or anticipated business or research and development of the Company, technical
data, trade secrets or know-how, including, but not limited to, research, product plans or other information regarding Company&rsquo;s
products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company
on whom we called or with whom we became acquainted during the term of my Services), software, developments, inventions, processes,
formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or other business
information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
<I><U>Employer Information</U></I>. We agree that we will not, during our Services with the Company, improperly use or disclose
any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that we will not
bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person
or entity unless consented to in writing by such employer, person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
<I><U>Third Party Information</U></I>. We recognize that the Company has received and in the future will receive from third parties
their confidential or proprietary information subject to a duty on the Company&rsquo;s part to maintain the confidentiality of
such information and to use it only for certain limited purposes. We agree to hold all such confidential or proprietary information
in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in performing
my services for the Company consistent with the Company&rsquo;s agreement with such third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<U>Inventions</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<I><U>Inventions Retained and Licensed</U></I>. We represent that there are no inventions, original works of authorship, developments,
improvements, and trade secrets which were made by me prior to my Services with the Company (collectively referred to as &ldquo;<B>Prior
Inventions</B>&rdquo;), which belong to me, which relate to the Company&rsquo;s proposed business, products or research and development,
and which are not assigned to the Company hereunder. If in the course of my Services for the Company, we incorporate into a Company
product, process or service a Prior Invention owned by me or in which we have an interest, we hereby grant to the Company a nonexclusive,
royalty-free, fully paid-up, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention
as part of or in connection with such product, process or service, and to practice any method related thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<I><U>Assignment of Inventions</U></I>. We agree that we will promptly make full written disclosure to the Company, will hold
in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title,
and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, discoveries,
ideas, trademarks or trade secrets, whether or not patentable or registrable under copyright or similar laws, which we may solely
or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the
period of time we am providing Services to the Company, and/or with the use of any Company&rsquo;s equipment, supplies, facilities,
or Confidential Information (collectively referred to as &ldquo;<B>Inventions</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
derogating from the generality of the foregoing, we further acknowledge that all original works of authorship which are made by
me (solely or jointly with others) within the scope of and during the period of my Services with the Company are &ldquo;works
made for hire&rdquo; owned by the Company, or its designee, and that we shall not be entitled to any additional compensation for
creation or assignment of the same to the Company, including but not limited to, any consideration, compensation or royalty pursuant
to Section 134 or any other provision of the Patent Law (&ldquo;<B>Additional Compensation</B>&rdquo;). We further waive the right
to bring any claims, demands or allegations to receive compensation, consideration or royalty with respect to the Inventions before
the Committee for Compensation and Royalties under the Patent Law (the &ldquo;<B>Compensation Committee</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby irrevocably transfer and assign to the Company and/or its assignees any and all Moral Rights (as defined below) that we
may have in or with respect to any Invention. We also hereby forever waive and agree never to assert any and all Moral Rights
we may have in or with respect to any Invention, even after termination of my Services with the Company. &ldquo;<B>Moral Rights</B>&rdquo;
mean any rights of paternity or integrity, any right to claim authorship of an invention, to object to any distortion, mutilation
or other modification of, or other derogatory action in relation to, any Invention, whether or not such would be prejudicial to
his/her honor or reputation, and any similar right, existing under judicial or statutory law of any jurisdiction whatsoever, or
under any treaty, regardless of whether or not such right is denominated or generally referred to as a &ldquo;moral right&rdquo;.
We further agree that, with respect to all Inventions and proprietary information and other matters concerning my Services to
the Company that may result in publishable material, all such publication rights shall belong exclusively to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
understand and agree that the decision whether or not to commercialize or market any invention developed by me solely or jointly
with others is within the Company&rsquo;s sole discretion and for the Company&rsquo;s sole benefit and that no royalty will be
due to me as a result of the Company&rsquo;s efforts to commercialize or market any such invention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
<I><U>Maintenance of Records</U></I>. We agree to keep and maintain adequate and current written records of all Inventions made
by me (solely or jointly with others). The records will be in the form of notes, sketches, drawings, and any other format that
may be specified by the Company. The records will be available to and remain the sole property of the Company at all times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
<I><U>Patent and Copyright Registrations</U></I>. We agree to assist the Company, or its designee, at the Company&rsquo;s expense,
in every proper way to secure the Company&rsquo;s rights in the Inventions and any copyrights, patents, mask work rights or other
intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent
information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other
instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey
to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions,
and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. We further agree that my
obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after
the termination of this Proprietary Rights Agreement. If the Company is unable for any reason to secure my signature to apply
for or to pursue any application for any Israeli, United States or other foreign patents or copyright registrations covering Inventions
or original works of authorship assigned to the Company as above, then we hereby irrevocably designate and appoint the Company
and its duly authorized officers and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute
and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters
patent or copyright registrations thereon with the same legal force and effect as if executed by me.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Conflicting Services</U></B>. Without derogating from my undertakings under my Services Agreement with the Company, we agree
that, during the term of our Services to the Company, we will not engage in any other Services, occupation or consulting directly
related to the business in which the Company is now involved or becomes involved during the term of my Services, nor will we engage
in any other activities that conflict with my obligations to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Returning Company Documents</U></B>. We agree that, at the time of termination of my provision of Services to the Company,
we will deliver to the Company (and will not keep in my possession, recreate or deliver to anyone else) any and all devices, records,
data, notes, reports, proposals, lists, correspondence, specifications, drawings blueprints, sketches, materials, equipment, other
documents or property, or reproductions of any aforementioned items developed by me pursuant to my Services to the Company or
otherwise belonging to the Company, its successors or assigns, including, without limitation, those records maintained pursuant
to Section 2.3 of this Proprietary Rights Agreement. Without derogating in any way from my undertakings under this Proprietary
Rights Agreement, in the event of the termination of my Services to the Company, we agree to sign and deliver, for the sake of
good order, a certification in form provided by the Company, confirming that we have complied with all the terms of this Proprietary
Rights Agreement and reiterating my undertakings hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Notification of New Principal or Employer</U></B>. Upon the termination of my provision of Services to the Company, we hereby
grant consent to notification by the Company to my new principal and/or employer about my rights and obligations under this Proprietary
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B><U>Unfair Competition and Solicitation</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
acknowledge that the provisions of this Proprietary Rights Agreement are reasonable and necessary to legitimately protect the
Company&rsquo;s Confidential Information, its property (including intellectual property and other proprietary information) and
its goodwill (the &ldquo;<B>Company&rsquo;s Major Assets</B>&rdquo;). We further acknowledge that we have carefully reviewed the
provisions of this Proprietary Rights Agreement, have had the opportunity to consult with counsel of my choice, fully understand
the consequences thereof and have assessed the respective advantages and disadvantages to me of entering into this Proprietary
Rights Agreement. In light of the above provisions, we hereby undertake:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
<I><U>Non-competition</U></I>. In consideration for compensation paid to me by the Company, we shall not, during our Services
to the Company and for a period of twelve (12) months immediately following the termination of my relationship with the Company
for any reason, whether with or without cause, engage, establish, open or in any manner whatsoever become involved, directly or
indirectly, either as an contractor, owner, partner, employee, agent, shareholder, director, consultant or otherwise, in any business,
occupation, work or any other activity which is reasonably likely to involve or require the use of any of the Company&rsquo;s
Major Assets or which competes anywhere in the world with the business of the Company as conducted or as then proposed to be conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
<I><U>Non-Solicitation</U></I>. We agree that during my Services to the Company and for a period of twelve (12) months immediately
following the termination of my relationship with the Company for any reason, whether with or without cause, we shall not either
directly or indirectly: (i) solicit, induce, recruit or encourage any of the Company&rsquo;s personnel to leave their Services,
or take away such personnel, or attempt to solicit, induce, recruit, encourage or take away personnel of the Company, either for
myself or for any other person or entity; or (ii) solicit, hire, endeavor to entice away from the Company or otherwise interfere
with the relationship of the Company with any person or organization who is, or was within the preceding two years prior to termination
of my Services, a customer or a supplier of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.
We further recognize and acknowledge that a breach of this Section 6 would cause the Company substantial non-revisable damages
which may create a threat on the existence of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>Representations</U></B>. We agree to execute any proper oath or verify any proper document required to carry out the terms
of this Proprietary Rights Agreement. We represent that my performance of all the terms of this Proprietary Rights Agreement will
not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my Services
by the Company. We hereby represent and warrant that we have not entered into, and we will not enter into, any oral or written
agreement in conflict herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
We further recognize and acknowledge that my undertaking and obligations under this agreement shall also apply retroactively for
the period we have worked in the Company prior to signing this agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B><U>Successors and Assigns</U></B>. This Proprietary Rights Agreement will be binding upon my heirs, executors, administrators
and other legal representatives and will be for the benefit of the Company and its parent company, and their respective subsidiaries,
affiliates, successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Benad Goldwasser </I></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dan Sztybel</I></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dan Sztybel</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pimi
    Agro Cleantech Ltd.</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    Contractor</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
    Dan Sztybel</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:
    </B></FONT></TD>
    <TD STYLE="width: 27%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser</FONT></TD>
    <TD STYLE="width: 2%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:</B></FONT></TD>
    <TD STYLE="width: 27%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Sztybel </FONT></TD>
    <TD STYLE="width: 2%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="width: 27%; font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    21, 2018</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    21, 2018</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    21, 2018</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>


<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 9</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>13
<FILENAME>ex10-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Exhibit
10.5</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Confidential</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SERVICES
AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Services Agreement (the &ldquo;<B>Agreement</B>&rdquo;) is made and entered into this 15 day of January 2019, by and between <B>Pimi
Agro Cleantech Ltd</B>., registration number 51-349712-3, a company organized and registered under the laws of the State of Israel
with address at POB 360, Yokneam, Israel (the &ldquo;<B>Company</B>&rdquo;), and <B>NSNC Consulting Ltd.</B>, a company organized
and registered under the laws of the State of Israel, company number No. 512422973, with address at Aharon Beker 4A/8, Tel Baruch,
Tel Aviv Israel (the &ldquo;<B>Contractor</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Company wishes to retain the services of the Contractor as an independent contractor, and the Contractor agrees to provide
services to the Company, as an independent contractor, as of the Commencement Date of Services (as defined hereunder) and throughout
the Term (as defined hereunder); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the parties desire to state the terms and conditions of the Contractor&rsquo;s engagement by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFOR</B>, in consideration of the mutual premises, covenants and undertakings contained herein, the parties hereto have hereby
agreed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Term</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractor&rsquo;s
Services with Company shall commence as of January 13, 2019 (&ldquo;<B>Commencement Date of Services</B>&rdquo;) and shall continue
in full force until terminated by either party as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Services</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
As of the Commencement Date of Services, the Contractor shall provide the Company, personally and solely by Mrs. Neta Matis&nbsp;,
Israeli I.D. number 039836234, in the name and on behalf of the Contractor, with VP Research and Development services (the &ldquo;<B>Services</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
The Contractor shall provide the Services in a part-time position scope of 50% (Fifty percent), on retainer basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
The Contractor shall devote time, and efforts necessary to perform the Services under this Agreement, at a professional standard,
well and faithfully, to the Company&rsquo;s full satisfaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
The Contractor shall report to the Company&rsquo;s CEO, on the progress in the services&rsquo; provision on a monthly basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.
Equipment (if any) furnished to the Contractor by the Company for the purpose of the Services&rsquo; provision shall be the exclusive
property of the Company and shall be returned to the Company immediately upon the expiration or termination of this Agreement
for any reason whatsoever. The Contractor represents and warrants that they shall not transfer and/or use any equipment furnished
to him by the Company, other than for the purpose of the Services&rsquo; provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6.
The Contractor represent that there is no contractual or other legal restriction preventing or limiting him from entering into
this Agreement or performing any of his/her obligations hereunder. The Contractor shall immediately notify the Company of any
actual or potential conflict of interest that may arise with respect to their Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7.
The Contractor shall not have the authority to sign contracts on behalf of the Company or to otherwise bind the Company in any
manner whatsoever, other than professional files, such as final reports, protocols etc. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Consideration</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
As final and total consideration for the Contractor&rsquo;s full performance of this Agreement and for the provision of Services,
the Company shall pay to the Contractor a monthly fee of 15,000 (Fifteen Thousands) NIS plus VAT as of the Commencement Date.
All payments shall be made against issuance of a valid tax invoice by the Contractor at the end of each month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
The fees shall be payable within 14 days following receipt of the Contractor&rsquo;s tax invoice by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.
Withholdings shall be deducted at source from the payments made hereunder to the Contractor according to any applicable law. The
Contractor shall bear any tax imposed in connection with the payments and benefits provided hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.
The Company shall bear and reimburse The Contractor for all expenses incurred by him in rendering the Services under this Agreement
including but not limited to travel expenses, flights expenditures (business class) etc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5.
In the event of the Employee&rsquo;s continuous employment with the Company at the date of grant by the Save Foods Inc., the Company&rsquo;s
parent company (hereinafter: &ldquo;<B>Save Foods</B>&rdquo;), to its and/or to Company&rsquo;s employees or service providers
of options to purchase Save Foods&rsquo; shares under its 2018 Equity Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;), then the
Company shall recommend to the Board of Directors of Save Foods to grant the Contractor 750,000 options to purchase up to 750,000
of Save Foods&rsquo; ordinary shares under the Plan, as determined by the Save Foods&rsquo; sole discretion and subject to any
approvals required by the applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.
Such options shall vest over 36 months period following the Commencement Date of Service, as follows: (a) 250,000 options shall
vest following 12 months as of the date of grant, (b) 62,500 options shall vest following the lapse of each 3 months period thereafter.
All other terms and conditions of the options shall be consistent to those applicable to other options grant to employees/service
providers of the Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Proprietary Information</U></B>. As a condition precedent to the coming into force of this Agreement, The Contractor shall
execute the Confidential Information, Invention Assignment and Non-Competition Agreement attached hereto as <B><U>Annex A</U></B>
(the &ldquo;<B>Proprietary Rights Agreement</B>&rdquo;). The Proprietary Rights Agreement shall survive the termination of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Termination</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
Each party may terminate this Agreement at its discretion at any time by providing the other party with a 30 days prior written
notice of termination (the &ldquo;<B>Notice Period</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
During the Notice Period, The Contractor shall be obligated to continue to provide all of their Services and to take all steps,
satisfactory to Company, to ensure the orderly transition to any person or entity designated by the Company of all matters handled
by the Contractor in the framework of the Services provided to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
Notwithstanding the provisions of Section 5.2 above to the contrary, concurrently with, or at any time after a Termination Notice
is delivered by either party hereto, the Company shall be entitled to waive the Contractor&rsquo;s Services for the Company during
the Notice Period or any part thereof and/or terminate the business relationship prior to the completion of the Notice Period.
In such event the Company shall pay to the Contractor an indemnity in lieu of notice in an amount equal to the fees that the Contractor
would have received for the remaining part of the notice period, and payable on the same dates at which such fees would have received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.
Notwithstanding the above, the Company shall be entitled to terminate the Services hereunder with immediate effect and without
paying the Notice Period payments, where said termination is a Termination for Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement, the term &ldquo;<B>Termination for Cause</B>&rdquo; shall mean termination of Services as a result of
the occurrence of any one of the following: (a) a breach of trust or fiduciary duties, including but not limited to theft, embezzlement,
self-dealing, or breach of the provisions of the Proprietary Right Agreement; (b) any willful failure to perform or failure to
perform competently any of the Contractor&rsquo;s fundamental Services hereunder, or other breach of this Agreement, which was
not cured within ten (10) days of receipt by the Contractor of written notice thereof; (c) an event in which the Contractor deliberately
or gross negligently causes harm to the Company&rsquo;s business affairs or reputation; (d) conviction of the Contractor in a
crime or felony involving moral turpitude; or (e) other cause justifying termination of contract under applicable law, (collectively
&ldquo;<B>Cause</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.
Notwithstanding anything herein to the contrary and without derogating from the Company&rsquo;s rights pursuant to any applicable
law, in the event that the Contractor shall terminate his Services with the Company with immediate effect or upon shorter notice
than the Notice Period, the Company shall have the right to offset any payments to which Contractor shall have otherwise been
entitled for his Services hereunder during the Notice Period, or any part thereof, as the case may be, from any other payments
payable to Contractor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6.
No indemnity will be due by reason of expiration, termination, or non-renewal of this Agreement for any reason whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
<U>Relationship of the Parties; Indemnification.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
It is expressed and acknowledged that The Contractor are an independent contractor and that this Agreement does not create any
partnership, authority, agency or employer-employee relations between the Contractor and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
The Contractor alone shall be liable for payment of all the taxes, national insurance and any other compulsory payment applicable
to them in connection with its business, in connection with the Services provided by them to the Company and in connection with
the performance of any of its obligations pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.
Without derogating from the aforesaid, the parties agree that if, notwithstanding the agreement between them, it is in future
determined by any judicial instance that during the period of this Agreement, employer-employee relations existed between the
Contractor and/or anyone on his/her behalf, on the one hand, and the Company, on the other hand, and that she has the rights of
a hired employee vis-&agrave;-vis the Company in respect of the contractual relationship the subject of this Agreement, the following
provisions shall apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Contractor shall indemnify the Company in respect of any claim and/or demand submitted against the Company by Mrs. Matis or
    the Contractor in respect of employer-employee relations, within 14 days of receiving written demand, and including cover
    for the legal costs occasioned to the Company as a result of such demand and/or claim.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    it is determined that if any payment must be made to the Contractor and/or anyone on their behalf in respect of employer-employee
    relations as aforesaid, the remuneration of an &ldquo;employee&rdquo; providing services such as those that the Contractor
    or Mrs. Matis is supposed to provide to the Company, from the date of commencement of the contractual relations between the
    parties, shall not exceed NIS 75 gross per hour (<B>&ldquo;the wage&rdquo;</B>), for the provision of the Services as defined
    above and for the same number of working hours, as customary in the Company. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is agreed and warranted that the consideration payable to the Contractor and/or anyone on his/her behalf pursuant hereto for
    the provision of the Services is higher than the wage received by the Company&rsquo;s employees who perform work of a similar
    nature.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the avoidance of doubt, the Company shall not pay twice for the provision of the Services pursuant to this Agreement, that
    is to say &ndash; any payment made to the Contractor and/or anyone on his/her behalf shall be instead and/or on account of
    any amount paid as a wage to the Contractor and/or anyone on his/her behalf.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the event of a determination as aforesaid, accounting shall take place between the parties and the Contractor shall pay the
    Company any surplus amount received by him/her or anyone on his/her behalf over and beyond the wage during the period of this
    Agreement, together with full linkage and in accordance with the consumer price index and annual interest as prescribed in
    the Adjudication of Interest Law in respect of debts at the Execution Office, computed from the date on which any payment
    is made to the Contractor until the date on which it is actually returned by the Contractor to the Company, on the basis of
    the index known on the relevant date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
    </FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Contractor is hereby giving the Company an irrevocable instruction to set off from any amount awarded in his/her favor, in
    consequence of the existence of employer-employee relations, if and insofar as such an award is made, the Contractor&rsquo;s
    entire debt to the Company deriving from the accounting detailed above In addition in case of existence of employer-employee
    relations, the Parties will examine the need to enter into agreement which reflects the intent of the Parties. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.
The Company&rsquo;s failure or delay in enforcing any of the provisions of this Agreement shall not in any way be construed as
a waiver of any such provisions or prevent the Company thereafter from enforcing each and every other provision of this Agreement
which were previously not enforced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.
This Agreement shall be interpreted and construed in accordance with the laws of the State of Israel. The parties submit to the
exclusive jurisdiction of the competent courts of Tel-Aviv in any dispute related to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3.
The Company shall be entitled to set-off any amount that the Contractor owes to the Company according to this Agreement and/or
any applicable law, from any amount that the Contractor is entitled to receive from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4.
Captions and paragraph headings used in this Agreement are for convenience only and shall not be used in the construction or interpretation
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5.
This Agreement (and its Annexes) shall not be amended, modified or varied by any oral agreement or representation other than by
a written instrument executed by both parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6.
The provisions of this Agreement shall, where possible, be interpreted in a manner necessary to sustain their legality and enforceability.
Without derogating from the foregoing, in the event that any one or more of the provisions contained in this Agreement should
be held invalid, illegal or unenforceable in any respect due to the fact that it is over-broad or insufficiently limited in time,
geography or else, the parties hereby authorize, to the maximum extent legally permissible, the tribunal interpreting such provision(s)
to replace the invalid, illegal or unenforceable provision(s) with valid provision(s) the effect of which come as close as possible
to that of the invalid, illegal or unenforceable provision(s). The validity, legality and enforceability of the remaining provisions
contained herein shall in no way be affected or impaired as a result of any provision contained in this Agreement being held invalid,
illegal or unenforceable in any respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have duly executed this Services Agreement on the day and year set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Pimi Agro Cleantech Ltd.</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    NSNC Consulting Ltd.</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pimi
    Agro Cleantech Ltd.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    Contractor</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser <B></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neta
Matis</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman<B></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/15/2019</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:
    </B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/15/2019
</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Confidential
Information, Invention Assignment and Non-Competition Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annex A constitutes an integral part of the Services Agreement (the &ldquo;<B>Agreement</B>&rdquo;) entered into on 15 day of
January 2019 by and between <B>Pimi Agro Cleantech Ltd</B>. (the &ldquo;<B>Company</B>&rdquo;), and <B>NSNC Consulting Ltd.</B>,
on behalf of Mrs. Neta Matis (the &ldquo;<B>Contractor</B>&rdquo;). Capitalized terms used and not otherwise defined herein shall
have the respective meaning assigned to them in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
acknowledge that as a result of the Services provided under the terms and provisions of the Agreement, we may develop, receive,
or otherwise have access to confidential or proprietary information which is of value to the Company. We therefore agree, as a
condition of our relationship with the Company, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>Confidential Information</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
<I><U>Company Information</U></I>. We agree at all times during the term of our Services and thereafter, to hold in strictest
confidence, and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written
authorization of the Board of Directors of the Company, any Confidential Information of the Company, except under a non-disclosure
agreement duly authorized and executed by the Company. We understand that &ldquo;<B>Confidential Information</B>&rdquo; means
any non-public information that relates to the actual or anticipated business or research and development of the Company, technical
data, trade secrets or know-how, including, but not limited to, research, product plans or other information regarding Company&rsquo;s
products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company
on whom we called or with whom we became acquainted during the term of my Services), software, developments, inventions, processes,
formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or other business
information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
<I><U>Employer Information</U></I>. We agree that we will not, during our Services with the Company, improperly use or disclose
any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that we will not
bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person
or entity unless consented to in writing by such employer, person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
<I><U>Third Party Information</U></I>. We recognize that the Company has received and in the future will receive from third parties
their confidential or proprietary information subject to a duty on the Company&rsquo;s part to maintain the confidentiality of
such information and to use it only for certain limited purposes. We agree to hold all such confidential or proprietary information
in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in performing
my services for the Company consistent with the Company&rsquo;s agreement with such third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<U>Inventions</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<I><U>Inventions Retained and Licensed</U></I>. I have attached hereto, as <U>Exhibit A</U>, a list describing all inventions,
original works of authorship, developments, improvements, and trade secrets which were made by me prior to my engagement with
the Company (collectively referred to as &ldquo;<B>Prior Inventions</B>&rdquo;), which belong to me, and which are not and will
not be assigned to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<I><U>Assignment of Inventions</U></I>. We agree that we will promptly make full written disclosure to the Company, will hold
in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title,
and interest in and to any and all inventions,&nbsp;&nbsp; original works of authorship, developments, concepts, improvements,
designs, discoveries, ideas, trademarks or trade secrets, whether or not patentable or registrable under copyright or similar
laws, which we may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced
to practice, during the period of time we am providing Services to the Company, and/or with the use of any Company&rsquo;s equipment,
supplies, facilities, or Confidential Information, provided that such inventions relate to the Company&rsquo;s current or proposed
business (collectively referred to as &ldquo;<B>Inventions</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
derogating from the generality of the foregoing, we further acknowledge that all original works of authorship which are made by
me (solely or jointly with others) within the scope of and during the period of my Services with the Company and which relate
to the Company&rsquo;s current or proposed business are &ldquo;works made for hire&rdquo; owned by the Company, or its designee,
and that we shall not be entitled to any additional compensation for creation or assignment of the same to the Company, including
but not limited to, any consideration, compensation or royalty pursuant to Section 134 or any other provision of the Patent Law
(&ldquo;<B>Additional Compensation</B>&rdquo;). We further waive the right to bring any claims, demands or allegations to receive
compensation, consideration or royalty with respect to the Inventions before the Committee for Compensation and Royalties under
the Patent Law (the &ldquo;<B>Compensation Committee</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby irrevocably transfer and assign to the Company and/or its assignees any and all Moral Rights (as defined below) that we
may have in or with respect to any Invention which relate to the Company&rsquo;s current or proposed business. We also hereby
forever waive and agree never to assert any and all Moral Rights we may have in or with respect to any Invention, even after termination
of my Services with the Company. &ldquo;<B>Moral Rights</B>&rdquo; mean any rights of paternity or integrity, any right to claim
authorship of an invention, to object to any distortion, mutilation or other modification of, or other derogatory action in relation
to, any Invention, whether or not such would be prejudicial to his/her honor or reputation, and any similar right, existing under
judicial or statutory law of any jurisdiction whatsoever, or under any treaty, regardless of whether or not such right is denominated
or generally referred to as a &ldquo;moral right&rdquo;. We further agree that, with respect to all Inventions and proprietary
information and other matters concerning my Services to the Company that may result in publishable material, all such publication
rights shall belong exclusively to the Company.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
understand and agree that the decision whether or not to commercialize or market any invention developed by me solely or jointly
with others is within the Company&rsquo;s sole discretion and for the Company&rsquo;s sole benefit and that no royalty will be
due to me as a result of the Company&rsquo;s efforts to commercialize or market any such invention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
<I><U>Maintenance of Records</U></I>. We agree to keep and maintain adequate and current written records of all Inventions made
by me (solely or jointly with others). The records will be in the form of notes, sketches, drawings, and any other format that
may be specified by the Company. The records will be available to and remain the sole property of the Company at all times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
<I><U>Patent and Copyright Registrations</U></I>. We agree to assist the Company, or its designee, at the Company&rsquo;s expense,
in every proper way to secure the Company&rsquo;s rights in the Inventions and any copyrights, patents, mask work rights or other
intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent
information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other
instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey
to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions,
and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. We further agree that my
obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after
the termination of this Annex. If the Company is unable for any reason to secure my signature to apply for or to pursue any application
for any Israeli, United States or other foreign patents or copyright registrations covering Inventions or original works of authorship
assigned to the Company as above, then we hereby irrevocably designate and appoint the Company and its duly authorized officers
and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute and file any such applications and
to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon
with the same legal force and effect as if executed by me.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.
<B><U>Conflicting Services</U></B>. Without derogating from my undertakings under my Services Agreement with the Company, we agree
that, during the term of our Services to the Company, we will not engage in any other Services, occupation or consulting directly
related to the business in which the Company is now involved or becomes involved during the term of my Services, nor will we engage
in any other activities that conflict with my obligations to the Company.&nbsp; For the avoidance of any doubt, this Section shall
not apply to any engagement of the Contractor in the field of extraction of various materials from plant material, including extraction,
cleaning and separation of cannabis plant materials, other than sanitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Returning Company Documents</U></B>. We agree that, at the time of termination of my provision of Services to the Company,
we will deliver to the Company (and will not keep in my possession, recreate or deliver to anyone else) any and all devices, records,
data, notes, reports, proposals, lists, correspondence, specifications, drawings blueprints, sketches, materials, equipment, other
documents or property, or reproductions of any aforementioned items developed by me pursuant to my Services to the Company or
otherwise belonging to the Company, its successors or assigns, including, without limitation, those records maintained pursuant
to Section <B>&lrm;</B>2.3 of this Annex. Without derogating in any way from my undertakings under this Annex, in the event of
the termination of my Services to the Company, we agree to sign and deliver, for the sake of good order, a certification in form
provided by the Company, confirming that we have complied with all the terms of this Annex and reiterating my undertakings hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Notification of New Principal or Employer</U></B>. Upon the termination of my provision of Services to the Company, we hereby
grant consent to notification by the Company to my new principal and/or employer about my rights and obligations under this Annex.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Unfair Competition and Solicitation</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
acknowledge that the provisions of this Annex are reasonable and necessary to legitimately protect the Company&rsquo;s Confidential
Information, its property (including intellectual property and other proprietary information) and its goodwill (the &ldquo;<B>Company&rsquo;s
Major Assets</B>&rdquo;). We further acknowledge that we have carefully reviewed the provisions of this Annex, have had the opportunity
to consult with counsel of my choice, fully understand the consequences thereof and have assessed the respective advantages and
disadvantages to me of entering into this Annex. In light of the above provisions, we hereby undertake:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<I><U>Non-competition</U></I>. In consideration for compensation paid to me by the Company, we shall not, during our Services
to the Company and for a period of twelve (12) months immediately following the termination of my relationship with the Company
for any reason, whether with or without cause, engage, establish, open or in any manner whatsoever become involved, directly or
indirectly, either as an contractor, owner, partner, employee, agent, shareholder, director, consultant or otherwise, in any business,
occupation, work or any other activity which is reasonably likely to involve or require the use of any of the Company&rsquo;s
Major Assets or which competes anywhere in the world with the business of the Company as conducted or as then proposed to be conducted.
&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
<I><U>Non-Solicitation</U></I>. We agree that during my Services to the Company and for a period of twelve (12) months immediately
following the termination of my relationship with the Company for any reason, whether with or without cause, we shall not either
directly or indirectly: (i) solicit, induce, recruit or encourage any of the Company&rsquo;s personnel to leave their Services,
or take away such personnel, or attempt to solicit, induce, recruit, encourage or take away personnel of the Company, either for
myself or for any other person or entity; or (ii) solicit, hire, endeavor to entice away from the Company or otherwise interfere
with the relationship of the Company with any person or organization who is, or was within the preceding two years prior to termination
of my Services, a customer or a supplier of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
We further recognize and acknowledge that a breach of this Section 6 would cause the Company substantial non-revisable damages
which may create a threat on the existence of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B><U>Representations</U></B>. We agree to execute any proper oath or verify any proper document required to carry out the terms
of this Annex. We represent that my performance of all the terms of this Annex will not breach any agreement to keep in confidence
proprietary information acquired by me in confidence or in trust prior to my Services by the Company. We hereby represent and
warrant that we have not entered into, and we will not enter into, any oral or written agreement in conflict herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pimi
    Agro Cleantech Ltd.</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    Contractor</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
A to Annex A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>(Confidential
Information, Invention Assignment and Non-Competition Agreement</U></B><U>)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIST
OF PRIOR INVENTIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AND
ORIGINAL WORKS OF AUTHORSHIP</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifying
    Number or Brief Description</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
of Contractor: _________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
Name of Contractor: ________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: _______________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>








</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>14
<FILENAME>ex10-6.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">addendum
no. 1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SERVICES
AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
addendum, dated May 5, 2019 (the &ldquo;<B>Addendum</B>&rdquo;) constitutes addendum no. 1 to that certain Services Agreement
dated October 10, 2018 (hereinafter, the &ldquo;<B>Agreement</B>&rdquo;), by and between Pimi Agro Cleantech Ltd., company number
51-349712-3 (&ldquo;<B>Company</B>&rdquo;), and Dan Sztybel, ID No. 313935561, on behalf of a company under his control, Dan Sztybel
Consulting Group Ltd. (the &ldquo;<B>Contractor</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the parties wish to modify and amend certain provisions set forth in the Agreement, all as further stipulated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE,</B> the parties hereto agree to amend the Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Amendment of Contractor&rsquo;s Position and Scope of Services </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.45pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.45pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
Section 2 of the Agreement, subject to the approval of the Company&rsquo;s board of directors (the &ldquo;<B>Board</B>&rdquo;),
commencing April 1, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
the Contractor shall provide the Company, personally by Mr. Sztybel, in the name and on behalf of the Contractor, with Chief Executive
Offier services, in a scope of 100% position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
The Contractor shall devote all of his time, and efforts necessary to perform the Services under the Agreement, at a professional
standard, well and faithfully, to the Company&rsquo;s full satisfaction and shall report to the Board, from time to time, as determined
by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
<B><U>Amendment of Consideration</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
Section 3 of the Agreement, subject to the approval of the Company&rsquo;s Board:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
commencing April 1, 2019, the monthly fee payble to the Contractor under the Agreement for the provision of the Services shall
be adjusted to reflect 100% position (i.e. monthly fee of 47,125 NIS (plus VAT)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
the Company shall recommend to the board of directors of Save Foods Inc., the Company&rsquo;s parent (&ldquo;<B>Safe Foods</B>&rdquo;),
to grant Mr. Sztybel 3,000,000 options to purchase up to 3,000,000 of Save Foods&rsquo; common shares under its 2018 Equity Incentive
Plan (the &ldquo;<B>Plan</B>&rdquo;), as determined by Save Foods&rsquo; board of directors&rsquo; sole discretion and subject
to all approvals required by applicable law (the &ldquo;<B>Options</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
In addition, in the event that the Company will receive EPA (U.S. Environmental Protection Agency) and FDA (U.S. Food and Drug
Administration) approvals by the end of the second quarter of 2020, the Company shall recommend to the board of directors of Save
Foods to grant Mr. Sztybel of bonus of additional 1,500,000 options to purchase up to 1,500,000 of Save Foods&rsquo; common shares
under its plan, as determined by Save Foods&rsquo; board of directors&rsquo; sole discretion and subject to all approvals required
by applicable law (the &ldquo;<B>Bonus Options</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
The exercise prices, vesting schdules and other related terms and conditions of the Options and Bonus Options, shall be determined
by Save Foods&rsquo; board of directors&rsquo; sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>General</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
Any and all provisions, terms and/or conditions contained in the Agreement shall continue in full force and effect, unless and
to the extent otherwise expressly provided herein which provisions will supersede any such provisions of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
This Addendum shall be deemed for all intents and purposes an integral part of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.
Terms used but not defined herein shall have the meanings assigned to such terms in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Benad Goldwasser </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/ Dan Sztybel</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Dan Sztybel</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pimi Agro Cleantech Ltd.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Dan Sztybel</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Dan Sztybel Consulting Group Ltd.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad Goldwasser</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 15%">28/03/2019</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 28%">Dan Sztybel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">Title:</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">G.M</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/4/2019</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">Date:
</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">28/3/2019<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>15
<FILENAME>ex10-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.7</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B><IMG SRC="ex10-7_001.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B><IMG SRC="ex10-7_002.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-7_003.jpg" ALT="" STYLE="height: 868px; width: 670px"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>16
<FILENAME>ex10-8.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.8</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-8_001.jpg" ALT="" STYLE="height: 949px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-8_002.jpg" ALT="" STYLE="height: 949px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-8_003.jpg" ALT="" STYLE="height: 949px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>17
<FILENAME>ex10-9.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.9</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B><IMG SRC="ex10-9_001.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B><IMG SRC="ex10-9_002.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-9_003.jpg" ALT="" STYLE="height: 868px; width: 670px"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B><IMG SRC="ex10-9_004.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-9_005.jpg" ALT="" STYLE="height: 868px; width: 670px"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-9_006.jpg" ALT="" STYLE="height: 868px; width: 670px"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>18
<FILENAME>ex10-10.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.10</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
confidential information contained in this document, marked by brackets and asterisk, has been omitted pursuant to Item 601(b)(10)(iv)
of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMISSION
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
commission agreement (the &ldquo;<B>Agreement</B>&rdquo;), is effective as of September 22, 2020 (&ldquo;<B>Effective Date</B>&rdquo;)
by and between Earthbound Technologies, LLC, having its principal place of business at 156 Fifth Avenue, 10<SUP>th</SUP> Floor,
New York, NY 10010 (together with its affiliates, shareholders, or assigns, &ldquo;<B>EBT</B>&rdquo;) and Save Foods Ltd., having
its principal place of business at 20 Raoul Wallenberg St., Tel-Aviv, Israel (&ldquo;<B>Save Foods</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 6.1pt; text-align: justify; text-indent: 20.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
in return for EBT&rsquo;s role in introducing Save Food to the relevant third-parties, Save Food agrees to compensate EBT in the
form of a commission;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.7pt 0pt 5.55pt; text-align: justify; text-indent: 16.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the promises and agreements set forth herein, the parties, each intending to be legally bound hereby,
do promise and agree as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Services</U>:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBT,
    on a non-exclusive basis and under the terms and conditions of this Agreement, shall endeavor to introduce Save Foods to potential
    third parties (&ldquo;<B>Potential Customers</B>&rdquo;) interested in Save Foods&rsquo; solutions for food safety and food
    waste reduction opportunities (including but not limited to the improvement of produce safety, quality and an increase in
    shelf life) (the &ldquo;<B>Products</B>&rdquo;). <B><U>Exhibit A</U></B> attached hereto sets forth the list of approved customers
    as of the Effective Date, which have been pre-approved via email in writing by Save Foods, which list may be amended from
    time to time, upon mutual agreement of the parties via email in writing (the &ldquo;<B>Approved Parties</B>&rdquo;). If EBT
    wishes to introduce Save Foods to any Potential Customers, EBT shall submit the name(s) of each such Potential Customer to
    Save Foods, including high-level project scope and timeline to enable Save Foods to verify whether the Potential Customer
    meets Save Foods&rsquo; criteria for an Approved Party. EBT shall obtain the signed out written approval via email of Save
    Foods prior to any introduction of Save Foods to such Potential Customer. For the avoidance of doubt, only if a Potential
    Customer is approved by Save Foods, such Potential Customer shall become an Approved Party and shall be included in <B><U>Exhibit
    A</U></B>. Any Potential Customer will not be taken into consideration for purposes of the calculation of the Compensation
    (as defined below), and EBT shall not be entitled to any consideration with respect thereto. EBT waives any claim or demand
    with regard to failure or refusal of Save Foods to approve any Potential Customer or any other proposed customer.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    parties acknowledge, that prior to the execution of this Agreement, EBT has already introduced Save Foods to [**], which shall
    be deemed as an Approved Party. Further, [**] has invited Save Foods to perform a &ldquo;mini test&rdquo; of the Products
    (as hereinafter defined). Notwithstanding anything to the contrary herein, the parties acknowledge that once a third party
    becomes an Approved Party, such account shall be exclusive to EBT. Save Foods acknowledges that if an Approved Party, such
    as [**], introduces Save Foods to additional parities, those additional parties become exclusive to be EBT and will be considered
    an Approved Party and added to Exhibit A accordingly (i.e. [**]).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBT
    shall make best efforts to further assist Save Foods in finalizing and consummating a binding transaction, agreement or Commercial
    Transaction (as hereinafter defined) with such Potential Customers, as per and subject to Save Foods&rsquo; instructions as
    may be conveyed to EBT from time to time. The negotiations with any Potential Customer shall be conducted directly by Save
    Foods, with the assistance of EBT if requested to do same by Save Foods.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    decision of whether or not to enter into any transaction, agreement, Commercial Transaction or negotiate with any Potential
    Customer, and the terms and conditions thereof, as well as to terminate any transaction, agreement or negotiation, are and
    shall at all time remain the absolute and sole discretion of Save Foods. EBT shall have no claim towards Save Foods or any
    of its employees, officers and directors, if Save Foods decides not to negotiate, or to cease negotiations or not to enter
    into or terminate any transaction, agreement or negotiate with any of the Potential Customers for any reason whatsoever.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation</U>:
    In the event that during the term of this Agreement and within eighteen (18) months following the termination or expiration
    of this Agreement (the &ldquo;<B>Compensation Period</B>&rdquo;), Save Foods secures and consummates any Commercial Transaction
    (as defined below) with an Approved Party in connection with the Products, EBT shall be entitled to a fee of twelve and one
    half percent (12.5%) of the Net Revenues actually received by Save Foods under such Commercial Transaction, up to a total
    aggregate amount of US $2,000,000 (the &ldquo;<B>Compensation</B>&rdquo;), provided that in any event the actual Compensation
    due to EBT shall not be greater than 25% of Save Foods&rsquo; gross profit under such Commercial Transaction. In addition,
    if the Net Revenues received from an Approved Party aggregate to US $500,000, Save Foods, Inc. shall issue to EBT, subject
    to the approval of the Board of Directors of Save Foods Inc., which the Board will not unreasonably withhold, 50,000 options
    to purchase 50,000 shares of Save Foods Inc.&rsquo;s common stock (as adjusted for any stock dividend, stock split, stock
    combination, reclassification or similar transaction occurring after the date hereof) (the &ldquo;<B>Primary Options</B>&rdquo;).
    The Primary Options shall be exercisable for a period of 2 (two) years from the issuance thereof, at an exercise price of
    US $1.20 per share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>In
addition, if [**] issues a recommendation letter to its suppliers to use Save Foods products, </U>Save Foods Inc. shall issue
to EBT, subject to the approval of the Board of Directors of Save Foods Inc., which the Board will not unreasonably withhold,
50,000 options to purchase 50,000 shares of Save Foods Inc.&rsquo;s common stock (as adjusted for any stock dividend, stock split,
stock combination, reclassification or similar transaction occurring after the date hereof) (the &ldquo;<B>[**] Options</B>&rdquo;
and together with the Primary Options, the &ldquo;<B>Options</B>&rdquo;). The [**] Options shall be exercisable for a period of
2 (two) years from the issuance thereof, at an exercise price of US $1.20 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation and the Options shall constitute the sole and exclusive compensation for EBT&rsquo;s services in connection with
and as contemplated by this Agreement, provided that the Options may constitute compensation for several Commercial Transactions.
Payment of Fee to EBT shall be made no later than thirty (30) days following Save Foods&rsquo; actual receipt of consideration
received from an Approved Party, and if such consideration is paid and/or forwarded in installments or subject to contingent payments,
the fees will be prorated accordingly and the applicable portion shall be paid within fifteen (15) days from actual receipt by
Save Foods, of each installment or such contingent payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, EBT shall be entitled to the Compensation as set forth above, only for Commercial Transactions, including
transactions with [**], that were executed during the Compensation Period. [The parties acknowledge EBT shall be entitled to receive
its Compensation provided for herein notwithstanding the expiration or termination of this Agreement.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercial
Transaction</B>&rdquo; shall mean a binding agreement entered into between Save Foods and an Approved Party, for the sale, license,
distribution or marketing of Save Foods&rsquo; products, technology or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
Revenues</B>&rdquo; shall mean payments made by the Approved Party (or its affiliate) and actually received by Save Foods, after
deduction of all (a)taxes, tariffs, value added tax, custom duties, import or export levies and any other governmental fee (not
including tax on Save Foods&rsquo; income); (b) transportation, freight, handling charges and insurance costs; and (c) discounts,
rebates, allowances, returns, refunds and credits. Save Foods shall provide backup documentation for allowable deductions as reasonably
requested by EBT. For the avoidance of any doubt &ldquo;Net Revenues&rdquo; does not include revenues received for sponsored R&amp;D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term:
    </U>This Agreement shall terminate twelve (12) months from the Effective Date, unless otherwise agreed to by the parties.
    This Agreement may be terminated by either party for any reason, upon 30 days advance written notice Upon termination or expiration
    of this Agreement: (i) EBT shall immediately cease all activities hereunder, and shall no longer represent itself as, or act
    as, a contractor of Save Foods as provided hereunder; and (ii) Save Foods shall continue to pay EBT its Compensation and/or
    Options as provided for herein.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranties
    and Indemnification</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods warrants and represents that: (1) it has the right and authority to sell the Products for commercial purposes, (2) the
    granting of rights to EBT under this Agreement and the performance of all obligations under this Agreement will not infringe
    or otherwise violate intellectual property or other proprietary or contractual rights granted by Save Foods person or entity,
    and (3) the performance by Save Foods of any obligations or services to be rendered under this Agreement will not conflict
    with or be prohibited or restricted by any agreement with any other party.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    parties hereby agrees to indemnify and hold the opposite party and its affiliates and their officers, directors, members,
    managers, agents, employees, other representatives and their successors and assigns, harmless from and against all actions,
    claims, suits, proceedings, lawsuits, judgments, damages, costs, liabilities, expenses and disbursements, including reasonable
    attorneys&rsquo; fees (collectively, &ldquo;Losses&rdquo;), arising out of or otherwise relating to any claims of third parties
    against such opposite party relating to a breach by the party of any warranty, representation or condition made or agreed
    to by the party under this Agreement.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBT
    represents and warrants to Save Foods that: (a) there is no contractual or other legal restriction preventing or limiting
    it from entering into this Agreement or performing any of its obligations hereunder. EBT shall notify Save Foods in a timely
    manner of any actual or potential conflict of interest that may arise with respect to the services to be provided; (b) it
    has the requisite qualifications, knowledge and experience to perform its obligations under this Agreement and (c) it has
    all licenses and approvals required under applicable law for the performance of the services under this Agreement and shall
    maintain such licenses and approvals for the duration of the Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Relationship
    Between the Parties.</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBT&rsquo;s
    relationship with Save Foods pursuant to this Agreement is that of an independent contractor, and nothing in this Agreement
    shall be deemed to create any form of principal-agent relationship, partnership, employer-employee relationship or joint venture
    between the parties. EBT shall not be eligible for any employee benefits. EBT&rsquo;s personnel are not and in no event shall
    be deemed to be Save Foods&rsquo; or joint employees. EBT assumes full responsibility for the acts of its employees and contractors
    and for their supervision, direction and control, as well as for their compensation, withholding taxes, social security and
    other taxes or benefits.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is specifically agreed that EBT has no authority to enter into agreement or contract for or on behalf of Save Foods with any
    Potential Customer (or any of its affiliates), or accept any offers or bind or obligate Save Foods in any way. Without derogating
    from the foregoing, EBT may not (i) make statements or representations concerning Save Foods and/or Save Foods&rsquo; business
    that exceed or are inconsistent with the materials provided to EBT by Save Foods; or (ii) make any publication in respect
    of Save Foods, Save Foods&rsquo; business, or any public use of Save Foods&rsquo; name, logos, trade-marks or marks without
    Save Foods&rsquo; prior written approval.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the avoidance of any doubt, EBT acknowledges and agrees that in carrying out EBT&rsquo;s obligations under this Agreement,
    EBT (i) shall not make any statements or representations that are in any way inconsistent with information provided by Save
    Foods, (ii) has no authority to make any commitment, undertaking or obligation in the name, or on behalf, of Save Foods, and
    (iii) will not present itself as having any such power or authorities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality.</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of the mutual Confidentiality Agreement executed between the parties on the date hereof, attached hereto as <B><U>Exhibit
B</U></B>, shall apply to the information exchanged between the parties in connection with this Agreement, and shall apply to
any employee, sub-contractor or other representative of either party that is or will be involved with the provision of the services
contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Miscellaneous</U>:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    parties agree that this Agreement constitutes the entire agreement between the parties hereto on the subject matter hereof
    and supersedes all prior and contemporaneous written or oral agreements and understandings pertaining to the subject matter
    hereof.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
    party may assign and/or transfer any of his rights or obligations under this Agreement without the prior written consent the
    party</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    waiver, modification or amendment of this Agreement or any covenant, conditions or limitations herein contained shall be binding
    unless in writing and duly executed by the party to be charged therewith.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    notices or other communications provided for by this Agreement shall be made in writing and shall be deemed properly delivered
    when (i) delivered personally, (ii) mailed to the parties entitled thereto, by registered or certified mail, postage prepaid
    to addresses designated by the parties, or (iii) delivered by facsimile, the transmittal of which shall be confirmed or by
    email. Notices will be deemed effective on the date of delivery in the case of personal delivery, or three (3) business days
    after mailing or on the date of dispatch in the case of notification by facsimile or email.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing
    Law and Arbitration</U>. This Agreement shall be construed in accordance with and governed by the laws of the State of Israel.
    Any controversy or claim arising out of or relating to this Agreement shall be determined by arbitration to be held in Tel
    Aviv, Israel, in accordance with the International Arbitration Rules of the International Centre for Dispute Resolution and
    judgment on the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the parties hereto have duly executed this Agreement as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earthbound
    Technologies LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>List
of Approved Parties</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of the Approved Party</B></FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    of becoming an Approved Party</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
        2020</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    2020</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality
and Non-Disclosure Agreement </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Confidentiality and Non-Disclosure Agreement (the &ldquo;<B>Agreement</B>&rdquo;), dated 1<SUP>st</SUP> day of June, 2020 (the
&ldquo;<B>Effective Date</B>&rdquo;) is made and entered by and between <B>Save Foods Ltd.</B> (the &ldquo;<B>Company</B>&rdquo;),
and Earthbound Technologies, LLC ( &ldquo;<B>EBT</B>&rdquo;) pursuant to the Commission Agreement between the parties dated September
18<SUP>th</SUP>, 2020 (the &ldquo;<B>Commission Agreement</B>&rdquo;). Capitalized terms used and not otherwise defined herein
shall have the respective meaning assigned to them in the Commission Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
In this Agreement, a &ldquo;Disclosing Party&rdquo; shall be that party dicslosing Confidential Information (as defined herein).
A &ldquo;Receiving Party&rdquo; shall be that party receiving Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
In this Agreement &ldquo;<B>Confidential Information</B>&rdquo; means all information disclosed by a Disclosing Party to a Recipient,
whether of a technical, business or other nature, in tangible or intangible form, on any media, including without limitation,
inventions (whether patentable or not and whether registered as patent or not), ideas, know-how, trade-secrets, concepts, methods,
designs and information related to the technology, business plans, projections, trade secretsfinancial information, marketing
information and other business affairs of a Disclosing Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B>Ownership; Purpose</B>. All Confidential Information is and shall remain at all times, the property of a Disclosing Party and
no use of Confidential Information is permitted except for the purpose of providing by EBT the services and/or obligations of
a party detailed in the Commission Agreement (the &ldquo;<B>Purpose</B>&rdquo;), subject to the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B>Use and Protection</B>. The Recipient shall at any and all time: (i) treat and maintain all Confidential Information in the
strictest confidence, using the same degree of care that the Recipient uses to protect its own Confidential Information, and at
least a reasonable degree of care; (ii) not disclose any Confidential Information to any third party without the prior written
consent of Disclosing Party; (iii) not disclose any Confidential Information to any of its employees, except to those employees
who have a &ldquo;need to know&rdquo;, are bound by confidentiality agreement and must be directly involved in the use of Confidential
Information for the purposes of this Agreement; (iv) be responsible for the compliance of those employees who have a &ldquo;need
to know&rdquo; with the provisions of this Agreement; and (v) not disassemble, decompile, reverse engineer or make any copies
of Confidential Information (in any medium whatsoever) without the explicit prior written consent of the Disclosing Party; (vi)
use the Confidential Informatuion only for the Purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties agree, and acknowledge that the Confidential Information may be considered as Insider Information and/or Material Nonpublic
Information (as these terms are defined in the Israeli Securities Law, 5728-1968, and in the U.S. Securities Act of 1933, collectively
the &ldquo;<B>Securities Laws</B>&rdquo;), and the parties, their employees and/or anyone on their behalf&rsquo;s shall refrain
from any action that might be considered as use of Insider Information and/or Material Nonpublic Information, according to the
Securities Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B>Exceptions</B>. Confidential Information does not include specific information which (i) becomes public knowledge without a
breach of this Agreement by the Recipient or any third party; (ii) is disclosed to a Recipient by a third party lawfully entitled
to make such disclosure; or (iii) is required to be disclosed by law or court order (provided that the Recipient promptly notifies
the other partyof such potential required disclosure and assists such other party in preventing or limiting such disclosure).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B>Return of Confidential Information</B>. Upon the first request of a Disclosing Party, the Recipient shall promptly return to
the Disclosing Party all Confidential Information including any copies thereof, which were at any time in the possession of the
Recipient and all materials (in any medium whatsoever) which contain or embody Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B>No License</B>. The disclosure to a Recipient of Confidential Information or its use hereunder shall not be construed in any
way to grant such Recipient any right or license with respect to Confidential Information other than the right to use Confidential
Information strictly in accordance with the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<B>No Representations</B>. The disclosure to a Recipient of Confidential Information hereunder shall not be construed as placing
any obligation on the Disclosing Party to disclose any particular information to the Recipient. THE CONFIDENTIAL INFORMATION IS
PROVIDED TO RECIPIENT AS IS, WITHOUT GIVING ANY REPRESENTATION OR WARRANTY WITH RESPECT THERETO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B>Injunctive Relief</B>. The Recipient understands that any violation of this Agreement may cause immediate and irreparable harm
to the Disclosing Party, which monetary damages cannot adequately remedy. Without prejudice to rights and remedies according to
the rule of law, the Recipient therefore agrees that injunctive relief may be sought against it, in order to remedy, or to prevent
a violation hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<B>Governing Law</B>. This Agreement shall be construed in accordance with and governed by the laws of the State of New York.
Any controversy or claim arising out of or relating to this Agreement shall be determined by arbitration to be held in New York,
New York, in accordance with the International Arbitration Rules of the International Centre for Dispute Resolution and judgment
on the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
The provisions of this Agreement shall survive the termination of this Agreement and the Commission Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.3pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS THEREOF THE PARTIES DULY EXECUTED THIS AGREEMENT AS OF THE EFFECTIVE DATE SPECIFIED ABOVE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earthbound
    Technologies LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>19
<FILENAME>ex10-11.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.11</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
confidential information contained in this document, marked by brackets and asterisk, has been omitted pursuant to Item 601(b)(10)(iv)
of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Distribution
Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
DISTRIBUTION AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;) is made as of September 22<SUP>nd</SUP>, 2020 (the &ldquo;<B>Effective
Date</B>&rdquo;), by and between <B>Save Foods Ltd.</B>, a company incorporated in the State of Israel, with registered offices
at 20 Raoul Wallenberg, Tel Aviv, Israel (the &ldquo;<B>Company</B>&rdquo;) and <B>Safe-Pack Products Ltd.</B>, a company incorporated
in the State of Israel, with registered offices at 7 Astoria St. Hadera, Israel and its Affiliates (the &ldquo;<B>Distributor</B>&rdquo;)
(each of Company and Distributor may also be referred to as a &ldquo;<B>Party</B>&rdquo; and together, the &ldquo;<B>Parties</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company develops and markets the products listed in the products list attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Product
List</B>&rdquo;) as may be updated by the Parties in writing from time to time (the &ldquo;<B>Products</B>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Distributor has represented that it has the necessary expertise and marketing organization to promote, sell, and market and
support the Products; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company wishes to appoint the Distributor as a sole distributor of the Products in the Territory (as defined below), and the
Distributor wishes to accept such appointment, all subject to the terms and conditions set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the premises and of the mutual covenants and agreements herein contained, the Parties agree
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interpretation;
    Definitions</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    preamble of this Agreement constitutes an integral part hereof. The headings of the sections and subsections of this Agreement
    are for convenience of reference only and are not to be considered in construing this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    this Agreement, unless the context otherwise requires:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
    means any entity which Controls, is Controlled by, or is under common Control with relevant Party.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 84.45pt; text-align: justify; text-indent: -34.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Control</B>&rdquo;
    means having the direct or indirect ownership of more than fifty (50) percent of the shares or interests entitled to vote
    for the directors thereof or the equivalent, or the equivalent power over management thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 84.45pt; text-align: justify; text-indent: -34.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>End
    Users</B>&rdquo; means any person or entity, which will purchase the Products from the Distributor as an end user.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 84.45pt; text-align: justify; text-indent: -34.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
    Property Rights</B>&rdquo; means good will, patent rights, copyrights, trademarks, trade names, service marks, brand names
    and any and all other intellectual property rights in inventions, improvements, designs, ideas, concepts, innovations, designs,
    original works of authorship, formulas, concepts, techniques, know how, methods, systems, processes, compositions of matter,
    computer software programs, databases, mask works, and trade secrets; each of the above whether patentable, copyrightable
    or protectable as trade secrets, irrespective of whether it has been registered in a patent, copyright, trademark or other
    form, and irrespective of whether it constitutes a commercial or professional secret.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 84.45pt; text-align: justify; text-indent: -34.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
    means an individual, corporation, partnership, joint venture, trust or unincorporated organization.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Quota</B>&rdquo;
    means Products reflecting an aggregate minimum quantity, which the Distributor shall be expected to purchase from the Company
    in accordance with the terms and conditions of Section &lrm;8.6 hereof and detailed in <B><U>Exhibit A</U></B> attached hereto.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo;
    means the territory defined in <B><U>Exhibit B</U></B> as may be updated by the Parties in writing from time to time.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
    of Distribution Rights</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the terms and conditions of this Agreement, the Company grants to the Distributor, and the Distributor hereby accepts from
    the Company, an exclusive right to resell, distribute, advertise, and market the Products, and to use the Company&rsquo;s
    trademark within the Territory (the &ldquo;<B>Services</B>&rdquo;), directly or through its sales agents. For the avoidance
    of doubt, the Product List may be updated by the Parties in writing from time to time to include future products to be developed
    by the Company, and the Company will sell such Products in the Territory only through the Distributor. The Product List shall
    include the Products, each Product&rsquo;s price, Quota and specific crops.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributor
    shall be entitled to appoint sub-distributors or agents for the sale of the Products in the Territory, provided that such
    sub-distributors or agents shall be bound by the provisions of this Agreement, and that the Distributor shall be responsible
    and liable for any breach of this Agreement by such sub-distributors or agents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the avoidance of doubt, Company reserves the right to sell, license or appoint other distributors outside the Territory to
    distribute any products, including the Products listed in the Product List, all as determined by the Company in its sole discretion.
    The Distributor shall not deal with the Products in any territory other than the Territory without Company&rsquo;s prior written
    consent. The Distributor shall not sell or deal with End Users which, to the Distributor&rsquo;s reasonable knowledge, intend
    to use and/or re-sell the Products outside the Territory. Without derogating from the forgoing, the Distributor shall not
    solicit End Users outside the Territory.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor shall determine the prices and/or any other terms and conditions of Products&rsquo; sales to its End Users, by
    its sole discretion.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
    Products. Right of First Refusal. Company shall offer to Distributor the right to be the exclusive distributor in the Territory
    of any and all future line extensions and products in the field of post-harvest (&ldquo;<B>Future Products</B>&rdquo;). At
    such time when Company wishes to distribute any Future Products in the Territory, it will offer the opportunity to Distributor
    and the Parties shall engage in good faith negotiations regarding the terms and conditions, including but not limited to pricing
    and minimum quantities of Future Products to be purchased by the Distributor, pursuant to which the Distributor will have
    the right to distribute Future Products in the Territory. If after thirty (30) days the Parties have been unable to reach
    an agreement and have acted in good faith, Company may enter into negotiations with third parties and/or to distribute and
    market the Future Products by itself in the Territory. If Company intends to enter into an agreement with a third party with
    respect to distribution of the Future Products in the Territory, it shall first offer to Distributor a right of first refusal
    with respect to such agreement. Distributor must exercise such right of first refusal within ten (10) business days after
    Company conveys the terms and conditions of such agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.55in; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representations
    and Warranties of Parties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
    hereby represent and warrant to each other and acknowledge that each Party is entering into this Agreement in reliance upon
    the correctness and completeness of such representations and warranties that the following are true and correct as of the
    date hereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Party is duly incorporated or organized, and validly existing in the jurisdiction of its incorporation or organization and
    has all requisite corporate power and authority to enter into and perform this Agreement and any related agreements, in accordance
    with the terms hereof and thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    execution and delivery of this Agreement and any related agreements by each Party, the performance by each Party of its obligations
    hereunder and the consummation by each Party of the transactions contemplated hereby and thereby have been duly authorized
    and requires no other proceedings on the part of each Party except as required by law. Each Party has the right, power and
    authority to execute and deliver this Agreement and all other instruments, on behalf of itself, and to perform all of its
    obligations hereunder and thereunder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Agreement and any related agreements have been duly executed and delivered by each Party and constitute the legal, valid and
    binding obligations of each Party, enforceable against each Party in accordance with their terms, subject to (i) applicable
    bankruptcy, insolvency, reorganization, fraudulent transfer, composition, reorganization, moratorium or similar laws from
    time to time in effect affecting creditors&rsquo; rights generally, and (ii) general principles of equity (including, without
    limitation, standards of materiality, good faith, fair dealing, minority oppression and reasonableness), whether such principles
    are considered in a proceeding at law or in equity or any limitations imposed by general principles of equity upon the availability
    of equitable remedies or the enforcement of provisions of any documents referred to herein.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    execution, delivery and performance of this Agreement by each Party and the consummation by the Parties of the transactions
    contemplated hereby will not: (i) result in a violation of its incorporation documents or (ii) conflict with or constitute
    a default under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement or
    instrument to which each Party is a party, or result in a violation of any law, rule, regulation, order, judgment or decree
    applicable to the Parties.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
    as specifically contemplated by this Agreement, Parties are not required to obtain any consent, authorization or order of,
    any court or governmental authority in order for it to execute, deliver or perform any of its obligations under or contemplated
    by this Agreement. Except as specifically contemplated by this Agreement, all consents, authorizations, orders, filings and
    registrations which each Party is required to obtain pursuant to the preceding sentence have or will be obtained or effected
    on or prior to the date of delivery of the Products to the Distributor.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor represents and warrants that it has the necessary funds, expertise, personnel and marketing organization to promote,
    sell, market and support the Products.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Party assumes full responsibility for all costs and expenses which it incurs in carrying out its obligations under this Agreement,
    including but not limited to all rentals, salaries, commissions, advertising, demonstration, travel and accommodation expenses
    without the right to reimbursement for any portion thereof from the other Party.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
    derogating from any of the forgoing, at all times (including after termination of this Agreement) each Party shall conduct
    its business in a manner that reflects favorably upon the Products, and the other Party&rsquo;s name, reputation and goodwill,
    shall refrain from engaging in any deceptive, misleading or unethical practices, shall make no disparaging statements about
    the other Party or any Products, and shall refrain from publishing or using or permitting the publication of use by a third
    party or any misleading or deceptive advertising.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributor&rsquo;s
    Obligations</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor shall use its best efforts to promote and market the Products in the Territory.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor shall provide the End Users with maintenance, technical support and all service coverage required under all warranties
    with such standards, procedures, guidelines and instructions agreed by the Parties from time to time. The Distributor shall
    be responsible for guidance of End Users with respect to use of the Products in accordance with the Product Protocol (as defined
    herein).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor shall refrain from making any representations, warranties, or guarantees to the End Users or to any other third
    parties with respect to the specifications, features or capabilities of the Products that are inconsistent with the literature,
    protocols, trainings, explanations and covenants provided by the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor shall comply with all laws, regulations, orders, decrees, rulings and judgments, practices and procedures applicable
    in the Territory, while performing its obligations hereunder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall cooperate fully with the Distributor in resolving any and all matters and/or disputes with End Users arising
    against the Company in accordance with the Company&rsquo;s instructions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor will use its own label for the Products, but will attach the Company&rsquo;s trademark, which identifies the Company
    as the developer and Sasa-Tech as the manufacturer of the Products, in a manner approved in writing by the Company prior to
    the distribution of the Products. The Products will include technical and regulatory information provided by the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company&rsquo;s
    Obligations</B></FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall provide the Distributor with warranty for the Products as described in Section &lrm;12 herein below.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall furnish the Distributor with technical information, including any required literature concerning the Products,
    their use and applications in Hebrew and if other territories are added to the Territory, in English (&ldquo;<B>Product Protocol</B>&rdquo;),
    essentially in the form attached hereto as <B><U>Exhibit C</U></B>.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall be available to provide the Distributer and/or the End User with technical support during the customary working
    hours and days of every week.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall apply for and obtain any and all licenses, permits and other authorizations needed to fulfill its obligations
    under this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
    derogating from the generality of the above, each Party will immediately notify the other Party in writing of any complaint
    drawn to its attention (or to the attention of its employees or agents) by any End User regarding any of the Products.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    shall maintain throughout the Term, all regulatory approvals required for distribution of Products in the Territory.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independent
    Contractors</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    relationship between the Parties under this Agreement is that of independent contractors and nothing contained herein shall
    constitute each Party or any of Parties&rsquo; employees or representatives, the agent or employee or representative of the
    other Party for any purpose whatsoever.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
    each Party will have no power to act for or to bind the other Party in any dealing with third parties, unless specifically
    authorized in advance and in writing by the other Party.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
    shall indemnify each other against any expenses, losses or damages, including legal expenses, caused to other Party as a result
    of or in connection with any claim or demand which contradicts the Parties&rsquo; obligations in Section &lrm;6.1.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Force
    Majeure</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
Party shall in any event be held liable with respect to the other Party or to others for losses or damages caused by non-performance,
or a delay in the performance, of their obligations under this Agreement (except that of payment) to the extent that the same
resulted from circumstances amounting to force majeure, including, inter alia, strikes, embargoes, riots, fires, floods, war,
terror attacks, hurricanes, windstorms, acts or defaults of common carriers, shortage of materials, acts of God and acts of the
state or of public authorities, or other causes beyond the reasonable control of the party affected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
    Procedure</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    time to time, Distributor will submit to the Company purchase orders for Products via e-mail (the &ldquo;<B>Purchase Orders</B>&rdquo;).
    Each Purchase Order will specify the quantity and description of the Products as well as any other relevant information.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Purchase Orders from the Distributor are subject to acceptance in writing by the Company, at its discretion, which acceptance
    may address any item of a Purchase Order. The Company&rsquo;s acceptance will be subject to the availability of supplies and
    shipment facilities as well as the nature of the Product ordered (depending upon, for example, whether Products ordered are
    readily available or require customization), and the Company shall have no liability to the Distributor with respect to any
    Purchase Order which is not accepted by the Company. Each Purchase Order shall be deemed to be an offer by the Distributor
    to purchase the Products pursuant to the terms hereof and, when accepted by the Company as hereinabove provided, shall give
    rise to a contract under the terms set forth herein to the exclusion of any additional or contrary terms set forth in such
    Purchase Order. Notwithstanding the above mentioned in this Section &lrm;8.2, it is hereby agreed that the Company shall be
    obligated to accept, and if ordered by Distributer, to supply any and all Purchase Orders until the quantities of the Product
    ordered meets the Quota set for the relevant calendar year.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall deliver the Products CIF (Incoterms 2010) to Distributer&rsquo;s address, using the Company&rsquo;s standard
    methods for packaging and shipping the Products not later than 15 days of the submission of the relevant Purchase Order.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    of loss or damage to the Products shall pass to the Distributor upon delivery, in accordance with the provisions of the agreed
    Incoterms.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company retains title in and to the Products and reserves all rights with respect to delivered Products permitted by law including,
    without limitation, the right of recission, repossession, resale, and stoppage in transit until the full amount due from the
    Distributor including any charges, in respect of all delivered Products has been paid. Notwithstanding the above mentioned,
    if a Product&rsquo;s End-User has paid the full price of such Product to the Distributor, the Distributor shall then be entitled
    to transfer the title in such Product to such end-user, without derogating from any of Company&rsquo;s rights hereunder with
    respect to the consideration hereunder due to it from the Distributor in connection with such Product.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Minimum
    Purchase Requirement</U></B>.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General
    Requirement</U>. Starting on the second calendar year of distribution of the Products in each Territory, the Distributor agrees
    to purchase and take delivery, during each calendar year (or part thereof) during the term of this Agreement, of Products
    reflecting at least the Quota established for such period in accordance to Section &lrm;8.6.2 below. Failure by Distributor
    to satisfy its obligation under this Section &lrm;8.6 shall not constitute a breach by the Distributor of his obligations
    under this Agreement, but the Company shall under such circumstances be entitled to terminate Distributor&rsquo;s exclusivity
    in the Territory in which the Quota has not been met.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Determination
    of Quota.</U> As specified in Section &lrm;8.6.1 above, the Parties agree that the first calendar year shall be regarded as
    a &ldquo;market penetration&rdquo; year and therefore no Quota shall be set. At least 45 days prior to the end of each calendar
    year, the Parties shall negotiate in good faith the Quota for the following calendar year in each Territory. In the event
    that the Parties fails to agree on a Quota in a certain Territory, the Quota shall be equal to last year Quota in such Territory,
    plus 3%. In the event that the Parties fails to agree on a Quota in a certain Territory for the second calendar year, the
    Quota shall be equal to last year actual sales in such Territory, plus 3%.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Terms
    of Payment</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributer
    shall pay the Company for the Products included in the Purchase Orders approved by the Company and supplied to the Distributor
    net +60 days from invoice.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Products are sold by the Company to the Distributor at prices set out in the price list as attached in <B><U>Exhibit A</U></B>
    (the &ldquo;<B>Prices</B>&rdquo;). </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall have the right to change the Prices upon sixty (60) days prior written notice, but in any case, will do its
    best to avoid price changes during season time in the Territory (September -May). </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    and for so long as any payment from Distributor to the Company under this Agreement shall be overdue:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    at the rate of one percent (1%) per month shall automatically become due on the overdue payment.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    shall have the right, in its sole discretion, to require payment for additional shipments of Products either by cash in advance
    or by a bank guarantee or letter of credit, for a sum of not less than the Price of the additional shipment.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the event the Company shall enter into additional distribution agreements with Affiliates of Decco Worldwide Post-Harvest
    Holdings BV, the terms of payment set forth in this Section &lrm;9 may change with respect to such Affiliates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warranty
    and Limitations of Liability</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company warrants that, on the date of the delivery by the Company, the Products shall: (i) meet Company&rsquo;s standard specifications
    for the Products in effect at the date of delivery which are provided to the Distributor with each delivery of the Products;
    and, (ii) shall comply with the Law in the country of manufacture as well as in the Territory. In the event that a change
    in regulations in the Territory results in a change of price of a Product in such country, the Parties shall mutually agree
    upon the new price of the relevant Product in such country.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall supply warranty for the Products to the Distributor in accordance with the Company&rsquo;s policies as may be
    applicable from time to time (the &ldquo;<B>Warranty</B>&rdquo;).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Excluded
    Claims</U>. Company shall have no obligation under the Warranty in the event that:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repair
    or replacement of Products or parts shall have been required through abnormal wear and tear or necessitated in whole or in
    part by the fault or gross negligence of Distributor or its customers and/or End-Users; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Products or parts have not been properly stored, used, mounted, maintained, or repaired in accordance with Company&rsquo;s
    then applicable operating and/or maintenance manuals, whether by Distributor or its and/or End-Users, or shall have been modified
    or altered in any manner without prior written consent of the Company; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fitting
    and/or mounting of the Products was performed with equipment and/or accessories other than those recommended by the Company,
    if recommended.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limited
    Warranty</U>. Subject to applicable law, the warranties set forth in this Section are intended solely for the benefit of the
    Distributor. The warranties set forth above are in lieu of all other warranties, express or implied, which are hereby disclaimed
    and excluded by the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limited
    Liability</U>. Distributor understands and agrees as follows:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delay.
    The Company shall not be liable for any loss or damage caused by delay in furnishing Products and services or any other performance
    under or pursuant to this Agreement during a period of up to 30 days.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Sole
    Remedies</U>: The sole and exclusive remedies for breach of any and all warranties and the sole remedies for Company&rsquo;s
    liability of any kind (including liability for negligence) with respect to the Products and services covered by this Agreement
    and all other performance by Company under or pursuant to this Agreement shall be limited to the remedies provided in this
    Section &lrm;10.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consequential
    Damages</U>: In no event other than to the extent provided under any applicable law shall Company&rsquo;s and/or Distributor&rsquo;s
    liability of any kind include any loss of use, sales or profits or any special, indirect, incidental or consequential losses
    or damages, even if Company and/or Distributor shall have been advised of the possibility of such potential loss or damage.
    This Section shall not apply in the event of Company&rsquo;s breach of its obligation under this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Distributor and its representatives and Affiliates shall not be liable to the Company for, and the Company assumes all liability
    for, and agrees to defend, indemnify and hold the Distributor, its Affiliates, and representatives, harmless against all losses,
    claims, suits, damages, liabilities, costs, and expenses (including reasonable attorney and professional fees and costs, and
    the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers) resulting from
    or arising out of (i) the Company&rsquo;s breach of this Agreement, (ii) defects in the Products (iii) willful misconduct
    of the Company or its representatives, (iv) any act (or failure to act) by the Company or its representatives, in contravention
    of any applicable Law, or (v) use of the Products in accordance with the Product Protocol and/or other recommendations on
    how to use the Products received by the Company or its representatives. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company and its representatives and Affiliates shall not be liable to the Distributor for, and the Distributor assumes all
    liability for, and agrees to defend, indemnify and hold the Company, its Affiliates, and representatives, harmless against
    all losses, claims, suits, damages, liabilities, costs, and expenses (including reasonable attorney and professional fees
    and costs, and the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers)
    resulting from or arising out of (i) willful misconduct of the Distributor or its representatives, (ii) any act (or failure
    to act) by the Distributor or its representatives, in contravention of any applicable Law, or (iii) use of the Products not
    in accordance with the Product Protocol and/or other recommendations on how to use the Products received by the Company or
    its representatives.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Party seeking defense and/or indemnification shall provide the other Party prompt written notice of any third party claims,
    suits or damages and the right to reasonably manage and control the defense of any such claims, and shall reasonably cooperate
    in connection with such defense and will not unreasonably withhold its consent to any settlement includes no admission of
    liability by the indemnified Party. Without derogating the foregoing, for the purpose of settlement, including, without derogating
    from the generality of the aforesaid, the referral of such claims for mediation before a mediator, or for resolution by arbitration,
    the prior written consent of the other Party shall be required, regardless of whether the such Party has elected to exercise
    his right to manage such claims as set forth above, or not.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
in any way limiting either Party&rsquo;s liability or responsibility under this Agreement, at all times during the Term, and for
a period of seven (7) year following the date of expiration or termination of this Agreement or for as long as the Distributor
has Products in stock for sale after the date of expiration or termination of this Agreement, whichever is longest, both Parties
shall maintain sufficient, adequate and all relevant insurances to cover any liabilities it has or may incur under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
    Property Rights</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the provisions of this Agreement, the Distributor hereby acknowledges, confirms and agrees that any and all title, interest
    and right, of any type or nature whatsoever, in any of the Intellectual Property Rights which is disclosed, communicated or
    delivered to the Distributor by the Company or any of its directors, officers or agents is and shall be the sole and exclusive
    property of the Company for all intents and purposes. This Agreement shall not be construed to constitute a grant to the Distributor
    of any Intellectual Property Rights, except for the sole and limited purpose of fulfilling its obligations under this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
    anything else to the contrary herein, the obligations under this Section shall survive the termination of this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
    derogating from the above, in cases of mutual development of new products and/or applications, the parties will discuss in
    good faith regarding the ownership structure of the new IP.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIAL
    INFORMATION</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Parties covenant and undertake that, during the Term and thereafter, either Party (the &ldquo;<B>Disclosing Party</B>&rdquo;)
    may disclose to the other Party (the &ldquo;<B>Receiving Party</B>&rdquo;) certain Confidential Information, as defined below.
    Absent the Disclosing Party prior written consent, the Receiving Party shall maintain the Confidential Information in full
    absolute confidence and it shall not use such Confidential Information, directly or indirectly, in whole or in part, for its
    own benefit or for any purpose whatsoever except as specifically and explicitly provided herein. The Receiving Party will
    be responsible for ensuring that the obligations of confidentiality and non-use contained herein are observed by its consultants,
    employees, subcontractors and affiliates. The Receiving Party undertakes not to transmit or transfer the Confidential Information
    to any third party, without the Disclosing Party&rsquo;s prior written consent.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;<B>Confidential
Information</B>&rdquo; shall mean all information, written or oral, relating directly or indirectly to this Agreement, the Services,
the Parties or its business (actual or planned), disclosed to it by the other Party, developed by it or which otherwise became
known to it in connection with the performance of this Agreement, including, without limitation, any and all patent applications,
drawings, specifications, test results, techniques, diagrams, charts, plans, statements, assessments, analyses, estimates, views
and opinions, know-how, processes, machines, practices, inventions, improvements and records.</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the termination of this Agreement, for any reason whatsoever, the Receiving Party shall return to the Disclosing Party any
    and all Confidential Information, including all records received, and any copies thereof, as well as any notes, memoranda
    or other writings or documentation which contain or pertain to the Confidential Information or any portion thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
    anything else to the contrary herein, the obligations under this Section shall survive the termination of this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Competition
    and Non-Solicitation </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company agrees and undertakes that, during the Term of this Agreement, it will not, directly or indirectly, engage in any
    business activity, or hold an interest in any business that is engaged in distribution of the Products within the Territory,
    provided that the Company has not terminated Distributor&rsquo;s exclusivity in accordance with Section &lrm;8.6.1 herein.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company, its shareholders, directors and officers agree and undertake that during the Term of this Agreement and for a period
    of twenty four (24) months following termination of this Agreement for whatever reason, the Company, its shareholders, directors
    and officers will not, directly or indirectly, including personally or using a different legal entity, solicit for employment
    or any other kind of business relationship any person who is an employee, consultant, advisor, agent, customer or service
    provider of the Distributer (&ldquo;<B>Non-solicitation Provision</B>&rdquo;). Notwithstanding the above, it is hereby agreed
    that the abovementioned Non-solicitation Provision shall not apply with respect only to customers of Distributer, in case
    of termination of this Agreement by Company due to (i) Distributer&rsquo;s material breach of this agreement which is not
    cured within 30 days of written notice; or (ii) with immediate effect, in the event Distributer ceases to do business, or
    otherwise terminates its business operations, files a petition of any type as to its bankruptcy, be declared bankrupt, becomes
    insolvent, makes an assignment or other arrangement for the benefit of creditors, goes into liquidation or receivership, or
    otherwise loses legal control of its business.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the avoidance of any doubt, the business of the Distributer is postharvest treatments.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
    and Termination</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term</U>.
    The term of this Agreement shall commence as of the Effective Date for a period of five (5) years, and shall be renewed automatically
    for an additional period(s) of three (3) years each, unless either party notifies the other party, in a prior written notice
    served at least sixty (60) days before the end of relevant period, of its election to terminate this Agreement (the &ldquo;<B>Term</B>&rdquo;).
    In the forgoing period, the Distributor&rsquo;s exclusive rights shall continue provided that the Distributor meets the new
    Quota set forth in Section &lrm;8.6 for each year (and, in the event the Distributor failed to meet the Quota for any particular
    calendar year, it shall thereafter remain a non-exclusive distributor of the Products unless and until the Company terminates
    this Agreement in accordance herewith).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination</U>.
    Notwithstanding the foregoing, this Agreement may be terminated as follows:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
    party may terminate this Agreement, at any time; with or without any reason whatsoever, upon ninety (90) days advance written
    notice;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
    Party may terminate this Agreement at any time upon thirty (30) days prior written notice, in the event the other Party is
    in material breach of this Agreement and shall have failed to cure such breach within such notice period;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
    Party may terminate this Agreement, with immediate effect, in the event the other Party ceases to do business, or otherwise
    terminates its business operations, files a petition of any type as to its bankruptcy, be declared bankrupt, becomes insolvent,
    makes an assignment or other arrangement for the benefit of creditors, goes into liquidation or receivership, or otherwise
    loses legal control of its business;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company may terminate Distributor&rsquo;s exclusive rights hereunder in the relevant Territory in the event the Distributor
    fails to meet the Quota for the elapsed calendar year in such Territory, by providing 90 (ninety) days prior written notice
    and if Distributer fails to cure such a breach within that timeframe.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miscellaneous</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.85pt; text-align: justify; text-indent: -17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Assignment</B>.
    Except to Affiliates, neither Party shall have the right to assign any of its obligations and rights under and according to
    this Agreement to any other Person or entity without the other Party&rsquo;s prior written consent and any such assignment
    shall be null and void.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entire
    Agreement</B>. This Agreement constitutes the entire agreement between the parties with respect to its subject matter, and
    supersedes and cancels all prior agreements to the subject hereof, if any, between the Parties. No amendment to this Agreement
    shall be effective unless it is in writing and signed by a duly authorized representative of each party.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Severability</B>.
    In the event any paragraph or provision of this Agreement is held illegal, void or unenforceable, to any extent, in whole
    or in part, as to any situation or Person, the balance shall remain in effect and the provision in question shall remain in
    effect as to all other Persons or situations, as the case may be, and the parties shall draw up an arrangement in accordance
    with the meaning and the object of such paragraph or provision.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
    to Breach Not Waiver</B>. No term or provision hereof shall be deemed waived and no breach excused, unless such waiver or
    consent shall be in writing and signed by the party claimed to have waived or consented. Any consent by any party to, or waiver
    of, a breach by the other, whether express or implied, shall not constitute consent to, waiver of, or excuse for any other
    different or subsequent breach.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
    Law and Jurisdiction</B>. This Agreement shall be governed by and interpreted in accordance with the laws of the State of
    Israel, without giving effect to the rules respecting conflict of laws. The competent courts in Tel Aviv-Jaffa shall have
    sole and exclusive jurisdiction over any dispute between the parties hereto.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B>.
    All notices shall be in writing and deemed given and received when delivered in person, by facsimile, email or by commercial
    courier service. Notices shall be addressed to each party at its address set forth above, or such other address as the recipient
    may have specified by earlier notice to the sender. Any notice shall operate and be deemed to have been served, if personally
    delivered sent by fax or email on the next following business day, and if by courier, on the fifth following business day.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -31.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF </B>the parties have signed this Distribution Services Agreement as of the date hereinabove set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe-Pack
    Products Ltd</B>.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Save
    Foods Ltd</B>.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Products
and Price List</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Product
1 - PeroStar for the citrus industry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
price: $[**]/liter</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="15" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Quantities &ndash; discount table</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">More than</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Price per Liter</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Discount*</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Price After Discount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">PeroStar for citrus</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">500 liter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">PeroStar for citrus</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">2,000 liter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">PeroStar for citrus</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">5,000 liter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">PeroStar for citrus</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">10,000 liter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 18%; text-align: justify; padding-bottom: 1.5pt">PeroStar for citrus</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: justify; padding-bottom: 1.5pt">20,000 liter</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 17%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[**]</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 19%; text-align: right">9[**]</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*The
discount will be determined by the quantity sold in each calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, following the collaboration in Save Foods pilots, Safe Pack will receive an additional discount in the next 3 citrus
upcoming seasons as follow:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Season
    2020-2021: [**]% discount</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Season
    2021-2022: [**]% discount</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Season
    2022-2023: [**]% discount</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
no event shall the maximum discount exceed [**]%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>THE
TERRITORY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    State of Israel including the Palestinian territories.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other territory agreed upon in writing by the Parties.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Product
Protocol</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PeroStar
</B>is added to fruit and vegetable wash water as a processing aid. It should be used before waxing as a post-harvest treatment
for fruit and vegetable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target
Crops/Produce: <B><U>citrus fruit</U></B> (grapefruit, lemons, limes, oranges, mandarins, clementines, tangelos, tangerines and
pomelos).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Important
note: prior to commercial use, it is important to test the compatibility of PeroStar with any new crop for the first time</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Functional
purposes of PeroStar</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
acts as a processing aid and fulfils several functions. These functions are listed hereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
    keeps the process wash waters of fruit and vegetable at a stable relatively low pH.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peracetic
    acid-based products are used as disinfectant in wash water. When used with peracetic acid-based products, PeroStar eliminates
    the strong odor of peracetic acid allowing a more friendly and safe working environment.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    used with peracetic acid-based products, PeroStar may optimize the efficacy of peracetic acid. When used with fungicides including
    imidazole fungicides such as imazillil, thiabendazole, etc. PeroStar may optimize the efficacy of fungicides.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
    both helps to clean the fruit surface and can improve appearance of treated fruit by leaving a glossy finish on the outer
    skin of the fruit.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
    Helps to extend shelf life.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
food acids used in this product do not leave any residues of toxicological concern on the treated produce surface and are all
recognized by the FDA as GRAS (Generally Recognized As Safe).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
Instructions:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
is a highly concentrated solution and must be diluted prior to use!</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
can be applied at several locations on the packing line by either spraying, dipping or in a spray dip sequential combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is recommended to use (co-inject) PeroStar (in combination) with Per Acetic Acid (PAA). The PAA should be applied according to
its label and the relevant regulatory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>When
used with sprayers</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilute
PeroStar with water from 1:800 to 1:1200 (190-290 ppm of lactic acid) according to the fruit variety, its ripening level and to
conditions in orchard prior to picking.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>When
used in both cold and hot wash water tank (or flodder):</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilute
PeroStar with water from 1:1000 to 1:2200 (100-230 ppm of lactic acid) according to the fruit variety, its ripening level and
to conditions in orchard prior to picking. For use in hot water wash take extra precaution when adding the product to the hot
water.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>When
used in recirculation or once-through fruit washing system</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PeroStar
can be applied in recirculation or once- through fruit washing systems. When applying PeroStar in a recirculating system, it is
important to monitor the liquid level. Once the level set by the operator declines by 0.5% from set level, add fresh use solution
of PeroStar to the system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washing
with clean potable water at end of process is not mandatory.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rinse
and clean circulation tank on a regular basis of at least once every 3 days or according to local tank and water conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dry
all liquid residue from the fruit surface prior to waxing. The use of hot air blowers at this stage, prior to waxing or coating
is recommended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STORAGE
- Store in original plastic container at 39 - 95&deg;F (4 - 35&deg;C)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISPOSAL
- Wastes resulting from the use of this product may be disposed of on site or at an approved waste disposal facility - Never reuse
or refill PeroStar containers!</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Container
Disposal: Nonrefillable container</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
plastic containers equal to or less than 50 lbs - Triple rinse container after emptying as follows: Empty the all the contents
into application equipment or a mix tank and drain until completely empty. Fill the container &frac14; full with water, recap
and shake for at least 10 seconds. Pour rinsate into application equipment or the mix tank. Drain until dripping ceases. Repeat
this procedure twice. Then either recycle or puncture and dispose of container in a sanitary landfill, or by incineration, or,
if allowed by state and local authorities, by burning. Make sure to stay out of smoke when burning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
plastic containers more than 50 lbs - Triple rinse container immediately after emptying its contents into application equipment
or a mix tank as follows: Fill the container &frac14; full with water. Recap and tighten cap. Tip container on its side while
rolling it back and forward, complete at least a single revolution, and continue for at least 30 seconds. Stand the container
on its end and then tip backwards and forward multiple times while repeating the process. Ensure that all insides of the containers
have been thoroughly washed and rinsed. Empty the rinsate into application equipment or a mix tank or disposal tank. Repeat the
entire process twice. Then either recycle or puncture and dispose of in a sanitary landfill, or by incineration, or, if allowed
by state and local authorities, by burning. Make sure to stay out of smoke when burning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>20
<FILENAME>ex10-12.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Exhibit
10.12</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITIES PURCHASE AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;) is made as of September 23, 2020, by and among Save Foods,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;) and Medigus Ltd., a company organized under the laws of the state
of Israel (the &ldquo;<U>Investor</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires to issue and sell to the Investor, and the Investor desire to purchase from the Company, upon the terms and
conditions stated in this Agreement, for an aggregate purchase price of up to US$100,000 (the &ldquo;<U>Purchase Price</U>&rdquo;),
in consideration for 91,743 units at a price of $1.09, each consists of (i) one share of common stock, par value $0.0001 of the
Company (the &ldquo;<U>Common Stock</U>&rdquo; and &ldquo;<U>Purchased Shares</U>&rdquo;, respectively); and (ii) one warrant
to purchase one share of Common Stock with an exercise price of $1.20, in the form attached hereto as <U>Exhibit A</U> (collectively
the &ldquo;<U>Warrant</U>&rdquo;, and together with the Purchased Shares, the &ldquo;<U>Initial Purchased Securities</U>&rdquo;),
all under and subject to the terms and conditions set forth in the Warrant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Investor and the Company agree that the Investor shall invest up to additional US$25,000 in excess of the Purchase Price (the
&ldquo;<U>POC Investment Amount</U>&rdquo;), which will be conditioned upon the mutual agreement of the Company and the Investor
to jointly perform a proof of concept procedure to test the effectiveness of the Company&rsquo;s sanitizers and its residual effects
against different pathogens including a COVID-19 virus&rsquo; surrogate, based on agreed terms of study, its scope and cost (the
&ldquo;<U>POC Condition</U>&rdquo;), with such POC Investment Amount to be allocated specifically to such purpose, in consideration
for up to 22,935 units at a price of $1.09, each consisting of (i) one share of Common Stock (the &ldquo;<U>Additional Purchased
Shares</U>&rdquo;); and (ii) one Warrant, all under and subject to the terms and conditions set forth in the Warrant (together
with the Additional Purchased Shares, the &ldquo;<U>Additional Purchased Securities</U>&rdquo;) (the Initial Purchased Securities
together with the Additional Purchased Securities, the &ldquo;<U>Purchased Securities</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>PURCHASE AND SALE OF SECURITIES.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Sale and Issuance of Securities</U>. Subject to the satisfaction of certain closing conditions set forth in Sections 4 and
5 hereof at the Closing (as defined below), the Company shall issue and sell to the Investor, and the Investor shall purchase
from the Company the Initial Purchased Securities and subject to the satisfaction of the POC Condition, the Investor shall purchase
from the Company the Additional Purchased Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
capitalization table of the Company, reflecting the issued and outstanding share capital of the Company on a Fully Diluted Basis,
immediately prior to Closing and immediately following the Closing, assuming the investment of the Purchase Price) and reflecting
the issuance of the Purchased Securities is attached hereto as <U>Exhibit B</U> (the &ldquo;<U>Capitalization Table</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Closing</U>. The consummation of the transactions contemplated hereby, including the purchase and sale of the Purchased Securities
(the &ldquo;<U>Closing</U>&rdquo;) shall take place remotely via the exchange of documents and signatures, on September 23, 2020,
or at such other time and place as the Company and the Investor mutually agree upon (such designated time and place, the &ldquo;<U>Closing
Date</U>&rdquo;). The Closing shall be subject to the conditions of Section 4 and 5 below, which conditions shall be deemed to
take place simultaneously and no transaction described in such sections shall be deemed to have been completed or any document
delivered until all such transactions have been completed and all such required documents delivered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Closing Deliverables</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Closing, the Company shall deliver to the Investor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
True and correct copies of written resolutions, or minutes of a meeting, of the board of directors of the Company, approving and
adopting in all respects the execution, delivery and performance by the Company of this Agreement and the transactions contemplated
hereby, including, among others, (i) authorizing the issuance and sale of the Purchased Securities against payment of the Purchase
Price therefor and the grant of the Warrant and the issuance of the stock underlying such Warrant, as applicable, upon the exercise
of such Warrant; (ii) reserving a sufficient number of shares of Common Stock to be issued upon the exercise of the Warrant issuable
under this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Book-entry confirmation representing respective Purchased Shares issued to the Investor at the Closing in the name of the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Warrant, duly executed by the Company issued to the Investor at the Closing in the name of such Investor, all under and subject
to the terms and conditions set forth in the Warrant, in the form attached hereto as <U>Exhibit A</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
A certificate duly executed by an executive officer of the Company as of the Closing stating that the conditions specified in
Section 4 have been satisfied, in the form attached hereto as <U>Schedule <B><I>&lrm;</I></B>1.3(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
<U>Purchase Price</U>. Upon the Closing, the Investor shall transfer to the Company the Purchase Price by wire transfer of immediately
available funds according to the wire instructions attached hereto as <U>Schedule 1.4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
<U>Additional Closing</U>. Within three (3) days following the satisfaction of the POC Condition, the Company shall sell and issue,
on the same terms and conditions as those contained in this Agreement, at an additional closing (the &ldquo;<U>Additional Closing</U>&rdquo;)
the Additional Purchased Securities. Upon the Additional Closing, this Agreement shall automatically be deemed to be updated to
reflect the POC Investment Amount and the number of Additional Units purchased by the Investor at the Additional Closing. Thereafter,
for all purposes under this Agreement, the &ldquo;Additional Purchased Securities&rdquo; shall be deemed to be &ldquo;Purchased
Securities&rdquo; and the POC Investment Amount for the Additional Purchased Securities shall be deemed to be part of the &ldquo;Purchase
Price&rdquo;. At the Additional Closing, following the Company&rsquo;s receipt of the Investor&rsquo;s wire transfer of the POC
Investment Amount, the Company shall deliver to Investor a book-entry confirmation representing respective Additional Purchased
Shares issued to the Investor at the Additional Closing in the name of the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby represents and warrants to the Investor that, the following representations are true, correct and complete as of
the date hereof and as of the Closing (as if made on the Closing Date); except, in each case, as to such representations and warranties
that address matters as of a particular date, which are true, correct and complete only as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this Agreement, &ldquo;<U>Material Adverse Effect</U>&rdquo; means a material and adverse effect on the assets, properties, conditions
(financial or otherwise), operating results or business of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Subsidiary</U>. The Company wholly-owns Save Foods Ltd., an Israeli company (the &ldquo;<U>Subsidiary</U>&rdquo;), and as of
the date of the Agreement, the Subsidiary is the only subsidiary of the Company. The Company owns directly all of the capital
stock or other equity interests of the Subsidiary free and clear of any lien, charge, pledge, security interest, encumbrance,
right of first refusal, preemptive right or other restriction, and all of the issued and outstanding share capital of the Subsidiary
is validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Organization</U>. With the exception of the Subsidiary&rsquo;s current &ldquo;breaching status&rdquo; with the Israeli Registrar
of Companies, the Company and the Subsidiary are each an entity duly incorporated or otherwise organized, validly existing and
in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization,
with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Neither the Company nor the Subsidiary is in violation nor default of any of the provisions of its respective certificate of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiary is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a Material Adverse Effect on the legality, validity
or enforceability of any Transaction Document, (ii) a Material Adverse Effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and the Subsidiary, taken as a whole, or (iii) a Material Adverse
Effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Capitalization</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The authorized share capital of the Company will be on or immediately following to the Closing, as set forth in the Company&rsquo;s
Certificate of Incorporation (the &ldquo;<U>COI</U>&rdquo;), and such number of Common Stock as set forth in the Capitalization
Table are or shall be (immediately following the Closing) issued and outstanding, which shall reflect as of the date hereof, he
number of shares of Common Stock issued to Investor pursuant to the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The issued and outstanding shares of the Company were duly and validly authorized and issued, fully paid and non-assessable, and
offered and issued in compliance with the provisions of the COI as in effect at the time of each such issuance and in compliance
with all applicable corporate and securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Immediately prior to the Closing, no shares, options, warrants, rights (including conversion, preemptive rights, rights of first
refusal or similar rights) or agreements for the purchase from the Company of any of its stock capital, or any securities convertible
into or exchangeable for stock of the Company shall be outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Immediately prior to the Closing, no option, security or other equity award convertible or exercisable into stock of the Company
shall contain a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions
or other terms of such option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or
series of its stock capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>Authorization</U>. All corporate action on the part of the Company, its directors and shareholders, necessary for the authorization,
execution and delivery of this Agreement and the other agreements, instruments or documents entered into in connection with this
Agreement and to which the Company is a party (collectively, the &ldquo;<U>Transaction Documents</U>&rdquo;) and for the performance
of all obligations of the Company under the Transaction Documents in accordance with their terms has been taken or will be taken
prior to the Closing and the Additional Closing, as applicable. The Transaction Documents, when executed and delivered by the
Company, and assuming the due authorization, execution and delivery by the other parties hereto and thereto, constitute valid
and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except (i)
as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application
relating to or affecting the enforcement of creditors&rsquo; rights generally, and (ii) as limited by laws relating to the availability
of specific performance, injunctive relief, or other equitable remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<U>Valid Issuance</U>. The Purchased Securities being or that may be issued to the Investor hereunder, when issued, sold and delivered
in accordance with the terms of this Agreement for the consideration expressed herein, shall be duly and validly issued, fully
paid, and non-assessable, issued in compliance with all applicable state securities laws, and free and clear of liens, pledges,
charges, encumbrances or other restrictions on transfer of any kind (including, without limitation, preemptive rights), other
than restrictions on transfer under this Agreement, the COI, the Company&rsquo;s currently effective Bylaws (the &ldquo;<U>Bylaws</U>&rdquo;)
and under applicable securities laws and other than liens or encumbrances created by or imposed on the Investor as to itself.
The rights, privileges and preferences of the Purchased Securities are as stated in the COI and Bylaws, as may be amended from
time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<U>No Conflict; Consents</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction
Documents to which it is a party, the issuance and sale of the Purchased Securities and the consummation by it of the transactions
contemplated hereby and thereby do not and will not: (i) conflict with or violate any provision of the COI or Bylaws or other
organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time
or both would become a default) under, result in the creation of any lien, charge, pledge, security interest, encumbrance, right
of first refusal, preemptive right or other restriction, upon any of the properties or assets of the Company, or give to others
any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company
is a party or by which any property or asset of the Company is bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;) since the Company&rsquo;s registration statement on Form 10 was determined effective (collectively, the &ldquo;<U>SEC
Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements
of the Company included in the SEC Reports (the &ldquo;<U>Financial Statements</U>&rdquo;) comply in all material respects with
applicable accounting requirements and the rules and regulations of the U.S. Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with Generally
Accepted Accounting Principles in the U.S. (&ldquo;<U>US GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by US GAAP,
and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
<U>Material Changes</U>. Since June 30, 2020, there has been no event, occurrence or development that has had or that would reasonably
be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<U>Continued Quotation</U>. The Company is, and has no reason to believe that it will not in the foreseeable future continue to
be, in compliance with all such quotation and maintenance requirements of the &ldquo;Pink Sheets&rdquo; published and maintained
by OTC Markets Group, Inc., and shall make commercial best efforts to maintain such compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
<U>Financial Statements; No Undisclosed Liabilities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as set forth in the Financial Statements, the Company has no liabilities or obligations, contingent or otherwise, other
than (i) liabilities incurred in the ordinary course of business, subsequent to June 30, 2020, which, individually and in the
aggregate, do not exceed US$100,000; (ii) obligations under contracts and commitments incurred in the ordinary course of business
including debt of the Subsidiary to the Company in the principal amount of US$100,000; (iii) liabilities and obligations of a
type or nature not required under GAAP to be reflected in the Financial Statements, which, individually and in the aggregate do
not exceed US$100,000;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company is not a guarantor or indemnitor of any debt or obligation of another, nor has the Company given any loan, security
or otherwise agreed to become liable for any obligation of any person. No person has given any guarantee of, or security for,
any obligation of the Company. The Company did not extend any loans or advances to any person, other than advances for expenses
to its employees in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
<U>Assets and Properties</U>. Both the Company and the Subsidiary have good and marketable title to all of the tangible or personal
properties and assets owned by the Company and the Subsidiary, which are material to the business of the Company or the Subsidiary
as currently conducted, and such properties and assets are free and clear of all mortgages, deeds of trust, liens, pledges, charges,
security interests, conditional sale agreement, loans and encumbrances, except for statutory liens for the payment of current
taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially
impair the Company&rsquo;s or the Subsidiary&rsquo;s ownership or use of such property or assets. With respect to the tangible
property and assets it leases, the Company and the Subsidiary are in compliance in all material respects with such leases and,
to its knowledge, holds a valid leasehold or license interest free of any liens, pledges, charges, security interest, claims or
encumbrances, other than those of the lessors of such property or assets. The Company and the Subsidiary do not own any real property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
<U>Intellectual Property</U>. The Company and the Subsidiary have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property
rights and similar rights for use in connection with their respective businesses and which the failure to so have could have a
Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Neither the Company nor the Subsidiary
have received a notice (written or otherwise) that any of, the material Intellectual Property Rights has expired, terminated or
been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor the Subsidiary have received, since January 1, 2019, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe (and will not infringe) upon the rights of any Person, except as could
not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual
Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.
The Company and the Subsidiary have taken reasonable security measures to protect the secrecy, confidentiality and value of all
of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it or the Subsidiary from having
valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that either it or the Subsidiary
lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct
its business. For purposes of this Section, &ldquo;knowledge&rdquo;, including the phrase &ldquo;to the Company&rsquo;s knowledge&rdquo;
(or similar phrases), when used in this Section 2.11 (<I>Intellectual Property</I>) shall mean the actual knowledge of the Company,
without conducting any patent search, freedom to operate, infringement, or any similar search.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
<U>Labor Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company and the Subsidiary have complied, in all material respects, with all applicable employment laws, policies, procedures
and agreements relating to employment, and terms and conditions of employment. The Company and the Subsidiary have paid in full
to all of its respective employees and consultants all wages, salaries, commissions, bonuses, benefits and other compensation
due and payable to such employees or consultants on or prior to the date of this Agreement. The Company and the Subsidiary have
complied in all material respects with the applicable laws relating to the proper withholding and remittance to the proper tax
and other authorities of all sums required to be withheld from employees or persons deemed to be employees under applicable laws.
To the Company&rsquo;s knowledge, all persons classified by the Company or the Subsidiary as consultants or contractors thereof
are correctly classified as such and not as employees for any purpose. The Company&rsquo;s and the Subsidiary&rsquo;s liability
for any obligations to pay any amount of severance payment, pension, accrued vacation, and other social benefits and contributions,
under applicable law or contract, or any other payment of substantially the same nature, is fully funded by deposit of funds in
severance funds, pension funds, managers insurance policies or provident funds (and if not required to be so funded) adequate
provisions have been made in the Company&rsquo;s Financial Statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Neither the Company nor the Subsidiary is a party to, bound by or subject to, and no employee of the Company or the Subsidiary
benefits from, any collective bargaining agreement, collective labor agreement, extension orders (<I>tzavei harchava</I>) (other
than extension orders that apply to all employees in Israel generally), or other contract or arrangement with a labor union, trade
union or other organization or body, to provide benefits or working conditions beyond the minimum benefits and working conditions
required by applicable law. No labor union has requested or has sought to represent any of the employees, representatives or agents
of the Company or the Subsidiary, nor is the Company or the Subsidiary aware of any labor organization activity involving its
employees. There is no strike or other labor dispute involving the Company or the Subsidiary pending or, to the Company&rsquo;s
knowledge, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
<U>Taxes</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in
a Material Adverse Effect, the Company and the Subsidiary each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the
payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. Except
as disclosed in SEC Reports, there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and neither the officers of the Company nor the Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
<U>Governmental Grants</U>. Neither the Company nor the Subsidiary have applied, obtained or received any grant, loan, incentives,
benefits (including tax benefits), subsidies or other assistance from any governmental or regulatory authority or any agency,
or any international or bilateral fund, institute or organization or public entities or authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16
<U>Litigation</U>. There is no claim, action, suit, proceeding, arbitration, complaint, charge or, to the Company&rsquo;s knowledge,
investigation pending, or, to the Company&rsquo;s knowledge, currently threatened in writing against the Company or the Subsidiary,
any of its properties, or any officer, director or employee of the Company or the Subsidiary, including, without limitation, arising
out of their employment or board relationship with the Company or the Subsidiary or in their capacity as such, or that questions
the validity of the Transaction Documents or the right of the Company to enter into them, or to consummate the transactions contemplated
by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17
<U>Insurance</U>. The Company and the Subsidiary are covered by insurance with respect to its properties and business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18
<U>Compliance</U>. Neither the Company nor the Subsidiary (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or the Subsidiary
under), nor has the Company or the Subsidiary received written notice of a claim that it is in default under, any indenture, loan
or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental
body, or (iii) is in violation of any law, rule or regulation of any governmental authority, except in each case as would not
have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19
<U>Permits</U>. The Company and the Subsidiary possess all licenses, certificates, permits and other authorizations issued by
all applicable authorities necessary to conduct their respective businesses, and neither the Company nor the Subsidiary has received
any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, singly
or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20
<U>Certain Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or the Subsidiary
to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect
to the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21
<U>Disclosure</U>. No representation or warranty of the Company contained in this Agreement, and no certificate furnished or to
be furnished to Investor at the Closing or the Deferred Closing contains any untrue statement of a material fact or, to the Company&rsquo;s
knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading
in light of the circumstances under which they were made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>REPRESENTATIONS AND WARRANTIES OF THE INVESTOR</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor hereby represents and warrants, with respect to itself only, that the following representations are true, correct and
complete as of the date hereof and as of the Closing (as if made on the Closing Date); except, in each case, as to such representations
and warranties that address matters as of a particular date, which are given only as of such date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Authorization; Organization</U>. The Investor is duly organized, validly existing and, if applicable, in good standing under
the laws of the jurisdiction in which it has been incorporated and has full power and authority to enter into the Transaction
Documents. The Transaction Documents to which the Investor is a party, when executed and delivered by the Investor, and assuming
the due authorization, execution and delivery by the other parties hereto and thereto, constitute valid and binding obligations
of the Investor, enforceable against the Investor in accordance with their respective terms, except (i) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or
affecting the enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, and (iii) to the extent the indemnification provisions contained
herein, as may be limited by applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>No Conflict; Consents</U>. The execution, delivery and performance by the Investor of the Transaction Documents to which it
is a party and the consummation of the transactions contemplated by such Transaction Documents do not and will not (a) result
in any conflict with, or a breach or violation, with or without the passage of time and giving of notice, of any of the terms,
conditions or provisions of, or give rise to rights to others (including rights of termination, cancellation or acceleration)
under: (i) the governing documents of the Investor; (ii) any judgment, injunction, order, writ, decree or ruling of any court
or governmental authority, domestic or foreign, to which the Investor is subject; (iii) any material contract or agreement, lease,
license or commitment to which the Investor is a party or by which it is bound; (iv) any applicable law; or (b) require the consent,
approval or authorization of, registration, qualification or filing with, or notice to any person or any federal, state, local
or foreign governmental authority or regulatory authority or agency, on the part of the Investor, which has not heretofore been
obtained or made or will be obtained or made prior to Closing or the Deferred Closing, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Purchase Entirely for Own Account</U>. The Purchased Securities will be acquired for investment for the Investor&rsquo;s own
account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and the Investor has
no present intention of selling, granting any participation in, or otherwise distributing the same. The Investor does not presently
have any contract, undertaking, agreement or arrangement to sell, transfer or grant participation rights to any person with respect
to any of the Purchased Securities. The Investor has not been formed for the specific purpose of acquiring the Purchased Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Disclosure of Information</U>. The Investor has had an opportunity to discuss the Company&rsquo;s business, operations, properties,
prospects, technology, plans, management, financial affairs and the terms and conditions of the offering of the Purchased Securities
with the Company&rsquo;s management and has had an opportunity to review the Company&rsquo;s facilities. The foregoing, however,
does not limit, modify or qualify the representations and warranties of the Company in Section &lrm;2 of this Agreement or the
right of the Investor to rely thereon. The Investor acknowledges that any projections provided (if any) by the Company are uncertain
in nature, and that some or all of the assumptions underlying such projections may not materialize or will vary significantly
from actual results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Investment Experience; Accredited Investor; Non-U.S. Person</U>. The Investor acknowledges that it is able to fend for itself,
can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is
capable of evaluating and understanding the merits and risks of the investment in the Purchased Securities. The Investor is either
(i) an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;), or (ii) a Non U.S. Person as defined under Regulation S promulgated under the Securities
Act. To the extent that the Investor is a non U.S. Person, such Investor (x) is not acquiring Purchased Securities for the account
or benefit of any U.S. Person, (y) is not, at the time of execution of this Agreement, and will not be, at the time of the Closing
or Additional Closing, in the United States and (z) is not a &ldquo;distributor&rdquo; (as defined in Regulation S promulgated
under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Restricted Securities</U>. The Purchased Securities have not been and will not be registered under the Securities Act or any
state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state
securities laws or unless an exemption from such registration requirements is available. Investor is aware that, except as set
forth herein, the Company is under no obligation to effect any such registration or to file for or comply with any exemption from
registration. The sale and issuance of the Purchased Securities have not been registered under the Securities Act by reason of
a specific exemption from registration which depends upon, among other things, the accuracy of the Investor&rsquo;s representations
as expressed herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Legends</U>. The Purchased Securities, and (if applicable) any securities issued in respect of or exchange for the foregoing
may be notated with the following or a similar legend as well as other legends as may be required by applicable securities laws:
&ldquo;THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO TRANSFER OF SUCH SHARES MAY BE EFFECTED WITHOUT
AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>CONDITIONS OF INVESTOR&rsquo;S OBLIGATIONS AT CLOSING</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Investor to purchase the Purchased Securities at the Closing are subject to the fulfillment on or before the
Closing of each of the following conditions, unless otherwise waived in writing by the Investor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Representations and Warranties</U>. The representations and warranties of the Company in Section 2 of this Agreement shall
have been true in all respects on and as if made as of the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Performance</U>. The Company shall have performed and complied, in all respects, with all agreements, obligations and conditions
contained in this Agreement that are required to be performed or complied with by it on or before the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Delivery of Documents</U>. All of the documents to be delivered by the Company pursuant to Section 1.3, shall have been in
a form as attached to this Agreement, or, if not attached, in a form and substance satisfactory to the Investor and shall have
been delivered to the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Additional Investment</U>. The Company consummated additional equity investment(s) for the Company&rsquo;s Common Stock, in
the aggregate amount of no less than US$200,000, not counting the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>CONDITIONS OF THE COMPANY&rsquo;S OBLIGATIONS AT CLOSING</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Company to the Investor under this Agreement are subject to the fulfillment on or before the Closing, of each
of the following conditions, unless otherwise waived in writing by the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Representations and Warranties</U>. The representations and warranties contained in Section &lrm;3 shall have been true in
all respects on and as if made as of the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Performance</U>. The Investor shall have performed and complied, in all respects, with all agreements, obligations and conditions
contained in this Agreement that are required to be performed or complied with by it on or before the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>AFFIRMATIVE COVENANTS BY THE COMPANY</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Use of Proceeds</U>. The Company will use the Purchase Price for general working capital purposes. Notwithstanding the foregoing,
the POC Investment Amount shall be allocated specifically to conducting a proof of concept procedure to test the effectiveness
of the Company&rsquo;s sanitizers and its residual effects against different pathogens including a COVID-19 virus&rsquo; surrogate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Conduct of the Business between Signing and Closing</U>. Except as otherwise expressly provided by this Agreement or with the
prior written consent of each of the Investor individually (which consent shall not be unreasonably withheld or delayed), the
Company shall (i) conduct its business in the ordinary course of business, consistent with prior practice; (ii) comply with legal
requirements applicable to the operation of its business and pay applicable taxes as due; (iii) maintain its books, accounts and
records in the ordinary course of business; and (iv) not take any other action that would result in a breach of any of the representations,
warranties or covenants made by the Company in this Agreement or that would adversely affect its ability to consummate the transactions
contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Effectiveness; Survival</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Investor has the right to fully rely upon all representations, warranties and covenants of the Company, for which the Company
shall be held responsible (the &ldquo;<U>Indemnitor</U>&rdquo;) contained in or made pursuant to this Agreement and in the schedules
attached hereto. Unless otherwise set forth in this Agreement, the representations and warranties of the Company contained in
or made pursuant to this Agreement shall in no way be affected by any investigation or knowledge of the subject matter thereof
made by or on behalf of the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The representations and warranties of the Company contained in or made pursuant to this Agreement shall survive the execution
and delivery of this Agreement and the Closing, until (1) in case of Section 2.11 (<I>Intellectual Property</I>), until the 30<SUP>th
</SUP>months anniversary of the Closing Date; (2) in case of Sections 2.2 (<I>Organization</I>), 2.4 (<I>Authorization</I>) and
2.6 (<I>No Conflict; Consents</I>), until the expiration of the applicable statute of limitation period; and (3) other than as
set forth in clause (1) above, the 24<SUP>th</SUP> months anniversary of the Closing Date; in each case, with respect to any theretofore
un-asserted claims as set forth in clause (d) below;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In respect to Section 7.1(b) above, no limitation shall apply to breach of any representation or warranty which constitutes fraud
or willful misrepresentation by the Company (&ldquo;<U>Fraud</U>&rdquo;). The applicable survival period shall be referred to,
as applicable, as the &ldquo;<U>Claims Period</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Except for Fraud, the Company shall have any liability with respect to any breach of representation and warranty, unless a claim
is made hereunder prior to the expiration of the Claims Period for such representation and warranty, in which case such representation
and warranty shall survive as to that claim until the claim has been finally resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
It is the intention of the parties hereto that the Claims Periods supersede any statute of limitations applicable to the representations
and warranties, and this Section <B>&lrm;</B>7.1 constitutes a separate written legally binding agreement among the parties hereto
in accordance with the provisions of Section 19 of the Israeli Limitation Law, 1958.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnifiable Losses</U>. The Indemnitor shall indemnify the Investor (including its shareholders, limited and general partners
directors and officers) (each, an &ldquo;<U>Indemnitee</U>&rdquo;) against, and hold each Indemnitee harmless from all claims,
actions, suits, settlements, damages, expenses (including, reasonable legal costs and expenses), losses, or costs sustained or
incurred by such Indemnitees (collectively, &ldquo;<U>Losses</U>&rdquo;) resulting from, or arising out of, a breach or misrepresentations
of any the Indemnitor&rsquo;s representations, warranties or covenants made in this Agreement, subject to the limitations in this
Section <B>&lrm;</B>7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Limitations</U>. The Indemnitee&rsquo;s right for indemnification hereunder is subject to the following conditions and limitations,
notwithstanding anything to the contrary in this Agreement, but in to any other limitation or condition contained herein; <I>provided,
however</I>, no limitation shall apply to Fraud:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
No Indemnitor shall be liable for any Loss, unless and until the aggregate of Losses equal or exceeds US$50,000, in which case
indemnification shall be made from the first dollar amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Indemnitor&rsquo;s liability shall be limited to the Purchase Price and each Indemnitee shall be entitled to receive a pro
rata share of the indemnifiable Loss, based the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 113.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Claims Notice; Third Party Claims</U>. In the event that an Indemnitee wishes to assert a claim for indemnification hereunder
it shall give the Indemnitor a prompt written notice thereof (a &ldquo;<U>Claims Notice</U>&rdquo;), which shall describe in reasonable
detail the facts and circumstances upon which the asserted claim for indemnification is based and thereafter keep the Indemnitor
informed, in all material respects, with respect thereto. In the event that such Claims Notice results from a third party claim
against the Indemnitee, such Indemnitee shall promptly upon becoming aware of the commencement of proceedings by such third party
provide the Indemnitor with the Claims Notice and the Indemnitor shall have the right to assume the defense thereof (at Indemnitor&rsquo;s
expense) with counsel mutually satisfactory to the parties; <I>provided, however</I>, that the Indemnitees shall have the right
to retain their own counsel, at the reasonable expense of the Indemnitor, and within the indemnification limitations herein, if
representation of all parties by the counsel retained by the Indemnitor would be inappropriate due to actual or potential differing
interests between the parties in such proceeding. Failure of the Indemnitees to give prompt notice or to keep it informed, as
provided herein, shall not relieve the Indemnitor of any of its obligations hereunder, except to the extent that the Indemnitor
is actually and materially prejudiced by such failure. The Indemnitor shall not be liable nor shall it be required to indemnify
or hold harmless the Indemnitee in connection with any settlement effected without its consent in writing, which shall not be
unreasonably withheld or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Sole Remedy</U>. The indemnification provided by the Indemnitor hereunder and the enforcement of such indemnification shall
be the exclusive remedy available to the Indemnitees under this Agreement, other than for Fraud; <I>provided</I> that this provision
does not limit the right to seek specific performance, a restraining order or injunctive relief with respect to any provision
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>MISCELLANEOUS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Further Assurances</U>. Each of the parties hereto shall perform such further acts and execute such further documents as may
reasonably be necessary to carry out and give full effect to the provisions of this Agreement and the intentions of the parties
as reflected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Entire Agreement</U>. This Agreement (including the exhibits and schedules hereto) and the other Transaction Documents constitute
the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and supersede all
prior agreements and understandings, both written and oral, among any of the parties hereto, with respect to the subject matter
hereof (with no concession being made as to the existence of any such prior agreements or understandings).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Amendment; Waiver</U>. Except as explicitly set forth herein, any term of this Agreement may be amended only with the written
consent of both the Company and the Investor. The observance of any term hereof may be waived (either prospectively or retroactively
and either generally or in a particular instance) only by the prior written consent of the party against which enforcement of
such waiver shall be sought. Any amendment or waiver effected in accordance with this Section &lrm;8.3 shall be binding upon the
Investor and each transferee of the Purchased Securities, each future holder of all such securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Assignment; Successors and Assigns</U>. None of the rights, privileges or obligations set forth in, arising under, or created
by this Agreement may be assigned or transferred by an Investor, without the prior written consent of the Company. Nothing in
this Agreement, express or implied, is intended to confer upon any party other than the parties hereto any rights, remedies, obligations,
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Governing Law; Jurisdiction</U>. This Agreement shall be governed by and construed in accordance with to the laws of the State
of Israel, disregarding its conflict of laws rules. Any dispute arising under or in relation to this Agreement shall be resolved
exclusively in the competent court located in Tel Aviv-Jaffa, Israel and each of the parties hereby irrevocably submits to the
exclusive jurisdiction of such court. Each of the parties hereto (i) consents to submit itself to the exclusive jurisdiction of
the abovementioned courts in the event any dispute arises out of this Agreement or the transactions contemplated by this Agreement,
(ii) agrees that it shall not attempt to deny or defeat such jurisdiction by motion or other request for leave from the abovementioned
court, (iii) agrees that it shall not bring any action relating to this Agreement or the transactions contemplated by this Agreement
in any court other than the abovementioned court, and (iv) irrevocably consents to service of process in the manner provided by
Section &lrm;8.6 or as otherwise provided by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6
<U>Notices</U>. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be
deemed effectively given upon the earlier of actual receipt, or (i) when delivered, if sent by personal delivery to the party
to be notified, (ii) when sent, if sent by electronic mail or facsimile (with electronic conformation of delivery) on a business
day and during normal business hours of the recipient, and otherwise on the first business day in the place of recipient, (iii)
five (5) business days after having been sent, if sent by registered or certified mail, return receipt requested, postage prepaid,
or (iv) one (1) business day after deposit with an internationally recognized overnight courier, freight prepaid, specifying next
business day delivery, with written confirmation of receipt. All communications shall be sent to the respective parties at their
address or contact details as set forth below, or to such address or contact details as subsequently modified by written notice
given in accordance with this Section 8.6 or, in the case of the Investor, as used for purposes of sending shareholders&rsquo;
notices by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Company:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Habarzel
    7, Tel Aviv, Israel 6971011</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Sztybel</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+972-72-2116144</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dan@savefoods.co</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>with
    a mandatory copy to (which shall not constitute a notice):</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meitar
        Law Offices</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16
        Abba Hillel St., Ramat-Gan, Israel</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew
    Rudolph, Adv.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+972-3-6103717</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>matthewr@meitar.com</U></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Investor:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Omer
    Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liron
    Carmel</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+972
    72 260-2200</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Liron.Carmel@medigus.com</U></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>with
    a mandatory copy to (which shall not constitute a notice):</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Meitar Law Offices</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">16 Abba Hillel St., Ramat-Gan, Israel</FONT></P>

</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Shachar Hadar, Adv.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+972-3-6103961</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>shacharh@meitar.com</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.7
<U>Delays or Omissions</U>. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing
to any party to this Agreement upon any breach or default of any other party under this Agreement, shall impair any such right,
power or remedy of such non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed
a waiver of any other breach or default therefore or thereafter occurring. Any waiver, permit, consent or approval of any kind
or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of
any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement,
shall be cumulative and not alternative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.8
<U>Interpretation</U>. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement. The words &ldquo;include&rdquo;, &ldquo;includes&rdquo; and &ldquo;including&rdquo;
shall be deemed to be followed by the phrase &ldquo;without limitation&rdquo;. Unless the context requires otherwise, the words
&ldquo;herein&rdquo;, &ldquo;hereof&rdquo; and &ldquo;hereunder&rdquo;, and words of similar import, shall be construed to refer
to this Agreement in its entirety, and not to any particular provision hereof, and all references herein to Sections shall be
construed to refer to Sections to this Agreement. Reference to &ldquo;governmental authorities&rdquo; (or similar terms) shall
include any: (a) nation, principality, state, commonwealth, territory, county, municipality, district or other jurisdiction of
any nature, (b) federal, state, local, municipal, foreign or other government, (c) governmental, quasi-governmental or regulatory
body of any nature, including any governmental division, subdivision, department, agency, bureau, branch, office, commission,
council, board, instrumentality, organization, unit, or body, or (d) court, public or private arbitrator or other public tribunal.
Reference to a &ldquo;person&rdquo; shall mean any individual, corporation, partnership, limited liability company, firm, joint
venture, association, joint-stock company, trust, estate, unincorporated organization, governmental authority or other entity,
including, any party to this Agreement. Any reference to a &ldquo;day&rdquo; or a number of days (without explicit reference to
&ldquo;business days&rdquo;) shall be interpreted as a reference to a calendar day or number of calendar days, and if any action
is to be taken or given on or by a particular calendar day, and such calendar day is not a business day, then such action may
be deferred until the first business day thereafter (where &ldquo;business day&rdquo; shall mean any day on which banking institutions
in Tel-Aviv-Jaffa, Israel are generally open to the public for conducting business and are not required by law to close).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.9
<U>Severability</U>. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision
shall be excluded from this Agreement and the balance of the Agreement shall be enforceable in accordance with its terms and interpreted
so as to give effect, to the fullest extent consistent with and permitted by applicable law, to the meaning and intention of the
excluded provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.10
<U>Counterparts</U>. This Agreement and any Transaction Document may be executed in one or more counterparts, all of which together
shall constitute one and the same instrument, binding and enforceable against the parties so executing the same; it being understood
that all parties need not sign the same counterpart. Counterparts may also be delivered by facsimile or email transmission (in
pdf format or the like, or signed with docusign, e-sign or any similar form of signature by electronic means) and any counterpart
so delivered shall be sufficient to bind the parties to this Agreement or any other Transaction Document, as an original.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.11
<U>Waiver of Conflict; Acknowledgment</U>. Each party to this Agreement acknowledges and agrees that it was advised, prior to
the date hereof, that the law firm Meitar, Law Offices, is representing the Company and the Investor in connection with this Agreement
and the transactions contemplated hereby, that the Company and such Investor have previously provided their consent to the foregoing
in accordance with the applicable rules and shall not have any right, claim or demand against any party, such law firm or any
of its employees, partners or representatives with respect to the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">-
Signature Pages Follow -</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this SECURITIES PURCHASE AGREEMENT to be executed as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>COMPANY</U>:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/ Dan Sztybel</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SAVE FOODS, INC.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Sztybel</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Company
Signature Page to Securities Purchase Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this SECURITIES PURCHASE AGREEMENT as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INVESTOR</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/ Liron Carmel</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">MEDIGUS LTD.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liron
    Carmel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Investor
Signature Page to Securities Purchase Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>21
<FILENAME>ex10-13.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.13</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONSULTING
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; letter-spacing: 1.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none; letter-spacing: 0pt">This
<B>CONSULTING AGREEMENT</B> (this </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt"><B>Agreement</B></FONT>&rdquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt">)
is made and entered as of November 1, 2020 (the &ldquo;<B>Effective Date</B>&rdquo;), by and between <B>Save Foods, Inc.</B>,
a Delaware corporation (the </FONT>&ldquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt"><B>Company</B></FONT>&rdquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt">),
and S.T. Sporting (1996) Ltd. (the &ldquo;<B>Consultant</B></FONT>&rdquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt">).
Each of the Company and the Consultant shall additionally be referred to herein as a </FONT>&ldquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt"><B>Party</B></FONT>&rdquo;
<FONT STYLE="text-transform: none; letter-spacing: 0pt">and collectively, the </FONT>&ldquo;<FONT STYLE="text-transform: none; letter-spacing: 0pt"><B>Parties</B></FONT>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; letter-spacing: 1.5pt; text-align: justify; text-indent: 1cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Services; Term and Termination</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
<U>Services</U>. The services which will be provided by the Consultant shall be in the scope of, and shall include further terms
and conditions as specified in <B><U>Exhibit A</U></B> attached hereto (the &ldquo;<B>Services</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
<U>Commencement</U>. The engagement hereunder shall commence on November 5<FONT STYLE="text-transform: uppercase">, 2020</FONT>
(the &ldquo;<B>Effective Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
<U>Term; Termination</U>. This Agreement shall commence as of the Effective Date, and shall be in effect unless terminated by
either of the Parties at any time upon sixty (60) days prior written notice (the &ldquo;<B>Term</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.
Nothing in this Agreement shall be interpreted as preventing or restricting the Company from obtaining or seeking from any other
person services of the same nature as the Services, or otherwise from performing or seeking to perform any action or operation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Compensation</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
In full consideration for all Services under this Agreement, the Company shall pay the Consultant the amounts set forth in <B><U>Exhibit
B</U></B> attached hereto (the &ldquo;<B>Compensation</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
The Compensation shall be paid to Consultant against an invoice issued by Consultant in accordance with applicable law, setting
forth, to the extent applicable, relevant calculations and the required reports, and to be paid by the Company within thirty (30)
days after the Company&rsquo;s receipt of such invoice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
The Consultant agrees to pay any and all taxes, fees, duties and/or other impositions that may be levied on Consultant pursuant
to relevant law in connection herewith, including, self-employment taxes, and to indemnify the Company in the event the Company
is required to pay any such taxes on behalf of the Consultant and/or anyone on the Consultant&rsquo;s behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
All sums payable under this Agreement shall be made in US Dollars and shall exclude VAT withholding tax and shall be inclusive
of all other taxes, duties, levies and like matters imposed by any governmental authority, which, if applicable, shall be paid
by the Consultant in accordance with applicable law. In the event that pursuant to any law or regulation, tax is required to be
withheld at source from any payment made to the Consultant, the Company shall withhold said tax in accordance with applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.5. The Compensation under Section &lrm;2 shall constitute the
total and exclusive compensation payable to Consultant for the Services rendered hereunder. Consultant shall not be entitled to
any other form of compensation, commission, fee, bonus, expenses reimbursement or any other form of payment in connection with
the Services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Confidentiality; Proprietary Rights; Non-Compete; Non Solicitation</U></B>. For the purposes of this <U>Section 3</U>, unless
the context otherwise requires, the term &ldquo;<B>engagement with the Company</B>&rdquo; shall also include the engagement with
the Company, prior to the execution of this Agreement, and any engagement with any and all of the Company&rsquo;s direct and indirect
existing and future affiliates, subsidiaries, parent or related corporations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
<U>Confidentiality</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1.
<U>Nondisclosure; Recognition of Company&rsquo;s Rights</U>. At all times during Consultant&rsquo;s engagement and thereafter,
the Consultant will hold in confidence and will not disclose, use, lecture upon, or publish any of the Company&rsquo;s Confidential
Information (as defined below), except as such use is required in connection with its engagement for the Company, or unless the
Company expressly authorizes in writing such disclosure or publication. The Consultant will obtain the Company&rsquo;s written
approval before publishing or submitting for publication any material (written, oral, or otherwise) that relates to its engagement
with the Company and/or incorporates any Confidential Information. The Consultant hereby assigns to the Company any rights it
has or acquires in any and all Confidential Information and recognizes that all Confidential Information shall be the sole and
exclusive property of the Company and its assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2.
For the purpose of this Agreement, &ldquo;<B>Confidential Information</B>&rdquo; shall mean any and all confidential knowledge,
data or information related to the Company&rsquo;s business as conducted and/or as proposed to be conducted or its actual or demonstrably
anticipated research or development, including without limitation: (a) trade secrets, inventions, ideas, processes, computer source
and object code, data, formulae, programs, other works of authorship, graphics, creative works, data, methods, drawings, models,
text, photos, audio works, translation works, broadcasting works, animation works, algorithms, icons, symphonies, tunes, melodies,
sound effects, know-how, improvements, discoveries, developments, designs, and techniques; (b) information regarding products,
plans for research and development, marketing and business plans, budgets, financial statements, contracts, prices, suppliers,
and customers; (c) information regarding the skills and compensation of the Company&rsquo;s consultants, contractors, and any
other service providers of the Company; and (d) the existence of any business discussions, negotiations, or agreements between
the Company and any third party. Confidential Information shall not include information or matter that the Consultant can document
that (a) was already known to the Consultant prior to disclosure as can be demonstrated by Consultant&rsquo;s dated written records;
(b) is independently developed by the Consultant without reference to or use of the Confidential Information as can be demonstrated
by Consultant&rsquo;s dated written records; or (c) which at the time of disclosure by the Company is generally available to the
public or thereafter becomes generally available to the public other than through a breach of any obligation under this Agreement
caused by an act or omission on the part of the Consultant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 78pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.3.
<U>Third Party Information</U>. The Consultant understands, in addition, that the Company has received and in the future will
receive from third parties confidential or proprietary information (the &ldquo;<B>Third Party Information</B>&rdquo;) subject
to a duty on the Company&rsquo;s part to maintain the confidentiality of such information and to use it only for certain limited
purposes. During the term of Consultant&rsquo;s engagement and thereafter, it will hold Third Party Information in strict confidence
and will not disclose to anyone (other than the Company personnel who need to know such information in connection with their work
for the Company) or use, except in connection with his/her work for the Company, Third Party Information, unless expressly authorized
by an officer of the Company in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Relationship; Warranties</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.
Consultant shall at all times act as an independent contractor, and shall not be, and/or claim to be, an employee or agent of
the Company. Consultant warrants that he is aware that this Agreement is only an agreement for the provision of services on a
strictly contractual basis, and does not create employer-employee relations between him and the Company and does not confer upon
him any rights, except for those set forth herein explicitly. Without limitation of the foregoing, Consultant will (a) not enter
into any contract, agreement or other commitment, or incur any obligation or liability, in the name or otherwise on behalf of
the Company; (b) not be entitled to any worker&rsquo;s compensation, pension, retirement, insurance or other benefits afforded
to employees of the Company; (c) provide for all applicable income tax and other withholding relating to Consultant&rsquo;s compensation;
(d) pay all social security, unemployment and other employer taxes relating to Consultant&rsquo;s compensation; (e) provide all
worker&rsquo;s compensation and other insurance relating to Consultant&rsquo;s engagement; and (f) perform all reporting, recordkeeping,
administrative and similar functions relating to Consultant&rsquo;s compensation. <FONT STYLE="letter-spacing: -0.15pt">The Company
is not restricted in otherwise contracting or engaging any partner by itself or through any third party</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
The Consultant represents and warrants that the execution and delivery of this Agreement, the performance of the Services and
the fulfillment of the terms hereof will not: (a) constitute, in whole or in part, a default, violation or breach under or conflict
in any way with any agreement, obligation, undertaking or commitment to which the Consultant is a party or by which he/she is
bound, including without limitation, any confidentiality, invention assignment or non-competition agreement and (b) do not require
the consent, permission or authorization of or notification to any person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
The Consultant hereby undertakes to comply with all Company disciplinary regulations, work rules, policies, procedures and objectives,
which are relevant to the performance of the Services or otherwise to consultants of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.
The Consultant shall not solicit or accept in connection with the performance of the Services or in connection with the Company,
any gift, benefit, favor, loan, or any other thing of monetary value, from a person who is or is possibly connected, directly
or indirectly, to either the business of the Company, a competitor of the Company or a potential competitor of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.
The Consultant shall take all necessary precautions to prevent the occurrence of any bodily injury or property damage, to the
Company, its employees or any third party, arising out of or resulting from the performance of the Services and shall be solely
responsible, and liable, for any such bodily injury or property damage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Miscellaneous</U></B>. Consultant agrees that any breach of <U>Section 3</U> above by it would cause irreparable damage
to the Company and that, in the event of such breach, the Company shall have, in addition to any and all remedies of law, the
right to an injunction, specific performance or other equitable relief to prevent the violation or threatened violation of the
Consultant&rsquo;s obligations hereunder. Consultant shall at all times act as an independent contractor, and shall not be, and/or
claim to be, an employee of the Company. This Agreement is only an agreement for the provision of consulting services on a strictly
contractual basis, and does not create employer-employee relations between the Consultant and the Company and does not confer
upon the Consultant any rights, except for those set forth herein. This Agreement represents the only Agreement relating to this
subject matter between the Consultant and the Company. Consultant will not (by contract, operation of law or otherwise) assign
this Agreement or any right or interest in this Agreement without the prior written consent of the Company. Subject to the foregoing,
this Agreement will be fully binding upon, inure to the benefit of, and be enforceable by the parties and their respective successors,
assigns and legal representatives. This Agreement shall be construed and governed by New York law, excluding laws relating to
conflicts or choice of law. The Parties submit to the exclusive personal jurisdiction of the federal and state courts located
in the Southern District of New York in connection with any dispute or any claim related to any dispute. No modifications or amendments
to this Agreement can be made except in writing, signed by the Consultant and Company. <U>Sections 3,4,5</U> shall survive termination
or expiration of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>-
</B><I>Signature Page Follows</I> <B>-</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Agreement to be duly executed and delivered on and as of the Effective
Date. This Agreement may be executed in two or more counterparts, each of which shall constitute an original and all of which
shall be deemed a single agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSULTANT:</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Benad Goldwasser</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Palach</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods, Inc.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S.T.
    Sporting (1996) Ltd.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benad
    Goldwasser</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owner</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>-
Signature Page to Consulting Agreement / Save Foods, Inc. -</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Services</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Services which shall be provided by Consultant pursuant to this Agreement shall include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Consultant shall serve as the co-Chief Executive Officer of the Company, effective immediately as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>Exhibit A to Consulting Agreement / Save Foods, Inc.</I> &ndash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Compensation</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the Services rendered by the Consultant pursuant to this Agreement the Company shall pay the Consultant:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a monthly fee in the amount of US$ 8,000 (plus VAT, if required by law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
an option grant subject to Company&rsquo;s current equity incentive plan, the terms of which will be negotiated in good faith
between the Consultant and the Company&rsquo;s board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collectively
(the &ldquo;<B>Compensation</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>Exhibit B to Consulting Agreement / Save Foods, Inc.</I> &ndash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>22
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIST
OF SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
    Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Incorporation</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods Ltd.<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods Ltd. is 98.94% owned subsidiary of Save Foods , Inc.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>23
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_001.jpg" ALT="" STYLE="height: 134px; width: 300px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have issued our report dated March 9, 2021, with respect to the financial statements of Save Foods, Inc. contained in the Registration
Statement on Form S-1 and Prospectus. We consent to the use of the aforementioned report in the Registration Statement on Form
S-1 and Prospectus, and to the use of our name as it appears under the caption &ldquo;Experts.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/Halperin
    Ilanit</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified
    Public Accountants (Isr.)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
    Aviv, Israel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    15, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex23-1_002.jpg" ALT="" STYLE="height: 41px; width: 670px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>24
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF DIRECTOR NOMINEE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
hereby consent, pursuant to Rule 438 under the Securities Act of 1933, as amended, to being named as a nominee to the board of
directors of Save Foods, Inc. in its Registration Statement on Form S-1, and any amendments or supplements thereto, and to the
filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Udi Kalifi</I></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Udi Kalifi</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2, 2021</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>img_001.jpg
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #O G4# 2(  A$! Q$!_\0
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MXG'0=._/6NPALK6VEED@MH8I)3F1HT"ESZDCK4D4,<$8CAC2-!G"HH '?H*
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MS[=ZZQ].LI+=[=[.W:&1B[QF)2K,3DDC&"<]ZEB@A@!$421ACD[% R<8[>P
M_"A R2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5&Z3_GF/^^JJZ3JEMK6D6FIV;%K:ZB66,D8.",\^]7: &;I/^>8_[ZHW2?\
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MZ_WA^=&]?[P_.D\N/^XOY4>7'_<7\J %WK_>'YT;U_O#\Z3RX_[B_E1Y<?\
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MWY/ %;?B'XE-9MK.DZEX)U!;N??! 1$'2Y3!"LQ Y_#->@R>)]*B>=&U&+?
MXC=5B9CN)QA0/O<@CC.,5836K-_MFV[0BR!-PWE-A,#)YZ''?&<4P.)^%7@Z
M;3OAW+I_B&R5A?S-,]I.N=J$* &!Z'Y<^W'>DL/#^FW?CF+2M)TV*ST#P\XN
M9ECCVK<7K#Y.?XMB\Y]2*[9M<L5\T?;8V,1<.$C9B"NTMP.N-R]/6J=SXMTN
M"RENDNQ.L5M]J*Q0NQ*=OH3@\'G@^E%];B/%[FSO%T6]\$-I=XWB*?Q!]KCF
M\@[#$6!\[S.F,9KZ'7A0"<G'6LRWURQNKY;&*]C-TR"01&-E., XY[X(.WJ!
MVK1Q)_?7_OG_ .O0MACZ*9B3^^O_ 'S_ /7HQ)_?7_OG_P"O0 ^BF8D_OK_W
MS_\ 7HQ)_?7_ +Y_^O0 ^BF8D_OK_P!\_P#UZ,2?WU_[Y_\ KT /HIF)/[Z_
M]\__ %Z,2?WU_P"^?_KT /HIF)/[Z_\ ?/\ ]>C$G]]?^^?_ *] #Z*9B3^^
MO_?/_P!>C$G]]?\ OG_Z] #Z*9B3^^O_ 'S_ /7HQ)_?7_OG_P"O0 ^BF8D_
MOK_WS_\ 7HQ)_?7_ +Y_^O0 ^BF8D_OK_P!\_P#UZ,2?WU_[Y_\ KT /HI%!
M ^8@GV&*6@ HHHH **** "BBB@ IKLJ(SN0%49)/84Z@]* /#M5O?#.J>,KG
M4K3Q5;&"XN(HIK2.W$ES<'="0(6SRF47G'RX?%>XUYCJ\.OV/BVY.GV^F64(
MNHKB.7; 'NE;RT*'=\PQB1F;KPH%>G4+8.H4444 %%%% !145U<1VEK+<RDB
M.)"[8&3@>U8&E>)WU&6 /;QQJ[F-]LNXJWSGTP0!'R?4^U '245EZ/JK:GYN
M^)8]JI(NUL_*V< ^C#;S]16DSJIP<_@": '44SS4_P!K_ODT>:G^U_WR: 'U
MP4G^MD_WC_.NZ\U/]K_ODUPLG^M?_>/\Z^;XB^&G\_T+@-HHHKY<L*<G^L3_
M 'A_.FTY/]8G^\/YU4=T!WM%,\U/]K_ODT>:G^U_WR:_2C$?4%W:6U];/;W<
M$<\#C#1R*&4_@:D\U/\ :_[Y-'FI_M?]\FFFT[H#B)? U[HDK77@W57L"3N;
M3[DF2UD^@/*_45):^/\ [!<I8^+=.DT6Z8X6<_/;2G_9<=/H?SKL_-3W_P"^
M35'6-/M-;TJXTZ[\SR)TV,47Y@/8D'!KLCBHU6EB5S>?VE\^OS^\R=-QUAI^
M0[1]9L==TY+_ $Z<36[DJ&'&"#@@CM5^N9\,>$=+\)&X&F3WICGP7BF?<N1_
M$!C@]JS]9^(<6CZO<6!TUY3"0-XE"YR >F/>N;$NC"H_9-N/2ZLR*F)A0@I5
MW8[:BO._^%JQ?] B3_O^/_B:/^%JQ?\ 0(D_[_C_ .)KG]K#N<_]JX/^?\'_
M )'HE%>=_P#"U8O^@1)_W_'_ ,31_P +6BQ_R")/^_X_^)H]K#N']JX/^?\
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M"-ZAF8D$>A8<^HJSJ'@S3+/6[;PMI=S?W5WJL:MJ=W=S&22'3XR/W8.!M#L
MH^AH ZOP3JL^I"YUO5-0,1UB7?INGS3!?+MEX0JA/WF^\3[BNVKYS\31Z-O\
M?OJQCCUZVN8DT@,2LD<8QY8A'IC'2O?-(FG;1;!KS?\ :C;QF;*G._:-WZYH
M T**9YJ?[7_?)H\U/]K_ +Y- #Z*9YJ?[7_?)H\U/]K_ +Y- #Z*9YJ?[7_?
M)H\U/]K_ +Y- #Z*9YJ?[7_?)H\U/]K_ +Y- #Z*9YJ?[7_?)H\U/]K_ +Y-
M #Z*9YJ?[7_?)H\U/]K_ +Y- #Z*16##(_E2T %%%% !1110 4444 %%%% '
MC?BK0]"N/';7-UJ,5E?M?Q'S-0T^0JR8BPL4I^0D,G'^^P(->R"O,M:\(:[J
MGCEM1M+2%+9)HV,NIW(N(F48SY4&T^6>O.1SS7IM"V#J%%%% !1110 5 UE:
MNQ9[:%B5*DF,'*DY(^A-2NZQHSNP55&22< "H(M0LYW1(;J&1W4LJJX)(Z9H
M EB@A@W>5$D>]BS;% W'U..]25%#<P7&_P F9)-C;6V,#M/H:EH **** "N"
MD_ULG^\?YUWM<%)_K9/]X_SKYOB+X:?S_0N!@>(]<?2!:0PO#'+<NP\Z9698
MU49)VKR3T %9NH^)+ZWMM-E@N;0Q3PO)-=1VTDL8*D 8 Y'OFM_4]*34OL\@
MN)K6YMW+PSPXW(2,'@\$$52;PPBZ?'8VVIWUM;B-HY51E(F#$EB<C@G)Y%>3
M0J86,(\ZUUOI_7R\]RG<V+67SK2&42)+OC5O,085LCJ/:IT_UB?[P_G4%M;Q
M6EK%;0+MBB0(@] .!4Z?ZQ/]X?SK@TY]-K_J/H=[1117Z28A1110 4444 %>
M(>-_^1RU'_?7_P! 6O;Z\0\;_P#(Y:C_ +Z_^@+6-?X3Q,^_W>/K^C.?HHHK
ME/DPI#T-+2'H: /H+1?^0%I__7M'_P"@BKU4=%_Y 6G_ /7M'_Z"*O5WH_1*
M?P+T7Y(****984444 %<SXD_X_8?^N?]:Z:N9\2?\?L/_7/^M>3G?^YR]5^9
M4=S' R0*Y73/$]Q>:G<P2FS5(3-M@ <3.$S@C/RG.*ZFL6'09O[4@O;S5)[L
MVV_[,C1JOEENI)'WC7R>'E149^U[:&C*7A_Q5)JU_':SK:9G@,\?V>0L8\'E
M),]&KIZQ].T(V>H-?7-ZUW.(S%&3$L812<GA>I/<UL48MT74O16EOQ$K]3K=
M!_Y!,?\ O-_.M*LS0?\ D$Q_[S?SK3K[? ?[K3]$9O<*;)&DJ-'(JNC##*PR
M"/0BG45UB.&NO!^H>'[J34?!=PD&\[IM*G/^CS>NW^XWTX^E:?A[QG9:U<-I
M]S%)INL1#][87/RO]5/\0]Q735B^(?"VE^);=4OH2)H^8;F([983ZJP_ETKM
M6(A67+B=_P"9;_/^9?CV9ER..L/N_K8VLT5P*ZYKW@EA#XD5]4T<'":M F9(
MAV\Y!_Z$/UKMK*^M=2M([NRN([BWD&4DC;<#6-;#SI)2WB]FMO\ @/R=F5&:
MEIU+%4[TV,[IIUZD4WVE6(AE3<KA<9R",<9'6KE8/B/0KG6?+%O="W(@FA+<
M[AOVXQC_ '<'V)K LN:;H&C:.[/IFEV5FSCYF@A5"1]0*DU+1]+UF)(]3T^U
MO$0[E$\2N%/J,CBN8A\&W4*62H;4>5#+'(7D=R ^[Y4.!M'S#E=I'OQC0M_#
M4ITC2K&\^RLEI=&9XD3Y"F'"KT&<%@<D#..E '0000VL"06\4<4*#:L<:A54
M>@ Z52_XE5I+<ZQY44<TA6&:Y\HAVVMM"DXR0">.U<JG@6]BM+A/M$%Q.]PL
MJRW#LRL1N^=DVX+?-T.<XZCC%J\\(7MS<12&6SF F:3,RMF',YES'CN1A3GT
M';B@#HKK1-)O+^&_NM-LYKR'_5SR0JSI]&(R*T*XBY\&ZG<VUQ ][ (]NR(*
M6'F+YQDPY(.,@XX!Z=^E=7I-D=.TFULRQ8PQA"2Y;I[GK0!<HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CF+B"0QE!(%.TO]W..
M,^U25'/#'<020RJ&CD4HZGN",$4 >83:[>:WXCA>'6[>SCB>.(O#?L]NCACD
M#8-CEQP!+M/IFO4Q6)H_A>QT9Y7BENKEI(UB!NI?,V1KR$7/0#-;= !1110
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MZCWK1\J/_GFOY5^@X#_=:?HC)[CZ*9Y4?_/-?RH\J/\ YYK^5=8A]%,\J/\
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M+F))9(%"G"R #;APR[20,DE#GVZ\<@&W16/HEK?6SW!O"^&Q]Z3=O?+;G'/
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MY)."._UJ9J\6D<N-I2JX>=.&[1X917J'_"J[+_H)W/\ WPM'_"J[+_H)W/\
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M_=7KNZ=_6D\M,YV+G.<X[^M #Z*** "F2]%_WA_.GTR7HO\ O#^= #Z***
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M.I@%%%% !4<[M';R.NS<JDC>V%SCN>PJ2B@#E(O%KHD,;VOGW3L59(B%VG'
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M/YTD4*PJ54N03GYW+']33V4-C/8YH&+144UNDQ!9I!C^Y(R_R-1_88O[\_\
MW_?_ !H%=EFBJWV&+^_/_P!_W_QH^PQ?WY_^_P"_^- 7?8LT56^PQ?WY_P#O
M^_\ C1]AB_OS_P#?]_\ &@+OL6:*K?88O[\__?\ ?_&C[#%_?G_[_O\ XT!=
M]BS15;[#%_?G_P"_[_XT?88O[\__ '_?_&@+OL6:*K?88O[\_P#W_?\ QH^P
MQ?WY_P#O^_\ C0%WV+-%5OL,7]^?_O\ O_C2?88O[\__ ($/_C0%WV+5%5?L
M,7]^?_P(?_&C[%#G'F3Y_P"OA_\ &@+OL6J*J_88O[\__@0_^-'V*$=9)_\
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D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>img_002.jpg
<TEXT>
begin 644 img_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $V ED# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&: "BC-% !1110
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M=:XW6/AU87-X=3T2XET351R)[3A&/^TG0_AC\:[#9)_SU/\ WR*-DG_/4_\
M?(K[&C7J47S4W;\GZK9_-&4H1DK,X!?%_B'PI((/&.F&>S!P-5L%W)]77M^G
MTKM=+U?3]9LUN]-NXKJ!OXXVSCV(Z@^QJRT+.A1I-RL,$%0017%ZE\.+=+MM
M3\-WTNB:EU)MQ^YD]F3ICZ?E73S8:O\ &O9R[K6+]5NOE=>1%IQVU7XG<T5Y
MVGC76O#4BVWC33FBBSM35+)-\+?[PZK_ )XKMK"^MM4M$NK"_CN8'Z218(K"
MMA:M%<TE>+V:U3^?Z:/R*C.,M%N7J*CV2?\ /4_]\BC9)_SU/_?(KG+.9^)&
MDW.M?#[6+*S0R7#0AXT7JY5@V![G%?/=Z/!\W@'3%TE+G_A,C.B2+F0ON!P?
M;'3&.1^=?47VJ/[>;'[5_I(B\[R]O.S.,_G4":#IL>H&_2QLUO2<FX6V02'_
M (%C- 'DNN7#^#?B[H'B/7BR6=UIRP3W&TL$E"%6SCWP?H:L> DA\7_$_P 6
M>(HHC+HLT)M%9UPLV0H(P?92?Q%>LWFG6^HVYM[Z*&Y@)R8YH5=3^!I;2PAL
M;=;>S2*W@3[L<42JH^@% 'ENO>"]+\/3V6D:#)>/K.KAK*U:XN#*+"T/,S1@
M_= 7(^K5C:]8>'],\6^)K#78[:.SM?#\<6D)<XP%5<?N\_Q;O3G.:]J.GP-?
M+?&.(W:QF)9S$N\(3DJ&ZXSVJ"^TO3=0G@74+>TN9DR\(N(4=EQC)7(]QTI
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M%&R3_GJ?^^10!)14>R3_ )ZG_OD4;)/^>I_[Y% $E%%% !11TJI_:=@8#/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&CR4_P!K_OHT 245'Y*?[7_?1H\E/]K_ +Z- $E%1^2G^U_WT:/)3_:_[Z-
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MQI%KHUJEA<_ZZ$KN\STW$\G';GBETL!YYIFO:[HGBN_\.2>)3K]O)I$MXEV
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MWB&$=LJRCTW @X]J;=^"O#E]IMCIUQI,!M+!P]K&N5\HCT((/^-"T&SS*_\
M$^N1>'OB5.NJW(ET[4$CM&#<P+OP0OH,<4B3>,_^$QT71V\9W'_$^TXW+R"U
M3%O\I.$7UXZ^YKTV7P5X>FM=6MI-/5H=7E$U\OFO^^<'.>O'/IBK'_",:/\
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MY4>3%_SS7\J?10 SR8O^>:_E1Y,7_/-?RI]% #/)B_YYK^5'DQ?\\U_*GT4
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M3_>'\Z;3HO\ 6I_O#^=8'@QW1]$>?%_ST7\Z//B_YZ+^=2=J*]$_1R/SXO\
MGHOYT>?%_P ]%_.I** (_/B_YZ+^='GQ?\]%_.I** *UU-&;28!USL;O[5Q(
MZ"NYN_\ CSG_ .N;?RKA1T%?+<0_'3]'^9<!:***^<+.L>5/^$?9=XS]E/&?
M]FO U^Z/I7OS_P#(NM_UZG_T&O 5^Z/I7W\OX</1?DCY3B'XJ?S%HHHK,^</
M=?#,L:^%]+!< _9D[^U:OGQ?\]%_.LWPQ_R*VE_]>R?RK6KT%L?H=#^%'T7Y
M(C\^+_GHOYT>?%_ST7\ZDHIFI'Y\7_/1?SH\^+_GHOYU)10!'Y\7_/1?SIGV
MRU'_ "\1?]]BIZX2<#[3+_OM_.O,S+,)8.,6HWO<J*N;MUH?AF]U1=3N;2RE
MO%(/FL022.A(S@D=LUK_ &VU_P"?F+_OL5P^!1@5Y/\ K#/_ )]K[V/D.X:2
MWFC*LT;HPP0<$$4K/ ZE'9&4]0>0:K:-_P @FW_W3_,U?KZ6C4=2G&?=)D-'
M+ZGX(\):N2UUI-H)#_RTA'EM^:XK%/P];3^?#WBS5=.QTB>3SH_R.*Z75?%^
MD:-J*V5W+*) JO*R1,Z0*QPID8<*">.:W <BNZ&.Q$%RJ;:[/5?<[F;I0;V/
M/Q/\1M(ZMH^N1#T;R)#_ "%*/B<;!MFO^&M5TTCK(L?FQ_F,5Z!2$9&",@U?
MUJE/^+23\U>+_"Z_ 7LY+X9?J<[IGCSPOJV/LNM6F\_P2OY;?DV*WUN(70.L
MJ,IZ,#D5CZGX.\.ZQG[=HUG*Q_C$85O^^A@USQ^%]K9.9-!US5M)?LL<Y>/_
M +Y/^-')@Y_#*47YJZ^]6?X!>HMTF=SY\7_/1?SH\^+_ )Z+^=<*;/XDZ1C[
M/J&EZW$/X;B/R9"/J./UH_X6#JFF@#Q!X0U.U4<--:@3Q_I1]0G+^%*,_1J_
MW.S#VJ7Q)H[KSXO^>B_G1Y\7_/1?SKF=,^(WA35&"1:O##*>/+N08F'_ 'U@
M5TT4T4\8DAE21#T9&!!_$5SU:%6D[5(M>JL7&<9;,//B_P">B_G1Y\7_ #T7
M\ZDHK(HC\^+_ )Z+^='GQ?\ /1?SJ2B@"/SXO^>B_G1Y\7_/1?SK*USQ/IOA
M]HDO&F:656<1P1-(P1?O.0.BCN:U+:XBN[:*XMY%DAE0.CKT92,@T +Y\7_/
M1?SH\^+_ )Z+^=244 1^?%_ST7\Z//B_YZ+^=244 1^?%_ST7\Z//B_YZ+^=
M244 1^?%_P ]%_.CSXO^>B_G4E% $?GQ?\]%_.CSXO\ GHOYU)10!'Y\7_/1
M?SH\^+_GHOYU)10!'Y\7_/1?SH\^+_GHOYU0UG7;+0H(I+LRL\TGEPPP1F22
M5L9PJCD\ FK&F:E::OIT-_92^;;S#*-@CV((/0@\8H G\^+_ )Z+^='GQ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW,:X^;AN,;E.TX.#0".THJM83S7-E#-<6S6TKJ"T+,K%#Z94D'\*LT %%%%
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M06-E%;"::81KM$D[[W;ZGN:L444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>img_003.jpg
<TEXT>
begin 644 img_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %( :H# 2(  A$! Q$!_\0
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MB@ HHHH **** "BBB@ JGJMZNG:1>7S$!;>!Y3G_ &5)_I5RN2^)::A-\/\
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M0"LQ^7]R2?F8$CMBJ.D^+]#\&Z!X?TW4-2U2Z>_MVN(;BZC+RE3\P# $G)R
M ,URNH6/B*_^"]AX;70+R&_6]2SGC2W(!B5L^;_NGCGUS710Z!>3?&6WNY+"
M<:3HVE+#:S/'\COC&%/<C<?RH_K\ .AT3XA^']<TW4K^.>:TATTXN_MD1B:/
MT)'X'CKGM6=9_%SPU?WMI9P1ZEYUY.L-LKVA3S0QP'4GJGJ?TK@O^$*\2ZU\
M/O$4WV":'5=2UG[6]K<?NWEA4D@<^[$\^E:-E+J?B#XP>'K75-*BTQ=(L&G6
MS282F($;06(X!)VX'8 4(&=U\3=<N/#WP_U.^M)FAN]JQP2+U5V8#(_#-<7X
MF\>"#X:Z;::-XFBNO$4YMX9)()E>4,<;R0/?CIWK?^*VF:CKUMH&D65E/<6\
M^I1O=O&A98XU[L>PY_2L_P 6^#XI_'GA&'2?#T4%A#<-<WES;6JH@VX*JS >
MW3WH0'2:UX]T7PF\&FWTUW>Z@L(>2&TA,TBJ!R[XX [\T^\^(GA^T\,V.OK-
M-<V5[,L$(@CRY<YX*DC&,'-<2;?Q-X7\9>+9[?PQ=:M-K3#[%>1,OEQK@X5R
M?N@9''^S6;J'@C6_#?A[P7:1Z9/JR65^U[J$-GACO)! &>P&1GI0M0/5+CQC
MI5KXJ'AV4S"\%H;QWV#RXXQG)9L\=/2J&A_$G0?$.JQV%DM^#,&,$\MHZ13A
M?O;']O?%<AIFG^);CQ9XQ\1W_AEGN)+1+6TL9I0J3(0-RA^A^4<XXR2*H>#_
M  OX@6^UJ+2[+5M%T.XTZ6%+75)@2MPPPOE@=%'K_.D!W$GQ2\,QZFEF)+QX
M6F%O]O2V8VHD)QM\SIUXXXKM<UX'X0\#"6;3])UOPGXBBE@DS<7)OL68*G(9
M5S@Y(' ]<U['XB\-V?B?3TLKZ6ZCB2029MIS$Q(!')';GI3#J;-<[XGL_$]X
M+>/0-7L],B 8W$TUOYK_ .SM!XQUSFF>&_ ^E^%KN:YL)K^229!&WVJZ:4 9
MSP#TKBOB%KGBG5-0?0=.\/:VFBA]EY>6D&9;A>ZQD\!3TSW_ )I@C9\#^*/$
M?B;P'?7:I93:Q;SR6T$S@I!.5QACCH.3T]*3X5>(-?\ $MEK%[K=U%,([PV\
M AC"HNT?-M(&2,D=:4ZS/H'@.P@T7P9K$9FADBBLXX@7MB,@-)SW//J:B^#L
M-]IWA,Z3?Z+?Z?/;N9));I HG9R2=O?@ 9S3ZL703XGZMK$>I>&M!T+4I+"\
MU.[96FC )5  ,D>G.?PJMX4UOQ+HGQ"E\&^(]2CU2-[0W5O>; C #U_7KGIU
MJEXUEUVU^+&G:S9^&-0U:TTVS*1B%2%,C[LG=@],BFVGA/Q7KA\2>*=6MX[/
M6+W3WL]/LE<$Q(1W/8GI^)/%);7]1O<Z"[^,?A*SDN1YM[-# 2OVF&U9H9''
M\"OT+?I[UOV/C#3;_P 1G0DCN8[P6:7O[V,*OEMC'.>HSR/8UY =(\3ZIX(\
M->%%\*7MC9P7T8OII%&7.XDMM'(7!)+'O@"MSXE1W]G\0=*&BJ/MVL:9+IB8
M/,>6'SGV"DG\*8'6M\4O#JZ8]_\ Z:T/VMK. )!N:ZD7KY2@Y8#UXKH/#WB*
MQ\3::;ZQ6X1%D,;QW$+1NCCJ"#7G7C3PNECH.C^'[;PMJ.H6%E"?L]]IDP%Q
M#/W)4]FZD_X5V/@"SU^P\$V=OK\I?4U#'$K[F5<G:K,.I QF@#A/$'B3Q#K/
MQ(O_  W:^)H?#<=FJ_9%EC!^UN0#RQ['/3]#1\0]4U*R7P3I>N7I:[:Y^T:@
MVGH_[P)CA57DYR1CN>U4/%]OXN\5VLFBZKX CEU<2%;;5[>3;%&F[(.[TQV)
M]\9KHM+T#5Q\4]'DO[>XEM-%T18!>LIV2S$8;!/4_,?RH0,ZC0?B%H.OV>I7
M,4L]HFF_\?0O8_*,8YY(/T/O4>C?$?0M<UF+2[=;^&:=6:V>ZM6B2X Y.PGK
MQS7G \'>(]9\$>,+DV$\&IZGJHN!:S#RWEA1L@#/KDX^E:G@SPQ$;]M23PQX
MAL+VPM7-J^J7N]#,5*[54G..>O% %71?%;Z8GCWQA,UU.C7IM+)5S(J%0=IQ
MG"KG;DUO?!ZU%UHTFNW4^KS:K<DI=/>NWEN<[@8U/&,$#/UKDX-#\0P_ V;1
M(]#U!-3O=2*7$9B^8J6#%\#^'  S7M4,/]DZ D%O&TGV2U"1H@R6V+@ #\*-
M@W.-\":SJ6N^,?%]Q-?2RZ;:W8M;2 XV)MSN(_(?G3];U.QD^)-I"=3UA+C2
M;&2\FLK5<P2IC^+G);VQSQ7(_#C5?$_AJU72KCP+JKR7U\9I[UR45-Y )(*G
MA1[UL:;8ZS#XM\?^)9--NQ*8?LVG*8SNF"J<%/4$JOYTM@,/P?XAL_$?BO6?
M%6O7NJV]M82&6S+.T=K%"/E",!P7.X?+R<UZ+H/Q!T7Q!J_]EV\=_;W31F6%
M;RU:'ST'5DSU%>>3>!=;?X':9IL%E,VH)=B]N[)CLDD!9LKS_%@J?PK=^'GA
MFS&MMJ[>'M?TV>VB\N&35KSS-V[A@JDY&/7OFGY!YGJ-%%% !1110 4444 %
M%%% !1110 48HHH ,48HHH ,"C%%% !BC HHH *,444 &*,444 &*,444 8G
MB7PQ:>)[.&WN;F]MF@D\V*:SG,3H^,9XX/7O5?PQX*TKPM)<W%JUS<WUUCS[
MR\E,DL@'0$^E='10 48HHH 3 I<"BB@ Q1BBB@ Q1110 4444 %%%% !BC%%
M% "8KFM&\#Z;H^N7&M&>]O\ 4IMRBXO9O,:)"<E$X 4<UTU% !BBBB@ Q28%
M+10 F!2XHHH ,"C%%% !BDP*6B@ Q1110 4444 %%%% !1110 4444 %%%%
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MRP?\\EJ:B@"'[+!_SR6C[+!_SR6IJIZIJ*:5827<D%Q.$Q^[MXS([$G   H
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MX/I6A-X=D'A>QOKF&:?5Q;00FW@#)',RMF(2KR<(2">1T/TKOLCU% (/>BZ
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M&_[Y'^%2T4 1>5+_ ,_#?]\C_"CRI?\ GX;_ +Y'^%2T4 1>5+_S\-_WR/\
M"CRI?^?AO^^1_A4M% $7E2_\_#?]\C_"CRI?^?AO^^1_A4M% $7E2_\ /PW_
M 'R/\*/*E_Y^&_[Y'^%2T4 1>5+_ ,_#?]\C_"CRI?\ GX;_ +Y'^%2T4 1>
M5+_S\-_WR/\ "CRI?^?AO^^1_A4M% $7E2_\_#?]\C_"CRI?^?AO^^1_A4M%
M $7E2_\ /PW_ 'R/\*/*E_Y^&_[Y'^%2T4 1>5+_ ,_#?]\C_"CRI?\ GX;_
M +Y'^%2T4 1>5+_S\-_WR/\ "CRI?^?AO^^1_A4M% $7E2_\_#?]\C_"CRI?
M^?AO^^1_A4M% $7E2_\ /PW_ 'R/\*/*E_Y^&_[Y'^%2T4 1>5+_ ,_#?]\C
M_"CRI?\ GX;_ +Y'^%2T4 1>5+_S\-_WR/\ "CRI?^?AO^^1_A4M% $7E2_\
M_#?]\C_"CRI?^?AO^^1_A4M% $7E2_\ /PW_ 'R/\*/*E_Y^&_[Y'^%2T4 5
MY8Y!$_[]ONG^$?X5Q )P.3^==Y-_J9/]T_RK@QT%?,<0MIT[>?Z%P%R?4_G6
MKX?#-?. Y4^6>>O<>M9-;'AS_D(2?]<C_,5Y66-_6Z>O4J6QT7E2_P#/PW_?
M(_PH\J7_ )^&_P"^1_A4M%?>&1%Y4O\ S\-_WR/\*/*E_P"?AO\ OD?X5+10
M!%Y4O_/PW_?(_P *58Y%;)F9AZ$"I** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@!DW^HD_W3_*N#'05WDW^HD_W3_*N#'0
M5\QQ%O3^?Z%P"MCPY_R$)/\ KD?YBL>MCPY_R$)/^N1_F*\G+/\ ?*?K_F5+
M8Z>BBBOO3(**** "BBB@ HHHH ;)C8V20,')'45Y]'>-<QR3Q2W\>EO*^R/?
M*95(C(1FS\PW."0O^[GDXKT.B@#C=4O+N2VMTDDNEN(K-E80JX_TTJA0' P>
MK>W7/2FW=OJ%C>7$I=/+9TEG?#N.7)4LHQG&<8!Z*,]<5VE% $%G+)/902S1
M^7(\:LZ?W21R*>[2AL)&K#U+8_I4E% $.^?_ )XI_P!]_P#UJXKQ;\0+S1=<
MM?#^CZ(VJZS<1^<(5EVJB<\DX]C7=FO+_'GA]6\9Z?KFE^*[+0];%N8PMV5V
MR1CJ1GZXP1S^%(#7\.?$>WU?2M5N-0L6TV[T?/V^VE?)CP"<CCGH1]:YZT^,
M=Z9+*_U'PO-9^'[^;R;>^,V3G.,L,=.#^1QG%<3I.G7NJ6?Q(O+6]EU2,VHB
M^V[<?:7#!F( XQA3@>A%6O$6L:=J7P+\-:39W$4NH/-%$MNC R*R[@<CJ.2/
MSI_\ /\ @G?:_P"/]:L]3UQ=*TVRELO#\4<M^;B1@\NX9VQXX!"\Y-;5YXMN
M9[KP_9:/;PR7.K*+EO-)(AM0 6<@8YY"CW-8^N_#YIUU&\&O-IUEJ%I''K$9
MA#[UC7EE8GY#@$$X-<LWVWR=%U".2XTZ+Q)J$-A%)&VV6VTZ-3Y4:M_"7QN)
M]Z/(#VG?/_SQ7_OO_P"M2[Y_^>*_]]__ %JXOX=W][)<^)-(N;R>]@TK43;V
MUQ.V^0IC.UF_B*],UW- $6^?_GBO_??_ -:C?/\ \\5_[[_^M4M% $6^?_GB
MO_??_P!:C?/_ ,\5_P"^_P#ZU2T4 1;Y_P#GBO\ WW_]:C?/_P \5_[[_P#K
M5+10!%OG_P">*_\ ??\ ]:C?/_SQ7_OO_P"M4M% $6^?_GBO_??_ -:C?/\
M\\5_[[_^M4M% $.^?_GBO_?S_P"M67XA\2VGA?1Y=3U0K';IP K99V/15&.2
M:VJ\'^/=_OU_0--N'9;%(S<2A>IRP4GZA0<?6D!JV_[0.FR7:+/H%[#:NVT3
M"4.?^^<<_0$UZ#XC\86/A?0/[8U!2(&P(HU/[R1B,A0I Y^O2O+4^,-G:2V=
MI>^"C;Z"C*;5G7YE5<8=5*[21UX/XU#\<[Y=2U?PQ:12[[.>/SE*GAM[*H/Y
M?SI^@>IT&C?'C2M1U2&TO=)GT^*9@J7#RAD!/ +<# ]^:Z[QCXYM_!UI;-/9
MR7=W=R>7;6D#Y>4_EP.1^8KBOCMI%G!X(TN2&".,VERL$6T8VH4/RCVX'Y5C
M:[?2P?\ "L_%^H^8VGP0QI<R@%MC<<GZ\G\*-P/1_"/Q C\57EYITFESZ9JM
MG@S6=RWS!?4''/;MW%6Y?%S?\)Q!X7M=/^T3_9S<74PFPMLG\.>.2>./<5YK
MI_B2PN/BEXD\<6LC/H>GZ=L>?:5$S[5"J,]R1Q4N@^)Y/"2BZN=)NM7\7^)6
M^W26EOPT4//EJ3@XXR<8_E1V ]GWS_\ /%/^_G_UJ7?/_P \5_[[_P#K5S_@
MSQG8^--,EN;6&6VN+>3RKFUF^_$W]1[^QKI: (M\_P#SQ7_OO_ZU&^?_ )XK
M_P!]_P#UJEHH BWS_P#/%?\ OO\ ^M1OG_YXK_WW_P#6J6B@"+?/_P \5_[[
M_P#K4;Y_^>*_]]__ %JEHH BWS_\\5_[[_\ K4;Y_P#GBO\ WW_]:I:* *\K
MS>2^8E^Z?X__ *U<0.@KO)O]1)_NG^5<&.@KYCB+>G\_T+@%:WA\L+Z38H8^
M6>"<=Q636QX<_P"0A)_UR/\ ,5Y.6?[Y3]?\RI;&_).\,;22I$D:C+,TN ![
MG%02ZK;P01SS3VD<,O\ JY'N5"O]">M8OQ"T^SU#P7J0O$W>1"\T0WE?G53@
M\'GZ&LR!]-@^$EE?W]C:7JV.FK*B3Q+( X3C@].<"OO>C9D=?;:@EZK-:O;3
MJIPQBG# '\*<]\L=PEN[6ZSN,I$TX#-]!C)KF_!]MIWA7P;I[74UM:O>;99I
M'(C#S2<X'\@/05PGB!('7QI>W(7^V;;4[=;*1O\ 6HN5V!.X!YZ=:'O8.AZT
M-6MVU%M/6>U-ZJ[C;B<;P/7&*GMKQ;HOY1B=8W,;E)-VUAU4\=17 ZIH^IZ7
MJ:7R&V9I=1:YM3D^:\\L0C$9&,;5Y8G/W5Z5:\)ZU/;WEEH_DPFRF>ZAB89\
M[S(6&]Y,G!WDD\ 8R.M '>T444 %%%% !1110 45A^,)I[?PK?26T\D$N$59
M(FPRY=0<'L<&N?NM;NO"MW?V$5Q<ZLJBW$ G)DDBEE9UVL5&YAA0P'7MW%*X
M'>5@^(/!GA[Q28VUK2X;MXQA)#E7 ]-RD''M6;:^)M9OFL[.+3(+:_>.2><7
MK/$OEHX7*C&[+9SST'7--N/%]Z/$4FFV=I!<HXFCMW7S,&:--Q5F*A3G!&%)
M(H Z32]'T_1=/2PTVSAM;5,XBC7 YZD^I]S618_#[PIINL_VO9Z':Q7V[<L@
M!PI]57. ?H*GL/$)U*UO[RWB7[+;P(Z,3RSE-[*?H"H^N:P;CQIK4-GIVS2(
MYKR]M_M@BMQ)*%BPN%.U<[B6Z]!QUI@=AJFEVFM:;-IU_$9;6<;98]Q7<,YP
M2"#BHM4T+3-:TO\ LW4+..>S&W;&>-I'0J1@J1V(KF-0U[4[^XC6WABM;*#4
MK2VFWS,MQO9HV8;0,8PX7!//-6#XS>*TM+F:U3;*M\\B(_S!;<M]WZ[?PS0!
MT&CZ)IV@6"V.EVJ6UN&+;5R26/4DGDD^IK0KBM0U/Q.;?177^RX9+J^0;8YG
M=3&T;,%)QST/(X.!3H?$&HO,UCIT$#73W5XVZ]N7V".&0*0#@G)W# Z*,T =
MG17#R>-=0E@^VV>GVQLXK2WO)A-,1)ME+ JN!@D;<@G@UV] "T444 %%%% !
M1110!P>M_$BW\->,I-(U:V9;)HTDCNHN2F1SN7N,CJ/RKM;.[M[^TBN[659K
M>50\<BG(8'N*XSQS\/+?Q0USJ44LBZHELL=L,@)N4EN?7.<>U7_ 7B?_ (2/
M0 +A!%J5FWV>\AQM*N.,X[ X_/([5Z5>E0GA85J"?,K*?KT?S[[7,(2FJCC+
M9['5UXY\=/#UY-'IGB2S@,XL"4N%"[MJ[@RL1_=R"#]:]BJ$7-O)<RV@D1ID
M17DBSR%;(!(]#@_E7F&Y\\>/OB':?$71])T31]*N3J!G5V0J#AMI78F"<CGK
MQP*V_BMX/O[/P9X;OX$::;1H$@NB@SM&%PWT#+^M>S6NCZ98W#3VFG6=O,WW
MI(H%1C]2!FKA 8$$ @\$'O3] /G+QOX__P"%EZ?HWA_1;"Y-Z\JR3*P!!DV[
M0%P3E1DDDXKWG2M$MK#PS9:+-%%<06]ND++(@97V@ Y!]Z?!8Z-I=Z@MK.RM
M+FY+!?*A5&DP,GH.>.:LWU]::;9R7=[<1V]O&,O)(V%':@1YKK]I:>)O&VG>
M"--MX8-&TTB_U5($"(3_ ,LXR!QSU/U]JSM?OK;P?\=H-<UEC!I5W8>5%<;"
M51@H!' ]O_'J]:M+2QB>6ZM+:"-[K#R2QQA3+Z%B.3U[TE_:V%Y$D&H06T\;
MMA8[A%8,W7@'J>M SS'X/J^H:YXN\10QNFG:A>_Z,6&-^&8DC_OH5ZS3(88K
M>%(8(DBB085$4*JCT '2GT %%%% !1110 4444 %%%% #)O]3)_NG^5<&.@K
MO)O]1)_NG^5<&.@KYCB+>G\_T+@%;'AS_D(2?]<C_,5CUK^'/^0A)_UR/\Q7
MDY9_OE/U_P RI;&QJNB:9KD*0ZI90W<4;;T65<@-C&:@A\,:);Z3/I4.F6Z6
M%P<RVX7Y'/'4?@/RKS_QKKVKV/BJZM[74;B&%53:B/@#*BN?_P"$IU__ *"]
MW_W\K[=UDG8\&MG5&E4=-Q=T[=#VFZT?3KZTAM+JSAFMX&5HHY$R$*_=(^E1
MW&@:3=ZI%J=QIUM+?0_ZN=XP77'3FO*=#\2:W/K^GPRZK=/&]S&K*S\,"PR#
M7M%7":GJCMP6-ABXN4$U;34@EL[>>X@N)8E>6 DQ.PY0D8)'X<5!!H^G6VHS
M:A!901W<XQ),J ,WX_YS5ZBK.P****  US+Z[J@M)91:1$PWDL,S1*TH2- 2
M&QD$GH/\:Z;K64/#NG".6/9<;979Y!]ID^8MPV?FZ'N.E %;4]=EMHX9+-8I
MD-I)>N[$@-&FWA?<[N">E5&\274=Y)#)"2&D'EJL#;E7<1CK\Q*[2". 6]JU
MYM!TVX/[RW)']WS& Q@+MQG&TA1E>AQR*L7.FVMV'\Z,L7"@D.5(VG(P0>.?
M2@!)H++6M+,4\27-G<Q@E'&0ZGD9%4TT30;33I=+73[1+27F2'RQASZGU/ Y
M]JU(HDAB2*)0L:*%51T '04^@#$DT/P[-9VUI+I]F]O;'="C1@A#WQ]>_K0V
MD:/'=S:A9VME#J;[F6Y:'<5<C&3C'XX(S6W10!C:/I]EI6D?8#*DP<N\[[-H
MD=R6<[1T!)/'84MWI>@W]M;6EU9VLT5L!Y$;IGRP !\OH,8%;%>:_%]M0M[+
M1;S2WN$NX;I@C6^=PRA)Z=N*Z,)A_K%:-*]K]?D14GR1<CLIM(T"XU%-0EL;
M1[Q-NV8QC<-O*G/J.QHATG0+>_DOH;&T2ZE9F>41C<Q88;GW[^M9OP]US4?$
M/A6#4-2DM9)68J&@SDXX^<= WL*ZJHK4I4:DJ4MT[#C)22DC"7P_X:2RDLDT
MVS6VDD$K1B, %QT/X=O2I+O1_#]];^1=6-I-%YK3[73/SL<LWU/?UK9HK(HS
M7L](D657M[<K-&D4@V<,BYVJ?89.*N?:H/\ GHM344 0_:H/^>BT?:H/^>BU
M-10!#]J@_P">BT?:H/\ GHM344 0_:H/^>BT?:H/^>BU-10!";J#_GHM>:^*
M@?!OBZ#QCIP+6-T1!JL*>_1\>O\ 4>]>H56U"QMM3L)[&[C$EO.ACD4]P:Z<
M)B/85+R5XO1KNG_5UYHBI#F6FXD&H6ES!'/#<(\4BAT=3PP(R#7%>);C48-6
MU>;2_,626ULU\U(W.(Q+)YA4J"=P##@<X.0*K^!;ZY\-:Y=>!M5D+&',NFS-
M_P M8CSM_#D_@P[5Z,*6*P_L*G*G=/5/NGL_\_.Z"G/FC<\T_M#4X-.TF674
M=1NB)7*0VT,Z&8;QM#.R9R!GB0 $'.>,UM^']0F_X2;4X9[C4+B,[G\R9'2*
M/Y_E0*R@9P>"C$$#)P:[&BN<L\OAN=3FU>WN/,U.76(A>&2*XB86T3[&$00D
M;<'Y<$$Y'7FH+>+4]5T41W^I7\@_M"S<JBSQRQ/YG[P[G4< 8.%RJD9%>KT4
M('J>:)?^)_[<U5H[QQ<1I<>3:O%*4=0#Y)4E?+S]TYSD\@TMS]FN;/1[A=1\
M22PV^HJUQ),LJR(6C8'Y0H.T-@' (&XXXKTK%% ''>&]0G_M_4H;BXU"="2_
MFW".D:'><(%90 <=T)! R<&NK^U0?\]%J;%% $/VJ#_GHM'VJ#_GHM344 0_
M:H/^>BT?:H/^>BU-10!#]J@_YZ+1]J@_YZ+4U% $/VJ#_GHM'VJ#_GHM344
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M+$]_K3HPE%ZHK*,%7H5G*I&RL;5%1;Y/^>)_[Z%*KN6 ,>!Z[A70?1DE%%%
M#)O]3)_NG^5<&.@KOF4,I4]",&LS_A'[#^[)_P!]FO%S; 5<6X>SMI?<J+L<
MI6OX<_Y"$G_7(_S%:G_"/V']V3_OLU/::7;64IDA#!B-IRV>*X<%D^(HXB%2
M5K)]_P#@#<E8\D^('_(Y7?\ N1_^@BN9KVW5/!FCZOJ$E[=I,9I  Q64@<#
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M.(\[<9(!YYY&#^-7ZJ:?80Z=;M%"6.^1I'9L99F.2>.!]!5N@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,T +114<TT=O"\LTBQQ
MH"S.QP% [D]J )**898UB\UI%$>,[B>,?6GT %%%137$-N@>>5(U+!078 $D
MX ^I- $M%%% !1110 4444 %%!I* %HHS10 4444 %%%)D>M "T444 %%1S3
M1V\+S32+'$@+,[G 4>I-/4AE# @@\@B@!:*** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>img_004.jpg
<TEXT>
begin 644 img_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "3 54# 2(  A$! Q$!_\0
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M'6BN0HH]G#L'UFM_,SZDHHHKS3Z,**** "BBB@ HHHH **** "BBB@ HHHH
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M !?IUO!H_P!HM+LSZ9=2RH8V7:Z.22"#SGD5IZ1X9DMO#VH+_8%IJFKVVH&
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M+4+C[0)+*4)+&1VR>",8'X5U_P#PK/P]_P!/O_?_ /\ K4?\*S\/?]/O_?\
M_P#K5/UG#^9?U?%WO='"W_B:"\\/7VG+'=^;<7XNEDEEWD(% PS=2>*LZ1XM
MT^TL=,^W6$\U[I)D-F\<@"-N[.#SP?2NQ_X5GX>_Z??^_P#_ /6H_P"%9^'O
M^GW_ +__ /UJ?UJA:VHEAL4GS:')V/C6SCCLKR]L)I=7T])4MI(W B;?G[XZ
M\9[5)9>-=-CAM)[RQNGU*WLGLC)&Z^65.<'!YS_]>NH_X5GX>_Z??^__ /\
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M*.GO5"U\"ZPVL-?:EJT%R3%=0>9^\+E95PI(8[1CI@ # [UW/GY_A_6D\_\
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M\NU#Q2M;!.KQKM3#9X&,9&/X1[UI^<?[OZT>=_L_K1SH"6BH?/\ ]G]://\
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MQCO71>%)$DT3=$7$/VB811.3O@3><1MGD$>G;I4:^')PK7+:D3JAN1<_:O(
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #L ?8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***CEGB
M@B:6618XU&69C@"@"2JUW?VMA"9KNXCAC'\3L!7#:]\1EC+0:.@D."/M$@P
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ME[?Y^E;]<M25W8[Z,.6-V%%%%9FP4444 %%%% !1110 4444 %%%% !1110
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M %%%% &3XATE=7TN2$ ><OSQ-Z,.WT/2O(9=T4C1NI5U)!5NH/I7NE>;^/\
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MNB_*D%J&?8N<X . #[Y->E:%H5AX=TJ+3M.B\N!.Y.6<]V)[FM.B@#%\8?\
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ME?S%)U)L:HP70Z*"WAMHECAC5$'15&*EID<L<L:R1N'1AD,IR#3ZS-@HHHH
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M].=BS6-LQ)R28E.3^5*FFV$<BR1V5NKJ<AEB4$'\J +=9'B70+7Q+H=SIET
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M*X')57WD@]@2#]*@U_Q9<0^"+/7M&B622Z>#RXI1G(=@"I]^<5U%Z1]AN/\
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M#ZA:MNBFT.$X[J?.?*GW!R#]*L^#%E;1]86!U2;^UKS8SJ6"GS#C(R,_3(H
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MO18V+R_QGY4'O0!S_B*^\^Z^S(?DB/S>[?\ UJQ">*5F+$EB23U)IF: &2$
M$GH*RI7\QRWY5<O9, (.IY-4C0 PTF*=WI".>*8&AH6EMJNJ1PX/E+\TA] *
M]4C4(@10 J@  =A6)X7TG^S=,5Y%(GGP[Y'(]!_GUK=I 8^NZ#!K, W'9/'G
MRW]/8^U>>WVGW.F3F&YB*-V/4-]#7K5075I!>PF&YB62,]F% 'D!:FEJ[34O
M P.Z33I]O<12]/P;_&N8O=#U.P;$]G*!UW*-R_F*8&>6KTWPMK/]JZ8%D8?:
M8<*X]1V;\:\O;*G# @^A&*ZCP-#=_P!L-*B,+?RR)&(P#Z?CF@1Z-1112&%%
M%% !1110 4444 %%%,F5WB=4;:Y4A3Z'L: /-[S6YM!\4:GI^DF&:/49T+W,
MQ(BL;EQ@JYQ@Y ! SG/'>NYT+2H]#T>VTV.5I1"IR[8RY))9L=LDDUQ6D7^E
MZ9X4_P"$<U[3+S[6%9+F$6<DOVER22ZNH(;/7.>OTJ7P?;ZG9>(6.N0WK2SV
MWEZ=-,-YC@5B?+D9>%DY4\]<=>* /0J\MM"VC:]JWB2,$Q0ZQ+:WRCO ^S#G
M_<;!^A->I5RGAS3_ #QXGM[RW?R+G4YAM=2 Z,JC(SU'7F@#'\8O_;XUN)&W
M:?HNG3R2>CW31-M'OM4Y^K"N@U?4SI'@<W2D^<;5(H .IE<!4'_?1%07WA^W
MT3X>ZSIFG)-+NLK@@N=\DKLC=<=3T'Y54U>RGUFZ\.:(\=S':)%]MN)H\J4:
M-0(USC .YLX_V: &Z%IB^$?$MIIHF!M;[3DB0]-T\ PQQZE&S_P'VJIXATE]
M8^(-S%;R"*^AT:&>SF/_ "SE6>3:?Z'V)JWXD\/RZ?9V^MP7FIW]SI<Z7"02
M2>9O7.'4 #.2I/Y5>ABE;XF2W0AD%NVBQJ)"A"[O.<XSZX.<4 9>K:PNN>'=
M"NPACF&L6T5Q$>L4JOAU/T-:OC5UN;&RT/YLZO<K;-M/(B'S2$?\!4C\:QO%
M6CW=IXCT^\L8))K.^U"V>[C0$^5*C#$O'8KE3]!6A>:;<:]XZD:2:\M;32[5
M5@EA.S=+)RQ!(.?E !IB)]!*:9XIUG1(XQ' X34+<#T?Y9 /;>N?^!4OAF18
M%\1W#*[D:I.6V*69@H4  #D\#&*J:EHUSHVOZ+J]O>:C>*LYM;D3/YFV*0=>
M!T#!2:?;ZB/"FIZI#J5O<BTN[MKJWNHH'E0[E7*-M!*D$'KU%(9<T[5M&U'Q
M*KQVE[!JC6C*K7-K+#NB# D#< #@L/?FL3POKB:>VNPMIVHSG^VKL[[>U:1?
M]9ZBM;39Y-=\5Q:M#:W$6G6MI)!'+<1F-I7=T)PK8. $'/?-9?AS7K70WUJU
MOK?4$D?5[J5=EC*ZLC.<$%5(- '0W]\-0\):G.+>XMP;:5=ES$8V^X><'M7/
M>$V'AV>QLW*1:=JME'<VY)P$G" RK^(P_P!=U;USJUOKGAS5A91W19;>1-LM
ML\9)*'  8#/X57_X1JT\0^"M+T[4HY4"6T)RAV21L$ /TX)!]B: .5D#:KXC
MT'Q+/&R&\U7RK56_AMDCDVG_ ($<M]"*Z'4M273?B$':UN[C=I0 6VA,A'[T
MGD#H*F\163)J'A2.U@8PV^H#(121&@B<#/H.@J/4]1BT?QZ+NZANS ^F"(/#
M;22C=YI./E!QQ0!MZ;K2ZE.T0L-0M]J[MUS;F,'V!/>N&CCETJ\U/Q/:H[FT
MU6XAO8E_Y:6Q*Y/N4/S#\:[73O$MAJEU]FMDO!)M+?OK.6)<#W90*J>&+=A'
MKB3Q,$EU2X8!UP&4XY]P:8%266.?XFZ5+$ZO&^D3,K*<A@9$P14OC/@^'O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #9'6*-I'8*BC))["O/
M=1O6O[V2=N >%'HHZ5T'BG41%$ME&WSR<O[+_P#7KE41Y&"(I9CT51DTT A-
M5-0NA:VK,/O'A1[UO6WA[4;DC,7DKUW2<?IUK5@\%:>TJ37Q:Y9>B'Y4'X=Z
M!'G.E:1?ZQ+MM(&D&<-(>%7ZFO1=#\&V>F%9[HBYN1R"1\B_0=_K72Q0QP1B
M.*-8T'15  'X4^D, ,4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %*32;&6X
M:>6W621CDER3^AJS'!#",11(@]%4"I** #%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ]!%D# 2(  A$! Q$!_\0
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M #]7NK*-08[>*-G?/\3$D+_WR ?^!"KM<A9%_P"QK/4E:2.;5-1CN7&<$J[
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MCRR:9I\,>H0E9[=D !\Q&# 9]\8_&NIHH YS58KF#Q!INLI9S74$<$MO)%$
M7C+E"' )Y^X5..?FJ*-;_4M1U:Y;3IK>"2P%O;F8@-(07))&3M^\,9KJ*,4
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M[(I<EB 3C)? '7CWK?Q1B@#C-$\.7J>&-5M-07_2[E# A)S\D<8CC/XE2W_
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M;3*BR%#N^]@X*<@'H>.F*Z*B@#$TT7%[K=SJDMI+:PB%;>%9L!W 8LS$=AR
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M3T^,)=3*T=O<(KE51=H)'(!)W'V!%;^** .:/ANSC\76EU%I-HEK'92 NL*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56D;<Q
M]!4LK%5X[U!0 4444#"BBB@ HHHH **** "BBB@ HHHH ****0!4+'+4^0D#
M%1T %%%%,84444 /'2BFBG"D(**** "BBB@ I50OTX'K4D42N"235@*!C XH
M B2+MT![]S4P  P.E+13$%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex3-12_001.jpg
<TEXT>
begin 644 ex3-12_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 39 XP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_L/45T?2;$7^K.40!WVQQNY 13W+'(X&.HR1F@#OZ*\TN;+XK)&+V/6=">0
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M?*U,,\*CJ6^7G'L#6OX2\>Z?XNDDMX89K:]C3>T$I!RN<$J0>0#C/0C(XYH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%4*,  #T%>.>$_!NOV'Q+?4M0LO+M+>6XF%V9%83EPP!&#GD.2<CC!]J]D)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH A,2^;YF!OQC..<>F?QKC_ 48DM_$P<!DDUZ\R",@@D#'Z5U]QYOV>0P!
M3+M)0.2%)[9([5RWA'1M>T26]BU#^SI+:[N9;LO;22!U=R"5VL,$=><@^U %
M*[@OV^),UMI,MI:.-%A7S)H#(J*)GP%0,N?SP/0T@\97EIX7>>]BC?4EU)],
M#06\CH[JQ'F"-<N1M4MM&3QC(ZC032M=3QW=ZR8=.:QDM%M8E^T.)1M8L"1Y
M9'))[\<=:QH_!_B&YT;4+6[DL+.].HMJEA<VL[2A)BQ8*ZM&/E&2,\Y!Z#%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?*BN).9"Q9"P14*D?(3UR1D4 >RT5S/@J.[7P[%)=ZS_ &LTSM(ET#D%"?E
M.!G@#G'7-.\1:S<6EWIFDZ>\::AJDKQQ22+N6)44L[X[D 8 SR2.P- '1YI:
MX%Y=4TG5I=/N?$T\UJVFS7<UW/!#OLBC*-X(0*58%^"#]PGU%8OA:[\7>)K6
M1HO$.H6TT:02G[7I]NJ,LA)^4A,DA #GU8>] 'K%%(N<<TM !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#)%'(,.H8
M A@#SR#D'\ZFHH 0 #I2T44 %%%% "$ T;12T4 )M%(44]13J* $VC.:-HI:
M* $VBC:*6B@ I,4M% ";11@4M% !31&H.0.:=10 PHI.2HIGV>'<6\M=QZG'
M)J:B@"M]BM=FS[-%M)R1L&,^M LK81&$6\0C8Y*!!M)]<59HH I)I=C$XDCL
M[='7D,L2@C\<5=HHH HW.E:?>7$-Q=V%M<3PG,4DL2NT9_V21D?A4-[H.D:C
M.)K[2[*[E"A=\\".V!G R1TY/YUJ44 11QI$@1%"HH 50,  =A4=Q;0WEO);
MSQ)+#*I22-P&5E(P00>H(JS10!AVWA3P[:).EKH.FP+<1F*816J()$/56P.1
M[&HO^$(\+%(5'A[3-D+%XU^RIA6.,G&.O _*NAHH YD_#[P@V<^'=/.>O[D5
MT,<4<,:I&H5% 55'0 = *EHH Q=6\,Z-K;QR:G81W$D0(C=LADSC[I!R.@Z>
ME-B\,:+!I<NFP:=%%:3.&ECCRA<Y!RS Y)X')/;%;E% ',IX%\.1Z=-8)IP2
MSG(,L*S2!7QG&<-T^8\=.:EG\':)<FP\ZUD/V''V8?:90$P<] V#^.:Z&B@#
MF4\"Z"FK#51;W1O?,$OF-?SL"P.X94O@C/;&/:FGP)H7GSSC^TEEG??*R:K=
M+N;IDXD] !]!BNHHH IV%C;Z=I]M96J>7!;1+#$FXG:B@ #)YZ 54UC0[+6H
M8XKQ9=T4HEBFAE:.2)^F5=2"#@D>XXK7HH YB3P-HKZ=>66RY O1MNIOM+F:
M=<$;7D)+%<$\9QSTK3TC1H-'M3;V\UW*F<@W-PTS+P!@%B<#CI6I10 4444
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MJ87ML6Q]HASV'F"O +&3PQJ,CV]\OAZ.QO&E*?84A:],DTX6.,;QE JMG(X
M^E:]Q)H][K/B/4-&\.>&];M(&A1F(222.-8QND2()\R_,1D,"=G?% 'MIE52
M S*,],GK2B12V 0?7!Z5XIXFTWPX/#6E_:/$MCJ)&G06-DEU)%CYYU62Y7=D
MC"@C/\(3&>M=)?:+X'\/Z?J6H72Z(UEJ"I=6=I)'"D3>7%A?+'\>=Q.1_?H
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MOV%[I/#PFVK(XAAOD>5E201E@@7)&XC\Q5T>/0+O6[&32W6]TJ,2F'[0F)4
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MZXM9[A7E-K(9(D+G9OQ@,1T)';/0\]>: +R-O16P1D X(P:DI ,4M !1110
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M5-&DT>*&VT\*QNTO1)O#\Q_*$&"RC<>3C(]:ZJ>=+:VDFD;;'&I=V/8 9)H
MGHKS)/B;K)MI)SX/F6...WD=FOHQ@3G$8QC.22..HSS5JY^(UW9V6M7LN@-]
MFTJ8PR2+?1'<1UXSVR,@9.3CJ#0!Z'17%ZGXOU?3(K)Y/"=\_P!J,<8"W,'R
MRN2!']_.1QSC'/M5^]\2S6=OIZ-I%Y)JEZKM'I\;1EQMP6W.6" #(YW=QC-
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MIF\LJI.(B%VEF..<\=*A\2:-K.LZM&T^AZ1J>EQP#RX9[HQR13'EG5_+) X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 0>E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% %._GCMM/N)YKE+2..-F:
M=R L8 ^\<\8'7FO/? 'BG4=;U2_LY]?AU&*2U\^S<"'S8@LC(2Z)C!(,;8(X
M! ZYKKO$_AN+Q3IITVZOKRWM68-(ML8P9,'(#;U;CC/&*H7/@EKB]M;J+Q!J
MUK+;VYMU: 0#<"%#,V8SDMM!/;(R * .(L_&?BBYT][>74A%?3W%O)IDQMXR
M+N"640G@<#:?F/?D=C76(/$E[XBU+3K/Q$L,5E!;[I'L4?=*ZL6[C^ZK?\#Q
MT JW:^!K6%-%6:_O;IM'?=:R3"(,J;0HC^5!\ORJ?7(Y-5QX*U$W5[,?%6J*
MFH/ONDBA@1G^4* '\O<H"J!QS^/- &QX2U>ZUSPS:W]ZB)</OCE$8(4LCLA9
M<\X.W(^M6->-ZFF//97\5B8<RRRR6_G H%)(V[E]N<]JN6%A;Z986]C:1B*W
MMXUCC0=E P!67XET2]U^P>Q@U9[&WFC>*=4@20R*PQC+=.,]/6@"/PG)K-UH
MMM?ZO>PSO=P1S)'%;>5Y09<D'YCD\^W2MJZ\_P"S2_9Y(XYMA\MY%+*K8X)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOZ$UOT4 <L?A]X5*NO\ 9$>)"2X$C_-G@YYYKHK>WCMK>."% D42A$0=%4#
M%3T4 9&K^'M,UQ8?[0@9V@8O#)'*\4D9/!VNA##/?!YJE/X)T"?2DTUK25+0
M.9"D-S+$7;^\[*P+GIRQ/05TE% %'3M.M]+LUM+4RB)22/.F>5LDY.6<ECR?
M6KU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;Q,YSA44!5) [GN:YLP*^G6=U,TNLZG<7EY<RD7[P&:*(,BC&["AF*L!P<8
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %(1FEHH ,4FT#M2T4 (
M!TI:** $P*, =!2T4 )@8QVHQ2T4 )@#M2!0.@Q]*=10 FT>E)M7.<<TZB@!
MH50,  ?2EVC.<4M% !28'I2T4 )M'I1M7T%+10 W:.>.O6EVCTI:* $P*38O
M]T4ZB@!"H/7FC:,YQS2T4 -VKZ#BD"* , #'3':GT4 -V*?X1^51M;0-]Z&,
M_514U% #$1(T"(H51T & *AO+.VO[=K>[MXKB%Q\T<J!E/X&K-% &9-H6D3Z
M?'83:79264>-EL]NAC7'3"D8'4_G4NGZ58:3;FWTVQMK.$L6,=O$L:Y/4X4
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MM78%Y.TUW*882TY.T8(VX  4#@"B3P;?3375Q-XBNI+N>W%KYWV:$&.+<68
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M "BBB@ HHHH *,TC' SC->8>*]6T#QCX<:.V:";5I+EK*SA+JTRMYWELX3/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN].?4+?4;2:R0,6N(YU:,!?O$L#@8[^E &C16&OC+PO)@)XDT=R>@6^B.?\
MQZI5\4^'FQMU[3#GIB\CY_6@#7HHJD^I64<S0R7<"3(-S1M*H8#&<D9Z8YH
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MZ/HNC3ZF9HI(6C,R!I"ZMF21I& ;)Z]3STQ7844 <SX)LFTWPS:V3:5)IK0
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M  1D*?H/;]@!S1L&<T >8_#?3= ;4[C4["&Q.HV]LEM<3:;L%J2[,Y$84#)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%,W'?MQQZT^@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *C>-7/S $9!Q[@Y%244 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB:&.>)H945T<;61@"".X(/45R[>#WTN5IO"^H2:468NUF4$EH[<DYCX*9S_
M1]* .OHKCXO%]SIUP\'B?3'TU4 QJ$;&6TD/'1L IU_B '7DUT]K=V][;)/:
MW$<T3_=DC<,I^A'% %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ^4Q$7V9HVM+A O$42IDQ@,X?<3GCG))K6U^RM+S3IKO<;:"64?;GBD^:W<
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MB,+&\L.I1MNY;SEV.,?[\+'_ (%0!J^)M'77_#M_I9;8UQ"5C?)^23JC<>C
M'\*PM&6[\9^"+)M4N+RPO26%TELPC;>-RLC YRO/3Z5VM<GX<4V?B[Q1IZJ!
M$TT-ZASR?,CVM_X]&: (8_AUHD6I&\C^T*Q$?[LR KE)(I,],\M"F><=>.:D
M7X?Z*$OHF$[)>ES+EQGYY#(<<<?-C\A7744 <;8^"A8>(--N8YO^)?I]JR)'
MG#RS$G#N  IVJ6 XS\QI=1^'>B:I<:A-<12#[?*LDZH0N<+M(!QD!N_K[5V-
M% '-:UX637;2UM[F^ND:UNS=1R((V.2' 4AD*E0)",$= *HGX?6(DMFCOKY$
MCA2)X]T9678'V$_+P09&/RX'M79T47 X.?X9:8Z1+#=W,810C;@C[TV0ICD<
M'%O'\PYZ^M/;X<:?+%-;3W4[V9G2X@C"JKPLH?@R8W./G_C)/%=S10!S&HZ#
MJ&JZ!>:9<ZA$3+*AAE:U20*B[3AD(P3E6^F1SQ6'!\,4CU'3;N;5YIS:PO%)
MO3YVW9P8VW9B ST&>E>AT4 ><0_"Z/\ LY;:[O8)I%LY;598[!(MK,5VR  X
M# * 3_$">G2HA\*MD*K#JD<,C6!LY9$LQ\P,B/D MP"$P5Z<G&,UZ910!YN_
MPU%IH\T=C)%)K$@MXH[\CR7@CCBCB;:5!(RJ,<>KUK:UX&BU)M.6VG2VALXQ
M"%:)9&1 0=T9/W).#AQR,UV5% ''2^#Y%\)'1;*2TW+=27$;7%ON0;I6D PI
M!! 8 $$$8K!G^&VK3:5/:G78GN;B.,2SRVV]B59CC<6W;<-@<YX')YKT^BG<
M#@'\!220O'_:&Q&OH[LJJE1*1'$CA\$9):,L#G^+N*[N-%2)44?*J@#//%24
M4@.6\5Z=J6MV\.E6<4,=O-(K7-U*0=B Y*JO4D@$9XQG-=+'&(XP@SA1@9.>
M*DHH ,48]J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!B%LMNQC/RX]*?110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &'XMU*
M32/"6J7T*LTT4#>6%.#N/ (_$YK \"Z,NDM):E'1].MHK-@&W('):9\' W9$
MD9)_^O6EX]W-X;2$,5\Z^M(B1UPTZ"GZ.TD>EZS>V\9DN9+VZ81J>K1DQ*!]
M1$OXDT <K<:Y?:EXEAET^[L3.K7"VEM'*OFE41756YY60;MP(^3Y2.5-:EMX
M@NKJ\EUU+*\FC@_T";3XHMTMM(5C<DCJ3N.TXR,!6'&2<B+1=7OW*SVU](R!
M;@2WB1QNDA3#*D@SPKNY / VC;E>O1:!]LU#23/;ZC9IJ2NT%ZT*B9'E0A27
M "?O   <<>Q&*>P&;J'DVF@W@U;4+E39Z@AC.FQ*&$AB1RB*01@,[L,Y(]<B
MN0\2Q:-!+H]E8WD^H6]L955)V$@C^1<;#C@=QTZ9'!S75>.1I=CI\-F[7#W$
M9:X<17[6[E#DL21DL3M(48QGT%8'C$RIJFD6PO()X[<SQ0I&VYHU58Q\QP.2
M,9!R<YY[!@SE/[2<//9R:[?6=LS89FO'D#,I'!549E )ZY/0\=:NW#W,ES)'
MK+F]D@8PGS;H7$) Q@A>%SCM@$'@U2O5F6W5WM[&98L1K(]H6F5"QP V\#(+
ML1\N>G/%0:6\D;O9RNF[!E'[T2,,DCG'3IG!YYYYHN2:D%TMK<QG3IKBQF"[
M8X;*1E#9/41C(/\ WS6/<^)[RW,$-OKNJ>3&VP/+.J8)(R%(4,.GKV]JT;H>
M2(KJ;S EO*CR-;N4F$6X;]C9!#$9'4=:BT&Y@TYIM8TE;C[?-_JK>)/-M[=&
M;YHY99#O9BO.5Z$=:+@=/X,G5=:O#%J<L,SK;!&:4R?:Y-TA"N[9."2!G/>N
MH\,MK6CPZF^I19A,R1Q;)TF,DS,$)8C!R6(ZGIUVGBN4^'4%W9ZH]K;3VRQQ
M0VT<@FDVLX^?[N5))QNX!')!SQBNE\(:3'#>ZQIS7MF)1#%'<6MG(S&*0 XD
MR549.,=/X.3VH&B\MVVC:O*]S/->:KF-KD1MA#;.Y ?821&$PW ZX/4MFI;O
MQ";WQCI>EH]J+=B\@1R1.[KD!@IQA.'P>=V#C@9,^OQRMI4\6LR)'II:-)Y;
M;)DN%+@;&7;\JG.&Y/!/05R]IK-_/XLWW,<9LVO+>=C#N=(=PEB5=_W6.?+)
MV],-P,&D,Z#QOI3ZG!+90R2QW-W9RBW9'92;B(I+"1@8!!5N>N,UO^'-4;6O
M#NG:BP59+FW2214Z*^!N SV!R/PI=9=8#I]TPRL-Y&,#K^\S$/R,@/T!K*\!
M[8=#N+",$0Z??W%G%EMQV)(0N3W.#2 ZNBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *XOQBEUI%]I_BFR0$61,&H* /FM&()/J2K*I'H&>NTJ*2
M))HVC=0RL"K C@@]10 D,\=Q"DT3J\;J&5E.00>AKE4F9/BU- I 270TD<=\
MK.X7_P!#:JEE:ZWX+E^S6EG+J^@%F,,,)47%IDYV@,0'3)..01P,<5=T"WO=
M1\1:EX@O[&2Q$D,=G:03!?-$2$NS-AB!N9R,>BB@#KATHHHH **** "BBB@
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MF<;AGTK-FU>WAM+BXC6:X6"3RI([>)I'#9 (V@9.,C\* -6BFAU/\0HWKZT
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MIIITMX/M;,J^4B,Y0L<+NV@A<]MV* -FB@=** "BBB@ HHHH **** "BBB@
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M@$O"9)U7_9PKMM_ 8]ZZ'4O"?A_5BYO]%L9V?EI'@7?_ -]8S^M9J_#GPN@
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MFBO)"2W$[M(2&))!+$DCD\>G%96E^$--T>:-K<7++!&T5M'-.TB6Z$@E4!/
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MMEB#.ZI]YEY&X#(^I8 9/%$'@Q8O$<&LRW8EFAG:<.\"F5BT1BVF3KM 8D*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH #0*** "BBB@ HHHH **** &[1_D4ZBB@!"N: ,4M
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex3-12_002.jpg
<TEXT>
begin 644 ex3-12_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 37 XL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN8]"DTY]5MI"QMS'.MHRO$8DV*R'S/E?(!STZC'- STP'-+35XSFE!!Z'I2
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** .3\>)#)HUDDRHP?4[- &Q@YG0'],_AFN5&O7VD:I?:5H
M2>;"=2G^RIE-I$<4#/""[* N^1^AR,$#TKTRZLK6]0)=6\4Z*=P25 PSZX/>
MN=NM>\%6LR:==:GH4+VDFY8)9HAY+CT4_=(_ T <!I6LWVFZW#>17)%O#9P_
M:=^9/W3WLJ,0,\$9!SC.!BNGU?Q/XATR35(8EM9O[-TO[1+.8Q@RB,R;B-X.
MUMI7 'OGC%;FFW?@Z\G,.EW&A2S2@H4MGA9F .XC"]1G)_6I99?"FKW;PR2Z
M/>74D9B=':*1V0'<5(ZE01G'2@#E+KQKXDT]M0BN[>RFGL6$,WV>!_*C:1=T
M4C.SCC#1@H!DDMAL"NI\%F5O#[F:5I)1?WB,2[-C;<2* -Q)    '858BT[P
M]JLCW$-MIEXXB^S/*D<<A$?_ #S)'\..U7K+3;'2X7BLK2WM8F<R,L,80%CU
M8@#K[TP.0\97VH6VK,UM<3(+>*S>.-'95=WNU1@0.&RORX/][WI- U'5A>^(
MPER]^\.M1VRB[E51%"?+W[<  85B0 .2!U)KL)M-LKNYANIK:&6:''ER,H)7
MD'@_4 _4 U3B\,Z/"\Q2RC!GN%NI223OF4[@YY^]GG/M2 X^WUZ3Q*WB@6^K
MW4442(UO]E5HF10&X&Y<[F.W/ /8'I6EKDFIVWA'P\MS/<KJ#7=C%=^1-L>1
MF*K(N5('.3W [UT-]X<TG5%G6^LUF6X9&E!)&\I]W.#SC/%+-X?TN>PL[)[;
M%O9-&UO&CLHC*?<Q@CIVS0!Q6B76O:-KNC0ZU=7!^UVTT,EO-*)-DF^1X<L,
M@OY:,I.><=S5K2M4U#_A7/V][R1[R:^,1F9MQ4-=>5QGIA>E=;<:)I]W=BZG
MA>6421RJ9)&(5DW;2JYPI&YN@'7FF6OA_3K71FTJ&!A9L6)C:1G(+'<2"22#
MG)Z\&G<#@= \97-_)I=EJ=_<QJL\B23Q(H\]_M#QPHQZ@'9@E1R>I SG9DUW
M4T\7Z.GVM6L+R"^E\A8A\PB;Y&W=>59./:M]/">B))9RI8HC6?\ J-FX!?F+
M9(!PQW$MDYY)/>I7\/:=)JMEJ312"XLHFAM\2L$1&X(VYP<X'4=AZ4@.-\*:
MUKNK17=C<:@6N"+)XKAHDRGF6PE?@  @LK#'8-5+4/$7B73+8P/J7FO#_:=P
MMT\$:M/';1@J" , >8V#@ D+VKMK7PCI&GI*MI%+ \L9C:6.9O,QM5 0V<@J
MJJ!CH!57_A ](;3H[%I]0EB0N TMV\C>6ZJKQ;F)_=L%&5_$8H0,HWNLZVDV
MMB.966*QM+FVC@M\O"LDDH<D$G>P5">@'&-I[[/A/4KG4]+N'N93,8;VXMTG
M*@&5$D*JQ  &<#!P ,@TQ_"RR:CJ-[_:^IK)?Q) X21%$2(Q8",A<K]YQG)/
MS'G."-73=/MM*L(;*SC\N"(85.3WR22>22222>23F@"_1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445DZAKUKIM
MR()DN'?9YC^3$7\M,XW,!SC/IF@#6HKF[7QEI5YJG]GK]I2873V>Z2$JAF52
MQ3=TS@$CUQQ6MJ&I6VE64UW=NR01C<Q52Q^@49)/L!0!>/2O."UI<>*O%TUQ
M-8O:VT<3R1OM9ED6(%7R3\NTAAR!SBNIB\4Z-<2V445\DC7L2S0[02"C#*DG
MHN<'&<9(..E-?Q7H:6GVM;])H!,T -LK2[G5=S!0@);"@DXR  ?2A >;>$M:
MT33M?L+N6_L@MOX2M48B9,^8&)91_M>W7I70Z'<Z.GC;7)C/IBK_ &AM@10O
MF^;]GC!92#TP9,\<?-D^G5R>*='CU-+#[2S3O'YX*0.R;-I;)<#:.!GD^GJ*
M(/$VA7.C_P!L+>P?8U?RC,_R[7SMVD'D')QCWIW%8\W\%$'Q#X5.CM&(S:WA
MU,6Q&TIO;R2^."=V0._7I7H'CA7D\,R1*6"27-JDQ!_Y9&XC$F?;86S[9JW+
MX@T2PCO6ENX($L\&X)&T+D[1]>?EXSSQUXJ:WUC3+^SM[B*YBDM[MC'"QX$I
MP<@9Z\*?RI#//K4^7XA\''SRJG4M42.(2%4\H>>(\)TX&T @=, <59UC7+QK
M[PQ:O)+>PS:B#)>V* 0.1(ZK&3NZJ 21SG:3VQ7=I'IMQ=;$CM9)[3:I&U2T
M/&5'JO'(JP;2 A%\B/:C;T&P85N>1Z'D\^].X')>$;;3X=1U[^S[OSK9ID4P
MM=F=@RJ5=VRS$%FR.>NS-<=8>$[NZ\-7FI6]TD0EMO*M((7;/G+.S)*W3#8^
M3CJO&>U>I21Z/H%C-.T=G86G'FOM6-/3YN@_.LR*^\(FRB,5QHPM()M\7,01
M)1@Y'8-\P.1@_,/6BXK&#X:U9_$GBC2-7D7:)]",IC&X*DGF*&&#Z'>,]Q6-
M-K6MPW^HK:R2(]WYD3S2.=L+'4C;1$==I$;'H.?+]J]%EL=#TP_VM+:Z?:-"
MFTWC1I&8T)Z;^,#GUQ3(I/#]W/+:1-IL\U[$)Y84,;-/&> [#JR].3FBXSA+
MK6A=?#;4-0T=[S37LK.60A)R[^<)"I^=LEANB;GJ<GI6M<W-U!XFAE>XFQ;2
MVD 4R,%,;Q2&0D9PW3.2,_(/2NNET+3)M..GRZ?:O9,H4VYB&S Z#;TP*A?3
MM#^VQ0M;V?VF* QQH0N]8L$$ =<8+#\32$<=K#ZMI7VG5;>_OC<)HMS=7-O+
M)NBBEV QJL9&,EPY[\*1TP*H6NIZI#I=H4U2]*Q^(+*U!9PYECE6!W5G8%B,
MN_0CK@Y KT$>&M'35I-6&G6XU"0%7N2@+L",8)/;'%(WA?1VM+>U-A$(+>43
M0HF5"..C<$<^] SFM!N-8B^(-W9W\MT5D2[G"O(&B:$20B HH^[A6D4\ D@Y
MS@5W]9UGIUI8SS2P0)'-<-OE?JTASGDGGC)XZ#/%7A(AZ,.N.M #Z*9YBDXH
M#@]/K0 ^BD# TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<#XOT:YOM=LKJPM]2@U"! +:_M)!Y9R_S13J>?+X5CUSSW&#W
MU)M% 'E.C:?J=MXMEOY=+OGL#KDS"*2$ *)$(2Z7OQAE(/0/G (KO]>O[C2]
M#N;RVLY[NYB3]U!!'O=F/ P..F<GIP*U]HHP/2@#RC3?#]W!XAT^X@TR\BLI
MH+ QB>,!X1 )-ZRXR V"I]RW'.:GN[::[L;R>"QU4W_]L3O91?9&16,D1CW2
M&10!'M9LMGC/&3@5ZA@>E!4'J* /-+2VN_#VM/-:W/B"YBLX4@O+,P%X98TM
MP%EM^,%MZJ"H).2V1@5C:MI&L?\ ")JEI#<7-G)JK3*;Z!TN9"SJRNT:KP,[
M\D@'!!P#T]DVCT%&T&G<#S72M.N;?Q5>:A=6S20V,%\75D)W.]XT\6W(Y(0*
M01G&14VHZ?K%OJ_@T+:13Q03KYDAN&5A,T4WFL5VD;<<@YZX4 9S7HFT>E&T
M47 XGP3#J<.I^(_[2M8HI7O(Y&:.=I S&"/."47C 7\R/X<GJ+^3446,:?;6
MTS&0"3SYVB"IW((1LGVX^M7@ .E+2 YWQK-''X&UPS.J*]A,@WG&69" /J20
M,5P/BMXK71M&$]U9G[5:SN\B(JK(H\D(<DD\)L'!YQWKU\@'K1L7TH X33=9
MN;L>)'U2_MOLEK)+$89 $-NJNX4L=H^5HQ&W)))SC@@#)66]\(Z-K5K;D1VV
MF_96L+Y@&!MI)22A9@1A/F7/IM/'6O3C$C#!4$'L:78I&-HQZ47$T>+IX_UW
M^P]+O%UR!YI!.9-\46V0)>PPKD#IE)&/&.F>QIUUKE__ ,)+8:A]LBFO88+R
M&*4*N)]E]Y2KCI\R'MSZ5[$]I;R??@C;_>4&FBRM0% MXP%;>H"CAN>?KR?S
MH&>=-XH\03W1^SZC8Q+-JWV%8W0.\&))4P4X/*JKC)R3[' ]#M([F.Q@2ZF6
M:Y6-1)*B; [ <D#G )[4CV%F[;GMH6;>),E 3O'1OJ/6K>.,4Q'E&J:]JD_B
MG5X4%_9RB"*SAEG@\N.)'O%B,J?-DY5LAN,[.V*(="T/4X]!E;0R+U=2DM8R
MLLC1QK!-(\DO)YWF,C+9)+J,G%>F7&GV=RTK36L,K31B*0R1AMZ9)VG/4<GC
MWI8+&UMTB2&VBB6%#'&J(%"*<9 QT' X]J /-7TY+'1O%<VF:K<K:R7D;111
MSEFC(*K*Q))8>8^_/3(0$<&M"ZDN'^)R1)-,%D/V5MCX A-L\A('KY@7GWKK
M!X7T!+::V70].$$Y4RQBU0+(5^[N&,'&3C/2KPL+-;H7(MH1.(_*$@0;@G]W
M/I[4@,+P?IEKIEE=+8^?]G>\E"K-,\A7RSY7!<DX)C)_X%QQ745!;VT-I"L-
MO&L<:YVJHP!GFIZ!A1110 4444 %%%% !1110 445EZIKNF:(D1U*^AMS*VR
M)7;YI&]%4<L?H* -2BN=;QMX;43;M8MU:%=\J$D/$,@99<97J.H[TZU\9>'[
MV6WBM]4B9[DX@RK*)3Z*2,'\* .@HKG%\<>%S*\3>(-.CD5MK++.J%3TP0V,
M'/8U<O?$>B:;*L5[J]E;R/'YJK+.JDIG&[D],]^E &O17/IXT\+NC.GB+2B%
M 9B+R/ !.,]>F>,T]?%_AIPK#Q!I6U\A6%Y'AB.N#GG&1^= &[161'XGT":*
M26+6]->./[[+=H0OU.>*LPZI87-J]S!?6TMNF=TJ2JR+CKD@XH O45GVNLZ9
M?9%IJ5I<$';^ZG5^?3@U<\Q-VW<,D9QWQ_DC\Z )**IR:C8Q3B&6\@24](VE
M ;\LTZ.^M)HQ)%<PNI)4,K@@D=LT 6J*B2>*1BJ2HS#J%8$BI"0.IH 6BDW#
MU%(&! (/!H =11VI-Z^M "T4FX>M(6 (!/)H =12;AZT;AG&: %HI-P]:-P]
M10 M%)N'K1D8SVH 6BDR*-P]: %HI-P]:3<N<9YH =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPG=W=M;11ZQ;O+ UL[?(DR\JI/T*Y^IK'B\4^*Y_&6I>&H4TA[BR@\U9O)D
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M;3("H8VUL8YI@H(4,Q<J.V<+R1VZ4 59O$VI>)/&'_"/:!>_V=;Q6BW4]ZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 3:/2EHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***K75U!96\EQ<RI##$I=Y'8!54=23V%
M %FBN5L?&]E>ZK8Z<UAJ5M-?QM+;// %25 NXL&!(Z8X.#R.*ZG- "T4F:0G
M )/:@!U%<K?>.]%T_5)M.G74/M<(W-'%I\\GR9QO!5""N0>1Z5N:9J=KJ^G0
M7]C,9;:==T;[2N1]" 1^(H O4452U+4K32=/FOKV80VT*[I)""0H]>* +M%1
M12I/"DL;!HW4,I'0@\@U(3@$T +1638>(-&U6=X-.U6RNY4&YH[>=9&49QD@
M'(Y-:U !1110 4444 %%%% !1110 4444 %%-WTZ@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;J*Z.3P'H,^D7.FSV\\T-U,+B9WNI"[S  "3=NR&X'3 ]JIGX8^&3%)$+6Z
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METMX]I\A+2A@QS(1NVDJN5[\\\F@"GJ'B2[U#5]"FT^*_ATV;4! +E9%$=R
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M+*)HE)^[+!D[U9L#<#P,GK0!M7/BEM.\7MI>IBSM-/-F;F.\EN=N3O5-I!
MR6XY-;=UK&F63PI=ZE:6[3_ZI99U0R?[N3S^%<OXBT:^U+Q!=W":6LUN=%N+
M-',B9>5V4@8)X P>?>N7MO"^JV=O;VVI>'+O4X9].M[21(-4\I8S&I4I(H<
MIDY!&<9/&: /4/[4L!>FR-]:BZ! ,)E7?D@D?+G/(!/X&LO7_%5MI'AV[UBT
M1-22U*^9';S+D D \^V<UQG_  AM\VH>+9%T6&%[FUMTTV9FC8;DB*N%?=O4
ML21N(![FH]2\,WM[X:UH:3X9O;34;BUCM\7E^K&4"13M0!RNU5#$,2IY '?
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M4 +1110 4444 %%%% !1110 4444 %%%% !1110 5$B*@PH"@G. ,<]34M%
M!1110 4444 %%%% !1110!GZII5IK-B]E?Q+-;N060DC)!R.0>.E6+6UALK:
M.VMHTBAC 5(T& H'858HH **** "BBB@#%O- L[[68=2N?.FEMPIAC:9O)1@
M3A_+SM+<GYB"1QBMJBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHI,\XH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ IIZTZFGK0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MFO'LL4'@#Q TLB(&TVX0%V R3&P Y[DD"NEIC!<$L.!0!Y?\-K22]\.6$MY?
M6MUI,43.L"E?W$R7)=78@\] 1GI@^IKFO#VIV$FA_$EOMENCS),R$2K\V1-@
M#GGD@?B*]SV1;2,+@\'WJ-[6U;[\,1XQRHIW ^>K:[632O"$>M3QQ>'_ #Y#
M%=6QVO#-YQRLC,Q  &ULX& QQ]W-=-K&^-_$6O\ AW6[&]L7EE75='O2A5PO
MRL0V1U4$CD<8Y/2O4KJ?1K22"QNGLXVO7*Q0/M'G,!S@=ST_2GRZ%I$TL,DN
MEV3O"=T3-;J2A]0<<47%8\L\9-:-\)]+N4L%TXW4D&Z%V)*A(RJKEN2   ,_
M7C-=[:V%M;V-E<6]Y'IMU=+;)-,H0M<;1PGS9!)R1G&:V[K3+"]*?:[.WG*?
M<\V,/MSZ9Z=!^507%AH\%A&MS;VD5G;.)D#JJQQ,IR&'8$'G-(99N[&UO1%]
MJMXYO*?S(Q(NX*V",X]<$UPOAK3M.FT'7+FZL+>:2'4[]TS$I*_,PP.HZ<8Z
M5VEK?:7K=F[VES:W]JV8W,3K(A]5.,^O0TR'0='M;6XM;?2K*&WN05GBC@54
ME!!!# #!X)'/K0!P&E:QK&AZ)X=C?4K0VESH+SH)H-J6YBAB*DE26888Y]>P
M[55G\3^(KC0M<B?46@\B"WECNS B,Z2DJ2 "=BD;67=\X'7D\=]_PC_A?[1'
M:'2M)\^.!DCA\B/<L1R& 7&0IR<XXYI(/!?AJWMI+>#0["..2(P/B 9:,G.T
MGJ1G!Z]0/2G<"34KFYTOPW/.;^#[5&F!<7$9\O>3@95.>IZ#DGBN$F\2>)KS
M3M0A>[:SDL[RRC$LEEY4DBSNJX*"1MF,AN3NP<$ \UZ1-HNG3Z0^DR6L;6+Q
M^6T)'!7TK,3P7X;BAN(DT>U5+E%CE 3[ZJVX9/UYS]/04 2ZSJ%UI7AR2Y^U
MV@NT5%\^:-O+9R0#A%)))SPH/)(&:S_"&O:EJ\NJ6U]$ZM93)&CO!Y+L"@/S
M)N.#G/M@BMJ\T73[_23I=Q:H]D0J^620 %QMP0<@C P?85%IGAS2-%N)Y].L
M8X)9U596&26"C SD_P#ZZ0'(W/BCQ/!::C?9TAH+#4UL7C:&5#(K-&NX/O.,
M>9_=/0_0K>^,/$.GWD^ER6EK=ZE]IBAA^QQDC:T32$['D7<0$/&\=>O8](W@
M[1)$F0V\^R>?[3*JWDRAY<@[\!^N5'TQ4-[X&T._M[J.:"<R7+K(TYNI&D1U
M!"NC,QVD GI].E ',MX_UZ..SL)?#]RFK7,LP'[C*^7&%(?R_,SDAEXW<<G)
MQ5^VU_Q1>:QX=BELX-.^UP3RW=I,-S@Q,JMR#T(8%<=SSD<UI2^ =&FT>"P*
M7"RVY+17ZS,+I7/WG\W[V3W['TX%67\)::K:;Y/VF Z?O\LQ7#@N'^\)#G+@
ML%8Y.25!]<L3.5_X2C4M(M5-AIED);WQ#+I\@ENY"HD)/S L.AVG@8 [+5BU
M\?:E-%);SV-I%>QZRVDM,)B8%(4L'_O<X( XYZD=*VI_ FDW$859;^,B];4%
M:.[<%9VSEP?Q/'3DUS_B7P!,(Y%TJ35)8+N^-[>1Q7R+)OV%1LWK@Y)!(9OX
M1CV!G3^%M<O];M[Y[RVMH_LMW):K);2LZRE#@L 5&!GMD]_2LN'QM>20:?J9
MTR(Z/?WWV2*47'[U06*+(R%0-I(Z;L@$=3D5?\%Z7JVEZ=-!JES<2J9,VZ7#
MH\D2;1P60 =<\#./7FJ]KX$@M=0B==1O3I<%Q]JM]-)!BCEZ[LD;C\Q+ 9P"
M>E(#-L+?5]?\9ZE_:ADMDTYX?*^PZC(H0E ^S;M <-N.XG!X Q@ T:[K>N7+
M^+K1(XHK33K3,<T%VT<R/Y3R!AA1G/R#&X8P>N:Z'0O#3Z-J6HWTFKWM]-?E
M6E%PL8 *C P$48XX_"J&K>"/[2U+4[J/6;^UCU*'R;FV01O&_P FS.&4D<=N
MF>: ,R/X@7&E:7*=;T:XMTMM,2\23[2DS3@E4 .WHQ9ASGOFM[PQXH?Q!<7M
MO+8/;O:E,2HS212A@?NN57)!!!&."*SK[P!%JAV7^I3SPG35T\H(T3@$,),K
M@A@RJ<#CCI6EX;\/7NCM++J>M7.K7;@1K-,@CV1@\*%4XSSRW4\>E '-:QJ,
M]IX[U"SGU+7[>TCT];J);*,SEG+,"R@(^%'3# #*G@BG>&O&NJS^%-)-Q;?V
MOKEZ)&6*VDC3]TC &20YVIU4$>IZ9R*UKSPGK,_B.[UJU\2O;330"V1/L,;B
M*,$D $]3N).3_+BJ5O\ #N;37M-0T_6)/[:@GFN)[F>+,=TTI&_?&I&!@<!2
M,&@1+<?$:&+3(KN+2+^60),]U#\J"U\IMKJ[L0N_<" H//XC*R?$6 O:+9>'
M]<OS=6<=ZGV:!#B-O7+CD=#_ %JM<_#NYFBC\O6 L\BW)NVEM1(CR3/O:2-"
MV$<9*AN?EX]35_0/!^HZ'=:;(VL07$5GIRZ>4^Q;"R*00P/F8!X'8T#,^Y\7
MW^H^(-#72[:_M],GOVA-TZ1&&Z4*VX8Y=<%1@\9Y]!74ZUKD6BQP V]Q>75S
M)Y<%I;!3)(0"3C<0   222 /RKF;3P9K5D=(M8]5LFL=(NS/;EK-C*4(<%&/
MF;<X?&<#L>QSN^(M$N]2N],U+3+J.#4-.E9T\Y2T<J.NUT8#ID8Y'(Q0!A:U
MX^!T."73+6_%S/=+:2C[-NDLWW!65EZ>;@G:O()QG@\SZ[=Z]HG@.YOUUB5[
MN(K,LL]K$L@1B!Y<BCY=PSU '3\VR^#]4>W!2[MC=3:HFIW#.C; R%-L:#.=
MN$ZG)Y/K@;?BS1[W7O#5SI=G);QRW 56:8-M4 @\ =^* .?OM9\1^'-/TG5+
MF[CU*QN988[Q)+?RY+<28^=2G! )Q@CTYZUH0>,--LY-6GOM;DN(+>[%N473
MY%^S,3@)PI+Y/\72J]UX5UC68M-L]6O;6'3;&2.1K>U0L;DIC:'+8"KD9P!Z
M>E0OX2UH/J[#^SI/MFIPWL:O)( JQR*P!^4\G;[@9Z&F(UW\=Z!'"\TES=HB
MC=+NL+@>4NXKN<%/D&0>6P.#Z&K)\7:)]O2S6]+R22B!9$C=HO,(R$\P#9N]
MLYKG]6\-:Q-KTFIP:=H-^+N"..>#402('4')C<(2RG/(('W:FT?0_$FB74UC
M'_9LVFS71NFNSN652Q!=1$!MR2.#N &>AP 4,OZ=XZT2_M;RZ:X:"WMI_)#R
MQ.N_/ VY49).1M&3Q5IO&7AY+$WLVJP0P"7R6\[,;+)_=96 8'V(KG)?"NOB
M666 V+R6NLOJ=IYTC$3J^_*,-O[L@-@,-WK@<5#)X1UF;6+G63%;1W%W?V=R
M]LD^!'' #QOV?,S;CG@8 '.>: .JLO%^@7\T$5IJMO,\YQ&$).3S@=.#P>#S
MQ5_4-5L=+@$][<I;QLP4%SRS'H .I/!X'I7*7>@ZO+XWBU*UMTMH(YD\V83@
MI=1",??BP?WBL6"L".#]*M^)=*U67Q#H6M:;$+I-.,WG69F"&02*%W+D;2PY
MZD=2,\T .\0>,+/3].L)K/4+$F_F6.">9LQ*G\3G!&<>F1R1TJ23Q0NBZ%'>
MZ]<V7F2/MA>V?"3J<;6&X_*,$$Y) ]:YRT\*:S86Z7"VPDFN/$+ZQ-:Q2J!"
MC*1Y>XX#'D'C'.:ZCQ387VIZ'&EE;*\\=Q!.87D"DJDBN5!Y&<#'I[T 4['Q
ME;OXBU*PU"\TVWM8A;FSG-R!]H\T,0.< G"]!Z^];\FN:5%J,>GRZG9QWLHR
MEL\RK*W7HA.3T/;L:X#5O#NMZC/XJF71FC;4HK,6_P"]B)W1,=QR6XX.1].<
M=*?/X=O[G5KT7?AN[NX[V\6[BF?4S'';G:H'F(LGWD*X!4'C&",4 =KX@UI=
M"TO[487N)'E2&&",_-+([8"C\\_0&JD.J:[%J=E;:AI5N(;DLIGM;EY1"P4M
MA@8QUQP>GTXS'XLTF]OX],NK&/SYM.O$NA;-(%68 $$9(/S8)QG R>34<U]J
MNM:9=6EKHEW8F2VD4RWSJFUV0A0NQF).XC)X&,G)/% CH(-0LKEYE@NX)6B.
M)!'(&*'T;'3\:4:A9G'^DP\X/WQT(R/TYKS&+PW?W=YH\ZZ#-9IIFDW%E?12
M;-ET2F%C7!^<;@6R1CIWJ&3PUI%CH/@Y;WPPINOM*17L)MD>:8K;RELG.64.
M V,]!@#M0,]7-W;B$SF>/RAR7+#:/QJ02H0"&R#R#7E">'[W3[NTO!I$O_"-
MKJ<]P^E)%N=$>-%1_)!.X*ZLVT D;LX'($%AX2EDNK :QHSSZ6^J7<D%LT32
M&UM73$2,.=HW<[1D+NY]@#U_S$R!N&3VK*GUD&.-M/A:_!O%M93"PQ#SAF8G
MLO<=:\QN='FLO%VF/IWANZLH[352@:VMB[-%M #>:3CRV08V=%'&0>C[/1K:
MW@M+6/PY=VVH6FNK)-+'I[!&B^T,ZX91AE5"F,DX_ T >P*XQR>:#(H&2P%>
M3:M92RSZRLME?_\ "4/J(?2[I;>1@(\KLVR+\JH #N#, #G-17FFK-X:\4>7
M::Z+\7LMQ9#9=J<Y54:,8(//3'./89H ]@R./>C</6L:UU_3[W59])C:7[7#
M$)726!T&T@="P /WAD \9K@[_3;F6Z\8WNF'5FU&UEWV 6:<+DQ@/L5FVO\
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MA\A(S@[?3O\ C7G]_?:G%XGL-=EU'3Y[Q]&FO(=ML-D6$+;,A@S+VR2.I]0
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M<N% R,X)[UD2>"=6@\2:C-!;Z1>65_<+=_:KZ+,\# KN4 +AC@?*>-O7DCE
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MW+]_Y05(^?/' R,5K3:1-;S:G:WOA^YN(;G3HH=-" W(MRL9#1&1N5.XYW'
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MX*AB1E0%SC.!Q5G36NX/#_AI=3BU%=,$]T+\R+,LD9WL82X.)-G;)&/NYXH
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M/RC RO\ >&2!D9&3CK7)_P#",:^9M*=;&%6M=6NKV5OM"G<LLA9>PR1NP?\
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M%@5O(_,N6LH[PVQ,!N!QL#=SG(STR",Y%94_P_FN(+[3!JB#1+Z\-]+$;?\
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MZ5:K<:B!<N(@S LL<;;,DE1NR0 ,@<YR+[^#-*NE625KTS?:4O'E-RZR-*H
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M?$5S9+);QV]T@@5Q)L4*'3/W'P.O(Z<5U4$*V\*0J6*HH4%CDG QR3U-6**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBD+ =30 M%)N%)O7UH =CVHI"P'4TF]2,YXH =
M12;AZTF]<=: '44TNHZD"EW#.,T +12;ACK1D>M "T444 %%)D&EH ***.@H
M **0'-+0 4444 %&*** #%%%1[FW8VG&/O9&* ),>U&*** #%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+:UGA>&1K*-G>0,A7^/A!SG'S'CJ*0RM_P +.\+"VEG;47$<<:R@_9I,NC'
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M<H656R %(("NI/(// .#4WB/7K[2]1T6TL;..=K^X>-P\@4X6-GVC/<X'/0
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M:2.XCO$DCOEL&06[.?-9=R_=SD$$'CGVK,G\#ZG-J.H7PU>T62ZN[:]4+:,
M)8,!58^9ED.T<9X[5%=>!];O+F6:;5K+>VJ6^I BU?&Z*-5"XW],J,<Y ZDT
M]!&L/'FD$2&2*_B6&807+26CA8')  <XQR2.A-95AXN.D:YK=GX@U1YH8+N.
M.*X%H4AA#HK*KNH(7E]N6/4=JDN?"&L75EK%N]YIY;4KI+LL87&QD,>%Z\C$
M8YZC)XI=3\&7VL3ZS;7-S;C3M9D@DN-BDR1>6J*54$8.[;][@KZ$\@T#4UIO
M'.@6]\;.2^3>LXMBX!*"4@G;N QGC'U..O%-7QUH+EF2ZF*JQ3<;28 N'V;
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M;;KKEB[1[^!MWD\X)P<5WBC I:* "BBB@ HHHH **** "BBB@ HHHH ****
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M:U/"_A@^'OMSO<QS37<OF2&& 01@XQD("0&/4GO5L^,/#0X/B/2!_P!OL?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@MH1DB.&,(OY 5%KQQX?U+_KUE_] - %V)=D2(/X5 J2FJ05!'0TZ@ HHHH
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MC4-3TZ_6[N;>>R+[##LPROC<&# \?*.F#UK';X?:9(EM'+=7KPV\-S L9:,
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MYE=+0,5STW,S'+L>I/';CC)P[OP9J-U<S0&.T6/^V$U./4/,/GJN_<R ;?O
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MQZ],C/>G?>$]5T#3-*ATM-0FN+T*-5GCWS8*+E4P6#!"S'(! (0 D4 >P%5
M^GZ5S$_CO0+2ZGMI;F7]Q*()IH[65XHY#P$9U4J&Z#&>O%<VNE>+/#NAP_V#
M<(EA#&99+7483<7;R%B2/W3;1DD !>!USUK&,ESH^NOK>GV6I6NFW%K+)K=I
M<VSP01S!25:,MU9I#_!N^N#P >Q855))(7&:YZ#QGX?N$@*7Q*W,[6T3-#(
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MRHX)"D9P>M-MO%5JL^J37MY;Q65N\2Q*8I(YD9ESL=&&2Q/*A1D@]/68^-]
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MD[<[BHW*"P'!./7&KKO/AW4O>TE_] - &@G*"G4#I10 4444 %%%% !1110
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MXBA9W0+<)L?*L5.1DXY%<9I5E=)XFN+C4M#U*:]_M&2YM=1\PB-;4@A4^\2
M%./+V\G'&>1C>#=*U+3;_P )R-IVI6KYODU/=%*%^9LPAOX<9.>.!S[T >HZ
MGK%GI-O)/=28V1M+Y:#<[(I 8A1R0-RY/09&<4_2=5M]9TBUU*U6007,8DC$
MB[6P>F1VK@?$NG7,?CB]U :;>303:!-%%-!$\@\_YOE(7.#L  '<D=ZQ;.'4
MM.T14BT[Q%(7T6VCGMT^T1M]H# . 2#MPIYV#D#CFD![$\T<94.ZJ6.U=S 9
M/H/>I<@KFO&K*WO9+6QAO[/6)5M=?$B_Z-<J%MWB)!4$EMN_U)*YY(!Q77>/
MCJ!L[ 6\]];V?G'[5+:PR2E1M^4LL;*Y7.<X/7'44 =H(T5RX10QZG')JH-.
MLQ#'%]D@\N)U>-?+&%9>A'H1V/6O(=7EUNSTZUMDO/$%U<1Z?+/;7<L$Z1L5
MDRN8X\MYF!D&0X"XW+DG/1V6HR7/B.[FU.XUVWFBO?,M L<L4#V6Q?OC&S )
M<DMAP<#KQ0!U]E=:/XHM4NX%AO(K><A'DA_U<J'!(W#@@@C(J"_B\.Z#;M?7
MEM8VZ"=KG?Y"[FF()+J ,L^%/(R<+[5P7AZ[O;7Q1H9MKC4$MKV]U$WT+B7R
M]A9S#\K *A)P<CD^N*Z;Q;%;R^+?"@EEF0&YF4F.5DVYA8 \="6(&?<CN:!&
MT/$.DZAX=FU*RU>%;)@5%XC B-LX'7^+)  (ZX&#TI=#@TJY\+PV]@R76F31
M% S?,)0V=VX>I).1QR3P*\WNM1BU+P[IJSZO=LA\1+&CF0QEK?S=R/CC "A6
M!/(QFI'NI=(@U=K;4KNW+ZZ\=[)*7"0P%6*N3CY0S>6IDYXQ1H&IZ./"F@^4
MT7]C6/EM.;DJ;=2/-(P7Z?>]ZAE\'>'I[..SDTBR:VCE\Y(A" %DQ@L,=S@<
M^U><R^(-;1+:"3Q1:Q026\KVE^_F>3*Q=@ 'VCSF4 8'&>O-7(?$NI?;HWF\
M3B6>#6K2T>%%CBC>.5(BXV$;N"7')R"#GD8#&=I)X-\*VUMF71=.2&. P9:)
M558R22/8$DD_6K%QI.A:AHT6C7,-M/82*#%;L^0RCD;><D#MCM57Q2K7&K>&
M]/D0M9W%^S3J5RK&.)Y$#?\  U5O^ UBZ]':+\5_!XV6R3+#=Y/R[S^[ 48Q
MGC)QSW-(#3E\!^#!:G39-(LEBFF^T>46(W/TW#G/3CBI[/P;X7,.GSVNF6QC
MM29;5HV)5=S;\CG!&<$9R!@8Z"N?$&G_ /"Q+/5-/U.RU9[J=XI[=A#-+:;8
MVPT3J-T:KM"E3W8]SSN^'1]EU[Q'80G;8P7$3P0JN%A+QAW"X]6^; [L?6BX
M$H\&>'K:UGA^S,EL\$D&PW,FR*)\;UC!;$:M@9"XSBI%\&:+MDQ;RKYEH+)M
MMU*/W(Z(/FX [8Q7GNK:Y=ZKI.I6^KW =7MEGAA:.)X''GHH>*5><8;;M?YL
MDGZ:USXGUK3%O]-FUO3Y+L7T$%M="#;N66/?L2/<5W#'!9@O/) IA8Z:'P)H
M-I/'+;P7,1CN!=(HO)MJR@8W!=V,D<'U'6DL? FBZ:+06<=S"MG*TMN%NI,1
MEAM(&6Z;?EQTQ[\US-MXB\4ZI:>'C8ZI8QS7[W,$OGV9;#Q;R&^5N"0!QT]^
M:2W\8^)+J>\NK9]*DM#'=1P0R3)&T<T60I)WDD'&2"  ,'..:5PL=!_PKCPV
M8)H6MIS$^3&K7,C"W)<2$Q9/R9<!CCK@9XXI\/@#2;6598)=0607GVXYO'.Z
M;;M+')/49'XT_P (:O>ZI8W;7UR)IX;DQF,VQMY(1L5MCH2?F!)P02""#FL:
MT\8ZI?:A'J$1M%T9M3.E_9PK--N/ D+9QUYVX^Z>N:=P+VI^%;QM/N](TYX7
ML-4:1K^6\E8R1EQR\2A<;NIP2!G!]:W=1T*RU'P]/HD\>+.:#R"J'!5<8!!/
M<8!'T%<KX0TBXOM>U36=9^R7-[;7TL,5Q#')&ZX 4KRQS'C&%Y&<GO7/S7^O
MWPO);V>&ZFMO%%O;6J)))$J$%,J<9PA!'."?F8]#BD!V"^ +);6\A;4]4<7G
MD&5GE0D^5MV_P8Y"*#QT';G+IO -I+<3W2ZEJ$=W+=K>B=6C+),$,>0"A&-I
M(P<BLL^-M86WCL/L%K-K;WES; 1R%(BL.TEE#$,Q^=1CK]YN@K6U3Q%?P_#B
M[UP6IM;^.U9F@=@_DR [6R1D$*<G\.:8&KHFA1Z'%<PQ75Q.MQ</<,9BF0SG
M+8VJ._/XUFMX#TF32IM/WSA9;XWQD#?,K>9NVCT7 VX]*K:;H$#Z%I]]+KEX
MUZ1!<RW\5](8YVX8_*6VF-B3A< 8;@"F-XUNQI\>MKIUNVAO="W$@NB9P#+Y
M(<ILVXW8X#$X/KQ2 T=6\)1:O>WLUQJ-UBZLGL6B58]J1M@G;\F<Y&>2>OTJ
MF/ D?V6YBDU:]GEN-*_LIGF2,XB&<$84?-\S=2>O/2J4'CS4)KDQKH49!U-]
M,&V_&?.52<X*#"G:W/7IQS4L/CN^N+V"QAT!GNY6N8R#=*J!X'VN Q'(Z$'
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MP'S>8""< #J1T%@^-K=));1M.OQJB3+!_9V(Q(Q*&0$-O\O;L!).[C'."0*
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M2OL0L>,L1S@=3CG XK.\-^'CH5C:1?;;B1HX"DD>\>4TC.7=P,#DLQQZ#C%
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M6  QVYQECS@'O7!Z<;32-6TA!%97EK(DLNA:M:A?M"YB?(N$_C !//JF3SG
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M$^H17L[FU_=GRT**BIORHQW+'FN@US2TUG1;S2W=HDN8FC,B 97/?'MUQWH
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MM1N%GN[9Y7544[I7P^PDH77.'())!8'K44OA33Y-9743YH E^T/;"0^3),
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RNJ('^(GAX[L-':7K
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M6UO9DIG.3M?D<X'3''6LC3O%>M1:KK"72V]R3J<=A:1!RB1L<GKMY&.2>3G
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M*G/=2#C [4 9.A>)KJUO;RTU=[R[$NL2V=M="*,1Q_*"L9VD'^]S@_6K4?Q
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M\/W,,TD6H(P@:-)%\M]^Z3[@"XW-N[8!S60? #3Z=;V=SJ2F%=+_ +,F,=J
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M1N/+'F;,YV[NN,\XZ54OI-+T:W,US%'#'<7"JQ6'.^5B%!. 22>.3^- '/>
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M)9W&&ED9BS.1VR2>.U9;>!K3^U);Y-2U.)VN6NUC25 B2L"&8#;GD'H21^M
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M9DW'86'9BFTGISG@58U=]FH:*<9)O6'_ ) E_I0!L 8%+0** "BBB@ HHHH
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M3\+0:A;^+]0>:RN#;3^<WVB>)DEC)D!$;L3MD7KL9<X7@XXKT HI.2.:7:*
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M+%D2;[0J^0O$N02_3[QP,GOWJ2+P_HUNT#PZ38QM;L7A*6Z@QL>I7 X)R>E
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M0O[(&;<ENI8R$[NI8MP .OM74W]EK']AVMOI=U;P7D,D)=V0^6Z*1O7!R0"
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M.\P_K0!M#I2T@Z4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '/"+=X[\W$?RZ<%Y/S#,G;V
MX/3VSU%=#6&D4;>-9YCCS4T^-!S_  F1R?Y"M#4(;BXL+B&TN!;W3Q,L4Q4,
M(W(X;!ZX.#B@"WD>HI<UP5G'KMWXAU73E\478;3OLS(6MH"'WJ2V]1&#@X(&
M",?AS#H/C::#2+:77(YW1Q=L+_$>V00EV;*I]W"(1D@<C'<9 /0Z*YCP]XSL
M?$5_+:P1M'(D"7" R(^4;C#;20K@\%2<C(]:CUCQI9:)JCV4UI>/Y:Q,\JH
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MH/\ $>01C/IQ7+7GBV]UO4_#=U8/Y3C4)+>2TBO7VR-L5BLH* J1EAAEXP<
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M,D?F*-HE8"1<L%X&3@=0,U7'PZD:><2ZNKVUS*TUP/L,8G9V7Y]LN<H"WS8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF.@S7L.Q1T&/I3?)C(P47'IBD,XR#7[T_"Z?6K$W5U?+;2O']I13('#,.0@
M8*1U ^8+GO7/>)=3N9-'\0V4&O/?Z6VB/=BX/E%HY<D+&'50I5P#P?F&#@],
M>JK&B !5  Z 57^P6GD"#[+%Y(.X1[!M!SG./7/- ' ZC::79?!Z]9WMI/M.
MEDF601@RR"([1E0 Q7&!WX[U6ET?5/#=CJ?B2VN+#2YYH884M;"#= ?G&))
M0-SX;&1C '?MZ1-96MQ$(IK:&2,'<$= 0#ZX_$TLUI;W$'DS6\<D0_@= 5_(
MT >=>(-<\1:5J3:9;ZU:>=%9_;$EO)(K=92TC+ALH040*,A2&)8?-WKDK[S+
MCXH>(;F^*WXMO#YNS;21++&Y C81@8^49;@CGOGDU[=)IEC*D226=NZPD&)3
M&"(R/[H[?A3?['T[[4UW]@M?M+$EIO*7><C!RV,].* /.;7Q/XK:5(CJ&D.D
M]U;11.C)<LH=L,2(ROR]QT/OW.G?ZMXFT^^U=#J=E+%I.G)?2*-/;=.3YI*
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M9@0?KE>:V"< FN";X@/<:AJL.FZ4EW_9K.DD!NMMS,4)#&*(*0PX_O GTZ9
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MG*LC8(X%77\;0SWNF0:78RZC'J-N]Q;SQ2*J$(0'!W8((+*,>IQU% &N=.O
M"!K%V2Q)!,41QGI_!V[9].<TC:7J  V:[=#GG,$)S_XY7,6?Q1L[FQEU&71-
M5ATZ&8037.(Y!$QQRRJY;'(Y /6NUL[VWU"UANK6598)D$D;J>&4]Z ,Y=-U
M11AM<E?K_P NT8//3MVZTL=CK( W:NC<][11Q^#53\0>*T\//*\^E:A/;PQ+
M+-=0B,1H&8J!EW4ELCH <9'K5:+QU&][86L^@ZM:&^D1(I)EBV?,NX'*R'/
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M0 #.3O';.>_;!_(TTZ59$C-I;\<#]T/\]S^=-.D:>>ME;G@CF%>AZ]O<_F:
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MR0\Y!'!'!!)!.*Z'4-?LM*FC@F\Z6YD4N(;:!YI-@(!<JH)"@GJ?IUKD-/\
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MW8>+.6BD( WG 'S-UKJ;6XN?$7A-YFM)+.>[MY%$,C@[200#E3R#P0?0C@4
M8C_$&":[\/S6GV;^RM1:99IIY=KP;(R_S#[J\;>I_B'2NKDUG38+)+R;4+6.
MU?[L[S*$;Z-G!KS^UT'74D\'BYT9C'I+2BY59XF#AD*J1EAD@X/T&>O JVWA
M;6X$T^YFT>YGMX/M4,EA#>B&1%EF,@="L@4\$*02I^7N,4 >KI(LL8="K(1D
M$'((KG;;Q9:77C*\\.)D36]NLRN<D2'G>HXQE08^_P#$>.*;HUK>>'?"$-O%
MHZM/"&*6%E."J[F)"AY6'3/)SZX':N5N_#&LV=CH>JVB:G=:W9R"X>!WM]NY
MROGH6)!&X%R/G;ICTH ](>]MXVV231H^0-K. >>GYTJ7=O()-MQ$WE'$FUP=
MA]_3\:\O\2>'+S5+CQ5<)X4DDGO[6V2RD=;<LKKG><[SCJOUVU7U;PQJ5QKK
M3Z;H=W;6K:5;I/'&R0B>5+A)7!VM@N4#+D]^,T >M17,4Z!XI$D0\;D8$4&X
MC\LOO78,[GW#"X]37E<_A6TN[6*>'PA?1++JEO-<+?,LSLO)D?9YA"C&U3@Y
M/&0<4ESHVHVMW*MEHEQ_8R:Y'=S6<,21K)!Y<0W! ?G =&.WJ>#@]: .^\/Z
M\VN+J!>T$'V2]DM!B42;]H4[N@QG=TYK:\U3[?6O)&TJ6?2IHI/#]XL$GB5;
MY8C9CB#*;CM'*_+N'3)YQFJGB/PS'+I'B3^R/#US%.US:R:2(;%D:,X0R&,8
M'EYV-N(QV]10![,)5+[.^,XI3( ,D<5Y1;Z<)?$$C:EIGB"74EU W,=U'"@C
M,1?Y<R[0VWR\ QGTVXS@54T#3?[,?1+J71M22X349Q<EK2X9EMVC=5& I&S+
M)Q^G!H ];MKJ"\C:2WE25 [1EE;(#*Q5A]001^%6JXCX<V<>FZ'+9?V=-9W,
M5Q*)B]NT8?,KE=I(&X!2O(R,$<YSCMZ "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $(R*\CUG
MP-J]C?:L=$L[3[%',NMZ>3$&:.[0?-"!Z/C(QP.E>N$X4D5R]EXKDOVO5@T>
M],EI?+9NF8\\D9?.[  !R1G/3UX .*UOP]<A]'>\\.&^N=0EGN+Z2VA,WDSR
M ;5*LPC&%.P2." %Z9-9=S9W]SX=T"SN/#VJ23VUDT$-O=V'F1.2RC:2IS;M
MQA7R" ,G ->WC:>_ZT87CD>W- '#_$6%[KPK9P7,-\V^ZB:865K]K1"H+9EC
MQ^\BRO(XR<?0\I;:?;V3>&+RX\*RQQSP7EK-;6=L[!D=LQ[E;[@8O(P5C\H8
M\\&O93C S33MQG.?UH \'T*"P@TK0!XKTO4VT]-,N+:0O9S-NE\X, P0%L$'
MC/' IXB5=5MK;7X]9G@BT=PZ^5<M\^XO#&Y089A&RY/(W#'!!KU?3/$=IK%\
MT-M;WK0D.8[MH?W$H5MC;7'OV.,]1D<UOX7UZ^] 'C.AZC81#0KJ^EU<3W%E
M-#JTCQW(9BH7RPV!Q@@[2.>O/)S7MH8KB\\!ZEJEOJ=QNM+BVN+@>>95F)PB
ML0=RMDMSD'IDX KV_CUINU/7VZT >%Z?J<&F>"-&C2YU2PT^)VM]5D6*8[92
MC%% R#LZD[,#)3.>16FFL6VGC11KNKZXWAJ:&X$-W+YL+2R;P%$I0[]NT-M#
M=<@U[#M0<YQ^-+A0.V* /-O"TMI?_"F]M8&N6>.VG,I,4D3%FWL,,0NXXQR"
M??K6%X<UG3TTOPQ9W.JW5KH<]FT<DRSR0(UZJIE/,)!$8!; 4A=V1U&!["TD
M:/Y9<!R"0N>2!C.!^(_.JFG7UGK6FI=VX9[>0L )8FC.5)4Y5@".0>HH Y;2
M[G4=0^'%W-<W5S,QCN?LLZ-MFEB4MY;$K_$54<CKG.>:YRPN-(EN?!UM;>(_
MD6UG$DJ7:%HV,40V _PC((QZJ1ZUZWM3&.,5&;:!F!\M"1T..E 'C,?BK4YU
MT2TOO%":=826EP?[2;:PEG24A$=U(PRQA6Y(W9Y&3BNTO-3U!_A_9SQZO';W
MEPT4:W=W#]F\W+@9(^;R]Z@\X.,YQV'7R65J\/E/;Q-&#NV% 0#ZXI;BUMKJ
M%H;B*.:)NJ2*&4_@: /*9M0>YE\/27VL7=I%;ZO<07,DES&RHZ0.R[9=H#C^
M$$C/S$8W"K1\3ZPVD#5[?4GFU9=3^QMHA"*F#*R+'MV[U8H ^YF[$\#BO24L
M+**W6!;:%84.Y8U0!5([@=!6?8/X?O\ 5;M['[!/?VI\NY:((TD1.?E8CD="
M,>QH Y32_$L][>P7-QXC6WNFU&:SDT80*^560JH08$@(4*[.<@ L< # R?".
MNW4FEVFFR7#V21:?+/;)F,C4<ELG)^8;2>5&#WSBO35TS3EN)K@6=L)YQMED
M\I=T@QT8XR1CL:K'PSH#(J'1M.* EE4VR$ G&3TZ\#GV% '!>!+_ %#3M/\
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M1M)NK59I9%MKZXB1969F2+S6\L9;DC;C&>U=90 4444 %%%% !1110 4444
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MFCB"JZ2R@$;9"P4@*V3D@YJ;QK?W>NZ#XDA06":;ITT=JRW-NTCRO^[8L"&
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M@3/"[^6 Q>4[9 WSE@1C 7KSD ]0BE2>))(W5T90RLIR"#T(-0F_M1>BR-U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD$<D@'G)K1N]8\7P:E)H]I-IES>6]N+MYIX6@216=P%QN. NT L">HX]=D^
MO"N6VZ%9*2H4E(]IP#D<CGJ!^0]*L:GX1T'61;#4M,BN3;(8XFD))"D8(SG)
M&/6@$7]*O3?Z5:7;&(M- DI\F3>GS#/RM_$/0]ZT*H6NF6=G=3W-M;I'+.J+
M(R<;@@(48Z< XJ_2&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'IB^)-/&C/JUP;BUM8VV/]I@='5MVW&TC))) &,YSQ3M.\0Z?JE]-90/,EW
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M&GEMKJTG6YM;F+&Z*1>_N",@CO56Y\&I=:1JMF^HRM/JLBO=7+1)DX55 50
M ,*/4\GGT ,O4Y]1\*>#=6U: WQN#$!'!?78G%JP!42;CDD$E6*Y/MBLVX\2
MZKIWCY)IH]3N+;^P#>RZ;"R$(XDP6 SCH#_$3DXKM]9T0:[X;N-'NK@@W$01
MYEC'7@[MIXZC.*PY/!5Q)J3WTNLEYI-+?3'+6J_ZMF+9&",$$CVP!G/6@!=2
M^(>CZ?+LV3W&R.*:?R@N8ED&5^4L"S8YPH) P?3-_P 57NJ1^&)+C0XYI;A_
M+(,* R+&2-S*K<%MN< CKVK+A\#75C>"XTO79;(RVT=M>"*W4B81J%1U#$A'
M"C;GGH..*WM9T>?4;2V2UOVM;FUF2:*8H),E<C##(R"#@\B@#AK;QE=66G:]
MJNFZN^N65O:Q&""Y$:3VTY+JPE4!'VY"'D9.3CH:ZB]\<6>F/&-1LM0M%R@E
M>:)2L);IG:QW=.2FX+GG%9M[X DU235[V\U&)=2U&T6U\VVM2D<:AE;.PL2Y
MRB\EAQTQ46L_#[4-9GGFGUV$O(\3J[6&7CV9^53Y@PIR"1U)ZD]* +L?C<1Z
MKX@&H6\EII6F%(UN67[TG\0)!(YW)MXYYS6GX?\ %VE^(Y;N&PFW7%F^R>(N
MK%<]#E201P>03C!!YK*N?!%U<?VV@U98X]0FBNHF6 [X9TV$,?FPRY0';CN>
M:Z#2+75H%=]5OK:YF;"J+6V\F-0,\X+,Q)SSSC@8 YR 4Y/%^GQ7!4QW0MQ<
M_9&NS"?)$V[;M+=?O?+NQMSQFL>?6-:UGQ9<Z;IMS/IRV/D.X>S#K*&+%PY(
M.,J $((Y#9ZC$LGA#49;:YTA]1@_LB;4/MN/)/GJ#,)C&&! Y?/S'G!Z5IZ;
MI5]9^*-5U65[=H+^.%/+0/N0QJ1GG@YW'TX H Q;Z?Q3=^-+_2M.UVVMHHK-
M+F)9+ /@LQ7:3N!Q\O7W]JDT?QJ4;4[+Q!&EIJ.ERQ02F EHYS("8S&O7D#.
MWG'/.,U<DT;7(_%-YK5I)IQ\^!;98YM^5522#D>N>GZUEW?@*\ NM5CN[.YU
MR>\CO'%Q;XM7V(Z"/8"3C:[<DDYP>V* )+SQC-=:QH3:->1'3YKYK2]A>W(E
M5P,X)8@KQ@].>N<5OP>+=(GN1#'<R.6\WRV6"39+Y>=X1MN'(P> 3TXS6))X
M8UB:[T>[8Z9&UE=FY>&W0Q1J-NW:ORDDG)))Q]!4>G^%=7MO$=CJ=PVG2RPS
M3F>X)=I94<$#&?N #:-@XXSDT[ ;UGXNT;47L$M+N287Z,]LRV\FV0*<-SMP
M,'KGU'J*C;QMH$<2.VHK\ZF3'E/E8PY0R,,95-P(WGY>^<5SUUX#U#[?<WFF
M:BEI)!??:--0I\D*NF)@0 ,Y+-@<CY5YZTOB7P7JFI@Z?8&R_LN/35M8$DF:
M)TE!X9BJ$LNT  9P"2<&D!TK>+-#75#IC:C$+T,%,))R"1D9XP 0,@G@Y'K5
MFP\0Z5J=U]FM+U9)]GF*F"I=,XW+D#<N1U&17.0^&-4O5\1Q:@+2V76+-+8/
M:S-*8RL;1G(**"/FS^8IGAWP[J.CA9?[ \.Q7=K;/#'<VY99+E\#:2?+S&IP
M<\N<F@#O:*KP&8P1F=524@%E5MP!QR <#(]\"K% !1110 4444 %%%% !111
M0 8I,#%+10 F!3=@/_ZZ?10 FT5E:KH6G:RUN;^!IOLTGFPXE=-C]F&TCD=C
MU';K6M10 P* ,<\>M.V@TM% "$9.:0HI[4ZB@!NQ<8Q2!%&?>GT4 )M!I-@I
MU% #&0."&&0>"#T-'EJ>HI]% #"BG&1G'/--2"*-"L:*@/91BI:* ($MXHXS
M&D:JASE0, YZ\4"V@6(1+"@C'\ 48_*IZ* *?]G6864"U@Q*"),1CYP>N?7-
M,BTC3H+);**PMDM%^[ L2A%^BXQ5^B@"A;Z5I]I-Y]K8VT$I7;OBB521Z9 Z
M<#\J9/HFE7,S2SZ;:2R.<L[P*Q8\=21[#\JTJ* *LMI!/&(I88WC!5@C*" 5
M8%3CV(!'IBLZX\*^';NZ-U<Z'ILUP[;FEDM$9R>N22,]JVZ* (GC26,QNH9"
M,%2,@CT-9EMX;T2RAN(;32;*"*X3RYDB@50Z\_*<#D<GCW-;%% %'3]-L=+M
M1;6%M';P#D1QKM4?0=NE7J** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH+FYBM+:2XG<)
M%&I9F/85B)XX\,2*S)KVGE%*AG\]=JELX!.< \4 =%16/=>(]#LK:WN;K5[&
M""Y7?!))<(JRKQRI)P1R.GK4VI:YI.CB,ZEJ5I9>9G9]IG6/=CKC<1GK0!I4
M5D+XBT5[E;=-6L6N"XC$0N$W%B,A<9SDCD"I5UO2S-Y']HVGG9(,?GKNR#@\
M9SP>* -*BJ4>HV4FWR[N!_,^YME4[NW'//2K'G1\?.HR<#GOZ4 2T4SS%XYZ
M]/>EWC/>@!U%)N%(6 ]: '44W<,9[=<T;_8T .HIA<#UI=XSCG- #J*;NXYX
MHW#..: '44W>*7<* %HI-PHW T +12;A2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^P#:QZN23GRVX/?/I6KXQ%WX*T&UUJPU?4)9[>9!/'=W;RI=*0<J5;(4\=5
MK=M_ NGK8ZI9W]Y>ZFFI(B3&\D4E0F2NS:H PS%NG7FHH_ 8EN+/^UM=U+5K
M.R8/!:7?E[-P! 9RJ N1GO0!S7B/4Y].\?7D,MYK36,>GFY^S6L\CEI.<$!,
ME!QWX'X\>A:!;26NCQI+>S799FD629B6"L254D\\ @?A68_A'/C!_$B:I=+.
M\8A:V94:+R^,KC&>HSG/>K%YIFI2>*-+N[74)H=.@C=+BS!41O\ *0O&W);)
M4]< )TYH I>(O&/]AZM#IL=@]U<20>>%\Y(BXW;0L>X@2/GJH(.,>M)+XWBB
M\2)I,VG31H\ZVZ322(KL[#@B(D.4/(W@$<&G^(_!X\1SRBXOG%K-;B![:2!)
M%7!8[X\C*/AR-P[ =P,9MQ\/)'O))H/$=];Q/?\ ]H"!88CMD'^T5W$ <#)X
MX]*!D]EXK@MH=5E*:I/.=6:QAM)O++M/L4B./!P$QDY8],DFIO"FIZG?:WXB
MAO\ [3&(+F,16]P8R85,8; *<$<@CJ<$9.:K/X#F>"[1==N4NY=4_M2&X\I2
MT$NW;@ DADQQM/:M3P_X?O\ 2-1U"\O-8:_DOF1Y,VRQ894" \'N /;BD!E^
M'[C6_%UK<:L^J7.F64D\D=E!:)"6V(Q4M(9$?+%@>!@8'2K=KKFHZ/:Q:=J,
M5UK6K0QF:Z?3X4 6,NPC8@E1DA<;1D_*?3)9;>$]3T6]O)-!UQ+6SNW,ALKN
MU-PD,C'):,AT*Y/8Y'M1_P (CJ%KJ::CI>OR1W,EM]GNGO(3<>>=S,K@;EVL
MI9L8XQ@8P* )F\>:8TMK':6^I7OVNW^TP&VM6<,F0#Z$8W#.>G3KQ3+?X@Z/
M/+;[DO[>&XF-O'<7-JT<1E!(V;CT.0?;C'6FZ;X2ET34=+N;6_3[)IMB]F(&
MMRTDB,49F+!OO;DSPO?%87A_0;CQ!;!-0,\%A;ZQ/J'D36,MO+*YDD*9+X&S
M#!C@$YX)&* .HA\::=*T!\N\6VN7>.UN3 3'<.H)*J1DY.#MR!NQQFH+7Q[I
M-W;13VL.J2).0L)%A*!*><A21@XP23G'O5/3_!-W:V>EZ9<WT-UIVE7)N+4-
M 5D8@-Y:N0<84L#D#G:.G-5H_ FI0^%-*T9;^QE6QF+O'):OY%RAR0KH'YP3
MGJ<X% &@_CRSFU71;.Q@NIDU$REI/(;Y%C!##'7>'V C' )/I3],\6V1L;JY
MFU&2\+:A);01+9M%+N&/W2H>6*\DGCC).,50L/!.J6&I:->#4K1SI\]VQ46S
M('2=@QX#8##Y@.W(].6VW@O5(%%Q'<VBWD6KR:G'A'\MO,!#QL"21G.=W4>G
M:@#8;QWH$2QA[J=9GG-L8?LDK2)*/X&55)4^F>HY&16II.MV.N6\LVGRLXAF
M:"4/&R-'(N-RLK $$9'%<JW@O4KK5XM6N9K-+DZG'?RI&7*JL<0C2-2<?[9)
M(_BZ5K>%]!O=#FUMKB2&1-0U"2]B$1/R!P!M.1_LCGWH J:'XP@\Z2PU>\ O
M#J$UG XM7C23:?E7=RN\@$XSD^E:EIXPT"]DV07V1Y;RK(\+HDB(<.R.RA7
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M<]CLW$\\<5R$M_'I&K>(1;>(O,DN(-/CBNG*S2?,S*P4@@ DL"&8X4L.,8H
M]<W#.,T9%>1:7K/B#4= U633=8-S>Z3J)EAMTFCF>ZMEVEHBP7DGYL/C.1C.
M.:[CPO?3ZS%=ZRMW+)IUY(#8PL@7RXU7:3T!RS!C@YQQ0!TN15"?6--M+N*T
MN=0M8;F7_5Q22JK/] 3D]#7#-KNL-;7/B"#47E\C5?L+:1Y2;/+$XBQV<2D$
M/DG'/W<5=T#2I;CQCXEEN[Q[R"*ZBVQ311%0_EHRG(7(* [1]<]>: .\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** (Y45XF5U5E(Y##(->/^%[K5/"=A::'9OYW
M]M6$%UI7FH2D,[!5G4^JKN\W: . W?D^NSP175N\$\:21N-KHZY5AZ$'J*K0
M:796UO#!#:PQQ0@K&BQ@! >H&.F<]J /,=&G;0-)O8;"^5+B379H"WD">YO
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MW,S9+,O*$9&%(QUP*[+Q;XJU/2=5T_2='TPWEY>)))NP&V*N!G873=R1_$.
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M ,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M])K+LD\K6M27_GH(I?S!7_V2G%Z-$O=%30=*U+3(93JNM2ZK=RN/WS1"%54
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]A
M363)VEMPI_X"W_V9K0IA4%U?N,@?Y_"A: /'2BCM10 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !FBFX )/K3J "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex3-11_001.jpg
<TEXT>
begin 644 ex3-11_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1! O$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5@6"Y4KD=0.3C\:]<^&$[W/PR\/2.26^QJO)S]W@?RIQ]Z#?5,)>[)+NC/\
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M P5N%/&<$C\,'WJ#PA/-<^"]#GN)7EFDL(7>21BS,Q0$DD\DTEU'V-JBBB@
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M)0I^7($("]B1D_6LK_AH[P?_ - W7/\ OQ#_ /':/^&CO!__ $#=<_[\0_\
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MW=K"MK<]@KRSP3\+3X<^)6O:_-&GV1G/]F\@X$GS.<#IC.T9]ZI?\-'>#_\
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M4 <__P ()X/_ .A4T/\ \%T/_P 31_P@G@__ *%30_\ P70__$UT%% '/_\
M"">#_P#H5-#_ /!=#_\ $T?\()X/_P"A4T/_ ,%T/_Q-=!10!S__  @G@_\
MZ%30_P#P70__ !-'_"">#_\ H5-#_P#!=#_\37044 <__P ()X/_ .A4T/\
M\%T/_P 31_P@G@__ *%30_\ P70__$UT%% '/_\ "">#_P#H5-#_ /!=#_\
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M)X/_ .A4T/\ \%T/_P 37044 <__ ,()X/\ ^A4T/_P70_\ Q-'_  @G@_\
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M36A28(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[N]CDD6[UBX,-K&$QP2.2QSTXK&U;QAXXT?P#?Z_=6WAQ)K:9!&Z2R2P7$1
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M!6.>*=G?E#I<]EHKR/6?'GC2T\?3>&;6;PE$Y\O[,+H7)>0O]U?D/WN"3QM
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M +;%SDC.3BO4:*76X7T/)?&'@'Q=XA\01RI;^%;G1[2W:VLK6_:XRJ-MR[;
M,/\ +@$'@5+J?@[X@:EX-N=(EOM!DN+Z[\RX1Y9_(BA79LBB&TD+\AR#Z]<G
M->JT4=+?UO</Z_0XO0/#VM>'_!E[;Z?8^';+7;B5Y0EJ)EL]Q( )!RP^4=!@
M>E9/PZ\!:OX6EFN-5L_#IO5MC##=V/G>=*68LQF+  \XY SVZ"O2J*+ZMATL
M>11_#'Q!KEUKMQXK_P"$?^U7^)K:^L!*;BUF4*$",P&V,;>1U.>M5];\"_$?
MQ++8-K?_  AU_%90O$L,S76R0N "[8 ._ X((P3Q7LM% 7ZG":-I'CO2O#FH
M*;G0Y-7EF3[) 9)S96\*JJ[5&-PX!./4\FI?AOX>\2>&-'ETS7'T=H5<R0M8
M>879F9F<R%P!U(Q@=J[:BG?5ON*VE@KR?Q%\);KQ!XF\5:U//9M)?VBP:8K,
MW[IPJ@L_R\<KQMSP37K%%38J_0Y72-!U?PQ\/[+1]&;3Y-5MXE4R79?R6<G,
MC':-QY+$=,\9Q74)NV+OQOQ\VWIGVIU%4W=MLE*RLC/UP:NVCW T(V0U(@"$
MWI81#GDG:,],_C7D6G_"3Q+)I\.EZI#X0BB$@DEU6UMY7U G?O)$C #)Y&>P
M[5[;126CN-ZJQP&J>%?%L'BG4M1\-:KID%MJT4<=TU]$[RVY1=H:+'!X).&X
MS65KO@/Q<-,TG0/#TVA'0]->&<#4&F$UQ*A+'S-@(*ECG P?>O5**%I_7W?<
M']?I^1Y2WA/XD,=<U 7OAM=6U=4MY"KW'E00*A4>7\N0^6)YR*31OA_XLFGT
M.S\13Z)'H^CVTL,,>EO-YCL\?E[GWC!."3D8Y)XYKU>BCR_KK_F_O"[_ *^7
M^2/-+'P7XU_L=/"U_KVF)X=BC$ FM('%Y-"./+;)V)D<9&35F;PGXL\/:W>W
M?@N[T465\(_-M-4CDQ"40(-ACY(P!P>E>A44[O?^F%CS/6_"WQ U.\T82:CX
M>O[6QN/M4ANXI(S)(=PQL0$%5#?+DY)&2:V/"GAW4_!U_K$37-B/"S2/=6D(
MW^=;EL%U[*J [B ,]>U=I12NTM WW,+PKJ.K:OILFHZG;PVT5Q*7LX%1A(L'
M\!DR3\Q'. !C-;M%%# X7Q+H_CC4-3N_L$OAFZTB4+''9:M;/($7;\S94<L2
M2-IR, >]<WJGPT\4Q^'-.\/Z1<:!/IT5S]NNTODEC6:7>6\L1H"!",CY<YXK
MUZB@;=SRC3OAQXEN-"U'1M6O-*T[3WM!#8VVCO,T44@E\PR,LO))( ZGC(XK
M=M+/XGL<7NJ>&XT@!,7V:"4M<D X60MPBDXR4!/7%=U13N(\?MOA;X@O;/5;
MC69-"BUZ2Z^WV&IV D\Y)\YVN[ 'RQ@ * <#GDU'K_@7XB>*-1M[O6HO!5XE
MO;O EO(UT(QN()?@!@_ &01BO9**7]?H!PNG:5X]T[PO>*MYHDVNW%WOC662
M<VEO#M"A(QC<,8X'3))YK+TSPO\ $'2_AW<:!;W7AZ+4&8K%<QO/PC[C([,5
MR9"QXP,5Z=10];WZ@M+>1XC#\(=>T6]T+5/#EKX:M-4LAYEU-)<W;+-)\PVA
M26^3:1GH<YZ#BK\/PN\0:LFMS^(VT%-5NYA=V6I:>LIG@G&-HW,!B,!0-HR?
MQKU^BG=_U^GW!_7]?>>=^+= \>^(O!MOHB3>'?-N(=NI22&906# CRL \$#G
M(^F*['P_'JT.B6\6MBP%^@VN-/#B$ 'Y0N_GIBM.BB^_F*VWD9VOZ1'K_A_4
M-(ED:*.\@>$NO5=PQFN*M_"'C/5K*'1?$^LZ6=$@**RZ?"XFO47HLI;A <#(
M4<\C->C44EH[C/*&\ >)]2\>2:SK5GX4NK!YH=@(G,UO%$Q*"/@ ,<\Y)!/;
M'%>KT44=$@ZW,3Q/;>(+O3HHO#E[9V=UYRM))=1^8IC )*[<=S@'IP3@YQ7-
M>&?!6L0>*3XFUT:%;WZ0/ D.BV[1I)NQ\\KM\S'C &.*] HH6@/70\[T70?'
MT?CU]?UA_#36\T MG6V,Y>.)2S 1[@!DL1DG/2N?U/X6^(O$NI:SJGB6W\.W
M][-&%TX?:KM$M\$ *=NWY<9/0DL>H%>R446'?6YYC!X9^(EE\-X/#5M=^'?M
M2QO:M.SS_+ 5PNTA?O\ )YQC&.*EU#PQXYN?AG%X9MI/#EO=-&;69HVG6-;<
M+@!#@G>>Y(QS7I-%#=[WZB6EK=#R_P '>"?%NAZW:-<#P[IVDQR//<6^C/<*
M;F0Q[%WA^"!P<# SSC->H444VVQ)6."O/#/B_3/%&I:CX6U+25L]6=)+J/48
MG9H'50NZ/9][@=&('%9'B#X=^))=$M=+TFZT>^$MX-0U6?5A(&O)P00"J CR
M^,;?0 9KU2BETL,PO!^B-X?\-V]A+::?:SAGDFCT\.( [,2=N\EL<]_PP.*W
M:**;=Q)6/.AH/C^?XA6VO74GAHV-NKVT<:F<R) S@LP& /,( &<X]JAUWP5X
MDUGQG?ZO<V?A6_LQ9FVT^#4(Y)3&<Y#,-N 22<D9X  [UZ714VT2[7_$=]6_
MZT/%W^'7CP>#M(\-HWA1K*RN/M$T<AGVSL'+!7 7E><D<9X].>K\ ^%_$N@7
M;C5GTBWTV*V\FTL-)DF,2L7+L["3DL<XSD_A7>T55WJ)JXAS@XQGMFO+-4\$
M>./$ML=-U^[\*W%G+DO>_86>Z@SGY8L@+P#@-P>_6O5**74=]#@_'?ASQ9K.
MBPZ%X>ET=-,,2)<'4'E\U]K A04!&T@8.>3D]*H>+O"OC;Q5I>DZ9._AT62;
M9-2@$EPB3."?E7;\VP#!^\"2/2O2Z*/7O<-MNUCRSPK\/=?\'>,-3O-%AT&U
MT6ZB,:6WGW,DA*[C&S%LX.2-V"1CH,\UH>&-!\>V'BC5=7UF3PW)_:$:A_LQ
MG+*R+B-%W  )DDGJ>37H=%%W^%@/%A\/OB%_;MWKDD?@R75IYC,EX[77F6Y*
M; (R !@#H&!YYKUO1;2XL-#L+.\N&N;F"W2.:9G+&1PH!8D\G)SR:O44[Z6!
MZNYS'C3PY?Z]:V$^D7L5IJFFW0NK5ITW1,P4J5<#G!!/(Z5E1>&_%UW.-<UF
M_P!(GUJSA==-LX8Y%LH)6&#(Y.78D<=L<XZUWE%(#S3X>> =8\.:L]]KMKX=
M>X$<NR]L!+]HD:1]S>86 4CL.,@<>N?2Z**;8=6PHHHI %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7G'C/2[O7_B%HND6?B'7-
M-0VDL]XNGWAA58E.%. /O%CC)SPIXKT>N&U3X86FJ>([G7&\2^)K6YN $9+2
M_$2",?\ +,87(7/.,]2:75#Z,X77KW5[#P1XET]/$>MW$FEZK%:Z;=P7!%S<
M.ZKF)V R^"QX&"<5L_#?3'U);76V\5^)-LL$X_LW4]2\UV4-L$P7C:!@\$,
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M:ZDD2:XN'F81DX12S <[0,X&,DXK-\0?#:U\1:ZNK3^)/$EM+&P:"*TO1''
M=NTE!L)4D9R<\Y-=G&GEQHFYFV@#+')/U/K23T?=@UJO(=1112&%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$YJ'4;S2;'6]=\96$.G7M@=0FL;K3(O+=7MRBA)3'TP95W9(Y.#2>B_K^M]
M6O\ 7]=#WP^-?"@@6<^)M&$3,4$GV^+:6&"1G=UY'YU9_P"$FT'^S/[3_MO3
M?[/W;/M7VN/RMWIOSC/MFO&H=-\)V,'@/P]K']B6[10MJ6I/=&)3DH"(V+?W
MF8<'J$[XK(\4'0+T:Y8:%_9UIIFLW=M;V).R.'S(@QEGC#$*!TCW# )/6G)6
M;2\_P:7^=O0(M-7?]7O_ ,!_,]]O_$6AZ5'!)J.LZ=9I<+NA:XNDC$@XY4L1
MD<CIZU2_X3OP?_T->A_^#&'_ .*KQ>VL-/A\2^'[?QWJ.D->V=LTMY;SSQM'
M;Q1QA(;?!)4LQ8NP[_3%9_@__A')+NZN=?M/#DVDZE(6M;&U\AKP233!43 (
M>,(HSA=HPW<]&E=V7]:V_K^F*]E=_P!:'T%'XH\/323QQ:[ICO;QF695NXR8
MD'5F&>!R.3ZU7_X3CPD$#_\ "4Z)L)P&_M"+!/I][W%>%ZO=:/:>+->\7Z<F
MG75I97_V2ZTR$QD7%JT81Y"G\0,I')&">];$>@>$O#'PRL=>U>WTUM9GTN1K
M:SNEBVRRRL&#!&&25RHS_"H[5/V>;^M=OOT_I%6][E_KS^X]HTWQ%HFM2O%I
M6L:??21C<ZVMTDI4>I"DX%:5<3\._"&@:!IL6H:-<0W+W-I#!-/;NC1.T>=S
M*5')+$Y))Z#TKIM>N[FP\/:E=V<1ENH+:22&,#.YPI(&/K1.T+^0H7E;S'7.
MM:59WT5C=:G907<W^JMY9U61_HI.3^%5[_Q3X>TJZ-KJ.O:79W  )BN+R.-P
M#T.&(->/.O@*_P#AP(X38ZSXLU6W^5AB6^:[<=3_ !(%8^P %4/%L0U#QK:V
M&F2^%;K4[338+.[EU)H6>:X=@C%0_#R(%'#9(!(P20*?*^;E\[!=6O\ U_7^
M1[QIFMZ3K22/I6IV5^D9 =K6X24*3T!VDXJZS!%+'. ,G S6-X=\+:9X76]7
M3(5A6\G\^1$1516VA<*J@ +QT]S6U2?D)>9AZ;XOT+5YK&*QOC*]]%)-; PR
M+YBHVU^648(/8X/M5R]U[1]-N8[:_P!6L;6XE_U<4]PB,_T!.36=#X5TC2Y+
M:]1I(A83W-TA+#:OG;C(IX^[SG'L*\;U2;P_YUSJ%O<>%/%EGJ]X6:VN%9-5
M D8 )&P.Y=N>,A< "C=I+^NW]>0WHF_ZZGMMWXL\.6#1+>>(-*MVEC$L8FO(
MT+H>C#)Y!]:FU#Q#HFD"$ZEK&GV0F&Z(W-RD?F#U7<1GJ.E>$_$:XT_Q3KD]
MMH>CZ7?6&B6317%RM];6[J^W:AWN=S1QY' X+<9XK;UVYTGQ!\(/#?B>2.TO
M9M'EM#=DHLK*H*K+&PP>#D$J?8TU9J_FON;M<.MO+\4KV/5;SQ;X;TZX-O>^
M(=)MI@ WESWL:-@C(."<X(J&/QOX3FE2*+Q1HKR.0JJNH1$L3T &ZO-Y(O#E
MU9:W\1_$&FZ;]GN(6BTBVN[>,>:B+\KE6'S2.1QGD*!6#\,K/08+BQL->A\/
MWUY+<0_V:-,,,DR.%:5I)70[P <*0W&5P%QS1%7=G_7EZV%)V5U_7_ N?0E9
M>H^)=!T>=8-4UO3;&9EW".ZNDB8CUPQ!Q6I7AWQ:N;._\;Z?;:;_ ,(Q+J=E
M9S//_:KQ ,S85(SN."XW%E5CCO4ZW2126C9Z]I_B+0]6\W^S=9TZ]\E=TOV:
MZ238/5MI.!]:FT[6-+U=)'TS4K.]6-MKM;3K(%/H=I.#7D>L^&O#WASQ+HEG
MJ[P6&D:M&)=2VJD%K-/"BA(SL"JJ$EG(/!-4M?N-.L[_ %?7?A];P6]E8:6U
MM>WFFQ;86D>1,%=HVLR)N8D=..:K^ON_02U_#\?U_P CV@:UI1U/^S!J=E_:
M&,_9?/7S<>NS.?TJI=^+O#5A=O:7GB'2;>YC.'AFO8T=3Z%2V17ENL:=X$O-
M(TO2?!PT^[U^2XAEBO+0B2XB"N&DEED'S#@'.X]3TI4U#X>7_B?Q=KFMOH%Q
M&K):VT+")Y)MB9>1%Y9F9FP&'/R]:3T_'\+;??8%K^']?J>PW>HV-A9F\O+V
MWM[4 $SS2JB ?[Q.*;8:II^J1F33[^UNT&"6MYED R,CD$]:\-%I9)HGA^QO
M]>T"#5](L6:32/$B%K<"4[HP<D?.JX'&2!V]?1?A@VG-X1EU*TTBSTE;FYED
MF%JQ\B4J=OF1[L;4(7@8 %.V_D*^W]?U_P $[BBH+.]M=1M8[JRN8;FVD&4F
M@D#HP]B.#4](9E:AXG\/Z1<_9M2UW3+*XVAO*N;N.-L'H<,0<4D7BGP]-/;0
M1:]I<DUT ;>-;R,M*"2,J,Y;D$<>E>>>-KKP3JWC[P_9WL_A]FBFDFU">9X2
MP$:[4AD8^K-]T_W>E8'Q'T_2;_QK;V&A/IMCJ.BZ6;JV6W,<;23JZM'" ,$D
M*K$+VW9[T)Z)OS^Y#:U:7]-GLMGXCT/4;R2SL=:TZYNHP3)#!=([H <$E0<C
M!I+;Q+H-Y=FTM=;TV>Y#^688KM&<-S\N <YX/'L:\#TR;2-1MAKES90Z+HNO
M:R+:YDC18E2WCBR8BR_=5Y!\W3..:]/TG2/AQ?\ BW3[CPZ=,.HZ;&\JC2@A
MC*D;,R,@()&> 3GKUJDMK_UI?_(F_8]!K.U'7=-TJZL[6]N1%/>,RP)L9BVT
M98G . !U)P!ZU9AO[.YNKBU@NX);BW($\4<@9XB1D;@#D9'K67J?A73]7NKJ
MXNGN#)<P+:L5<#;#NW,B\<!^C'J1W&!4C+VD:O9:[ID6HZ=*TMI-DQR-$R;A
MG&0& ./0]#VJ]5::>QTC3S+/-;V=E H!>1Q''&HX')X Z5.CI+&LD;*Z, 59
M3D$>H--VZ!ZCJ***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGN;=%C^]MY;>>^,XS@$9I)/C%I,4^H0R>'_$B26+I'(K6*@L[L%15!?.YLY
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M(YXF6TL9/*E9K%1SDAL?/CY<?-G&,BH1\8[,W26H\'>,3</%YRPC3!O:/IN
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M/XUD0_%K2+G2=+O[?1]<F.J7$D%K;1VZ-,^S[S;=^-HZ9SV-.SO;^M17TO\
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M+^.Y;2?(-R2 &5(\XW$C(4<8].E2?"N"%/%&NW,OA37--GN9Y9K6:_LS%%#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!<1X(,;]P#P<@9XK,\.>&=;77U\0>)KG36OXK0V=O;:9$R00H6R3E_F8G ]
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M33Z'9^(I]$CT?1[:6&&/2WF\QV>/R]S[Q@G!)R,<D\<T=_Z[_P# 0:?U\O\
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MUUVE?VR3=G5_L 'GM]E%IO.(?X=Y;^/UP,4]+*W]:BUOK_6AHT444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444F1G&1GTH 6BBB@ I,C.*"0!DG K)O/$>D
M6,A2>_B60?P!LM^5 &O17*R>/=&C<J1=-QU6 G-/C\=:+(I9GN(@.\D144 =
M-D9Q2UAVWBS0;R39!JELS=,;\5LQNKJ&1E8'NIR* 'T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *@N[>*[MI+>90\<JE&4]"#4]-9=V.: /'+ZSN= U..UW$:CII:72ISQ]
MJM#R\!/<J>@],5ZEHNJP:WI=KJ-L08IDW#U4]P?<'C\*BU_P_9Z_I_V>Y0[T
M.^&5>'B?LRGL?YUY]X$;6/!WBF]\/:]_Q[W\S3:?<=$D; W@#H"?E/US0!ZS
M7-:O?75_J#:+IDAC8(&NKD?\L5/10?[QK1UC4I+*SQ" UU,WE0)ZN?\  <TW
M1=*&EZ;Y!;?/(QEGE/620]3^6!] * )]+T:PT>V$-G;I'GEWQ\SGN6;J3]:X
MCQU<P^&?&&@^)&Q'"^^TO''\2=4SZX.['UKT4#  ':O,/C7=PQZ%I=G+&)//
MOXWQCHJGG^= &_X6LKG4[R;Q/J))ENU"V<3=(+<?=Q[G)8GKS["NL903]T>@
M^E$(0P1[%"IM&U1Q@8Z4YAW[T >,:)%L\;FR<[[*RUNY<*P^5&D2-U_'+-7L
MK#'.,^F:X+P'"EWX@\8RLBM&-7^7(SAEBC&:]!(X/K0!Q-YX@UG6/$EYH&A>
M3:BR"?:[R9<LI8!@$4]3@CDU:@\"V,CB;6;BZU>XSDF]E+1CZ1_<'Y5-K7A"
M"_U-=6L+F73=650OVF X\P>CCHP^N:IIJ?C#201J.FP:I"N?WUG\CGGNO^ H
M ZRUM+:S@6*UMXK>,#A(D" ?@*P_'1V>"M8*N4_T9LL#4=MX\T6286UW*VGW
M73R;Q?*)/MGK5WQ#:1:OX<O[1I56*Y@9=^>.1UH DTCRK3P[IRJRI%%:Q@$X
M  "BN&L[R;Q-\5X9IXA_9]A:F6R!_B+9'F'TSCCVQ3O!U]/XU\/6=E<%4M-/
M1;:\4'+3R( "/]TC'US6H[1:?\5K6-<1QWFF>6J[<#*$G'Y8H MZEF[^(.DP
M(H*VMO)<.V.<ME0/TK-\ 72FY\7W4S@R)K$ZN['&%4X SZ  5?\ ##?VMXDU
MW7%SY+2_8X#V(B^5B/;>&KSWQ6S:-J7C71@PBAOHAJ,0+;?,)'[Q1^1H ]"C
M\7WVN$CPUIXNH?\ G]FRL)^G][\*G70-9OB#JGB"XQW@LP(5_P"^@-WZU?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP4D4<LG([="K5Z3I&KV.NZ5;ZGIMPEQ:7"[HY%[^Q]".A':@"[1110 4444
M%%%% !1110 4444 %%%% !1110 9&<9HK*US3KC5-+EL[?4;FPD?&VXMCAU]
M<5R ^'.M8X^(/B$#_KJ* /1**\[_ .%<ZW_T4+Q%_P!_11_PKG6_^BA>(O\
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MUGH+W=^=/@^).NB0(K(%E 5U901M_ B@#KO#_AV]CUF37]?G2;59(_+18_\
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MZ9[5SWAKP^VD7%Y>7-Q]HU"_D\V>0?='^R/8=*Z0@,"",@]J7 SG% !1110
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M(U(P0H!'X4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU'N\B09+VD@(X* #:&Y(!'\() ':;J4D%@NG6^JVJWMYYDJ7DA\X2LORR.B
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M5;RF'56P?E(]#7F\.JZAI:^)P]I<+XDNKJ 7"V5J]Q%;QNFU)4" LZA58DD
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MW!H Z'Q$=3U8V6G7%H  [M-9K<>4+ME^:)DE_N KED!##(Z@$-C>%KW5)?\
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M)%%&L<:*%1$& H'0 =A3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ @AT9#D*,Y7MQBL_P 5>&KW4?#]Q#!?7M[<M:BV:*:2-4F'F*S.4VJGF8!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
JHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ex3-11_002.jpg
<TEXT>
begin 644 ex3-11_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIK'% "YHR*912'8?
MD49%,HH"P_(HR*910%A^11D4RJ]U?6EBJM=W,-NK' ,L@4$_C0%BWD49%0I*
MDBAD8," 00<@@]#3MPSCO0%B3(HR*929% 6),BC(JI!?6ES//!!<PRS0$":-
M) S1D]-P'(Z'KZ4R]U33]-$9O[ZVM1*VR/SY53>W7 R>30%B]D49%5K:[MKV
MVCN;6>.>"1=R2Q,&5AZ@C@BDM;RVO8?.M+B*>+<5WQ.&7()!&1W!!!]Q0%BU
MD49%1Y%+0%A^11D4RB@+#\BC(IE% 6'Y%&13** L/R*,BF44!8DHIBGFGTQ!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-;K3J
M:W6@$-HHHI%!1110 4444 %<+\0;/4;FYTR;0M:BT[6;6*XFB2?_ %5Q"-GF
MH_M]P]#WZ=1W55;X6!CC^W_9MA<!//VX+=@,]Z /*9=>_L_^VKF6XETZ[>#3
M1';>:V(D=%R@!8!!DD;NHYQD\&GJ?BR[&F6FN1ZA)]JE\-02,\4F0K-,BSNJ
MC(W*"<\'! ]*]E:"WD)=HHV+;>2H.=IROY$Y%'V2U*!/(A*!#&%V# 0]5^G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK=:=36ZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "FMUIU-;K0"&T444B@HHHH *\^^(UM;W&O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ IK=:=36ZT AM%%%(H*0TM(1D4 >)742V>O
M>++RPC6/48?$-@+5HU 8ERH=1[,I;([\YK5UO6K[6^;FV06=OXAM8;=_DW1O
M'=B-AC);E=K9('WB.F*](AT+2+:]>]ATNRBNG?>TZ6Z*[,>,E@,D\GGWI)=
MT:>622;2K&22259G9[="7D7A6)(Y8=CU%"Z SS[P;K.M+>Z9IDL@2QO+,W%H
M8XAC='-B9"3DY*\C_>IEMXY\2ZK9:7=V:06\>IZB+>$S*K!5;[0"I .[Y/*C
MY.,DMVZ>EVNF6%C%#':6=O!'"&6)8HE4(&.6"@#C)Y..M0-H&C-)O;2K$OY_
MVG<;9,^=T\SI][_:ZT+S$]M#A;/Q=X@NHO)NHH +B_73Q, A5'69XY1LSN(*
MHI!8#!<^PK9^%/'PRT3I_JFZ?[[5TAT;3&^T9T^T(N766?,*_O77&UFX^8C
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M_#NB:?!/!9:186T,^/.CAMD19,=-P P>O>C^OQ"Y2\$2S3>#[!IR2P#JI/\
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MGQIITEY\<K/4KKPWJ^HZ'%;?9KMH]-EEC8E'4[?E((&]3E?0XYYKJ+>_EMO
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M'6I*8F%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW)4(98ED*AMP&1G&>_UJS0 4444 %%%% !1110 4444 %%%% !1110 4444
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MO[;3;1KJ[D\N%,9;:3C)P.!S46GZ19:4)!96XB$A!;DGH, #)X [ <#M5W%
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MVQN?*,<V,Y :-VP>#P<=O45J^(]?L?"^AW&L:DSK:6^WS#&NYOF8*,#ORPH
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MXX^0CMBO:+BV@NT1)XDD5'610PSAE.5/U! -5=3T/2]:BCCU*QM[I8FWQF5
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MW=L9^\H'.1G=^(VEWGC.:[T>VTJ;4;>QMR%,5PD2PWCH65F#,-Q5-N!TQ/\
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MU4\]1B@#R'5K>;4OVG]-_L\_-8V:R7;KCY%V-G=CU$B+_P "':I_$_@:XO\
MP[:^+_#,;VOBC3II9PT*@O<*LC_*0,AG &!UR/EY!&/5['0M*TRVFMK+3[:"
M&=F:9(X@!*3U+?WB?>I++2K#3(6AL+*WM(F))2WB6,9/? '6@#E?A7K$^O\
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MVGB2UBFDM;U8HU\[:"P 4C;G'(^4@KGOU3X?^%?$WAOX8^(M"OM#G2_O#,8
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MG 7TSNZ"NGH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]SU_H:$<."5((R1QZCK0 ZBN2T[Q7>7?Q%U+PU/:01P6UFMS#-&Y<R L%YR
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M((.!G%8GQ!NKBVUCPH+CRO[ EU'R]0$@!&\K^YW9Z+N!S[[:[A0J*$4!5 P
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MP"0$ A2<YPN< 8(!Z)U6O/+6>:V^)WBEY9=0FL[&QM[A+?[9*4#,&+%5+B,
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MZ213HY,D; A=D@[9&2OKL:@"/6_&4&C7MY:_V=?W365@=1NI(8P$BA!;^)B
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MLOYP=$4.O[O(S@G:<=.<<4 =-J^OG3M1M-.MM/NKV]NHY)HTBVJH2,H&+.Q
M'WU ]R.F<UBO\1[$IH+6VF:E<MK?F"VCC6+S%>,'>C*7&&4C!/W5[L*L>)M(
MUK4-9TU[2.UN]*5)$NK*YG>%"Y*E9&VJWF ;2-AP,D?4<SH_@?Q':6G@ZUGB
MTH1:#=RR2$3.2Z$LH*KLQG!W<GTSSDT =%9?$/3+W2KN[-K=Q7-IJ TR6Q?R
MS,;DL%"+A]I!8X#%@.#R,5D>'-0>;XQZ_;SV\]M(=-@D2&XN [*-WS%0K%0#
ME,^X'8\U5^'VO!=1NXY["&^/B)=;LT$K&-L J8Y"(U(RK-R 3SR3R3KZ!I'B
M0^/+KQ#JEA96L-UI\5NT4=VTK1NK,>/DP0?J, CJ<T 6O$GQ%TOPXVH"6&>X
M&G>7]K\MXTVEP"%4.ZEVVLIPH(YQG/%%S\0]*M+J.*:"\$5S8&_LKC;&([Q!
MM^6++[B^&!VD XYK(G\(:UIOC/4K_3+#1M1L-7D2:7^T%(>T=5 ;! .\-R0.
M.<= ,FUXC\%ZEX@CC,K6,=QI<$;:/+$S1A+I2"9'4*=J_*H" L -W4E=H!IZ
MQK%E!KOAN+4=/OHKF[F=;5_.55BD\MLJX63#<<=&'/'-/TKQI9ZV(9M-M+FY
MLIWFBAND,>QWCW97&_(W!25R.1UQQFMJ>D>(M3U#PO?2Q:8)=-F,]XJW$FUF
M:-HR(P8SD?-D9Y[<=3G:%X2U>Q\8+J[)!IY)D.I?9)RT6IE@=CF+:H1U)R6X
M).>NXD %:R\91Z[X*TG5=6TV^"7FJ11P-:RQ_?\ M!$>"KY*C 4\9//'.:V]
M1\;O9:IJ6FVWA_4KRXT^))YC$\*H(V+?-N9P!PI(4_,?3&2,&W\$^)(/!5AH
M!_LR3[!J$5RDANY1YRK.96W_ +OC.0-HX&,Y[#:ET'7#XKUO58XK#RKW3TLX
M%:[D4@J7.Y@(^,A^Q)&.O- %D>.M/N#HD6GP7%[<ZS;FZMH8]HVQA029"3A<
M9QCD[N*N>'/$T?B;1FU.TT^^AB!942X6-6D*DJP&'(&&5EY(Y'H03YM>:5K>
MEZCX,T738--G\0Z1I<K2O'=F-UC/[H;2Z[64_,<%&P5ZC/S=K\.M0:;2;K2I
M-"_L:32YO):W%\MV"6&\DR+_ !DL2P//(/>@!Q^(>FIIFE7[V.HB#4M3_LN+
MY(R4FWLF6PYRN4;E=W3I56\^)MI:2ZX#HFK/%HKHEY,HAV)NR20?,^; QP.>
M1QUKGKOP;XN^S6FDVEO9?8[+Q+_:27+WC*9H<O-\ZA20 S!.I;<,X &XV[OP
M)XANCXZRNE+_ ,)$D2P8N)"8BBE?G)BY'.1@<<_6@#K[KQ+;2WL>FV%M<:G)
M/:"[W6<T:JL#$A7#LZYS@X*Y_ <URG@+Q3;Z;\,_#/G2&XN;Q9EB5YE4L$=]
MSLSMP!P#R?F91WJ[%H'B/0/$D.J:7;VM]#=6-O9WUO)<&+8T1VJZ-M.1ARQ!
M&0%;&20*R+7P1XBTSPGX=>*RTNZU315N%:QFDW17,4IW% VT!7RJ 9&W(ZXH
M W+?XHZ5?6]A-8V&H79O+R6Q$=NL<K)-&I8@[7(88 ;<I*[6!+#FMV?Q(+/P
MU'K-WIM_"7:./[$45IP\DBQJN V,EF'?H?PKF-3\)>(=0'AZ46OA^*33]42_
MG@B+I$ HV[5^0[F_B#';@X&#C-=-XNL=6O\ 07AT654NA)&[1M(8Q/&&!>+>
M 2FY<C</TZ@ Q]2^(]GI.E:]=7>G72W.B/$EW:I)&2/- ,; [L;3N ]<Y !Q
M5G3_ ![87FO/I-Q;75A,; :C UR4 F@)P6&UB01@_*<' )Q7):G\/?$5UIWB
MS3K*VT6SAUH6SQ*DSB.)D/S\"/))"Y+$<EL^U:E]X$U75_$WVV\DM(K.7P])
MH\QBE+R[GSEP#&H(Y/4_@* (]7UR34O%?@6[%G?6EK=74I3[0X595,3[=R!\
M@_=89'L>F#Z57F%EH?C&>?PQ;W>E6$2>'),?:3>Y6\40^6&4",LF<YP1V/M7
MIPR1S0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR;Q\Q&,J/E['Y@ >@UD7/B.R@U1M-1+FYNXPK3);0-)Y*G."Y P.!D+G<1R
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ML"H SQSC*T?7_$/_  CO@_7;G6+R>74=4%C=6DD4(C>-I)5W?*F0PVJ<[@,
M@#G% 'H=WIFAV5M)<2Z1:&*,;F\NS#MC_=523^ K,TZS\'>+M-BO+;1K*[LF
M&Z-I]-*(W4;@)$&>AY]_>N@U +_9=V'0R)Y+[D& 6&#QSQ7+_"YUC^%V@,Q
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M/@\@#&,>M<L=8U;7]4\8QV>MM9'162&TM8(49@XC+F23<"6#ME0H(&$/&>:
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M-/\ GFA<G:#@#/TR<56\/VE]?:[<^(]4TE--GDM(K."%IA)*J*SNQ8K\HR7
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M [MO7Y00HR<#FDD\&:+);Z3!Y%Q&NDJ4LFBO)DDB4KM*APP8K@ 8)["N@HH
MY:+X>>&X;5+>.RE2..X-S'LNYD*.=^=I# @?O'&T<'/(-:$'A;2(+K5;@6I>
M354"7WG3/(LZA=H!5B1]TXX'2MFB@#!L?!^CZ?)!)##,S6T+06QEN9'^S1D8
M*Q9/[OC RN#@ 9P!BO#X"\/P:?8V$=I,+:PN#<VL?VV?]U*2QW#Y\YRS'\37
M344 07-JEW;26\I?RY%*ML=D.#[J01^!KG8OA]X?AT]-/C345L4!46PU:Z\O
M;_=V^9C'MC%=310!S&H^ /#VJRW[W5I*POW62X1;F5$:11@2! P4/P/F SQ]
M:UI]#TZZETZ6>U66337WVC.Q)C;:4SUY.">N><'J :T:* *.G:19Z5)>-9PB
M+[9<-=3X)^:5@ 6_':*;J^BV6N6JV]]$72.59HF5RC1R*<JZL,$,#T(K0HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S=>UNV\
M.Z1/JEXDK6MN-TIB )1?7!(S^&3S6';?$/2[O3+;4X;#56T^Y*B.Z%KF,9;;
MEB#\HSW/2HOBN$/PO\0;[E;=?LWWVZ$[AA>A^\<+^/4=:Y'X6:1KDUCX6OIV
MAFT!=*GC6)4V&.5I5/SJS-OS@D,NWIT ^\ =MIGC_2]8U^^T.RM+]]1L0QN(
M7C5-F#CJS 'DC&"0<@].:JP_%#1+BTU*ZAL]5DATQV2\=;7/DE<EL\]L')Z<
M5Q_@*XBF^/7C<1M&/DQM1\Y*LJL<$]<]>."<<=*XJTN_$EIX5^(4OAZ&RDLV
MU&=+T*C&2.$[@6BYQ@ G.<X'/N #WF;QIHH\/V.M6UPUY:W\J068MUR\\C$@
M(H.,'ALYQC:<XQ31XOM(VOH[RRO[*XLK-KZ>":-6;RAGE2C,K'@C )Z5P4WA
MOPWXA^%?A?0],U2:V@FEWZ;?N@W+<@.S*P!&&)\S@9Y4]P*L?#_4/%.E>+)O
M!7C.2'49TL#=VE\N96,1<(R,^,E21U8 Y&"3E: .C;XG:.FNP:(]AJZZG.GF
M1VK69#LN"<X)]%/Y5TNC:O!K>EQ7]O%<11R,Z^7<1&.12CE&#*>0<J:\FU(Q
M_P##4VD8BBS]@;+%CD'R9><;NN.,8Z<X_BKU:ZTE)]8T[4$O+N#[$)A]GAD"
MPS^8 #YBX^;!&1R,'- &G7*^(/'^E>&A>2:C:ZB+>TD2*:YCMBT09E5@ V>>
M''X\5U5>;?'09^%>H%=W$T.=HS_RT Y]!G]<#OB@#<OOB!8Z>CFYTO5HBCP(
MPD@5-OG.40_,PXRK9/;'N,]8#Q7$_%&WEN?",<<+S(YU*R :$98$SH!C@\Y(
MQP><<'H>.U;5-7\)77Q"M+"\NS%#:6<]@;RXFF^SK)\DLBL^6."6;()&5QR0
M0 #V?<*;-(8HF=8GE8#A$QEOID@?K7%>%;.\M]<ANQK$$VG7^FK)#;"YEF:9
ME9<W +]BLBAL#J5]:[<X[T <C9?$;2;_ $F358+'5CI\3LDT_P!C)$6W[Q90
M2V%[\=JZBTO+>^LX+RUE66WGC66*1>C*PR"/J"*\;\-V>LZU\*_$"Z+J=A9V
MMQ=WIV^0S%D+DE5E+D*&7C<58@'.<X(T/#.M'6KGP;HR6$]CH,^BO-$@F8&2
M6(B,H64C<% #9/7<#UH ]:W"C(KQ;1]4U/4++_A'[S5]4N);#Q1-96S0R 3W
M\,"LS12N64!<$,S$DD# !-2W$FK7?@/4%_M#4+>YM?$S64;VMQ*YCB:Y5/+!
M/,BC=M&Y>V,>H![%)(4C9E1G8 D(N,M[#.!^9K,\.Z_:^)-+.H6<<R1>=)#M
MF #;D<J>A/&1Q7%VNE0V/CBW\(SZCJD^F_8)M1'VN]9FN99)=I0G@LJ %@,_
MQDG-:?PIA,'@UU+RNO\ :%YM:1MQ($[C.[)ST/.3SGF@#MR<4F017*>/M3N=
M.T[28X9?(AO-6MK6ZG$A0Q0LQ+$,"-I.T)GMN/>J6FV\UGX_U30(3=MHLNDP
M70_TB3%M(9'CVHV[*[@A/'=3^(!L:5XJBU>[MEMM-U$V5TKM;Z@$1K>0*<=5
M8LN>HW*N?KQ6IJVIQZ/IL]_-!-+# C2R^2 65%!);!(S@#H,GVKD_A-9Q0?#
MS1KA&G+SVJ;@\[NHP6QM5B53KSM SQGH*Z#Q:ZQ^#]<=PNU=/G)W=,>6V<T
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MC(XKB-'?4+_Q)IGA?6]5-_'::9-=33VQ9$NYEN3$0S YS'M&5S]YL]A6I\+
MEMX.V-<.ZR:E>+$\K',F)I.A/)/RD\DGK0!W-9S:FRZ^FE_8+TJUN9_M@C'V
M<8;;L+9SOY!QCISV-:->>W+W#?'6.R^TW+6DOAYY&@$[A$8S;2Z@-\I("C(
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M.R-2=H9V PBD\ L0#@^AH CT+PGH7AD3?V/IT=J9B/,*LS$@9(&6)(49.%'
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M+:!;I628 $AD;[RC/13Z# H3P7X=BM;>WATN*!;:0RPO S1R1L5"DAU(8?*
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M%Y:MR%SD9SSR<Y!["NP@\1:7<WUK9PW:23W<'VFW" D218!W@XP5Y'.>X]:
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M.FE$\BB2X$;RCI(8\["_^UC/O4%]X$N=3O;Z\O-'\.37%\BI<NQG^<+P#@'
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M-PGF$^FW.>X_.M 8/2@#R?7)[GQYX3U=M/\ #&HVNJFPB2>2ZA,+.R2K(;9
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M\;00:;>,^LZT]W864-K(7\GSXR"8PN4)52<$ @ ?2O=** (X9EGB615<*PR
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M#=N,G\1 RV!GDCU'PW8PZ;X>L;2WLFL88XALM6<NT(/(4DDY(S@\GG/-:M%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MREEW E2V2I\O;P#C=D5>O_!5]/K/AW4[36GBN-,66.XDEBWM.LF"Y'( 8D$
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MLR\R-N'S9&,# ZD@%Y?$^O7?B&TTO3K?2FCN=(6_6>:61""2%SY94/MR1\I
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MG'RX' Z\G/0!^'6J/IFJ0/K]NMU<ZD=6MKFWL#$UM=<#/,C;EP,8/.">2.*
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M#D_+][!&T\9]00 0_P#"7:C8CPS>ZE;6WV'7I([<1P9:2UFE3?&"V2)%X(+
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MZE>KC[-+(F_R7901E7D!).=F5RW#8H ]HJIJ.HVVE6+W=W)LA4JN<9)9F"J
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MP;5/)GF4;II&,K;XG3"[E"E<1XPH QC&: /=Z*\+UFUA9?BC,MQ<L]A)#-;
MW3JT,GE@[\$^H^4DGH0H7G/K, TJ?6;"]:Z5M4:R81)Y^UI(6*EF\L'!&0O.
M#C/6@#;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVT*R0IY<;",91./E4]AP.!Z59HH **** "BBB@ HHHH **** "BBB@ HHHH
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MIVB6GVO4KR*V@R%W2-U)(  '4\D=* +]%48M8L)M7FTE+N,W\,0FD@S\RH>
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M(V@#Y<  <<52OK9]8T%],U?0_'MZTDL;R7+VMGO81G,:X+%<#G/&6).2<XH
M]&%YJ&A>'-1U'79[>Z:T2:Y9K2$QCRE!8+@L<D $9[\5SD/B;6;!/#.JWMQ;
M75AXAG@A-M%#M-HTL6Y/+;/S+E3NW<G.1@?+5F3QC//8M:7'@GQ9+&\9CD+6
MT +@C!SB48S[8KG].F:RATFWF\,^-[RUT@[K*&>UM<1L RH25<%MJ,5&3CN<
MG& #9\-P:A-X_P#&"SW-I+;+=V_G1-:MEQ]F0H%)DPN,C.0V<'IGB36!_P 7
MB\,')P=/O..P^Y_G\*HZ=K4FFZUJNJ1>$_&DDFI.LDT4EM:[%*J$7;AP1A5
MY)JMJ&H7&H:_:ZR= \=P7-K')' L5K9;$#[=W#,<YVCKGI0 GBHR:7\:O"=Q
MI,@2ZU6&:"_B .V6)%RK. 1DC+$'K\@'3BI%\8^(I?#.E7<;V"WEUKS:9(6M
MG*[?.=00-V1@+@Y['J#S3]-U-=/UNZUE_!_C.\U*XC$)N;F"W9DB!W"- ) %
M7/. .3UK(CLXH],L=/\ ^$=\?-#8ZB-2M]UM9$I+N9NYZ;G8X_6@#>;6O&!N
M;O1(D@N=5T^R66:YM+=/+>202"(;9)EQ]P$^K=@O6S;:_P"(=<O+K18$M-%U
M6TT^&XN!.!.1-)O^50K8V#8,MS][&,X-86NW%UJVN0ZS9:%X[TF^6%;:62T@
MMB)80^\*0\A ().&QW(.14%_"MSK%EJUCX>\?:9?VUN;4SVT=NS31%BY#^9(
MP)W$MGU.3G P ;3WFMW'Q&\,137MI&3I<TEU:Q1;U256C64;MX/7*@]BO0Y.
M(&\;:O\ \(E:>.T>$Z0\PCDTPQ8?R7F\I7#Y.91\IQPN"PY(#57:>*.^T6ZL
MO!_C*R_LE9$CCAMK;;*LA5GW[I"<LR@EAACELGFHK9EM[1M//A;QM)I/VS[8
MMA):VIC#>9YNTG?N*^9AL9SV)()% &C:>(O%VI>+?$EA9R:8;?1)HAY1MY U
MPKQNP4'<<-G SST' Y#6O!_B?5-=-S:W-Y:IJL=L7GL)[-H9;2XR!C&[]Y#G
MHPY]6R<##ME@M[KQ'.?"?C:4^((S'>*]K:8 VE<KAAC 8]<CGG-36]Y-#=37
MTGAOQK/J36!T^.]DM;42QQ9SG*R#+;N<GN.@YR >C65O<R:)!;:L\,]TT 2Z
M:)2$=BN&P#V)S7):I"L7Q<\+I%"JQQZ;> ;,X _=@#'0 <?GCL*AT+Q?J]CH
M5I::CX2\5W5W$FQYC! Q;!XRWFC<<8!; R1G SBJ5[J37OBBS\0'PMXVBN[2
M%X8DCMK39M;&[.7)/3UH O:MKVI6^N7WA;PKIY6>UM/MC2(D;_O)7<[0LDB
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M8QC![D9'>F>"O$D2>$_!GAW0[Q'N;Z*>*:YECW&U:%=\B%-V=^74 'C!W<C
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M/.(!VOEP2.&Q@CKSG%5]*\7>*YM+T&\E%C<3:^4-K;PP%?)54>67.^1=Q*J
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M1V;E(60,R2KAMN[*D@X(]2< <8[;2VQ\:->4%T#:3;$JK$(^'?YF!'+#H""
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA0IPHD7<A!Z-D8.1GJ*X7PKJ(\'>-O$VA:X%L[?5-2DU+3KR4D17!D +QAR
M-RX7CKUZ\9 +GBOQ?XH\.^&]<O?[(LOM6FQVSQMO>6*97D9788"G@ 94XV\G
M+#!/8C6;"VBMEO=0M89YT0JLDBQERW3"DYY.>,G\:X/XKZW97_PO\2"VE\R&
M-+=1<+&'CD9I4.U">&P,992=N?5<5S/C76-*N=-\:6L<\,<\FGV;.+E3)+?
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MGVYP;<A=[9'DY("@YZ=/QJWIWB74+SQQJ'AZ3288X;*".=[Q+IGSOSM7;Y8
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M,2N\)G"@L0YV9&2" F3\IP"/P\]\?6&FVWP_LK^_L[>2[O-7@OY(Y(OF9I)
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M]X,"V0!P/4L0,<@U1OOB+I6GQ&]FAG;25O/L+ZC%M>))>Y;#9" _+NQUX]Z
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M0>0* .I\J/S/,V+YF-N['./3-<WXM\+3^(;2&"RN[6Q9+N*[DDDL_.,C1$%
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MUM=)=0VJQ2^6/.:494QMOVLO#<Y'*D=0:UM)U,ZG#.SV=Q:2P3-#)%/MW @
MY&TD%2""#W!H O?+35AA65Y5C02. &<#!;'3)[XR:X7XB6C?VCX8FBU#4K4W
M6KPV4ZVU_+"DD161B"JNHR2!\P^;MSP*KV^FK'\83IG]I:PUG%HT5[';OJER
MR>:)BFXY?##"C*MD').#S0!Z&8HV=7**67.UB.1GKBG8%4-;U>W\/Z'=ZK<I
M+)!:QF1DB7<[>P!(R3]:R'\:10KK:S:7?+/HUNES<PIY;,8V5FRIWX/W&XSG
MIZT =)+#%.H66-)%!SAAD4XA>]<CI'Q L]5UK3M,;3;^SDU&S^UVDEPJ!95
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M:#7_  /91:CK207<DL-R(M5N2)5$;2#<5D+$[B?F]!@G:!CTF*-8HUC4L0H
M!9BQ_$GD_6@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBUSK=OIL:VVO6UTD-Q!>!2"&/!>+GDG)Y.%).:]7HH Y*WTG4X_B1_:KQE[
M:.MDT[.H,DJR%]VP=L$\]CT !S7.Z1X3UN3PWH?A;4K"*&STZ[%Q<7JS(/.6
M-R\8C11E2Q(#9V[0#@L37H@U!#JAL/(N0XA$WG&%O*(+%=N_INXSMZX(-6Z
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M'6J$6A>.DT?P]H;Z-93QZ%J<,D=XU^(UN((E(4[0&(ZX.02,#"GJ/7$8.@8
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MD]N(H L)>Y\OS5)098+V.%R?08KT:3PYILFN2:T8IAJ$EN+5IEN9%_=9W;0
MV!SSP,YS5:+P9H,7A>7PT+#?H\N[=;2S/(.6W'#,Q8?-\W!X/- %#PH?%4.N
M:E!KK)_9LBK)IZ2S1O.F !("44;ER<@XXR!47BK4KV/6FL;35+J/&F2S?8]/
MBC>XW;OEF)D&T*-K*!N&YCCM6UX=\,:?X9MY(K'[0[2X\R:YG:61\?=!9B>
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MII<=[!Y4,,CHY9^S)\R?+R"<GCYA6=I'B3Q#)_P@NJ7&LR3#73Y5U8_9X_)
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M<?:M,UE=/DF6!(Q<[+R(++M*D X(/R\9SG->M10O':K$T\DL@7!F<*&8^IP
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M/V</]HDVB/.=NS=MQGGI7(^&O!LT\NLMK5K?VL-QK%Q=BV^U*8;N)SE-Z([
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M&H0F2U>(*AB=2JE"58AMQ;Y>A^4CDXSTJ>(=';4/L']J60NR658#.H=BH)<
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MFVUO# OF(A(Q(Y5^1DXX ! !!ZUG^&/$UYJW@WPUJ.HZO96-]>SXD614;[4
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M317"L54!'*K\^]U7:<<L,$C)%V+Q-J(\20:'=Z3!#=7-J]W"R7N]=JE00_R
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MW [3NQG"X],5/^$[BCM-(U6>R,6BZK,D-O=&7+HSY\MI$VX16P.=QQN&0.<
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M5Y'/3KQGT%:7B73;W5-+^RVBV<BO(//AO%W1S1?Q(?E.,\<XXZUL9'K1D>M
M'G:_#JZL_#-G8Z=-:I-9:RNJVMK<.\L$ #9\E7P&"\LV<9R3QSFGWG@/6M5M
M_&$-WK$%K_;Z6^QK.-@8F2-4<')Y5MNTC/()Z9Q7;:IJ=IH^EW6I7TPBM;:)
MI97(SA0,GCN?;N:J:=K4U_<W-O-HVI6,L*(X%RD960-GA71V4D8P1G(R.QS0
M!BW7AO7=4EMKV[O;."ZL[.6"W@C#S1M)(%#22%L;@0I 7;QN)RU84OPH2XL]
M5BMC;:*+M+>2*WLG::&.YB8MYVU@H&<A=H&,#/4\=);>.K2]:^6UTK6)S83O
M;7/EVN[9(F-RC!^8\CIG(.15N'Q;I^H>'9-:T9;C5H$8)Y-F@,I;(!7:Y7!&
M<D'! H Q[[PSXG\1^%[VPUW5+&&[DC @6PB/DB1'5TE<N"Q.Y!\HP "WWN"*
M5N^N)\4M#36IK)IFTFY&RQW[,[X2Q(9B0"0,<#[HY8\#T)6RJD@J2,D'J*KM
MIUBUW]J:SMS<Y!\XQC?TP.>M 'F\'P\\21VWAVP.HZ8UEHNIM>(S+(S3*6=@
M[J>"X+>O<G=FMK1?#/B?0K^XL+75-./AN2YDGB1H'^TP+(Y=HU8'!&6;#-D\
MY[8KMP0.!44%W;W33+!*LAAD,4FW^%@ 2/U% '"7W@K6+_3?%MM)+8^9X@D5
M@YD<B "-4 ^[EL;0>H'/0=[VD^%=7L/'=WX@DO;9[>]M8H)X&!=T,:X^1L#
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MYR*3(]: /&=9\-7F@>%K?P_>ZEI<<FJZ\;F*:Y#"!00TC(6&TQGY0%*G<2P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\P8;=N.",*<#.<5T<WA71;G16TB>R$NGO(99(7=B)'+;RSDG+$L=WS$\\]:
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M^2JQJ=L:XX"@KG XYW'LOAY:W%CX"TBQO+=K>ZM;=8I8FC*;6 ]^O7J.,YH
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MFCD-ELG\L\JAC11EQTX52?[H-<M?6]S)H?@1(["\#6%Y;37,?V9]T*)!(C9
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M2)I&\DMP0I#?>P%+'MC- &]\.=9O/$'@32M5O[A+BZN%D\R5%"AB)&7@ #&
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MFK01O+;)$8=Z2.H;(+/\F-V!U+<<S77C:YMSI6G[(7U'4#/(L]M!+<P+!&Y
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M\>74 %NC_:-R!(H;<%P),  ] , #@8%:>BZ#8Z#!)%9_:',K!I);FX>>1L#
M!9R3@ 8 Z#GU- '*^)[>\U+Q_INCIKFK6%K>:;<NZV3*GS*T8!#8)4_,>2/0
M#J:PC+XRU9=9ETR_LHY=*U P1W%WJ$J;(X#SYD"1;6\Q?F))YW9& % ]#N/#
M.E77B"WUR:.X.H6ZE8I!=RA4!Z@(&VX/&1CG S6=>?#WPQ?^*(O$<^FJVI(0
MQ<.P61EQM++G!(P,<>F<X& #B_$7B*[L;ZZU#3M:OKX0:]!:SNH$=O9IN57M
M]A8><W0D@#&?O @@Z6KZY<:;XON%UBYU"WTY[^V%AJ%DY>W7B,/;3H"0I+ _
M,1G#GD  5N7/PR\)7=[?7<NF-YU]()9RES*H,@</O4!OE8D#++@XR,\G-R+P
M/H4&HF\AAN8\RI.;9+R46YD3;L?R=VS*[$QQ@;5P.!0!Q=YK^JS_  _UOQ6E
M]<V^J:=?7&R DB*-(I=HA9.C J.6P&RQP14\LVIZOXGUFWDU;4;(IHEO>?8X
M+C'V>9A)E1A Q P,G /3CICK'\$>'VUF351;2I/-.+B:-+F189I0  [Q!MA8
M8SG'7D\T^Z\%Z)>7][?3)??:+V,17#QZE<1[T!R%PL@ '7@8ZGU.0#B_^$@N
MM8\,Z B:G>SZQ)H37LUE:DPM*2BA9WD5AM57!&%R6+\*<8JK;W-WXFE^&MQ/
MJ5U#<W=A=^?<0(L;L?*CW8;#;22.P&1E@5(6NW/P]\+M%I<3Z8)(],1XK9)9
MI) (VZHVYCO3T5L@=!@<4P?#KPTFD6FFQ6D\*6;&2VGBNY5GA8@ E9 VX=%^
M7.WY5XX% '#7MS?C0[S3[^\N;V'3/%=G!;74T8D=X_,B;:Y(&=NXC=SD\=.:
MU]:U36O"WB'5K2.:XU(:M:!M%@F=P$N=P1H=P/3+H^XE<#/(P375WO@CP_?Z
M=:V$UI,+:U?S8DANYHOWF0=[%'!=\C.YLG))SDDU4AL=5U7Q%;RZIH]M:6.C
MS2-93&[\^6Y)38K_ '1L7:S9#$DMCT!(!O6-E+9Z3!9O>SS2QQ!&NI"#([8Y
M<YR,D\XZ#IC'%>3:9>^(8/!7ACQ/_P )%J-Y=SZC%;R6\TL9BFBDG*;=JK]X
MC!SEBIS@X''LDK,D3,J-(5!(5<9;V&2!^9K@?A]X$AT32;"34K">#4K8M(T1
MNS);B5BP\Q(PQ16VMMR%7J<#!H HW.H:EJ_A_P 9ZN-4NK/4M%O+I+)8)#&D
M*0("F^,G;('P22X/#\8 !JEJ'B+6XKU-7UF2YM]"N;6U/VK3IF(TF<QJ[":,
M<NK&0<L,@;<8.#7=7O@G1-0U4ZC+#,KR;#<117#QQ76S)7SD4A9,9_B!R  <
MCBG7?@O1;W69-5FCNOM$KH\R+>S+%,4"A=\8;80-J\8P<<YH X[6=<O]/\9R
M1ZQ>75CISZC +#4;25I8,#9NM)HQ]TOACN(R-_7:,5F^([K4+KPAX\MKZ],T
M5OK5M%;O+@F-2]N<!<  #((S\I.<\9)]%_X0W1#K)U5K>=[AIA<,CW4K0F4
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M0 4444 %%%% !1110 4444 %%%% %34-3LM*MC<W]U%;PY"AI&QECT4>I/0
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M1_.:W72XD\ZX*$;&8.6)RNT  (0QX8D@ XYN6.N65MH&EW$^J-J#74"&*>.
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MVT+R3CWP,;P]+J6F1OX4OO#%Y=2QW\\T%Y+&KVC1M.95D:0]'&\G;C)*]NV
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M4#@Y^4G) [56OYKG5OB98VZVEE?:=)H<TL<=S*0CJTL.7*F,X;.!CGCG(/%
M'<2:E8Q2I%)=VZ2.NY4:506'J!GD<'\JGCE2:-9(V5T8!E93D$'H0:\K\.:9
M')9>*([SP]I%S:V&J,$BEG)$7DP0F.-28_NC'4XZG(Y.=WPSXMCU#2-!M-(T
MFUM;B]T][P6BN8X;>)6"\%4YRS#  '?\0#NJ.@KBI?&]U;'3K"ZTB>'6KI96
MDM0'E6)(R5,F8T8LI;;C@'#9.*VO"^LW6OZ)'>WFF76FW!8H]O<1LA!'&Y0P
M!*GJ"0#[4 :3WUI%<I;27,*3N,I$T@#-]!U/0_E5@'->36]];P6WB_6_$^D6
M5Y%IVL[XFWF61)Q';K'&F4&%R5&[(ZG(QDUUD_BG4--UR+2-1L+9;F\MI;BR
M:&=C&YC +QNQ3((!!# 8.>@P,@&WK>BIKEI%;R7NH6BI*LN^QNF@=L9&TLIR
M5.>1]/2K=C90:=906=K&([>!!'&@).U1P!D\G\:YGP/XJU3Q?IL.K3:-#8Z=
M<0EX7%V97+AV4J5*+QQG/\\U4\1^/+CP[?WB7&GVZVEK) %:6[V2W*2$!GC3
M:1A"V#D\D$<<9 .YHKEOB%JVIZ'X$U;4M*\K[3# Q$DCD>6",;U&T[F&00#@
M>I['.D\9WMM:M9V]A]MU&UL8KB81F:=6WA]@!CA)+$1Y.0H&\8W4 =U17!2>
M.M9GO-(M=.\,R&XU&SDN1!?3M;21&-E#JX*';U.#SG*G@&H+KQ_KEM;>(9_^
M$?LF30G'VL?VD=Q7RU<[!Y7S'!/7:.F,\X /1*0\#.*Y/3O%5_/XFL]*O]+A
MMXK^S>[M)H;HS':I7(D&P!3AUZ%AGH36;XXUK6;'Q?X0T[3Q&(+R[D9_](=#
M*R1M^[;"D;/F!/!Y X&,T =W'/%*7$<B.4;:VU@=K>A]#R*DKR?0-2U7P_I7
MC*YTG2K2YM+#6[Z>99;GR3L5%;9$J1M\W!^]CMR<G'2ZYXVN--TRVU"VLK=[
M:;3S?"2[N_(#D ,(5.T_.5).3@#'U( .SHKS1_&NK:IXI\#PV%M#'I^KVSWS
M*T[AR1"<HQ"$;5WY''S,J\KCGJ_%/B:+PU#823K&L5U="W>XG<QPP95B&=@#
MM!("@GC+9)P* -N6YAA=$EE1'D.U S %CZ#UJ4<BO'_%5Y<:CXH^'FK+9V3W
MTEU=)&(KE6BF4#",)MA.PC## ) 8X!.*Z;3O'=W?Z/J,QTJ**^TW5#IMTC7)
M\F/! :;>5!\L YY /';K0!V\DB0QM)(RHB@LS,<  =23Z5&+RV,Z0">(S.N]
M8PXW,O\ > ZD>]>3^/=>C\5_"?Q>LEM$)M,O%@!MV\]6VR1L'5L+@%6P?3#=
M16K';PQ?'+39XT"F;PV0S(/E;$HQ]Y?3_:SC&<#[P!Z516+J.N/#KEMHMC#'
M-?36\ET?-D*)'&I5<Y"G)+.HQ]3]<D^,KH7>D:3-I7V;7=1,V+26?,<2Q9W2
M%U!)4[?EX!.>W4 '62S10[?-D1 S!%+,!DGH/K3QR*\UUKQTITZ\M]6\-6LM
M[INIV]K=6D]PLL:^808IHV*?-E3N *JP[CBK^I^-M7M;WQ/;6>CV<@T&W2Y>
M2:^*"1"A?IL)#84\'CC[U '>5%)<0Q310O*BRRY\M"P!?')P.^*YF3Q9<7LT
M%GHEE'<WLNF+J6VXF,2"-R0BY"G+$@CL!C/L<J\\3._B'P0FH^%HHKO4_/VR
M715YK!U3+JIVG[WR\@@D#D#L =U+<P6Z;YY$B4D*"[!02>@YJ:O*/%6M7/B/
MP[I&KQ:=;?V2^M6HMY'<F4J+@ 28VX"O@# (.#G/.VMS6?']U9W.HII&A7>K
M+IUPMO/';Q3%Y&(4L$*QE<J'!^9AGGIP2 =W16/K>K76F^&;K5[.P:[D@MS<
M?97<Q,P"[B/NDAL=L=:QX/',#^(]+TR:.WBM]1TS^T(;HW6>V=F-N/N[F#;N
M0C<<4 =7)<0Q31PO+&LLN?+0L 7QR<#OBJ/B"T@OM#N;6YU&YTZ*0 &[M;CR
M)(N1@J_;G ]\X[UR5WXH\[7/!S7?AVPDDU4SM9W,EP'EM@$W94%,C>NS)!XZ
M'M7"Z_K6IZW\.=:O]7M+9I+;Q$L<"PR32,2LJ*40-M.,# ,3)GGA6W$@'MNE
MZ7;:18I:6@?RE+,6DD:1W9B2S,S$EB22<DU<-<[H?B&\O_$6JZ+J%A%:7%E'
M#/&8IS*LD<F[')1<$%#G&1SP3C-9VL:GJW_"R=(T9(H&TJ>SN))8VE/[[!C!
MWCRS]T,<#.&)Y(XH ["*:*8,8I$<*Q1MI!PPZ@^XJ2O%?!'B6^\*>%-)B338
M9M)FUZ73I9Q,1*A>5@K^6JE54'&>5[ +SD]=?_$&XCFOFTS1+S48;&]-K*((
M+AGDPP60H5B*91M_!;)"YXR,@'>45S'COQ5+X.\-2:Q'9)=K'(B.CS^5C<P4
M$':0<$]#CZUF7/C?5+/5(M$N=%6/5I(9+K9$\UQ&D"N%1B8XB26)(QCC&2>0
M" =U01FN"A\?:I=R>'X(_#4MK=:N)E-OJ,S6[PR1)N8$%"2A[,!DC^'TKR?$
M35H-#U#59M MO)TB^-CJ*I?EFW!U4M"/+^<8=6PVP]L=Z .CN_!UG<:U<:O!
M>ZE97ETJ+<-:W3*LH0$*"IR!C)Z =3ZG.K8PVMA&MC#(6=5WD22EY&!/WF))
M)R1U-<?XM^(-UX4DU"6;2HC9V7DE3+=[)+M7P&,*[2#L) .3R>..,W9=<5/'
M%S:0:/:/<IHHO(K]GVO+'YA B)V94 Y;J>H.!0!V%1QS12LXCD1S&VU]ISM;
MT/H>17#Z-X\U#46\-3W6CP6]CKP<0R)>-(\;A&<!EV 8(4C(;/.2!@BLZ_\
M'K>'=*\2ZG'X=L4DL-32VN1#<A?.9U3$A;8-Q^8 YQP.M 'IM%</#XZNK?6M
M<TS6-*2VETS3O[2'V:X:;S8L'(Y1?FR.V1SCM4]IXPOYM<T*P?3+7RM8M7NX
MY5O&)C10A(*F,9/S\=/ZT =C17$^-->U73?$OA?3=/:!1?W;;E:8JTP1&)4X
M1MJ9*$D ^G ZP?\ "PKJ=XI]/T"\O;!KYK4/!#,[O&&*&4?N]@ =6&"^<#/!
MXH [VBN(3Q=X@N]8U.TLM LW@TNY\FYFDU!EW#RMX*CRO]I<]<>^<BI:?$#5
MKFT\-WC:# MOKQ,<&;XAXY"&9=P*8V87[P))_NYX(!Z%BBN=\,>(;G6IM5M;
MZSBM+W3;O[/+'#/YJ,"H=6#%5/(;N!TJC=>,KJ:ZUZ+1].CNET,#[2TTYB\U
M]I8I&-IY '5L#)'49( .KN+B&UA::XECBB7J\C!0/Q-+#-%<1++"Z21L,JZ$
M$$>Q%>;ZCXA?Q/J?@.^TJVBFTZ_FN9EBNY#&6D6WEPK@*P&WGD9Y[=ZTO%\E
MUX3\(6T>@V-I:)+?0I*L,C)Y1EF7=L"I\V68CH.#T/W: .V$T1G,&]/-"[BF
M1NV],X]*DKR>\N]4T3Q]XHU'2M)M)KJ+0X+FXC,I1=X,C,%(CW2,<'!XR1R1
MP!O7/CR\.CZ9JEGI,8M+W3Q>FXNKK9&LF 1;C"DL[?, <>F W2@#NJ*\^F\7
M:KJ6I^!GTRTMQ9ZQ%)=2)+<2*P(@)V$JI&!NSD@@D#A>#7H SCF@!:*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#GO&OAIO%_A:\T,7*6JW6P-*\1DVA6## #+SD
M#OCV-9\7A#58O$M[K2ZW%YEWIR64D:VLBC<N<2DB;ELD^X!P".2>QS61XFUZ
M/PSX>O=8FMY;B*UC+LD17)_,C_/8T 4O#GA>3P[X,A\/17JDPPM%'<Q0^606
M!R^ QYW$G@_XUE6WP]5[K5+O4KF!KG4M-?3KE[.!H1,&ZRNI9@9,<9^O)SQV
ML,RSPI*N0KJ&&>O(S4F1ZT <':>!]8>[\/3ZKK5K<+I-K/:,D5FR^?')&B?,
M3(?F^3).,=/E[U-X9\&:QX=@ATH>(GGT.UDWVT)@VW 7=N"/*&P5!X("\@XX
M'%=MFB@#@5^'VH+X=CTD:W;@0ZH-2BE%DXV-YQEV@>=P,G''OWYKH/%GAF'Q
M;X=GTFXGEMB[+)%<0_?AD4AE8?B.?8GD=:G\2Z_#X8T*YU>YMKBXM[8!I5MP
MA<+W.&90<?7-7-,OO[2TVWO?(E@$\8D$<NW<H(R,[21^1- '.-X:U[4- O['
M6=>AN;BZLY+,-%9F.)5< ,S('^=\#@Y4#)P.35&X\ ZA-+"?[;AV?V,VCS;[
M+>6C./G7+D!C@9SN!P.*[RC(]: . 3P)JP\+V^@7.KV=]8C3X[&6WN+-MGR-
M\LJ_/D,HQQW*@Y7@!FM?#636]'&BW6II<:>L$$4+W,!>>V:-0ID1]P^9\#/&
M/8Y(KT+-&1ZT 8VJ:3>W6E6]K8WXBEA927NHS,LZ@$%9 &7(8'G\\5R5O\+C
M96L<5CJ4=H!K,6KM EJ3 K(,"-$WC Z9))Z# &!7HU&: .%U;P%=ZI_PE8_M
M>.-->$!""U/[IH@H&27(8,% ; &:A/@#59=3\3W<VMVV?$%@EM/LL3M60(8]
MP4R'Y0IX&2<D9/!W>@9'K1D>M '(1^$=22^\,79U>!I-$MY(&_T,_P"D!T5,
MD^9E3\@/<9J_XG\/W6OG2C;WT=H=/OX[W+0&0N4R O#K@$,0>N0<5T%% '!Z
MK\.Y]6;Q%)+K)@EU62VN();:!D>SF@ ".I\PY/RC.-O3J.M:$/A.ZG\06GB'
M5KRVN-5LK1K>V\BV*1(6&&<@L22>V"N 2.>M=9FJ-W>7<.H64$&G27%O.7$]
MRDJ 6^!E<J2"V3Q\N<8YH XNQ^'5]I&E^'H[#6(%O]">7[/*+0K%)%*3YB2)
MYASG@[LYR,]3FMSPQX:O=#OM8O+R^MKJ74[@7$GD6AA",%"X&7;C SCU)Y/6
MLI_B7"-#UO5%TBZ\O2=2&FR(\B*3)O5"<YP "XZ$UW8Z4 <(? =Y_9NJZ!_:
M4/\ PCU_.\PB,#&>%9'+R1(V_:%SRIV\9.0>M:Z^&)8/%MIK-G<VMO:VU@;"
M.R2T("Q%T;@AP!C9@?+@ ].*Z3-&<T <OIWAB\L(O$$9U""1=7N);D?Z(1Y+
MO&J#JY# !.G&<]JQ(OA]K&FV&@OI?B%$U;2+=K/SY;4F*XMV(^1TWDC;M!!#
M=NW&.[O;K['937/E23")"YCBP6; S@9(&?QJAX9UQ?$GAVQUB. P1W<?F+&S
M9*C) R?PH Y[5_!.J7<VDZO9Z\4\1:<9?])E@!AG60_-&T8/"CHN"2.^3\U=
M3IEE<65J1=WCW=U(V^:8@JI; 'R)DA%  PH]R26))O9'K2YH XN7P%]LT?Q)
MI=]?K+;ZW=M=DQV^UH'Q'MZLP8 Q*>@J8^%M0U*[MK[6[RSGO+*UFM[5HK7"
M;I4"O(P)SSC&T$#&>3GCKLCUI,CU% '/>"/#4GA#PI::$]XMX+7?LF6#RLAG
M+8*[FYRQYS7.ZM\.=1OKSQ,UMK4$,&MR03EI+0R3))%@JN_>!L!7CC(SP1C)
M]$R/6C(]: ,'Q#X=/B;P;=Z%J%RIENX-CSI"-JR<$,$)/ 8 @9S@?>SS6%)X
M/\2V^JVVKZ;XCMX-0>V2UU!9+(R0W(1F*/@ON#*&(Y8Y]1SGNZJ07-S+?W<$
MMD\,$)00SLZLLX*Y) !RN#QR!GJ* ,$>$[D>*=)ULZKYQL;:6!Q/;AI)O,8,
M3O! 7&!@!>!D51G\"WDMMXM@CU:")/$)).VR.8,H$//F?/\ *#Z<G/J#V^:,
MXH Y6+PK?#Q%HNJ3:G;NFEVCVJPK:,N[>$#-GS,*?D'&#Q^%'BKPC/X@U;0]
M3M=0CL[K2)9)(S);><K[P 01N7'0'.>OTJS>^++:VNM#CAADN8=7G,,-Q&1L
M7Y6;)[GA3T&/<5T&: .-C\%WT6B>(]+&JVS1:U<7,S%K-OW0F7#*!YO..N>.
M23CFJL_@'4IIK<G7("@T,Z-<;K'<70GET!<A2>,[MP^7ISQWN1ZT4 >>V?PZ
MOK2?PE>+K</VS0+=[4LUEN6:-E" #Y\J57/.6Y.< ?+75:YI-QJL4,44EH(=
MY%S;W=MYT4\9&"I7<.1P1G/2MC(]:,CUH \\M/AD]A<^'I[/5$@71[JZN4A%
MNQ4"<Y,2'>"J <8YSU/I3!\,KJ+[;+!K,(N;C7EUM"UE^[# DB-U$@+J,Y'*
M\@&O1LUG:YJRZ)H6H:JT#SI96[SM'&0&8*I)P3QT'_Z^E '&:I\-[[5M#\3Z
M5/KT:Q:W=QW6Y;+_ %+*8RW&_G/EJ!T(Y)+$\:Z>$+U?'EKXH.K(6BTT:=);
M_9C^\7>7W;M_!R1V/2MO0-7CU[P_8:M&AC2\@2=4)R5##.#[BM+(H Y3Q+X8
MU'4-8L-;T/5$T_4[1'@;S8?-BGA<@E67(Z$!@0>H^A%>\\%WLVHZ/K<>LL^N
M:<9 \TL7[FXCDSN0QAOE S\N"<8&=QYKL\CUHH X74?A]-J,=W.VIPPZE>ZA
M;WMS=0VA&1 %$2(#(2F O7<3EF/ .!8D\&7[7WBBZ35;:-]>@2%F2R8-#LC,
M8.X2Y8X.>V*['/'!KGV\3R37MS#IVESWT5G>I974D<B H[*K$A2?F50Z[CD=
M3@'!P 8S>!]4LKO2+[0];BL[NRTY-,F\ZT\R*:%>5.P,"&!R?O=STYS8OO!=
M]>:WX:U0ZX7GT4S,SSVVY[EI1A\E74*,= %X^G%;VOZW'X>T2ZU:XM;B>"U0
MR2K!LWA ,D_,R@]/7-8G_"?VT6@V^O7FC:M::1-$D_VMTBD"1O@JS+'(S@8.
M?N\=\'B@#$'PVU6'0H_#MMK%@NAVEXEU9QRV!>90)?,V,WF $=><9.>2.^N?
M"NOV>NWEUI&OP6EGJ4B3WD+60D9)@JJSQ$M@;PHSNW8(SSG%=(;^5[FR%K:F
MYLKE&=KR.5"D8 !7C.6#9."N>G/6KP/% $8@0VOD./,0IL82?-N&,'/KFO.;
M/X1VD'ARWTB2^F=(=1>=6W$$6K%U:W5@=RJT<C@\]78^F/2\U'<7$-K;2W%Q
M+'%!$ADDDD8*J*!DDD\  =Z .<USPO<ZOXJ\/ZS%J$=NFD/*_DFVWM+YBA6&
M_<"HV^@//7. *YR7X77IT+5M$AUVU33[_4CJ C?3=Q7,BOL8B4!Q\BCH._MC
MT2UN8KRTAN8'#PS(LD;CHRD9!_*ILT <]IGAZZLO%NHZY+?12+?6T,+V\=NR
M8:/.&R7/]YAC'ISUR:OX=N+[Q/I6MVM^MO)8QRPM%+!YJ2)(5)Q\PV-\N-W/
M':NAR/6B@#S6+X77,'AC3M&CUFV4V.K_ -JQS)I[* P8L%"B48 RPR2>".F,
MUKIX4U^RUJ^?3?$GDZ1J%PUQ-;RVPDF@9L;O*D)X#<_>!"X& >:[(GCK6-X=
M\0IX@3466UFMC8WTEDZ3$$ED"Y/!(Q\W8F@"EXW\*S>+_#YTJ*^6QS,DOG>0
M9&!5@PVX=<'(ZYJKKOA+4[OQ!9>(]'U6&RUB"V-G-YMMYD,\1;<05W KAOF'
M)Z >IKL<T9'K0!R<WA*\N-<\/ZM/K'VBYTIYF=IK5<R^:FU@NTCRU QC@GCD
MMR3GW?@"_NO#OB/2?[<A7^VK]KPS?823"K;<ICS/FX11D]LC&, =HE[;R7\U
MFDH,\*))(@_A5RP7GISL;C_$58S0!YGKGPQU'5O^$I"ZY;JFOK TH>RRZO$!
MM ;?PF1Z$@$<\9.X?".I/KSZK)J]O))+I(TV5'LF(8Y+;_\ 6_WF;CK@X+'K
M789'K10!P]KX$O(+3PK;2:M;S)X?=65FLVW3 (R8R93MX/O@@=N*I:M\-M0U
M73-:LGUZ"/\ M/48]0WI8,#"ZA1A<2CKL7G@]?PZ34_%UI81Z9+$C7<%_J(T
MY9HG4)')O*'.3DX96' /(KH,B@#S[7_#UUH^H>(/&KWD,TIT.2U%M%IY)RHW
M!N7;.2!D%<8 STK \(*VA:EIUKH&L^&_$*,T=OMLXML]O;LVZ5LB5EC4<L1C
MYVQWQ7L'!XS4-Q/;6%M/=W$D<,,2&665R %51RQ/L!U]J ,7Q1X<N==GTBXM
M-1%G/IMW]I3S(/.C<[&7!3<O/S<'/'/'-96G^#=;TW4+R"#Q-*= NIY)S:-"
M?/C,C%G5)PVY06+'=]X9."&^:NRAFCG@2:-PT;J&5AT((R#4F1ZT <MI?A2X
MTZ\\1SR7MO,NLR^:8UM-@B.S9S\YW# !/3G/3-9]IX#OK72?#&GC6(&30;@3
M*?L.!/A"H!'F84X=N>3R/?/<Y'K1D>M '/Z%H-[I6J:Q>W6HI=?VE<+<;%@:
M,1$(J8&7;L@[#^6,R7P?J5OK6N76EZM%%9:V@^T6EQ TBPR;=C21X=1EEZ@C
MD@<X  [.DSQ0!Q\/@1=.'AJ+2;U8+?03*T:3V_F-,9$9"6(9>?G).!R:T_%W
MAT^)]#^P)<I;2K/%<13/#YJJT;AAE<C(.".HZU!?^*YH-2NK/3M'N-2:RDAC
MN_(D16C,@R,*Q&["D$\CJ/?'2T <7>^"]0O]1UB[GUBWD_M/25TQXWLCA  V
MY@1(#@EW.W(QD<\5G0_#?4+:?1IHM>B9K#26TEO-L=P:,Y^= 9/E?&T<[AQT
M[5Z+D>M&: ."MO .HVUGX6VZY%]NT".2&.=K$.K1O&(]JJ7RI"@'))Y[8^4=
MX,XYI<T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!P_Q0UNXT+0]-FBN3;6L^
MJVUO?3J^QTMR27VMD$'@#(Y )^HR_%MK9VG@7QK:V.I7%Q$+-9/)FE\V*U^3
M'EHSGC(3=LSD;@0/F45Z+=V=M?VTEM>6\5Q;R#:\,R!T8>A!X-9\'AC0[;2#
MI,6CV"Z<3EK;[.IC8\<E2,$\#D\F@#S7XAW[7%EK7V6YOHI],TFWG8RWCP"V
MD9F*.@7EY2?E.0 ,#GDBG:W=ZM<::=9/F:E91:+ UZEK?/:SV+8,CSQ,/DDZ
M;L9SF)1GC!]'F\*>'[AT>;0]-D:.$P)OM4.V,DDH./NY)X]SZFFGPCX=*+&=
M$T\HL(@ ^S+_ *L'.SIRO7CIR?4T >>ZKJDL7B1]>FFN]0T5-0M81) \EO-I
M,I\LF-HSA9(W#IN(Z[R.<"O5H;F&9GCBE1VC.UU5LE#Z'TJD?#NCMJ!U!M+L
M_MK.KO.(5#NR_=+'')&.">G:K5OI]I:7%Q<06\44URP>=T0!I&  !8]^ !0!
MROQ7('PO\09?;_HW7C^\..?7I^-9=[9-?^.?#-M)>7T5M/HT[2I%JCH9"IAQ
MAD8$G)!)7;NQU(!%=YJ&F6.K6QMM1LK:\MR0QBN(ED0D=#A@151/#.AQR02)
MHNFJ]NFR%EM$!C7T4XX'L* ,7X9W$TW@]89II9C:7ES:H\I8L429PH);DX7
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M)8;:6[N'FN&M;65$9SY@<D88\DL#\Q&0Q%>G)X2\.1A F@:4H20RJ!9Q_*Y
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MF:UU&X6WM@BJ7=R2!QNX&5.<],'. ":Q=+TO5[+XL:OJKZ9.VG:K:P 7!EC
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M ##.<9JK#XBO]'\3^-;_ %J^6;3=)MK5A##;8.TQL_R?/PQ9B#NSGY?F !
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M)P20 6))V@-O>$=6UC5M!6;7-+.GZE'(T4L>TK'(1T=,DMM((Z\@Y';) -[
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MK,C_ '65N W!SP>A^E5%FO1K+1-' +#[.&5RY\PR[CD;>FT#'/J>_8 Q]?\
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MX)+,?F9B21QQUKN6D55+,0% R2>@%,DN888I9994CCB!:1W8 ( ,DD]N.>:
M.;?PG=/KFI:L=43SK^R2S>,VN8U5<G(&_D_,W4GK7">*O#MS93^'-#^WZM:Z
M3IVGF-;NVTQKV"67(C59(E#;7VG[Q!!WD#;R*]&L]=EUO3]$U32(HGL=0P\O
MVA]DD<90MP!D%@0 1]>>,U'HFOW.I>*?$6D3VJ1)I;P"*123YJR)NR2>_MCC
MU- %?P.FNIIMPNM7\U^OFAK6YGL%LG,> ,>4O*@$9&X!N3D  5#/X%W2ZY%:
M:I+;Z=KCJ]]:^4'.2-LOEMGY/,7 )(8CDC!QB[=^(+BV\=:?H!M8Q;7=I-<"
MX\S+90J-NWC'WO?\.:U+Z:\6"&33_LLA:5-_GR%5,9(W%2 <MCIV)H SKCPT
MTOB'2M4CNHXH],BDA@MQ 2-D@0,"=W7Y!@XXSSFM\# IH=0P0D;B"0,]1_DB
MGT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!Q?Q,LXK[0;&!]8@TN07\4L,UTH
M,#R(&=$ER0-A*CUYQP>E>=W9TV;4O"VHZCHEKIUI%K5W;WC+Y,EH[&/.5<@$
MH[!B >X<=0M>ZR1)+&T<B*Z."K*PR&!Z@BB.*.*-8XT5$4 *JC  '0 4 >&7
MC?VAX1\<6^L*I\6#57%K$PVW&/D\@0?QE" =N.OS=<G.J;O2IM3U_2/B!<16
MUS=:;:K;R7 'RHT 67R&9?O"4L>!G.#S@@>N-;0-<)<-#&9D5D20J-RJQ!8
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M#SCRU7$A.2W(*C)XP=H&./6?&_A\^)_!NIZ6BHUQ)"6MBW&V9>4.>W( S71
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M#D'!ZX!XP17=^%;RVD^)?CF&.>-I ]F2B29Z0@$X]0< XXX4=<Y[G:/2CY:
M/.O%$6E7WQ4T.UU0VL]JNF7336]P5:/[T9&]2"",C(W<94$<BN02\TK_ (5G
MHZF:R/V'Q(%A!=<K$+PG'4$+M(Z < < <U[I@48% 'CT"1:?XYED62RUNWO]
M=+,H9%O],N Q7..2T.V/'8[#G'K["O2H_LT'VC[1Y,?G;-GF;1NVYSC/7&>U
M2@8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#)\0^(;'PUIZWE\S[9)D@ABC
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M(Q+=JHC)9#&9,I\_/RC.#@\CBL/Q-X.O];UU[ZVM;6SOH94>PUJ"X,=Q NU
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MX X/R[O3&,8J]XS\-MXDAMK>2QMKRU17+;K@P3P2?*8Y8G"G###9&0#GOC!
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MST&<#L?%?A_4]0O]!\0:4+<ZOHSRNMM-*1#,DJ;9$W;<AN!M. .N1Z $5_\
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MT/\ PC[SFUAD!VE9QN<>9(%48QT_7I6Y:>/]+U&TT:2PAN;FXUB)IK6U4*)
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M@YX(4$ >M:FH:WXOU6\U?_A&(H]^G7PM$CG:/R9"JHSF3(WY(?C:0,8Y)R
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M3KU..*VM/O\ Q!J^KZYH8UA8KO18H%%S#:JHN9I$,@+JX<*F-B[5.[ACD97
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M0O$UM8:TMG:7J,BRVMQ-; LJGD%=PW+U]JYB?5=8\0W/B#3UN'TAM)LXA+%
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M0?E^;"Y )YY//I/>>%H;G6)=5MK^_P!/N[B%8+AK610)D4DJ&#*P!&6 9<,
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M9Q<^5,K>3U^]@\=#R?0^E1V/BC0-3O$L['6M/N;IX_-6&&X1G*X!SM!ST(-
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ME1D9QR< '!$][X!TN[UMM6CN=2L[F5$CNOLMX\8NT0 *)><MP,9R#@]:V/\
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M[$^B*L$U]$#&95F<E59_EWA6S@?-@GMU]!MK:&SM(;6VB2*"%%CCC085% P
M!V  J0KF@#Q>*WN_#>C>#I]4DU*TT6&ZO?,"(V^R$C$VQ9=A. NY>0"OF8XQ
MBO0O ECHUEHDYT!;C^SKBZ>>-Y5V)(6 RT2X&V/(X  '!(&"">E*\=:5>E '
MD&GZ';7GB3XD_8M,MAJ!"G3;B6)=PE$)!**0<;9",L.I(]*L>$/^$8U6;2)
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M6+,WS<]6.#2.IQM\/=.TJ_7_ (J6QUN*;48)(Y/,\S[0S&4G'(9>=W*X.!T
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M8&T!NF#7>Z7IXM/"$%AI8N;<1VOE6OVLGS$&W";NI&..#R!Q@8Q6V1D4HX%
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M4-SI*PV3:LNFH9IF268-L'GHA3E 6(QGG&<CH8YO&NNCQ5J&DV_AJ*:VTZ6
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MJ"1C[Q(R?F.<5O?8)="\5ZKXMU66P@LIK.*&5O,?= J9).=H# EAU&>!SVH
MMV'BIM3M/#DUI;0S-JZ&9U2=L01*F6<$H"P#%$Y"\N*I>-=3MK'7?"L5SHD-
M^;G45B@N'EVFUD/\8!&"<9[@\<9JG\._#T5GJ&O:W;R2O8:A>2/IR2# CB+9
M<HN!M5GZ>JHA[Y.IXL\,WVO:IH%W;/:A=*O!=LLQ8&0@8"@@<?7GZ&@##OOB
M-J]K/XGV>'8WA\/LGVAS=D!T(W$H0ARVW!VD #&2W(%;_C37;W2_ -_K>C-;
MF1+8S1R7!8!5*Y# !3N;D8!P.>2 *P;OX?ZM<KXU'VJQ'_"1^4$+ DP!05.3
MM^;@C XQ]2371ZSX;?7O ESX>N5M86FM?(& TL<;#&UAD@G! (R>"._< XJY
MDOU^*'AVYMK.SDUFXT28RV[W3;(QD;9'?9QG&W(4DD;>@#5L6/Q-MM1\-:-J
M,=O':7>IM.GD7,IQ!Y08.Q(7+@,$&  3O'3!Q9M?"^N)XBT;6+I]+DDT_37L
MRD.]-[,1SD@@* H' !Y8]"%&1I7PZU[0_#V@PZ;J=A'JVCW$[K(\;F">*8Y=
M60$8/3&/[O49- '9>%-??Q%IDUS):-;R07,ELP^8I(4.-Z,5&Y&&"#C]0:YZ
MT^(\5Y>:8UO;13V%]>FT5H97>5 2PCF*[,;&PN><KO&>0176Z-!J4-F6U:>"
M6]E??(+<,(DX "H&).,#\22<#.*Y;PUX7\4>'V723JUC/X?AG,MN2CBYCCW;
ME@!SMV# &3N."5P!C !D:3KUCX3F\97$D<2"77U@MH_,"B69XH\)D9V]SG'
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M;Z59>?'+/]OW'S8Y1'MV^6#@\G=R  ?3!ZO0=2O=1,[7,=F8%V^1<6<[2QS
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MU#4K@0FX>#3XU=XX@<;B&9>,\#&2<'C@U?T35TUO2XK^.UO+5)"P$5Y 8I
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M7CJ]QYUU)NE*G* L&!P,# Z<9Z\TL'CKPS=26T<&KP2-<SM;1;<D&0'&TG&
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M&(T9Q)%@'>A (9>1R,]: &1>%-'@U&ROX;>6*XL;86EOY=Q(J)",?)L#;2O
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M[VXUI+J]L+RWA+HZ-"0(C)SM9 N I[ ;1R ?7L"HH+FWNE9K>:*958HQC<,
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M0@<C(HP/2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&7A2"H9?O Y(Z+DUM7OAR[7Q8?$6E7,$-U-:+9W$5Q"71D#E@XVLIW#..>H
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M<#8?#_4M/UVZ:#Q'+_8%Q>&[.FF-ODRQ9HE(?8(V9CD;.1Q[UWP&* %HHHH
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MW$T)FC0$(7?=N+="6&"V>@Y /1M>U==!T*^U5[6:YCLX6F>.$KN*J,L1N('
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MQ/'., 'K-%>8C6)M,\;6SZO/>?8[K5Y+>SO[:Z=X)'*O&MI-#GY2&RP;:1D
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MY)INCP6KWB%)VC+ E#C*@Y^5>!P,#BM?2-'T_0M/6PTRV6VM$)*0H257)R<
MGCGG [DGO5ZB@##U'PAH.JZBVH7FFQ2W4D/D2ON9?-CSG8X! =<@<-GH/2KE
M[HMAJ-U;7-S"S3VQ)AD65T:,D8)!4C!()&?3BM"B@"IJ6EV6L6$EC?P">VE&
M'C8D!AZ''4>U9\'A#0(+VUO%TV-KFT!%O)*S2&')R=NXG;R2>*VZ* *%QHUA
M<ZBNH21.+M83 LT<KHPC)R5^4CC.#]0/057M_"^BVFARZ+#I\8TN165K0DM'
M@DD@ GC))/'?GK6O10!@:/X,\/Z#I-UI6FZ5##8W0(GB8EQ*"NTABQ)(QQCZ
M^II=(\&>'=#TZZL-.T>V@M;M2ERFW<9E((VL3DD8+<$XY/J:WJ* .='@;PY'
M;V4%OIB6J6+O):M:R/ \3/\ ?(=&#?-T(SR.#Q5B7PGHDUG86;Z>@M[!E>TB
M1V5867[K* 1AADX;KR>:VJ* ,F_\-Z5J=V]S>6IF>1%CE5I7V2HI)573.UU!
M9CA@1\Q]35G5=*L]9L'LKZ'SK=RK,FXKDJ<J<@@\$ CW J[10!AOX1T.6&&*
M6P#"&X^UHQE??Y^ !*S9RS@  ,22!P#3I_">B7/]J&:P21M44+>EG8F<#A0Q
MSV' ]!P,5M44 <U:^ /"UD;G[)H=K;_:;?[--Y(*>9$<90X/(.T9]><YR:M3
M>$-"N+:PMY; /%IS!K-3(_\ HY&,%#G*XP,8Z8XQ6W10!1U31]/UNU2VU&V6
MXA21951B0 R]#P>U5G\-:2TE[(]JTCWT7D76^9V\Z/!&ULGD ,P'IDXK7HH
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M7>I65A9F\O+NWMK50"9II51 #T^8G% %JBHK>XANH5F@E26)NCQL&![=14M
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M %%%5-2U2QT>R>]U&[AM;9!EI)G"CIG'/4\'B@"W138W66-9$.58!@?4&G4
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M\CH7VMM#') &!QD5&W@?3_\ A!D\(Q7%U%IRP>0SH4,CKSG)*D9).<@#GTH
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M@A1WYM:)XA\8ZO/HM['I$0TG4K;SII9!&OV7<@:,KB8M(.<'*J>,_+G UXO
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M22%0*H &YBQR#DXSP%  ,'X40W3_  ^T6>[FMYD-NIMPL)62,'.[<Y8[B3W
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M1*^T^HR.#[UP*>)9O#WB3QW>7$&KZCI]A+:OY,+*XMT-OO=D$D@^7/) Z9&
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M1XW?,X.00N[&.> 2-*U\;QWEZD<.BZFUH;E;1[S$>R*4JIVR*7WI@MM.5QG
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MZA:+RX))-FW<"X? #@DA2.W4'&7<?%+3[30M6U:XT76(HM)O!9WD3)#YD;G
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MJ)+OR5RRL,*VWYL?N\YZX8<!N+FJ^'-=O4\<JFG[9-<@BBM6$ZL@V1!#G)!
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MJ%W>2:@IU")([F*WNVBCD*C"NRK@,PXQNR.!Q0!C:W=Z]/XTGLK37KFSLO[
M>^\N*.!MDOF8X=E/& .2#P#R,@U@6WBCQ-K-G\.)8]:EM7U@SQWQB@B.\H"-
MX!7 .-QQRH.#M.,'T"#P-IMM?_;8KK4/M L6T]7>?>5A+;B,L"2=W.XY/O5>
M'X=:-;C1%BFO%31"S6*B1<1ECDD_+\V??/ZF@#ECXGU^#PM.4U:0W5CXG_LH
M3R10L9X/.5 ' 4#.UN2H!X[<XV;_ ,2WUEK7C.UDUJUMH;/3H)K*6["K':RR
M"0#<0OS L(^#N/0 $G%:S> M*?2-3TV2XOGBU&Z^VRR&;$B3[@WF(P VG*J<
M#@8X')S4B^&'A\17BW<FHW[WMHMI<27EVTK2A<X=L\,X)R"0=NU=NW% '/Z1
MK^KW'B;Q#H=_=7$EJFBK=1B\BC1PY&&;: ,*<_=?&,= #70?#Z\,/PGT6[VR
MR>3IP.UGW,VT'@''MP.PP.U.L_AKHEC?-?1W.I/>/:&SDGFNC(TB$8^;=G)Q
MP/08 Q@5T&BZ-;Z#I-OIEH\AMK=0D*N%RB@8 X SZY.223DF@#S]?$>N6^A>
M%?%8U1I[?4KF*.]T_P I74K.P51&0H8-'G&/XCU/K+X+F\3ZQXKUV2Z\2R/I
MVEZQ- +4VL>9D"852P V@90\#DAL\D$=+IW@/2-+FM?LTEX+.SF>>UL&FS;P
MNW)(3'."21N)VDDKBK>@^%;'P[>:C=6<MR\NHS&XN3,X;=(>K# &/H./:@#E
MO&OB&^TG6+A+J;4['23:((=1LHXY([><^8&-Q\K,JD-$!\I&>1SR,N]OO%>I
M^,?%MEIGBIK2RT^S@N[,"UB<'=&6 WLN"FX')YR,#=P0>[U7PM:ZM<WDLU[>
MQQWMK]DN;>)U$<L7.005."0S#<"&P>O QR%KX,N;KXC^*+B>VOK#2;^S@M@U
MO)&L<\80HZD;FQPH *A64'C&<D K:%XQUWQ9:Z);B.]AN)=+^VW+6CPQ>;F1
MH@1YBM@ IN^4C.\9P!@Z&G:QK]YJVB^%]8U$6U^=.GN;RZLF3,\B2B)0I*;>
MFYF50"" #@ AMOQ!\/- \0KI_F1S6,FG*4M)=/D\AHE./E&!C''IQSCJ:-6^
M'FA:O8Z=;L+JUETY=EM=VDYCG1<$$>9R3G)SGJ23WH Y^ZU#Q/I5UX-L+WQ#
M:S7<VI26VH2Q1(4G4*SJI4*"K;<#C@$@FH)=?UJ#7=+N%U.>[AGUV2PE$"1_
M8EA9G"QDLJNTB[1\ZY&0RD\@5UDG@727MM&MUEO(X]'E$]J$GY,F<EW)&6)R
M<YX.3QS5)_ACH$ADR]_M-^-0B07)"VTFYF(B'1%8L<@=>/08 $\,IM^(WCA_
M+*[I++YN<-_HX]>_T]O>LG4KWQ!=_$K5M%M]>N+2PAT<7D?E01EXW+8P"4*X
M.W/S9;'"XY-=CIWANUTS6]2U:*>Y>YU+R_M/F,NUBB[4(  QA>..O?)YJO+X
M.T^7Q%=Z\;B\74+JT-D[K(,+"2#M48XY&<]: .-T3Q!XADM_ ^L7FKR7']MR
M&"ZLUAC6$ Q,0R[5+ALH"<L1DMP@X$L.K>+]=6VUG19'2!=4D2YAFE@$'V6.
M1T9 <%MQVAMW'WCU&">F7P'IJ6.CVB75\(M'D\RR_>*3&=NT9ROS8&<9SU/M
MB!?AMX?7Q/+KB_;%DFG^TR6@N"+=YO\ GH8^[9Y^M '/OJ/B_P 2Z7+J&@R7
M4$RWDPA5IK?R1Y;NGELI0/C**3DDY+8.,5!;R:HNK?$"_MM8NQ=0:;;2V[?N
MIHU;[.SK@",[L-N^Z!N#=":Z"Z^%GAV[UR?5"^H1?:9C<7%I#=,D$TAQEF0=
M2<'//.X^V-'4/ VDZEJ6J7\LEXDVIVHM;E8YRJ,@5E^[T+;69<G) )Q@\T <
M5_;GB.YL/AQ+%K[0G5U"7Q-O'^\/E[MPR#ANH'8D@XXP8X?&>OVG@_Q2\EQ-
M=RZ+KC67VU4C,L=HKJ&<@(59E7/.TXSDCY2#VL?@+2XET-8[J_5=$!^Q#SAA
M,\'/'S<?+ST'U.<3Q-X%6'P]>6NEV=YJ1U'5$OKV,7B02E@=Q:-R  250;3P
M!DC!YH T?"UQJUSXMUQ6U>6^T"W2%+-GB0AI&7,F)5 W[2/H-Y'5>*]UK%_X
M@\<:[X<TW4Y=-?2;&-E=8D;?<2C<'.<[D5=GR_+DLV<_+2>!_#][I>J372R>
M(8K!HGB>VUN^29C*&7#HJ%@!@,,ELGC QR=_5O"MIJFK1ZH+J[LKY8#;/-:N
MH,L).3&P92",YP>",D@@T >5ZIK.H^+/!?@#5+^2XM+Q_$UO;S(D2J!(KR+Y
MBAE/(V].@)((.*])\6WFJ:5H-LVGQWEY*)D2X^S"/[3)$ 2YC4@!GP/NJ/7
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M#()-4+&72+^Z/A36M7UB+7K?7)+E+"V@C!9Q*TD<B/Y6=GELK9+#"J<848H
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M=#D3H8Y/XMQSYK@Y/KZ^]2W/CM['7]-TZ\TF:"/4;Z:RMW=_WK-&<>9Y>/\
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MB?0"=(D%MKV6LG$XWJ@029E4@!3MW-A6;[O7) H [+ ]*9'#%$,1Q(@QCY5
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M[I)&FN8\_*)"#U4$@*/E&!TR:]5HH \ZN/ VL7'AGQ#I)FLE?5]4-_YH=\1
MNC;,!06XC SGG/3 P7>+;2#Q'KNB:;:ZG';ZW#,\=_'93!Y([)XB95?H55AY
M85B.&9"/4>AU EI;QW#W"0QK-)@/(J ,P'3)ZF@!L]G#+8/9; L#QF(HG "D
M8P/3BN3\*^&O$V@P6FD7FLVMWHUA@02)"R7$J!?EC?YL!5..G)"@'@D5VM%
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M?$-Y/F":TN=S$2QF-,E1N7"$\[!DDDD]]10!Y[/X:O\ 1_$4?BFZNX+B#3]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_&&G*MP%BFL;D20@G+LKPE&QZ*#(,],N!W%;= !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ex3-11_003.jpg
<TEXT>
begin 644 ex3-11_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :[I'&TDC*J*"69C@
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MFM[>.P>S1VRS"99R>5VXQM _'/Z/U+2+/5GLC>1B5;2?[0D;*&5FV.GS @Y
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M5N%DCM"9?LDD6#M:924?*LIP,%20#U%+;^,YH;&X<Z=;0W,_B)M(A5 0A;<
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M=N!@8W*<GW_'J-;\6:Q%JFIV.AZ6+N331$'1HG;SG==VT," F 5.3G/(P.M
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M'QEK-_+%=:=H[W.GM>M;E%A;?Y2R;#()"0N058[<=Q\W6NYH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,\T ;=%4M+N[J]M7EN["2RD$KH(I'#$JK$!LCL<9J[0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM;:9I%7SU4IN(&XD9P.3S]":F9T3[S*O!/)QP.IH =13&EC6(RLZB,+N+D\
M=<Y]*&EC6(RLZB,+N+D\ =<Y]* 'T4BL&4,I!!&01WI: "BBL*WUNYLK!9_$
M*6EI+/?BTM8X)=Y?<X1,Y_B)R2!G"C/8@ &[17-:+XEN+_Q/XCTF]MH+:/27
M@"2+*6\Q9%9@22!@X X[9QDXS72T %%<?XN\;C0]#U6]TN&&]GTN:**Z1Y"J
MIO(Z8!W'E1CC&?;!Z;3[U+VS@EW()7A21XU;)3<,C^OY4 6J*:'1G9 REEQN
M /(^M*S!5+,0 !DD]J %HIBRQO&LBNIC< JP/!STP?>E5T?.QE;:<'!S@^E
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MR2R;2;$VB A8#;)L7/7"XP.@J:73+"X@A@FL;:2&#'E1O$I6/ P-H(P,#TH
M\:L[BRO?AGI*F:UF>SUZ-5:-0OD(UP2,<DJ".1STQ4&MW^F7MG\1H];N+?\
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MWGBMXDF=0K2*@#,!T!/<"@#D?B+:0P66G>)# LDFBW:32#;DM Q"R*/P.?\
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MY.=\$"J0L'F*I\QAN.6X'8< 4 ;-_P".;6RCU"ZCL+JZT_3;G[->W4+)B)P
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M-=.?F$AX&<!1@@DXLZWHOB;Q=X!U2RU*.TLK^[2+R;.-]ZQE'#G<_=F(QQD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !165XCO[K2M OM2M?)9K.WDN&CE4D.$4M@$$8Z=>:Y?7?'&H>&M%T/6
M;^WM9[2_9!<1VX.^$,F\E<L0X #<\=!ZT =[17.ZSKUQ:OHLFFRV<]IJ=TEL
MLF"X&Y'8.I5L,,+T_6KGB;4+[2?#M[J.GP13SVL1F,,F<.JC+ $'@XY[],8Y
MH UJ*\ZNOB!J$.E^%-1CAL3:ZW+'!-(^X?9G9L'O@@<]2/NGUXZ275M2F\6W
M&C67V3RH+1+F262-F*,[$*APW4[6/; QP: .AHKBO"WB3Q%XJ\.6>K6UKIL0
MN&D!61G(C"-M[')).>PP![BF:#XC\4>(=-^VVMII2(MZ;:169RP57"NXY .!
MDXR.E '<45Q'A#QU+XBU/5=&O8(;35+-W$90EHY45BA9<D%L,#G'MS2ZSXKU
M?2/"^L:R4LI3IMR8/)$3CS '5=V[<<<-G&#TZ]Z .VHK%MY/$$>H6L=V=+DA
MDSYPAWJZ@*?F4,3D;BHQV!S7.P^*?$.J:%J6M:0ND2QVKS(+!A(TR^6Q&693
M]X@$A O0KSS0!WE%<QJ>O7Q\80^'=/FT^VF-G]K,EXK2&7+,H1$#+R-A);)P
M.U:7A^\U.]T^1M7MX(+N.>2(K 6*$*V 5+ $@^O\NE &K17&6_B?6)?'.J^&
M)(;*.6"T^U6<K*P$X.T8/S'&&)!QGH>.*KZ'XYO-5\ ZAXBGBM;:XM'D3[-@
MGYU Q&<L#O8E0!ZL.#F@#NZ*Y+4-=UO3O$OAS1Y/[/9]6$WFNL3XA\I%<@?-
M\V02 2!V..U6+O6-53QO!H<!LA;3V;W0EDC8NFUE7;C< W)SVX/3C) .EHKD
M-'U_7-8&LLHTR!-,OY;(M*L@#B, ESS\HY7CGOSP,FI^(=<L=9\-Z2MM8"[U
M>*4R!RQ6"2*,.P!!^8$D@<#I0!U]%<QX?\17NK:EKNCW4-O!J&E21JTL1,D3
MK(I93@D'. <CMZU3\/>(?$7B'PQ!K,4>D0>>75(IC(!N60Q@%NV2#VSTXH [
M.BN8N_$E^?$%CX>L;&)M1EM1=7<LK_NK-,XR0.7).0%!'8YQDTT:_J6F^(['
M0M8^QM+J44ILKRW1E1G3DJ\98D<$'.[GI0!U-%<;HWB+7-:CUEXAI<(TW4)K
M &8.!(T97YB<_*#N/KC'?/'6VKRR6D+W$7E3,BF2/(.QL<C(X.#0!+16/J'B
M.QL=:M-(>XA6\NHI)$#R !=N,;N_);CUP:S/!WBW^W-.)U*>QAOC=30QPQML
M,BHV 0K,2>E '5T56GU&QM;B.WN+VWAFD&4CDE56;Z G)J'6]7MM!T2\U6[W
M>1:Q&1@O5O11[DX'XT 7Z*Y>QO?%M]I,6J"UTJ)I4\Q=-8N7*GD S@[02,?P
M$9[^FE8ZY;_V-IMUJD]O8W-W;QR-%,XB(=E!*@,<\$D8H UJ*JWFIV&G F]O
MK:V 4N3-*J?*"!GD],D#/N*CDUG2HI%CDU*S1W?RU5IU!+XSM SUP0<4 7J*
MK7>H65AY?VR\M[?S#A/.E";CZ#)YHNM0LK'9]LO+>W\S=L\Z0)NP,G&3S@ D
M^PH LT53?5M-2X@MWU"T6:?'DQF90TF1D;1G)X]*JQ>(M/F\33:#'<1->0P+
M,ZB0$@DGY<?W@!DCT(- &M169IM^ZZ%%>:I?Z<[@'SKBU;;;@[B."S'ITY/4
M'ITJT-1L39&]%[;FT R9_-78/^!9Q0!9HJO;WUG=R2QVUU!-)"0)%CD#%,],
M@=.A_*N=U/Q1-I7CBSTNZDLH=+FLY+B2>4E63;@<L6V@<^GXT =515:34;&*
MR6]DO;=+1@")VE4(<]/FSBDEU.P@L!?S7UM'9D BX>51'@]#N)Q0!:HJ."XA
MNH1-;S1S1$D!XV#*<'!Y'N"*B&HV+7OV);VW-WC/D"5=_P#WSG- %FBJJZG8
M/?&Q2^MFNUZP"53(.,_=SGI2KJ-BT0E6]MS&7\L.)5P6Z[<YZ^U %FBJMQJ=
MA9SK!<WUM!,REUCEE56*@X) )Z9[T2ZG807D=G-?6T=U+_JX'E4._P!%)R>H
M_.@"U16%XJU]-#T6]GAN[&.^AMI)XH;EN9-JL0 H8$Y(QQ4UAK2_\(C9ZWJ;
MQ0![*.YG895%)0,<;N0,G@'F@#7HKBKSQN_F>%[FR:S-AJ[A9S(2S0@Q[SR"
M " 1G(_*NCO-1$VAW%YI5]IY*H3'<32;H 1_>*GI^- &E15&XU:PT^*/^T-2
MLX&9-^Z258PP R6 )Z=^IQ5Z@ HKDXO&L$OQ$?PPL8\L0';<8X:X4!FC!Z'"
M,">X-='<ZA96;A+J\MX&*EP)90I*CJ>3T'K0!9HJHNJZ<TD$:W]J9+A=T*B9
M<RCU49Y'TI9-3L(KU;*2^MDNW&5@:51(1G&0N<]2!0!:HJG)JVFPRF*34+1)
M XC*-,H(<]%QGJ?2EU#4+;3[?=<7EK:M(=D37,@56<]!R1GGL.: +=%<QX/\
M4G6?!^F:MJ\UG:W5X)#L5O+4[78?*&.?N@$\GUZ5LQZSI<JV[1ZE9NMRVR K
M.I$K8SA>?F.#G H O456NM1L;%D6[O;>W+G"":54W?3)YIMYJNG:?G[;?VMM
MM3S#YTRIA<XW<GIDXS0!;HK#OO%>EV.O:5I+W$1FU%79&$@PJJNX$_[W;IG!
MJSX@URT\.:)<ZI>NJQ0KD*6P7;LH]S0!IT53EU;38((YYM0M(XI3B.1YE"N<
MXP"3SR0/J:LM+&L1E9U$87<7)X ZYSZ4 /HKSSQ!\1V@TNSO]!:QN(GU<:=-
MYA+Y'S8==K#@["0>01BN[MKZSO(&GM;J">%&*M)%(&4$=02.X[T 6**JV6IV
M&IH[V%];7:H<,8)5D"GT.#QTK#\0^*VTS7-+T"PM5N=6U(L461]D<4:@EG8]
M3P&P!UVGIQD Z:BN?%SXBL=6TZVO!8WMI=RO'+<6T#PM#B-W&4+.""5QNW#J
M!CFM>+4;&>ZDM8KVWDN8SAX4E4NOU&<B@"S16%K?B_1M$T:XU&6^MI1%$9$B
MCG7=*<D +SSEE(^H/I3XM5>[OM.FM]0TU=/N+=I6B<EII"!_ =P 4<Y)!Z8X
MSD &U17 0^+M;UQM7ET6YT"WATZ^DM2NH,Y+1H/FFWJV,$LN!C&,_-78G4K6
MRL[:34-1LT:15 E+B))6.!E06/!)&!D]1R: +U%5KG4;&S6)KJ]MX!*<1F65
M5W_3)YJE>^(]/L=>LM(FN(EN;I)) #(!M"XZ_7=QZX- &M151-5TZ34&L$O[
M5KU1EK<3*9!]5SFK= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <]XXF2/P3K4
M1?$LUC-'$@(W.Q0@  ]>O;FL)'M9;+P'!<M#(%7$ZL1M"FSEC(93V+?+SWXZ
MUWU% 'D5QH&H>%?&6AZ-9Q/)X9GU9+NT)8N;:01R!XLGG!R6&?0]3N->MNB2
M1M'(JLC AE89!![$4ZB@#QF'P#<:AI_B3PU<)*;72&E.CG><;I=LJ#)SG&T*
M3C_EHV.<UV_@N:8>#_[=UD"&\U!1<7#'Y#@*$09..JJ"/=NYR3U]% ' ?"$_
M9/AW;PW++%) \K2))\K1J78@L#T[G/'%3?#&5(?#-^LK",QW]Q(X?Y=J%B0W
M/8COTX-=S10!Y-I_AR37_#-[=:3+]EUZPU>YN]/F8X90TA(#9'*NH[C!^F14
M>H7=[=_!_7AJMJT&K75RX:U7[S2"1 VT<DC(SQGCOWKUVB@#C+,>'-/UZSO-
M*DN;BZN5-L(EEEFXD9"7.\G8%$.3T[>HSQOB-M(N+>37_#&IRZ+XHEE/F6-N
MS;[Q@3P8^-P)^;?@J><Y)X]EHH \_P#%B^'=7GCT_P 3F/3-1@LHKNWU$2&/
MR9&+@JK],JR A2QSG@<9K1^'$NKOX<GCU:ZEO/(O9H;2[F4J]Q I 5R"2>3N
MZ\XQUZUU]% ' _$73+];S1]<T5-NI12M8F1!@[)P44L?[JNP(R>"<UEZ?X/_
M +(^(0T.TM6'AZ2*#4F#$D&2 % N>.2YCD/7.WT)%>I44 >?>,XK:]^(?@Z*
M6640PF\%P\$[Q-$6B79ET(9,G ZC/TI#:V>D?%?3_*N;CRO[-E25[J[EG"N6
M4JNZ1CM) SC//IR*]"HH \HTS3_#VIGQ;_:=Q-;R7.IW,<+^?*H:.15 <*I"
MNN0><'@#)Q4_B2[MO$/BWP;<R?;;*SQ?;Y1(T$L2M&HC<E3F,,1QG&1U'45Z
MA10!P'@NX3PS<ZCX?UD"&^29IEU&4'%_&QRKM*0 7&=IR<\<9YK"\'VOAN+P
M?9SW\UU:WL5XUT\;/.3^[G,B_NAP<JJ]%Y)Z9KURB@#SO[9-I'C]/$E[9W$.
MC:MI<:R3M%D6DJG($I!^12.Y'4@<8)J;5YX/$_C+P[-ILBS6&E-+>75^O,"C
M;A5#]&)(YP> ,\UWU% 'EWA'PWI>NS^)OMXN/-_X2"XN(=EQ(@:/<I5PH.UE
M)SS@Y_*N]MO$.F7>NW6BQ3L=0M5W2Q-$R\84Y#$8/WTZ'N*U*HQZ5 FM3:JS
MRO<R0B!=S?+'&#G"@>IY).3TYP * ./\1B"T^*?A_4+V'_1OL4T:RF(N/,!!
M4< \\Y%<=;VL$/@F.=+>%=1C\1K.',?[Q5\W(?@;MN!U]*]OHH \<NX=)?5_
M$6E>,GU!I;^_-U9+!"T@N8 !Y01E0X*CY>H W$=S7;^.=$O=>^'-]I=G&QO)
M(8RD<CAF)1E<J6Z$G:1GUKK** .6TGQYI&H:?$SRO'J14"33FB9;C?W C/)&
M>_3U-8(O+*T\<>)!XHA$%GJEE;"U-RI*L@C(DA!_O;B3L')_*O1Z* /%_#6A
MDZ[X0M/$%C!/,FE3)<1W$2ML)/[I'!'#",J,'D8Q39;#PR(?'VGS6FG#4/.D
M73K<0@2[A#\@A YX;LHX[\&O:JQ-"T&;1[_5KA[U)TU&Y-R8Q!L,;$!<9W'(
MP!^OK0!PFGQ2Z-XINH?&KHUI=Z);VT4LY+([*BB:)3W9GW-M')X(KFM/T2\A
M'PZMM<LMS1SW)FBN(LF*$LOEK(".!G<0#_3 ][HH \-\7-;6\_BNTL((],>)
M[/;:PVTK27 C=-LIXV)$J[@H3!..3T#=?8RV3?%;4[N>+_1K[2HVAEE@(5U&
M=Y)(X&!U.!C'J*]#HH \<T=I[3P'X%NIU866GZBQOP4(\CYG"NXZ@+N!R>.0
M>AJIXPL8[G3?&EWH\*/I=V+(P>3'\D]R) 7>+C#?)G++P<YYYQ[=10!Y7HMO
M!9_%31GLHHH+9O#R13&%%5&DW$[6(_BP%..O [5K:]#:S?%?19+R*&2VAT^?
M>TR@HC'IG/ .,UWU% 'BVG7RV'A[0;.2#R$CUFY:*\:.0Q6(WDH2BX!9]Y"9
M^7D^]5M&F4^$K6V;6)])O['5YY+.]NK0K# "&&V3> @W;FY X) P">?<J* .
M:\!W,UWX4ADN+6*"433!S!GRYF\QBTB9_A9B6'UXXQ7)^$+W1I['2]"U*PN'
M\2Z;?&26(1NKI,6.Z=G& 5*MGDX/ P>*]1HH \%?4!-J^@Z@L5S9K#KSR3Z?
M]FED>UW,-QE<@L9'ZX!QST.#5S5K^&U\)>-]'E>4:C+X@:XC@\EW(C:>(J_
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MBP/8ZEI+6WB-+V*R_L[S<JSR#*-O .$QDDX/3O3[CXB2Z=::Y;:AI/EZUI$
MG>W28&*>,X D1R =O(R",C(')SB#4OAW<ZI?SZ\US;V^NM?V][&J%G@7R4"K
M&20">A); Z]*DU/P'?:U-KNI74UI#J.J62V,<<3,T=O&""Q+$ N257^%<8H
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MH7>[$#8/E4[0&YSR1Q0!FZ#\3KW5H]'O+G0DM=,U"^-C]H%T'*RG<4 3 )'
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MZ=)%9>8X.7+%ANQCKQUZD>Y +%CXVGO#X9D?2XH[;75;#K=;GA<*S8*[ &&
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MMX[0.L"[B#YKA@2SC:,= ,L.]4[#P*=,N]1M;1HET+4[)+>ZM#(V\.$*-(A
MQEE^]D98\D]J *VF_$=[O6;**?2ECTR_1Y(;N.<R-$H!*^<H7Y"PP>I SC)P
M<7K3Q5KM])I\]OX<1M/U-'>TF-R^8P 61I\1GRPZXQC=@\'K46B>&O$ME91:
M'J&J6,NAVR^5&\".MU+&!\JN22JCH" .@QFI?#.A>)])AMM*O]2L9-)L2%MY
M(%?[1/&N=B29X4#Y?NYR%QTSD IV/Q&DN[#PO>MI")#KMPUOQ=[F@8.5!QLP
MPXSU!&<8XK)T+Q]K$<WBBYUBTA=+2^%I!%'<X GR(UB7*_=)!8N>G/![+:?#
MKQ#;6OARP%_I@M-$OVN(WVR&212Y?)Z#.3C;T[[NU6W^'6I>9KZPZI;PI?Z@
M-3MI!&QDBG#[U!Y VCIW//;'(!H6?C\06VLOKEFL)TM$<S63M/%=;N (R57G
M<0N#W(YQG&#I[7\WQQMIM7T^WL;M]&+B."?S@PWG&3A?F RIP#]W(X.1OW_A
MGQ%XF\,ZA8>(=0L8;B>(+ NFJXBC97#AFWY+'**.V!G'7-1:=X9\32^.K+Q+
MK%SI:-!I_P!CECM#(WF'<QS\P&.H/].,T =3K\,=QX=U**9%=&MI,J1_LDBO
M/_!_BW5=*T;PW9:AH(ATN\AAM+*^-TIWS%#M#*,E0Q'![?H/2KVW^V6-Q;;]
MGG1-'NQG&1C.*Y#2_".HBP\/Z9JALOL>ARI/')#(TCW$B*RIE64",#<3P6Z#
M&* (;;XAW4NBZO=7&CV]MJ&G7JV9L)+XEI7. H4B,_>)PO&#@DD 9KN83*T$
M9G1$F*@R(CEE5L<@,0,C/? ^@K@=.BTGQ5\14\0:1??:K*VM5-R%!V-.-RQ=
M1U"M(2.Q"'J:]!H \=\3ZWK>JP^/-,U*QMEMM-MHMA2<D1EMS(0-OS%E8$GC
M&WZ5M>#/&%S:IH&@ZII:VEM-HT<]K=B</O6.-<[E ^7(!/7T]3BYK7@C4K_4
M/%,EK=VBV^O001MYH;?&T:E>,<8[_IQUID?@.];4_#5Q/-:M#I&G&PE17;,H
M,9C+*<<'!S@Y],]Z )='^($^IZU8PMIT2Z=J);[/+%*SR1#;E#*NW"[AZ$XW
M 'H:[#4[J6RTRZNH(4FDAB:01O(4#8&<;@#C\C7+^&]!\4Z2EKI5YJ=A)HMC
MM6"2%)!=2HOW5<D[5 X&!G(&.*ZR[MQ=V4]LS%1-&T9([9&* .6L_&TMU'X8
MF.EJL.N*^-MSN:%@A8#&T!@<8SD8STXK(E^)6I1+?7[>'E31]-U5K"]N&NUW
MQ@,J[@N.3E@2!D<@9ZD&F^"O$MM'X;@GN]*$&AS.T?EB4M*I4@$GC!.3QT'J
M>E27'@/4Y_#'B+1_M-JAUC5&U 3*[?N=SH^W&WDC9C/'7...0"E\0=>NM8\+
M^([?3M+BGTS3\P7%Y-/L8S @.(TP=VS(R21DYQG'-H^,)-&T32]/T2TMKQK3
M2K>XF6>X\G,90;$C +Y<A6/WB!@<L2*COO!/B8VWB+3+&[TPZ7K4KW3"X>3S
M8)9,%PI"X*Y'&?RZU<A\*>*-%N;.]T74]-EN6L8+*_6^24H_E<+(NULEL$C!
MQW/&> "*Y^(VI3:M8Z9H_AN2ZNKS35OHTGN5A())!4AAQC:PSW/;')OZ-XWG
MUWQ$]G9Z?$+.*Z>UG\RXQ=0%$8EWB (5"X" [NOUP"'PEJ2>.[#Q%/>Q3BWL
M3:2!B0SL69F8<8 RY 7T YJJW@W6;[Q!IFI:C<V2W-A=M-_:-H6CGN(<Y$$B
MA0I'1<Y/RY&.22 /L/%%CI7AGQ/K2:0EFMKJL\;PB89GFW*FYVQA2SD GD <
MY-+<>-==TN]U.SU+P];L]AISZ@TMI?[E=/FV@!D!'*D$]>,@'BLS7M-D\-^!
M_$4.HSV6S6-4,J.ZM)'%Y\BY#@X("@$[EY[@9'.=X>M[V[@U30H[G0-1N=3L
M98IK^QU&>Z:%<%4WE]V% 8@*#SCZF@#=T3XC7E_JF@PZAHBV5GK<3&TG%T'.
M]!E@5QP"2 /J/4@26?Q%>]U>Q2+3$?2KVY-M'<13EY5S]R1HPN C' ^]QWQT
MJ*V\!ZE _@\FZMB/#XD#%78&??@?W?EQCWSG''6K?A_PSXET(0:.FJV3^'[>
M7S(G\M_M80/O$6<[=O12>NTD#'& #FOB+K=SKW@[4YK?2K>71(;I+;[<UQB5
M2LJ!W$9 !7<-GW@><\#./6Z\TOO ?B-_#NK>&[.^T[^R[NZ%Q!-,T@GB!E60
MJ0!MX(./7/;MZ2@<1J)&5GP-Q48!/L,G'YT >/Z[J^KZ[H/CJWU>QMDATXXA
M,5P7$3A0  "HW @LVXXY/3TZGPOXMO9-6B\.ZCHYM91IB7EHR7"R&:(84!AP
M%8D$]<=L]S'J'@C4YQXJMK>[M/LFN,'!D#!XFP >G!'!X[YZC'-F'PGJ,/C+
M3]?WVC"STL6'D^8V6(R=^[;QR<8P>* ,30_&MEIG@#2[W3M&L],CO[V2WACE
MN2MO"V6.^27;Q]T\8Y[8'3O]$OKK4=*CNKRT6UG9Y 8DD\Q<*[*K*V!N# !@
M<#((KC]$\&ZWH'A6ST6-M)U"&&:1IX+L-Y=PC]LE6V$9/0$'N*Z+P?H$GAKP
M^FFO*'"RR.B*[.L2LQ(12W) '<]>: &>)?"^CZ\DDVO/++8PP\0F9HXXB"2T
MGRD9.,=<@!>.ISB:)J5_I7P^TBSFF=-:O \5FMZ09%3>=KR D<)&5+?0#J0#
MH^+-"US7+NS6SGTT6%LZS&WNTD82RJ<J6V,N5'4+G!/7/&))O!]KX@@@E\76
MMCJ%]$6V- CQQHI*G:!NR?N@\D]6'0D4 <9X1TNXUSX?>-=(-PUQ>2:G=1*]
MPX=G<(@4L2.Y4<X'J,8J[:>$=4=HKN?1;>VNH[[3IDV31LR1PJ!)AN.N&X[[
MOK6YX%\"6W@U=0<")IKBY=HWC+?) =NV,YZX(//O78T %>-^.M:F\26?A_41
MI\":*VN1QVMYYQ,L@5G4DQD* K;<CYL_+SC(Q[)7EDWP[\2'1-/\/PW^F_V;
MIFIK=VEPYD\_RP7.U@!C(+]B/PQ0!N:AX[N].\0?9;C25AT[[?%8K-/*R33%
M^/,C0KAD!XR&/ S]+T?BVX76M?TV\L+:T.EVWVJ*62\)6XB.[#G"911M^8_-
M@GH:YR[^'NNRW6J-'?::XO-4CU%9Y5E\W"MD1<'A5 &"#GMQP0OB&QM_%7C3
M1+2SOQ+J6G%XM8\A2D8@*J6!#$XW,0 H)/S'GY<@ [[2+JZOM(M;N]M%M+B:
M,2/;K+YGEYY +8&3C&>.N>O4X.K>)M574]0L?#^E0ZA+I:127BRSF,MO!81Q
M@*<MM&<D@#(ZYKJZY5]!U;3?%>J:UH[64HU6*)9X[MW3RI(P55UVJ=PP>5^7
M/]X4 <]XH\1W6O:?X8N-(TV.\TG4;R)B)KH1^<X$A,$B;2, H"3DC*XP>M=S
MH>B6&@:=]DTZT6UA9S*T22,ZJ[=<%NWMP/85SD?@NYTW1O#>E:;+;M!HURMT
M\D[,K3/A]P  .T$R$]3CIVY[1<[1N !QR <T +1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OKO[#:/<?9Y
MIU0%F6$ L  23@D9Z=!D^U6:ANR%LIRVW C8G><#IW/84 4-)\0Z?KNB+JVE
M2-=V[ _+&!O##JI!(PP]#_459TO48]6TV"_ABE2"X198C)@%T8 AL G&0>_/
MM7E>FVESX'TG0_&%@TLFC7.G6HU>PC!)!,2CSU'3(.W/3OS\QQI^'YCJ&H^%
M]"O))ETX^%H;E(TE:-99LH.JD$E5&0.<9SQ0!Z;17DQ?66\#7MZU_J4MSX9U
M::/S%NY$:_MH9 7$F& /R[N>OR=>35C7-?:]LAKUEJ5Q!I6H:E!81S&YDBB$
M*!BTI(.8PT@V%AM.U1R,DT >HT5Y-XHM=2\/>#/%<8UF6-U^S75K!!<R[K17
MDV%0[$91MK87MSP>*U#HFWXE1:-_:>L#36TG[9)%]OF_>S+*5R9-VX?ZS)5"
MHR%)&.* .KU+Q-::7XBTK19X+DSZGO\ (E15,8*#+!B3GICH#UK1N=.L;R6*
M6ZLK>>2(YC>6)6*=^"1Q7BD:W&NQ?#2'4K^[$LDFH027"N8YB$8(!GJ"0H4]
M_P >:N6^J:QI9U/09=3N[C3H-=MK)+NZN#Y@C=78H\BC<JY6-2>.&.,4 >T5
M'<7$-I;2W-Q(L4,2&221S@*H&22?0"O)_%5KJGASP7XI7^V95E3[+<VT-O<S
M9M5DEV, Q/W&VMA>W/UKTO2-'CTBQDM!=WEXLDKR%[V;S6^8\KD_P^U &5IO
MCC3-2UR/21;:C:RSHTEI)=VK0I=*!DF/=R<#GD#BI;CQEIEM-<;EN&M+6X%K
M<WJJ/)AE)"A6).3RP!*@@'J15/[19Z[K^GZ\ETO]DZ:[PVTX.4N;B4B'*D'E
M5)* ]"6..!D\8/W?P<\5V\_SSIJ-S Z#YV\TS* O&><E?S!H [GQ!XYT[P[-
M(DUGJ5TL!7[5+9VQDCMLC(\QL@#@@XY."..1FW<^*]-CGL[:T\W4+N\@%U!;
MV@!9H?\ GIEB%"_4@GH 35/6);IM*'ANR=9-9N[0)-+G(A0C8T[$X)Z':.K$
M>QQS.@VL.E_&;[%%(/L\?AU;>VW/G<(Y%0@<]04;CV)H ] TC5['7=+AU+39
MUGM9AE' Q[$$'H0>U7J\]^$/R>$[J<R#[/>:I<268.1E.!A0?=7.![^]>A4
M%%%% !1110 4444 %%%% !1110!5ATRPMKJ2Z@L;:*XD)+RI$JNQ/4D@9-6J
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"ZLK6^B$5Y;0W$88.$
MFC#@,.AP>X]:GHH **** "BBB@ HHHH **** "BBB@ HHHH @M;*UL8C%9VT
M-O&6+E(8P@+'J<#N?6IZ** "BBB@ HHHH **** "BBB@ HHHH 9+%'-&T<J+
M)&PPRL,@_45#9Z?9:=$8K&SM[6,G)2",("?7 %6:* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ J**UMX)998H(HY)B#*Z( 7(Z$GO^-2T4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %17%O'=0F*7?L/79(R$_BI!J6B@"K;Z;9VNG#3XH%^QA/*$
M+DNH3&-N&S\N.,=,52G\,:1<06,+6K1BPC$5K)!/)%)$F NU71@V, #&>:UZ
M* *MMIME9Z<-/MK6**S"E/)1<+@YS^>22>Y)-0S:%I=QHJ:-/912Z='&D2V\
M@W*%7 4<^F!S6A10!@6_@KPY::))HT.EQ+ITCB22#<Q$C#&"Q)RW0=?05<_X
M1_3?[0^W^5+]L\GR//\ M$F_R^NW=NSC/./7GK6G10!A'P;X?^R6MJNGB.*T
M9GMO*E=&@+?>V,I#)DC)P1S5B3PWHTNC2:1)I\+V,I+21,"=[$Y+$]2V>=V<
MY[UJT4 <_;^"/#EKHSZ1#I<:Z?(^^2#>Y61N,%LG+=!USTK9FLX+BR>SF5G@
M=/+=6<DLN,$$YR>/SJ>B@#G;/P'X5T^\AN[70K..XA8/&^S)5AT(SW'4'M5V
M?PUH]SJ'VV6R5IC(LK?,P1W7&UV0':S# P2"1VK5HH Y_4/!'AK5;V2\U#2(
M+FYD.6EE+,Q_7I[=JLS^%]%GL[:U:PC2.U3RX#"S1-&I&"H92& /<9P>^:UZ
M* ,UO#^DD:<HL8E737WVBH-JQ'!' ''0GK]>M:5%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 456OM0LM,MC<W]Y;VD (!EGD$:Y/09)Q2VM]9WZ,]G=07"J0
M"T,@<#(SV]J +%%,$L9E:(.ID50S(#R <@$CT.#^1J&?4;&VD\NXO;>*3&=L
MDJJ?R)H LT56N=1L;.18[J]MX)&&56655)Z] 3['\JB_MG2O^@E9_P#?]?\
M&@"]13$FBDA$R2HT1&0ZL"N/7-43X@T4;LZO8#:<-_I*<'&<'GTY^E &C15:
MYU&QL[07=U>V\%L0")I955#D9'S$XI]K=VU];K<6EQ%<0N,K)$X=3]".* )J
M*H7FNZ1I]TEK>ZK8VUP^-D4UPB.V>F 3DU8N+VUL]OVFYA@W9V^;(%SCKC-
M$]%5[>^L[MF6VNH)BHR1'(&Q^50WNLZ7IL\4%]J5G:S3?ZN.>=49^<< GGF@
M"]14<%Q#=0)/;S1S0N,K)&P96^A'6F7%[:V>W[3<PP;L[?-D"YQUQF@">BJD
M&JZ==.B6]_:S.XRJQS*Q;C/&#SQ3YKZSMY5BGNH(I&&51Y I/;@&@"Q15*^U
MC3-+:-=0U&TM#(<(+B=8]_TR1FK,-Q#<H7@FCE4'!9&##IGM[$?G0!)1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8T=Q=ZS,C
M6V8=)*DF?<5EG((QLQT0C/S<$XXX(:@"W<:DD5TMI!&UQ=-G*(1B/C(,A_A'
M/H2>P-0MI]W?@?VA=M'$1S:VCE%/0_-)P[8([; 02"IJ[:6=M86X@M84AC!+
M;4&,DG))]23R2>2>M3T ,AABMXEB@B2*->B(H4#\!3Z** "BBB@!&8*I9B
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M6A++'#&TDKK'&HRS,< ?4UE3ZC?7NR/1H$,;G#WL^0D8(SN5>LGIC(&3UZT
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M)+]I$\?ER%GR-Q+;P<'&-I "X!( J>:QO=21HKZ;[-;GJEE.ZNYSD9D&UE'
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MV*TK2SMK"V6WM(4AB7HJ#'/<GU/OWJ>B@ HHHH **** "BBB@ HHHH ****
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M22=_/E3C^*-<(#GT=AP.N<#E(?AYX%UX3);;KD6KF-S%.3L8KTSWZY[]O:K
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MV,GRV;D]AGMSGURZ@>XMVB2XEMRPQYD6W</IN!'Z5F+X9T]O"J>'+L27FGK
MMOB?&[8H 7E0.1@$'KD9H XV"66ST+PO%I=Y]AFO]-C9KE+<W=W@1H51(R&
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M_%G&6STQA0.36MHWB3Q3K,FEZS:V(?2+Z79) RPJL$.\@2"3S=[2=,C;@C@
M$?-M:;X.CLAID=SJ=Y?6VE8^PP3!%6,A=JLVU0695) SQ@],\U!IW@"STR]4
MV^IZE_9:3?:(]*:4&W20/O&!C(4-A@N>HR<Y(H C\% _VYXP.3C^UCQZ?NTK
ML:RM(T&+1[O4;B&[NI?M\YN)4F*%5<@ E<*".% ZGI6K0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *15"J%4  #  [4M%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J6VFVMK9&R2,-;%F
M/E2?,!N))'/;)/%6Z** $VC<6P,D8)IODQ&)XC$GEOG<FT8;/7(]\G/UI]%
M#2B&02%5+J" V.0#C(S^ _*@(@D,@50[  MCD@9P,_B?SIU% $%U9V][:S6U
MQ$KPS#;*AX#CH0<=01P1W''2IZ** *QL86U)+]@QG2%H4)/"JQ!; ]RJ9_W1
M[YLT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ex10-7_001.jpg
<TEXT>
begin 644 ex10-7_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .=\5?\NG_ _P#V6NBKG?%7_+I_P/\ ]EKHJ\S"_P"^U_\ MW\C
M>I_"A\PHHHKTS **** "BBB@ JM?F\^P3?V?Y7VLKB(S E WJP!!('7 (JS1
M0!PT6I>,9O%=]H2ZGH6ZULXKH2G2IL.79QMQ]HXQLZ\]>E6[;Q#=6'B;4H/$
M&I6-M90V-K.NX"%(GD+JREV8[N4XZ=<8[FMI]T3\6-4D-GJ*P36$-M'.^GSK
M$TB/(6'F%-N,$8.<'/!-0WTZ?\)GXCEDT[4'C_L>.!)1ILSI(P,I948(0W#K
MP,Y]\'!>T;^3_4I)-M/R_3_@G7W$A.I6.S4HH48/FV(4FY^7C:2<C&">*EAU
M&QN+N:UAO;>2YA(66%)5+QDC.& .1QSS7FVB*$O_  !/)I.HI=VU@UM=3/I<
MX:/]V$"NY3@;@W4X[]#FM[2H-2TSQ.EG:2W-YI4LDDTL=Y9,C69;<V4GP%<%
MN-O+#=G.*IQL[>OX,S3TOZ&QXOU#4=)\+W^IZ7):K/9PO.5NH6D5U522N%=2
M"?7)^E7=&>_DTJ"74I[::YD4.6MH&B0 C(&UG8\>N?P%97CZ1AX'U>".WNKB
M:YM9((H[6VDF9G9" ,("0/<\>]1V'BB%[2PLK;3]7:Z81Q'SM)N8HTX 9F=X
MU4 <]ZE=?D6]D_4+76M5\1O>/H,EE:V=I<-;"XO+=Y_M#IP^U5=-J@\;LG.#
MQ5WP_P"(/[7FU&QN(5@U'39_)N8E?<O(W(ZG^ZRG//3D=JP_#P?P1!>Z5?6=
M]+;->RSVEQ:6DEP'21B^UA&&*LI)&2 #P<U';I<^'V\2>*[C3[U[S5)8Q;V4
M$#3R*B)M3<L><9.6/H"!G-"_3\=/^"+K\_PU_2QK0>)Y)/&S:-)"BV<L+_99
MQG,LL9'FKZ8 9<>ZM4'B3Q%J7AG5K2YGC@N-!ER+CRH6$]J !^]+;B'0$\@*
M" <\X-8'B#1+W1]#TO6K35-?U2?3[F.Y@LA8QLS[CB0%4A$@)1G^\>">>:Z6
M?6[6[U?2 ;'5#'<1/N\S2[@*F_  D)3"=#D-C'4\$&GV[H.[Z,MWMUJDFK:7
M_9U[IXTZYR9!);-([ #=E'$B@9' ^4XZ\]*VZXK2="U+P_XIMK"V'G>&\2S6
MQ)RUFY&##[H<Y7TP1Z5M^)]6?2M))AM[Z::=A"AM+22X,>[@N0@) 49/OC Y
MI/;0.NI4TCQ/)J'BK4-)F@2*%8A/8R#.9XPQ20GZ.!C'9@>]3:EK=VVO+H.D
M1P-?>1]HGGN 3';1DE5)4$%V)!PN5X!.1QGEM<TF[\+3:!K-M?Z_K!LIA;BT
M2QCD/V=QA_\ 4PJPP K?,>J^M:$\-YI/C4^*[6QNKO2]2L4ANHXX6\^W9,LC
M^40&(()!4#<#VIZ:?/\ X'WA?>W]=S?MV\0QS_9+MK"7= [)>PP.B+("-JM$
M7)Q@D\/S@_=KCQXO\4V?A.\\37<FCW-K8W,T,UI%:2PNZQRF,E9#*X!.,X*^
MV>]6H['3M3^(,7B>'091;VUA*)KJ?2WBE:;<FTJCH)'8*& (!]!Z5B:#H37.
MD3ZE%I^IRW]GJ=Q=G3M1CN(X;B-I790D<V(P^W#!E&0P&>IH7=_UK_E_F'I_
M6G^9V/BG5M9L5T>329[&%+ZZCMG6\M'E9=^2&&V1,8QT[^HJW:?\)&MW<6UU
MJ6DSG[.61X=/DC\J0GY2RF9MZG#< J>.O-<SXOU2R\0:9HBR:+J\]O\ VE%+
M<VT^B7+[8USNWKY9!'(]<]LX-;&A7/A_3Y;H:'H5[8P&+S;@)HTUJGR]-J&-
M2[G/103@?3*[_/\ 07;Y%#1]6\7ZMH#:G_:>@Q,)Y8%B;2YL,R2M&/F^T<;B
M!VXSWJU?^)=5T?QM8V%\+-]&O55!(D3)+!*V0@9BY# E6&0HY*BN8\,6_ANT
MTP7&I>%K\:PM[-<K./#EP9S^_9T(D\GN-O4].#BNCU:&'Q)JFH://:W\#SZ>
MB+,UE*(XYE8N")2NPE25.0>O'6GM;^NG_#_,??\ KK_7R+?C;Q)?:#:V4>EQ
MV[WES=11,UPC.D4;R*A<JK*2<L !D=_2HM3U#Q/#XKTS1[6_TA$O+669I)=.
MD<JT>P' $XX)?(],=3UK UO^U6\*65SK&GW;ZS<WMF\L-E:2W BCAE0GE%..
M-S\\_,0,XJSXH;2M3\:Z)+J>AWNH:=!9SF02:)<7"*[^64X\H_-@-[CH<467
MXO\ (?\ E^IM7MWXJM=#U*YBO=%N+FSS(C?894CD55):,KYQ*MD?>R1[4^#Q
M+/K/A.\OM,,-GJ=HK"XMKR(R>1*HRR,JLI.>S X((/-4S>:9:^$-6M]'T;4K
M>R6-UBA32IHBTD@/RQP^6&QD\G;@9Z]<0>)=)O;FR;Q+X9BD%_+:F*ZLYHFB
M-Y#@C:RL RR+DE21GMT-+_@?U_7KW!6NOZ_K^D7=:O/%FG:'<ZC%>Z-ML[$S
MOOT^1O.D 9B% G&Q<!1SN.<U<\.7'B*[AL[S4[G3)K2ZM%FVVMH\+QN0I ):
M5]PP3V'2CQ@[)X%U.)8+F:6:RDACBM[=YG9V0@#:@)Z]^@[U:\*3>=X5TP>5
M<0M';1Q.EQ \+JRJ 05< ]1UQ@]J:W?]=_\ @$](_P!=O^"3:MJ$EJ]I9VP4
MWE[(8XBPRJ  LSD=P .G<D#C-9-WXJLGGU/0M/UBT&MV5KYG[W:Y+X)/[L%=
MQ 7) QC<*?JT+Q^.?#U\S$0>5<VO_;1PK+^D;50OGFT_Q'XEFDL;Z2*YTZ'R
M7M[5Y0Y42 @;0?FRR\=><] 2(E\+^?X;%+XE\OQW-CPSKL&IZ1IR37]M+JDE
MC#<3PK(OF#<H.XH.0"3Z8JQ!?06=K?75]K-K+;Q3N6F8I&ENO&$8YQQGJ>>:
MX?2G\FZ\!*-,U*/[/9217).F3J(F:,+ASLPN74]?8]"#1HFFQ3Z%K%I;PZKH
MXBUB2[M)(=,DC*+U5EC9,.IP1@ ]1TX-:3MS.WG^?^1$+\JOY?D_U/28IHKB
M)989$DC;D,C @_B*Y^\\7V%E=ZQ;S.Z2:7"DTR>1(Q$;8_># ^91SPN3\IJS
MX6N-2N=&$FJ1(L_FMMD6W:#SDSQ(8F^9">ZGGZ=*VJEHI,R-4UR.P\+3:S"I
MN +?S845"#*Q'R *>1DD<>]5_!7B1/%OA#3M:4(KW$?[Y$SA)!PP&><9!Q[5
M1UJ\O=3\26NDZ<);5K4F=[F\TF>:VD;:0%#AD7(!)SNQG Y/3B_AW%J/ACQ#
MXC\,7EGJ1TNYG::TU"'2YX8%<CYP"P.T=,')'R]3D47W^]?+_/\ 0+;?C\_Z
M_$])?Q9X<BO_ +!)X@TI+S>(_L[7D8DW'HNW.<^U2KXCT)VF5-:TYF@E$,H%
MTA,<A. C<\,2" #SFO#O!&J^&Y-;\*Z;_P )/:+_ &/-.+9A#.DUXTI/RR;D
M")] [;N.G2NP\-:+#J/Q&\<#5='O?LE[-;O;R7%G+'%+Y74JY4#APIZ\XR,B
MJ2_7\+?YO[A/2_\ 7?\ R7WGI/\ :NG?VG_9GV^U^W[/,^R^<OF[?[VS.<>^
M*&U73DU)=.>_M5OG7>ML9E$K+ZA<YQ[XKRKPMX7OV\07]IK\NOV]Q!K3:G:M
M! AMIQG"L9O+)^[D%2XXX HT7PQJ$OB[7+/79M?@\S6!J=G):0(UO. ?DS,8
MV*E0,%2Z\<8I1UMY_P# _P W]PWI?R_X/_ ^\]);Q7X=0SAM?TI3;R"*8&\C
M'EN20%;G@Y!&#Z5;@U?3;F_EL(-0M);V%0TMO',K2(#T+*#D#D=:\4U73[Z3
M4?BDZZ)JKG488H[%AILQ\XK\K;#LY^;!]QST&:U= T][3Q[X-DMM$U&VMX=$
M:"YE.G3(B3,,X=BN,YR23W/O26MOE^3?Z6^8I.U_ZZK_ #_ ]775=.?47TY+
M^U:^1=[VPF4RJOJ5SD#WJI%XI\/3[/)U[2Y-\OD)LO(SND_N#!Y;VZUYKX&\
M,WZZB;;Q!+K\&H:=JLM[$$MT%K/NR-_G>7ELAB"I?/H...5U73=3F\*>+K>#
M0-9-W>>(Q=6X&ESAGAW9# [.G!^F?>G'6U_+\TOU?W%-;VZ?\'_)?>>TZGXU
MT+2?$=EH5UJ%M'>W63MDE5?+&.,Y[L< #J?PJ ZCXHCBA+V^DR.-3\F01/)\
M]L3PR9'^L7/S \?*U8.H65\WQC\.:VEA>2:>^ER0&98&_=N<D!^/DX(^]CTK
MT:A;7?G^#)OK]WXHRK&^F359])O'#SI&)X90NWS8B2.1_>4\'''(/&<#0GN;
M>VV>?/%%O8(GF.%W,>@&>IK!EB:?XC6TT;';:Z7(LP X_>2)L!_[]O\ E6=X
M^B@>Z\.ROIMQ=S0:E'+YD%A)<&*(??)**=H/R\<9QWQ2[>?^=AOK_72YT7_"
M0Z(;9;G^V-/\AI?(67[2FTR9QL!SC=GMUJ6_U?3-*\K^T=1M+/SFV1?:)UCW
MMZ+N(R?I7G6JEI(?B*D>EZFSWD02VVZ9.?.;R1'\AV?-\XZCL,].:M:L;K5+
M:>WM].U" W.A^4MQ]AD9YV&[,1#KMBP>?G7+;N.G*O[M_P"MK_H597M?^M/\
M_P #O=0U&STZU\^\OK6SC8A$EN) J;CT')&>>V>:YWP?XCEN?![ZIX@U"U4Q
M75Q%)<MMAB"I*R \G & .I/U-4;22ZLM8T74+S3=0DL7TE+6,):M(UM/D;MZ
M*"R[@ ,D8&WG%<K;V&L:=X<L)[GP[K<EI9ZE>M/9V$[0W!21RR2Q^4ZLP )7
M:<9W$XP :JUF_P"NK_KYHA.Z3_K;^ON/8+:Y@O+:.XM9XYX)%W)+$X96'J".
M"*KW>L:9I]U!:WNI6=M<7!Q#%-.J/*?103D_A6=X/MK6WT!&L]+U#389Y&F^
MSZC*SSY8Y+/N=R"3SC/UP:Y7QK!>WR^);2VTZ]21[2)D:WM&F^VA.<!R"BX)
M(VC#GJ.U%O>M_70%JKG?SZC8VUU%:W%[;Q7$P+1122JKN!U(!.3CVJS7#^((
M]1M[]=5T9[PW<\20OIT]BTT%R%R0"P'[D\D;F.!W&:[&Z2::QFCA?RIGC94?
MKM8C@_@:3TC<:U=B&'6-,N-0ET^#4;26]A&9;9)U:1!_M*#D?C7,V_B2+Q'X
MFO-.TGQ-:VTNGS(HMXFAF^U+M#2;E/S8&=N5(P0<YZ5EV5E=WVD>&=*&G7=I
MJ^CW,+7,\ELPC15!$C+*1M<.,CY23\W('.-3PI=[_%OB@-::A$MS=I+#)/83
M1(ZK$B$AW0+]X'C.3C(R.:JVOW_IJ'3[OU-S7?$VD^&TM6U2^M[;[5,(H_.E
M" GN<GH .2?IZUF:=XA,&MZW#K&K6*VL5Q"EFS;85Q(FX+DL=S<]<\]@*G\7
M1S;-'N(K>>=+;4X991!&9&5,,"VU<D@%AG%<GK,IN[;Q^%TG5#-=6RQ6^=,G
M)E/E;,(0F&&_T..,].:A/]?T_P"".U[+T_-GH,S/_;-J!J4<:>5)NLRJEICQ
MA@<Y&W!Z==WM4MMJ-C>R2QVMY;SR0L4E6*56*,.H8 \'D<&N&0Q2>.O#5\FF
M7X9M*EAN+DZ;,I!;9L5W*#;]U^&(Q[9&;_AB'4=-UD:7'+<WND0P-LEO;)H9
M;4Y4K&)" )@1Z XV\DU5NGK^9-]+^GY'57WVTP;+ PI,W EG4NB<=2H(+?3(
M^M8^E:].(-876_L\3Z3)MFN8@5BD3RUDW@$DKPW(R<8ZFK'B;7F\/:2UW%IF
MHZC,6V1V]A:M,Y/J0.@'J2*Y:&>Y\7>"];L;'0]8TV=EW;M8MQ ]U*3N(QD_
M*<!<] "!VI+K_78KL:NGZ]/K[--'<Z<ELA^:R1_-N4R,J9"&Q&<?P;3UZUN6
M4D<,4\DKJD: %F8X '/)-<Q*G]L^(M*U6VL;NR6R@E@N?M%N\!8L%VQ@,!O
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MW6MZ_ID<5Y$NDPC?<&PG<!\,6R%4X  &,X+<XS4WTO\ UH5;^O4[:BN%\/\
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MGO0#T->BD(R",X]Q7!>#_%$5GI]S!K>J74TQU:YM8[FXB9EPLFU%=U78A/
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MW$9YS-:*'EB6TE:0J<X95"Y=>#\R@C@\TV;Q?H$!ME;4XF>ZMS=0QQAI'DB
M)+A5!., ]O;K2&;=%8UYXKT:PCCDGNG\MXUE+QV\DBQHW*M(54B-3ZO@<5+J
M6LV%K D;W<JO<H3$;6)IG"GC> JM\HR/F(VCC-#T!:FI17+?#J\NM0\#V-S>
M74MU.[S;II6RSXE<#/X =.*QM:U=[#QW/I^H^.9M&L'LDN85D-G&-Y=E*JTL
M1)&%!ZD^]#T=OZVN"U5_ZWL>A45R?@S7[G4M,U&XOKN*ZLK6Y:*VU-5"+=1
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M,#LN1US3L[V_K05]+GH]%<UKFHZG9>+/#MO!=1+87T\D4T/DY9ML3N#O)Z9
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M7:K,D\FAV\30>)4O5CM9HHT>V7_EIC(W.>I+_-^'%>ST4)V::Z?YW!ZW\_\
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M:YZZTWQ!-X2\16*^&[_[3?:H;B%#/;<QLZMDGS<#&S&.N2.O./3J*/Z_%/\
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M[@,$8YZU?NK>X\0O!!=Z1/8K:7B3K/++$=VQL@Q[&8\XP=P4X)KH:*=VW?\
MJXK:6_JQR?B:'4YO$_AR>ST>[N[>RN'FGFBDA55#1NF,/(K$@L"<#IZGBMS6
M+6:^LTM(US'-*BSG(XB!RWUR!M_X%6A12Z6'UN8/B6P74%M8O['FO9D<O#<1
M77V;[,V.ID5A(H/3Y WN,4VQL9O"^C-]FL9]4NI[AIKD0.BN[N>2/,=1@<
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MP;3PMJKZ;I>BZB]G)I^DS12P7,<K^=.(O]6'0KA#D+DAFS@\#/ _B_KS_P"
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M4P[L3MJ4I )<L#L^S\XSTW#IU%.FT#Q;IOB:ZO/#^I:4=/U&1);R+4879XI
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MLDN?#FEWESI=Y_:%]"'BLXS$7E^4,64[]H7GJS+V!P2!5+X<<0>(@!. -9G
M6X=G=1M3@EB2<=.II+7PSKMA#X?O(#ITFHZ5:-8O \KK%-$0@)#[25;,8/W2
M.2/>K.A:%K^B1ZPRW6G32WVI&[C5D<!$9AO!(/)VCC@8/4FM';F=O/\ -6_
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MPC<V]M?QVQU51#<L^V&Y0QN<A0^3RJD%U'JO&:T=!T/Q?;0R:/K6IZ5=:)'
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M3T_KT_ST#^OQ_P CI*XOXCR:P=)MX-.L]:DM&<O>W&C7"17,2*,@)N.22<9
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MQG9=XCN;M(F*^N&(..#4LFM:9'H[ZN+V&33T3S#<0MYB[?4%<Y_"DO+^M?\
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M;8V"1G)KM6944LS!5 R23@ 51L=;TG4S(+#5+*[,;;)!!<))L;T.#P?:A:;
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M=-YW.0<%LC( X%6/#?AU/#T%TJO!ONIO/=+6#R($; 'R1[FVYQD\G))-;=%
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M@TG:S\_U!7T\OT.3M/AII]KIOAFS^U2.VA7!F24K\TP((*GG@9*^O"XJ[?\
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MAA]0?4Y/-5=(^'UCH5Q</I^K:U'#(C+!:M>;X+3/>*-@5R.VX-BETMZ_F_\
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M1@JW7(W#G'%2M?Z]/\QO3^O7_(],N)KJ.YM8X+3SHI'(FE\P+Y*[20<'[V2
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M>\@QY-Q+;HTD>#D;6(R,'TH70](29I5TJQ65IOM#.+= 3+TWDX^]R>>M7Z*
M*?\ 9.FC4SJ8T^T_M KL-UY*^;M]-^,X]LTCZ1IDFIKJ;Z=:-?HNU;HP*90/
M0/C./QJ[10 UT26-HY%5T8896&01Z$50AT#1K?39--ATBPCL)<^9:I;((GSU
MR@&#^5:-% %+3=(TS1H&@TO3K2QA=M[1VL"Q*6Z9(4#GBEFTG3;C4(M0FT^T
MDO81B*X>%3(G^ZQ&1^%7** *MQIMA>7,%S<V5M//;DF&66)6:+/7:2,C/M4<
MNB:5/:QVLVF64EO%CRXGMU*)@Y& 1@8-7J* ,VZ\/:+?7JWEWH^GW%TB>6L\
MULCN%YX#$9QR>/<U7_X0[POY$<'_  C>C^3&YD2/[#%M5CC+ ;>"<#GV%;5%
M %*72-,GU"+4)M.M)+V$8BN7@4R(/16(R/PIPTO3Q?B_%C:_;0I47'DKY@!Z
MC=C.#5NB@"I!I>GVMW+=V]C;0W,JA9)HX55W Z L!D@4Z\TVQU$1"^LK>Z\E
MQ)%Y\2OL<=&7(X/N*LT4 4CHVEM;_9SIMF8/.\_RS NWS,[M^,8W9YSUS3]0
MTVPU:U-KJ-E;7EN2&,5S$LB$CH<,"*M44 9+^%?#LNGQ:?)H.EO91.7CMFLX
MS&C'J0N, ^]">%O#T<MK*FA:6LEH,6SK:1@P\D_(<?+R2>.YK6HH IKI.FIJ
M3:DFGVBW[+L:Z$*B4KZ%\9Q^-%QI.FW=[!>W.GVDUW;_ .IGDA5GC_W6(R/P
MJY10!5N--L+RY@N;FRMIY[<DPRRQ*S19Z[21D9]J1M*TYK>"W:PM3#;L'AC,
M*[8F'0J,8!'J*MT4 8A\&^%S=&Z/AO1S<%_,\W[#%OW9SNSMSG/.:NW^BZ5J
MLL$NHZ99WDEN=T+W$"R&,\<J6!QT'3TJ]10!GZGH.CZT8CJNDV-_Y6?+^U6Z
M2[,]<;@<=!^5$.A:/;ZDVI0:58Q7[+M-TENBRD8 QO SC  Z]JT** *-MHNE
M64MQ+::99027.3.T4"J9<_WB!\WXU2_X0WPO]E%K_P (WH_V</Y@B^PQ; ^,
M;L;<9QQFMNB@#';PGX<=KEG\/Z4S7/\ KR;.,F7D'YN/FY //<4J>%?#L<MO
M*F@:6LELNV!ULXP8ADG"G'RC))X]36O10!B)X1T""...TT73+:-)UN,0V<:_
M.OW6&!PP]>N":TK_ $ZQU6T:UU&RM[RV8@F&XB61"1TX8$59HH K6.GV6EVB
MVFGV=O:6R9*PV\0C1<G)PH '6H+[0M(U.YAN;_2K&[GA.8I9[=)&C/\ LDC(
MZ#I6A11Y@4M1T?2]8MT@U/3;.]A1MR1W,"R*IQC(# @'%5].\,Z!I%P;C3-#
MTVRF(VF2VM(XVQZ94 UJT4 17-K;WMM);74$4]O*NV2*5 RN/0@\$5'8:=8Z
M7:K:Z?9V]I;J21%;Q+&@S[  59HH J6^E:=:7L][;6%K#=W&/.GCA57EQTW,
M!D_C2G3;!M174396QOE3RQ<F)?,"_P!W=C./:K5% %.WTRUMM1N[^."!+BZ"
MB62.(*SA1QN/5B,]3VJ"[\.:'?Z@NH7FBZ=<7J;=MQ-:H\BXZ88C/':M.B@#
M*?PQH$NI_P!IR:'ICW^\/]J:TC,NX=#OQG/OFH1X-\+A"@\-Z.$+B0J+&+!<
M9PWW>O)Y]ZVZ* ,'5-,U:^OK:R@DTZ'P_P"6!<QF)C.Q!&$3!"A"!@\$^GJ-
M6]TZQU*-([ZSM[J-'$B+/$KA6'1@"."/6K-% %)M'TM[>2W?3;-H))?.>,P*
M5:3.=Y&,%L\YZYJ[@8QCBBB@#,T_PYH6DW+W.FZ+IUE<.I5I;:U2-F!.2"5
M)&14EAHFDZ5-/-IVEV5G+.<S/;VZ1M(>3EBH&>IZ^M7Z* (X;>&VC\N"&.*/
M);;&H49)R3@=R23^-5(-#TBU:Z:WTJQA:[S]I,=NBF;/7?@?-^-7Z* ,7_A#
MO"_D1P?\(WH_DQN9$C^PQ;58XRP&W@G Y]A6E>V%GJ5H]I?6D%U;/C=#/&'1
ML=,J>#5BB@"&TL[6PMDMK.VAM[>,82*% BJ/0 <"HK72].LKF>YM+"UMY[@Y
MFEBA5&E/JQ R?QJW10!633K&._DOX[*W6\D4(]PL2B1U'0%L9(JO=^']%O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML\5W6G:=:KXA?2HIK)A IE9]L@8J<9/(4$_[H/:O2J*J3NV_4/Z_&YY5#<:
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M<A],_)T/)!SGC%=;*':%UC;:Y4A3Z&O*Y8M2;PSX;T_^P=1EU32]4@DOL6^
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M-MS"Q5(WD,05P?,V)\S[< [1UQZ5Y_K.GS#2O$D5UI>I7TEQJ]K=6TATQG+
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M$5=4O6ME1M.E8P+L=P2PG <X4 X Y-7I==U>PO++1+D65WK5[)(T4D,;10K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUEG;! 5$90Q  &3C'/6DM(Z[Z_F#^*R\OR(O^$Y0?$\>$GA"Q269EBG(/SS
MY9 >A 7]0:F\5^+/[#U;2=)2ZL[&74O,V7M\A:&/9CY<!ERS;N/F']*\\\:Z
M)XCATSP]XCLV_M"_L+O[1!;V>AW,<[[VW2"3+MCG^\J_ATKO-9?2_%>CVZ:Q
MX:O[G29H6ED\VSD6:UD'&/+QYFXY;!0'IZ$&BWNKNGK^?]>GF&E_)K3\O^#\
M_(Z+3)M1E\]-0BMU,; 12P,2LRE0=V#]WG(VY/3J<UH5YOX,MKCP3HVM2F+6
M;K0%N8SIEM) SW*1D .?+(#*H)Z$ X4G'KZ.K!E##H1D4V)%/5!J36@72I+:
M.Y9U'F7,1D1%SR2H92>.G(YKDM+U3QCJ.I:U:K>Z&QTJY2#:-.E4S@HKG!^T
M'8?FQT/2NZZ"N(\&71D\4>*F:SU&%+N\6>![FPGA61!$B$AG0#.X'CKQG&*4
M=_Z\AO;^O,NZ/XA>+5=;M=<U2R3R=26VL]P6 ,&B1U0 L2S?-CKSZ#I6]>ZM
MINFR01WVH6MJ\[;(5GF5#(WHH)Y/L*\UUEGN='^(*Q:3JC3W<ZBV_P")7/NF
MQ%&@*_)R-R-R.G7H0:76T9]?GDU/PYXGU;3-5@A6W;3)IX=@V[6BGB$D849R
M<N/XB#TI[I?+\ARW?]=CU6N2U;4O$:>-+31M/O=*AMKJUEN%:XL))73RRBD$
MB90<E\YP,8[]:Z>TB$%G!$J&-4C50A<L5 '3)Z_6N"\5)I=Y\0=,.KZ'=ZC8
M6MC.DA;1IKN)9':,IC$; G ;D9QT.*6G-;U_)B7PO^NQO^&]>OM0U75](U&.
MW>YTQXU:ZM PBEWKG&TDE6'=<GJ.>:U[36-,O[F>VL]1M+B>W.)HH9U=H_\
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M]4T^U@AGN+ZVAAF8+%)),JK(3T"DGDGMBK2L&4,I!4C(([UP<^DK9:%I5UI
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MTJQMO%GA$VOAW4+:VCMKE9A/:RSM$LGW$EE^<?>+'!<[<\X!K2:3F[=W^O\
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M''(H&24D90K@#D[2<4W2_%&C:W)$FFWRW/FH\D;(C;75&VL0Q&#@X[]P>AH
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MVYRHC WEA@_+C(P>.*XO2M>MO[-\82:UXBO(+"/4?)ANY'\J6%6B1@J *"K
MD@#;GUYII:V_KI_F']?G_D>D45S\GBNS@\3C0WCNP5M?M#7!M9#&!GC+A=H&
M <L2!G SGBETK6M'B\.I?V^K37]E)-(([AMTSRMO;*( -SX((4*#P!C-+S_K
ML']?J;]%8A\7Z FDRZG+J4<-K#)Y4IG5HWC?LC(P#!N1\I&:L0>(=+N+B[@2
MYVR6L8FE\V-XQY9S\ZE@ R\'YER..M &G152QU*VU&,O;^< .=LT#Q-C) .U
MP#@X.#CFF76KV=E=I;3/)YK*7Q'"[A%Y^9RH(0<'!; .* +U%9FH^(-,TJ0+
M>32(/XY%@D>.+WD=5*QCW8BJEIXHMKSQ7>Z"D%V)+6*-_--K((V+;C]_;M P
M!@D\G.,XH6H/0WJ*Y3QGXBCTB32K!Q?!;^Z$4K6MM.[>7M8D*T:DAC@< [L9
M(Z9%A-8TCPQ9I:W6I7\R*/,,ES'+.\",25\UPI**.1F0@\<GBA:@SHZ*Q;SQ
M=H-C=/:SZE%YZ6_VIHXPTC+%Q\Y"@\<C\.>@-<WX@\7#4]"\66NFRZG876DP
MNRW*VKQ[BJ!SAW3: <@8X8CD<8- TKNQWU%9.EZ[87MP-/CN':\C@25E>-UW
MJ<?,K, '&>"5)P>M9OB*[FL?%/AR7[?<1VLLLT<ULF-DF(F8$@#<QR!@9_#-
M-K6W]=?\B;Z7_KI_F=116;::_IM[IAU&WN&:W#F,YB=7#@X*%" P;/&W&?:J
MC>,O#\=HMS/J*VRF=;?9<QO#*)3R%,;@."1SR.G/2D,W:*QV\3Z4MH;E9;B1
M!(\92&TFDD!5MK9C52V >^,>]0W&LZ+<ZGHBKK16:Y+36D$$O%TNQL[@!RH&
M3S@9 ^E &W%$D*;$&!UY.2?J3UI]847C+P_.L3P:DDT,MQ]F6:*-WB$F<!6<
M#:N20!D@$\#FM./4;274Y].27-W!&DLD>T_*KDA3G&#G:?RH M45G:KKNGZ,
MJF\DEW.I98X+>2=RHQEMD:LVT9&3C R*@;Q7H0EM8EU*&26[@^T6\469'ECQ
MG<JJ"2/3UZ#F@#8HK*C\1Z5+I"ZHET6M68HN(G\PN"04$>-^_((VXW9'2N9\
M-^(5CO\ QC>ZAJ=W+IME/&Z-<QL&@C,0<KL"@C!)&-N[CG)HMK;^NG^8=+_U
M_6AW=%(K!T5E.589!I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N)O_#6IS6VM6<"(D*3&
M_P!+?>/^/@X?!'8"0,>>OF>U=M10!QWBG3]5NO 4MG;:;+=ZE=.CR10R1C8Q
M<.WS.R@@8V\'TINKZ1J,NK0:KHUOJ-AJ4WEB9A<1&W9  2)XRQR0,KF,%N!\
MV*[.BC9W%;2QYYJUEKMW;^-X8O#UX3J4(BLV\^WQ+B/R\_ZWY1GGG''OQ5+5
M?#VK'5;74CX'TS7XKFTA@EMM2D@6:R= 02'(=2ASDA2>:]0HH6A3=_Z]/\CB
MM=\/W86UNM$L[FQU:&W2"*33IHTMT R0DL;D!HU/HI;!. *Z75K2XOO#M[9J
M4-S/:O$.R[V4C\LFM"BB2NFGU!.S370XB.QUNSN]#UM=)FF>VT\V-SIZSQ>:
MN=AWJ2P0G*8(W#(P>HQ6UX8TF?3(]2FN 4DU"^DN_(W!A"&  7(XSA<G'&2>
M3UK=HIMW=_ZWO^9*22M_6FAYF?#&HVOBZZ67P3H6M6=W=M<1ZQ<M$)K<,<E7
M#(6<J<[<=L#([:7B#3]8N]3DURPT68:EI3K'8Q[X,7T9^_N)?Y5Y.,X*XR <
MXKNJ*2TMY#>K;[G)O9:G?>(A?/ITUM#>Z4;64M-'OM7WD_-M8YX;@KGD<XK"
M\':#J.D7BQ7W@'0[:6PB(36+)H1)=$+CY$V@JS=RS <FO2:*-MOZW_S#U/,;
M73/$$/AC0;1O#=]]HL]8-W,@GMN(_,=\Y\W!R'QCU!]LR:KH'B)_"FN>&[?3
M?M#W-T]S;WS7""-U>82;6!.\, 2.A&!U[5Z511_7Y?Y(/Z_/_-F9J*:A-X:N
M4@MK5]1>U8+!,V^$R%?NDD#*YXZ#/M7/Z!I>J6_BB/4;BRNTAFTU8)6NKF-F
MCD5R<;(R5 (/&SCZ5V=%'6XNECE?$MMJ,_B?PS/::7<75O9W,DMQ-')$HC5H
MV0<.X)Y8'@'@'OQ6.WAW6&\-7_A&2R=H9[B22+55ECV*CS>9EESO\P9/12"0
M/F&>/0J*:=OZ\T_S0W_7XK]3S_Q'HNN:D^LP)I\KH9+>6S:WGCBCG"%"?,.0
M[29!'S?)@+CG-+=6FMR:EXOE'AZ\*ZA8QP6S+/;XD=593UD! ^?.2!P#WP#W
M]%2U=-?UV&G9I]OT,OPY'<1>&=.@N[62UN(K9(I(9&1BI50.J,P[9X-<E::%
MKMIHWA^46!-UH=S(S6OGI_I2,'4LASM!PP*[B.X..M>@T53=Y.7]?UJ2DE%1
M_KL<]H6FW*ZYJVMW,$EH=0$*K:2.K,@C4C<VPE=Q+$<$\ <^C+VWU&U\8MJE
MOITEY;/IOD'RI8U8.KEL8=AU!X[9') YKI**3U_K^NX_Z_+_ "/-+33M?CT?
MP?!)X<O1+IU\9KI1/;'8NUUR#YO/^L!X[ ^P*:)X8U#3?$IMKOP1H5Y MR\\
M?B%FB$P!<LNY-A=I!G&<@<9S7IE%-.SO_73_ "!ZK^O/_,YSQW;7U]X,U33]
M.T^:]NKR!X$2)XUVEE(W$NRC'TR?:L'7=/UCQ59:981^';K3)K:XAF_M&\FM
M\P!&!;R_*D=BQ ([#!Y->@T4D[?G]P/56]?Q.*DTO5["X\1646FM?VNLR/-%
M<"6-5@9HE0K*&(;:-HP5#<'&.*BTW1-3TSQIH^+&ZGL+#1O[/:_:2+#OE#G;
MOWX^4_P]?SKNJ*:=OZ\FOU!Z_P!>G^1P6F:!JE_I?C.PO+*XTS^U[F9[>622
M)OE>-4!^1VQRIX/8U;@T[5M8O/#[:AIKZ<^C2F263SHW2<^4T>(]I+;3NR=P
M4X&,>G944)V_#\%8'K^/XG&:AX:O[QM<L$ CLIR+VREW#*71'3;V"NH?)[M[
M4NN:#JFL^"5C:UM)-5::.\EL[K#P2N&!,3]01@;<^H!KLJ*72W]:?U^ =;GE
MEYH6K7?@:\MK3X?V.BWUW/"#:Z?/;DE4D#%Y&&Q<<$  L>?K7H"ZC>?VM:VC
MZ5*EM-;F0W#3(3'(/^6;("3T_B&1VK3INQ=Y?:-Y&-V.<>E._P#7RL*W]?.Y
MSOBJPOKB\T+4+*T:[.G7WG2P1NBNR-&Z$J7(7(+@X)' -<IJ>B>)1'K"QZ$U
MPEWKEM?P^1=Q;]B&,MN#E0.(^,$DD] .:]/HH3:_KS3_ $&]?Z]?\V>>ZGH>
MLZSJ_BN)--N+.'4M.A@MKJ:6+87CWDA@CE@#O ^[V/MF6[T[Q!K?B71;Y](^
MP006EU:W)ENDW1F0* R;-VX<<9P?7;W[VBETM_75?DPZW_KI_DCS;P=H.HZ1
M>+%?> =#MI;"(A-8LFA$ET0N/D3:"K-W+,!R:Z#X?6.H:9X66SU.PEL[A+B=
M]DCQOE7E9P049AT8?C74T4[O^OO%8YN]M]1M?&+:I;Z=)>6SZ;Y!\J6-6#JY
M;&'8=0>.V1R0.:YBTT[7X]'\'P2>'+T2Z=?&:Z43VQV+M=<@^;S_ *P'CL#[
M ^ET4EI_7FW^HW_7W6/,]$\,:AIOB4VUWX(T*\@6Y>>/Q"S1"8 N67<FPNT@
MSC.0.,YKL/%]A=:EX8N[:QB\ZY)1TCW!=^UU; )X!.._%;E%'1+M_P #_(.K
M?]?UJ>;^)-!U27Q*-67P5I/B.WO(8XW@OY(EELF4GD,ZL"I!&0N>0<9K4T[3
M=1MOB$+O^Q&MM-328[)9(7B$*L&+X50V[:,[1\HY[8YKM**%H#U_K^NQYC>Z
M9K]SH'C&U3PY?";4[T2VJF>V^92J+DGS>,>6>OJ.O.->>SU#4/&$D]UX<NVT
MVXT?['(99H NXG>58"0M_LY //MS7;T4?U^%@ZW_ *WN<QX5T[5-,N;R"5[_
M /LE0JVD6HS1RS(P)W;70DF/&W&\ENO2JGBG2]7U2_OK:&RD:SN--:&*>VE2
M)C+\WRRL2'V\C:%XR6W=J[*BAJZLQIV=T<)86^MVWB;3KR;P_>>3;Z*;1V2>
MW(\W*MM&9 ?X<9QC)'..:HZ!I/B'2K70+Z31;EI-/2YMKBP-Q#O*RNK"5#OV
M'&,$%E/)_'TFBG?6_P#6[?ZLE125OZV2_0Y;P9IFJZ;-KQU*UAA2[U*2Z@*3
M;V*M@<@# ^Z.YSGH*S;NV\4Z7XEU..ST*SUS1M7E65VGO%A^S$(J,KJRMO4A
M01@>M=W12[?U_6P^_F<=]@U?2M8UOR]-;4;75]LBR12QJ+=Q&(RKAV!V?*""
MNX\GCUHZ=H6JZ%K_ (;B33KJ]M-,TB2SEO$DA"L[>61A6D#8_=D=.X]R._HI
MIV_KU_S#^OR_R/--$TCQ#I]KI-^^B7/FV%Y>M+8M<0AY(YW+*Z$.4W*"!AF7
MJW/3+;[0?$C:%XW@&CB5]9N/,M(XKF/?\T:H=P8A0!MZ[B3GIZ^FT47_ *^[
M_)!_7Y_YLY>*#4T\4P:H-*F\B72Q"ZF6(/#(K[MK#=@D@X!4D9') YKGM)T/
M7[?1]*NVTF:*\TO4[JY-C+-#FXBE,GW&5V4,!(,;B.01G!S7I-%"=MOZU;_4
M5M+?UM8\ZU_0=7OM)\2WMOI5R;O6(X(8K#SH0T8C'+N2X3)R1PS< ?A?FLK_
M %#QA)/=>';LZ;<:/]CD,LT&TL3N*D+(6[[<@'GVYKMJ*7]?A8?G_6Z?Z',>
M%=.U33+F\@E>_P#[)4*MI%J,T<LR,"=VUT))CQMQO);KTJ#Q5HUY<7J:CHT5
M_#JZQB**ZM9XUC(R2!.CG#(#Z M\QQ7744=@6AYGJGAG5(_%MS<R>"]#\2VN
MHM'(;J[>)'LV"*K*=Z,S)\N0!DC)KJ=/L+ZR\9ZA<&T7[%=6ENBS(ZA4:/>"
MNW.?XACC&,\]CT=%-.PFKG)>,(M3FU3P_+8:-=W\=E>_:IF@DA7"^6Z8'F2*
M2<L#Z8SS49L=7TS6=;:+3)-0M-9*R(ZS1J;=_+$960,P^3Y0<KN/)X]>QHI=
M+>OXE7_KT//]"\/:IHGBO0XS97$]CI^B_8'OO,BVM(61LA2^_'RD?=]/K2ZU
MI.MK8^-K6UTB6[.K &U>.>)0VZ!8R#O88P5).>Q&,GBN_HIN3?\ 7G<(OEV\
MOP.,@@U63QQI%^^AWD5I'I;VTLKRP$1R,R-@@2$G&P@D \D=1DBYX@BU&3Q3
MX=FM=)N;FUM9I))YXY(E6,-&R#AG#'&[)P#QZGBNGHHOJGV_X/\ F396M_7]
M:'F$_AW7-1T+5$.@H)UUIM1ALM3>%X;R,\%&V,X!QD\\ [327>B:K<>$$AM/
M =GHUU+J%M,]GI\]N<)%(KEW;Y%)P" !N/Y\>H44EIMY?A;_ "0WK^/XW_S/
M/_&>AZE<ZW9ZS;>%-.\20FV\B73M0>)7A.[<'1G#*.I#8ZX'I5B^T[48;_PB
M;/PX(X+"9Y;B*PDA6&V#1NFU=S(6P6R2%Y )Z\5W%%-.VW];_P"8/7<\OFTS
MQ!)X3U"S'AJ^%S/K@O4C,]M_JO/$N<^;C.%QC/4CMDCOH-1O)-;>RETMX;7[
M.LT=TTR-N;.&0H#D$9'/(.3CI6E30B*[.JJ&;[Q Y/UI+:W];6_0'K_7G<YO
MQ!9ZE=ZU9K#9R/8M;RQ23VTB1RHS8P&<D,L9QSY?S9 ["N>T32]>T^Z\&I/H
M-SLTRPDM[F5+B!E5F55'60$_<). >"/<#T>BA:?UZ_Y@WI;^OZT/--+T?Q#;
MP6E^=$N$FL=8N[PV4EQ"&GBFWX*%7*[UWCAB!UY[UJZ7;>(=+U/Q9JYT6.47
MC1W%G;F[19)&6)5V,>57IUSU]1S7;4UT21"CJK*>H89%%_Z^[_('J[O^M_\
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M%O;R3D+_ 'B(U8A?]H\>]4I_&?AVWE\IM5A>3[-]KVPAI"(>/G^4'CD'Z<]
M: -VBLNZ\1:79W<=O//(I=@GF""0Q*QQA6D"[$)R,!B"<BJ.G^,+"^U36;-D
MN;=-+?;+-<6TD<> H9CO90H^]P,Y(&1Q@T =%169IWB#3=4NY;2VFD%S&-QA
MG@DA<KG&Y0Z@LO\ M#(]ZRO$5W-8^*?#DOV^XCM999HYK9,;),1,P) &YCD#
M S^&:.J%?1LZBBLVTU_3;W3#J-O<,UN',9S$ZN'!P4*$!@V>-N,^U5&\9>'X
M[1;F?45ME,ZV^RYC>&42GD*8W <$CGD=.>E S=HK);Q+I8LC=+)<2()'CV0V
MDLDNY&VM^[52^ >IQBN;U'7PGCC0+JWU.YFTFZL;IVMX$+J[)MP0BKO9OF(Q
MSTZ YHZ@=U16!+XTT&&QM+TW,[P74OD1-%9S2'S,XV,%0E&SQM8 YK1CU>TE
MUB72D,_VN*(2N#;R! IZ?O"NPGKP#G@^AHL!>HK)U7Q-I.B2;+^Y="%#R%()
M)!$I) :0HI$:\'YFP.#SQ3]1\0:;I;Q)=3OND7>!%"\NU/[[; =J?[38'O0!
MIT5AMXR\.!K58]9M)VNPYMQ;2><9=@);;LSG&#^/'6GS>*]&@MX+E[J3[/,@
MD$RV\C1QJ1D&1@N(Q@Y^<B@#9HK+U#Q#IFEN%NYY$7^.1()'CB'7,CJI6,>[
M$"M&6:*&!YY9%2)%+L[' "@9))]*/,!]%9%EXGTC4'N4AN71K:/S95N()("(
M^?G&]1N3@_,,CWJY8ZE;:C&7M_. '.V:!XFQD@':X!P<'!QS0!;HKC?$VO6X
M\3:;X=F.II#=12R3-907(<D;0FV2)<XRQ)(/&!NP#SJ+K^D:-Y&F76I7$LD9
M6!KJ>)V7?Q@23*OEJYR."03D>M"U!Z&]17&[KZ3QUK]@-6O5@;2H9H0I3_1V
M9I%)0;<?P@_,&Y]N*F\*:ZL7P^T34-5NII9Y[926VM++,^"2%5068X!. #TH
MZ7_KK_D-JW]>2?ZG645A/XQT..PAO3<S-!+.+8;+29V24G 1U"ED.2!A@.2*
MF'B;2S<ZE;;[KSM-C\RY7[%-\JG."OR?/G!QMSG% C7HK-_MZP\V&(M<!Y8A
M-@VLO[M#T,GR_N\\X#X/!]#5B'4K2?4;G3XY=UU;*CRQ[2-H?.TYQ@YP>E%@
MN6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** &NQ5&8(7(!(5<9/L,\5RK:(GB[PG>
M:3K^C7-BDLTK*LTD3.N7++(AC=@",CKW!ZCKUE%%AIVV//KWP!?ZY\+F\,:M
MJ(?4DD9X[W'#,LA*,P'JN,]^34VL1^*-?\)3>'&T0VEY<VXMKB_DN(FM@" '
M9 K&1CC. 47ZUW=%#UO?J):6MT.9N?!EE)\.W\(K\UN++[,CN.=P'#_7=@UR
M5_X UG4?@]9:/.X;Q#:^3-$Q<?NY(\ *&SCA!C.>O->IT4[N[?>S^X%HDNU_
MQ.4UN_USP\= @TRPM[VUFNE@U"623;(H8@;T7(R226.,].G<=//(T-O)(D+S
MNBEA%&5#.?0;B!D^Y ]Z5HHVD21D4NF=K$<KGK@]J?2Z M#S7X6:+KN@WOB%
M-7T2XLX]0OY+R&5IH'4*3PIV2$AN?3''6DM]+U]?C7<>(V\/7@TJ2Q^PB8SV
M^<A@=^WS,[>/3=[5Z7133LT^RM^%OR#HUW_SN>9>%-.\0:;\1?%.MWGAJ^BL
MM5$;0'S[9F!C4\,!+P2>!C(YYP.:J>"M-\0>'[GQ#)J7@S4)UO\ 5&O[7RKF
MT)3))&[,PP1QTSWKUBBDM/NL#U^^YY7\1='\2>+-%T"W3PU-/+%?)>W<1GM]
MB(-P,1W2#<V".@VGUJ72/#VO>"O%K77A_19IO#6K+YMUI@GA1[";U4%]I'LI
M(XZ\"O3Z*:=MOZ_JP/7<\IATK7HOBGK^O7/A"^N=)U"S6U5%N+3>VW:,E3,!
M@[3WSTXK;\5CQ#X@\ ZS91^'+I+N]#6]M:FXM]R)M'SNWF;0"<\ L>G%=W14
MM7CRCO[W-_6UCEO 6G75AX2TNVU/2Y++4+*U6T?S'C<L !R"C,-N>F<'KQ61
MX=T'5? -[K,%GID^KZ5?W9N[<6LL2RP,P^97$KH"O P02?:O0**IR;DY=R4K
M*QP>B>&M0TF]\2^)[VT-QJVKD!;&UD0^7&HVJNYRJEL<DY XXSWX#0?AAK]E
MX.M[BVTAM)\8:3<-<6]SYL)6\5B?W3,CG/''S8'.,X)KWNBDM-O+\!^O]=#R
MGX@V7BSQCX+TRTA\)W46I)=QW%Q&;NV\M-@.0&\WG)/''8YQW[*QO]4EU***
M/PM>:=!,YEN[FYFML9"8&!'(Y))"C.!P*Z2BCO\ ?^@K;?=^-SG/!VKZYJUG
M??V_I]O97=M>/"JV\F]'0 %2#D\X.#[CH.@P]:TG6UL?&UK:Z1+=G5@#:O'/
M$H;= L9!WL,8*DG/8C&3Q7>1Q1PQB.)%1!T51@#\*?3O_7W?Y%)M.Z.&DL=6
MO?%FG3OHU];6AT>6SEN#+!^YD<H1P)"3C81D \D=1DBEX)\/W^EZE%;ZAX%T
M"Q>R38-;M3%ON#C&514W*2.N2.IZUZ-11?6_];M_J3;2W]=CCO&LLD.M^$I(
M8&N'74G(B1@&?_1Y> 6(&?J0/<56N-*UK=?ZO#IK>=?WMO(]GNA:>&*- NY2
MQ\OS<\_>P!T.:Z74_#NG:O?65[>)<M/9/YEN8[N6((WKM1@"<$CD'@D=#6K2
M6W]>7^0WK_7K_F>7ZGX=UX>&?$.FVVCW5P]]JL=Q S7D;L4_=,68NXZ%&&/7
M&!CD=;J=MJ$VO>']3M[!W2$3)/&TB*T/F(,$\X(!&#M)//&:Z.BC^ON5A6_7
M\7<\WE\/:UJNE^*[5M)^S27>I)?6BWS120W*H(_D<(['!\L@@CHP]P+6B>'_
M +;H=]#J7@'3M \[8K0Z=<1^;+M.0^^,*%VGD?,3GT[]]10,P/"=MJ]K8SQZ
MI+=/'YO^BB]:-[A(\#B1HR5)SG!!)QC)S7-ZM9:Y=P>-X8O#UZ3J4(BLV\^W
MQ+B/R\_ZWY1GGG''OQ7H=%#U_KT_R&G;8\QUOP_JTFH:?JR^"].U]);&*UFL
M-2D@66T="WS*Y#KM.[D*3T%;%GIFHV_CW3;I-!%KIUOI3VC-;/$(8G9U<*J[
M@VT;2,[!SVQ7;44[ZW]?QO\ YDVTM_73_(\S/AC4;7Q==++X)T+6K.[NVN(]
M8N6B$UN&.2KAD+.5.=N.V!D=M+4/#>K7P\664<0A74)XKJUN3(NQBJ1C8P&6
M'S1X/&,-P3TKNJ*2T5OZZ?Y(IN[;[_U^IRMO9:CK'B;3-8O-.FTS^SH)XFCD
MEC<S-)L'R[&;Y!M)^;!SC@4_Q!%J,GBGP[-:Z3<W-K:S223SQR1*L8:-D'#.
M&.-V3@'CU/%=/13OL2U='F$_AW7-1T+5$.@H)UUIM1ALM3>%X;R,\%&V,X!Q
MD\\ [327>B:K<>$$AM/ =GHUU+J%M,]GI\]N<)%(KEW;Y%)P" !N/Y\>H44E
MIMY?A;_)#>OX_C?_ #.#\;Z)J-[J&G:Q:>&-/\0I% T,VEZ@T2E=Q4AT9P5#
M#!!]1ZT]]$O["_\ #VKV>@6\26$%Q'-I6FR1KY9E*GY"VQ#C!S]WKQFNYHH6
MFW]?U<#E(/#'G:%KD6H/]G?5;E[LA7S]F.%"$'^\-BL3ZYJ[X22\DT6/4-2V
M&_O0LLI3.W&T!0,]!@ X]2:MZUX>TGQ%#!#J]C'>103":-),[0X! ) //4\'
M(K2 "@   #@ 4(&<+XPT;6=8?6[2"P=H+K3?+MIK>:.+S) &^69B0Y&3\H'R
M\MNZUF^*=6U#1-4MI;71-9DN[C35@N&L+ 7ZJH8X4@2)L89;#9(.3PV*]-K*
MO/#NG7U\+V0745QQN>UO)K??CIO$;*'Q_M9HZ6_KK_F._P#7W?Y'&VD%Q>OX
M'FTG1=6.GZ7O6=KT1Q30CRFBPZ.X8L#R< C'0GI3-9\-:A'XRO+G_A"M%\26
M6HR)(+J]>))+,A54J2Z,63Y<@*.YKTB.-(D"(H51T IU-N[OZ_B2EI;^M#S/
M5/"^H6_BVYF'@G0O$=E?M&XN;IHHWLB$5"IWHQ*?+D!<XR:[S58;L^'[N"P@
MM9;LVS)##,O[EFVX"D?W>V/2M"BETL-:.YP=AH5_)J\MQ?:5=2VMYI'V6X2\
MNHRP<,<IM1BJ@@\;./I6KX5T[5-,N;R"5[_^R5"K:1:C-'+,C G=M="28\;<
M;R6Z]*Z>BG<5CDM6BU0_$'1[Z#1;RXL;:VFAEN(Y8 H,ACP<-(&(&PYX^F:S
M)_#^L?V'KGA8V+S6^I33R0:D)8]D:RL6/F*2'W*2<;58' Y';T"BDNW];W_,
MJ[.+2UU6T\::G=KHU[/9G2HK6*<2P?OG0NQP#(",[P 2!R#G Y.?H^B:[I^@
M>$[HZ7-]LT:-X+C3VFBW2JR[2R,&*9! QEAP3G%>B44[O^OG_FQ=+?ULE^B.
M/A\-7-]:^);B='LYM9*/# S*S6[)&JJQ*DKOW#/!(X')IJZ-K$^J:;JDT"12
MWL/D:M$)%81H,,@!_BQAEX_YZ$UV5%"=M@>IR'B;1;^74UU+0TO[?5B%B%Q#
M/']G=1R!/&YY7.1E5+<\&ND@GO'U"X@FLA';1HABN1*#YK'.X;>JXP.O7/M5
MNBDM%8'KJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117#^&_$FNW_Q%\0:%JJV
M<<&GP0R0I:@G[_.69N2>W0#VH6KL'2YW%%%% !1110 445#=BY:TE%I+%%<;
M3Y;S1F1%/NH921^(I-V5P)J*\ATKXA>+[[P#J/BU_P"PS'IT[I+9BUE0R(F,
ME9/-.#SP-IK8\9^/-7TGX=V'B[1XK.-)TB9[2^@=V_>8QAE=<8Y['/M56_3\
M=@ZV]?PW/1J*YW2Y?$;ZC$+K4='O+4#%REM92021$KN7EIG![9&.XK(TSQC?
MZ]?:NFDS:69=.FE@_LJ<,MQ(4) <N&PBMCCY&^OHNM@6IW-%>>^*O%7B72?&
MGAW1;&32E@UHLH:XLY'> J 3G$JALY]!CWI?B#XE\5^#] O]=MY='>UAFCCA
MMI;.1G96*J69Q, .23C;TQ1TO_78.MCT&BL/09=?D59]7N--GMIK=)8VM;9X
M61CR0P:1\C!&",=ZR_!GCA/%6K:_8-"(9-.N0L2X(,D##Y'.?7!/T(IVUL*^
MESL**\_U3Q1XCM?BIIWA:";2OL5[;M<B62SD,D:KNRN1* 2=OWL#&>AQSU?B
M365\.^&]1UAH&G%G TOEJ<%L#IGM]:5_=YOZ[%6][E_K4U:*YG0-9U+58;.\
MCN])U33[ICNGL0R?9QM)"D%FWG(P3\N/[M;\%[:W4D\=O<PS/ _ES+'(&,;8
MSM8#H<$<'UIM-$IW)Z*X#QQXI\0^'_$_A[3M,DTLV^LW'V?-S:R.\)&,ME95
M##YNF!TZTW6/$_B:P^)>C^&()](-KJ4+S>:]E(7C" DCB8 YVG!XQGH<<I:V
MMUT^X;TOZ7/0:*\WG\6>)Q\2K[PN+[1+>U@L3?B[ET^5BJ;@-K#SP. ?O<=.
M@KM]&.JFT?\ M:2SEF\P^7+:1-&CQX!!VLS$'KGGM0M5<'H[&C17'Z3XX34O
MB)JWA=HA&MM DMM)@@S8)63V(!P!]#6;XW\6>(O#_B_P]I6G2:7]FUF8PAKB
MTD=X2-H)RLJAOO=,#IU-"UMY_P!?H#TOY'H5%<78^+M0MO&A\(:Y':K?SVQN
M+&]MD98IP,Y!C9B588Z;CG'450\'>)_%'B/7/$VG75QH\0TB8VL<D5C+^\?G
M#D&;@#'*]3GJ*/\ *_W ]-_ZOL>AT5YYX5\<:Q?:Y>>&_$4%G8ZN\7GZ;/%$
M_DW,1'!VER21U*[AW],U=U3QC>>%_#$%YJXMM0U.\NOLMG;V4+0+(Y.%4[G<
MCH23^&/4_7_A@\CMJ*YN>7Q?96$]V5TF_E";ELH89(67V$A=MY'IL7/M5/5_
M%LD/C*#PS;WNGZ?</;+<B:_C9Q/EB/+C =/FXSG)^AH\@\SL**IZ;->S6K-J
M%O'!<+(R[(G+J5!P&!('48/3C..U7* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "O._#]EKL/Q3US6KKP[>VVGZE###%*\]NVPQK@EU64G![
M8!/TKT2BA:.X=+&3H5QKEP+_ /MNRMK79=.MIY$F_P R ?=9O0G_ "*UJ**
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M642\*ZD[BN0O'KC/:O1_^$$\'_\ 0J:'_P""Z'_XFC_A!/!__0J:'_X+H?\
MXFAZJWG?\;@M'?RL<7?_ !6\)?\ "'6%I:^(;>.XOH5MO,\EW^S8 5VD088
M<XZ9Z@XY'':AXPTOPC\6].UW_A(=*U.WN[7[-J']D6S*D48X1C^\D#'@=&R
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MW%M;*R-YDC;?]88\;@@R.2!T(ZX%=9_P@G@__H5-#_\ !=#_ /$T?\()X/\
M^A4T/_P70_\ Q-'V>7^OZU'?6YXGXI\2:?H.N>$O$MIXHT;5I[(B)H=-M6CD
M:W(^8R$RO\W)X;:<L?0XO?$#XA^%M4\:^!]1L]52:UL;@W%TZQN?*1BA&1C.
M>#D#)%>O?\()X/\ ^A4T/_P70_\ Q-'_  @G@_\ Z%30_P#P70__ !--.UO)
MW):NGYJQYQ_PDWAOQ+\4K'Q4^O:;::/I%FZ0M<7<<<MQ(VX'$1.\  _Q $D<
M"L_X=?$+PKI_BKQM=WFKQV]O>WANK9Y49?-C&[.!C.>1A>I["O5_^$$\'_\
M0J:'_P""Z'_XFC_A!/!__0J:'_X+H?\ XFDM-NS7WNXWKOY?A_PYP>HZSX,\
M:>#]/FM/%>FZ;K.GX>QN9[A8)(95'0JY!*'H>,'\*S/$NHZ;KWA'PSJ \1Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9,91"YA5&E"G8'8A2>V2
M <#\#0 ^BN*\ >(]9U^\\20ZS]E$FG:@;2-+92$"@>IY)/O^0K4\;:KJNB>$
MM0U/2([1[BUA:8_:BVT*HR<!>I]LBDW97&E=V.AHK&\):C<:OX/T?4;M@US=
M6<4TI48!9E!.!VZULU4HN+:?0E.ZN%%%%(8452U0:DUH%TJ2VCN6=1YES$9$
M1<\DJ&4GCIR.:Y+2]4\8ZCJ6M6JWNAL=*N4@VC3I5,X**YP?M!V'YL=#TH6K
MM_7]:@]%<[JBN5T?Q"\6JZW:ZYJEDGDZDMM9[@L 8-$CJ@!8EF^;'7GT'2MZ
M]U;3=-D@COM0M;5YVV0K/,J&1O103R?846V!Z.Q<HIKR)'&TDCJB*,EF. !]
M:J6VL:7>W)MK74K.>X5!(8HIU9@AY#8!S@]C0!=HJI'JFG33B"*_M7F(9A&L
MREL*<,<9SP2 ?2DLM6TW4XY9+#4+2[2%BDC03+($8=02#P?K0!<HJC9ZWI.H
MP33V6IV5S# Q662"X1UC/HQ!X/UI%US26>5%U2R+Q1">11<)E(ST<\\*?7I0
M!?HKDO%'B"XMK;0+[1]1M6L;S4H8)9$42B6-SU5\X X/.#U[5/XDUXGP1JVK
M>'=4LI);2&219DVW" H,E>&QGC'MZ'I1TO\ UT_S&E=I+J=-16:=8LM/T>UO
M=5O[:T22-,RW,JQ*6('<D#-7S-&(?.,B"(+NW[AMQUSGTIM6N2G=)CZ*Q-&\
M6:)KVFSZA8ZE:/;0.RRN)EQ& Q +<_*"!D9[5I6.H66J6JW6GWEO=V[$A9;>
M59$..N""12&6:*Q9_$^E)XA_X1Y=1M8]4>$R+')(,@G[HVY!8]3@<X'O5+PE
MX@^VZ3:1:KJ5H^K323@1@K&THCE9<K'G.  /7W-"U!NQT]%9T%PL$^I37.K0
M2P1N&V'8@M%"C*LV?4%LG'7VJW:W=M?6Z7%I<17$+C*R1.'5A[$<&@":BN>\
M8>(+CP]I!NK.V6YG7]Z\;9XA3!E;CT7@>Y%;D5S#/:I=1R*8'02*^>"I&0?R
MHZ7 EHJI9:II^I6K75A?VMU;J2#+!,KH".HR#CBFQZOIDHE,>HVCB*,2R%9U
M.Q#G#'G@'!Y]C0!=HJG;:MIM[IYU"UU"TGL@"3<13*T>!U^8''%-@UG2[G3_
M .T(-2LY;+I]ICG5H_\ OH'% %ZBLY]?T:..ZD?5K!8[1MERS7* 0MZ.<_*?
MK4]UJ=A8V/VZ\OK:WM, ^?-*J1X/3YB<<T 6J*JG4K!88I3>VPBF4M$YE7#@
M#)*G/(P">.U9NI^+]"TK18M7FU2T:RGD6*&99U*2,QQPP."!R2>P!/:@#<HJ
M.">&ZMX[BWECFAD4.DD;!E=3R""."*KV>JZ=J,L\5EJ%K<R6[;)D@F5S&WHP
M!X/UH\@+E%4K35],O[F>VL]1M+F>W.)HH9U=HS_M '(_&C^V=+^TPVW]I6?V
MB<LL,7GKND*_>"C.3COCI0!=HJK_ &G8?;9++[=;?:HU#O!YJ[U4]"5SD#@U
MB6_BK2O$>BZE+H^OV=NUN7C:ZWI)Y&"0'92<8.#C/!'- '2T5@W/C#0;'6_[
M'N]7LH;I;?SW\Z=$P/Q/7&6]@,U>37='D:S5-5L6:]!-H%N$)N .I3GYOPS0
M!H45BZ5XJT76KW4+2QU&VEEL)#',JS*2, 9;&<[03C/3(-7+;6M*O;*6]M-3
MLI[6+/F3Q3JR)CKE@<#% %ZBH;6[MKZW2XM+B*XA<962)PZL/8C@U!<ZQIEG
M?06-UJ-I!=W'^I@EG59)/]U2<G\*/("[15*[UC2[#?\ ;-2L[;85#^=.J;2W
MW0<GC.#CUJ[D8SGCUH **S=/NXX=/5[K6+>\W3NBW V(I)<A4&#C(X7U)'K5
M?4?%NAZ=H5WK#ZG:26=L2CO%,K#S!QLR#][/&* -JBLU_$.BQ:?;W\NKV$=G
M<$"&=KE!'(?16S@GZ5/?:II^F6ZW%_?VMI Q"K)/,L:DGH 2<4 6Z*@FO;6V
M5&GN88ED^X9) H;C/&>O%59O$&BV\=J\^KV$27>/LS/<HHFSTV9/S?A0!HT5
MS<FHZE'\1K;3#<Q'39M-EG6%8<,'5T7)?)SPQX 'XUNW%[:V>S[3<PP;\[?-
MD"[L#)QGKP":.EPZV)Z*I1ZSI<VF'4XM2LWT]06-TLZF( =3OSC'XT1:OID^
MG#4(=1M)+$]+E)U,9_X$#B@"[16#=>,_#UIJEGITFKV/VBZ=T4?:$X*\$'GK
MNPN.N?I3/&&H:CIFEVMUI]Q%"?MUO%,'BWEXWE5" <C:?FSG!Z?C0M;!Y'0T
M56L]1L=0$ILKVWN1"YCE,,JOL<=5;!X(]#45KK6E7R7#VFIV=PMLQ6=HIU<1
M$=0V#\I^M %ZBJ/]M:5]FGN?[3L_(MP&FE\]=L8(R"QS@ @@\]JDCU*PET\:
MA'>VSV17>+E95,>WUW9QCWH M45D77B;1[?P]/K::G8RV$:$B=;E/+9AT4/G
M&2>/K5'PE?2ZS:IJ\?B"+4;6YA0O;1K$RVTV 6573!P,XVMN/OVH%<Z6BBB@
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !3)G:*&21(GE95)$:$!G/H,D#)]R!3Z* /// &GZ]I>L>*)=0T&YLTU.^
M>]MY))X&4 CA6V2,0WT!'O5O6O\ A*=6^&5[9WN@A]<OH)K=K:RGCV1[@P5B
MTC@8QC."3ST].XHI-77+Y6^X:;4N;SN<1H__  E&D_#*QM+'0U77+&"&W%M>
MSQ[)-H4,P9'(QC.,D'CIZ]JA8HI< -@9 .0#3J*N4N9MOJ2E;0****D8=!7$
M>#+HR>*/%3-9ZC"EW>+/ ]S83PK(@B1"0SH!G<#QUXSC%=O10M'<'M8\IUEG
MN='^(*Q:3JC3W<ZBV_XE<^Z;$4: K\G(W(W(Z=>A!I=;1GU^>34_#GB?5M,U
M6"%;=M,FGAV#;M:*>(21A1G)RX_B(/2O5:*?]?A8;=W<Q=:LK>3P9>V<]JC0
M+9,ODS?O ,)P#G.<8')]*Y'1(AJVF^#/LME<Q?V7 DUU+):NBF-K<J41B,2;
MBP.%)Z<\X%=[JEC_ &GIEQ8_:I[43H4:6 )O /7&]6'(XY'>F:-I:Z+H]KIJ
M7,]S';1B)))]F\J. #M51P,#IVYH3U;]/U_S)MM;S_3_ "/.-%T2>?X;:M:Z
M?I$UO?)>7,EM!+;/:.\+3;A&C,%*!T4+QC''3%6--2UO=#UV]M_!OB6.Z:S-
MM+#K%W,S7(Y^2/?*S$#)Y '7CDUZ;12O_7W+]!W_ *_$\KOK62:7Q)/>Z?J%
M_;W^BPI%G27"F13)A1%M+@@E#ALL,YS@9%RRD5=:\$-_9FI*MMITL<S'2YP(
MG94 #'9\IW(W7V/<$^D44[_U]_\ F']?E_D>3V]K=WOAB,QZ9J&++Q(U_)#-
M92Q.;<S.VY$=07^4@X7)]LUH:_:SW6G>+M7M+&^%OJ.EI:P6XLI?.GF <;_*
MV[Q]]5RRCID\#->D44NEOZV2_0:?O<W];W_4\P\0-<0W.D:I/HGB/4M*?3EM
MS%I4D]O<6\H/.Z-7C8AA@'=TV^]=[X?M(+'0+*VM;*:R@CC CMIY"\D0ZA6)
M9N?Q/UK2HIM[_P!?UN3;;R/-K>UU2'P_IA_LZ]9=+UF6>\M?).Z:,R2D,@/^
MLV[T<;<YQQDC%=!X?M9)?%6L:U;PS6^G7L,"K'- T+R3+NW2%' 8<%5R0"<>
M@%=310G_ %\DOT'_ %^+?ZG,7+2V?CXW;VET]M)I?EB6&!I%#+(6(.T'!P<@
M=3T&3Q7'6TK1^&_#_P#Q*=62>+7GN9E_LJXWHGF.2Q&S.-KKSWY'8X]8HI+3
M^O.X-7_KRL><:;IEO=W?C*R2TU/3H+B_BN()H+"2+YE5,R)N3:_[Q23USR>0
M<UTWA*XU2XLKDZF/,VS8ANFM&M7N4VCYGB;E6!RO.,XR !70T4=+ ]7<XV*&
M;Q7JNH7,=_KFD1VX^R)&;!(Q-'U+C[1"V<G(^7'"C/:N?TZ[$7PUUO0=1BUB
M"+2HY8HKNXTZ5!-;JW[MAE0&^7 (&#@'C'->I54U&P34K)K9YIH02&$D+[64
M@Y!]#R.A!![BC967]=;CW>IY9HGB+PGXOUW5]1>73+V^_LW[.EG;6<TSM&N[
M+#?"K,2& **#@#J:LV^DWJ_"G07M]&O7O+$0"]LXUDM+J6-,Y16^5\@MN&#R
M1CO7HVGZ;+:*/M6I7>HRJ24ENEB!7/8"-$'XXS5^F]M/+\+O]1+S_K2QY7+8
MM=>%9-3T;PUXDMP;Z*XN[*^O9DO+M$!4E6,K.I'RD?,"=F,8Q4.IV>G7O@#4
M;BU\*^(8)[NZB=(M3AGN[EY$(_>;2TC( H(W'&>GIGUJBC^OR_R#^OS_ ,S@
MC=0CQ]?7@T[4OLQT5(UD&EW&TL&9MH^3[VUAQUSQUR*YN)-0MO"7A.\GT7Q#
M=VEA:O:WEG8_:+6[BD.W#JH9&=1@CTYSVKV&BE_7Y_YCO_7R2_0\QCL-/M-:
M\'2VOAO5;2));B1Q<6LMS+"LBMCS)!OVYD.<%N,Y.*8JW-SX8UT0Z;J64\0)
M>K&]A-&SP^?&Y9%906X5CA<GVYKU&BFG9W_K=/\ 0G^OP:_4R=?M[S4_"NHV
M^G$PWEQ:R) 9/E(8J<9]/Z5R%M<7?BC2;Z&V\+:IH6M0Z;)9)=74:Q1*2!\D
M9#?.-P&&VX Z'L?1:*7<I.UO(X&*%M7O?#<UOI=W82Z3N6^$]FZ!8O**F%21
MB0%MOW"P^7/I7.VB"S\#VEO;Z+JD+Q>(A<"&/2+A66$7)<-M$>0OED?RZ\5[
M!15<SO?^M[DVTM_6S7ZG%+%J.G^*T_LZ6ZN;.]N3-<V=W8ML@!X,D<^ %]=C
M%B0>,5A:M92/\,_$NF7.CWL]V+VZ:",6+REG>9GC9,*<\,#N' [D&O4J*E.R
MM_6Z?Z%7_K[_ /,Y.!I6\9V]VMG>?9[O2%CCD:W=0K!R2'W ;#@YPV#UQSQ7
M,6$&HP:%X.LUT;4I+C2M2VW:"W*!!LE7<&?:K+\P.X$CWSQ7J=%-.SO_ %NW
M^HNEOZVL><ZE8:M+IOBRSM+"[>X;4TO$12T(N80(B524$8+!&'!R".<9&4T;
M3M/UO2=2N(M%\5:+-/Y2/<:C-+)<%HVW(461Y"54Y/(&?0UZ/12 Y[PE<:I<
M65R=3'F;9L0W36C6KW*;1\SQ-RK Y7G&<9  KE_%<-[>2:_!#IM[$5FMIE$%
MHTOVU4*$OO(*C&"NQ<-\N>]>DT4=;_UT_P @Z-'F-RL*ZOXZECT74$^V6"+&
MRZ5-^^DV,K $)ACEDS@G/7H"1VGA]UE\'6'VF"< 6:)-%/;NKY"X8%&&X]#Q
MCGWS6U11TM_77_,.M_ZZ?Y'CMO;0KX*T.W?0=1WVFO-*L7]C3[H8?/9R0OEY
M"[&7IUZ=016KJD=S?2^/K>UT[4&:Y@B,&ZRE19BB;6V,RA6.<#@\]LUZ;13O
MU_K[/_R(K?U\V_U/,_%#3KK\&I76@^)-2TF\LD@C329IH9H'#,2)(TD0[6##
MENF,'%)XFUG2? O_  CMW(@L5BLI;6WM+XS/&B'R_E:2-)2' 4=B",C/0UZ;
M65J6BO?7:W=OJ^H:?.$\LM;&-@RY)QME1U')Z@ \#GBEY?UU_P QK^OP_P C
MR_3+?P_);>"[G0+==22#4I9;J]L=+DP@*/N#E4RO)C&&Y("GM6[XQT^>:/7]
M,T[2KBW$FD".%[6S:076W>1&#@QQ[2W3 9MW!X%>AP0+ A 9F9CEW;JQZ9./
MI4M-OM_6W^01;3O_ %NW^IP\,[O\1-&D-CJ*1C2)(6D:RE\M'9HV"L^W:#A&
MZGCH<$XI?'"6L/B/PA?RV@EEBU!QOC@\R0)Y$A(  +'D X'H.,UV]8NL>'5U
MG4],OGU*]MFTZ7SHHX!%L9\%26W(Q^ZQ'!'7UYIWU3\_\_\ ,25D_3]+'*3P
M7$+ZEJ\6E7+65]J=M-$AM93)#L0!K@P+AR=P VXSQDC%8FMZ;<-X4\1V<^E:
ME>7,NMQW%LYTYG9\^42ZA$P!M#C.!CD$Y//L%%2M/Z[6?Z?UH-Z_UZK]3E-0
MA6'Q+X=U"TT^<VS?:/-,-LP*O(B[2XP"N=N,MC'&<4GQ"<GP]!"MG=W1>^MF
M,=M:23G:DR.Q(13@!5/7KTZUUE%"TMZW!:?UZ_YGF^H07NHZ[XQMM-M+V.2[
MTR!+=Y+6:&*5TW[E$A4 $AE&0<\\=#C+-M8:IX8U^8^#_%%O>C3WM"-4:>[W
MN>56)&>0L X!W!0!C.:]<HI-75O*WY_YC3LT_/\ R_R/--6L9X_"7AS4;;1M
M2N4M%3[?:6)EM+Q@L10,-I1V*G/RYY!-2)8,FA:7J>E:%K-M:1ZH+Z\L+]WE
MNIEVE2Y5G<Y!VMMSD[>F:]'HJG+5OSN2HI)+RM^AY[>0R$>+-:MK2^2PU'3T
MABMUL91+-<;74OY6W>.&1<E1TR>!FN@\/:F(_#>AQ?8=1WND=JX>T>,PLL?)
M<.%(7*XW8P217144E_E^%_\ ,>^O]=/\@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIDQE$+F%4:4*=@=B%
M)[9(!P/P- #Z*XKP!XCUG7[SQ)#K/V42:=J!M(TME(0*!ZGDD^_Y"M_Q!:ZU
M>Z>;?0]2@TVX;)-U+;B<KZ (2!D^ISC'0YX'HKAUL:U%<A\-==U?Q!X16ZUL
M1->17$MN9XAA9PC;=X'09.>G'':NOIM6$F%%%%(8452U0:DUH%TJ2VCN6=1Y
MES$9$1<\DJ&4GCIR.:Y+2]4\8ZCJ6M6JWNAL=*N4@VC3I5,X**YP?M!V'YL=
M#TH6KM_7]:@]%<[JBN5T?Q"\6JZW:ZYJEDGDZDMM9[@L 8-$CJ@!8EF^;'7G
MT'2MZ]U;3=-D@COM0M;5YVV0K/,J&1O103R?846V!Z.Q<HH[<5R_AO7V>.>V
MUO5+,WQU&>U@&%A\T(> B%B3Q[DT=;!TN=115.[U;3;"Y@MKS4+6WGN#B&*:
M94:4^B@G)_"DN=8TRSOH+&ZU&T@N[C_4P2SJLDG^ZI.3^% %VBLGQ!JL6F:;
M*!J-G97LJ,+7[20=\@!( 4L"Q]@:S?#&J7>K:#X9U"[U2*.>[M!+/;E$!N69
M ?E[C;R>!0M?Z]?\@>AU%%4FUC2TN(K=M2LUFFD,<49G4,[CDJ!G)(]!3I]5
MTZUOH+&XO[6&[N,^3!),JR2XZ[5)R?PH MT56N-1L;.>&"YO+>":<D11RRJK
M28Y.T$\X]JL-DJ=I .."1D4 +17+>$_$)NK!(-9U2S;5)+RZ@C0;83,(I67*
M1DD]%]3]:W9M6TVWU"'3Y]0M(KV89BMWF59)!_LJ3D_A3L#T+E%5'U33X[D6
MSWULLY<((FF4,6() QG.2 >/8TD&K:;=7T]C;ZA:37=O_KH(YE:2/_>4'(_&
MD!<HK-T^[CAT]7NM8M[S=.Z+<#8BDER%08.,CA?4D>M6;+4;+4HGEL;RWNHT
M<QLT$JN%8=5)!X(]* +-%5K_ %&QTNU:ZU"\M[2W4@-+<2K&@)Z<D@4AU.P%
MO#<&^MA#.,Q2>:NV08S\IS@\<\4 6J*SY]=T>VM[:XGU6QB@NB!;R27"*LQ/
M382<-GVK0!R,CI0 45R/C_Q(^B>'[HZ;JEE;ZM&JRK!+M>1H]P4E4)'KUP1[
M5T-QJ^G6,UM;WFH6MO<7/$,<TRHTI]%!.3^%"U!Z%VBJTNHV,%['9RWMO'=2
M*72!Y5#LHX)"YR145M(?[2OMVI13HNPBV 4&V&#G)!R=Q!//I0!>HJI9:II^
MI122V%_:W4<;%'>"97"L.H)!X/M38]7TR:[CM(M1M'N94,D<*SJ7=0<%@N<D
M \9H NT5276-,?4VTQ-1LVU!5W-:B=3*!ZE,YQ^%4M*\5:+K5[J%I8ZC;2RV
M$ACF59E)& ,MC.=H)QGID&@#:HJG8ZKIVJ6[7&GW]K=P(2K26\RR*I'4$@D5
MSEAXDEU'XAFPL]3L[S2&TUIT%L%;;() ARX)R1SP,8SSFA:NP/17.OHK+\1:
MY:^'-!O-4NY88T@B9D$L@0.X!*H">Y/ %96CZS;1Z:^N7OBVRNM+G5</(\*1
MP2?Q*)%P,<@;6RPQU- '4T56.HV2V\-P;RW$,V!%(95VOGIM.<'/M4EM<V]Y
M;I<6L\<\$@RDD3AE8>H(X- $M%4WU73H]2337U"U6_==Z6K3*)67U"9R1^%)
M<:OIEI?0V-SJ-I#>3_ZFWDG59)/]U2<G\* +M%4KS5],TY9&OM1M+98PID,\
MZH$R<#.3QD]*9-KND6VH0:?/JMC%>S@&&W>X19) >A52<G.#TH T**SUUW2&
MANYEU6Q,5FQ2Z<7";8&'4.<_*?KBI8]4T^:TANXKZV>VF($4RS*4D)X 5LX.
M?:@"W169-J5IJ.CWDNFZS:1[%>/[9&Z2I!(!C+<XR#U!J6YU73]+M()=1U.T
M@23:B33RK&LC$=LG&3Z"@"]156YU*QLT+W5[;0*(S*3+*J@(.K<GH/6DDU73
MHM-&I27]JE@4#BZ:91%M/0[\XQ[YH MT55;4]/73?[2:^MA8;/,^U&5?*V_W
MM^<8]\U):7=M?VL=U9W$5Q;R#*2PN'1AZ@C@T 3453O=6TW3@QOM0M+4(GF-
MY\RIA<@;CD],D#/O2#6-,-U;VHU&S^TW$9D@A\]=\J?WE&<D>XH NT51M];T
MJ[L_MEMJ=E-:[_+\Z.X5DW]-NX'&?:F/K^C1P-.^KV"Q*&9I&N4"@*<,2<]C
MP?0T :-%5FU*Q33_ .T&O;<66SS/M)E7R]O][=G&/>F1ZOILNF'4X]1M'L I
M<W2S*8@HZG?G&/QH N456_M"R^PM??;+?[(J[S/YJ^6%QG.[.,8[U$-;THZ7
M_:8U.R.GXS]J^T+Y7I]_./UH O44V.2.:,21.KH>C*<@_C56^U?3-+,(U#4;
M2T,S;(A<3+'O;T7)&3["@"Y15>XOK.T -S=00@J7'F2!?E R3SV KG?$^N7,
M.F:1J&B:C:M:W&H6T,DB()1-%)(%.QLX'7K@^V.M"U=@.JHK,B\1Z'.UVL.L
MZ=(UD"UT$ND)@ ZE\'Y<8/7'2KMI>6NH6L=U97,-S;2#*30N'1AZ@C@T 345
M2?6-,CU--,?4K-=0==R6K3J)6'J$SDC\*)]9TNUD6.XU*SA=I1 JR3JI,AZ(
M 3][VZT 7:*SM9U*WTZR(DU&SL;B8&.V>Z88:0C@!2PW'V!R:H^"-4N];\%Z
M5J5\ZO=7,.^1E4*"<GH!TH6MP>EC?HJL^HV,=\MB][;K>,N];=I5$A7.,A<Y
MQGO7/Z#X@<7.IVNN:I9"=-4>TM 0L'F#8C!%4L2Q^8]R?Y4+4&['4T52N]8T
MS3[J"UO=2L[:XN#B&*:=4>4^B@G)_"L1[_5SX[N]*2]@6U;2_M%NIM\^7)OV
MY8[LOZX&WKCWI7_KT ZBBL#P5J5YJ_A&QOM0E66ZE#^8ZH$!(=AP!T&!6I>:
MKIVGK(U[?VMLL:[W,TRH%7.,G)X&>]-Z M2W156YU*QLK$WMW>VT%H &\^65
M5CP>AW$XK.U;Q;H>C:;::A=:E:+:W<J1P2^<NQ]Q R&SC ')/3 H VZ*9%+'
M-$DL3K)&ZAD=#D,#T(/<55AUC2[C49=.AU*SDOH1F2V2=3*@]2H.1U]* \R[
M17!7/C33[[5]22W\7:?IZ:5(F8_.@=;E< ONW?, "=@*D8/7/2K?AGQ#%J.E
MKXEN/%%HVG2VZM<VKM#Y=E*0#M\P8*X!P0^3T.1TH6JN#5CLJ*J'5-/73?[2
M-];"PV>9]J,R^5M_O;\XQ[YK-U/QCH&E6=C=W.K60M[Z58[>;[0NQ\]6#9QM
M Y)Z?G0!NT4BLKHKHP96&00<@BEH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "F3.T4,DB1/*RJ2(T(#.?0
M9(&3[D"GT4 >>> -/U[2]8\42ZAH-S9IJ=\][;R23P,H!'"MLD8AOH"/>K6I
MZCXZ?P9 %\-)-K=R[)<Q6E]'$L$>3RKN3\Q7&,9P3GMBNYHHMI;T7W#OK<XJ
MPN?%EMX)<6'A*STS4+9DAM-,EO5E3RP1EC(N!T)XZ\=\UV:%BBEP V!D Y -
M.HIMW)2"BBBD,.@KB/!ET9/%'BIFL]1A2[O%G@>YL)X5D01(A(9T SN!XZ\9
MQBNWHH6CN#VL>4ZRSW.C_$%8M)U1I[N=1;?\2N?=-B*- 5^3D;D;D=.O0@TN
MMHSZ_/)J?ASQ/JVF:K!"MNVF33P[!MVM%/$)(PHSDY<?Q$'I7JM%/^OPL-N[
MN0VL:V]E#&L;1K'&JA"Q<J .F>I^M>67DS3>%=4,6D:N+B7Q EPB_P!DW D:
M,3JX?&S.-JL<_AU.*]9HHO[W-_6Z?Z"6BM_6S7ZGEFN6Q;Q3J$&K^&_$NK6&
MK-&UM+IES-'"$V*ICFC$J*F""<L.<^U3^)K:]N5URUATN]A*26LJK!;//]L5
M-F6\P@KQ@KL7#_+GO7IE%):6!ZW.'NVNK?7=>^UZ9>W*ZE:(MB\=L9% $9#1
M,5!V'<2?FP#NZY&*P=!M9+&Y\ F\T*_M[VTL)+:ZD^P/(4&S:H:1 P + G!(
MQG) S7JU%"T_KU_S!Z_UZ?Y'CXC6W\%:C;VFB:G"[>(%GBACTBX5O*%PL@8*
M(\X"*3[=.I IOCCQ/H&GZIKVBZAJ4-L-8BA,K7MM.7A79@-&JQ,''3Y6*X;=
M]*]BK(.A2+J;W<&LZE!%*^^6U4Q-&YQCJZ,XXQPK <<4+HOZV2_0;>_]=;_J
M<OJMN+:WM-4\*3R$/9QP0VD5@9[.\C^9D4[ !%U/S951N&<UW:NPMQ)*A5@N
MYE7YL''(&.M.CC2*-8XUVHHP!Z4ZFV)'DGF/_P (G"5TG5UG_P"$E^ULO]DW
M'F>7]I,F\C9G'EGK^'7BIY+,GQ3>:=K/AKQ+J'VN^^TVUY:7DRV93(9#*HE5
M(RF /NY.W.":]4HH3_KY+_('K?\ KO\ YGGVAZ='+XM\9+%ILML+F6.2UGET
M]XXS*L>UI%9E )#G.0>>HSUK/\'VEN]Y;V^J>$_$EOJ&F0,DMQ>7<\]GRFUO
M*#2L'##^%4/6O4:*2T^ZWY_Y@]?Z]/\ (\=M[:%?!6AV[Z#J.^TUYI5B_L:?
M=##Y[.2%\O(78R].O3J"*[3P[,6\<^)_]%O8HIC T<DMG+'')L3:VUV4*><=
M#SVR*ZZBG?\ KY)?H*W]?-O]3F_$TDL>IZ,8[.=AYL@^V16[SFW)7 ^1?[V2
M-S JN.>HKA+6PDMX_!L=QHVHM<V&K732S-IKLR1%I>2R)@ DH>, \$# X]?H
MHB[#:N>9>*+(:;XF<7/AS7M2T>[MHK>W70KB6(0D;MT<D<<B+M.<[CQR17H>
MFV\=II=K;Q0O!'%$J)$[EV0 8"EB3DCUR?K5JBDM%8'J[GE6MVNIOX/\1Z')
MI%]=:O->O<1R);%DGC:8%&60#;D)A=I((V],<TFK6TC>([V#7/"_B?4;35O*
M: Z==RK%&OEJK13HDRQKM(/S'(.>^*]6HH6G]>5OT!Z_UYW.(UBVU+3M:2\T
M>2ZDFN#%%-ITUH\]O,% ^83 ?NB!_$QQD?=)-9<L%HEU\08VLK^RM+JW#F:+
M3Y4$A$9$C(2H5VR>Q^;KR.:]+JMJ%C'J-E):RR2QH^/FA<HPP<C!_#IT/0\4
M?\$:W7R_ \J\/>)O"/BWQ/)>3SZ5=7=OIKVT-I;V<TKR1C)9AYD*G.W(\M-W
M!/)J320]IX=\!P#2=4BEM+\M<H-+G!B'ER*2WR<#+J,]_H#CTG3]+ELP#=:I
M>:DZMN1[I8E*<8X$:(/7J">36C57L[K^M6_U)6UOZVL>9)#>RZMHEPNEW]O'
M::U<-+9I:.5C#K+^\,C []Q8'<I"#=@]!4^I6&K2Z;XLL[2PNWN&U-+Q$4M"
M+F$"(E4E!&"P1AP<@CG&1GT:BIOI;^NG^0WJ[_UU_P SRR&R.J^'-2O='\->
M([*ZD>W%U'K$\CRW<4<@9HT$LC'&W>.=N<X[ULV,D]]\3+?5;;1[^/3Y-(,!
MN)K8P;'\S.&5]K=%QP#V[<UW5%._]?*PFKJW];I_H<[X\9SX&UF&*"YGFGM)
M(8HK:W>9V=E( VH">O?H.]8_VJ>+4]!UQK+49M+BL)+66,6,WG6\I*?.82N\
M@A2N0I_(YKNJ*2T_KR:_4;U5OZZ?Y'DM]HTEG+I,S:5=/&?$;7UM'%I\DC6M
MJ1\V=JG8&;YMIP>>F0<>K000V\(B@B2*,9(1%"@9Y/ ]ZDHHZ6_KI_D'6_\
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M9&F^3KB,+N/M@<]LUR%]HFJW7@&[M+/P)9Z->W=S#FRT^>W.%1PQ>1_D7H"
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M_2$P(]S$RC&<C&..&YZ#%=10_P"OP#^OS"BBBD 4444 %%%% !1110 4444
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M&NZOHUI!"T$$L-I'(MRK'YR0T<A7.!CA>!R<G EWY?/7[M/U_ :LI7Z:??\
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MOFW6F"%DDL)O50<*1[*2..O JOI7Q:\-6GQ#\4:U>Z?J$^FZM'$D4:QH7!0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &+K]_<V7V?[/)LW[MWR@YQCU^M;5<[XJ_P"73_@?_LM=%7GX:<GB
MZT6]%RV^XVFDJ<7ZA1117H&(4444 %%%% !1110 4444 %%%% !1110 QXHY
M'1WC1FC.48J"5.,9'IQ3Z** "BBB@ HHHH **** "BBB@ HHHH *S[FYFCN&
M57PHQ@8'I6A63>?\?;_A_*OFN*:]6A@XRI2<7S+9VZ,VH).6I8L[B668J[9&
MW/05>K-T_P#X^&_W?ZBM*MN&JU2MEZG5DY.\M6[]4*LDIZ!1117OF04444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/CLZO!X9N-0T;4[BRN+-3,ZPPQ2>;&,%EPZ-SM!QC'/7-9-YJ=]9>./#:_\
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M@+,^?;@2#RECS_K>!E2><''OQ6G]GU27QCIE]-H-Y'91Z1);3R/-!\CL4;!
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MN(]8N6B$UN&.2KAD+.5.=N.V!D=M'6;#69M6;Q)8:%.-3L)A;V]OOM\7EO\
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M ^E<+IVB:[I^D>%KG^SF>YT2-[>>R$\>9U*;"Z'.W/ (W$<$YP:.K_KO_P
M%\*_KH=KIFJV6L6OVFQG\V,,48%2C(PZJRL RD>A -95WXC@?Q,_AI5OX;A[
M0R?:8K1V5"3@$/L*#&#RW&<#KQ2^'=+N+?4M9U:YB>V;4YHY%M796,06-5^;
M:2NXD'."1P.34=[;ZC:^,6U2WTZ2\MGTWR#Y4L:L'5RV,.PZ@\=LCD@<U,OZ
M^Y@NMOZU13\'>)+9]#T:SO[^:;4;I'"RS(Q$K@L2/,QLWX&=N<X'3%;D_B'3
M+:_CLYIY$D=Q&LA@D\G>3@(9=NP-GC:6S[5Q-IIVOQZ/X.@D\.7HETZ^,UTH
MGMCL7:ZY!\WG_6 \=@?8%MCX7U"P\5S0W'@G0M3M9;Q[J/7IFB$T09R^'4H7
M9U)P""!@#D56[5_ZV!Z+3^M7_P #[SL?%\MW;>$]3N[&^FLKFVMY)TEB2-CE
M5)P0ZL,''/&?<5Q4/BN6(:*^D^,X_$.H7<L,<^EL;5SM;'F,/)1638,G+9'&
M,5VOB^*[N?">IVEC8S7ES<V\D"11/&IRRD9)=E&!GGG/L:Y/6M,UKQ-X8L=#
M7PW=:?=0F KJ-W/;XMBA4EH_+D=]V <<#W(I1^+YK_@@]OO_ . =GJ?B+3-'
MDV7DT@8*&<1022^6ISAGV*=B\'YFP.#S4%WXNT"RF$,VIPF4VQNQ'$#*QA'.
M\!03BLYK/5='\2ZG>0:?+JEIJB1#]W+&K0.BE3N#LOR$8/RY(.>*Q]&\-ZKH
MGB'PQ%]AGN+33=-FMI[Q9(M@>1D. "X<JNTC[O3&,T+7^O7_ ('W@_Z_#_@_
M<=3#XOT&YNVM;?48YIEF2!Q$K.$D8$A6(&%/!Z_3O4D'BC1[G44L8[IO.D)$
M+/#(D<Q R1'(5"2$<\*3T-8FD:9J3^)_%LEUI]S9VNI>6MO<-)$<A(]A("N6
M&>HR.G7!XJI9Z'K%UH^A:#>V#6O]CW$$C7Z2QF.98AQY8!W@M@ AE7&3R>[6
MMOE_7R!Z7_K^K[&Y)XVT.*PN+YY;T6]O<?996_LZXRDGH5\O..1SC&2!GFM,
MZQ9)=S6SM,CPQ+*[/!(J!6.!ARNTG/\ "#GVK#O_  [/?:OJEJ\:_P!CZI K
MSL&PPF4%,8Z\CRSG_IG[U2O?#VM:OX >TO$M6UIS%+)%/AX96B*X1^H*MLY'
M^T:73^OZWU] Z_U_7EZFVWC#08K&[O+F^^R16FWSQ>0O;N@8X4E)%#8)!P<<
MXXJ_I^K66J&<6<QD\AE63,;+@E0PQD#(((.1Q7GS:+JEQX#UZW@^'VG:'J%[
M;-;);Z?-;EYB01N9@$4*,YQDGG\_0]+$HTJT6>!X)5B56C<J2I QU4D?D:=A
M%NBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CEMX9
M\>=#')MZ;U!Q^=2444E%)W2"X4444P"BBB@ HHHH ***ANKF*RM)KJ=ML,*-
M([8)PH&2<#VHV!*^A-16+I/B.+5-0EL6L;RSN$A6=%N0F)8F) =2C,,9'0X/
MM6;\2X5F^'>M%FD4QV[2*8Y&3D=,[2,CV/![T?U^-@6IUE%8UYKJ6!CM8+*[
MU"\$ F:WM-F]8^FX[V4=<X&<G!P#BH3XNLIK"SN=/MKO4'O YAM[=560[#A\
M^8RA2IX()!SV-#!:HWZ*YW_A--+,6C.D=Z_]KEA;!;=C\P!)5CT4\'C/8]@3
M5_1=;AUJ&X:.">VFMIVMY[><+OC< '!VLRG@@Y!/6G8#3HK"UR_TJWUC0[74
M+>XDN9KHFS=(VV)*$;EF&%'REN#UYXXJHWCK3A!<W*V>HFVM+S['<S- $$+9
M W$.0Q7+ < GOC'-):_U_7<'I_7]=CJ**.U>;:[K5SXB\#^*/M>F7MBME+(D
M3^>@#%"!C]VY)YR2"-O..:%O;^MTOU#I?^NO^1Z316'#XGLQ>WEG=PW%DUI;
M"[+W"J%DAYRZX)( (((8 CTJIH7CW0_$.KR:997"-<!#+'MGAE$B @%AY;MM
MZCAMI]N#1ULA=+G3T53U34H-)LC=3AV7>D:I&,L[NP55&<#)) Y('J16;:^+
M+&;3=1O+F"ZL3IKF.Z@N%4R1MM# ?(S*V0RD;2>M S>HK"M?%=G->R6-W:7]
MA>1PFX>*X@W!8N<.9(RT8!VG +9XZ5%:^,K&XNK6WELM2MVO5,EF7MC(+B,8
M)<>7NV#YA]_:>1Q0!T5%<Q9^.]*O+%]0$%]!I\8F\V[N(/+CC,3!65LG*DD\
M CL?2DT;X@:#K1OUAN4C:QB,\W[^&4>4,_.&B=UQQT)#>HYH ZBJ\MG'+(79
MF!/H:Q[3Q=:3WT-E<6.HV<]PAEMUFM]XEB&,R;HRP0<C[Y4\CCFF6'C"VU"Z
M2WBTZ_5I[5KNS:18PMW&,9*$.=I^9>'VGGZUSXG"4<3#DKP4DM=?+^F.,FM4
M;D-JD#EE+$D8YJ>N/TSQU#_PB,6NZW;-IJRR%(EN)H5$I)) 5M^T<#&7*]*U
MO#7BC3?%5E+<Z=)N\F3RI4WH^QL XW(S(W!'*L158?#4L-#V=&*C%:V7G]X2
MDWJS:K+U'PYI&KZE8ZAJ%A%<W5@Q:V>3)\LG&2!T)X'4<8XINKZ]'I4L5NEC
M=WUU)&\JV]J$W;$P&;+LJ\;EXSDYX!JFGC339IM*AMH;V=]4MS<6NRW(5E"[
ML%FPH;VSQD9P.:V\_P"OZW$SHJ*YA/&]BUE#>-8W\<#7?V.=G1!]EFW[-K_/
MS\V!E-PY]*MZEXG@T^:XCCL;Z^%H ;MK1$86X(SE@6!;CG"!CC''(H"QN45A
M1^*K2?5[73[>VN9_M=DU];7$?E^5,B[<@'=D'YUZ@#GK5.U\>:;<PZ6_V/48
MY-2GEMX8F@#%9(RP96924'W#CYN>O3.'9_U_7D!U-%<AJGC5HO#%_J-CI=VU
MW:7(M)K60Q!X7)49)W[2,,I&&.<CISCJK:5Y[:.62WEMW=06AE*ED/H=I*Y^
MA(I 2T5S^H>+K/3WN'-G>SV=HYCO+V%$,5L0 3N!8,< C)56 [XQ6)K]\-5\
M;6&@W6A3ZEI,UE),R'R&BD.Z,"7#2 X3)[9R<J#UH6NW]=0VW.[J.>"*ZMY+
M>>-9895*.CC(92,$$>E5)](MI=&&EB2ZBMUC$:M#=21RJ%Z8D#;L\>O/?-<E
MX6U6\-K;^&O$D\SSW5J)+*_65HVNHB,E=ZD,)5SR0<D?,.]'<-E<ZG3] L-,
MD9[<W;;NB3WLTR)_N*[D)U_A K3KS+Q!8&U\#Z'/#J6LI/)>VD;RC5KG<ZRR
MHK@GS.<CIZ=L5=\1ZE%H?B*%-?FU.V\.K!$MG>V]Q,$CG#$-]H=&W'(V8+Y4
M\YYI_P##?A<+?U\['H%%4M).=,A;[<+Y6!9;D%3YBDDJ<KQTQTXKF/B/)K!T
MFW@TZSUJ2T9R][<:-<)%<Q(HR FXY))QD = ?6D] 6IVE%<+:7L,^G^%]%TW
M4]1N;344EDEO+B=OM+Q(N2#)PRMN90<8( (&*V?#=Y)]OUG1Y)99ETVX1(I9
MF+N8WC5P&8G+$$D9/)&,Y.33M_7H*^E_ZU_X8Z&BN/DEFU[5=?"WMW:II#+#
M;^1,R#S?+$C.P!PX^=1M;*\=*K:?K4GC&XTBT9[BVMI])34;D6TS0N7<@(H=
M"& &'/!&>,\9%)*_]>O^0WI_7I_F=S17 VFNW>JR:=H,EQ.'DOKRVN;B-C'(
M\5OD9#+@JS9CR1@_>QBMWPW>2?;]9T>2669=-N$2*69B[F-XU<!F)RQ!)&3R
M1C.3DT;_ ->G^8/3^O7_ ".AHK$UZ]<7>F:1#(T<FHS,KNK898D4L^#V)P%S
MU&[(Z5ERZK)<>(M0\*C1[N/3H=/1OM,,R( 'WC.5<.H^3:-HSG.<#!*;TOZ_
M@-+^O4Z^BN'\$^(8H?#WA;3+FWNU>\L5$-TX!CDD5-S+G=NW8!.2N#C@FKC?
M$;PZ/$$>CB\B:62;[.)%N(2/-W;=A0/Y@.1C)3;[U;C:7*+U.LINQ2X<J-X&
M V.0*AO_ +4-.N?L(0W?E-Y(<X!?'RY/UK"@?6[TZ?!?:/);6MS:,+LIJ9\R
MTD_N[DP7)R,,I&,$U('2T5Y?\&Y+J]M_$%S>ZCJ-Y+;ZI-:1?:KV694B7:0
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M"TP%F; DY9BQ/[QNI/)/O0OZ^]K] >CM_6R?ZG4T444 %%%% !1110 4444
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MD&\XP^%!$@ R-C8'.<YK"TSPQXBTZ7PFABTJ2#1K=H96%U(K-N4)\J^40<
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MLZ"7*1S-+N\Q20&* EB<@'&!P:C^P:KI&FZGJ-H+!]:OKA)Y$G=_)  5!&K
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M&;?3=32U6>!G -M,TBL"Q;.612#SC&.W6N@HH_K\;_J#U_KRL%%%% !1110
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ML2^#3MMY(+Z,7 OFOKKS[;S(KEV&#F,,,;1C;R<8!.352;P1J/\ 9T-G:ZY
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MSR>PFOZ_PM?F#Z^C_-/_ #*7Q3@AG^'>I&6%)#'Y;IO4':V]>1GH>3S[U?\
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MDGAD,X=B6)RI4 8P #GG.?:DUC5HK/Q)H5A+I1N#>2R"*[8IB!UC9C@'YMQ
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M,A3S5P&!(QD>_>N8TCP=<:;>Z3<OJ<+M802V["*S\OSU<H=S$N?G^0;F[Y/
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MF;R@R2$C&#SRAR/2G9WM_6]A=+_UW_0[^BN+O?%&LZ</$\!AL+JZTJVCO(6
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M[926\=W&C)':.C$^2A4AC*0  <$8.3SQTIV=[/S_  _X<72Z\OQ.U)"J68@
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MX8]/LHIXXVB::WDEVXND# /(I#$GYFYW $YSC!S1X5N#OUK3AGR]/U!X8L]
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ML<L;@1/^[43*1UV)++MP>.7.>OL)-<U::RN-/T^S$?V[496BA>92R1A4+,S
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MKL8AASA@#Q@]::5_Z]/\T']?G_DSO:*Y&TN=8G^)5[";^V_LV/3X)5MS;-O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  =Z;!-'<V\<\+!XI5#HP[@C(-']?U]P#+*V^Q64-MYTDWE($$DNW<P'3.T
M?D*XW7HIKSXDZ2D#ZM:".PN(FO;6S9DC=VC*@NT;1\A6ZYQ['%=S13OK<%HK
M(YO4O!&DZGH<>ER-=0^7,;F.[MYBEPDQ))D#_P!X[CVQSTJ!_ EN]GIEN=<U
MICI]P+E9I9TFEEE P&=I$8G )P!@<]*ZNH9KJ"WE@BEE5))W*1*3R[ %L#\
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M=".,XYZUJ:?HVEZ1"\.FZ;9V43\LEM L:M]0H&:UFUS.W]:W_+3YF<+\JO\
MUI_7W'+K UMXJL+"POKZ[TO5;.>2Y#WTDACQMVR1N6W)G<1A2!Z8Q5;08TEN
MIO"MS=ZL]YIEVUQ).]_/ODA/,1+[\D$,%VDXRC<5V5AI&FZ4)1IVGVEF)6WR
M"WA6/>WJ=H&3[U86WA2=YUAC$TBA7D"@,P&< GJ0,G'U-3_7ZK[A_P!?H_O/
M.?[9U'3;'Q LNIW,J)X@BLS=SLN;:!Q%N(P J@;B!QQG)JO<W*>'O''B!=,N
M)+B\B\.K);17%PT\C,KR-@%V+/C(.,GKV&*]!M?#^BV/VG[)I&GV_P!J_P"/
MCRK9$\[K]_ ^;J>OK4MEI.FZ:%%CI]I:A4$8$$*IA02=O Z9)./<TO\ +]+?
MUZE7U_KO?_@'F^EZW+#I^IZUI?C*PUR5=/EN/[,@64OO R'*R3R&/&,;5"CG
M&.E6+A["U\8^!KH:M)<_;//<RW%V9%D9H0 5R=J[CP%7 ]!7?V6D:9ILD\EC
MIUI:O<-NF:"!4,A]6(')^M-M=$TFQD\RTTNRMY-[2;HK=$.YL;FR!U.!D]\4
M[JZ?]=?\R;:-?UT_R.?\=V%O>OX>%Q)<(O\ :L:9ANI(3RK=T8<\#!ZCMUJG
M+*=8U/Q#;7.IWEB^EK&]B;>\:/$1B#"9@#B0%MP^?<OR_6NTN[*UOX/(O+:&
MYAW!O+FC#KD'(.#W!YJ&\T?3-0G@GO=.M+F:W.89)H%=HSZJ2./PJ;:-?UT_
MR*OK?^MRGX?N+O5_!^GW&J1/#=W5FC3JA,;!F7G!&"I^G(K@]'L[:W\'>$HX
M+F??-JL;-ONGE*G]Z/E#D[1P>!@=>]>JUDS>%_#]R4,^A:9*4D:5-]I&VUV(
M+,,C@D@$GJ<53UDW_6]R?LV_K:QQ=UK5_H6F>+D@O9_(T_48$CGN2]R;:&18
MC(QRVYE7<QQNR!T(Q6OX&=6DO#!XOLM>MV5&$5JSR?9VYR2\DTK?-G[I( V\
M#K71VN@Z/8SW,]II-C;S76?M$D-NB-+DY.X@9;DGK4NGZ5IVDP&#3;"ULH2V
MXQVT*QJ3ZX4 9H3_ "'+78Y_5/\ DIWA[_KPO/YPT_QIX@?2="O9+.=8Y[?R
M3/-Y9D%O$\@5G9003A=QP"#@9S6C?>%/#FIW;W>H:!I5W<OC=-<6<<CM@8&6
M()/%6-/T/2-)@E@TW2[*SAE.9([:W2-7XQR% !XI=+?UN-O6YYK<7-S!X,UZ
MZTOQY#J0CCCD0:<[.8#NYR\DLSC<#TR,;>,<UM:IJ-_X?US6C8RW5WMT)KX0
M3S-(#,K$94'.W(ZJH XZ5U/_  B_A_\ LXZ=_86F?82_F&V^R1^67_O;<8S[
MT^#PYH=K?1WMOHVG0W<:"-)X[5%D50-H4,!D#'&/3BC^OPM_7^8EO?\ K>_Y
M'"W,EA:^,/ ]TNK27)O//D\VXNS(LCM" "N3M7<> JX'H*A\-ZO-K6M6MW+X
MVL;?4#.\5QHX203<$@Q>6TY3(_OK$"=N>F:]$M=$TFQD\RTTNRMY-[2;HK=$
M.YL;FR!U.!D]\4O]BZ5_:$FH?V99_;94\N2X\A?,=?0MC)'M3O\ K^/]6%;3
M[CE_ $=W>V#W]]JVH74]O>WEJ/-F^211*54LH 7("\$ 8R:T8FE?XEW*RK^Z
MCTF/R"1W:5]^/^^4S]!6QIVCZ9H\31:9IUI8QL<LEM L0)]PH%1ZAISS7EMJ
M%HZ)>VX9 7'RR1MC<C=P#@$'L0.O()?5?UTL/O\ UUN>=W]C:6MA\3)UGN/-
M(D4+)>2,N#;1L?D9BN<G@XR!P,#BMV.:[TOQ?!!:W%U<+<Z))<M!-.SJTL;(
M%*J3A,AB"% !]*ZB\T'1]1:9K[2;"Y:<*LQGMD?S IRH;(YP>F>E1P^&M"M[
MR"\@T338KJW0)#,EJBO&H& %8#(&"1@47TM_6S7_  1MW_KT_P OQ.&\$ZFV
MKZK97X\<6-U//$3=:4B2B4G;R#&]PXC*GJ410?QKO;_1--U.^L+V\M5EN;"0
MRVTFX@QL1@]#SQV/%26^D:99WL][;:=:07=Q_KIXH%623_>8#)_&KE#>Q/<\
MD^,>C:=H?PIOH--MDMHIM0CG=5)P9&?+'D_H.*T_&]Q<P^)/ :6NHWMM'=W?
MDSI;W+HDJ;0<,H.#]<9YKN-3T'1M:,9U72;"_,6?+-U;)+LSUQN!QG _*H7\
M*^'9$M4?0=+9+08ME:SC(AYS\G'R\\\4EHOFG^%K#EK]S_%W/&KS4;^_^$GQ
M M[F_O+A=.U62"V>2X=G6(.HVEB<LN">&)K9U/4+[3YO!'AS3IY18ZC:L\IF
MU6> R2A%*I]H =U&3D*.O X%>G6GAK0;"&YAL]$TVVBNEVW"0VJ()1SPP ^8
M<GKZU)/H.CW6FQZ=<:58S6,6!';26Z-$F.F%(P,?2A?Y?@K?\$'J]//\6G_P
M/F>9^*)?$FF6'@2*_P!:9-4?6$M+J6QNG\J:,L>'&%#G &<KUSZU)XHFUK1?
M$^@^&HM3N+FSU2>ZG+W.H2VA)SF.'ST#. N> .O Z<5Z+?\ AW0]42!-0T;3
M[M;<;85N+5)!&..%R#CH.GI5B_TK3M5M1:ZC86MY;@@B*XA61 1TX8$4[_G_
M %_F'^7]?Y' :K:>+HO#FC_;+N+4;FS$QU&UT_49+:6Y0<*Z2KL)91U4X!)^
ME8FJ&RUCXD_#ZX2ZU$6-SITLJM)>2QR8$>020P(;^\1][OD5ZU<Z5IUY:"TN
MK"UGME  AEA5D '(^4C'&!2SZ;874EM)<65M+):MNMVDB5C$>F5)'RGZ4)VE
M?SO^#0GJK>5B1K6%QADW N)#DDY8=,^N./RK!O\ >OQ"T4Q]'L+M91G^$-$0
M?S_F:Z2LZTT]UU*?4KID:Y=/)C"?=BB!S@$]23R3[ =J2W'T,CQ3*+C4;#2U
MN;OS)HII?LUM<-;%U7;\[3*P954D<#.=W3 -<WI6H:EJ,?@<S:Q=G[6L\5W'
M%*,2%8V(+, &)XZY'K@'FO0[O3K&_D@DO+*WN'MWWPM-$KF-O521P?<53;PS
MH#SP3-H>FM+;MNAD-I&6C.=V5..#GGCOS0M/Z]?\PEKL<;#K-Y8Z++:/?3BV
M7Q"VG-=S3%I(8"W&9&R2<X0,3D;ASFK'AP6=C\5=?T^*\>1QIUIL2XN6ED(#
M29^9R6;&X<DG&1766OAS0[*WN;>TT;3K>&Z&+B.*U1%E_P!X 8;J>OK5FSTR
MPTY0ME8VUL @0"")4PHZ#@=!Z4XNW]>27Z?B#_K[[G-7>5^(YMI+R[2UNM'E
M>2/[7(J;ED5=RC=A& /5<'G-<QHNJW=[I?@GR=>NY!+?SVEXJ7 D+X25@)&.
M6W#:O?H?H:]-N=.L;V:":ZL[>>6W;?"\L2LT3>JDC@^XJK-X<T*X:V:?1=.E
M:U.;<O:HQAYS\F1\O(!XI1TM?^M6_P!0?]?=;]#SO5HC=^'M8T^ZN[V2WT_Q
M';0V[/>2^8J,\)(,F[<V-[8R3CC'08ZFQ,]M\16LH]1NY[#^R%DC@EF\Q482
M!<@GYF) Y+%CR>:VHO#.@P1W<<.B:;&EY_Q\JEI&!/SGYP!\W)/7UIQ\/:(;
M\WYT?3S>%/+-P;9/,*[=NW=C.,<8].*=]%_72P/7^O.YC?#K_D4O^WZ\_P#2
MB2N5O[&TM;#XF3K/<>:1(H62\D9<&VC8_(S%<Y/!QD#@8'%>D:;I&F:- T&E
MZ=:6,+MO:.U@6)2W3)"@<\4R\T'1M1:9K[2;"Y,X593/;(_F!3E0V1S@],]*
M+ZW\O\O\BHNWWW_%O]3D9[J_T;Q'LL)KJY,^@S77V>:9G5IHR@0JI.$SN((4
M 'TJMX'U!=3U:"^A\<V&I&X@+SZ;$LGF$X'S%'G?RMIZ[54<_2NSA\-:#;WD
M%Y!HFFQ7-N@2&9+5%>-0, *P&0,$C JQ::1IEA=3W5GIUI;W%P<S2PP*CRG_
M &B!D_C3OK?^MW_G^!%M+?ULO\CG?B$L[:9I*VTD<<YU>T\MY8RZJ=_!*@J2
M/;(^M5]"A\GQO?RZ[<1R>(C;B*V*)Y4,EJ&W9B4DG.X_,"Q(('8C/2ZGH&C:
MTT;:KI-A?F($1FZMDEV9ZXW XZ"GW>BZ5?I;I>:99W*VQ#0+- KB(CH5R/EZ
M#I4K3^O(;U_KSN>=>&M7FUK6[6[E\:V-OJ'GO%<:-LD$W!(,7EM.4X_OK$"=
MN>F:%EOU\):QJ*ZWJ5QJVFZI/#:%KHCS2) JQO&N$;=TP5XSQBO1AI&G1ZC)
MJ<6FV8U%UVFY$*B1AZ%\9Q7/^%/#$UA->7>M:9I/V][R:XM[BW<S/&LC;BNY
MHU(Q[=?:FMU_75?U\V#Z^OZ/_/\ !&#XBU*Z6_EU"SO[LM:ZM:VSO]J:&&%6
M:-7A\H$K,?F)+,HQNX/RUH:L3X>\1S7(N=0N+76K=H+9&OIF2.ZZA4&["!P>
M",;=AQC-=9-H>DW$\\\VEV4DTX432/;H6D"G*[B1DX(!&>E4?[/UBZ\1&:_F
ML/['MG$EE##&_G,^W&9&)VX&6P /0]J79?UMK_P ?]??I_P3GX]+N+/QI8:&
M^M:M-8R:/,TD;WKY+B2,%Q)GS,G<>=W'08'%4-.OK\:%X6U-]1O9+I]5-C(7
MN&*R0[Y$PR9VL<*/F(+9[UW4_A[1+K4#J%QH^GS7I78;F2V1I"N-N-Q&<8)'
MTJL?!OA<VZ6Y\-Z/Y".72/[#%M5C@$@;< G Y]A3OW_K5O\ )V$U_7RM^>IP
M\VL3:CXJO(I_&EAHM[97YABL)ED$C1Y&T!?/6.7>O?RV(W8'(%+J=SJ,6C^.
M;MM8U%Y])O?,LF\\H(_W4;A2$VAERQ&U@01UR>:]%ET?3)M0AU"73K22]A&(
MKAX%,D8]%;&1^%5&\)>&V6X5O#VDE;E@\X-E'B5@<@MQ\QR2<GUH6B7]=5_E
M^)3U?]>?^9AK96K_ !2%Y+-<+-_94;A1=R*A;S"N-@;:1ST(QGG&:M>.O^/3
M1?\ L,VG_H=;T6DZ= ]J\6GVL;6B&.W*0J#"AZJG'RC@<"HM3T#1M::-M5TF
MPOS$"(S=6R2[,]<;@<=!2VM;H_UN3:Z=^J_2QRWQ+=-0L=-T&SD5M8N;^WEM
MXU.7C5'#-(0.B@ \^]4-6U&X76(=2L]0NW1-;BLI)6NVBA5"P1XA!DJY!)R[
M!3SP3@5W6FZ)I.C*ZZ7I=E8JYRPM;=(@Q]]H&:1]"TB6>>>32K%YIV5YI&MT
M+2,IRI8XY((&,],4UH_Q_+] :NOZ\SA;DKHVJ>.-7L)K@WL4<3Q@W,DJ#,08
MMY1?:V "0,=!@8%7_ ]PESJ4T]MXUL-:@EAWO9VWF,T;$CYSYD\K)W&T;1[<
M5V@L;07CW@M8!=.@C:?RQO9!R%+=<>U16&DZ;I?F_P!GZ?:6?G-OE^SPK'O;
MU; &3[FE'0;U_KT,:0R-\2K=9!^Z329&A)_O&50^/P"5S7B34;E-1GU"QU"[
M;[)J]M:L_P!J:&&%6:-7B\H$K*?F)+,HQNX/RUW.I:<]S-;7ELZ1WMJ3Y;.,
MJRM]Y&[X.!R.A /.,%TNAZ3<333SZ58R3SA1-(]NC-)M.5#$C)P0,9Z4XNUO
M+_.__ #OY_Y6_P""<U/?WVF>*6NK^*XN-,O+B*"UO+2\)2'. (Y("<<M_&H8
M\\X%:?B_4I=.LK!4F-O#=7T5M<7(;:88V)R<]LD!<]MU:QTO3VODOC86INXP
M0DYA7S%!Z@-C(S4]Q;P7=O);W,,<T,B[7CD4,K#T(/!%+HD'4\LGOE\.>+/&
M2Z;=R27=OHUO)"L\S7$H"F3<WSMN?:&!Y)Z@9Z5I^&/)U0W_ )7C>UUBVN+8
MM):V,LZR1,3D/O:XD>+N-HVCVKN;32]/T]0ME8VULH01@0PJ@VCHO Z#TJ"/
MP]HD-K=6L6CZ>EO=DFXB6V0),3U+C&&_&AZJWE;\_P#,.M_ZZ?Y'G&EP3:7\
M,_"5W8ZEJ,#SWED)T^U.ZRAY%4K\Y)5<'[J;1ZYK6U+[9-JGC6*35M1\NSLH
MKBU6.X,7DOL=OEV;3C*C@YSWSQ74_P#"'>&/L@M/^$<TC[,'\P0_88M@?&-V
M-N,X&,T]_"OAV26XE?0-+:2Y&V=FLXR91D'#''S<@'GT%.;O>WG^*7Y6!;I_
MUNW^MC@M8\07%Y=:;8ZCXFL]!CFTN"[BGNO-C6>4YWD/'/$!M^7Y6R#GI6Y#
M=27VLZ;HE_K,D]O_ &6+I;NUE:V-](& + HV<  -@-@[^<BNE?PYH4MC;V,F
MBZ<]I;MN@@:U0QQ'U5<8!^E6+S2]/U%(DO;&UN4A8/$LT*N$8=",C@CU%#:O
M\_\ /\K^F@DG9)]O\OS_ %.3^%=Q!-X1F2&X29HM1NU?# LI,SD;L="00?QK
M 2.2#1?&>H6U[=6VHV>KW$EJL4[*K2;4V*T8.'#' PP/M@UZC!;06L?EV\,<
M*9)VQJ%&3U.!4#Z3ILFI)J3Z?:-?HNU;IH5,JCT#XR!^-%];^7^7^7XC_P [
M_G_F>;ZQK-U?^([ZQOO%]CX:NK0QFVBN1(I8-&IWKB=(Y/FW#:RMC%;FH7-S
M;>-[NZM8_M-U%X<:2-,;?,<2$@8[9/:NKN](TR_NH+J\TZTN+BW.899H%=XC
M_LDC(_"F_P!B:3_:W]K?V79?VEC'VS[.GG8QC[^-W3CKTI/56]?R:#K]WYK_
M "_$XRUN9XT\*ZKIVI7M[)JTJ17L4ERSI(IB8NZH21&5(_@"^AJMJ-E<P6FL
M:):ZAJKZA9W U"USJEQYDEOM#;2V_)4E7CQG R#UYKOK;1],LKR>\M-.M(+J
MXYFFB@57D_WF R?QJS]GA\\S^3'YS($,FT;BN<XSUQDGCWIM]5_75?)/\ 7G
M_7])F1H+V^J)/K<$L[P7RKY2O.[1[ H&0A)523G) &>*J>"KE(?".DPW,T4<
MCAXK=6< R*K-M"CO\@!P.U:]U8R?V:MAIWE6D1'EY1<>5'CG8H&,]AV'7G&#
M+!IME;P6D,=K$$LU"V^4!,0"[?E/;CBC2[["ULOZ\BU1112&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !114<TRP0M*^=JC.%&2?8 =30!)16/I_B&*\U233+BQO+"]
M6,RI%=!/WL8."ZE&8$9(R"01D9 S5S4+YK*(&*RN;V9LE8+?9N8#J<NRJ.O<
MB@"Y16?H^L6VMV1N;994V2-%+%,NUXI%.&5AZCVR#U!(K0H **** "BJ>J:I
M:Z/I\M]>&86\0R[0P/,5'KM0$X'<XXJAIWBW1M4NXK6WN)X[B9/,ACNK2:V:
M5>I*"55WC_=S1N!MT444 %%%% !1110 44@922 02." >E([K'&SN<*H))]
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M6Q)>SO)IMI'=6D^I6L8D(*NQ!6/8,?)@9 (SR#QGJQX6T?\ LRXT^2VDF@N
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M%2!@K@CMBC^OR_R8K:_UY_YF##J.HW&A>,;"_GNIULH&$,MY%$DS*\);YA&
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MZ'&,XP!QGFNAEUK4=&\0:G;SW$E_;QZ0=0CB,2J4=2043: 2IP/O$GWK5O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFN--I*K)>[%MV$:$9##$V6&.<*"?:M3183HD86^UF74)+^5/LS7'EB0_(!M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %8/B[PK;^,=%_LJ[O]0L[=I \AL9A&T@P1L;((*G.2,=0/2MZB@#RNR^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX<CUZWM=1F_LJWN+5!>W;/=&T\PGS027#LH&P_>RN_@\"A;??^G^93_K\?\
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M;275KYK*31H[@107'E!'+LI*M'AA]W/7/4=.*.E_ZVO^@[?U]W^9W=8OASQ
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M6*RM-]H9Q;H"9>F\G'WN3SUI[Z3ILFI)J3Z?:-?HNU;IH5,JCT#XR!^-7**
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M2?QK8W^L/92:'=Z+Y,<]RRFWF<R!@H8_*Q(Y _*O1J*=_P"OE;_@BM_7SO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/7L*DTCQ'/=Z[<Z%J=@MGJ<$"W.V&?SHI(F8J"K[5/4<@J/QH6H/0Z"BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;O5-4MK>QELK!M->=?W!B,>0X608*H6   (''O619QZ'J.A_#>]OH;&\A1!
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MR?\ G^ ?U^7^7XGG5AX;L8-1E\&2:-;-I4=U_:D9-NIC:(YPAXY82?+_ +@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZNU^GXB3T3_K:YU'A+7;O6-:\1137UM>6EK<1+:26R (8WC#CD$[OO=<\XX
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MV2#GA2,=2* -.BO/]/UBW\,:AXMGFM[^>SBU-&ED5O,\A&AC)8EVSM!)X7)
MZ#%=#K7BVTT5Y@UG>72VT*W%T]LJ$6\3$X=MS*2/E;A0QXZ4[;#:UL;]%<9<
M012_%.RD5YBMSHL^X><X&/,B *C/RG!ZC!J;X;H(_!R1AG8)>7:@NY9L"XD
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M?U_7WF]17('XC:4-(EU;[!JYT^+SA).+)B$:-@K*R_>4Y/< <')&*T3XIAV
M#3M0,\KA+: QHKW/[OS,H2P7 '4L5P1@]J0&]17,S>-;6+2)[]=,U&1[6<07
M=JJQ++;,<<ON<+MY'*L1@YZ9-63XG1=9U#3'TR^2:RM1=EV:$),AR!L/F9SE
M2/F  QR1D9/Z_4/Z_0W:*Y;6/'NDZ##;?VB#;W4T0F-G-<V\4L:'/)WRA3C!
MX5F/L:4>/-*FN(8+&WU"^>:Q_M"+[/;$B2+('REL9;YN@],=< EK@=112 Y
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;V,"QM--/<^2S[S@"$%2)&'<%EZCKFJ]U:6K?%>SD^S0[KC1;A9F*#,@$D0
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MGMY_U_7S&K7_ *_KR^1SVI^)[O3M&L=1^P6EQ'<74%O(8;XL@$K*H>-O+^<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML88#<0W.>..:DK7\OT)C[R7G^IT%_J%MIMOY]RS[<X"QQ-(['&<*B@LQP"<
M'H:SCXNT/RK247C-%=%1'(L$A52QPH=@N(\G@;\<C%<K=ZKJ7B#7?!>I:5=V
MEM;7T$T\<=Q:/*R'ROFW$2J#P<#@8(SDYQ5[PF-8;QEXI-U?64D$=W&CI':.
MC,?)0J0QE(  .",')YR.E"3O9^?X!?2Z\OQ.PN[N"QMFN+ABL:_W5+,3V 4
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M-(DU2>VTZ..VU?\ L^>W3?(74RK%E7)7!!.>5.>F!UH2O;^NJ7ZH;5OZ]?\
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M1W))P!WY/XUR=IXVN8(];6^>TNVL/L_DW$$$EM'*9B548<OP&_C!(.?:C=V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*RJ 9' W,?4X &?H!3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHILD:RQM&XRK#!'J* *UCJFGZGYWV"_M;OR7,<OD3+)Y;#JK8/!]C5B
M66."-I)9%CC499G. /J:Y+2YKI/B!=1ZKIT=K<S67^B26LWF120HXSN)53O!
M=>", '@]<ZWB^UM[OPAJ\=S!%,@LY6"R(& (0X.#WI2=H\WD5%7ERFQ%+'-$
MDL3K)&ZAE=3D,#T(/<55N=7TRRO(+.ZU&T@NKC_4PRSJKR?[JDY/X57\-?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!S?C*5UL]+M0"8KO4[>&;']S=N(^AV@'V-
M4]7M[N7XEZ&(]6O;>'[%<2-!$(RC%7BX.Y">0V"<YXX(YST6L::NK::]L7\N
M0,LD4F,[)$8,K8[X(''>J[:3!JK6=YJEGY=_;!U4Q3L-N[AL%2-RG .&] <
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MCA.Y [8&,X&["@#.!D@GO5/2/ /A;0KZ[O=,T6VM[B[4I,PR05/50"2%!]
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MU-+6S2\_R0T[.[\OSN<O_P )-K^NP:+9:9):VM]>:5%J$CM<B N6ZB/=#,&
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M'8[3P.5P>!Z"K7A_PSHWA73C8:)8QVEL6+LJDL68]RS$D_B:%_D)^14\>?\
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MKO\ \ 'L_P"OZU*&C:S>W&I7.E:O-J-AJ4OF&*.2"/RBHX!MY N&P.<.2WJ
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M;U#8],BGUP-W-?:-JEK)HT]U>FXTN>>>UEN&E0,B*8W4,2$RWRX7 .>G%5O
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MF+B>-),MN&UD;&*>]O/^G^(=_+]=CNM/UMK[7]4TI[&2 V"Q,)7=3YP?=@@
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M$L==U;0[6#2;H0DRVNH--)$)2H4LC1)Q\PS@D^QKMJIIK<E.YG?\(_HI\O\
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M1W\G^LND@42OQCE\9/'O6/JGC73K :5#;;=1OM6.+*"SE5UE Y+[^@0#JWY
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M3*V^0QH%WMC&3CJ>!S7(^-_!<?BNZM7NM'TW58($(2*ZO)K1HV)Y821JQ8$
M#:0/7-=K10"T.9T?P'X=TJQ@MQH]I(L#EX%G!N/L^<96-Y,L!D9XQSV%;-SH
M^F7ES]INM.M)YS$8?-E@5F\L]4R1G:>XZ5=HH;N"TV,EO"WAYYWG;0=+,TD?
ME/(;./<R8V[2<9(QQCICBI8= T:VM(K2#2;"*VAE\Z*&.V1423^\J@8#>XYJ
MAX4UR]UM-6^W6]O!+9:A):!8'9@0H7G) R>3V%=!1_7ZA_7Z%.RTVVL9[J:"
M"&*2ZD\R4Q1A-[>K8ZMZD\FK$T$-S$8IXDEC)!*.H89!R.#Z$ U)5:X^W?:;
M7[-]G^S[S]I\W=NV[3C9CC.['7MF@"46\*W#7 AC$[*$:0*-Q4$D GK@$GCW
M-9C>%/#C"Z#:!I1^UG=<9LX_WQSNR_'S<\\]ZI^(/$DMEHMQ?:2EM<FVNDMY
M_-<@+EE5L8!W$%AQD=^>*Z.C^OU#^OT,N/PSH,-S;7,6B::EQ:J$MY5M(PT*
MC. AQE1R>!ZUID!E*L 0>"#WI:* *EAI6G:4DB:=86MFLKEY!;PK&';U.T#)
M]Z2TTC3+"ZGNK/3K2WN+@YFEA@5'E/\ M$#)_&H[O4@KW=I9&&748;?SQ#(Y
M51G(7<0"0"5/8]#47AK5)=;\,Z;JD\:1RW=NDS(F=JEAG S1Y_U_6@6+UY96
MFHVKVM[;0W-O(,/%/&'1OJ#P:C32M.C698["U03J%F"PJ/, & &XY ''/:K=
M8WBK6;KP]X=N]6M;*&\^R1M++%+<&'* $G!"-D^Q ^M U=O0NV>D:;IRA;+3
MK2V4)Y8$$*H F2=O Z9)X]S3;31=*T]P]EIEE;,"S PP*A!;&X\#O@9]<5@R
M>*M3TR73FUS1[6WM+^=+>*>ROFN-DC_=#JT49 /3(S764]=R="E#I&F6^HRZ
MA!IUI%?3#$MRD"K(X_VF R?QIJZ)I*7<EVNEV0N97$DDPMTWNP! 8G&20">?
M>K]%(851.BZ4=/DT\Z99FRD)9[;R%\MB3DDKC!)/)J]10!#:VEM8VT=M:6\5
MO;QC:D42!%4>@ X%5KO0M(O[^&_O-*L;B\@QY5Q-;H\D>#D;6(R,'GBK]%'6
MX%.^TG3M3MGMK_3[6[MW8.T4\*R*S#H2",$^]5(_"OAV)K9H] TM&M<_9RMG
M&#%SGY>/EY)/'>M>B@"**W@@:5H88XVE??(44 NV ,G'4X &?:J.I>&]"UF=
M9]4T73KZ95V+)=6J2L%ZX!8'CFM.B@"CINBZ5HT;QZ7IEG8HYRRVL"Q!CZD*
M!FD&AZ0+NXNQI=B+FY4I/,+=-\JG@AFQEA[&C6KR[T_2+F\LK6&YF@0R>5-.
M8E8#D_,%;!QG''Y56\,:^GB30(-2$!MI&W)/;LVXPR*<,A.!G!'7'-&]PV&_
M\(=X7\B.#_A&]'\F-S(D?V&+:K'&6 V\$X'/L*VNE<UX:\4S^)-2U:.+3XX;
M"QG\A+AK@F28[58,$V8"D-D'<3TXKI:>H=3,?PWH4FJ#5'T73FU$,'^UFU0R
M[AP#OQG/XU-=Z1IE_=075YIUI<7%N<PRS0*[Q'_9)&1^%4/%FMWGAW0)]5M;
M&"\%O\TL<MR8?EZ94A'R<D<''UJD_B?4M,U'3K;7=(MK:+49Q;03V5Z;@"0@
MD!PT<9&<=1GWQ27D#-.7PMX>FFN9I=!TN26Z&+AWLXRTPR#\YQ\W(!Y[@5,-
M!T9;:UMETFP$%H_F6T0MDVPM_>08PIY/(K0HH I3:/IES8O8SZ=:2V;G<UN\
M"M&QSG)4C&<T2:-I<MI-:2:;9O;38\V%H%*/CIN7&#T'6I[IKA+65K2*.:X"
MDQQRR&-6/H6"L0/?!KFM"\5W^J:7K%Q?:9::?>:;(\3VKWQ?#*,Y=O+&U2""
M" V0?PH[AV.CM["SLY))+6T@@>0*':*,*6VC R0.<#@4R[TO3[^2*2\L;6X>
M)@\;30JY1AT()'!Y/-5]"O-5O]-2YU;3(=.G?E;>.Y,Y"X_B.Q<'V&?K5<ZO
M>KXU31W@MQ9/8M<I*'8R%E=5((P !\WJ<^U.SO85U:YMU3@TK3K6:>:WL+6&
M6X $SQPJK2 # W$#GCUJY12&9L7AW1((5ABT?3XXE1XU1+5  C_?4#'1NX[]
MZ9%X9T""VBMHM#TV.WBE\^.)+2,*DG]\#& WOUJGIVNWMUXUUC1+BWMX[>RM
MX)H9(W9F<2%A\V0 /N]!GZUT-/S#R,N;PSH%SY?GZ'ILOENTB;[2-MK,<LPR
M."3R3WJM>Z?K&H:]&D\NGC0(O+F$2QN;B253D G.T("%/ R<8K=K$AU:];QE
M<Z1+!;K:)9K<Q2([,[$MM.X8 7!!Z9^HZ4EN@>QMUR-MX9N+GQGJFIZQI>D7
M%E-Y)M2TAFDB>+< VUH@%)#=0W&,<YS775@:]K5]I6L:#;06]N]KJ%V;::1W
M;>AV,PVJ!@_=/)/''!H6Z!ZHU+C2M.N[I+JYL+6:XC0QI+)"K.JGJH)&0#W%
M5V\.Z&]Q:W#Z-IS3VBA;:0VJ%H0.0$.,J!VQ5/P_K5]J>JZ[9WMO;PG3KM88
M_)=GW*45P22!SAAQCCWZT^?6+V'QK9Z.;>W^Q7-G+.)M[&3>C("-N, ?..<G
M/MW%TM_74&MRZ=$TDW<MV=+LC<RE3)-]G3>Y7[I+8R<=O2K]%% %(:/I@L);
M :=:"RE+&2W\A?+<L<ME<8.3R?6IK.RM=/M4M;*VAMK=!A(H8PB+] .!4]%
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M?F8#/J0.M>L45?-K?SO^?^8NECB_!^HV-WXO\916UY;S2"^C)2.56( A12<
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M9/+ECSW5NQI-+TR#2-/CLK=I71,DO-(9)'8G)9F/))/.35RB@ HHHH ****
M,:'0'M[QY(]9U(6LC,[6;-$T9+$D_,4,@Z]GX[5L*JH@50 JC  Z 4M% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %8NG^'5L/$.H:R-3OIY+
MY562"41>6H7.W;M0-P"1RQZ\YK:HH\P"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K.U323J30R1:A>V,\.=DMJR9&<9RKJR'IU*DC)QC-:-% %:SM#:
MQ@27$MS-M"O/,%#OCIG: HZGH .:LT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %,:)&D61AEDSMYX'OCU]Z?10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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0H **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ex10-7_002.jpg
<TEXT>
begin 644 ex10-7_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@!LDD<,322NJ1H,LS'  ]2:Y+0/$
M<^J^--:M4U*SO-)AM+>>T>V"E0'+ALN"=WW.O ]JN>,H;N33[&:WMY;J"VOH
MI[NVA7<\L2DY 7^+!VM@<G;WZ5Q^J66KZKKGBBYTO2+Y8;[3;4P22*;;SS&[
M,\9W%71F4[<XR.^.*%O]_P"G]?)CM^GY_P!?>>D6&JZ=JB2/IU_:WBQ.4D-O
M,L@1AV."<'VKEKOQ<B^.=/M;?6M.?1C;7+7>QD/DR1!2=\FXA0 W3 QCDG-8
M=E9OK'A[7I]&\/>)-+U:2S-MYFLW<K-*1SLC\R5CC[PW8 YX[XO%YM0\;>&;
MZQT+4(K2"SN;:9I+4P^02$ #!\?*,'!7(/;/-/K_ %V8KZ/^NJ.R37='D:S5
M-5L6:^!-H%N$)N .I3GYOPS4CZKIT>I)IKZA:K?NN]+5IE$K+ZA,Y(_"O.+"
M#48-"\'6:Z-J4EQI6I;;M!;E @V2KN#/M5E^8'<"1[YXJ[IUQ>0:K-X>UGPI
MJ=Y+_:;WMOJ4$:FV(,A>-WDW JRC"[<$X7H1197_ *\O\P>B_KS_ ,OQ.MTC
MQ3H^NW]_9:??VT\]E*8Y4256;@#)P.<9.W/3(-:TLL<$3RRR+'&BEG=S@*!U
M)/85SOAI)[;6/$4$]K<1^9J!GCD:,A'0QQ@%6Z'E6X'3'..,]+2Z+T!;LR5\
M4^'G2U==>TMDNW*6S"\C(F8$ A.?F.2!@>M%[J5K<PSP66NV=K<6\\:3N&20
MQG<"8V4GY2PR.>><BN6O=)U-+'5+"SM)0-+NCJ6FN!\LK$^8(U_X$9%(]"OK
M1XTMS<>#K.>;2[FXOI-0M[M8XK-YY(3YJLW"*2I6,%2>.F.^*:MI\OQM_P '
M[@_X/Z_\ WKSQ3ISZO>>'K/5;.+6H[?S$24ARK$$@;-P+$ ;B >F/6F^$_$,
M>KZ!I0NM0M6UBXL4N9(0RA^1][RP<[<U1GFDLO&>IW\EE?O:W.D0B.2&TDDR
M4>0LI"@D-AU^4C)SP#@US6ER-9Z;\/=VE:K&]EO^UA=*N,Q9A9#NPG&7(^O7
MIS325K/^OB_R0Y62T_K1'6^$_$)NK!(-9U2S;5)+RZ@C0;83,(I67*1DD]%]
M3]:W+K6-,L;N"UO-1M+>YN#B&&:=4>0_[()R?PKS'S'_ .$3A*Z3JZS_ /"2
M_:V7^R;CS/+^TF3>1LSCRSU_#KQ6W=0S1/XITW4M,O+W^UV:2RDCM7E21#$J
MK&S 8C*L#]\J.<YZTGM?^ME_FP=N:W];LW)-1U*/XC6^F-<QG39M-EG$(APP
M=71<E\G/WCP /QJGXK\2R6.H:3::7JED)VU*"WO;8;9)1'(?3/R=#R0<YXQ6
M?:0W]GXRT*UN5O9KB#0GM9KU;25H?/)C(S)MV\[&/)_4BLB6+4F\,^&]/_L'
M49=4TO5()+[%O@.06+R)(<(X8\Y#=^<'BG972\__ &YK^OD3=M-^7_MO]?,]
M%AN4MY]2FNM7MY($D!"'8@M1M&59L\Y.6R?6K-MJ-C>3W$%K>V\\UNP6>.*5
M6:(GH& .0?K7E&L6<#Z5X[M8= OS]IO8YK2--'F(D<(@9TQ'@G<KG</KGG)Z
MB"=)/B"'BL]1BM)-%$(E_L^:- V[>%W%  0IZ'H>.O%3TO\ UM?_ ( WO_7=
M+]3K;75-/OKF>WM+^UN)[<[9XHIE=HCZ, <C\:=;ZC8W5Q-;V][;S30-LECC
ME5FC;KA@#D'ZUX]X9\2>$]:UWPWI-Q?Z<TFD*8K2.6VE\Z:3:  _F1!(W! /
MRNV6Z$5VV@0:EIGB%=/@EN;S2=CR'[;9-')9EN0JS8"R@GC R1U+4[";M<[2
MJ3ZQID>IIICZE9KJ#KN2U:=1*P]0F<D?A5VO--7BO;F\D,>F7\(MM?@N'@AL
MW<3)O4>=YA!## SB,C;CGO26K2&]$V=EIGBG1M7UB_TNRU"VFN[)]DL2RJ6R
M ,D+UP"0">F<CJ*V:YCP\D]OXG\2I-:7$8N+J.XBD:,^6R>3&O#="=RL" <C
MZ$5T]#V0/=E:WU&QNKB:WM[VWFF@;9+''*K-&W7# '(/UJ.WUC2[N\GL[;4K
M.:ZM_P#70QSJSQ?[R@Y'XUQEM8ZU;7-WH^F7=U-9RVLQCDO;)HY+"1P2@6;
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ML=764VDDF^(@2130/#(F>FY' 89[9'- B_1110 4444 %%%% !1110 4444
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MBUNXHXFCOGB22T9<_,&=6^0@\@<YKT&&%((Q'&,*/4DD^Y)Y)]S3Z;_K\/\
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MAVD$\5S;QSPN'BE4.C#HRD9!KDO'=IYLNA.MYJ%N9=2AMI!:WTT >-LY!",
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M?W SC;U[Y[8I+?\ KNOTN-[?UV?ZV.L7Q+&][>V2Z=>B[M[;[5'$XC4W,9R
M4.[CD8P^TCTK'L?B!;1^#K#6]:MVL);Q0889KB!/..W=\C-(% Q_?*GCI5J+
M2=<D\9+JMQ;Z=':-IHLW\N[=Y%;.XD*8@",\=1QS[5E#PEXFL_#^AC2[[38-
M9T9&@B\T.]O<0D $/@!ESM5N <$8R>M'3^N[_P" "_K[E^MS3MOB'H=[#IDE
MJ+J<ZC.]O$L,8<"5 2RLZDIGCC#$'J,CFDU7XBZ)HL5L;_S+>XEB69[2>:"&
M:%#GEEDD7/0\)N/M5>^T7Q5J,WANYO#H\USI]V;JZ,4DD*9V,@2-2KDCYL[F
M(Z=.>)=:T7Q5!XC;5?"]]I:I=I''>6VI1R,@V9Q(FP@[L'&. <#FFP-:#Q-9
MWES%%813WB/;I<M+!LVQHXRA(+!CG!^Z#[XXJ#2_$%Y?^*M7TN32KF&WLMBK
M<%XBA)7=D@/NYR,<=!S@\52\1>%KG6)+:XBCM8]3B4(NJQS/!-".I(50?,7=
M_ S!>>:TM/TN^LO$^J7I>W>SO1$P.3YBNB;2,8Q@\'.?48[T=?O_ . +I]QM
ML0JECG &>!DURT7CW39K*"^6RU(64MV;)IW@">5+NV .A(?EN.%.#UQ74N6"
M,4 +8X!. 3]:\Z/A7Q0WAA].^S:/]H;6?[1S]OEV;//\[;GR,YR-O3W]J%OK
MY?G_ )%=/Z[/];'4Q^*K(?VL+N"YLGTN,37"3JI)B()5UV,V0=K<=>.0*K_\
M)BOEZBIT/5A=V,23O9A83+)$V<.A$FTCY6XW!N.G2J$^A^)GUWQ!?6S:?9_V
MA9106\R7+N\;Q[L$J8P,'>1D$XQGGL_2]&D\/:U>Z[?G3+"RFL8H[H_:6<JZ
M%R6:1PNX$,/F;!XQCO2Z?+\0_K\O^":MOXE2Z71V@TR]==4C,J%6A(A0 '<^
M).F&'W=W7Z5N5R7@NPA1[^]M+M+K3#,T>F,A#*D).Y]I[CS"P!Z81:ZVFR3S
MC0=83P[?^,99;34;JSAU8M+-&WF_9T\F-BS;WW%1D\+N(';%;FN_$/P]X?F2
M*ZNXW8HLKA+B%62-AD-M=U9QCL@8^U02>&-6ANM?M[66S:QUR5I)9Y'82VV8
MUC(5 I#\+G)9<9Z&H9_#?BC1M9\_PE?:6EA<1Q1W-MJ<<C^68U"!T*$$DJ%&
M"0.*.R]/R_K4;W;.T@GBN;>.>%P\4JAT8=&4C(-9>J>)+72]6LM,>VO)[N]#
MF!88<JVU22-Y(4'CIGW.!S6M&&6-5=M[@ ,V,9/KBN1\6FZ7Q7X4:RCADN!-
M<E$F<HC'R&X+ $CZX/TI=4OZZB^S?^NA9F\=Z7;:<;NYM[^%TO%L9K8P;I(9
MFQ@/M)4 [AAMV#D8)S3=5\?:5HL"MJ$<MM<NSA;6YF@@D95;:7!DD52O<8;)
M':LO6/"&L7NEW/V<6!U#4-3@OKH27#K'$(BF$0B,EN(P,D+U)]JO^(-&\3G5
M[?6_#-WIL-\;<6UU;:@'>"10=P(9,,"I+8X&<\T?U^'^8_Z_'_(F@\>:7?3V
MD&FV]]?RWEFUY;B&$*LB*0" [E4W9/3/'?&1FPGBZRFTRWN[>VNYIKB=[5+-
M459O.0,6C.Y@H("MU;''!.16'J/]L0^/= *"RN]2&DW7F!V:")SOAS@@.5'I
MD-T_&KA\,:I;6D"VUQ!*9K^2\U&!IGA2;?GY5=03A?EXQAL<XS3M_7S#^OP+
M#>.+;[%87<>DZG)#=W)M&($2_9Y@^S9)ND&/F!&5W XX/(S=N/$L-K<ZC'/8
MWB0V/EAKC$921WQM1<.6W?,/O #GKBN>72M.\-^#+_1O$%_IME:7-Q<-:^5)
MY9^=VD4(#CYQD85<\CC-:,>D:XW@A((KQ(];N-D]U*Q,8D8D%TW+DIE1L##)
M48QTHT_KSM^6OX#Z_P!>?YZ&+XYUB+6O &NH;6_L+RP>(2P3.$=2S*1DQNRL
MI4],D>HKJ(M9MM0O9M#NK6]LYY+=GC$I">?%P&:-D8D8W#KM89'%8$W@6[NK
M+Q%9YL;*#5EA=1!N<I(@&=V0-PRH^;J<]!6Q#I6J7&IQ:SJ$-BE[:6LEO:V\
M%P[1DN5)9I"@(SL48"G'/6ET:?\ 6C7YV%UNOZU7_!,+PSXDTWPS\-])GU&Y
M53(95B66X1&E8.Y(WRNJYQW9A76^'_$.G^)M*74=-EWPEVC8;E8JZG!7*DJ?
MJ"0>Q-<?;>$?%5EX=T@V%UI=KKFE/,J!WDFMKB*0Y97.U67G'0'[O7GCM='3
M55TV+^VI;22_/,OV-&6)3Z+N))'N>OMTI[WO_6PMK6_K5_\  *_BB\TZP\,Z
MA/JT,\VGB%EN(X(V=BA&#PO(&.IXQUR*JGQ19P7T>DVMA?W%U]B%W'#'$ &C
MX  =R%)Y_O8]3G&;'BS3KW5_"FIZ;IZVYN;NW>!3<2M&B[A@DD*QX!SC'/MU
MK&MM(\21>)+/4WL]*\N#2C9,@OY,E\A@1^YZ94#UP<XXP5W_ *Z/]1O96_K5
M'2Z1JEMK>DVVI6F_R)TW*'&&'8@CU!!%0:_K0T#3?MSV%W>1!U5Q;>7E 3C<
M=[J-N<9YXSZ9JGX+TO4=$\,V^FZFEJL\#. ;:9I%8%BV<LBD'G&,=NM;%_91
M:CIUS93KNAN(FB<>S#!HEIL$?,RCXG1=9U#3'TR^2:RM1=EV:$),AR!L/F9S
ME2/F  QR1D9PQ>M:>-[G45TW4GEGT=)FLO,5G4B0@@ R>6IP!G# ''<U:3PM
MJ4G]BW-U>6[W\&Z+49%#!9X2H!51]43K_M>M3W.G:]_PEUYJ<%KIKVCZ?]EA
M#WDB2%@2V6 B( ).."< 9YZ4/3;S_)_GH"\_+\U_P2X/%-C-INGW=E%<7KZC
M%YMK;0A1+(H&2?G957&1G) R0.XKF_%VJ6FO>$4NX/M4$UIJMK%+ [-&\4GG
M(K)(JG#<-[J<@C/!I^D^$]=TK2_#T\?]G'5M'MWM&B-Q(8+B)MN?GV91LJI^
MXW3'.<AVK>$-6GTB^^QK8-J.I:E!?7(EN72*,1E"%5A&Q;B,#) ZD^U5HI?/
M]5^@?U^#_P" :?B+Q_H7AF[^RWURAF50\J"XA1HT/1MKNK-T/"!C[5TD$\5S
M;QSPN'BE4.C#HRD9!KD+_1?%]IXBEU+PY?:1'!?B,WUMJ"22"-U 4O&4())4
M 8.!Q78QAEC57;>X #-C&3ZXJ5L#WT,_4]9CTZ6*VCM;B]O9E9X[2VV>8RKC
M<V795 &X=2.O%9DOCG28=/M+QH[TBYO!8^4+<EXIBVTK)V7!]3SVS4FL:/J!
MU^SU[2#;27<$#VTEM=2-''+&S*WWU5BK KD?*<Y(]ZP]3\':J]E&+$6+W4^L
MIJUV9KAXT4HRD(F$8GA0,G'KCG :\_ZU_P @?E_6G^9VEA>&^M!.;6XMB693
M%<(%<8)'0$C!QD'/((K+\3W^E64.GIJMO<3)/?0I#Y,;$++O&PLPP% ;'4\]
M.>E;BYVC< #CD YKG?&.E:KJ]A90Z7%9N\-[#=/]JN&B&(W#X&U'R3C';'OT
MH6Z]4'1C+KQOI]L-69;+49ETEPMZRP!!&N,EQO*[E Y^7)(Z UTD<BRQ)(AR
MC@,I]0:X.^\-^)+N'QA&MOI*_P!MH$@)OI/DQ&(\M^Y]/FXSSQ[UV>EQW,.E
M6L5VD27"1*DBPR%T! QPQ52?R%);>>@/?3^MO^"4M6\1VFCZCI]A-!=RW&H.
MT< AA+*6"EL%SA0< \$^_0$U6C\7V;V=Q(]G>Q7=O<+:R6$BIYPE;!1<ABGS
M C#;MOO6?XU-P-;\)&U6)YQJ3E%E8JK'[/+P2 2/K@X]#1/X=UMH[R_AFM4U
M&^NH9;JV6X=(FA1=OE"4+N'KNVC/3 %"V_KNO^"#_K\2U-XZTVTT.XU.[M-0
M@%M<_9)[<P;Y(I3C .PE<'<OS;L<CFH[KQ;>IXBTW38?#^I&.XDF621_)3A
M.5#2#*_,&SZ# !.0,6_\$ZT?#^M:5I\6DQQZAJ*7<8\UXQ&@\MFSA#EMR'Z[
MLY!XKI]0TS4KK5]$U*$6B26@D6XC>1B )% )0A?FP0."%R.XIK=?+\O\Q:V^
M_P#/3\#>KSZQOCHOCKQA*EEJ%\@%I(R0N)&C!1BQ =QQSG:OX"O0:Y:;0]7M
M/$FJ:CIC64D>JQQ1RFY=D:W**5#*H4B3.>A*_6IU3NNS_0?3[BS%XMMKC5M-
MLK>QO)H-2@,]M?KY8@90NX]7#9P1QMS^ )&AI.J_VM'<2"QN;5(IWA!G,?[W
M:2"R[&;C(/7!]JY77+#3=)\.:3X>L=4@@UJS,1TM7=3,[@[<[,Y*D%@V. "?
M2NRL;1+"P@M(R2D*! 3U;'<^YZU;MK;^OZV%V,WQ;K-QX?\ "]]J=M:/=2P1
MDJBLHQ_M'<1P.OK6 ]W+#X\M=1_LW43<SZ-*6L?-5GRLD> !YAB4XSR& /&3
MFND\3:5+K?AK4=,@D2.:YA9$>3.T-VSCM60=.\2'Q7;ZJUII1ABT][8J+V0-
MO8JW_/(C:"H7/7!)Q_#4K^ON?Z@[O^O-?H3W/CK1+3P]9ZS+.$AO ?(CFECA
M=V&<KF1E0$8/5A6CX?\ $.G^)M*74=-EWPEVC8;E8JZG!7*DJ?J"0>Q-<?;>
M$?%5EX=T@V%UI=KKFE/,J!WDFMKB*0Y97.U67G'0'[O7GCM='355TV+^VI;2
M2_/,OV-&6)3Z+N))'N>OMTI]P[?UW_X!?HHHI#"BBB@ HHHH **** "BBB@
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M&(QDJ, ]#THM_7SL&RO_ %W_ $.]J-KB%)DA>6-99,[$+ ,V.N!WK.UV]O\
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M8@D*H9%4C )W%@>/NUDW7C"67PY8ZK>>&?.T^\-F\9-Q&X4RL,%@P!&UMN"
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MLORQXV['0DAP1C/(!(!P.E=M11_7]?>P.1F\*ZU.^@RS^(X[FXTRX-Q+-<6
M)N&*E, (Z*B[6.!@\X))YS?\/:%?:/?:Q<76H6]TNHW7VD)%:M$8VVA<9,C;
MAA5[#G/K@;]%.[_K^O(/Z_K[SD=5\'ZC-XC?6-#\376C/<A%O8DMXYUG"C (
M#@A&QQG!Z#BKDOAN[@UB;4=)U-+62[CCCO$N+?SA+L& XPR[7P<9.1TXKHJ*
M72P>9R<7@V:QU/0IM,O[>"RTFW>!+>6T:1Y-^-S%Q(H!. ?N]<]<\&E^$]0L
M=#OM.N=1TV]%U<33D3:83%F1BQ#(93N )./F''KUKK**/Z_4#B;KX?R+I6F1
M:+KL^E:EIOF""\CA610DC9:,QL<%.F%SQM'7%7)/#&L2:AH5W)X@CN)-,9WE
M>XL<O<,ZE6QL=50;3P IP>3FNJHIW>XK'&0^"]1&GWD$^LVS33:FNIQ21V+(
M(Y X8JRF4[E.T#@J>O-=)JFDV^LZ+<Z5?%I(+F(Q2$<$Y'4>A[U?HI=+?U_6
M@^MSGK/P[>?;+*ZU;4HK^73PXLV6U\HJ67;ND^<[FQD9&T<GCI@\,:#J>AOJ
M'VW4[2\2\N7NL0V30E';&>3*^5XX&,^YKH:*=Q6,2]T2[DU_^UK'4([>4V9M
M626W\U3\VY6X9>A)R.XZ$=:PX/!6KP:?X?M?[=LF_L>Y-P'.FM^^X8 $>=QP
M[<\\XZ8P>WHI+3;^NHWK_7E8X^U\&ZEIWB&6ZT[Q1=6VC3SM<2Z4+:-@78Y;
M;(?F1223@#/)YK8\4:1=Z]X?N]*M+V&S-W&T,DLMN9L(P(. '7!YZY/TK8HH
MZ6&G9\QS=OH_B39:VUWKNFO90E/,2WTQXY)%7^'>T[ 9P,_+5.U\&ZEIWB&:
MYT[Q1=6VC3S-<2Z4+:-P78Y;;(?F1223@#/)YKL**=];DVTL<-<>!]7N-(UJ
MP;7;$?VI>B[9QIK_ +OIE0/.Y^XO/UZY&+MQX0O9)-3\C6(X(M7AVW\8M,YE
M\L)YD1WY3( R#NZ<$'FNLHI=+?UM8J]G?^M[_F</<^ ;^*UTMM%\4W>G:E86
MHLS=FVBE$\(.0KQD!3CL>V3US6B/#&H_\)/I>L2:RDPL;5[=EEM,R3%RI=BZ
MN%!^48 3 ]ZZ>BG=WN3;2Q6M(;F'S_M-W]HWRL\?[L)Y:'HG'7'KWJS112&%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !44EQ!%-%#)-&DLQ(B1F 9R!DX'? YXI
M+NYCLK.>ZF)$4,;2/@9. ,FO#X/'N@Z[\8O"^HP:NTZM%- R"&54A>3B., J
M,DYY;U[@8P1UDH_UU_R%+2+E_70]VHHHH&%%%% !114%Y:V]]9RVMW!%<6\J
ME9(I4#*X]"#P:3=E<">BOF'PZ/#K?#J\T[[!&OBB[U&2+2[D6YA8."NT+<D!
M1C^[OSSTY%=W\7])DA^#=D^L+#>:Q9_9XWNR@+[B0'VL1D XY]:JVB?I^-OR
MOJ.WO<OK^#:_&Q['17%^$]$T=[PZA#X2AT*[LF$<96"&.216C&23$2I4Y]3T
MKSNXTK0(_B)X]LI/#INW-O!]BBLM.:0QRM'G<K(I$1+$'<2OKFD]';U_ 45=
M7]/Q/>**^?O&FC7EC\._!#^*;:.XUF/4HH;B1XQ-*827(B8@$OQC(YR?6NG\
M*P66H_%*34/!@CL- L[<P:G;)']G62?G ^SD J1Q\Q4?=(YYJN75KU_!7_X'
MJ)O2_P#6]O\ @GK5%>#W.GZ79_&?Q4J^$;?5H8]/CF6V6VA9(W(0F0JY'<G)
M4%CD\5Z'XG\.75CX&FT_PA:11LDZW'V%&\M)4WAGB!&-H;GCW(J5\*EW_P R
MOM./];7_ %.UHKS/P1K/AK7M0GTC^PI-"U"*U>.ZT*XAVP.C%=S*F C>F=H)
M!YXKCOAGI&CW;:M8WG@^VOX9=<GM_MTMO"R6Z!<A 2=XZ<8&!NZYIVULNU_Q
ML+I?^MKGOM%<%XX\ :?XDT_3;&'%K?VR;;.^51YL9124!;J5SU'X]:S_  WJ
M-IXLN=.M/$VEVC>*-$NC#=+-"K,,1N5D0D?=; ;CN ?2A:NW]6[B>G]=3TVB
MO%/B_P"&-#TY/#<EKI5FDUUKB?:9O(7?,&)+!VQE@2>AXKTS^R]-\*Z;>-HE
MA;V;W3J$@@C"1F8X13M' [9QZ4E\-_E^7^8WO;^NO^1OT5Y?\+;NX$?B/P3K
M,S2WFFW4@WG@R0RDG=^9)_X$*P_$GA7P]:?&OP=IL&AZ='8S6TWFVXM4V2D*
M^"PQACP.3FFE=I=_\F_T#H_+^OU/;**\:^,OAK1M+\"Z5%9Z=;QK%JB)%B,9
MC21G9D4]0I)Z=.E:GB)Q=_$KPWX%CC6UT 6;W4UK /+2? 8+&0,?(-O*]#GF
MDM=N]OPN#TW[7_&QZC17EGBZ*#P'XI\*7?AVW2Q@U"^%E>65JHCAG5L88QCY
M=P_O 9]ZB\4^&+K0?$5WXX\*6RK>V4N+ZQA0*MY 55GX'\>23GJ?J*--&]M5
M_7EJ%GLM_P"O\CUBBO/8K73_ !)H6N:UX-BL[?4M4LAY-['&L<F]@<AF R#D
M<^XSVK*\&>(-(/B&RT74?#\_A;Q"A9S %VPWS;2"VX8$A[Y;)]"::6MGO_PX
MKZ77];'J]%5M0O%L-/GNF4MY:$A!U8]E'N3@?C7G'PYU'4-+\:^)_"6M3^;=
MF;^TK>3H'23!8#V!(X^M):NW]?U;4;T5SU"BO+/&/A.ZL?$<_C/PG D>L:>%
MDGM8TVK>QG)<$ <N?7J?KBM+3H/"?C"SU+7[72=/G%]IZ-*TELA?=F3<KY'W
M@57/^Z/04K^ZY=OZ_$=O>MW/0:*^?_!.@6$OP&N];@ACM-9M%N)X=1@4).IC
M)(&\8)'&,$XKUSP)K$_B7P'I.IWZ SW-N/.!7AB,J3CT.,_C5N-KKM;\24]G
MWO\ @=)17BNCZ'HGA?XF^)?"]_I=J^DZQ:"\M5>%2,+DM&"1T!R0.VT4OPYL
M;:RT_P 3> -1L+5KB&]5=K1JWFQ2<AF)'S%0"03TXJ5KMVO^-G]PWIOW_2Z9
M[317F/Q46^M?"ZIX>6.WCT'R;]XHE"KM1OD0 =  &;'^R*T_%UUIWBKX.ZAJ
MIMXIX9=,>[A$J!O+?RR01GHP.1D=*3?NN2Z?U_G]PTKR2[_U_D=W17SKI<&F
M:IX>\':5X5B33O& $=Q-=B VK&$9WL68+YX.!PN[.#V!KJ/B[8Z6GC/P1=WF
MGPSB6\9+HBT\UYHQL^4JJEG')PN#UJFK-+SM_P $E.Z;\K_\ ]BHKROX?007
MOCS5]8\+.EMX2,(@-JGR*]R,;F$/6/ ]0N<]*F^+E[JT&G0ZEI+D)H%S#?7*
MC_EIDD;?P!R1Z,*3TM?K^'];_,:5VTNG]?\  /3J*Y;7K+1O&_@J!KB".YLK
MT0R1,R@L@<J-RG^%L,1D5P^EHNE17/PY\7PP7R0+YVC7%S$&6XA!^[SQO09'
MT]NKL[N+W_JXKJRET/8:*\V^*?A;08?A_KNHKI%E]KBM$2&8P*6A5<!50X^0
M =ACK5OP'X1\/-X)T6^_L:Q$]SI,<5R1 H%PK*K-Y@Q\_*@Y-+HWV_X+_0;Z
M>?\ P/\ ,[ZBO!_AYH>DW'P9\4S3:;:2RF2[&]X59OD3*<D?PGD>AK1^%>B:
M/JOA?1(;OPC#'*+=[E=6>"'?+(DHV['4E\C/\6.G0BFE=V\D_O$]/O:^X]GH
MKR[QU/?:)XM&LZKX:;Q#X;-NBJ(U$CV$BEB9%C/&3D?-QC'48Y[7PA?Z7J?A
MFVN]'O);NQE+M')*S,XRQ)5BW.1G'/I26JN-Z.QN4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8/UJUJP^(>L2Z5J4WP]6#7M,R8;ZWUFW5#D896C.<H?3=GT(KV:BA:;>H?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445Y7_8VC1^.O
M$ZGP'#K"@V[@Q6MH1&S1DMQ*ZG+'DX!SWI7U#H>J45S,5PV@^'=-ATG2H<2J
M76-Y#!;VX(+D,X5MB\D#Y3V%-T_QA_:^CZ;<:?9QR7NH"7RH'N0(QY9(=C(
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MM?;+C^R]/L8;Z5[99[B.XF\M$A?( /RMECAL+C!P<D5F_"U53X>:<JH$56F
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MCMU.Q969F1XR<..1GIT!XKN** .4NO#&MW-IH\;^(TGN+&Z%U-/=6 8SL 0
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M*6]LPIN(D.3%NZ9[ \=.M'EY#OU.>T3PGX@T:&>W;QA/?6JPF*Q@N[-"(>,
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MQPTO@C5YM U;3&UVQSJ-[]K:4::_R98,5 \[GE5P<\<]<\=K"LJP1K,Z/*%
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M,W))^\?;#+?P5';3:)(NN:JW]CQF*W5A!AU(P0^(LGY<+QC@>N24OZ_\F_X
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MR+'+'F,;'W;FQASR"#GOCBMJYO\ 4=9UO5],TO5QI]WIBQ-'"8D83%EW9DW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%#<O;.VFW@\V-59E^:'E=P(S]01[5D1>*]9G\-:1#'/;_P!I7UY<67VN:40
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M&FG;Y?G_ )$IIJ_]=/\ ,[VBHX$DCMXTFE\V55 >3;MWG')QVSZ5)2&%%%%
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M])E9-B_=4(6*@#L !CM5>Y\$Z#=69M)+6=8#<_:MD-Y-$!)NW9&UQ@;B6 '
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M#D*6ZXSVJ&STC3-.N)Y[+3K2VFN#NFD@@5&D/JQ R?QJ8Z6_KO\ Y_@#UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<MK7@\:SK
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M8KRM=,MOL_@F7Q%90S!+NXC1[V'S&6(K(8$8L"=V F >=P'>O4\X&:;5E?\
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M@D1V9W#LRG=D #E3P,_7M6M8?;?L4?\ :'V?[5SO^SYV=>,9YZ8KC#J.E/\
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MT#E)IC<H$C8'&&.< Y(&#WJ5-6TV2^2Q34+5KQXA,MNLRF1H_P"^%SDK[]*
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M-#M+!E(^_@ ]1@5Z?13OU$M#R[QAXMTCP]JUO=7EPD+:CI0@$6HV]PBA-QY
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MS'/MZ2[V?>WZ?YZ#TO\ /]3H]-\76%[X<LM7F6ZA%R@*PFTF,K-MW$)'MW.
M.Z@@@9K5TW5++6+-;NPG$T))7(!!5AP593@JP/4$ BN-LM*UVPM_#&I#2Y)9
M]+LFL;FP6>/>RLJ#>A+!,YCZ%AE3V/%:NDV&HZ2NKZDEBTMQJ=^D_P!B,RKY
M*$)&26Y7< I8@$YZ GK5R2N[?UKI]ZU(5[*^_P#5_N.HHHHJ2@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K*L_#NG6&LW>K6ZW(O+L8F9[R:16 /'R,Q48[8
M QD@8S6K10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8D_>\<@],]/4@%;L-D=117+^(==TV+2+\:SI>H&PBN$@)1 XF;(((,;$JH.
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MMA,=.C@DO-O[I;B0I&6_VB%)Q]!5FBAZ@<)>> +/4/",\5SX?T)O$4\#![O
MR9C_ ,M/.\K?G/S?=Z\>]0:^_B>+P_HL$NGV-[XECF+(ECJ B<A4*M+&TT>
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M!QCCG;VSQV(S@9P3WQ2T47TM_7]: <4_A/4Q'KNE1R6C:7K5Q)/-<,[":(2
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M?'O3]7\):I+H%S!8"QEU"^U*._NFFF>*-2C(P5<(Y/$:KT'<^U=Q13YG>_\
M6]_S#^OS_P V<7/HGC"Q\1SWN@WVD)8:BZ2WMO?I)(89 JJS1%2N[(4<-CI[
MUV:@A0"VX@<GUI:*72P=;G)2>'M7M=8UN;3WLGM]:*F62=V5[8B,1_*@4B3I
MGED_&J.N6&G0P:'X>TG58K?6;(QPV\2RAIQ;E=DA*YSCR\G)XW*M=W4"V5HM
MZ]ZMK"+MT$;3B,;V4=%+=2!D\4+I_6P>9)##';P1PQ*$CC4(BCH !@"N<\0:
M'J.KZCLS:7&DR6KPO;W$CJ$D.?GV!2)>,#:Q&,9'6NFHI-7W!:;&7X;L;K2_
M#>FV%ZT+7%M;1PN822A*J!P2 3T]!7/ZJ^H)\3;9M-AMIYQH\G[NYF:)2/.3
M^)58C_ODY]J[2J!T+2#JPU8Z58G4A_R^?9T\[IC[^-W3CKTJFVY<S\_Q$DE'
ME1S:>$]1M%L8(I[>ZLVEN)]0MY9'B6225MV\;0=P7+ (V <@DY JC#X1U^UL
M_"MI&FE-'HMT\SD7$B;EVNJJH\L]GSVQC'/6O0:*$[.XWKN8#Z?<V7BZZUQI
MK5-/EL8XIVE<JT1C9VSTP00YR21C'0YXS?"MI:7&NZGJ6FW\5WH_FDV@A8-&
MLL@!F*L.",@=.A9Q77R1I-$\4J*\;@JR,,A@>H([BF6UM!9VT=O:P1P01KM2
M*) JJ/0 < 4)@]26N2OO"5S=QZY;BYB2WNR9[$8.8+@@9<_1U##']YJZVBD!
MROB+0M5U#P4=)L_L<E],4::2>9HH]V\.Y&$8G+#@8'!Z\4Z72M;37KK5K:/3
MV:ZTV.W>&2X<!)49R &"'*G>?FP",?=.>.HHH?7S_P K M/Z\[G 6/AGQ):V
MO@Z!X-*/]B$BX9;V3YQY;1Y0>3Z-NP<<C&>]3GPAJ7]C7OA@O:/H5S*\@N#*
MXN(T>3>T>S;@]2 VX8R/E..>XHIN3;O_ %O?\P_K\_\ ,XK5?"FJW#^)[>R>
MR%KK=J$$DTCAX9!'Y>-H4@J1@YW CT-7[;0]6M]:T>_>>RE-O8-9W157CZLC
M!D7YL_<Q@D=<^U=-10G;^O7_ #!Z_P!>G^2&R)YD3IG&X$9KAH_#?B2UT+PU
MIL4>E2_V3<(\CM=2)O2,%5Q^[/)!R0>F,9.<CNZ*2_KY!TL<%-X2U^[N-?E\
MZQL9KJ^AOK"XAF>8QO$JJ!(A11@A><$_>(YQD]'X<3Q*MFS>)YM+:[)PJ::D
M@C ]27.23] *VJ*%HK ]7<P?%FB7FM:;!_9EZEGJ5G<)=6LLB;DWKD;7']T@
MD''K6;+H7B;5]%MGUF\TM-9M+M+NV^Q1R"!2F?E;<2S;@6!/&,CCCGL** .*
MU/PUK&J6^KW\L.GQZO?:;_9T<"W3F&-"6)8R>7DGYLXV#IC/.:6'0_$(USP_
M>R6VEB+3["2UG O)&)9]HRH\H9 V#J1G<>F.>THHV_KU_P V']?E_DCB(/ N
M'U:WC2+2],OK5[<VMG</(C.V/WH1E58F'S<+D'.2:=9:=X\.CZA9:Q=Z%=YM
MVAM6A66)I21C=*Q#!>.<*IY[UVM%#U5F"=G<X>Q\/^(K>Y\)-+;Z7Y>CV[07
M!6]D);*!,H/)&> #R1R<=LG<\-:3>Z-!>VURUN\+WL]Q \98LRR.7^8$#!!8
MC SG&<]JW**;DW=]_P#.XDK*R\OP,+Q%HUUJ$VFZAITL2W^FS--"DY(CE#*4
M9&(!(R#U ."!P>E9MSX=U26SU^]6*Q_M?5[=+<PFY<0Q(JE1\_EDL?F8YV#/
M XZUU]%2U=6_K7<I.SO_ %IL9?AVVO[+0+*TU&*VCN+>)82+>9I48*  <LBG
MG'3''J:K:EI5]-XITK5K1K<I;0SV\R3,P.V0H0RX!R04Q@XZYSQ@[M%4VV^8
MF*Y59'GEQX9\4W'AV]L6MM&%Q<:LM^"+^78$$HDVY\G.?E"].^>V#?&B^,=.
M\0S3:/?Z0-)OYA<74-Y')));N5 ?RBI 8'&?FQCTKM**2T_KY?H-Z_U\P' '
M.?>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *HZSJD.B:+>ZI<*S0VD+S.J]2%&<"KU17-M#>6LMM<1
MK)!,A21&'#*1@@TG>V@U:^IS U[6+#5=)BU/[!):ZPQC@-M&ZM;R["X5B6(D
M4@$;@$Z#CGCEWGUFY\$W4^IWMM=O_;\<<>RW:(@I>A>3O;C@8  P.[=:[?3?
M"UOI\MLSWU[>I9Y^QQW;HPM@1M^4A0S?*<9<L<=^:I7?@6VN;*6SCU?5+6WD
MOOMVR%HB%DW^9@;XV^7?\W.3GC..*M-)W_K=/\A+;7^M&OU1%)XLN]*N/$4.
MIQV\YTN"*YB:V4Q;UDW!4;<Q&05QNR!SG JJ_B3Q?9:;J]Y>^'T2*UM7N8))
MVCA7*\F,B.:8L=N3N^4$C&!G-:W_  AUK+JFJ7EY?WMXFIVPM;FUF$7E% "!
MC:@8$;F_B_B^F*-I\.[.ST?4-,37=?EAO(S#FXO!,8(CU2,.I501QG!..]0[
MVTWM_7Z#5KZ[7_R_X)M>'[O4[^PBO;_[((KB"*6%8%8%=R L&R3WZ8[?KSK>
M)O$DD'B2>.#2XCHERRF$^9)]HC$2R8#Y78V&Z[6&>,=SUVEV TO2[:P6>:=+
M=!&LDVW<5' SM ' XZ5P^B:5_;>O>*DN'UBTLKF^#-"]JT$5W%Y*(?FDCSC*
ML/D8$CKD$5;LY/E_K4F.D5S>7_!+7B3QE?Z=IIU*Q%G';I8I?)%/&TTMR#DL
MBJC QX 7+E67YO8U;D\0:[<^+)M%L;?3HE&GQWL4L[.Y;<X4JP&-O1L8SV/M
M5W4?!]CJ,VH.;J\@BU"T%I<P0L@1T (4C*DJ0&/0@>H-+9>%(K+Q$-:&JZA+
M,+9;3RI3$4,8YQP@;[QW=>O'3BEI?^O/_@!KR^?_  W_  3G]/NO&/\ 8WB&
M[M;_ $RZN[>^G$,4MA)\P3C:")AU  'ICG.<C>TS5[W5[[3WL[NRET]K)+BY
M;[*X=F?[NP^9A.A)!#$8Z\Y"S01>$[74M2M[?5=1%Q<><;*U59&#N0&*+\O&
M>3DG'.,"H]$\.I#X?N(=MSILM_</=2+!+B2$L^X(&&0,# ...N*4=ON_*W_!
M&_\ /^OT^9TM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#) '<X!/'I4M !1110 4444 %%1&Y@6Y6V::,3NI=8BPW%1U('7%2T %%%%
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MR;3FNI2]RRNOS("<;"#C/ R,Y)R,8I=1\'3WLFNK%JHBMM:MA%<*UL'=7";
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M.?#"X,$9G2X2-9=@W*I@D)4'J 2!Q["O3=2NY+&PDN(K66ZD7 6&(9+$D#\
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MRE64J&4]#P<\'UZ4:77]=_\ @!K9F*OCFY2T62XT1C+_ &O_ &6ZV]TKHK9
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MMI=R"6^L4MHY%E<  E&?)CR ,X!I[M7_ *T7_!"6[:_K5_\  .P!R ?7UHH
MP **D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***S]=ENX-!OYK&:.&ZB@9XY)(_,4$#/*Y&>GK2D[*[&E
M=V-"BN%L-7UF >$KVXU%[N/6D2*XMVAC58V,+2>8A50PY7D$D<\8IEGKFKGQ
M-I2C4)+JTU&6XB?$""U38K,GE-A9&/RC))93S@CBJ<6G;U_ GF5N8[TD 9/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT'EEB@ R<8'&3CJ:JIX*T**73I(X+I&T[_CU"7TX$?;H'P1CCG/''3BN@HH
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M!-Y-C+YMLLMU++Y3;2@P78G 4D!>@]*V***;=P"BBBD 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !114<\1FMY(A(\1=2N],;ER.HR",_A0P,/2O&_AW7-
M>N]$TW4?M&H6F[SXEAD 3:=I^8KM/)QP:U=4U.ST;3+C4M0G$%I;H9)9""=J
MCV')^@KE_#FF:KX5UN'0GU2XU71Y;9WMGN57SK4QE1M9@!N4AN#C((K:\2Z
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MXRA4\#GBFW/A2.;7K#58=5O[0V,1A@MH%@\I8SMW+AHRV#M4=>,<8KH**2T
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MBX/4XYW53'P_A71(=*&OZN(8;W[<CXM]_F;_ #/^>.,;\MC'?'3BM76_$/\
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MJ>GO+/<1SF&2>5 N$#J0P)#,WRD$[?3-7?AQ/;,_B>WAN1,\6LS%@9-S[2%
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MJ1B)661D!VR!FW??!'&!C%5VLVU?QIX1O-2%];W=QI4TT\,5[-$J2 0G 57
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MY?</-9Z+J.J6E[<Q3P^)-B".8K&5:X1'5E'#@@G[V<=L5Z>0""",@]0:Q?\
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MEI%L+/Q0@C=H[=<1R+_K-W'0QDL!TW*>[5WEO;6VG6"6UI L-O FV.*%,!5
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MER>V<GBMG2],@TC3X[*W:5T3)+S2&21V)R69CR23SDU<IWU3$CS#6I#=6_Q
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MDLI;:6"2W>[<N"% (5B% ;D==WRDUU/B/0$\2:8+"6_N[.+S%D9K7R]S%2&
M.]&XR >,=/2M2)&CB1&D:1E4 N^,L?4X &?H!26E_P"NEAM[?UUN>:/;2R7W
MB*XO;&_OK6^T2%$+:4ZJ64RC8(MI?()7Y6RW.>G2>"P>/X<>&Y8]*N5N[5[#
M[6@LW6<+$Z[LIMW-M^8\ ]R*]'HIW_3\+_YDM75OZV2_0\WOK*>[\7^*(],L
M+JTN=0T5(DN6LI(XWG&_.9=H4G:R#.[V!XX3PI;6>HRW#S^%?%&G7L%F]M--
MJ-Y-(FU@-R0%Y6W9(&"% XZUZ312Z6_KK_F4W=W_ *Z?Y')>$UU2UU"YT^>>
M:^TZWB5(;RYL6MI@0?\ 5G( E&.0R@#MR:MZ_!=VVL:9JMA:O/+E[.94&<1R
M#(8^RNJD^@+5T5%-N^XK6.4\,:=>Z=>7>F30R_8=.E=K.5^DJR ,,'_8)=?H
M17/6,=Y+K'ANZ.EW]O%;7MTDMF+)PEN71SDR,,N"3]\'9S]*],HH3UN)JZ:/
M//#6D0ZCX<\2:3#8W&GI)J$TUJ)K&2W5,D&-T#JH.&7/'3'/6M.W>\U3P/>W
MOB/262YN+9HY+$0-,<*, ; "3ELL!CH1Z5V%%2U>+CY6_"Q2=G?SO^IY5H4<
M::EX$EFT;45GM-*>WN97TF<&)MJA59C'Q\ROCG'?N"6K?VVF^ [N]U%+VQBM
M->>[7[783QJ5:X+H64INV$'.0#@XXSQ7J]4-4TP:G%$HO+JTEB?S(YK9E#*V
M".C!E;@GA@152DVV_P"M[B25K?ULU^IQ?PXU?P_X@U77-8T^[TZ?4[N1'GCM
MHG!A0*% WR1H[@E<D[0,GIW-^YCCC^+=I<QZ?<@OI<L$UVEC)Y9<NC(K2A=O
M16ZGCIW%=38V+6D:^=>3WLX7:;BX"!R,YQA%51^ %6Z':ZM_6EA:M._7_@?Y
M'G=C8W+>"M,1GU72M0TJ21EECL6FPX+ @Q8)D4@]5ZYX:NDT)M2O;;3WU2T2
MWGA62201QE%9BQ56"G[N5W,5))&X9KH**+C9YIK8NK?0/&UDVF:E+-=W9> 0
M6<DHE5XXP"I4'/*MGTQSC(S:N/-O?&%S'IMM?VOVC0#;0W#:?-'&DI)906*!
M00#T)&#QUXKT&BENK?UM8%H[K^M4SS#PI!97$V-2\(>)+6[L+1XKB34+B>ZM
MBI7#I$K2/YH;'14[?3.9;VRCPOX)C;0]1%QI^J[Y%.DS[H(@7+?\L^%.Y/KC
MC.#CV*BG?6_I^=Q6TMZ_E8S-4M[*'P]>0-9*]H8'#6\5L9 P(.0(U!+9)Z &
MO-Y=*B_X4KIL,V@W+ZI##;Q"/^RY&G1T8,>-FX  M\W3D\\UZW12V_#\!^7K
M^*L>4^./%>C:'K=R+RZBA.KZ7'"RZA;W"JD>9/F4+$Q)&[YD;;SCD<U?TZ31
MX[_P8FC6\UWI<%K,5N[33I#!N8* Q*)M5BRL2."#UQFNPN-#DDU-KVVUG4K,
MR%3+%"8G23   Q(C%1C^Z5ZD]>:U(HD@C$:#"C)^I/)/YT+;^O/_ #!_U^'^
M1YCI0N/[#MI!INIJMMXEDN7C>PF1Q"\DA5PC*"1AP3@'&><<UMZE%J5AXE%W
MI3W<QOIXC<Z=<V;20D+M!D68<1,JX/)()7@9KMJ*:T_KR2_0'K?^NK?ZE:UO
M/M4MTGV:XA^SR^5NF3:). =R>J\XSZ@U9HHI %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%1SSQVUO)/,X2*-2[LQP% &2:
M&[:L-R2BN&\#>*=8\6WES??;/#TVAX/DQ6;2F[C)(VB8-\H.W.<#KTKI=>UR
MWT&P6XFVM)+((H8BX3>Y[9/   ))[ $T/3<%J[(U**R]!O+C4+#[9-?:;=QR
MG,3:?EHU&.1OW'?SGD!?I6I0U8$[A1110 445S4'B>23QLVC20HMG+"_V6<9
MS++&1YJ^F &7'NK4+5V#I<Z6BN;U74-2M?&VA645S$-/O$G\V'R<N61,@[\]
M.1P .G7M2^#]0U'4+;5!J=S'<3VNHS6RO%#Y:[5QC"Y/ZDT+7^O.P/3^O*_Z
M'1T56NM1LK$,;N\M[<*AD8RRJF$'5CD]!ZTAU*P73O[1:]MA8[/,^TF5?+V?
MWMV<8]Z +5%8NI>+-$TS0#K<FI6CV!(6.9)E*2,3@ ,#@_\ Z_2IX;R*]U*U
MGM-9MI;66V9TMHBC^=RN)58'.!TXX^:@#3HJG%JNG3ZA+I\.H6LE["-TELDR
MF1!ZE0<C\:(M6TV?49=/BU"UDOHAF2V293(@]2N<B@"Y15:WU&QNKB:WM[VW
MFF@;9+''*K-&W7# '(/UJ2YN;>RMI+FZGB@@C7<\LKA54>I)X H EHJG!JVF
MW5E'>V^H6DMI(VU)XYE:-CG& P."<\4^SU&QU$2FRO;>Y$+F.7R95?8XZJV#
MP?8T 6:*X^3Q,]Q\0=+TW3M4LKG39H+CSXH-KNDT>WAG!./OCY< C'?-=<[K
M&C.[!449+,< "CI<.MAU%9+>)]#&C7.KIJUE-I]L"9;B&=71<=L@D9]JQ1XJ
M%WK.AW=IJMDVAWEM/)-MVMM=%!.9=V !G!&!@CD]J/Z_K[@.PHJJNIV#Z=_:
M*7ULUB4\S[2)5,6W^]NSC'OFF1:QID]E%>Q:C:26DK!8YTG4HY)P &S@DGB@
M"[145M=6]Y L]K/%/"V0)(G#*<'!Y'O4#ZKIT>I)IKZA:K?NN]+5IE$K+ZA,
MY(_"@"Y15*XU?3+2^AL;G4;2&\G_ -3;R3JLDG^ZI.3^%%YJ^F:>LK7NHVEL
ML2AI#-.J; 3@$Y/ )H NT5435-/DOA8I?VK7AC\T6ZS*9-G][;G./?I3&UG2
MDFCA?4[-9993#&AG4,\@&2@&>6P1QUH O45GG7='$%U.=5L1#9MMN9#<)M@/
MHYSA3]:>FLZ7)=06J:E9M<7$7G0PK.I>2/\ OJ,Y*^XXH NT5236-+DNH;5-
M2LVN)@QBB6=2\@4X;:,Y.""#CI26TA_M*^W:E%.B["+8!0;88.<D')W$$\^E
M %ZBJ=GJ^F:C#--8ZC:744+%97@G5UC(ZAB#P1[U5;Q1H0T:YU>/5[*:PM@3
M+<0SK(BD=L@GGV]Z&[:@M36HK#M-9M=:BTB^T[6K5;>=B3$C))]H^0YC#9X*
MGDXY^4BK[:QIB:FNF/J-HM^R[EM3.HE(]0F<X_"FU;0+]2[15*[UC2[#?]LU
M*SMMA4/YTZIM+?=!R>,X./6GW&I6-I-##<WMO#+/GR4DE56DP,G:">>/2D!:
MHHJI!JFGW,OE07]K+)M9MD<RL< [2< ] >#[T 6Z*IV.JZ=JB2OI^H6MVD3%
M)&MYED",.H."<'VJ*'Q!HMQ#/-#J]A)%;[O.=+E"L>W[VX@\8SSGI0!HT5GI
MKNCR-9JFJV+-? FT"W"$W '4IS\WX9IEO=Q6YU":ZUBVFA2?')1!:C:O[MB#
MU[Y//S4 :=%49=:TJ"REO9M3LH[2)S').\ZA$8'!4L3@'/&*?-JFGVVG_P!H
M3W]K%9;0WVEYE6/!Z'<3C% %NBN7\%:O?ZO#K)O[J&Y-MJ4MO%)#&$0QJJD8
M&3ZYR2>M;NH:KIVDPB;4K^ULHF.T/<S+&I/IEB.: +=%5Y;ZTMTC>:Z@C23[
MC/( &XSQGKQS4EO<07=O'<6TT<T$BADDC8,K ]""."* )**H+KFDM=Q6JZI9
M&YFW"*$7";WVG#;1G)P>N.E/FU;3;?4(=/GU"TBO9AF*W>95DD'^RI.3^% %
MRBJDFJZ=#<"WDO[5)RP3RVF4-N() QG.2 >/8TQ-:TJ2XCMTU.S:>56>.-9U
M+.JG#$#.2 0<GM0!>HK,FU&UU'1+JXTW6;2--CHM]&Z2I"XXR>=IP>Q-5)?%
MNBV.M6NBW6K6BWLMOYPWS*FX< <9ZMDD =@: -ZBL71/%>B^(-.GO[#4;66W
M@=UE99E/E@$C+<_*"!D9[5?M=5TZ^L/M]I?VMQ9X)^T13*\?'7Y@<<4 6Z*Y
M'P_XBGU;QMK-I'J-I>Z5%:V\]HUJH*C>7#9<$[C\G7@>U7/$.I7^G:WX>6"Z
MACLKJ[>&Z1HLLP\IW!#D_*!LYX[]1W=MO/\ X/\ D'?R.BHJK:ZE87UC]NM+
MVVN+3!/GQ2J\?'7Y@<<5%;ZWI-W8&_MM4LIK('!N([A&C!]-P.*0%^BL^?7=
M(MK)[V?5;&*UCD,3SR7"*BN#@J6)P#GC%2?VOI@NX+3^T;3[3<(9(8?.7?*G
M]Y5SDCW% %RBJ-MK6E7EL+FUU.RGMVD\D2Q3JRE\XVY!QNSVZU+9ZC8ZC$\M
MC>V]U'&YC=X)5<*PZ@D'@CTH LT5Q\7B62]^(MIIUCJEE=Z3+8SR,EN%<I-&
MZ*0S@G^]TP,=\UTEMJ^FWES<6UKJ-I/<6W^OBBF5FB_W@#E?QHZ7#J7**JV^
MIV%Y*8K:^MIY N\I%*K$+DC. >F01GU!JCJ?BC1](U>PTN^O[:"ZO2?+2654
M.!WY]3@ =STZ4 ;%%4FUC3$U-=,?4;1;]EW+:F=1*1ZA,YQ^%37OG_8;C[-(
MD<_EMY;NF]5;'!*Y&1[9%)NRN-*[L3T5RO@CQ1%K7AW2OM^I6CZS<VWGR6ZN
MJR$9/S",'.WWQ6\^K:;'J2:;)J%JM^Z[DM6F42L/4)G)'X535G81<HHJI9ZI
MI^H23QV5_:W+V[;)EAF5S&WHP!X/L:0%NBL-=<TW2+4OJ_B73B);B012S2QP
MC[V1&.<$J"!Z^M:*:II\E_)8)?VK7D2"22W693(B'HQ7.0.1S0!;HJA;:WI-
M[;SW%KJEE/! Q6:2*X1EC(ZAB#@'ZU+;ZG87=U/:VU];37$&/.BBE5GCSR-P
M!R,^] %JBLS7M>T_PWI4FHZE<1P0J0H+N%W,> !G_/4TZ;Q!HMM9V]Y/J]A%
M:W.!!-)<HJ2YZ;6)PWX4 :-%("& (((/(([U3FUC3+?48=.GU&SBOIAF*V>=
M5DD_W5)R?PH NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !45Q.+:VDG*22"-2Q2)"S''8 <D^U2T4
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M#HMX-.U$VVFZO=37=H]G*DIC=I3&Z1LH+[=ZG"@^W(Q7J5%-.W]>;?ZC>O\
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MZGX'O[JR\)^)(+NZNK;:NJ1SW5P[(X^8*S2,@"[AN.W.<=Q7L5%):?A^%O\
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MI7(S@]12T44@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,+&0/#F(D9DDC=05QMX+8ZFIK3Q?H5\UF+6_$R7KM';RI$YB=QG*^9C:&X.
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M#:*L06NM'Q%X9N3H-W'%::;+;SR230;8Y'"  @2$D?NSDJ#U'7G OZ^Y_P#
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M4VV\.ZO>^&+S[)X/T;PKJBRPS0QP21N+AHI X#F-0 I*XZD\]L<I;:]E_7_
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MK3:--H5EJ.CO>R7<6J2W84Q!Y#)AHBI9G4DX(P.!R*MI7LO/\_\ (E_U^/\
M7S.PU35;#1-/EO\ 4[N*UM(L;Y93@#)P/QSVJD/%6CFYDMQ<3&981<+&+64M
M+'ZQC;^\ZC.S)'>HO&EO>7O@W5K*PLI;RZNK9X(XHW13EE(R2[*,#//.?8UB
MQP:Q_P );H-^?#]\MO;:5+;S,9K?Y)&,9"X\W)_U9&1D<CWQ*_K[F5T_KNCH
MCXDTG^RH-26Y:2VN#MA$4+O)(PSE1&JERPP<KC(P<CBJ5[XBT&]TW3K@ZV]M
M%=7D<=N8F:.2657QY14C=U&&4@8YSBN;T?3O$-MH6G6TNA7,!BU.XEGQ);-.
ML<C2,K1-O*C[^&Y#8W;<]:ADT+7;/PK!IT6B7-S)#KWVP!+N)V,(N#+N+2.,
MDKP,G)/7'6J25_N_3_/\!=/O_7_)?>='H\UV/B%XBM9KZXGMTMK66**5AMA+
M&3(4 #CY1UR?>KOB'Q1;>'KK3()[>[E:_G,2FWM9)MH"EB3L4G/' Z]3T!Q2
MTJWU)?B#K5[/I5S!8W-K;QQ7+R0E6:,OGA7+#.\8R.QZ<9M>)K&]N;O0KNRM
M3<_8M0$TL:NJML,;ID;B!P7!/.< XR>*2^S_ %W_ . '5_UT19O?%&CZ?=?9
M[JZ9&#!7D$$C1Q,0"!)(%*QDY'#$=16I+,L,#S,&9$4L0BER0/0#))]A7#SZ
M+K,-CXBT(:>UW!K$D\D-Z)H]D/FK@B4,0WRGIM5LC'2NSLK7['IUO:>8TGDQ
M+'O;JV!C)I?9O_7](.O]?UJ</>^*3K?A[2-9LKF_T^+^U8(Y8WA:$21M*!AB
MZC<,=2IQG()/2NNL]?TV^CNWAN&7[))Y<ZS1/$T;=LJX!YR,'&#GC-<8VG:]
M;>$=%TP:!<SSV6H1R2>5<0<I'+O+#<Z\$8P.O7('=FJ^']:UF\\5(FD&%+M[
M6:T:]:%X+@P$91U5V;:V.Z].N.E'3^NT?^"+6_\ 7>7_  #N--UNPU9YH[62
M42PX\R&>"2&10<X)210V#@X.,'!Q2:KKNGZ,JF\DEW.I98X+>2=RHQEMD:LV
MT9&3C R*PO!%A/;0W$]SX*TKPQ*V$,=E)$[38[L8U  ]!D]>W>QX@L]2N]:L
MUALY'L6MY8I)[:1(Y49L8#.2&6,XY\OYL@=A1+38:\S2G\0:9%I]O>BZ:6&Z
M4-;FVB>9Y01G*(@+-QSP..]<[X(ULKX9O[S5=3FNEBU.X@2>?YG=1)M0!5 R
M3QA5')/ JGH>CZ]HD7AN\?2GN&L],.G7-I'<1^9&24(D4LP0CY3D;LXQUZ57
ML/#GB2RLEN7L(7FM->GU%+6.Z&;F*3>,9("JPWY )P<<E:JR3=OZU_R_K0.G
M]=F6=*\66MCXA\57NJZS.FE0"U:$7JF/R=ZL2@C*JP.>Q&XXYS75GQ+I?D3R
MI--+Y,AB>.*VEDD+  _*BJ6888'(!&#7!>(-"\37Z>+Y8="9TUJWMX[>,740
ME1D7G>"VW')R0QY' (YK6\9:)J6H_P!CZM;>&[+6S:Q/%/H^HM$,A]OS*S;D
M#J5ZYZ$U/V5\OU#J_P"NQU/_  D.F-96]W'.\T5PY2(0PO(Y8'!&Q5+#!SG(
M^7'.*DGUJQMY($>21FG!9!' \F%'\3;0=B^[8%<S/X>\[PW98\/R:5>6Y::&
MWT&YBC>V<XX!;8CYZD$;3CH>M1ZCH>LW&FV%V_V__A(X(!$+W3YXD!))XE1R
M$91P3A3U;:!38+4ZC4==T_2U4W4DV" 3Y-O)-L4Y^9]BG8O!^9L#CK2OKFG+
M<10B9I&DB$P:*)Y$"'HS.H*J#SC)&<'&:X?Q#X=UC_A(8]2?PCHOBE;JVAAG
M6Z:.-K61<[F1I%;]V<YP,G-:6L>'[Z.6VN]!M;FPU1(D@5[*:,6@51D++&Y&
M4!XRB[L=,4)?F([>BD&<#.,]\4M(84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %5M0L+?5+":RNO-,$R[7$4
MSQ,1Z;D(8?@:LU'//%;6\D\\BQQ1J7=V. H R2:3M;4:O?0@TS3+71]-@T^R
M61;:!=L:R3/*5'8;G).!VYX'%6Z\^O[_ /M'XA^$KE;/4+5'-R$-PV$F3R20
MP0,0#R?O!6]L5JP_$;P[<>((M'BO(WEFD,,<B7$+!I!G*; YD4\'ED ]^15:
MO??4G1>AUE9=[X=TC4=8LM6O+&*>^L@1;2OD^7D@D@=,\#G&1VI-/UV'4HI)
MX;6Z^RKN\N?"NLP7J5"L6]@" 3V%96D>(=%@\,07NEV=V(+FZEBM[0KB:68R
M/N #L,$L&/S$8'7%+S'Y'545RTWCW2;:TN)KBVU.*2VF2"XA-D[&*1\84NH,
M9ZCD,1R.>15^+Q/9M=ZE;7,%S:2:? +F03JOSPG=B1=I/'RMP<-QTH VJ*YM
M/%RRQWZKI&H)=VUK]KCMY?*!N(SG#(P<J 2.C$$>E5+?QW:VOA#3M8UN$V,U
MY&ICAGG@C,S;0Q*LT@0 ]MS*?4 T?U_7W =?17.67C;2M3TB"_TX2WCW$KPQ
M6L!1I'D4$LH.[9P!][=MZ<\BLOX?,3J/BWY;E -6XCN9"[IF&,E223W)Z$CT
MXII:O^NW^87T_KS_ ,CMZ*X&2YDTSXIZO-!9W]^6TB"3[/!(&.?,8$J)'"KP
MHX!&<=":VH/&=I=7NE0VUA?2P:F&\F[ C6)64$LC!G#AAM.1MSP<9P<):I?U
MW_R!Z7_KM_F=)62WAO36U$WZK=13,V]UAO)HXW;U:-7",?<@U-I>JG4WO +&
MZMTMIV@$DQC*RE3@E-K,<9]<'VZUB/K-SJGB/6_#T^E7D=E#:I_I23(@^</S
ME7#C.,# SP<XXI-VU\KC\F=4JA5"J % P .U+7#^"?$,4/A[PMIES;W:O>6*
MB&Z< QR2*FYESNW;L G)7!QP35R#XC>';CQ!%H\5Y&\LTAACD2XA8-(,Y38'
M,BG@\L@'OR*N4;2L+;<ZRBLK7]?L_#FGK>WL=R\32K$/L\+2$,QP,XX SQDX
M'(]:@B\46GVN^M;RUN[":T@-R5N%4^;".LB%&;(]N&'&0,U(6-RBN<B\96A%
M[]JT_4;1K6V%WLDA61I822 Z"-FSTZ'!'<"LW4?'LHTJPO=,T+4YX[R6UV2,
ML2*R3-V+. 6[8[$@DXYHL%]+G:T5SL>KZ2WBN:*6UNK?4X-/$LTLR%42'<#M
MW9VL03R5R.",U4TWXD>'-4U*6R@O(]RPM.D@N(9%D11EB!&[,N!V<*>O'!H_
MK^ON#^OZ^\ZVBJ&EZG_:=NLPL[FW1AN3SMAWKG@@HS#GK@\^H%4-7U#2H?$>
MAV=[;W,E[++(UG(D;>6C"-MVYN%SMW#')[X[T[:V#I<WJ*Y=/'>FRVRW:6>H
M_8_MOV*6=X!&(9-P0;E8AL%B!PIQWP.:W]0NVL-/GNDM9[LQ*6\BWV^8^.R[
MB!G\:3T5PMK8LT5SMOXNAN;O18%TR^5-7@,UO.QAV+A=Q5L2$[L8/ (YZ\'"
M2^,;6VEL(;G3M1AFO[B2WMD,2L'*Y.=RL5 .#C)!.,XH:MH!T=%<O9:[IM]X
MA<QZ5J4>L+IHE,=Q"8CY1;(0;B%+;CU!(!R":S+?Q9::KX:TJ]\0:-?PB[OX
MDMU"AU\SS/W;;HV(50<#Y\9QT-"5W;^M[ _Z^ZYW=%<S=>-]/MAJS+9:C,ND
MN%O66 ((UQDN-Y7<H'/RY)'0&K]_XA@LYX+>"TNK^>:+SQ%:A,K$" 7.]E&.
M1P"2>P-'2X&O15#1]8L]=TZ._L&F:VD^XTL$D1;W < D>_2N)U*]@U?QCK%A
MK?AV^NM.T^UAEC8+&Y@;,I,J!)/,!;: I0;QCD+1ULPZ'HM%<W9>--/O-.@O
MH[2_2UN(XGMI)(AB<R,55%Y^]D<@XP"#G'-._P"$RLHK34)+VRU"SN-/C$UQ
M9R0B281G.' C+!E.#R"<8.<8H>FX+4Z*BN>A\7VTUU:6ZZ=J >]M3=6A*)B<
M  E1\_RL-P^]M'H36CHNL6^N:<+RW26("1XI(I@ \;HQ5E."1D$'H2/>G9A?
MJ0#PUIB:@U[&ES%(S%WCBO)DA=CG):(.$8G)R2O-:X    P!T%<M_P )3<#Q
M-K.FW&CWOV&PMHY3/$$DW;@Y)V*Q<YVX "D\'..*9IOBC0K#1_#L%A:WJVFI
M*([!!"S!0%) 9B2 < \$Y_(TEM_7G_D!UE%<N_CFSBL+R[ETW48UL)_)OD98
M]UKP#O;#X9<,#\A8X/2G>(O'FA^&;A+>]N(S.4$C1BXAC9(SG#XD=2PX/"[C
M[4!Y'3455AOXKO2X]0L@;F&6$30B/ ,BD9&-Q Y]R*Y_0O%[WWAJVU/4--N;
M6:YE,5O!F-FG8D[0FUSV'5MOW23@<T=6@Z7.JHK*T?7H-7EN;;[-<V=[:E1/
M:72J)$#?=.59E(.#@J2.#W%4=2\17EEXQTS18M)N;B"Z@DF>XC>+"[2HZ,X.
M!NR<#/(P#S@MK8.YT=%<=:^+O#^G:7<ZA;V>HQP2ZH;:4&UDW&X8@$E3R@R0
M/FV\]!R,WY/%T23ZE;?V3J37=@BRR6X6+<\39Q(I+[<?*W!(;CI1TO\ U_6H
M?U^AT5%<UJOCO0])TNQOI;F-UOHA-;1F>*%I$X.09G1>-PXSFM;1=9L=?TF#
M4].F$MK."48>Q((_ @BG9Z^0K[>9?HJKJ.HVVEV9N;IRJ;E10!DLS$*J@=R2
M0!6*_C6QM;>_?4;'4;&>QA%Q+;2PB20Q9QO7RF=6&>N#QWQ2N.QTE%9ND:PF
ML1&6.SNX(BD<B//&%$BNNX%2"<XZ'T-9USXRM(+S5K2+3]2N9]+C26X6. +E
M&S\REV4, %)XZ]LG-#TW!:ZHZ.BL2U\46=WJ-E:I!<K'?P&>TN751'.  2 -
MVX$ @_,H'H345KXMM+K5+>S%G>QQ732):W;HGE3M'G<HPQ<$;6^\HSCC-%N@
MKK<Z"LN+P[I$/B"?7DL8AJDT8B>Y.2VT= ,\#\,9[UQ/B.XTG5OA_K5UID-[
M;B+4091(9(6:;>@<E20=IW8VL,>W2ND\1>.]$\,7"6U]<1F?8)'B%Q#&R(<_
M-B1U+#@\+N/M0N_]:JX_+^M'8Z:BN=O_ !!8W]B+>RAO-06ZM!,QLF"&*%P=
MLA8LI&><!26X.!Q5;X:LTGPXT-W9F9K8$LQR2<GDFG9Z^7_!_P @Z)]SJZ*\
MW\,ZU#X;@\227%M?S6,.M3B6Z#>:+= $^9R[;R![!L#K@5UL/B19O$%SI']F
M7T;PV_VE;AS$(IDS@%#YFX\^H&.^,C*Z7_K:X=?Z[V-NBJ&CZG_:^E0W_P!C
MN;19EW+%<;-^WL?D9AR.>M9%IXYTN\@GNEM[^*RMY)HY[J>#RTA,0!;>"=R]
M>,CJ#[9'H[ =-17*:3\0_#^KSWL,5U&C6D+7#GSX908EZN#$[@#V;#>U7+3Q
M;:7%]#93V&I6EQ<(9;=9;8N)8QCY\QEP@Y'#E3R..: -^BN3TGQ'HL.B"ZTN
MSO-MU?S11VK+Y<LMQN8N )6&WD,<,1TQCH*F\0>)KS2KC18K;1KRY-_=-"X1
MHE9-JLV,.X!)V]<XP#SG +L!TU%<GJ7Q&\.Z5K TVYNX_-$HAE87$.87.,!H
MRXD/4<JI [G@U<M/%]E?:A<V=M9Z@YM;HVMQ*;<HD+;"^YMQ!VX_BQW'8YI>
M8'045R>E_$;P[J^M)I=K>1-)*I:"1;B%UE &X\(Y=,#/WU7I6-XBU9-6UWPC
M<V]M?QVQU51#<L^V&Y0QN<A0^3RJD%U'JO&::5VO,._D>BT56U#4+;2[&2\N
MWV0QXR0,DDG  '<DD #U-8W_  F%I"]Y%?V&H6-S:P&Y-O+$)'EB!P73RF<,
M >HSD9&0*06.BHK)T37X=>MTN+>SO(8)((KB*6>,*LBN"0 03R,<CZ>M1ZMX
ME@TIIA]BO;M;90]T]LBL+=""=S;F!;@9P@9L=N13:L[,%KL;5%<QX@\?:%X<
MECBN[F-I7193&+B&-EC.</B1U+#@\+N;VI1XXTV:]-I8VNH7TOV2.\'V>W.'
MB<@!E+$;NN3C/0CJ,4@.FHKASXLBOO#OB.?Q!HFH0Z9:RRV\@4+(7C'RL/W3
ME@>I).  >O%,\2:F9-7\/:0N@W=_IEXCN\ \@I,HCX4B209VY!(/'3&2*-[6
MZ_Y7!Z'=T5Q^@7WA?1+37380SZ?;:=.%O6NO,4!@@QCS"3MV[0.@QC'%3:5\
M0_#^K"_\NY6,V,?G2CSHILQYP&!A=QR>,9W=..11Z!ZG545P$5T]W\7-.F>S
MO[,OI-QF*ZD!# 21[655=E&<GT;U%=5K'B"TT.:PBNHKIVOIQ!$88&=0Q_O-
MT7\3DX.,T[:+S_SL'<U:*YB7QM:P6FI3RZ9J2MIDFV]BVQ[H4VAO,)W[67:<
M_*2WMGBK6K>*K;2P=EG>7NRW%U+]E5/W4//SG>RY'!X7+<=*7F.S-VBN=?5-
M&N_%6FVYAN6U"6QDFMI_+=8Q"VW<-W )^[QR1QTS5/X=1B'P_>0JTC+%JEY&
MIDD9VVB9@,LQ)/ ')-.W]?.PNEU_6ESKJ***0!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZ[I4>N:#?Z5
M+(8TO('A+J,E=PQFM"B@:=G<XH^'O$E]J_AZ^O9]+A_LEI5D$/F2"X1D"[@"
M%V$C/&6 ]6[.\.Z)XOT.^336U+2I_#<!;R&:&3[8$SE8\YV8'3=R<#IZ=G13
MN*VECD[#PQ<:?XEDU.RMK2PB>-S-%;7,GEWDK#J\97;&0>=PW,<\^_/7&G:_
MH?A"TT\Z;8WFL?VG)<VD-IJ.QR&=Y"R/)& &7<00001GUQ7IM5;_ $VQU6U-
MMJ-E;WEN3DQ7$2R(?P8$4M;67]:W'UO_ %M8\VM=,\3:OX;U+2Y/#BZ=JD]W
M#=3SZAJD<HN,,IW%H8R W[M5V[%&.1Z5T,^B^)9O$FK:E VG67VO2TM()DN'
ME>&5=S!MAC (W/CKT&>^!U=G96NGVJ6ME;0VUN@PD4,81%^@' J>FW_7RL)7
M7]>=SB]-\*ZA!JTE[+'86_VG3/LESY<TD\AD!)#;V4%^IY."/?K4,WA?Q-#H
M.A/IE[IMOKFD1>0HE#O;SQ%0I5S@,,[5;@<8QSUKNJ*5_P"OO_S8+^OP_P D
M<C/HWB2;^Q]7FGTN;7+$R"2%1)%;2)( &56^9E(V@AB#GG@9XL^&-"U+2-4U
MV[OKFUDCU*[%RD<*-F,[%4@L3R/E&.!]><#I:*=_Z_KT#^OZ^\YJ]T;5(/%K
MZ]I8LYVGM$LY8;J5H@@5V;>I56W'YOND#IUK(UG3].T3PG;Z(FJ6\>M^:;K3
MPSA9);HR%LHA.2I=B"!T4G-=Y4#V5I+>17DEK"]U$I6.9HP70'J W4 X'Y4E
MV_KO^8>?]=OR&:;9#3].@M0Q<QK\SGJ['EF/N22?QK&FTK5K?Q#JVHV0LI8[
MVTBC5)I7C(D3?@$A6^4[^O48Z'.1T=1P7$-U"LUO-'-$WW7C8,I[<$4/7^NX
M+0X2R\,>([:T\'020:4W]BDBX*WLGSCRVCRG[GT;=@XY&,]ZN>'=$\7Z'?II
MK:EI4_AN MY#-#)]L"9RL><[,#INY.!T].NBN8)WE2&:.1HFV2*C E&ZX..A
MJ6GS-N_]:A_7]?><I\1]W_"%7.P@-]HML9'&?/2G3Z'K-_=W>J236EAJ8L9+
M.Q,#M,L6X[O,8LJY.57Y<<8/)S6YJ6CZ9K,"0ZIIUI?1(V]4NH%E56Z9 8'G
MFK444<,211(L<:*%1$& H'0 =A277^NEAWV_KK<X9/"FLPSW5Y!;:6EQ=:4;
M.9&NY7+29.&,ICW,,$\D9[>]6T\-:L/ NBZ439#4-,>U?'FN8I/)93C=L!&0
M/[IQ[UV-%._]?C^I-OZ^5CD+[P[JFI>*KFXNHK+^R[G2VT^1DN7$WS$L6";,
M=3C&_IS[4OAW3O&EHLEGKNH:->6,,/EV\D,$@FG., RY.T#U"@Y]?7K))$AC
M:25U1%&69C@ >YH1TEC62-E=& 964Y!!Z$&DNW]?UN,YKPWX9?0M4O9;>&&P
MTZ50L=A;7+RQ;LY\P*RJ(SVVJ,'J33O$.EZO?>(- O;"&R>WT^=YIO/N7C<[
MD9,*!&P. V>2.F/>NEHHOMY!W\SSJ7PMXHD\-7NG_9M'$]QJXU '[?+M">:)
M2N?(SG*A>G?/;!]#3>8U,BJKD#<%.0#WP<#/Y4ZHWN((YHH7FC667/EHS ,^
M.3@=\4=+?UM;] >NO];W.0D\(:@-+>""\@2YM+T3:9(0<0Q;RVUOP9TX[!:L
MZ_H.I76H>&VTV.S-KI5QY\GVBX9&8"-D"J C _>SDD=/>NJHH3M8'J<W_9>K
M?\)^=7\FR_LTV/V3=]I?SL[M^[9Y>WKQC=TY]JQ;CPOXB7PGIFD0)I<LEC?Q
MSAI+F2,/''+Y@Z1MAFX!&,#KD]*[ZHI+F"*:*&2:-)921&C. SD#)P._ )H6
MEK?UK<'K_7E8X:^\-^)+N'QA&MOI*_VV@2 F^D^3$8CRW[GT^;C//'O5/Q&W
MB6&ZTR'1M'6[U2"P\N[_ +/U2**2)2PP,S1D,AV'!V@@YQCOZ56/J5IX;U:(
MW&J6^DWD=J^TR721R"%N.,MG:>1^8H\OZ[?J-O\ K[O\B'P=O7PQ:6\FCOI+
M6X\DVCW"S[-OI(IPWUZYSFLS^R?$D?BC7-2CLM*>WOK5+>(-?R*X\O?M+#R2
M!G?R 3C'>NP551 J*%4#  & !2T2U;_K<2T.(LO"&IQ^!M$TN6:UAU31Y(I8
M)(W:2)VCX^;*J<,"P/'&<\U+>^'M8OTU74Y8-/35[S3O[/C@6[<PQH2Q+&3R
M\D_-G&SMC/.:[*BB7O7OU_7<%I:W3_._YG$VVA>(HM3\,7#VVE^7I5F]O/MO
MI"6+!5RO[GD (#SCJ1VR=+P;I6JZ/87D&JQ62-+>S7*&UN&E&)'+D'=&F,9Q
MWS[5T3ND2,\C*B*,EF. !2131W$*30R))%(H9'1@58'H01U%.[=W_6KN)*R2
M_K16,"32=4M_$6K:C:"SEBO;2.-4FE9&$B;\ D*WRG>/FY(QT.>.?M/"_B6V
MT;PC8FWTEFT6<23M]NDPX",@V_N>I#D\XQC'.<CO1<P&Y-L)HS.%WF+<-P7U
MQUQ4M"=OZ[7_ ,V/^OO5CSV^\+>);O2_%]HL&DJVMS[X&-[)A%V*AW?N>N$!
MXSUQVR;E[HOC*WU:/5=!NM'@ENH8HM0L[WS98E9,@/&RA23@XP0H.!7;5'+<
M0P%!++'&9&"('8#<QZ >II7_ *^5@>NH1+(L"+,X>4* [!< GN0.U<;#X2U6
M/P_I5N)[-=0T:[,]FP+F.4?.,/P"NY7(X!VGGYNE=M11UN'D86D:/<QZW>:[
MJ*P17UU!%;F&WE:2.-$+$?,54L26/\([#W*ZEI5[-XITK5K1K<QVT,]O,DK,
M#MD*'<N <D%,8..N<\8.Y44ES!%-%#)-&DLI(C1G 9R!DX'?@$T[[?UW_P P
M[GGUQX6\4S:)J-D+71A)=ZNNH*?[0EPJB17VG]QU^0#\<]L'4DT;Q"?$FMZD
MMKI9BOM.CM8E-](&#IO.6_<\ ^8>F?NCUX[*BETM_6UOR'?6_P#6]_S//(O"
MWB_3M(T.;1[K2(-8TZR%A-#</)+:W$0VX;<%5E8;<\#N1FNHCEU^"[TJ&X;3
M9UD5_M[1AT96QE3$O/R@Y!W'/(^E;=1SSPVT#S7$J11(,M)(P55'J2>E-RN[
MLE+HC+\2Z*^N:6D$$X@NH)X[JWD8$J)(V##<!U!Q@^QK!U;PUK6M0:A?3P:=
M%JLVF2:;!"EW(8560Y=VD\L$GI@;.V,\Y':JP90RD$$9!'>EJ6M&OZ[%)V::
M_KJ9^A6MS8Z#8V=XL*SV\"1/Y+EU.T8R"5!YQGI7.7&B>(7UWQ'>QVVF&'4;
M)+6WW7L@8%-X!<>20,B0G@G&WOG([.BG+WFV^M_Q%'W4DNEOP.&L_#_B.WG\
M),]OI6S1[=H+@B]D);*A,H/)YP &P2.3CMDEKX5US^U=(U*\;3I;VQN9C-=-
M+([SQ.C*" 5&SDK^[!V\=:[FBG=WO_6HN56L>>3^%_$\_AG7--^SZ0L^HZ@;
MN,_;I"JJ6#$$^3G(V@=.<GICG0U/1O%\.N#5O#MYI,37D44=_:7XDDC5ES\\
M;+M).#C!V@X'2NSHI+3^O*PW_7WW.7?1-9M=?N=1LIK*==0MHH+L3EHS&Z!@
M)$P&W#YON''3[U6O!FB7OAWPG8:1?W$$\UJFS? A5<9XZGD^_'T%;U%%_P"O
MZ]0.*?PGJ8CUW2HY+1M+UJXDGFN&=A-$)  R+'MVMP.&W#&>AH\2P:??:II6
MEZ=JD,.L0-Y+P1R!I1:.N)0PSE1M (8_Q!?6NUJ!+*TCO);R.UA2ZE4+),L8
M#N!T!;J0*%I;^MM@[_UON2J@CC"1J %&%4< >@KBM+\):H_ASQ!I>J/:VSZG
M=37,4MG.TIB:0Y'WD3[I /O[5V]%']?J!QD"^*[7P_JI\6W.@7,*6[I"L"2(
MLV1@>:6.!GIA1WZFL7PFWB:+Q#:2:YX2O(1]G:VMKN;5[>X$"X!VA8U5MIV#
M+'<W3G%>ENB2HR2*KHPP589!%4M-T32=&$@TO2[*Q$ARXM;=(MQ]]H&::>MP
MZ6.6T[PKJ!\-7VFZUI>CWGG7TUVD/VN1D^=F<?/Y0*,I(&X ^O'2IT\+ZM#I
MFA(MW%/<Z;?M<[;F9W B977RQ(06;:K\%A\VWG&>.QJ-KB%)DA>6-99,[$+
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MXJ#@G'7'(Y]ZFUU;O_E;\BKV^7]?F9GA73[O2/"VF:;?"#[1:6Z0,8)"Z-M
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M%%]O+_AQ=S@K_P -^([J+QC&EOI0&MH([<F]D^0",1Y<>3QQ\V!GGCWJ6_\
M#.NZM;_9;X:<]I)IGV7[.;B1D@FP1O V 2Y&WE@I7'&<FNM@U33[J]N+*WO[
M6:[M\>?!',K/%GIN4'(_&K=%M+#N[W_KI_D<;#H?B"/7_#UZT6F/#IU@]M.1
M=2*Q9PF2J^600-@ZD9ST&.6Z18^)O#_A^[3R-(^VRZC)<HGVF21&CDD+LN?+
M4AP"0."">3CI7:5'#<0W 8PRQR!&*,48':PZ@X[T^9WO_6]R;65OZVL24444
MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 53U:^?3-)NKY+62Z:",R>3&RJS8ZX+$#]:N5E>)KJWLO#&ISW
M4\4$(MI 9)7"J"5(')]20*F;:BVBH*\DC+LO%T\TFBR7NF+;6>L1K]FF6Y\Q
MED,9DV.NT8X!P03G'(%,?QH\=K#J[:<A\/S3"$7HN/WBY?8',6W'EDXYWYP<
M[:I>#-,_M?P]X;U"YU*VOK.RMHWM(X(L;)/+V-O<,0Y&6& %QWR15R'P4T=G
M_8[:@DGA\3"=+-K;]XI$GF!/,W8V;NVS..-U:R24VO/]?\C.+O%/R_3_ #M^
M)H:?XC74M<O]/MTMB+.3RI!]IQ.I]6B*\+TP=QSZ5E:-XAUZ2TU>YO=,@F,.
MH-;6Z6MP[G.\)\P,8VH.&+<\;C@8K2OO#/\ :&OV.ISRVN;*0R1NEKMN,\_+
MYN[[F#@KMYP.:IW/@^YELM1M8M65(KF^^VQH]MO4$L&9)!N'F(2.@*\'!S4+
MS_K5?\$I_P!?<_\ @"67C>.;2-4N[FUB$^G7:V<D=I<B>.21MNW;)M7C+J#E
M1@Y]*EC\7O;76H6FKZ8UK-I]K]KN);>=9H1&=VT G8Y8[6XV8R.O2LS7-'N-
M#T+Q#<)J-F3J;QL%N;4BWB8(B'>5)*QX3KQM![G%9O@S3]2U6VU.TU5O#6HZ
M7J,#1RWFCWUQ<R$]-K/*6R,,< -\OI1O>W;]!NRL=-H/BRXUC5WLIM$OK6(Q
MF2*Y>VN$0@$?*YEAC"L<YPI8<'FM77]5;0]"O-46SEN_LL1E:&)E5BHY)RQ
MX&3Z\< ]*R_#'AS6M$=UU+Q7=:O:HNRVAEMHXS&O;<Z_-(V.Y('M4OCJZM[3
MP)KDES/%"ALI4#2.%!9E( R>Y)  [TINT;H*:O))D"^*[N.ZL8[O1]D6HP&2
MR:&Z#O(ZQ[S&P8*%8C.#N(..2*KV'CEKKP]%KUQI,L&GS1@Q%)/.E:0R>6(_
M+5<DG@\9[CMRW0]*GU;2M*U,ZO9W8M[3_B7-';Y2-VC"%G(D_>$<CY2@Y/?D
M/LO _E^ E\+7NHF41\PW=M"87C8-O5@"S?,&YS5R5FU_6_\ D1%W2?\ 6W^?
MZE1_B%=V^BZC?W'AF_#601CA)8HG5B1D-/'$V1@9 4]1C/.-@^);BVU>33[_
M $MHY'M9+NT^S2^<9T3&Y<;5VO\ ,.!D'/!KE?%=GJ'A_P"&NL+XC\6_VG-,
M@B@DF@BME!R"%55^\W&>23Q]:Z+_ (1Z36X)+^XUI)I9K*2VL;NPC\L0Q2 '
M>#O;<QPOS @<< 4NC_KI_F4MU?\ K7_*X_3/%=Q>:I?Z9<:;$MY;6HNEBM;P
M2EE)("-N5-DF1T/'^U4.E>*8KC0-);3=)BAN]1\W[-8&41H@0G<695.T<<D*
M>6'7K4NG>%KW3[V.\CU&T25+#['Y<-AY<.0<JVW>2 ,\C//J*IV'@B_T_2M+
MCCUJ :EI<DIM[I;(B-HY/O))&9"6!]0RG@?BNO\ 7=_I86O]>B_6_P#PQ%\/
M8O)U+Q<GV6*U/]KY:&(@HK&&,G! &<DDYP,YZ5W-<A%X7U/28M;N=.UZ5;[4
M[E+D%K-)$C<;00%SG#!=N2V .>V:ZY<[1NQNQSBF]E\OR'U?S.;O_%%U$VH2
MZ;I:WUIICE+U_M'ER9"AF$2[2'(!&<LO/'-0)XTEO=8.GZ5I#W>ZQBOX9GN$
MC6:)V ^7J1@$_>QR/?-33^%;E;[4GT[4TM;/526O8'MO,;>4"%XFW#82 ,Y#
M#CI2:?X3FTSQ4FJ6][;I8Q6":?%9"U;<D2\C]YYG)S_L]./>DNE_ZT_SV!];
M?UM^ESI\X&3Q7)OXT>.UAU=M.0^'YIA"+T7'[Q<OL#F+;CRR<<[\X.=M=81D
M8-<E#X*:.S_L=M023P^)A.EFUM^\4B3S GF;L;-W;9G'&ZA;Z_UW_#8'M_7]
M;F9J]WJ6K?\ "::;J5AI\FEVMIB/,Q=@?*+J2ACP3GG.[@@8SUK3TGQ&]G+I
M>F7UFL$$VF?:8;@3[B1&J;PZX 7[P(P6SSTJ;4_"]]=2ZZUEJT5LNK0+&ZRV
MGF^6P4H2,.N05/3L1G)'%0+X2U%]4T>ZN=5LI8;"R>SDA%@R^<KA0QSYIV\(
MO8]^N>$KV_KM+_@#=KZ_U\/_  1-*\;S:IJB6Z:!J(M9XR\%Q]EN$Z+NQ(9(
MD1<] 0[ GN*JQ^.=8O/#+:[8^&4>VC69I5GU (R>4Y4C"HV3@$\<<$9Z9M>'
M_"6M:!*\(\67-WID492RLI[5/W/&%WR##R =AE:T/"OAV;P_X?.E7=Y#?*9)
M7WI;F($2,6((+MW8]^E4[=/ZU_R$O,B_X26Z3Q$^F36=FD!L#>07(O&/F8QE
M2OE\8SUR>,''4!IUN4:]H-EJ.AI'=WD,LBW"S+(EN0N6125#DD8S\JCGJ<5'
M'X*1=/TJV?4)7DT^??YQ09EBVE/*//39M&?]G/6KFJ:%?7_B;2=5@U"WAAT_
M?F![5G:3>,-\XD '&,?*<'UZ4:77]=_\U]PM;?UY?\/\R+2O%MOJ=G?7Y^RK
M96ADWLESODC"#D2H5&QNO&3]>U0:'XPGUC6!9OH=_;V\L9DAN7M;A%& #B3S
M(452<\;6<'!YZ9DE\'PWFN/J-\UK)NMGMF\BU\J297&&$K[CO'<# P?6F>&/
M"^L:!.8[SQ7=ZIIT2;+6UFMXT,8Z#?(/FD('K@>W3"7F-^1T-_?6^F:?<7UW
M(([>WC:61SV4#)K@[^6XN_B'X0OKS2X+1Y/M/E2+*))#'Y.0K_*-I!/W06'O
M7<ZIIUOK&DW>FW0)M[J)H9 IP=K#!Q[USB>#]0FU+1;V_P#$#3/I+.(O)M%C
M,J,H7$F2P)P""5"]> O<6]_ZV?\ P/D#^%K^N@VR\<G4=9M[:WT6^ETZY?8E
MXMK<8'7YFS"(_+..&$AZCCTQ-/O;3PWX6\12+HB7=E%KDT9M8Q&D:*64 D'C
M ..@)]JW-$\&ZGH6JG[-XINSH*NSQ:4UM&=A)SM\W[VP$\*,>F:JR^"-7FT#
M5M,;7;'.HWOVMI1IK_)E@Q4#SN>57!SQSUSP+H_ZW7_!"7E_6C_X!N/K6H1>
M+(])ETZU2SFMWFAN_M;;GVXRNSR\ Y8?Q=.?:LZ^\8WNGV=LLND"34[A&E2W
MMC<7$:Q@@!F>.W9ESG@%,<=:OZ_X:'B*PL(;J[,5S:S)*9X$*[N-LB@$DJ&4
MLO4XSWQ4'B;PK=ZQ=6FH:-KDVBZI:HT2W$<"S*\;$$HR-PPR 1Z4!_7]?F5S
MXUG:30H8] O4FU;S55;H^1Y3HK':P8;^=O!V]#GKQ4%_X]N+.7R8O#][<SP!
M1>PV\,\QC<J&*(T<+1NPW#.YTJY=>%]3N=3T"\?7$E;2F>1VGL]SW#LI5CE7
M55&#P O!]:AO_!VIMXEEU;1/$]SI$5VRM?6J6T<RS,H"AE+@[&( !.#G IZ7
M_KY?J'3^OZ[$?BG5?[6T/7M/M=-AO+:VM66]:XDV>6QCW@*A4[F *D@E<9')
M/%;/@_\ Y$K0_P#KP@_] %9][X0N)+C5OL.K?9K35HBMY#)!YC;_ "_+#H^X
M;3@#((;..,'FMK0]+.BZ'9Z8;J6Z%K$L0FE50S <#A0!P./P[T+9_+]1/=?/
M]/\ @G(2+<V?Q7UB;2=.M9[N71X'=))?(60^:XRSA6.<  <'H.16@GC.YN!H
MEU;Z7#_9VHS_ &:::>[*/;3 LI0H$8-RI4'< 3@<9!K0OO#UT_B$ZWIFH1VM
MU);K:SB>W\Y6C5BPV@,NULL>22/:LC7X]%T?PY#X4S<-=WZ.+)(X79Y)@V[S
M"RKM4AV#%C@#K23T2_K=_I^)3U;_ *Z+]?P.CTO4;R_NK\36D$5K!.88)H[@
MR&;'WB5*#;@\=3R#Z<X_C."(W?ARZ^RI+<Q:K&(FVC>H*MD!CT!P,_2NATVR
M73M-M[16+^4@#.>KMW8^Y.3^-9GB+1=0UB?3'L]1M[1+*Z%RRRVAF,A ( R)
M%VCD^O;\1[KY"3NG\RO;>*;J:#5(WTECJ&GW:6KP02F1&+A2K[]H(7#@L=OR
MX/7%9_\ PG[1^'=8U)]+6:?2KG[//%97BRQDX4[ED(7(&X9^7(.1@TLW@K4I
MY=:=];ML:C=Q70C%@VU3&%4)(#+^\0JH!'RY.>W%&H>![V[T[7+2#68(1J\D
M;ONL=RQ;412% D']P8YXYSGK35NOE^E_U&[:V-%O%8LM3O[75K5+.*VLOMZS
M+-YFZ')#;AM&U@1T!8'UKG[Z2YO/B'X/OKO2X+1Y/M(BD6422-&8<A7^4;2"
M?N@L/>M6[\'WFJ:O/<ZEJ=K+:7.FG3I[>*R:-F4\EE<RG!W<C@X''/6E3PAJ
M,NI:+>W_ (@:632&?RC#:+&9490N),E@3@$$J%Z\!>XMTW_6_P#P"7LU_73_
M ()U4LJ00O-*P6.-2S,>@ Y)KF(O%\P.FW=UIBPZ1JCI':W0N-T@9QE/,C*C
M8&Z##-U&<5T\T23PR0RJ&CD4JRGN#P17,6/@Z6WM['3KK4DNM)TZ5);. VVV
M5=F=@>3<0X7C&%4\#)/.4M]?Z[_\ ;VT_KM_P271?$]YK6H7<$6BO##9WSV=
MQ)+<IN3:@8/M&0020, \9!]<5OBA!#<?#37A-%'($M6=0Z@[6'((ST(]:O>&
MO#]YH=SJTUUJ$%W_ &C=F[(BM3%Y;%0N.9&R,*/3O6AKFD0:_H5[I-R[I#=P
MM$[1D!@".HSWH>R^7Z#3M(QX=?U"WO;?2YM+@6:YM6DT]_M9*3%%!*2'9F,\
MYX#C&>>U,LO%.IWVD65Q'I-HM_/>O:26C7S8A*;MQ+^5R0%)Q@#'0G(S;M=&
MFM;F'4]8OXKN2PA=+<PVQB6-"!N8C<Q9\+C(('7 &:S_  LNG:SKM]XHTMYV
MT^Z1%A\R)HEDDP/,E56 /(6-<]]I_&MW_7?]=B4K1_KM^FYU[$A20I8@=!WK
MC(_'EP^EP:F^AO%:G43I\Z/=+YT;^9Y0(4 JWS=?F&.V:[-PQ1@A ;'!(R ?
MI7"GP+K!\/OIAUZQW-J?]I&7^S'QN\WS=NWS^F_OGIQUYI*U]?+\]?P'T_KL
M_P!;&LOBP6T^MPZI9BWDTN-)S]GD,WFQONV8^53O)4C;@\XP35.T\=2/'J4M
M]H=];0VENURLQMKA4=1_"3+#'A^^!N&,\\5)/X-N+_5M;GU'4;>6RU:T2UD@
MAM&C>,)NVLLAD(SEB?N^G3'-CP_X?U[2HITU/Q7<:L"-MN);2.,1+_M;>7..
M,D_A2_R_K] _K^OQ$G\6K:>%O[;G6P,3>6$DAO=]N2YP"9=@*J,C)V\9Z&I]
M2\3#2])@NIK;SKBY?R[>*U+W"R-M+9!C1G*\'D(3QTJ+2_"O]F2ZE/%+9)-?
MN#)'!9^7;G&[DQ[SECN^9LC.!TK.?X>1C0/L5KJ)T^^2[^W6]S8P"..VFV[3
MY<1) 0C.5R<[CSS0P0Y/'=P-/M9Y_#E_%+-?QV+*ZM$@+XPZF98W9><?<'(.
M<#FKR^+?L\&OMJ=D()-%422K!+YHD0IO4J2J\D<$$<'N1S5*Z\):_>:386UU
MXI2[O+:\2[>ZN=.7#E#E55(W0*,YSU)SUINHZ3J.DCQ/J\FIVDBZE J)&-/<
MB)@-B%CYC;EP?F^4#OP!BANW]>G_  06K7R_-W_"Q<3Q;/:ZB;+5M*-LPM7O
M3-;W*2Q1P+U+EMC;LX&%5AR.:@TSQK<ZC?R0#P]J2PM"TT$OV:>/=@9V.9HH
MT5CVPS#W%<UX(M=5OKJYCO)?">J:9=PM;7$VDW]S<R1+MX3,I8*G/W 5ZY K
MIM!\*:]HB302>+[B_M$B,=C!=6:8AXP#(RD/+CTW+_+#:M]W^?\ P/Q$OZ_#
M_@E[POXCNO$MA;:@-*-K8W$)D21K@,P8.5VE0/09R"1U'UZ"N2TKP]J_A[PK
MI^D6>L1--:SJ?-6QXECR2R,"YVYR?F!XXXSUZVAVZ CBK#Q5J5L_B"YUFVM1
M:VFH"UMA;W#.[N1&$0*R*.2X.[/4GC S6O8:_<MKW]BZM816=Y)"UQ;M#<>=
M'-&I ;DJI##(R,8YX)YJK<>#$O(]:MY[]_LVHW*W<:I$ ]O, F&#'(.#&I P
M.^<]KFGZ%<KJD6J:O>PWM_!"UO"\-L8%1&(+$J7;+':,G('' '-"MU_K3_/\
M ?7^NO\ E^):\0WEWIWAW4;VQCADN8+=Y(UF8JN0,\D G\._MUKD$:]EUSPC
MJ5QIUH=6ELKA2T<V[>NQ"NZ0H& R<D;3@DXS7<:A9KJ.FW5D[,B7$+Q,R]0&
M!&1^=<[%X8UF/4=$NFUNT=-,@:$QG3V!EW*%)!$OR\*.,'G/J )6_P#79_\
M &]OZ\AJ>.(_^$?COI;"47KW4MD+2(23YFC+!L&-&8I\A.X)G':M/PUKLVNV
M4LMQIEU82Q2>6R312HK\ [D,B(Q7G&2HY!XKGU\ 7KZ#+92Z\([]-0DU&SOK
M.T,36\KEBV59VW+\S#&1P<>]=-H.GZEIVG"+5M9DU:\)R]R\"0CZ!$& /S/O
M5::_UV_X(/R_K^M!VL:C<Z?##]DLA<S3.4!DD,<4>%+;I'"ML7Y<9P>2!WK&
MT_QJFIZ+8W-M:1O?WMQ+:P6RW ,;21EMS>:!_J_D)W;<XQQDXK2U[1)M7DT^
M2*[CB^R3^:8IX/.BE&",,NY>1G(.>#S@UD1^")[>VB-OK!2]M;^>]M)VM@53
MS2Q9'3<-X.\C@KT&,4E;J-^1C^'-0AT'5O&MW=V<5L_V^W!MK9@0\SQ( %.%
MR69NI ZY..:22[NM.^)-WJEUHT*W:: \KQ6<RN9@LHQ\[*G.!WZ8X)K7;P"9
MWUJ6[UB=Y=4EAN/W4*(L$T07:Z@Y)Y0<$D8XYZTEUX-U6\U%]4F\0QB_?3VL
M&V6.(&5B3DH7+>G1QR.N/EH=[:;I?H_U_ -&WYO]5^E_F31>-9/[!M=6N=)D
MBAO8H'LUB=IWE>12Q38B%QM R2%/'.."*A3QXR:'/?7^E2:?+%.EN#>^=;V[
M%NC>9+$K!>Q)3@\8.1F=_!<D_@G3] EU5X[K3Q%]EU"UB\MHWC&%;:6;MP1G
MD$]*N:9HFLVVC/:ZIKXU>\<G=-<V*+$5P0%\I"..<GG)]<<54K7=MNA*V5Q-
M4\3#2TTY94LTFOYO+C,]WLA/?B0*<DC[HP,^U,U[Q4^CB""'3Y;K4)HS*($C
MFD5%! )9H8I".O'RX.#R*CM?" L?#<FD0/I[1RL[O#/8;[4%B"0L.\;4'.%W
M=SR:I7O@*X6QTL:%X@N=)U'3H6@CNQ"LRO$Q!*-&W! (&T9XJ6-%M/&BR-H\
M1LOL=SJ(=O)U-VM64(<$*&0EF[A2%R.<CI74(6:-69=C$ E<YP?2L#4?#EQJ
M6@KIEW>VM_E0LTFHV*S"0YY8*I0*?3' XX-;&G6:Z=IMK9)+)*MO$L0DE;<[
M!1C)/<\4]!&6WB-3XHDT2%+9IHHEDD66Y\N5@W0HFWYU'.3N&",<UF7OCHPZ
MN;6ST:^OK:.?[/--!:W#$," 2A6$QL <YS(I&#P:T/$'AG_A()(!/+:B&*99
M59K7=/$1@CRI-PV'(ZX/4BL\>#=3M?$<U]I?BF[L=+NI_M%UIJV\<@=S][8[
M#,8;&3@9R2<BE'I<;ZV+6CZIK-WXPURRN;>T73[0Q)$Z7#%QE=P^0H <YY^;
MC '/6MC69[NVT:[GLHHI;B.)F1)93&IP.?F"L1Q[57M-&EM/$6H:DEYF"]6,
MO;F+D.B[<[\]",<8SD=>U6M4MKF\TNXMK2>*">5"BRS0F55SP<J&4GC/<5,D
MW"RWM_F.-N:[VO\ Y'%^%=4N8?#/ALSZ78RZW>602R87))>(1J[-)(8]R G&
M0 _)'7M=N_'S6%C,UQH\IOK6^ALKNWBG4K$9<;'#G!9#N&"%SZ@8-/M/!E[;
M:-HT']K0?VEHR^79WD=D50Q[ A62,R$L"!SAEZ#&,4S5/ ]SJ5C,JZI;Q7UW
M>07=Y<&R++(8=NQ47S!L7Y!U+'D_6M9-.;?2_P"%U^E[^9*OR^?_  __  +#
M[W6O$B^)-%L1I=E##</<>:DE\V65. P(C/&TAL'OP<8R<O1]5_X1;3KXV^EQ
M?V8NNRV[^7((S$))0BE$"D, 6&1E>.F:ZO4=&N+W4M*U".^2"XL?,#_N-RR*
MZ@-@;OE.0"#D_0US\W@C6I]#NM.?7['=<:D-0,HTQ^"'$FW;Y_3<J\YZ9'4Y
M$1T>O]:K]+C>O]>3_6QW-%-0.(U$C*SX&XJ, GO@9./SIU !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
M#>2RP64\T$0EE2-F2,N%#L!P,G@9]:&[:@E?02\O+;3[.:[O)XX+:%2\DLC8
M55'4DTEA?6VIV$%]9RB6VN$$D4@! 93T/-<?8>)+W4;C5=-NI;*YC&F_:XI[
M2!XU ;<-F69EDQC[ZG!]!5#PEJ^I:-X2\&--]DETN]@@M-B1LLT3LA*MNW$,
M#C!&T8SU-.W?R_7_ "!O^ON?ZGH]%<._C#44T6W\4!;-M"EF6-K<1MYZHTOE
MB3?NVGJ"4V#O\U73K&L6NO:KI][>::JBU$^F[;1PSY8K\V9?G*G:"!MSN'(S
MBE_7ZA_7XV.KHKBM1\0^)HKMM,TS3H]0O[2*.2\EAAC$3,^2$"R7*,G3[WS_
M $XKKK.6>>Q@EN;<VT[QJTD!8,8V(Y7(X.#QD4>87)ZC@GANH5FMY8Y8F^Z\
M;!E/T(K*\3ZB-/T=@#/YERX@3[/ \TB[OO,J("Q*KN/ /2N=^'MY;VUSK'AZ
MVCN8K:TF^TV*7-I+;L()>=H615;"OO&<=,4+6X/1'=T5P0\8ZX-(DU2>VTZ.
M.VU?^SY[=-\A=3*L65<E<$$YY4YZ8'6M&?7-6TWQ#J5GJ5S8+:?8GNK!H[1P
M[;3AE8F3#%<KP -V[C'2CI?^MK_DQV_KYV.LHJAIQU,:/$VHFUDU$Q[G$*-%
M'NZ@8)8@#IG)]<=JY33_ !?K-QIVAZG=06"07]^UC-;Q*[,IWNJNKD@8!3D%
M>>N1TIVUL3?2YW5%<;>^)]4>QU?5],6R:PTB:6*:WF1C+<>4 7*N& C.=P *
MMG Y&:9IVHZQJ/CNZ>VOK5],.EV]S#;26[*V)#)@;P_!RH).T\8  QDI:_UY
M7*M_7SL=98W]KJ=M]IM)?,BWO'NVD?,K%6&".Q!%6:XO2O%NHZGH^FAX[*VU
M74+JYMTX9X8O*9P3C*E^$'&5SG/%3W_B#7M-LK:SFTZ.?6;J>2&#[-L*2*JE
MO-"22IVQ\ADSUY.*&(ZVBLCPY>:Q>Z:SZWIIL;M)"@7*8D7C#[4=PN>?EW'&
M.M9TOBAH?&#:/<SV]BI*+;1W4+@W>0"3'+NVY'S#9@G([9IVUL'2YU%%<3%X
MI\1:CJ@DTG0GN=)6Z:VD<F$9"R%'D#F<,,8)VF+)QUYJ"]\7Z[!8^);P6^G1
M)H5WL:/YY3/%L5\!LKL8AASA@#Q@]:25_P"O3_-!_7Y_Y'>U6O=0M=.BCDNI
M?+225(5.TG+N=JC@=R17-6ESK$_Q*O83?VW]FQZ?!*MN;9MX#M(.'WX!RN22
MIR,# QDW_%6M7VB0:=-9V]O*EQ?P6TQF=@461PN5 ')Y[D8]^E.VWG_F#Z_U
MTN;]%<-J'BO78(_%4D4&G1+H1$BAM\IGC\OS,'E=K$8YY /9J[2WF^T6L4X7
M'F(' ],C-+I<'H[?U_6I+17%:?XMU!_$5K97ILF@NHIW:.WC<M:M%C*-*&9)
M#R<@!2,=*O:5K.LZC%8:N([*31;V(S%(U99;9-NY69BV),\ @*N">IQ1TN'6
MQT]%<UH^KZUJBZ=JB1V4FCW\?F;(PRRVRE=RLS%L29X! 5<$]3BLQ_&&HIHM
MOXH"V;:%+,L;6XC;SU1I?+$F_=M/4$IL'?YJ=G>W]=@.XJA>ZUINFWEG9WEY
M%%<WK^7;1,?FE/? ]O7M7/:?XDUF\U/6DFAT^"TTB\,<^#([O#Y6_<IXPW*\
M8QU'N<;5[W4M4N?!6IW)M5L[S5(IK>".-A)$&AD(#N6(<D'LJXZ<]:$KM>=O
MQ!]?G^!Z317%?\)7J<7BFPL9A8F"[O);1K>*-FD@VJ[*[3!BF6" ["JL-W?!
MJ";Q?KD6F:OJ+V^G1QZ5J?V62%=\AECR@X?*[6^?.2I';'>A*_\ 7FE^J!Z;
M_P!;_P"3.\HKF+C6=8O;O4DT)+*3^S)EAEM[A6WW#%%<A7W 1\,,$ALG/ JC
MJGBCQ#)JEY;>'M#>]6PD$4^?)Q(Y17V[FG0QX##G8XI =K15>X^UR6$GV0Q0
M7;1_NS.AD1&Q_$%89'T(KCX/%&L^7X<N+B;3A#=S&VU)5M7!AE!9/E8R\#S
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M29K.20F!_+ECEA>%T;&<%' 8<$$<<BO, =>'P:T>7^T;#;++9[1]B?<%:9,
MGSN2#R3@9'&!UKJM3\0^)(;U]+TG3TU&^LXXY+N6*"-8W+[B%"R7*,F0/O9D
M'7CBJ:MH_P"NH/\ K[[':45RSZUKFH33VFF065K?V=M#/<V]V#*6=PQ\H%&
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M",[-97]D22MA?S6T>>R [E ]@& _"G_PX;&PNH6KZE)IRRYNXHEF>/:>$8D
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M#BJT_@OP]=)<QW&G+-#<S_:)())':(R9SN"$[5R>3@#)ZYK5R3E?SO\ C?\
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M(PA)?![@ICKVKNK#1H+#5;_4(P1->^7YQ\QF$C(N VTG"G&!A0.G?L+X5?\
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MX _Z_+_@_>4]4UG6]*73)]36X2U6#-]=:1"MQ&LPX.]64OY??*C([D 4^_\
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MWB.F,4[?U]_^0?U^7^9W-%>?V$,4&KZAX-N+S5WGDG6]AG;4;@O]E//$F_<
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MA(<O:K;((F/'5,8/0=NU:-% &7<^&=!O8VCNM$TV=&9699;2-@2HVJ2".H'
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M=5_ USWB+4-'AA^),"ZPBRB*)T7^T6WB0(<J/GR!O.-@XR<8[5[)12_K\O\
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M<'GFM6N3\(W,VF^%=-M+C3=069)C;2+]G(V-N;YCG'R=/F&1R,9KK*;_ *_
M/Z_,****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 9^MZ4NMZ-=:8]U<6L=RACDDM]F_:>"!O5AR..F?3%3:;9?V;IMO9
M?:)K@0((Q+-MWL!TSM"CIZ 5:HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_+N=/9YRR.H>0HF_8-BXR=N>1]>CU"W%CXXT35(-/G^PO:7,+M;VK';+(T;
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ME&)+QF2"(JPD=E^\NS&X$="" 0>*0&W15>QOK?4K&"]M)#);SH'C8J5R#[$
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MO$D>Z(&,1(0-@; ^\P_J,FTT[7X]'\'02>'+T2Z=?&:Z43VQV+M=<@^;S_K
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MN+!RH 'E_P!XDD].,UU"6VH?\)G!J8L'%K/IRP2%I$!@</NPP!.>#_#N&1U
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M_ ]CG'&=TZ+?VGBR.\TA+^TAN)C)?J\\;VDJ\@D(2760\'Y0!G.2:["BG?\
MK[E^@K?U\V_U,S7[K4;31YY-)T^6^O2-L44<D:8)_B)=E&!]:X[7_!S6N@65
M[H%AK%QK%G-#<6UM-JSLJ,#\P99)C& 5W*=N?O<<5Z)126FHSSCQ9KNI:;J.
MG:E:^']:%_-9/%*EM8K?^4I=3M=$E7!X)#!L<\@]!%;07%[IW@O^Q]$UAK72
MKHO<"^6.":("-DPZ.ZG<2X/R@C'?H*[B_P##VG:C=B[F6YCN  IEM;N6W9@,
MX#&-EW 9/!SUK1CB2&,)&N%'^?Q--.W]>O\ F)]CSOQ'X<U%?%]Q?Q^#-&\3
MV=^(QNOI(DDLV4;3RZ-F/ !PH)SGUIOB+PUJ$7B*.^M_!FB>)+2XMX8##<M%
M$;(ID90NI_=X(^4#.1TKTFBDM+?U_7YC>KN<3%:ZG9>,OM47AR<6,.D?9$-K
M);K'O!WA44R*0O\ ",J.?0<UCV.F:_;:#X,M7\.7QFTN\,MTHGMOE4(ZY!\W
MG.\'CT/3C/IU%-.SO_6[?ZA_7X6/,['POJ%AXJFAN/!.AZG:RWCW4>NS-$)H
M@SE\.I0NSJ3@$$# '(IMYIFOS^'/%%HGAR^\^_U,7%NIGMOFCRG)/FX&/+/!
M_O#WQZ=126B_KNG^B!ZN_P#77_,YB&VU.'QC<ZJNFR&WN],AC&Z6,&*1&D8H
MV">3O&"N1P>>F=K2+VXU#2K>ZN[)K*X=?WMLTBR&-@<$;EX;D=15P@,I5@"#
MP0>]"J%4*H 4#  [4[_U]X'(:[HM^==34M#2_MM0D=$DFCGC^RRHN/\ 71L<
MGC(!1=W Y K%U33=?O-'\;VT?AV\\S5)A]DS/;XD7RDCR?WO'*$\\X([Y ]*
MHI+3^O1_H.YY]XDTG7-<M=4MTTF>)+O2A'!Y<\,;&4!OW<[!MQP3\H4E.6R>
M:NK!JZ^-M+OVT.Z-K!I4EO)*DT!"R,R,!@R G[A&<8R1U&37:44[_P!?>OU%
MTM_73_(YCP%::A8>'&M=2TZ:QG6[N) DKQON5Y6<$&-V'1@.>X/;FFZUI^H0
M>,M.\06EC)?PP6<UK);P2(LN79&##S&52/E.?FS[&NIHHOK?^MK!W_KS/,]8
M\&ZI'9V^H0Z-IVMSB^N;N?2+QD\IEF(X1G&T.NU?F([MZUV?A>T:ST.)7T*Q
MT-W)=K"R962,GU954%O7 _/K6S126BL#UU.8N[35;#QG)JMM8O?VEY:1VK*D
MR*ULR,QW$.0"AW\[<GCH:XA?!WB*S\.Z+)<>&=*UN?3VN(Y=*N9D99$E<.)%
M9U*HX(QWXSS7KU%']?G_ )L>_P#7E8\SUKPOJ!T_1K^S\$Z%=?95E2;P\S1>
M4HD*G<CL@3>"O)P."1SWNW6F:G''X5%GX2CLTM;_ .UW-KITL BME*.N,EDW
M-EP3M7'7KQGOZ*:=F(\SU'2M?N='\<VT?AZ],FJW&ZTS/;X=?+2/)_>\<H3S
MS@COD UW0M5FUZ+5AX'TSQ!!>6\44EMJ4D"S6+KG)W$.I4@\A2>>E>F44OZ_
M"P/4XZ+3-5T?7KB>UTJ.>TOK*"W5+:1$6S:,.-NUBO[OYOX<GK\M7? 6FZCH
MW@K3--U6"*&ZMH_+98Y?,&,\$G Y]AGZFNDHIW_K[_\ ,/Z_"QP/B[1M;U<:
M]:P:=(\<UJGV.2WGCA69E&=LIR'+9S@'Y,=>IKNH"[0(9$\MRHRF<X]LU)12
M6BL#WN<CJ'AJZO[W6K$J$TN_1;E90_S+<[=F O8#:CY]13KBUUY_!)8V4,NM
M3F*2X@)C?!!7=LW_ "%PJ_+N^7<!FNLHHZ6#K<\YO=#UI=*\8PP:3>3MJULB
MVXDNXVD9S%L(;<^%P>3@XQ]W-:^K:=K5SH>C7VDV_P!FUJR*+Y-RR']VP"2*
MQ4D$ 8;@GE!77T4>7I^'_#A_P?QM_D<1XU\.WMS;Z3<Z?H]CKO\ 9Y=9=-OR
M@6=6 &Y2X*B0$#D]BWK5&32-4!\*/:^#X=-2UOVO+JUT^6#RX 8V3!.4W.2P
M/RKCCJ<<^BT4T[?F#U7X!7G\_A_6/[#USPL;%YK?4IIY(-2$L>R-96+'S%)#
M[E).-JL#@<CMZ!12_K]1W./BM]3@^(<=R-'O9-/33ELOMIE@VE@^[<1YF_';
M[N<]L<UO>((KR?P_?Q6%O;W%T\++'#< &-R1T(/!_'CUK2HH>UOZWN):/3^N
MAYK>:)KG_%03PZ1J%P=3T:.V19[N$RB7]X""-X10-ZG"G;C..>*T;6UU@^)O
M"]R^A7D=O::=);W,C2VY$3OL R!(2<>6<X!ZCKSCN:9+$D\+Q2+NC=2K*>X/
M!IW>_P#77_,/+^NG^1R>DZ5-;^+[ZV5T;2;63[;"@ZQW$P(9?H/F;'_37Z5T
MFJV1U+2+VQ$K1&Y@>(2+U3<I&1^=0Z)H6E^'-,33M(LH[2T0Y$:9Y/J2>2?<
MG-:-*237*--I\QQ%MI.KZE%X>LK_ $YK%M%GCEDNEEC:.?9&R8B"DM@Y&=RK
M@9ZU2N]*UZW\'ZGI46ASW4\FJ231F*XA >-KCS=XW., #C!P<]L<UZ)13;;_
M *\T_P!!+16_KJOU//=7T36-<U_7572Y[2WO](BM8;F=X6C\U6=]KJKEBIWA
M3QSANV"8]%TK48=)U9I/AWI.C7OV5[>-M-E@,ET6&/EP%")WPS9XZ5Z-14M7
M37R_/_,=]4_ZZ?Y&'X.M;NQ\':197UJ]M=6UK'#)$[(Q#*H!Y4D$<>M4M:T_
M4(/&6G>(+2QDOX8+.:UDMX)$67+LC!AYC*I'RG/S9]C74T5;DW+F_K^M24K*
MQYSJ'AW6+:/23!IDMW(=>;5KE8)8@L"G=\@WLI)^8=!C.[IQ3O%7A[43XK.I
MP^#](\46MW%'$T=\\226C+GD,ZM\A!Y R<BO1**G^OP2_0?]?BW^IY[XC\/Z
MQ?VFJ:;;:4D5O-I(@M?L$L<,?F -^[D.5<J"0% &S!.<9J:_@\6:5K4.K:5H
MD&JPWEE%:75C+>+"UNR%B&W$%2N'.0 3Z9KO**=V'2W]=/\ (XQ8=6M_%]G=
M#P[*+2WTI[<FTE@\M9"5<(@9U; V[<[0,D=!R+W@.TO]/\(VMEJ5A+97,#.&
MCE>-L@L6!!1F&.?7/!KI:*+_ -?._P"HK?U\K'+3VFIZ5XOO-5MM/EU*TU"W
MAA=(9(U>W:,M@_.R@H0_8D@CH<UA:=X;U?1];\*(-/GN;>P2Z:YN(Y8MD;3G
M(10S!B%_W>F,9Z5Z-126EOZ[_P";&];_ -=O\@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYYXK:W
MDGGD6.*-2[NQP% &234E9^NZ5'KF@W^E2R&-+R!X2ZC)7<,9I/8:M?4XZ_O_
M .T?B'X2N5L]0M4<W(0W#829/))#! Q /)^\%;VQ6K#\1O#MQX@BT>*[C>6:
M0PQR)<0L&D&?DV!S(IX/+(![\BJQ\/>)+[5_#U]>SZ7#_9+2K((?,D%PC(%W
M $+L)&>,L!ZMV=X>T3Q?H=\FFMJ6DS^&X"WD%H9/M83.5C)SLP.F[DX'3TK3
M;U_,G7?KH95EJ-IJNL:[J6OZ#>1KI%[NM[N4Q;K4+'&?+4QR%\L220,J0<$]
MJZ-_&4,5AJMQ/I&IQ3Z7&LMQ9L(?-\L@D.I$A0C 8_>SP>,XK+M-#\60P>(U
M7^S+.;4KG[5!+#>2.4.U%*',2X!5#\XR1G@'%/M_!UWYNOATL;2WUBPC@<0.
M\KI*%=6)9@-_WA\QY.,8%)_#IV_&W]?UJ5]K7O\ A?\ R-H>(K:YU6RTEK2\
M3^T;)KF&?*A"H"[ER'W*PWKVQSP:X_0];NO#G@"P-GI]S?M+K$MK\LJEE4W3
MKR9'&XD< D]3DD=:V;?P_P"(?[4T#4)7TN)],LY;66%7DD$H8( 5;"[<[!U!
MQ_M56L?"NNQ>$8M/G734O;?5!?QA+EWCD7SS+M+&,%3R1G:>@/? K2[M_7O?
MY$._*N_ZV_S.JUC5)M,\.W>II8RS2P6[3?9MR!L@9P3G;QWP3TXS7)?;IKK7
M_"FKSV%_'=SV=P&M3*IWD(I!"JYC&<G!)!P>2*[+4K*34=$N[%I%26XMWB+@
M< LI&<>G-<U#H_B1=4\.SR6^DF'3K9XI]MW(&+,JK\H\K! VYY(ZX[9,]?Z[
M/_@%=/Z\B^?&^CQ^'AK-S(;6(S/;F*Y>.)Q,I(,9+,$!RIYW8]ZI6_Q)T&ZT
M^&[A-Q();U+$I"JS>7*V,!GC9H\?,.0Q!Z#)XK,A\(>)ET)O*N-.L=9MM4FU
M&S=)GGA;S"Y:.3*(<8<C(!]>.E6M4T7QCK&BZ9'?MH<E_!J$-W,())88E6-@
MP5<J[,3SDG:!QQ35KZ^7Z7_4'Y>?ZV_0T-5\>Z5HMK#)J"2VUQ+O*VES-!;R
ME5;:6_>R*I'<88DCD9J&/QM]OUS0[?2M/N+W3M2M9+D7<;1  *RKT9P<+NYX
MSTP#SAWB+1O$QUF#6_"]YIT5X8!;7-MJ*NT,J!MRD%/F!4EOKFK,NC:M)KFB
MZI)/9S2V]O-;WG#1J?,V'=&.>A3&">ASGCD7G_6__ !_I_D/;QC8I-$S6MX-
M/EF\A-2VIY!DW;-OWMXRPP&*[3ZUAZE/'KOCVZT+5=!N;K38+*.17D:'9$S.
M_P"_!\S<.% ! WC!X&<F6/P?J7]B#PO,]H^AI,LD=R)7%QY:RB01E-N.V-^_
MI_#5LZ)K$WC74+^>VT\Z5>62V+%;Q_."J7.[9Y6,G?C&[C&<GI2_X/Y?YC[_
M -=?\BW:^+;%Y[*$VE[#9WA$=E?2JIAN"1D $,7&0."ZKGMFFVOC;3KN2[V6
MU^MO9W$EO<W$MN42$HF\ELG<%QT..OU&<^T\+:J^G:5HNI/9OIVE3PRPW,4C
M^=.(ON!D*@(<A<D,V<'@9X-,\*ZC)8>*;+5Q:PQ:U<22HUI</(T8=%3G<B\C
M;G\:;MK;^MOQWT$NE_+]?^ 7="\>Z'XAU>33+*X1K@(98]L\,HD0$ L/+=MO
M4<-M/MP:UM3U>+37AA6":[NY]QAM;?;YD@498C<RJ ,CDD#D#O65X8M?&5L[
MQ>);[2+BWB79"]E#(LLO^U(6.T'V4=>_K-KFC7TVLZ=K>E-;M?6220F"Y=DC
MFBDVY&Y0Q4@JI!VGTQZ#MI_7]= 76Y!)X[TF*RM[B2&^5Y;U;![?[.3)#.2!
MMDQ\J]0<YP1TS6Y9WS7EB;G['=0,"X\B=0LF5)'KCG'!S@@@UQFJ>#M7GB\^
MT6P:\NM7@U.[$MRZ(GE;0J(1&2W"]2%YYQV'>C)4;@ <<@'-'3S_ .&_X(=3
MS6[UNX\1>'M+U6]TZ]L7@UR)44S*5=1<%<;8W.[ &/F'7D9ZUUB>+]-2WU26
M_673O[,=4N5NRB[=V-C95BN&R,<_7%8,OAGQ'#HEIIMJFE3"VU7[8'EN9(]T
M8F,H'$;88YQCH,9R<X#KWPGKFI:AXAD>6RLA>O;S65Q#.\KQ2P$;"Z&-1@XR
M1N/ISUHZ?UVC_P '[A6=[O\ K67_  "S;_$WP]<:7J=\KS$::BR7$4!CN6",
M2 P,+NN.#GYN.^*N7WCC3-,LFNK^*>T!<+ MT\4'VG*!\HSN$Q@X^9AR"*S+
MS2/&^L>"M6TS5Y=!DO[N%K>(6IEBB56&"[,P8D^P4#W]+6LZ#X@GL='O='NK
M&TUS34,>R<O);S(P 9&( ;!VJ<@9&*3_ ,AK_,M6GC?2]1T>VU#3DGO&N9VM
MHK> QEVE4%F3=N\O@*3G=M/8G(K+\2^+WE\$KJ.F6%^QFNTM)4'EH\#><(W1
MMS@9)W*"I(R<YQS6A<:;XHO-.TP7ESITMPDV^_M[=Y;>&5"" JM\SX!P<'AN
MAP.*Q9O!VNP>$7T.PBT@C^U#=IF=X42,3^<% $;<_P ..@ZY/2G97U\OS5_P
M!;?UV?\ P/ZVNZ)>)I?BLZ+8>%;K3;2>V%Y,!) $C<G;DHLI"CY<'8#DG..]
M6+3XD^'+W6DTRWNUEDEW"%XIHI?-*@L5"(YD4X!^\@ST&<BKG]E:G+XDBU25
M+-(IM/\ LMU$LK,8V#;OD.T;@<D9.W'!P>E9OAS1_&FAN--FU#1[O1+2,I:,
M8Y%NG4#Y$=N54#@%@&) Z9I>O];_ / MW#^OZ^>YKZ#XJM?$212V5E?K;2K(
M5GF@V)E'V%3SD-GD CIGN"!8U+74L+G[+!97>H7@C\YK>TV;UCSC<=[*.N<#
M.3@X!Q5'P1H^HZ#X=73]36U$RSRR VTS2*0\C/U9%/&['3M1?:/J=MXG;7='
M%I,\]LMK<VUW*T2D*Q975U5L$;F&-O.>HQ3=K_U_6X=_Z_K0G3Q58W.GVMUI
MT-S?R72NT-M JK*=AP^=Y4+M/!W$<\=:1/%-K/86UQ:6EY=7%SO\NSC15FRA
MVOG>RJ-IX)+8Z8)R*YVX\$ZUI<5C?^&=0LTUBW>X:5+Y&-O.)W#N#M^9<,!C
M'IS5K5] \6S_ -EZSI^I:4OB&TCDBE26%ULYHW*DK@$N,%5(.>>>F>#0#4C\
M86<LVCHMG>[-4ED@CD*(HBE0,620%MP/R-R 1QUZ56E\>Z;;6US-=66HP&WU
M!=.=#"'/FL%*G*,RA3N7DD=<=>*-1T77;ZWT.\EFT^?5=.N_M,D8WPP2 HR%
M5.'9<!L@D')';/&)J?@SQ'<1:K'!-I4L=_JT&H!7>2(QB,H2-P5MV?+  P,9
M)R>E-6OK_6J_2XNFG];_ / .@F\:6L%_!I\FEZLM].LS10&VP7$6<X;.TYQQ
M@_Q#.,U67Q3H5K?:[J#66HPW5E:P27Q>UDW&,[B@"=\?-D@8]^.)M3TC6+SQ
MEH.K10V(M;"*59@URX<M( #M'EX(&,@DC/H*S=6\.^(KO4_%$MO;Z68=5L$L
MX#)>R*R[0XW,!"0.)"< G[H]<B=;>>OZ6^\I6;UVT_X/W&_9>)[6]U2VL#:W
M<#W5L;JVDF10LR#;NQAB01N7(8#KQFJW_":Z>LL1DM-0%K/,;>VNTMS*EQ("
M0558RSC&UN64#@D&J$&C:]'KWAZ_N(-+2VTVPDMKDK>R%LMLR5!B ( C'4C[
MQZ8YY;39?$(U>SN9/"4]SH,-VT]K);ZQ;F!-[-B9(RHD/#G"EL<\ '%59<UE
M_6O^1.O+=_UI_F>N456M?MWFW7VS[/Y?F_Z/Y.[/EX'W\_Q9W=.,8JS4C*6J
MWCV6G22Q -.V(X5/\4C'"CZ9(S[9K#\%7=Z+;4-%U2YDN;_2[IHFGD.6FB;Y
MXW/U5L?534^LZ3>ZSK=I!>:=I5YX>C4M-'<R,SM)CY3Y9C*,!SP6ZG/&!G,A
M\+7NA>-8]0\-:5H=GI$MN(+V%':!Y"&R'")&5RN3U/.<<8S0O/K_ %_7J#V]
M#F[VRC3X9>-H1)<[;?4+DQL;F0M\NW&6W98>Q)!KT^:ZCL=+:ZE61HX8=["*
M,NQ &>% ))]A7$3>%_$EQX2\2Z4T&DI<:K<R2Q,+V0HBR==Q\D'(P.@YSVKL
MI4OWT)HQ!;?;V@V^49V\K?C&-^S./?;^%#;4--]/_2?\P7Q:[:_F8T7CS26T
MA=6FCN;73Y(8Y8;FZ"11R[R0%#,V W'.[ &0<XJO!\2M!GT.YU2/[1(EM,L$
MT4 2X9&;[N6B9DP?[V['8D'BJMOX0UJ/X?Z1I4=Y:6FM:08WMKB-FEB9D!'S
M JIPP9@1CC-/U/2/&>L^#)]/U%M"DU.XD3(MWEA@C16#9!*NS,2/11S[<MVN
M[?UM_P $71?UW_X!L/XJC6^O;%=*U%[RUB6<0!8P9HB2 Z$N% R",,5/M4-_
MX[T.PT.QU62Y3RK^/S+6-YHH6D& 3@RNB@C(X+"JQTOQ%_PEEUJXL]+\J73%
MM%3[?)N\P$MS^Y^[N8C/7 SCG Q[;PEXMT[0-"?2[K2;?6])@:T*2O)+;7,+
M;2=Q"JRG*@\ ].O-+I_7G_P"M/Z]%_P3I+7QGIFI:5:7VF+/?M=EUAMK?89'
M*'#\E@@ _O%L<C!.1GD-&O\ 2].\,^)FU>VU":Q.NR1F+]Y+(O\ J]H9LD@
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M)WEQ@?-G/ YIIV=_ZZ?\'[PZ?UY_\#[CF-5UG6[&_P#&4=MJ086&GPWEHMQ
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M^SO*DN_]X6+@J3\I&,9P>N0*F7P3X=6*VB.G!X[64S6RRRNX@;_8W,=@'8#
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M:E_#9;V_R_R'IS7>U_\ ,Q+;5]1UFZTS2%U&:PEFTB._ENX8HR\CDJ,*'5D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&)"DA2Q X [
MTM(Q(4D*6('0=30!R[ZOK^G^(M*M;Z*QFM-3=T$=NC++:E4+Y9BQ$B\8R O)
M'!KJ:Y73[O5+C65NKSPKJ,,['RDFFGM3%;Q9R<;968DX!.%Y.!P!FNJI] ZA
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>ex10-7_003.jpg
<TEXT>
begin 644 ex10-7_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX9!(>0IC<!P2.>1TYZ46Z ;M%8C^+=&C%Z&GN-]D1Y\0LYC(H/1@@3<R=?G
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MBA>5V/\ NH"<#N<8'>H+[7M.T^".6>65O-4LD<%O)-(RC&2$12V!D9.,#/-
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MY\*:[9KH]U/X.T;Q&5TZ&QGL[F>/-LT><.DDB8VD'Y@!G(&,]:]8HJ?Z_/\
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MR""751\P(; Z8%3>);;49_$_AF>TTNXNK>SN7EN)HY(E$:M&R#AW!/+ \ \
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MGD$[L5HMX@LT\3Q^'REQ]MDMFN58Q$1[%(!^8\$Y(X&<=\5JT)NR_K;0'O\
MUU.<M?#VH6WBG4]7_M2W:*]@BA$ LSN01D[27,A#?>;/RC/'3'-0>!8FT[7K
M<W$%O)JZ;7^Q6ODQ(1G#^66;+G/S-GYL#I6SJGB"STB_TVSN5N#+J,WD0&.(
ME-V,_,W0<9ZG)P< XK5I=/P X_5_!VK7E_;:II?B>72M56%8+J:*T22.X0$D
M#RW) ().#DD ]ZM2^&]3/B;3]736(66SLY+;9/9EWE+E2SEED4#E%. H&,CT
MQTU%%_Z_KU XS3_!-_9Z9I]O)K,#W%CJ4E]%*ED54^9OWH5,AS_K&P<C'&0<
M'/9 8 !.?<]Z6BG?^OZ] .<N_",-Y_;B/=.(=43 C"_ZB0J%9U/<G:A]BOO1
MKGAJZU3PD-#M]1B@=MGFW,UL92Y!#$[0ZX)89ZGO6U>WGV**-_LUQ/OE2+;
MFXKN.-Q]%&<D]A5FET_KH'7^NI@'0;]=;EU:#4X$N9K%+656M"R%T+%7 WY"
MY=LKDD\?,.^/!X*U>#3_  _:_P!NV3?V/<FX#G36_?<, "/.XX=N>><=,8/7
M6UY]HN;N'[-<1?9W";Y4VK+E0V4/<<XSZ@U9IWZ_UW_4/+^MK?D07ML;RPN+
M99Y(&FC:,2Q'#)D8W#W%<K;^#=0M7MIXM6LTG@L);+Y-.VQON*D.5\S.?EY^
M;G/:NQHI6_K^O4#B;/P5JMG;>%X!K=FR:$3@G3V!F&PQX_UWRG:3SSSSTXHO
M? -Q<Z/<Z+%KC0:6]R+J%%M@TL+>;YI4.6P5SG *Y'J1Q7;44VVW?^N_YA;^
MOO\ \QL:E(U5G9V  +MC+>YQQ3J**0!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZ[+=P:#?S6,T<-U% S
MQR21^8H(&>5R,]/6M"L[7Q<-H%_':VDMW/) T:0Q,BLQ88ZNRKWSR:F=^5V*
MA;F5SEK'6-9@7PG?7&H/>1ZRB1W%LT,:B-C TF]"JANJ\@DCGC%1Z#JOBO7K
MFUUFWN-,3299&26W>[W&,9(QL$ 990< @RD=1W!&MX-\/1:;HFG375A<6VHQ
M6J0O'<7)E$150K; '9$!QGY,9[\U+#X"\+V_B*37X='@CU23=NN$9@06ZL!G
M 8Y/S  \]:UG;F=MM?S,XW<%??0Y6/6O%4W@75M>77+=;K3FO8S']@4QR>4Y
M"D#=E3A2.21\W(.*V5O=8;Q/I^FG6)O)U/2Y+AB(8MUO(AC&8_E[[SD/N''&
M*U(_!6A1:'<Z,D%V+"Z8O-']ON"7+$ELMOW<DG(SSGG-/7PAHZ7UI>A;[[1:
M0&WA<ZC<';&>H^_@YXY.3P/05.G]>G^>I7]?CI^!S(\2ZX_A'1[]+V(3'6%L
M;IV@!:>/[28LC&%4D#)P._&*FFM+Z3Q=XL=->U&%4T^$I'&(=J967&W,9(P1
MD<]2<YXQKCP#X>&FIIXAOA:I<?:E3^T[GB7.=V?,SG/S=>O/7FM8Z)IQU)]0
M-OFZDA$#N78AT&<;ES@D;CR1GD\\TI:IKU_%+]4_O!;K^NK?Y?D<'9:CK5IX
M>\+:)I^H^9>:C8>>MS>3QP,NU8_W<;""12?F/#(3@'FMF+4-?:ZTOP]J-Y!;
M:E<Q7$T]Y8[9,)&5"JN] N\AU))3'!P!D8T;[P)X9U+08=$O=+2?3X2&BC>5
MRT9' VONW#CC@]..G%3MX0T(Z99:<E@L%O8G-K]GD>%X3W*NA##/?GGOFJ;3
MDWY_U]WXB2LDO+^OZZ&/\/ P'B57E\UAK<X,F -Q 3GCBNON/^/:7_</\JI:
M9H.EZ-)=2:=916\ET_F3NH^:1O4D\GJ?I6CU&#425XV\K?A8:T=_,\M\+7.J
M:3X#\(WUM?RR6\[0VDMCY*%=LCE=ZG;O#+G/)*X!X[UK)=ZS;3:EX>N-?O'U
M9[F(V-RT-N&\A^2P41;3M"R;L@_=&,9%=+9>&=(TZZ%Q:VI1E.8XS,[10G&"
M8XR2D?!/W0.M4]+M=1U+7FU?6=(@T^2T22VLU6X$SNC,"9"0H"Y"KA>2,G-6
MW=_UY?JON;#^OS_1_@=!$C1Q(C2-(RJ 78#+'U. !GZ 5@^);N[2XL[*TU"6
MU>=9&VVD227+[<8VAU9 O/S%L#E1D$UT-9]]HEAJ-[:WES"YN;7<(I(Y7C(#
M8W*=I&Y3@94Y!P.*EZ@M#C+?Q#K]Y8^"YOML4 U25X+Q1;*7)$;L"#DJOW.@
M!Y/7'!BU/7O$>F+?646J),UCJMG;_:Y[52\T4Y0%3MVJ&7=U"\C' /-7-?\
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M[4(5@,TL\DC,BDD EF.2,GD\\]:.EGVM^8^K_KL<E;:[J4;>&[^YUBY-J?\
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M&04D8,.-P8% /O8QVSS3]8\1:O;:C>I;:G'#J27J6UEI,D"2+/$Q3,NT8D;
M9CE7"C&#WK=C\"Z!#;Z?;QPWJQ:?(9;51J5S^Z8]Q^\Y[C![$CN:Y>[\':GJ
M'B6[N#>>,-.,\S2!].U>%;(8X4E&._) &1L(_"G=77]=O^#]X=/Z\_\ @?<>
MD1"01()65I HWLB[03W(&3@>V36)XDNKF,V5K:W\EH]P[!OLT:R7# +G]VK*
MR]<9+# '<'%;<*/'!&DDAD=5 9R,%CCDU3U#1;#5+BUN+J)S-:L6ADCF>)ES
MU&4()4\94\''(I/<%L<38^)/$%U9^$F>[CB-_>W%G=A[93(VP2X.0VU3^[Y
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M:>U:81P7@F;<%W*(L01\<'(9G/OQSNVO@_0;2[M;I+ 2W-JC)!-<RO.\:MU
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M!Y0N) C@#&'4-AQ[-G-)=+E/4U000"#D&BCI12 **** "BBB@ HHHH ****
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M" P/-)?:3INIVBVFH:?:7=LI!$-Q"LB#'3Y2"*N44 5;G3;"]L38W=E;3V9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M MW(BDB6, ;0P4CYN1C!.,@X%<_;/-9:%;:G:WERDH\3RP;4F81-')>,CJR
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M<+(&9"JD, +A(Y0W/#(Q&2/2BUVOZZ+_ #%+1O\ KJ_\CU*BD7E03Z>F*6D
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M-)X[5%D50-H4,!D#'&/3BM.N:U35=9GOKZST :>)]/2)Y5OU?;+OR=H9#E,
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M:,FC:7+:36DFFV;VTV/-A:!2CXZ;EQ@]!UJ"Y\,Z#>QM'=:)ILZ,RLRRVD;
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M^4R8#;CU^[FO1Z*71_UTL.^W]=;GFFG_ -G3ZMH5WX1$"WWS+JZ(</L\IO\
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MWW@OPS97$ME=133W$>+F56M-X+$)*,$,_P P*IP2><\5ZY14VU \JTRVL_\
MA!M*UN>&&YN_#U]*6D:$YCA69T=5#9("IR%R<;5K0T[1+&'7;W0I-'M/L&KO
M'JHC-LNQ0IPR%<8X*Q'GO(U>BT55];_UT_5)BMI;^NOZ-H:R*T93D*1CY3C
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M)[2ZTZ&VLC%$UPL14/OB=ADKG*G<W![GBKOPXM[RS\ :3:7]C/9W,$/EO%.
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M3WT-\]U'J"7LQL&^<LLF/-"*<'E I^E=MXQM=0O?"E]#ID2S79566%B )@K
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MCS;J:[GVA6GG"!V ]0BJH_ "K5% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:EX>
MM]5U6SOKB[OPEKDBTCN62"4Y!#2(/O$$<9X]JUZ* "BBB@#(U+P];ZKJMG?7
M%W?A+7)%I'<LD$IR"&D0?>((XSQ[5KT44 %%%% !1110 4444 %9'B/0$\2:
M8+"6_N[.+S%D9K7R]S%2& .]&XR >,=/2M>B@!D2-'$B-(TC*H!=\98^IP ,
M_0"GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI;4$,,:M;;2JF:/8@)7))93G Y'3%;4RW5]X@M)+/7[N.PN+.240P) T;$;
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M9H)!%(PSE5E*[&;@_*&)X/'%%N@&I14%W>6]A;-<74JQQ*0-Q[DG  '4DD@
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M4N;B4ZM-:QSSH6Q\P"*S(H1,]!G:">G-=#?>(=,TVX6&ZGD0D[6D$$C11GC
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M9ZC.)Q?WK0K-9Y504?*L7 (XVY],UZ;126EOZZ)?H#U_KSN(HPH'' [4M%%
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M"=8I%)QC,T49W>H (YZGFL[QC>ZQ!XE\,6^GVEI-%+=N<37CQ;W$,AVL!&V
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M802V["*S\OSU<H=S$N?G^0;F[Y/ I;'P6UI:1:5+J"SZ+!<"YAMC;XE+!_,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSM))A'MW&0_(#@9;CU[9JY!I,.K?&'Q#_:.D7SZ9?:9':K++9S)#(<#>-^T
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MF>,$$,J. #'#TPI)R3V[[/BR30?^%RWGVV6Q$;^&Y?.$CJ%=^2 W8G8 1GL
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ML/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 8ESH>H3W,DL?BK6+9';*PQ16A5!Z#= 6Q]2:B_P"$>U3_ *'/7/\
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MT! I?L^NO@-J-D@[F.S;/ZR$57)%[2)]I);Q?RM_FC3DECAC:25U2-1EF8X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[NI=TJQ-A8A)&WW$C&2>3^_(>2?IV'L!5ZBBLY-R=V:QBHI104444B@HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ JGJ5E<7UNL=OJ=WI[AMQEM5B9B/0^8CC
M'X9XZU<HH Y__A'M4_Z'/7/^_-E_\CT?\(]JG_0YZY_WYLO_ )'KH** .?\
M^$>U3_H<]<_[\V7_ ,CT?\(]JG_0YZY_WYLO_D>N@HH Y_\ X1[5/^ASUS_O
MS9?_ "/1_P (]JG_ $.>N?\ ?FR_^1ZZ"B@#G_\ A'M4_P"ASUS_ +\V7_R/
M1_PCVJ?]#GKG_?FR_P#D>N@HH Y__A'M4_Z'/7/^_-E_\CT?\(]JG_0YZY_W
MYLO_ )'KH** .?\ ^$>U3_H<]<_[\V7_ ,CT?\(]JG_0YZY_WYLO_D>N@HH
MY_\ X1[5/^ASUS_OS9?_ "/1_P (]JG_ $.>N?\ ?FR_^1ZZ"B@#G_\ A'M4
M_P"ASUS_ +\V7_R/5K3](O;.Z$T_B+4[],$>3<QVP3Z_NX5;]:UJ* "BBB@
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MC#_\50!T%%<__P )WX/_ .AKT/\ \&,/_P 51_PG?@__ *&O0_\ P8P__%4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_A!/!_\ T*FA_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HJ(7,#7+6PFC,ZH':(,-P4D@$CK@D'GV-$MS! \:2S1QM*VV-78 N?0>
MIH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>ex10-9_001.jpg
<TEXT>
begin 644 ex10-9_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT9MT3'(R>.![5H6.I_$JTU1[Z7P7J-V7A6%H9]=L AV]&^2%3G)8]<?,>,8
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M6Y\C(Y.(_D;<W'0[1R.:H+XP.H1Z6FBV'VJ[U"S^W+%<2^0(H>.68*W)+
M<G/('-+^OZ^X9U%%<[%XCO-5TB"]T+2UNGD0LZ75P;=8RI*M'N"/EPP(QC''
M)'&:=YXY\GP"?%5KH]U<(J,\EL72-H]I(8L2>@*]5R3U -.P+4ZZBFQ/YD2/
MC&Y0<>E8=QXBCCU6\A#V\5AID8DU"[F? C)&0B^^,,2>@(X.>$]-P6JNC>HK
MA(?B)#?WWAV:PDTXZ/J7G?:)VN,R0,D9?:P& IQM)R<C.,=ZZQ];TF/2QJCZ
MI9+IS#(NS<((B.GW\X_6FU978=;%^BF0S17,*302I+$XW(Z,&5AZ@CK3Z0!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1152?5=.M;;[3
M<7]K%!L+^;),JKM'4Y)Q@>M %NBL!?'/A%V"KXIT1F8X &H1$D_]]5IWNKZ;
MICPI?ZC:6C3MLA6>98S(WHN3R?84 7**IQ:OIL^HR:=%J-I)?1#=);),IE0>
MI7.0/PJY0!R/Q-:1_A_JMI!:7EU<W4)AABM;:29BQ]0@.!QU.!6?X[E_M'P3
MIBPZ?J%R);VT=H5T^9W")(K/OCV;E  /W@,^]=ZS*@RS!1TR3BH5O+5[Q[-;
MF%KJ-!(\ <%U4\!BO4 X//M33M]Z?W ]?Q_$\?\ %437R^.X4T+59Q=-:M8@
M:1.P>1%"LR'9P1C[WY5TNH/?0:W%J&B17\S7\UN+C3[S3'\F15"?O!(5'DLJ
MG^,]4(VYKT*BB+M8'J8/C709?$W@W5-&@E$4UU 5C8G W Y&?;(P:R?!^L7%
MAX;T[1=1T?5(-5L[=+=XA9NT3E% !68#RL$#/+"N@U+Q+H.CW"V^J:WIMC,R
M[UCNKI(F*],@,0<<&K.GZII^K6_VC3;ZUO(,X\RVF61<_521277S!]+G!#2K
M_P +_%/4?$TME<W.E:O:(DSVD;3R6TJ[1@HH+,IQU4'WQ26.EW6H?$Z\\<W%
MG>6NEVFG_9;9)+=Q/<'DLPB W@#) !7)XP*])I RL6 8$KP0#TH[>5_QO_F#
MUOYV_3_)'F^N^%)/%?AC2=:T7[1IWB32XE-I+/ \#DJ,&)U< [3SU&.>X)S:
MU_1--UW2=/M?$V@WDT5O912+>VD3M-;S'AE"QYDSP#PI''..*[>[O[.P$1O+
MN"W\Z011>=($WN>BKGJ3Z#FJZZ[I3SI FH6[NTS6XV.& E7K&2. W^R>:'KH
M'6[/,=6\*^)]6^#NIZ,\MU?W*W8DT_[9\MQ);(ZE0^>CX#<'GIG'0=_I6JC6
M8;'R;'4+?RB&G%Y9R6YC(0C'S@;CD]5R.O-;]9[ZWID>N1Z*UY'_ &E)$9EM
MARVP?Q'T'UZT[]/ZVL*W]>IYIHMX^F_&/Q3K%UI6MKIUW!%%!.ND73AV0*&Q
MMC)QP><8-=U=:TM]X4U*]6PU*./9)%'$]E+YTG& 1%MW@$GN.G/ KH:*EJ\.
M7RM_7WE)^]S>=_R_R//OA.TNE?"^SMM0L=0M;BQ63SX9K*59.79AM4KE^"/N
M@^G6L#X?W,^D>%=>CU#2-;@EGUA[F.(Z3<%FC=E(( 0_W3GT[]17L%%6Y-R<
MN_\ FG^A*5DE_77_ #/.]>\'7<?B_3O%OAIF@>YFACU:UV%1<0EA\Y4]&7J<
M\\>V"Q])OO"WQ5U'Q.;.ZO=)U:U2*5[6(S26TB[0,QJ"Q4@=5!QWKN-8UO3=
M L?MFJWD=K;[P@=\_,QZ  <D^PJ74=2LM)T^6_U"YCMK2%=TDLAPJBIO9772
M_P"/0>^CZ_H]SC?#<GBJ_P#'&HW%Q?ZF?"Z1AK-;NSBMVD<_>4J8UE"J<XR!
MG Y/?=\37\L44&F6R7*W%\_EBX73YKF&)<\F3R\8!Z<LO7.< ULVEU#?6<%W
M;/O@GC62-L$;E(R#@\]#4U-JUD^@)WU74\CTF+6/"/Q<U!KFWN[_ $_6HE:Z
MN-/TBX2""<?=/5Q@C.2&/+<XQ5SPCI]YX BUW1=0@U/[-=7DES9:E86;W1(<
M <JB.5=<?Q+@^]>G1R)+&LD;JZ,,JRG((]0:=26BMY6^5[_@#W_'Y['C>IQ^
M,;KX6>)(O$/]JW][>RM!IUK'8HS&($%7*PQY4D9SOP.!P,\QZ99ZIX7O_#?B
M"#3]8U32I;5+2[L[BVGFN=.E"X:2)9 75"1R%X('&1MKVBBFG9W7E^"M^/Y@
MU??S_%W_  L>*:A#!K/Q8U#5+O3O$T.DR:6D$5S#IE['NE# X*J@++UX8;3C
MZ5L?%#4+GQ)\,[ZUT_1=9>>YN$2WA_LZ;S&5'1F=EVY0=<;L9QQ7J=07E[::
M=:O=7MU#;6Z#+RS2!$7ZD\"E]E+M_G<:^+F_K:QQWA>_L-+V6-A9>(93=OYT
M\E[8W>(-L0!S),N3]P  $\G XK#UW3M0U/6?#GBKPY:7:7UK?R6=PMU9RP$V
M\K,=S*Z@E5W9SC'/M7IUM=VU[ D]K<13Q.H9)(G#*P/0@CJ*FIM^]=_U_2T)
M2TLOZ_K<\HMV:R^-\NHC3-7_ +,BT?[$+E=+N&0RJ^2 0G/ ZC@]B:R? T,.
MF:OK6KZKIGB>WG_MB>\M(ETV]9)HW5E!,80IGYCR0&'KBO;:*$VONM^-QO7^
MO*QS!OK;6-0M;&_TN^"7NGMYL4UC*8E#[3L=]NP-@'(SU&.N*R_ WA34O!^L
MZEI9N7N- ""33"_+0[F)>,GV(!'U^M=+J'BCP_I-U]EU+7=,LKC:&\JYNXXW
MP>APQ!Q4VF:[I&M"0Z5JMC?^5CS/LMPDNS/3.TG&<'\J%W7]?\,#VLS@;%I_
M^%]7VH'3M46QETP6:73:?,(C*K@D;RF,8!^;.T^M>C7T+W&GW,$9P\D3(I]"
M00*L45+5X\K]/S_S&G:7,OZ_JQYE/!<77PAT*&WM)I9[":R6Y@@C+O&8)4$H
MVKDDC:>!S6?KWF7EU\0)%T75F>]TR&WM2=+F8R.%92JD(0<,R]#COT&:](@N
M=#BU^YM;>\LUU:50\]LDZ^:P X9H\YZ8^;'3'M6K52DY-OO?\;?Y"7NZ+I_G
M<\HM;>WO_%>H&;1]7CMM0\/1VUQ,FF31-)*,[AN9 "X7')],=L5UG@^;5FN]
M1M[\/<VL'EQVVH3V+6DLV-V49"!NV\8< *=QQ743316\,DTTB111J6=W8*JJ
M.223T%9^F^(]#UF9X=+UG3KZ5%W,EK=)*RCIDA2<"B_]?-O]16LOZ[)?H:=8
M7B?49+:SCL8([K[1?$PI-%8RW,<(/5I/+Z#G'4=>HP2-VBD,\B@@UGP?\7I+
M^>WN=1LM8ME2^ETS1YUBAD7 1CS)G@<X;C)R!6!>:CH%KXLO="OO$,5D/^$A
M&IM/<PSK<*XQ^['R;-GHY<<?PXYKWRN=E\(P2BX@;4]1_LVY9WGT_=&8I"Y)
M;+%#( 23P' [=*<79J_3_._X ]4_/_*QS?@VQ\[Q]XUGN]+NE@N;J"6VENK-
MUCD\M<;D++@X8 @CV(K)\*>%]0&M7L&LW&N07UIJT]]:^7 GV68." YF\LD_
M*Q!4R9]!Q7K8 50 , # %8;>-O":RF)O$^BB0-M*&_BR#TQC=UI=EY6%;?UN
M>??#_P .W6GVD+ZX_B!-4T9KK=;_ &53;RK)DLRN(MTV[@XWL=W:N:TC1)G\
M+>!-.U#PYJA^RZQ-+?0R:7-A(RQP7^3I\R_D?0U] HZ2H'C971AD,IR#5+4M
M;TW2'M([^\C@>[F6"W1OO2N2   .3U'T[U2;O]WX,;UBUZ_D>+C1-=OO!OC:
MVL--U*&677OML4,EJ\+3V^\'Y Z@-POW>>@R.16CXQT)Y? -W-I\?B+4[C5-
M1MKB:*[T\B0%,!OW4<2[0%49)7!P,$YKV:BDG;\/PM_D@E[S;]?QO_F>.?V9
MJ5[K/Q/CMM+OU34K&-;(R6DD23,L14A2P SD@5Z+X)\Q?!.BQ36\]O+#9Q1/
M'/$8W#*@!!5L$<@]?Y5O447TMZ?A?_,'O?\ KI_D5[^ZAL=/N+NY<)!#&SR,
MQP H&36)X&LI].\!Z1:WD3)*EL"\3#)7.3M(]@<5MW=C;7PB6ZB$JQ2"558G
M;N'0D=#CJ,]P#U%6*7<.QY1X>T]&\,W]NEKK&D-;ZY/>6;PZ5(#$IW,C")D^
M92N1M )!('!Q7=^$KC4KKP_'+JMJEO<F23[D!A\U=QQ(8SRA8<E3R">:W**.
ME@>OX_U^)XE=6JIX7\56UIX>U-)+G7X[BWC31IQOB#QG<!Y?0!)/\L,ZFM/,
MWB7Q+)!H&H7<%Q;Z>(MVG7 CS&Y+-@!2Y0,K; <MC'8UZS133M_7DE^@/7^O
M.YY#]AU1+G5;DZ?J5Y;)KUOJ$\;V1C:Z@$*C*)M 8JX!V<M\O/-%[8ZI?ZWX
MDO-/TG5K>RN+NPN_.6U6-Y4C4;]L<H)+@D-@I_"1UP*]>HI7_K[O\D#UW_K^
MKG+>#M*MK-]2U"WN=7N#J,JRS/J5N+=BX&TXC$<97@#)V\\=:Y;X@6=[?3>(
M[:UTJ\$DVG1!)K>S><WFQBVS=@HFTD_* ';.0>!7I[2QJS+N!=%W%!RP'/.!
MSV/Y4D$RW$$<R!PDBA@)$9& /JK $'V(!IWU373^OT!:'C^J01R3?$&2TT#4
M@VH:=%%;LNCSJ9Y=K!L?N^3N9<GOUZ#-:X-REWJ$M_I&I74.J:+#!:.+*1RC
M*C!XG7&8R6(.6 !]>*]-HI/6/+\OP:_4%H[_ -=/\CF?!,%[%\.])M+BUGL;
MR&Q2 QS@!E95VYP"<#C///J!TKCM"\/1&UL&UP^(9[W2+:6*:SFT]#;LK(0X
M5D@!G5NH4,S$XR,YKTZ2_M8KZ*R:9?M4JEDB );:.K''0=LGC/'6JQU_21J]
MMI0OX6O[F(S10(VYF0?Q<=!P>3UIR?-)OO\ \'_-@O=278\M\.0S6.G_  [@
M&C:I!+:3S_; -+G7RMZ.N7.S !9EYZ=^@S5BPT_5[?PYH8>WUBS33-1NFNC:
MVBO,N]Y-CHCH_F !ARJGA^.AQZY10V%OZ^__ #/(X_#6FZ=XH\+&WTW5KZ%K
MJYGFNKS3&)594. VV)1&OF,3L(&,DD '-6KCPP9]6U/2M0EUVW@FODNK./3[
M.(V[J@7R_P![Y+&(KMVX9U'''!KTP7=N2,7$7+F,?..7_N_7VHNKNVL+9[F\
MN(K>",9>69PBJ/4D\"A.UO+_ ('Y60-7_KU_S9Y-JMIJ*>&=0TB;0M2N]877
M%O1+%:LZSQFX5E=9?NY"87!(( Z8&:]"\5B2?P;J072WOGDMB#99.Y\CE3L.
M3]%/..*T['4]/U2!9]/OK:[A?.V2WF613CK@@D5:I/:W];)?H%];_P!;W/+K
M+3)+[4_$:WL>KB#4+6Q,5S'IS0E61F&54KQL.TE6RV,YR*ZOP;=:K<VM\=3C
M+!;C;!>/9M:272!1\SQ-RI!^7. #C( %=-13N*QYSJ=C-%/XPL=1TR[OFUK'
MV%H;5Y491"%5&< K'M<$_.0.<@U)IOVG3_'.AVMY!J,[VVB?8I[Q;*9H6G+1
MG_6[=O(4G.<#N<UZ%10G;^O)K]1O7^O3_(Y_QC=BUT>$_9KVX8WENVRTM))V
MPLJ.Q(13@!5/7Z=:Y?3]&OM+U6^M9(9SX6MI#JMH$@=I"\F3Y(C"[B$?<^,9
M!*\5Z102 ,DX%+H_Z_KN.]]/Z_KH>/>'UO1X=\,63:-J=M/!:7-O+=2:;,7@
M=L?NPC *-P(_>,&4;2.I.$T'2XGU3P"MYX?O/,MM+FM;V2?2I=J$J%1'8IC'
MW^IP,]L\^IP:YI%T;86^JV,WVK=]G\NX1O.V_>V8/S8[XZ5-!?VMS<W%M%,K
M3VY ECY#+GD'!['L>AJKZ_U_743VM_7]:'#Z/86]O<ZAI&MZ+=RSC56O[6>.
MU=HI%#!HF$JC:I0 +M8CA<8(-<P/.CT"9X]%U<7+^+!?#&D7&\P^<&\S_5YQ
MLS[]O:O:**2=FGZ?A;_('KI_77_,JZA?II^G2WK07,RQKN\JWA:21O8(H))_
M"N<TC^R]=EO4O=,NKF:]16N_MVES10A%/R1CSD4,!DD8!YR3C-=;5#6-;TW0
M+'[9JMY':V^\('?/S,>@ ')/L*0%3_A#_#&UE_X1S2,,2S#[#'R2,$GY>N"1
M5ZRO+.66:RME:-K/$;1- T048XVY #+P0"N1P1GBKG6JD)L8;^:".6+[;(HF
MDC,F9"N< X)SMSD#MUH Q?$VKPH_]D30:IY,\>9Y[33KB<>6>"BM&C ,>GL.
M>N*S"PTSQ/:^(8=-U'^S+C2_L0BBLY&D@*2;H\Q %U# GJ!C SBNXHH0,X#3
M9+CPQX8MM-N[?48[N_EGN9I+2PFN1:B21G*YC1AO ; SQD$]N9/%+V[_  HU
M"STG3-2$<EJ]I:6RV$WFDX(&8]N]1QU8#]1GMK>X2YB\R-9 NYEQ)&T9R"0>
M& ...#T(Y'%)=75O8VLEU=W$5O;Q+NDEE<(B#U)/ %#?Z?A;_(:WO_74CTVX
M6ZTVVF1)D5HQ\LT31./JK ,/Q%<QHD$D&J>,K"1?](GN?M40[R1R0JJD?\"1
ME_"MZW\1:'=Z?/J%MK.GS65O_KKF.Z1HX^_S,#@=>]+:RZ/KIM]4L;BUO?(+
M+%=6LP<#/WEW*<$=,CIP/042UOYK\Q1T2\OT/--)6>)/AS;7>C:JK:8CK=%M
M-F98F\HH"2%('S=_QZ8-5]+MM3$%I=^3KUA8VVJ7[.+?3"9D69]T4BQ2Q,67
M&X':I(W=N:]@:X1+F. K)OD5F!$;%0!C.6 P#SP"<GG'0TEW=V]A9S7=W.D%
MO"A>261L*BCJ2:;E>[?G^=P2Z?UU,CPCI%OHF@1V=I)?26_F/*C7JA9/G;<?
ME"KM&2<+M&/2MVJUA?VNJ:?!?64HFM9T$D4@! 93T/-6:'N)!1112&%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!%<0)=6TMO)G9*A1L'!P1@UG
M6VBM:SP7!U.\F>*$PR>8L($ZY)7=MC&-N3C;M]\UK5#=VL=[:2VTQE$<JE6,
M4K1MCV92&'U!%)[.P'D?P<2^NO"K6,]A:2:'+=W8EE,I9RV1A2FT!5Z\ACT'
M2KT^F+JGQUGAGO99K5]!658WCA= /-^4 ,AX# .#UW <XXKIK;X:>%[*P>PM
M;;4(+-R2]O%JUVL;$]<J)<'-:'_"&Z(->;7%@N5U%H?(,RWTZXCQC:%#[0.^
M .#SUYJD[->GZ6!]?-_K<\HT+5)O"?PYU;7X?],U+^V9K2&:>*,M"'F =@0J
M_>X)!.W('05TNH^*O%.BZ=;6NHPW-HU_J\%C:7]Y]F:80N,N[+$3&'!# <8Y
M&0<&NNL_ OARQT>]TB+3V?3[UB\\$]Q+,K,>2PWL<'/.1@YP>U6)?"6B7.@G
M1+FT:YL" -EQ/)*PQTP[,7&.V#QVH3MOKM^"5_R_$5OU_%NWY_@<1X^M];L;
M7PO93>)+N8W.OPQ-/'!%$QC)++N&TJS*5'. I[K3X6UNX^(_BC1[36&CN(]*
M@>VO&M+?S5?/ 9A'\RYSP<XW'&*[6[\*Z-?:?;6-U:O-%;2I/"[W$AE21?NM
MYF[?D=,YZ<4EIX4T:Q\0SZ];VTJ:E/&(I)?M,I#(,8786V@# QQQ2\O7\4DO
MR&^_I^=SC-"\6:K<> /^$BN+^YFO-)M+DZA:M'"%FN$+ *VV,%0-I/RXX(SG
MK6EX!UGQ1JX@N]4M;E]-O+%+E;F<VZA9B>4C6)BWEX.1O&[@Y-=;9Z-IUA!=
MP6UG%'%=RO-<)C(D=_O$@^OI4.B^'=+\/6YM]+@>&')*QM/)(L>3DA S$(/9
M<"G?5M_UW_X K:67]=CAOB]_Q]>"3_U,$']:@U3?I_[0>CC2OD-]ISMJ:)]U
ME7=L=QZY &:[;7O!NB>)KFWN-6@N9I+9@T.R]GB6-AT8*C@!N?O8S[U:TWP[
MI6DO-+:6I\^<;9;B:5YII!V#2.2Q'L31%V2\F_Q5AO7[DOQN>=Z9XSUQ_&_A
M^S?58;ZRU62\BE\B-/LZF(?*8&V*YQP#N+#.<$UCV'B;6/#OA?Q;K@U&ZO;G
M^WY+%$G$91?F1!)]T'<%X +!>!P*],L_ /AC3Y=/EM-+$3Z=))+:,LTG[HO]
M['S=#G[IX]JG_P"$-\/&#4[=M,B:#4W,EW$S,4=SC+!2<*3@'*XY /6BZM_7
M=/\ )- ]?Z]?\T_D4?#\6N:G8WUGXBMKR*V69?L\ERUOYMQ$5!(D$)*#YLCC
M&1CWJ]XATJWE\/:WYCN7GMW<R,V"A524*^FTC(]^:T=-TNUTFS2UM!+Y2# \
MZ=YFQV&YR6P.PSQ5?7=-GUBQ.G"58K.X!2[8$[S'W5>PW<@GL.@SR%/567]>
M80T:;%\.7LVH^&-*OKD8GN+2*63C'S,@)_4US7B.":Y^)?AV&"[EM)&T^] F
MB569>8N@<%<_4&NFMM-:WU=[F.1X[;R%B6 3.R'&,$(3M3 &/E'.>>@HU70=
M.UEH7O87,L.?*FAF>&5 <9 ="& .!D9P<54FG+F7G^O^8HJT>5_UL<&VN^(E
MTFTU:?69EM=-U=[#4_*MXMMS"LNP3<H2I!*[MI QNQBNVT%[JY^W7LU]+/;S
M7#"UB=$ BC4[>"J@D$@G))XQ5?6-.4:$_A_3]&,EK=P20%E,8A@!'5P6#'.2
M?E#$GKCK6Q864.FZ?;6-NH6"WB6*-1V51@?RI=/Z\K_BOQ8/^OT_/\$<%K/B
M+6;3Q(KVVI-+:KJ]O8M;0VZ&!(WVAA([*&\W+$X1B -N1UJE)XC\2V]EJVH3
MZNDAT[Q!'8K!%:(D<D+-$I5L[F_C)!# YZDC@=G<^"]!N[B>>6SDWSSI<OLN
MI47S5((<*K *W R0 3WS55OAWX:>TGM7M[YH;BX%U*K:I='?*.CD^9G/0_4#
MT%$7:U_ZU7^3^\<M;_UW_P"!]QQ_C&_U#7_!GB&_&H-#:6FH"S6Q6)"K+',B
MEG8C=N)R1@@ $<'K7?\ BW_D2M;_ .P?/_Z+-5[WP+X<U"6Y>ZT\R"ZV?:(S
M<2B.8KC#.@;:S<#YB"?>ML6=LMB+(6\0M1'Y0AVC9LQC;CIC'&*B2O!Q[_Y6
M*B[34NW^:9Y[I^K:IX=M?#+->R7MA?:6Q:T:)!Y#10!PR,H#8.,$,3R1@CI5
M9-5\8ZCIDETZZC!IMYI<LTEPYLU%O+LW(8/+9F*GD'>"1P<BN\TSPSI&CRF6
MSM6#[#&AEF>7RT/5$WL=B\#Y5P.!Q3;+PMH^GK,EM;.L,H*F!KB1XD!!!"1L
MQ5,@G[H%74]Z_G?\;_Y_@1!<J2[6_"W^1PNBRZIHFB^#KB?Q)J!TF^LA!*CP
MVV()#!NC(;RLX&"/F)R=N<\@V_"VO:OJ426E]JEX-0TVXN)+Y&A@5Y85 :)6
M CPN5=/NX/#<^G6CPGH?]AQ:*UB'T^)T=(9)';!0@K\Q.3C:.IZ#'3BKT&DV
M-MJEUJ4-LB7EVB)/*,Y<)G:#VXR:<G=MKK?_ #7]=@2LDOZ_JWXGG5EXM\6"
MQ@\1MIUY-I$UA+=7"3FT6*(B,NGD^6YD()&"'R><\=*2YUWQQ;:3J&I)'<16
MG]F27:W&H1VC+%,H#!8EAD)*,N[&_)'!)/2N[L?#.DZ;/++:VSH)"6,)GD:%
M2<Y*Q%BBDY.=H&<FJO\ PA&@?V9<::+:Y%E.NQH!?3A54]50;_W:GH57 (XQ
MBIEJG8I-75S(T+5]7'BG2[&^U$WD.HZ-]M96A1!%*I0'9M&<'?T8GD<8Z5;\
M;Z1J>J'2YM"O[6WUBPF:ZMH;M2T4^%VL&QTX?J.1G\:OVG@[1;+4[/48(KO[
M59P?9X'>_G<+'_=VLY!'3J#T'H*T;_2;'4S&UW;B22+=Y4@8J\1/!*,""IQW
M!!IR:>J_K5V)C=*S[?IJ>>6WBR\@T7Q')<V-EX=\06<L)OFF):"7=P)$*@EF
M900!AN0HYI^AZQXGUVW\8Z/!JT\5_I<J+87<T$/FY9"P610FP\C'"@X/K77W
M'@S0+O2)M+N;$SVT\BRRF6>1Y)'7&UFE+;R1@8);IQ5G3/#>DZ/J%]?V%KY-
MS?%3<N)'(D*C )!)&?<#)[TM[^G^7ZC[>IP]AXQU&3X;_P#"6K?7%Q+8:;(;
MFUECB"RW()!W%4!&T@\*0,$?4[/@;4_$NHDRZM;7)T^>TBN(+JY-N&,C<LJK
M"Q_=X*E=WS=<DUTEKH6EV6GW&GP642VEP\DDT)&Y7,A)?(.>I)XZ4S1M TWP
M_:"UTV&2* ?<1YY)0@]%WL=J^PP/:G?5O^O/\=A6T27]=O\ @G _%!KA/&_@
M![2&*6Y%]+Y:32&-6.U>"P5B!^!K3\2ZQJVB>';+43:P6FLZC?P6%S+&/,$2
M-*P!!( ; /!([].U;^L^"]#U_4K?4=2@NI+JVY@>._GB\H^JA' 4^X&36I?Z
M99ZG8-8WT"SV[ 91R3R.0<]000"#G.>:4=%\[_E_D4]7?RM^?^9YIK/CS6M
ML?&5FDOVVYT5[46]Y-$N2LV,[P@525R>@';-3:UXXU;PK/XDL6F;4VL=+BO[
M:>>) RN[E-K[ H*@D$< X!R3UKM[;PIHEK;:A;K9>;'J./MGVF5YS/A0HW,Y
M)/ '>F6OA#0[07@6R,OVV%;>X-S/).9(U! 4F1F.,$\4/:W];?YAUOYG#0Q:
MA%\5M :?43?W<F@S.LLT:)ER0<?( -N>G&<=2:W_  -K&I7=W>6&NW=^NL01
MHT]C=6\2HF2?GA>-1OC)X&2Q&.36Q:^"_#MI/;W":9')<6T7DPSSN\TD:<_*
MKN20/F(Z\#BF:GX1TR]TW4;868F:^C$4@N+F4C8#PH.[**.NU<#/IG--NVWG
M^=R4K[^7Y6.AKQ7PK=W6E^#OB9>Z=.;6ZM=4NY89$16VE1D<,",<8Z=Z]>M-
M.6VT:#37FFD6.!8#+YC*[ +C.X'(/N#GWK"M/AUX8L;'4;*VL[I+;401=Q_V
MA<$2Y.23F3J>Y')&1T-)KXK=K?BO\BD]%?O?\_\ ,XS1_'.NVVI:6=0O6OX+
MKPP=5EB,,:$3*,_+M4'G'0Y]L=*ZWP+<ZQK.D6'B"\UO[3;W]J)'LOLT:K#(
M3_ ZX; Y!#;CGN.E7++P)X=T_4+*_MK.9;FQM_LMNS7DSA(N?DVLY!')X(/;
MT%3V'A#0M,L;JRL[(Q6ET'$D GD,8#_>"*6PF<_PXJFU=M>?YO\ 1K[A=OZZ
M?YFY7->*[V]AFT^SL=1DM'N&DW+:PK+<R!5R!&'5D SC<S8 '<$BKMEH,>FW
MEF+%I+>QM+;[.D N)'5E'W1L8[1C^]RQZ9P.9M2T'3M6N;2YO(':>T),,D<S
MQLN?O E2,J<#*G(/<5+78%YE+P3JMWK?@S2]1ORINYHLRD*%R02,X' Z=N*H
M>&XHY/%GC2-XT9'O(-RE00V;=,Y%=!I.D6.AZ>EAIT30VJ$E(S(S[<G) +$D
M#)Z=!6./ 6@">ZF5=35[M]]QMU>[ E.,?,!+@\<<]N*;>M_+_(%HK?UU.#TK
M6+K0]0UC1- BG?3)];-K9?8S$6A/D&258O-81\,. >!D\'I6EJEQK\V@Z2GB
M&VDAN(O$EJD+S&'S)8=X*LXB8H&Y(...,X%=U)X9T6318]'_ +/BCL(R&CBA
MS%Y; Y#*5(*MGG((-5[[P;HNI6EM;7<5Y)';2B:,_P!H7 ?S!C#LX?<S# P6
M)([4)VMY6_"PGK?SO^-_\SF+[Q#K,7BBU$&J/+:3:O\ V>\4-NAMXT*'J[*'
M,P(YVEE'0CK6;J?B'Q!H^GWT<NN7\]]I.J9N,6]O^]L2%<L0(^ $)&1@[L^V
M.W;P3H#7#3_8Y0YNA>#;=S +,/XU ;"D]\8W=\U?DT'2YM0NK^2SC:ZN[86L
M\AS\\0S\I[?Q'_(%):+^O+];_)C=F_Z\_P!']Z.8O-4U V:W5OK\BP:CJ)BM
M@L,<DJQ*&&V ",[F)4G+[@%YSQFL.S\2>*;VW\-Q_P!J+;M=ZI=:?<L]I&9F
M$?F;6."4#809"C&?;@]Y-X6T>?3M/L&M"EOIQ4V@BF>-H2HVC:ZL&Z<=>0><
MU23P%X=CNK>XCM;J-[>X:ZA"7]PJ)*Q)9@H?;SDYXQ@D=#35K^0:V\SF+K6_
M&<ES?6VDQ7E_=:1-';LR):1V]TVQ&<RAW$B$[CC9@#CKT'8^*M:FT'PG?:K#
M&C30Q!E5^5#$@9..PSD_2IKGPWI=WJG]I202+=%0CM%<21K*HZ"158+(/9@:
MT+FU@O+66UN84FMY4*21NN593P01Z4F]/Z_K_(.IQFL7OB'POIT]U)JT>HP7
M,EM!;23P(KP222!&.$"J4 8$9R<\$FL_7-9\2>'I];TZ'5A=F'1WU.VO+JV0
MO$4;#1L(PBD'L<<<YW5V%MX6T>UL);%;:26UD788[FXDG"KQ\J[V.U>!PN!P
M*B;P=HDFF7>GR07,D-V@CG:2]G:61!T0RE]^WD_+NQR>.30]G;^O^&''1J_]
M?TM#E#?>*X-0\+)+XC22VUMOWJK81K)$?LY<[6R1C<,C*Y!/4CBBW\2ZV=97
MPO+?L9SJDMG_ &HL,?F&)8!-]W;L\SY@OW<<9Q5OQ-X;GDU'PG9:?I-_<Z7I
MTSM-+'?!7B0QLBX=Y1(2"0<@Y '!SQ72_P#"+:-_9::<+,K DAF5EE<2B0]9
M/-!W[SD_-NSSUJFT]?-_GH2DTDGO9?J<)?>)/%-I=2:8FJ0EK/7+6P>[>T4O
M<13!6&<856 )!PO.1C;4OBC6?$F@6U[Y6OO=SZ9:QS%8+./]X2YR;C<NU5VX
M ",K'#''05UUUX*T*\M;:VFM[DQV\WVA"M[.CF7C$C,'#.PP/F8DBI-2\'Z'
MJ]Q=3WMF\CW<(@N MQ(BRH.FY58 D=FQD=C23M;^NW_!&SCS_:L'C#QM>VFM
M3I+;:?;R11S11R1#Y)& VX#8'.,,/O$G=5S2=<UCQ%)I.EIJDMC,^A0ZC/=P
MP1,\DCD  !U*A>"2 O<8(KH[GP?HEW)<2S6TWF7,"V\SK=2HSHN0 2&!S@D;
MNI!(S@TB^#=#2PL[.."YCCLT,=N\=].LL:'J@D#[]O3Y2<<#C@4=+?UU_P T
M_D'G_73_ "?WG&Z5XG\3:UJV@6<NH0V<=VM]#<M;VJEV>W;9YB%\@9X(&T@8
M/7/'6^!M6O-9\*PW-_*);I)IH'EVA?,\N5D#$   D*"<<5-+X.T26_L[W[-/
M%/91&&V,%W-$L2'J J.%Y[G&3@>@JUH?A_3O#EBUEI<4L5NTC2E)+B2;YFY)
M!=B1D\\=R3WH3T?]=0?]?=_PQREJ9[W1O'%_]JFM[W[5<0+-'C?%'"@"*N0<
M#J>G\9/O6#I%G=F[^',2:K<"272+AA.T<9>,&*+Y4^4+QV+!O?->A+H?V?5K
MV:#RFL=2&;VWD!Y?;MWKCU  (/H#GKFK#X#\/6]Q93PVUW'+91&&W9-0N!Y:
M$8('S^@ Y[ #L,):?A^":_6X/K\_QM_D<C8^+]?U+3M*TZ+[=-?3+>&:ZL$M
M1,WD3",$+,1&,YRV ?8#J.Z\,7&L7/AZV?7[5;;4P&6>-64C() /RD@9&#@$
MXS5.#P'X>MM/CL8;6Y2&*9IXF%]/YD;M]XI)OWKGN 0#DYZUOV]O%:P+#"I"
M+TRQ8GU))Y)]SS3NK!U,NW\/"V-J8]3O?]%D9H\B+_5MC,1_=_=X'/W_ /:K
MB=7=M0^/6E:;JJA]-@TYKFQBD^X\^3EL'@L!G'I7I]9VKZ#I>NQQIJ-HDQB;
M=%("4DB;U1U(93[@BDM&GV_RL#U37?\ SN9/C*XBT+1M2\2VMO"VK65A+Y+,
M.67Y20<<E00I_P#UUS]KXAUF+5K;2)=4EN#J6A-J"7)AB#VTH ^Z H4KSD!@
M3GN:[:UT/3[2UDMUBDF25#'(;J9[AW4Y^4O(68CD\$XJA;^"M M7F>&TF#RV
MILRYNYF9(22=B$OE!D_PXQQCH*36C7];/]6G\A]4_P"MU^EU\SSC2?%GB^^L
M? DBZY&9]>%Q%<^;:1E%V$D.H4 [\<==O3CK2'QKXG?P:]RFL%;VT\2_V69S
M;1'SXMX WKMQGG^';TKOK?X<^%[4::(+*YC&F,SV0%_<8A+')Q^\[US?C#P"
MEGX:AT[PKHEQ<^=JL5[=1F\W9VG+,3/)U/3CKWJ[J_S_ %7Z7(L^7SM^DO\
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M'104(('&,9Z<5!?^&=+U30!H=[%<3:>%"F,W<H9@.@9PVYA]2:2TE?\ KS_
M/LV,/4[W7)?B =&M]7%I82:3)<KY-LAD20.JYW/N!Z_W<8[=QBZ1XE\07D'@
MZ^?4U+:VLL$T#6R>4C+&[+( ,/G*<C=@@\ 5U*>!-!CO$NU34/M"6YM5D.JW
M181$<J#YG3O]<'J*C'P]\-I:V%LEO?1Q:>6:T$>IW*F$MUVD29'!(^A/K0M/
MZ]?T:^X'_7W+]3E;;Q+XGNO#OA2Y&JP)-J&K265VXLU)9=\@!7G"X"8Q@GD<
M\'/I%C!<V^FPP7MW]MN$3;)<&,1^:?7:.!^%8,/P]\-P6]G!%;7JQ6<YN;=!
MJ5SB.0]6'[SKU_,^ISU%-V::_K9?\$.O]=W^ECC_ (=/$/AKIV"H5(I5?MM(
M=@0?QK(NKF_TWP-X=^PZM>VU]/90V]G86D<&;B8H#EC)&^% Y)&, $\\5U,G
M@W0I+B68VLRK,Q>:".ZF2"5CU+PAA&Q/?*G-/U/PGI&K:C!J%S'=K=6\1ABD
MMKZ>W*(>2!Y;KUX_(>E&_P"'X#O^IS?]J^(= \0Z=I^IZJFHQ#1KBZGVVR1M
M)-&4R<CC'S8  'OFH-'U;Q9?M#=75I=MI%]I[R3/<FT5(9"FY/)\IRY0\C#Y
M/0Y'(KIK;P5H=KJ=MJ,<5X;NV5DBDDU"XDP&.6!#.0V2<G.<\>@J2#PAHMM;
MW%O!!<103J5,27DP2,'.?+7?B+.3]S;2EJG\_P!?\_P$M']WZ?U\RI\.?^2;
M^'?^O"+_ -!%=/5#1]'L= TN'3=.CDCM(1B.-YGEVCT!<DX]LX%7ZJ;YI-BB
MK*P4445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &NZQQL[D!
M5!))["N'N/'$NG^&XO$ES'-):ZC<116%O!;.^R-WPKN5!.Y@=V..R@$\GL[R
MW^UV-Q;YV^;&R9],C%>?-I]_J?PRTW2;6W$VJ:1<6B7-J'5&S!(I8#<0.57<
MN2 01S36_P!WYZ@]OO\ RT+=IXV^P^)_$":W?E=-MHK6:V46,B-"D@8DR  L
M,?*"S8 ]%KIM1\4:/I,R1WMYY98*2ZQ.Z1AN%+LH*H#V+$ UPVKZ7XCO9O&[
M1^&[O.K6$5M:D7-OAG564DYD! ^?/(Z ]\ N7PE<W-Y/_:^AZK>6>IP0B2*'
M5C"MNRQK&R3(LRJZ_+G<N\\D8Z4+5+^NX/=_UV/1[R>2"PGG@B,\B1LZ1K_&
M0,@?C6./$0A/G7BRPV2V1NFG>RFC!QG=G</W> /NM\QW<=.=NWB$%M%$ %"(
M% !) P,=3S5;5]-AUG1KW3+@D0W<#PN1U 8$?UJ972=AQUM<YOPUKWB#Q981
MZY:1Z?8Z5,6-M;W$3R33("0&9PZB/)'3:_%:3^*K/3X;>/63]FU&2(S26D"2
M7!C4'!8[%)V _P 9 '?BL3P7:^(?">A6WAN]T:2]6TW)!J%K/$(F3)*[U=@Z
MGL<*WXTFKZ%K$'C,^([>S-_]HT=]/E@@D13')NW*P\QE!4\@\YZ<>E2LMMO^
M!^KT%&[^+?\ X/\ EJ;][XQT&PGTR&>_^;5!FR,4,DBS\9^5E4C/(XSDYIL7
MC/09]'BU2&]>6VEF-O&([>5I6E&<H(@N_<,'(VY &>E<#;>#O$.FP_#B$:;-
M=?V*9'OG2>+]UO &T;G&[&>V>!Q4OAWP;?GP=J=AKFA7L4S:M-?VWV:\B2XC
MW<H\;*^T..F"P'/<4-6O_75?I^0D]O/_ "?_  /O.Y'C+0S?V%C]IG6ZOX7F
MMHVLYE,BJ"6ZIPPP<J<'IQR*YSQ!\10FDZ%JWAJ6VN[*_P!633YC<6\BD D@
M[02I!&#U!JK-X?\ %(UCP7K%W VI7&FK<Q7FV2-) )%PC-DA20,;MI/.< US
M,/@WQ7!X#T/3#X?F:\L?$'V^:-;F#!B#%LJ3( <[L8X/!Z4TES*_?_V[_(?3
MY?H_UL>D67CK3KSQ5J^B^7<1#3(T,MQ);R+&"0S-N;&U0% P6(W9.,U;L?&6
MA:C/<6]K>2//!!]I:)K:5'>+^^BLH,BGL4R#VKG+;0M>T_Q3XVOH=,@N(]6M
MXGLS-(AC9TB*^6ZYSUQVQCO6-X<\*^)-/\6VFLWFD$1_\(\;25(9H0$G#;MB
MH&"JO8!?E'?'-3T^7XV?^5A]?G^&G^;.VTOQ]X9UF6PCL=2,AO\ S/LI:WE0
M2E/O %E R/3K5&R\;C7Y]<LM'CGAN=.F\E9+C39I$=EQN! VC.3@*6!_BQBN
M#\.^#O%.G6W@*&XT&=3H][<R7A%Q 0B2-\I&).>#DXYX/M7>>"]$U/1-;\4B
M]M0MO?:D]Y;SK(I5U8#C&=P(QSD#VS5-*[^?Z?YO[A=/N_7_ "7WFY:R:M/=
M7$-SY<430*4:*$AH9".5W,2).<G(4 < YJ/0M5FO)K_3;W9_:&G2+'*R+M65
M64,D@';([=B#6T2 ,G@5R&CM*^N^(?$-O9S75O<-!;6R0% TRQ AI 791C<[
M#.>0G&>,I:O^OZ\A=/Z_KS.OK-U8:T[6\>CS64&2QFFNX&F"@#@!5=#DGOGM
M6E45Q*\-M)+'!)<.BEEBC*AG/H-Q R?<@>]2QG$>'-7\8:[I"ZB;O1EB:>XM
MW1+"0-'Y;.BODSD,-RJ2N!P3SWJQX&\:0:SH6C1:E>[]7O8'DR(&6.0JQW!6
M V9 ZJ#D#K1X'MM7TKP?=6VH:)=07<<]Q,D'G0,9A)([@*5D(!^8#YBO/MS7
M-Z7H/B.#2O!%E+H%Y$VF23"\D%Q;D1AT= PQ+EOO@\<X![\576WI_7W@[?BS
MT&T\3Z/?:G_9UO=EKDJ60-$ZK*!U,;D!9 .^TG'>H?%/B(>';&W:.W^U7M[<
M):6EONVB25NF3SA0 23@\"N;\)>$?[/FTQ-1T>_^VZ2NR*^FU62:W8;2I:*,
MRG:2.JE% [9P*V_&?A^\UJVTVZTUXAJ.EWJ7ENDS$)*0""C$ XR"><<&AI*W
M]:!W)UD\46DML;HZ9>PRSJDHMH)(F@0]3R[^9V&?EQUQVJ1/%NAOJ4=@+W$T
MCM'&YB<12.N<HLI78S#!^4,3P>*=9:CJVH8CET.XTS!_>274T+C'^QY;L2?]
M[;USSTKD;?PQJ[^'-+\+7-A($TZ]CN#J?FQF.58Y?,&U=V_>W0@J ,GD]Q;Z
M_P!?\-OYAT_K^M=CHXO'OA>=4>'5HY(7G-L)TC=HA)_=,@&U2>V2,]LT^3QS
MX;@AEEN=32V$,ZVSI<Q/"XD894;'4,<CD$#!'-<,VC^)6\,W=H/#-\+B7Q$-
M25?M-K_J?.$O7S<9PN,>I';FH/%]MJUO-XFOI]&N(;6]OM,:VEDFAPYCE12"
M%<L,DY&1TZXZ4)7M_7\O^;7R!];?UO\ Y)GHR>+M#>&^E-Z8A8E1<)/#)$Z;
MN%.QE#$,>A (/;-0-X[\,QV7VN?5$MX_M(M2MS$\,BRG'R&-U# X(/(Z<]*Y
MW6-(\0:G>ZCKEMHX@F>WM[2*TG>!Y65)B[R#+-$' /R9)Y&3BLF^\/\ B)(=
M6A@T#4+@7>LVFH1N]Y [>7&(BX8M*#NRA&!QTP<415]_ZU_R!^7]?TSM[GQU
MX>L["[O9[NX2"SF$%P?L4Y:)B,C<H3< 1C#8P<C!YK3CUJREU&&P4W'VF:W^
MTJK6LJCR^G+%<*?]DD'VKE]-T:]U#Q+XO&JZ-/;Z9JT<4<<DLD+!PL91N$=B
M,YR,CIZ'BK?@&#4/[)DN-5*O=(WV%9 <^9% 60/]6.YOQ%"V_K^M_P  ?]?@
M_P K_,VM7U_3=#6,W\TBM(&*1PP23.P498A$4M@#J<8'>J3^-_#BS00KJD<T
M\]M]KBAMT>:1XO[P5 2?IC)YXX-5/%-CJMYK&G_9+-Y;+R9HYY;>2..9&8#:
M-[$,L9P<[#NR%[5S'A[2O$6F7_AF2X\-7VS2]&ELYV6XMCF0[" O[WD?)C)Q
MR1[D);?UY_Y+[QOR_K8[J7Q1I"Z3:ZDEV9+>\&;7R8))7EXS\L:@N<#D@#C!
MSBLWX?ZU?:]X>GN[^ZCN95OKB%98XO*5D1RJX7MP.Y)]ZY?PUH7B31+7PY?R
MZ'-)+I\5U:7-B+B'S-LL@<2QG?L/0 @L#U_'I_ >FZKI6F:A#JEE%:F74;BX
MA"3B0E))"PS@8'7U/X=*JRU_KJOT)?3^NY5U'QG+-J/B/1].2:WO-,LQ-'<3
M6,KQE\.QR>%QA1@DC))QG%7/"?BZSU;2=+AN;W?JDNG1W<I:%D60;1O96VA&
MP3SM/'M6;J.EZS!KWBRYMM*DO(-3L(8H&BFC4EU1U*X9ASE@><#&><\'$_X1
MSQ#?1^';%]'O+-+?09]-N;DSP$0R2(J@X60D@%,\#N/?$K;[O_;O^ 4]_P"O
M[O\ P3T#3?$NDZM>R6=G=,UPB>9L>%X]Z9QO3<!O7_:7(]Z@\3>(CH4=C!;V
M_P!IU#4;D6UI"6VJ6()+,><*H!)XK&\*>'1;7MM>WNB:A:ZE:P&W-Q=ZL]W&
MP.,B$&5L*2 ?F53TXJ]XPT&^U.71]4THPMJ&DW7VB.*9BJ3*5*NF1G!(/!QU
M%-I)HE7U+,<GB:SN;-;UM-O8)IML\EM!)"8$VL<X9WW?, ,Y7KTIT'C'0+BZ
M^SIJ 5BC21O+$\<<JJ,LT<C +( .25)Q3?M&K:YI\]I)I%SI'FQ-&\EU+$Y&
M5(R@B=L\GJ2OT-<W;Z%J\UAX9L+G2983X=9)6G66)ENC'$R!8OGS\Q(SO"8I
M?U_7I^-Q_P!?UZ_@=)I_C7P]JLUI'8ZB)OMC.EO(L,GER,F=RARNW=P3C.2.
M1Q3IO&&BV]O=7$D]QY%MN\R5;.9D(7[Q4A"' [E<XP<]#7"Z9HOB.WTGPG;2
M^&[Q9-/U>:[N?](MB%C8R8(_>\_ZT<#^Z?;.HWAK6#=7UEIT5[8Z5>VEPMS;
MW=S'+ )9%.TP8)=?F)R#A<=!FB6BT\_T_P""AJU]=O\ @V_X)TTGB;3[J:+3
M[&\*7]Y9-=V;26DAC9,9#9("G&1E=P//;-<QI/Q!E@\,^%)]4BN+F]UAV622
MWLY'50-Y.!&IYX  &3C)Z FH;/3?$L=_X9O6\/,J:7I<UI<1->1>8SE4 V8)
M4YV<99>O.WO#I'A_Q!;>&O!<<FC2)=:->L;F!KB+)4I(H<,'((RXSSG@\'O5
MDI>5_P!7^EB+OE5]_P#@+];G9Q^,M DU%K$:AME'F8=XG2)C'_K LA4(Q7G(
M!)&#GH:98>-O#NJ2VB66H^?]K9UMW6&39(R9W*'V[=WRDXSDCD9%<C;Z/XCB
MUC1]2N="N&DL+VZ>6&UN($AV2(X4Q)O4')(R7P^2>Q-5M,T7Q';Z5X3MI?#=
MXLFGZO-=W/\ I%L0L;&3!'[WG_6C@?W3[944G8IZ7.U\+>+(/%!U+R;>YA%I
M=/ /.MI(\A>,Y8 $Y#?*#D#&0*T+W7].T^]^R7$LOG>7YK".WDD$:<_,Y52$
M!P<;B,X.,UD^#--U'2?[9MKVT\I)=3N+F&42*PE21MPP <CT.<<^O6JGBS2=
M4FU'^T- M[Z#5PB11W<-Q&('4$G;/&YY09/*J6^;BDNGR_) ^OS(+'QG_9WB
M/Q+:>(-10V]E=01VYBM&VQ)(FX;]NX@9(&]B!D=NE=!>>+-$L-373[F\*3ET
MC)$,C1H[_<5Y I1"W& Q!.:X76-&\27=KX\BB\/7;2:QY2VC"XMPK[8PA8YE
MRHR,\\X([\4_6-%\2ZI]J<Z)<)_I=E=01Q7%O&KK&8RXDP^7E&&'S$I@+@Y'
M+BDTK^0/K;S+&K>)?$5I8^/7BO[82Z,8WM&^R\*ACWD$;N6P<;B2.,X[5Z':
M2-+902.<LT:LQ]217F>JZ3XBNX/'T47AN\)UE42S)N+8!L1B,D_O>.F?I[\5
MZ-IIF.DVOG6SV\PA4-#*5)0@="5)'Y$TE\'W?DP?Q:>?Z?\ !*-EXLT74=4_
MLVUO"]R0Y0&&14EV'#;'*A7P>NTG%8&L^,BWB?P]8Z1?@P7%^UM=*;1RLH",
M3LF8;#@K@A<G)ZCOEZ9H'B%M9T2ZO=+GMV@6\@N3%/"(8?,'RM%&K#Y,]R-_
MJ.]1PZ%XH33?">E#1$#Z%>+YMTUW&L4T8C= Z8R^>02"H.?7DAKI?^OZ_K8'
MI<U_$OC(PZOHEIH^H+B758[2Z'V1F60$G<J2D;,C:0P&2,]L5-J7C[2M-TBX
MU*RO)]50ZBEG^YMS(D+L4!4%$Y !SU)). 2< 8(T'Q1%H6@:*FB)++HVJ1S_
M &M[N-(;B)2YW#JX8[AD%>O3-(^@^(;O2-=0Z%<0RS:_#J<$<EQ 3+$KQD@%
M9" V$/#8'(YZX(I;?UO'_@_<$M[K^OB_X'WG;6OB31[K4+X1ZN=UG;)+<VTJ
M>6+93D[GW*&5B.JL>,#@=VIXU\/,MTTFHBW%K%YTOVJ)X#Y><;P)%&Y<\!ER
M#ZUR>L^'==U_6_$\?]F364&I:7#;0W3S1-'YD;,Q!"N7VG<!G;Z^V;>LZ7K&
MMW*ZI_85S;S6.G7-I';&: O<R2A5&TA]H08)RQ4^U)_#=?UO^ME\QK5V_KI_
MP?N.FTWQ;H>K7$<%E>[WEMOM41:%T62+C+*S* V,C.#D9YQ55?%NG:Q:WMOH
MFH 7Z6K3PM/:R!&7D"10P42)GNI(Z<URMAI7B**\\*'_ (1Z=/[.T:6SG>::
M QK*RH%R%D)*YCYP#PP]\)IFC>(+34;;49M"O78:+-920K<VX"2[E*K&@<(B
M<'&.V-U.:6J7G^MOR7WBB]K^7Z7_ %+.F^*M:FC\"7-Q=HT&JVTDE[&EMEW9
M82^1CMG'RJN>.O:NFM?&FAWFD?VK;SW4EG]H%KO%A/N,F=NT+LW'GC., \9S
M7'Z1I/B&UC\ Q3>';Q?['1X[U_M%N0FZ,Q@C$N6'\7';WXK9L=)N;3XA7MI&
M%.D.5U; ;E+A@8RN/0D%_J*J5N:RVN_S_P MB=;7\E^OZV-+Q_J6I:/X'U34
MM*N8[>[MH3(KR0^9P.H ) S[G(]C5NR\4Z1=-/";SRY[6 3SB>)X<)C[XW@!
ME_VER/>F^,M(N=>\':MI5F8Q<75NT<?F'"[NV37+ZSX9U?Q9YES)9OI3PZ9)
M9Q1SS*7ED9D8DF)CM3]WC.<_,3@8YA;/^NG^9;Z?UU1V.E^(-,UF>X@LIW,]
MO@RQ2PO"Z@]&VN 2IP<,.#V-0ZOXKT/0KR&SU'4(X;J9&DC@"L\C*H))"J">
MBGZXQUK,\+Z'#;:A)JDFBZC87S0_9Y)+_4WNV=000$)E?Y,YZ[3[<TGB.SU*
MY\:^%[JUTJ>XL[&65[BX22(*F]"@X9PQQG)P#QTR>*=M4OZZ_P# $MFW_6W_
M  31?QAH*36T37__ !\%%201.8PS@%%9]NU&8$85B"<CBN=;Q1/JGBK4[2#5
M;S2K;26C+>;I;&&9<;I/,=T&WCA<,N>HW U#<>#C/K>IP:EI.H:C9WMW]JAG
MBU62*W0X4@2P^:O*LO!5&SQ4-_H>NZO>>+(!I%W9QW\EO-:SR7,2K)Y&WY28
MY"Z;]O! X!R<'BDNC_KI^6OJ'E_77^O(ZB7QWX:M["YO;K4UM8K9U29;F&2&
M12P)4>6ZACD D8'..*@?XC^$HYY+=M9C^T1[R\ BD,@"#+'8%W8QR#CD<C-<
MQK7A>YN?">L'3/"^JIJVHPQVSK>ZJMQ(P5MP.Z2=E"#GOG)Z5NW]KJMUX[\,
M:@FBW0L[2VF6XE:6#]RTJJ "/,R<;3G:".1C--+^ODW_ %Z@]OZ[K_@_<;2^
M*]$?48+%;W]].=D3>4_EN^,[!)C9OQ_#G=[5SWC#QD;*;3K71]0"3G5+>UN?
M]$9T=6D"M&LI&P.!G(Y8#L.M5-.\&&+4GMM3TK4+P1:@]];7PU606H)E,BDP
M^;PZY(X0@XZ\FJ5QX?\ $\?ARWT"'1EN)+'5TO([QKJ-(IXQ.9<GDNK<X/R^
MI!/2B-KJ_E^:!]?G^3_X!Z-JNHQ:1I5UJ$Z2O%;QF1EAC+L0!V YK$TSQOIU
MUX;TW5+L7$,MY")!;I9S-(3@%BD84NRC(^8 C'.:VM5MI;W1+VUC"B:>V>-0
M3QN*D=?J:XC1M(UW2&\/ZK+I$\[V6D?V;/8Q3Q>:K90^8I9PA!*D$;LXP?8)
M=;_UO_P >R_KM_P3NM/U&SU:PBOK"XCN+:4921#D'_/I7'V/C/\ L[Q'XEM/
M$&HH;>RNH([<Q6C;8DD3<-^W<0,D#>Q R.W2MKPAHDVAZ3<1W&U9;J]GO&C4
MY$7F.6"9[X&/QS7&:UHWB*[M_'L5OX>O&;6#$MFWVBW <*@0L?WN0.,\\X([
M\4?:_KR_X/W!NOG_ )_\ [R_\3Z/I=XEK>79CD9E4L(G:.,M]T.X!5"<\;B,
M]JKQ^-O#DNIOIT6JQ274<WV>18U9@DF&.UF VKPK=3VQUKDV\(S7FHZ@-6T/
M5+RTU4QS[8]6:&.!A&BF.:-)@K8*9W('_05=L=!U6[U#QO!/83Z?!JR+':W3
MR1L"%A\K.$<L.>1D#CT/%#T_$%9_@;W_  F?AYX[LMJ@MUMX?.>2:)XAY><>
M8A=0'7)'S+D=*CC\9^'X$L[5M8:ZN9K,74:B%GGFBP#O\M$SDCG 4=\#BN:M
MO#<\>DW%P?#.J?VU#826:-/K!N5DWKM(A\R8@*2 3N"$ =":CT6P\0V>J>&;
MB?PS?K'IFB264^+BU.9<)@+^]Y!\L\_[0]\-]?ZZ/_)?>+7^OE_P3T33]0M=
M5T^"_L9EFM9T#Q2*" P/UY%9S>+-%365TIKPBZ:7R!^YD\LRXSY?F;=F_'.W
M=GVJA\.[#4-*\%65AJEC)97<#2*T;R(^07+ @HS#&#]>*YZ]T3Q#<:W#<OI$
MI6UUU;M1;SPQPO!@C>%W L^""Q?G^[D<4/XK=/\ A@^RW_77_+\3N+/7M.U"
MZ:WMI97969 Q@D6-ROWMKE0K8Z':3SQ4NIZM9:/;+/>RLBNXC14C:1Y&/151
M068\'@ ]*YC1M(U73?%"-907UGH\BR27=M=7,<T/F-R/(P2ZG=G(.U<'@9K2
M\6V^IW":8=.LS<+'>![CRO*$Z)M89B,F%!R0"<@[2<<TNB'U9K:5JMEK6GI?
M:?.)K=R0&VE2"#@@JP!!!!!! (K.OM:N[:3442SF)MO+*;;2:0,C8W."HPY&
M3^[7YOE[9%5/ >F7VCZ'<V5_:R0.M_<2(9)A+YB/(S*VX$D\'^+!S744WO\
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MQ50%!9BQX]2>2?<TZBB@"M?6,6H6QMYGN%0D',%Q)"W!S]Y"#CVSS4L$$5M
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MCBGGPOX?:QBL3H6F&SB<R1VYM(_+1CU8+C /O6M10 BJ%4*H 4#  ' I:**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP?,Q&2H&5Y /)Q0K=?Z^'_-_<#_K[W^EOO/2Z*09P,@ ]\4M( HHHH ****
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M04(R&YZ<<\U%I&L:?KVG)J&EW27-H[,JRH#ABK%3C/49!YZ&G9[!YEZBBBD
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MA/6[_KX?\G]X/R_KXO\ -?<<UXJU[6]'N+EK+6)IAIYM4:*.WC96WL YN6*
M D'($9!YSC!%5]8\0^);5?&MRNL(BZ%)#);10VB .I0.4<MN)!!P2,'(R".E
M=?=^"/#U\]RT]BY^U(B3*ES*BOLQM)56 W# PV-WO4,OP^\.3QZA'+;WLB:B
M5-V&U.Y/G8Z;OWGX?3CI26G]>G]?,-#+\.Q74OQ/\23R:G=O$MM:$6[>64PR
MN0/N;@%.<8(ZG.:T_%NHZGIEQ8W$7V]-)0.UY+I\"32H1C;N1@Q,>-V=@W=.
M0,UIV?AO2K#4!?V]NXNO)2 RO/(Y94!"[MS'+ $C<?FY/-2ZEHMEJRXNQ/\
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M@?,5SQUH3M:_]:+_ "'+6]OZW_S,[X@:EJ6C^"[_ %'2KJ.WN;=0^]X1)D9
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MM/:>5_U_R-R'Q_>(_@RR@L;S4WUFW,\EQLAB>55CR<(7"J<D$\X X&37HA(
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M?\()X/\ ^A4T/_P70_\ Q-=!10!S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\
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M?PK=WSLEM"#N:0KG=@#TP<D\9XK2H ***BDNK>+S/,GB3RUWON<#8OJ?0<4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0444UY$B0O(ZHHZLQP!0 ZBHA<(UTUN%DWJ@<DQL$P21PV-I/'0'(XSU%2T
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MC7"F3?-IET'!E8K\K18PI.!U/( SWKHM9L$U'2YH'LK>].TE;:Z<K#(V. ^
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MQW-H($6,%(G<.I W!B4Y^;'/05UTO@S1)M4_M)HKM;OR#;^9'?W"8C/50%<
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M\EMP/8UO0> /#EJNFK#;7:KICE[-?[0N"(B>N 9,$'D8.1@D=#4D/@;P_;-
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M]/\ (\@TR"\/A7P?(^J7$\LWB5R&N%1O+.Z<$C:JDD\GYB>3Z<5NCQ7K=O\
M:-&\Z[O[L:W)I\=U#';K/Y8A\T$!]D6\=,D8]B>*ZAO /APFW(LYX_LUPUS"
M(KV= DA))8!7 ZEL#H-QQC)IZ>!O#Z17T?V2=A>S"XG,E[.[&4='4ER4;_:7
M!X'H*=^_]?#_ ),'Y?UK+_-#O"%QK\VFW">(;:2&XBN&2%YC#YDL/!5G$3%
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MN.JP:?;RV=PEM$)(W8N"6RI5B2G/ '/ '6LN'Q/JJ^#X-6;4KF6\TNQGEU.
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MIIEQ=C4+HQ.T31 X",VT;V7DXSG@8!YS@56\/:-)9^,]<=)E?3(I/,MX@/\
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M@EU*?R(=JY"GU;G@9(&?5A61X#U*WN-+OPEGIUK#:S[#<::^;.<!%^>(\
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M9H6MAO0]?HKP?5[OP^FE>/[@:A;27EMJD<EE))>;Y(WVIS&2Q(.X...P(Z#
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M_P##?FK;VY\Q9Y59LLYP!+*.-S!0<TND7.@6-U\-/L=S:6TSP.)8EE\M&D:
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MDG(XZ]BSO9_UK8;VO_6S?Z'JE%9MCJ-U=ZOJ-LUI"EI:LB)<+.6:1RH8@IM
M7 (YW'K6'=^-)[+Q':Z?<:4(K6ZO?L,4LESMF=]I.]8BO,?&-P;\*79=P>AU
MU%<;>^/)+.6YG71I+C38+X:<98[A5F:<D*,1N%79N8#<7'TQS59/B)<C^U9[
MGPY/:66E3&*\DFNXM\?[L.IV@E3DE5X;C<#GK@6NO]?UJOO Z/6=)O[V\L[W
M3M22TN+7> D]OY\+[L DJ&4[@!@$,.IZYJWI]C):F6:YG6>[GVF61(_+4X&
M%7)('7J2>>M<?:?%/2G.J)=O8;K&%+@26.H)<PR([; #)A0K!B 0>!D')%+8
M_$ZQNFO;8Q6L]] \*1)IUZMU%.96VH!(%7!!!W CCKS379 ^[.\HK@/"7VL_
M$OQ4;ZV%M<-:V;/&ETUPF3YG*,P! ]MHYSQW.C?>,+VTO?$MJFDP2/HUK'=H
M3>%1/&P8G/[L[& 0\?,#QR*3T5_*XTFW9?U<ZZBN,M_&VH:AJ,.GZ?X?WW,V
MEQZDC7%ZL<;*VWY055FZDC)4<CI@YIUGXY?6HK6+0],6XOY;5KF6WN;GR5A"
MN8RI8*^6W!@.,?*>13::_KU_R9*::O\ UT_S1V-%</:_$1]3O=*M-.T.=Y=1
MCG(:XG2)(I820\;8W-PV 2%/4$9YQO\ AW64\4>'8[YH&MS(9(98A(24=&*,
M XP3R#@C'X4K.UQFS17EW@K7KCP]X4L?.L/,TJ35;BU:[-T6EC9[EU0E"IW+
MD@%MV>^#UK3'Q0L)M;MK"V_L^9+NX>T@VZBIG64;@#)"%)1&*\-DGD949IOR
M_K1/]0>F_P#7]6.^K,O=-N;^^C\^YA.G1LDHMU@/F-(IR"S[L%<X. H.0.>U
M<1X;\9^(_P"Q=+O-3TRPEMM0U*2U:Z74'#0EI7490PXV@@*/FY^7.,\;%AXS
MU"_;4;:/2K+[?9:BEB81J#%7!&2^[RN,#/&/X3SQ1;7^O+_-?F#_ *_'_)G9
M45PD/Q0TN;7[.P5K%X+NY:TC:*_1[A) 2 7A RJ$KPVXGD9 S44'Q4T^YU2W
MM;:*TNTO/,6U2TU".2X+JI($D1P(PV#@ECVSBD!Z!17%:+X]FU5M EFT?[+9
MZV)%@D-R'D61 S89 N-I53@[LYX([U-XQUC6M.UGPW::7#:R1WMZ8Y?.N&B+
M8C9@N0C8'&<\] ,<Y#L[I=P[G7T5Y;H.M2^%CX@<6+7%A_PD?V>6:6[)DC\P
M1(I7<&+X)&<D<=,UKWWQ/TNRUL6>^QD@%Z+&3%^GVE9"VW<(,9* \$Y!ZG&.
M:$KVMU_X'^8/2_D=W17)?$K,7@:_NTN[NTDM0LJ2VUU) 5^8 Y*,,C!/!XKG
M++Q +'Q3-_PB]Y?^(=&33VEN8DNGO1'/N4(J2L6()!.5W' &<"DM?Z\K@]/Z
M\['J%%<%<?$>:ST77+R714GN='E2.>*RODEB(=00PD8*>,X(VY![&FMXD\52
M>/M.TV31;6VLWMYYA&=0+/,BF,;^$P" W"$\G.6& 2+7^O*X?U^GZG?T5P5K
MX_TZV\.P7OV"RTJ:\OKB!+>[NX[>(2(S;VDD (&2#G 8DGOUI]C\2K34['3I
M;:&T2:[NI;5C<7H2!7C(W!90I#D@@K@#</2G8'H=U15&XO9[?1)+U[!Y)T@,
MC6D<BDDXR5#$A?QZ5R6F^-7DC\-V.E^&Q&NK6#7-LOVA(X(0J@[. 3@97D+W
MX!YPOZ_/_(/Z_K[SNZYW1_#M_IOBK6M8GU*WGAU/9_HZ6AC:+8-J_/YAS\O7
MY1D\\=*L^'=>;Q%X=34HK40SL9(V@>3*K(C%"N_'(W*><=.W:N;/Q!OH;+3[
MF[T>S@\_53I=RAU!BUNX?:&_U7S XSVZKZG#2]ZW7_/^D#V_KI?_ ()WM%<7
M>^-=3LM2L[3_ (1Y9EOKZ6SM9H[T;6*!N7#("I)4\ ,, \G@&C?^+[^*+Q&\
M?AR*PUK3M)CNFDN)T;<I#G;N0$D*0V <9/89S4MV5QI7?*>A45PVF^)+M;KP
MW8ZGH2S7]UI\EQ#=QW"R<J@RJE@K;V!7.0!\W4XIVD^/Y]171;B?13:V>JW4
MMFCM=!Y(Y$WXRH7!4^6>=W![$<U3CK;^M[?H2G=7_K:YV]%<6GCV0S6LO]BR
MR:?>WSV%K+%<)YK2H6!+H^U57Y&P=Y/'09K5\2^))/#SZ6B:9+>?;[M+1665
M46-FZ;LG/KT!Z=N*78;T-^BN$O\ XAW6E"YM[SP^[:A;7<%O-%;W:O&%F.(Y
M [!203D8VYR.<#FK2>)W3Q/;66L^'5L;E;*YN5NVGCE"1HRA@A W8(VL<A>W
M!QP>?];7#R.QHKC8O'-P/[+N+G1&2PU@?\2^2*Y#R.Y0NJ2(0H0L <89AZD5
M<\)>*+[Q1;)>OHC65BZR!97N5=MZ2%"I4#T&<@D=1Z$NS"YTU%<#)XNU+3/%
MGBE]2AM_['TJT@D BN&,@W!R,*4 +,< _,,8'6MJR\377_"0P:+J^F)93W<#
MSVCPW'G)(JXW*WRJ5< @XY'HQI+6W]=_\@>G]>G^9TE4KS2[>]N+:Y8O'<VS
M9BFB.& /WE/JIP,@^@/4 CFM0U/6)?B5;Z&D5N=+DTR263%T\<A!=5+?*GWA
MT !'4G<.E87@+Q!-I'A[P_8SV.ZROKVZMDNFN=T@D$DKC*D'*D*1N+9SV[TU
MKK_6[7Z ]/Z\KGI]%<+IWQ.TS4M?L=/B:QDAU!WCMW@OTEF5E!/[V$#,8.#@
MY/;(%;'BCQ)=Z @:VTQ+A%@DN)9[FY^SP1JF/E\S:PWG/"G&<'D8I=+CMK8U
MK'3(+&6XF0O)<7+[I9I3EVQT'L .@' _$U<KSCQ)J=]X@G\'K;:99W.E:KF9
M[:]NF02Y@=MDBB-QM (/?+ <#&:MQ>+(-!T8W%CH^?#%A<&SDN!=LTL95]C,
ML94[HPW&=^<#A< 4^5[/T_&WYDWZKU_4[RBN)C\?3F;6))M!EM]/TB9X[RXD
MNH]R*(O,#!!G.<@8SQN'N!G2?%NUBAU/996M]/9V9OD33=2CN%:(, =[8&QE
MR"5^;CH6I#/1Z*Y$^+M4.J/IJ:%"+I[$7]L'OL*T>0&#D(2C D= X.1R*S[G
MXHZ?'I6GW40L8Y[NR%\8-0U!+7"'(VJ2#O<D' P!QR10]-_ZW_R8+7;^MO\
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M_P!.7[$;FS5)"]C>BZA=&S@APJ\@C!!''O26NWJ#TW.JHHHH **** "BBB@
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M>G^7Z@]?Z]?\S@M4\ ZIJ$_B+R]=LH+?6K=+9H_[-9C#&@(7!\X9."<G'7'
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M5)=<=.:72_\ 77_+\07]?A_G^![A6;>ZU;VEZ;!$>XOS:R726T94,RH0.K$
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M#K;^OZL<_%XAO;W6I[73])%Q96EU]DNK@W(1XWV*Q94(PRC< ?F!ST!KH:\
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M16_A>:\N-0TV5Y]8GMS<W$)18 )74L5\W,F2JA47!&<9/6JM_7W?YAZ_UO\
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MI5AI^[3X+\I>F4RJ&<*Z,N%VMP^.O12>I [>^DN(;"XEM8XI+A(V:-)7**S
M< D D#\#1+W5=@M79%BBO.[7QWJ\.B:!X@U."Q_LS5!LDAMXW\V!RK,K;BQ#
M [<$;01GJ:-/\<:_>W"^3I)F@N;)[B)Y-/NK6.VD50P225U*R!AG#*!R.G.:
M'I>_0#T2BO.H/&/B0^%--UZ\BTRWL[](7,\5M-.+,%6+-(@8$KP@!!&W<<Y
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MM::KIU_*\5G?VMS(BAV2&97*J20"0#P"0?R-(=6TX:@=/.H6OVT ,;;SE\P
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MT7#^OU)=5\+0ZO9/97.HW_V.8!;B .A6<<D@DH2N2>=I4\#&*W54*H51@ 8
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M5PI#;@0!QGFNNHHO_7W?Y(/Z_K[V5[*U-I;B-[F:YDZO--MW.<8R0H"CIT
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M%E(#%21C<.H_.EHHZ6#K<XJ3X<03:5=Z;+XCUM[>[NQ>2Y^S9,N[<2#Y/ +
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M. FX 8<@G@YXZ\^MT4[_ *?G<+?K^)P4QV>)=7U#4--OKO3M7L((+0)82R$
M!]\;IMW1Y+ _. .>3Q7/^&O#26/BO2;+6-&DN730#:WD[Z>\D+R[E8(TFTJQ
M"#;G)'&/:O7:*2T_KU_S!Z_UZ?Y'B,=G'!X-O+2V\.ZE$6\3+<QPIHLZ_P"C
MB8,&"B/[HC!&.W3OBIO%L9O)/', T+5;EKPVAL-NCW#J\D:X9E;R\ CGG(]L
MU[1133M;^OY?_D0_K\6_U/([]+>;7/&-Y;Z#J6V^T*.&)QHTZF:8APP_U>2W
MS1YSZ?[)Q!<RW/EV\2Z?=RR7OAV&RNTN["[<P<L-P6.)VSG=E6"!L*0W7'L=
M8MSX=,NKR:E::OJ5A+,%$\<#1M'+MX&1(C;>.,KM/-)ZZ?UU_P P6FJ_K;_(
MH6>EH/AK_9?A^6-'_L]X+>40^1^]VE2Q3 *-NR2",@YSS7,R:='J47AM?[&O
M(5T6VDCU))M/DPT7DE#"HVXF#-@X3<.,^F?2;6VBL[=((00BYZDDDDY))/))
M.234U.3NV^__  ?\W^ HJR2[?\#_ ".+^%VG167@72P^F/97T<1BF$]HT,H^
M<M@[@"1SGTYJK=P:I8^*"NC?:IH=0NV>YM;NP;RX#MVF>.? "] =I+$]@*[Z
MBE+5W&M$>5>'O#5U-!IZW%YX@CUS2[:6!4GM8XK9&="I82K"OF(3@CYV.<$\
MYJ"ST81:.MY<GQ/)JFFZ7+9_9)-/41KO3:54Q0+YPW 8VLV.IQS7KE%$O>3\
M_P#@_P"8UHTSR?P7=7&GZ9_9?B'1=2NHI],C\NX;2;A@J*FUK:1-AP05)'&'
MSGJ1G/TBS"Z5\.DN= U$76G73K<F32)LP)M<#)V<+N9#Z<9[''M%%4Y7ES?U
MU_S)M[O+_6R7Z'CD<UQ!92W*Z=J22Q>*);RU@N+"X1)496()41E\8W'*HQ#8
M)&.:[#X?6=G;Q:M<)%'%J%[>-<W,0LI+=HPWW5_>HCNH^;#%0"2V .E;^KZ(
MFK/;3+?7EC=6S%H;BU=0RY&""KJR,"/535BPT\62LSW$UU<. )+B<KO?'3A0
M% Z\  <GCFE'1?UY?Y#EJ_Z\_P#,\ZGTG5I]/\56,.GW6]]=2]*M&0MQ;@Q,
MRHQX8D*W ],'&:Z#2+8ZAX]G\06=M=6MB^G+;2_:+9[=IY0^0=C@,=JY&XC^
M+@GFNQHH3M_7E;\@>O\ 7G<\PN&L+#XA^+XCI$UT;W3K93':61E\UV\T$.5!
M"[N/F; XY-4(_"E_!"ND^(+O6UMKS2K:S9].M4N58JI#QNQAD9,$Y#9 YSG(
MKT*R\,QV7BF_U]=2OI9KV-8I+>3RO*"KG:!A W&3_%WYSQ6Y26R_KO\ YC;U
M_KR_R/-?"FDV-EXV\0-)HMTL*6]JT<]QIS_O)(E;>P?9M=]Q!RO+'D9JC817
MUWX=A\O3M2"67B*2_NK:>PEC>6W::1E**ZC>1E6VC)XZ9P*]8HIW?]>MQ66W
M];6/&O&6C#4XM=U:#1;V:UOYK$6\!TV4RM+&Y\V7R]FY/W?R[B 3@CG(SO7E
MEIEC\4M,U*UT">.$Z=<-<7-OI$I!D8H5W,L?+;0XYY&<=3BO1Z*6RM_6S7Z@
M]=_ZU3_0\;TA9[;0_!D9T;5HI+36II9U&E3@Q1GS0&;"<##I_E3CN/%OG?VQ
MH?EV$[KOF'VV&V>X-N2F -B\#=DC>X*KCGKFNLHH>JM_6U@ZW_K=O]3QK1;$
M6TOP^^U:%J/VC3S<)=2MI,I,0(<)N8)@#<<C' SG@<U<L;&ZE\#WVH06%Y;Z
MCI&L7&I6:75K) S1^8SE5#@</&6'U/->LUGZEI?]I[(Y+VYCM<,LUM&$V7"G
MLY*E@/\ =9>O.:=W_7JG^GXAI_7S_P R'PXCMI"7LT31SWS&ZD5@-R[^54^Z
MKM7\*\]L;:]?Q%H%P-*O[..WU*]$D"V,A2 R+)AS(P)?<Q!W [!NQV%>L  #
M X%%'6Z%K:S. \)6,*Z9ING:KHUXNN:4TI\][=Q&SMN#2K-@(^\-DC)//(R*
MYI;6:W\ ^#;:YT+4VO\ 3=3A:3;ILLCPJDA,A&U20,8YZ-VSBO9**$];^GX,
M;UT]?Q7_  3RW4-*O)]"\3:!<:?=RZKJ=_)<V5RMJYB(8J8G,H&U"@ &&((V
M\ \9R-2L##8?$2&UT/43<7ODK;-%I,P^T.$ 9E(3G]X&.?Q[YKVFBDM/Z]/\
MAW_K[_\ ,Y7Q7:7VN_#^:'38Y#/-%$_DRH8WD0,K.A5L$$J",''7!KD?&&GI
MK_\ :FJV>CWS6PT2:S>&3395DGN"RF$+$4W-L()WXP,\'KCUBBAZW\_\K!%\
MMO+_ #3_ $,3PI:6UMX:T\V]E]E=K6)95:W,+[E0+\RD!LC&.:X4Z-?7'AB/
MPW+8W0UV/5OM?VS[,_E ?:"YF$V-N=A(V[MW;%>JT'D=<4W*\G+^M[DI6CR_
MUM8\:L[*&YT#Q3X=TS29A=SZ]*+9X+0B&':Z$.9 -B;,9P2#Z UICP[+=:K>
MV&M77B#S!J9O[=;:SC:WF ;<A\[R25( VE6<'C X(KMO#GAF/PW]O\K4KZ\^
MVW#7,GVKRN)&^\5V(O7CCD<<8K<I+1+Y?@E_D-ZM_/\ -_YGD6CZ7;P>!?$?
MD^%)7E_M*=X+:73I8&,#R+@HNU690H!VJ02%V\5%J6G:E<Z?XP\NQU*Y>YGT
M^[B9M/>(S(A3=M7:.0%/R\MQS7L5%"T=_3\+?Y ]?Q_&_P#F>5^)K.ZU3QE?
M_P!DZ;>V]U?>'IK479L9$0S,0R*\NW:#M'4GCIP>*NS6<&JZEHUW'I%Y#;:7
M8SP:A'-I\B^9&8PH@5"O[X;N?E#+Q[BO1Z*.EOZZ_P";#K?^NG^1XYX;AFL=
M/^'< T;5();.XG^V :7.OE;T=<N=F "S+ST[]!FO7+2ZCO8!-$LRH25Q-"\3
M<''W7 ...N.>HXJ>BFW?^O3_ "%;^OO_ ,PHHHI#"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\OR1W]%>7W5KHR:U>6/BB<2Z:FGV\6CS:B_S2, X=D8X_?9V\K\QXQ6#IWV
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M8_U:Y4A<D'I0]%<%O;^OZ_X![117B.D7NB7^H?#]=3U."??H\R7<5Q>$H<(
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M7<NX, N0!C!ZYYY Z5N5X3K][X=DA^(=S'<V/G6SVK6 \P Q2)$H4QKGY6#
MKP >"/:M34HCXBUV]%SXATO3[B1X9]'N);,S7#1>6AW6L@F4'+!@5523GG((
MHBKI?('HW_78]BHIJ9V+N.3@9.,4ZD 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%-E9DB=E7<RJ2%SC)],UYU9^.M=>XNX)(M*
MN9AI4FH1I")$2%T8!HFE!=9<9^\F.1T&12ON.QZ/17 Z?XJ\17MQX>@<:5&V
MN::US&PAD;[/(JJQR-XWJ0_3Y2,=31I/C75-<ATO3[9+*WU6[%T99I(GDA00
M2>62(PP)W'&!NXYY..:<6FU_75?H3?2YWU%>>V/C?6+G6M)T^:"RB9]2N-,O
ME$;MF2.,R+)&V[A2,<$$\]:@B\;^) UM ]MI4TCZ_)I$DP$D0 49#!,MR0&S
M\WIQSD%MO/\ X'^:&]/Z]?\ )GI-%>6Z_P"(]?N_#E[;K=V<%Y8Z]!I\TL5L
MVR9&>,@A3)E?OC<-QS@@$9R.BC\37T7BHZ+?WFGVL@,:0QS6LD9O<A2[Q.7*
M]V C^8@@9/-"5_Z\D_U!Z?UYV.PHKG?%NO3Z#;V<J-'!;RS;+B\FMGGCMUP3
MEE0@@'&-Q("YR:QM6\;7<3PVFEM!<W)LQ>&:WT^YO8I59F"*OD_=W;3\Q.!Z
M'LK]1V.[J&[O+:PM9+J\N8;:WC&7EF<(BCU)/ K@="U?7M8^(=O)<,ME;-HL
M=R^GW%JPDB+N0RY+C#;E')7H,8'6KOCI-4?7/"B6-Y:01OJ6-L]JTOSB&0AC
MB1<C Z<'.#GC%.ST7?\ S?\ D)=?ZZ7.QM;JWOK:.YM+B*XMY!N26)PZL/4$
M<&IJ\\E\3W^G:)JNKZ19:8FC:/=RQ3VBP,DD^P_O9$8,%0[BQP5;..2,U)%X
MD\6:OJ&O6MBFCV46FNF)95DF9HWB+@@ J-PRG'3J,G&2F]+K^M+@ET_KL=S)
M=6\,\,$MQ$DTQ(BC9P&D(&2%'?@$\>E35XYI":C<_P#"MM1FELIM3N8Y]ERU
MN5*H8"</\Q+D$D\%0<]!UKT3PCK=WKNB27%XD NX+J>UE\D%8V:-RNX DD X
M!QDXJG&U_*_YV%?^OO\ \C;AN(+CS/(FCE\MS&^Q@VUAU4XZ$>E25YR_CK7U
M\,OJ(T_3/M4>M_V9*GG2;%7S1'E3C+')ZG;ZX/0])X>UJ_O=<UW2=1%LTVFR
MQ;);>-D5TD3< 0S-R.03G!]!TJ5K_7DG^J&]/Z\VOT.BHKQ;QII^G0_&VPD_
MX1B'5_-TF6:6T2"$F9P6P[!R 2,#GD^@-=CJUO?^$O!=U?>"[#389%_TV:QD
MMV*,"HW"-49=I^7..<\]*2:Y>9_UK8=GS<J_K0[BBO'/B+J,_B'X)WFLSRV5
MQ;3O;S67E6Y1XQO4'<2[_-R1QC R.:UKSQ?JIB\9:--!8.^DZ8ES"_EOLD1H
M]S(X#@D]1N!'7.*<M$[]/\KA%<UK=?\ .QZ;17A]H6NO%GPON[&WM+.YGTB<
M+B-G1 (OE'+;F49. 6SR>>:T/$'C.\U7P,EQ=Z?8236>OII]W$ZR^7(Z2#$D
M95U*\X."6]#FJ<;.WG;_ ,FY2.;2_E^C?Z'L%%<!X9U+6[_XH>*[:XO[=K'3
M_L\2P_9V!VLC,-K;\*<GDD'/'3%9_P 4],LKCQ%X.N)-%BU&9]0,4D0BB+SQ
MA&;9F0A2,Y.&(%3_ "^=OQ*>E_+_ (!Z?17F/P[BCL/'7B>R2/\ LA&$4L6@
MD@^0N.9?E)C&X]D) R,UJ^-/%^J^')[F2V73Q;VMND_E3*TLMUEB&"A&!B"C
M'SLI&3[&G;;S_K^O^'#OY'<T5YMJ5]XD_P"$S\2_8]5LX8;31XYXDDLF<H#Y
MAX(D W97)8@YX&!CF.T\0>(-)\#Z"PNM,+R:9]H\^:W=V<JBE8A$LF]F())<
M<#'W>:72[_K?_(-W9?UM_F>FU$+JW-T;43Q&X";S%O&\+TSCKCWKB[;Q9K6O
MI'%H5O8Q7::9!J$R789U<RABL2D,NW[I^<YQQ\IK+N6U*U^(FJ7VG6UA9:@_
MAV*XN!.AD7S!(V5;85W' V[L\8'!Z4Y+E=I>?X7_ ,F"]Y:>7XV_S/3:9++'
M#$TLKK'&@RSN< #U)KSNX^(E]=65L^DV;&Z;38-0>/\ LZYNQ(9 Q$0,(_=G
MY3\S9Z]#SB/7]=O_ !5X6\0006%K;V]GIP>\M]1@9I#*\/F; ,C84&T[B&Y[
M#&:4[Q3\AP7,UY_J>C+<P-:BZ6>,VY3S!*'&PKC.<],8[TL$\5S!'/!*DL,B
MATDC8,K*>001U%<JMO#=?"2.&XACFB.BJ2DBAE.(01P?< U@:!XJO?#^BZ#!
MJ"6KZ?)X>-X@A1A*AAC0D%B<-D-V48/'/6JDK2DNW_!_R)@W*,7W_P"!_F>F
MT5YW!XW\0R?:BFD^?']@>[BEET^ZLXH67!,3O(IWDJ20R@9(Z#.:='XSUV/1
MM(N;V*R6768HY+8VEE<7)A'E;W+Q)EGYQC!'!Y/&3-OZ^_\ R8[_ -?UZGH5
M%>6_\)!XFUG6?"?F!=+9[VZCEBN-/E43>7&V) KLK!64\*>A/).,5IR>-]47
M1XO$R0V;Z&U[]E:W"-]H"><8A*'W;3S@[-O3^*G;^ON7ZB;_ *^__([^HXYX
M9H1-%+&\1!(=6!7CWKG/&<[LNC:2&VQ:IJ"6TY!QF(*TC+_P()M^A-9$R7]Q
M\3;K27FLFT:/10WV)[,L#&[E2OW\9RHY*D8XQWJ7M?U_!7*M^GXNQW-O<P7<
M"SVTT<T+?=DC8,I[<$5+7DW@SQ'?>'O"?A%+E;1M*O+>=-B(WG1F-7D#;LX(
M(4C;MX]370>'/&.K:MKEG!-ILS6%[;&83+IES +1@ 0CR2C;(""<,NWD=.<U
M=M;(F]MSN:*RK_2[F[U$7$5XD41MWA93$6=20<-&VX!#SSD'.!TKS_6);R\^
M(_AWP1J$ZC2_L3W5PEHC01W;#=A"NYCM  )7<<]ZE:M+^NO^0WHF_P"NG^9Z
MK17,:G8:7X1TFXUO3[);6'3;6:7[':_NH9/ESR@^7=D?>QGD^M9&E^--5GO=
M'L[U;$2ZYICWUF\4+@0,JJVQP7.\?-G<"O3&!UH_K\W^28>O];?YH[ZBO(]-
M^)/BF\T/POJ L=(FEUJ[ELC HDB"LK,%<.6; ^7E<'/8C/$MU\2?$%OX&\1Z
MH(=,.HZ'J9LG_<R>3.NY5R%WY4_-_>/3WX=GM_71?JAI-NW]=?\ )GJ]%<#<
M^.[W0=;O['6X+::./2&U:![-&0A5.&B;<QR?1N,^@K-MOB)KUSX:U+4AIRJ8
M]*.I6]Q)IMQ';J1R8&9R/,.,8=2 <YQQRGHK_P!=?\F"5[>?]?J=QK.DW][>
M6=[IVI):7%KO 2>W\^%]V 25#*=P P"&'4]<U;T^QDM3+-<SK/=S[3+(D?EJ
M<# "KDD#KU)//6N%\.^/=:U#7-)L+VULI!J>AC4XQ;JR%).Z$LQR#]!CWZU9
MT#QGJVJ:+JUT1I\^IV<(9M),;6<UM+R2DK2.05Z8<;0<'\&URW7:_P"=G^(M
M[?+_ (!WU%>967CW6;U/%5EOL#<Z9IRWMM>0V[*C!HRV"A=LX[,&P>O2L>RU
M75_LOPUEU5]/U :A<!TD:"6.6%C'][<)=K-\S9RN.>@H2UMZ?C?_ "8/17]?
MP2?ZH]EHKS:7XCWT=MJ6LFWM1I.GZQ_9<D&QC,PW*IE#[L#!;[NWGU%4=;^(
MWB+2[WQFL46ER0>'VMGC#02!I4E(RI/F8! /WO;ISPO/^NG^:';6W]=5^:/5
MZ9%-%.&,4J2!&*-L8'##J#[BL-]"L=99]3DM;3=>V2Q.DELKB0'##S<_ZS&!
MM!Z9/K6?/$/#WB_P_%:%O*U&*2TN0?\ EHT<>Y)&]6 5AGN#["G;6S_K?_(F
MZM=?UM_F=.]G')?1W3L[-$I6-2?E7/4X]<<<_AU-6***0PHHHH **** "BBB
M@#G;_P /7UWXTTS7H]2MXH+*&2'[*UH69Q)C<=_F#!^5<?+QSU[=%111TL'6
MX5F:MIUUJBBU^U0QZ?(I2YB,!:20'LK[@%!&0<J<@]JTZ*      8 HHHH *
M*** "N=O_#U]=^--,UZ/4K>*"RADA^RM:%F<28W'?Y@P?E7'R\<]>W144=;A
MTL%9FIZ=<ZFZP/=0IIK >?!Y!,DA# XW[L!3C!&TD@GD5IT4 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2K+#'IMOY5K;G&&6/]XXY(R0#P?K7!+#I7]E^(;2WDW^)H==E&E;Y6DNE(9
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M4BU_KT_S0>7]?UH=X;ZT5YT-U 'MT#S*9!F-3G!;T'!Y/H:FCD2:))8G5XW
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M2PR+)&XW*Z'(8>H(ZUQ/B>+59OB%X9BM[RR2W:.Y81SVC2X(0!B2)%!RK8'
MQSG=G%5(O%U[8^'[?7K*RTZ/PXMW]C%E%"R2I'YQB$BL&V]<'9L''\5*.O\
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M6;QEXHAT&YU=[&&*VTRZVWC7&FSP-<VWRDRPI(ZE2 6RK;N1P>Q2Z_UV_P"
M#V7]=_\ @GI%%>8ZWJWB6_\ #&BZA'J6F11ZAJ]L(1#:NW[EI 8]Y\WD\ L
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MR[N^#5;3O&^OSVNE7UY;Z9'!=:Q)I<L,*R.P(9U5U<D#@IR"O(YXZ4)7_KY
M]/Z^9Z+17%_#RXU>[BUR;4[ZWN0-5N(E\NW,; HVWJ7(VX P,<8ZFIK77M?U
M:[DN]*M;*33(-1:RE@DW+.RHVUY0^X*,')V;22!U!.*2UM_6_P#PX=_+^OT.
MNJ*"Y@N0YMYXY0C%&,;AMK#J#CH?:N*/C#5(_%UGILZZ>;:ZOI;(V\:L\L(5
M&97>56* L%SY94, ?8UD>%M3;1-.FTK2X+>*XO\ Q'>VMMOC_<P!2SDE5(R
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MJ.Y4D"G6_B328M M-1_M.2[MKDE;>80EY+@Y/"QH@+'@\*O09]Z+O?\ K?\
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M[UTE]XKT73K:&YN+P^3-&)E>*%Y0(STD;8IVI_M-@>]"T2_KO_P0W_KT_P"
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MGCH.>IZ T6T2^7Y_\$.K?S_+_)%:V\!6=GINE6MMJFIQ7&E(T=I?*T7G)&<
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MA\<>'KGR?L]Y)*)XFEMV2UE*SA021&VW#L #\H);VI[:_P!?UI^ ;_U_7?\
M$K'P'9^?YBZIJ:*NH#4HX@\>V.;DL1E,D-DY!)QVQ3;SX?V%WI.JZ8NIZG;V
MFI7+7,R121\%CN95W(< L ><GT('%7_"'B6+Q7H$6J10S0B1F^66!X^,G&"P
M ;C&2N1G-2-XMT1-22P:]Q*\OD*YA?RFEZ>6)=NS?P?EW9]J+6T_KI_DON"_
M7^NO_!*\OA"&29YH]5U&"6>)(;UX3$#>!1@&3Y,!L9&Y-A_(8K/X$M!J-Q>6
MNJZC:":P73U@@$'EQ0#HJ!HR>,DY)/7Z8HPZ_?:_XSO],L-0OM/33I(@$;2G
M:*<8W2>8SH-O'"X9<]1N%=/>Z_IVGWOV2XEE\[R_-81V\D@C3GYG*J0@.#C<
M1G!QFENO4-OE_7^1C)X#M1X<AT"35]4ETV.)8'AD:+][$N<(Q$>0,8&5VG@<
MUKZWH5OKFGQ6DD]Q;>1-'/#+;E0\;H<J1N!!^A!%4[CQMH-K::E=374Z0Z;,
M(+P_8YB86(SR-F=N"#N QR.:FNO%FB6=_'9SWNV5W2/=Y3F-';E5>0#:C'(P
M&()R,4[MA:QCW/P[M;B1V&N:Q$'OUU%E1H"#.H4!OFB)Q\H.,XY^E/?X>V,T
MVI33ZIJDLU]<I=B0O$K6\R#"/&5C&"% &#D$=0>:J:/XS^R:OK]IXAU%&%MJ
MB6MNT5JP2-71"@8KNVY+8W.<$^G2NF\0ZOI^BZ/-=:EJ?]FP'Y!<@ LK'IM!
M5@3Z#!^E"V7]=O\ @!UM_7];E;1_"MKH^L7NK"^O[N]O519Y+B8;6V@ '8H5
M >.N.YQ@52U;P'8ZL^LDZCJ5JNL(BW:6[Q[6VKMR-R-C*\'],'FKE[XS\/Z?
M>7-E/J(:[M81-/!#$\TD:<?,512>X)XX'/2I(/%>CW.L1:5!<327<UO]JC"V
MLI1XL [P^W:1R._4XZ\4M_Z_KL']?U^!FOX!LKC46O+[5-2O0]A_9\D,WDA'
MBZ_P1J0V[YL@CGVXK:TK27TQ-LNJ7U^0-L;7;(2B\<#8JYZ=6R?>J;>,M$6R
MBNS-=%)0Y2,6,YF*J<,WE;-^T'JVW'O2_P#"2Z+=:AI$%OK:&6^#2VT,)5A<
MH%;)/RDA1@G(*\C&>Q>O]??_ )B$L_"T%IK^JZL]_>7+:FBQSV\XB,05<A0
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MN"-V)/\ O;?7GI6Y12MHUT#K<\[L_#>JR:-X=\/W6G/$NAW,,[7_ )L92<1
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M?,_F$ #;G'7VYK+\(6&HZ_X/\&0?V<]M:Z<4NVO))4*RX1PJH%);)+#.X
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M'/7OF3?$#69/"EGJ\,>F6SM8S7,BRH\QF>-BICCC5PZ@XSO.X+D YHE[N_\
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MYFGC>U*+(#:2G<S_ '50A<2,?1,FEK;^OZZ_B']?U]QQO@C0%U6TO6U$ZS#
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MC#/F!F #+P?F7(HM=-?UL&S5OZ_JY0M? EK::1IUC%J^J"733_H5YNA$T"$
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MDU[Q5IOA[3;R^NO/F2S*K,EM$9&4L,C..!P1R2!R.>:VE.Y01W&:G?7^NO\
MFQ^O];?\ \ITG1/$5IIO@:VF\-W9;2993>?Z1;[5#(Z#'[WD?.#QV![\5>_X
M1;6WT_6M%L8[RTT:YTR2"*UO[B.41SL/E$+*681C)!#X[8&*])K/U37-.T98
MOMLY5YB1%#'&TLLA'7;&@+-CV!H;O_7?_AAJZ=_Z_K4X<Z?XEEUC3M4_X1UT
MBM]$EL98'O(O-\QMN-H!*GE!C+#@Y.",%F@:#K]DO@::;2)$?2K.>SNXWGBS
M&650'RK$%?E/3)Y'%=UIVN:=JLTD-I.6GB17EADB>.2,-G&Y& 9<X/! /%:-
M4V[W_KK_ )LFVEOE^"_R1YC#H_B*+6=(U*?0[EVL+ZZ>6&VN+=(BCHX5HH]Z
MCDD9+X;)/8FJVF:+XCM]*\)VTOAN\633]7FN[G_2+8A8V,F"/WO/^M' _NGV
MSZO123L-ZW.7\#Z;J.CZ;>V-_:>3B_N)HY/,5A*LDK." #P,,.N#G/'<X4UQ
M?0_$?Q1%8Z5)J$D^G6D>%EC14)\T ON8?+Z[<GV->BUDVOAO3+/7KK6X([@:
MA=*$FD:[E964=!L+%1CM@<9..M+??M;\$OT'>VW>_P"-SB[+PKK/AVX6"UL3
MJ$<OA^/33,DR(L<T>\_-N(;:=W!4-C'(I/!^B>(=,\0Z%_:6B/%!8Z'_ &=)
M<QW,4D>\,K XW!\87!^7@GN/FKTNBJYG>_\ 77_-DVTM_73_ ".#L]!U:#69
MH;"*]LM(N8)C=6]U<QS0"5P<&#!+J=Q.0=JXZ#-9-CH7BI(?"")H<,;Z+9SV
MLYNKM-KL8U0,H3=E3C.#@]0<=:]-BE>1Y0]O)$$?:K.5(D& =RX)XYQS@\'C
MH3+4]+?UU_S'_7Y?Y'E$6A^(X9$O&T"^EE?0IM/>%;FV58Y69=H1!($2/@XQ
MS@#/.*O:/I6O1:MX/,^@W4,.G:3)9W4K3VY$<C*BCA9"2/W>> ?O#WQWE_JU
MIIR2F9G9XH&N#%%&TCE%P"0J@D\D4FC:K;ZYHMGJMJLBV]W$LT8D #!2,C(!
M/-.]_P"O\7^;%;^ON_R1C^ -.U#1_!UCI>I6GV>>T4Q']XK[_F/S#:3P<C&>
M?4"N>OO"FM75QXEBCMU1+G5+;4K:5I5VS",1?NR!R"3&>2 .G7G'H]%%W>_]
M=/\ (?2W]=?\V<MIFG7E_P",F\27>GRZ:%L/L2V\[QM(Y+[RQ\MF4 8 '.>3
MP*C\1V>I7/C7PO=6NE3W%G8RRO<7"21!4WH4'#.&.,Y. >.F3Q76T47LUY?\
M'_,._F>=0^#F_MB\MM3TG4+^"6_:^M[M=5D6V4E]X#P^:,,IX&U&!P#D<U5E
M\.:[J$OB-GTFZMA-J\.H6X-XD1N$150H'BDW(QVD@G';D<X]/J&6Z@AG@ADD
M"RSL5B7NQ )/Z TEII_73_('KJ_Z_JYQ8\'PW?AO5TM-,O=,O[X)*K7]\;F;
M[1%S&[,9)!@$+C#=.N*DO;+Q#+X;L;AM,5]4GO([F_@B>)I(5QC$+2'9N4!1
MG/\ >(.<5V%S=06<0DN)5C1G6,$]V9@JC\20*S].\0V>IZWJ>DP1W*W&G>7Y
MQEB**=^[&W/+#Y3SC'H33_K[@Z?UU//WT#Q#;:9'9QZ!>SE/$HU+>+N!\P!P
MV=SR ECTP>X^E/O] \0WTWB21-#N(Q<:O9WUL'G@S-'"8PP&)#@_(2-V.".0
M>*]3H) &3P*$^7^O3_Y% U?^O7_-E:>6==-DE%J\D_E$_9XW7<S8^Z"Q"Y[9
M) KS71-#\2V_A_P[IUSHD\"VMM<6]RT4\ F5F(VD2!R1$><["'R!QCKV9\:^
M'P)7-Z_V>($O=_9I?LPQU_?;?+)]@V:WU8.H93D$9!I6W\_^#_F.]CSFS\.:
M_;>%/"36MG]FUG3$^R3I)*AQ"Z[';<"0<$*X'4[<5J^#_#%[X?U34+>4*=*M
MY'_LQB^Y]DI#R ]^&&!79453DVV^_P#7]>K)MI;^NO\ F<G\0;+4M0T.TM]+
MTR:^F6_MYV6*2)-J1R*YR79>H&!COZ5RVKZ1XCO[/QW'%X:O0^L^4MH&N+89
MVQA"6_>\<C/T]^*]5HJ5I_7I_DBK_P!??_F8VHZ?/K?@ZYTYE>SGO+)H2LA!
M,3,F.=I(.">Q-<Y=Z-JOB/P7<:/=:,NFZFEE]E6[DDC='QCB-E)?8Q49W!3C
ML<5WE%.^K8EHDNQPUYI^JZKJUOK,FB7-J^FV%Q;I;&:%GN7D"@;2'VA!M/+%
M3ST%86GZ7XDT^#P3N\+W\AT>RFANE2XM<[F0(-N9AGD9^A'?(KU*:5XO+V02
M2[G"G85&P'^(Y(X'MD^U24OZ_/\ S#^OR_R/)],T#Q'#I7@BRFT"\B;2Y)A>
M2"XMR(PZ.@88ERWWP>.< ]^*FL?A^]QH:Z5?:9?Q:A:6DEK!J4VJR36_S1F/
M?%$925R",J44#MG KU*BFW=6!-IIG(V=KJ6H>'I+*^T!;/48K![,7+RQ.CY7
M'[ME);:2 <,%[<'%86EZ5XAAU3P7Y^@7,<.EZ?):7,RW$!",Z(F<>9DX*$G
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M4?B2!4K3^O3_ "15_P"OO_S8^&,0P1Q DA%"Y/? I]%%&XDK:!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R9#+!)&LCQ%E($B8W
M+QU&01D>XKR32;W5;S3/!!EU_4F^UZI=V]SB8 SJ#,1N(&>-H P0 .@! (];
MFABN(9(9HTEBD4JZ.H964\$$'J*QH_!GA:%HVB\-:,C1-OC*V$0*-QR/EX/
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M_+\0>KOZ_C?_ #_ \^CU6Y7PWI8LKRZEN-1U-X-36^U*:$VTFUR8!(-[0C<
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MOUK6A\,:!;Z@E_#H>F1WJ8"7"6D8D7 VC# 9'''TJ[?6%GJ=JUK?VD%W;O\
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M;'!*L/+9EP<'DD8P<XK;UZUU"]T&\MM+NEM;^2(K#,2<(WU R/3(''6N%O/
MVO/8^)(;2VT>%M:L8;<@WDI\MU#!F9S$3)PPY."<8..M+O\ UV_X(^QT,_CN
MU@%ZO]CZL\MK:+>B%8X]\T#'!= 7'3!R#AO8U9'C"S%KI]V]G=I:WEF]ZTY,
M12WB4 DR8<_WAC;NZUGZ=H6NKXUAU>]M],2R&E+82)%=O(^X'<2 8E!&>.HX
MY]JS]#\(&\\.^(='N+LFQE:;3["1!S%;AF..>I5V9?H@IOK;^M6O\F)=+^7Y
M+\M4;0\<V$<_DWMAJ=D\EN]S;"6 ,;J-1DF,1LQS@@[6 ;!Z=:72?'.G:O<:
M9'':7UO'J=LUS:3W$:JD@4 LO#%@0"#R,$=":I7'A[7=0DL[F]BTP7&EP31V
M:Q7,FV=W39O<F/,8QGY0'Y/7BLO3?!WB.W_X1""YCTK[/HUK+;7+1WDA:0.F
MS* Q <  X)ZG';)/3^M_^ +I_7E_P3I[+QC87FJ6EE]GNX%OD9[&YE51%=A1
MD[,,6''/S!<CD9JWJNO1:9=0V<=I=7U]-&TL=K:A-Y12 S9=E4 ;AU/.>,US
MWA3P0GA^6WCDT3P\K68VPZG;P 74RX(^8>6-K8ZL';// S6IJVC7X\2VWB'2
MA;374=J]G);74S1(Z,RL&#JK$$$?W3G/:AVTM_7;_@C[E9/B%H\\NF0VMOJ%
MQ-J+2I%'';$%'C!W(Y;"JP*D8)XX)P.:V=#URWU_2_MUK%-&!(\3PS "2.1&
M*LIP2,@@]"1[UR,7@S6=/UG1;NT&GS1VUY=7UV9+AXRTD^X%441L,*",$D9Q
MVK;\$Z/JNB:9>V^JI9K)-?3W2?99VD&)'+8)9%Y&<>_M0K6_KR_X/W ]]/ZW
M_P" <;JGB_6-4T&XOA%J6E+9^((;7$31$2QB98VC.PLY/4G& <X!8<5V\/C"
MRD&H)-:7EO<V-PEN]M*BF1WDQY>S:Q!#9&.1CG.,&N8O?!?B,:7>:?9_V5+'
M+KG]J(\UQ)&=GFK+M.(VP<C;W]?:EO\ P/K&L:MKMU?0Z1Y-Y/;7%M$\C3HS
M0C;LE1HP-K G."<>]);?UVC_ ,$'OI_6K_X!V.B>(+;7#>1)!<6MW92B*YM;
MD*)(F(R,[692"""""16%I^I:GXNU?6([+4Y=+TW3+LV:O:Q1O+/*HRY)D5E"
M@D  +GC.>U;'AO1H](MI"NBZ1I4DN-\.F*-A(SR6V(6Z_P!WCWK+MO#^L>'-
M9U.ZT 6%U9:G<?:I;.\F> Q2D89D=4?(; ."O'K3TO\ +\0Z?UL7/[7OM%+6
MVJ;]1O+FY9;"&TB1'FC5%)X9@H(^;)9@,],9 JL_Q#T>.RMYWM]1$DMZ+![8
M6Q:2"<D#;)C('4'J<C[N:?J>A:M<:GIFNPRVDNI6!E5;:1FCA:.0 %=X5F!&
MT'=M.>>!GC&U'P;K<D23VBZ<][<:S%JMXLMRZ1IY84+&A$9+<+RQ YYQS@"W
MU_K5?I<'Y?UH_P!;&XGC:R>*X'V"^6]@O!8FQ81B5I2N]0#OV8*\@EA^?%3_
M /"51C7+?2)-*U&.YN()IXMZQA6\LX9?O]>1@]"".:P$\)ZM/>^(FU/2]$O+
M/5+I+A+>2ZD/"1[%R?*^5LJIW#.,GV-+8>$=?TVYT*^2ZM;NYL?M,4D5U<R$
M1PRD$*LA4LY3: -P&X?W:%_7W?Y@_+^OZ1%<^)Y=;U'P?J.G3ZA9VEUJ4]K<
M64NQ=Y1),[]I.<,G&&Q[59TSQ[/)+K1O]'OD6WU/[#:QQF%C(^U0(QA_O$DM
MDX4 CYN*S;'P5XGT\:#'YND74>G:I/?.WF2PDK)ORH&U\D>8QSD= />KLOA3
MQ)!+JBV-U8_9KO5OM[1&>6)IXBJAHF=5)3E<\;MW0X&<FG]?]N_\$'N_Z_F_
MX!I/\0=+BT^VNI;/4T:>_P#[.,'V;>\4X;:5<J2HY/4,<]LU1UWX@26ND7$M
MAI-[]MM]2AL+B"4Q!H2[+@_?*G<K#;@]3SC!K.;P3XAM].2QLH-&\J/7O[57
M_2I(P$#!@F!$<'.1G/YYJ2\\&>(KZ37Y'&EQF]U.UO[8"YD;_4E/E?\ =C;D
M)G(S@G&#UHC9VO\ U\/_  ?N!Z;?UO\ \ [$27B7WV^9[B"P%IOEMYO*(B?K
MQL!;<!G=\Q7ICN:?H^L_VQ DZ:?>6T4B"2)YPF)$/0@JS8R.<'!]0*NLMPUD
MRGR6N#&1@@["V/SQFN9\->%[C0];O;F*.WL--EC")I]K</)$7SDRA651$>VU
M00>I-'6P/:YGS:S?Z5\1M90KJFJ6J:9!<)90>6?*)=PQ4$J.B@\DL><9Z5K3
M^.-,73H[ZSM[S4(&MEO)#:HI,,!S\[!F7^ZWRC+<'CBF7^B:Q#XLGUO238R_
M:K*.SDCNI'C\K:S,'&U6W_>^Z=O3[U8<?PTATZYLGBTS1M;B2SCM)DU:, J5
M+'S(SY;XR7.5QCIR,4ELE_77_@:C=KW_ *Z?\$;'XL:P\7Z[?";4M5TD:5:W
MT44 0K#&Q?<R@E1C !Y)8\XSC WM3\>:9IN6%K?74$=O%=7$]O&I2WBD.$9M
MS G."<*&( Y%8MSX1\0+?:^;*UT5+6^TF/3K9%N7B$>W<,E!$0HPYP 3]T#O
MD4[_ ,"^)=3T"32[M]+E3^S(K:W5[J4QV\T8P6"^6 V[ .X\KT -4K:=O^'%
MK_7R_P"";EIJ%_!\0O$4/G7E_;Q:=;7$%F&0;68R J@.U>=HY8_C4/P^>\UN
MPA\0WKZQ#<3JX>*>Z5[:;+'#)&&;9M V\!,]PW6I[32/$=MXOU36C::4T5S8
M16\48OI,[X]Q&[]SP"7(XSC'0YP+/A'3=>T'PS8:7>6NFO+;R;'>&\D(,1))
M89B'S G&WH>NX=*2_3]7^EA.[_KR7ZG4T444AA1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MREE9S74BR,D*%V6*,NQ &>%&23["JVB:O;:]HMIJMF)!;W48DC$@PV#ZC)H
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M(0#@$X.. 3V-&X&K16(?%VAK<R0F\8;)/*,Q@D\DR;MNP2[=A?/&T'.>U;=
M!17.2^.=#AU&ZT\G4GNK3'GQQ:3=2; <X)*QD;3@X/0XXK6TO5]/UJT^U:;=
MQ74.XH6C;.UAU4CJ"/0\T ]-"[16;KVN6GAS1;G5KY9VMK==SB"(R-CZ#M[G
M@=S4,'B6RN/$2:(D=R+MK/[8&:(K'Y>5'#'@G+=LXP<T+7^OF!L4444 %%%%
M !114-W<I96<UU(LC)"A=EBC+L0!GA1DD^PH;L&Y-15#1-7MM>T6TU6S$@M[
MJ,21B08;!]1DU?H:MHP"BLG2O$-GK&HZI8VT=RLNFRK%/YT1C!8C(VYY(QWQ
M@Y&,UK4 %%<W=>-]*LWUQ98K[_B2HDET1:L<ALX*CJP^4DMC&.<]<;MG=)?6
M-O=Q!A'/&LBANH##(S[\T>8>1/1110 445E0>(+.X\2W.@(EP+RW@6X<O$50
MH3@;6/WN?3(X/.: -6BBLF[\0V=EXBT_0Y8[@W5\CO$RQ'RP$!)RYXSQT&3R
M.U'D'F:U%%5[Z]ATZREN[@2F*(9;R87E;'LJ L?P%&P%BBL:P\5:3J>@2:Y9
MRW$NG("QE^QS L!U*H4W,/< ]#Z5:L-:L=1T==5MY)!9,AD$DT+P_*/XMK@'
M'?..:'IN&Y?HK-@\0:7<^'AKT%T)-,,)G$ZHQR@')VXW9XZ8S[5DM\0?#ZSR
M0,=5$T48FDC.C7@9$.<,1Y7"\'GIP:.M@WU.HHIL<B31))&=R.H93Z@TZ@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH YG6],L]0N;6V5$B2UO4U"YN2<>6RG<!N_O-P/9<^P-[Q%<:A%9Q1
MV&G7=X)GV3_9)(DDCCQR1YCH,GIP<C.>U+)X4\.RZA_:$F@:4][O$GVEK.,R
M;QR&W8SGWK2AM;>V:5H((HFF?S)2B!2[8 W-CJ< #)]*.E@ZW.-^%3G_ (1"
M2$6$UG'%?W:HLA0C'GOP-K'[OW3GN.,CFNWJHNEZ>D<<:V%JJ13&>-1"H"2$
MDEP,<-DDYZ\FK=-N_P#7D@"JFJ:C!I.F7-_<G$4"%SCJ?0#U)/ 'O5NJFHZ5
MIVKVPMM3L+6]@#!A%<PK(NX=#A@1GDU+&CRZ.;4/#GB/0]?O]#O[#[3(]IJ]
MU<20&-S,VY#\DK-A7PHR!A3VKH;IE_X6?J_S#_D7$/7_ *:R5U=[H.CZE9PV
M=]I-C=6L&/*AGMT=(\# VJ1@<<<55_X1#PSO+_\ ".Z1O:/RBWV*/)3&W;]W
MI@ 8]*<E=6]?Q5A)V=_3\'<H_#@Y^&_AW_KPB_\ 0:K>,I=0M+N#4(DN+O3;
M2W>2ZM;._-M.GI*!D"0 !AM8@=\$UU%AIMCI5J+73K*WL[=22(;>)8T!/4X4
M 4R]TG3=2*F_T^TNMI!7SX5?!!R",CL:<WS2YD**LK,\NU#47&E>/I8M8U*.
M".QMKVP=[^5'C+0E@5.X%06_A& >F.U78)Y]8\27,/\ PD&H2V$GAR*[C6VO
M-BK(2065TPW\.<Y/).<CBO0KG1-)O+K[5=:993W'EF'S9;=&?8>JY(SM]NE5
MI?"OAVXN9+F;0=+DN)4V22O9QEG7&,$D9(QQCTI/:R_K1K]5]PUI_7FO\G]Y
MY[I^I:K)#X.O%UJXCNM8TFX-S)<3DP[UA#(^P_(NT\Y !(ZYKJ?!U[*E_=:/
MJ%O?6^J6T$<DJ37S7<4BL6_>1NQ)&3G((&,# P*U3X.\+LL*GPWHY$'$0-C%
M^[YS\OR\<DGCO6A9:7I^F^=]@L;:U\Y_,E\B%4\QO[S8')]S5-J[?J*VGW'-
M_$RYN[+P+>WEEJ-Q8S0O&?-@95)!<*020<##9XP>!S6%K=_+H6LZK:VVN7RV
M4VFI/*[2FY>WG>4(GE[V^7S 2 ,A1C(P*Z?QWHVI>(?"EQI6EK:&:X=-S74K
M(JJK!OX48D_*!CCKUXP=&ST+38M)>S?1M-@CN1NNK:&%3$[G[V?E&_GN0,^E
M2NO]=/Z^8WT_KJ>>1Z=J^JV7BW2[74M4M[G3I89K"-=6FD=6,6XQM(&W,&.0
M020,\'BKD^LV^JZ#<>);35-2M+>:.UL8%BG=\NS*74*SA0Y+"/>2"I!.:[5M
M*BTM?.T+1M+2Y8)$Y.+?]TO0;D1B<=EQCW%%CX?L;?0$TBYMK>ZMV#&:.2$&
M.1V8LQ*G(P6).*:_R_X/X?B']?U\SS#4I[MO"OB2QNKB<Q66O6<<*S7C7+0H
M7A;'FO\ ,>23R3CIDXJ]XM,UE9>.--@O;JZTT:*+AA<7#3>1.Q<%59B2 5 .
MW.!VQFO2(=$TFW$X@TNRB$ZA)MENB^8H& &P.0!P :C_ .$;T+^R_P"R_P"Q
M=._L[=O^R?94\K=G.=F,9S[47_KY)?I<?6_];W.$U5_$.LZK=:5I5Q%;26NG
MV\MG(^J2VNQF4YEV)&PF7(P0QQQTYS7HVGM,^G6KW+Q/.T2F1HL[&; R5SVS
MTJK)X=T.:*UBET;3WCL\?9D:U0B#'38,?+^%:5#9*5K?UV/,]<GEM]7\>0R:
MI?00QZ1#=P#[=(GE28E^:,[ODRRKD+@'H>M9NFW5UK-Y*C>(]2FM#X7ANP(+
MS8$FY4L'3#9RG.23DD'(XKU&[T;2[^Y6YO--L[BX1&C66:!78(>"H)&<'/(J
MK)X4\.33RSRZ!I3S2ILDD:SC+.N ,$XY& ./:IZ6\OT?^?X%7UO_ %T_R_$X
M31M7N?$RV=KJVI7-L$\/V]]&8+AH#/*P;S)&*D;@N%^4Y7YCD'BL7PQ?:EK/
MA_0-#TJXA*)HZR1LNK269,X=E;!BC<N4^7*' ^;D'MZQ_P (SH(MK:W_ +$T
MWR+5B]O%]DCVPL3DE!C"G/<4^X\/Z+=V<%G<Z1836MN088)+9&2,_P"RI&!^
M%7)IM^?_  ?\_P !+16_KI_E^)P6D6NMW_C1=-U?Q+?2-'I%O<R"QN-D7G"7
M:2N%!*G9R&!SN/;&/374.C*<X88."0?S'2J$6A:1#J9U.+2K&/4"-INEMT$I
M&,8WXSC  Z]JT*3=U86S/$+&QMH/"%A'#<W*RR>+%0AKIY"H6Z< A7) /J0.
M3R<FM+6=0U&PTKQ7;VNM:A$FFZS:K"QN2[^7*(MT9=\MMR[$8((]<<5Z/<^%
MO#UXQ:ZT'2YR9#*3+9QMESC+<CJ<#GKQ4,G@SPM,TC2^&M&=I7WR%K"(EVYY
M/R\GD\^]"?\ 7_@/_P B_O&]?Q_]N_S_  ,#4;RZTGQ:UUJ)NY]-NKN&VMKB
MSOFVVS':!%+!D [F_C 8X;!P*[NL]-"TB*Z@NH]*L4N(!MAE6W0/&, 84XR!
M@ <>E7R P((!!X(/>ETL'6YYEXNAN_%4VK)9:+?WR6D7V?3[NV> )%<JP=G_
M 'DJDD,J+PI^ZPYSBK=WXFEUOP;X>U**6XBBNKE(]1@LF?[3PK>8B"/Y]P89
M(7YMH)%=G8Z%I&F6LUM8:58VEO/GS8K>W2-).,?, ,'CCFN>UCP18^3;)HOA
M_P /&W2;S;BPN+98HK@[2%)9$;!7)(RK=>W6A:*WI_P?Z]![N_K_ %_7F<I>
M+XCATZPN9=>UVUM9M?AM;2WF*([VK.,%\QB7<>1\[9(ZBKFIV?B&?5[_ ,/:
M5J,N^QM8Y+.XO=8FAD!8L3(P6)O/4'"D.<87U.:Z;3_ ^B^6S:AX=T--Q5EL
MX;9)(86 Y9=R#+'NVU<@*,<5NWNC:7J<D$E_IMG=O VZ%IX%D,9]5)'!^E/^
MOP7ZJ_S%_7X_TCS:>?Q=KE[J2VEY96U]IK0F.9M4F@B5?+1F<P"(K*C$N-S'
MZ8Q4.KW.II!\0;EM=U(RZ5Y4]F$N2BPMY0? "@97)QM;((ZY/->GW.CZ7>7L
M%[=:;9SW=O\ ZF>6!6>/_=8C(_"J<GA'PU*]P\GAW27:Y.Z<M91DRG.<M\OS
M<\\]Z+_U]W^0(X+7M:U3P_J]\+&]N9%GT:"[D%S<LRQN9PCR#(81@(23M7 Q
MG'%1:]#XGT?PGX@N3K)L[8V\4]FEKJDEY*C;MK'S98PP1LC !X(X(%>C0^&/
M#]O=)=0Z'ID=Q''Y:2I:1AU3;MV@@9 QQCTXIO\ PBOAW[ ;#^P-+^QF3S3;
M_8X_++_WMN,9]Z/Z_&X+^ON/-_&2RQP^--*>^OIK4:%%?!);N1BLNYP2.>%.
MT90?+[5Z=H4$%MH=I#;RR21I&!NDG:9L]P68DGGU/'2HXO"_A^WG>>'0M,CF
M>+R7D2TC#-'@#:2!RN !CI@5H6]M!9V\=O;0QP01J%2*)0JJ!V ' %%]+?UU
M_P Q6_K[O\CB_%]U=Z5JLFK7!NY]%M[95E%C?&&6S8EMTK19 E!!&,Y(V\#K
M7,:V\L$WQ&U:UOKNWGLI+6> P3M&-XA4_,!C<#T*MD>V:]3NM(TR^N(KB[TZ
MTN)XF#QR2P*[(PZ$$C((R:IR>$?#4K7#2>'=)=KAM\Y:RC)E;.<M\O)SSS26
MG]>G^15_T_4X/Q'J]V=5FOK'4[TM:ZE8V[8N3##"'*;XA$"1,2&R2RC&[@_+
MBHM?8?8?BQR/]5%_Z3"O1#X7\/,I4Z%IA#1K$0;2/E%P57IT&!@=L5&W@_PP
MYG+>'-(8W!S-FQC/F'.?F^7GGGGO3TZ?UM_D)/\ 3\#2T_G3;4C_ )XI_(5P
MFHV=O>_$O6H[J]N;.,:' _FV]TT#+B27YMRD'C\O45WUK:V]E:QVUI!%;V\2
M[8XHD"(@] !P!5>^TC3-3>%[_3K2[>!M\37$"R&-O5<C@_2B6KOZ_B$=(V]/
MP/,K;4_$_B&#1]-D<)<S:0MTCOJ4M@TLNXKO'EQL7PH0E#@?/R#V])T#[>-
ML5U.X@N+]856>: DI(XX)&0.#]!4NH:1IFKQQQZEIUI>I&VY%N8%D"MZ@,#@
MU;50JA5 "@8  X%%]Q'GVJ)=7?Q!UG3Y-9U)+(:(MRD$-R81$^]AE2F&'W0>
MO<YXXK%M-<O;6T\(ZO=:S>1G4M(N9;Z221I(\I"'#B+.T$')^4 GN37H]QX8
M\/W=Y->7.AZ9-=3*5EFDM(V>0$8PS$9(QQSVJ(>$/#(\C'AW2!]G_P!3_H4?
M[OG/R_+QR2>.]3TM_7VO\U]Q76_]=/\ +\3SVUUK6-%?6I+6>]N"GAY;^**\
MNS<,\V3^\VY81Y&#L5BM,U2Z@T3Q+HFIV&J3:A<SZ)>S0?:;LR^=-M0KL!)Q
MN(^ZN!QP.M>G6F@:-I\D4EEI%A;/$ACC:&V1"BDY*@@< GDBBST#1M.F\ZRT
MFPMI<L=\%LB-EL;CD#O@9]<"J;_K[_\ /\!+3^O3_+\3DO!\6O/JEGJ<M_:O
MI5[:%GC&JRWC32\$2('C41C&054[>1Q74^)?.'AC4W@NIK25+:1TFA(#(54G
MC(([>E6++1]+TV:>:PTVSM99SNF>"!4:0^K$#D_6IKRRM-1M)+2^M8;JVD&'
MAGC#HW.>5/!I3]Y66@0]UW9YII<E_JFK^$K>YUO4S;7OAUIKB*.Y*;G B^?<
MN'W'<3G=GCC'.>K^'>H7.J> ]+NKR=IYRC(TKG+/M=E!)[G &35Q/!OA:-E:
M/PUHZ,JE 5L8@0ISD?=Z')X]S6AIVEZ?I%M]FTRPM;*#<6\JVA6-<GJ<* ,U
M3DFV^_\ FW^3L2EM_72W_!.<\>RK;1^'[N7Y;>#6K=I9.R*=R@GT&6'/O5_6
MI(YO$'AV!)$:9;F2<H#D^6(9%+8],LHS[BMR:&*XA>&:-)(G&&1U!##T(/6J
M>FZ'I.C*ZZ5I=E8K(<N+6W2(-]=H&:E:?UY%/_@'F\AN_#.DR:GH]Y!J_A26
MZW3:9<G$]N[2_,(77J0Y^XW/'!KU8'(!J@="T=M0BU Z58F]A7;'<&W3S$'H
M&QD"M"CI;^OZ_P"&![W.1TUU'Q1\1DL,+IUENYZ?-,>:XNXU.:+Q1XBU+0I6
MBT>\O["RN+R'[GF%MLSHW3@%5+#N?45Z-/X,\+75Q)<7'AK1IIY6+R226$3,
M['DDDKDFM86=J+3[(+:$6VW9Y.P;-OIMZ8II[/L@?7S/+?%7VO3M.\;:-%=W
M5UI,>B"X3[5.T[02MO!3S')8@A0V"3CMQ6E>WD=EXWANI+G[.D/A660S!=_E
M@.AW;>^.N.]=E_PC6A?V6=+_ +$TW^SRV\VGV5/*W=<[,8S^%,B\*^'8+F.Y
MAT'2XYXT\M)4LXPRKC;M! R!CC'I2Z6_K9K]?P#K?^MT_P!/Q//+&YU..?5[
M9-6U."-_#ZWR22WHFE\W<<R -O6+< /D4D 'C%6[*RUE?#>@:M#?ZEJQGLXK
MF]L7U5H9),1K\\3 CH3\RE@K9&>>O;_\(GX;,(A_X1_2O*5#&$^QQ[0A.XKC
M'0GG'K4K>'-#?3X]/?1=.:RC!"6QM4,:@G)PN,#D _6G?M_6_P#FON!+O_6B
M_P OQ%\/7]OJGAW3[ZTDGDMYX%=&N/\ 6$8_B]_6N%^(FHW,<NK_ &'4;Y+G
M3M+%TL<-R;:.W;<V)&*MF4MMP$*E?EY(S7I2(L:*B*%11@*HP /2J=YHNE:A
M.)[W3+*YF$;1"2:!7;8W5<D9P>XI/>Z'%VW/.-3EU"XU7Q6)-<U,16^A0WL"
M17/E+#*5D.5V8.,H#@DYSSD8 N6^IS>(K^*SU/4;BTC30H+^$6]PT'G2.&WN
M2I&X+A?E.5^;D'BNN_X0WPO^\_XIO1_WJ[)/]!B^=<@X/R\C('Y"K#>'-#:W
MM;=M&TXP6AW6T9M4VPGKE!C"GZ4/5-?UU_S7W"6EG_73_)_>8?PMN(;CX::$
M8)HY0ELL;E&#;6'4''0CTJ#QG<7NGWQU-A=7&D6MH6N8K&_,$]L23^^V9 E&
M,\,>"N0":[&VMH+.W2WM8(X((QM2.) JJ/0 <"J]YH^F:C+')?:=:74D;*R-
M/ KE2,X()'!&3CZU4G>7,$=%8\IU>9X_^%AZS9W]Y!+:-:7-N89VB&X0*1N
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M;[)K,4GV;;<J9O-1"Y0J0% .T@-OZ]0*+3P=KMKJ]IJ/]OZ>SVVF'3E3^RW
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M/XE5I 1GC*Y[4U:_]>3_ #N@?]?>_P!+/Y'8C.!D 'OBEHHI %%%% !1110
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M!'(&#G'":$=#U!/!4]REC>6UMJ5_:[F190BCS&ACZ'MM*CZ8H2N_Z] >B?\
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M TK0/&<#)8V-Y)KT:+A5B<Q;X7 ##! ^\PY[,1T)H2UU_K6/^;!VMI_6DO\
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M(U+<9)QD ]VH2NK_ -?U>Z^0/1_U_6UF=91112 **** "BBB@ HHHH ****
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M_P [ G=+S_RN=Q17FD/C/7KPWUD9],2X;1Y;^*6V@=UMI$(!C+;RDQ&?O*0
M1R.170^$KC4H/AKIUW,4O[L:<DL211F,R?NP54Y9LMV+<9]!4O1-O^M_\A]4
MOZZ?YG545P<'CUAX>FOS=6%[="6"W%M'#);20S2OM"RH[,R@9'/&<' Z55\1
M>,O$?AN/5K.<:9-?6NG_ -HVUPEM(L4L8<*Z-'YA*L"1A@Q'/2G9WL"U/1J*
MX'7_ !AKND:KJL-O!IMQ#;Z+_:D*2*\; AL,K,"V[@$C"KV&>]3V_B+Q)/+I
M=BZZ5%>ZM";JWE$<CI!$L:%PZ[@7;<^!AE&.>V"OZ_/_ "8?U^7^:.WHKA-0
M\7:[9):Z=<64=MK#P23RF*QN+^+"OM7"0_, _7+'Y>G)KHM(U'4-:\*6]\UH
MVEZC/!DPW<+'R9.GS(2K$9'J"10]FPZV+L.K:;<W\UA!J%I+>P#,MNDRM)'_
M +R@Y'XU<KQ_PWJ.O:=I'A I!HEU)J<LUO'=RV[I-!G>[9^8[@2N205SC&/X
MATLGB?Q)+:ZO+:1Z49="55O8F21A<RB-9'$;;AY8 . 65LGL*'HK_P!=/\PZ
MV_KK_D=W17 Q^,=;U;59K;3(-.M[9M&CU2WFN0\KG?T5T4J!T(X;C@\]*ET;
MQCJ=_?\ AA[B&S6SUZTDF2*-6\R!T0-RY.&!STVC'J:=G>W]=?\ )BNK7_KI
M_FCN:*XGQOXLU3PX;B2T_L]8K:S-ULG5I9+D@X9%5&#( ,9D(91N'O3+WQ1X
MA?Q!J&FV,&EP1P:2NHPS3^9*6R2-K*"F.0PX/'!YZ5-]+_UW*L[V_KM^IW-%
M<)IWB_5KG5-!N+MM/@T36; W$7[E_-281AS&7\S;TW,#MZ*1[UJOJ^M6?@*?
M69XK*XU".V:Z$85X(]@&X C+D';[]>..M.7NIM]/^&%'WFDNO]?UYDFG^'KZ
MS\9ZGKTFI6\L%]#'#]E6T*L@CSM._P PY^\V?E&>.G<'AV__ .$\/B/^TK?[
M.;/[']D^R'=LSNSYGF==W^STXQWK)MO%6NPR:))?6]A/#K-FTL$=NK1M%,L7
MF;69F(96 /.%QWSUJOI/BOQ%JUY?:;;RZ/)>C3TO;:9+>4PJQ8@Q,?,Q)TQY
MB,![=J;O%V[7_6_ZB34E?O;]+?H>@45PNG^*->U30],N[,Z8]VUI//?PR0NB
MJ\9V^6&#L4(?(.0V=I/'2J^E^+_$5_'X7DD32HQK]L[(%CD)MY%3?N/S?.I&
M?E^4@_Q&BSO;^NO^07TN>A45YO%\0=1GM8;/RHTU0RW<;S0Z=<7<6() F1%$
M2XW$CJV!ZG@&>T\9>)-1U#P_9#2;;37U2WN&D-ZDOF121<$^40IVG*D9()![
M=U8>QZ#17EJ>(M?U[4/!DL=W9VAFO+N*XC^S,Z/)"LB%A^\!VD X&>"023C%
M=;XKU[4]%O-#AL+:TE34;Y;25[B1@4R"05 '/"GJ?3CGAVV\P[^7_!_R.EHK
MSJ[\:>(+'3M:N95TR0Z)J"6UQLAD7[2C["-HWGRR!(.27R1T%6M7\8ZKIOB2
M*VVZ?]D;4(+/[,%:2=DD _>EU;;'\QP%=<G;UY%"5[6!Z7.VN;JWLX&GNIXH
M(5^])*X51]2>*EKRGQ]J-YXB\'ZS<Q0V']F6%^MNBRQ%IFD255:16SA,$L -
MI)'.1G%:VI>.M3AU2=-,TV>\@L[Q;66WCTRYE>4?+O=9E'EIMR?E.<[>HS26
MO]>2_P PEH_Z[GH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!'/&TUO)&DTD#NI42QA2R'U&X$9'N"/:N*C^&<$5I#:+XFU
MTV\5[]O1#]E.)]Q?=GR,_>)..GM7:7,Z6MK+<2+(R1J7(C0NQ ]% ))]A7,Z
M%X\TW5?#=OK$ZW%N+B1DCA-I*9)#DD!%"DR':,DH".#Z4+>Z![?UV_R-#1?#
M4>BZKJFH)J5]=2:E*)9DN/*VJP&T;=B*1\H Y)Z>O-9>I?#VQU&+481JNJ6T
M.H7BWDT<#Q;?,&T\;HVXRBGOTXP"0>BTO5['6K$7FGW G@)*DA2I5AP592 5
M8=P0"*X#7?B'=3:+K5SI+26+:7J45N\EU8R /&6C5OF<!5;+DX.3@#CG-'5+
M^MU_P Z-_P!;/_@G0R^ K*ZU+4;V]U/4;I[^**.1)#$JH8SF-T*1J593D@Y[
M_3&[IFG2:?#MFU&\OY< >==;-V!T&$55_'&3W)JM;^)]'N5OBEV4^P,%N1-$
M\13/W3A@"0>Q&0>V:FTG7-/UM)C8S.S0/LFBEA>*2-L9 9' 9<CD9'-/78"I
M#X8AM=4N+NUO[ZW@N9#+/8QLGD22'JW*EE)[[6 /<<FIO^$=L?\ A*?^$A!F
M%X;86Y4/^[8 DABO]X98 ^A(K+_M[4]:U_4=*T$V=O'IC+'<WMY"TRM(PW>6
MB*Z9P,9);C.,&KL6M7.GPWC^($@MUBF6*![<._V@%01M7!8L6W#:,GCO271@
M^HMKX8AL;Z>:TU"^@M9Y#,]BC)Y/F$Y+#*;QD\D!@IYR.36,?AO;'3FLCX@U
MKRVU#^TBW^C[C/NW9_U/3=SC^G%:C^.O#,5BMY-JT4$1N!:E9T:.193_  -&
MP#*><\@<<]*G3Q;HLEM=SK<RXM)A!-&;:42B0XVJ(RN]B<C& <YXS0M-?ZZ?
M\#\ _K\_^"/TGP];:/?ZC=V]Q<M]OG-Q)%(X**Y"ABH '7:.I..V,UF:EX#L
M=1CUN+^T=1MHM9(-TD#QXSM"G;N0XR% .<].,9-:*^*M(;4K;3_.G6[N5=H8
MWM)EW;!EADK@,!_">>G'-8.M^+WN=.T;4?#U\!:S:Q%8W(EM&5R"^UUPX!0C
M!!RI/IBA*]E\OQ_S"]M?G^%R:\^'=IJ%U)/>:UJTQDL!8,I,"@Q@@@_+$#NW
M#=GUXQCBII_ 5C>1:HEWJ6I7!U.UCMKEG>,$["2KC" !AD]/E]J32O'FG7[:
MX]PMQ:6^F7)@,D]K*@8 *.I7!8LQ 4?-C''-6F\=^&8[+[7/JB6\?VD6I6YB
M>&193CY#&ZA@<$'D=.>E/7^O,-OZ[%#X@VLT?PSU6PMX[Z_N);<PQB.%II9'
M/<A%X_( >U6+#PM87]A)<WUQJ-\U[9&US?*(WA@8<QA0BE>V2P+<#).*BUOX
M@:7IN@WVH6HN+B6UG6V>+[)*&21L;=RE00O((/0\8))%=3;7"75M'<1K(J2*
M&42Q-&P!]58!@?8@&ENG_70-K6Z?Y_\  .7'@"T\ZWN7UG69+RVLVLHKDSH&
M6-NQ4($8].JGH"<D U>T_P +#2_#]GH]GK.I1QVD1ABFS"7V\8!!CV' & 2O
MYU5U3Q9Y'BM?#5M'/'=2V4DZW+64LL:/E0F=N 5Y.22 .!D$U4\#>-(-9T+1
MHM2O=^KWL#R9$#+'(58[@K ;,@=5!R!UIZR7]=W^MP>G]>2_0O1^!].MFTMK
M&YO;-]/BD@1H9%S+'(0SJ^Y3U(SE<$'H152Q^&^E:9';I97^JQ+#!);,#<A_
M-C<Y93N4[>>?DV\UM6GB?1[[4_[.M[LM<E2R!HG590.IC<@+(!WVDX[U4U[Q
M#/9ZQIVA:9#'+JE^KR*TV?*@C3[TC@<GD@ #&3W%+?Y_U_F&WR*=MX"AL[K3
MKB#7M75].L6L;?\ X]R%C( YS%R?E4Y_V1[Y72_A]8:5'I"Q:EJ<C:6TWD.\
MD88I+]]&VH,KD9R,'WQQ6A;W.N65]%%JK:?-9>3))+>V\;P"-EVX!1F? P6.
M=W;H*2'QIX?F:<'4!#Y,)N&-S$\(:(=9$+J Z?[2Y'(YIW=[_P!=?^"%M+%C
M5_#]MK%]IMY+/<PSZ?*TD30.%SN4JRG(/!![8/H15)/!EA'+L6YN_P"SA/\
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M3QQ,L?WRDC*$<+WVDXIMOXX\.7)A\O4U$<\330S21.D4BJ"6VR,H4D $D Y
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M( R58$XYS6_10M-@>H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW3=TS5?2=&\1VFD>!K6;PW>"32+MWNR+BV(52CJ"/WO/WP?P/MGU:BG?6_\
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M+_-DG'!KTVBDG8;U/-K?3=?T[Q5#XHM?#EP9M2=XM1L!);#[/&,!)%;S.7.
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M##AR,H=V<KD@YXKE7\*^+)?"9T:XT=58:"MG&UE=Q#=,H8;9G.UR.F%7*9+
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MD4ND;Y/WU.,9P.Q()SC%:4'CC4VANH+BULH]0.N?V1;*C.T8^4-O8G!; W'
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MT,;EXB^Y'D52!\PQ][\LCC.0R?7_ !!/<:M::8^F23Z+%&;HS02!;J1DWE4
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M@N_<,'*[<C!XJL/'7AEC9*NK1/+>A_L\*(S2.5SN&P#<""I&" <C'7BC^OU
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M"FKK8'_7]?>7J***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!#>6R7ME/:RY\N>-HVQUP1@_SKD?"T?B#PSH]KX>NM$DODLU\F
M"_M9XA$\8)VEU=PZG&,[5;VS7:44 <:VGZSIGB74]3_LYM335;6&$I;RHHMW
M0."&\QERAW9R,GK\M86C>'-:\-ZOI\::/=7MM8Z"]B;B&6 +),S"3"AI V."
MN2!SCMS7I]%'2WR_/_-A_7Y?Y(\ML?#>MP>"M&B72]5L=?TZT^SQ3VEY -K$
M])%+E'CX4\Y// !J?5/#_B1T\5P+IJW<^N:9"@N(YT2)9EB*.I#'<,GD<$>I
M%>ET4V[MW!:6//K?3-?;Q=937&B21P)H36$EQ'<Q/$LI*MQE@Y7Y<9V=3TQS
M5/3M#\20:)X;TZ?2'CCM+&2TN7M[B$3JVU0#YF<K$<$G8=W"\=17I*3I)/+$
MHD#18W%HV"G(SPQ&&_ G'>I*&[K7^M_\V"TV_K9?HCRWP]I7B+3+_P ,R7'A
MJ^V:7HTMG.RW%L<R'80%_>\CY,9..2/<@\,>'O$.GGPA-<Z-)$VFK>07,;7$
M1*"4AE?*L05['&3GMWKTYYTCGBA(D+29VE8V*C'/+ 87\2,]JDI\S;O_ %NW
M^HK:6.2\7PZI+K/AV:PT:ZOHK*\-S.\,L*X7RW3 $DBDG+@^F._:L>[\-:NV
MB^(?#7V%[B+6+J:>/43+'Y<*RD$[U+;]R\XVJ0<#D=O1:*E:?UZ/]$._]??_
M )G'>$].U*Q\5>)9[O3+BWM;N2$VT\DD3"18XQ&>%<D9(R,@<'L>*9JVG:O!
MXUO=6M-,DO;:XT;[(/*FC5A('9L8=AU#<=N#DBM[4_$VD:/<+!?71CD;:3MB
M=Q&&.%+E00@)! +8!Q6M0U=?A^#_ ,P6C_KR_P CRS2=$\0Q+X'MIM"O(%TR
MRFMKR;S[<B,N@0$ 2Y8 C=P.A'?@:7A+PC_9\VF)J.CW_P!MTE=D5]-JLDUN
MPVE2T49E.TD=5**!VS@5Z#5#6-:TWP_ILFHZK=QVMI']Z1_4]  .2?8<U7,[
MW[_J*W0P?%.EMK!N;75/#0US2FC3R(XI(EFCD^8,079-HQMY#9Z\5SZ^$-:M
M+;0[B]74-4-G%<026UGJ;V]PD<CJT>)1(@D*JH4@L,]><"O3%8.@93E6&0:6
MI6@]SSW3/#MQI'C31&T_P_<VVCVME<Q-(UTDOEO*ZOSND+D_*<X!Y;C(YK4?
M0M1B\<32P1*=$U 1W-VV\ K<1<* O4[ALSV_=^]==13OM_7]?\ ._F>87OAW
MQ!J.J>*)8])DM_/O[.^LGN)XO+N/L^S*'8[,N[;D9'UP>*V]>TN^\1:+Y\6B
MS6%XES#<20/<I%-<",GY?-A<[>#\K;NO85VE%+HD#U=SS_\ X1.U-A+<P^'M
M;MKJ:59V<:L'O4E1&57#O,R]#M +X(/([5=O+/Q'<?"V^L+Z![_6KBUF@5$>
M)6._*IO)*IN"D;L'&0<9KLZ*'JFNXXNS4ET. U'0-2N=/\,7ATZ_=M/MC;W.
MGVVH?99QN51N62.55)!3H7P0WJ,57@\/W>D^*?#\^E^&KZ/3;2.[>;-Y'(ZO
M-M.&,DI8ME23@D?,,$\UZ/13;N[_ -:W_P R4K)1\K'EF@Z'XETN#1M1?0IV
MEL+N]\ZP-Q!O>.X?<)(SOV97@$,R]\>[(?"?B#S9[VYTN7RDUFYO$M;/5##/
M+%*NW(=&0*PP#@O@@G.._JU%+^OR_P AO7?^M_\ ,\XC\.7.G^(O#4NE^&[Z
M&Q@NI[N[:6]CE>-I8]A+EY2S-GD[2PQT)/%/N/!QGUO4X-2TG4-1L[V[^U0S
MQ:K)%;H<*0)8?-7E67@JC9XKT2BG?;^NW^2$U?\ KU_S9Y;J'A[Q-'X;O?#U
MMHXNV_M87T%Z;J-(Y$-P)2&R=X8<C[I&!P3TKH_'%IJM_9Z(MCI,UY)#J5O=
MSB":("-8VRPS(R9)[8].<5U]13W"6Z*SK(0SJ@\N-G.2<#(4' ]2>!U.*$]O
M5?A9?H-]?G^/_#GEUUX:UZ^\0:KJ+Z-?QP+JJ7D,27Z0/<QB#R6"/%*"C?Q#
M) (X)&35R]\-7-JVAMH_AK4%C&LKJ5XLU\DTJX0J2[23'+'(X5F&%ZYXKTJJ
M&L:UIOA_39-1U6[CM;2/[TC^IZ  <D^PYH3M;Y U>_F<=J_A)[KQ+JK7VEZC
MJFFZJ(S_ *+JCVZ1$($*2Q^:@9> <@,>2,=*H:SX8UW['XQTJPTKSH]8CB:V
MN/M*+&I6-(V1MQWY&W(X(/J*].5@Z!E.589!I:2TT_K^M!WN[GE5]I/B>ZC\
M9!O#5P)=5TV&UM_+NK=D:149&Y+J=N7R"5!(!X!P*TH-,U^RNKV==$EN(]5T
MN&W*>?"KVDL:,NU\M@H=V<J6YSQ7H=%#U5OZZ_YB6CO_ %T_R/)]+\%ZK:6^
MG#6=(O;N)]+@T^>WTS5VA,)CW#+XDC5U8-R.2#D#.<UO^&M%O=*\;WKC19K3
M2AIEM9VTOGQR)F(MP/G+XPP )'.#G'&>YHJG)MW]?Q%;2QFW=J-?T"\LKRVG
MM$NXI('CD*%PI!7/R,PY'(Y^N.E8/AIO$.A:/9Z#>:$]T]G$(([^WN(A;R*H
MPI8,PD4X R C<],UV%%2,XZ33]7TOQ-J>I+I[:I'JEK!"5@DC3R'0.#N$C#Y
M#NSD9/7BL'1O#FM>&]7T^--'NKVVL=!>Q-Q#+ %DF9A)A0T@;'!7) YQVYKT
MU)$D7=&ZNN2,J<C(."/S%.HZ6^7Y_P";"_\ 7W?Y(\ML?#>MP>"M&B72]5L=
M?TZT^SQ3VEY -K$])%+E'CX4\Y// !J?5/#_ (D=/%<"Z:MW/KFF0H+B.=$B
M698BCJ0QW#)Y'!'J17I=%-N[=P6ECS>#1_$,WB&[:XT1X8IO#RZ=]H6YB>(3
M#<?[P?;\P&=@YSQCFHX]$\1OH^BV$VC211Q:0UE*T%Q"LR2;5&'DW;A&<9Q&
M2<@$^@],HI/5-/\ K?\ S8+3^O3_ "1YII&G:_8:KX8GE\.7ICTW0WLYRD]L
M?WI"8 _>\_ZLC/3D>^(?!_A[Q#IEWX9GN]&DA^QVMW:7"M<1'RS)*KJ_RL<K
M@$<9.>V.:]1HJG)M\W];M_J+E5K?UM;]#DO&.DWE[(EYI=OJ*:I!$4MKNQN8
MTVECRLB2$*R< G(8^@S7,:AI/BBY3QD)= N)I]4TV&UADBGMPDLJHR,P!D!5
M<OD9&< \9P*]"FU_28-5L],>_A^W7H8V\"G<SA023QT P>3QQCK6E4K8J^IY
M9K^@^)-8TJ_M5T6=//TN".$17$$9:5,[DF8/N;!^Z 2F"<]:O75GKS^(?$EX
MGAN^:&]TB*T@/GVWS2+OR/\ 6\#]YU/]T^V?1:9++'!"\TSK'%&I9W8X"@<D
MD^E$G=._6_XBBK-6Z6_"W^1Q3:?JY^#AT?\ LBX_M3^R_L7V3S8=V_9LSNW[
M-O?[V<=L\5AZCX:U_6[FRM3I%U90MX=ETR2ZDF@(BE<(1D+(6*_)@D ]1[X]
M!TKQ#IFM2W$5C.[2V^WS$D@DB8!ONL Z@E3@X89!QP:TZJ3;DY/K_P '_,(Z
M))=/^!_DCAVT;4]<U+2+FZTM]-.DV\\>Z66-_/=X_+ 38Q.SJ<MM/ X]+WA3
M2M1MOAW::+?VHM;N&R^RE6D5P2%V[LKD8)Z=\=<=*ZJBIEJFGU_X/^8+1IKH
M>=Z3X;UBZL/#&FWUBU@N@QD27+2HXG?R6B'E!6)V_-DEMIX QZ/\)>$?[/FT
MQ-1T>_\ MNDKLBOIM5DFMV&TJ6BC,IVDCJI10.V<"O0:H:IK-CHT"2WLKJ')
M5$BB>61R!D[40%C@ DX' &:IS=[L5M+'):[X7DN_$]]<7>F:CJ>FZE!'$Z66
MIO;"+:"I$B>:@="#G/S'KQ6=>:+K4.H^)$M/#MTUM<Z'%IUH4N8"K.@<=7E#
M;?G'+#/RGOC/HMC>VVI6,-[9S+-;3H'CD7HRGH:L5#6G*_-%)Z\R_K^K'FNB
M:1K^FW,UU+H4[";0;>S,:W$.Y98@X*_?P<[@0<XQG)!XI-!T'7[&/P//-H\B
MOI5G/9W<33Q90LJ@/D,05.T],GD<5Z715N3;O_77_P"29*BDK?UT_P D>5VW
MAK7KG0KH3Z1>6TT.O2ZFEL+Y(7N8G+?*LD,F4<!L\D#( S@DB^?#%SIUWINN
MZ-H5VLD-XT]W8W=^)KF;?&8R^]Y'3<!C W\C/(Z5Z+14K3;^N@WKO_74Y+P;
MIVK66I^([C4-/2T@O[_[5;_OU=R"BJ0RKD#[O]X]3Z9.#8^&=>L[.S=K M)I
M6MW-^L*SI_I<<ADQL.< @2#&XKR"..M>ETT2(9#&'7> &*YY /0X_ _E3O;;
MR_ -]SG/#NE7,>NZWKMU;-9MJ9A"VKLK.@C0C+E"5W$D]"> .:Y:'1_$46LZ
M1J4^AW+M87UT\L-M<6Z1%'1PK11[U')(R7PV2>Q->DM<(ES' 5DWR*S B-BH
M QG+ 8!YX!.3SCH:EI?U^?\ F#\_Z_JQY1IFB^([?2O"=M+X;O%DT_5YKNY_
MTBV(6-C)@C][S_K1P/[I]L] NDW5O\1Y[>$(=)O%34YQGE)T_=XQZ-\C?6,U
MV]4[#2[73?,-N)2\A^>2>=YG(R2!N<DX&3@9P,G%-/7^O+_),'K?^NK?ZLQ-
M=T^_B\4Z7X@L[66_2UMYK:2TB=%D/F%"'4NRJ<;,$$C@_A7/2^$M6MX+.^@L
MA).WB/\ M::S25 8HV4K@$D*2,@G![G&>_I%%):?UYW_ #!Z_P!>5CR?5-'\
M376D>,((O#5YY^J:C#/;#[3;8**(P23YO'^K/O\ ,/?&B?"+W6J7\>JZ)J5Y
M;7]R+N-UU9XX83A2$FB68#*LO5%?.!7H]%"T_K^NP/4Y'PA9:E:Z[XGGOM+G
MLXKV^6>W>22)A(@C5/X'8@Y4GD#@COD!FH6VJS_$2*YCT>\_L\:=+9&]66#:
MK.R,&"F3?@;2#\N<] 1S77M(B,BLZJSG"@G!8XS@>O /Y4V&=)_,V"0;'*'?
M&R9(],@9'N.#1O;TM^%OU#O_ %Y_H>>0>'=7.@Z!H5QI4H_L*>*X-XLL16Y$
M0.!$-^X,QP#O"@9/)J@="\1?\*E711X>NO[2^W^88/M%OPGVCSMV[S,8QQUS
MGMCFO5J*=WO_ %NG^@?U^?\ FSSC4K#7KO6O%5U'X=OO*U'1H[2WS/;9:4!\
M@_O>/]9U_P!D^V=*XT+4]4^&^EZ<;=K/4+06KM;32(=S0LI*ED+##;.#GN,U
MVM-DD$43R,&*J"Q"J6/'H!R3["E>R^[\+O\ 4+7_ *[I+]#A[O3]4OM5O_$7
M]AW<,QTIM/BL3+ 9I69\EB1)L"CC'S9Z\= ;FEZ1?WWPO30+RUETV].F_86$
MKH^&$>S<"C,-N??/L*Z6;4+2VM3<W$Z00B(S,TQV;4 R20V",9&<]*;IFIV>
ML:=#J&GSB>TG&Z.500&&<9&?I0UHX_UU_P V"=FI?UT_R1QUWHVJ^(_!=QH]
MUHRZ;J:67V5;N22-T?&.(V4E]C%1G<%..QQ3[S3]5U75K?69-$N;5]-L+BW2
MV,T+/<O(% VD/M"#:>6*GGH*[=I$0J'=5+G:H)QDXS@?@#^54=)US3-<CN)-
M+O([J.WF,$CQY*AP 2 >AZCIQ0_>O_7=?J"]VW]=G^AY_H^E>(;2/P%%-X=O
M$_L>-X[UA<6Y"YC,8Q^]RPSSQV]^*RM/CUG1O%.@"[T"\2=M0U6YCM_/@+R)
M(-PVD2%<@'D,1]37LM8>L:)H<NHVWB#5'>*;3E+17#7TD,<([D@.$P>AR.1P
M<BFY>]=BMI9'(3>$-5*)JLEG</-)JD]]-IUG?M;RJDB! %E5U&\;02-VT[F&
M:>OAZZTW7_#D^D^&;^.R@N;B[NC)>QRR*TL>PEC),26SR=I(QT).17?V6HV.
MI0K-87MO=1,NY7@E5U(Y&00>G!_*K-"T#<\MT[P_JQT6<W>@ZQ::A'J%W=VD
MUE>VZS)YL@91_K-C @_,&./DZ'BEUW0?%^JZ7=6E[9"XN+C1! 9[*6*$27(W
M$K*Q(<KR-H7Y,ELC!KU&HI+A(I88V60M*Q52L;, 0"?F(&%''4X&>.II>7]?
MUH5>SO\ UO<XR/3]9M/%@UA='FFAET-+5HUFB#I*CEBARV"3G@@X]2*R/#&@
MZ_HUAX:O[C1KEKC2[2>RGL%G@+MYC*PD1O,V$?+@@L#_ %]/HIWUO_6[?ZLF
MVEOZV2_1'F(\-:S9:SI-Y%H\\ROKD^J7*Q30@6R/&8POS.-S<ACMR.N">,ZG
MA674M"356U70KVV2_P!:DEC8RP/M24@*6"R$]< @9/(ZC)'=4QXHY'1WC1F0
MY1B,E3TX]*$[?UZ?Y#>O]>O^8^BBBD 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 5=2NS8:7=W@C,AMX7EV#JVT$X_2N*_MCQ#IO
MA1O%LFIQ7]F^E->26;0JHCEVAD$14 [.2#O+'C(-=\0&4JP!!X(/>LC3_"VC
M:6LB6EJRP."/L[SR/"@.<A(V8H@.3G:!UI=QKH<O>:EXCTC4-,@75Q>KJ]I.
MP:XMDQ:2I'O#*$"ED[88D]/FJEH^N>(KR'P9)<:VY.O6KBX"VL0$;"/>'3Y>
M&[<[E_V178P^$-%@AFBC@N LL30Y-Y,6CC/5(V+YC7@<)M' JM;^ O#UJVFF
M&WO$_LS(LQ_:-P1"#U 'F8QCC![<=.*JZO\ UY_YHG6W]>1REGXE\27#Z!;_
M -JQA9M:N]-N)&M4,DJ1^9M;(PJG"=EZ\]."2^(?$%II-_=MK,DSZ5KJ:?AK
M>("YB:2,?O,+U DX*;.G.:Z:#X<^&K>>":*WOP\$YN8\ZI=$+*?O/@R8R<G)
M[Y.:<_P]\-R6ES:O;WK0W-P+J93J=S\\HZ.3YF<]#^ ]!@3VO_6W^3^\;ZV_
MKXO\U]QD'6/$\USXOL[:474^GW5NMLMO"B.D+J'?:')#.%)QN."0..U+)XAO
M[G18;G3+K6+N&"[,6HF.RB6^M@J [3$RX/."=JYPWRCI6]9>"M#T^XN;BWBO
M?.NBK322:C<2,[+C:Q+2'D8&#UQQ4T?A32(;1K>**YC#,S/*EY,LSLV,EI0^
M]CA0,ELX %+9?<#U9SJ^*+QO$/ATVFII>:/?V-U.P%KLD=H@#R3T^]C;@$%3
MGT%.W\0^(/[)\->(AJ'GQ:U<10S:>T">7 )<[3&5 ?*\9W,<\].W5+X-T)-0
MT^^CM98I].0I:^5=2HD:DY/R!@ISWR#N[YJ6W\*Z-:W9N8;:1&RS(GVB0QQ,
MP(+1INVQDY/*@'DT]/Z]?Z] _K\/Z?F</IGB3Q']AT;4;W5EG,^O2:9- ELD
M<;Q[Y$#="P(V@C#=.#GK7J-<LOP\\-);6]NMM>B*WN3=Q+_:=S\LQ.2_^LZY
MY^I/J:V=-L);.6\=YI&2>8R)&\[RA!WP7)(SUVC"CH!W)T_KLOUN+K?^MW^E
MC@KJ>\T#Q;XUUI=2O+C[#I\%P+9UA"2?+*50D(&VJ>F"#ZDT3^)?%^B07EY=
M6%]+8201^1+>FS#I.\BIM00R8*8;(WD$8Y;G-=E!X3T>#5[O5%BN6NKQ2EP9
M;V:1)%Y^4QLY3 R<#&!GC%.M?"FC6=C-9):O):3(8V@N)Y)D5#U50[$(O3A<
M#@4ELA]7_78S?"MQXE;4KZ#6;:\%@$1[2>^-J)RW.]2+=BNT<$' //.:3XF_
M\DT\0?\ 7HU:#>&K:VT>:QT]KI"X 6234+@NF#QB3>7 ']T$ ].]:<]C!>::
MUC?(MU!)'Y<JRJ")!C!R/>ACB[.YY_K_ (FUCP=-.#=G4H9=)DNX4FA1?L\B
M,B@90#*'S/XLD8ZU/J^J>(] U(64>KB]%[IMS=1RW-JA-M)$%8X$83*$-@!L
MD'')Z5U=EX8TBQAGBCM#*MQ'Y4INI7N&:/\ N;I"QV\GY<XYZ5"O@_15M+FV
M\FY:.XC\ER][.SB/.2BN7W(G'W5('M1+5.W];_YK7R%&RM?^MO\ )Z>9QUKK
MWB%H]%676I7?5M EO&9;>)?)F18V#(-IZ[CD-D>@'2K.DZ_KEQ=>!)9-2>1=
M7TZ1[N!HHPCR+$'#Y"[@<MR <<#BNCMO ^@6=U87,-O=>;I\)@MM]_.ZQQGJ
MNUG(([8(/ 'H,);^!/#-M)9NFEJ[61;[*9I9)?(W8R$W,=HX& .!VQ52:;=O
MZ^+_ #7W"5[6_KI_E^)1\):U>W%^=-UJZOHM86%I9;*ZMXT0\J-T#H &C!XY
M+-\PSS6SXIU>70O#&H:G!&))H(LHIQC<2 ,Y(XR?4?6HI/"VGQI<RVL4WVN6
M'R%E>^G#1IQ\J-N+1C@$A,9QS6FMDDFF"QO"+M&A\J8RKGS1C!R/>IEJM!K<
MXFV;QG=?VK;S7=]I=L;836FHWRV1DCE!.Y"L1=3'C!R1N'//0UA#Q3XEG\%Z
M[KL>M/:WVFVZQMI]Q:QOM8*,R_<1OG^\O5<'.#T7O_\ A#M%.ERZ:8KMK67
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MX?L;R5M-N(XEBC-H+>;*(["4R.) <,<%  ..O('1S> O#UPNIK-;WCKJ9!O
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MG:2JE5QN*L"I/RGUX-;$GB;1XM6_LM[P?:PRHP$;%%=AE49P-JL1R%)!/84
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MVN5+QB6[G5L9(Y'F<=*T/^%)?#S_ *%[_P G;C_XY3>^HEL7-1\##_A/=/\
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M-?#:UA,T^A+'&, LU[<=2<#_ ):>IQ4G_"DOAY_T+W_D[<?_ !RG?2W]=/\
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M07+("RPKC=@_.#T(;(/IGFM'4;CQ1KNL:P-,NK:SGTV6(V[S:I- J1F-'+/
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M$2C@C'W3QGUXN5KZ>?YO_@$1O9-[Z?DOUN=O#XFTVY\*R>(H)&:Q2!YV)7#
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M.:2VN/(#I<B+[^Q48OD=@5&>V:;IOC_3]4.FM;Z?J0AU-)&LY98T1970$F,
MOD,0"02 I]:Q+7PCXFM]3TW595TJ\U"T6YCFFEO)0UR)!\K9,9V8(^X 0.Q[
M4S2?!_B:PM?!UO)%I#+H<TCSLMY)F165E^4>3U <G!/48SWI17?^M_\ @#>F
MQT-CXVAU#1VU"'1=4!6^^PFU<0B;S VT\>9@ 'KDYP,XQS73LVU2Q!P!G@9-
M<?::-)%\2+^>&53IYBCO9(<'Y;HJT>[/3E <CUP:Z+2;^?4+:62>WCA9)6C!
MBE,B2 =&5BJY].G4'KUI;K^O3\PZ_P!>I@6_Q#TRXMXKQ;'4TT][LV;WDL 1
M(9=VT!U9@X!;C.W /7%*OQ TZ6YOH8M,UJ1;&9H+F2.Q<B-@F_I][!' ..N.
MQ!/,>'-(U+Q#H6I:7_H2:2^NW,DTWF,9B$N=^P)MV\E1\V[@'IWKHM*T/7[&
M7Q7-+!II?5)S-:JMW(0/W8CPY\KY>%!R-W7';)'\-_+]%_FQ];>?ZLM6?BW3
M_P"Q]);3;/4KZ2]M?M-M:JRO.8AC+,TC@<;AU?)SQFJ[?$C1F.GI;6NIW<U]
MYJQ10VIW!XPQ>-BQ #C:1MSW!Z'-9^A>$=>T*VT.\C739M3T_3CILL#74BPR
MQ[E8.)/+)5OEZ;#UZ]Z+?P7J]AKFB7=M]@EAMKVZOKUGG=&+S[@PC4(1A01C
M)&<=NM4TN;R_X?\ 2WS)OI?^OZN:_C#Q/=:'X._M>ST^XDEE,2JC!4:'S& !
M96(Y!.,<\]>,FI;SQE!9"4-I.IS26L237T<*1NUFK D;_GPQP"<1ESC\*E\9
MZ)<^(O"]SIUG)$EPSQ21F8D(2DBO@D D [<9P?I6<WA_6[/4]6N[#^SY?[91
M/M0GE=/L[JFS<F$/F#&/E.SD=>>)[V_K3_,K33^NO^1J:SXBCLO!MUXATZ+[
M?$EH;F(1,H#KMR#DD<8Y/?T!/%<A;^(M6/BOP_=3Q:LZWFBS2OIBF'#R*8_G
M 5MO()(W-QP."<5U4GA=(_A_)X6M)\+_ &<UE'+(,_P;0QQ^=8EMX?\ %$&N
MZ+J#6^CNNGZ7)9%!>RJ6=@G/^J/&4'/^UTXP6[*3M\ONE_P"=7%=_P#@K_@F
MPGC2RN=*L[ZPLKZ^:[@:Y2V@1!*L:D!BVY@HP3C&<D],UJ6&MZ?J6A1:U;7
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M!KF>13 L;*6C"!"JYPQWC).[!&*I:AX/\5WVE^)[80:,DFLWT5RA-]*1&JA
M0?W/)_=C_OH^G)&VE_ZV_P"#]P/R_K?_ (!;^(_BB2+PKKD.D-J:3V28FOK+
M8$@DP"$9B=W(89* XSR5KL;W5+?2-";4KQG\F&(,Y4;F/08 [DDUQFI>#O$5
MQI/B'2;633!::V3.7EFDWVTK*H=0 F'7*\'*D9Z5U&K:?K-UX2:QLKZ"+53$
MB^>@:)&((W $%F0$ C(R1G-'V?N_+7^OF&[7S.8\7>*)K_P/X@>Q.IZ-J6EF
M/S8W\M9%W8(^92ZX(/56S[BM.QN;T?%.]LY+^XELSI$5PEN[#9&YD*DJ !UV
M]3D\GG'%85_X%U^32O$MG8V^C0C6A;D W<N(2B@/D^42YR!SP3GG%;^GZ/KZ
M^/6UR\M]-CM)--CLV6&[D>165BY(!B4$98CJ.!GVHC_7_@/^8GM_7=?I<UM5
M\0Q:;=K90V-YJ%ZT1G^S6@3>(P<%B795ZG&,Y/8&N3UWQ:VL2^'(=(M=4N=-
MU.603/93);R/MC?,08R(Z,K*"WW>F 3TK?U'1M1@\4CQ#I"VL\\EH+.:WNYF
MB7:&+*RLJ/R"3D8YSU&.<6/PAK6EW>@'3DTZXAL+J>\N7GNGB:22;?O"*(V
M4;\C)YQCCK1&VE_ZW_2PWHG;^M%^MSM=.LS8:?#:FYN;GREV^=<N'D;_ 'B
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M?Q?X?N_$NCII]KJ$-CBXBF:22V,V?+8.  '7'*C/7C/UKH** &QAQ$@E96D
M&YE7:">Y R<#VR:=110 4444 %%%% !1110 4444 %%%% !1110 4444 <_X
MP\/W?B;1TT^UU"&RQ<1S-));&;.Q@X  =<<@9Z\9^M;T8<1()65I !N95V@G
MN0,G ]LFG44>0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9JANR\<$!D&55Y'"!C[#.?PKI:PO%UOI=[X=GL=8@O);2Z(C(L[66>16^\&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML>^,4; M34HJEIVK6&K+,UC<K-Y+^7* ""C8!VL#R#@CCM5V@ HHHH ****
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M@V66Y.9W?PR6,O.?F)N/FY //<5IVND^)[*UCMK35?#UO;Q+MCBBT.5$0>@
MN< 47TM_77^OD*W]?=_E^)1U$RZQXVO=&N[V]LK*WTZ.XMS:W+VY>1F<,^Y2
M"P4!>#E>>1TKE[>&?Q W@"\UJXO#>3RW$;20W<L'F(L<FR0!& !8 $D8)!QT
MXKK]0\.:[JRQKJ5YX8O5B;?&+GP^\@1O4;KDX/O4%[X1U34KJ*ZOG\)75Q$
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M '8@UW^FZ%I&C>9_9>E6-CYGW_LMND6[Z[0,T1Z#H\4UU-'I-BDMVI6Y=;=
MTP/4.<?,/K2_K\_S_0?]?UZ'F?A^_P!1CL/!NH2ZSJ%S<7FK7%I.9[EF26+,
MV 4&%R"JD'&1TZ<5:O[F_M;?4]/U&34A>WEM=W%AJ%EJDC0S[%+* H8&%E&W
MA1M..ISBNX3P=X8C$(3PYI"B%S)%ML8AY;''S+\O!X'(]!5V#1],M;J2ZM].
MLX;B5 DDL<"J[KZ$@9(]J):JWK^GZC3L[_UO_EH>?66KA?$W@WS-8F)U#0Y#
M-%)>L4FD"1E6V%L%N7YQD\]<5A:=96MUX7^&3W$T\:?:9$9HKN2$!?+E.<HP
MP<@<]<9&<$UZO'X;T*&W,$6BZ<D)5U,:VJ!2'^\,8Q@X&?6EA\.:';VB6D&C
M:=%;1RB=(4M45%D'1PH& WOUJN;WK^?ZM_J0E:/+_6R7Z'GVF:E=S>+-#N;7
M5K^>UU*[O87GENCLF15<H$MR65 A4 -P3C)!W54TR]U*'2]"U"76]2N;A_$D
MNGNTUR=LD)DD3:47"G[H(.,@],#BO2SX:T$NSG1--+M*9F;[*F3(1@N>/O8)
M&>O-5QX,\++&D8\-:,$C<NBBQBPK'&2!MX/ Y]A23M;^NO\ PXWK?^NC_P"!
M]QS7PYTRR%EXAA,MPY?5[J-HY+R5_D63C@L<>YZMW)J?Q=<W6D:F^J3?:IM$
MMK55D6POC#)9DE@9#$"%E!!&,Y(V\#K796]A9VDT\UM:00RW#;YGCC"F1L8R
MQ'4X[FHKK2-,OKB*XN].M+B>)@\<DL"NR,.A!(R",FDM+>5OT&^OG<N*P=0P
MZ$9%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 1W$\=M;RW$S;8HD+NQ[ #)->?P?%BRGN3%#:VUV9+.2[MH['48YI"$ +)*
MO B;!SC+#@\Y&*[^YMX[NUEMIEW12H4<9Z@C!KFD\-:U'X?GT8:_ ]OY!M[:
M22Q)D1"NW]X1(!)A3Q@)R 3GI2=];?U_6GXC5M+_ -?UJ0Z7XYDO+C35O=*^
MR0ZCIC:A ZW'FL H4LK*%&.'!!!.>X!XING>.I[NZTN*?0YDCU:W:ZLGM[A)
M#Y2@$F16V;6PR_*N_K[52/A/5-$32=3?5X;B/0=,EM1!!IC&2=2HY'[T_-A$
MP,'G/K@9'A+38%: :?KNDZE.\)MI19I,9K)7!+%2T[K#@C.T1H"0!@<"KE:[
MY?/];?H2KVU_K:YTVD>.)+W5WT_4-+6QD^P'4%1;GS94C! *RQ[5,;\CY?F'
M7GBH[+Q\\LVF_;=&D@M]3MGO+2:*Y23;"H#,TH;9M(# X7?U]J@M/"=UX96+
M53J$=S_9VF36S0VNG;6F!(8,!O.9,H,YSN)Z"L7PAIEGYENEMJ^C:R9(3;7,
M%M'.9;9'!W@%IW6$9'*A$!(P .!2?]W^M_\ @#\W_6W_  36L/BE97^H"U@M
M[:Z>>TDNK6.QU".:1M@R8Y5X$3X/ W$<'GBK&G^.[[4$T)UT)(TURW:2TW7H
MR)%7=M?"<+CG<-Q_V16E9Z!K5GH\FF?V[!+!'#Y-H\ED=Z#:5'FD28DP/0)T
MYK*T_P ":K8CPNG]O6;QZ K(@_LY@9@RE.3YW!VG\^?:C2_]>?\ P!:V_KR_
MX(QOB;:II\)EBL+349);B(PWVHK! &A?8^)2O.21M^7)[XP:?8?$<ZS-HL6E
M:-),=6@FDBEEN42-'BR&0D;B<''(4\$$9YPW2_ 6JZ3+]L@U^U_M%;B>5)?[
M/;RRDSAY(W3SLD;@""&!&.]:=[X9U6Z\2Z5K*ZS:AK"&9/*DL6;>TF-QR)1@
M#"X&#T.2<T?U^ WUM_6IA-XTUG5K_P )-IMC;117US<QW4,MVRG?$KJR;A&<
MJ""P..2!P.M=WJ=ZVG:7<WB6L]V\,;.L%NNZ20@?=4=R:X_2_A_?:?%I._78
MI)]-O;BZ21+'8&68-O7!D;!!8D-TZ9!KJM>TMM:T&\TU+I[5KF,H)D&2OX9&
M1ZC(XH>VG];?\$%\7E_P_P#P#E)/B+-:Z;XAFN-&CEN]$CCEFALKY94*N">7
M95*D8.1M)Z8SFKC>.A975]%J^G&T6#3EU&(QS>:TD9.W:1M 5]V!@$@Y'-4K
MSX?7]S9:Q;QZU90#5;**SE$>F$)&$W#**)1C(8\$G'J>E/O?A_=ZMJ,L^IZS
M;R6\VEC3GBM[)HV !W!U8RM@AQGD$8X]Z-/Z]&+^OR_X)5LY+^;XP64VH6'V
M.231IBJ)>-.I7S8\<$ (P[@#'3DUL_$#5]5T;0;>;24@:66]MX':65D(5Y%7
M@A3US@GL"3STI++PGJ:^)-/UO4?$'VF>SM7M=D%FL2S(Q!^?+,<Y4$[<=.PR
M#I^)]!/B+1Q9)=?9I$GBN(Y3'Y@#1N'&5R,C(]11I[J[?Y_Y!KKZ?I_F<,NK
M7OAKQ3XTU-=.%R8+2SNKJ)KYBJ#:Y<1LRDG') PHX_AZ5K^(/BAIFB33*&L9
M%MHXY+B.6_2&<JX##RHB"9" 02,KUX)-%]X%U>^D\1LWB"T UNV2V<G36)B5
M05!&)@"=K-V'.#VP='3_  OJFE78N++6H$,\4:7R/9%EE=%""2/]YF-BH .2
MXX'%"V7]=QO=_P!=BI;^/I[B_P!44:%+'8:6ZF[NI;I 5B:,R"15&<\!>,@X
M;U!%5K#XGVE[>7%K%:P7DXLWO+>+2[U;MY N,QNJ@;).1Q\PZ\G%:=AX/FCO
MO$<FI:A#>6FM@+)"ELT3(H3RP-_F-GY>O YYXZ4LGAC5[KPY<Z+>>(?,C:'R
M8)XK3RY0.@,AWD.<<' 3/-+^OZ_ /\_\O^#^!5@\8:CJ-IX@M(=/LH]5TN%'
M*QZ@9(B'4D?.(\AAM.5*^G/.:X_PP^K6&M^$)8=)TR&35=/:6ZN$U&7?=JL:
MDO*/*QO^?/.XD\;@!79V_@[4K1]4EM]6L8Y;^RBM2JZ:1%$4W#*H)1P0YXSP
M><GI26/@F]M?^$<>768GFT6&2V#1V9030LBKC!D;#?*/FY'7Y:>B=UY?^W?\
M 3U5GY_I_P $IVGQ2TZ\UBUL[9+2Y2],B6JVNH1R7!=02!)%QY8;'!+'J,[:
MV/"7BB^\46R7KZ(UE8NL@65[E7;>DA0J5 ]!G()'4>A+](\/:GHMLUA:ZQ"V
MFQ!OL<4EH3)"/X59Q( Z#TVJ<#&[O5;1]%U;PGX..GV]];WUW',[Q/\ 87 ?
M>Y8H5$O!))&[< ,C(..16&]]#J93((7,2JT@4[5=MH)[9.#@?@:\>75-8UC2
M_".KZE"K73>(7CC6"\<JZEI<AD(50%*@ _,<#MG%>QC)4;@ <<@5P:?#[4;>
MUTFUM]?@%OIFHO?Q++IY8L2SD*2)1_ST8$]\#@8.4OBU\OS!_#]_Y?YD[_$.
M"UT^X.I06=C?PZ@VG&.:^"V_F!-X8S,HPI7!SMSGC!K6\(^*[;Q;IL]U L2R
M6UPUM,(9A-'O7!RD@ #*000<#Z"L:#P'J$=W?7S:["+V74?[1M98[$J()#'Y
M;*RF0[T*8&/E/4YZ8["QBNXH/].N8[BX/+-%$8TZ?PJ68@?5C35K?UY?\$'O
MH<I=7=UXA^(%YX>^UW%KIFG6<<\XM96BEGDD)VC>I#*H _A())ZXJY=O_P (
M='<ZA+>WMW8LD-O;VDTQD<3,Y4 ._)W%UR6)(Q4VJ>&)9]>37M(U#^S]4$(M
MY&>'SH9XP<@.FY22.<$,",]Z=?\ AN76M)>VU;4#+<%HY$DMXO*CBD1@RLJ%
MF[@9W,?3BDME^/W_ .0/=_UT_P S&U3X@76A1:I%JF@D:A8V?VY8;6[$D<T.
M=I82,J$;3U&W/IFK$OCI[*>_CU'2O(-OIJZE%LN/,+QD[2&^4!"#UP6&.<U'
MK'@B_P!=L-1^VZQ:G4KRS^P?:8[!A'% 6RP6/S2=Q..2V.!Q4T/A/68_$D>L
M/KEF2NGI8F)-.(RH8,3DRGJ<\8Z''7FC^OP?_ !_U^'_  0O/&-[9:5INH'3
MK"X@O+R"V,EKJ/F(!*P4.C>6-^"1P0OUK \=:W-JWACQEI=S:?99-(\DI+!=
ML1*'Y!("KCCJIW#GOBM9OAX&L-11+ZWM[N[O8;Y&MK/RX(I(F#*?*WG)./F.
MX9]JAU7X>:CJ<>O'_A) DNM+"MP#8!HT$8 ^10X8'CC+' /()YIJUU_7\K_1
M@OZ_']+$J^(M<A\=:O:-8Q7&G6&F17"Q03,9FW;S\J;,,[%=N,C QR<XJ*?X
MCSV=GKKW6AJ]UI-M'=/!:7RR#8^>'9E78R[3E<'VS5^\\%WE[>W]V=<,$NH:
M8EC<-;V^P[EW8="7)4?.?EY/3YO7,O/ASJ%S9W]O%K=A;K?:;'ITRQZ60BJA
M8[D42C;D.>#G^E']?BP7]?A_P2_<>,=15]3LQI4$%[#I?]I6OF71973D$/A/
ME8$=!N!]?35\%7FH:AX-TF[U-8Q<S6L;EDE,F\%0=Q)5<,>I'./4UEKX-U&7
M7'U"\UFUDBDTHZ8\,-BR':>=X8RM@[N<8/''O6]X=TJ;0] LM,GNQ=-:Q+"L
MHB\L%54*/ER>P]3SGZ4::_UU?Z6%KI_71?K<YK5?'6IZ3;>(I)M$L_,T8QOY
M?]HL#/"X)#C]SP>,;>>0PSP,O\1>+I+31-1O)=!M]3TF&VB9]MR")#( =K*Z
M ;0".06)W#Y>N-;4/"MOJ/B:#5Y)R(UMFMY[78"MQSE"Q_V<OC_>]JR)?A]*
MOP^F\*VFL!/.;#W<]N96\L$;5"AUY"JBYR>%Z<\)>?E^>O\ F5U_K^O(J7=K
M'+\1M=B+W CG\/*[*MPXVDNP^3!^3A1]W'3/6MSX=LS_  Y\/,S%F:QB)).2
M3MJHWA/7&\07.KG7;#S9]-%@4_LQ]HQD[_\ 7_WB3CTP/>MGPKHL_AWPS8Z/
M/>1W9LXA$LR0F+<HX&5+-SCOG\!36BM_6\O\T2]_Z[+_ ".&BUF?PKX@\=7\
M-B]Y:6UU;2W!FO""B-$"VS<&)(+$[?E&. 1TKJ=0\67,=UJ$.D:4NH#3(TDO
M-USY1 9=P6,;6W-MYP2HY'-9>I> =4U"/Q1$=>M(TUYDW_\ $N8F%54* #YW
M)V@<\<Y..U:(\)W\%Q<W%EJ\$$NH0QQZCFS+"1E79OB'F?NVQQSO' XZY7V5
MW_X'Y7*=N:_G_D8D.M:=+\0+;Q%'/*-/G\-27C-([$*@D0Y"DX4X'.!S3);V
M^U+XC^#[ZZTYK**X@N7A'VMI,IY8(WQX"H_S'INX/WN,5IM\/A_:L12^@71H
M]*;2?L/V5BYA(&3YOF?>R!SMZ=N]/M?!6IIJ.A75WXC:9=&\Q(!'9JCRQL N
MV1BS G P2H7/;!YJM+JVR_SE_FB7=I]VOT7^3-/QKK$>A>%;R_GTK^T[=% E
MMBR!2IXRV[MTS@$^U9FI>-[VSU'6K*VT R'2;)+UI)KM8UEC.XG;@,0<*<9
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MZ_UM_P '\"GY?UO_ ,#\3.O!<:AXG\47>M>'[348=($3VXBOF\Z$!-X$>Y%
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MQ3+>LQ1E7<4*^4/SR/NMQQ@]H!A0"2W'4]ZX:7X:6LFF/:?VC,KK?_:K>8(
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M>-A(49R&''2A6TO_ %M_P?P&^O\ 7?\ X!L74\L>GS7%K&DTJQEXT=RBN<9
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M4MO/_@+];C>_]=W^EC/U/Q#=Q:O+I.D:='?WMO;K<SK+<^0JHQ(4 A6RQ*G
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MFCYF._++M (9LXZYK7^W01CQ;I^A7=HEC;ZS;O+%"GFQPP%$\UO+1E)3>#N
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M#:%+!&)(&,#G!JG_ &?I>C>(/"]OX@UE-0L#I]Y')<WC,EM*@9=F4=V7 #$
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MI8,=Q+?-\V!M!X''6FEK;^MVOT!O2_\ 6USVBHC<P+=+:F>,7#(9%B+C>5!
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M@HW$%L<D# )I:\]M_'.L-)I5S):Z?):ZK<S0);;GCFM1%N+%V&\.<(> JX)
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M4WK-;G=&X/0KSR/QKQ^^.IW_ (8OKS4Y[*]G@\51QVY^S&-D=;A$)#%FPI4
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MEJMVLTUM*D?EL< EBN 22/E)W<]*KKXW\.7US:6UOKOESS3HL4:QD-.2H8*
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M<'FK$WAG2[C7;?6I8[AK^WC,44GVN8*$/4;-VT@\9R.<#/2F[;+S_+_,2O\
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MAG4]5CC$KVEL\JH>C$#(S[4D7AS2X=1BOU@D:>'=Y7F3R.D1;.2B,Q52<D9
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MB.PE,CB0'#'!0 #CKR!T$OP^\-S1:A$]K=F/42IND&H7 67;T! DP !Q@<8
M'2K@\)Z.+J*Y$%P)HXEA+"[F'FHHP!+\_P"]P/[^ZFGHK@]]/ZV-I"6121@D
M9QG.*6CI12 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>ex10-9_002.jpg
<TEXT>
begin 644 ex10-9_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M("EMH. 2R\GU!Z5:UK5]/TQK&&]U3[#+=W*10!0"TS;A\@!4\'."0. >HZT
M:M%<Z?'7AKS9HUU1)##<K:S-%$[I%*2  [*I5<DXR2!GC.:LWGBK1;#45L+F
M]V3F18B1$[1H[?=5Y -B,<C 8@G(Q0M0-FBL6?Q;HEMJ*V,UZ5E,H@\SR7\D
M2GI&9=NP/_LEL^U4[CXA>$[2XG@GURV1K>;R)F^8I$^"=K,!M4_*1R>HQUXH
M Z:BL.P\8:#J4]O#:WQ+7,)G@9X9(TE0#)*.RA6P.H!R.^*2V\8Z!=7#0IJ
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MX&]"&X*\<'D]G;6W]=?\@[_UV_S.YHKGF\<^&XX[F2;5$@2WC$KM<1O$&0G
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M/Z_K[P-^BF0RK/!',@8(ZAAO0J<'U!P0?8\T^@ HHHH **** "BBB@ HHHH
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M.)&C)4_-G!R3C&3FN;OO"FM75QXEBCMU1+G5+;4K:5I5VS",1?NR!R"3&>2
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M=N"'VQ7;U2M-*M+*YFN(A,TTS$L\UQ)*1DY*KO8[5S_"N![4T[6\O\DOT7W
M];_UUN7:***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM(W;#R+(Y+8;Y0.RDY%=C:Z!HUDRM::180,L7D@Q6R(1'G.S@?=R3QTYHM]
MT:TL)K"VTFPALY\^;;QVR+')GKN4#!_&G?\ K] _K_@GF?B-[S3XO'%A9:MJ
MHAT[3+:YM3_:$K20N3(6(D+;R#@<$GCCI3O%6K2VOB'68K/Q#=VLK^&3>1QI
M>[OWRG.41B0I*KSM .,GKS75:-X6NM-\8:Q='3M)AT2\M8K:*"!SE1'NZQ^6
M%P0YX!XQWSQMGPOX?-I]D.A:8;;:$\DVD>S:#N VXQC))QZ\TGK'^NS7^3&G
M:7]>3_1KYG%/'?ZKXG\.6+Z_JL-M>Z"\LJ6]P$PZ^5APP&=V6)R2>GH2#%IT
MOBG5M2&IP7=M;_9-4>WN1/JDW,"R%1&;;RM@8KM(;=DY!S@XKN[?POX?M+J"
MZMM"TR&XMUVPRQVD:O&.>%(&0.3T]35@Z/I9U/\ M,Z;9G4-NW[5Y"^;M]-^
M,X_&J;UNO/\ ._\ P"$FHV]/RM_P3DO#%Y=6>OQ:9K'VM[ZYAEN(;M+XW%K>
M("N6"$_NB 5PH 7DX)JUXDFO(?'?A2*'4KJ&WNGN(Y;=&4(VV%B&(QDD$]R1
MP.*Z.TT?3+"YEN;/3K2VGE 626&!49P.@) R0*BO_#^BZK<QW.HZ/I]Y<1#$
M<MQ;)(R#.< L"1S4]O+_ ()7?S/,]+OM2M],T'49=;U&YN7\2RV#M/<DI)"9
M)%VL@PI^Z"#C@],#BN[\97(ATZSMQ=W4#W=Y' J6K;))\Y)C#[E\O(!RP.0!
MQSBIQX,\++&D8\-:,$C<NBBQBPK'&2!MX/ Y]A6G?:=8ZI:FUU"SM[NW)!,5
MQ$LB9'0X((I]$OZZ?Y?B'6_]=?\ /\#RE;_5V\.62C6[^%HO%(L3Y=UYK-"9
M0 C2,NY\#N>O?-6KRRU*^M/%]E8:IJIET:^2:S1-1F#NIB21X6</N96^8#)X
MSQBN]G\)^'+HDW'A_2IB7,A,EG&V7. 6Y'7@<^U-;1H=*>2X\/Z'I$5W<OBY
ME(%N64Y)8E(V+G)S@XSD\BE=I>?ZZ?JOQ#K_ %W?Z/\  I^%[JWUV>X\16ES
M<R6=PB16Z&X=HMJJ"S!"=H;<2I.,_)[FN4\;ZG=1:AJEU8:G?"739;-,)<F"
M&W+LNY2@)$Q93GYEP!T.<UZ)I&FQ:/I-MI\."D"!<A<;CU)QVR<G\:CN] T:
M_N);B\TFPN)I8_*DDFMD=G3.=I)&2,]J;MS)K9?U_F)+W6G_ %_6AYUX@FU!
M+[Q^_P#;FI@:=8P75FB7)C6!RCMP$QD9 X.<CKGBG:O?OK]AXK34-1N+9K#2
MDDMH(;@Q*P> LTK $!P6)7#9 V],UW3^$/#,C3,_AW2&:?\ UQ:RC)DY!^;Y
M>>0#SZ5-)X:T&5+=)-$TUUMD,< :U0B)#P57CY0?05+5X\OE^C+3M+F_KI_D
M9>B:E;1_#&ROX[Z-((=*5C<Q@2"/;'R<#J5(/'J,5S/ARZO8];O[26[O9+6;
M0DN]MY>&=FD)8&3!+"+(Q\BL5'%>E"WA6W^SK#&(=NSRPHV[?3'3%9J^%O#R
M1")=!TM8Q&T006<8 1CEEQCH3R1T-.?O.3[W_&_^9$%RQBNUOPM_D>>^'V'V
M3X4<C_CWE_\ 28UO?%02#P]ITSJ6TV#5+:740!D?9P^6)]@=I/TKH8_"/AJ)
M[=X_#NDH]L=T#+91@Q'.<K\OR\\\=ZV" RE6 (/!![U4I7=_._XIA%6T\K?G
M_F4+N?3KBS@>5XIHI)$:WVMG>X.Y=N.O(SQZ>E>=VU_JLOAW0O$L.H7IUFZU
M)+>YLVG9HF5I2KQ>3G:I1><@!AMR2>:]#L- T;2KB6XT[2;"SFE_UDEO;)&S
M_4J 34D>C:7%J<FI1Z;9I?R#:]TL"B5AZ%\9/YTEH[_U_3V&]K?U_74\MFO-
M3M--UO46UW4YKBP\2Q6\!DN2$\LO$K(R+A6!#'@C ZC!R:T5TN.WUSQ_=6FH
M:C;7,$<;QRI?2-M)@W'Y7+*>>!D':.%Q79'P9X5,;QGPUHQC=P[*;"+#,,X)
M&WD\GGW-$7@OPK"LBQ>&=&C$J[) MA$-ZY!P?EY&0#CVJ6KQMY?HE^EQW]Z_
MG^M_^ <AHVHSZS-H.EZEJ=Y!"WA^&]5X[IHGN9C@,S."&;: "1G!W<@USGA.
M_OM2\.Z!H6F7,,D9M+EF(U62S9IA-TWQ(Q+*I#;. 0V3D5ZU_P (WH7V.WL_
M[$TW[+;/YD$/V5-D39SN5<84Y[BGSZ!HUU8)87&D6$UG&<I;R6R-&I]0I&!5
MR:<F^_\ FW^OX(E+1>7^5OZ]3@K6'7)?%&@Z5K6OW,S2Z1<_:TL+DQQ/)&Z*
M'#*JONYY.1R.,#.<?1&_MK5? %_J=]=M.UI>J\XO)$+>6P"DX8 GU_O=\UZE
M<>&M!N[D7-SHFFS7 C\H2R6D;,$P1MR1G&"1CT-+!X;T*UBABM]%TZ&."0RQ
M)':HHC<C!90!P2.,BE?6_P#77_,+:6_K9?Y'GNG:E=3:*;&[UG4KB>3Q%<6:
M;)=DURB;L)YBE/*  W$KCI@#)Q5:UO;J[T3PB;VY:>6'Q3) '>8RG:AF51O(
M!?  &X\FO1HO"7AN&W>WB\/Z5' [K(T:6485F7HQ&,$CL:)?"7ANX</-X?TJ
M1A(TH+V49(<X);D=3@9/M0G:WR_"PWK?Y_C?_,K^.CCP#XAS_P! Z?\ ] -<
MI MQ>>)/#%C_ &O?IIUUX?>1[>WN/*3*B(!@R88'YCSNSQQCG/H.H:9I^K6O
MV74K&VO+?(;RKF)9$R.APP(K,B\%>%('WQ>&-%C;!7<EA$#@C!'W>A!(_&DN
MO]=&OU_ ;V7]=5_D>? 'Q#X,\"7>I7EY+<-JB0-*E[+&S@&1<DHPR_RCYNO7
M!&35_4KB^GTSQ=?_ -IZA9WVASM'I\:73A0BQ(R;TSB7>2>7#$YX-=FW@OPJ
M\,<+>&M&:*,DHAL(BJDXR0-O&<#/T%7IM%TJXO8+V?3+*6ZMQB&=X%9XA_LL
M1D?A3[_UV_R?WB7]?>]/Q_ X'3+75=:\4Z]#>>(=9M7MK>SN8X[>94$#NCED
M"[2I7MA@>@R20#6=H5UJ$^D^ [R;6M3EGU6:6WO"UVV)$V2-C:. 05&& # =
MZ]*'AO0A<7=P-%TX37BLES)]E3=.K?>#G&6![@]:@3PAX9B\CR_#ND)Y#[X=
MME&/+;(.5^7@Y Y'I0FK_=^O^:^X36G]=E^JO\S@+*_N+HR:')JNI2F'5[Z&
M&!;QXY)(8P"-]SO#A4+ ]6)X&",U6L_^)P/AO?ZK>W3SO]I$LXO9(\[(W()*
ME>>.3U(X/'%>DQ>$/#,#AXO#NDQN)!*&2RC!WC.&^[U&3S[U930='CAAA32K
M%8H93-$@MT"QR'JZC'#<GD<\THZ6?H.2O>WG^)YU!J^J00WUG)JEY-#)XI%A
M-=R2 /# 44X!  3)PN0!][CDYJ'Q-/J^CZ=XPL;#6M2CLK""VGMK@W!DEBD<
MD/%YK[F(QM;KN&1SBO1[;PUH-E%<Q6FB:;!'=#%PD5JBB8<\. /FZGKZT-X:
MT%],33'T336T]&WK:FU0Q*WJ$Q@'D\X[TT[6^7Z?Y?B/K_7G_F8.ARSVGQ$U
M72_MMU/;'3K>ZV7$[2;9"[JQ7)^4$ ?*,#T K%^(FHW,<NK_ &'4;Y+G3M+%
MTL<-R;:.W;<V)&*MF4MMP$*E?EY(S7=6GAW1+"]^VV6C:?;7>P1^?#:HC[0
M NX#., #'L*DO-%TK4)Q/>Z997,PC:(230*[;&ZKDC.#W%#Z>0HZ;_UL><:G
M+J%QJOBL2:YJ8BM]"AO8$BN?*6&4K(<KLP<90'!)SGG(P!<M]3F\17\5GJ>H
MW%I&FA07\(M[AH/.D<-O<E2-P7"_*<K\W(/%==_PAOA?]Y_Q3>C_ +U=DG^@
MQ?.N0<'Y>1D#\A5AO#FAM;VMNVC:<8+0[K:,VJ;83UR@QA3]*3U37]=?\U]P
M+2S_ *Z?Y/[SG_AI)%>_"S1H[:[&19^4TL#*S1OR#UR P]"/PKE--N]7M_ -
MGK?]LW]U=75X;*9[N]*1+&;EAN+!&\LX 7>!P&]ACU9+"SCL/L"6D"V>PQ_9
MUC CV$8*[>F,=J@M-#TBPL)+"STNQMK.4DR6\-NB1N2,'*@8/ %.3O)OO_F)
M*R2//&;Q!HUU9Z5J^I)#I6HZFD8:#4IKB:WB:)R(S<.JN-TBC!Z\D ]*U=0B
MO-*O-$T!]9O;BPO=0F2:<S,LT4?E%XX#*#OR3T;(8@=:ZV/0M'ATMM+BTJQ3
M3WSNM%MT$39ZY3&/TIW]C:7_ &7_ &7_ &;9_P!GXV_9/(7RL>FS&,?A1<9Y
MY/?:O9V^KZ:M]?SZ9::S!;I*DCO=/ R!I(D<'>[*3U&7QGDFJFI-XAM]#FNU
MUO7;.Q_MJU@T^*?:DC6[.BG>73SNK-]]LD 9'KVWB'PU]KTJQL=-T[2)+*UF
M#MIMW%MMY5 ("_*IV8)!^Z>G2HM/\#Z,8W.H>&]"B1]I%C;VZ201L,Y<;D4%
MCG&=HX '-$7;?R_3_('_ %^/^9QWB&^U'3M/\>6EGK6HPKISVT]N_P!I+R)Y
MB#>F]\L%)YP",=L5L^([$ZUXCCTG2]2U:*]D"7%]<PZG/''90   *B.$WO@X
MR#_$3T%=1)X-\+3/*\OAK1W:5MTC-8Q$N?4_+R:;)X)\)S,&E\,:*[!0H+6$
M1. , ?=Z  #\*2T2_KH#Z_UV_P"#]YQ4LOB36-3U&72;ZV@.F7J+%+/JTRJ+
M<*A^> 1E9 ZDD.S$_-P1BMB2\N]+\8"34Q=S65]>K!9W=K?,8HCCB&2#( ^8
M-\P#$]R,5U;:'I#WEO>/I5BUU;*%@F-NA>(#@!6QE1]*>-(TT:@NH#3K07J@
M@7'DKY@!Z_-C/--.UA-')?$VRAN['0?.>= -:M4S%</%PSX/*D<^AZCMBN5U
M<M:?\+#U2QU"\BDL&M)K9X+IE!98%P6(.9 1P0Q(/IGFO7+RQM-0MS;WMK!<
MP$AC'-&'4D'(.#QP:S'\(>&9#.7\.Z0QN&W3;K*,^8<YRWR\G//-):?UZ?Y?
MB5_7Y_YG">(]7NSJLU]8ZG>EK74K&W;%R8880Y3?$(@2)B0V2648W<'Y<5K^
M$[*V@^(_C*437'FBX@"(]W(RG="K'Y"V#ST..!P,#BNH/A?P\RE3H6F$-&L1
M!M(^47!5>G08&!VQ5V/3[*&\>\BL[=+IT$;SK$ [*.BEL9('I332_'\;?Y">
MJMZ?@>>?$34;F.75_L.HWR7.G:6+I8X;DVT=NVYL2,5;,I;;@(5*_+R1FK2R
M^;\0M0D=P6;PQ$Q/K^\?FNTO-%TK4)Q/>Z997,PC:(230*[;&ZKDC.#W%5#X
M0\,F5I3X=TDR,GELWV*/)3&-I.WICC'I4M>[;U_%-?J.^M_3\T_T*'PYY^&W
MAW'_ #X1?^@UE?#"6.*QUFQNG"ZS'JEQ)?1N?G)9LHV#_"5VX/2NTL--L=*M
M1:Z=96]G;J21#;Q+&@)ZG"@"J^H:!HVK313:EI-A>RQ?ZM[FV21D^A8'%7*5
MY.7?_.Y*5HI=CF=1FAN_%&DZ-:SS6^D7J74\LMI.\/G3JR_*)$((^\[':1G'
MUKFX+O6Y=3T2RFUS4#9KKUS8(Z2@&ZMUC9@78#<Q!!7.>V>O->H7VEZ?J=G]
MCO[&VN[7C]S/"LB<=/E(Q4%QX=T.[:U:YT;3YFM !;F2U1C"!R-F1\O0=*2T
M_K^O3T&]3S#4$.H^"[^WO+V^F73O$Z6D#M?2[_+^T1@!F#9<@,<%LD8!'(S6
MKJ^I:GX<\1^(8["]O+J.T\.BZM;6XE,HCD#,N>?F;[H)+$GKS77GP5X4,1B/
MAC13&6WE?L$6"WKC;UJU;^&]"M+Y;VVT73H;M4"+/':HL@4+M # 9Q@ 8].*
M72W];)?H/K_7>_\ P#S/5+J#1/$NB:G8:I-J%S/HE[-!]INS+YTVU"NP$G&X
MC[JX'' ZTZX_X2>/PW?:W#K<=O8SZ1+.'@U:2\DDF50ZN@DB"QC@AE7 YXP>
M:],L] T;3IO.LM)L+:7+'?!;(C9;&XY [X&?7 J(^%_#YBN8CH6F&.Z8-<)]
MDCQ,0<@N,?,<\\T2U5EY_C_7X!%V:;\OP_K\6>>W)N%F2QEU+4)X=1\+2W-P
MLMY(<RH$PZX(V$ACG;@'O3M =]._X5S%::K>"VN;9_M-JUR9$9A;;^=V6XR,
M+G:., 5Z!!X7\/6US%<P:%ID4\*;(I8[2-61<$8! R!@D8'K2?\ "*^'?,MI
M/[!TO?:X^SM]CCS#@Y&PX^7GGCO5.6M_Z^U_G^!*7NV?;]$OT.%\/:G=R>+]
M"GBU*^N;/4XKQWDN+D[;@*0498,LL0'08P3W%=#\+R#X#M"""/M%ST_Z[R5M
M_P#"+^'^?^)%IG+M(?\ 1(^6889NG4C@GO5G3=(TS1H&@TO3K2QA9M[1VL*Q
M*6Z9(4 9X%):*W];W&]7?^MF>=ZU//!K'Q'FL[Z6TNH-,MIDE@*AU*QR'N#P
M<8]>>"#S5G2O/_X2;2].FU+49X-3\/&>Y$E[)DR*8P'0AAY9PQR4QGKUYKJI
M?!/A2>9YIO#&BR2R,6=WL(BS$\DDE>33SX/\,%E8^'-()6/RE)L8N$P1M'R]
M,$C'O26UO+]'_G^ /5_UY?Y?B>>^&%:T\,>#;"&YOHK+5IY4O)A>RY&U9"J(
MQ;,>X@?<VDX]:35[K6K2RU.RM]<U%+2QUZSMK6X$H:1XY#'OC:1@6;:6/?/8
MD]*])A\-:#;:?-I\&B:;%93G=+;):HL<A]64#!_&BX\-Z%=V,%C<Z+ITUG;G
M,-O):HT<?^ZI&!^%.^M_ZZ?Y?B#_ *_'_/\  XQM+N;;X@?V*_B+7)]/ETB>
MX\F2](*,95 PZ@/QG@DDCIG'%9NAZM?BU\!ZM/JMZ\NI":&\,L[-'(BQ.P/E
M_=W J#N W'N37HEQX8\/W=VUW<Z'IDURR>6TTEI&SE=NW:6(SC;QCTXJ-?"/
MAE! %\.Z2HMV+P@648\IB<Y7Y>#D \>E).W]>OZ-?<#_ *^Y?KJ>=Z5=7-[J
M=I$VI:C<6.JZ+=3R237KAK@J5VR+&&(@&&. K XZ@$4WPTTFG:)\-Q9:I>K%
M=R!+JV-TSHY-NS<AB2 "!A00HST[UZ;!X=T2UECEM]'T^&2)F>-X[9%*,WWB
M"!P3W]:B;PKX=<P%M!TMOL[%H<V<9\HDY)7C@YYX[U2:7]>O^?X ]3@6U#5I
MO#,7B6*_O5UP:M]F:S\]C$5^TF/R3#G;D)SNQNXSFJLUYJ=IIFMZBVNZG-<6
M'B6*W@,ER0GEEXE9&1<*P(8\$8'48.37J0T?2QJ9U,:;9C4"NTW7D+YI'IOQ
MG'XU0/@SPL8WC/AK1C&[B1E-A%AF&<$C;R>3S[FE%V?]>7^3^\'K?^N_^:^X
MW**:B+&BHBA44855& !Z"G4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@".>46]O+,59A&A8JHR3@9P*\T\7:TWB?X4:GJ B@6W\
ME9HGLM0,G.X#8^ OS8)RIR,\<XKTR97>&18Y/+D92%?&=I[''>N#UGX<W&J_
MVO)'JEE9SZE$D$K0:<0K(K;MSJ)?GDR -V0 ,C'>A;_=^:&C5C\67,-WJ]C<
MZ-*;G3[..\AAM9?.>XC;<  -HP^5(QR/<US7B?Q))K_@KQCIUU;):7NEVBRL
M;*_,J992RC< A!!4Y4C'U!K8O? ^JZAJ6IW<^OP1_;].2Q(M[%D*;26# F4Y
MR6;(]#C/<PWGP^O[JRUBWCUJR@&JV45G*(],(2,)N&442C&0QX)./4]*>G7^
MM11TL.LHA'\4[!U:3]YX>+,K2,5!$D8X4G"\>@&:3Q MS;_%+0I["'S[F33K
ML"*:Z:.(E3'CLP7[QY"DG//2M&S\+ZK!XKLM;N-8LY5M[#["\$=@R;UR&+!C
M*<'<!V/''O5W6O#]Q?ZO8:OI]^EI?V4<D2&:W\Z)DDV[LJ&4Y^48(8?C3;U3
M]?SE_FA):->2_)?Y&%+\3+..P@\R.RL]3D>>*2WU'4%MXHWA8*X\TJ<\D;<+
MS[<XWM"\21^)?"<>MZ7$I,L;E(II,*'4D%2R@\9!Y -9Z>"GL'M;S2-3^SZI
M$\S2W%Q!YR7'G,&D#H&7N!C!&,#K7300RK;>7/-YLA!WN%V@D^@YP/3D_4U+
M^%]Q]?(\DM-3U?5[;P!K5] KWL^HS"-8KQRDBM'*<LI 5<$>C$ <'G%=6?B+
M;PZ4)+V&RLK_ .W36!BNK]8X%DCR23,5^[C&/ESR.*BM/ &I6,'AVWAU^W-O
MHEPTT2R:>27!#+@D2C!VN>?7!P.A?8^ ]2LFFNAKT']H_P!H2W\$R6!5$:48
MD1D,IWH1CNI&.M-VV_KI_P $7]?G_P  W/"7BBV\6:(=0MT5#',\$J)*)%#H
M<':XX93P0>X(K/T_QO%=Z/>ZS-!;IIMI'+)(T-V))8]G\,D>T;'//RY.,=>:
MZ6SBN8K8"[N4GN#R[QQ^6F<?PJ22![$GZURMQX!BU/4[F[U:Y@E$]B]E)]EM
M?L[S*X&YI6W'>01E<!0,GK2>Y2\R3_A))[F^@T;6=+-DFK6TC6<MO>,Y8!<L
MCD*IC?:<_*2.#AJYSPSXQMO#WP\\-P2SV/VVZMI)4.HWXMHV"O\ ,3(P8[B6
M&!@YYZ<FNIC\+Z@\UO<7NK6]S<6$,D>GM]B*+&77;OD'F?O&P,<%!R>/3/TC
MP)J.BZ7I,=KKD']HZ9')!%<M8DQR0N0Q1X_-R3D [@PZ?7+TU_KJ[?I<GHK_
M -:(W_#GB.U\2^&K?6[2-_*E5CY8PS!E)#*,<'D'!'6L.Q\>75Q?SV5SH9BN
METXZC%;17:O-L! V2JP3RGY'&2.O/%=4;6:339;:6Z<S2HRM/&-I4D'E1SC&
M>.3TZFN0L? >HZ>UM+!K5F)H-.EL,_V:0KARI\P@2Y+_ "\G/)/:D^MOZT?Z
MV&ME_7]:"V'Q%$L6DW>HZ8+&PU.PEO(IOM/F,GEJ'8,H4 #:<@@G..0*SY;V
M^U+XC^#[ZZTYK**X@N7A'VMI,IY8(WQX"H_S'INX/WN,5,OPVO)+/0;&[UNU
MFLM*M);-HUT]E:>.1=C?-YIVG;C!P><GV&A:^"M334="NKOQ&TRZ-YB0".S5
M'EC8!=LC%F!.!@E0N>V#S5:<UUW_  U_S0G?E:\O\O\ (O\ BCQ?:>&Y;:U>
M6P6[N4>2,7]ZMI%M3&<N0>?F&  <^P&:Q/\ A9>[2])UN/2T_L.^W1R7C7+%
MK>8;AL9%C;(+*%# X)/TSTFLZ'<WNI6>JZ;?I9:C:H\0>6 S1R1N065D#*3R
MH((8$8JKJOABYUMXX=3O;6[TX0N)+.:S)629NCY$@X7LN#Z[LX(GI_7]?\'R
M*Z_U_7_ (AXGU;9I]D^AP)KM["]P+%KX^7%$A4$O+Y?7Y@,!3R>N.:Q+J\N;
MWQUX3U(6-S:7<]C>[K&[F90KH%P"!D#DGY@N2".O J_9>"M:LXM,N&\2Q3:M
MIJ/;PW4EB2DD#;<QRIYN6(*@A@P/ SGG-^\\-:G=^*M'UIM8MMNGQR(T!LB3
M)YF-^&$@VC &.#CN6INU]/ZW_P U\R>C_KM_D4+'Q[<WECX9O3I$:0ZU</;/
MB[):W<;R,#R_G!V'NO;@U-:^,Y-1T*_U2'2X+JU@CE8PP7JO,-N/DE1@H1L;
MB1DXV^^*JP?#ZZA@TJU&OM':Z5?M>6JPVBA]K;_D9F+ XWD9 '';/(FO/ ]W
M=ZA=:B=3LHKV6Q>R$T6G;2X?&YIL2?O#P=H&T+GO2EJG;S_3_@HI6OK_ %J_
MTL.L?%4Z/X5@M]$M;?2]8ME,4@NMOV=O+W^4$$>#\HXY&<'@8Y@U#XA'3!Y5
MY!I-M=2&9X%N=6$,<D4;;=V]HQ\S'.% (XY85<D\&W$_@:PT"35@EY8"+[-J
M$%MM,;1D;6V%FYP,'G!R>G2KEYX;G6\LKW1;^.QNK6W^R_OH#/%)%D'#*'4Y
M!&00PZGK52MS.W=_=T_R)C>RN/L/%$&J>"X_$MC:3SQ26YG6W!4.<9RN20N0
M0>_:LFQ\=75Q%HMS<:&8K;6H-]F8KH.YE\LN(V4JH7(!PVXCUVUO:U+'I_A;
M4);Z[0*EM(9)I"$7)!_(9. /IUKC/ >D7&L>$?#.HMK-K<0V%FILHHK?B*;R
M]A,I#_.5RPP-G?//-+1MV\OU_P" /HK_ -;%_3_B%<W>CPZK-X?DM[6YE^S6
MV;M&=YS,8@A&.!QNW9(X/H,IJGQ$N=#BU&'4M ?^T;%(I6AM;I7B>*1MJN)&
M"' ;Y2-N<GH1S5C3_ CV_A&#1+S4TGFM;S[9:W<-MY1CD$AD&5+MN^8D=1D'
M'7FL#XC::FE^#M8U;6=4M7U2\2WM$E2+R$"K,'"HC.Q)Y9C\QZ=@*-+_ '?I
M^M_D%K_C^OZ6^9T=YXZ71;N^M]>L8[)H;<74#I=!TFC+A.695",&900<@9SD
MUC2_%J"*UOVCTV#4)[)X=_\ 9FHQSPE)6VJWF$+R&P"NW()';FM=O"*^((I]
M0U'6$O);FV2.SN+*(1I @<2*Z?,VYBP5B<X.T< 4[7/"VNZ_X=.F7?B"S$IE
MC=IDTU@I5&#CY/.^\2HR<XQD #.:-M_ZU%NM/ZT_S*$WB+Q:WCK3=-.CV-M#
M);W,ODOJ+?O C(H<LL1QPV0N.YR1@9NZ;XPU34-+ED.B6L.I1ZD=/:R:_8X(
MZL7\K^[E@ #E><]JTKSP_-<^(]+UP:@L4UE;R03*(,K*KE2<9;Y.4'7=P3]:
MS-(L;'4?'5YX@TN]2YT][9-Q@97A>Y&Y-ZL.K!!M//<4*VB]?S_78'W]/R_I
M_(V];UPZ7+86D%NMS?ZA*T5M"TGEH2J%B6;!(4 =0">1Q7'>)_%NIWO@_68;
M:QCM-2L;F*TOHFNV 179<-&ZI\P8,!R%(!)ZC!Z_7-!.JSV%[;W(MM1T^1I+
M:9X_,0%E*L&3(W*0>Q!X'-8FI^![R_T>_MX]6MXK_4[F.XOKIK(NK>7MVJB>
M8-@&P=6;OZYI>O\ 6J_2]QOR_K1_\"Q=2P_X1;PEJ-UI.DV%E>>4]PUI%<.;
M=9 O\)V# P,\(N3]<UQEA=ZO<Z[X#U*>W6?4KK2K@[/MSF*3$:%7?*X0G<<[
M58\]6 KTV:REO-&EL;V=&EF@:*66&,HI)&"54EL=>A)^M<I9>"-7LKWP_<+K
M]HZZ-:/:QH^G'YPRJI)(E&.$7UYSZ@!]?Z[/_@!]G^O+_@C&^)=FNC6%PZ6%
MK?78F_<7^HK;Q(8GV./-*G)W=,+S[<UN:-XKL];\'#Q';(P@\F21HR02"F0P
MR.#RIY'6L32/ 6I:-;VLEMKUO_:5M+<%)S8-Y3Q3.)'C>/S<GYAD$,"..O.>
MSB@?[)Y-U()V8$2';M#9Z@#G [8R?J:4OA=MP6_D<?X2LKGQ+X=LO$6J:IJ
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M'D/J']G &U8,)=P7Y@?N#)Q\V.:-W8/,ZJBBB@ HHHH **** "BBB@ HHHH
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M&T>V=/#^E*UKS;D648,/S;ODX^7YB3QWYJT-&TM;N6[&FV8N9F#2S"!=[D#
M);&20">M6Y7ES>=__)D_^ 3;W;>5OP:_6_R/-/[3\4:[X]UZWT^\MH#I5Q;F
M 3W\D*"W(#,?)5&67>,C<Q^7(QBN<\2:MJ]A!\0;NVUK5$DTO4[0V:_;9"L6
MYAN&"W*G)^4_+[5[A-I&FW&HQ:A-I]I)?0C$5R\*F1!Z*Q&1^%4I?"/AF8SF
M7P[I,AN'\R8M91GS&Y.YOEY/)Y/J:F+M;R_S7^7XCZW_ *Z_YG#FUAO?CKFX
MN+I1_8"3*([R6,;S+C'RL.#Q\O3/.,UB^'M>N7\#V,5[K^HM/<^()+-%,SO+
M<INP(_.WAHP!SO!R,=#G!]>;1]+>2"1M-LR]O&886,"YC0C!53CA<<8'%5H?
M"WAZV@$$&@Z7%")1,(TLXU42#H^ /O#UZT]/E_\ ;-_EH*S^?_VMOSU/%+W5
M[S5/A.#?WCW36WB=+>.264R-Y:R#:"YY; /4\FOH&LF?PMX>N8GBGT'2Y8WE
M,[I)9QL&D/5R".6]^M:+VT$EJUJ\,;6[)Y9B904*XQMQTQCC%+I_79+]+A;6
M_P#6[?ZGANE7$L'P_P#B?=6EU/!/#JUS+%-;3-&ZD$$$,I!_QK=\,7U])X]M
M=(N-3U">SOO"T-U.DMW(3YI(!=3G*$@]5QZ]>:[^/P9X6ABEBC\-:.D<P"RH
MMC$ X!! 8;>1D \]Q4B>%/#D<GF)X?TI7\HP[ELXP?+(V[,X^[CC'3%"VMY6
M_P#);?\ !&]7?U_-,\=\,7%YI?PQ\/\ V"YNH8;_ ,0BVOI4G?*Q&5A@$GY,
M\ E<'G/4YJYXIUK5;7PCXYM;?4]0BCT74+>.PNEO)!*H;9N0R9W.!N/WB>OL
M*]:MO#NAV5C/8VNC:=!:7'^N@BM46.3M\R@8/XTU_#&@26)L7T/3&LVD\TV[
M6D9C+XQNVXQG'?K3O_7_ (#_ )/[QW]Z_P#7VO\ -?<</\0HKG2?#^G7UIK>
MJPW%UJMH&9;UP,-A64+G&T@9V\C/.*Y?Q!=ZO;3_ !%\CQ%JT5OHWD36<*WC
M?+)(H))<G<5Z_)G;STZ5[)=^']%U"S@L[W2+"YM;? AAFMD=(L# VJ1@<<<5
M6?PAX9D,Y?P[I#&X.9B;*,^8<Y^;Y>>>>:3ZV\_T_P OQ$M+7\OU///&OB"X
M>QC2+6[N._3P\VH&VMY'MQ&X (F,B,"W.0(R&![XJK+(VN^)/AA=:E=W)>[T
MZ::X>.ZDARXA4[OD8;3DG.,9Z'BO5O[ T;]U_P 2FP_<PFWC_P!&3Y(CU0<<
M+[=*<-$TD0VD(TNR$5FVZV3[.FV ^J#'RGZ55U>]NM__ $K_ #7W"M[MO*WY
M?Y?B>.PZ[K=GX1\8FVU2_D-KXB%JLTMP\KP6Y=5(5F)(&">>V<UH^(]4U"QM
M_'VDV>HWXM=-L(+JUF^V2&6"5@20)=V\@X!P2?3IQ7IUEX>T335N%L='T^U%
MR,3B"V1/-'/WL#YNIZ^M,7PQH"6,UBNAZ8+28J98!:1^7)M^[N7&#C QGIBH
M:TMY?HE^E_F5?WK_ -;W_P" >>^$M1U#_A8EEIDVI7MQ:WGAB"[F2>Y=\S9
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M[<Q7$:-P-RX8 _B:);>Z$=US'!W.H7U]\0_".HW6F26L4UO=20HMVTI9/*R
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M&](HUW,%SP&/ SCCGO5S^Q!HLMO>6VJZ@ME;%Y;N*[O)+@2+Y;#.9"S#!P<
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M!96DUU<R+%!"A>1V. J@9)->):7=!-0M;KP\\$-[?:+?+&JOON);A2I07#X
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MX&UR73O+/A6XELDS;2B.S:X+MYA+@%?*(""3 P<XZYH2ND_ZV3_4'H_Z[O\
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M?#][H%MIO@FXCOK,WDFL7,$TCW >1H6,N48L2=IW1G!XRP/4T)7T_K4;TO\
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M^YED7! 9@H)!Y. <YQ1H]UHU[:>'O^$CFL9?#9T"*.![J13;_:@0)%))VB0
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M@!P?NU7TBVO8/C#<OJ L&N9=$5VELX#$'_?8&X%F)(  SGD <#I32U_KL_\
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M2X+*'9K[H/.98X8581!G(RN0 2=H()Z#DTTM_P"NWZ-#?]?C^J9Z517G5O\
M$&].FR1SQQO??VI)IT<]OI]PZ,%C\SS/LXS(>.-H//7('-=+X1UO4-;TV>34
MK":UN(+AH0SVLMNLZC!$B)(-R@@]#G!!&31;^OZ]0.@HKG/&FNZAX=T2.^T^
MVMIV-U#"XN)&4*'<)D  Y.6'<?TKG?$?C3Q'X;76;=[;2[NYM+6.]@E DB0P
MLY0JRY8EU8#N 0>V,4EK_7I_F%CT6BN.;6O$3:U'H ;28M1F@DO%N/*DDC2
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MC=C=CG'3-+2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=>*).RN^GZ?\,"WMW_K]3*NOAU;WD.MQ3Z_K#+K)3[6?]'!.T8 7$/'  _\
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M35"--,HM4>2,A$D&"GW,D>A)W>]6F\,B&\FU0:AJ5QJ M3;6\I,.^!#@D)E
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M&Y9[>2%QGIE74$?E3U3_ *]"4TUZ_P##ERBBBD,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O,+OP?X@CM+G[#&GF:-J!NM#0S
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MV_@S0;?^T-MI*XU%Q)=+-=2RAW'1@&8A6&!@C!&!CH*=U_7_ &[_ )/[P?\
M7X_YK[CD/$&O^)?#\7B;3X=5%S)8Z8FHVU]<VR&10696C8(%0GY<@[>.X-;F
MBZGJJ>-FTJ]OVO()])COEW1(GE2;]K!=H!VG@_,21ZUIS>#=$N-)N=,G@N9;
M>ZP+@O>SM+*!T5I2^\KST+8IUGX2T>PUB/5H([O[=' +99)+Z>3]V!PI5G((
M[\CKSUYH7G_6C_6WW"?E_6J_X/WF5XDOK_2?$]D\FM75MI%];SPE(XH3Y,ZI
MO5@6C).55^"2,@<=JP=&\4ZRWA][F_U"Z?4-$BO)-3M_+A!F9#^[5@$^4$'(
MVD=#R>M>A:EI-AK$,,6H6R3QPS)/&K9^61#E3QZ&B#2-/MKV^O(;6-;B_*FZ
M?KYNU=HSVZ<5/1K^O+\W^!5U=?UZ_P!=SBGU7Q'8R^'Y1JZW0UV)D9)K5-EI
M+Y)D5XPFUB@P059B>GS"N>O;_6]2^&6E:_JVI&\^TW=D_P!EBM43:PNARI')
M)&!@]Q[UZ1;^$=%M!((+>= \;1*/M<Q\E&ZB+Y_W0_W-O0>E5F\!^'FT.VT7
M[-=#3[6430PKJ%P-C Y!W!\\'D#. >15WUNOZUO^1-M+/^M+?F8T.J:WJ?A>
M?7M)U"]O#=3+BQ@CM_,LHPV'1-R#,H&<AR0#Q@XR>D\,ZK!J^E&X@O9[K;*T
M;FY@\F6-AU1TP,,/H.M1V_@_1;6YN[F"&YCENY/-F9;Z?YGQC>!OP&QQD8-.
M7PY!9K91::9;:.&X,\CBZE+2$_>WY/[TMT)<G'4<XI:?U_7_  09D?$H,VA:
M8$;:QUFR ;&<'SEYKG_$OB'Q1H3:W8VFL),UFUG/%<W-HC.$GD,9C.S:O! (
M.,XX]Z]'U+2[+6+)K._MUG@8AMI)!# Y# CD$'D$8(K)NO!&@7FF-IUQ:W#V
M[RK-(?MLXDE=?NEY ^]\<8W$XP/04+3[_P#+_+\1O7^O7_,RO.UR;Q-)X9/B
M">-H[-KXWL=K")&W2%4CPRLFU0#D[<GCD=\/_A*]?U/0[=EU VM[%#>>:FGV
MZ22SR0N45\2*42(X.<D') !KOK_P]INIBW-S'/YENNR.>*ZEBE"\9!D1@Q!P
M,@GG'-0S^$M#N)+9VL=AMH6@C$4KQCRSU1@I 9>^&SSS2=[6_KKK^0UO?^NG
M_!.7T_7]6\4"&TCO_P"SGCT6WU"9X8D8SR2AOEPX.$&TYQ@\C!&.<WP9?:C>
M>'_#'AVQU!]-W:*;PW,<:.[,'"A0'#+@9R>">F,=:[3_ (0GP^(K&-;.1?L4
M7D0,EU*KB+_GFS!LNG^RQ(]J:G@;PW#86=G;::+6.SW&W>UFD@DCW?>Q(C!^
M>_//>J;3;MM_P_\ FON)5[+^NW^3^\Y?Q5KGB72=.G_XFT8U#3]+%U+#IULK
MAY 3EI3(I"1$#@!@Y^;&<5I:KK^H:?K$$VH7%]8Z1+!%Y5U;6T<MN)6/S"8D
M%T[8(PO/)K:O?!F@:A)+)<V+,TUN;:;;/(@EC.>'"L QR203D@DD'-2R^%=(
MGCBCE@GDBC*GRWNI2C[0 N]=V'Q@?>!Z4D^XWY'G/VO7-%\/>.M6L-=G:XMM
M5=0+F&*08"QC(PHPV"!SE0%'R]ZV=8UCQ&NM>*;:'65MH-/TF.^M1#:)N#$2
M'#%]VX'9SP.#QC&3TM]X'\/:C'?1W-E(4OY1+<K'=2QB1L 9PK#&<+D#@D G
M) J-O /A]WNW>*_=[N!;:X9M4NB9(QT4DR=.OYGU.5KRVZV_2WYZC5N:[[_K
M?\M#G]6\67H729)]7CT2WNM*%Y'-MC(N+C /D_.#Q@YPN&.>",5U7A^?5M5\
M)6EQJCBTU&ZMP[^1!Y9@9AD *Y?E<]\Y(Z=JYZ]\-&QU:WB@T;5KG2X+1+:V
M?3=8>&6(!B2)"TT99>1CYFQ@\"NMT:TGLM,C@N))'=2Q'F3-*RJ22JEVY8@8
M&3R:IV=[?UJ_Z^1"NK7_ *T1YNWBC6].@TMKS6;N66QU5[361Y, 0P^8%5VQ
M&-OWXB,8X+>F:VH=3U:ZU;3=(36KI%U2.YOUNQ%"7BA5E$<<>8]O(8$EE8^_
M<=-<>&-%NO[5\[3XV.K(L=\<D&90NT D'C ],5+?Z#INI6UO!<0.JV_^H>"9
MX9(N,?*Z$,O''!YI7TU_K^G^I3WT_K^M5]QY\GB3Q5/J&F::=3@A(UFXTJXN
M%M%+3JD9=9!D[5., @#&1Z?+4']H7>F>/M6TF75I(+Z^CT^W.K+ BJKA').U
M@RAGQ@*1CGKTKO9?!VAS2:?(UM,K:?(9;;R[N:,*Y.2Q"L-S')R6R3DYZFJ]
MYX"\.ZA/J,UW:W,KZB%%UF_N,2;6#+QOP,$<8QCD#@FA/;Y_I_DP[_UW,V]U
M;4=%\0QV^JZAJ,.G,8(;:]%M#)!,Q(#"8JFY'8Y (VI\P[UV]8K>%-(=H#+%
M<2B%UD"2WDSH[*%"LZLY#D;5P6!Y&>M6M-L);.:\=YI&2>8R)&\[RB/UP7.1
MGKM&%'0#N3H [6KI['1+ZZCGMX)(8'=9;DD1(0#@MCG'KBO-+OQ3XFLM,\3B
M'4YGDLM+AU"WGO[&-6RV_<%10F%^7C>NX=P:]1OK&VU*QGLKR%9K:=#'+&W1
ME/45@7'P^\-W44D<UK=LLL"VTI_M&X!EB4DA7(DRP&3USZ=*0[F'/K7B"SU3
M4K%=569SH0U*%YK5"L,@8A@JKM)4C^\20>YZ4S3M:\1:IJOABT;6!!!J>A-=
MS-%:IYOG 1Y8%LKU?@;<#G@Y&.AE\ ^'Y[AIY(K]I7MA:,_]J763#_<_UG3^
M9R>]);> ?#UI/:SP0WZ26D#6]NPU.Y_=QGJJ_O.!T_(>@IW7]?\ ;W^:^XFV
MG]>7^3^\YG2/$VNRVOA34+G4_-&H7\NGW,'D1K&P02CS.!N#YC!X;;S]VG:?
MKVMW?B&QMFUB::TU.&\S+#;QK#$8\;#;LR!VP#R6#*3TXKHX_A]X;BMK*VCM
MKQ8;*=KBW0:E<XCD;JP_>?7\V]3FQ9^"M L)[2:VLY8WM'=[?_2I2(MXPRJ"
MV I_N_=]J3U&<'X?U#6]*^'?A&[@UB247VHPQ7"W$*.VR20@JK #'<DL&/S=
M16IJ/B/7)-#U_P 266H&%-&O)H4T]H4,<\<1 ;>2"X9N2"K #C@UT4G@'PY+
M86UC]CG2VMIO/ACBO9X]CYR"-K@\'H.BY.,5=F\+://J!O9+5S*S!Y$$\@BE
M88PSQAMCL,#E@3P/2G?7^O+_ ":^8?U^+_S7W'!ZEXE\316WC&]&K+$-%:":
MV@BM$ 960.8W+;B1AL$C!R,C'2O1-1BO+[1)4L+R2QO)(LQ3QJC%&QD<.I!'
M8\=/2LJY\ ^';O\ M(3VUVXU-@UXO]HW $Q'3(\SH.F!QC Z5T%K;QV=K%;1
M;_+B0(OF2,[8 P,LQ))]R2:3UC;^M@V=_P"NG_!^\\OMO&FH0W7AV\O-6NSI
M\]H\.HJ\4 6*["MCYA&#G='("!QG;QS@[-G<:_?:J_AYM>NK>YL].BNY;OR(
M&>661G^4@Q[=B[<<*"?7UZ-O">A-:3VITV+R+B\%]*F3\TX8-OZ]<@<=.W2I
MM2\/Z=JT\<]U%*)XQM66"XD@<K_=+1LI9?\ 9.1[4V[_ -?UL_PL&VW]?\.O
MQ//]*\1^*_$>HZ+;+JD&FB^TZYD?RK-7*RPR*F\%R<J2<XXX)Y/!$/A#49[G
M6+_P_!JEQI<W]KWMRTR1QG[4HD(,:>8C#(ZMCD#'7)([\>$]&75K74X[:6*Z
MM(?L\'E7,J)''C&T1A@F.G;L#V%4$^'?AI(DC6UO $NC>(W]I7.Y9B""X;S,
M@G)SSSWIIJ_]=_Z_('M;^MG_ %^)5TO6K^/Q4^G:W=7MK<3W$OV6"2WC^RSQ
M*&VB*11G=MPS!FSE3@ 5V=9"^&],CO4O5@E>XB#>5YES*RQELY**6*HQR1N
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MS'X:TI--?3W@EGMW #?:KB2=\ Y&'=BPP>1@\'IBDM$OE_7_  1O?[_Z_P"
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M<2(;G3YY+9F&-GFPG;G_ &ER/Q%<KX(\7K-H/AVSU-+[[5>:;]H6]N "DY0
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M-/O+:*1!)$\X3$B'H059L9'.#@^H%6=2U&UTG3I[^]D\NW@7<[8)/T '))Z
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MQN-,^POJ(O[>YG:3S$S.)61D"X;G.&W#/3 ZAJUU?R_]M_X/W ^OS_\ ;O\
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MLM+T[P5J5U#XFTV:PN[RT:W@TH-:6T3AP) @$S DKDLN>,;L \T)?U\[!?\
MKY7/:-4U*UT?3+G4;V01V]NA=V]AV'N>@JTIW*".XS7AWB=M#F;Q]INGM830
M"QM;Q((2CCS06\R4 9^;!7<W7D9ZUZ]H]WHHMX=/TJ6R18X1(EK;E5VQDX#!
M!T4G.#C![4):7_KK_D#T=OZZ?YFI17,?$62WB^'FNO<W'V=1:/L<3&([\?(
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MCC=C) [4):KY!_P?U_R/9J*\VLI[73/'D4<:Z;J7V^ZD=9(P8[ZS #C]XO\
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MU'4[FVUC[.NIZ<+&Z#VHD<[0P5U.X 'YSD;3GMCK70Q:OIL]])8PZA:27<9
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MTU[66401S+=QE'D_N!LX+>W6FVW\_P!?^&$M/Z[7_P V1>%] 3PUHB:;',)
M)'D.R/RT4LQ8JB9.U!GA<G [FF>)- EUU;#RKR.!K.Z6XV30>=%+@$8=-RYQ
MG(.>" >U:UM=VUXC/:W$4Z([1LT3A@K*<,IQW!X([5776=+?5&TQ=2LSJ"KN
M-J)U\T#UV9SC\*+W=P.1'@'4HX]/BAUZU$5EJTFJ+YFGDLS.S'82)0,#>W('
MITQR+\/[_P"UWE\VNPB^?4AJ5K+%8E1#)L\ME93(=Z%,#&5/4Y].MCUS2);N
M*UCU6Q>YE+".%;A"[E3AL#.3@]?2L+Q;XP&ASV%I83Z;->2WMO!<6\MQ^]CB
MD<+N$8Y/7J<#Z]*%>Z2Z_P# _P D#ZW_ *W_ ,V6O#_AJZT?5]7U*ZU8W<FI
MR)+)$ENL4:,J!<J,LW;NW3U/)TM<T>WU_1+O2KIG2&YC*%XSAE/4,/<'!_"F
MZWJZ:-8"<QF::61(+>$'!EE<X5<]O4GL 3VJKK&N'0]#,UY=:8FI-&WDQ3S^
M3'+(!G:N<L?P!)]!4R>EWT&M_4KW'AJ\U?0)])U[54NU<*(Y;:U\AE*D,KME
MGRP*@\8'^S5'5/!FH:U:WC7^L6KZC-926$-PE@RQPQ2$;SY?FDLYP.=P P..
MN9=!\57=U8Z!=:I#;QQ:U;QM#)#D!)C'O,; D\'#;3GM@\X)T=>\6Z/X;NM/
MMM2O;>"6^E\N,2RA H )+$GH!@#ZD"JE%WY7Z?/847;5=#)M_"&LP:OI.H'7
M+%GT[3WL53^S7 ?=CYC^^XY1./KZC'':;IEUX;\>Z+X=@\3:8;^#2[E8Y)+3
ML\J.$:/SLEL;B,,.!T.#GM]$\8"YU35[+6IM-L9+;419VB"XYFS&KC!;&YCN
MZ ?GUKH'U;38]2339-0M5OW7<EJTRB5AZA,Y(_"B[NGW_6[_ %N*R2Y>W_ 7
MZ6.>B\%/IT=A/I&I_9]2M?.#W%S!YR7 E??)O0,O5@",$8QZ4ZY\,:Q-XGM-
M;36K0/;6DML(Y+!F!,A!+9$HX!5<#T!&23D=+=7=M8VTES=W$5O;QC<\LKA%
M4>I)X%43XDT(-:*=:T[-[_QZC[4G[_G'R<_-SZ9I;C.;L_ E];>#$\-SZIIU
MY JNN;G2]Z$,V[.WS?O#+8.<<CCCFO<_#69[6ZM8=<S%-;VT*275KYTT9AVX
MP^\?(=N2N!R2<UU0U[3+ZV673M<TMT^T+"T@E652V1F,;7&'(.!R<$C@]*FF
MU[1[:>>";5;*.:W7?-$UPH>-<$Y89R!@$_A3O;7^N@6Z&'-X1OOM7B&>VU>*
M)M9B175[/>(W$?EEA\X)!7H.,'N1Q4&E>"M1T6.TEL=9MEOX[*.PN)GL&:.:
M*/.PA/-!5P">=Q!_N^FIHWC+0]:\/MK<6HVD=DC,))'G4"+!.-Y)^4D8.#ZU
MHMK6E);PW#:G9B&=2\,AG7;(H!)*G."  3QV%+;^OZZ,-_Z_KLCFHO UQ8:K
MHESIFJ00V^E031K%/9F1I7EY=V82*,D@' 7U]1C4\'^'[KPSHK:?=7\5Z?M$
MLRR1VYAQYC%R""[9Y8\Y'&/K6@^MZ3'I8U1]4LETYAD79N$$1'3[^<?K2W&L
MZ7::<NHW.I6<-BX!6YDG58V!Z88G'-.[5_Z\PW*VO:$-9%G-%/\ 9KZPG^T6
MLY3>JOM*G<N1N4AB",@^XK#U3P1>:EH^K0'5K:/4=7V+>7?V(E/+1<*L<?F
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M0G:WE_P/\@>M_._XW_S/$Y+<0>'?$"6/A_5(7G\1PW5ND6C3HQA5XVW >6,
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MHR_.=J0KY2E]AVE1D@G&!FO0?$&DVD_AW^SXTN+6%9(VB-A"&:%E<,K!,$$
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M-^]0>X!P?2M'1_#^E>'XIX]*L8[59Y6FE*Y)=R<DDGD_TJKK7^NJ9+_K\?\
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M=F"<X)-=(NBZN^O^)9OL!2WU;388XI7F3Y'6-U*, 2<Y8=.,9Y[4YJR=O/\
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M@>/C)Q@L &XQDKD9S4S>*M%35TTMKW%R\GDJ?*?RS)C/E^9C9OQ_#G=[50\
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MFMBS^U:=XI\.#3]3O+VVU2VE>^CN+EIU^5 PF7<3L^8A<+A?F'%"5TOZ[_Y
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MIN;HH^IR<' .*UJ\9O-0AO=$\)^(]1U>474VNQ?:XYKHK#"0SY3RR=J;.F<
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MMHVG0L^_<8[5%SNQNS@=\#/KBFR^'=+_ +.O+.VTW3X8[PEIU^R(4D8]6=>
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M2"?.X^5FYYYP<=JV]%\,7>E:7_8LVJ)=:/'&88(3;;9A&01L>3<0P .!A5/
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MT_RT]0>JM_77_,IZ7IMCI5@EKIT2Q6NYI$16)4;B6.,GIDGV]*X*(ZE!\/\
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M'/ !-=/<W5O96[W%U/%! @R\DKA54>Y/ J4'(R*GHEV_X'^0=;_UU_S/+O\
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M0 3U! ]*]XJGJMK/?:5=6EM/'!--$T:RR1&15R,9*AES^8J9MM.W]?%_\E^
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M:;DYMPQ?O@B+@'"_]\C&.<S7G@"TO5OEFU?5<7R0_:-KQ#?)%MVR?ZOAOE'
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MCP0#GD$4^'PCY.OVFL?V[JCS6UN+58F$'EM'P2#B+/)4$D$'TP.*>GY_D_\
M@!K;3^MO^"<3X7\3ZII?A33;62>&6ZOIKMH7ATF><0)'*0V8H6)8$D 8V!1Q
MSCG5C\9^*;N30+:/2+2QGU-[B%S?),A5XU8AA&0K!&PIY.>2..M;4/@'3[6T
M@BM-0U*WEMIY)K6XCD3S(-[%F1<H5*DL<A@V>.>!BS<^$DN]7TK4Y-8U+S]-
M9G0 P[968;6+YC[KQA=H Z 'FB]WK_6@/3;S_,Q?'EO*\7A&XGAM?[2CUBV7
MS I*HQ#;@I/S;20/3.!3+GQQJ.DW5[I&I16\NIQ7,,,$]I:3/&Z2H[AC"I9R
M5$;Y4$YP.1GCK-;T.VUZTB@N'FB>"99X)H6 >*1?NL,@@D9/!!'M6?)X,T^>
MRFCFN+R2]EF2X;43(HN!*@PK@A0JX'& H7!/')REUOW_ ,O\F';^N_\ F8EG
MXUUBXB@L)=/\C4KJ_:SMKJYL9K>&1!&9#-Y4A#X !&W/7^+'-76U_P 0PW>G
MZ'<P6$&L7LLX2YVL\!AB /FB,,&R=P&POQSR>^E>>%(-1L((;S4;^:[MY5GA
MO]R+/'( 0&&U G0D8VX.>0:==>&([R.U>74K_P#M&U8M#J(,8F4D;6XV>7@C
MJ-F.^,\T] .6;QWKR75KIQL-/-XNLC2KR4NX0DIYBO&O)P5[$\'CGJ%N_&GB
M"QT[6KF5=,D.B:@EM<;(9%^TH^PC:-Y\L@2#DE\D=!6U=^ [.Z^Q,NJ:E!-:
MWGVYIHC#NGN,8WR;HR#QQ@ #';@8@NOAU:WEIK%M+KNK^7JURES<X-N#N7&
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M&, \Q';GC.,#CC%:-AX56Q\22ZXVKZC<W,MJEJ\<WDB,HO(X6-3G))Z]SVP
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M60?AO;'3FLCX@UKRVU#^TBW^C[C/NW9_U/3=SC^G%$;)KY?FK_J#U3_KH_\
M-':T4@&  23[GO2T@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC75$D,-RMK,T43ND4I( #LJD+DG&20,\9S4L/C#19VU58YKDG203>@V4ZF/
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M QY(QP*KZKX;\01:#XJT"TT@7<>JL9K6Z2XC5$RJ*4?>0V1MX(!!&,D4NO\
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M\SR)HY?+<QOL8-M8=5..A'I0!)4%W:QWMK);2M,L<@P3#,\3CZ.A##\#4]%
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MN:NR4OG_ .W6_+4G5Q_KM?\ ,Z'XA^,/["\.:F-,U 0:K;Q!PWV1YDC)Z*S
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MB82)Y:IC".Q!^4GGL1[@0>"-,NK"_P!1LY]K6>D2O9Z>X.28W(E(/^Z"B?\
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M3S$ 5OF(R,CG&3[&E?PY/!\4#JMI*B65]9 W\.,[Y8F'EM[=>O\ LTET^?\
MP/PN4^MO+_@_H=BK!E##.",\C!_*EHHI %%%% !1110 4444 %%%% !1110
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MPI>3EXO.18[20%@#A@"P WC!RF=XP>*TK2[@OK2*ZM95E@E4,CJ>"*9%I]K
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M>O\ D#T_KT_S/6*P]2\6:9IJV+/Y\ZWEZ+&-H(BRB7?L(9NB@'/4\X.,UG>
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MIEB1F#,"S #&[;UQP=M8?$-OK'A+3-7U^=GEN+N&XCLKHE9$6-F0,^Q79@"
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M:+3+_4+ZVM8M$MKJ&2WNW@:65MP>0NI!;;A>"2.>0:R-!N]:US6/#L6K:QJ
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M1M7LH;![.P@G1A-=.DCM( . (V&!M'?G)Z8YPM \&>(=%%EJ!73)-2LWNT$
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MC'4@XR:]BJG>:MIVGS00WNH6MM+<-MA2:94:0^B@GD_2B^M_E^7^0=/Z\_\
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MI37)\NX,!1E1K=R0QW$L<\G&T$XX'6N@C\>7ZV(M9XXO[4_M&YL&FMK">XC
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MQ&Q%ZGG'Y8I:?U\O^"#_ *_'_@&1K&O:YIOB"_L?M.F16[:<]Y8/)9R,Q=&
M='Q*-W!&, 'YO;G.@\>7_P#PBL7B"7[&T4&FFXOK98&5_M!8HL:L7.P;E8'(
M8_+[\=?JN@66L7NFW5T91+I\_GQ>6VT,<8VMZKT./5152W\&Z-;V>L68MVDM
MM6F>6YC=N,L.0N.@SD_4DTEMK_6O^3_!%=?Z_KI^+,/4_%/B+0KXV5W!IEY-
M<V,UW:/$)($0Q %XWR7)^4Y##&2,8'6N<UW5KJ;3O!OBGQ#%IL47VVWN(I;6
M)S)$C0.TBDG)QD \>@STR>YD\&PW$$ZW.KZG/.]N]K%<R&$R6\38W*F(]O.
M"S!F]Z@G\!V\^EZ'IYUG5%BT9U>W($!+E1M7?F(@X4D< 9!YR>:?^:_7_@"Z
M:^?Y?YFKX?GU2\LC>:C-9/%<'S+9+:(J4C/*[VWL&;&.5P.O6N'OKBYT_P 6
M^,=1U9]/O=-LM/MYI+5K$EG0>:T:!C(0"&ZG:0>P6NU\.>&H?#-M/:VE]>36
MCRM)%;SF,I;Y))6/:@(7GH2<8X[U4'@RV?6-4O[K4K^[CU.+R+FSG$/DM& P
M51MC## 8X^;/KFA[W7;_ "_J_P P6VO?]?ZT,75/%GB30I+9+JVTN[.H6LL]
MKY8DA$+QIYA1R2^\;<X8!<D=!G(W_".HZUJ^BV^I:JM@D=W;0SP+:AP5W("P
M;<3GGICL<=LFO)X)@GMGAGUC5)F$#V]O+(T1:UC< ,$_=X)(&-SAFQWK9T32
MDT/1;32XKB>XBM8Q%')/MWE1P =JJ.!@=.U&FO\ 7?\ X M=#R/71J=]X9\6
MSZG<6=Z;77X4M@;8HT;J\*@JQ9MHVG;@#/).3G%=A=^-K_1KS6[/48K>XFM&
MM?LQM8)/F%PQ50R@LS%2#]W[W8 U<U+X>V.HQ:C"-5U2VAU"\6\FC@>+;Y@V
MGC=&W&44]^G& 2#)+X"LKK4M1O;W4]1NGOXHHY$D,2JAC.8W0I&I5E.2#GO]
M,"VL_P"M$OT93U=_ZW'^$M?U/5[G4;74;*51:LAAO#I\]G'<*P.<1S?,"I&#
MR1T/>L?2+6V\8>+?$QUZ".]MM-NUM+2QN4#Q1@(&+[#P68MU(R .*[+3-.DT
M^';-J-Y?RX \ZZV;L#H,(JK^.,GN36=>^$[:XU>35K&^OM*U"952>>R9/WZK
MG:'21'0D9X.W/O1I?Y?TQ="A>E?"<\%GI6WS];OA% MP6>.V(BY.,Y*@1\*"
M.3U%8VI>.?$&EF]L)++39]0L;^T@DFR\<4L5PV%=4^8ALY!!8@=<GI76W?AB
MSO;2-)9[G[5%*)X[X./.24 @."1M'!(V[=N">*S=0\!6FI6303:MJ:SR7,=U
M/=H8?-G>/'E[LQE0%P,!54?F:%OK_6W_  ?4'MI_6_\ P#+U+Q9XBT\>)X_^
M)4\NAQ)=[_(DQ-$REA'MW_*WRD;\D=/EJ9/$_B34M7U>RL(-*M_L5G;WD!F$
MDIE$@8[6P5VGY<9&<?[6>+EWX!@O9=;>;7=6)UF!8+H#[. $7@!?W7'!8?\
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MNU\0Z(S,%UC3R5A^T,!<IQ%_?//W??I3_P"W-)^R0W?]J67V:<$Q3?:$V2
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MCZI)<7I@2T9=+G)F*(%^4[.0&!YZ=^G-,UJ*"]O?&#IX>U.1-1T2%(LZ)/\
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MDUCQVU[X;DDMI9(Y81+H\A69ECVLT8,?S-O+'Y<DY)Y!S5.TOKR/P/X:\/\
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M$1]S 9"D.K#!Z=,TOL\P[>]R_P!?UJ;=%>6_\)C>G689(=7O'TS4M))M-\<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-U>[U.TMR^FZ=!=NJEV$]
MUY"@#L"%8[OP ]2*ET?4EUC1K/4DAE@6ZA6412C#+D9P:R_%BZ7?V(TC5(M6
M>.Z'']GPW)SVPSPC '/1SCUZ4[PW]MTGPWI%EK$MU<7S+Y1D,32MW(\QE! (
M7 +$X)[\T+9@^@^R\0R77BV_T&339;?[+;I<).\BD3*S%05"DX&5/7!]JV+B
MXAM+:2XGD6.&)2[NQP% ZFN1MKDGXL7I-GJ A?38K=;AK&80F17=B/,V[>C#
MG.#T!SQ6IJ]M>:Z$CTZ[BM?LESF9+[3I9(Y6 !7 WQ[@#@Y!()'M1T7]=6-[
MO^N@OA3Q*OBG3;F]2SEM%ANY;81RGYSL.,D8^4GT[5NUP?@2+5-#TS7)M:#&
M-M6N'1(-.F$C;I/OA0SED;((P.!G)/4=Y3Z+Y?DA=7\_S"BBBD 5SWBWQ!J'
MAVUM+BSTRWO4GN8[9_-NS 4:1PB'B-\C)YZ$>AKH:XWXC3LNE:=!%9W]S(=2
MM9B+2SEGVI'*C.S;%., =#R>V:%NK]T'?YEB3Q9>:1J5E:>(])BL8KZ7R8+R
MUN_M$/F$9".61&4GG'RD>]:R^)=!>"VG36]-:&ZD\J"07<965^FU3GYC[#FN
M6\0O<^-YM,TO3M.OHK&&^BNKN]O;62V"K&=P1%D"LS$X&0,#GFN>N;/4H-"G
MTJ+1-3N+NW\3B]*QVQ"-"9_,#([81OEXX/!ZXIQ5]'_6J7Z@_+^M'_E^)VMG
M\1/"UU/J$;Z[IMNMG<?9RT]Y&F\[021DCC)(SW*FMV/5]-FNXK2/4;1[F:(3
MQ0K,I=X_[X7.2ON.*XS2-#.IP>,]%U.PN8HK_4)94DDB(0JT:!65NA(()XS@
MKSCBM'P+-?ZG9/J.JPF.]A T\Y_B,)*NX]F?/_?(H6J^2_+_ #!_U_7H=5//
M#;0//<2I%$@W/)(P55'J2>E9-[XKT6T\-W.O)J=E/80HQ$T5PA1V'1 P.-Q/
M 'K5+QK9WES:Z5/;PO<6]GJ,-S=P1IO>2)<]%_B()5L#D[>,GBN<OK:0Q^,]
M:M;'4%LM3L$MX+<6,PEFGV.I?R=N\9W(N2HZ9Z#-1*_*VO/^OGT]"HI<R3\O
MS_3<Z?PEK&H:[:?VA->:/=V,T:O"VGLQ:)R,M&^68$KP-P(SS\HJ/5_$>K6'
MBW3=$M=(L[A+]))([B2_:,J(P"^5$3?WAC!Y[XK1\+SB?PQII\FXA9+=(VCN
M('A=650""K@'J.N.>U<SXEO_ +-\1_#]R;'5);>SM[I9YK;3;B9$,BIM&40@
MYP>F<=\5I*RG;I?_ #_X!G&[A=[V_P O^"=O<W5O96TES=3Q001C<\LKA54>
MI)X%9\OB?P_!I\6H2ZYID=E,VR*Y>[C$;MZ*V<$\'I7*:UJ%[KNHZ;?6NF:A
M_8VE7T<UPLUC+'+/\CC<D3J&8(2AX7).<9Q20>%AK_\ PELGD36FGZOY36JS
M0M$ZS(G,^Q@&4[MO4 G9GTJ>E_ZZ?GK;T*ZV_K^EU.QFU[1[>9X9M6L8Y4@^
MT.CW*!EB_P">A!/"_P"UTK%\3>+?[/\ "JZYH4FGZE";B.(RB?<FUG"$J4R&
M()'&1WY[5S?VG4-7\(+K5_HLDU[)=6\#QK$\I@$#X:41QG<X$@=@HZC&:R=1
MMKZ'PCXGM#IVKW%Q<Z[%<1;=-D+2IF%RX")C&$;\L'D\U97^[\U^C_KHNGW_
M )/]5_77O7\?^&8->OM)NM:T^UELT0R-<721@LV[*#<1D@ 9]-PK8CUS299+
M../5+)WO5+VJK<(3.HY)09^8#VS7+65C]N\;>)8[S3KI].U:QM0CR6[+&RA'
M#!BP&&&0-I^;GI1X&2^(FAU2)R^@JVFQ2D9,P!#>8.I.8_*]\[J2VU[?YW_0
M;\OZT7_!.XK U/Q(UOK4>AZ79B^U5H?M#1O+Y44,><!G?:Q&3P %).*VK6Y2
M[M8[B)9521=RB6)HW ]U8!@?8@5QEU!>>'/B'>Z^]C=7FEZE9Q0226D3326\
MD9.,QJ"Q4ANJ@X(YI=;,.ET=!8:O=R7MQ9ZGIRV3P0),TJSB2%\E@=K$*>-O
M.0.O2K%MKVCWEC+?6NK6,]I#GS;B*Y1HTQUW,#@?C7/>*OMWB/PQ(NF65SY*
MSP3,D\30O/&LBLZ"-P&'R@_> STKD_&NF#78M?U>RT>_>WGT<6BPOILHDGNM
M^8V$13=\@_C(P-W!H_K^OR&K?U_7S/4(-8TNY>Y2#4K.5K49N!'.K&'C/SX/
MR\>M0+XDT)XK>5=:TYH[EQ' XND(E<]%4Y^8GT%>?RVT.H>*&MO[-UF'3[CP
M]'9M+#ILT863?N !9 N5!S@^XZ\4NH)K]_H$YNK6XOX]/U:SGBNETYX+BYBC
M=2Y,)&XLHSR  W84[*]OZWL3=V_KM?\ X!U'BKQ>FF>&=5U#0Y]-U"ZTY@MQ
M$;C=Y)S@A@F3N_V3CH>15T>+]'_X2I?#IO;8:@;?SFC,J@YXP@!ZMC+8Z@#/
M>O._$JZA<1>.WAT'6&BU-+1;1TLG8RE5&1L&7'U*@#!!P>*W[[[7_P )?>ZC
M#HU]>6]YX=$4*>2\8D<.S&-B0#&Q##@X//'(I+:_]?"_U15KNW];K]&=G;:]
MH]ZER]IJUA.EJ<3M%<HPB/\ M8/R_C4,WB?0H+>\G;6+$I9QB6XV7"L8E(R"
MP!R,]O6O*+^QFFL]3,^C:E<177AH6MO"-%F"QS*YVQA=I8%2007)/&0<<UJK
M#-)JVF06>DZE&A\+S6;$Z=-%&LI"E48E  ?E;KW^M$MG;S_)_P"7X_>1U:O_
M %M_F_N/1?#^NV?B30[75+&6*2*= Q$<@?RV(!*$C^(9P14VH:QI>DB(ZEJ5
MG9"5ML?VF=8][>@W$9-9O@CS5\%:-#-;7%O+!9Q1/'<1&-@RH ?E/(YR.?3T
MKF_'EO=W>HWMM;Z;=;I]&FACNX+5YS*Q)/DYY2/H#EAEL@ \<NI:,G;S%3O)
M*YV]YJVFZ>\"7NH6EL]PP2%9IE0RMZ+D\GZ4EWJ^F6$HBO-1M+>0@$+-.J$@
MD*#@GU('U(KR[47G62&&+3[B4WOAZ&SN4N;&Z?R =PR$BB<YSNRK!,X7#=<3
M>'M!T*#QQIL5EHGFV(T0VTUW_8[Q0S3AU)WG8%#X4YSR#\IYXIVUMZ_A?_+\
M17]V_DOT_P _P/3%U;37U)M-74+1K]5WM:B93*%]2F<X]\40:MIMU?3V-OJ%
MI-=V_P#KH(YE:2/_ 'E!R/QKSC2O#=Q/=6]KJ-WKZ:II][+=0HMK&MJ69F_>
M"<0\J5;)4ON[8XH\-^'=R::=5E\2/J6DV\D,ELUK''#AD*OLE6%?-#=0-Y.<
M$\YJ>E_Z_KN/K8](LM5T[4BXL+^UNO+)5_(F5]I!P0<'C!JCXE\3Z9X5TY+S
M4KB*)9)4AC#N%W,Q ZGL!R3V -8G@]-3L]4GTR0SWFE6MLB6]Y=V)MID(./*
M)( E '.Y0!QSDU9^(=K<W7AJ+[+;37#0W]K.Z01EWV),K,0HY. "<#FG;5?+
M\Q)[_P!="/3O&L4GB/6+34KK2K73[<6S65R+D8G$P8@[FP"2 , 9^IKH;S6M
M*TZX@M[[4[.UGN#B&*>=4:4],*"<G\*\PU[S+RZ^($BZ+JS/>Z9#;VI.ES,9
M'"LI52$(.&9>AQWZ#-,\3PWVJZ5JD=OH^I1S3Z/;8==/E>2[*9)0[AB,J2?E
MP'.<CH*%9I?(;W?]=CT.S\6Z1?>*;WP_!>6[7MI&C.@E7<S'=E0O4E0 3Z;A
M6X[K&C.[!549+$X %<=H27$7Q"UR=[*[6WO;2S:&9H&5#M5PP)(&""0-O7GI
MBKOCRSOK[PM+'8P/<LD\,LMLGWIXED5G0>N5!&._3O1T7]=06K?]="A9^/[&
M;Q1J5K/J.C)HMO:Q30WZ7BE79V92&<D*#E2,#/U[#IEUG2FO)[-=2LS=6Z"2
M:$3KOC4XPS+G('(Y/K7E_B&SO=?U'Q3+I>@ZD(=0T".*.66T,&Z5&<[2K[6W
M8P!P>W;!,^LB34]:O;U_#FJ7&G3>'#;9ET]C^^WEE4QL-Y(('13C@].:3TC?
M^MG_ )6^X:U?]>7^=_D>AC7-.NFB6QUG36)E16'FK)O##(5<,,,P((//'8U*
MVN:0ERELVJV(N'E,*Q&X3<T@ )0#.2V"#CKS7E[Z9:6FB_#V\C\.W:ZA;36X
MNY8M(E,T4:1LKAR$W ;B.#UZC(YJG+;BW\/>(([+0-4B>;Q'#=6Z1:/.A,*O
M&V\ 1] $?_)&:Y5S->?ZI?K?Y$WTOY?Y_P"7XGK\VJZ=;ZA#I\VH6L=[,"8K
M9YE$D@_V5)R?PJY7D7B6+[?JOB32OLLSV.I2V[SW,FG74[0%40_(L<+J1@#A
MV0@EL@CKZM8BV6PMQ9"-;41KY(B "!,<;0. ,8J5M<;T=CB=9^)%L-"UZ[\/
M2Z?>76D2B.2.6XZK\N7"KR0&;;V!*GFNQM-5T^]\\6U]:S/;G;<+%,K&)L9P
MV#\I^M>7ZY;7T7A7QWIQTG4Y9[W4VDMQ#922B56$>""H.1\K<]!C!P2 7:W;
M7VIZ_KD>CZ?J4,<^DV:HWV!X5D,<I=XU,B;-WEM@!N,G!Z$4UJON_) ]_O\
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MXXJEX.U74='TSP1"]Z\]C?Z3*7M?*0*ABC5U*D#=G&0<D@]@*-+:_P!?%_\
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M:SR742P3S&YE\V5!CY6DW;R#@9R><<YJ?3_%<.IP:+-;:=?&/5HVFC.8OW*
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MX5T5]#NM&%HT>GW4CR3Q0S21[R[;F^96#8)/(SC''3BIM$URWU[2?[0M89T
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M@YBSG:6#Y.#T))([&HK7P)X?LI],F@M[M7TM2MGG4+AA"IZ@ O@@],'/&!T
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M!QUQ@FI+XRMA<ZAY6E:K_:EGI@NWM)B(UV'D 9?RRWJRYZ$9R,4GHM?ZM?\
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M21G[WS$<L1P.G6B_3O\ \'_)_,'^7_ _S1NS^ O#MS#<Q36MTRW<*07'^GW
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MK98-_$O(4@9Y(JY9Z_'?W\MO;V-X\,4[6[78">5YBYW#[VX8(QDJ!DC!-&K
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M&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAB1[1M$6\^TBZ\UOM!7SO-\OR]NWKQOW]/X:[NBA:?U\_P P>O\ 7JOU.?\
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M_"'ZI)+JMU<N?%<<2?:5C8*5ND ;Y54DD8R,XXX H2]ZWI^+2_4'M?U_)O\
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M:\B1@%W502%!8XR2< ?G7E]AXF\3WD/AI&U)8?M6JW6GW1DM$,SK'YFTD@[
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M3[XZ*^G]=%_D-ZO^N_\ F,;P!J3WFIW4FI:3))J<1AO!)8W;)*GIL-YM&.V
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MQT'' X&!4FH^'=,U6Y6YNH91.%V&2&XDA+IUV/L8;UY/RMD<]*Q;'XAZ7?V
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MD>)HAPL;':-[#G.&)]!QDG%/NO'&FV<KO);7ATZ.X^RRZDJ*;>*7=M*M\V_
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MV]_(S6=Y'&S2*]NZ9E4-A2<; 02!].:[:JL6FV$%]/?0V5M'>7  FN$B422
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M6+HS&,%"-W#!6Z=.<5I>(/"MWKEYINK76F:)?7=M&\3Z??9DMRK[22LAC)#
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M5%"=OZ]/\OQ8/7^O7_/\$><ZY#H]_P",]3T_Q9*D$$UM -(FF<1A&^;>87/
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M..57,LP;*N3DDR!3D'KC!KUVH+M;I[61;*:&&X(^22:(R(I]U#*3^8H;OO\
MUHU^OX OZ^]/]/Q.!\$PVUT+=]1L;:"?PO ^GM*T2HJ2Y^=U.!@&-4;(X_>&
MO0;>X@N[>.XMIHYH)5#QRQL&5U/0@C@BJ^FV T^W=6D\V::1III=NW>[>W8
M8 &3P!R:N4-WW_KO^(DNW]=@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXVL);VUM=.M+S4WN+5+S-H(_DA<X5R'=21UX4,1CD=*Z6G9H04444@"BBB@
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M3TL;729+*XMUMKMD,^S8DH_<C> .<'&#TSUKZ'HHD^:]^O\ P5^K$M+6Z?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 1RW$$!C$TT<9E?9&'8#>WH,]3P>*=)(D,;22NJ(HRS,< #W->9^*;O4G
M\5>'[F[\/:CF'6!':L);8HR>7(/E_>YW-]X[@N ,=>O=^(;6WO?#FHP75O%/
M"UNY:.5 RG )&0>." :4G:'-ZE)>\H_UO8OP3Q7,$<\$J2PR*'22-@RLIY!!
M'45)6#X)_P"1$\/_ /8.@_\ 18K>JYQY9./8SB[I,*;)(D4;22.J(H+,S'
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M3JL YVD9X)Z]^>HH2O\ U_A_^2!Z?UVYO\CVBBO*/&U[+9Q:HVD:MJ+/I-E
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MHG:A'RX8#<?4YK)M[[59?#FA^)(=1OO[9NM12WN;0SLT15I2KQ>23M4HO.0
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M#6]G<3,7=XPJG!<\N58E<GGCG)KBL2V>B>*-4LK^[@U.U\0S?988KAE29V=
M(VCSM?=G'()],4+>WDOQ:_S![?/]'_D>OT5YCJLOBC6==UN/3;FVL[C3)X_L
M[SZI- L<>Q&+/ L;+*K$L-S'Z8QSZ8A)12V,D#..E%M+AU'45Y;K>I7:^)1>
MV6IWSB/7;:R<FY,4,:-M5X1""5D/))=E!YX)VU2FO-3M--UO46UW4YKBP\2Q
M6\!DN2$\LO$K(R+A6!#'@C ZC!R:(J]OZ[?YH'I?^N_^1Z_1112 **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFNZQQM([!44$L
M3T %<L_C_3(7(N;/48$>U:[MG: -]JB7!8QJI+9 (.&"G!SC%%PL=717*VWC
MNTO'L4ATK52^H6GVNR4Q(/M"@ E1E_E8;A]_:.>":C@^(>EW;:;%:V6IS7.H
M++Y,"VX!#1;@Z%RP0,"I'WL=#G!S3LUI_7]:!YG745Y_J_B5]4G\,7>FW=]9
MJVMBQO;)PJ-N"L620#/(*CHV"#WXK:NO'&FV<KO);7ATZ.X^RRZDJ*;>*7=M
M*M\V_ ;@L%*@]Z27]?=_F#_K\?\ (Z&:UM[EH6G@BE:%_,B+H&*-@C<N>AP2
M,CUJ"72=.FM[FWET^UD@NFWW$;PJ5F;@9<8PQX'7T%8L7C2!YM=A?2=2BDT:
M,23+)Y(,JD$J8\2<@@'!.!VZY%)<>.+*T$<EU8:A#;B6."XN&2,I:ROMPDF'
M)S\R@E0R@GDT)7"YLP:-I5K:V]K;Z;9PV]O)YL$4<"JD3\_,H PIY/(]35ZN
M>N_&-A97RPRV]W]E-R+1K\*OD),3@(?FW=2!D*5SQG-:&K:S!I"VZO%-<7-U
M(8K>V@ +S.%+8&XA1P"<D@>]&^H>1HT5R$OQ&T>"&,S6NI)<M>K8R6OV;=)!
M,Q& Y!*@'<"#N((Z9K:.OV\/AR76[VWN[*"&)I98KB+$J!<Y!4$\\<8)SQ1T
MN'6P^U\/:+8W[W]IH^GV]Y)G?<16R)(V>N6 R:EET;2Y]2CU*;3;.2_B&([I
MX%,J#T#D9'YUC0^-]/\ LVIRWUI?:=)IR1O/#<HA<K)]PKL9@=QX SG/4"EA
M\;:<TMU;WEKJ%A>6L:RS6\]N6*JQPGSQEHR6/  ;)YXX- %R3PCX:E:X:3P[
MI+M<-OG+649,K9SEOEY.>>:L0^']&MY[>>#2+"*:W7;!(ELBM$,8PI R!@ <
M>E8%Y\1M*TR&[.HV.J6MS:O$LMJUN)) )"0C_NV9=I((SNZ\=2!5?Q'X^?3]
M"U^2STN\74M,1"8I_+&%DSLE^^05X/'WN,$"A>7]?U<+7>IU']A:1]KFN_[*
ML?M,S*\LWV=-\C+T+-C)([9J*/PQH$*W:Q:'IB"\&+D+:1CSQG/S\?-SSS4C
MZO%::"VK:E'+8Q10F69)MK-& .<["P)^A-9L/B^*6]DL'TK4;>_,#7%M;3")
M6ND'4QG?MSR.&*D9Y H>@)W5S2G\/Z+=2>9<:183/Y/D;I+9&/E?W,D?=]NE
M5?\ A#?"Y\[_ (IO1_WPQ+_H,7[SD'YOEYY //<5@> );W6=-C\1WAUF.YF1
M]\,UTC6\^6."D8=@FT#:/N9[YZU@W7B_6-7T;3M3:/4M,6/Q$EJT<31E9X_.
M*%#L)<D;<'H"2?O"FEK;^M7_ ,$.E_ZTO_D>EVVC:79RPRVNFV<$D,7DQ/%
MJF./KL4@<+[#BB\T?3-1ECDOM.M+J2-E9&G@5RI&<$$C@C)Q]:RH/&-E/!>%
MK.]BN[6Z%FUDZIYKRE0RA<,5.5(.=V,9SC!J[HFO6VNQ7)ABGMY[68P7-M<
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M^-;"VU?["UG?/$MW'927B(IACG< JA^;?SN7D*1R.:>_]?UW_$-OZ_KL7?\
MA$_#9A$/_"/Z5Y2H8PGV./:$)W%<8Z$\X]:(?"?ANWGMYX/#^E12VW^HD2RC
M5HN2?E('R\DGCN362GQ#TM_.=;'4Q;P7ZZ?/<26XC6*1BH4D,P;:2P' )'<
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MYH7?[N[82NTYX8-@],YXI^G]?U?\?,.G]?UT_ Z%M(TQ]034&TZT:]CSLN#
MID7/!PV,C.*?>Z;8:FD:7]E;7:QN)(UGB60(PZ,,C@^]8C>-K&(ZC'/9WT%S
M8O"AMY%3?+YIQ$4PY&&/'S%<=\5+<>*H[.]TRUN])U&!]0N/LR,ZQ%8Y-F_#
M$.<C&>5W#*FBVP;%]_#^BR6,EB^D6#6<LAEDMVMD,;N3DL5Q@G/.:E.DZ:5M
M%.GVFVS.;8>2N(#C&4X^7CCBN'\2^*9M1TAI=.?4M+GT[7;:QN8V,:F7<Z C
M*ELJ5<'@@^OI6C;>-Y$USQ/'J.G7-MIVC*A,^8V ^3<20K%B6!&  >!S@\4+
M^ON7^8/M_6__  #J;W3;#4TC2_LK:[6-Q)&L\2R!&'1AD<'WJJ_AK09(&@DT
M337A9S(8VM4*EB<EL8ZYYSZUB7'Q$TZQT_4KJ_TW5K633A&TULUNLDFV0$HP
M\MF7!P1DL,$<XJ+7?'PT_2-=>VTN]^WZ;:+<B&<1IOC;(64?-]T%3D'#<?=I
M; M=#KYK:"XMGMIX(Y8'78T3H&5E]"#P167+X0\,SQK'-X=TB1$5457LHR J
MYP "O09./J:!K4\'A4:O/I5\TJ0B22T3RC,0.I&'V'CG ;I[\52M?&UI=:CI
M5F-.OD_M2S:\MI7,.PJ%#%21(3N&X=L<]< D-JS:_KK_ ),2=TG_ %T_S1J6
MGAW1+"]^VV6C:?;7>P1^?#:HC[0  NX#., #'L*CO/"_A_4;Q[R^T+3+FZ==
MK33VD;NPQC!8C)&./I6-<?$&SM;%;J72-5 %J+V= L1:W@)($CXDP0<$X4LV
M.U27'C[3H=5NM.BTW6;N:U2*24VUBS@)(<!@/O,!WV@^V<' _,>QIP^$_#=O
M-;S0>']*BEMO]0Z6<:M%R3\I ^7DD\=S4\&@:-;7;7=OI-A%<M(96FCMD5RY
MZL2!G/O6!:_$;3;S31J$6FZO]F<[(7:V"B:3S?*$:Y;ABV/O8&#U&#A[_$+2
MX;6.6XL=4BF;4!ISVYMM[Q3''#%"4QA@00QSVR>*+,#8GT6SMA?7FEZ5IZ:I
M<1D&4H(C*V.-\BJ6Q^!K)\">%1X:\/VD%[I^F1ZK%$();JS&XS*.A+E%;\#G
M'K5#7?B!):Z1<2V&DWOVVWU*&PN()3$&A+LN#]\J=RL-N#U/.,&M^U\2+=W\
MMI'I=_F!HX[A\1%8)&"G8V')) 8$E05Z\FA)]/ZZ_J#\_P"NA8;PYH;RW<K:
M-IQDO%VW+FU0F<>CG'S#ZU%#X3\-V\UO-!X?TJ*6V_U#I9QJT7)/RD#Y>23Q
MW-9WBOQ+>Z'JFA6=IIEQ=C4+HQ.T31 X",VT;V7DXSDX& ><X%87A[Q3)H\V
MMQZM)JE_"NO&S6[D",L 81A W*X7<<?(IQGG&<T15]OZV7Z@]-_ZW_R.U@T#
M1K:[:[M])L(KEI#*TT=LBN7/5B0,Y]Z1_#VB27-S<OH^GM/=(8[B5K9"TRG@
MJYQEA[&LRZ\:V-KK!L&L[YXUNTLI+Q$7R8YW *H<MOYW+R%(Y'-1^$_$M]KV
MHZ[#=:9/:Q65ZUO$[M$5PJI\IVL3NR2W3&"!FDE?^O0'H:$?A'PU"UNT7A[2
M4:W;? 5LHP8FSG*_+\ISSQ6C:6%G8+(MG:06XE<R2"&,)O<]6..I/K7 Z5XI
MET+5/% U235-0M+?5XX1.0C+:I(D>W/*C:&;&%!(ZD=ZZ34?&6GZ7=,D]O=M
M:1W"6T]\B*88)6QM5LL&_B7E5(&>2*:UM;K^H/2_D:JZ/I::FVIIIMFNH,NU
MKH0*)2/0OC./QI$T72H]1DU%-,LUOI5VR7(@42N/0MC)'XU2\3:U8:-9VK:@
MEZT=S=10(;0."'9QMW,I&U<XSDX/3G.*D@U^.ZU.XL[>QO)([>40272A/+63
M )7&[?P",G;CGK27]?U\P>A%_P (7X5\GR?^$9T;RM^_9]@BV[L8SC;UQWJ>
M[\,:!?F0WFAZ9<&5P\AFM(WWL!@$Y') XSZ4S6_$4.BRP0"RO+ZZG1Y([>T5
M-Q1 "S9=E7 R.^3G@&L^V\<6M[=6<%GI>HSB]L6OK651$JS( ,J-T@(;+ 8(
M YZXYH_K^ON#8V9]#TFZD@DN-+LIG@C,4+26Z,8T(P54D< CC IDGAW1)HK6
M*71M/>.TQ]F1K5"(<=-@Q\OX5F:7XTM=7LM-O+?3K\0WPF;+^3F!8CAC(!(3
MC/\ =W'UQ5:#XAZ9+%++)I^J0QBS^WPLUN'^T09 WHJ,Q[@X8*0#DCK0] MT
M.F-A9M?+?&T@-VL?EB<QCS G7;NZX]JJ1^'=#AANH8M&TY(KS/VE%M4"SYZ[
MQCYOQK*LO'%K?V4-Q;Z5JI-TJ-:1-"JM<AD+_(2VW@ YW$ ?B,Z&F>(K;6=$
MFU*P@GD:$R1O:L%2594)#1G)VALC'7'OBAJU[] 6NP3^&=+?3[:PMK"RM;6W
MF$T<<-LBB-@<Y3'"-U^8#/)^M7[[3K'5+8VVH6=O=VY(8Q7$2R*2.AP017F9
M\6ZMJVC^#M;<:C8B[U812VT9C*7,;;R,;"6(&T+SM[DCO771^-[*2R:4:?J
MNQ>FP^P%8_.,X&[;G?LQM^;.[&.]/7^OE_F@_K\_\F7Y?"7AN>X\^7P]I,DP
M?S/,>RC+;N/FSC.>!S["GQ^%_#\,-U#%H6F)%=_\?*+:1@3<Y^<8^;J>OK7-
M7WQ E<Z VEZ/?3)J%]):S(?*62-HP^Z/#.!NRIYSC .#G%:7C#Q+>Z ^C16>
MFSW;7]\ENQB:,$#EBHWL!N(!'H.>1QE6_'3\@_X<WK+3+#349+"QMK56QN$$
M2H#@ #.!V  ^@J*70M(GN6N9M*L9+AD9&E>W0L5;[P)(S@]QWKA](\52Z)J7
MB?\ M5M5OK6#5HX1,P1EM4DCCP#RHVAFQ\@)'4^IZ"?Q;I%IK.KQ2)?BYT^"
M$S!E81N'8A!&K$*26.-P '0%N.#?7^OZU#R+J>#O#$8A">'-(40N9(MMC$/+
M8X^9?EX/ Y'H*F/AK02[.=$TTNTIF9OLJ9,A&"YX^]@D9Z\U9L+R2]B9Y;&Y
MLW4@&.X"9Y /!1F4]<<$\@UROCKQ+JFC-"^D[#%8;+W5 5#'[-NVE1Z$C>V?
M^F9HZV V?^$+\*^2(?\ A&=&\H,7"?8(MH8\$XV]>!S[5?U'1]+U>W2WU/3;
M.]@1MR1W,"R*IQC(# @'!-0:IKUII>G07CB2<7+I';10 %YW?[JKD@9/J2!Z
MFL*;XE:-;LD4MGJZW1NTLY(/L+GR9F(PC2#]WGD'Y7/!XS1Y!?J;UOX<T.TN
MI;JVT;3H;B5#')+':HKNIQ\I(&2.!Q[5+::)I-A8R6-GIEE;6DN?,@AMT2-\
M]<J!@YK$N?'-I:6+W4NDZL%@B$UXAA4/9QY8;I 6Y^Z3A-QQSC%3:GXTT[38
MWN/(N[JSA1)+FZME5H[='&59LL"1@Y^4,0.3B@#>M[:"TMH[>VACA@C4*D4:
MA54#L . *KV>D:9IT\\]CIUI:RW!W3200*C2'U8@<_C7/7'Q$TJ$:JR66IS1
M:4Z"\E2W"K&K#.\;R"R@<_*"2"" 1S5Q?&6G+>WEM=07=FUM:B]#3H,2PDXW
MH%)/7C:P#>U'F'D7_P#A'])C%ZUOI6G137J%;A_LB'S@>TF,;QST)JQ8Z=!8
MZ7%IZJ'@CC\O:RC!'ICH![= .*YJ^^(NEZ5#?MJ5AJEK/91I,]LT >1XV)"N
MNQF7:2".2,'KC-.U+QS':6&N-#I=[]MTRT%V()@B>;$P;:X.[[ORG(.&&.F<
M4GHFQI7:1K?\(GX;,(A_X1_2O*5#&$^QQ[0A.XKC'0GG'K3K?PMX>M+FWN+;
M0=+AGMQB"6.SC5HAR<*0,CJ>GJ:ATS6I)/!\&L:C:7<+BU$LL819)&^7)*K$
M6SGJ .>>@JKI_BFPDT[1!IUIJ-W_ &C;^?!$75I5A&W+NTC\XW+GYF8YZ&J:
M:;7;_@_\$E-229I1>&]"@=WBT73HWD+,[):H"Q;[Q/'.<#/K5R^T^RU.U:UO
M[2"[MW^]#/&)$/U!&*AO-7M=/T9]5O?,@MTC$CAT.]<]%VCG=DXQZUA7'C[3
MK!;Y=3L-3L9[2W^U&WE@5WEAS@NGELP(!ZY(*]2 *3[,I7>QKS^&]"NH[6.X
MT73I4M!BV62U1A"./N CY>@Z>E:;HLB,CJ&5A@J1D$5RI\5P:Q'<:=!'J6FW
M,^FF]M9Y$C4O&0/F0$M@J2,AE'7N.:S?"/C"3^R?"6G:A::C<7>JV*R+?L8S
M$[A-S!F+AMV.<;>>V<'#L]G_ %O_ ),FZW_KI_F=0/"_A]=.?3ET+3!8R.)'
MMA:1^6S?WBN,$^]!\,: RJK:'IA"P_9U!M(^(O[@X^[[=*ETK5AJD%Q-]CN;
M9(9Y(09]G[S8<%EVLWRY!ZX/'2L2U\?Z;<R<V.IQQ/:R7EM*8 XN8D(#%%1F
M;/(X95//2D,T)/!WA>:1Y)?#>CN\@"NS6,1+ 8P"=O/0?D*<OA'PTCQNOA[2
M5>.,Q(PLHP50@@J/EX')X]S5+2/'&GZS<Z9%%9W\":I;M<6<UQ&JK*%P67AB
MP8 @\C!'0FK6N^)X-#FCM_L-[?7+PR7!AM%0LL28W.2[*,#<. 23G@&AZ;@M
M=C0T[2=-T>W-OIFGVME S;S';0K$I;UPH SP*C;0='?3Y+!M)L6LI',CVYMT
M,;,3DDKC!.><UEW'C33TCM'M+:]OS<V@OMELB[H[<_\ +1@[+QST&6/. :I?
M\+*T::X@@L;'6KZ2XMFNH1%ITB>;&N,E/,"[N&!XR/Q(!=G>W]?UI^ )]4=9
M;6T%G;1V]K!'!!&NU(HD"JH] !P!5<Z1IAU,:F=.M#J 78+KR%\T+Z;\9Q^-
M9+^,]/BO[>&2WNUM;BX^R1WY1?(,^2/+^]N!R",[=N1C.:8WCC3H[J*.6UOT
MM[@2?9+H0AH[ID!++&%)<G .,J-V.,TO,+=#9N='TN]O8+VZTVSGNX/]3/+
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M946>)HM0B_YZ01L)$/X/A?I(:@;P+&GB*^NGT3P_J%O>W!N/M5["#<V[$#(
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M3CMD[7BC0-4UJ_B6)[6;2VM989;6XE=%$C=)-JJ1)@9&UL#G-=511+WM_/\
M$%IM_5CRO^Q-:-UIFCV4]DFI:9HT=M>FWU PET8X RUO)N4[">%4J>C<UJZ'
MHNHMK^@ZE:6&G6NDZ;8S:?Y2WKR/]Y1N0^6 Z_NQ@D@G.>,8/8:AH>D:O)%)
MJ6E6-Z\1S&US;I(4^A8'%7E4*H50 H& !VJN9WN_ZW_S%96M_7]:'"Z9X"AT
M_5I_,T3P_=0/=/=1:C+"#>1EG+[2/+PQ!) ;>,<<<5'H?@5] 0Q0:#X:EEM0
MQM-2*;+F3KM$F(CM/."X9L]=O-=)XC\0GP__ &;_ *#)<K>WL5H76156(NP
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M$'N6#$MTS7L$\\-K \]Q*D42#+22,%51ZDGI31=VQN$MQ<1&:2,RI'O&YD&
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M]2?6"NG:=/=V<5^;*6&/2[EW(#['E$X'E *<_+SP.H/%==IUK=VU[=*TLAL
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M>O-.\0^&5\0P6<+ZIJ%DEK,DZ_93$2SH04+&1&S@C\>^:$[6]?\ +_(/\O\
M/_,YY];U:WCUYM$M]) T9\WJ&V9#>S>6LDA4J_[O@XRV\D]>G+(?%OB37=;^
MP:);Z5;0S:7!J-O->>9(VV1@"&5=N#][@$]!SSQO77A"VN9[B1=0OX%O$"W\
M4+1JMYA=N7^3*D@8)0K4EKX4M[/Q0VN0WUX&-JMFMIB(0)$O*J $W<')^]W]
M.*7]?A_G;T!^7];?\'U/,K3^TKW1/!VI7TUG=W[>(Y%AF-N8V0%YMX+;FR"5
M!P HX [9KTKPMK-YJRZM:ZD+9KK3KY[1WMXV1)!M5@=K,Q'# $9/2L\?#JRC
MCL(H-8U:&&PO&O8(E>$JKEF;'S1G@;V]^>2<#&KH7AF/0;K5+B/4KZY?49_M
M$HN/*PKXQE=J+C@*,'/0>^7=6=_Z^'_)@]]/ZUE_FC@O#>IWOAG3YVLX;!-*
M;Q1-9/;B)MX624("A!"IM)'&#D=Q6N/'NJW.JQ'3M,FN[)[Y[)H5TRZR@5RG
MG&XVF+;D<KC('?(Q5T_#>V.G-9'Q!K7EMJ']I%O]'W&?=NS_ *GINYQ_3BM>
MV\+16-W<26>IZA!;3N97LT:/R?,)R7&4+ D\D!MI.<CDT+97_K1?\$'N[>?Y
MO_@'+V7CG7_^$?DUO4+/3EMQ=R6(@M5FED\X3B)2, EE^]D!=QP,=<".X\>^
M(K/2-0G?2DD-I<VZ+=W%C<V4<\<K!24CE&[<K$ C=C'.>U='8>!["S\.W.B3
M7E]>6T\[7.^=D$D<A??N5D1<'?\ ,/0^W%&J>"UUG0_[+OM?U>53(CM/F 2,
M$;<JG$6W ;!R%!.!DD4:?E^E_P!?O#_@_K;]#&UCQAXBL[SQ6D%OI<<.AVT5
MTF_S)&G1@S%3@KM)"]><'^]GCH-=\2?V3X?M=1CA=Y+MXHHD$3RD&3OM0%FP
M,G &3C''6LZY^'T-V=9:?Q!K+MK$"6]T?]'&448 7$/'!8?B>^"-FX\.6MWX
M?@TBZGN9E@">7<EE6963!5P5  88'08]J7V?N_6_Z!U_KRM^IRG_  E/BZ?0
M=5N;6QMUN-,E#>;=Z9<6\=[!MR3&DCJR,O(P202!R,TV7QOKO_"*_P#"36::
M5=:?=7D45FC*\<B1/($W/AF#-DC@;<#)//RCIYO#+75G!;W.N:G,8YDEDD?R
M<SA3D(X$87;GK@ GN:XWQMX6_LG1=1DL;C7+QM4U*"X>SM[?S4B82H[.BQ19
M3"J>2>3URQIJU]?+]+_?^&O<6MOO_7\OQ^0OCC4;V?P_XM\/ZW#8W#0Z4;^U
MGAA*KMR0 59FPZLH(8'GK@5NKXHN].\0KIMS;VXTV+1&U 2(S-*Q0J"". .I
M]<\<CI4USX(L]6TG4(KG5-5DEU2%8KB[?RUF,(R1&%,85!\Q_A!YY.:EA\%P
MIK=OJDVL:E<R169L3#,(/+DB/4,%B!Y(!R".GIQ2UM;^MFOSL/1N_P#6Z_X)
M6L]8\5SV":G]BTN:SNK W4*AWC-N^ RH[9;>"#]Y57!'0]:PK?7==U[6_ ER
MMU9V\.HV4UW-;_9F==P1=W/F ]'('IR3NZ#J[+PDFGZ7+IEMK6JK9>68K>(O
M$WV92",(2F6X.!O+XX]*KV/@.QL(-$CCU+4F?1T>*VE9XPQC< %&P@!' Y !
MXZT]+WZ?\/\ YH6MK/?_ (;_ ()QVDW^I^&?"NJ7FBKIT.GVOB"Y2[CFMF;R
MH#*%+(%=0 HR<>GICGT73;R^O-5U(O+;-IT+K%;[(F#EMH+$MN(89.!@#OZ5
MC0:#9>%]'U"PDGU;5H]5FE=HI+<2YDD!+<Q1@(&]6PH]16EH6@2Z3X4T_24O
MKB&:!$,LZ%7=VSE\EU8$$Y!.,X/!%"V^[\DG]UOQ&]_O_-O\;V-VBBBD 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 17+3I;2M;1
MQRSA28TDD**S=@6 ) ]\'Z5P,WQ$UB#PC<Z_)X<LU2TO'M;J ZHVZ':X0L3Y
M/3)SC^[@\YP/0Z\WU+PK=:AXRU;1IK5W\.:O&M_-)M^19E4QE,^I/E/_ ,!-
M+K_737\5<:MU_KI^=CK+G6;Z'6=-L8K&TDBN8&GN)C=LOD*N,D#R\,,L ,E<
M^@JK=^--(TJ?2;.]U;3Y;C47=8Y4E6./ #'=RS8&0$Z\D_A6/X/LKX>%+JX\
M3V,K316O]GM \#2F6*'<"VS!+;R2< '(V]:P/#EO?6NC_#^5](U-?[-DN8KJ
M(V4BO$6C8+E2 =I) W?=]ZJRYK=/\[_\#[]2=;7ZZ_>DOUN=CX6\8+JL<T.L
M3:=9ZC]OGM(;6.?F3RC@[=V"_?D ?05OS:SI=MJ,6GSZE9Q7TW^JMGG59'^B
MDY/X5Y(/.CT"9X]%U=;E_%@OAC2+C>8?.#>9_J\XV9]^WM6MJ&E7D^A>)M N
M-/NY=5U._DN;*Y6U<Q$,5,3F4#:A0 ##$$;> >,BU2^7Y1_S?W#>[^?YO_)?
M>=])XET&*">>36]-2&WE\B:1KM L<G]QCG ;V/-5K+Q?H^H>*+S0+>]MWO+6
M-'91,N6)W951U.T $XZ;A7!:]IVI16/CS2DTS4+NZU-(9+5X;9F24>4B,=_W
M00RG()SW -=)X;2\B\=:Q/<Z9>V\=[9631M)'\JE$<,K."5W D# )//IS0DG
M_7E_F#T7]=U_F=L<XXZUR?A[Q-=ZMIEQ-J$NG:=<0ZH]CM+%T?8X7:I)4EFY
M ..I'RGI75D[02<\<\#->*$%].A=]!UAKF+Q8U]&QT:X+I;F7<7!\O(!7''7
MVI1^*WI^:!_#?^MF>NW&N:3:2F*YU2RAD$BQ;9+A%.]ONK@GJ>P[TAUG3IEO
M4MM5L3-:#$_[U7%NW;S &!'T)%>5:I:IY'Q*2TT#41)J"H+0QZ1,//;8 Q4A
M.?WF3G_@7O2^*46\O+]5T+5+B"?PO]EB5=&N&7[1NW(N/+X8<')QM/H12?PW
M_K:__ &E[UOZW2_7\&>ACQCI$?B.R\/R:C9O?W%MY^5E50Q^4*%!)R6R2!DG
M [U=;Q+H0%[_ ,3FP8V*E[I5N4)@ ZEP#E?QKCM+%VGB;0;\:7J#0MX>-J=U
ML\>R4.A*ON V< _>QG'&:R="M+YM9T29M*OK6,:5>6AM_L$B1VCDH1&78%FZ
M'YV;:Q&1C)%5-6O;S_6WY+[R8.Z3?E^2O^?X'=Z-XJT[Q%ING7^G:G8K'<R;
M3$[AW8[2?+&&&UQP2"#@9X[C3_MG2_[3_LS^TK/^T-N[[+YZ^;CUV9SC\*\M
ML()8+'X<";0]26\TU_*N9/[-E9H4\ID.6"G"[RO7@XST&:M_V-?S^&8_#DEE
M=#7H]6^V"\^S/Y0'V@N9A-C;G8<;=V[MBJ:5[+O^J7_!"[M?^NO^5CT677-(
M@N%MYM5L8YFE$ C>X0,9,9V8)SNP0<=:OUXKJ5IY6C^.(K'0-22:[U6"6U$.
MD3J9%7RR67"=-R2'/KS_ !#/LT$@F@CE4.%=0P#H589'<'!!]CS4+:_I^5QO
M1V]?S*^H:OIFD1I)J6HVEDDC;4:YG6,,?0;B,FL#Q5XRM-#N]-TV/5-+M;R_
M<XEO904A0(S!V7<I()4*.1R>O&*KZC&^G^.+S4=1LKF\TV\TZ.T@^SVKW&Q@
MSET94!*A@5Y(QQR>*YZPM;SP^/ MA>6>I2O8RSR3&"RFG2WCD218T9T4KD;E
M7 /&,].:<5>U_P"M_P#)?>#TO_7;_ACTK3C?'3X3J0MOMFW][]F+&,GU7=SC
MZ_K7.ZOXYL;6_P!4TC3[BQFU>RM#<"">XV!FP24X!)(52Q '&1TSFNLKSS7$
MNK+Q9XGN&TZ_F@O-$BA@DMK5Y@SJ905^4'G+KQUYST!(B;=G;L_RT'!;7\OS
M.G\,^([;7=)L7>[LSJ4MG%<W%K#(-T>]0?NY+ <\9K0M=6TV]NI[6TU"TN+F
MW.)H8IE=XC_M '(_&O+]+ANA=>$+>TTW4K6:+0)[265M-FC2&9E0*'8I@?,C
M'GZ]QG6\&Z$HU#2;NZF\0#4M,M3:M;W=I'#!&K*-P#K"HE7*@C#-V)[UK)+G
M=MM?S?\ P/O(3?*OD>C$@#).!7%:9XT;Q!K]W#I&IZ$]C8W'ESQ/-NFDB"J6
MF1E; 4,VW!4@X/S#I7:DX&:\I,-]K&E^)[>ST_44:76HKX1W-C-!]IME,6X*
M9% ).QAMZG\:A;Z_UJBGM_7F>CVFN:1?V<EY9ZI8W%K$<23PW".B'W8' J.3
MQ'H<5I+=R:SIR6T+A))FND"(Q (!.< D$''N*\\\4Z<NM_\ "0ZQ;:1?/9SZ
M(;3R)--E$EQ=;B8R(2NXE/[Y7 SP>#B:?29+:/PSJ5M#JFGV*Z>;>Z.GZ:KW
M"2E8U!>%X78C"LN0N1QV)H_K\_\ +\4']?E_G^!Z'=ZSI=A;Q7%YJ5G;03$+
M%+-.J*Y/0*2<'/M3K_5-/TJU^U:C?VMG;Y \VXF6-,GIRQ KS*YL!X3N-#AT
MRUOM02.QNX5CO[>:3]T\BG)$$+E#G "E -O!((Q4OAS2H/#4V@W<4$]WI-KI
MTUI*UMIL@D2Y9T+,\ 7S 6 QDKGCGKFG8#T:>^AV6CQ7]I&D\BA&D(83 _PI
M\PY/8\_0TUM<TA+E+9M5L1</*85B-PFYI  2@&<EL$''7FO+I=%ET>W\,M+I
M-X[1>()KR)8+&29K.T8OA244[!RAV_IP<5);<6_A[Q!'9:!JD3S>(X;JW2+1
MYT)A5XVW@"/H C_Y(R15W_7]W_-_<P>G]?XO\E]YZ^^JZ='J2::^H6JW[KO2
MU:91*R^H3.2/PJY7CVMPIJ&IZ]I4MK*=,N]3@NY[J;3;J9XRBQDJ L+1E2%
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M*8!B54=EY'K7<6NJ6]W=26JK/'<1HKM'-"Z<'T)&UL9P=I.#P>:+:?UV%?\
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M>M*RNH92&4C((.012TU$6-%1%"HHPJJ, #T%.I %%%% !1110 4444 %%%%
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M&MX@+F)I(Q^\PO4"3@ILZ<YH2O\ UZ?YH;T_KU_R9Z5]JB#SJQ9!  7=T94
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M# L8.]HT<D1@J"Q7&"/E]\D[+ZGKMC>^$MVK-/;:M>2"=)K>/?L,;NBAE"@
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MMKZXM#,553((Y&4,0H !P!G  KBK>[U31]%\4ZWI^H/']BU^X=K,Q(T=RI=
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ME!'.UBHZ$9K*O89)O _Q*\NZFMRFH7;DQ!3O A3*G<IX/?&#Z$4EJK_UNO\
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M<[RBL&PO[^^\!6NH))'#J$VG)/ODCWJLAC!R5R,\]LBN-TKQ9KEO;>%M1O\
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M,Z81 !M*J0'! QAN!G."16=I/CS3=8ETH0V=_%!JJR?9+B>)41V3)*8W;@<
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M8G! C8%1MP<9%6O&!O;2\AU*PU+57BGL@-7A@NI2+.!L?Z3&H<!'&TX '/)
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M4D D]>*JZO>W]7O872W];-'GAUC5;4WFBVUS+-;+XA>Q\V[U&6-EB, D5#<
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MOKB*XN].M+B>)@\<DL"NR,.A!(R",FDM+>5AOKYW+BL'4,.A&12T44 %%%%
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M;Q!X-T61]9MY]/L;EYEM881O$RNQ42/N.0,A@NU3TY(JM&W_ %I<3V_KL_\
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MC"@=R1EL#H!GO7":NNLZEIWE7>@S6E]<Z%-$9;2S>4.Y+'R0.4AS@-\P).[
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MHWR!AE.U21N],U5U'18-.^'UOH6GO?3->ZC%]E^V )*29A*S;0J[0H#MC:,
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M;6PD622)HG19F@Y=,DC((R.O%9$RZA;VDJ3:#K"!O%HOT*63RY@#@L^(]Q
M'<#.>,\XI+5?UU7Z/\!/;3^M'^J7WGHFG>--"U/4M5LH-2M-^FMB8F=1P "S
M8S]T$X)Z9R*T(-=TBZL5OK?5;&6T9Q&L\=PC1EB<!0P.,YXQ7GU]#>VQ\8QM
MH-W>"YU.WN8LV\C(8]L0\P!2#(5*D[%.3MP<9K#U?3Y)(M82ZT?5+Z6;7[.]
MAE;1I&W1!8O,8;8\*,!@1][L<G-**O;Y?I_G^ WUMY_U_7<],UCQMH&D:'/J
MK:I9S012^1^ZN%8&7.-F03@^OH,FKJZOY]_8I:"VNK&[B:1;F&XW$8&0P4+@
MH>F[=U(&#G->9Z]!>7\_C9;/2M49)9[":$?8)D$HB9!(4RHW$;>@Y('&:]96
M03V?F&*55="=C+A\?3L?:E]F_P#6W^8=;?UNOT(K/5M-U"62*RU"TN9(F*R+
M#,KE",9! /!&1GZT[4-3T_2;<7&HWUM9PE@HDN9EC7)Z#+$#-<CX0CU'3]9&
ME(MS=:-;6F(;B]L6MYK8Y7$.\@"48[J.-O))I/%]E=GQ-97KSZK%IILY+9Y-
M,M$N71V8$[HVBD.U@,94=N>*'I:P+J=9=:QIEBH:[U&SMU,9ES+.J#8,9;D]
M.1STYI+G6M*L["._NM3LH+.7'EW$LZK&^>F&)P<UYQ9:+8^'?&F@+#I>JS6U
MCI%Q"UW+ITDS\LIC5G2/!.T. .HSCJ<',T>>]TK1?"<W]E7S7UI%>0O9W=E<
MJH1F'.$B=P<%<'85P2,@T_3^M6OT#^OPN>MW^KZ9I=JMUJ&HVEG;L0%EN)UC
M0D],$D"B[UC2]/MXKB]U*SMH)B%BDFG5%<GH%).#GVKS#2]+ATVPT6QTVQE8
M^7=I<7\&ER*\4K[?W9B91L+#: \JGY4'][-06<EWI.F>$772KF6\BT:6TGM+
MJRN<("4!.(HI&!R.ZA2#]X<4-?U]_P#7X@>L7^J:?I=L+G4+^ULX"0!+<3+&
MI)Z#)(%-N=7TRR4-=:C:0*8S-F6=5^08RW)^Z,CGIS7EUAH*:39Z(+2YU1-+
MBL9;2XFTS2E,HG9E+^9 \+N-P &=N?E&>M6K'1K'P]XV\/)#I>JS6MCI-Q ;
MR73I)7Y93&K.D>,[0^!VSC@G%']?G_7S%<]&BUO2I[J&UAU.RDN)X_.BA2X4
MO(G]Y0#DK[CBE35],EOYK"/4;1[R%=TMNLZF2,>K+G('UKR;2DN+?0?!L?\
M8^K136NM3RSJ-*G!BC/F@,V$X&'C_P J<7=)\.J]M:Q^(&\0W%[I/G-):MIZ
M-;2;@P<JZ09E5P<[-[,<\C(I/0?]?G_D>DQ:]H\]P+>'5K&2<QF81I<(6* X
M+8!SM!'7I6=H?C;0-?@DEL]4LR%NC:J#<+N=LD+QG/S;25'<#(KSWPW#-8Z?
M\.X!HVJ02V=Q/]L TN=?*WHZY<[, %F7GIWZ#-=7X,N_[!T2ZMM5M+VU8:K<
MC>]K(4/F3.RMD C;@CY_NC.,YXJK?U\U_F)O^OO_ ,CN****D84444 %%%%
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MS%./:H)EUBR^)T=]<0Z5-J#:!<2(84:%6(DCPCL2Y./[W?/W11Z[:_@F_P!
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M'\0:SY=[?+?S$&WR95((Q^YX&54X_P!D>^="P\'C3]2U*_37=6DGU!TDF+F
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M:AJ@3[@O/* 7C'2-$#?5LU1@\%V=NL,4=_?_ &2U8O96A,9CM'P0&3*9.,G
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MY 9LGL326H]5J=O%$D$*0QKMCC4*H] .!3Z**!!1110 4444 %%%% !1110
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MVC+%8XV^8X..ASG'?%:&A:S:^(=%M=6LED%M<J7C$J[6QDCD=NE">GI_P/\
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M:E/JUD9Y8FY$AE7E&8#(RISZGK7>>'X)HM%@>Z39=W&;B=<YVNYW%<]\9Q]
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M&8@E@,Y&T 8( [ 8&(O$P-WX*\9QWNL7YN-'/V2&*2[(S$$3#2*"%D,F2=S
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGQ1SW(%G,2D;C*N $RRX!.5SC!SC%9,GBJXB\9*1<F?0I-$;48XH+5C(2'0
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M2HD$'VEWGB>)&BSCS$9U =,_Q*2.1ZT@.@HKE$^)7A"26WB76HO,N0C0(8I
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M0;W3+W4;>>[>VL9!%<$V%P&1SCY=I3<3R,X!QGG%;Z.)$5QG# $;@0?Q!Y%
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MQVC)&H*IL5B 0F23@NW)Z'M71S^)]'MM433IKLK</((@?*?R_,/1#)C8'/\
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M92<^9ALELC&> <X/%6/&&A^(-5N=:BM]+DEBD-M):/;3PQ+-L92PERP=GX.
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M!D8 JRG((]:=2M;3^NO^8V[Z_P!=/\CS>32=9M-:\0&U\.736D^BPV%J8[F
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MT6J1>,_$5Q=:+=VMI>O$T%Q)+"RL(T"'(60L,]1QTZX/%=;11_7X)?H@>O\
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MZEN&M[6:$10W-XUTT0>(%@9&R3SVR0.QKH'\/VKWUW*5C>UOE_TVSEB#QS,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>ex10-9_003.jpg
<TEXT>
begin 644 ex10-9_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **Y>UUZ_;QLVBO<Z9<IY+RRPVP82V8&-GF,6(;=G^ZI'N.:ZB
MCI<.M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH YS^R=0U+Q#8ZGJ5I86O\ 9S2&!K:X::24,I7#$QIM&#G
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M=TUK(+B(QDNH!.%/./F'4"M))7>>6-H)$5,;9&*[9,CM@YX]P/;-*WX_Y?\
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M*E"1DJV,CV..*\W\3:'XAU&_U(Q:5+)&+^TN;;[-/#%',D;(6+Y8,\G#??\
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M&=H[#H*COM#TC5+F"XU#2[*[G@YAEN+=)&CYS\I()'/I0M.7R_X/^8:Z^?\
MP#E-"O+NP\3QV&KB[DGOGGEM+V*_,UM<H.0/+)_=%5(X5=O'4DUH^,9MTND6
M"W=W&UU<-_H]K*86N%5&)!F#*8U'#$@Y.,8.:W;?2--L[M[NVTZT@N9%"/-%
M"JNRCH"P&2*=>Z;8:FD:7]E;7:QN)(UGB60(PZ,,C@^]+HD'5M&!\.[V[O\
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MQCNX)5U"4M;W1+@)OW;MK  E"<#J .*]'FABN(7AFC22)QAD=00P]"#UJ@+
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MQ8HN"0J_* <<\G--/^ODOU5_FP?]?>_T=ODC71 B*@)(4 #<23^)/)IU%%(
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M-RS"*0*$:WBSF-%_W.Q-&J^&M<UKPM?:->Z_:M)=1&#STT\@!#C)9?-Y?W!
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M4I*[M_6Z_P [^AZW17CWA"^T6U\2>!TL;VS6XO-">.ZV3*7E8"/8'YR2"K@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7R7LEL5L+B
MW@GR,// 95QGGY0ZG./?\ZLT4 5=.L(]-LDMHV+8+.[MU=V)9F/N22:Q]/\
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M-9;^ Q(VI[M28)<ZDNIVV(1FWG&W!)S\X^3I@<,?8@TYO+_AO^"/I_7G_P
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MJY;&"JC(*Y]"*;_P@5U<:EJ4U_K8N;:^L(K)E6T\N9?+R4DWA]N[<23A .G
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MOG?* YQAL#..U"6E_P"N@/1V-;6-<@T?[+&T$]S=7<ACMK:W"F25@I8XW$*
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M/S #D?=YJ'0?&6M7TWAA[Z"Q,.NV,DRQ6Z.'BD10WWF8@@@],#![FG;^OO\
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M^OZL2GI=_P!;?YG6T5P,<<7BOXDZ[IFL1"XTW2;>W6"QF&Z*1I 6:1E/#$8
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M8Y!M?8<%E[C/8$<<<^]3T4 ( %4*!@ 8 I:** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_QAX?N_$VCII]KJ$-EBXCF
M:22V,V=C!P  ZXY SUXS]:WHPXB02LK2 #<RKM!/<@9.![9-.HH\@"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** &2Q)/"\4JAXW4JRGH0>HK!L/!]G
M9:9)I3WM]=Z4T1ACL;ET:.)""-H(4.PP<?,S8XQTKH:* .;3P?"$(EU;4IY$
MA>"UEE,1:T1@ =G[O!. !N<,<=^35.S^'UM8R:&T>N:N5T6)HK5&,&-K#!#8
MB!/RX&<CH.^37844?U_7WL#G9/!MC=7-S/J%U>7[S6;V(\]D'EPMC<J[%4DD
M@'+;CZ$50F^'5E<>3)-K6M/=0V;6*7/GH&$3=05"!#QQRIZ ]0#78T4/7^O7
M_-@M/Z_KLCF+?P196\6AK_:&HN^CQO#;RLZ!GB8 %'VH!C 49 !XZ]<UX/A]
M:VBV(MM:U>(V F2U(:%O*208*#=&00.H)R?4FNOHH;ON&QQUE\.[6QCT..+6
M]7,>BR-):HQ@P=V00W[K)&"1V.#Z\U?L/",6E:<UEI^KZG;QEY&0J\;>7O8L
M0 R%3@DX)!//4\5T5% &;8:#I^GZ"NBQ0[[$1M&T<AW;PV=V?KD_G5"R\)6]
MG) QU&_N!:(4L5G:-A9@KMRF$!8XX!<L<?4YZ&BCS#R,3PWX;7PU;W$$6IWU
M['-,T^+OROE=F+.1L1>I.><^V*H:MX#L=6?62=1U*U76$1;M+=X]K;5VY&Y&
MQE>#^F#S7544?U_7W <F_@&RN-1:\OM4U*]#V']GR0S>2$>+K_!&I#;OFR".
M?;BMK2M)?3$VRZI?7Y VQM=LA*+QP-BKGIU;)]ZTJ*=PL8>I^%[74-4358+J
M[T[4UC\G[79LH=H\YVLKJR,,^JG':G7'ABSO=/:VOI[FZE9DD^UR.!*KH<HR
M[0%4@\X"@=>.36U12 Y34? =KJVF7EI>:MJ<D]ZJ1W%[F$321H25CXCV*N3G
MY5!/K3F\$J^J7.HOK^K-<W%B+!V(M\>6.X'D_>R2<^IZ8P!U-%'E_78#RNR\
M-R:?X^M=(M+[Q%#:6NC"RCU!;08R)-PC,GD^7]SOC/;.ZNID^'^E$*EM<WUI
M#]@.GR10RJ1+$23\Q92=V6)R""2><UU=%#U6O];_ .8+1W7];?Y')Q^!8X;^
M&]CU_5Q-#I_]GQG_ $<@18'_ $R^]D Y]1Z<5FW?A*R&@Z;X-@?4[D6<\4R7
M,\1411!LL/-5%0Y7<FT'=\W/%=]13N[W_K>_YA;M_6EOR(&MW-W%,MU,D2(5
M-NH38Y.,$Y7=D8XP0.>0:GHHI %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &7J?B"QTG4--L
M+AI#<ZA-Y,*(N<'!.6]!Q6C+*D,3RRNJ1HI9F8X  ZDUY]XAT'Q+_;VCW,-]
M9W*-K F++IDA:!!'(%WL)L%%!V]%Y.>I.>IU>VO=9B6+3;R*U-M<?OA>6$DB
M2X&0 -\>5R0<@D$C'K1]F_\ 70;T?]>98T'7;3Q'I8U&Q680-+)$/-38Q*.4
M)QVY4]>?4"M.N+^'\6HZ1X<:'6%<2S:E<B-([&5"-TSG<W+84_>#'  (&3U/
M:4W;I_6B%_7XA5'5KJ_M;5#IMBEY<O(J+'),8D /5F<*Q  'H>PJ]2$[02<\
M<\#-(#C-,\6>(M1N[Z(>'+#9I]\MG<F+5'=@2%)=%, W !P>2#P:L>%O&"ZK
M'-#K$VG6>H_;Y[2&UCGYD\HX.W=@OWY 'T%4_ ERSZMXJ=['4;=;C4C<PM=6
M$T(DC\M%R"ZC)RIXZ^U<>/.CT"9X]%U<7+^+!?#&D7&\P^<&\S_5YQLS[]O:
MFMTNZ7XM ]G;N_R9ZY_:VFC4_P"S#J%I_:&W?]E\Y?-V^NS.<>^*BUW6[+P[
MH\^IW[LL$('"#+.Q.%51W)) 'UK@-.\/37.J"UU>Z\0+=VVJOJ$"16L8MGS(
M65O/\G(&UL,K.#P0!C%=/\0-$OM<\-*FFHLMY:74-Y%"S!1,8W#;,G@9&>O?
M%+HOZ[?\'[@ZV7];_GI]Y*==URV@2ZO?#R1V\DD:*(;T22QAV"[I%*   ')V
MLW]:U_[9TO\ M/\ LS^TK/\ M#;N^R^>OFX]=F<X_"J%CXD74@(H-*U2*ZR!
M)%=64D*Q^N9&78P'^R6SVKA_[&OY_#,?AR2RNAKT>K?;!>?9G\H#[07,PFQM
MSL.-N[=VQ36]OZ_I;BZ7_K^NAZ++KFD07"V\VJV,<S2B 1O<(&,F,[,$YW8(
M..M.DUG2XKU[*34K-+I%#O TZAU4]"5SD#WKR+4K3RM'\<16.@:DDUWJL$MJ
M(=(G4R*OEDLN$Z;DD.?7G^(9ZQ/M]KXI@ETE+V>SU&[$UW97VG.JPC;M,R3$
M#8> =C$D]@*2U2_KI<;T_KS.J3Q)H<J6C1:UIT@O6*6I6Z0B=@<$)S\Q!XXS
M7,VGQ$AM/#UUJ7B$V=G+%JDFG)'',=K,KA<[FQD#EB<# '2N92UU*TT/2--7
M0]4GN=.\2O<S+':D+Y1DE<.KMA6!5AT)QT.#BEC@O;KP9JJQZ5J@D3Q,M]Y4
MEA,CM ;E7WJK*"WR@G R1Z4TKO[OSC_F_N"6G]?XO\E]YZ=_PD&B_:;6V_M>
MP\^[4/;Q?:4W3*>04&<L#ZBG2ZYI$%PMO-JMC',TH@$;W"!C)C.S!.=V"#CK
M7FOB:*^O;W4VBT74( -2L+DI%8R2M=(C1YD+_,!M&1L3##;DY!-9NH6P71?&
MZV&@:HDM[JD$UHL6CSHTBCRR67]V.-R2'/KS_$,BU_KT_P _P!^7];_Y?B>G
MZ;XMT?5?$.H:+:7MO)=V.W>BRJ68\[@%ZD+P"?4XK1O-4T_3FA6^OK:U:9ML
M0GF5#(W7"Y/)^E<QX86XB\:^)Y9+*\CAOFMIX)I(&1&00A3R0,,",%>H[BD\
M9PW<-TFJ:7+>1ZE!;M$D:Z>UW!<JQSY;A1E>5'S94#/)(XI/1*_];@M6[?UL
M3Q^,!;^+M6T[5IM-LM.M;>WFM[E[C'F>:6'S,V #\O &?J>V]>:UI6GW%O;W
MNIV5M-<'$$<TZHTI_P!D$Y;KVKS34O/GU?Q5-<Z%J"S7'AZ*UC6+39I4,V'W
M1HP0A@"Z=..,]CC/U:WU'4O#-[;QZ-J<-S)HEJA8:=*TETT>24.X;8]IS\N
MS9R#TII+1?UNQ7Z_ULO\SN;OQ3JT&M^)+".RLF&F6$=Y;;IG'F[M^=YV_+]P
M\ 'MSSQO>'M1EU?PWIFI3JB2W=K'.ZH"%!902!GMS7!W=VY\3^*K@:;JYBN-
M#B@A<:9<$22#S,J/DY/SK^OH<==X*+#P+HT<UO<0R164<4L5Q \;JRJ%8%6
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MJ65R]L<3K#<(YB/^U@_+^-<'#I9U7P.-/M=&N['Q+9Z3)8J\UN\2QLR88"3
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M4_$SV6G?%3P[J$UB\KFPNU=[>U::4@&/;P@+$#<>@.-Q]Z;6J7]=?\@6S?\
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M[Z_UK85U:Z_KJ=W17GFI^,_$-J/%LL=MI<<7A]D<*WF2-/&4WD9RNUBI'."
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MB0PZSJR1Z-)YEJNZ$CH5 ;,9X"DKQCKDY/-=/9WL%]!YL!<J#M(>-D8'T*L
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M3_[/C/\ HY BP/\ IE][(!SZCTXK/OO"ME'X7M/!,$FJ7/E-%)#<R1%?)19
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MM]A\7:RFK7KKI$-A;W=O&+"19(5<N&+K@OQM&20 ,\@=VNW];+]+ _/^M?\
M,W;[PE:7EY=SQWE[:1WPQ?06S($NOEV_-E2RG;QE"IQWIVG^%;?3?$=SK,%]
M=EI[=+;[*1$(4C3.P* @88R?XN_.>,3:CXJT7251KR\VHR+(72)Y%1&Z.Y4$
M(I_O-@>]0+XV\./JK:9%JL4MVDJ0ND2LX5WSM!8 @9VD<GKCU%"OT!]V6-5\
M/PZKJ-AJ'VN[M;FRWA'MV4;E< ,K!E(P<#D8([$5CVWP^MK.31F@UO5E72&D
M:U3,! WYW!LQ9/!(Z]/?FKFO^+(=#UW1M+>VNI'U&5U+Q6LDH550GC8#DYV\
M=ADG YK(\.^,O*NM6M/$.I(\\>L-8V[Q6K+&H*IL5B-P3))P7;D]#VI1\OZU
M_P""#\_ZW_R%N/#5IHWAC4?#JS:MJCZN9Y$\V'<%E?DDR1QJL8W'=EB/;TKK
MM+L$TS2K6Q1F=;>)8][')8@<DGN3UJG/XGT>VU1-.FNRMP\@B!\I_+\P]$,F
M-@<_W2<^U9GCO5]1T73]-NK"[C@C;4K>"XW0[R\;R!2 2?EXSS@GTQUIK7YV
M_P D'Z7_ ,RQ/X-L9Y[K%U=QV-Y+YUWIZ%/(G<XR6RI<9P,A6 /<')S7U7P%
M8:JVL_\ $PU&U36$1+N.W>,*=J[>-R-C*\'],'FK+^./#\<+R27DR".Y2UD5
M[.97CD?[H=2F5![,0 ?6IW\6:+%<ZC;274B3Z=L^T1M;2@C>2$VC;^\W$8&S
M.32_K\O^ /J9K^ ;*XU%KR^U34KT/8?V?)#-Y(1XNO\ !&I#;OFR".?;BIKW
MP:-1\/W6C7FO:O-#<(8C*[0^8L9QE ?+P0<=2"WO5B\\3:.L=F)=5EL9+FZC
M@A1X2DLCG:?+V.F1D,,\ @'J.M1GQUX:\V:-=420PW*VLS11.Z12D@ .RJ57
M).,D@9XSFGJ]/Z_K46VO]?UI^!MV5L;.R@MC/).8D">;+MW/@8R=H S] *Y6
M;X=V4D"00ZQJUM!'J!U%(XGB*K*7+\;HSP&)//KR2  -J\\3Z/8:@EC<WFR9
MI%BW>4YC1VQM1I -B,<C 8@G(Q4@U_3CJ,EB)I#-&P1V$$AC5CSM,FW9NQVS
MD47UYOZ[ALK'.WOPWMK\:H)?$&M!=3N8[FX53;@%TQLQ^YX VK_WR,]\R7/P
M^ANSK+3^(-9=M8@2WNC_ *.,HHP N(>."P_$]\$;^FZ]I^KMBRDE<$%D9[>2
M-9%& 61F4!E^88*Y!SQ1JNOZ=HNQ;V:3S'4NL4$$D\A48RVR-6;:,C)Q@9I;
M:!U.#O\ P_ WB)(M2DU[-G%#!87*:5!>K)M&=^\V\BQ-DX/W/N@\]N_M;:6Z
MT-+75D69Y82DZNH^<$8(8#C..N.,YQQ7,^)O&=O!!HB:9=7+0ZM-M%[8V;W)
M6/8S93",I?*@;2"<9.,"K>M:]/X,\&B]U*>;5+E66-9DLRI<LV%+HGW<9&>F
M3T ) IO5:]_Z_,-FFOZ_JQ9LO"5O9R0,=1O[@6B%+%9VC868*[<IA 6.. 7+
M''U.9O#?AM?#5O<01:G?7L<TS3XN_*^5V8LY&Q%ZDYYS[8KG8_&WV'Q=K*:M
M>NND0V%O=V\8L)%DA5RX8NN"_&T9)  SR!WZ;4O$^D:3%'+>79".@EW10O*%
MC/\ &VP':G^TV![T:[]_Z_0/+^OZU,:[^'MM>_V\)-=U<)KF/M:J8,  8 7]
MUD#:-O?CWYJ27P#97>HF[OM3U&\5K#^SY8)?)$<D7OMC!!W?-D$<^W%;FJ:U
M9:1H-SK-Q)NL[> SEDYW+C(QZY[?6L2&^\7W.C'5XX-+!DM_.ATMHY/-&5RH
M:;=C/J!'[9[TMM.P;_/_ ('_  ":3P;#<03K<ZOJ<\[V[VL5S(83);Q-C<J8
MCV\X +,&;WJK!\/;**?2WEU74KF+3K-[&.";R#')"PPROB($Y 4<$?='OG3O
M_%NCZ4XCU"Z:*155IBL$CI!NZ>:RJ5C!]7(J.[\;>';.YO+:34E>>RC66YC@
MC>9HD/1B$!XQR3V')P*/Z_/_ #?W@OZ_#_@#[#PQ%96$EA)J>HWEF8FACAN9
M$/DH1C"LJACP<9<L?>J$'@&QMDLEBU35 ;6S-CN\U"98"!\C?)QC Y7:>.<U
M?/C/P\LLB/J4<82 W/FRHR1O$,99)" K@9&=I.,\TMAXPT+4[BWAM;XLUS#Y
M\#/#)&DR 9)1F4*V!U )([XH>N_];_\ !_$/Z_+_ (!2T[P/;Z9J>DWL>L:G
M(=+M#9012>24,1QD-B,$GY5Y!'W1[Y1-.MM8\;VVNQ0748L+>2W=IH9(1*Y;
M"X5P"P4;\-@CY^#UJQ#XZ\-3I<.-36.."'[0TD\3Q*T6<>8C.H#KGC<N1R/6
MGVWC70+M<V]Y+*#:_;$V6LI\R'C+)\OSXR,A<D9P13;=[O\ J]_^"%K:?U_6
MQNR(LL;1NH9&!5@>X-<U'X%TR'PG'X=BN+U+>*59HY_-#3(ZN&0Y((.W"@ @
MC"@5;M?%^BWNG6&H6TUS):ZA-Y%LZV4WSMSVV9 X/S$ <=:W*-4']?H<=?\
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MSVH5]'_7<.Z->BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]45\X%:%SH^K0>*4O-'MKVVCN+@OJ"27,;V=Q&!MSL)+K(0!@J /[Q-=O12
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M_P '_,E*R5OZV_R/-HM#\1PR)>-H%]+*^A3:>\*W-LJQRLR[0B"0(D?!QCG
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MGNH(I9%O+N,11KU*[PG8# ) YQTJ"Z\%:#>Z>EE/;W+0K,+@D7TZR/(,8=Y
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M&2Y^ULD5Y-&/-SNW#:XQ\WS8' /.,U)-X)T">6622TF+2S)</B[F \U,%9
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MH-]I;:=<V]S+;O*LTA:^G\R5U^Z7DW[WQQ@,2!@8Z"DD\#Z%-/>SR17K2WL
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MJ!7A$9F^5B(@_P!TN0,+VZXQD9QD4 =+17.V7CKPUJ$;26FJ)+&J&3>(WVL
M_E_*<88[N,#).1QR,C>._#*01RRZK'!YEP+41SQO%*)>/E,; .IY!Y X(/2B
MP'145CP>*-&GL+J]6\V0VDODS^=$\;QOQA2C -D[A@8YR,9S38/%FBW%A->1
MW4FR&7R9(FMY%F63&=GDE?,W$<@;<D=* -JBJ6EZM8ZU9"[T^<30[BA)4JRL
M#@JRL 5([@@$52;Q;HB:DE@U[B5Y?(5S"_E-+T\L2[=F_@_+NS[4=;!YFU17
M#0Z_?:_XSO\ 3+#4+[3TTZ2(!&TIVBG&-TGF,Z#;QPN&7/4;A70ZQXIT;091
M%J-VT;[/,;9!))Y:9QO<HIV+GC<V![T+9/N'6QL45SUWXX\-V5Q>6\NIJ\UE
M&LMRD$3S&)#_ !,$4X'<GL.3BK%OXJTBZUJ72()YWO8H1<,@M9=OEGHP?;M(
M/;!.3Q0!LT5BS:O_ &EX3N-4T6<QEH'D@EN;5QR >3&^UL<>WK69X.\86NK:
M-HL%]>,=6NK!+AO,@:-9CM!<HVT(V.X4\4[;_P!?UL!UM%8MGXLT2_U".QM[
MTF>4%H2\+HDX'4Q.RA9,=]I.*P-9\9$^)_#]CI%^#;W%^UM= VC[90$8G9,P
MV'!7!"Y.3U'=+5I!W\CN:*X/Q'XL8>%K_5?#6N1W/V?48K>5FA5UCW,B-&A
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M(CO8(I"NX.@^:,E2P^9=R\$]:[*J5WI5K?74-Q<"9VA^['Y[B,\@Y:,':Q!
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M.F:GXA6[L_+@N]1>[AF\Q2'5D0 8!)!&TYSCMC-=3133LK?UT_R0/7^O-O\
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M'0MY<BA6.5+ [659!@] >G->DU2_LJT.I_V@PF>XP-N^=V1#@C*H3M4X)&0
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M 3 VY8\$<X&<D9KV*LM/#6@Q27<D>B::DEXK+<LMH@,X)R0YQ\P)Y.:76_\
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MLP?X!U)SGG(QCO+GPWH5Z)A=Z+ITXF97E$MJC>8RC"ELCD@< GI4 \&^%@'
M\-:./,0(^+&+YE&, _+R.!Q["E]FW];6_P""4FN:_G^M_P#@''7^J7U\-&>Y
MN-5:&?15N(UTD2F071QAI!%SL.>-WR9!SVKM?#$>JQ^&M/\ [;GDFU-H5:Y,
M@0%7(R5^157 /'3\3UK!U/P:CZK$]OX<\-:AID<"PPVEY$(A:_,2Q3$;@[L]
M,+TZ\UTVC::FD:9'9QB-40L0D2[40$D[47LHS@#VJFT[^?\ F_Z^XA)JR?\
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MP[]:HZQHGB&?QI)J]C;Z7):_V9)8HL]Y)&Y+$-N($3  $8QD\<^U)WTMV_\
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MM97;P!UO,+NP@0EMQ ) 95)[ U>\-^*[7Q1"MQ96.H16KQ"6.XN(-B2#<RD
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M4I\$>(H]/L].MKC2HX;#6FU*":0R.TB%W<*R +M(+XX8Y'/&,&M/Z]5?\'^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>O\ F/K?U_X'^1[%:^(Y;7QQ!H-WJ.H2>5I!NY/.M8-D_P P_>;T(((Y7:$
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M_K[O\P?]?C_D>[4=*Y3Q6LL7P]N$\.0[$6.,1I:(4*P;AO\ +"XQ\F[&/PK
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M(_E;CP=Q'0T+5+^NEPZ_UY?YGME8,/B*6X\5ZEH*:<R2VEHES'-+* LV\D#
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ME::1?6FK:5)?DQ;E$,0 &QE.\2'+#YLH#@\<8I-V5U_6_P#DQI:V?];?YH]
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M3?;;;RFE$(?S5VF0G:%SG[V>,=<UQ%GXXU+4]7LEATN:YTN\N7MI$72[D&%
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MVW21E9$#$E"58@C)QSR<UN>(O&.J:-K?E(NG_94N[:#[.5:2>5)2%,FY&Q$
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M\DMHIPB+,I4[E(7<,[1D;L=Q@\U6N/AM:W-EJMI)K^M>5JEPEQ<?- 264
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M2(+FXN(+5!'&]QLW[1T!VJHX''3/UI-7T*#5Y+:<SSVE[:,6M[NV*^9'N&&
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MKRW3-#\1V.G^";*7P_</_8]V[W,D=Q 1M*R(& ,@)!W@^N > >#ZI10M'?\
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M=O\ ,QQC;C/\5=QK&MZ9H%E]LU6\CM8"X0,_\3'HH Y)]A6AUI\S;OY_Y/\
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M<<XQWXKU*"XBNK6*YA;?#*@D1L'E2,@XZ]*6WG2YMXYXQ($D4,!)&T; >ZL
M0?8BF]='_7Q?YLE;77]:+_)'GFD>#D^QQ1ZGX;OY;VSM'M?,N-8>:&963:PA
M#2MM#8'#*N.W2M[PC8ZS87&H0WCWO]E*46QCU":.6X7&=WSH3E/N[=Q+=<UU
M-0W-W;V<0ENKB*",LJ!I7"@LQP!D]R2 !1=W"W0\[UK0_$%[JLTHTF5DAUFV
MO(?LT\,44L*E=S$;@SR8!SOXX&WI6QHNFZCI=UJ&EWFB?;K.?4)+ZWO?,B,:
M[VW@.K-O#JW0JK#@<BNRHH3LK?UT_P AO7^OZ[G+^#--U'2?[9MKVT\I)=3N
M+F&42*PE21MPP <CT.<<^O6N=UK0_$%[JLTHTF5DAUFVO(?LT\,44L*E=S$;
M@SR8!SOXX&WI7I5%):-/M^EO\@>M_/\ X/\ F<58:3JUCXMBFTVWO;+2YI)9
M;^"XN(Y;=BVX@P@,75RV&(P%P3U-2>+--U;4-6B2UL7ELY+&:%I[:6.*59&Q
MA6=B'$9Q_!SD#/ KL:*35U8:=G<\TTC3M?L-5\,3R^'+TQZ;H;V<Y2>V/[TA
M, ?O>?\ 5D9Z<CWQO> ;/4M&\!VUGJ.F3P7ML)<V_F1,TF69AM*N5YSCDCGK
MZUUM%5*3E>_7_-O]24DK>7^5CR;1]'\26UIX3@G\,WJ'3=4N+FY;[1;$!)/,
MP1B7)_U@S]#[9FLM"\2([ZE_8<T<MKX@FU-+.6XAS<0R(R84JY4.N<X8@>]>
MHQR)+&LD;JZ,,JRG((]0:8;A!=+;E9-[(7!$;%, @<MC:#ST)R>?0T7=_P"O
M+_(;U_KU_P SRVY\+>(KW7=1U:32)H[9M2CO8[6+4O(N)E^S^4RAHV 1AG/W
M\$@CH<U+J^F1:%+X9FL-&NX9+C7OM#VL]YYT\CF!P2SO(R[CC^_C@<C->I5D
MZOX;TS7+JRN;^.X>6RD\VW,5W+$$?^]A& )[9.>"1W-"=K ];G$W_A+5K^\N
M/$#65Q'++J*71TR&^,$S1+ 8O];&X"R<D\-CC&:=>^&[FT;0WT;PUJ"H-974
MKP37Z32KA"A+M),<L<CA6884\YXKTJJ&KZUIN@:>]_JMW':VJD R2'J3T  Y
M)]A0G:U@>MSSJVT3Q+!XFNM<70)RD6LR7B6SW$&Z>*2 1$H0Y =2N<,5&&ZY
MXI9/"OB&Z;5KJ336B1M:74X;:+43%-.GE>6R;XR C#J#OP3P<#D^I @@$=#2
MT)VT_KI_D%[N_?\ X/\ F>9WGANYM[C1;C2/#&I(/[7CO[W[1J$<TPVHR$NT
MDS9/S# 5CPIS@X%5O[!\12ZO<7O]@W"*OB6/4T5[B#,D/E>62,2'!!&2#C@\
M9/%>JT4)V_KT_P @_K\_\Q%+%06 #8Y .<&EHHI %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %74KLV&EW=X(S(;>%Y=@ZMM!./T
MKBO[8\0Z;X4;Q;)J<5_9OI37DEFT*J(Y=H9!$5 .SD@[RQXR#7?$!E*L 0>"
M#WK(T_PMHVEK(EI:LL#@C[.\\CPH#G(2-F*(#DYV@=:7<:Z'+WFI>(](U#3(
M%U<7JZO:3N&N+5,6DJ1^8&4(%)3MAB3T^;UJ^']?UZZ?P>][JSS+KVGS-.BP
M1((G5 RNGRYSR0021[#I770^$-%@AFBC@N LL30Y-Y,6CC/5(V+YC7@<)M'
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M.4>T?[(,(ACWD8W<MSC<21QG':NHN/ _A^Z:=IK29C.T;R_Z9,-[QXV.</\
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MRNP=>,AALQR2O^SZML_$?B6?6=.TMM87R6UJ\TV68VL?G2)'&SJQ.-@/T3J
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M9BN"22^&R!Q25M$_ZTU_'\P?5K^M=/P-^UBD@M8HIKA[B1$"M,X4-(0.6(4
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MX/W _+^M_P#@?>78/B3]D37+K6=(U*"TLM2^QQ-#$DH!VH K;&)!)).3\OS
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M^Z0O3K4TOA;4)M<\0SR3VIL]9L([=V&X2(ZHZG"],'>#G=GC&.].6E^7S_X
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M<6<EPBA+J,8R4PQ(QD'#!3@]*NZKK4>EO%"EI<WUW*K/':VH3S&5<;F^=E4
M9'4]QC)K \)^#QH4L'G:'X>@EM4\M-0LH L\XQC+#RQL)X)PS9YJ;Q9X3_MK
M5-/U1-/TK4I+6.2%K/5$S$Z.5.0VQ]K KP=IX)%-VZ K]1+?XAZ3?7-G;:?:
MZC>SW=J]U"D5OM!"':REG*J&!X()P#U(R,OM?'VFW2Z9*MEJ*6VHEHX9WA&W
MS5#$Q%0Q?=\K=%*Y&,U03PQJ]CXJTS4--TW0[>PL[*> 6T,[0@-*P;Y56(C
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MGC: N"#U.3D8P.N>/%9[;3Y=#\>6%I%ICV[Z5;WEM:V";H0VUP9$'1FR!EU
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M,;+96EM8LL/ERF'#@?*,J1R6QQ_$3@YS7(WT?AO1[3P'J%M>P027=];R3/\
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M5TK3-0M)-8L+HWEY+=L'TT^63)DLK(93E=Q!&"#QC)S6MX7T!/#6B)IL<PD
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M>1:IHUU'+>SO:.(PBAO-*R8VR>9G&%))W<CK7J=-:1$*AG52YVJ"<;CC.!^
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M8==X 8KGD ]#C\#^517ENUW936ZSRVYE0IYL6W>F>XW C/U!HDVT_P"OYO\
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MB^&T,NE:NCV$<D=WNTR<" F(QC<=F!\W?ICGIS7K=%"=K?+\+_Y@U>_]=O\
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M+CQ%%'>7R7UHMK9)Y4@4(8]TIA+1,NW!#LO3WJ]X0T33;C6O%T<VA/!#-?\
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M+.:X\JT@26X=EQM)\Q2BQ]<DE23@ UT.BZ)8>'M,CTW3(I(K2+.R-YGEVY[
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M.#R,]#S69+\/O#D\>H1RV][(FHE3=AM2N3YV.F[]YZ<?3CI26G]>G^3^\?\
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MD _V@:;-X6T>?4&O7M6\UV#R(L\BQ2,,89X@VQR,#EE)X'H*2Z?UV_/]1O\
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M&MK&$3Y78.O&0PV8Y)7_ &?4@\2>)&N;"R&K(4_X2"?2I9GM4,LL:J65LC"
M\8X3G@^QZNW\ >';6/3HX+:\1--D,MHHU&YQ$QZD#S/J,'C!([FN<\1>"([;
M4-(71=%U*ZMVU3[=J#KJ1)!V,I8&68,')<'*<_+UR!3TNOZ[?\$3V?\ 7?\
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MEDTUN) L4_FM(Y\S9C "@!B?7';:\0Z!=7GB2'5GT[4[VSN+);::ULM2-K+
MP8MD[945U.X@C<<8&,YI= Z_U_7_  QT-[XIT73X[:2>\W)<1^=&8(GFS'_S
MT.P':G(^8X ]:CF\8:!%:17,>HQW<4JLT9L$:Z+*IPS 1!C@'@G&!WKC]2TF
M^TS5K.T\-:9*GD:5]DF2$1W CA9SM0^;/&0PPQ#;FSSE3Q5K1M-N]&O;#5--
MTW4+ZTATM=*>S>6%;B!XG/S'<X1@>0=K=AC(Z/3I_6__   U_KY?\$Z1O%&A
MSWNE1Q:[$'O%::WBB*L+B,*Q))VG"C!.<KR,9[%EEXX\.:E+:I9:DLXNY6@A
MD2)S&\BYRN_;M!X) )Y'(S7)6_AO6M#O_"_DZ//>Q6=U>7=TUO-"JQ>?OPBA
MW4MMW#)QC'3TJI;Z-XECT32+9O#-Z);?Q$^HRK]HMOEA,CN.?-Y.'QCU!]LM
M)/\ KS_K[A/3^O)_Y+[SO;OQCX?L+V2UO-2CMVB;9)-,K) CXSL,Q'EA\?PE
ML^U;:LKJ&4AE(R"#D$5Y5-9W\E_J!_L_4#X=75SJ#O:I;L2\; LPD:=6V[DR
M5$1/! )KTC3]36_ENH_LT\#V\FPB7:=P(R&&UCP1S@X/J!4K6-QO<X3Q'\0+
MI]&\4?V,9K*YT:15\ZXL)"K#"[N6 0'+\9R<#."#FNL'BW0VM[]I-2$'V"-7
MN7EC:/RU;[KC>H#*>Q&0:XSQ!X?\0MI_C6RM-%DN_P"U[J.6VDCN(E!&R-3D
M.X(P4.?J,9YQ;O+37IO$6NWL?AN^\B[T2.SAS/; M*"Y((\WC'F8S_LGVROL
M/^M;?YZ#^U_7=?H=1%XFTF"RL2U]<70GM5N$F%L[LT6W/F.$3" ^I"C/ ]*W
M 00".AKS/^P==7PQH[V6EZGI_B&RT^*T2>"[@V!ER")E+E7B! / 9L/P <UV
M>OW&LVWAR0Z98/>ZH\8C58710C$<O^\91@=<9R>/J+G9-V[_ /#$QUM<S-*\
M837_ (VN]&FMDBLFB9]/N.<W!C;9,#]&QCVYYK5U'Q3HNDWGV6^O1"ZJ&D8Q
MN8X0>AD<#;&#V+$9KBM6\(ZUI=MX=U#1I=8U6[TN=#'93M91B.(C$BLZJA)*
M\?>;)QUZU#K5EJVL:MKD5GI.H+8ZC!##J*0K;22!@G*AVN$".%8 X$@Z$8I=
ME_7K_78?G_7]?\$Z^/Q_X4GO/LMMKEK=2[HT/V8F907;:N60$#)XZ\9&<9%7
M+;Q3HUWJ)L(KS]_L9UWQ.B2*OWC&[ *X'<J3CO7.Z+;7U[XTU34UTV[@TN^T
MN"WM[N5XCDKO)RH<N/OCJ.QZ<9R=.\ O-HZ:9>Z;J$.HV=K);0:G+JLDUO\
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M)U=SE]Y'R?,.5W'VK"L?#^M>'=8\/K%H]UJ%MIND3VLL]O+ JM+(RMA0\BG
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M*NL5S$LR!P P# $9QWYKSGQ#>-K2>,8+[4+BU_LW30]K!%<&)65X2QD8 CS
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M,9D1&"N<<?,#Q6!X2M]=CUD7D][:OI%Y:;UA759;YGER#YB%XUV*0<%1P#C
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MX>DO=<UF".\UTV\=O+Y<;-:_.4W_ ""3<549#,3R<\]"VMOZZ?YC>GX_A?\
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M_@F>S44BL&4,I!!&01WI:0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5D-X5\.O)%(V@:6SPN9(V-G&2C$Y+ XX)/.?6M61_+C9
M]K-M!.U1DGZ5P\'Q"N?/NK>ZT$I<1Z<=2CMHKQ6F$88 K*K!?*?D'&6'!Y)%
M%^H['21>%O#UO:3VD.@Z7';7!!FA2SC"2D=-R@8/XU?M[6"QLTMK*VA@AB7;
M%#&H1%'8  <#Z"N2L?'^]K"34]-6PM+[2WU**47'FE50*75E"C'# @@G/H#Q
M65+>WVI?$?P??76G-917$%R\(^UM)E/+!&^/ 5'^8]-W!^]QBG9WY7_6_P#D
M3?3F_KI_F:_@OPG-H_VNYUC3=(_M)[N:>&ZMF,LBI*Y<IO:-2,$XXZ^U;\WA
MO0KB::6?1=.EDG=9)7>U1C(R_=9B1R1V)Z5'KVMMHZ64<%L+F\OK@6UO&\GE
MH7VLV6?#;1A3S@GVK"M_'KW4@L8]&E353>/8K#+<H(6F1"[X=<L$  .2@)W#
M ZX6^W]?UH/;5_UO_P $Z.R\/Z+IMK/:V.D6%K;W'$T4%LB))QCY@!@\>M,C
M\-:#%>07D>B::EU;J$@F6U0/$HX 5L9 &>@KF;SQ]?6VE7\Z:'$;W3+M+;4+
M>2]*)$'QMD5Q&=Z88'D*0,\=JOZUXR.A7-P+R"PCM%:*&"YEO_+5YG!;:^Y,
M(H )+9/!& 2<4>?]?UJ%NAMPZ%H]O-<S0:58Q2W7_'PZ6Z*TW^^0/F_&IK'3
M;#3$D2PLK:T21S(ZP1+&&8]6.!R?>N'B^*4=Q912VNE"\E_M---F:TO8Y($=
M]NUEDX+J0W&%[$'%6?\ A.-:_M"]TQ_"A@O[2Q-ZZS:@GENH8K\KH&/.#C*@
M^H'6C9?UZAO_ %\CJ+O0-&O[B6XO-)L+B:6/RI))K9'9TSG:21DC/:JO_"&^
M%]LJ_P#"-Z/MF(,H^PQ8<@YRWR\\^M<YJ7Q2TVTL;:X@^Q%Y;&/4&AO;]+9S
M&X)"Q@@[WX/R\#IR,BI=5\4CQ!HEY!HMB]W$VFK=7$ANFMFCCD0E A4$E\#.
M,J,?Q<T2O%/3;^OT&M6O,Z:7PYH=PMNLVC:=(+:,Q0![5#Y2$8*KD?*,<8%:
M$<4<42Q1QHD:C:J*, #T KE?"4*77PHT>&4R;9-)C5BDC(W,8Z,I!!]P:Y_P
M;XDU'2O!GA6WETN*2"_MQ!;7+79!-QM9E61=AVJVT_,"Q]152C:4H]O^#_D2
MG=)G;'PIX<,D,A\/Z5O@.8F^QQYC.<_*<<<DGCN:(_"OAV*PEL(]!TM+*5@\
MENMG&(W8="5Q@GWK'TKQ?J>IZ5:SC1K:*^EU%[&6S:^8^5LW;F+>5R0%)QC!
M!'/.*G\<Z9+J&D1-::E?:?>BXABAN+6YDC";Y44ED5@K\=F![U/]?E_P!K?^
MO/\ X)I7'A?P_=M;M<Z%IDS6Z!(#):1L8E'("Y' ]A5G3='TS1H7ATO3K2QB
M=MS):P+$K'IDA0,FN";59=>M[73-8EO+#7].OX+>\BL[Z6W6:-V \Q?+8;D<
M=,\J<CBKD_Q0TZ'6(K& V$T<EV;!/^)BOV@3!BH+0[2PC+#&_)/.=N*?I_7]
M?F+]#KTT328]5;54TNR747&&NUMT$S#&.7QGH .M":)I,=_/?)I=DMY.I6:X
M%N@DD'HS8R1]:Y$_$&^ALM/N;O1[.#S]5.EW*'4&+6[A]H;_ %7S XSVZKZG
M'6:3?W6H"[>XM88(H[AX86CF+F15)4L047:<@\<].M*VG]>7^8_Z_K[C%\5^
M%/MWA/5M,\/Z?IEM=ZDNR61QY*G/5F*(2Q'N/QK8T72+73-/")IEA93S -=)
M9H-CR8Y).U2WU(!KC+TR> _&"W<\^KW^D:I&8($EO9Y_L]SU6,*S$8DZ D9!
M&,@&M.TC/@O2H9+JXO\ 4-4U*Y6"."XU"65%D<DB-3(3M51G+8R0N>>!36WK
M^>U@>_\ 7WG26>B:3I\$\%EI=E;0SDF:.&W1%D)ZE@!S^--B\/Z+!IKZ;%I&
MGQV#G+VJ6R")CUY3&#^5<IJ7Q&N-&M]0COO#\K:E820B:"VNE>,QRG:DBR,%
M)!/&-N0>V.:H:QJ,EE\0?#VJ:M;'3Y3!?1F$W9E20+M$94#C<V[H%W<XYP*7
M]?A?] _K\O\ ,[N#0='M=2?4;?2;&&^<;6N8[=%E8=,%@,GH._:K4-I;6WF^
M1;Q1><YDEV(%WL>K-CJ>!R:K:3/J5WIRRZK80V-R_6"&Y,VT>[;%Y]@/QKA_
M"6H7.C:!J26=G+?2'7KJW3SIVVQJ&.&EE(8A0%QN()Z4=;?UN'2_];/_ ".Z
ML-'TS2FF;3M.M+,S-OE-O L?F-ZMM R?K1>:/IFHRQR7VG6EU)&RLC3P*Y4C
M.""1P1DX^M<K:^/;F\T[1]0ATJV-I>WYL+B4WV1 X<H&4B,B121@'Y<DKTSD
M2V'C/4-0;4;:/2K+^T++44L3"-08JX(R7W>5Q@9XQ_">>*=G?^O+_-!M_7K_
M ),Z2YT72KVZ^U76F64]QY9B\Z6!6?8>JY(SM]NE)<Z)I-[/;S76EV4\MM_J
M'EMT9HO]TD?+^%7ZX36OB?IFCZM+:LUD\5O=):W -^BW(9MOS)!@EU!89.0>
M#@'%);I('M=G73:/I=SJ$.H3Z;9RWL/$5S) K2)_NL1D?A0='TLZI_:9TVS_
M +0V[?M7D+YN/3?C./QKE8_&NLOKLNA'P];+JJ3+MA-^^Q[8@DW ?R<;0<+C
M&<_K?7Q9>7%Z6L-%DN],CO?L,US'-^]5P=K,(MO,:MP6+ \$X(YH72W]?U^8
M/K<V8]#TF*>6>/2[))9D\N61;= SK_=8XY'L:=;Z/IEG;36UMIUI!!.Q::**
M!560GJ6 &"3[UYY9:W+X5N_%ES#:F\A&OPP.LUVP9%E2(94D-G#/]W@8Z'C%
M=%=>.#I^KZU87NG!?L MOLYAGWM<F=BJ+@JNP[ACJ1SUII76G];/]0>_]>AL
MGPQX?;31IIT+3#8*_F"U-I'Y0;^]LQC/)YQ4L^A:/<P0P3Z58RPP!1%');HR
MQA?NA01QCMCI7G4FJ7FD>,/%>I:GHQE>+189IK*&]\^-UWN&*F0* -HY4*.A
MP#GGHE\8W8U&VTG3O#P+/I(U")I+I8H=HVC8-JL0!NQG:.0.,<A=+_/\_P!$
M%M;?UT_S.CBTF"+6YM45(EFDB$),<84LHP?G;JV,<9Z GUI]WH^F7]Q'<7FG
M6ES/&K(DDT"NR*PP0"1D CK7/0^-7U&QT-])TT3WFK6K74<-Q/Y21H@7=EPK
M<Y8 8'/L*UO#6OQ^)M%34HK*YM(W9D"SLA8[3@D;&;C((YP>.E-I[=@OU[DR
M^'M$1K9DT?3U-J0;<BV0>5@8&WCY>..*=_86D?:)KC^RK'SIHS%+)]G3=(AZ
MJQQD@Y/!XYKB/"6H7.C:!J26=G+?2'7KJW3SIVVQJ&.&EE(8A0%QN()Z5H6O
MCVYO-.T?4(=*MC:7M^;"XE-]D0.'*!E(C(D4D8!^7)*],Y"6OX?B#T_'\+_Y
M$VL^"[4K9QZ1H'AZ2QAD>273;FW6&&61@%$F51@& !'*'.>V!5K3O!.BH@DO
M?#^BJX<216\-JCQ6QP,["5')(R6"KG XXJI8>,]0U!M1MH]*LO[0LM12Q,(U
M!BK@C)?=Y7&!GC'\)YXK1\/^)GU^>X\FWM1;PS20L4O-\T90X_>1[1L)(X&3
MQ@TT#[,M)X4\.1K.J:!I2K<?ZX+9Q@2]?O<<]3U]36G!!#:P)!;Q1Q0QJ%2.
M-0JJ!T  X KGO$/BB\T?6],TJTT62]EU$2"*4W"11AD1FVGJ>PYQCGOTK$U#
MXIV.F7@AN8K)/)GCM[N%M13[3%(VW.R$ ^8JEL$Y'0D XI+71?UT!Z:LZE_"
MGAR1&1] TIE9VD96LXR"S##-TZD<$]Z;'X1\-0M;M%X>TE&MVWP%;*,&)LYR
MOR_*<\\5RFA7LVBWGC-[2TN;^0:S&D41E9L%XX^6<[BJ L23@[1G XQ4&I^.
MM7OM&MY-+M+*.Y378M,N=M\7C8[E.$D6/E6S@DJ".>#32VMY?B#ZW\SNO[ T
M;[<]]_9%A]K=Q(\_V9/,9AP"6QDD9/-/U+1M+UF)(M4TVSOHXVW(EU LH4^H
M# X-<E?>-O[*D\47+^&6^UZ1;P/.T<T>ZX4AR#NX.Q<$C/S<GY0>*N_\)P;2
MZU"+5---JMMI@U1#%-YK/%R&!&T!6!'0%@<]:70-;_UY?YF_-HFDW-U;W4^E
MV4MQ;#$$KVZ,\0]%)&5_"N4E\%RW.JWLE]H7AJ^-U,\BZG/'_I$0/W1L\LYV
M@  B1>F>#6GI?BN[NM=AT>^T5[>XGMOMD<D%RDL8AZ9<ML8-G (56 R.<57U
M_6=9M/'GA[3+*&U:RN4GEE,EPT;-L !SA", -D#N>ZXS1;57_K>_Y!?1V_K^
MKFT?#6B.6:?2;&XF<()9IK='>4IC:68C+$8R,U+8:%I&E3S3Z=I5C9S3_P"M
MDM[=(VDYS\Q4#//K7.IX[8Q6&IOI8&@WUR+:&]6XW2!F<HC-%MP$8C@AB>1D
M"MW7=:71H+8+ ;B[NYUMK:'?L#R$$\MSM  ))P>!P">*>NX6Z?U_6A-#HFDV
M^IRZG#I=E%J$H(DNDMT65P<=7 R>@[]JAGT6SMA?7FEZ5IZ:I<1D&4H(C*V.
M-\BJ6Q^!K+;Q;>06\<-YHKV^K37IL;>V,_[J9]F_>LNT$Q[0<MMR"",$UFWG
MQ%FTZ.Y@N= F.I6E[!:7$$-RK1J)B!'(KL%+*<X^Z#D<X'-*U]/Z_K4+VU_K
M^M"[X*\'Q:%X9M[+4]+TDZ@L'V:XGMD$GVB,<#<S(I.1_"<BM^TT/2+"PDL+
M/2[&VLY23);PVZ)&Y(P<J!@\ 5Q_B#Q9JK^&?%]O!8PVFIZ3"=S+>,5$;QEE
MD5O+SN _AP.1][O65I^BP:/X]\+W<6E6]C>7MG=R7,-E<-)'*RHFUOF"#>0Q
MR=H.2<D]:=^9W?7_ ";_ $"UEI_6W^9Z$OAW1$T[^SDT;3UL>3]F%J@CYZ_+
MC'-.N=!T>]M(+2[TFQGMK?!AAEMD9(\=-JD8'X5S.D^,H[G2K0Z?H:6^H7]]
M<P16+3*B[XV;S'D=5('()) 8Y/?K5:^\3^))=;\,6\6D161NKJXCN;>YN64L
M8T;HPC.4_B!Q\V!PO6BS;L#LKG57'AC0+N[>ZN=#TR:Y=/+::2TC9V3&W:21
MDC'&/3BGV_A[1;1;=;;1]/A6V9F@$=LBB(M]XK@?*3WQUK/T7Q-)K>HW<$%M
M;""VN7MWQ=YGC*9!9XMHV@D#'S'(8'BK&L:[+9:E9Z586D=WJ5W')+''+.88
MU1,;F9PK$?> &%.2>W6EV L6_A[1+2:.:VT?3X98F9XWCMD5D9OO$$#@GN>]
M1-X5\.N\3OH&EL\3F2-C9QDHQ.2PXX)/.?6N;'Q&FEET^V@\/SO>7-[+I\T;
MW"*D$Z*6*ENK @9!"XP?7BNEO-;&E>&'UC5;5[9HH!)-;*XD97./D##@G)QG
MI3Z7_K^M@ZV_K^MS0:TMGNTNVMXC<QH428H-ZJ<$@-U .!Q["H#H^EG5/[3.
MFV?]H;=OVKR%\W'IOQG'XUP/CZ_U*_\  VOVVJ:/-8O;P1W$$UO=L\4H+8VE
M@$^8<Y0@KR.36Z_C9=-EUB'5[#[-_9EG'>J8IA*98GW #&!M?<N,9(Y')H2
MZ&'1M+MKF6Y@TVSBGE3RY)4@56=?[I(&2/:K%K:V]E:QVUI!%;V\2[8XHD"(
M@] !P!7+R>+[VSOVT_4]#\NYFM)+JS2VNEE%PJ8W(2RH$< @XY7T8U!IOBXW
M6CZ/#H.AP&ZN].%\ED9Q#%!", #<$/))P %QP<XI=/Z\_P#)_P!;G]?E_P
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ME#1;O*W;3M^]G@&JFKV6DZ5HVE&7Q+8W5G/KUO+;+9.;:UBB++YBQKYK!D&
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M2">,=*]J!# $$$'D$4M.^M_ZZ?Y"=FK'D>J6T$'BOQM/I5I -6ET^VELY88
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MQ3%);3>>NY%+19*<\ J'SCJ%.>E;>H6;ZQXIODNM?TW3M22^6;3FDLFDNWA
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MG!(Z@'!Q]*FH6CN#/)-4L)-5\5ZA!?:YIVF:I%?K+8>;8L]XT*A2! _G %&
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M #J2?2ECD2:))8G5XW 964Y# ]"#W%*.G]>=_P#@#EK_ %Y6'4444@"BBB@
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MRW,EN&B>5#V$I!'SAODR I &2,4TM;?UU_K\!7TO_7]?\.=D_C#04FMHFO\
M_CX**D@B<QAG **S[=J,P(PK$$Y'%2OXHT>/54TU[S;<.YC4F)_+9QU028V;
M^/NYS[5R5QX.,^MZG!J6DZAJ-G>W?VJ&>+59(K=#A2!+#YJ\JR\%4;/%-T[P
M:8-1>VU+2-1O1%J#WUM>C59!;9,AD4F'S1M=<D<(0<<GDT*S_K^MOQ!G11>/
M?"\ZH\.K1R0O.;83I&[1"3^Z9 -JD]LD9[9JW#XKT::WNYENG7[)((IHY+>1
M)5<_= C90Q+9XP#GMFO/FT?Q*WAF[M!X9OA<2^(AJ2K]IM?]3YPEZ^;C.%QC
MU([<U-JOAO7M1\4ZQ?KHU\EL;NUNH0M\D#7*Q1M&R!XY=R,=^Y2< [<$C-)=
M/ZZ+_-KY!U_KN_\ @'9OXY\-1VD%S+JL4*3W'V5$E1DD\W(&PHP#*1D9R!C/
M-4M9^(.EZ=HSWUJMU<LM['9/&+.;=%(S*/G7:&'#9''S9 &<U@ZGX;N8;"Q?
M1O#&I"275[>_NTGU!)IL1$9+M),020  %8].<5!?Z!XAOIO$DB:'<1BXU>SO
MK8//!F:.$QA@,2'!^0D;L<$<@\4TD]_Z^'_-_<)[?UY_\ ]-6ZA:S%VS&.$Q
M^86F4QE5QGY@P!7CJ"!BLBW\9:!<)=.NH",6L0FE\^)XCY9. ZAU&]">C+D'
ML:?XDTJX\0>$-1TM66WN+RU>(9;(1B.A([9K$OTUS4O#$X3PO%#JZ0+"?M#6
M\@D 92PB.6!'!(\S:,A<BEW'V--O'7AN+3+K49]2%M;VD@CG%S#)#)&Y&0IC
M=0^2.1QSVK0T[7]-U6[N;6SN&>>V"M(C1.AVMG:PW ;E.#AAD''6O.=5\/>(
M9-)\76]OH>H3R:N+8VYFO(&?*J V\F0 $8Z#CD8XKIM)MM6;XC7FIW&BW5K8
MS:9#;K-++"<2*S,00DC'^/&<=0>V"6E??^M/\Q/^OO7]?(;?>)[G2/B#<6>H
M71;25TL720V]D\DBMY@4D[ S-T)X  !YZ9K:N?%FB6MA;WS7OF6]Q'YT;V\3
MS9C[N0BDA1W8X [FLS4['5++QTFO6FFOJ$$FG?8C'#+&CQOYF\,V]E&WMP2?
M8US=OX%OM(DL7N+2^U.![1H+F#3-2>U,+M*\AQ^\C$B?O"O)S\HXY-);+^NK
M_P" -VN_ZZ+_ ()Z0=0LQIIU$W40LA%YWG[QLV8SNSTQCG-8UOXZ\-W?V4V^
MH^8MVK-;NL$A2;;U56VX9N/N@[O:KME8IHOAJ.RL;!PEM 4AM(I=S8 X0,[#
M)[9)Q[UY_H^C>([32? UI-X=O%DTBZ=[LBXMB%4HZ@C][S]\'CG /MEZ.5NG
M_#_\ 7V;]3N!XQT,Z:E^MW(T4DS6ZQK;2F8RKG*>4%\S<,$D;<@#/2GMXKT8
MZ1;:E%>&6"[)6W\F"2621AG($:@N2,'(QD8.<5Q%AI7B6*YG+^'KF&"77)[Q
MI%FM3.L4BX4QMO.P]FQAL'Y<\T[0?#_B'0&T6^_LB:X-B;VVFM!=1M(4FFWK
M*C,^&X !W,&YH236HWHS8\(^,#/X7EU#6[X7$OV^XMXFMK1BTJHY V1(&8\#
M..2!U-=;IVHV>K6$5[83I/;2C*2+W['Z$'C!Z5YC9^$?$$(AO+S2KAD@U&]D
M^QV&JF"=XIW#!PZL@!&!\I?D$]",5Z#X;TFVT;2!:VEE)91-(TODRSM,X9CD
MEF+-EB22<,1[T=+^GZ ]]//\V-/BK1AJ8T[[6WVABZIB"0I(RYW(C[=K.,'*
M@EN.E5;7QSH%Z+8V]Q=O]IN6M(Q_9]P#YJXW*04RN,\DX'!YX..=T7P>UI>0
MP:EH^HW4MC=O=6U\=5=K8G>2&$)F^5\,1C9MSGGFH[?3=?T[Q5#XHM?#EP9M
M2=XM1L!);#[/&,!)%;S.7. 6P3N YQM&2.MK_P!?UMY;@^MOZ_K?SV.Q;Q5H
MJ:NFEM>XN7D\E3Y3^69,9\OS,;-^/X<[O:F?\)=H0O7M'U!8W57;?)&Z1,$&
M7VR$!&VX.0I.,<UC^'M+U'2DGT6]T;[5 M]-=VVH>9$8P'D+@L"=ZR+N/12.
M!R.V=X9\'M82V,&IZ3J$MUI<A:#4)-5DDMFZC>D1E.UBIY78 .>:73^OZT!G
M26GC?P]?R6JVM^91=[A;R+!)Y<Q7.55]NTM\I^4')ZXI/"7BN#Q79W5Q#;W,
M(AN9(@)K:2/(5BH.6 !/RG(!^7H<&N(\'6.HZ[X,\,V"Z<\-I:7WVR2^>5-K
M+'*Y"HH._<3@'*@ 9Y-=AX'TW4='TV]L;^T\G%_<31R>8K"59)6<$ '@88=<
M'.>.YJRU_KL)]OZZ_P"1+>>+_#VFWVIM>:_'&-/BC^U0-C9 6)P<A<EFZ;<G
MH, 9YOZ;XBTK5KV:TLKEI)XHUE96B=-T;?==2P =3@\KD5P/BW2?$-]JWBP6
M7AR\N(=3TN.QMIEN+95+J7)8AI0P7YQVSP>*VM+M-8/Q!M]1GT.[MK$:,EFT
MTDT!VR!MY!"R$X[9 Z^W-*.J7]='_7S'+3;^MO\ -_<=%=^(]-L=8CTF=[G[
M;)"TZ1I9S.'11EB&52I(],YR0,9(S43QOX??2[?4A=S"RGDDC29[295!3._=
ME/D VG); X//%1^+],U*Z73-0T6-'U*PN@R*[A08W!23)/8!MV.^T5E:#X:U
M+PYJ>K*L3W>EQ*\^GHKJ99)90/,7YB #N0D$D#]X:71_U_6GX@_Z_K^M"[+\
M0?"ES9[HO$*P+($,<Z1G+[F*@)N0AB2K @ D>W%#>.].C\0ZSI=V9[*#38(W
MDNY;>14!;=D[RNT# 7&?O$G&<5S+:#X@7X-6&@KH-RVJ12Q!X!/ ,!)A(6W>
M9MP0,#G.3T'6M6[T[6TUCQ3>PZ+-/'JNG0)"JSPJRN$=2AR^,@L.<XQG!)P"
M2T3MY_DAK5K^NMORU-J/QGX?@2SM6UAKJYFLQ=1J(6>>:+ ._P M$SDCG 4=
M\#BK<GBK1H]*L]2%VTMM> &V\B&25Y>,_+&JES@<GCC'.*XO1;#Q#9ZIX9N)
M_#-^L>F:))93XN+4YEPF O[WD'RSS_M#WQ0T_3O$&E:'X6MHM'GAUZP>Z;R\
MP3XB8\DKYR*5.]1G>I! X-5)*[M_6K_2S)5[+^NG^>AZ=I>LZ9K5NT^F7]M>
M1JVUS!(&V-C.UL?=/L>:74M5L])ACENWD D<1QI%"\KNV"<*B LW )X'0$US
M?A>Y30M'M]/DL-3$K7CI<-.(<Q2RMYF2$D8;27X"%L#KC!-:?BK3!J=C"OV.
M^GDAD,L4EA<+#/"X4@,A9E!)R1@G'//%)Z#7F/D\0Z3)JVFV2ZL8KNY:0Q6H
M3YIPH8-N#*2H!4G/R\KC)Z%DGC7PY#=/;SZK#;E7,7FW :*%G!P465@$9@>J
MAB17,+8^*VU3P?/J6G3WLEA+.]W<I+ NQ'5D3<-XRX4J6VC'7&>E9FEVM^D]
MG<7&G:@- LM2FOK1H$MR 69P&,GG[WC.\D 1 \CD@<EOZ^8GM?\ KK_7H=M:
M^.O#5])"EIJB3K-<&U26*)VB\W^X9 NT$]LD9[9JW/XGT>VU1-.FNRMP\@B!
M\I_+\P]$,F-@<_W2<^U>>-HWB4^'Y;<>&;WSW\2#4PGVBV_U/G"3KYN-V!C'
MK[<UJP>#F.K7EOJ>DZC>PRW[7UO=+JSK;(2^\"2'S1AE/'RHP. <]:%T_KHO
M\W]PWUM_6K_X'WEOQAXR-E-IUKH^H!)SJEO:W/\ HC.CJT@5HUE(V!P,Y'+
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MS;?Q$^HRK]HMOEA,CN.?-Y.'QCU!]L[MGH.KP:S-#80WUCI%S!,;NVNKF.:
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M! 9B!GUQBN9UG2_$%[<>.##X<O2NK6$5M:$W%L-S*K*2?WO ^?//8'O@%_\
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M)]LM\(6.I:[X*\-6":<\-K:7OVQ[YY4V,(Y7(5%!+[B< Y4 #/)IZ7_K^O\
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M/%%U=VE_'X<<+'H4VG20/>0B42/MP5PQ0C*CJPX)Z$8(]%I_6C_5+[QJS?\
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M'0EM;?UT_P Q[?UZ_P"3/4:*YCP=J5]=OKEC?W;W;Z;J+VT=Q(B*[IL1QN"
M+D;L9 '2N?U'Q'KDFAZ_XDLM0,*:->30II[0H8YXXB V\D%PS<D%6 ''!I=?
MZZV_S#_ACT>BN%\/WWB/5_%NLPW&L1QV>G7,)6WCLU&^.2+>48DD@C<OS ]5
MZ8.*D\4:UK;>('T718=0\V*R%UYEDMJ269F50WGL!L^7G:,\CD=QZ6!:W_K^
MMSMJ*\O\0:YXKT6TTO4[N_>V-Y:F&]L(TAD%C+M -P&$;$QH>6!) R.>U:C3
MZ_\ \)?I^@#Q*[VD^DR7)NH[2$3-(KH-V=I3'S< +C'J>:=OZ] .WDN$BEAC
M99"TK%5*QLP! )^8@84<=3@9XZFI:\UTOQ1XBO-0\,PRWMN$N;F^L[C%L/W[
M0"0+)G/ )4':,<CKCBF:7K/B:;PK=:S>>)+9'CNI[((;$!<BX"*R!0S%\!@J
M_-DE<]"26_KYI?J'6W]=?\F>EO(D2%Y'5%'5F. *8+A&NFMPLF]4#DF-@F"2
M.&QM)XZ Y'&>HKR/6=1UG4?#^HV=SJNHQFQ\06=M'*\4$<TD;M$P\P*NW@OD
M8 Z#<.HKH+WQ-K&@:IXJ2YNQ?V^E:1#=VR-"J,6.\'>5ZDE 20%'H!1;2_\
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M!PH_SU]ZEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M044 <_\ \()X/_Z%30__  70_P#Q-'_"">#_ /H5-#_\%T/_ ,37044 <_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%59M2L;>]M[*>]MHKNX!,$#RJLDN.3M4G)QW
MQ2V6HV.IQ-+87EO=QHYC9X)5D"L.JD@]1Z4 6:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&. *-+_U_7<?0YW05UG0;:+PU;/9B_/FWLC2EY8-.MV<[(P,JS]P!E1\K'L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>ex10-9_004.jpg
<TEXT>
begin 644 ex10-9_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **Y=_%4TGCBPT6V@C:QGBN#)<DG+21;<JGL"V">><CL:ZBA:J
MX=;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !2,H92IS@C'!Q2T4;@<4GP^MK/Q7HNHZ?+=1V5A%,K12ZG<N06V[
MH9R-O!R,@'C(-=K111TL'6X4444 %%%% !1110 4444 %%%% !1110 4444
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MJ-Q)$D@5E# '##!&?4=C0[I%&TCL%1069B> !WIWLVWY7^7]:]PLFK+U^_\
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MU#0W$D)+LP55S&02"2!CH>]78((K6WCMX(UBAB4(B(,!5'  %$=/N2^[_@:
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MM,NZ1ODR&8=SW-:;>&- >V%LVAZ8T 8L(C:1E02<DXQC.0#]:U JJ@15 4#
M ' %$M4UW_K^OZL15I)]CSN".XM_$'AV"SU;4+RTUFSE-_')>R2<! 1,C;LQ
M?,<?(5'(P*N_"RP@M?"1EBDN6:6ZN%82W4DJC;,X& S$+[D8SU.3730>']%M
M8[J.WT?3X4NP1<K';(HFSUW@#YL^]2:9HNE:*DB:5IEE8)(076UMUB#$="=H
M&:I/5^?^=_N6PN5V6NW^5K^KW/'-8L[2VTGXF%;B<3&[5422[D8$%8B3L9B"
M03UQD @=.*V=:UC5/#>J^(;>POKJ9%TRTN1]IN&<0L\I21P2&V#;R<# QG%>
MBWGAO0M1DEDOM%TZZ>8J9&GM4<N5^[DD<XR<9Z4EOX9T&TNC=6VB:;#<&/RC
M+':1JY3&-N0,XP ,>@J4K)+^M%8;5W?^M[F%X0M-;LM5O!?7EL^G7$*2VMNN
MIRWSH>C-YDB*=K9&!SR.*S[N+5)?C#=#2KVSM91HD6]KJU:<$><_ "R)@^^3
M7:Z=I.FZ1"T.F:?:643'<R6T*QJ3ZD*!S5&Z\'>&+ZZDN;OPYI%Q<2G=)++8
MQ.[GU)*Y)IO=/M?\K EHUW_S7^1QWB^)=2\/Z+%J-^]QJ%IJUI;7<EG<2P1F
M1F4M@*5!.",'JO8@YI]SI<-C\2KR>U?4);BVT$3Q1MJ%P^]U=@ 07.X' ^4Y
M!/.,G-=?)X0\,RVL-K)X=TA[>$L8H6LHRD9;[Q4;<#.!G'6I(_#.@0Z@FH1:
M'IJ7J8VW*VD8D7 P,-C(XX^E2U?;3?\ %6_X(=?N_.__  #S&*_\6V?A\>*;
M2_MI89=,E>2,ZG+=F>;9N#I$T2K$5P<JIQ^5:^MZ3$/ NKWT/B*^O+2]T5YE
MMY;QY-\BKN\U&W9 Y *+A>1QVKOK71=*L;N>ZM-,LK>YN/\ 7310*CR?[Q R
M?QI+30M(T];A;+2K&V6YR9Q#;H@ESUW8'S?C1-<R:[_U;T'#W9)O6WX[?C_F
M>>Z8C6^N^#-.MM7U V%YI<XGMOMKL XC4Y#9W@_.<?-A<# &*DT%)Y+N3PK<
MZAJDM_IFI27,TK:A/YDEMC=%EMV2#N1=IX^5N,UVZ>%O#T=Q;7":%IBS6H"V
M\@M(PT(!R AQE<$GIZUH+:6R7<EVEO$MS(H1Y@@#LHS@%NI R<#WJGJV^]_S
MNON(C&T5'T_*S^_\SS/PK/XGU:YTG7FO;:*"2=X]0BDU2:0OG(\L6YB"1.IQ
MT.>#DGK71^-F U7P@"1DZTF!Z_NI*Z&+1M*M]2DU*'3;..^E&)+E(%$K_5@,
MG\ZCU+P[HFLRI+JNC:??2(-J/=6J2E1Z L#@4;<MNA5OB\_Z_KT./\9307GC
MWPG:Z<ZOJMI=M/<F/EH;780^_'0,<  ]36)I%_<WWB+2BNIZE<6&K6][YDDM
MZR_: OW62$,1"!T!4J3CD UZAIVC:7H\31:9IMG8QL<LEM L0/U"@5##X<T*
MWF2:'1=.CE24S*Z6J!ED/5P0.&/KUJ'#2WK^/]('J[^GX'DOAN>ZM_"?A'2=
M/F8IJ23/<>=J\]MF13\B+(H=H\_,=JA=VT^^?3_!\.KVV@K;:W>07=[#*Z&6
M&5I/ESE0SLJEF (!..U7'\/:+)8/8/H^GM9R.9'MS;(8V<G)8KC!.>]3KI6G
M+]DVV%J/L>?LV(5_<9&#LX^7CCBM+[^?]?UY"M_7W_U\B:2.(MYS(GF(C*'(
M&0#@D9]#@?D*\]\)I%)\%!(ZHYCM;MD8@':<R#(/8X)'XFO0;JTMKZUDM;NW
MBN+>4;9(ID#HX]"#P15&'PSH-OI\VGP:)IL5E.=TULEI&L<A]64#!Z#KZ5G*
M/-&2[JWY_P"9:=G%]G<\]\+FYL[[P=9PZG?+%J7A]S,C3EE5D6/8R(<JI&2.
M!SWS4&D7FN7/A+2-2-U>:M#:M>/>6Z:DUO<R!9B%D# C>% (V$A>1Z 5Z&O@
M_P ,*T;+X<T@-&A1"+&/*J<Y ^7@<GCW-*GA'PU';&W3P[I*P%MQB6RC"[N.
M<;<9X'Y"M)OF;??_ #;_ "=OZ5LXQLDOZVL3:3J5G<>&;/4H[B4V36J2B:Y.
M'*;<[G/KCK7E>K7>I0_9_'/_  C^I1RP7_VM[MG@\LV##9LQYAD V8?&S[Q/
M ZUZ_=6%G?6365Y:07%HX"M!-&'1@.@*D8[57?0='DTI=*?2;%M.7&VT:V0P
MC!SPF,=>>E)_'S+Y??K_ )#2]WE?]:?TSDO%FHM-KFE*+K4GTF>RFE T<RM*
M9?E\MV$/SE,$_P"SDC=6!86?B6\\0^']-U[Q'K<4]]I,\UU#%-'"8I%9 NWR
MT'(SGG=Z9QG/2ZKX*C.IV\ECX>\-WVF0P&*/3[R(0I Q8LSH5C<$MQD;1TZ\
MFM71?!NC:6Z73:1I8OT=GCEAM%7R >B1G&54#TQU)P,XHC9._K^O^:U[)()7
MV_KI_5O,XS39?%.JZ@-3BOK>W-GJKP7(GU289@$A01&V\K8&*[2&SDD@YYP#
M2'\4:U=6VKQZE#:*M_+!>AM4E8["[((A;&+RT=?EP<DG').:]'.C:4=4&J'3
M+,Z@!M^U^0OFX]-^,_K3)- T:6]EO9-(L'NYD,<D[6R%W0C!4MC)!':E9V7I
M^/\ P?U&U_7]=CRS2;K4FT'PG>OKVJRW-[K,ME.[79(>(M*,;?NY^48.,CL0
M,8>-6U>'4KK0(;R:6S&N2VJM=ZG+"VSR%=8OM 5Y!EB2._&,UZ*O@SPLBQJO
MAK1U6-RZ 6,0"L<9(^7@\#GV%2KX5\.HERBZ!I86Z.;A19QXFYS\_'S<DGFC
M^O\ TG_)_>#7;^OB_P TOD>?20^)+&\\+Z=J?B"<M)JTUO)'9W9?="8V=5DD
M9%=F48&?QZ\C+ND_M :7;7M_?2Q67BZ2RCD:_E#K"%8@%PP)([,3N []:]6D
M\+^'YA:B70M,<6@Q;!K2,^2,YPG'R\^E)#X5\.V\#P0Z!I<<,CK(\:6<85G7
M[K$ 8)'8]J:WOY_JO\G]XFOZ^_\ S7W&-\2)[BU^'6H76G:E<V<D,:-'/;R
M,1D#&XY/(/4<^]85W!<?\)3K.E_VQJQM1H:7X OY%(FW,-RL""HX!VJ0I]*]
M"U#2M.U>V%MJ5A:WMN&#"*YA6101T.&!&:HCPAX9#LX\.Z0&:/RF;[%'DIC&
MT_+TP ,=,"I<6T[/>_Y6_/7Y%=O+_-/\M/F>5ZEX@U*_\)17J:O?OJ%MX>AO
M7$-R;:.&0Y_>LRMF5FQ@(5*\<D9K?U.ZN/#VOPZC->ZA<6VMZ:T4$+WTOEI>
M8!"HN["[P>,#@CC&:[9/"?AN-%1/#^E*J(T:JME& %;[RCCH>X[U!-HLUWJ%
ME ]G8VVDZ=,L]LL+DL[!2 "FP", G/#-G Z5<K-OS?X.]_S5O-$I-+T7^5OR
MU\F226!TSP9/9&XN+EXK)U::>5I'=MAR2S$DY-><:+<WFC>'_!-UH]Y=W-S=
MV#+<6+7#21M&D!;<(R<(58*,J!UP<FO8JI66CZ7IL\T]CIMG:S3G,TD$"HTA
M]6('/XU+NVWW_P"#_G^ [))+M_P/\OQ.#\&#Q#=7^D:S+J5L^G7ML1<QG59;
MHSR[=P9(VB58B,'*J<?E5[QA<:K=^*;+0[-UCAGLI)4!U.6Q,DH8#Y7CC9F*
MCG;P#GG-=;::-I5A=S7=GIEG;W,_^NFA@5'D_P!Y@,G\:=J.DZ=J\ @U/3[6
M]A!W".YA610?7# TY:V_K^K= BFK_P!?U?J>5:U%XATZPTZZ_MF]O]56TDBU
M:*PNIFB6$?(;E%W(!(N., ;CD@<$UJZE/<W=YHNB:'J$ESI]SISSP7$^M36\
MEP^X8;SE1W<J#G;D#GD8&*[I_#VBR22R2:/I[/-#]GE9K9"7B_N$XY7@<'CB
MF'POX?;3ETXZ%IAL4?>ML;2/R@WJ%QC/O2M??O\ Y_\ #KSOTM8M;;^MO^&]
M+=;WX/2QK6LZJ?#>O:_+#>VNEI)!<:;<O&)IM[J\N1M\S;M4%2-N2<BI)II8
M?$FO6UQKEW);-X>BN1,MZ\:&4%@TL>&Q'G:N=N!S[UWUYH>D:A'!'>Z58W*6
MY!A6:W1Q$1TV@CC\*6ZT;2[ZXAN+O3;.XF@!6*26!7:,'J%)&0/I2DG)->OX
MIZ_E]P15G]WX6T_KN>/^#KJ.YURVUD7US>7R^%X9@3?RMYMP&92K#=ACD8VG
M//.,U=@U#Q99:"OBJVOK::"33)7DB.IRW9N)PFY76)HE6(J0<JIQCCM7JJ:1
MIL5Q!<1Z?:)-;H8X9%A4-$AZJIQD#V%-M=%TJQNY[JTTRRM[FX_UTT4"H\G^
M\0,G\:J6K;7G^+;_ %_ 45;?R_3_ "_$\YM/L%I\1O!]PNM37?V[3;AA)=7A
MD\QV"<H&)V[N?E7 XX'6NA\87%Y;>*_" M]1NH(;B^>&:WC<!)!Y3D%N,G!
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MHE^ES250B*HS@# R23^9ZTM     P!13&@HHHH **** "BBB@ HHHH ****
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M-I#V!\1667U;^U3)_9;??W[]N//^[N'UQ^=$=U?;3\U?_P!N_ )7Z?U\5O\
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M<#@ !>.HS6SKGQ"?2;--0CTCS-.%K#<R7%Q<^1O$AX2'*D2.!R1E>H]:CE\
MZG]IU62#7[<1W^FQZ:!-8-(Z1H" Q;S1N8AFR<#G'''-:;X9WMQI\UI+KT#^
M=IT=B9#I^6CV# ,>9/E!XW+W/<4EI9=%_F_^ -7W?7_*/_!*FH6T<GC'QLH>
MX"RZ%#-Q<."K?O/ND'*CY1P,#\S73>&X$N?A;I<$A<))I,:L8Y&1L>6.C*01
M]0:I3>"]9EU75K_^WK$-J.GI8E?[-8B-5SAA^^Y/S-^GIST'A_1YM(\,6>CW
M5VET;: 6_G1PF+<H&!\I9L''O^53*-Z<HKM_\G_FAQOS*3[_ *1_R9Q'@;Q/
M<Z/X/\)P:AIZKIU[$(([U;G<XEPS .FW@'!Y#'W K2T7XH:=K.OV&G1BR,6H
MJ[6KV]^LTJE1G$T0&8R1DCEO0X/%6=,\!&UMM-T^^U,7FE:4Q:SMQ;^6^[!
M,C[COP&.,!??-:6@:!J.B0PV!UA9]+M?EMHOLVV54 P$>3>0P'LJG@9)K1N\
MFWM_7XDI-*R_K_@#]:UJ:'48=%T^R%Y?W$#S,KW!@2.($ L7"L023@ #KW'6
MO/\ P?XQMO#/@JQLY#:1WES<WKHFI:@+=%5)F!#2L&);D <$DY]S7?:OX<N;
MO7[/6],U%;*^@B:W?S8/.CFB8@[2NY2"",@@_@:Q-+^'EYHB6T^G^(6_M"WE
MG99;BT5XC'*P=XS&K*2-PSG=D'VXK.-];]?\W;]/Q*E?I_6G]?@0M\5],FT?
M3[RU%BD]Y!),(]0U!+9%"-M91(0=S$YQ@8.,DBI-.^(\VN75I!I&@O*+O36O
MXI;BZ6)/E8*4. QZY&<=<<8.1LWGAS47U"UU6RUE(=4BC:&62:U\R&:-FW;3
M&'4C!'&&SZYJI-X4UE_%(UR/7;7>MB]F(Y=/9_O'<6R)1T;&!C[HQU^:F[ZV
M\_R=OQL"O_7JO^"5].^(+7IT&XFTH6^GZRKB&8W(:2-T4LP9 N-N%.&W9]5%
M4K+XN:/<:A!'*UDMG<PRS0RP7RS2H$7<1-$!F,E02.6Z8.#Q3[3X=:C;6'AN
MS.NVDD6B22,,Z<P,RN"I!_?<<,W/KCTP=>R\(W4&C2:!=ZL+G1/*:"*$6VR8
M1%2H1I-Q#  \84'@9)IRZV\_Z_KMJ"W5SG9+Z^U/XC^#[^ZTUK**Y@N7A'VP
MR;D\L$;X\!4?YNV[@]>,5UOB7Q!=:&(A:Z:MSOCDEDFN+C[/;Q*@!PTFUL,<
M\#'.#R*R+3P/JD>HZ#<W?B4S)HH=(!'9*CRQL NV1BS G P2 ,^QYK3U_P +
MRZUK.G:A'?1Q"T21##-;><IW@#>OS#;(,<-SP3QS2DK1M#N_\U^EPC>]Y=E_
MP2_H6M1ZYX;LM:BA>..ZMQ.(C@LN1G''6N93QT]]X0OM=&BV]Y81VSRO!!?)
M(X48RDJLJA&V[B5^;&TCDFNA\-:)-X?\+V>C->+</:Q>4DZP[,@="5W'G\:Y
MS4?A[=:A-J=S_:MG!=WUBUB\L&G; ZMC<\JB3]X_!VG*@9Z&BKJY*.W0</L\
MW?7^OQ)E\:7:ZA:Z3IWAP$R:2-0B9[M8H@H"_(,*Q &<9VCD#C'(?!X\DU*U
MT=M(TH7%SJ-BU\8I[CRECC4@,-P5LMDX P >Y%16W@K6[?4[:^_M^P9[?2SI
MJ+_9C@%>,.?W_7(''IGZURM]H46B/HGA[4_$MA9IIMDZPWUW;RVR3;VQL5TN
M$.X!3N7?@@CY?1RWLNO^<OTY?7U(CS)*_9?E'];_ /#&K+K,'B/Q-X$UZ&WN
M[6*XDN0L=Q*.5$+?-M1V7KGD_-ZXK0TWXHZ9J6OV%A$;)X-0D:*W>&_66=64
M$CS80,Q@XX.3VR!267AK4=3ET"]AO-.L[31I)$AAATUU2X0@H64&7* KG'WN
M?FR00*V]!\.W^A1I81ZNLND0L3;P&VQ-&N<A#+OPRC_=!QWIK?RU_%AJU=;Z
M?J6?$.MW>CQP?9-/6Z>4MNDGG,$$*J,DR2;6VYZ#CDUC6OCR35-/T1]*TI9K
MW5H)+A()[GRT1(\!LR!6R<D8P.?:M/Q#X;FUK4]+O8KZ.'["SDPSV_G1R;AC
M=MW##CLW.,G@YK@]7T6/0UT'0=0\26=E#9Q3R17]W#+;HQ9OE021S1D/C=D>
M8 1_">V>NW]=?^!^6Y;\C<C^)=U>OI*:?X5O7.IM,D+W%U#&A>-6++\K.>JX
MR0/7VINH?%6RTR[\FY@LT\F>.VNX6U&/[3'(P7.R( ^8JEL$Y'0X!%+I/AO4
M+ZZT2\AO--MK'0YY%MDM].=4NT9<,Z[IB5'+ 'YLD;LD$"MZ'P[?V.K7LVG:
MNL%A?2F:>VDMM[JY #-%)O&W. >5;FM+6:O_ %M;[U?TT)U:T_K?_@>NIA3?
M%73(]:BM$%G-;R7IL1Y=^ANA*&*Y,&,A"PQNW9Y!QCFG6OQ&O+C3[34'\.M%
M:W&HMII#7J&5)0Q5?E VD$C!^;CMN'-;-AX;U'29KF'3]8CCTN:9YUMY+4O)
M$[-N8+)O'R%B>"N>3@CM@Q_#O6(]&MM._P"$BLB(-5.J!SI;?,^\OMQY_3<3
M[XQ]:F/2_E^:O^%_P"5];>?Y.WXV_$N2?$6*Q@U%-4M;:RO;.^2RVO>@0.[I
MO5C*RKM7;DG*\8XS5*+XJ1SV,<MKI(O)AJ<>G3?8[V.2%6?&UED.-X(/&%'(
M(.*M/X OI=4U34&UV)+BYO8[ZU>*R*FVE1=@SF0AU*9!&!G)((JYKGA;6M<M
M+!)M=M$GM;N.[9AI[&-FC.5"KYV5&<YRQ)XQC%$>E_+]+_J-WUMY_K;]#"\2
M>.-:_L>_AL[&VM=0LM5M[&X_TMF7;(R%2C",'Y@V#D#;SC/%>CP&9K>,W")'
M,5!=(W+JK=P&(!(]\#Z5PMS\/+Z]?6WGURWW:C>P7J>78$"%X2NT',IW A0#
MTYYR.E=G;0WT4W[^[BF@$2J!Y&V0OW8L&Q@^@48]33C\.N__  /\Q:\WE_P?
M\BW11104%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6>GW WPQ*-PWF,_*6..I!]J7XI/=>$O###1;FXM8]6OH;:5T<XM8R#GR\GY
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M>U4U9M=B8RYDGW_X ZBBBD4%%%% !1110 4444 %%%% !1110 4444 %%%%
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !113)IHK>%YIY$BB0;G=V"JH]23TH2N ^J.K:QI
M^A:?)?ZG=QVUM&.7<]?8#J3[#FN6;QG?^([B:R\&V(G1"5;5[L%;5#WV8YD/
MTX_"K6B^!+2TNQJFMW,FM:R3N-S=#*1GTBC^Z@_6NWZK&EKB79_RKXOGTC\]
M?[I/-?8HPZOXF\:*W]CP'0]%?A=0NDS<RCUBCZ*#V9OJ*U]%\+:)X0MKB^&Z
M2XVM)=:E>-YDS@#)+.>@P.@XKHR0H))  Y)/:O/IC-\2M4\JWE,?A*QGQ,ZG
MG4I5_A'_ $R!ZGO^HVIU'64HQ_=TEO;\$WO)OHMKZV238FK>;+'A6*7Q;K7_
M  F>H6S0V\:M!H\#]5B/WIB/[S]![#OUKNJJ7^H6.C:=)=WMQ%:VD*_,[G:J
MCT'] *CT76+;7M)AU*S69;>;)3SHRC$ D9P>QQD>U<V(E.M^]4;06B[+LK]^
MK\VV-::%^BBBN4H**** "BJMQJ-G:WEK:3W,4=Q=EE@B9L-(5&3@=\"K5-IJ
MS?4 KFW\4M/XPCT#2[07@A4OJ-R),): CY5Z'+D_P_\ U\4?$VO7][JQ\)>'
M>-3EB#W=Z?N6,1_B]W(^Z/<&M[0/#^G^&M*CL-/BVH/F>1N7E<]7<]R:ZU2A
M1I\]57E)>ZO+^9_^VKKN]-YO=Z&I1117&4%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!2U+44T^)/D::>5MD,"?>D;T]AZGM5&#1I;V9+S6I%GD4YCMDSY,7X?Q
M-[G\ *+YTM?$]C<7 Q#)"\$<AZ)(64X/ID#],=ZVZK9:"$ "C P *Y/2+S^U
M_'FJW"'-O8P):QGLS%B6(_%<?A6OK5W)B/3;0D7ET" P_P"62#[SGZ9X]215
M7PI906UM>2VZ@127#1Q\Y.R,",?GL)_&JCI%L.IT%<MXBNFGFN(R@>ST^+SY
ME_YZS8_=Q_GAL>NVNEGF2W@DFD8*D:EF)[ #-<E9Q/<_V?8RK^_NY?[3O ?X
M%!#*I_X%L7Z*:4.X,Z32+3[!H]G:DY,4*H3]!5VBBH;N,**** "BBB@"O?7)
ML[.2=87F=1\L:#EB> /_ *_:LIK'5+J%I]2U1K10"WDV6%51[NP)/U&/I6[6
M%J+'6KQM(A)%M&0;V4=".HB'N>_M]151 M>'YKBXT.UFN69Y'4L&< ,RY^4G
M'?&,UIT@ 50H& .!2TF[L"AK5X=/T6\NA@M'$Q4>K8X'YT:+9'3M$L[1B"T4
M2JQ'<XY-9WB:0S3:5I:'YKN[5F&/X(_G/ZA1^-;Q=$*J6 +<*">M-Z10NHZB
MJL6H03:C/8Q[FE@16D(' W9P,^O&<>XJRS*B%W(55&23V%388.BR(R,,JPP1
M0 %  Z#BFQ2QSPI+$ZO&X#*RG((/>GT %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%8FO\ BO2O#D0^V3,]R_$5G;KYD\I]%0<GZ]*NG3G4DH05VQ-V
MW-NL[5M>TG0H/.U74;:T0]/.D"EOH.I_"N7MSXW\4-YLKQ^&=+?[L:H);UA[
MD_*GY9%:6E^ /#^FWOV^2WDU#42<F\U"0SRY]06X'X 5U?5Z-)_OYW?:.OWO
MX5\N85V]BE/XXOM2 7PKX<O=3#_=O+@?9K?Z@OAF'T%1Q>'O&FL/YFN>)UT^
M(_\ +IHT6WC_ *ZN"V?I7<44?6XP5J--+S?O/[WHOE$.6^[.3_X5UX?;YI_[
M2GF_Y[RZE<%\^N=]:.A^'YM$FN/^)UJ5_;R ".&]E$AB(SG#8W'\?2KVJZOI
M^B6+WFI7<5M @^](V,^P'4GV'-<?#<^)?'4C&);KP[X?/ D*A;RZ'MG_ %2^
M_7T]M(2Q->FW4G:'5O;T6EV_*/SLA:)Z;FKK/C:TLKE]-TBVDUK65X-E9D'R
M_>1^B#Z\^U9]IX-U+76%WXVO_M@8[TTFW)2UA/;=CF0CU/'UKI=#\/:5X<L1
M::5:)!&>78<O(?5F/+'ZUIU#Q,:2Y<,K?WG\7RZ1^6O>0^6^Y';V\%I;QV]M
M#'##&NU(XU"JH] !TJ2BO.-<URY\62WUA93FP\*VBN-3U<$ S #YHX3TQP06
MY_QRP^'EB)/6R6[_ *W;Z):M_-IMV+.I7MWX\U4Z+I$A7PY"VW4]0C;'V@]X
M(SW']YA^?KJZIXATCP?:V^C:=:^??F/;9Z59KEV]"0/NKU)8^YYKQ;P/XHU2
MTU233]-F\MS;"VL3=R*L%I"TAD,LN,!G (QQDD_@?6]!D\(>&?/N9_$VG76J
MW/S7=_<WD?FRGT'/RJ.RC@5[>/P'U62I23E%:J*3NWWDTG;MWZ1LDY/*,N;4
M--\(W.IRKK'CB6&]NT/F0V0/^BV8Z\+T9O5CG^M=%IOB;0=7F\C3=8L+J;&?
M+AN%9L?0'-9DOQ&\'1Y5O$%D_M&QD_\ 00:X+QGK?@2;19+S0XEAUFS87%I<
MVNG21;74@X9M@&T]#DXKEAA:^+FE6A*-](VC:,;^3M97MMKNW=E.2BM#MO%F
MM:E)>V_AOPU*BZQ<X>><@,+*#/,C \9/0 ]:ZU 5159BQ P6/?WKRCPEXGTW
M0[6>\FTSQ#J>LZ@PFOKJ+3'.]NRKG&$7. /_ -57;SXMRSRSZ;H?A36I]75-
MRP7-N$"?[3@$D#\L^HI5LMKR:I48:1WEHKOJW>6D5LK]-=V"FMVST'4M4L-'
MM&N]2O(+2W4X,DSA1GTYZGVJO>^(-*T_0O[:N;Z)-.,8D6<'(<'[NW'7/8"O
M"O$T.OW6@W&H:YX:U>ZU251$MW<LODVVX@$10+G'' )R<G/6M^QTSQQ>W6GW
M-SX2233+"-!IFGW%^B1P +A6D7&YWQCEL8.>*W>34H4U.=5;N_O15[):1U>M
M^KLK:VV37M'?8[3PII5SJVKS^,=9A=+F<%--M91S9V_;CL[=3]<>U.^(7CF#
MPGI1@MY5?6KH;+2 #<02<;R!V'ZD8]:Q-=\7^/M$MX9)]&T-);B016]L+AY9
M9G)Z*HQGU/85C2_#CQUJFH_VQ>W^B0ZLTR3K=J96EAVC"HHQL"CTP<GG)JJ6
M%IRK*OC)Q4%\*4KK39:+9=7N[OJV)R=K16II^&H?&<&GM!HNC1VCW#>;=ZMK
MCGS[B0]6\I>5QT /;\:WH_"/BFY^;4_'=[D_P6-K% ![ X)-0V^B?$B.'$OB
M[39']6T\'^6/Y54N-&^*[$^1XHT8#_KVQ_[(:F<_:3;C4I1\[-O[Y0;^Y)>0
MTK+9FTO@1?\ EKXH\3R_74BO_H(%._X5_I3?ZR_UR7_?U6?_ .*KD9?#/Q@G
M/S^+]-4?[ V_RB%7]#^'_BB268^*/&&H3QE1Y<=A>21X/?)P.*FI%QBY2Q<?
M2*;?X0C^8+_";_\ PKW1!R+C5U/J-5N/_BZS+[1/#>F*?.\;:KI^.S:X1C\'
M)JRWPK\,S_\ 'ZNHWO\ U\:A*W\F%7K+X=^#]/(,'AZQ)'0RQ^:?_'\USQQ5
M..KJS?\ V['_ -NO^0^5]C@[K7KRR<_\(CXVO_$-VA&-.DLOM0D'O*JC:/?-
M>NVDDTME!)<PB&=XU:2(-G8Q'(SWP>*=!;PVT0BMX8XHUZ)&H4#\!4E<V*Q4
M*R2C&UNNEWZV27X7\RHQL%%%%<104444 %%%% !1110 4444 %%%% !1110
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M& ]%_P!\CEC[D>M=G115UZ\JT^:7HET26R7]=V]6)*P4445B,**** "BBB@
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M_A'M4_Z'/7/^_-E_\CUT%<UKOC*UT+Q#I.DRV[R?;I DLRMA;;=D1EN/XF!
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MFO;33;ZPN=3MHRS6OVD;D;' <+EE'OBDW97?]6!:E+_A'M4_Z'/7/^_-E_\
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M*?VN;RM^7^06]WE_KK_F>7:KIEU]C\9Z1>:7=W5[K%PTEA-%:O)&P\M1'F0
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M7J:?X(L[72]4M+N#3KJWGD_LV>,02R1[5WML 'SC.?H>G-=EX2CT]+#26N=
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M#>B&UCTNXU-_$IU/1(9$> V*B$90ARKI #,K'! #,Q)&1UKUBBAJZMZ_C?\
MS8K:_P!=DOT1R'PP2:'X>Z7:W-K=6MQ;HT<D5S;O"RG<3T8 D8(Y'%=?115-
MW=P2L%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !114<\C0V\DB0R3NBEA%&5#.?0;B!D^Y ]Z
M )**XJ/XD6S:3)J\WA_6[?2XI'CFNW6!EB*,58LJ2L^ 01D*?RKLHI8YX4FB
M</'(H96'0@\@T"OK8?1110,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M1WZE3;J%<L0<CNG#<@@URVJ^(/ ?]JW!\36%_P"'/$/FE2UH+A))B#A762$
M29&,9]:FF;4-1T3P.=<CDE=]=^3[7&!(\($GEM(N.&*[2>*4-4OE_P '_AN@
MI.S?S_K_ (/7YG86_CO1-;\/:MJ/AW48+Y["%W92K#:P4D94X.#CKW[&B[\>
M:'H7AW3-2\1:E!9/>P)($"LQ8E03M106P"?PKGM=54\;^*]JA=_A@%L#&X[I
M!D_A6=!K%AX0UW2=>\0++'IEQH%O;V]X+=I5AD'+*=H)4L"O;G%)._SM_P"W
M?G;^NH[IV_K[/Y7/0!XO\/G2+75EU6!M/N9!%%<*24+G/!('R]#G.,=ZR_\
MA:/@K^R)=5_M^W-G%-Y#OL?=O] NW<>A.0",<UP?V=+VR74%L7@TG4_%EO-:
M6\\.S<FT*S[#T#,"??K796=M ?C%K4AAC+C1[?#%1GEW!Y^@'Y4VW^?X)/\
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M+.!MVC:,EG)/11^%>/KK-GJ&H>&&B\3:MJCP:I;&XMO[/^S6EB?NE2 @ .2
M "1UZUT-G;76E^(M8\7/,]UI^G:[.D]DT8*PQL%#SKWWKQ_P'.*I;J_G^<=?
MQMVZ[&;D^GE_[=I^%^_3<]'\0^/?#'A1H4UO5H[2290R1&-W<CU*J"0..XHN
M/$\,T_AZ32[^PELM4G9 [B1FE4(S8C*C ;(YWX& >]<!XR\006WC:>.]UZ[T
M&&2WA-G)IFG^;-J0()(\T(3P3@+TYS6=X,^72O D>)PT>O7JLMP,2J=LIPX_
MO<C/O13][?O^K7Z?\,.;LM.WZ)W/<Z***"@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5/\ H3-<_P"_UE_\D5T%% '/_P#"0ZI_T)FN?]_K+_Y(H_X2'5/^A,US_O\
M67_R17044 <__P )#JG_ $)FN?\ ?ZR_^2*/^$AU3_H3-<_[_67_ ,D5T%%
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M^A,US_O]9?\ R11_PD.J?]"9KG_?ZR_^2*Z"B@#G_P#A(=4_Z$S7/^_UE_\
M)%'_  D.J?\ 0F:Y_P!_K+_Y(KH** .?_P"$AU3_ *$S7/\ O]9?_)%'_"0Z
MI_T)FN?]_K+_ .2*Z"B@#G_^$AU3_H3-<_[_ %E_\D4?\)#JG_0F:Y_W^LO_
M )(KH** .?\ ^$AU3_H3-<_[_67_ ,D4?\)#JG_0F:Y_W^LO_DBN@HH Y_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *R]2\2Z#HUPMOJFMZ;8SL@=8[JZ2)BN2,@,0<9!
M&?8UJ44 <;<ZU\-+R_6_NM3\)SWB8VW$L]LT@QZ,3FKDGB_P-+<PW,GB+PZ]
MQ &$4K7L!:,'KM.[(SWQ7344 <__ ,)WX/\ ^AKT/_P8P_\ Q59R:W\-8]3.
MI)J?A-;\G)NEN+82G_@><_K78T4>8>1S_P#PG?@__H:]#_\ !C#_ /%4?\)W
MX/\ ^AKT/_P8P_\ Q5=!10!S_P#PG?@__H:]#_\ !C#_ /%4?\)WX/\ ^AKT
M/_P8P_\ Q5=!10!S_P#PG?@__H:]#_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\
MQ5=!10!S_P#PG?@__H:]#_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\ Q5=!10!S
M_P#PG?@__H:]#_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\ Q5=!10!S_P#PG?@_
M_H:]#_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\ Q5=!10!S_P#PG?@__H:]#_\
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M=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\ \&,/_P 57044 <__ ,)WX/\
M^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5=!10!S_\ PG?@_P#Z&O0_
M_!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5T%% '/_P#"=^#_ /H:]#_\&,/_
M ,51_P )WX/_ .AKT/\ \&,/_P 57044 <__ ,)WX/\ ^AKT/_P8P_\ Q5'_
M  G?@_\ Z&O0_P#P8P__ !5=!10!S_\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#
M_P#H:]#_ /!C#_\ %5T%% '/_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AK
MT/\ \&,/_P 57044 <__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P
M8P__ !5=!10!S_\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\
M%5T%% '/_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\ \&,/_P 57044
M 1P3PW5O%<6\L<T$J!XY(V#*ZD9!!'!!'.:DHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKG-#U33SK_\ ;4"Z)J6J:G<1F2S2/&H6*MA2I/)P@&3E4Z'D\4UK*W]=+?\
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MZ*I%'&N=Q8(2025&=H^]G'&*LW'A.YF;Q"RZNR'5XO*4B 9A_=A <Y^;&&(
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M,W)RA!("[C@\<50D\82:#%J^G6^FM>?V*45GDU%Y&D5@"-[NA/F'< %RV3W
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>ex10-9_005.jpg
<TEXT>
begin 644 ex10-9_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **YG3]=N=0\3W%E]LM;:*%W5;&XL94N957 ,BNS@%,D<JC#&.
M>>.FHZ7#K8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** ,#^S=3U+5[*ZU.*RMX]/G>6 VL[2/+E60;MR+L&&)
M*C=D@<\<[]%%'2P!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%>=:AXJ\26_Q)F\-)?:+;V2Z>VH"ZGL)7,:!B-K8G4'&,
M[N/I6[<^*4\+:7'/XONXD:2<QQ3V5E,8G'&W*C>4)SC!/)!Q0M4GW_X8'H[?
MUW.HHKA?&WCJ;1?#,FJZ,J,UO?1VTZW]G,BD,V#M)V9QUW#(K2U'QOI46B:W
M=6E]&+C2UVSB>VF(A<CY2Z*N\H>#N4$8R<T=&^W]?J'6QU%%>?'Q[>0>*]"L
MIC:3:9J.DF^>2UM9FDW@9^09+%3U V;JT]2\<6"KX?ETW4;-H-6O%A22:&9E
MD7HRJ47"R9QP^.ASTIV=[>=OQM^@K_U\KG745S.F>-+/5/&.I^'H;>[$E@L8
M:5K:3:78,2"VW"C &"Q&[)QFMC6;]],T>ZO(H&N)HHR8H5ZR/_"H^IQ4MV7,
M4E=\I>HKG_!/B5/%WA&PUE0J23)B:->B2#AA],CCVQ70535G9DIW5PHHHI#"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \F\0>&=0UCXIRZQJ'@
MRYU+15TXV2_O;4LTFXD2(KRC;P>#PP]!72:TNJ>)/#=WI5]X5O$@OG-N%,]N
MS0187]\V),9SD@*2?EJI_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\
MXY1;W>4=_>YCG=3T7QGJWPIM/#]SX=G.IVEU H;[3;@2Q(V0_P#K, X !&>I
M[\X?J'AGQ+<7OQ%ECT"X*ZY:Q166;BW!9E38<_O..N>>P]>*W_\ A27P\_Z%
M[_R=N/\ XY1_PI+X>?\ 0O?^3MQ_\<IMWOY_\!?H)*VW]:M_J9VG^'/$%AJO
MA36VT>63^RM&^PW%FD\7G&0C;\N7V$#&<EAP>YXK-N? _B&QTKPM!!IK7L]O
MKK:M>B":)5A4L3L&]EW'![<<'VST?_"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_
M ,G;C_XY3YGS<WG?\;_F3RJUOZVM^1=\/Z)JFE_$7Q3J$]J#8:I]GD@N%D7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT!F'<XK"T=;BRMO <4>A:IYMIIUS#=Q_V=/&%=HP CML 7<ZGG/OT.:2VO\
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MQ9-X<COK<W\42R-'YJ[B3GY .I( R<= 16A?:OIFF9^WZC:6F$,A\^=8\*"
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M-_;FD&[BM/[5L?M,KM''#]H3>[+]X!<Y)'<=J237M&BFN89-6L$EM1FX1KE
MT0P6RXS\O )Y["O([>W^Q>&'BM- U2!QXJ6\2.+1YT86XF#!@!'P F?Y>U=9
M8PZA9^)$L=/CN[G2KJ2XGFBOK!HS9,^\[XYB K!F)&SE@&Z@4=+_ -;)_P#
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MG;D=":$D)['I%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%07HG-C.+65(KCRV\N1X]ZJV."5R,CVR*\TTWQ+XF/A#1-6N
M+^6]N-:=+98+:V@1H6S(Q="[*I8JH&'.,C//0@[?U^)ZE17G$NN^*--T@+K;
MRZ9;MJ2P'4[DVWG16K*2)'"%HE;> N<8YSBDM/$6NW>D[GUJ$02:F;.TNX++
M-Q=PJ"=\0^9'9N.=BH K'IC +^OS_P CTBJ>JZK8:)ILVH:G=1VMI",O+(<
M9.!]3GM7F]GXD\4WMOX;C_M1;=KO5+K3[EGM(S,PC\S:QP2@;"#(48S[<$\1
MW6L:KX3\86TNLLHT:U:UE5+>-1>-Y =Y'!!*@[N A&,=^E#3M?\ KI_FAI>]
M9_UO_DSTR*]AF>%8_,;SHO.1Q$VPKQU;& >1P3GKQP:L5Y^FJZY#KT.F6U_;
MQVK>'3=P(UKN\N52BY8[@6[\ KU[U6\.^(M>EF\'37FHF[&MZ?+)- 88XT61
M$5U92!NR<D')QZ 535G_ %_>_P#D2$]$W_6B?ZGI-4=2UG2]%B275=2L[&.1
MMJ/=3K$&/H"Q&37 ^'O%.MZGK&D01:O!<SW7F'5K%K97_LTI_"-A5DR<KF0O
MD\@8K?\ B7L'@*_:0 HCP,Q(R !,A)_*I:V_KJE^I75K^NO^1M77B+0[*Q@O
MKO6=/M[2X_U$\MTB1R\9^5B<'CTJ\;F 6WVDS1_9]N_S=XV[>N<],>]8WBL"
M32+51@[M0L]H]?WZ'C\!2>,M,&L^')+ 7XLI998O)E9-Z^8'!167NI( (]Z'
MM?S_ ,@[&G8:MINJQ++IVH6EY&V=KV\RR X(!P5)Z9'YU<KAO#NI7C>+_L7B
M31H;'7_L3".ZM'#P7D*LN2.-RE6(^5NF37;NVQ&;&<#.!0[)7!7O8=17%^&K
MW7]:L],\1_VK#]ANUD>YL)(E"0ISL\M@N[<" &W,0>< <"L*R\2^(GU"-(]6
M%PEYI5S=I-)9K]F62-EP8,!)&3#=7SG@@FAZ;CM<]1J".[ADC,F7C42&+]\C
M1Y;=MX# 9!/0C@\8S7 Z1KFO_9_!U]<:I]K&NPB.>W>WC58G,)D$B;0&X*\@
MD@YXQ6+/?ZUKFC^&9+S6[B*Y/B26TDDM(HT5@C2A6VLK#C8, Y'/.3@U3BT[
M/O;\;$WTO_6S?Z'K]4-+UO3=;2X?3+R.Z2WF,$KQ\J' !(ST/4=*XFZ\0ZS;
M^*+,1:H]S:2:N-/DBCMT^SJFP]7*AS-D<[25'3 -:O@7_C\\6?\ 8=F_] CJ
M8ZZ_UT_S&]/Z]?\ (["BN&U*_P!?F\;ZKI$&L"TLXM(6\@\FU0R(Y8KRS[@W
MW3VZ''!&:H:3XHUF6;PG>W.HHT.M:?--/ \2)%"Z1APRD#<.ISEB/0"CI?\
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M7VGWD"-&LUHR'*,02I6160\@<[<\=:O65DEE&P$DDLDC;I)92"TC8 R<  <
M<  #L*XCQ[K^K:8]^^F:D\36.G_:Q;6T"2,6#')G+J56/ X"L&.&QG%6;S7]
M0LM?A;4[B]L=-G$"VL\-M'):NS;=RRM@NC$Y4'(7!'4TEJ-Z;G;T5D^);V;3
MO#MY=6]U;VLR( DUPI95)( X4$D\\  Y.!7GM]XH\3V.C^(%@U.3S=.O;2.*
M;4+*/SFCFV@@JFU1RV02N<<$9Y"6KM_73_,'HK_UU_R/6*J:AJNG:3")M2O[
M6RB8[0]S,L:D^F6(YK!T'4-1'C+7M%O+U[R&VBM[B&22-$9/,WY3Y0,J"G&<
MGGDFJWBC3M6?Q)9:QX?FM)]2LK9T?3KS(2:)V&2KC[C97&>1TS1M;S_K] [_
M -=O\SH;[Q!HNF0I-?ZOI]I%(Q5'N+E(U8@9P"3R<5'IWB?0-7N3;:9KFF7L
MX4L8K:[CD; ZG"DG'->=ZY?VM]\*-3-EIC:?<PZI$MS82D 0W'VB-F4,HQM)
M.<@=_P *Z/Q!J7B.V\.ZU=76FZ=:74%@YT^2UNS<.TI5BP!:-"" H. #GUXI
M-V3;Z?Y7&E=I+K_G8Z5]?T:/4O[-?5K!;[&?LS7*"7'^[G/Z5H*RN@=&#*PR
M"#D$5R_A32='N/AWI]HL,-Q8W5FK3%P&\YF7+LQ[L2223WK7N5EM_#DBZ9<Q
MI)%;?N)I$\U>%X) (W=/454_<O?H3%\UFNII45Y?9>(O$H\,^';V:_N+ZXU]
M8T$=K;V\<D!$;NS1F0JA) 7AL@8) .<5)_;/C6WDT2TU&3[#]JU9K,M-#"\\
MT!C+HY\MVC1OE(( Y// X+<6G8+Z7/3**\W_ .$EUNUUJ3PQ)?O-*VJI9QZH
M88Q(L30&8Y4*$\P8P/EQR"1536/$?BK2I-1TR+5(I'L=1L8EO9K12\T5PP&U
M@NU R\Y(7D$< \TDKVMU_P"!_F-Z7OT_X/\ D>HF1!(L9=0[ D*3R0,9./Q'
MYTRWN$N8O,C60+N9<21M&<@D'A@#CC@]".1Q7GB:;K4/Q1MH)_$]Y<2KI,\J
M,UO"J &90%*!>1C;D@ACM'(Z56T[Q+XFO=/\(.^JPJVI:A<VMVRVB[F"&7:5
MYPH 0#&">A)/((E?;^M6OT!Z?UY7/4:*\T7Q3JT.ARI=ZIY4=OKLNFW6K.D2
MM% ,[9"-OEAL[5R5QSG%=%X)U35-6L[Z:]NX;NTBNF@LKE+?RS<1KTE+!MK[
ML]551P<9!I+7^O3_ #!Z?UZ_Y'4T5P=Q>^(;WQ7XETR+719PV-I!<VIAM8_E
M+;^'+[MP^7G&/;;WSM%\2Z[K4E^\FHS6JS>'[?4842*(_9Y6W[MA*'*G8#AM
MW4T=+^5_S_R8[:V_KI_FCO8]<TR;7)=%BO(WU&&+SI;=<ED3C!;L.HX/-+<Z
MWIMIJUII4]Y&E_>!C!;]7<*"2<#H, \GBO-]!EU/Q#XDTFZ;59K2_NO"D,LE
MU#%&6+F7).UE*XSVQ],59M=6N]<U'X?WUX$%TT][&[(N%<I&Z;P/0[<X]ZKE
ML[/^M9+]";[O^MD_U/2H9TG\S8)!L<H=\;)DCTR!D>XX-25YKIWBG7+FUM]/
MNK^,7EYKMSIIOHH%7RHXE8Y1#D;CLP-V[KWKN-$M]5M;.2'5KV.\E65O*G5
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ME7.7$@E8H<'&%<CKZU?/@S03:36OV)Q#-="\91<2C$P((=3NRIR/X<9K>HH
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M'L/#&EZ;K-QJ]M'<_;KB-8I9)+R:0.HZ JSD<=N.,GU-3:AH6G:I,)[F*07
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MVFG>9T!&]W9SC)(&YB6; XR3DXR:R_\ A"= $ZS+9RHZ71O(]EW,HCE.=S*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUV_K^KK^KGL@S@9&#2UYEX:O/"\&MZSKL1MKV*)?M@UF%#)(BS'YH)&7))3
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MF1@UN44 9.@Z(NBP7(,JR374QGF,<0BCWE0IV("=H^4=R<Y))K6HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@""[LK>^B6*YC\R,.'VDD D'
M(R!U'L>*GHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>ex10-9_006.jpg
<TEXT>
begin 644 ex10-9_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **X^T\9_VEXG6P@DAM+(3/#'+<6\K&]=,AUB?B-<$'NS'!^4#
MFNPHZ7#K8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .+LO"6I0R6.GSR6;:5I^H-?6\RLWGMDNRQE=N!@N?F
M#'(&,#.:[2BBCI;^OZT **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** /*O%?AS4-:^*-KJEWX.GU30[:Q>U<&2U)D<EB&57E& ,]3@UT]S<:K?\
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M>&<@\$CD5V%.^R#K<****0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !5>_FN+?3KF:SM?M=U'$[PV_F"/S7 )5-QX7)P,GIFK%% 'CD\7C@:Q<
M:MI?P^OM(O;K'VI[+Q!9E9\="R21NN?< 'WJQJ,OC74[.&&;X:7"SP7 NH;M
M?$5L98YAP'!*%>G&""N.,8KUNB@#PV]T/Q??>'M2T:7X?ZD(]3O#>W<Z^(K,
M2ROD'&?*P%X'  Z?6DN-%\<75[J-W+X,U@RZA8+I\Y'B"P ,0 ''[C@]>?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 1SF9;>1K>-))@I,:2.45F[
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M%.LZE)&)P K9P23QQ65J_C?P_I&CKJ;ZK92V[SK;(\=PI5I"P!&X' VYR?0
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MY8WB($H(]'_=?FU2M;?UV?Y7^X;TO_7?_@?>=XCK(BNC!D895E.01ZBG444
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MC$BMU"JP'!P.3R,=#:CUKQ(UEJEM%<7UZ--UAK:>ZM8(3=FW\L."J%=C,&8
MX7)&<#-.W7^NG^8>7]=?\CT>J%YK6FV&HV6GW5Y%'>7K%;: GYI,#)P!V'KT
MKD;+7[K4?%.AQV.NSW&F:C8W;,#;QH4DC=0#@IN5UW%2#QE>G6L2RU*_U:+P
M1<:C=M<W0UV\A,Y1%+!%G13A0%S@#M0HMO\ KNT#T3?];7/5ED1RP5U8H=K
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MK_D"Z_UV_P SL:*\MM?%WB35H;;3($O7OECN?-N=.2UWRF*8Q*P$[! IP2P
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M![!RXJE87%W-<^-]1AFCCU"VN/LT#RQ;Q%''"KJ-N1D$NQZ]Z3:2OTM?\O\
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M=N;J9;>!6R3)(QP% ')Z_AWKD8]2UZT\2>&XY-8>XT_5I[EVAFMHPZQB-FC
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M@MG;^OZL:MQX4T6YM;.V-F84LP1;-:S/;O$#U"O&RL >_//>E_X1;21K=MK
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MV16CMT< JSY8$\$'"AB!R0*'KN&PEM\/?#-C-!-96,UH\$+01?9KV>((C?>
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M=]0N9+2;0C.;9F'EK()$&X #)..Y)ZG&*37M1O\ 3OB/HRP27]U;3V%RS:=
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MJPB+; Q]0H/)KE-<\*'3=7\//X>T.[EMK;4C=W"Q7:B*%2C*0D<D@"Y+YP@
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M=+>TN[&_MXUF,%TJ!GB8D!U*,P(R".N1W J.[N=;1K\0V5TX21#"8C!\\?\
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M)*DR8=D*NIRK!E(((/H:O44 <Q+\/O#<T6H1/:W9CU$J;I!J%P%EV] 0),
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MOOY_\!?H%OZ^=SSM/!?B&R\/#3M)O[>QA?4TG:R%S))'':C&Z!)2H8 D$_=
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MCAL;2>.@.1QGJ*\G\47FK:UX"UR[GU8^797JV+6R0(JR^7+&K._!8,S98 ,
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MBSO1?FW C:W+*H.#@TG@GQ)>^)M.N[J[TV>S\N[FB3S&C*D*[+M&UB<C;R2
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MG#[%%&@FC,1Q*&WNJ@J2!C=SGC-3?3^OZ[CMJ6_^$+T 6#60L6$!N6NU N)
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ME>M8*66+,,H<KAP).A*MRN[I]*FMO&]A=:K%9+9WZQ3R30V]VT2F*:2+.]5
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M%']?=L 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.W%,M_&]Q.4 TN%L:I_9TK17990=^W*YC&YA@L5P  ,[CP*$K_U_7=";MO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV!@+8G^)CYO[PD8!^[TXVY.>(U#2_P"P-!MO"NM:UI@MIYY+PZA?V'EVSGS
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M\A,3R(!N&1P??'O6+-X*.K1SMK^HB\N'LI+*)K>#R(X$<89D4LQWD8R2QZ<
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M 5)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>ex3-14_001.jpg
<TEXT>
begin 644 ex3-14_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4& XT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,0!G@UYS\,K^'0/B#K_A2(7<>GW9_M#3A>6\L+G/WQMD"M^..=IIK5V_K^K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "H;JTM[ZUEM;N".>WE4K)%*H97![$'K4U% &+8>%-'TQE^S0S^6I
M!C@ENYI88R#D;(W8HF.VT#':J=UX \.WNN-K<T%]_:; K]ICU.YC=5/\*E9!
MM7D\# ]JZ:B@#FYO ?A^XTVYT^>&]EMKJ027 DU*Y9I2!C#,9-S#'\)./:DG
M\ >&KKP]#H-QI\DVFP.)(8I;J9VB(X&QR^Y0/0$"NEHH P]6\(:-KFC0Z1J4
M-U<6,0 $37TXWXZ;V#Y?H/O$TX^%=)/AW^P-EW_9NW9Y7VZ?=M_N[]^_;CC;
MG&.,8K:HH#MY'*_\*Y\,?\(__8/V.[_LK=O^R_VC<[/ICS.F><=,\XS6UI>B
MV6C:4FF6*SI:(NU$>YDD*+C&%9F+ #L >.U:%% '/Z)X)T'P[J-Q?Z9;W,5S
M<DF=WOIY1*?5@[D,?<C/-2-X0T3[?)>PVTUK-*_F2_9+J6W25O5TC95<_P"\
M#FMRB@#(N?#&E75]8WCQ3QRV(Q;""[EA2/\ X C!3GH<@Y'!XJIJG@?0-9UR
M'6KZVN9-1@QY,R7T\?E8_NA7 7WP.>]=%10!@>(/!>A>*)X)=8MKBX:W(:$+
M>S1JC#HP5' W<_>QGWI^L^$-&\0Z5#IFJPW5S9Q  1->SC?C&-Y#@N>!RQ)S
MS6Y11TL%^IS]IX*T6RN+2:)=0<V9#6Z3ZG<S1QD# PCR%>![5NRQ1S1/%*BR
M1N"K(PR&!Z@CO3ZYCQ;?>(M+T_4-3TR?3([2RLFG*75J\KRNH8E05D0*, <X
M/6E)Z:CC&[LB>+P1X>B>/%B[0Q,&BM9+F5[>,@Y!6%F,:X[848I-<\$:!XCU
M"WO]4MKF:YMB# RWT\8B([J$<!3P.0,\"L/P?XF\0ZOX9T_Q/JUQI":7-#+-
M<Q06LD;P!=V"':5@P^7GY1UJ70O$/B;Q=HQU[2$TRSL)&;[);7D$DDLZJQ&Y
MG5U$><?W7QUYJFFGKT)335UU.VC011)&I8JH"@LQ8\>I/)/N:S8/#^GVVN3Z
MS$+D7UPH21FO)F1E'0>66V#&3C XR<=35+P9XL@\8:"-0C@:VGCE:"YMV;<8
MI5^\N>X[@^]=#0]&/I8YB'X?^';;6+K5X+>]BU"Z#">X34KD,X(QR1)^7I@8
MQ@5?A\+:/#:65K]FDFBLIQ<6WVFXDG:.0 @$,[$\9.!G K8HI; <X? N@?\
M"1'7_(O!JAZW U&X!QG.W'F8V_[.-OM5>W^'/ANTO;B]MHM2ANKD@SSQ:O=J
M\N.FYA+EOQKJZ* ,&+P;HL"620I>QK92-+"$U&X'SL269OG^<DD_>SP2.AQ6
MQ-9V]Q-;S30H\ENY>%R.48@J2/P)'XU-11<#E1\.O#2ZI<:FL%^M]<C$\ZZK
M=*T@_NL1)R.!QTXK3E\+Z.^BIH\=JUK8*=PALIGMN?<QLI/7GGFM>BCI8.MS
M.&@Z<+J.[\AC=1VIM%N&E<RB(X)&\G=G(!W9S[UD6'P]\.:7]M-C!?0&^S]I
M*:I= RDG)8GS/O?[77D\\FNHHH Y*T^&GA>PL&L+.WU"WLW)+6\.K7:1MGKE
M1+@YK9MO#VGVFJ_VE"+I;CRQ%@WLQC" 8 \LOLX^G4D]36I11<"$6ENMZUX(
M4%RT8C:0#YBH)(!]0"3^9K"N? OA^[\1)K\UO=G5$^Y<#4+A2@_N@!\!>3\H
M&.3QS71T4>8>04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1139)$BC:21U1%&2S'  ^M #
MJ*S[#7='U6-Y-.U6QO$C.UVM[A) I]"5)Q6?_P )WX0_Z&O0_P#P8Q?_ !5
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MBFF2,1>:741A=V_/&/7/I3$N8)+5;I)XVMV3S!*K@H5QG=GIC'.: ):*Y_\
MX3OP?_T->A_^#&'_ .*J23QIX5A6-I?$VC(LJ[XRU_$ ZY(R/FY&01GV- &Y
M16;IOB+1-:E>+2M8T^^DC&YUM;I)2H]2%)P*ORRQP1-+-(L<:C+.YP /<F@!
M]<[X[=AX&UF&.WN;B:XM)8(HK:W>9V=D( VH"<9[]!WK1TW7]&UDN-*U:POC
M']\6MRDNWZ[2<55N?&7A>SN9+:Z\2:/!/$Q62*6^B5D8=006R#2DKJPXRL^9
M=#E?A]I<FH?!Z+P[?6U[8W'V66UG2YM9(60N6Y&\#=PPY&12^"[R^\'>$;?P
M]J^D:E)J%COBA^QV<DT5RNXE6$B@HF<X^<KCOBNXTW5],UF!I]+U&TOH5;8T
MEK.LJANN"5)&>15*/Q=X:EO#9Q^(=)>Z!*F%;V,OD=1MW9R,'\JJ3NV^Y,4E
M%+L8?PS\+7GACP]<G4@J:AJ-W)>SQ*VX1%^B9[D <^]=K5#3M=TC6(Y9-+U6
MQODB_P!8UK<)*$^I4G%+INM:5K*2/I>IV=\D9VNUK.LH4^AVDXH8%ZBLZ'7]
M&N+^2P@U>PEO(AF2W2Y1I$'J5!R*FU#5-/TFV^TZC?VMG!G'FW$RQKGZL0*0
MRW15.WU;3;O3VU"VU"UFLE4L;F.96C '4[@<8%9J>./"4DBI'XIT1G8X55U"
M(DGT'S4>0>9O450U'7-(T>**74]4LK*.4XC>YN$C#]^"Q&:33==T?6=_]E:K
M8WWE_?\ LMPDNWZ[2<4 :%%9M]XBT33+I+6_UG3[2XDQLAN+I(W;/H"<FI=0
MUG2](MDN=2U*SLH)&VI+<SK&K'&< L0"<"@"[1638>*?#VJW/V;3M>TN\GQG
MRK>\CD;'KA236G++'!$\LLBQQHI9W<X"@=23V% #Z*AEO+6"S:\EN88[54\Q
MIW<! F,[BW3&.<UB_P#"=^#_ /H:]#_\&,/_ ,50!T%%8L_C'PQ:F,7'B32(
M3(@D3S+Z)=Z'HPRW(/K5^\U33M.LA>WM_:VUJ<'SYYE1.>GS$XYH MT53L]6
MT[4;(WMCJ%K=6HSF>"9708Z_,#CBF:=KND:Q'+)I>JV-\D7^L:UN$E"?4J3B
M@"_15'3=:TK64D?2M3L[Y(SM=K6=90I]#M)Q5Z@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT),;71B79QCI&B _5@:Y_3_ATNEZQJ.K67BC78KW42K74F+5O,(Z<& @8SV
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0$^GF5Q/B72/$GC+X/WD$]EY6NI=^9-:H?\ 6M&V#M]=P&X?45VVC>--#O\
M3[=([Q!?B%3)IQ_X^HS@94Q?>&,^F/PIVW[Z?EN%]OG^>QT4$GG6\<NW;O4-
M@]LBI*R+/Q'9WOB2_P!"CANEN[&*.65GBQ&0_0*W<\?X9P<:]#[AY!1112 *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "JUG9160EV%W>9_,DD<Y9VP!
MD_@ ,>@JS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+PR3>1#@E0[B17^]A=^\$9'-=9HO@+PYI%M;QIHUFS6[[[?S@;@VW0XC>3+
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MR:'M?K_P/\QJU_+_ (/^1T\OBFX_X2VPTRWTNZGLKFQ:Z^U1F/&-R@':6#8
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M,9%L(\']S(02'1@<;<>G)XS@C%U"[U'2HO'.JV%^T$EC>QSA!&C";%O%E7W
M_*1_=VGWII7_ *\TOU';3^O/_(]+HK@;W5_%.LZYJ-IX?FL+=M-=%,=Q=;/,
MW1JVYT\AR4^; *NG0UW<3%XD9MNXJ"=AR/P/I4VTN*XP74)!*N2-_E\*3ENX
M'KCGZ8/I6')XXT6.^N;+&J/<6QQ,D>D7;[,YP25B(P<'!Z''%)_PAUL('A75
M=813?_;D*WA!B/>-3VC/.5_VC4&C?\E$\3_]<+/_ -!DH6O]>@/0W=-U?3M8
MLS=Z?>0W$"L59D;[K#J&'4$=P>:SQXQT(EV^UR?9T4L;O[-+]FQ_UWV^6?\
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M*L]7@CAO8C(D<JS(5D9&1U.00RD$'\:R9/ ^@RKJ2O!>;-2 %VHU"X D Z#
M? &!C QQQTXKHJ* N<SJGP^\+:W#8QZGI2W?V$!8'FFD9PHZ!G+;G'LQ(KI(
MXTAB2*)%2-%"JJC  '0"G447 R;OPUI5[-)+)#+')*X>5[:YD@,QQCY_+8;Q
M@ 8;(J6?0=,N#8[[15^P$_9A&Q01@C:5PI&5(X*G(/I6C10!AIX/T.-HRMFV
M(KDW42&>0K'(002J[L*#N.5  .>13[CPGH5W;ZA;W&G1S0:@_F7,4C,RLW&2
M 3A3P#E<<@'K6S11Y!<R?#_AG1O"NG&PT2QCM+8L795)8LQ[EF))_$U:U/2K
M+6+0VM_ )8MP9<,59&'1E92"K#L0015RBAZ[@M#&G\*Z1<Z//I4L-PUK<',^
M+N823<8^>0-O;@ <DY Q5_3M/@TNQCL[8SF&/A?.G>9@/3<Y+'\^*M44 8FI
M^$]*U?4X]1N_MXNHE*1O!J-Q#L!Z[1&Z@9P,X'..:L:7X?TO1WEDL[;$\P E
MN)9&EFD Z!I')9@,GJ:TZ* .<TWP%X7T?5KK5-.TB&VO;E2LDT3L" >NT9PF
M?]G%.M?!&@V45O';V]TGV>9YXF-_.71G^_AB^=K=2N=I/)!KH:* ,F+PUH\.
MCW.D1V2BPN3(98=[$-O)+8.<CDD\$8SQBK0TNQ74(;Y;=1<PPFWC<9^6,D';
MCIV'^35RB@##E\(:',\[26;D3W"W3H+B0()E8,'50V%.1DE0,]\U+IWAG2M*
MGOIK2"4/?,6N1+<RRK(<8Y5V('  X'08Z5KT4>0'/Z!X'\->%[RYN]%TF&TG
MN?\ 6.I8G&<X&2=H]A@5JZGI\6JZ9<V,Y81SH4+*<%3V(]P<$?2K=% >9D-I
M2ZO96T>MVRM<6DPD22*5E!=1@.I4@@$$@J?4@Y')IR>!- EM]1@>"\,6I.'N
MT_M&XQ*1Q_STX&,# P, #H!71T4 <SJ'P]\*ZM>65YJ&D1W5S9HJ12S2R.Q
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M=AO!DD!4JPQG)8'(]:S[1M-7XA:1/X1U-]866.2+46:]>_2WAVY4B5V8QDL
M-H;YO3C(4=?Z\O\ ,)?U]_\ D>H45Y,OE7.DPF,0I\0(;Q?,YQ<D>?\ -G^(
MP;"?]D#'I1K5SI[Z^=1A-O%>V>NP13RS_->)&75-H(P8X3G@'<&!/3/#2NTO
MZZ?YCEHG_7?_ "/6:YW7M>OM*\0Z!8P6UO);:E/)#)([G>I6-G 48QSMZD_A
M7'Z&EEJ&J>-9=,FCO=1LKUKC3MURTK))]G XRV<;F9<=!T[<55N-#;5?!%WI
ML?F7?VTC47BA9YA*8&4^> -V_<?XN@]!1%7:^7XW_K[@>B?S_"W]?>=O#XAU
M>2/3!-X>DM9+N62"<M<I(+1U!VD@']XIQ_#T[UK:9J)OEGBEC$5W:R>5<1!L
MA6P""#W!!!!_J#5P0Q+LVQH-G"X4?+]/2N?TQ9#X]UZ16!@^RVB$>D@\PG_Q
MTK^8H6]OZZ ^_P#74Z.N?U77+VP\7:%I4=O;M9ZCYP>5G;S%*(6P%QC'3G)[
M\=ZN>))-0B\,ZG)I2EM06UD-NH&27VG&!ZYKSL/X<N/$_A"32H([B.8W$=\8
MH3(QD,(0B< $[\G#%^1WP*2W_KLP>D6_ZZ'K%8'A_6K[4]5UVSO;>WA.G7:P
MQ^2[/N4HK@DD#G##C''OUKSNV?3+7PSX:B:",WFE:\T<D4-N9);53+(2NU06
M4%=IP!R #T%;-EI^A>,M3\=://+97>^\C90&61HF$")O [%6!&?4$>M'=_U]
ME_J'KY?FU^AZ517%^%+6/5[J#4[[2;>WO-)A_LZ/]P%V2*2)#&<<)T"X[$^M
M=D[;(V;!. 3A1D_A0[+4%J.KGO$6NWNCZIH-O!;V\EOJ-Z+6:21SO3*EAM4#
M!X4\D\<<&N#T>ZMAK>C:GI/V9)KRVNXFQ\]S+,%!1;EQ@&08Y4C*\\U$;G2'
MC\&WD,1DUD:E#_:S)"S7(E\I]PF &[.XG&1P,XXII:K^OZ_X8'I?Y_D>Q45Y
M-<>3<Z5>K((D\?PW;FW)XN2/._=[?XC!L(SCY<9SWJ2>WT!=8\8V>L,DD[31
M/9I/*SR><8-W[C<2P?<3@)R,\8%+I?\ K9/3[_O';6W];V_KR/3?MUO_ &B+
M 2 W/E><4'4)G&3]3_(U8KS6ST]8/%EC-J=I9GQ$^@1F.:2%2[72G#$-C)(R
M,D=![5D^#)]+O-5::SU36CXK@MF^V65Q8Q1#S-F,3R) N\ _=W.3TH>E_*_X
M-_Y?B2M=?3\;?YG?^(M=O='U30;>"WMY+?4;T6LTDCG>F5+#:H&#PIY)XXX-
M=#7CINM(:/P;>0Q&361J4/\ :S)"S7(E\I]PF &[.XG&1P,XXKU72]7L-:MI
M+C3KE9XHY7@=E!&UT.&4@\\&G:R^;_3\ OK_ %YDU[]K^PS_ &#R?M?EMY/G
MY\O?CC=CG&>N*ECW^6OF;?,P-VWIGOBN8^)#VT?P\UM[FY-NJVKF-Q.8CYF/
MD&01G+8&._3!KD;:^\+ZAXLNTNM3T^[M'\/Q/)%->+)#N!.[Y2Q484*3QZ'W
MJ;Z/^NC95MOZZI?J>KT5R_PYOTU'X?:+,MVMRXMD21Q)O(8#!!/J/?FNHJI*
MS:)04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%9&N:M=Z8D8M+**=W5G:2YG,$$87&=\@5MI.>!CG!Y%)NP6N:]
M%<Q9^+CJNF:7+I=E'+>ZC;M<1037'EHJ*0&+.JMQE@!A3G/;G$P\1WDT-I;P
M:24U>Y25_L=W-Y2HL;!68N%8[<D;2%.<C@<XJS Z&BN;'B:\G%K:6VD[=8GB
MDE-G=S&)(U1PC$N$8X)(VD+R.>*I-X]"I8H-(G-S/J7]F7$9F0"VF'/)ZL".
M00.1UQ2 [ D*I9B !R2>U,@GAN85F@E26)ONO&P93]"*YJYUF\U**?26T2VE
MN5MP^HVT]T#'%&^X!0=A$C$*3M(48ZD5@^$M:NM(^&?A_P"RV$4V+!IGENK@
MV]O&JD<-)L;#'/ (YP>1BCHV_P"M_P#(=MK'H]%<G;^-6OY=#CLM)F?^V+)K
MN&269$1<*#M;&3_$,D#H>,]*?8^+Y=1LH%MM/C_M6::X@^RO<[8U:%BKDR;2
M=F<8(3/S#@<X;37]?(1U-%<K>>,);'3+=I]'N4U2=I$6R"2RC,9PS9BC=O+/
M&&V?Q#(%:WA_6)-;TI;N;3[FQEWLCPW$3H<@]5WJK%3U!*CZ#I2 U**Q=0U>
M^LO$&GV"V%N]I>AU6Y>Z*L)54MLV;#G('7=V/' S0TKQ/J6J6.\:79QWBZ@U
MG);_ &YB%5027#>5SE1N P 01R,XH6O]?('H=+#<07&_R9HY?+<H^Q@VUAU!
MQT(]*%N(6G:!9HS,@#-&&&Y0>A(ZXK@K[Q5?_P#",W=YHVC6]C<IK*64\5Q,
M$)+2(K,3&K#<2V,Y.!SSC%.$MWIGC;7KVTTFS>^;2+6>XB6X\M&<-+N_>;,L
M<# )7G SBA;7?]:)_J.W]?.QW]%4])U&+6-'LM2@5EBNX$F16Z@, 0#^=<;X
ML273_$HU;5M"?7=!\F-4$,0FDT^56.Z01GJ""/F7YAMIM6=F):JZ.^HKDAXH
MTS3/#-A<Z5)-JL=X7^Q[%FF9_O,=Q1'D '0G:2#C(I]CXON=0M((XM&FAU6=
MY$2UO/,MT8( 6<,\8?9\P /EYR>G6E8#JJC2X@DFEACFC:6+'F(K LF>1D=L
MUQVJ^(_$(.@+:Z1!;S7=^]M<P7=RR<HCGY6$9RAV9#8R1@;1DXM+XJM+2[\1
MR76E-:/IQB620%"]T6'R8QZ\ ;CGGD"BW]?=_F#T_KU_R.KHKF'\47MC?M8:
MGHXCNI+>6XLTM;H2BX$>"R9=4VOR#@Y'^T<5%IGC.6_?P_++I@@L];B+6[_:
M-TB.$+[60+C;M!^8-G/84TK[?U_5@>AUE%%<AX9MTM?&OBR.-I"@:V;]Y*SX
MS&2>6)(&2>.E+K8'L=?17":[/<7GBOPI=^8RV;:DZ01@\2#[/*3(?7)Z>PSW
MJYK5NB?$;PQ<*TN^1;I6!E8K@1C'RYV@\GD#O3MMY@]+G622QPKNED5%)"Y8
MX&2< ?G56XU?3+6_@L+C4;2&]N/]3;R3JLDG^ZI.3^%94-Q_:?C._A8!H]*A
MB$4;=/-D#$M^"A0#VRWK6'X8M[KQ&VNQ:_I.G/;IJ<I5Q<M,\<J!5&P-$N-H
MZ.""/04E_P $'_P#OJ*Q?"FI2ZIX>@FG?S)XGDMY7_O/&[(2?KMS^-)J&MW*
M:G)I>DV4-[?Q0+<2I/<&%$1B0OS!&.X[6P,8XY(XH>@(V7=8T9W8*BC+,QP
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M<LW.>F.F,GNJK7<US#Y'V:T^T;Y523]X$\M#U?GKCT%.[O<32.8'@JZ$Q?\
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MKQU!Z$_6MBC;\/\ - ^O]>1S,GA!+AM>AN;UI;'6 IEB$85T<1A"P?/HJD#
MP>YZ"A#X/\1?V!J>EWWC*34/M4+6\#W%@@$$;#!R$96D;'<MCOBNQDFCC>-'
M<!Y"0B]V(!/'X UF^']:;7+2YF>RDLW@N9+=HI75F!0X))4D?D31OH.[3O\
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M4D_>%OF?=MR$&54D <@C-;^JP7FGIX=O(-9U/%YJ5L+B%YPR.&0 CD9 ^7.
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M-K;[?,D"C+$;F50!D<D@<@=ZB\.:=>:;HD$6ISQW&I,-]W/&,+)(>I' X
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MV-<6UI?6EM>V^J2:CIUQAG!+NS%9%P,##LAQGCGVI:6_KNOT_KOII_7S_P"
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M1ALME8?*[L $7+;1\S   A1["GW.NK:6,4\VGWBW$T@BBM,)YCR%=P4'=LZ
M\[L<'FK6I62:CIDMI/:VUS'*H62"XYC<=P>/UQ7)6_A;7;+2H[:UN(4@^VB9
MM-:^F:-8-N#$LY7?C=\^-H'\/3-&[%T+>I>)]$O?#\=QJ5C?B!K]+5[<Q'?%
M<+(-H<H2H 8+SNVG@9.<4_QAJL4FBZQIL-M?7#QVCF>:T?8+8E"REFW*W8<+
MDX/(P:R+KP=K<7AR\TK3XM)VRZLM[$IF>)4C$BR8XC;G*XQCOG/:K]WX;UI9
M=>2Q:P^S:Y&6F,LCA[:;RA&=N%(=3M'7:1R>>E*2O!K^ME^MRHM*2?\ 6_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H)H>D1Z
MJVJII5BNHMPUVMN@F/&.7QGIQUJ_110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% %"VT+2++4)M0M=*L8+V;/FW,5NBR29.3N8#)R>>:OT44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17,77B*_MX]78Z)
MJ\C64Z(JP6ZMYT;?Q0Y/SD#KGIZ<<Y3MK%QXRUBQ/BO4+&SMK*&[C'DVF(C(
MT@():$DJ-@[YZ\T>?]=P_K]#O**YCPAXCN-4\&6VKZNJ1R.SKOBC($X#E5=%
MY/S  @#.<\5//XUT*VT\WLLUVL2S"!U^P7!DC<XVAXPF],Y&-P&<C'6FU9V
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M6#X<Z9HVH7,0MD73I[?=/R"6)&P*@QT+$\].*[C_ (03P?\ ]"IH?_@NA_\
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M PNX'YNO%7H_!L4.K6.HQ:SJJR6=L]M&KR1RAE?!9F9T9V8D*<ENP[9!@M?
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M&$6E_>M+%#&>-L:\ <<9Y/O0 _4M4\3:-I>K7L]OIE[';VC74$D>^!05Y,;
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M"5&E^V6BM$J#&0,%G##&?FW#ITYX32O&.@:QI5QJ=MJME]DMW99I3<*!& Q
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MRNL<:#+.YP /4FN+\#+9W5Y=:A#X=\1Z7<^6L$LNM7,LA?!R%022.2H)/S8
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M:E936T>G/I\]NMBR^:KXW$,93MY48&#QGKU'64R8R+!(851I0I**[%5)[ D
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M)P/P!/X5EZ!K%[J6H:W:WMO;PG3[P01^2[/N0QJX)) YPW(QQ[]:=V_Z[?\
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MNK;Q(8XKJ6[$DB1&Y.X!V8G:8L$\\KR?6NIO]!L])UV\TZPTFV^P^*8PC/%
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M8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM/#<L\<EV[RWETK>==RRKA9Y ,*[$ ^I !/4Y-/DL+3_ (6J]U)-<)*-+1U
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M*RX4D[#@?+TX-,UV"PM/'%K;PZI=LUQH5X\3MJ$AD9RR,/+?=N&=I.U3C X
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MJ2HY' :-E#*.0<D 8YI?U_7W@:D/AW1+>]CO8=&T^.[B0)'.EJ@=% P & R
M!QBI7TC3)-374WTZT:_1=JW1@4R@>@?&<?C527Q-IMO9PW,QNT250Q7[#.7C
M7GYI$V;HUX/+@#BDU?6["&R\H7TR274):&2SB,S(I'$GRJP5?]IAM]:&[:@M
M38(!!!&0>H-4+;0M(L[>XM[72K&"&YSY\<5NBK+G@[@!AL^]97P^O+G4/ 6C
M7EY/)<7,T&^260Y9CD\FMV]OK;3K5KF[E$<2D#."223@  <DDD  <DFG)6;3
M!.Y!IFAZ1HJR#2M+L; 2X,@M;=(M^.F=H&>M27>E:=?N'O+"UN7$;1!IH5<A
M&X9>1T/<=ZP]1\<:7:^';K5K875P()1;O"+2421R$@ /&5#KU!Y X(QU%=%;
M7"7=M'<1K*J2*&42Q-&P'NK ,#[$ T@V,L>$?#2I B^'=)"6[%X5%E'B-C@D
MK\O!X'(]!5U-(TR/4WU)-.M%OW7:UTL"B5AZ%\9(_&L[Q#XHMO#UUID$]O=R
MM?SF)3;VLDVT!2Q)V*3GC@=>IZ XQ=*\10Z1J?B--8U2ZEABU)$B>6,N($>*
M-@&V+A$!8C<V!ZG--7?]>G^8-67]>?\ D=O6=#H&C6VI/J,&D6$5\_W[E+9%
ME;ZL!D]!WINH^(=,TIPMY/(@_CD6"1XXAZR.JE8Q[L16F"" 0<@TO,"E=:1I
ME[>07EWIUI<75O\ ZF:6!7>/_=8C(_"HI_#VB76H'4+C1]/FO2NPW,ELC2%<
M;<;B,XP2/I4=_J=S:Z[IUFMA>2V]R)-UQ!&&CC8#($AS\H(S@XY.!]>:\3^*
M;ZU^%VIZXHU#1[^W#!!<0QAQ(&V@;6#*4)Z'J1SD=:3=E?\ KL-)MV.@/@SP
MLULELWAK1S C%UB-C%M5B "0-N 3@<^PH'@SPLMLUL/#6CB!W#M$+&+:6 (!
M(VXR 3S[FN%\.>)/$%WXB\/6UCKI\16T]L7UJ00PF&S?:" LD2J V21M)8\5
MW=SXNT*SU&.PGU%%GDD:($(Q175=Q5G VJVWG!(.*IJW]=B4[_UW+$'A[1+7
M4/[0M]'T^&]"[/M$=LBR;<8QN SC  ^E+#H&C6T5U%!I-A%'=Y^THELBB;/7
M> /FS[U7MO%FA7L%E/:ZE%-#>W!MK:2,%EDE )*@@>BGD\4/XKT1-5BTPWZ_
M:9F=$PC%"R#++Y@&P,!R5)S2& \(^&E2!%\.Z2$MV+PJ+*/$;'!)7Y>#P.1Z
M"MAD5QAU##(.",\CI6!#XX\,W&SRM9MG62&6=6!.TQQG#OG&-H/?O@XS@U<L
M/$6EZC:RW,-PR111B60W,+P%$.<,1(%(!P<'IQ0!/9:-I>F33S6&FV=I+.=T
MSP0+&TA]6('/XTX:5IP@N8!86HANF+7$?DKME)ZEQCYB?>JVE^(M*UF[NK6P
MN3)/:A&E1HG3"L"58;@-RG!P1D5J46 JVFFV%A9"RL[*VMK0 @00Q*B8/7Y0
M,52;PKX=>P%@V@:6UFK^8+<V<9C#_P![;C&>3S[UQ>E^*-=UW7?%5I#J*66J
M:3*Z6>DR0*4FC ^61R1O;<?[K*!D=<UTVF^,+*[\07'A\?:'N["W#WMPUNZ1
M1O@<%BN!D9/4#'3/.#?7OK^O]=@VT[?U^OS-6WT+1[.^%[;:58P78C$0GBMT
M638  %W 9P  ,=.!2ZIIOV^.!XY!%=VTGFV\I7<%;!!R.X()!'H>QJMIWBG1
MM6O_ +%97GF3F+SDS$ZK+'G&^-F 61<D<J2!2VWBC1KO5!IUO>>9.Q=5*Q/Y
M;LGWE63&QF&#E0<C'2GJ!:_LRRGN8+ZYT^T:_B'RS>6&:,D<[7(S_*B31M+F
MNI;F73;-[B95665H%+N%.5#'&2 1D9Z5R'A;QNUS \VM7#.;[4KBWTU;2RE=
M6BC;9D[%;'.3ECC\C7>4O,.MBE<Z1IEY=6]S=:=:3W%O_J)98%9XO]TD9'X5
M6E\+>'IIKF:70=+DENABX=[.,M,,@_.<?-R >>X%<SXN\3WFG^-]"T%K]M(T
M[4(W+:@D:,S2@_+$#(&5<^I!SD 8K6M_$"Z/.++Q)JEHM[<W31V,<<95YH^
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M/L#A+OR(GE\@G/W]@. ,')/ [XJY;Z]IMUJ?]GQ7!-R8O.0&-U61.,LCD;7
MR,[2<9&:$!+J&E:=JT21:EI]K>QHV]4N85D"MZ@,#@U#J/A[1-7$(U/1]/O1
M""L7VFV23RP>R[@<=!T]*A@\4:/<:BEC'=,)I,B)GA=(YB!DB.0J$<CGA2>A
MJ*+QEX?G6)X-22:&6X^S+-%&[Q"3. K.!M7)( R0">!S0@-I8HUA$*QH(@NT
M(!\H'3&/2L^3PYH<MM/;2:+ISP7#B2>)K5"LKCHS#&"?<UIUR'B[Q ^E:MIM
MG=:E)HVF722;]41$.V4%=L9:161 06.6'.,#%&[]0Z&U'X9T"&ZANHM#TU+B
M!/+BE6TC#QIC&U3C(&"1@>M*OAK05MUMUT331 J/&(Q:)M"ORRXQC!P,COBL
MW5?$4GAG1/MVHL]\LEU'#;R6ELS[E<J%+!,^IZ=3@ 9(%7KSQ1I-A'&]S+<+
MOC64J+29FB1LX:10I,8X/+@ 8/I0!:BT72H--?38M,LX[!P0UJD"B)@>H*8P
M?RH71=*331IJZ99BQ (%L(%$0!ZC;C'Z5%>^(-,L+:*>6X:1)D\R,6T+SLZ<
M?.%C#$KR,MC S7.C5V?XC6LL&J33Z1<:))=+$C!HN'3#J%&6)![Y]J.NO]65
MPZ71V,%O#:P)!;PQPPQC:D<:A54>@ X J2JFFZE;ZM8QWEIY_D2?=,UO)"Q'
MKM<!L>^.:MTW?J"\@HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <5_9=Y>>+_ !&;W0[E
M]+O[*"W24S1!9=A?=C:^]<[Q@X'0].,Z'A.QU73S>07<M\VG*5%G'J$D<EPF
M,A@70G*?=V[B6ZYK0U77$TQ_+CLKR_G">:\%FJM(D><;R&89&>PRQ[ XK35P
M\:N P!&<$$'\J$]/P![E75[)]1T:^L8YC#)<0/$L@ZH64@'\,UQ+Z9XDO9?"
M6=$CMCHUQBY,EVFQU\HQ[XRN21SD!E4]L#K6V_CS24T2YU8P:C]GM[LV;J;1
M@XD&!RIY49.,MC^5=/0N_P#7]68/MZ_Y/\CS+PSX8U#2M:2RO? ^@S1V\C.G
MB$-%YLBY)4E-F\R$<$Y SDY]=?2M)U31+VZCTZUU(:.ML^+"XN(9 93@J+<E
M\JOW@0Y4=,"NVHH>JL.^MSRJ1]4\,^"O"K2:#JO]KZ?NA$5K;I>,G[LJ28TD
M&Y#D<A@1[="6CWFJ>'+%-.T#7I+N'6DO[R.]MX[1Q^\\QBJ22 ;3DA0"W3D]
MZ[N?3[#Q$SR75I?6\MK*\*3++);2$<9*O&P8H>.^#CI6I;6L5I"L40?:!]YW
M9V;MDLQ)8^Y)I\VMWZ_J2U?3^NO^9PEW9^(6U3Q1/:Z#+MNWM3 \[V["18\!
M]BER ^,LF\ 9 SCI3;CPYK$UAXN@BLILZG!&]NUU=J[NX3!0\D*<C_=YXKT.
MBDM!O4\U\0:%JTWB%-6'@C2O$,%Y!%$]OJ$L*RV3+GG>RL"I!&0N>0<9K9BT
MS5='UZXGM=*CGM+ZR@MU2VD1%LVC#C;M8K^[^;^')Z_+6]J.NVFF7.GV\RSN
MU_/Y$+11%D#?[3=%[]3DX.,UIT;JWK_7XAL_N_K\#F_ 6FZCHW@K3--U6"*&
MZMH_+98Y?,&,\$G Y]AGZFK7BF+4)M&VZ;:+=3">)FCQ&7"!P28_,^3>,97=
MP"*VJS]9UJQ\/Z<^H:B\R6L?WY(K>2;8,9R0BD@<=3Q3D[N[!+H<6_AS61I?
MBJ"*QF8WEW#=VWGW:N\NU8LKDDX.48<D*. .*] @=Y(4>2(Q.PR8R02OL2.,
M_3/U-9.G^+-'U.^2QAGGBNI$,D<-W:36SRJ.I02JNX#OC.*VJ/Z^[0+W=SGO
M$UC>W-WH5W96IN?L5^)I8U=5;88W3(W$#@N"><X!QD\5RNIZ;K]YHWC>V3P[
M>"75)@;0?:+?#CRDCSGS>!E"><'!'?('I=%"=OZ]'^@[_P!??_F>77GAW5/^
M$EEO)/ >D:[:ZEY<ADU&2!9K!@BJR,2K[E^7("9ZFO3XD\N)$PHVJ!A1@#Z#
MTIU%%]+$V"O/OB;I^N:]#IFDZ;H=S>6"WL-S?2I- @:-&R44/(I+=#V'3GT]
M!HZ4MFGV'Y'G5EHOB'1O&GBA].T]_P"SM:A6>WNO.CVVUR(R#O7=NP3CE0>W
MX.^'O@ZXTS3=-?7+.[_M&P\S:;N:)T5W^\\0B.#NR?GD^?DCH:ZRV\3Z1=W
MABN7^9PD<CP2)',QZ".1E"R?\!)K6#*6*@C(ZC/2FM/NM^?^8/7^OE^AP&E^
M#=5T[PWKMM%)!'=2WMY=::N[B)I,B-F/8@'H.F?7I#X/\+7VC^&;6ZN]+NY=
M<T^SDC@BNYX3B1ADB+RSL 9NKO\ .<\FO1J@O+J.QLI[N596CA0NRQ1EV( S
MPHY)]A4O1/T_)6'N_G?[SB]"\%Q:1X-MX;G1[:_U6>V$-^9-@=D?F2,/Z<G
MS@GDGDFL#4_!_BE_ %OI-L;F6--423[-+-$;H6*G(B+L3&S*>Q)7  YKTS1M
M5MM<T>TU2T#BWNHQ+'Y@PVT],BKU4[W?];.Y*V_KKH8WA_1H-,2XN!!*MU>,
MKW$MPX>:0@8&\K\HQT"K\H[5:UI=1?1KI-)\H7[)M@,K%45CW) )P.O S5=_
M$^D1W<MN]RZ^4=KS&"3R5;.-IEV[-V>-N[/M6O2>NHTK:'G6M>&]3U_QQX?U
M>#2&TNYTV8-=ZB9XR+B+',2!2689XRZK@9]:S+GP?XEO/"/BZ-[7R]3U?5#,
MR+.@,ULK* BL#@9C!'S$=><5Z)<Z]:6GB"RT62.X-U>([QL(3Y>%!)R_3/L,
MGD<8JU:WJW*SLT$]N(96B)G39OQ_$OJI[&A;:?UJG^:0/?[OR=OS9PESX0U?
M5)]5UB-%TRZ_LEM-T>T+KFV4CEG*$J&)X&TD #K6EI>G7UGX%MT@\.):ZO8:
M:]O;0R/$TGF;<860,0%8@$DD9[@8KLZ*'JFN_P#P?\V"T:?;_@?Y(\X\#^$M
M=\*ZM91,JRZ<VDPQ3O+."8)U9F=40==Q;KG'&<FO1ZS=.UNUU2_U"S@2X66P
MD$4WG1&,$D9&W/)&._0]LUI4V[ZB2L>>>*M&UOQ#X1O]%U+0(]0N;B:5K*XB
MN(PEL"Q,;.7*LI4$ [ ^0,=ZI>5JD'BCP[I9AEUBZ\.Z5YUQY<BKYD\@\I#E
MR.@#G.<X[$\5W%QXELK;7GT=XKPW*6CWA*6S,I12 0I ^=OF'"Y_E6;X4TOP
M]=2R>+=(M[V.XU,-YLEQ<S$R ,1\R,Y QC@8X'''2B/]?<TOU')_U]S?Z'+Q
M^!]8L8=$B>W%ZUQK;ZOK!AE5463!** Q!90VWIS\N<59NM$\3RZ9X[N8]."Z
MKJC&"R7ST(:!4")@YP.KGYL<FO2:*3U5OZZ?HDO0:>M_ZZO\W^1F>'M.&D>'
M-.TX1^6+6W2+:2"1M '..,_2J/C&$WVF6NFIDS7=[ % ."%219'/X*A_2NAJ
M$6L NS=^6#.4V;R<D+UP/0?3K3;O+F?K^I*5E9#+::ZEN;M)[3R8HG"P2>8&
M\Y=H); ^[@DC!],U9HJM:7?VOS_]'N(?*E:+]\FW?C^)?53V-(9R]Q#JI^*%
MKJ*Z)>-IT5@]FUT)8-NYG1MVTR;]H (/RYSV/6I+E=53QO>WB:%>368TS[/'
M.DL $D@8O@!I 1U R0.?0<UUM1SSQ6MO)<3R)%#$I=W<X"J.22?2DUI9^?XW
M_P Q]?N_ \CC\*Z]:Z1H-S-X*L-;DM; 6-QIFI2P;HF5LB6)SO0 Y.>YP..*
M]2T>V^QZ1;0?8;6PVIS:VN/*BSSM7 &0/7 SZ55TGQ-INM7$\%J;A)(7*8N+
M=X?,P 2R;@-PY'(]1ZC,UOKVFW6H-8PW!:<%@"8G".5^\$<C:Y&#D*21WQ5-
MM_,G?4Q/'[.FGZ.T<?F.-8M"$SC=\_3-4M0TO6[R75=<M]+\JZN8;:VCL+@P
MO)LCD9F?[S1[\,=F6(! )]*W_$FDZ-J-I%/K33K!:2"5#%=S0X?(VG$;#<V<
M8ZG)XZU<L]8L+RPDO(IRL$.?-\]&B:+ R=ZN RG&#\P'!S26B_KR_P A]?Z\
M_P#,\_UKP_KLFC>++:TT>\N&U9(# 9;R)GW!0&W;G &,= <<\9KTFT9WM(6D
MA>%R@W1N5+*<=#M)'Y$U6T_6K#4Q-]FE?,/+K+$\3 '.&VN =IP<-T..#3=.
MUW3M5E>*SG9W0;@&B=-Z_P!]"P&]?]I<CWI]+"\RY=6T5Y:36LZ!X9D,;J1D
M%2,$5R%CI?B2'P=J5M>QVM[J2QO:VB3[66:%<A"^>"S#D@\=,]ZZ2RUS3-1U
M"[L;.\BGN;/;]H2,Y\O)( )Z9^4\>U:%+]1G VNE:Q:ZKJ^H?V7?S+>Z5%$%
MGNH6E\U3)E,!]B_>7A2%ZG.>*9I6DZU96O@NZDT><RZ9:/97=L)H=Z;D1?,!
MW[2N4SP<X/3/%>@T4[_U]_\ FP_K\O\ )'E=SX3\0G1F>30=,U%[75[J\33;
MJ99$NXI68_Q+M1QN&TG/?.,XKM_"5FUGHJ^9X=L- DE8NUC9,C*IX&69%52W
M'8?B:W:*2T5OZ_K0'J[F-XKTFXUSPU>:?:RK%<2*K1LQ^4LK!@&_V3C!]C66
MMMJ>IZ_8:Y<Z1<V+:9;3QFW,T+/<NX7A"KD;?E.-Q4YQD"NDU"]BTW3Y[V99
M6B@0NPAC:1R!Z*H)-&G7T6IZ9:W\ 80W,2S('&"%89&??FA?U]S_ $#^OR.>
M\ V^HV.A26>I:5<V$J7,\H\Z2)PZR2NXQY;MT##.<<],UT\JEX70=64@4^BB
M6JM_78%IJ><V>FZ_::;X*LGT"Y<Z5./M3QW$!"JL3Q;AF0$@E@PQS@'(!XJA
MJ'AO7K\:Q<#PY'.5UG^T(+'4G@:&]C\D1%#AFVMP6!8 #CWQZK13<F]?ZZ/]
M!W_K[_\ ,Y[P?926FDLTOAC3_#LDK[FLK)T<>FYF154GZ9Z=?30U_1X?$'A^
M_P!(N&*Q7<+1%EZKD<$?0\U4U'Q;I.E:HFFW7V\W;H72.#3;F;>HQDJ4C(.,
MC.#QGFKFEZS9ZPLQM!<J86"R)<VDMNX)&1\LBJ<>^,4G[PE[K,K1;SQ!:VMO
MIFHZ'))/#&(S?03Q?9I,# ;!82+G'(V'&>IJ.[M-5TSQ<VMV]C)J<%U9QVLT
M,$B(\+(S,&42,H*G><_-G@<&NIK-UK7+30H+>:[2X99[B.W0PQ%\,YVKN(X4
M9(Y.*=VW?K_F"5E9'&6&@:OH^M^'PNEW-S!!/>7%Q-%+#Y<)N&)" ,ZL=N><
M+],]*J3:9XAD\)ZA9CPU??:9]<%ZD9GML^5YXESGS<9PN,9ZD=LD>H53U74X
M-&TNXU&Y69H+=-[B&)I&Q[*HS_A2O;7^MT_T0U=O3K_P5^K.%N+77KQ?&<@\
M,:C$=5M$CM4DGM<LPC,9!Q,0.6SUZ ]\ S-I^LW6L^'6?1+^""'2IK.XF\ZW
M_</($4' E).-A.5!ZC&><=U:W"7=I#<QA@DT:R*&Z@$9&:FZ"AJVC_K=?JQ)
M]5_6W^2."M-#UBYT;0M"O-/>V_L:X@D:_26,QSK"./+ ;>"V "&50,GD]\R;
M3/$$GA/4+,>&KX7,^N"]2,SVW^J\\2YSYN,X7&,]2.V2.\T/7K3Q!;W$]G'<
M(D%P]NXN(C&VY<9^4\CKW I+/Q!9WVOZAHL27 NK%(WF,D112'SC:3][H>1Q
M[T[MN_7?\G?\@6B]/^"OU9IHQ>-69&0D E6QE?8XR/RK(UC[8[R1-I":IIDD
M&V6VW1[W;/0+)A6!'7<P[8SS6S12>H+0\[C\)ZA9>$+VUL+%XHWU*"^M-*,Z
MEH(TDC=HPQ;8"2K$ -M&[&:UQ;:OI?B/4KZ/2Y;^VU5(LI'-&&MG52I#;V7*
M8P?EW$'/!KK:9--';P23S.J11J7=V. H R2:&]-?ZTM^@_+^M[GG,&@^*O!T
M>DRZ-8P:ZL=@+*ZM'NA 58.6#HS#&T;B",9P!46LZ!X@U#Q+8W%OI$EBEOIC
M1A[66!K=9MZR+&59E9X_EVGY1DGC Y'=Z9K/]I7$T7]G7]JJ*KQRW$:A)D;H
MRLK'_ODX8=P*TZ>M[BW,_1;R^OM+BFU+2Y=-NR,26\DJ28/<AD8@CTZ'V%:%
M%%#$@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .!:*[M_BAJ]W_:E^\=OI4,_P!F1(<.
MN^7]W_J]V.,CG=D]2.*6'7-7BTWP]XA.H/=V^KS6\<U@(4V1"4<&)@H?*DC.
MXMD ]*Z5/#&EQZ^^N*MY]OD&UW^W3E&49PICW[-HR2!C )SUI;/POH]A=FYM
MK5D;>9$C\Z0Q1L<@LD9;8A.3DJ!U--:)?UU?YA+6]OZT.$O_ /D1/&/_ &&Y
M/_1L==/->:EK.NZOIMEJ<NF'3$A*;(8W\YG4MEMZG*=!\NTY!YJ=O >@-I]U
M8M#?-;7<PN)T.IW)WR>I/F9]SZX&>@JY=>&-)O)H)IH9_.AC$0F2ZE1W0=%D
M96!D7V<D'FI2TM_6UOS#K?U_.YS6G:[J>HQ^']9N=1N+*QU.VDAFMDBBV13A
M25D#,A;!"O@$X^[QU!L>';S5K^./3KS6+S^TK.]D-TQBA!DA #(K#R\ %7CS
MM .=V#Q7476D:?>V,-E/:1M:PO&\<0^55*$%<8[ @<=.W2GQZ=:0ZA<7\<(6
MZN$1)9 3EE7.W\LG_(JKJ_\ 7]=_D+^OZ^7XG!?\)#XD6Q#-J5JTR>(QITCB
MSP&B+* %&[Y>^<ECSU%:/]LZS9#Q9:QS/J$^FB.6U>6-=X#IN((0*&"X)'&3
MTY-7S\/_  \4*&+4-IN/M1']JW7^N_O_ .L^][U'K/A&U%EJ\^G07KWVI($N
M"NI2JS+D<IO8JK 9V\ =L@9J=E_7E^J?WCMK_7=_HU]Q%X=U6_O?$=Q9VVM1
M:OI%O KR7;0(7\YBP,7F1E4&W .-A//)KJ+Y'EL+A(YY(':-@LL>-R''4;@1
MGZ@UR'@WPQ?:7>F]EU7Q8R%2CVFNW\-R&]"HC+ ?7</I7;$!@01D'@BG)7C9
M!%ZW/,M+ANAX%\$O+J-Q<S3WMM()+A4)CS&W VA<CW;)YY)JU/XIU?3/[5T]
MKN.YFBU:*QM[N\98 BR1+)\[)&5!!)53L/)7(-=&W@C06M[* 6]RD5C*9;98
MKZ=!&WJ-KCIR #P 2!@'%*W@GP_*NII/927":FP:[2XNI95D(Z':S$*1@8*X
MP  .@IMW;??_ ('^3'I_7S_S0[PS'XA@@N(?$$]I,X8- \4PDDV$?QD11+U!
MQA1Q],F#XA_\DZ\0_P#7A+_Z":O^'_#.C>%=.-AHEC':6Q8NRJ2Q9CW+,23^
M)J;6=%L?$&G/I^HI,]K)]^.*XDAWC&,$HP)'/0\4I:[!!V=V<?;P7VK^+]"&
MNQVU@VG0M<V,5M*TPNF9-C?O&5,;0<E-O\0.2 :?<ZKXJU?7=1CT*?3H(],N
M?)>&XN]F\;5.9$^SNV#DX*R+Q72W/A?2;S2;?3;F&>6"V<20N]W*9HV'0B7=
MY@/)&=W3CI5*]\ >%M2U:TU6]TB*XOK4*(YY9'9CMZ%\GYR,=6R:=]?O)2T,
MTWVH:?KVIZ1>^(+MYKZ%)=*)B@&S<=K!2(_F*L0?F!^4@XX)J"^O_%-YK-WH
MNAWUL+C3$BWR7ERD4EP67.]XQ;N&0GCY#&<@CCBNSN-+L;N_M+Z>V22ZL]_V
M>5NL>X8;'U%9.O>!O#/B>^M[W6=(@N[FWQY<C%E. <@-@C</8Y%)=/Z]!]_Z
M]3*TV_\ $6I>+=6TZ75;>*.SCLYT2WMP4(?<70LV20=N-W'8X'(->W\77NG:
M=J;:NM]'J]K:S77V*Y@41/L YAD1<,@]RS8;FNHL_#>EV&KW6J6T4ZW=TH29
MFNI65E'0;"Q4 9.  ,9XJ2'0=.ANWN1"\DKQF+]_,\H5" "JJY(0' R% SCF
MA[?(%OK_ %_6IB>&9/%$U^MWJ-YIL^DW41>/RKL3,'."OEE8(ODQG[Q8].:Z
M>Z$1LYA.<0F-O,/^SCG]*Q= \#^&O"]Y<W>BZ3#:3W/^L=2Q.,YP,D[1[# K
M>EC2:)XI%W(ZE6'J#UHE9JR".CU//;8ZUX(33["\$&L>%C-#;VMTOR7-IE@(
M]X^[(H)4;A@]R*B_M"_\/S^-M6_M*[N_L]Y'%%!.L9BCWQQ88[4#87=T#8P.
M<GFNRA\+Z1;W44\5LZB$#R8//D,$6.A2'=Y:D=B%!J4Z!I9N[ZY:S1Y+Y0ER
MKL624 ;>4)VYQP3C)  /2G?K_73_ ">OF"V^[]3F]1UK4_"NK+%<7D^KVES9
M7-TOF0QJ\+0J&P"BJ"A!QR"0<<G-6]/?4KFSCU/^W(K_ $V]LF=HS&BA)"H(
M\DJ =OWLARQZ<]:U]-\/:9I)8VL,A)4H#//),40X^12[':O ^48''2LS3_AY
MX4TJ>]GT[2([2:]0QS202R(VT]0A#9C'^[BI:NFO+_/^OD-.S3.<^&M[+J>@
MZ'9PZA=6*Z=8Q-+:^7'_ *6& (;+(3L&",J02<],#/I5<[:^!] LCIIMK>ZC
M.FAEM"+^?,:D@E?O_,O ^4Y'M715<G=W)2L><7,>K>#+*[OK#R-9\(R-+<SV
MK_)<6RNQ9S&W1U!+':V#V!K36[UO4_%VLZ7'K1M+6*RM[JU:WM8]Z;RXPQ<,
M&'R<\#KQCJ=IO"FBM(A^RNL:,6\A+B18'8G)+Q!MCDGG+ G/-81T&?4OB%J=
MU?Z3?Q:=):00Q727:Q*[1LY8$1RARIWCAA@X.1TREV]?R7]+[BGU?];_ -7*
MECJMQK>J>!-1ND5+B:&[,FT84L$ R!Z'&1[&J6IWNM:GX2OEN]8EBN;;Q#%:
M>;9Q)$&C$T:@;6#<?-GDG)ZY'%=Q<>&-*N=1L+YX9TGL%V6HANI8DC7T"*P4
M\<'(Y''2J\/@S0X;"]LA;W+V][*)IUEO9Y"9 <APS.2K9 .5(/ ]*%:_]=T_
MT8OZ_!K]5]QMP1M#;QQO-).Z*%,L@4,Y]3M &3[ #VKEM?UR\T?7T>]-]:Z+
MY(VW=O DL(D)(/G_ "ET XP1A>N3Z=7'&D,:QH,*HP!G-4;_ $6QU-@;N.5U
MSEHQ.ZI)QC#H&"N/9@12ZW#H<7JUS?V,_CC4M.OVMI;..&Y3;&CB0K!G:VX'
MY3C!Q@^A%2>+/$&K6UA=WFGW\D<EIIR7BVUI"DGS88MYYD7"I@# 5E8X;&<"
MM^;P3H4_]I^9%>,-4_X_!_:-P!*/3'F<#'&!CCCIQ3V\&:$Z2(]K,ZRVWV24
M/=S-YL0! #Y?YR,G#-DCL10M$AW5]?ZV_P""9LDAE^)>DR-C+Z).QQ[R15/\
M.O\ D1--_P"VG_HQJNMX0T=M0BOA'=I<PVYMHWCOYT"QD<C <#G@YQG(!SD
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M::@]]#;E9F)8 RNR(3]XHA.U"<\E0,]\TT]K^7X"MHUZ_B9?BP3&_P##6/\
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M1T.ST*;1$LC)ILY8R6]Q-),"6.3R[$C)YX[\T=/Z[_Y:#Z_UV_SL1>&(_$<
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M?*C;@'FJ/AJVOK,^"GGTV^C$&E364N;=LQRGRB-P_A'R-R<#CW&:25_Z\_\
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M''4<4EJOE?\ K^NHVOSM^7]?([/Q5K__  CNEQ7/[I3-<QVPFG.(H=YQO?\
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MLFBZG)=)XB-U KZ3<&14-SYF]08\@>7GGWQU.*TY4I-?UNM?Z[=@6J_KL_\
M)?>>C6_BG1[KQ)<Z!%?VS:A;HK/#YJ[R3DD!>I( !/ID4S6]>>PU+3](L8HY
M]3ORQC21MJ1QH,O(V.<#(  ZDCIR14T[SH_'FJRM:7(@O+.V:&8PL$.WS-P)
M/1AN7Y3SSTX.(/$>G7EIXMTCQ1:6DEY':PRVEW!#S((W((=!_$5*\CJ0>,D8
MJ.U_G^/_   [V^7X?\$UK5M?MKJVAOS8WD,K,)+BUA>#RL*2!L9WR"1C=N';
MCG(MVVKZ9>7L]E:ZC:3W<'^N@BG5GC_WE!R/QJA+?R:]HUY%I27MM-)!(B3W
M5K);F-RI"G;(JL>2.@Q[US-K;3ZE'X6MH-,N["^T:5/MC2VKHB1B)E=$D(VR
M!CC[I;L3BCK;^OZ0=+_U_3.T;6=*2:.%]3LUEEE,,:&=0SR 9* 9Y;!''6EB
MU?3)DN7BU&TD6U;;<%)U(A/H_/RGZUY8\,47@K7K2TT/4HO-UQ9K>"/1[A"8
MO-1PRKY?0!6[<=.I&9_&)BO=1\3Q?V-JES%=Z'%!; :/<2(TZF1E Q&0"-R\
MG&#W!!P=/Z[)_P":*2N[?UO;_@GI)UW2 ;D'5;$&U027 -PG[E3R&?GY0?4U
M*^J:?'IHU*2_M5L"GF"Z:91%M_O;\XQ[YKB89XQXT\-W"Z;J*P1:/-&\G]F3
MA8W)C*J3LX/R/P?ZC.9H'VZWL-$OWT[4FL].U"]:YM7L)5E42LYBE6-E#. &
MZ*"1O/&15-?U\VO\OO(OI?\ K:YZ5'J=A-9Q7D5];/:RX$<ZRJ4?/ PV<'-+
M9ZC8ZB)397EO<B&0QR^1*K[''56P>#[&O+O$&E%K2^OAI5W+:7FMV=W9VZZ;
M+))&J[/.D*!"T>X!L@@$X/&3@]5HLQ;XCZ\RVE]'!-:6RQRR64L<3LF_< [*
M%) 9>_TZ'"2O_7DF-Z?UYV+FL:]<Q>)K/0+.XL[.XN;=KA9[V,R+)M8#RT4.
MF6Y)/S<#'!SP^^\56N@6MNWB*>SL)KBY\B(&<!&&?O[FQ@8Y/ITR>I@\56VF
M:FDECK^ASWNF+&LB3P6[S.DA+ A1'F0'&#E1QGDBL&"RU6TT+2VN%U*\M;76
MTEMS-&TERMK@A3(H&XD%NXR!C..:2_K[_P"OS!_U]W]?D=Q<:UI5I<6]O<ZG
M9PS7/^HCDG56E_W03EOPIU]JNG:7Y7]H7]K:><^R+[1,L>]O1<D9/L*XNYAG
MB;Q1INIZ5>7;:NS26;I;-*CJ8E58V9<K&58'[Q4<Y!ZU3E?5O#5ZMMK.@:CX
MBM+_ $VWLGGT^%965U5A(K@D85BV=Q.*/Z_X ?U_P3HAK=[;_$.]T^\O;=-)
MBTH7B@H$\L[]I+N3R/E)SP!GVS7165_9ZG:)=V%W!=VSYV302"1&P<'##@\U
MYEK":C'XU:73=.OTAMM'BC:%K.9XYPCEV@\T*1N*XY!()^7G)%>C:5?Q:II,
M5U%:W5LCKCR+FW>"1/8JP!&/R]#1]G^N[_K^D'7^NR_K^F07VJ1W.EZC_9&I
M6;7MLC@D$3")U&<,H8'/MD=:A\,Z[!J>D:<DU_;2ZI)8PW$\*R+Y@W*#N*#D
M D^F*YBT_M'18[W3T^WZCI$%C((S-IL@N+=B!MB5@O[\'/\ "#C;R:JZ;(T%
MQX#":7J:M;64D5P/[-G01LT87:Y*87+J>OL>A!I_\#]?\A.]_O\ T.^CU?3[
MVZN;"RU.RDOX%/F0I*LCQ'L60'(_2N(A\1^(6\'Z1J#ZA ;A]:%G=,+4#S(_
MM)BPHSA.!_M'WSS4.CK=KJWAJ_DTS4+>&WBN89+1;%PMH2 =NY@7?H1O!VL>
M@YQ5".69? 6GPG3-7\Z/Q )WB_LNXWB,71EW;=F<;"#G\.O%.*UU\OS_ ,@E
MU2\_R?ZG<^.]2U#1_!.JZEI<\4-W:PF56DB\P<=1C(Y]SG'H:T]-U:QU -#;
MW]M<7,*K]HCBE5FC8C/S 'Y?QK.\;Z?=:SX%UFQL8C+<W-HZ11D[2S$<#GI^
M-85Q8W6OWEI<Z3!<Z?)9Z=<VLD]Q:O 2[HH1 ' + ,-VX97C@\U.R?\ 71_J
M5O;^NJ.QM=6TV]NI[6TU"TN+FW.)H8IE=XC_ +0!R/QJ2^O[/3+5KJ_NX+2W
M3[TL\@C0?4DXKS_P-##-JMO]H\*^)-.U.P@,3W&HWLTMLN0 RQ%Y6#@X'1<<
M=>!5[Q]'=P:AI6I_V9K&IZ; LL=Q;Z/<2Q7",VW;(HC=2X^4@C/?-$M+"6MS
ML#J5@L,4IO;813*6B<RKAP!DE3GD8!/':LO4?&?A_3+*QO)]7L?LU[*(H)A<
M)Y;\\L&SC [G_&N/CL-/M-:\'2VOAO5;2));B1Q<6LMS+"LBMCS)!OVYD.<%
MN,Y.*;9&X>&29=-U01P^)S=E6T^9&\E\@.JLH+#)R< XZFG;7^NZ7ZBOI_79
MO]#MKG5[33)-1U&]UNW^P06\<A@^4& ?-\Y(.3OX !_N\=:QYO$\U_J_A2XT
MG4;672M3EDCG2(+(2PB9\>8"0,$8( SD=>U9AM3+XG\:Q6FE7<+7^F1JCFR>
M..:8+(&_>;0C-\R#.3GMG!P^XNI)+OP(W]G:H! Y,Q_L^8^4# T>7PIV_,0/
MFQZ].:([KY?^W?Y('L_G^G_!.V_M;31J?]F'4+3^T-N_[+YR^;M]=F<X]\5S
M?COQ,^CZ<(],U2RBU))X/,MGVO*87D5"0N[(^]]X@CC%<YH]B5\1KI>L^&O$
MD]]#>O=1:@E[,;!OG++)CS0BG!Y0*?I4>K6VIMX+O-&?1=0N=8CU1;EV2W)6
M=?M(82+)]PG9@8R" .0 ,T1ULWY?FOZ8WU7K^3_X%CT77=<L/#FC7&J:C.D-
MO"N268#<>RCW)XHD\1:+#IL.HS:OI\=E-_JKE[E!&_T8G!_"J/C*WN=0\#:K
M#;6TKW$MJ=L"@%R<9VX!Y/TK+EN9K3Q6NKW=A?SZ5>:<EO%LLY)7MW#L6#1J
M"ZAP5Y*_PX.*2_K[@_K\?Z9V:LKH'1@RL,@@Y!%54U33Y+D6T=]:M<$L!$LR
MEB5QNXSGC(SZ9%9'@S3+G1_#*6MVI0"::2*''^IB:1F1,#T4@8[=.U<?H>BR
M77@SQ19Z?I4MI=O>W4EBD]G):YC?[H0LJE0P!7C!&>U#W?I_E_G^##_/_/\
MR_$]&L=6TW4S,+#4+2[,#;)?(F63RV]&P>#[&BRU;3=2\_[#J%I=>0Q2;R)E
M?RV'9L'@^QKS>QL7UK1M9?2_#7B+3=8%DUKOUN\E=).03'&9)6RIQC=@#GK5
MNXN+OQ7H6J26/A'5M+U6*U6W;[8!;B=5<,88V5\D'# /@8SP:'_7]?TP6IVZ
MZM8:GI]V^F:Q9MY0:-KB&5)5@?'\6#C(ZX-,M]<TJ.:TTV;7+";498E9(_/1
M9)P1]]4!S@X)XXK@8+?3=3\->(+H^$?$MO.]D;9UUCS[MYFY*+&C/(S ,<[@
MH Z^N->=+^+P?X>UK2M.N)M2TV*)&M)86BEDC8!)8]K $= W(_@':G_P/QO_
M ,#[Q?\ !_0ZL:_HS6ES=KJ]@;:U<QW$PN4V1,.JLV<*1Z&KEM<P7EM'<6L\
M<\$B[DEB<,K#U!'!%<-XRL[^TMM&OCI^IZG;6S2&^M])N)(;C>Z_ZQ-CJS8.
MX;<]&]JZ#P?;VMOH"-9Z7J&FPSR--]GU&5GGRQR6?<[D$GG&?K@T+9C?0T4U
MC3)-3;3$U&S;4%7<UJ)U,H'J4SG'X59FN(;9 \\T<2E@H9V"@D]!SWKS9(+V
M75M$N%TN^MX[36KAI;-+1RL8=9?WAD8'?N+ [E(0;L'H*VOB5!'<:'8!M.GO
M98]2MI4$%D]PR*LBEVPBL5^3=]>G?%"6WG_P/\QO=_UW_P OQ.@?Q'H<=O)<
M/K6G+!%-Y$DAND"I+_<)S@-[=:G75=.>]GLEU"U:ZMT$DT F4O&IZ,RYR![F
MO.M?@NM3U'QG;V6G:@QN=-MA 6LI8TE:,N65690I.&7 SSVZ'%S5W^W>(+B\
MET+4KG2[C0F@9GL&;#[R0K1$;R<]@I/<@#FI>BO_ %L_U5A=;?UNOT?X';)K
MFDRRF*/5+)Y!"+@HMPA(B/1\9^[[]*P/$WB*:&UT"^T74K22QO-2AMYI(PLH
MDC8\[7!P.AR<'\*YS2LQ0_#N-]*U)&M(62YSIDX\EC%L^<[/E^<=3_O=.:A^
MSW5_IURT6F:B4M?$PU!HY;&6,M;[L[D5U&_O\JY/MS5M)2MV?Y.WY,F[:^7Y
MI_JCTVSU/3]1MFN;*^MKF!"5:6"5752.H)!QD5%;ZYI%W8RWUMJEC-:1$B2>
M.X1HT(ZY8' KAM;TG4M6&NZQI%G=+#<PV@6T</:2W9BD+OUVO&2I"@G!X],5
MBZK9V.K> ]>N;7PCXF@O;F..%5U59[J:213E=BL\C +EOF(4<^]2O\BSURWN
M[:[$AMKB&81N4?RW#;6'4''0^U354TZ.W6T26WMQ#YP5W!A,;,< 98$ YP .
M>>*MTV2G=7"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:CJ=KI=MY]TTFW. L4+RNW
M?A$!8\<\#I7.W?B'5KG^V+C1A8^1H\K130W*,7N&5%=@KA@(_O8!*MGVK*N-
M0U+6?&OA6]TV]M(;.\TZ:YB2>T=V"GRBP)$J@D@C!P,<_>SP)-[?UHW^@=_Z
M[?YG=V5Y;ZC90WEI*LMO,@>.1>C ]Z@U+6-.T=(&U"[BMQ<3+!#O/,DC=% [
MFDUN^FTS1;J]M[9[B6%-PC1"Y/OM')QUP.3CBN-UK6H]<\#Q7-O?V5^RZC9(
MSVZ-$ XGCRK(Q9HSGL22*:U=O3\0M^IZ#17*)XAU6"^\0V$\5E<7&GPQ7,#I
MF!&23=A7+L0"NPY;(!'85B7?CK6;'1_$<R)IU_/I,<,R3K#+;12))GHK%BV,
M=0V#ZC%)*X>1Z-17'ZIX@U^RN(].M[."[U"[5Y[?[-&K".%=@)=))HMQW.1\
MK],'':H+CQ?J>FV^EMKUK%H?GF3[3/<Q>="NUL*I:.0K$6!SEF('3GK0!V]%
M,A?S((W+(VY0=R'*GCL?2N-LO%'B+5-3@GL-!>719)VA:4F$$*'*F4/Y^[C&
M=AB!]Z.M@Z7.UHKB+KQ;J@T@>(+5+(Z7)=K:Q6[QOYK S"+S=^[ &>=NWI_%
M27_B;7+6Q\8LCZ<9M$Q);L;9]KH8Q)M<>9DG'&X$#OCM1_7Y?YH:3;LOZZ?F
MCN*H1ZUILVLS:/%>1/J$,8EE@4Y:-3C!;TSD<&N6\3>+=4T?3WO8/L")#8I>
M>7+&\SW1Y+HJHP:,# ^=@P^;V-6X)/.^)R28QOT-6QZ9FIV=_O\ R?\ D3?2
M_I^G^9UM%<OX^N-3MO#T3Z7>16TK7MM$[20F3*O*JD8#+CKSZC(XSD(VK:U>
M7U]IVF3:=]JTM(OM3SV[[9Y&4L510^8QC'S$OUQ@XI=+E6V_KR.IJEJNKZ?H
M=BU[J=W':VRD*9)#W/0#N2?05!X=UJ/Q#X>LM6BC,2W,>\QDY*'H1GO@@\UP
MFI3:Q/X8\>'4+^VN((IY(HD2V:-EPD9'S;R,8.,8SG)SSBG;6W];I?J3?2_]
M=?\ (]/!R,BBN0N?%-WHNIZG!JB6TMM;:9_:,1MU9&4 E3&Q8D,<@8;"_2I]
M U;Q/>:JT>J:&UOI[QF2.X/DH8SD80A)Y2^03\V%Z=.>%O\ U_78+Z?U_74Z
MBBL#Q)K5_I-WHT5G;6TL=_>"UD>:1@4RI(( '/W3W&..#6#?>+=<LM/U@YT]
MKK2M2@MI'^SN$GBE\L\+YF48>9URP^7ISP+7^O3_ #0[?U]_^3.]HKCM3\2:
MS8:QX@M88K"X2QTV._ME</$>2X978%MWW"1A1UQ[T6WB'6YM1T6W?^SPFKV#
M3QD1/F"150G/S_.IW]/E(QU/6C?^O7_)@]/Z]/\ -'17NM:;IMY9V=Y>117-
MZ_EVT3'YI3WP/;U[5?KS+4=8O-:@\*S3K MY!XCDM79%(C9HUF3<%)) .,XR
M?3/>M>7QAJ.ERZCINH6T%YJ=O+;I ;-?*2<3DA/ED?"L-K9!?!P.1GAVT_KR
M_P P>C_KS_R.VHKS^[\6>+M*T<W.HZ%!$PO+>!99F6(2)*^TD1QRRX*DCJXS
MG/;%=M8"_%NPU%K9IO,?:;<,%*9.W(8DYQC/.,T6 M5D>(M0L[+2IDN[RYM1
M*C#S+2 S2HO=@H1^!D9)4@9YK$O?$^J/8ZOJ^F+9-8:1-+%-;S(QEN/* +E7
M# 1G.X %6S@<C-5;>YU34/B7;7%M?6:V,ND+<(CV;E_*:097=YH&[C.[&!TV
MGK4VYM._^5_Q!OEU_K>QTWAK3+?1O#MC86=[/>6D,2B":8H6,>/E&4501C'.
M,_6K-[J^GZ==6=K=W<45Q>2>7;Q,?FE;N /;OZ5#X@U&?2=#N+VVMWGDB ^5
M(S(5!(!;8O+!02<#DXKE]0U==9TWP]=VE]8WY_MB)?-MPR)N"-D,I+%"#GY2
M2>E4W=W\_P Q6LOO.[HKD(/$FJBVUV&=;!KO3+R. W',,/ENJ-YC*SG[JN<C
M=\VWC&:RI_'6L6WAO6+Q8+&ZN=-OX[5I?+EMTD1PA#B-MS9'F 8W8(&0>@HM
M^GXV_P RFK'HE%<=JVO>(K.[&E6EE#=ZE*KW"-;1JRQP!@%W))/%ECD@E7XP
M#CG%,O/%VH:9!I#ZW;1:&+@.;J:YC,\4; X"%XWVQE@<AF) Z<FD([2BHXW:
M2V20&-V9 P*M\I..Q]/>N'L?&>LOX?GUR]L[ 06]Q/:/;0.Q=IEE$<>UVPN"
M<Y+ =CQS1UM_78/,[RBN!O/%'C'3-!UK4+S0(4%G ;B"2X9(58#[R%(YIB2!
MR#E0>GR]:T+G7];T_4K>VGBT^X%_:2S6@0/%Y<D:ABDC9;<""?F &,=*'HK_
M -;7_0/Z_+_,ZZBN$L_&.LR^&M+UB2RM9FU:.)+2UMN)!,VXMDR.JE0JY W*
M201GD5*WB7Q+8>'KFZU?1VM)HYUC6X%N)5\MNLC0132-A3P0'YZY SAM6T8'
M;45QE[XPN9K>P@\/B#5KN]BDFCGM!')&$1E4G8\T>>6 P'R/>A/$?B1;S0+.
M\TBUL9]1>>.;SI=[(45F5@J$K@@ XWGT_P!JBS"_4[.BO.KS7/$.HV=A%#>6
M-K=0Z\=/N'%H[1S;<E6"^8"HX&5W'Z^M^\\3^))M3N(M#T-K^WLI_L\[ 0J)
M7 4MAFN%:/&>\;YXYYI+7^O3_,'I_7K_ )'5ZEJ=CHVGRW^HW45K:1#+RRMA
M1DX'ZU/#/%/;1W$;YBD0.K'C*D9!YK@_%^JW^K^%O%BV1MHK&PMY[:=9HV:2
M9_*W-M8, @&X#D-G!Z=:['1/^0!IW_7K%_Z"*%LWZ?D#Z?/]!=*UG3M<M&N]
M+NX[JW#M'YL1RI8=<'O]15ZO+M%U74]!\,ZWJ]M]DDL;36;U[J"2-O,D3SCD
MHX;"D#G!4Y]16]_;^N6MSKEG>7&FFZBACFTP1V<BB57.U=V93N._"D C'!S\
MV ]]OZT3_4'H[?UNT=G14-H+E;2(7DD4ER%'FM"A1"W?:I)('U)KC[;Q?=WU
MMJ\<5W8VVJ6D<DJV%U:2++"J="REQYJG!^==HY'6I;M?R!*]CMJ;)(D4;22.
MJ(@+,S'  '4FN2L_$NISWWA7S/L8MM8LFFG186#I(L8?*MOQMYQ@@GCK5G2M
M7UK5OL&J6L=C+H]X6!B4,LT*<[9"Y;#9P 4"@C/4XYIIIM>O^0DTU?\ KN;>
MF:I9:SI\=_IUPEQ:R$[)4^ZV"0<>HR#S5NO.O#^K:CI&CZ,RBU>PN]6GLY(R
MC>;EYI<.&S@8(Y7:<^HZ5VNN:K'HFB7>I2KN6WC+;<XR>@&>W..:'W7];?Y@
MG_7W_P"1H45S-UK&M:%::A>ZM%9W5G#;^=#): PG?G B8.[9ZCY_E'7(%9C^
M)/%]EINKWE[X?1(K6U>Y@DG:.%<KR8R(YIBQVY.[Y02,8&<U+=DV4E=I([FJ
MT-_;7%Y<VD4NZ>VV^<FTC;N&1ST/'I7$:IJ'BF[L= N8K[3+6._N[8J!:R2'
MYHRQ#?O%X##L>1CICG8L]8UF^U#Q'IKK86T^GB,6\RJ\JMO4MN=<J?3Y0>/4
MTY:7OTO^!*=[6ZV_$N3^,-"MM12PGO6CN)'$<0:"0+*Q8+A'V[7P2 =I..^*
MW*\R\/:UKNB_#SPS=,=/NXKN>V@/[MXVBCD<+_>;S&YZY4#T-=.FL:SJ4\MS
MI"6,ME;7K6DMO(K"60*P5W#[@J8Y(4JV0!R,\4XVT_KI_F-_U^/^1TU%<9JG
MBK4M.UZ"$_8C;/?Q69M1&\DVU\ 2F16*Q\G[K+DXZ\BJ<&O:MI-_XMOK^Z@O
M+6SNXX+>UCM_+?<Z1;%#M)M R^#D=23D#@2M5?\ KI_F']?G_D=_17.>'-1\
M27=Y<Q:WH[6MN%#P7!$4>3GE"B3R\@8.[(SZ#O/J^KW$6L66B:>T$=]>12S"
M:XC,B1I'M!.T,I8DL!C<.Y[<@&Y17 WGCC5K/2KG-E92:A8:I#I]V=[K&1(4
MVR(,$\AU^4GCGDXY[2P%^+=AJ+6S3>8^TVX8*4R=N0Q)SC&><9IVZ@6J*YBT
MUG6=5D6^TR.RETU;Q[62W96$VU)"CR"3<%&""=FTY'?)Q5"/Q3XBU'5!)I.@
MO<Z2ETUL[L85R%D*/(',X88P3M,63CKS20/0[:JUQJ%K:7-K;3R[9;MS'"NT
MG<P4L1D#C@$\UQ"^(O%&J^'-<O(3I=@]A+=V[X628@Q+\K*25!YSU ZCTP;E
MEK.M:<WA&PNOL-S%J2E)KA$>-UQ"74!"S?W1EBW/]T=A:_A^*;!Z?C^!OZKX
MDTG1'5=0N6A!QEQ"[I'G@;V4$)D\#<1GM5ZSO(-0LH+RU?S+>>-9(WP1N4C(
M.#R*X32)_$-OKOC2Y6YTVY^S3+B!K>2+>P@0K\^]]H ZC:<GGC.!HZ=XEU37
MK'38=/:PMM2N-+BU"9IXGD0;^ JH&4\D-SNXXX.:%M?^NO\ D-JSM_73_,[&
MBN0UK7]<L-.MI#'86%R;1IYDF5KHM(N,Q(D;*Q]=X! ].:IKJ^LZIXG\+SV]
MW;6UE>Z7)>2VSV[2'/[K(W!UYP^ <<<Y#9X:7]??_D+^OR_S.[HKBM)\3^(M
M8U&SNK707;0KEL>:WDJ43G$F\3EFZ#Y/*4C)YXYN^'/%!UC4KJRN+BWAO(F8
MMISP/#<0H#@$[F/F G^-0%YQSUI6!Z'44=*Q]>UEM,;3[6 (;O4;D6T!D!*(
M=K,68 C. IXR,G R.M<[J&MZRVG^)-%N);%-4L;'[4MS';OY4T+AO^6?F91O
ME8??/8\]*3=HM^OX#2NTOZU.HL=?TW4KZ6RM9W:>)!(5>%T#H> R%@ Z_P"T
MI(K2K"\')>IX2TP7UQ;S.;:(H8(&B"IL& 07;)]\C/H*W:N2Y78B+YE?N%%%
M%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 8-WX4M;B_NKJ&]O;1;T8O8+=U$=S\NW+94E3C
MC*%3P.>*;<^%(YM>L-5AU6_M#8Q&&"V@6#REC.W<N&C+8.U1UXQQBN@HH6@#
M)HS+$4$CQG((9#@C!S7,WW@>WO[:5)-8U-)YKF.XFN8_($DK1G,8(\K;A2!T
M49QR3S74UAZ!K%[J6H:W:WMO;PG3[P01^2[/N0QJX)) YPW(QQ[]:%OH'0I7
M?@:VOK[4[JYU?4W.H11Q2(#"JIY9W1LN(P<J<GDD'/((Q4>I^ ;75HKY+C6=
M6#7\$4%TZ/$#(L>[!P8\ G<<X Z#&*ZN0N(G,:JT@!VAC@$]LG!Q^59'A75K
MK6_#\-]>Q0Q7#22QND))0%)&3@GD_=ZX'T%-?D!5U_P;9>(K"RANK[48;NR.
M8-0M)A#<(2,'#*,<CJ,8JROAQ8M(33H=5U)$"[))GE6:28=][2*V2>F>..F,
M"MJL"SUJ^F\;:CHL]O;I;6]I%<PR1NS.X=F4[L@ <J>!GZ]J6^@>?8V+&R@T
MZPM[*U3R[>WC6*-,YVJHP!^5<Y:^ =-L?$<FKVM_JT*2R&9]/CO66T:0G)<Q
MCJ2><9Q[59O==O;7QQI>B"WMS9WMM-*9MY,@:/&1MQ@#YASD]^!70T[OX@M]
MD\]\8Z&-(T&1=/;5KB&XU&"<6$%NUPD1$ZR2,H1"ZC 8X)QGH,G%;][X2L=5
MDU*<W5]##JUN(KNWC*HK_+M#_,NY6"\8R!Z@UK:O=W5AI-S=V5C]NN(DW);^
M<L7F>HW-P.,]:GM9_M5G#<>6\?FQJ^Q_O+D9P?>DMK?UM_P!WU7]=;G.R>!-
M/>&Z@6^U)(+NR%E<1^>'\Q%!"L6<%MP#'H<'N#5FT\+):>(8]8&K:C))';"U
M\B0Q&,H.>?W>[.[G[WMTXK><L$8H 6QP"< GZUQ'_";:S;:9?ZK?>'K1=/TZ
M>2&Z:UU)I95"'#.J-"@8#K]X'';M1?7^O3]?Q%;2W]?UI^!U&M:1!KFF/8W$
MDT2ETD62$@.CHP96&01D$ \@CVJG<^&(9=0^WV^HW]E<O&L5Q);NG^DHN<!P
MZL,\GE=I&>#6S#,EQ!'-$VZ.10ZGU!&13Z+6T"]R"RLK?3K&"RM(A%;P($C0
M=@*P-1\%6NH6^K6XU/4K6'5)1+<) \> < ';N1L9"KGKTXQDYU==UFWT#29=
M0N59D1E157JSLP51D\#)(Y/2F6-_J3W4=MJ6F1V\CQM()+>Y\Z(8(&W<51MW
M.?NXX/-&[O\ UW#9% ^$(9=8;4;O5+^[WV7V&6WF6'RI8B.=P6,')//!'/MQ
M3?#7@JS\+RR-;:GK%U&1MA@O;UI8K=?[L:]!Z9.3CO72US&D:UK>KV_B"%8-
M/AO["\:VMP7=HCA$8%S@$_>YP!_6FM]/ZU_X(/;^OZZ%[7?#RZ[/I\KZE>VA
ML9Q<1K;"+#.!@%MZ-T!(XQU^F*#>![24:TMSJ6HSIJTBRRJYB'E.N-C(5C!!
M7:N,Y''.><[Z7T#W[V D4W4<2RR(I^ZK$@$_4@_E4&M:Q;:'IS7ET'8;UCCB
MC&7ED8X5%'<DG%+;^OZ[(>K_ *_KN8]WX'MKV>XNI=7U87ES9"REN%E0%XP2
M3E-GEY.XC[O&>,'FG0^#5@O-'N1KFJ,VE0-! K"WPRG .[]UR<!1QC[H[Y)L
M_P!K:S;XEOM#B2W>5(T-M>>;(@9@-TBE%  SSM9_ZUNT_P"OZ^]B_K^ON1RE
MMX#L[>P-J^JZE.ZWC7T%Q(81);SMNW.FV,*<[FX8,/:KESX/TV_TB\T^_:XN
MS>%6N+F1P)79<;6!4 *1@$;0 /3DUOT4@\SC?^%=6IT5-,E\0:_.JW"7#3W-
MTL\K%&#(N70@*" <*!G'.:[!%*1JK.SD  LV,M[G&!^5.HIW"QS]SX1LY[N\
MD2\O8+:^)-[9Q.ODW)(VDME2RD@#.QESWS3AX7">)UUR/5K]'6$6XM56#R1$
M#G9_J]V,\YW9]\<5O44EH#U(YXC-$4$LD1R"'C(R,?4$5S,W@:":6"?^V=42
MX2[%Y),GD!IY0H52X\K;@+QA0HYR<GFMG7=9M] TF74+E69$9455ZL[,%49/
M R2.3TJ.RU'43<);ZGIL=L[1M)YMO<^=$ "!@L51MW.?NXX/-"[_ -=P>QDO
MX%MY9]1F?6-4:2]NH[S=F$>3+'C8R8C[!0,-N''(SS2:CX"L]2@U"&35=4C7
M4)X[BY\MXOG9 H'WHS@'8I./3C R*Z2QO8-1LH;RUD$EO,N^-QT93T(]JL4;
M:?U_6P'-^(?!EGXDALS<7^I6M]9@B+4+&<07 !QNY48P<#(QCTQ5UM 4:7'I
M\.IZA%&J!'D,BRR2CON:16R3R">OIBJOC#7;WP]I=M>6=O;S![R&WE\YV&U9
M'"94 <G)'!(_I70T;IAU16M+&"PTV&PM 88((A%$%.2B@8'7/3WK$T_P7I]G
MX>OM#N+F[U"ROGD>8710$F0EG(,:KC).?;MBNC.<'')[9KE_#NNZUK^CS7 M
M[""[@U*2UE3>[)Y<<FU]IP"6P#@D =,BC=O^NO\ F&R7]=##USPG'X<^'VOV
MUK>>(-8GN[5X(([F66\=,C"HBJ/E7WQZ9/%;^GZ!'=V*7CZCJ;3RVIB@DN(T
M22T1P-RHC1C!X'+JS<<FNFJM_IO]I?\ +O\ 8/*_VO-\S/Y;<?CFB]U9_P!:
M!Z&$/ VF/X-A\,7$]Y<64 40RO(JS1%<%2K(JX((R#BK.D>&%T;2S9PZSK%Q
M*6+&\O+KSYNA &7!7 SP-N,\U'KFNWNE^(O#]A#;V[VNI7#PRRN[;T*QLXVJ
M!C^'J3^%=#3U>O<-M#DM1^'FE:EI\,#WFHV]Y%.UPNI6LXAN?,? =MRJ%&X
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M_I<$K6BO+_@'+#P!$OAZQT0:_JXMK&:.:!L6V]=A!1<^3@@$9Y&3W)'%2/X
MTP^(GUF&_P!6M7E<27-K:WK16]RX &Z1%ZGCGH#W%77UN\'C"PTL6\'V"[L9
M+E9MY,NY"@P5Q@##CG)_#OO4]=_Z[?H'E_7<YJ;P59RF=?[0U%(9;Y+]8DD3
M;%,K!B5.S=@D<AB1Z8J>;PCIMR^KK<-<2VVK*!<VS2?NR0@3<.-P)4+WQP"
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M';:KX!EMK^Q6ZO-.>&X=9UWS?NU"JQSEL." #T(('I7J]%"=OZ]?\_P!J_\
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M-WSCG%<&M[IMIX70W-R]D8/%I:,7$CP*R?: 2?F(60!>3UV]\&O;JCFN(;9
M\\T<2E@H9V"@D]!SWHB[/^N]_P#@ ]5;^MFO^"<'J6F6.C>+S]DT6VEA\3PF
MVEDC@0@2C+,6XY5D+,<]2GO528V.C>/K_3M FMHKY= 9;:Q$^0LH.558\X7@
M D #/4^M>ET5-M+>OZ_E<.M_3]/SL>1K<:&VJ^"+S38_,N_MI&HR10L\PE\A
ME/G@#=OW'^+H/05'I,VF7GC58-5U76;?Q9#=NPMDL8L21AR5Q,(-WD$8X:3&
M.*]@HJKZW]?Q[?UL*VEOZ^9XOJESITWAJSN+N(2>*(=6MCJ02%FN4 N-V"H!
M<QX'RCD8QBO5=?BDNO#&IQ01L\DMG*J( <L2AP,>M:=%3)7@X_UM8I.TE+^M
M[GEFC:?I6I1>%XM-AM9KQ(5M]<15#?N1 0T5P/7?MPK<\<<9J]I'AZS34!X/
MGTBV:PTNY.H1,UNI1XWSY0Z??#%P3U(CY^]7H4JN\+K')Y;E2%<#.T]C@]:Q
MM"L6TA)(=2UO^T]6D02SW$J1Q,R#@8C7A4'/XD\\U;E>3?\ 6]_P)2M%+Y?I
M^.Q9\0VS7F@W=LEX+-Y$VK.R;E4DC[PXRIZ'D<$\BO.[K5;A?!TR1VT$%A97
MD4=Y<^'E6:&2WP0S1(R%1M.-Z88 9&37I_V^S,,,WVN#RIF"Q/Y@Q(3P ISR
M?I5BIMN5<\NT?PUX9\3^"-0BT2XFU:U:3SK1KZQ2*&*=1TB011@*2 &VC!R>
M<DU<FFDUCP7>>*].T9[/5)+584\J!1=+"C#S%0E>OWPHY!VKQ7H!N8%N5MFF
MC$[J76(L-Q4=2!UQ4M-OM_7];"6EOZ_KN>&7-QX3?P1X@OM&\0:DZLB+*DT*
M6,2S;LXQ'%$KR$;LCYL@<]J[72;_ $2'XGO;:9>V/^F:2DKI!,I,\@;(<X.6
M;8<YY)7GI7?5'-/%;023SRI%#&I9Y)&"JH'4DGH*+_U\K"M?^O.YSOB99?[?
M\*RYQ;IJ#B3TR8) N?Q./J:TM?=SIAM(B1+>NMLI!P0&^\1]%W'\*M7MG;ZG
M9&"4DQOM=70\J00593Z@@$&IH$EC@1)I?-D48:3;MW>^*72S'?6Z.=\:0X\-
M06]N DGVVS6!0.A$Z8P!Z ?I6KK]PEIX>U&X=;IDCMI&86G^MQM/W/\ :]*D
MFT\7&HPW4\A=+?YH8<8"N007/J<$@>F35VAZJPT[->1Y!;S:39S:NR76GV=A
M>Z#YP;3YFCC:0,07:52H=\D L IYP:=IVI:5:S^"9],OK :E=Z5+$["=2\["
M(!$<YRV) 0 >A! KUJ66.")I99%CC499W. ![FE1TEC62-E=& 964Y!!Z$&A
MZ_U_B_S_  )M_7W?Y?B>/FYTAT\&WD,1DUD:E#_:S)"S7(E\I]PF &[.XG&1
MP,XXKO\ Q[9I?> ==@>V6X)LI62-DW_,%)4@>H(!%;T]Q!;*K3S1Q*SA%,C!
M06)P ,]R> *EIMW7]>7^147RR3['F(N/";^*?#>G12Z4M@=(NC]F5D2)@YB/
MW. 0V'/3!P3VKGTUFR;P/I7VG4ICX<AO+RVO9;&**Z$"B1O)$B.DB^7L_P!G
MNA%>W44-W_KS;_42Z?UTL>1>9X>M7\$+:ZY=S64VH2F$W\OV??$T3\"(+&-F
M_:%^3O@<'GIOA]>::UWXFT[3;FT-M::FWDV]LZE8HS&GW57HN_?[9S[UV]%.
M_P#7W?Y":_K[_P#,\ZN(=&U+XOWNG75Q'<"32HRUL]T3ME$FX!5W?*VU5; Q
MTS[UEW'DW.E7JR")/'\-VYM\\7)'G?N]O\1@V$9Q\N,Y[UZS14QTM_76_P#P
M/0;UO_72W_!]3S#5[?3+75_'%E>6]HC7^FQ7$<#1#_2'5)-SJN/F(;!)ZC@F
ML[1;SPY>ZVT&H7<#0_\ ".0>?:W\I54=<[LQ2'"X55;H.,-WS7L%%*VEO+_-
M?K^ ?U^7^7XGDN@ZM87^C>$QK]S;76A/IK1R/<L)(#=JR!5E)RNX+G ;OGOB
MLM+V.U\*W N3J-KH::]>#4)(;,2%8F+;"RRQNKQY^]P<''<5[3)<00RQ12S1
MI),2L2,P!<@9( [G )X]*EJF[MO^M[_U\@\OZZ_U_6GE=M+I%KX?T9[;4+V]
M\(W%\[7<U[;B*)4,9V+L$:!8-X'\(7/M6OX#:RC\5>+8-/A,=I]H@> QQ$0E
M/)4?(V-N/0 ],8&*[VBB^O\ 7E_D+I;^NO\ F</JD.F6?Q-AFOH;:.+4=)EM
MF:2,8N7#K^[/'SMMSA>3C-<?HS:5'8>"9;XO!:0R7D$ZW/F10! CL,JV$*X(
M^;&,<9QQ7M%8&KZ%?ZCXBT?4X-1MH(-.=G\A[1I&D+*5;YQ(H'RGCY3@\\]*
M2T:_KN_U!JZ?]=$OT*?@B 0KJ_V(*-$>\W:8$^YY7EIN\O\ V-^[&./3C%96
MN65K'\0;FYM[*R_MF31F:PEE@4NTZLPRIQG(!7..@]J[M;B![B2W6:-IXP&>
M,,"R@YP2.H!P<?2E:XA29(7EC663.Q"P#-CK@=Z)*_\ 7E8I.W]>:9YKI?\
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M74J4"YSD*5X'IQ6EINB7$6J?VMJMW#>:B+?[,DD%N842/=N.%+,<DXR=W88
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M<LARB-]UA&<H<;@V 3P,#)Q8@\66=NVOS3:2UG+9WL=LXRA>ZD<*(S\O'.Y
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M9&C+QY<*SD^AP"< GL*2U7]=E_F'6W];M?H=[6!K/BAM'U:STX:)J5[+>;A
M]LT 5F4%F7]Y*I! &>1CT-9WAV*];Q'<-:W.M)H<,"@1:B&)DN"6W\S*92H&
MT@A@N>F:9XP2]D\4^$UT^XMX+DSW&V2X@:9!^Y.<J'0G_OH4=5_7?_(+Z/\
MKL;FB>(K37'NX(XKBVO+-PES:7*!9(B1D9P2I!'0J2/>M>N"T%CIT/B:Z?\
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MXEMH9)X,^3*\8+1Y&#M/49'I4(T?3%U,ZF-.M!J!78;H0+YI7TWXSC\:NT4
M4Y=)TV?4(]0FT^TDO8AMCN7A4R(/0,1D52'A'PR(9X1X=TGRKA@TR?8H\2$$
MD%AMY()/7UK9HH C2"&.!(4B18D "(% 50.@ [8P*J0:/IVGSW-WI^EV,%Y.
M,R21Q+&TI[;V R>>_-7Z* .2\&^%Y=(AEGU?3M*&I_:9Y([JV8RN(Y)&DV[V
MC5A@MC X.,\=*UYO"WAZYN+BXGT'2Y9KD8GD>SC9I1D'#$C+<@=?05K44,"C
M'HNE0V]K;Q:99)#:/OMHU@4+"W/*#&%/)Y'K5F"V@MD9+>&.)6=G81J%!8G)
M)QW)Y)J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**YV_P#'&A:9.\5T]^I686^]-,N9$:0G 176,JQSQ@$\T1>-M(GU"SL8TU'S
MKJ<P*)M/FA"N$WX;S%7'R\CU[=#0M=@.BHHHH **3<N[;D;L9QGG%+0 44@9
M6S@@X.#@]#69K^O6GAS3#?WL=P\(=4Q!"9#DG SCA1GN2![T :E%%% !1110
M 454U348-(TRYU"Y$I@MT,CB*-I&P.N%49-.TZ^BU33+6_@#B&YA69 XPP5@
M",^_- %FBBB@ HHJIJ&H1:=;K)(KR.[B.*&/&^5ST5<D#/!ZD#U(% %NBJ>F
M7YU*R6X:SNK-MQ5H+J,*ZD'!Z$@CT()![&HM=UNU\/:3+J5XEP\$6-P@B,C<
M^PZ#W. .YH T:*0'(!]:6@ HHHH **** "BLG5-?CTV8PQV-[?S(JR31V2*[
MPQL2 Y4L"1D'A0S'!P*U@<@'U]: "BBB@ HJM?W?V&S>Y^SW%QLQ^ZMTWNV2
M!P/QS]*L;E+;<C=C..^* %HJ&[NDLK.:ZD65DB0NRQ1M(Y '95!)/L*KZ/JM
MOKFCVNJ6@D%O=1B2/S%PVT],CM0!>HHI%96&5(.#C@]Z %HHK+\0:]:>&M&G
MU6^2X>WAQN$$1D;GV'0>YP!ZT :E%(K!T5AT(S2T %%%9NCZW:ZV+PVJ7"?9
M+AK:03Q&,[P 3@'G'S#J!0!I4566\W:E)9?9K@>7$LOGE/W39)&T-W88R1Z$
M4S5=3@T;2[C4;E9F@MTWN(8FD;'LJC/^%#=E=C2;=BY14-K<)=VD-S&&"31K
M(H;J 1D9J5F51EB ,@<GO0U;0E.ZNA:*S=.UNUU2_P!0LX$N%EL)!%-YT1C!
M)&1MSR1COT/;-:5 PHHK(G\3:5;WK6GG332HVR7[-:RS+"< XD9%*IP0?F(H
M UZ*AM+RWO[5+JTF2>"3)22,Y5AG&0>XJ:@ HHHH **** "BFEU&1G+ 9VCK
MBH;"[^WV$%W]GGM_-0/Y-PFR1,]F'8T 6**** "BBLVRUNUO]7U#3(4N%GL-
MGFF6(HIWYQM)^\/E/(X]Z -*BBLFY\16=KK\6BR1W1NI;=[E2L#%"BXR V/F
M;D<#)Y'J* -:BLW0=;M?$6DIJ5FDZ0.[H%GCV/E&*G*GD<@\'GUQ19:W:W^K
MZAID*7"SV&SS3+$44[\XVD_>'RGD<>].VM@-*BBBD 4444 %%%% !16=K>M6
MF@Z3=:E=B9X+9=\BP1&1P/7 [>YX'4U?BD$L22+D!U##/O0 ZBBH+VY^Q6,]
MUY$T_DQL_E0)ND? SA1W)["@-R>BF)*KJA(*,Z[@C<,/P_&GT %%(S!5+,0
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M1GW+(H*IO5EZN2<@^V*Y^7Q/XA5K"U-W$KQZ_P#V5<S?9AFX3;N5UYPIQP<
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M@BXO45;J*>:VD9%*K(T<C)O4'H#MSCM6[45M;0V=M';V\2Q0QC"HHP *EIL
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M\U4%O,(]A,@8YVD*OW0QSGCO45EX?F\*W%E/IEE)?HFG1:?-''(JO^[/R/\
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M"L=#=R7:PLF5DC)]655!;UP/SZULT/1@@HHHI#"BBB@ HHHH **** "BBB@
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MNXTQ(L>6]F(\J!VPZLI'U%5]1T5I]'GM+:]OH+B9UD:[MY524L".22,8X (
MQC( J[<:II]F^RYO[6!L [99E4X) !Y/<D#ZD5:9E1"[,%4#)). !1Y@C)U#
M0(K^X%P+RZM9FC$,[VS*IGC&?D;*G R3@KAADX(S2W7A^VE%J;2>?3I+6/R8
MY+3:"(N,QX96&W@=LCL16=XEUV0>%SJGA_4[-PLL694"SJZ,X4A2&P#SUYZ=
M*W;;4K"\:X6UO;:=K9MDXBE5C$WHV#\I]C1_7]?>!4F\/V4FEVUC 9;46A#6
MTT)'F0L 1N!8$$D$YW @Y.<YJM/X>V6$<%G?7\,_VI;F6YCE4/,XZ^;Q@J0
M"H X  P!QH6>MZ3J,$T]EJ=E<PP,5ED@N$=8SZ,0>#]:1M<TA+::Y;5+$6\
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M'U&VUZ>*Z+EI+:]\+JK>66R8FN\#>!GJK'V!Z5Z7I&I+JFGB?9Y<BN\4T?\
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M%)8?;[*U\(:E/IVH-96%DUK=6XM7:6&4HBB3R@-[ ;77(!/S9&0<UZ+11?\
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MBMV2SF:%U6Y_?JRYR7B*C:"0,'<<@@\5FZ=XLC?0TN+311:W5UJ4ME%9O(J
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M,$%GK<1:W?[1ND1PA?:R!<;=H/S!LY["G0^+YSXBL]+N=-CMUOC*+;==?O\
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M[=]Z;RC9(;:I;/J0#6[KGB&;2-5TBPBTV2Y.I2M"DWFJB1L$+ 'JW(4]!^N
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@4O^!^O^13_S/7:*\:,ND6]MX<NI]>A(NM=9DB76FEBB@^?;'@2%/E_=@[>
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M;EBPI;+GL#C'U(JS0 4444 %%%% !1110 4444 %%%5;J]6V$!6">X$TPBS
MF_9G/S-Z*,<F@"U16/JWB"/2W:..POM0FC02316**[Q1DD!BI8$Y*GA<L<'
MJ_I]Y_:&G6]Y]GN+;SD#^3<Q[)$SV9>Q]J +-%%(652 2!DX&3U- "T444 %
M%%07EW!86<MW<R".")2[L>P% $]%9^F:F^H-<)+IM]8O"P7;=(H#@]&5E9E(
M_'([@5H4 %%92^(+-_$S^'PEQ]L2V^TEFB(CV9 X8_>.3VST.<5JT>8!14%[
M<_8K&>Z\B:?R8V?RH$W2/@9PH[D]A4L;^9&K[67< =K#!'L: '4444 %%(S*
MHRQ &0.3WJO'>>9J$]I]FN%\E$?SF3$;[L\*W<C'/ID4 6:*** "BBB@ HHJ
MGJ.I1Z=$A:.2::5MD%O$5WS/@G:NX@9P">2!QUH N454TV^_M&PCNC:W-J7R
M#!=1[)$(."".1VZ@D'J"15N@ HHHH **** "BBB@ HJ*XF^SVTL_ER2^6A?R
MXEW,V!G '<TMO-]HMHIO+DC\Q VR1<,N1G!'8T 24444 %%%-=UC1G=@J*,D
MDX % #J*RM,UQ=3N6C33[Z&(QK-#<RQKY4Z'H596./HP5O:M6@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM90PRW4UTZK@S3! [^YV*J_D!5?7;N2QT2[N8;B"WE1/DDN 2BD\#( )/7@
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M6!'M)<XX9P-R2$Y'S$ \8!/7/T'5?%>O7-KK-O<:8FDRR,DMN]WN,8R1C8(
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M*SCX5TEM+N-/:.Z:&X 69VO9S-(HZ*9=^\CDC&[&"1TJ&KQ:_K;]-RT[-/\
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M>03R9\HO!(L<I R0DA4(Y !.%)/!H_X2#2V@NI&NFB@MPQDGEC>./"CYF5V
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M(,XSD#C.:MV<B=EI_6__  #L]/\ %>AZK<1PV&H)<M([QHT2LR%D +#?C;D
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MZZ'16>KV=_-)%;O(Q1BNYH756QUVL0 X]U)%37M];:?;&>ZDV1@A1P6+$\
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M<;K3,]OAU\M(\G][QRA//.".^0"R_K_MW_-_<']?G_DOO.XU/Q%IFD/LO)Y
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M  K_ $_/7?/G_O\ /77TVK,2_K\0HHHI#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,:X\/\
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MD/D;@6 5MO[K RH Y!]L'FI=0\%6&J>&[31;J[OB+/:;:\CE$=Q"R@A65E4
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MULZG"@D_<=60]3R5)],54D\)V3V$5N+B[29+M;TW:NOFO,/XFRI4Y'&,8QP
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M<JN2R%NB\'C)]AG%=G152?,V^]_QO_F)*R2/+;.*9[C0;N\T>_6SAMKNWN+
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MT>3<PO%;QQ.EQ;O"ZLJ@$;7 /7OC!K9HHJI.[;)BN5)!1112&%%%% !1110
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M'IS:_P!:_P"7XEC3?%DUY>Z-'/IJV]OJ]H9[>07&]U8*&*LNT #!X()SW J
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MQJNFZ3;7OB.&\FL[H74TUWIRL)V ("A$=%5<%N.2>.?4[/S7]?F'=>OZ_P#
M.CTJ^O[\SRW-C!;VA;_19$N&=YD[,R%%V9&.,GK5*^U^\^WW=GH^G17\MBJ-
M="2Y\G&X$A4^5MSX .#M'(YI_AS1;[0HY[234H[G3@Y-G!]G*/;)GA-Y<[E
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M](9F:QN/*@^V;_W8380N\C(91UX!'-:>K6&@V=WX0U='5+>[NO\ 2Y!<N8)
M+9P6==VS^ 98CL<GK32O_7K_ )!_7Y?YGJ-%>6LK6=I?S:0@/A,ZK;/MMLF/
M[/L'G&(+QY6_;G;P1O[9K/\ $?\ 9=MH/BF;0KNVM_#3Z4K0M97'EP?;-S8$
M10A<D ;E'!. 1R:0TKNQ[%5>:^MX+RVM)) )[DMY:=R%&2?H/ZBO/;^V\.G^
MQ;?R+.5=5B:5FNW#V<TBHBY*G(DEX&U00>&.<CG.T:'2KI? MSJMO;7,D4=Q
M;&:X@W'S5Y1 6R<@@[1DG(XYIV]ZWG_G_D3?2_E_D>I6WV[[3=_:OL_D;Q]F
M\K=NV;1G?GC.[/3MBK->3B^ _P"$Y@T2]:ZDBU*"26*&Y::808C\_9R6_P">
M@P.AR!C&*BU]M%CM=6O/#=W:6^A2:1.;U[*X\F$765\GE" )2=P(ZD<-GBD]
MK^7Z7_X'J7RWE;S_ %2_6YZ[5:Z^W>;:_9/L_E^;_I/G;L^7M/W,?Q;MO7C&
M:\[TG4-$M_&GA3[#?6*RWVD2+.8YU+7!'E^7N.<L00X7.>C =ZU?'-W86?B7
MP?+<WZ6\QU$J$DN=BLAC?)*9P?FV#)'!('>J<;-+SM^+1"=U?RO^%SN**\JT
MJ+P[?ZCXV>[OXY([*^::*8Z@P:#]P%<AP^5 9F'7 Z=A69!]D@^%_A_65DN/
ML\D44&M75FJSRB$*Y^='5U8!F&X%2<&IZ7]/Q*MK;U_ ]HHKRVRL='NO!!ET
M+7A-IGVO[0IUNT6.SD 0AH]@CC"Q_P 60N PSR<TEU>V%Y?>$M3U2".RMFEO
M(IT:Y9[1D6-_G&<*8SU#$#Y3CI3MK8F^ESU.BO'=39=.TJYD\RZ@\%/J;;7L
MH(YE2W, Y$;HZF#S-W&TCH1QBK/VW1M)\*Z7>03:EJO@][N1KQ[BTVJD9C(7
M]TL:?N0W8)C-+^O^'&_Z_P" >HW=];V0A\^0*9I5AC'=G;H!^I^@-)']N_M"
M?S?L_P!BV)Y.W=YF[G=N[8^[C'O7F]_;>$[_ ,.Z%=VMNEQH7]L(R-?6I$44
M;@@JBR*-L6[: ,8Z8[5;L+;P_J_C[Q7HDLEM=0W-E:[[267S"I'F;@$8G9MR
MAP -I(X&:+/7OK^2?ZAI^7YM'HU%><Z'9-=Z+/91:+:QZGX:BEL[.5X%P9]O
MRNAQQE=C''=_:J/P\FT"_P!?^T6.JZT^LQPD:A9W-C' %8@9\]T@3>P(X)8G
MK[T[7=E_7]?@+979ZI5#6]431=&NM1=#(($W! <;CG 'YD5SOB^:"'6](_MM
M83X;=)ENC< & 3$+Y?FY^7;C?C=QG'?%<=XAATR#P#KL=\;$Z.-10Z']J96&
MSY-WE%OX<^9C'\.<?+26O]>:7ZC>G]>3_P M3U'3O[6C^T_VM+8R(&W0R6T;
MQ_+CD.K,V"/4-SZ"LR\\2S"]\.MI\=M/INK3M$T[.=X'ELZE5 P0=AY)].#V
MOVUIH]QX:^S:;;V$FDRPL(XK9$,#J<Y "_*0>:\QTFX\.V7A_P"']DLMA:22
M7@-S&I6(O(()$??C&6W%5.>Y /I5)7E;T_4%\-_7\CV.BO%IM5L;73M<M+&\
MV:%9ZZ1>1:8L4QM[5H1R(BKKY?FYW#:1][TKN_AXFCC09)=!U&^OM.EE+QO<
MVZP(IP 5B01Q@+QGA<9)]Z25U<'H['745Y7<V_AY=;\96>K,LDK31O9)<2L\
MOFF#=^XW$D/N)P$Y&>,"FZ5;VM_X^CTO7+F*YOVT"W^U6[W1;%R&#'"[OE;"
MAL+CIGWI+6W]=&_T_():7_KM_G^9ZM17DR^5<:3"8Q"GQ AO%$@SBY(\_P";
M/\1@V$_[(&/2MB[TBQT?Q?<:;;Z%;/:^)XOWKI;KM1T_UF_C&TH=PS_$#ZT)
M7_KRO_7F@>G]>=OZ\CN/]-_M+_EW^P>5_M>;YF?RVX_'-27'G_9I?LWE_:-A
M\OS<[=V.,XYQGTK@/^)/8?$NZTRSOXK-CH?EK!%/DP$-QY<6<*0@#84#(&<5
MGK<06?A;Q'I-Z^E+%:63,=3TFX,$;29.%E (V2EB"1N.[//7%3)^[?R?YL<5
M[UO-?C8]0M_.^S1?:?+\_8/,\O.W=CG&><9J2O+K.]T:[.DKXCDL)_#TVC0+
M92W+*UM]H!(D!8_*).%QSG@X[U4MWBM]5\'6VN7^V1KF\CAANKM@TEL=XAWH
MS<DC:,D9.<'J16C7O6_KK_E]S(3]U/R_1?Y_>>N45Y-ISZ=J7AG5;/3M7T:.
MTT_69G2WN2LEF8,$B-P#A8_O$'H"O .,5W_A;4'U+P]%<FS2U8LZ[(Y"\388
MC=&V!E#U!P.#4]+E>1M5S^H:GJEQJ]QI>B&R2ZM(8KB7[;&[)*KEP$!5@4/R
M'YL-U'RFN&7RKG283&(4^($-XOF<XN2//^;/\1@V$_[(&/2M+14\*M\7]<\E
M=&.H"" Q;!%YHF_>^:5QSOQC=CGIFG%7?]=DP>B?]=;'6ZOKDEC?66F6=M%<
MZG>J[Q133F&,*F-Q+A6/\0P I)SV&35[3[R>[$ZW%F]K+#)Y; N&5_E!W*1U
M7G'(!X/ K"\86V@ZB(+/7?,MD1&N(M11VB^RLI SYHXC)SW.#@]:Y:6_UM/!
MFI#^U+O5M.M;R$1ZI:1(T\]H=I<K\I20KG!.TA@#2OI_7<+'J55[Z^M].MOM
M%U((X]ZH"3U9F"J![DD"O*M.N=(M?!UWJ7A6\U75M)^UP->1+9K;HL2M^\$4
M<<40/'WMH.0*741X,UCP5<WVA6Z2Z.NHVDLB269CMH,2J)&170!1MW;R..N>
M].VMO3] 7]?B>I_Z;_:7_+O]@\K_ &O-\S/Y;<?CFK->;2W%E:_$"]M- N[9
M+Y] *VEKY_RK(#E%6,G"#:%.% XY]ZKZ>=,FE\/7.A-%%K*R(NM@-MG$7E-Y
MGVG^+((&"_.>E):_UYO_ "U[!_7X)_KIW/4:ANI988"T$'G2DX1-VT9]SS@>
M^#]#TKQ>TU+0+;PCIVH)JEF;JV\2&.*[ENQ)(D1N3N =F)VF+!//*\GUKUO7
M/$&F>'-&EU75+I(+2,9WGG<3T"CN3V IM65_ZV3_ %#[5OZW:_0@T;6[B^O[
MW3=0L5L]0LU1Y$BF\Z)T?.UE<JI/W6!!4$$?C3;;Q-!=^)[S188)&^RVPG:<
M=&.\J54=\%3D^O'8USF@>+=-\5PZJ_A2]BOM8D17F>1)8(XESA4WM&3P-Q!"
MGG)(&<5%I4FJ6/Q(E2[T[3+.VAT:,2F+47D$<0D<A@6A7)SU!QQSD]*.JOV_
M1AT=OZU1THU^]MM<M+#4M+2WAOV9+2>*Y\TEU4L5D7:-AP#C!8<=:H^*/%-_
MI>B:SJ6DVUK/'I2'S3<.RAW !8+M'\((^IXXP365IWQ(\'^(?%EM:VNJ?:;Q
M)&AL[>.WD.6/#2;BNW&T''/3/K@5Y[2\N/@_XELA%)-?&2_5HT!9V8S.1P.2
M2"#^(HZ7_K=?IN-?%;^MF>A!YY=/62'RQ.\89=X.W<1WQSBJ"^(+==&GOYT*
M/;N89H 06$P(78.F221CIG<#WKFM'CTVX\6:;>^&VMVB^S2IJTEJV4=@%""0
MC@R@YZ_,!G-4]0CF_MC4KA'_ -"'B2R,GIQ'&I_\>*?B*=M;?UO;]25\-^W^
M7_ .ONKW78+56@TNVNIU&^93<F%0.?E0[&WL/?:#ZCI44'B1+C3=-UA(\:5>
MHF6<;9(6<@+N'0C) /H>>1TS?&7C_P .^%Y(]-U/6$LKJY0G*QO*T2?WL*#@
M^F>_TJ'5KS3M3^$UW+H9864EF8K(E&3=SM3 .#R<8SR:E:Z^:&^W]?U^AVU%
M8'BXZDG@V^.G"1[P1#(AR'*Y&_9CG=MW8QWQ7-68T"3Q'!<^'SIPT.2SN/[;
M6/:(.B[?-'W1)RV=W.,YH[_U_2#HG_73\=3I-+U35=8NUO;4V0T@336\D4D;
MB<&-F3>'!*D%E^Z5'!SN[5-K6MO::9J\FFK!<7NG0>:\4LA5!P6P2 3G:,XQ
MW'3.:YGX3)X?_P"$=N'TA=,^T_:IQ.UH(]^SSI/+#;><;?NY[=*H:HN@:1JG
MCRYN8;"TO'LU9)GC5'*O"02&QG#.,>[8'6E4T5EV_1,J&LOG;\;'HVG7#W>F
M6ES(%#S0I(P7H"0"<59KRRTU#2K?Q1X<_L>^L%O;[0YE8I.I-PX$?E;^<M@A
MP,^C =#4/@"71+[Q%#(FJZW_ ,))#'C4;.>QBB^;;@^=(D"[P#RNYR>E:->\
MTO/\V9I^ZF_+\D=OXEU[4]%N=,BL=,M+Q;ZX%L&GO6@*.02.!$^5PIYZ^U1K
MXHO-/U6ST_Q!I4=C]ND\JVNK:Z^T0-)C(1F*(RL><?+@XZUG>/\ 5],T[4/#
M"WVHVEJRZJDQ$\ZH0@1P6Y/W02!GIS57Q/?6GC:;1])\/W$=^L>HQ7=S>6Q$
MD-ND1W',@^7>> %!SSTQ41UMZ_AH5+]/\_\ @'12^(+N[U"[L="T^*]ELW$=
MS-<7)@A1R,[ P1V9@""0%P,]<\4]_$D=CIVHWFKVLEBM@0),D2"3(!!CQ]X$
MG:. 2>,"N9\-ZA!X,O\ 7-+\17"V44^HRWMI?7+;(9TE.=OF'Y0ZD$%20>A%
M8-]HESKFG^(;S2Y]2U*WMM2MKFP22^FGBN(4$<CK%O8JV3NP1WXSBA=/E^E_
MNN_N&^O]7W_/3[SOVUK6X;62^N?#ZK:! ZI'>![D>N^/8%&.^UV/' /2HV\0
M:Q_PF?\ 82:18F#R!<_:CJ#AO*W;?N>3][/;=CWJUI_BW0]5PEEJ$,UUM!:S
M5L7">S1GYE]\@8KG+KQ/H%C\59?MFN:;;^5I7DR>==QIMD\W.TY/#8YQUI_:
M2]?R)Z/^NIWU%8EIXLT:_P R6E]#<6QN%M([B!O,228C.T%<C@8YZ<^U;=(8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !6!KV@WVK:OHUY;:C;6T>FW!N#'):-*9&*LA&X2+@;6/8\X/M6_11UN 44
M44 %%%% !1110 4444 %%%% !6!J^A7^H^(M'U.#4;:"#3G9_(>T:1I"RE6^
M<2*!\IX^4X///2M^BCK<.E@HHHH **** "BBB@ HHHH **** "BBB@# T70K
M_3=?UC4KG4;:XCU&17$,=HT9C*J%7YC(V?E'/ YYXZ5OT44>0>84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4HM.%OJ<MY!(46?
MF>+&5=@  X]&P #Z@#ZU=HH CG61X'6&01R$85RN[:?7'>JB:/9KI+Z:R-)!
M*&\TL?F=F.68D=R3G(Z=L5?HH @M(9;>U2*:X:X=./-90&8=LXXSCJ1C/H*A
MN]/%[=0//)NMX6$BP;>&D!R&8]\=0/7GGC%VB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>ex3-14_002.jpg
<TEXT>
begin 644 ex3-14_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4& XT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,\JQ(Y(Z@DXYHOI<?6Q?HJK)J=A%'#))?6R),"T3-*H#@#<2ISSP">.PJ/\
MMO2CI8U3^T[+^SR,B[^T+Y77'W\XZ^] %ZBF1313Q++#(DD;=&1@0?Q%/H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .)^)$KFRTB&*SO[F1=3M[AA:V4TX6-'!8DHI
M P.QY/;-.\73K<:MX3(L+^XB6_%Q(4L)I%C3RG4%\*=IW,O!P1U[&NTHH6GW
MW$U?[K'D5W!J5S;^(7L]*U::.+7DOFM%BGLWNH-BJ?*D(4[@P+?*<G;[\]CX
M%BLFM;R^L]#UK2OM4BF4:S-(\\K 8W$.[D # R2,^G KK**(^ZK?ULE^@-7=
MSSVYDL-*^+5_<OI\DAGT>+S#:V;3.S&5ERP123D #)XP.2!532-,U/PQ-H%[
MJ%E=3:?#;W,306T+3O9-+*'3]VF20$^0E0<8]#791^&TC\6R^(?[3OFFD@%N
M;9A%Y(C!) &$W=23G=GGTXK;I15DOZZO_,)*[?\ 71+]#SN'0;ZW\+ZI=V]K
M(DD6J-J>F6@BPZ*I!V!>Q<!^.OS]CQ5JVT_4T\5;C:S"QUM%N[LE<"WDB881
MNP+)Y:D=]C&NZHII6?\ 7:WZ+[@:NOZ[W_5_>>3S:>Z^*;_3-;\,>(]2-W?F
MYMKRSO)ELV7(*&51*J(4P!T).W.#6AX;TJREU?QFDVBW45O->>?;DV#PEOW0
M1FB9E W;B^"#DY)Z'-=]J.I66D6$M]J%S';6L(S)+(V%7M4UO/'=6T5Q"VZ*
M5 Z-@C*D9!YI)*UO*WWV_1#>]_._]?><-HM]J?AX7Z7,>H:QIEC JPSC3&BN
M\AL>4 0/. !SN4 #'<UW"/%=VJN 'AF0'##JI'<'VI9H4GB:*0$HW4!B,_EV
MJCJ>L:;IDEK9W=^EK<7S^1:J,%W?I\HP>F1U&!WH;NM=?Z_427+MM_PQYCHU
MI'?^";CP]INFS)='6II()([5EAA"71._S -@VJI 7.[C &*O:+HAO=,\:VEE
MI<MG=37D\VG/<:>\ &^((&0LJXR=XXYY/K7<^&_#L?AJQFM(;^\O$EG><FZ\
MO*LY+-C8B\$DGG^5;-%M/56_"*_3Y@M[]G?\6_U/-?"#V?VIM0G\)^*-.OK"
MU:*6;4)[BX0+QE(5,CF0$@?=7M^>7#%J+_#G1O*TC69FTN\:6]L(XY[.XD0F
M3!C;Y&8C<K84\]*]>HIO5W]/SN)12T_K:QX]=6.GNF@:A8^%/$%J[:REW,;^
MWGN;@(%P[L<R% <(,$@MCIQ6IXLLCI?B=+B3P]KFHZ-<VBV\<>@S2Q- ^YBP
M=(W0%6W Y/0@UZ;12LOZ]$OT';K_ %O<\OTNRL=(\:7+P>'M0L[1-"2%/] F
MFPZECL\P*V]@A4<,W]T$XJCHUWJWA_1_"^IR^&]6U"UM=.>QN+6&S;[3;R%E
M.X1N%)4@8R.,"O7J*?\ 7XR_^286_KY)?H>5ZW:OIPT348O"VOMHL=M+#_9^
MF7,D=W:,[A@2L4@+ XP5W$# J]<:4;#1],O=#CU?1;BVA=8+6:UDOPZR-DQS
M*"S D@'(;CN>,#O=0U"UTNRDO+V7RK>/&Y]I;&2 . ">I%6:5M&E_7]>?W!;
M74HZ=)=/HEK)=6:6]V;=3):QL-J/MY0'T!XKSC2X+G^T?#MY<Z1?QVD$-U!-
M8KISE+4,H^0E@7DZ'YLE6[#G%>JT425Y7_KK_F%O=4?ZZ?Y'C^G)]C\(^&H(
M]&U2&6VUSSY(TTBX#1QAW^8@1\#:RCZ<=CA^KVVI'P1>Z,^AZC<ZPFJ+=.Z6
MK,LZFX#"19,;2=F!C(('4 #->NUE'Q'I2ZQ'I1N6%W*66,&%_+=E&2HDQL+
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M!]MVS=0DH8*I'(VD$D^@K&M/$&JZ*OB?4-0N[:\1-56TMX5MVB(D81*F6+L
M@W#(QG@G/.*ZW5?#\6LYBNKV[^R.X>6U4IY<F,8!)4L!D _*PY^M5Y?!VF7
MU:.=[F6WU-_-FMS+A$?"C>F "&^13G)P1QC)I*ZW_K5/\KK[AR3;T_K1_P#
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MY/"LH)QUY%5;SQEK\%GXGO/L^F1QZ%=!#'B20SQ;%;&[*[6PW7! Z8/6M=O
M=B8I85U+5$@>\2^6,3*?+F5@VX,5+')'(8GVQ4,WP^MY[/6K5]=U<Q:Q('N>
M8,\ +A3Y7'R@#G)X]<FE&Z6O]?#_ /;??]SUO_7G_P #[B277]9U*XU(:!%9
M2?V9(D<MM<*WF7+%%<JK[E$?#  D-DYZ54U/Q3XCEU2]MO#NAF]&GR+%,&,6
M)'**VW<TZ&/ 8<['!J:Y^'.GW&JPZFNK:W;781$N7L[S[.+S:, RA  3C^[M
MJ74OA]IFH:\FKPW^K:;/M5)DTZ]:!+A5X42 <G XX(IK=?U_2\MQ:VU_K_@^
M9T=Q]LDTYS:&*"\:/,?GH9$1\=&"L,CZ$5Q<'B[6/*\-W%U-IRQ7DS6VI*MJ
M^890Q3Y6\W"C?M3D$Y.?8=VB+&BH@ 50  .PK G\&Z7<6NKV[FX":I*)9"KC
M,3#!!CX^7YAN[\DFC[5^G_!_R?X(;3Y;=?\ @?Y_FS-F\1ZY9WFB"5=.GL]5
MU![=9$1XW2+#%,+N8,2%R6R.H^6N?U&36)O#/CUK^_MKB&.X>*-$MF1EPD>/
MF+D;<8&,=<G/.*[75O"T.JRZ2XU"]LUTN02P1VPBVE@-HW;T8]"1@$=?IBKJ
M/@>TU"'58!JFIVL.IR"6XC@>/&< '&Y&QG:N>O3C&3E6_KYQM^3!W?\ 7^+_
M #1)INL:D/%DNB7ZVC1FQ6\@>!64H-VTHQ).[U# +]*Z2N:D\)D:J^JG6]7D
MN?L)L]J&!<ICJ"(P0V[YLY S[<5L:3:SV.DVUK<7,MS+$@5IIF#.WH6( R<=
M3@9I]/Z[O]+"2:T_K9?K<Y&X\9:HNAS^*($LFT2WG>.2V9&\\QI(4:02!MH/
M!.S9T[YJYIFOZ]JOB;5=/BATV*WTZY@#%C([20NI;(/&'QMXP1U'/6K?_"%V
M FN%6[O4T^XF\^;30Z?9WDW;BWW=XR1DJ&"GN.:L:5X:CTK7=2U9-1O9Y=18
M--%-Y6P;1A=NU 1@<=3[Y/-*/2_]:+];_)A*_3^M7^EOF.\2:G=Z9:6[VKVD
M(EF\N2YNOF2$;20=@93(20%"J0><]JYE/'=\?"=IJEQ%%;DWTMK=7?V.62*!
M8V9?,:+(=0=HZGY<\DXP>LU?0XM6GL;@W5S:W%E*989;<KD9!5@0ZL"""1TS
MZ$54L?"L6F6EQ;V&JZE!YTTLV\2(Y1G8L<!D*]2>H)]2:%?7^NO^13U_KU_X
M!J:9>)?Z;#=QW%O<1RKN26V;,;KG@@_2N9T3QG]NN;^.]N+:">T62273GMWB
MN847H?F8B0'!^90!]:Z/2-)M=$TU+&S5A$K,Y+'EF9BS,<<9))/  JHOAR!M
M4AOKJ\NKQK>-HX(Y]A6(,,,054,Q(X^8FB5[OE["6RN86B^(/%NKW,$S:&+?
M3+R R1W#B$BW)7*DE;AC*"?1$-7/AY+J=SX0M;G4[R&YDF+NK1P&,C+MG=EV
MR<Y/ 'IBDT#P!IOAS47N;+4-7:WY\G3YKUGMH,_W(_\ '..U;&AZ)!H%A]BM
MKBYE@#,8UG<'RU))VC ' )/7)]2<"GI?3M^O]:BL^O\ 6G]:''75[J6F_$O6
M;Z>]M/L%GH\<\D8LW+F$/(=H/F8#9!^;&#P-O>M!?$VLV;Z)=Z@FGR6&LND4
M4<"NLEM(Z%D#.6(D!Q@D*N/0UIGPG&WB6YUM]6U"1KF$6\MJRP&%HAG"?ZO=
MC+$YW9]\4VQ\'6EB;9!?W\]O9G=96\[HZ6IVE04.S<V 2!O+8[4E=)+^MW?\
MU9]/S<M6[?UHK?K?N<I<^)O%FK>!-9U6%]*L!:)>0R;$DE=7B. 4)(!R W)'
M'!QVJ\R:J/%7AA#<V;WQTFZ_?_9V6->8<'R]Y)QQQO&?4=*V]-\%V6G^'M1T
M1[Z^O+2_:5I3<&,,#)DN041<9))]NU(G@X1ZK8:B->U9IK*V:VC#& JRMC<2
M/*ZG:IXP..G7+6GX?^DM/\6#NU]_YJWX(M^$M:GU_P /17MU'&EP))891%D(
M6C=D)4$D@';G!)ZUMUC^&_#T?AK37L8;^[NXVE>8-=>7N4N2S8V(O!))Y]?2
MMBF_Z_#];@@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .<\/:]?:KKWB'3[RWMX1IEPD
M41A=FWJR;@6) YP1P!QSR>M='7E%_;:*/$7C.#7H8_M-S)%+IB2*?-E80 ;K
M<=2P;C*<BLW7Y88+ZPL_'^I:C9K)I]NMM-!9QW,;7 !$F"T,C++D]5P<8]*F
M+NH_+\G^.FW_  PGI)_/]/PU/2)-;OX_'T&AM!;"QFL)+E90S&4LK*N",  ?
M-[Y]JZ&O,-0OEM_&>FV6GZB'U1?#MQ';"]D7SWE)0Q[UX.X[<XP.AXJ'34TN
M[F\-2:"D0UOS4CUN/_EL8O+;S!= \DY P7[XQ5+HEY_FU^%M>WYKFW;\OR3_
M !Z=SU6BO)=0\.6L-KJN@6&CVAFTBZ.L60-NI'EG#A <<;G5D_W5^E=YX8BM
M+FWFUZ&SBAFU9A.SB,*[1@ )N.,GY1GG^\:%JK_U_5[KY#;L[?U_5K/YFI%]
MO_M*X\W[-]AV)Y&S=YN_G=N[8^[C'O5JO'_$5_H]OK7Q#A.KQQ2MI43@?V@5
M<2@2?*OS9'S%!M''S 8YYO:-?Z);>,_"'V&^L5EO='D6<QSJ6G($>P,<Y8Y#
MA<^A Z&E#WK?UTD_T_().U_Z_E_S_ ](NM0MK2YM+:5\37<ACA7NQ"EC^&%/
MZ5F>&M8OM5?5TOX+:&2ROFMD6!F8%0JD$D@9/S>@_J<3QO9:3)XD\+76JV5K
M-"MU+&TD\ <#,3%5Y!ZL!@>N,<UQNKZEX>FT/Q9J"ZA8->6^M(]K-]H7=$W[
MOYDYX)VN,CJ%/4"A/OY_G%?J*3:T7]:2?Z'L$7V_^TKCS?LWV'8GD;-WF[^=
MV[MC[N,>]6J\NM[K2M0\9>,;6QUZ&-KS3K<K,ESYQ0G?DJ-QPHW+D+@#=VSF
MM[P%>;Q?:?\ 8]+46>Q!=Z0W^BS?>X"]$<$'<HSC(YIQU^Z_YAS:_/\ 1'2:
MSJ:Z/I%Q?&)IFC7]W"IPTKDX5![EB!^-)H6KP:]H5EJMN,1W42R!<Y*D]5/N
M#D?A7/:MJBZWXLAT+1]8TV*^TT?:YX[B,SY8@JJ[%D0Y&2QYX^7CD5S>BZQI
MNAR>*/!VLZYIZR)YEU$T$AM5"R*6=%^<E"K9.-V<'-1S63?E=?+?^O(KJEYV
M?SV_KS/2]0U"VTRT-S=R"./<J GNS$*H'N20*$_M#^U)=_V;^SO)7R\;O-\S
M)W9[;<;<=\YKQV'2-!O?@]I.LS6UK=7"_8TN[B3$NU5G!;?G(&%=LD\X)!XK
M4FN;:W\7^)[3PO<P_;FT!/L=K%/]V0;\+&A/R878=J@#D''-7+W6T^E_P5Q)
M\R3[V_\ 2K'J%_)<0V%Q+:1Q27"1LT:2N50L!P"0"0/P-9WA/5Y]?\*:;JUS
M'''-=0B1TCSM4GL,\UQOA?6_!EXUUJ&CM/8W,%DR:G&\#P1HW!+3LRA6D!&-
MVXGDY]N8&J6"^ /"#ZG?SQ^&_LKPWDUI!%=)'/E=HE1XY%QC=_#D'%)Z-_+\
MW^=OR!.Z3]?R7XJY[BVX*=H!;' )P":XNP\6^(M0_MQ(?#FGM/I,ODM&NJO^
M^?:K84F <8;C/?CCK6IX-CL+;PK;_P!GWU]=6'S/%<7Z;'*$YX&U-JC) &T8
M XXQ6!\/M8TR_P#$GC!+/4;2X:74A-&(9U<O'Y48W#!Y7/&>F:;3YG%=G^G^
M;%S>ZGYK]3<TSQ+=ZCX&'B+[!:Q3/;M.ML;PE !SAI/+R#P<_*<&M&PO=3GT
M%;R[TR."_:(N+*.YWC.,JI<JHR>,\8'O7'V\%Q8>++OP@L,G]G7LXU2*0#Y$
MBW;I8_QD"\>DA]*[B34+-=2CTQY!]JEA:98BI.Y 0"<XQU8<>]#]Y76E]O+O
M^-_N&M'9]/Z7X?F9%EXCU"XO-)AN-!FMH[Z*3S9#<(_V>9,YC('WAP?G''3U
MKHJ8L,2,K+&@95V*0HR%]![<4^@$GU"BBB@84444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% !1445Q#-)-''(K/"P20#^%B V#^!!_&BXN(;6,23R+&A94!/\ >8A0/Q)
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MBJRT46,ABN[1[J.\,B[3M*@J%^]GYAR<=>_;;I@%%%% !1110 4444 %%%%
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MZ[AZ< "H2V7];)?BU^++?5_UNW^3/0;**:"QABN+B2XF5 'EDVAF/<G:%'Y
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M#'9G2(-*CTV,FY<S%5.[>5\O'7C&[WSVJO'X,U3^PAX5FDLVT))UDCN5D<7
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MM]-U-;43P,^#;3-(K L6SED4@\XQCMUKH:MB6VH4444AA1110 4444 %%%%
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MY3B2/S8P^QAT89Z'WJQ110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#7Q?YK^MRUF[>?Z?Y,ZC3)[NYTNVGO[/['>/&#-;^8'\M\<KN'!Y[UR/\
MPE^IQ>*K&PG%@8;N]EM&MHD9Y(-H=D=IE8IE@H.PJK#/L:[.UMH[.TBMHBY2
M-=H+N68^Y)Y)/4D]:YQ/ MC&+5%U'4O*M+QKRWC$J 1,V[<H(7<5.]NI+#L1
M5_;OT#7EMU_K]3G+'5]3T'5_'.KW]U:7%K93(7ABM61Y&\E-@5C*0HY .0<\
MGCI6S>>(M>T:^M;:^33+HZC#*UF85DA$<J)OV.27W @'YP!T^[S5VU\%6T-U
MJ\MSJ=_?0ZMG[7:W(A\M_E"C&R-6&% '7ZY/-.B\'11Q!9-7U.=XHGAM99FB
M9K56 !V?N\,<#&7#''?DUFT^6RWM^C_6SOZC?Q-^?^7Z7T]#"L_&NNR>&M*U
MB6RLYCJZ11VEM;9$@G;<6R9'52H5<@;E).1GI5B3Q/XGT_P]=7>KZ,;66.=(
MTN!;B51&W65H(IG;"G@@/SD'(YQHCP'I;>#(O"US<7ES90[?)E=U6:(J<J59
M%7D'H<?7-6-(\*IHVFFUAUK69YBVXWEW=>?,>" ,N"NT9.!MQGGK5RW=OE_7
MWDI.RO\ /\?^ 4[GQ+<2Z)8WNG:EI$D5U(R_VA@R1  $@"(.&9B1C:&R/?%4
M+?QIJMQHGAW4%L[0#4-0^Q718R*4^=ERB$9&=IX8Y7CK6LG@JRAEL[B"_OXK
MRWFDG:Y1H]TS2 !]ZE-G( ^ZJXQQBJ[> ;7[%9VD.L:K!%:7K7L>UXF/F%BP
M!WQMP"S8^O)/%)7OKW7YZ_@)J5OO_)V_&QSGC76+_7O NNWEN;6/2H9S:B-H
MV,TA255+[MP"C<"-NTY'.1TKTV/_ %*?[HKEK_X?Z;?P:A:-?:C%87\GG36<
M4JB/S-P8NN5+*21R <<YQGFNFBMHXK-+4&1HUC$>7<LQ&,<L3DGWZT*ZB^^G
MY6_/\"MY7]?S_P CB]-\7ZM<>)+33IAITHNXIR(85?-K)'CY&F#,DA[': 1Z
M&J]GXR\03:+I>JSP:8JW&I-I\UL@D)SYK1JRR$\8(Y!4YZ\=*V;3P+:6<>FI
M#JNJ#^S0Z6A\R/,:,,;?N<@<8SD\<DU73X>01Z3;Z<OB#6!#;WIOD;%MN\S=
MNY_<XQN).,=_3 H2[^7Y_P"5Q2N[V_K1_K8CF\8WVE_VY;WT$%W=6%Q;PV_V
M9?)$OGX"*0[D @GDE@#[54O/%/C+2_#VK7]]H-O&UJJ/!-<,D2N"V&!CCFF.
M5X_B&<GICG7F\"6-Y<:P]_J%_=PZLJK<6\IB5!M^X5*(K KV.[ZYJJGPYM%\
M/7.COK^OSQW& \]S=K-($'.Q=Z%57@= #P.:2O;7?3_@C=[Z"7WC"]T+4=2B
MU6*VF@@TT:A"+965A\VSRV+$AN<8;"]>E9E\=;7XC>')+QK":Y:QO7@2)7B1
M3M3Y&8EB<''S #/]T5OW'@>UOM1DN[_5-0NUELOL,L$ODB.2+OG;&&!S\V01
MSTXXIA\"6SWMC?2ZUK,EY81R16T[3INC5\<'" /C'\0.?XMW%%G_ %_V\OOU
M0M;6_K[/^3,JR\9:[/IOAS498--$>JW;6<D"*^4;Y]KA\]!LP1MYZY'2I7\:
MZC9G4;">UAO-3@U*.PM_LJ"-92\8D!VR28!"YX+C..",U;B^'T$.G:58IKVK
MB+3+HW5N?]'SOYZ_N>0-S?\ ?1]L+<_#O3K_ /M<7VHZE<IJ<JSR*SQ)Y4B8
M"/&R(K J  ,D^^3S3U_K_MW_ .V_K9V_K_P+_P"U,^[\5>+]+T07.H:%:PS?
M;X+97G=8Q)'(P7<(XY)=I!.,%^G/M3=?\0Z[%IOB_3Q<VD5YIUBMU!<PV[ !
M'#_*5+GYAL/S9QR#M[5H-\/+9]$CTQ_$&O2[;A+AKJ>Y2>9V0[D!:1& 4'G"
M@>^<FK<G@JVN-0U:ZNM3U&X&J6HM+B%S$J; "!C;&&!&YN_?G/&"2NFOZV7Z
MW_X8<6U)/T_/_(UM$6[31;07L\,T_E+N>&(QJ1CCY2S'I[_E7*ZCX@\364'B
M&%9=+?4+!HY+.,6<A$\+@[01YN=Q8,N<@#:3CGCL-.LO[/L(;7[1/<>4H7S9
MR"[8[G  _( 57GT.SN->M]8?S/M,$+0A0WR,">"P[D?-CTW&G.[DVO/_ (']
M=FR8*T4GTM_7]>1BOXAU&6QGU.PGTZXL([.&0%U\H>8^"SF1I-H14(;;C/.-
MU9]KXTU0Z5K[M!#?SZ9)$J36EG*BR(X!+^2S%B%!)PK'=C@BMG_A"M+7PTVA
M127,-OYPG21''F1N'#J1D8PI"@ @C  .:GM?#,5I?7E['J6H&YNQ'YKF1.63
M@-@+C)'!&,>@%)[NW]=?\U_6@KI+^OZ[DOAS6(];TL7<6H6=\F[;YUHK(,@#
M(9&)*'.?E)/&*J7VL7USXBET/2FM8I;>V6YN)KF-I!AF(5%567D[6^;/''!S
MQ?T?1(-'-U(LTUS<W<@EN+B?:'D8*%&0BJHP !P!4&H>&[>^U>+58KR\LKQ8
M_)D>U=0)XLD['#*01DG!&&&>"*)Z[?UI^5QJZ7]?UL<1X%U?4+#2?"EC&;4V
M>H2WB2JT3&161I&!5MP&.,8*_C4FKZO?ZMX? U$VS36?B>"U#V\31JRI,F#M
M9F(//K716?@#3-.T[3[2QO-1@:PN&N()Q,'=2P(88=2NT@G@*!W&#45Q\.K"
M6*:.+5M7M_.OQJ#E)D?,JG<N!(C  ''0 G R337Q)OR_.+_),EQ;32ZW_'F_
MS3([CQ%K.F:MK=EJ,^GYBL_M6F>5:.#,,E<-F7YF#%5(&W.X'(S@=5IPO1I\
M']I/ ]YL'G&WC*)N_P!D%F./QKF+J#_A)/%EE!/HU_%#H<YE-]=1JD=PVWY5
MCP?G&2&)P "@_#L:%\/]?UK^A7VOZ_K3]3ACXQU.'Q38V-P+ P75Y+:/;1(S
MR0!5=E=IE8IE@F=A56&?8UB^*=6U#7_"NF:N&M$TJXU:T^SPB-O.VBX #L^[
M'./N[1C/4UU2>!;&,6J#4=2\FTO&O+>/S4 C9MVY00NXJ=[=26'8BH;CX=Z7
M<V;6#WVJ+IWV@7,5HEP%2"0-NRC!=X&>V[ [8I1TY;]+?FG_ )_U:Q)-IVZW
M_)K]5_6\-[XJU:2QUC5]+2Q;3](GEBEMYXW,MQY0!<JX8",]0 5;.!R,TVU\
M2Z_K.NW]AIJ:9;PQV-O>VLLZ22F19-W#@%-I^7L3C_:Z#4N/!EE-<WC1WM_!
M:WW_ !^V<<BF*Y.-I+;E+ D  E67/?-8"6$E]\3-42"36--MO[/@@2>WLV2*
M38S[D#O&4QAEP5(/H>M))[=;/[[?YZK[@=]_ZW_RW([+Q!K.O^(O"]W;W-M9
MVEU8W$T]K);M)AT9%?#!USU(4XXYR#GB]I'BOQ)K%]9WMKH+-H-RQ_?,85*1
M\XD#^>6;H/D\I2,GGCG<_P"$4TZ.XTF:U:>T_LR)H(4@<!6C;&4;()QE0<@@
MY'7K6?IOP^TO2==DU*SOM6CA>1IO[-%ZWV02$Y+>7ZYYY)&>U5U^_P#/^O03
M3M]W]?UN<QXIU;4-?\*Z9JX:T32KC5K3[/"(V\[:+@ .S[L<X^[M&,]37I=_
M)<0V%Q+:1Q27"1LT:2N50L!P"0"0/P-<Q<?#O2[FS:P>^U1=.^T"YBM$N J0
M2!MV48+O SVW8';%=1<VQN+&6V2>6 NA02QX+IQC(W @GZ@U+O[-I;_\!+\R
ME\=WM_P6_P CBK#QCK>H6_A)X[33T_MN.1I79G/E,J%L*O<<#J>>G&<C?\*Z
MQ=ZO97HOU@^U65[+:2/ I5)-AX8*22N01QD_6LZR\ 06"Z*L.NZL4T?=]F5O
MLY!##!#?NLD8)'8_CS6KX?\ #J^'_MNS4;V\^V7#7#_:1%\KM]XC8B]>.#GI
M5Z7?;7\U;\+DV>G]=_\ @&3XQ\2:EH9D-F]C$L5JURHN(VG>X*YS&J(P9<#!
M+X8#(XI?^$AUC5WEAT);".XMK.&ZDCNE9_-:12PC7#+MZ#YSNZ_=K0U'PI::
MEJ=S?-=WD+75I]CN8H779+'SC.5)!&YOND=><UEWGPVTN[EL9XM4UJRN[6%;
M=KJRO3#+<1KT20@<CZ8]JA)]?ZW_ .!_6[=[Z?UM_P '^MK%QK6N7UY=6.D1
M6$%[96T4\\-V&DWNX8^4"K*%^[]_YAS]VA];UG4=5N-*TM+*SO+.UAGN?MB-
M,"\F[$:['7&-O+\CGH:;J_P^TO5;^UOHK[5M-NX(UA:?3KQH7FC'1)&Y+#WZ
M^]7KGPI;/?0WME?7VG74<*V[RVSH3-&.0K^8K \DG.-W)YIZV^_];?+;3^FM
M?Z^7X[Z_TN<MO'.KZO=:%!I]G80'4X;D,]P[OY4\.0RX &5W8YSDC/ ZU0\7
MZOJVM_#WQ-*K6$=G9Q2VDZ"-V>65  [(Q(V*&R "K$@=175CP591ZGI-[;7U
M];+I4;);P1F,H=WWRQ9"Q+=SN]Q@\U'J/@33M1&IPM>ZA#9:GEKJSAE41.YQ
MEQE2RDX&<$ ]P:33_KU5OPO^!2NG?T_7_@?B9?B3Q5J?A[3O,M?L"16VGI<J
MDT;3276 =R*J,&C  'SD,OS>QJ>3Q-KUQK.KV%K#IMNEII\-[#+*))BP?=D,
MH*8^Z1P>.O/07;CP)I\\=U$M_J4<-W9+97$8G#^8B@A6+.K-N )Z'![@TV'P
M-'!>WMU'KVK^9=VBV;[C VU%SC&8LY&YNN>OH!ARN[VWUM^-OQL3!623Z6_3
M_@D%GXJU#7X["WTC[%:WEQID>HR&Z1I54.<*@567.2&^;=Q@<'-,U#Q1XA$M
MKIECHN=9-FMU=1KY4RPY8J%PTT6X$AOF#''&1S1/\,M,GT_2[<:KK,%SIL7D
M6]_:W*P7'E?\\RR* 5X],^]6=8^'VEZO%88OM6L;NQ0QQ7UG>LEP5)RP9SDM
MD\DGFG*U]-K_ (:V_2Z\OO(IVU[?Y?U?S-_2+B^N](MI]2LOL-ZZ9FM_,5_+
M;TW*2"/QKCM1\2>)K#3-<S+I;:AIMROEQBPD(F@90P(7SL[L;N<X^0C'<=M8
M64>GV,5I$TKI$N-\LA=V/<LQY))Y)-5)-!LI=>_MAPYN?L_V<KN^1ER2"1W(
MW, ?1CZT2O>Z_KJORMZ,:VU_K^OS1A:QXCU:TT76-9TUM.N[2RM$EB22-XRS
M; ['>&.1M((&T<G&[BH+6\UJ]\?6^;ZU6R.CI<-;FU8D;V^8!O,X.0.2#P,8
M[UJGP;8KX-?PO;W5Y;63QF)I(V0RE#U7+*1TXZ9 Z4J^$HTFMKB/5M22Y@L_
ML?GJT0:1 <J6&S;E3TP #W!'%3);V_K1_JT*SLE_6Z_1/[SE_"VLZEI.B>$H
MBMH]AJ$[VA0*WFJW[Q@^[.,?+@KM]\]J[/Q1->6WA;5)["=(+J*UD>.1X]X4
MA2>F1S_GGI6-#\/X(++1[1->U?R])G,]N3]G)+'(^8^5R,,W_?1]L=1>6D5_
M8SV<X)AGC:-P#@E6&#_.BHFZ;BM]?R5OU+AI--[?\%_I8X*!=4^W>"!)<VDM
MXUG<;91 R(H,28RN\EB._P PS[5/#XWU6;1K:.*PCN-9GOKFR"VZKL)A+9D"
M22ID<#Y?,!Y/)Q6M%X+2&^TJ[77=7+:9$8H49H2K @*=P\OK@*.,=/4DFFWP
MVTV;1)=,N-3U6;==M>Q7/F1QS6\S$EFC:-%QDD]0152U;?=M_C_D9QBTEWT_
M+_,V_#=YK-[ISMKNF_8;M)"H&4Q(O&'VK(X7/]W<>G6L+Q?XLU+P_-<R0&Q6
M&VC20021O++<@G#8V,#$!_>92#[8-='H>BQZ%IJV:7E]>L#EKB^N#--(?]IC
M_(8%9FI^"[+5)M5=[_4(8]5B6.ZAAD0*2HPK@E2P('8';Z@T2^)6_K;_ (/]
M;4D^4J-KGB.\\5:MHUFFEVRVMK#<V\LRR3%PY888 IC[IZ$XZ\YP*&F^,]<U
MS4='M;2VT^SCU'3I;CS9M\S1RQL%8% 5!7)X^;)]L8,,&FS7?Q(U.*.YUVSA
M_L^" 7:6K*LY1G+J9)(RG1EY7!Y^4]:74=*6'Q[H&GZ8FJZ?:V>G36ZW5G9N
MR1%C&54NT;1G(5LYS[X.*%]GS_\ MO\ @?UNG?7R_P#M?^",U#6;C6;#13>Q
M11WEIXECM)Q%G8S(6&Y<\@$8.#TK2_X32\M(O$SZA:VB'2KN.VMUBE8K)Y@7
M878CCEUS@<<]:OW?@FSN+.PMH-0O[-;.Z-X&A,1::;).]RZ-DY)Z8'/TPB>!
M[!SKBWUY>7\&M'-U!<>4$!  !78BL,  #D],]>:E)J_]?R_Y2]+CMK_7>7^:
M];!<:CXETNVU&2]ATRXCBC22"Z1OL\8RV'#AW/W!\V[(#=, UQ?B7Q#>:QX0
MUNTNWMIWL=0L52XM[>2!)E>1&!V.6(QTR"0:ZJV^'&GP:3-82:QKMT'9&BFN
M[XRO;[&#*(PPV@ JO!4YP,YJW/X'TV[.H&\N;ZY-^(C-OE ^>/!5P% PV0/;
MCIUI[._I^#3_ $:$[M6]?R:_49'K&IP>(KC0M5^QRB:R>[M9K:-H\*I"LCJS
M-DC</F!&?05S/AWQ!J&G^!O"VE:/9-=:A=6#3#"QN$1" 3M>6(-RPZ/D>AKM
M+?PVL"7,DFJ7]Q?SP?9_MTQC,J)R0%4((QR<_<YXSG%8\WPUTR?P]IVDMJ>K
M(VFDFSOH9UBN80>JAD0#'U!-'_ _-_YKUU'K^?Y+_)^AT&@7>J7ND1S:SIWV
M"^W,KPAU88!X;Y68#(P<9..F3UK3JEI6FQZ1IT5G%/<SA!S-=3&660^K,>2:
MNU3WT"-[:A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445P?C>/38O%_A>[U.0):[[A)C-*PA">4Q^92=N.>21TX)
MQ2;U2[_\$'HFSO**\2UHZ?8Z<C+=QVNB-XCMGTM/M/EQ-!\GFE%R 8PV2.PZ
MC Q72W]EH&F>)QI^N06D?AF6SWV NCFV%PTC-)RWRASE2O/ X6A:J_\ 6R?W
M]/45]?Z[V/2*JW_V_P J/^S_ +-YGFIYGVC=CR\_/C'\6,X[9ZUY?_9CZ;X6
MTWQ9?Z:+N[T:\D:-IHPT[V&]E3)8;B50AUSSQZDU8\76ND:1X?TC4;E+72[R
M\UBVNYE$@AW,9 6W@$!]J]20<8)]Z:U:]4OOM;\'KZ-";T?H_P +W_%*WJF>
MI55M/M_FW7VS[-Y?F_Z-Y.[/EX'W\_Q9W=.,8KA+N<:9XY%TC:7JRZC<QH(P
M=E_; ;1E/[\*G#$<  D\YK#MKZ-;#Q9%H]X;J*+7HI+M(+DS2_9<1^80<EB.
M&'T# =*2=]?ZW2_"^_\ 2&[?UY/_ "V]/G[#17C^MG1X;+Q!<>'+NUM_#KZ*
M[2O93^5 +O=^Z"%"%#GD$#D\ CGFSI]_H=KXJ\+?8=2LX9+W195N)(9U9Y2
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M^3! &^Z&<*QW$9( 4\=<9%2VNN2J]['J]DNGFR@6>643>9$RG=DJV 2!M/4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH5]J5O:/?FS;;+%'(J;3@$Y+=@",XR?8UL,[_9VDCCWOLW*F<9..!FE?1O\
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M;'&89XE=/^^2,4+2UNFGX)?H-J^G];W_ %.1N4;4OB[I\]C(&BTS3YDOG0Y
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M(+>)(H4&U(XU"JH] !TJ2J;NQQ5D%%%%(84444 %%%% !1110 4444 %%%%
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MLX(QM)''\596B>$->TF'0#)<Z;-+ILEPKA0ZJ(Y>X/.Y@?\ =!'I25^9=O\
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M<1R<>]6*** "BBB@ HHHH **** "BBB@ HHHH KI8VD=[+>QVL"74JA9)UC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD:QG%Q"T;L%^XS(P!&Y"IP1WK9LM"^Q:[>ZJ=3OIVNT5#;R^5Y4:KG:$P@8
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MH0JB9QE@(HTR>,9.< G'6J^I^%1J?B*QUHZSJ-O-9!A!#"(/+ 8 /G=&6.X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !5/4'S$ELK,'N&\L%<Y ZL?;BKE9%Y?QVLLM
MVZF1D_<6T*D;I9#R0N>_0?@: )M4OGM4BM;-5>^G^6%#T4=W;_9'^ [U/I]B
MFGV:P*S.V2SR/]Z1SR6/N35;2;&6W:2ZOI%DU"XP9-IRL:CHB^PSU[GFM.F
M4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$2L@<KM8X4G/9=O7MBNOHH77S_S;_6P<O]?)+] HHHH*"BBB@ HHHH ****
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MQI\3VT\QO;@6Z-%LPC$$Y;<P.,*>@)XZ4!<T**KQZA931M)%=V[HLODEED!
MDSMV9S][/&.N:ISZVD>DW-_!9W-U]F=TD@B,:R JV&^^RKCC/7D=*3:2NPW=
MC4HJKIE\NJ:7:WZ0S0I<Q+*L<P =0PR P!(S^-6JIIIV8DTU=!1112&%%%%
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M) ! ]$L[."PM([6V39#&,*N23]23R3W)/)J"\TN&^O+6XN'D=;5_-CAXV>8
M0'/&20">^.^,TK:_UY?Y?YE:VTW_ *_KY:'-B[6'7=5U06[M#HFFK;QP@9?S
M&'F.F1GG:(AQGKWK$M=:TW2M4OX-/N_MNA-:7&HW<*L2^FS#YBH8<H6+,0IP
MRD$C';N-+T,:5J&H74>H7<R7LQF>"41[$<X&5(0-T '+'@5JT--KY?G?]7?Y
M+S$DEIY_E;]%;YOR/(9+J_BM?#VGS7^H72WFG231QPZNT#FX+#YGF=U=HU#
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M35.WN4\,7&NQRSMJ.MZ-8?\ $F29D4O:F-3E$0*O#*0Q SA1S7J-I90V*2I
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MH@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>ex10-8_001.jpg
<TEXT>
begin 644 ex10-8_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4& XP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFJ'#/N92"?E 7&
M!@=>>><^G]2Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *3:-Q;G)&.O'Y4M% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%1/<1)<QV[,?-D5F50I.0N,G/0?>'7UH EHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBFR.(XV=@Q"@DA5+'CT Y/T% #J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
MM=VC73VS+=7$'D3"4B%@!* "-CY!RO.>,'('-6:** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_LPE,9^88Y/WN?H*L:QKM[XC'BG3M(FBAM-.TL$O-$&^T331&11C.1&(R,\
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M^< Y8JK#/1J/"GBC6-:M]$L9[M!K27-P=9A:W">5'%D%=O4$L\&TYY#,>V
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MX3  RIZEN1MP<VU\1>*M5\?W&CVSV-G:PV]E>RPS1[Y$C;_6Q!U8J6/.&''
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MIFH3Z=<R1(5CE>(CYP,G&0R\9Z@XXKK* "BBB@ HHHH **** "BBB@ HHHH
M**** "FEB'50C$'.6&,+]>?Y4ZB@ HHHH **** "BBB@ KFQX.@CUN\UF'5=
M2BU"\18YIE:(YC4Y" %" ,<9 !]\\UTE<)/XIUK4O'4VAZ%>Z!!#9.D=U#J*
MR_:I!C<[PJI 9 "%&?X@V>,9 -"[^'F@7'A=?#\$4UG:"Y6Z,EO)^]:56!WL
M[ EF.,$G)QZ8&+.G>#-,TW4]6OTEO)I=6@BAO!/.7$@12H;/4$@XZX] *?K.
MMW6G^)_#FF111F'4IYDED9CN 2!WP!CN0O.>Q&.<AGB[7;[08-+DM+19DNM3
MMK2>0AR84DE52VU5.<C*Y)4 E>IP" 4C\.M(/A"S\.&[U'R+&=;BSN1.!/;R
M*25*,%QQD@9!X/KS6]HVC0:+:R11S7%Q+,_FSW-R^^29]JIN8@ 9VHHX & .
M*C\1:RFAZ-<70 >Y\J3[-#@DS2K&\@08]D8_0&L;0/$>IZE\+K7Q"T5M+J3V
M!G*,3'&S@'K@$CIV_2@"[XKTRX\0V/\ 8 MW%E>%?MET67:L08%D4;MV]@,
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M)B=\!=AB ZC[V[VQ5F/6-,EE@CCU&T>2X#&%5G4F0*=K;1GG!X..AH Y[2_
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MH6'B+2=%U>RMR^I),8;FSE9E#QC<59&4%1M/!W')&,#(KI&R%.T MC@$X&:
M.>N?",-U;ZQ"VJ:@JZK<"XF*^3F-@J* F8^@6-!SGIZFIG\,QMXBDUQ=2ODO
M&MEM1@QE4C!W':&0XW'!/K@>E5] \2SZEH^KW][:JAT^]NK<Q6V9"RPL5XSC
M<3@]A]*Q_"OC;4-7OM-^VC3YK76+"2_M1IVYWM%1@&CF))W'YPNX!?G1AM]
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M7<2$CY ,(24&< 9W'H)]1\1W4NM3Z'HB6AO8 GVBZO69886<95 J\R2%?FV
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MX$9^H-9NE^*-/U#2+2^N)$T^2XG^R?9[N14=;D$J8>3R^5. .HY%;3,$4LQ
M4#))/ % &7+X?L;OPV=!OU-]9&$0L+A5)91T)P ,C P0." >M4I/!UBS:1/'
M=WD-_I5O]F@OD=#*T>W:0X92C9P"?EZCC%:5OKNCW<<DEMJMC,D40GD:.X1@
MD9SAR0>%X//3@T6VNZ/>WBV=IJMC/=-$)UABN$9S&0"'"@YVD$$'IR* *=OX
M6M+*"TALKJ^M4@O&O9?*G.;J1MV[S2<E@2Q)' R!Z"MRN/\ $/BE[?7O#MGI
M.HZ?,MWJ/V6\MU(DFV^6S9&&^4#;SD?Q+R._84 %%%% !1110 4444 %%%%
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MM9&CV\GA^[^&T&LB:&=--N[5 QR%F982D+,< -M5@!W*X%>IT4 >'>"[E8?
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M=FRN".H((K%\$16EAXL@N=#N/.BU6P>Y\0H<;;:Z3803_P \I"TDFZ/MC[H
MX]12Y@>YEMDGC:XB57DB#@LBMG:2.H!VMCUP?2I: /,K'Q=HWB'QAIVI2?VH
MUQ"YMM/T_P"PR((S(=KSR.R!<[>@#'"YQEF*CK?'7/P_\1J/O/IEPB#NS-&P
M4#U))  [DUT%06=[:ZA:K=65S#<V[DA989 Z,02#@CC@@CZB@#RKPJ]YX#\'
MZ5K%MMO/#]U:6[:A: O)=6]T42-VBZ[AD?-&<;=IQT(KJM6D2Y^)/A">!UEA
M^R7_ .\0[EY$6.1Z[6Q]#Z5V5% 'GO@+0=,U/X>3VMU9Q"2\>]MKIU0+*8WG
ME(!;&?NLI'U!%94B7MYX!UO4=<LY+PV%A-HRI$YS.(I62>X!7E0Y1"5P#^Z/
M4$5Z3K&FG5M,ELEO[RQ+E"+BRD"2IM8-P2".<8((.02.]36-E!IUC#9VR;(8
M4"*,Y/U)[D]2>YH \DDU6#Q')XNGLI[F^EO?"1$$BZ?-;I<LOG!O*5EY +Q@
M9+'YL G!QZ=X:U"VU7PUIU[9R/+;RP+LD>-T+ #&</\ -@XX)ZCG)!S6K4%K
M>VM]$9;.YAN(PQ0O#(' 8=1D=Z .4\52(GCGP4[NJI%<W32,3@(#;.H)],L0
M![G%6/%;VR>(?!_G#]X-4<JPCW%5-M,O7!P"[QCZD>F1TT<\,V/*EC?**XVL
M#\IS@_0X.#[5)0!YC-X57_A-;KPU"&CT+49T\07"QLP(E1@'CSZ.XA?&> L@
M 'RD5-8N+:WT3QYX<O4D?6;ZZDGLH I#W9E5%MWB!/S!"J*Q7A?+).*]9HH
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MZP;H%VLA:B+RSM!#;MW7U/3TQSQ0!2\"7T&I>!M'O+6QBL();<&.UA.5B&2
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M+>_T^"--D5RA"NIV@!NB_-CD8K4U:RU>YFMI-+U>.Q$6\2Q2V@G28'&,_,K
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M(G(!9=PX.#D9'7%>>Z9INFWEGXFU^0EK_3[_ %2.&9;B0"$$;64C(!X4'!!
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M$&;()W!ACNP4'OS=$<<&F+NNY5TVQ\61QV5W*^=L 9"R"0DDIYN^/)/;!QC
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M7&KZ-+]L(>\LKN>QGD50HE>*0IO '3< #CL21TH V5M+9+I[I;>);AQM:4(
M[#C@GJ>@_*LCQAHUUX@\-SZ7:2QQ/.\>]Y&(&Q75F' /4+M_X%GM@[M% %:V
ML;6UA:.&SMX%<?O$B0!2?? &:$TZRCBCB2SMUCC<2(@B4!7_ +P&.#[U9HH
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M2Z-:S7]A<E0J61D>*!5 3S'P-_ Z@;QZ?.21D C1HHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%,9V$J((G96!RX(PN/7G//L#TH ?1110 4444 %%%% !1110 4444
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M(ST'7O2> KO_ (27XB>(?$%_;)INKV,*Z3)IJN'*(&W&0N,;]Q& <#A>_!H
MZI?'OA]UNFBGO9?LC,ER(M-N7,##&0X6,E3SWQT/H:WK*\M]1L+>^M)!+;7,
M2S12 $!D89!Y]017EOA7^T8O$OBXV@VAO%$0N1YA9A">X/N2G'8$CH*Z?4M<
ML-&\)Z=;:"USY#7*Z7;FSMWN)(4B8I*54JQ;8L3X)# D _,#R =1I^HVFJV:
MW=C.L]NSN@=0<$HQ1ASZ,I'X5DW/C;P[9I<2SZALM[=_+EN?)D,"/NVE3*%V
M;L\8SFN,^%6IV>E:MK?@E9+S%K,;W3_MMO)%));O@G(D53E6/.0,YR,C)KG;
MVWUKPEX8O+T1Q^)_AWJF;Q[9I'@N;:*8AACG(&6!('4[B0F2: /=:*BMKB.[
MM8;F+)CF19%R,'!&14M !6;_ &_IG]MKHS7/EZ@Z,\<$D;(9%7&2A( ;&>Q/
M0^AQI5PWC/0SKWBK1(;>8VNI6MC>7=A>*S9AF22U R <,C!BK @Y!/2@#K9=
M4M(=5M],=Y!=W$;RQ((G(*+C<2P&T8RHY/5E]1DTO5+36+!;ZR=GMW=T5F0K
MDHY0\'GJIKCO#VLWNN>,+ :E:1VFJZ;IUY;:C;I)D)*TEJRNHZ^6ZJ64\]",
MY7F"U\0Z[<^'/#$RZC$MWJ.IW%C/*8%=2 MQL;:O3:8E...F&(YH [O4+^VT
MO3[B_O)#':VZ&25PA;8HZG !. .34EM<1W=K#<Q9,<R+(N1@X(R*Y[Q9'-!\
M,-<BO9_M4\>C7"S3*@C\UA"VY@O(7)R<<XS6!INMZSINL6VF/>V4MK/X<^W6
MZW">2EO+&$7YG!)\L[B6R"1CCC- 'HM%>>>&/$6K7GB&VL_MUQ?6][HTM_&]
M[;+ /-65$'EA45Q$=Q(W@L05.?6[X,U[4+S4I=*UB\D&JV]HLEW8W<*1R+(6
M(,D)0!9(#G /)&%W')H [:BN3OK_ %:\\>/H-E?K9V\>G0WKN(%D<DSLK*,\
M#*(PR<X.#@\BJ&EZSXEUB.QU:T4?9YK\Q3P.\/V=+99'C)1A^\,OW20>,J0
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M8W,8>-82 2<<AM['ID =  =Q17#:+J'BN];2K\RV[6NH63R2I<&(1),R!XA
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M]!7,>"-=/AKX5:UK"V4MZUMJ=T5MHL[I&,H4#@'')&3@X&30!Z,-=TT^(CH
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MMWC9I4F>X+&0G!X93E6SR& [XKV:YN8+.UFNKF5(K>%&DED<X5% R23V  H
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M]ZOD_=PKXX%:5ZVBK)\0K.:\CT^QCO\ 3@TEOMVP.RPA79<@!=XPW3A6[@T
M=[KFK7@T)[SP[<:3/,DT:L]Y<;8%4L V67H<']>AZ%WBK7!H/AS4[V&>U6]M
M[*:X@BG/$C(A8#:""1QVKS.36K'^Q9M0N[;3X8Y_%EB3J<4I%I<LDD>^X@#\
M+\L3!B"W\?S$5=\1ZM96]AX_LM791?ZI:2S::,&1+BU2U_=F/&1\K+(QZ8+;
MNA!H ]*M-4A;2K"ZO)X('N8D8!G"@LR@X7)]ZM37=M;AO.N(HMNW=O<+C<=J
MYSZG@>IKRG4+JSM;ZWC\03W5OIVL:#;65@]K:><TC ,9(BK1OB1O,0@  -M
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MT^&VNK:*%#LANI1)*BEB0&([\].W3M6[0 4444 %%%% !1110 4444 %%%%
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M!DCMP%&5E4E Q1^BE@H!SR< 'H+;4==NI-$D_LNUCM;E9&U K=B0V^%S&4(
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MBX49'RYSVKH]&T[4;-KF?5-5.H74[#'EQ>3#$@SA4CW-CJ<L26/&3@ #5HH
M*YI?"\]CXLU+7]*OHXI-42%;R"X@,BL8@55E(92I"G&.0?;K72T4 <5KW@.?
MQ#X0UC2+K5T%]JTT<MS>K:_*NPH55(]^54",#!8\ECU-4O&^A7%M9^+?$EQJ
M<!AF\.2V(MC;[2N%=@0^_G+.W&WN!GCGT*B@#CM(T"YU33]&O[[48V^S:=ML
M_LL.S8TD04R[BS'<%) P0.3USQ#H7@G4M&UO2;_^T[)H[+3)=.DBCLC&L@,@
M=9 -Y(<D L22#@X W9';T4 <!H?P\O?#&B:)!I6L6YU/2UG@%S/9DQS032>8
MZN@<-E3@KAQR/<UTGAG0)/#]K?0R7@NFNK^>]WB+R]OFMNVXR<X)//'TK;HH
M YN7P]JGV?5[6'6()+;4'D98K^R^T+"'&&0#>H9.2=I&.3VXJG:>"I=%O] N
M-%O8U73;+^S9EO(VD\VW+(S%2&&V3*=\J-W3C%=A10!Q^G^");!/"J_VHLO]
M@O,Q)ML&X\Q&3^]\N Y]<D=J;>^"[Z_\.:CI4VL0;[W45OC,+(X0"59 FWS.
M>449STSQ7944 %<K;A==\>?VBD>ZST6WEM(9\\27$C 2@<\[!$JGW=AU6NJH
MH Q/$FASZ[#IZ07<-M]DOH;P^;;F4.8SN"@!UQSCGFJ-QX5O$N=8?3=3AMH=
M8"F[BDMBX239L>2/#@ LH7J#R,\]#U-% ',Z'X4DT#7[F[M;Z-M/ELK:S2T:
M [XU@5E0B3?C^-LC;Z=.<W]>TR]U*&)+6YM1$ ZW%K>6WG0W2,N-C#((YP<\
M]^#FM5T$B@$L "#\K$=#GM].G?I3J .%M_AXUE_PCMS:7\45]HMQ=2Q+Y!-N
M4N"?,C$>X%0JD!,-QCD'-22>!;TZ79QP:]Y>J6&H3WUIJ!M 2#-)(TBO'N"M
MD2,O&WU %=M10!RESX5U2]&FR76O"6XM=3&HRL;4A'PA18HTW_(@!SR6)/.<
MDU/X<\+S:#K.O7\E_'<C5KD7)C6W,?E$#&,[CGCV%=)10!R.N^#KK7=1CFGU
M&V$4-[%=VTGV/_2;8)L)CCDW@88J>2IX8C!X(;8^#-0TN_NH]/\ $<\&B7-V
M;MK#R 7C9FW.D<N?DC8Y^4+D9.""<UV%% &%H&@3Z)?:U,]['/#J5\UZL8@*
M-$S*J[2VXAAA!V'.:B\/^$;;0-7U;4$GDF>^G9XD?[MK&QW-&@R< R%W.,9)
M&1QFNBHH X4?#ZZ2VWPZ\UOJ,>JSZG;W4-M@(TQ8O&Z%SO0[L=0>.HK0O?"=
M_>Z99L^O2#7;2Y^U1:E]F4JKE2C*(B<",H2"H(YYSGD]510!S@\/ZH]K'%=Z
MS#?&1F:\2[L@\,P*J $C#C8 4!QEN2WK69;:/K'AZZ\,:3I6IRR6,!E%[ UE
MF)XSN;/FG/E[20J("2<C^%6([:B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** *6KZ@VE:5<7RV-Y?&%=WV:S0/,XSSM4D9
M(ZXSGCC)XKFX/B1I%SX7_P"$EBL]3;1]\BM<K &VA%R7*ABP7<"F<<$9.%^:
MNQKR73M*OT\6>)_ J(@T>^N?[2F8R%0MI,")(H]I!5F<8Q]W:'Z$C(!W;>*[
M9-+T*^-C>[=9GB@@B"H73S%+!G ?&T*I)P20.W6H-/\ &MIJFLRZ1:Z9J;:A
M:H6OH7A5/L9QE%=BP4E_X=A<'KD#FN-^% OKV.WT[48Y5?PD;G3V9R-DTS/A
M67!_@B4KSG(DR#4VB1:O<?%_X@-I&HV-L%_L\2BYLVN Y\@XQME3;C#9Z]>V
M* .IL/'NF:FE]-:6>IO:Z>K"\N#:E5@E4@/"5/SF10=Q"J1CH2>*BE^)&@#P
M^NNVPU"[TUW1(YX+*3:Y:7R\ L!C#=<X]!D\5RW@ R1^#_B$;FXCFD76]2,L
MR+L1SY:Y8#)P#UQDX]365\*5GM/!^AZGJUS /#,>CZA'(LD>$1S=KN\PDX;<
MH.!CLP[\@'IMWXQTBR\0_P!@2M='5"@E2WCM9'+Q'K(I (*CG/.?E/'3-C3_
M !+I>K07\FGRR7$E@Q2XM_)=)D8#.TQN V3VXP>U>?\ B+4;N?XRZ&-)E)O#
MH%Q-;P743F$.^[83AOERRC<=HP%')R-EGX/7J:O'X@U?4)F/BBXO!'JT#)Y?
MV?R\I$@3L H(R>20P).* .F_X6!H,GAZ]UNU:^NK.T21I#%83 YC!++\R@ C
M'<@#N1723SPVMO+<7$L<,$2%Y))&"JB@9))/  '.:\<^'MIJ<L&GW#RQ/H,.
ML:F;N';MVDHX5Y"<AD'[P8X&77(.,CN-;OH]:BT;2[2SFNK'48C<W<"*J-]D
M"<*P<KMW.T8QU(#C'!( .BT_5;/4]%MM7MY0+.X@6X1W^7"%=V3Z8'7TK*MO
M&>F7-Q&ODWT5K<211V=[);,(+MI 2NQAG XQE@H.1M)!S7(^ [^#0_#?B3PK
MK/FG_A'C*S0E@\C63J9$P%).=K$8!..!GL,RPTKQ/X%U31X4U.#7O!-[?P6]
MM!(VZ6V5WS"ZMCD*=AR"0<=!U !['152RU2PU)KE;*[AN&M9F@G$;AC'(O56
M]"/2K= !6(_BS1TUJYT?S;I]0MHA-+#%93R%4/0Y5"#GM@UMUY_I'_)<O$?_
M &"K;_T(T =AI6MZ=K<<KV%QYAA?9-&Z-')$WHZ, RGV(%:%>8^)YIT\0^,[
M_2Y9(H[7PP1<7$$A7;=H9'B&5Q\ZJ<G))PR]!UOW^H7IOM(:&_F65_#=Y<SJ
MLI(W 0;)"F=NX%GPQ![CW !U?B#7(O#NCR:C-:W=RJNB"*UA,CDLP4<#L,Y)
M_+)P#J5Y=J=SJ,7PHT_7_P"W-16^O;72@X$P5<LR+(5P,@N)&+$'/RC&,59\
M1SZJ)O'\L>JZA!#I^F17-FL3A5CE6*1S@XSU1<CH<]\\ 'I%%<'>:C=7NNZ)
M#?RWRZ9<:.]U(NGF4.UP&B(SY/[P* S>BG..>E=!X034U\+V3:P]RVH2)OF%
MR5+J2> =H '&.E #M9\5Z-H$CQZA<2J\<!N)%AM99S'$,_O'$:MM7@_,<#@^
ME377B'3+;2[;4!<?:(+LJMK]F4RM<,P)4(%ZY )]  2< $U7UK4%TUF@TR&V
M?7K]"+>-UX<J,"27;SY:9&3Z' Y(%<1::&N@^-_A[IIF2XM;'3KRVAF X-R$
M'F?0D!N">,'T- 'HEOK-A=:/_:L$Y>RVLQ?RV!7:2&!7&X$$$$$9!!!Z56C\
M4:0_A:/Q(;K9I;P"?S60Y"GH-HR<Y.,#)SQ7-?#E7;5?&MQ$ MC+KLOD[0 &
M<*HD88ZY..?4'OFM#X<V*Q_#'PW!<I'*#90S@$;@"<2*>>XR#[$4 7=(\:Z%
MKNI+I]A<7+730-<+'-8SP[HPVTL"Z $;CCKUKH*X_P *27&M>)=?\03JPM1+
M_9NG?-\K0Q$[Y .AW2%OF]% Z#)U/&%\^F^$M1N8K_[!*(PD=SY7FE'9@JX7
MN26  ]2* -RBO)-1U[6[63QUI]K=7<"Z?+IKV7FR>9)!Y^T."S%MR@@MM#>H
M!&<#1\0>)-4\(:IXH$4]YJ:0:''J$,<D:R&*8R21Y 4+B,85F] I(H [BYUR
MTM=>L-&D$OVN]CDEBQ&=FV/&[+=/XAP,GFK\TT=O#)--(D<4:EW=V 55')))
MZ 5P,M@MG\1_!KB_N+PRV%]NEDF+J[8A)=020N[/0<8 P!BN\N;:"\MWM[J"
M.>!QAXY4#*P]P>#0!EZ9XJT75]0DT^TO#]LC02^1-"\+M&>CH'4%T_VER.G/
M-1V'B_1]3U1;"TG>7S PAN%C/DSLA/F(C]&9< GM@\$X;;S]S9R:_P")I_$E
MK*4M[33I[#3"J[7NIF!9I$;.2@"X7CG#,#MP3E6$EO-X$^&"V#1NYN[3:8/F
M 9;>3SLA3V D!]">>A% 'H#Z]IL?B&/06N&&I20&X2'RGYC!P6W8V]>.M5=3
M\8:%H\MU'>WVPV8C-T4A>1;?>0$\QE4A,Y!PQ'!STYK#O83+\;-*<HI$.AW#
M@\Y!\U%]1C[WOU/'<<?XL.FMK'B?4+*RN)-$MY88O%%LDWEF[P 0T/(P5X#\
MKO&0/[Q /9HY$EC62-U=' 964Y!!Z$&L.Y\8Z+9ZC=6$\MVES:1B69?L$Y"Q
MDXW[@F"F0?F!P,')X-;%H\$EG ]J%%NT:F(*NT;".,#MQVK@M8T[5K[XBZY#
MICPA[CP[!!YUR3L@+RS@8"C+?=8X)Z]\<4 =5+XELDU31;*!)KM-765[>[M@
MLD"K&@;+.#P&!^7&<FMFO-$MKOP=XH^&WA:SU&9[%H+V*Z7HL[1PA@Q')'S$
MD#)QP*K:?J.N3>%/#6KC5[^:Z?76LY4^4I)$UU)$VY0O.$&1G@%0: /1M9U2
M+1-'N]3GAN9HK:,R-%;0F61\=E4?SX ZD@ FKD;B2-74, P! 92IY]0>1]#7
MF>H7NK6N@?$/3[;5;S?HP6>SNGF_?)_HZ3,I<J<C=NXQT8C(X(]-50JA1G &
M.3D_G0!G:?KEIJ6IZGI]N)?.TV1(I]\94;F7<,9Y/!'/3GC-:5>3ZQ%>F]^)
MU]:ZI=V,FGBWNX#:$(QDBLU<;S@[E) !4]@1]+6OZYJ;:;KNIP7UTTEIHL5Q
M%#:,(H[*9HWD+R%B/,)PN%^; QD?,#0!Z=17 >(]1O=,UU+R_P!0N+;1/.LX
MX[V!_DM6WAI%NDW+A9044/@A,Y.W//?T %%>4Q:AKL/@K2/$::O>W.H)JHMO
ML;2(B7:-=F'R\, -Q4@AB>,9! J/6]>U*VUG3KNTU:[F$GBV+2Y7!*0>2Q8-
M L>>2FWF0C))."1PH!Z+IFNPZIJFJ:>EG>P2Z=*L<CW$.Q)=PR&C;/S#_P"M
MZBG)KEK)XFFT 1S?:HK1+QG*@1E&=E !SDG*GMCWKSJ;Q1JEE<^+HVU61577
M;2PAN)=I2RBE9=[8^Z  S<GOC/2N@TZSCLOC!?QQR3NK:% _[Z9I2,W$O +$
MG'MF@#J]6U6TT339M0OWD2UA4O(\<+R[% )+$("0  <G&*3^V+ Z)_;"3^;8
M>1]H$L*-)NCQG("@D\=@,UG>-IC!X*U<JB.7MFB"NNY3O^3D8.1\W([CCCK7
M&^)HW\ :;KD<4 'A34K658DA@+)IMTR$?,J\B%SSD?=8XX#4 =S'XCM)]5T^
MP@MKZ7[=;-=)<"U=8408QN9@,$YX')]<9&=BN2N8I[+Q?HMG#<W$=H=&NP\(
MN,1J8F@57/')'F,,_0]JJ?#&.^O?">F:]J6L7U[=WEF!)'+)^Z&)'(8+V;#!
M2<\A1P* .UDFCA"F61$#,$7<P&6/0#W-4-/URTU+4]3T^W$OG:;(D4^^,J-S
M+N&,\G@CGISQFN>\?1^9=^$E\R9%DUV*-Q',R;E,4IYVD=U!]L5S&NP7ID^)
MUYIVJ7.GWEA):WL,L+$<Q6B.5(!&X, 5(.1R#@XP0#UJBO-M9N]9U[7_ !!I
M%A=):W-K;6YM#)J4EIY+-&S^:%1"95W;00_'RD8'\7>Z9=-=:38W$DD<KSP(
MY>$$HQ*YR,@<'MD#M0!<HKRWQ%JE[;QZWJ]OJEW+/8ZO;V\#QSM';1(9(5>
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MX'% 'I]%5M.GDNM,M;B90DLL*.Z@$ ,0"1@U9H **** "BBB@ HHHH ****
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M]%X?TR#5X]5B@=+R.V%JKK,X7RAR%*9VD DD9'&36G10!ACP?H2ZS/JXL?\
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MF2@,RF-XR5+$#>OF;AE@./I6#>Z1J.KZ9XTU.VTVXCDUS2H[2TM)ML<S%8I
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M=%U&>TL])_LV[M+74Q:W,. A5@Z2HKC*8(WX[]<8[;PWIP\/>$+:TM]*-O\
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MC<Q+,<#N223ZDDT 2T444 %%%% !138W$D:NH8!@" RE3SZ@\CZ&G4 %%%%
M!11363<R'<PVG. >O!&#^= #J*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MJZAJ5AI-J;K4KVVL[<$*9;F58T!/098@5FOXT\*QPQS/XET98I<^6[7\05\<
M'!W<XK5O;.VU&RGLKR%)K:=#'+&XR&4C!!KQ73;*ZU;P+JGPSFMUGO\ 3[NX
M@$K%7-O;H!)%-CY22S,L:@8."3T4B@#V&77='@6S:;5;&-;U"]J7N$ G4 $E
M,GYA@@Y&>"*JP>,/#%TLS6_B/2)A!&993'?1MY: @%FPW R0,GU%<GX&UE_&
M[:%JDLJR'2K BZ&WI>N A))'!"+)P.GF\]LUO $KVGB_Q[Y-@]SNU?+/:B-
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M)  0, ^0<?KC%5M;\2^)K/Q%K&BZ59:0J6FEIJ-K/</(1MRRLCHN.24;&#@
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M=NSG!^^?[O//WFM7'B+6?A[JFGW$<-K?R3SI%+$S;'^R29W88;L98<8[\D4
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M<84AC2F\>:W_ ,+ NO"-IX=LYKF&W-TD[:DZHT60!G$!VL<CCH"<;CW +">
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MN]+O/,^SW,9C<QMM8>X/8@\UG6/A^Z34K;4M4U,:A>VEM);6TAMEC50Y4L[
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MELK5)(Y%#*ZF&,$$'@@CC%4/%UB^G?%_X=VEE%),MO;20Q>;(V6"*1\S@$G
MY)Q]>* /3SXET$:B^G'6]-%\AVM;?:D\U3Z%<Y%,'BKPZ3.!K^EDVXS-_ID?
M[L?[7/'0]?2N*#73_M"VQGB@BD'AL[@DOF IYYQ@E5(.?3/'XUD:;JMUI_Q
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MK=U.+C4-0U)VN)2Q9OE5<*V3VR2/9A0!Z7<ZMIMG8+?W6H6D%DX#+<2S*L;
MC((8G'(YJ.UUW1[Z:&&TU6QN)9D+Q)%<([2*,$E0#R.1R/6O)M!FGC^'OQ4T
MQ(@MAI]UJ<-H,$!%VN2@/?'7U^;KR*43S:PGPW\(&TN-,N[2*TU);ZY"A94A
MB&Y(0"27/.5<+@#)4Y% 'J=WXGT"PO/L=YKFF6]UC/DS7<:/C_=)SV-6;#5M
M-U7SO[.U"TO/)?9+]GF63RV]&VDX/L:\T\92W$/QU\'26]N+B9+"\:*+S AD
M<0RX7)X7)P,^]=CX-@MKG2[+Q(T44>J:UIEI+>M$H02LJ%MV!WS*1GTVCL*
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M\ $FK-<GXM5SXB\(&W>-;S^T)Q%YK90 VD^6*@@MCCICTR,YK#C\>ZI:6O\
M9ES#!=ZU_;AT>*6&+:DH5%D,Q0N ,*W*[^3T..@!Z117#7'B;Q-IFG6KZEI4
M,,\NM6]BC2E<3V\K!0^$D;8XS@Y)'&0.<!\^L^)_MMUHMJ+2[U*SM!<S7%O
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M+N&S@' Y&6DT'7O$VM/HVK1Z>/[)U(-)+&PB'V:$AC&P82%F8_)D;>YX4C%
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M **** "BBB@ HHHH **** "BBB@ K'T;P^FBWFI3Q:A>3KJ%P;F2&<QE(Y"
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M>O%<3X#U_3?#GP1T?6-2N<6-O;@221J7VDRE,8&3PQ ]O:@#T:BBB@ HHHH
M*YR[\6+9>+(O#TNF74MS<Q-/:O \95XU W%MS+M;<6&.> #GG Z.O/-=5W^-
MOAOR9#'*-*NSD@,IZ  CK@'G@C.!R.<@'26'BB/59M8LK*RF75=*=4GLKEE1
MOF&Y"&4LN&7)'/;G%8%K\4[+5/!FI^)=*T34KBWL?-5D=X$+,B!STD)Q@Y)
M)P"0#WI_"ZY2+4_$.F:U)N\9I<!]3D=ES<Q@?N9$ X"!&48 XSSC<*Y'X+PQ
M6GA&VU]]1%OI>GWMXU[',R!49HHPKY"Y)"X')_BX% 'IM[XU4:O8:/I.FR7V
MIW=DNH>2\JPK';E@NXL<Y;.<* >AR0.:CU+XAZ?I/@T^)[O3-36T2=[>6$+$
M9HG25HB&'F8^^I'!-<YK^C:'\2M3CDT^_N]$\4V=G!<VUTKE)Q;R*6 *!@<
MR$,1R"0,\X/-^+=8UJ__ &?=3&N*5NXK\6@N$50M\J3*1*!@8!(/3))3/0G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M74L96Y",VY2P++R&W*2?O!<]Q0!U4?C70SI\]W=7$EBULT<=Q;W<+1S0R/\
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M>.2&VOTOQ9INM7@M+7[7$9H//M)IH#&EU%A<O$6'(!=1R!U! (()I:3:W_\
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M48$??RVXG[P(QP.*]!K@O"5CK?A_2O$<XT"X:\OM=FOH[::ZA7?'+(HR&5F
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M[YKC/#?B"^L=-M;.VMS<7VIZ[J2R9.4AVRRNVU"5(' ^5RIR2>X![#6?#?\
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MF *]%; X)J:.?2AIOB^SOM1&GQW7BORTNEC$B12A(9$,@/&PO'M.[@YP2,T
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M5# @YR%;:<Y&::(='T:'2;BUU'4SX4;4[R:ZNKFW'EI*\8V%4,800;O, .S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!BWFB7%SXL
MT[6ENX%BL[>6#[/);;V/F%2S*^X;3^[0=#QN]>-JBB@ HHHH **** "BBB@
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M5C?#:QUK2CXC&MZ-+IW]H:Q/J,+/<0R+ME*@)\CD[ACTQS0!WU%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)SN/(VXX&.<_YQ
M2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<__ ,()X/\ ^A4T/_P70_\ Q-=!659>)M"U+5)]+LM7LKB^@!,M
MO%.K.N#@\ ]CP?3OB@"I_P ()X/_ .A4T/\ \%T/_P 31_P@G@__ *%30_\
MP70__$UO22)%&TDCJB("S,QP !U)-5M,U.QUG3X[_3;J.ZM)2P2:(Y5MK%3@
M_4$?A0!E?\()X/\ ^A4T/_P70_\ Q-'_  @G@_\ Z%30_P#P70__ !-=!10!
MS_\ P@G@_P#Z%30__!=#_P#$TK>!O"+L6;PKHA8G))T^+)/_ 'S6_10!S_\
MP@G@_P#Z%30__!=#_P#$T?\ "">#_P#H5-#_ /!=#_\ $UMV]S!=1F2WE25
M[QED.0&1BK#ZAE(/N*BU#4K/2K3[5?W$=O!O5-[G W,P51^)(% &3_P@G@__
M *%30_\ P70__$T?\()X/_Z%30__  70_P#Q-=!10!S_ /P@G@__ *%30_\
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M@< @X(R/\GK5Z@ HJM8ZA::G;FXLITG@WO'YB<J65BK8/?!!''I5F@ HHHH
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M5JGB32=&<I?W1BVJKR,(G=8E8L%:0J"(U)5AN; X/- &K1110 4444 %%%%
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MT*^%V,9EB(*^8S%E*L 5)79E3R >0,\@'<76L:98Q0R7>HVEO'."86EG5!(
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MN4*^8O)3.?O#N.M><W&FZD/ OP[US2;<G5M)6T@$=Q&0-DT:02!@<$#)7D=
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M"S,S <9(&!G).>@/TKD]/:'6'\"C2X)K:ZTY7-T'A\MK2!8?+D@D0XVEI#&
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MBRE3'(I8YZ-G&<UVO@N6>?PM;3W,$<4LTL\I\J%HEE#3.PEV,2R[P0^#R-]
M$47B&UL;[7IM5U[3$L+:XCCB!E53;9C7*2$X&XN&(')P1]!L6>K:?J%S=V]G
M>P3S6<GE7,<;AC$^,X8#I_\ 6([&O'_'\,MSH/Q02WC>5YKO3A$L:EBY58 V
MW'7!5@<=-I]#76V<C0_&^>"T0QZ=)X=C$FR/;&\R3'9@XP2(W.,=C[< '? $
M$_,3D]#VI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK!U;6KK3O$NB:>$@%IJ
M1FB\UPQ995C+J.PP0I[YXQWR #>IDTT=O#)--(D<4:EW=V 55')))Z 5PMIX
MZO;BT^SO!:KJZZ\=', 5]K;3N+\X('E@N#R#@#OD)/XIU'4_">L:E<Z!:2:+
M%9ZBLH:Z):9H6= NTH"$8(PR><D\# ) .Z@GANK>*XMY8YH)4#QR1L&5U(R"
M"."".<TD%S!<B0V\\<HC<QOY;AMKCJIQT([BN#T77M1O_$'A&WL8;6TTZX\.
M_;IK-/D10QA "X!^YN^48'!(SSPMIXJ73=*EN++1;:%IO%#:;,D4F-[-<;'F
M)P-S$\\X[<X&* /0*9-&)H7B+.H=2NY&VL,]P>QKD)O&TVF0^*SJEBIFT*)+
MD):;Y!+%(A*#.W(.Y6!., #<<#.+6G^(=7E\8'0+K3K1HUL$OI+VWGD**'+*
M$ ,>"=R-@EAE1N X( !OV&GVFEV,5E8P)!;Q [47W.23W)))))Y)))Y-6:Y7
M5+S53\0]%T^SFMEM/L4]S/&\K;F"R1(<J.. YVYXSNZ8YIKXWNFT6Q\2_9(/
M^$?NKA(B=[>?'&\GEI*1C!RQ4E1R >I(Q0!V-Q<P6<#3W,\<$*D R2N%4$G
MY/J2!^-2UQOQ1C,G@2<HK&9+RS,3)((W5_M,0!5R1L/)&[(QGJ*KWGQ GT34
M-9T[6M+C2\LM/&I6ZVDYE2>$OY>"2@*D/@=#D'('8@'2ZAH,&I:UI.J2W%PD
MNF/))#'&5V,70H=V5)/RL>A%:M<EX=\7W&KZ_/I5Q83(!;?:8[DVEQ APP5H
MR)D4E@2.1UR>!BK=_K6JKXEGT73;"TE<:9]KBFN+@HOF>9LVL%4L!CG(!S@C
MCK0!T5%</!XZOKRU\._9=)B^U:N;R!HYK@J(9X$D.W[IRI>-ANXP.<'/$O\
MPD_B"XAU 6>DV3W&DQ1?;4>X<"6<Q"22*(A2. R@,<\GD#N =G44ES!%/#!)
M/&DTQ(BC9P&D(&3M'? YXKE;;QJ\^O:1 UFD6D:OIQU"TOY)0IP$5FB9.S!6
M#;LXQP <$UF67B'^V]0\"ZK>Z' D^IR7C6LLCGS+2(Q,RX&,,715R<@#/ .<
M@ [Z:>&W0//+'$I(4,[!1D]!S4E>;^(=<O-8TW2+Q;.!-+G\0644!E)$X*7:
MJ7((P Q0XP<[2#GDBI-?^)YTS4;^#3=+EU--.G6"9+>*61IG.S>$=$:-2GF
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MXWP=?37'@?PU<Z)H]M;6ERX,UN)3MMH3O)*D\L=VT8_VC794 %%%% !1110
M4444 %%%% !1110 4444 %%%% !5'4=*@U0VPNGE,,$JS>2K[4D93E=^.2 0
M#C.,@9!P*O44 (P)4@,5)'4=169X>T*W\.:/'IEK-/-"DDD@:<J6R[L[?= '
M5CVK4HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\NULA9Q1Q1&&&-2P9V"%F^9F5<G/10.U;]% &%J6@3WWBK2-:CO8XETY)8Q
MT!8R++C?\VX8/R)C@XPV<Y&)?$NBR>(-)2P2XBA3[3!/(983*'6*19-N RXR
M4 SGIGCN-BB@#D-;\%SZS:^*;8ZJD4>N)"D?^C%C;!%"M_&-^<9'W<9[U/;^
M%+FW\1:=JRZC QLM(.G"-K4G<Q*GS,[^.47Y<=,\\\=110!Q5OH>L^&/#7AK
M1-(U(RO:7L23N+,8GMMY+JQ)(CPA)W9R64 8W8KM:** "BBB@ HHHH ****
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M_P!ENK?RIY("MS%L+;&*[U]4;&0>X(KSS35UJX\;>'-%UJ99=1T+[5=/=LA
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MT>Q-N26S_MKCZBM2O.QI,<_B#P1:BYN1"NCWS.R2R%W#"W! D^^G+9!!4C
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MF25TEB']U9%(;:>A&<$<'-:M% &9_P (]I0?3F2S2/\ LT8LQ&Q181C;\H!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH JZC/<VVGS2V=M]IN0,10[MH9B<#)[#G)/I7/6.I>(+#Q;:Z1K
M,ME?0ZA:RW$,UE:O#]G:(QAE8,[Y0^8N&SG)(Q@C'1WUV+&QFNC#/.(D+>5;
MQEY']E4=2:XWPI?7]QK1NM9TC4%UB]CP\AM62VLX5&1&CL><M@GNQ.<;5  !
MT>LG79;BUM-'^RP12K(UQ?7"^9Y.,!56,%=S-N)R3A=AR#D"JO@G6[_Q#X7M
M]1U*T2VN'9Q^[!$<JAB%D3.3L88(Y/!ZD<TV3Q)8W6F6C7VBZP(+\2(T$NE2
MRE-K;2)416VANHSP1S6/X(@OO"OAH6][8ZB8+G5G2PM5C\V2TMI'_="3#$*J
MCDG/RYQVH [NBBB@ KGM;UB_L?%'AS3K8VOV?4IIDG,J$N D32?(0P&3MQT/
MK70UR?B)F'C7PJXM+F5()+AY)8[261(@T+*"74;5))QSV)X[T ;$GB30XKNW
MM'U>Q%Q<3M;Q1?:%+/*O#(!GJ#P1V.!U(K4KR6YL[P> /$44&G:E]IN/$IN8
MD%E*)'0WB2;P-N2-JDY] .G2O6J ,^[UW2;"[CM+S4K2"XD*JL<LJJ26X4<G
MN>!Z]JS?&'B2WT'PWJT\6H6<&HV]E+/!'-(N2ZJ2ORD@G)P/Q%</\0K#4-6L
MO&%E9Z5?BXW6<EN8+1G2Y"F)FEW8^9U&Y-BGH,[2>1;U&VO+?3/B#ILVE7]S
M=:PEQ<V4\5JTB3(;952/<!E74J<*V.H"Y/% '<?VW:V6EVDFK7UK8W,ML)'%
MRXCVD*"Q()& #UZ>E8>C:UJ%_;^"I[C6["&34;(W-W9NJB6[+0AQY0Z@(22<
M=@*98&YT_P 77-S?:==SQ:IIULEM+%:LVTQA]\,@&5AR9 1G"G+9;BN>L].U
M!=9^$3MIUZ$T_39X[QC;.!;L;5$ D./E)8$<XH Z&3QK!KOA+6=1T75K'3/L
M=SY"7M^P,8"NJEV7L&.X*.I^4]3@=/J&MZ5I+(NHZC:VK.I<":4*=HZMS_",
MC)Z#(S7CVIZ/K ^"_BW0FTK49-4_M4NL26LCF=6N4<.A PXV@DD9QCG%=['.
M^G^,=;GO],NY[+4K2!K::&SDE#(BL&A=0"5;+$@,!G>1U!R =)=ZYI-@S+>:
MI96Y6'[0PFN$3$6X+O.3]W) STR0*LVEW;W]I#=VDT<]O,@>.6-LJZGH0:\W
M\$:'JNAZAX2T[6(KF>>QT.Z5YVB:2."22:)EB\W)4%45DP,<+P2" .C^'$-S
M;^";:&\@N()UN;HF.XC:-PIN)&7A@#C:01[4 6?%^LW^BVNF26'V;==:G;63
M^?&S@+*X4D89>1G-0+KM_%KVJZ'>3V22P::M_#?",QQQJS.F)%9C]TIDG< 0
M>V*K_$.&6YL-&ABMKN?;K-G-)]EAD<I&DJEV)097 YSQ[5HWVDV&FZ#K5Q8V
M4GVB[MG,KJCRSS$(0H/5VQDX';)XY- %BUUS3[;2;"34-;T]I9;,7!G,JQ),
MH4%Y5!/"<Y] ".:?;>)M"O&L5M]7LI'OT,EHHG7=.HZ[1G)QSGZ'T-<9I&G7
M,6I_#8-97>VQT:>&:1[9U$+F*%0'R/D)VL,''2LR&W8^%YY)=%OV>;QA]NB#
M:=.)DC^UK(9@HCW+^ZW#)V\$C.?E(!Z!IUY<S>*M;M9-5LKB"W6 QV<*_OK7
M<ISYAS_$02!Z8_'5NKNVL+62ZO+B*WMXANDEF<(B#U)/ KC?#%M=Q_%+QS<S
M64\-M<"P%O.\#*D^R)@Q5B,-@G''M79W-M#>6LUK<()()D:.1#T92,$?D: *
MT>M:5->Q646IV<EW+$)XX%G4N\9Z.%SDK[]*I/JRW6KZ5_9^LZ8UE,TZ2Q!A
M))<,@Z1D-@;"#NX/8<5Q*:9XDB\+>'-16SD;7M!NFTY0VXFYMV;[.TA!' .(
MY<G(VIG.#FNBEL8]&U[PGIME9W365I#/'YJ0NZI\BJN]@, L2222.A- %&Z\
M3:Q'X8\7WL+!KO3=2>WM1Y(QL B( &?F/SGDGK[<5WM>;ZA%,W@[Q=$=/OG:
M?5'9(ELYMTJDQX*@)N8<'D9QCKV'HZL&4,,X(SR,'\J ,^]U_1].%T;W4[.W
M%HJ-<>;,J^4'SLW9/&[!QZXJ6\U;3=/C62]U"TMD9"ZM-,J J,9()/09&3[B
MN/ENM/'Q/UU;[3VO671K6-6AL7G*(7G+Q,0#@ON!QP& _P!FLW0],U#28_"F
MFWMM?QW::%)!+<VD6^3=E,0&0@K&JCG)*Y95 ; PP!Z!'K6E37L5E%J=G)=R
MQ">.!9U+O&>CA<Y*^_2I[6]M;Z-Y+2YAN$1VC9H9 X5U.&4D="#U':O,Y=.O
M[+P%X-\0Z=YEGK>CVMK9O;W,3Q_:$?RXI()%.#]_!7@\J,#D&O1=&TR+1M'M
M-.A.Y8(PI?&"[=68^Y.2?<T 4-9\4V>C:_H>D3E/.U66559I HC5(V<L<]<D
M*H''WNO&#??6M*CO%LWU.S6Z:3RA"9U#E\9V[<YSCG%<GXPMKU?B)X%U2.SN
MY["TEO([E[>)I/*:6()&6502!G/S8P.Y%8]QI>H7'@/6/"DUC=MK<M_*T=S]
MF8QR&2<R).)<;!M4@GYMR[,8SM! /4JX>Z\8:EHWQ$30]4A@ETB>WB=+Z&!H
M_LTLCR+&DI+L"&,1 8 <D#'>NXKA;?3(-3\>>+[/5--GFT[4+.SB!FM9!#+L
M$N\!\;<C<O0YSR.E &ZVJ7O_  DVJV'FVD=I::;!<HTD;9$DCS+EFW8V 0],
M9^;KQREKXAL+#1[4ZQKVF2W?V(7<DL,BJLL8&3*BY)*>XX_E7/>%--UW1M7\
M0P^(6?4+>WL+:&TO8X6\RZ@5KAMK <-(N[:0HR<J3DG)Q-)T^XFUOX=PWVD7
MCVMKX?>WG$]A(8X96B1&5R5PI(1@<XX]010!ZRK!U#*05(R"#P17'ZYXQ"Z;
MXNATF:%-1T*T:;,J[\L(S(?DR. ,#.2,MWQ@]@JA%"J % P !P!7FVM6MS'!
M\3D2PU":?4+=1;1Q6CL)0;1(@4;&&.\L"HY&W..: .YTW6-/OY9;.WU.TN[R
MU51<I!,KF-CD?,!TY!ZU+:ZMIU]<2V]I?6T\T6=\<<H9EP<'('OQ]>*X36]-
MN-4\5R6VDVMQ:Q3^%;JQMIVM988897:,QJ6V_)@#..HQC&>*3PE8P/J&@@^%
M=7M;[2K8VLMS=W4RPVRB/:5C#-MF#$ # P ,Y! ! /1I YC81LJN0=I9<@'M
MD9&?S%<OX2UW4KRTUE?$,EG'?:9>20S);QM&J1A0ROAF8X92&!]_;CJJ\Y\8
M>']3G\9V8TNWSI_B"+[%K<@C<[(HLL&R" "REX\L".0.<XH ZOP_J=U/X2M=
M7UJ2&)Y8/M<A6(Q"*-AO 8$D@JI //4&J_A/Q+)XA_M:.XM7M;BQOG@$4D;1
ML82 \3E6^92R,I((!!SP*A\7(VH+IWAR&&Z6*^G7[1/#;,R0PIE^6V,@+,BI
MAN,,:R;R.]\-?$W3[Z*'5-2L]9M6M+^6.V+K;-&089&\M,<[W7G&!SG Q0!=
MU76?$NE+H(G;3%EU/4UM)(_LSMY*,DCCGS/F8!%![$YQ73:>=0VSKJ/D,ZRD
M1/ A57CP"#@LQ!R2.O:N;\:!Y]7\*0QVUY((-72ZEDAM9)$C012KEF4$#+,H
M_'-=A0!6OM0L],MC<7MS';P@XW2-C)[ >I/8#DU7&OZ.UO;7"ZK9-!=3_9H)
M5G4I++SB-3G!;((QUR,5C^)+>>/Q1X;U@6\UQ9V;SQ3K#"96C:5 J2;1EL#!
M4X' <D\ UP&L:!?37UMJ%KHU_'87OC.SU 6IMV9DB6/;-.Z#.P,^3\V#C&0.
M@ /7--U;3]8MFN--O8+N%9&B:2%PP#J<$9'^>A[U4\4:_;^%_#.H:S<@.MK"
MSK&6(\Q\?*F0#C)P,X.,Y[5E>&(KB/QCXR=[:>*VEO('A>2!D63_ $=%<J2!
MN^92,C/ZT_XD65UJ'PZUVTL[>2XN9+5A'%$I9G.0< #DGVH S+KQM)#XQT=#
M<01:%<Z/+J%P[+DQ[<<EQV&<?6NNN-9TVUTZ+4);Z 6DP#13!PRR@C<-F/O9
M'(QGCFN#M(+B;XA>$]0_LJ\CM8M"D1GFLY!Y#G&%)P=CX!X)SCCJ1FA86L]E
MH/@[5YM UAK.P@NH)K.U$T=U:M(Z[&\I<,Z@(RD>CA@"!F@#U.UN[:^MDN;2
MXBN('SMEA<.K8.#@C@\@BLW59=<DOX+/2%M((S&TDUY=PM*B\@*BHKKDGDDE
MA@ =<\1^%;:WM]*E>UTF?3(KBYEG$-PY,C%FR78$G;N.3MSP,<#H*OB_6[W3
M8K6SL+'4II+I_P![<V=JTOV>($;SP"-Y!PH/&>3D+@@&,GCV]30+836D+ZU/
MK;:&HA5C#YJR,K3%2=PC"J6QDGH,@'(V-"UZ^O-;USP]>",7VE+"T=V%PEPD
MJ$J^S.005(8 X)Z8S@<]J&DK<:5X>OM%T*^M8- U<2&UN499I(3D2R(OS,YW
M/N^;!;:Q&<@MJ>'],N_^$W\3>*KN&2.TN8X;:R1HV$ICB4^8S1XSR_W>Y Z<
MC(!9LM=UR?PKJ%['I\=[J4-_<VEM%'^[24)<-"KG))51C+=\*?:H=/UCQ GC
M:VT"_O=)NS]@>\O!:V,T)@^95C =I'5MQ+\8!PA/<5>\$R-)H,Y:WNH"VI7T
M@2YMI(6*O<R2(=K@'!5U/3OCJ"*AT'3;F=/$&J$S66H:K<R)%,\?[R**,&*$
MA'& .#( 1SO.>N* -36IM87[+;Z-';B>>7$ES=(SQ01@9)*JREF/  R!R23Q
M@\ROC'5-)T3Q(-5@M[S4=#FCMTE@S#'>-*J&+AL[&/F(&&2 3QQ5EI/$GA32
M+EKN_N_%-[<SA+-8]/6+R!@_ZPQ\;1C)/!/0#)%9%QITFK^ -7TS3=,U1;N.
M>*ZDDOX##)>W"2K*^T,>_E@ _=&0!PN* .ETW4M0M?%4F@:I=P7;R67VV"6.
M Q-@/LD4C)& 6CP<YY.<XS3O"NL7NK3^(([UHC]@U5[2'RD*CRUBB89R3SES
MWJM9V\NI_$(ZY'#<165MI1LU:X@>(RO)(KG:K '"A!DD=7QV-5_!R7B2>,"E
MK-!+-K,TUL;NWDB20&*-589 W+N0\CT]Q0!G>&?&.K:O?Z!-+-:2QZN+CS[&
M),/I_EC(R<DG!VHV0/F<'Y?NUZ)7F/AK3+R#Q%X>U*&POK34[FWE7Q(TL#JD
MS;."6(V,1*/E*G.UCV->G4 >;#QUK<>@>*M:D73G@T'5IK0P) ZM-%&4S\_F
M$*^&/.",CIZ=QJ&O:3I4R0W^H6]M(X! D<# .0"?0$@C)P.*XCP%H=O=7OBF
M;5-)O%9O$,]W;K?Q2*CH=OER*K@*W(8C@E>/8TSQA9W]\OCJVCTN[<SZ3&ML
M+2W(-V0K<F7^)D)P(P02N[Y6W< 'H,>I6$NHRZ='>VSWT2!Y+995,J*<8)7.
M0.1S[UG-XP\.)IXOGUJR2V, N?,>4#]T6VAL'G!8$#U((&:YWQ9I\EUJ>A:Y
MIOF6M_J"-I4H9=DWD3(SYP<_-$5,FW'\+ D=:OV=C%I_Q!M[>UL&BL;?1!;P
M.EJX2/$H.P28V\@*=N0?E[YX -N+Q%HL^JQZ7%JEF]]+")XX%F4L\9&0RCN,
M#/';GI4B:WI4FI?V<FHVK7N6'D+*"^5Y(QZ@<D=<5Y]X7M;C3O"GPX@GTN^C
MN+>[<SI]BDW0 P3H3)\OR#?(G+8SG/8U2\*>'YK*RTWP]K7AG4[W4M/U478O
M'N'2TXE=UN0P8IN"N?W8!). P Y !Z-_PE.@_;[6Q&K69NKMY(X(Q*"79"0X
M'N""/J*JV/C'2;W4]:M?M5O%'I)7SII)0HP5RQ.X#"C(^;)'/6N3:V?_ (1*
M!O[%O1._BS[656TD$BK]O,GG.H7)'E#&>1C'/&!8N[)8]6\>1ZMH>HW^G7[6
MDBQVT3G[1%Y21OL92,LI4DJ#NP. <B@#N;#5M.U57;3[ZVN@FW?Y,H?9D9&[
M!XR#GFI[BY@LX&GN9XX(5(!DE<*H).!R?4D#\:Y?P7'?PSZM'<FXN;-98Q:7
MUY;&&YF7;RLFY59MG #$<@]R#4WCE)VTBS\BUDF"W\#R2PVYGEMD4Y\V., [
MG4@8^5L9SM;&* -B'6]*N-/FU"/4;4V<!833^: D17KN)^[CKS4:>(M%<W2_
MVI9H]HGF74<DRH]NO7,BM@H/]X"O/-5C9/#OCF673M5$EQ>VDUH\T.U[EMD"
MQ$="W[U#F,8(!VA58[:AU:>74K#Q3<OI%Q=ZOJ5E"8M)GTR1%,$$N"RAL>?(
MAEW=CP@ P02 >ARZY8W^A:E=:9JUK']GA?==.-R6[;-P=P<?* 0WN.>AIZZY
M86=G -0U.T^T&S^U.0=N]% W2*O7;DC\ZX.XT[4)H?'TJ6NIW U/P]"MK+<6
MQ62X=89E(V!0 ^6 V!0<_P (R,ZL=I<S>*? EQ]@NO)M-,N!+(\#*(7DCBVJ
MV1E6^1P0<8X!Y(% '4CQ'HS:=::@NI6S6MX0MM(K@^<3V4#DG@Y Z8.<8-5)
M?%VF#7](TJ"XAG;4X7GBE23*E%'!4@8;)XX-<9!86TFC6B36&MV,W]IZC<Z?
M?6.GS*]CNF=D+QXR0\;XY3&/E.#6CIT&KP:EX(N]0TJ82K975M=?8X%5(99#
M$RM(HX12(W)QC#8'?! /0:X34O&\ESX7OM3TIDMY;'5XK)EDP_F)]J6%F(.-
MH;+8Y'3J.W=UYK]GO[CPWJ&F-IEV6A\3B=DFM'V30-J/G90\[EV?,6 QCC!/
M- '=6NN:7>+>M!?P,MBY2Z._ A(&3NST&.<],5)9:K9:C+/%:W"O+;D"6,@J
MR9&5)!P<$<@]#VKSCQ9X9U;7=0\;6MC:GSKNVTV2T:<.D,S02,[IO'&<$#&>
MI'3!(Z;PTD6H:PVL+X<O;"46OV9KO4Y6^T'Y@QB56+$Q@@G=D G&T,"2 #K:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ J![VUCO(K.2YA2ZF5GCA:0!W5>I"]2
M!D9QZU/7+ZQJ$UKX[T.VAT^VG-Q97K&4H/.79Y1"JY^Z"6&<\'CIB@#J**\^
M\/\ B?Q)=Z1JEU=-IUWJ5M8O,VDP6TD%Q;W(7B)E9V+(Q!PX')SCC%4D\:^(
M;?P[J6IF^T34$MI[*.-H[:2*0&64)*DT1DW1LNY<9QG'(YX /3J*Y/5?$&M:
M??>)(K:SM+W[#86UW91;Q ?WC2J_FR.^W"F(MGY>,CDUSLOCS7;"T\3VA_LW
M4;_2]/74[:\BB>."6)N2I3<2=H#88-AACIR2 >G45Q=QXLU#1O$FKV^L0P?8
M8M(?5;9;<DO&D6%E5R>&)+*1CIR.>IKQ>)O$VCZ;?ZUKUI8W&DC2O[1BEM#Y
M7E2@?\>Q#,S/D8(DP!G(QR  #O**Y70=4\0S:]+:ZE LUE-;B>.XCLI+86T@
M(!A;S&)DR""&&.0W&,8T_$6J7.EZ=&;*%);VZGCM;<2?ZM'<X#OR"5498@<G
M&!C.: ->JD&J6%S>S64%[;R74 S+ D@+H,XR5ZXSD9]01VKG;&_\1)J5[X=O
M+VPDU(0+>6FH"S81/$7VLCP^:#N4@C(?&&4GD$&C\+M(FC\$:#?:G'9378LE
M-K,MMB:*)QNP9"S%LY!XV^XH [22]M8KE+:2YA2=QE(FD 9A[#J>AHFO;6WF
MCAFN88Y93B-'D 9STX!ZUR7Q$ADLK32_%=M!YD_A^[^U3!4W2-:,I2X5 2!G
M8=W)_@J73'M?$WC:76XO)N++2[5;>REV$D33 22LI/ ^3REXYY89'(H ZUI$
M1D5G52YVJ"<;C@G ]> 3^%17-[:V2JUU<PP*QPIED"@G\:\R\:^(EGU=]1@N
M###X4NX9B-P#7A.5N%09Y"1DK_O%AT'/HPM=.U*>RU91%<M'$QM9U?<FR3:Q
M9<'!SM7#>G0X)R .@U;3;F98;?4+265ONI',K,>_ !JY7$?#BSM[OP'IYGC#
MF"_NYHCD@JXNI@",>Q(^A(KH/%6HW6C^$M8U.R6-KFSLI9XQ*3MRB%N<=>G3
MOTR.M &O17%7_B'7;.2WL)190WVJW,C6+Q127(M[5(U)9T7!DDW'&%(7YP<D
M#!2U\1^(M0ATO3'LH-+UJ\%PTDT\320K'#L4R+&61CO,B%5)RH)SG'(!VU03
M7MK;3P03W,,4UPQ2&.20*TK 9(4'J<<\5Q-WXJUVW;1] NUM;+Q#?Q7$DTT-
MM)=10I&Q"NL:MDEOE(!;Y><YZ&2UUO5[O_A$;C5_#]O;W\]]-:W >/<T3""5
MO-@+$%%8(2003M)7D\D Z*T\/PV7B/4-;CN[II[](HYHFV>6!'NVXPNX??;O
M6O7G6I>,/$]CIFH:P(-'.FZ5J4D-XN)&DDMU=1F/Y@ ZJ6SG@D=!C!L^%[SQ
M!=_$SQA!>ZG'+IUD]O%#;F#&Q61I%VX?@_/\S%27P/NXV@ Z"[\+65_XEM];
MN[F^F>U -O:-<'[-%(-P\T1CC?AF&3G@]*W*Y'XA2:S%HU@='NHX-^IVD-P6
MB+$H\R(,$.I'S,N<$$@\%>M4[KQ/KEU-K$.C/I[/X?B7[:\]NVV]G\O>R1@2
M9B4#NQ<Y.,87+ '=53_M;3?M'V?^T+3S]^SR_.7=NSC&,YSGC%0>'=:@\1^'
MK#6+>-XXKR%90C]5SU!^AKSVYM+RX^)_C:--,;5(Y]'MX5A&Q44LK *Y=AD$
MJQR.<=N.0#T^2[MHKJ&UDN(DN)PS11,X#R!<;BHZG&1G'3(J:O.]!CU/0+WP
M-H&K+;7=Z;"[,UY+^]FC*>6=B/@87# 'UV+SQDKIWC#Q->Z5H.K?8],:"[OY
MK&Y@1W5B?-DCC9">%"[ 6SNW G !P* .]NKNVL+62ZO+B*WMXANDEF<(B#U)
M/ J2.1)8UDC=71P&5E.00>A!K@)?$.LKX3\:VVK0:9>:CHT$A8JA^SSH\'FA
M2AR< ,5*G[P YYS7;Z:S-I5FSQ1Q,8$)CC&%0[1P!Z"@!UM?V=ZTRVEW!.87
MV2B*0-Y;8!PV.AP0<'UJQ7F>J:SK_A^Z\:ZQI=EILUG8ZA%/<BY=Q),@M+?>
MB8&$(7D,=W+?=XYOW'C6_P!.\0SQ:@;=-+N=(DU+3'2T<NY1=SQN?,.65<'"
MK\P;J",$ [VH;:[MKR,R6MQ%.@.TM$X8 ^F1]:ATG[?_ &1:?VH8C?F)3<>2
MNU ^.0!D]_>O/[N'6=.\6^(/$NB1_:!:7J6]_IX;;]IMA:P2;D'0S*TCD$D9
M!(]* /0)]6TVV2X>?4+2);8;IVDF51$/5LGY?QJU'(DL:R1NKHX#*RG((/0@
MUY1_:T%Q:?$W6])2RU"%H;>XC^T1[XIHQ9HQ#*>HQNX/?BNEU35?$-MKEKX9
MT==,^TRZ-+.)WB:-(ID9$5MN3B,EL;?F(XY('(!VE5=/U*PU:U%UIM[;7EN2
M5$MM*LB$CJ,J2*F@\[[/%]H\OS]@\SR\[=V.<9YQFO-;'Q#KNDZ#X?6/3](2
MXO?$,VF7L-I$8HAB64,\6<8_U3$DAB<GH3P >G45S/@O6-3U6SU.#6&MGOM-
MU"2RDDMD*))A4<$ DD</C\*D\47FL1RV%CI-Q!9FZ=Q)>RPB<Q[0"$6'<K.6
MY.1D*%8D=P =%17!V7BK5]<T?0+6UEM++5M6BN)7N6@+1Q+"P5ML3.&+$LN%
M)R!N)Z8JPNJ^*=1CT[1F6ST;79;-KN\FV"ZBC"N$VHN]22Q.<DD*.,L2#0!V
ME%<-9^)_$,?C30-#U6VLH&OM*>XNXH@6,4Z'!V/NQM.1P0<8ZFJ'A_QKXAU+
M2]$N)[>SEDNM8N--F6.-HPZI'*5<99MO,66Z\9P* /2**\RO_%/C+2='U6]N
M_P"R9!H-WC4#'$X%U&RQRJD66^0A)<$L#SCK@YZ.;4-?;Q3KVE65Q8L8].@N
M[ 7$!"QR.9$VR%7W,I,1.0O&[V&X Z*2^M(KZ&QDN8ENYD9XH6<!W5<;B!WQ
MD58K@=-NGU[Q)X%UBY@VW,^@7-VYAP$#.+7(Y).T;S@<GD>]1:9XE\1S:]8P
MW<UJJZPMU'!;+9EET^6(9&Z59-LXX(8*5RW3&#@ ]#HKR'P5XQUQO /ATW5U
M'=ZKXAO;B*WN'MR1 ?-D+O( _P ^,$JJA !@< 9KIH]>\21Z?::3>Q6T&MWN
MH36-M>/&1')$D;2?:O*R2/E7&PL/F[@4 =A!?6EU<7,%O<Q2S6SA)XT<%HV(
M! 8=N"#5BN(\$I=1^+/&@U"XAGOA>VPD:W@,497[-'M(!=B#CJ,GD=><"YXV
MUS4]%BL?L+0VD$KN;C4KFW:>&V"C*K(JL"JN>-^<* >Y! !U=%<O9:SJLWC"
M;1YFLQ'_ &/#>(T:$[)6=T;/S?,N5R.GU[USEAXR\3:I#X-BM8+)9==TRXFE
MDE4_NIHXQA\ \H6=3M SSUQ0!Z717FFB^-?$>JP:)J1M[(61OVTN_A0DR2RY
M*^<A. J@@-MY."1DG%>C7-Q':6LUS+D1PHTC8&3@#)H EJA>:WI6GWEM9WFH
MVMO<W+K'#%)*%9V;.T 'UVD#U(QUKC[/Q-X@2+P_KVH2Z<=&UN6*);.&!UEM
MA/S"3(6/F-RBM\JCG(Z5#X>L=2O_ !]XPAU.[TZ\L$NK7SK:2P8AL0(\>PM(
M0F"5)R&R02-N> #T&>>&U@>>XECAAC&YY)&"JH]23TIMK=VU_:QW5G<17%O*
M-T<L+AT<>H(X-5-6T[3;U(;C5%C>WLF:?$Y'E*0I&Y@>. 2<GIUKSG6(7M/!
MWBW4+*V-CINJ7]K';1(#$9(F:&"63:#\N_+8(P2H4D<T =KIVF:3J6NR^)+7
M5Y]3!(6*(7OG6MLZKL8Q(/E5R"03UY;IN.=Y)X9998HY8WDB(6158$H2 0".
MW!!^AKB(!'9_'*:"VE$:7?AU9KBW1,!FCG"1N3W.UF4>@'N*TO#-G!#K'B^"
M&$0PG4HU"P@1@ V=OG&W!!Y)_'CG- &ZFK:;+.((]0M'F)VB-9E+$^F,U;9@
MBEF("@9))X K@WTO1CX\T30M,TVWB31X6U&X>- "A*F*%&;!)8[I'Y.?D!.<
MULIJ7AGQM$=.CNX[Z)0ES);J659$S\NX<;T)'0Y!Q@Y'% &W8ZC9:G;_ &C3
M[RWNX-Q3S+>59%W#J,@XR*;:ZII]]<36]I?VMQ/ 0)HXIE=HR>FX Y'XUP5[
M"+$>-O$VBEK.TM]'>VA6$!(IKB)96>7 '.TE4# ]5<<X!J6""#2M3^&\-B@M
MU>":U94'WHOLID*D]?OQHWN1GZ@'>?;;47XL?M,/VPQ><+?S!YGEYQOV]=N2
M!GIFHY=4T^#4(M/FO[6.]F7?%;/,HD=?4*3DC@]*XA8T3]H=V5%4OX6W,0,;
MC]J R?7@ ?A7*:I#;)KOB+3K^^C;PSJ.MPO>:K&OEM87"@/Y#/CN5B <'"9.
M2"U 'K^JZ5;ZQ9BWN&E0+(LL<D,A1XW4Y# C_)Z&LO2+;1[*_#_VXVHZB4,*
MR75VDDB@D%E51@+DJI( &=H]!CHJ\6ET74-?M?B1IEEI374E_JODQ22-&L<3
MHBMN8LV>XQM!.2.G4 'M-%>9>(M=\0^%;"<6VHVC0:#IMO))#-#Y\U^?NLSL
MK@Q#(&"5Y.X\@$#?U'7]0T#QF(]5N+;_ (1^[M)9+9UA(DCGC56:-FW8(**[
MC@$Y(_A&0#KJ*\ZTK6_&DU_HVBWC6$6I76BSWMU)+"1Y,OF*$^13\VT,%*Y7
MJ6SP%+M-\2^*9E\,ZE>_V<NGWT_V&ZMXHV\PR[9 9 [$?+OC!"A<X<YSC- '
MH=%<$?$_B2]U::ZT?33>:7:ZF=.EM@$1F"DI)+YA?.5<@A=N-JG)YRL5[XH\
M20V.IZ@$LX[?3-=6U9!&2US:ET4XR1L8"3KSDJ> ." >A45P.E7'B)/%WC5_
M[1COTLD5;2Q\C;\[1B2-=V\XP&VG@;B=W%:/@S6;_6/MHO+^.9X5@WP^08)[
M:8KF6.2-AD+D95N<JW!.-Q .MHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L'5_
M#9U;6K;4#?20_9[.XM46-2KKYP4,ZN""K#8N".G/KQO5EW^K&#5;+2K5%EO;
MG,K!L[8X%90[L1T^\%4=V/H"0 9@\*W;W3W]QKDS:H-.-A#>10(C("P9G*\J
M6)5>P QP!FJE[\/K;4?[;GN;^7[?JR6PEEB0)&K0$-$VS^(Y SDG(&!M%;1U
MQAXR70/LR[3IYO?M'F\Y\P)MV8]\YS[8K*O?&DL%MJ^H6NE&XTO2)FBNY_M
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MC<K9PK!'*4"$HHPN0.,@ #-4?#/BRV\5:,UU8Q&*^A 6YL+DF.2WD(SM?*Y
M]&Q@_GC-/C34/[#\+ZBNCVI.O30Q)&;YAY(DC:0$GRN<*O(P.?SH Z^>"&ZM
MY;>XBCF@E0I)'(H974C!!!X((XQ65X;\.V_A7PQ;:)IKGRK97$3R@MRS,V2,
M\\L>,C\*H6WBR?5=:UG3M(TV.X.D.D4[3W/E%Y""<( K9&.[%<GCIS6[I=ZV
MI:197[6\ELUS DQ@E&'C+*#M;W&<'Z4 4=(T.33/#K:5+=)=DB3,TD.#(7)9
MF< _,2S,3C&<_C4/A3PY-X5\,PZ+'J!NDME9;>6:+!4$D@, ?F )]N*U?[0@
M_M7^S<M]H\CS\8XV;MO7ZU-.9E@<V\<<DP'R)(Y12?<@''Y&@#(\+:!)X:T9
M=,^V"ZA1Y)$<Q;'R\C2-GD@\OQ@# '>K6O:6=;T&^TH3B%+V![>239N(1U*G
M R.<'C^1K'TGQDFH^!)_$L]K':M;Q3--:M.3Y3Q;@R.Q4$'*X^[WXS6IHVJ7
M5YX<M]4U:P&ERR0^?);-(7,*XSAB54A@.HQP<B@"KJ/AN2^L]+\O4I+34--8
M-#=6\852,;65H_NE67MVX(QBJMWX.EN%LKF/7]135K.662*_<1R-B3 ="A7;
ML( P !C .<YS>\.>(X_$?A:WUN&VD0R(Q>U!#2(ZDAD[?,"".<5F#Q1KD>K:
M)IEWH-G!=:I!--M&HLWDB,*2K?N1D_.HXX^]SP,@#[SP/%/'IUQ!JEY!K-@T
MC1:F AD?S&+2*Z8V,K$GY<?+QC'>Q#X5-NVDNNIW$TEC=O>32W7[Q[F1HFB)
M)R-H"NP  P,+@8&"^#Q'/'=Z?;:MI<EBU\6BCD$GF1B==V8R<#&X+E&Q\P_N
MG /04 ><^&]''B+2_$-C<W4?]EW&N73RP)" TL?FY W;C\CXSD#)!.",@CJK
M+PZ;#Q3J>LPZA/Y>H^6T]HR(5\Q$$88-C<!M XSU&<XXK<HH S==TG^V]):R
M%U):OYL,\<T:ABCQ2+(IP>#\R#@]JRI_!L9U/4[ZSU":VFU>V2WU%MBN9MB[
M5D7/".%+#@%><[<BNGHH J:9IEGHVF6VFZ?"(+2V01Q1@D[5'N22?J:R-/\
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MHKN** "LO3=*ET_4]5NVNEE34+@7!C$6WRV$:1C!R<_+&OXY/'2M2B@#C?\
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MCCMN+8%7-)T%M,US6M3-WYQU25)73R]OE[$"* <\_*H_'GVK:HH R/$>A?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10>V PSF@#L***XW2/$6F:+X>T.(?VW<PW\LL-O+<H9YBX+N%?;R,A6"C'
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M9H[G[7;:8=4.U 5>$,5.W!SNR.A ZBJEAX]TS48;&6"SU3;?6GVJWS9/^\P
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MBB58%D6611\LBNQ;.]6 "X'?/<:/>MJ6B6%^Z&-[FVCF9"I4J64'&#R.O0T
M7:*\[A\1/X5\3ZC#J%W=R>&UN8[)9[@M,UG<&&%UW2'+>6XE W,3AEY.&S4V
MJS7,/A_XD3Q7UXDMH\CVSBY<F';90R@)D_*-[,<#'6@#OJ*\\UZ_N=#A\-OJ
M*ZI)H"0,VH7=G<2M(D_R;&E*_O#'R_ )!)&1@ 'J/##++ITMQ;ZD-0TZ>8RV
M,_GF9O)*K\K,><A]XZDX R<YH VZ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.UV74XM%NCHUND^HE"
ML"O($4,> Q)SP.N,<XQ6-X:M=5TFW:S&CK%;K TK3W%_YUQ=7)/61@N.0,EN
M>H  "XKJJ* .3OO"PUW3)+[48)[77+BP$$RV6J7$<60&*J=C*& 9VZ@_>/6I
M/#6E:IX<\,^'-*AMXYC%%''J#3WCL8L1?,8\[LC>  HP .@ Z=110 4444 %
M>?7NOZ/:?%-+Z\UC2[6&VTV6QE$^HP(ZR-)&X)0ON PA'(SDCC'->@U1DT72
MI9&DDTRS=W)9F:!223U).* .*\0^+-!O=9T@P^(- O-+0R"[MVUN.$!R4\N0
M@']XJXDRAX^8'!(%93ZCH4OPJET>/6M%_M6S0R6,5CJ,4ACG63-N5(^[\Y0>
MF#@XYKT6;1]%@A>:32K((BEF(M5)P.3P!DUSR3^#+R#PYJLNB01MJ;^78F6P
M :-W0L5; (4X4CKSCC(YH YO4[_18-/\*6O_  D^AW=W8ZI'J>H3MJ,,0D8H
MY=P!(A^9I=RC[N!R"/E9NM7MCJOACQE90:SI3OKMZ1I\K:E;[)2(;>,H"&ZC
M:#C&=K+G)-=U81^&]2O]1LK?3+3[1ITJPW"O9A<%D#C&1R"#U_\ K5!!-X:N
M?%5YX=BTBW-Y:6R7$K&T01@.2  >I/&>!CGKG( !R6H:]H,7BRZU:WU3PGJM
MMJ%O%&\-YJL$;6TB;@"#\V5(89QDC;P#2QZKI5GJ'B.\FUO0OL^JZ9;VUI)#
M?P)%))$DBN%!?A<R#'7&#GMGT/\ L+1_^@58_P#@.G^%']A:/_T"K'_P'3_"
M@#SW0M;TZQ3P:T6KZ'<&PTPZ3>*NK0@QN_D89<$A_P#4/@9!((]Q7HVG37TT
M4YO[6.W=;B5(@DF_?$&(1SZ$K@D=J8NAZ2C!ETNR# Y!%NF0?RJ_0!S?CW2[
MW7/!.J:3I\/FW5Y$8DRP55/7))/3CMD\]*I>(]%U'5OA;<:';VI%_-9+;"-W
M4 ,,#).<8XSQSSTK?TK6[76+C48K:.Y7[!<FUD>:%D5W !)0G[P!)&?4'L02
MMKK5I=Z[J&CQ>8;FPBADG)3"_O=^T ]SA"3VY'.<@ '*^)?"EWXKUJZ66*2S
MLKG1); W!,;-'(\B.#M!R0-N#R,D?1A?\*:;K%E)"NHZ5IEG]GMC!)/:L&:Z
M?<N'^Z"JX7."226_V<GJ]P#!<C<1D#/./\D4M &-XHL+S4=#\JPCCDN8KJVN
MDCDDV!_)GCE*[L'!(0@''4BL;6-$UW4Y-;U+3Y_[-OI],%C8JY7<C!F<R,RY
MVY+;0 3C;NZG Z/6-9L=!T][_49)([5#\\B0/*$'JVP$A>.6/ [FGWVJ66G:
M1-JMS-BQ@B,\DL:F0",#)8!021CGCM0!PL'A?5;?7]6U"WTBV@@O=#%HL27.
MY_.#/C>Q^\2",M_,]9M(\/:_9VGAZSNK.VO;2TTA+62&ZG 6&Y3 WE5!#J5&
M%.-P Y^\<=2GB.QDUZUT95NA=7-HUXI>W=%5 P7#%@,,<GY>H"G.,C.O0!Q/
MAW2-7TZ?PNEUI^(]+T)[":1)D;,I\CH,CC]P>?5AVR:Q]"\->*M"TO0+J&U@
MFOM,DOHKFUEN@GVF&XE$FY752 RL$." #ANG%=S'K]K)XHF\/K#=?:8K4732
MF$B$J6V[0_=AD''H?8XU: . U?PMK-]JNB>)9;6PO=0M%EAN=-E;,;12/D!)
M"H&]!@9*X;!^[WZW1+:YM;#%W!:6TDCE_LUH/W<(('RAL#=TR6P,D],8JY=W
M4%C:37=U*L4$*%Y';HH'4U4_MW3/[#@UDW:+I]Q$DL4S KN5P"N 1G)R.,9H
M QAINJZ-XHUG4+"SCO8-62.4DS!#!/'&(U4@CE& !R#D8/!XK,C\*WFC/X(M
M[*U>ZM] 1Q<2(RKYA:!HR5#-U+-NP> #P>U=9I&NZ=KD4KZ?<&0PN8YHI(VB
MDB;T>-P&4_4#(YK1H *X;3-%UR'0?!5I<6:13Z+<HMQY-PK@Q);20;P2!]XN
M#MZA<\@UW-% 'E]YX%U?48[V\6&"&\C\1_VQ;6]TP:.XB\I$:)]NX*3M/.&Q
MQCJ2.T\/V%Y;O<W5U9V=@)PBI96JJ1%MSEFD"@NQ+?0 #'.2=RJUW?VME#<2
MSR@"WA,\BJ"[A #D[1ECT/0<XXH P=;L]3D\9Z#J5K9O/964-RMQMD16+2!
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MCR;Y%)7*G.=F<MD\GL!A?#U_J]Q<^$=2N=3DE36-*S<6A0")7\M)%=/X@W+
MY)SGH,"NGE\.:7-J=YJ,D$C7=Y:_8YG-Q)@P\_*%W87J3E0#DD]S38/#6G6K
M:.8%F3^R(?(M5$S;1'LV89<X;@#D\\=>N0"?7?\ D7M3_P"O27_T UB^$Y+"
MV^&WAB]U![:**TTNVE$]P5583Y 4MN/W>&89]&([UTMS;Q7EK-;3J6AF1HW
M8J2I&#R.1QW%9MSX9TR[T2WT>9+HV5NT;1*M[,K@H<H?,#AS@@$9/4 ]A0!G
M>&(8YM8U;7GC^SSZOY30P2#9-]GB7:CNI/!)9CTR%90<$$"EK)U/4/B)!HD&
MLWEA8S:++.XM@@=76>,;E9E.&(..<C&< $YK=TSPOI.D:C+J-M#/)?2Q"!KF
M[NY;F01@E@@:5F*KDYP, G&>@JTVCV+ZY'K)A;[?';M;++YC8$98,5VYV]0#
MG&>!0!YO;:UX@L]2\#7MSK,UP-3FEL+NVV((9%7<$DQC(DX!8YP3P,#BIX]9
MU:?PS+XP.KS">WU5XSII=$A$*W)A\AAMR7*G(8\[BO;BNS/A#0RNE VDA&E2
MM-9YN)?W;DY)/S?-_P "SZ4D7A#1H-1GO(8)$^T7(O)K=9G\F2X!4B4QYV[\
MJISCJ >H!H XOQ-=Z[8Z7XPU6'Q%>HNB:BLMM J1@.#!;R&-SMYC'F$ #!Y)
M8N<8BNH)9/BUXPF:]NBD6@)MA+C9@JPVXQG .6Z]6)[UWUWX7TB^L=4LKFVD
MDM]5D\V\0W$G[QMJKUW97A%&%P,"F3>$](GUF;57AF%W/:&RG*7$BB6(] P!
MY(YP>O/TP <%\/[F_P!/;P1!_:$DMCJFB2YLP$$4#0B(JR[<G<=[;MS'DGA<
M!1:6#5K/P3JNJ:=/*&M/$=[J#P6QVO<V\=U()8B<=2H<C'.0HKMK7POI%E+I
M4D%M(K:3 UO9$W$C>5&P *\L=W"J.<XP,=*HW]EJ&@Z?';>%=,CE:]OW:ZDE
MG -OYI9GG^;[^UB#MZD<#U !+X=U :Y?7^LVEX9](E$<-EM;,;[ 3)(O/=FV
M=!_JNG.3@:FNOZIK_BJPLO$DFFP6=O;SVY6)2T<A1C@NPVB+*98?>)/WE7AN
MUTO3X=)TBRTVWSY%I D$>>NU%"C]!7,CPNNI^*_$LVI6ETEC>PVT"NMUM2Z0
M(X="JMG WD'<!G/''- '.Z_XDU/4/#JZG;7DUO(_A=M4%K8RA6@E*AQ*Y.,Q
MC!4#)+9;Y?ER)_[;U2T/@[Q?J.H3C1;W3HUU.-/]5#/)&"DI4<X+-M] =O<U
MV-YX3T:_U 7L]L^\V36#QQRND<D!S\C(I 8#+8!_O'VQAW'A^_8Z?X0M],1?
M"UJEO,;^:\,LC>3('$&P_-DE$YSM"Y YP  9X77X]2\):+=:W?V[ZC87LE[M
M*-)&XV,H5RIY3S"H)SPH.,\UGZ?=^(EL;74&\17L_P#9GB,Z3)$\<92YMS=>
M3NEX!\S#KA@<#:/ER2U>DW&CV-UJ]GJLT+->V22)!)YC (' #C:#@YP.H/05
M0/@_1#:M;""X6%KXZ@RI>3+NN"P?>2'Y^8!L'@$9QF@#C(=6\0Z[JWB2[LM6
M2R&CZPD"6]S,$C2",*)-\8C)=907(8L#D+M*X.6:O<:X7\?S1>(K^(:$Z7EH
MBB/:0+82F)L*,Q\XXP>Y+&NVN_!VA7NO+K4UD1?@QEWBE>,2F-@T9D52!(5*
MKC<#C ]!B27PKH\R:PLEM(PUD 7_ /I,O[X!=F/O?*-O&%QQQ0!QD<=R_P 8
M?%!M;EDNHM$B^S--,WEQN=V,C)&T$YQ@@<G&:T? S:I!J<MAK.H:B=0AL(3<
MV=YMD5Y,L&GBD7C8Q&-O4=P*W;OP=HM]J$][/;RM+<V#:?<8N) )X2,8?#?,
M0"0&///7@8N6&AV>G73W,37,DS1K$'N+EYF5!_""Y)ZY))R23UZ8 .3U2^U'
M6_'.J^'H-:;2/L.EK<VIB'S2R.2/-?/#)&54;>,[SG/:>UN;SQ+KEUI\NJR0
M);:1;31SZ;)LBGEG$F9XSR61=@V@EEY.02!6WK7@_0O$-U'=:E8^9<)$T'FQ
MS/$[1-]Z-BC LAR?E.1R>.34LOAG27N8+B.W>VEAMA:(;29X,0CI'\A'R@\C
MTYQC)R <)IFLZYKT_A&"?6+RU.IV%]%=FW6)=[P$()TRG!?=N'50,8 ZU3TK
MQ'K]SI.@ZW)JTA,&NIHTMJ4'E7,1?RC))_$9>0V<A<K]SDY]*7P[I27^G7J6
MNR;38&M[,)(RI#&P *A =O15'([#TK.7P#X:2PM[%;"06]M??VC"HNYLI<?\
M] =^<\GC..>E '(^(;[Q#8Z/XTU5/$%Y&=&U'?:P+'%M9?)@D".=N3&-^ %V
MGEMQ8GC4U+4M8\->(]:DCN[S5T.BRZC':2[ L<L;X"1A5!V8;U+?+_$372W/
MA31KRRU6SN+>62#5I/-O4:ZE/F-A1P=V5X51A<#"@=!5P:19KJZZH%E^V+!]
MG#F=RNS.<%<[3R.N,^] ' V]SXC-I::NFO6@L=1T>9WC:[WR-/Y9D6:!6CP"
M,X*9VA0#@D5:T"ZU>6\\&ZG-JUW/%J^F W-FVSR8R(%<,O&[.[.26).[L!BM
MW3_ /AO2VG-KIY42I)$JF9R((Y.72($_NU)R<+CDFKT/AC2+?^R?+MG']D)Y
M=B#/(?)7;L[MS\O&3GB@#D?#^H:CJ=KX>\22^(Q;+>74T5Y83@,LI<D1P(@^
MZ\>WJ/FX8MG!J**YUV/0])QKURUS+XDN+.6=HT)DB6::,;E. .(Q@( ,D94C
M)KK;/P=H%AKTVMV^GHM_++)-YA=BJ22!1(Z(3M1F"C<P )[DTZ/PEHT<%G"+
M>9DL[UK^#?=2L5G8L6<DL2<EV.#D?,>.: .2_M?7-+TGQY9QZI/>W6DR*]K>
M7*1&1%D@20_* B':2Q48 / Z<5H>&QK;^-]1 O-7;PY%;1&%;Z#9OG*@-@R(
M)", -P0 Q(]JO>)/"D-WHNNKIMG')>ZL8FNXYKAU6Y5"H*9.1&3&I4,HX)![
M57\+Z3JJ:DM_/;:AI5LL;QM9WFLR7[S$D88AF98]N#@JQ)W<XQR 6;^>YU'Q
MTNAFZNK6SBTPW>;=O+,LC2%!\W7Y ,X'&7&<\5S=EK>LZF_A:S;4Y$:>ZU'3
MKFZAV 7 A215G3J"V8\C@KDL=I &.]O-$L+Z_AOYHI!=PQM$DT,SQ/L8@E24
M(R,J#@YY&:B3PYI<4^GS1P2(VGJ5M@MQ(%4$$'*AL,3GDL"3U- &3\/]0U"]
MT"ZAU.Z>[N+#4;FQ^T2*JO(L4A52VWC=CC(].YY.3XOT^?QAJ]WI$<-Q+IUA
M:21R^5LQ]LE0&,G>RY,2%7&,\R+W%==HGA_3/#EI):Z5 \$$DK3,C3/)EV.2
M?G)QFI[#2[33/M'V5)%^T2F:7?*[Y<]3\Q./PH \U\2>,KZX^!E[K5G/<V.M
M6)BM;K/$D-RDR1RJ>H.<G\".AZ=+=7NI6GB[Q*]K,+F*UT6&YBM9YB$2=C,
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M1[@BA49V=B<!55069CV !)KB_A-'<VGAZ_LKVQO;.Y349Y2EU:O$"KN2I5F
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M#,N *EU*PU/2],T[PQI&C7\VB06JQ7%S:-;B215P/+7S)DVE@#N?!X/')W*
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M#^F2>(3XC5I)KJ2)1&QF+Q*-N-R+G )!ZCKD^M<K?3S+\9;U+>Q>_+>&45H
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MV_(1QN(KN=/TJ+Q;%H/B>[FT^XN8+:4P2V]N?+D\U63)#'=LVM_JS@@YR>U
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M:O+'-*DTUPUPK2R,H '+*0HXZ* ,D^M:%EX/M;/5M=U%K^^N)-;1$NHY6CV
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2J"/D<J&.,;CF_\ #&6YE\ Z>;B\-]&C2QVUVRLK3P+(RQNRMRI*@'&3@8H
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M);A+?[7G<J9^5GV?*YQC;@X) R:[&O+(=$EL?%]_X*2(R:/J=V-<)EVE%@#
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M)9-4\:>)M!:V2./1Q:[)0Q)E,T9<Y';& *WYS,MO*UO'').$)C21RBLV. 6
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M)IUHM[AA]I6!1)ANOS8SSWIQTO3R\[FPM2]PR/,WDKF1E.5+<<D'D9Z5;HH
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M$DLBRR.(5R[J<JQ..2#R#VJY10!A6/AZ6/7IM9U2_.H72F2.Q'DB-+2!V#%
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MRDXPWMG4\/6E[H%EHGAXVCSVUMIJI+J E^42H$4)M/S8;+$=@ !] #H:***
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MMN8!!\R=3\NYB)/%%K)+H'A%[:X6Q\66,]LEK"=AE&]0DR,H)&W9N8\GA.M
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M0!\V?O9 XK?\3:=J4VN:/KMKHHU6*&&:UN=-F:(.BR%&$B%FV;@8U!RW(/%
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MG?(7!M?#NOP^&M#FN-'^V7NG:I=W%QI]Q+"QN(II)3N5BQ7>!(",D<@@D9H
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M4!/*Q\W5F]!DY=YX5UB8:[-!87K&_P###Z?']MNHGN'N-TG^L(<J"V\'Y3M
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M227MH]NM[J\EU!N=&WQF.-0?E)QRAX/-9.N^%-1U;5_%=LJB.TUW2H(8KU,
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M=A[L223U.3ZFN>T^RT:R\3>)HG\+V6IQW'B>WLOM%Q:I+':),XW\_>7J57'
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MYS';HI\X@@R<#[^"1NZX)H \PU#0K>W^&?BS59+B\NIE35+...[GDG1(UNI
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M'3<P&6_&HX=#TFWN;JY@TNRBN+L$7,J6Z*TP/7>0,M^- 'DVK1W7A3P_J]I
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MC5%94)!Y'0\]0HY) JY'916WA_PO8W8BN+>W\63V5JUS^]?R5EN%569@>?D
MXQP%'L?3$T+1XY;:5-*L5DM2[6[K;H#"7)+E#CY=Q))QUSS3(O#FAP6DEI#H
MVG1VTDHF>%+5 C2 @ARH&"P('/7@4 <3J=M';>)_[4NME]9W&M6\<%Y!<>3=
M6,P*1>0PX\R$L.5']\L0?OCT::&.XADAFC22*12CHZ@JRG@@@]0:I?V%H_\
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MRB.!5\C<,-LP/ER"<XQG-._LG31:W5J-/M/L]V[O<1>2NR9F^\7&,,3W)ZT
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MG&<@DD'L35@:;8+J+:BME;"^9 C7(B7S2HZ MC./:@#RJW%O=^%/#6LRHO\
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M>-D(C!ZJN_C &<$\%L4 ;=UX\L+.TOKF>PU!(]/CADOLI'NM?,4-M<;\DJK
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M>02?F48R<53FTJZMOBG)XLN1'!I$>@&SEFEE5?+<3>:2W/"A>I_IS47@W3;
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MRHV2H&Y<9'R[2><$8SH^'K+4Y_'?Q @_MF[,R065K!<.4)1O(+[@N"%PSL<
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MS$"[8R&SZKL)!YXY_P ,7.IR:1X0\-P7/V6.30$O28[L1/.3MPJL49OE!W$
M+U !(!% 'J]%96AR7D.@QG5[^UNKF$R+/=0D!#M=AD\ !@  W  8-P.E<!X?
M\0ZW+KWA1I-3EO;;5)[Z"ZG:+RX;D1QEXWA3G:@V[0Q(+8)P<AJ /5**\[M+
M_6KZ2P1=2N1K']LSP7\-L%,<=JDDF/E<$*FU8\/C<2V,Y/%+6M?UBU\06US8
M:G-=6Y\2VVFS[8PMO% ^4>$#^.16P6?L6503A@ #O=-UV#4]5U;3XK>[CDTR
M5(99)8ML;LR!QL;^+ 89'!&1Q@@G4KSG7]9U;3_#_C^_M]7E!T^[C6T(C1C
M!! [*.,$$R$8ZCGG)S6PLFIVGB[5+"+6))Q+I2W,2WB+M@E#,@;*@?*<#(_V
M2>] '622)%&TDCJB("S,QP !U)-.KQ_6KZ_N/ FM6%_>:I;ZG9W.GK<P7!7<
MIDG0%XY4X>)^<# (*-D#H/7HU*1JK.SD  NV,M[G  _(4 4-'UJUUK2;/485
MDACNP?+CN $DR,Y!7/7Y2<>U-\0ZY:^&M O-9O(YI+:T3?(L"AG(R!P"0._K
M7GL(O=7N/AS=7>M7GG2SW2S+#<$"8B&4A^%"G&W;G X<X')QUGQ'OKS3?AYK
M5[I]U):W<$&^.:+&Y2&'J#UZ?CVH Z:&030I*%=0ZAMKKM89[$=C3ZX75)]7
MN-=\1VB:O=VMM9Z-!.JP^5N$S>?\RMMR!^[&<X.?;%;NAZM/>^ ]-UF[FACG
MFTR*ZEE<8C5C$&)('\.23]* -VBO-]'UK6(;JWNI;^2[AN=$O+LO(,17$L4L
M6R2-,92,K+@?,-PP<<!FN0WM_9>$(/%R:[+J#'1Y+E[69%$=W+Y/F+L48,>-
MK# !)&<\C- '>45P5EJ=[9>#3XO_ +8DO?,T%[][&X50KRA!(&7!^11DH5&>
MJY.1DB7>K:?-X3NX]5N+X:VZPW<,A3;\T#2>;& OR[2A.!P0<'L0 =[6;::W
M:WFO:EH\2R_:=/CADF9EPA$NXJ%/?[ASQCD>^/+M)\5:]/\ #;0/$5QKDL=[
MJUQ#I;R-"AB@S<NAGQMP&V+R6^7./I6J9'T3Q'X]D36&M7CT_3DCO;I//,3$
M2J#M R[%CD+SECC&,"@#TZBO*_$.LZSIFB^,19W]Y:_9=*L[VW6=EDGMI)#(
M'4L=P_Y9\@%@"25([69/$6M:+K5U)+>O?*WA5]6:SE0+LN(MH^7 RJMD_+SR
M#S0!Z717GNIZCJ6A^"'\4VNMRWDC:,TIMYPCK-,55EF7: %V@ME5&UACH1DZ
MWATZFE]:3WVM6UQ;7]D'CA,V]Y91AC)&-B87:W*@'^$\<Y .LHKE/$]\^C>(
M-"U&>^DATN>62QNTWD(&>-FB<@#@[EV9R.77TKG=-G\0'5W\(27UW/<6>J_:
M)M1DF D.GE-Z'^'<2Q$1^4C(<CD94 ] L]2CNXYY'@N+58KEK?\ TJ/R_,(;
M:&7/56/W3WS3;?5H+C7+[25CF6>SAAF=W3",LI<+M.><>6V>,?KCS35+R_U?
MPXD=WJ-UE/&R6@DC<(WE)=;57@8XP"..J@UL7_VJZ\7^-#;ZC<V9M='M &MP
MH8G_ $AP<L&Q@D],=?S /0JP[>?3/%NBQG4M&D6WFE94L]8M K,RDX/EOGJ
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M@TR>W:>&X\IO,9UP 58..-W([CWK>?PWI+OI;_8PCZ4?]":-V0Q C!&5(RI
M&5.0<#(-:M% '/P>"?#MM)IDEOI_DMIDLLUF8II%\EI/O@8;[IZ;3\N.,8XJ
M6^TBWL;R]\0Z9I$=SKCP"/;YYA$^.@)Y4-CC<1G  S@5MT4 86A:9<VUI?WU
M[:VZZIJ<IN+B(2;T!"!$C+[1D!549V]<G!SS)X5T,>&_#=KI2L"L!<JH=G6,
M,[.(U9N2JAMH)Y(4=*V:* ,B#POHEKK<NL0:;"E_*Q=I1G[Y!!<+]T.02"P
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M:9;P@6447DI"Y+@)C 7YB<C'&/3BK=% '/Z?X(\.:5/:S6.EQPRVF\0.'<E
MQ#%1D_=R,A>@YP!DU+IGA#0-'N9;BPTN&&21G8]6"[_O! 20@/HH K;HH Q]
M)\*Z%H<D[Z9ID%L9\AE0': >JJIX120"54 $\XIMEX4T;3IO-M;>5"L;11*;
MJ5E@0\$1*6(BX ^X%Z"MJB@#%B\):!#H+Z$NEP-I3DL;20%XU)Y^4,3MYYXQ
MSD]3FD3PCH:)=)]B+B[MDM;@R32.9HT&$W$L26 /#'YAZUMT4 <])X&\-207
M<+:5&$O+5+2XVNZF6)22 2#DG)Y;[QXR3@5;3PUI$>KP:JEIB]@L_L*2>8_^
MHSG85SAAGGD&M:B@#&T;PIH?A^:2;2].CMY'!&06;8IP2J9)V*2 =JX' XXH
MT7PIH7AV6632=,AM7D!!*9. 3N*KD_*N><# K9HH K7VGVFI0+!>0)-$LJ3!
M6Z!T8,I_ @&D73K1-5EU-8%^VRP);O-DY,:LS*OH.78\=>,]!BU10!C2^%-$
MFTVZTZ2Q#6MU<_:Y4\Q^9MP;>#G(.Y0>".<GN:LC0],66ZD2TC1KN!;><IE=
M\:@A5X] Q ],UH44 5[2QM[&PAL;6/RK:&,11QJQ^1 ,  ]1@=/2LJ?P=H%Q
MIMMI\FGC[+:SFYA1974I(<DD$-GG<V1G!R<YK=HH RO^$;TDWINS:DR&;[04
M,KF-I<J1(8\["X*J0Q&01P14FM:%IOB&Q6SU6U%Q LJS*N]D*NIRK J001[&
MM&B@#&N?"FA7>JQZG-ID)O$*'S%RN[8"%W '#8SQN!Q@>@Q9@T33[6\OKN"!
MH[F_Q]IE65PTF!@<YXP.!CH.!BM"B@#*A\-Z1!;:=;162+!IS^9:1[FVQ-SR
M!GJ,D#/0$XZU"/".AK%.D=D8_/N6NW:*:1'\]@5,JL&!5R&(+ @D'K6W10!B
MKX3T118?Z%N:PN#=6[M*[.)2""[,3ER<\EB<UM444 %%%% !1110 4444 %%
M%% !2;1N+<Y(QUX_*EHH JZE8Q:GIMS8S?ZN>,H3W7(X(]P>1[BJ/AN[DGTI
M;6Z>1K^P/V6Z,K NSIP)#P/OKAQQT;\*V*R+_29VU+^UM-G$-_Y(AD23F*X1
M2S(K]UPS-AAR-S<'B@#7HJA_:%Q]DGE.EW9GB9E6W4Q[IL$<HQ8+@YR-Q4^H
M!!%5%&LZM:0>:K:*&PTJQR)-/[IG!1>>XW<=-IY !8N-6":A9VEI#]K,UPT-
MP\;C%J%C+DOC./X!CCEQ5!_*\0>(_)*)+8:.ZR,2 RO=\X7D=8UPW^\Z]"AK
M'C6/3KZ\N].,;L91I6EP@%V21I-US,Q)RYWG<_<BWSDYKJ]'TJWT32;?3[4?
MNX0<G&"[$EF8X[EB2?<T 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBHS(PN$B$,A1D9C*"NU2",*><Y.21@$?*<D<9 )**** "BBB@ H
MHHH **** "BBB@ I H!)  +')P.II:* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHJ,R,+A(A#(49&8R@KM4@C"GG.3DD8!'RG)'&0"2BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "H;NX6TLY[E_NPQM(?H!FI
MJJ:IIT&KZ7=:=<E_L]U$T,P0X+(PPRY[9!(R.>>,'F@#G/!^B3106]]J+2-<
M01>1$#@1EC@S3JF!@R2%R#_<VX"Y(KKJ;'&D4:QQHJ(@"JJC  '0 4Z@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH 1E#*5.<$8X.#^=-AB2"%(8P0B*%4$DG X')Y-/HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K$\5ZW<>'M";4;>UCN"LT4;+)*(PJNX3=GN1N''>MNN4^(R74O
M@NXALH;J:X>YM@$MHGD<J)XV?A03C:&SVQ0!U=%(K!E##.",\C!_*EH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH K7]M+=V3P0W4EK(Q7$T0!9<$$]?7&/QJS110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%,6)4DD<%\N03ER0,#' )P/PH ?1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444BDD<J1R>#0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!6L;LWL,DGV:XM]DTD6V=-K-L<KN S]UL94]P0>]6:** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IKIO4
M#<R\@Y4XZ'.*=10 4444 %%%% !1110 4444 %%%% !1110 4C,%&6( R!R>
MYI:1E### $9!Y'<4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%-!;>P(XX(./TZ_P"<B@!U%%% !4;S
MPQS1PO+&LLN?+1F 9\<G [XJ2B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ IJ,64DHR')&&QV.,\'OU_'M3J* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI
MJ,6W91EP<#..??@T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@"O96<5A;"WA:5D#N^996D;+,6/S,23R3CT&
M!5BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>ex10-8_002.jpg
<TEXT>
begin 644 ex10-8_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4& XP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HI"H)!YX.>#2T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%(H(4 L6('4]30 M%%% !1110
M4454U+4(=+LC=3K(T8=(\1KN.7<(./3+#)[#)H MT4U(TB0)&BHHZ*HP!3J
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI ""?F)R>A[4 +11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 44U X4[V5CD\JN.,\=SVQ_P#6Z4Z@ HHHH **
M** "BBB@ HHHH **** "BBB@ HID4AEB5RCIN&=KC!'UI] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44U7#,X ;*'!RI'
M8'C/7KU'T[4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *:X<[=C*.><KG(_.G44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% "<[CP-N.#GG/^<4M%% !1110 4444 %%
M%% !12;1N#<Y QUX_*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **88E,RRDON52H <A<'!.5S@G@8)&1SCJ<OH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 8[
M.KQA8RP9L,00-@P3GWY ''K3Z** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HJ"\NXK&TDN9M_EH.=BEB><# %3T %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@#JJ*\\\20-XA\7WNE7T>M6UC8V$5Q#>65XD"6TCM-F=ML@9N(E"@JV"'X
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M))XML%R),G8RKDHH. I!) '._NV7P1--=6=W)JJO=)K"ZM=2&U \UEB\I8T
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M(MI P K*!@'(]/G@AN86AN(HY8F^\DBAE/?D&B""&VA6&WBCBB7[J1J%4=^
M* /.=2\+^(YM%\8:;:Z=I26^J&*XM(UE* .8XD=&&,8 B)S_ !$]L\=#<QW5
MKXV77KJ!(-(BT9XYKB29087WB0[E_NA5^\">3Z<UU-,D195:*2,/&ZD,& *D
M=,$=\YH XSPIIJ7'BG6=:MKF.?1'EW:8(V5H_,D53<RH0#D,X SG[WF\ ')[
M:HX((;6!(+>*.&&,;4CC4*JCT '2I* //M"\(ZM'I'A_P_J45NFGZ)*EPUS'
M,6:ZEC=C&%7 VK]QR2<Y!4 CYJP[OP+XBD\/ZS9Q6<32WOBQM60&=1BW)##_
M (%\N,>_6O7:* .'U;0-:U6Y\310Q1VGV@VD^FW;2AE:: JX#J.5&]5Z9XR>
M#@&:PC\62:[-K5_I&GQ$:4T,5K%>EF,XD+!2^S 5ACG'R^AKLJ* /.=%\/>(
M+35?!DUU9J+;1M'>RG1)D8B4JJ9'(R"(U/MD>]9EWI^L:+X/\.Z1'!:)KBZS
M/<6T=Q<B,-EII 4<9&[$J@JP.1O&#P:]9JM?:=9:I;&VU"SM[NW)R8KB)9%)
M^A!% ',>!+BX!U6RO=+@L[^.=9[R2"\%R)II!\Q8A1L;"K\G92G8BKWB?2;V
M[O-%U738HIKS2KMI1#+(4$L;QO&Z@]FPP(SQE<=ZW+6TMK"UCM;.WBM[>(;8
MXH4"(@] !P*FH X>^\/:S<V&MZA%#;#5+O4+2[M[5YBJ>7;21NBNP!P[!&R1
MD#<HR0N:CU?POJ.KKXHU:2#9J&H:5)I-C:B5?DA(;#2'IN+NQ."<*!U/%=Y1
M0!Q6@:+JEA/X/6>R*IIFBR6%T_G+A9"(,$ 'YA^X/_?2GJ"!Q^D7VJVBV>I2
M:7:77ALZHTUB+?41$0\TK8(@VDE_WA(A+<-QP1Q[+5"'0])M]2DU*'2[*._E
M.9+I+=!*YZ<N!D_G0!YQ<^$/%5]?VEU?6=G=75CXC6]BNY+K+R6H,F%"LK")
M5RGRKG)YX8;C>O?">NR^#?&>A):P,=1O)[BQE$XS)YTA<AE(^3;P,Y.>>!W]
M(HH Y:YLM5T_Q-/KNF6 NUO[!(;BTDG$;)-$6:([B2-I\QE;'3 (#<U@Z3X.
MU71?$OAJY$236MA8W*W)BD'%Q.YD?9NP2NXG!..,>]>CT4 <_P""].NM)\,0
MV-[;M!/%+,2IE$F0TC.""/9NG;IR ":VM:9J</C+2?$6F6Z7:1P2V-[;EPK^
M2[*X>,D@;@R#()Y!XP>:ZFB@#SMO"6KVVDEEACFO;[Q##K-Y#%(-D"+(C&-"
MVW<0L8&[ W'.<<8]"C8O&K,C(2 2C8ROL<$C\C3J* /,?$?ACQ)JFH:S&NF0
M7:&[MKRRO9]0,9"H\;&&*/:PB;",#)_$",YZ#TZBB@#S>*#6M:L?%FAV]A&E
MG>ZG+;&^,P!2)\+,2A&=P7.W&02>P'-;QKX4\3Z]=ZY#!IME=6TKVT]C<3W[
M1/$L81GCC0(0LC,C?O,CAP,X4 >C6.EZ?I@D%A86MH)6WR?9X5CWMZG Y/)_
M.K= ',>'],U"R\5^)+Z[MA'#J4L$L3I(K*-D*1L.QZ@XXZ>AXKG84^R_#(Z!
MXWAATF.WM4L[?[/>K)/=&! 1+",#YR4#*N"P(YKTFH)K*UN9X)Y[:&6:W8O#
M))&&:)B,$J3T...* .0\[6_#/@.RNH[:"YUN>2"2_29L&61RHD"\C+X^51[#
MKTKMJ0J"02 2IR,CH:6@#S^S\/:YINO7%G#H^D76ES:BUXFIW!!GBC=_-DC*
M;<LVXNJMNX!4G.,55T[POKFGZ7K<+6*R/?>+%U9 LR BW$\4O<XW8B(QGJPY
MZUZ510!R4^AW5_XD\2I?6I.EZMIT%BDL;*"%59MY89#?\ML CT[ 9JE8Z3KN
MH0>&[/6M.CA.A2^?-/%<*R7,B1-''Y0ZX.\LV\)@C R.:[JB@#S?P]X-UJR^
M#<'AJ4QVVLVCF:!]X:,RI<?:(^1_"2%![CGVJ_?Z-XH\3^%+I-7CTZSU))HK
MBQM(V,L(>%@X\TG&X.PP0. N#R<UW-% 'G,^F>-YO#\SVNFZ1I5X;FW9K.QG
M*&XA4GS%:8*"F[(P5Y !YR:3_A'-?73M?M;;1-,MUFO[+4[6(76(Y'C%LTD7
M"<#,##><;BV=HZUZ/10!R=WIFIZA=:WJ$UJR";3Q86=LLB^80<EW<YP/F8
M,<!2>IP,+5/"FO)+HVOZ;96%UJ4.FQZ=>Z7?MNA95RP=7Z;E8D XY5CTZ'TF
MB@#/T2QN-.TB"UNI8I9UW,[0Q+&@+,6VJH P!G [D#)R2:T*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@!J*54@NSG).6QW.<<#MT_#O3J** "BBB
M@ HHHH **** "BBB@ HHHH *X_Q9<P'Q)H=A.ZB.6*YE=;F<1VVU0B[W!&9&
M4N-J CJ22,"NPJ"XLK6[D@DN;:&9[=_,A:2,,8WQC<I/0X)Y'K0!Y1'K(BT?
MP)->:J=0L0+F.[MDEW&["KA)""V'",$X)/WP><9J;1=/GBTOPMINL:C>7LNI
M7<\[6YU)FB6(*<1R2$DN8P5PJ\%P.<+NKK-6\+7DFKVMYIDFG_8H8I$.E7=M
MFW\QW+M.-O23)(R0>&;IDYMZ+X5M+&!VO;33I9WO3?*D-HJ16\NU5S$#D@X7
M);.2S,>,X !RNDW7VCPSX>D.IO<R0>()K998[IF61!/,JJ?F^<; N-V>,'WK
MG?$$\VG^$?'VO6^HWRWFF^(0UFRW+,L+@P=%)VD9D8%2",< "O8CI>GF,1FP
MM3&L_P!I"F%<";=N\S&/O[OFW=<\U#)H&C307D$ND6#PWKB2ZC:V0K.X.0SC
M'S'(!R<T <3K\DMKXE751+<7FEG4[>":XL[]X9=-?=$GE-'G;+$[;=RXS^\8
M\X!"?"=+>*X\:1))B5/$MZ/*\TG"93!VY^HSCMUKNGT72I-274GTRS:^4[A<
MF!3*#C;G=C/3CKTXJ:"PL[:YN+FWM((I[DAIY8XPK2D# +$<M@<<T <3K,LQ
M\=:_;_:)Q"/#*RJBRL K^;,-PP>#A1R/2MCX>&$_#OP[Y$OF#^SK?<?,+X;R
MER.2<8/;M6ZNG62:A)J"6=NM[(@C>Y$2B1D'12V,D>U+96%GIML+:QM(+6 $
ML(H(PB@DY)P..3S0!Y-KVK7T'AKQ3LO[Q)?^$LCMH9%G?=&A$!*CG[N"PV\C
MGI71^'Y9[7XN>)-+2[NWL3907(AGN'F"R,3DKO)V^F!@<#C@5U<OAS0YUF6;
M1M.D6>87$H>U0B24=';(Y;D\GFIX])TV'4&U"+3[1+UT"-<K"HD90, %L9P!
MVH X[Q=.+G5-8M1?W$2VFB^<1]K\B*"5FD\IQM.YI-T8ZX"X4CEL53M[RWU;
M4+[3=:UV\L9QHMK);2?;3;\.CEYU (#.KJ"6((7"XQDY[V?2=-NKU+VXT^TF
MNTC,2SR0JSJASE0Q&0#DY'N:AF\/:)<06T$VCZ?)#:8^SQO;(5AQTV CY<=L
M4 <?)?Q7OB35M,U37I[*SCTBV-A<+=-;>9O$GF3 @@,P(3V&.G)R_3M^MZSX
MCM+W6KU8=/MK:.UN(KIX,1O ',Y"D*Q+[OF(Q\I XR#V5_H^F:JT#:CIUG>-
M V^$W$"R&-N.5W X/ Z>E)>Z+I6I2K+?Z99W4BIL#SP*Y"Y!QDCID X]J //
MM/GU+Q9=^';+4]1U'3[B^\,R75T=.NVBRYD@V.,*-K\L3@<;BN67.XU">/5/
M"?B.YO+^[%S::K]D\MKED6-8YT6(; V#O7:V2,L7/48KT272]/GU"+4)K"UD
MO85V17+PJ9$7T#$9 Y/2H+CP]HEW=RW=SH^GS7,R!)9I+9&=U&" S$9(&T<'
MT'I0!YGXUUO467QQ>Z5JMZG]D16\2.;CR8[:3AF$:IGS2V<,9 ,'@9'3=U5+
MBZU3QRDVJW\%K;6%O+ MM=R1-;R"*4EU*D8Z+P."0<@UU=_X8T+5+BXN+[2+
M.XGN(/L\LDD(+/'G.TGKU /X"IAH6CA9U&E6(6XB6"8?9TQ+&HPJ-QRH' !X
M H XN/4Y=;UJ[TO5M4N]+1-"@NK66&Y$/F%PQFN 5Q]PA!M;@<DJ0PJ$75SK
MFM76GMXID@B71[:6SNL-"+@.KL]RNR1 QRH)&-J@#CEJ[BY\/:+>1VD=UI-C
M-'9G=;));HRPG_9!'';IZ#TI^HZ'I.KM$VIZ797K1',9N;=)"A]MP.* (K2#
M^T?"]O!+J,MQY]FBM?6Y,#R90?O%P<H3U'/&:\SMM:U?2]"L;^:XU&]N/"E]
M)::WB25UN("S*9L;OG*ILD^8' .> ,UZ^JA%"J % P !P!56;3+&XM[ZWEM8
MVBOP1=+C_790(=WK\JA?H!0!Q5^VI6EOX2F:[NUN-0U_S+A5N)"/*DCF<1$$
M_=50@VXP"N<=37G^M)&?AA\4KQA(\G_"126VQ[B5DVK-  VTMC=WS[ ?= %>
M\7-A9WKP/=6D$[6\@EA:6,,8W'1EST/N*J7/AS1+V6[ENM'L)WO @N3+;H_G
M;/N;\CYL=L],#TH S=%CGLO&&LV#7UW=0?8K.Z N9=^V1VG1RO\ =!\I#M&%
M!S@#-1ZQ=SP_$3PQ:QSS+!<6UZTL2R$(Y01;<KT)&XX/^1O1Z780Z@VH16D,
M=VT0A:9$"LR#&%)'4#'&>G..IITNGV<U_!?RVL+W=NK+#.R O&&QN"GJ,XH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !128.XG<<8Z=A2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=/I=WXG>$ZD/MMQ:+91>7Y[$."7V[^"%!P>Q XXKTEO"6FM(7-SK62,<:W>
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MBP1MPN-6)PP^;5[HCGKP9/R].U,;PGIS1"(W.L[0<Y&M7@/0#KYN>W3\>IH
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M#]X'@@'945YM>?$#6=2\*KJFB:#-#'<BR-K<3RKAS+.(G3&TX8$@ X.0V['
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MS&PQ9<D9()).[FKQ\<V)M=(F@T_4KAM6L'OK2&*)-[*H0E""P^;$@]N#STR
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MDR[OD;G.3L;!4$<<D5D?$#73J/@OQ#::3'?.T(^SM>VKA$CFWJ"F0P<X)PV
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MGKSQQVKN** .3L;/Q?<:1<V.MRZ8[BRDMUG@=O\ 2Y6&%D<;!Y7'4+NY8D8
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M[A$?&Y5=0P!QWYJ[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<;(6@90^W*[D=B#MX./K0!=N/&ME:66L3SV-^DND />VVQ&DCC*EED&&*LA
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MSL\9\N1Y$894/D\*>G'2@#6MO&&BW5[%:K<21F>)IK>6:!TBN(U +/'(1M8
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MYAG,$IAF\J0-Y<@QE&QT89'!YYH GHHJ.>>&U@>>XECAAC&YY)&"JH]23TH
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M %@&'(& ,8%-O? L<MUJ\ECJMW90:O9BUO( !(&*Q&))%+9*L%(!QUVC//-
M&]H7_(O:9_UZ1?\ H KSR^U#6M)UGXAZGHWV+-C/:W4XNMQ\R*.S1G1<=&(
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M_@BW;X<CP<MW(L)MA;O<[,LQSEFQGJ3D_CWH H^+?%>LZ5K(L-.33;9A%')
M=4#*NHNS$&&&0,J)( O1B=Q=> !N-.;Q(FB>+_&5S-HUBGV&VM'2>&/$]X\O
MR(CRGI\RJH&..N>*W-?\*W7B&QOM/N]4B:POHU6:%[,2&-@N"T)9OD)QGD-@
M\C!R3%J'@'3]4U'Q%/=RN8-=M8K>XBC&TJ8QA7!S@L,]2IZ =,@@#[36];LO
M$D.BZTFGR2WUI)<64MJ'C3?'MWQ/N+'C>I#X&1GY0>*Q-!\>:Q?ZGX/2_M+"
M.U\16,CJD1D\U)HTWN_/RB,C "\GD')YKI[30;O^V(=5U348KR[M;>2WM=EJ
M(DC#E2SD;F)<[$!(*C . ,FLK3_A]!I\_A.5+]V_X1N*>*$>5_KA*NUBW/!Q
MZ=_;B@"'PMXOUC7O$+V]S:V=G$J2^?ID@9;VS*LHC=]S8D1QDY5<#<HR>2='
MXAN$\#W[&!9B'@VHV!EO.3'7T.#^%.TOPO>6M_IESJ&K_;SIMNT$$C6^V:3<
M "TLA8[^!V"\Y)S5_P 3:(?$6A3:8+HVOF/&_FA-V"CJX&,C@E0#STS0!R]]
MX\OO#%WXB3Q+;V;16%I'?VAL"V6BDD:-8W+_ ,>X 9 P0<X'2I8O%GB&"/6Y
M+[2H_*M].;4+2<6T\,:D;LP2%QN9Q@'*J-PS\HZ5?UKP/;>(-6U2YU"Y+6FH
M:8NG-!''M9 KEPX<DC<&8G[N.!Z',4/@FZ?0+G2]3\07-^9-/ETV&9X@ICAD
M4!BP!^=\*OS-Z=.6R 4)?%WB2*UMQ+I]E%<ZH$;3@$EFV1B 22O*D>YB0WRA
M5P/F'S'J98O&>K*-.T>[TZ.'Q!J%S/;6[O&\=NRQQ^89PK'>4VE?EX)8$;A]
MZM+4?",M_I.D1IJC6VJZ00UI?0P_*"%V$-&6.Y64X(S]"*ANO!4UY_9U_/K<
M\FNV%PUS#>O&/+#,@1T\H$8B*J,HK D\EB220#G?&'BFZOOA]XSTJ5(HM9TJ
M 07XC9@C1RIE94X/#J3\A.5Y!)P"W>:-IC6<(N;NWL8]3EB2*YDLHRD;A-VP
M 'D !C@'IG%8E[X&%_X8UW39M0'V[6W\R\O!!QG"KA$+$A0J  %CC)Z]*ZR(
M2")1,Z/)CYF12H)]@2<?G0!Q6I>--0M?'?\ 84=I:001>41]LD,;ZB), BV8
MX3<ASE3DN>!MP6KEO^$JO?"FG>+]9TW3K#^S;+Q/B^ ?):(K#&XB5 H\S<0Q
MW< DY+G)KO-7\,WNL7$\4^JQOI5Q/%,]I-:;WCV;,"*3<-F2F22K?>.,=:P;
MWX8R7GA7Q3H/]M(D>O:JVI>;]D),!:1'*8W_ #?< SQWXH G\2>,M8T;4[AX
MK?3UTZRN+>*:&9RUS<)*R+YD84X109,98')4CBLSQ%Y<EW\4E\F-=OAZ#)"\
MN?*N2&;U(X'T45MZEX#FO[77;-=9:&UU2]COP/LX:2*9/+X+%L,G[I<* "/[
MQ'%6;[P;)>7?B64ZD%BUVPCLI%,&6C"JZE@VX DB1N,<''7H0"WX$_Y)YX:_
M[!5K_P"BEJK=77E_$=;>WTVQ>^;0Y98[F1BLDFV9 (BX4[(\MD\,26R -OS;
M'A[2WT/PYINDO<+<&RMH[;S5CV;PBA0=N3C@#O5'4?#L]YX@FU6"_6 R:7)I
M_E^6^=S-N$FY)%/![#!Y.&7- '-Z%X^U:^U3P=#J&G6D-MXBL)9$,3L76:.-
M79B#PJ$%L#+'D9(Y%7+;QEJ4NB^#=0DMK0'6+M;2\1=WRL8Y#NC.>!NCS@YX
M.,]Z=;> 'M;WP9/%J42KX9@E@""TQ]I$D8C)/S_*<#.><DD^U%IX"GM;71+$
M:PIT_1=0%W9Q?9<.8P) (W??\Q DP& ' Y#$Y  R+QMJ"0:UJ=S96YTC3)[N
MV+0LQEEECDC2)5'OEP>/O 8& "U[PSXBU?4]5N;/4=->.$Q&YM[I+2X@15WE
M?)?SD4F08SN  8'.U<<D'@F(^'_$&BW]V+FTU>[N;GY(C&T0F8MMSN.XJ3UX
MSCI5O0-"U73I$FUCQ!+JLT,1@A/D"%0AVDEU!.]\H/F)]< 9.0#(^)&KZKI,
M?AJ/394C2_UVULYQN*LRLV[:&'W0=A!."<&I;WQ5J\K:S/H]C:2VFAN4NA,[
M;[F18Q(\<6!\N RX9@03Q@#YJT_%OAE?$^G6D279M+NQO8KZTN/+\P1S1G@L
MF1N&"1C(ZUGWG@JY:\UI].UN2SMM;15OH6AWX;9L:2$AE$<C+C+$-D@'' H
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M/7CE5XYXSZ\4= \'RZ,+*"?6KJ]L=,8_V=;O&J^4NPH [#F0JK,HZ#!Y!(!
M!U-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5B>*K^]T[2(I["1$E:^M(&W1[B4
MEN(XVQD@ X?J?_KC;KG/'-D-0\+M;/;27,)O;-IHHHV=FB6YB:3Y5Y.$#'CG
MB@#8M-4T^_29[._M;E(&V2M#,KB-L9PV#P<<\U$-=T=K>YN!JMB8+7'VB07"
M;8<C(WG.%X(/-<%J]BWB>3Q'K'AZT^TVUYH\,"N!Y:WTBR,V%W##?)A=Q&/F
M YP0,[Q-8KKNA>(]4T_2/$4NHW&D+:N]W9F$R$NK+&(0BEW7G+@$ <!B.@!Z
MI!J5A<WMQ96][;2W=MCSX(Y59XL]-R@Y7/O44&N:3<S7$-OJEE++;*7G2.X1
MFB4'!+ 'Y1P>OI7$:C9R7OB R>'+3_1;KPE-!93Q1%;7<64P(2!M'!) SP">
M.:?X2DT^_P!1TV8VFM+JFDV36DZ7-KY268VQDQ%A&HD)^1E +<?-QGD IV7C
M77/$VAV^N:)K'ARUM)+LP7$-ZQ5K9!*53YL\O(HZ,H^^N,8)/=67B/2M0UN_
MTBVNXWO;$J)HPXR"PS@#.3@=?3\Z\?@TO4K?X :!8S:7J$=W::FLD\#6D@>-
M!<.Y8KMR%"D'/2O0?#TPM_B5XPM)8IUEN'M;F(^0^QH_(5-V_&T?,C@ G)VM
MCH: .TJI?:II^F",W]_:V@E;9']HF6/>WH,GD\C\ZMUP=S=6VC>/-=GUVTED
MM-1L[:"SG^SM+&Z@NK6W0C>SL2%XW;AQQD@&UXI\3P^'WTJW\^VCN-1O%ME\
MYAA%*L2Y&X$@;<=>I%7]".K?V<5UE[66X65U2:V!"S19^1R,G#$8R <9SCBO
M.],M[GPWX:^'NG^*+HBYM+J:[NG>1F$$:Q3!2[Y^54,T*'/R@D#.,9]&T[6[
M/4[[4K*W,@N-.F$-PDD97!*A@1GJ"""#0!HU3EU;38;]+"74+2.]<!EMVF42
M,,XR%SD\D#\:N5Y#K-S MYJH>":(V7B>ROIH39O,ZJ'B'VC?SL1D0A=HS@,.
M<G !ZC_;&F>8T?\ :-IO6<6S+YZY$Q&1&1G[Y'\/6H]8U6WTRS/F7UE:W4RL
MMJ+N4(LDF,@<D9[9 /2O%-3?21IOQ4FDDLUN(]2189?DWQR' &T]FW*W<<J?
M0UVE]J5K#XA\1?;!YBZYIT2:/<1*TL=W$(F/EH1D%M[NVT?># \T =GX8U&?
M5_">C:G<A!<7EC!<2A!A=SH&.!Z9-6M4N9+/2+VZAV>;# \B;P2NX*2,@$9'
M'J*RO H8?#_PXCI(CIIENC+(A5@1&H((//45IZQ%)/HE_#$I>22VD55'4DJ0
M!0!0\+^(8==T33)I;BT_M*XT^"\N+:%QNC\Q V=N2P7).,_G6C!JFGW5[-96
M]_:RW< S+!',K21C./F4'(Y]:\LT6UL=0L_!UIHD,8UW2[!UU%X%V/:,;1XC
M',0/ED,VWY6(;Y&..*M>"KBPU34]"M777(=:T&-DNK*:UCBCM-\6UM[+&H97
M(#* V6.&Q@< 'JE85[J]U9^+[*PDDM(M,EL+BYDDD!\P/&\2XW9"A?WP/0].
MU;M<)XNN-%L_'&A7OB..&/3;>QO!%<W4>85N&,1"[CQO,:2X!Z\XR>  =)J]
M[?Q)I<FE2:<T<][$D[74A :!@<^40>9.F!R#S5[^T;+S%C^V6^]I3"J^:N3(
M!DH!G[P';K7E#QVN@Z7X-AO?)LD;Q/--8076(I+>T8S%1AL$##1Y!Z;U!P<5
MEVEYH*:1XJU6ZGLK:6/QI"L-QE"T<:7$!W1Y&/N+(W Y ;.0#0!ZUXGUU-#T
M+4+F*:V-_#9S7-O;RMS*44M@+D$\@#CUIMOJ.I7%SH3(MF+2[M'EN]S$2!]J
M%/+&>1EFSUQQ7 ^(-3M+6'XA6FJ2*-0U6PDFTUAEX[FU2T.SRSS]UA*S#@ M
MD<'-7Y[VPM_%?@&2[N+>%!HMXTAG8)A/*A;+9Z#"N>?1O0T >A)J-E)+%%'>
M6[22KOC195)=>>0,\C@_D:<;VU%V+0W,(N6&1"9!O(QG[O7I7@'A6\TVU\)?
M"VXFFMXKO^U;A'F9U5@@>4%6.<X^=.#ZCUYZ&?5M#;4-7\+WNM:?$[^)!=^9
M=*_G#$D<FU49"IY_=J2V"O8X(H ]EJ.2>&%XTDEC1I#M168 L?0>M.CC2*-8
MXT5$0!551@ #H *Y;Q]<6MCI.G:A?,$LK35;6:>4J"(U#@!CGL&*\]NM '1B
M_LRLK"[@Q$^R0^8/D;.,'T.>,5+'-'*7$<B.4;8^U@=K>A]#R*\-\?SPWGAC
MXH3Q?/&USICQL5(XVP#(S]#^!!Z$9TM6LDU2\\1W7@-5FL9/#;VD\UBZM%/<
M[@43@_/,(BXS@D!U&030!ZY;WMK=M(MM<PS-&<.(Y Q4^^.G0_E21W]G-(D<
M5W [R)O15D!++Z@=QP>:X/\ M/0-:\2Z%J.AWEB^G66GW U-XF3RH;0QC9'-
M@X3##(5N@63C@URG@Y=)BC^$]REY&M\4O(B@D4F1&BDSN).>'55 Z DCC %
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M*YY .<''O@_D:\B\/:?9V4?PLNM.CB^UW-I*DMP3N>3_ $-WV._4JK]%SA<
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M*H 5Y(E9@!R,$BK-% &;;Z+!!KEUJ[33RW-Q&L0#L D48YVJ% ZGDELMT&<
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M;2V2Z>Z6WB6X<;6E" .PXX)ZGH/RHBM+:%@T5O%&R@J"J $ G)'XGGZU-10
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M!SN))4D?PXSD2CP>T^G>)-,OKM9+/6)WG1H4,<D!< 8SD@[=J$'C)SD5U5%
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MW_(Y554+M&X9Z#)/WLD [2BHX)X;JWBN+>6.:"5 \<D;!E=2,@@C@@CG-24
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MC;NSVP0#V"BO,M1N=6T^QU:U37$E@CU:R#P07,DMU;12R+YL*RG!9CG**!N
M8@9^6JWB/4=3T#3=4U*VO-4M=,EU&S@BFO)I-T<,FWSRHE!*#)P&8$J=P4
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M-*TGP[J&JP1W-Y)9W LVM5@DCD\]L;58,N5!W [L'@\;B0#U4;B2-74, P!
M92IY]0>1]#0!G0>'],MM2M=0B@=;JUM/L43F9SMAR#M()P>5')!/'6JVE^$-
M%T:Z@N;.UD\ZVMQ:V[33R3>1$/X$WL=H^G/;H *?9^*]$U"\AM;6^$CSM(D#
MB-Q',R9WB.0C8Y&#G:3T/H:Y_P#M75]<\3Z_IFFZA-8R:7<VJ0[K;=$ZE5>7
M>2F?F5F4?-Z,/6@#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF739;&*_A6&5(90WW)/,1PN53;E1GY2.@./=*;'(DL:R1NKHX#*RG((/0@T
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M.\Y)X.T>F1ZA)86<UW'=R6D#W,8VI,T8+J.N W44D>G64*S+%9VZ+.,2A8E
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MFM+^(LK.0/+D##D%2&Z8SNX((!H =I_B&>^ODLGTN6UN7T];T).^-I+%3&V
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MW]R)&CB  2)"[R,2%5%4=69B% [DBJOAW7AXAL);L:5JFFB.8Q>5J5MY$CX
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MF21G8@#'+,26/N22>]<_%X"\-P+IJPV$D::9<-<V:)=3!8I&()(&_!''W3D
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M-X ZXZG/7!$&H_#OPUJEQ>37-I*#>3QW,RQ7$D:^:A_UBA2 K,  6&"<>O-
M%SQIJ\^A>#]2U&U*K<1QA8Y&^[$SL$$C<'A=VXYXPISCK63/=:CH7BR'31J%
MYJ%K?:==7+"789()8BGS@[0%5A)C!&W(& .<];>V=MJ-E/97D*36TZ&.6-QD
M,I&"#6/8>$-.L+>ZC66]GDN(#;>?=7+3R1Q')V*SYP,DGWP,YVC !QNB^(->
MB\0^ 6O=7DO8?$NE.]S T4:)%)'"LH==JYR=Q!&<'KT  J:->ZE;> =4UG0F
MF"V?B*YNY;6%59KBV$^9(P64G.S/(P>*[F+P5I4-[H%VC77FZ# ;>QS+E50I
ML((Q@DK@9Z\"JD6B7OA&Q-CX3L%NA?7<DLKWUV1':,RY,FW&YUR!\BD<GJ,D
M@ N^&=3?7IK_ %B"X>72;@Q)89QM953+N!UY=F4YY_=^F*HZKK-SI/CF*TOM
M1D@TG4K$K:;8T)6[1QE5^4DLR,"%.<[6Q6_H6DPZ#H&GZ3;G=%9VZ0*VT OM
M4#<0.YZGW-27FF6M_=6%Q<1[I+&<SP'T<HR?R<_C@]J .,\):GK&NRV%KJ&H
M7"W^D+<1:LT&Q4DN _EHI79RI4-(,;>J'G)QC:5J.HZY%\+;V]U"<W-P]R\S
MIM =A;2<E<;<XR,XZ,?6O28='M+>?4YX0\<VI.)+B16PV1&L8P>HPJ#'H<GO
M67;^"=(MK+0[6/[4JZ)+YEFZSLK+P058KC<I!P0>HX.<G(!QA?4K.Q\6ZE8:
MA)9M:>)@ZHBKMG!$"N)-V<J58@!=O([]*[7QYY@^'WB)HII(9$TVX=7B;# K
M&QZ_ABH[SP1I=]INJ6$DUVL&IWHOKD1RA6,@VD;6QE0#&G3^Z/4YW;NRAO\
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MX*R(25XXY.0:[31-#T_P[I::=ID!BMU9G^9V=F9B2S,S$DDD]2?TH_L/3_\
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M2/S '5Q]Z/(QZUU?C&^O=&\'7UWIEU9VUY&$\N:\1C&"TB@DJ@)+')P "2Q
MP<XIUQX1TZ;3M(L(I;JUM]*E2:V$$F#O085F)!+=3D'@Y.<U;\0Z!9^)M#N-
M)OC*L,VT^9"^R2-E8,K*W8@@&@#B]1U+4+KPE\0[*]FGEBM=/<VS7,<:2A'M
M,D,$P/O9/(!&[GM5E58^+OA^0"0NDWA.!T&RWK8@\"Z7#;ZI";K4YAJEHEI=
MM<7CR&15386^;/SLO!/MQBM!/#MJFHZ7>B:X,FF6S6T"[AM*,%#;N.2=B?\
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MS69X?M"(P8,'6/@#<C;3WY'\)I[^#M(N4UJ.^B>^CUDH;Q+@C#;%"KC:!M(
M7!'(*@CGFIO#GAC3?"UE);:<LQ\U_,EEN)FED<XP,LQZ #  X_$G(!LT444
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MY(IICYCH004"N_\ &X( &,K]ZJ?A>UU*RT+X=V=WH][#)974RW):W),6+>9
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M*\+M&V0KH2K*?<$5S.F>*;_6I/#]O:QVMO-J&D#5+AY07" B,!$4,I/+G+=
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MIDUU()]^(I$52 &4XVY8@CENF0.X!WT\\-K;RW%Q+'#!$A>221@JHH&223P
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M36!97$1W>9-"1$,H<X#AI1U!!'ICD ]&HKCKOQ9>6_C)-&E6WLP\Z);174+
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M=Q. ,GN20!7%Q>,=6DMK2PDM[6W\0R:R=-E@\MY(555\UY%.Y6*^1AP?5E!
MY(T?B.Y3P+?,K*'\RW"[L8+>?'@$D'&3@9P2,Y'.* .JHKFXM;U(>+KW0+F*
MT5Y+-KW3YH]Q&Q6"%9 >X9E.1CAL=LFGHWBR\UJW\/QQQP17]R\W]IPO&?\
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MC_:$VW#'@",Y^8GT&:9->W4&OI#++81Z:;*28EY2)]Z,H)VGCRPK#)[$CUH
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M40$C+$_D 2< $T :-%<)KGQ ^P:1XAMVM'L=?TW3FO$MYF5U93PLBL#AE#$
M@X.>,="6RW-Y#XQ\+-?12/JO]D7HEA1D7SY5\@\#)4 G?C)&.Y[4 =[17)#Q
M_ISZ'IM^L96;4!*(X)I5B"-$2)0TC$* K KD9SP0".0Z'Q[8W-OI[V^GZB\V
MH"X6"!HU5C+"A<QG+8RP!VL"5./O#C(!U=%48]4B70EU:]22QA%L+F9+@8:!
M=NY@X[%1G/TK(A\90BW%W?Z7J.GV+64E\MS-&KJ(D +;O++%#M((!Y(XZ@B@
M#I:*YJV\96\E]I5M=:9J-DFJJ39W$Z)Y3MMW!&96.QR Q"GK@]^*@MO'MI<V
MNE72Z7J7V?4YWMHI0L9"3J9%\MP'R"3&PW %,D?-CF@#K**Y6?QU96>AZSJ5
MY97=LVCSB&[MI#&9$W;"K?*Q!4JZMP2>H )&"EUXW%G?ZA8RZ%J?VNW@:[@B
M'E?Z5;J=K2*=^% .,JY5L%< DD  ZNBN?T_QCI>IW>D06WGLNKV;WEI,4PC*
MFW<IYR&&\'&,<'G-00>.=.N-*TK4%M;T1ZG>R6,"%%+"9#(,-AB "8F .2.1
MG R0 =/17 ^*/$NCW_@K4IM8L-7M(+.]CM;JW$Z031R$HRY99-I0B1#D,>#G
MMQN7WB^VM+F_BBT_4+Q-.=$O);:(,L18 X&2"[ ,"54$@'ID@$ Z*BN7USQU
MI^@27GVNRU!K>SE@AGN8XU\M&EQMQE@S8RI)4'&>Y! K+X@EU#4O&&F7EE=+
M8Z:@CWP2*KE6@#M@A@0QW?+CIQD@] #L:*YG1]?TZ/2/#]IIT-Y<F[TY+BV@
M9D,RVX1,/(68#^)03DY)[\TO_";:?]FTZ8VMZ#>WKZ>(C&N^&Y56/EN-W!RA
M&1E>AR%YH Z6BN6M/'NEWFG?:4@NTF74SI+VCJ@D2Z!P4)W;#QSD,1@]<\5N
MZ9?_ -I6?V@VES:,)'C:&Y4!U*L5/W200<9!!(((H N45RT?CS37O[ZU-I?H
MFGW,L%[<M$IBMQ'$9?,=@QPC $ XSD8(&1F.Q^(V@7MW:0&5[<7EHUY;RRM'
MMD15W,/E8E6"_,0P''T. #K:*YV/Q?;O>Z1;MINH1C5Q(;.218PK[8S)R-^Y
M<J"0"!Z'!JJ?B!IBZ7I%^]I>!-3U3^RHT'E,T4_F.GSE7*[<H3E2W&#WH ZR
MBN+3Q'H>B/XLU/;J9:QNT&HI)*9%3]VN'C4OM"X/.,-QTP%%:5YXPL[&\^QW
M%I=QW)DE6..0Q1^8D84F12[A2AWJ <YR2,#!P =%17.6?C33=1LM*GL(KJYD
MU,2FW@C10^(SMD+$L%4*< \]2,9K%^$=Y/?^$;JXN99I)&U.ZYF8E@-_0YH
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MR%9B,<8*AB2<FM/Q5J.J'5]>M$O+JTN;73H;C0EMF*^?<-Y@(8<K)E@B[&!
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M2>&-D56!.!&P8DE-Q#9XQS0!)X*\7PV_@;P\FIS7]YJ5UILET,123R3B-@&
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MU=22L;;>0_=AUVY.GX3TRYTRZOH8[:\M=(\N(6EO>RK))$^9/,56#,?+P8\
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M("CC/(8C(Y(Z*;2TE?3G?PYJ>FF3[5=V]_9N6N;&9R,B507#F0<G)89X(X+
M ] L+ZWU/3K:_LY/,M;J))H7VD;D8 J<'D9!'6N9T3Q3IMIX>TZ?4-:EN_M]
M[<6]O=2VCQF:02R8CV@':0%*J#@MM&!DXK:\-KJ,?AK34U:../4$MT6X2-55
M0X&#@*2,?3\AT' :;H^I1>&_!UJ^GW2S6OB*:ZG0Q-^[B+W!#-QP/WJ?G['
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M>WD5X0%WY*%=WW>>!R*B_P"$QT,S-"EW))+Y(N(TBMI7,\9_CA"J?.7OE-V
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M2&.%&!4\/B35X]-U*WEU>T22U\0_V:+N[ 6:2 JC[8D1"))\.55=N#C)!Z$
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MUPRD\-TSSZ^H!UM%><W?BKQ;;^'/$4<5KI]UKN@7""8PQL8[BW9%DW(I8%9
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M& MWA*A)=F[+(P(/EY!^8?-P29(_%NJ/X<T:X,=I]MO=7;3)94B=H4V2RH9
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M!K2-5&'C3&7<=0A!(& 2W'/2Z3X"TS1]6-]!>:G+"DK36UA-=%K6U=LY,<?
M'WFQG.,G&*VUUK2GU :>FIV;7I+*+83J9"5&6&W.>!U]*Q?"7B==4T6T?5;N
MTAU*ZN+M([?>$9Q%.Z85"<G 5<T 'Q"M)=2\$ZCID$$\TMXBPA88V8@%AN/
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M&TS!9E( (#9!=<H0"1VP:].CO;66\GLX[B-[F!4:6)6!:,-G:2.V=IQ]*GH
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M(((7:"JD @$$5OT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5(8[BQ;&,#DBM+PEI5SING7<]\@CO=1O9;Z:($'RBY^5"1P2J!%)'!*GD]:
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MUMO]I?9H_M>W&/-VC?C''WL].* +U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M5_M*P\OS/MMML\SRMWFKC?\ W<YZ^U6J\3CN+.TTKQII%U<""Y?QE#<2+YFT
MQ0R7-NRREL?*O!^;H#C\0#V6:]M;<XFN88SN"?/(!\QZ#GN:6>[MK79]HN(H
M=YVIYCA=Q]!GK7F&I?\ "//K?Q%37([+Y8851)<!V0VV[*#KN+,P!49) ')
MJ'1)%LO$NH67CIXR+CPY9K"UP6\MXUC(N5P< .9.=H )"@XH ]7DGAB=4DEC
M1F!959@"0.I'TS2Q31SQ++#(DD;#*NC @CV(KR+P+;E+OP'IFM>2+^/0+R00
MR'!,<DD0C4@_>/EALKVPWI77_"^:&7P+ (9(W1+N\0>6V54?:9=H'<#:1C/;
M% '8URNK>+7L?'7ASP[;QVTL>IO<B>;S<O%Y41?;M'0DE.2>@(QR"-G7Q>GP
MYJ@TYBM\;27[,1G(DV';TYZXZ5Y+:ZCI%UXK^&*^'I[198K"^C96!&)/(&$D
M(YSOW$@G.<GJ1D ]F6Y@>XDMTGC::, O&'!90>F1U%<I8^)]7U'0=0O(+.Q6
MZM-8:Q,4DQ6,Q).L;G><?-MW$<#G'!Z'C_!%QH=X?"UM]IU./Q%ICO#/8)%
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M)*[0PSD=1^%>165SIMQ=^#[B*Z@MROB.\01R3G[1&[+,9$EEZ;F8H-FW)W*
MQ!W'-NK>SL?#=Q=VUO;?:H/'C&$LN=C"YX4 <@;0.%QQ]: /5?&/B+_A%_"^
MH:I''%-<6\#2QP22;/,P0#ZGC(/^&<UO5XEXFN-)E\+?$>UU&.V7Q EP\C"9
M/WC6^Y?LY1FZJ%4<*< \X&1GVQ6#J&4@J1D$'@B@"EJ^JV^BZ;)>W(D=5*HD
M40R\LC$*B*#C+,Q &2!D\D#FJL5]K!UJQMKBPMHK66SEEG9+@.R3!XPJC.TE
M=K-DA3SCI_%E^-TD:?PL5/[I-=@,N6P,;) ,^OSE./7![5%.P'QEL02 6T"X
M R>I^T14 :2:KK)TB&Y?3;5;IM1%O)$+M2J0_:/++[NA;9SMZYXQGY:FL-=:
M?7KO1;VS-I>1*9X/WHD6YM]VT2*1@@@D!E(&"1@D$&O-K.&/_A6GA+]VG[OQ
M6A3Y1\I_M"0<>G!(_&NWU@@_$CPNL:NTJVM\S[>BQXB!)_X%L S^?8@&IJM]
MJMMJVC6]A8PSVES.ZWLTDP0PH$)&U2<LQ//&>%/'.11?Q5//X@U/2-+TI[V3
M2VMA>$S"(XFR?W>X88JF&(++UP.:R/&T<;^._ 1V1M,+^?:2%)"^22V-WT'3
MG@8YQ47@RTLE^)/CR9+>U2Y2YM4!CQN5/(&./X<G))[G.>E 'H-,\Z,S&'S$
M\T+O*;ANV],X].#3Z\R,2P^((KZ'[#JEO=:Y-'#,R^3=VEVHE4HQY\R(>65P
M K!#GY@,D ]+$B&1HPZEU 8KGD YP<>^#^1H$B,0 ZDG/ /H<'\C7C_PY:QN
M?^$8:XU$CQ#:2W4=[:>41=[V60R&Z+,7*;@""1C<4'IANDZ;IMIHG@+4[&UM
MX[F77FB%U$P=C"1<_(KCI&1@[!P/UH ]6TW5[+5Q=-8S><EK<-;2.%(7S% W
M $]<9QD<9!':KU>>?"<V!T[6S"+07G]LWGG"%0K@>8<9& 0,8P"!QC@5Z#)O
M\MO+V[\';NZ9[9H 7<"Q7(W 9(SSC_(-9'AW7?[>M[Z7[-Y!M+^>R(W[MQB<
MJ6S@=2.E>9^!GTV]_P"$;FFU@'Q+!>W"74'DI]LDF(<SK,V\YB&,AL=%C ^;
M I3=R66EO+/+!%H__"97BZ@\R;D4&5Q&7!91Y8DV%N>, ] : /8E8.H92"I&
M00>"*HW^LV&FO8I<SA6OYUM[8*"WF.06 XZ# )R>./<5Y@AT'1_L:OJ(N/#S
M^))S=R'$5K%.8,I&,D@PJ^>,[0P]N:NN6GAQ=4\)'3_+FT=/$5QF6;8T + N
MRQGH(PY8 >JGZT >T45XS9:6KZI\1]8M('?5M+NKB;3S&2&25K9E) 7EB<]/
M4#H>:ET6*VB3X97?AP_Z3<HXO9%7:UQ$8R9S,-W/[P$C.0&Z>X![#5"QO+VX
MOM0AN=/%M!;RJEO,)U?[0I4$MM'*8)Q@_6O+="L+5?#7@N_$,7VM/$<\23,V
M'6,RW*E$)YVX ^0<<$XXJYK+7MG'\3;C3BZ/]IM-Y@/[Q8O(A\X@#D'RV<AO
M7D'(X /5:*XKPQ)X5E\6WD_AFZ,QN+&*2YBLF7[)" <1E@ ,2L,\==J<@<9[
M6@ I P)(!!*G!P>AKQR/2+271-2OL3"]7QEY,,R3-O@4WRQD1 MB,E&(.T<C
M&<X!$NNS:?X77XCPPB;3]-%K8.8]-5(RLDV^)BN5(7=A Q R!DCYN: /5M1G
MN+73+NXM+4W=S%"[Q6X<(9G )";CTR<#/;-9<WB&6W\1:+H\]@4DU*VFF+^:
M"(FC"%DP!\WWQSQ7GTLD2Z=\3+%7TP1C14F6WL% B1C;2;L?WB,1_-QQM^5>
M,[P_Y&_X>_\ 8*O/_1=O0!Z!1573M2LM7L4O=.NHKJU<L$FA8,C;6*G!'!Y!
M&?:LGQU!]I^'_B.$1>:S:9<;$V[B6\MBN!ZYQCWH Z"BO*?##VESJGPX\GRG
ME'AJ5)V5RN5$=N AP0'P=WR'=C); (!%7PEIUO!X6^'.K0FX_M9I1;>:A+-+
M RN723^]&JH,9^YM7&* /8**\5M7DU7X70^(+S$'C*#5P5DDB:.6.[-P$$&T
M#.UHV"E,$88D@XHUO3;9O#7Q'UDJYO+/5S):Y<E()(TA82(I. Y)Y;N..G%
M'M55KV_M=.CBDNI1&LLT<$?!)9W8*H '/4_@,DX )JS7%?$JTL+O3-%&HP6\
MMNNM6F_SXPZA2^&SGL1D'MC.>,T =K17G?\ 8&D7GQ"\1:SJ'GN^F/:7<:1W
MD@5'6%OF,:D#)  YSD#W;/+>'$A@\9>%(K65(X=3\/RNVZ4B2YWG<K3L,;G)
M9B>NTEL$]: /;:*\=\'V-OIZ_#"[MI;R2>]MYXIYKMG+E#;%_* ?&(E9%V #
M&!D9W$M+#9VEA-'=M!!?#4+>^^PZU Y2>16CDE>*ZC;YCMVX!_A*@$(3M(!Z
M[5/5+J[L[!IK*Q:^N Z*L"R!-P9P"=QX& 2WX5Y=I6E6JP_"TJKH][8^5=2(
MY5IXA:B81N1]Y-T:?*>-HV]"06ZQ9VR?#K6H(4:*+3?$JBUCCEPD0-U&-H"G
M 7;(PV$8&>G - 'K]%>6:U:00^+)-=FN8]7LSJUK 7B?;>:5*KHJQ*,'?$[?
M>0!20^X;C\U((;?2/B%IFHW,<5ZNH:K=0VFI6?R2JY$B-;W (^=$((7:PYCR
M1GJ >C:3>7=]8F:]T^2PF$LB>2[ASM5V56R/[P ;\>_4WJ\BTF9&\.>#].F$
MG]CWNNWR7.X'#[9KAH8W(XPT@7(/!QCIFJ7B^U>STGQCI&FN;;2X-1TT6T<#
MF'[-)+L\U(\<!2I1L $#>W% 'M5%>=>&+>/2OC!XIT^SWQVLUE;7<D;.7W3$
MD%\L2<D=?7O7HM !2%02"0"5.1D=#7D&H26XU4ZY:F'SAXNAL6O;D!KG'F+'
M)"IP/+B !P,MD$GY3UK:;8Q)!-J1FO/M5AXY:WM#+.2JH]Q'$Z@,?F!CR/XB
M"#C'S8 /6==U5=#T#4-6>"2=+*W>X:.,@,P523C/'0?_ *ZMVTQN+6&<H4,B
M*^PG)7(SBO*=>CLM3T/XF7FL-&;^Q$MK;&9@&MX1 CQ! ?NAW8\C[YP.<#'K
M,881J'.6P,G.>?R'\J '5G:SJPT>VMYVMI)UFNX+4["H\OS9%C#')Z L.F3S
M]2,#XBW4UMI&F*)X+>SGU2"&]EN(R\:Q$DC> R_*9!&IYQACG(S7(Q"/2],D
MTZUU^'4X#XGTY3%:VK1V]H6FCD,,67?"C"G"DA<XP,G !Z]17DFI"WUG4_%7
M]K:W::9J&G7J?8YY+,M=VL(5'0P'>"0Y#<*I+$D'<"!2VMQI6I>(/%-QXAU!
M[36-.UN$63)+F2&%=@A6%6SCS,N& &&WG.: /48+^UN;VZLX90\]J5$Z 'Y"
MPW+STY'-6:\IU.RT^+2?BO<QQ1K<?."T95'7_0XW!RI!Y<D^Y'.3D5H7>BVE
MAKGA_2YU:;3=:O+J]OA-(76:[,(*H1G:48>8VS&W*CV! /1JIZM=W%AI%W=V
MEC)?7,,3/%:QL%:5@.%!/3/X_0]*\>\0VBILT>*XV:3%XULK:R^SS-&T0=%>
M6*,I]T([' XVE3C!4 6KB)+>/XP:%""FFVEE'=0P@GY99+1G=MWWCN9%)!..
MOJ<@'L$+.\*/)&8W9060D$J>XR.#BGUYWJRZ9>^.8M#\4"V?3_[##6BWD:"-
MY3)B5@3\GF +%@#)4$D8!-=AX<:$^'-/%O-=SP) J1379!EE1> [$=<@ Y[Y
MSWH U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ IHC02-($4.P"EL<D#.!GVR?S
M-.KF[+Q+?:A):W%MHDCZ7<7;VPN!-^\55WCS3'MP(R4Q][=\P^6@"UIV@?8=
M>U75)+A9VOY4E"&+'DE(_+&TY/\ #U]R>@.*V'C23;O16VG<,C.#ZUQQ\?*V
MC'Q%#IZ3>'!.83>I<_O-HE\HR^7MQY8.23NR ,XQ27_CV6Q@UV[_ +'9['1+
MU+>YN/M*X9"(R[(N"2R"3)4X! X8DD  [)Y$C4,[JH)"Y8XY)P!^)(%*K!AE
M2",D<'N*X76TGU3XGVFD7-I:W>F_V+/,(9Y2!O,L2,^-APP4X!ST9N1DYK^'
M]<TSPWX:\O3M&FAB_M\Z483=&5FE:;RVE+MZG)Q^M 'H=-2-(]VQ%7<=QP,9
M/K7+6WBG59=4L](GT!+;5+BRGNVADO0R0B.58UW.JG(8,&R 2#@$=2(+#QS<
M7\6BWB:)(NG:C<-9R3&X4O!.I92-F/F3<C+NR#Q]WID [ 1HKLZHH9L;F Y.
M.F:1UC"2%P@1@2^0,$8[_A7&W?C]K'4K!+O1;BWL+_4QI=O),YCN'E)P)/)9
M1^YS_%NSR/EYK+UG7FU'X?\ C2YUJS2ZL+6ZGM4@M;@HS)&0A7<4&WY@23\W
M4XXP* /2"H)!(!*G(R.AI'C23;O16VG<,C.#ZUAWNOW(UN;2-)T^.^N[:".X
MNO-N?)2-'+!5!"MF0["0I"C')8<5DQ?$%+V?0H=.TBYN'UB"XDCW.L8A>'AT
MD)SC#?*2,_0\9 .R,:,ZNR*67.UB.1GKBLK2]#-AJ%WJ%U?S:A>S@1K-,B*8
MH0S,L:A% P"QR<9/&3P %\-:XGB/0+?5$@:#S3(C1,V[8Z.R,,]_F4\U%J&N
M3QZS_8VF6D-UJ(M?M;+<7!AC2,OL&6".<DAL87'RG)'&0"U8:-;V&H7^H*\D
MUW?,OG2R8SL7.Q % &U0Q XSSR2>:T:\^USQ(?$?A"%]/@*G^VK;3M1@DF:-
MX'%S&KQDH#P<@$_W7]\5U>B:%::*;R2UA^SF]E\^:!)2\2/@ [ 0,9P,X H
MTO(A_P">4?W]_P!T?>]?K[U%+IUE/$8I;.WDC+F0H\2D%SU;&.O)Y]ZY]/&:
MLFIW#:;,MEI-W<V^H7!D7$*11>;Y@7JP8%1@#()/I6?I7Q/TC4;F[1C"(8--
M?5#);727)CA3&Y90GW)!N'RC<,?Q9XH [62"&8@RQ1N0"H+*#P2"1^8'Y"I*
MY4>+KRT%U-K'A^[L[.#3'U/[0C>: B@$Q/PH68#)V D<<,><5M%\?:=KVLMH
MF^S:XFM#<1?V?J*W' P&1F3&R0$]B1CD-0!TVJZ7;:SITEE=;PC$,LD9VO$Z
MG*NA[,I (/J*6TL?*2"2[:*YOHX_+:[\D([#\.GN!QG/ Z5Q'A?Q39V/A[PG
MIFD:+>/'J5C-+:1&93Y8BP2K.<?WNN/P/2@_$&\U*RTF33K)+>YDUXZ1?V]Q
M)S#(BLS(&"D$$*/F'3/3/0 [D:;8"!(!96PA1]ZQ^4NU6]0,<'WJK9:,MOJM
MQJES<R75],GE*[*%6&+<6$:*.@R<DG+$XR<  ::Y*C< &QR <C-<F?'4"Z?!
MK4EF8_#\US]G&H-.HV@OL65EZ")FZ-G(!!( )P =--96MQ-'--;0R2Q',;O&
M"R'KP3TIL&G65K,TUO9V\,K AGCB56(/)R0*Q;#Q3)J6LR6-KI%T\$%]-8W5
MUO39 Z1AU)&<D,& ! X)&:Z.@ JM'IUE#<M<Q6=ND[$EI5B4,2>N3C/-8YBL
MO^%@/,MK-_:0TD*LYFQ$T7FD[-N?O;@#NQT(Z\USG@33/[=M[7Q3>Q+%J:WM
MXQNH9RSRIYTL?DON7_5*-NU<\%%(QS0!WPM+832S"WB\V4;9'V#<XZ8)[U&N
MFV")&B65LJQ/OC41* C>HXX/O6/KNJZM9^)-!T_3[6"6"\><W#R2[<!(R0O0
MXR2#D9/RXQ@DB&3QI'#:ZG>2Z3?+9Z9/<Q74P"G:(4#[P,Y8,#@8Z'[V* .C
MAMH+=I&A@CC:5M\A1 "[>IQU-2UR]QXQ&GG58=0TZ2.[T_3EU)H8IE??"2X.
M&.T J8SD'VP326?C6*?4_L=SIMU:J^E?VK%*S(P:(;0X(!RK N.,<\].E '1
MK:6R73W2V\2W#C:TH0!V''!/4]!^5,CTZRBMGMH[.W2!SEXEB4*Q]QC!Z"N5
MF^($</A6?Q$-->XTY;(7D4MM.LBN-VUHV;@+(IZCGH1G(J=/&KSZBFG6^B7D
MMY/8+?VJ;T598C@'+$C80Q P?4>^ #IOLEM]E^R_9XOL^-OE;!LQZ8Z4UK"S
M>".!K2 PQ$-'&8QM0CH0.W6N1EU/2O$\G@?51;WQ2\N&GM'1PBPR?9Y&*R#J
M>%<<<<'G'6K?^,];LO"VMZK_ &=%YUMJ_P!AAB:3A(]R1AB<?,2S?FPYP,T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KC]&\,Z]HNJFSM];B_X1E)3<06Y@_P!(C+,Q,&_IY0)!
M!P6Q\O &3V%<M>>,B+C5(=)TBZU9]+=8;I+=E5_,9<J$!^\!GYCD8[!N< &9
M:^ ;FST/_A$XKNT/A99!(JRPE[DJ93(T)).W&?X\$X)&T$!Z2^\$ZK<:)XTT
MN.\LMFMSF[M)'1LH[*H*2+R-O[M,,,_>8[> #V]I++/9P37%NUM,\:M) S!C
M&Q&2I(X.#QD<<5-0!S\^B7C>/+37XI8#;1V#V,D+9#X9MY<'H<%(QCCAF.>
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M_F>]=CJ>HR:<;+9875W]INDMV-NF[R0V?WC^B#')]Q5^@#B-1T+Q/;ZZNO:
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ME% 'DNJZ'K6L^*/&<:6EQ:RW_AV*".4PL8FEV_-&'QM/7;P3U/7%=!'(^O\
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MW/F 28'R-*H5OF^[@+U!I^D::U_\(7V))9W5G>75_:^;&<QRQ7<DT>0PR1P
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MR+"7&\H" 6 ZX!903[CUJ6@#S[Q/I5^OC!+72I1%!XGMFMM18$AH1"!F9?\
M:,;-%GC!,9[8KOXXTBC6.-%1$ 5548  Z "L?2O#5OI>JWNI&]U"]NKJ21E:
M]N#*+9'8,8H1T1,A>!UVKDG QM4 %%%% !1110 4444 %%%% !1110 4444
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MGR9!'F/U)'S=.!BQIFAV^F>&[;0O-FN;2"V%JK3D;VC V@$J%'"\9 !X]>:
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M#5EI^K6]]:/)"EO9?88K5 @B6/((Q\N[.0/XJ &^)=:ETB"PBMEC-WJ-ZEE
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MU*%XY&F$90JI5\;=W+Y^7' Z]Z@?P1K5SX8U+2;_ ,77%]/<VSV<%S-:J!#
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MA7)D6-H)BA=LX)*D$@#@\9/6N]L=-CL].-G)+)=ARYEDN=I:4L26+8 7OC
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M]TBIA52./<#A4R!EB2>2>U &SX5TNWL-#M=02QC2^GTZVBE%NQQ(L2'RU .
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M<R27UOYWG-)'Y950KH(U"EL  ]CSSNZ^@ HHHH **** "BBB@ HHHH ****
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M>(",*V,XCW[B!P!@^@ /4H;F"X:189XY&B;9($<$HWH<=#4C,$4LQ 4#))/
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M:8L$<X)QUJ331HJ^)8--UZY:\M(](MCHLNJY+7!S)YTBA@!YN#&.F_:!V))
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MJ6J6[6DKZW';&+?O+2M;VX"J[8RA=F*EMHPV2%Y N:;X]$]GJ3ZCI<D%U8O
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MW_&N/\8RWUEXX\%WD$5]-9_:+J&:&VE^621K=C&#&2 3PYW' 4 Y(!R+EO\
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M"P:%;KRFB+1&3:1\A<,V RD[0>O?!QUL<B2QK)&ZNC@,K*<@@]"#0 ZBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH CG$QMY1;M&LY0^69%)4-CC(!!(S[BN;/A62
M3X;/X7FEB:XET]K62X8%@TK*0TQSR26)?USW[UU%% 'EGC#SM$TWPE8ZYKEO
M&;1W;^U+RUEDAFECCVQ[]KADE;<6#>8/N/R<[:OZ=;:CXH\/VR63Z?';6&IP
MW=I>0PND-ZB'>V$8EERV07);))(SU/HE8^N:[_8MQH\1MO.&HWZV0._;Y99'
M;=C!SPAXXZB@#.UCP[K!\0G6O#VI6=C<7%L+2\6YMFE5U5B4D 5U_>)N8#/!
M#8/054N_!VK6^O6^MZ'KOE7TEI'9:@U[#YJ7"+TE"J5Q*.?]DYZ#G/:44 <W
M:^';NQ\6IJD5UY]HND1Z>$N)&:4NCLP<L<YR& )/.>:S]&\(ZEI.C^$-/^TV
MCKHDKR3MALRYBDB&WTXE).>X%=I5>ROK;4;<W%I,LL0DDBWKTW(Y1A^#*1^%
M '&Z%X'U70/*TFUU[;X<@N_MD,,<12Y3Y]_D>8&VF(MDGY<D,5X'-.@\&ZE%
MX6TK2S=P&XLM8&HR2;FPZ_:&F*],Y.[;^OM7<5SX\3_\7!/A0V?/]E_VB+GS
M>WFB/9MQZY.<]AZ\ "Z%H=[H^M:Y.UY#-8:C=?;(T\G;+'(45&!9<*5 1<?+
MNY.23R3Q#X<_M74-(U>UD2+5=)F:2VDDR49'7;+&P]&7OU! ([@[%E>6^HV%
MO?6D@EMKF)9HI " R,,@\^H(J>@#S[7/AU<:IH7B6*.]A&J:_<P3RRRQAHX5
MB9"D8&,N %QSP<DX'2N^A\PPIYP02[1O"$E=W?&>U/HH XZX\'7B:YXGU"PO
MXT_X2*"&&8R1Y:U,<9C#(.CY#=#C!'<<5D^(]-T1- L?AUIS7#:O!!;SV!6)
MS);A9 HNC*JA4*D,2<@GD '<%/H#7ELM_'8M,@NI(FF2+/S%%*AF^@+J/QJC
MH=]=:I;2W=_HTFEW"S20K%,ZO(8U;Y6)7CGK@$CW/6@#2AACMX8X88TCBC4(
MB(H"JHX  '0"N;U#PW>7WB74=02\$$%YI']G*T;'S(6W.WF*,8S\X_[Y%=/1
M0!Q^C^%M6L-:T34)[^T\NRTN33Y[6&)A'RZL)(^<J3L3=G/W>/6L^'X:+%X>
M\3:6U^TO]HWDEWIQRR"P8G?%LP<@I(2<@\^G)%=^V0IV@%L< G S7,>$_&*^
M)M#O-7FT^33[:UEDB822"1B8_OG"]AT[DX/'3(!T%C:)86%O:1G*PQJ@.,9P
M,9_&L231-2LO$6H:II$]H!J<4:SI=(Q$4D8*K*H7&_*D J2OW5PPZ5+X?U^[
MUB5UNM'GL4:WBNK>0L726.0$X+;0%D4C#)DXR""0:WJ .*T7P7<^'];T2:SF
MMWLM.TDZ8XD+"23+*YD'4 [DZ9/4]*ZV_L;?4].N;"\C\RUNHGAF3<1N1@0P
MR.1D$]*L44 <1:>"+MK7PUI^I7L<UEX=E66W:-?FN6C7;$74C";03T+$G!R*
M>/"FJMITFG27%I]GAUM-3M'5FWNGVHW++)D'G)*C![ D_P -=I10!R.J^##K
M$_B19YHX8M6BMUBFBR98GAR48@\'#'(&>WOQ#>^&_$FM>'[^RUG5+&:2XMH[
M=+>*$I!D/EY&/+$L,?*,!<8&<DUVE% '->,_#,OBSPTEBDZ6>H13PW-O<J2Q
MMY4<$LAX.=NX X'6JMKX)CLOB)_PD%MY*6)TY(#;\EOM"91)>>XA9H\]<$^I
MKKZH:5J$^H1W33V$UFT-U+ JR_\ +148A9!Q]UA@CZT <KI/A36]"M]7-M<6
M4YO];N-3EMI =DT,J%3 6(.T@[3N [8(P3FN/ NJVL&F:AIEU9V6JZ;<W$UO
M9+EK,13E=\&=H8*-HPRJ,$GY?3K-6U>XTR]TN&'2;R^CO;GR)9;< BV&"=[Y
M_ASU/\S@'5H S](MM0M[>5M3O([FZFD\QA#&4BB^55V("2<?+G)/)9CP" .5
M\0>#]9U2_P#$9M;RS^SZOIWV:.6X#-+:L$*&-!@@1L&))Z@L>#QCNJ* ,273
M=0D\3Z3JA>U,=O93VUPHW EI#$VY.O ,(&">C'GCG"?P3>7>D^*-/N+B"(:I
MJ8U&VEC)?8RF,JKJ0.,PH3@\[F'& 3W%8&H>))+6^N[>TTNXOOL0MS<>3G?^
M]<C"+CYBH&YN1@$<DY  ,O6/"^J>)(KN;46LK>Y;2;K3;>&)S+'&T^ TN\HK
M9PBC;CCYADYJO)X-U8>&_""V]U:Q:QX<6(!2[F"X"Q>4ZE@ RAAWVG'((-=O
M)/%"\*22*K3/LC!/WFVEL#\%)_"LW1-=BUN75HX[>6$Z=?O8OYI7YV54;<,$
M\'>,=_4#I0!S]YX0U74;77EN+NSBN+O4+?4K"6)&/D31)$%#9ZC,*C(QD%C@
M9 !J?AC7_$NCYUB[T^VU2VN8+S35M5>2"VFB8D.2VUGW!BI!& ,8&>3OPZQ=
MR>*[G1WTBZ2TBM4G343_ *J1BQ!C'^T.#W[YQQG7H Y#1?#NK6_CO4/$FHM9
M(M[80VY@MY'<QR(3GEE&5[@\'G&.,F7QWX;O_$6GZ4=,DMDO=,U2#48EN698
MY#&3\K%02,ACT':NHDD2*-I)'5$0%F9C@ #J2:S/#?B"R\4^'K/6M/$@M;I2
MR"4 ,,,5((!(R"".M '-3>%-?M+SQ%_9=W9_9=?16D69W'V*8Q[))(UVMYF[
M"G:2O0#I78Z=8P:7IEII]L"+>UA2"('J%4!1^@JS10!PR>$];@(V3Z=*R:T+
M]KB;?YUS"7+;7(&%9 Q5<!E(5>$JE!X)UNST;7[-$TRZ;4?$O]KQI+<.B&$3
M1R['_=M\Q\K;C!'S9R<8/HU% 'GFKPZ9XH^(VDQ6$LDE]I8D75Q$,PK;D!EA
ME)'S,950JOHLA(X%>AU##:6UO+/+!;Q123OOF9$"F1L 98CJ< #)[ 5-0!PY
M\&7W_"/:AX6WVC:+=W,DJ2L[B6**27S'BV ?-U<!]^>0<<8.E!H^JK\1;K79
M([,6$FGQV2;;AC*=KN^XKL '+XQN/3.>U=-4<T\-L@>>6.)"ZH&=@H+,P51S
MW+$ #N2!0!F^)M-N=7\.7MC9M$MS(@\HS$A-P((W$ D#CL#6'=^'=8N_%6H:
MLT6GI'=:$-.4?:'+)+N=C_RS^YE\9Z_*#CG [*L_1-2DU?2H[V6QN;%G>1?(
MN4*2*%=E!((!&0 P]B* .(TCP9XF\.Z=X<ETVZTY]0TZR>QO+::9Q;SQEMP*
ML$W!@0#DKW(^O=Z7!>6^GQIJ%RMS=DL\DBKM4%F+;5']U<[1GG &>:N5EZ'K
M<.NQ7LD,4D8M+V:R;?CYFB8J2,=B1Q0!RD/]JGXB>,DTE+7[0]EIZB2XE*B,
MD3 , $;=CDX.,X SSD0S_#^^CTR\T6V&G7%A)HJ:?:W%TS"6UE6*1&98PI7Y
MRX)8%3R<AL 5W5OI>GV=Y<7EM86L%U<D&>:*%5>4CIN8#+?C52RUV*^\2:MH
MJV\J2:;' [RN5VR>:'(VX.>-A!SCGMCD@&5I/AW4+'Q;%JDOV7[*-%@T\JLS
M,XDC=V)^X 5^;&<@\=!6=J/@_5[GP/XET"&2S,NI7ES-;2R2L%5)I#)\P"$@
M@DC W9ZY&<#J9M8$/B6TT7[),S7-K+<B<%=BB-D4@\Y)S(O0=Q[XCU_7XO#\
M>GO+;33?;;^"Q7RL81I6VAFR?NCVR<D?4 &')X?\1:=XHU+6M$N+!EU:&+[5
M;7KN4@G1 @="JY==H *DKG!.1P W4_">HZKY,=XNG3W%FT'V+5]S17D84+YC
M':N"2P<X5E4@@$=Z[6B@#G?#6LZCJU_K"W"V<NGP7&VQN[/?LE7+ H2W#.I4
M;BN5RV,Y5@%\1:3>:M-';FRT[4=*DA=9[6]D,963@I(C"-CG[PZC'!'-=#10
M!P&D^#=<TWQ#!J4][#?-#X<323(]R\;R3*Y?<V$SCD#=NW#DX)-1:'X-\0:5
M8>&K.X;3+RTT^T>UNK229_*W,ZD3J-GSL%# *P'4X89)KT2B@#B-'\,:SI^F
M>$K25; MH]U)+<-'<R$,ABEC&P%,D_O<_,>-N,G.:V=#TO4+'7/$%[>?9A#J
M%S%/ L,A=E"PI&=V47_GF#U(Y[<YWJ* .5\1^'+_ %'Q?X8U^Q>V;^QS<^9!
M.[)Y@FC"<,%;&,9Z<^U9=YX,UE[HZ_:S::GB/^U/MRA]_D"+R/(\DM@D_(,[
M]H^8D@ <5W4<\,SS)%+&[POLE56!*-M#8;T.UE.#V(/>I* ,_24U0032:L;8
M3RREUBMG9TB3  4,P!;H23@=>E8FJZ/K-MXSB\2:,EK=F2Q%A<6=U.8%"B0N
ML@<(YR"S C'(/M6[K&JV^B:5-J%R)&CCV@)&,O([,%1%S@99BJC) R>2!S4&
M@ZV-;M)I&LKJRN+>9H)[:Y3#1N#TW#*L",'*DCGKF@#FW\+:Y;^-[+7X;N&Y
MDDTAM+NYI&V-"QD\T3(FTA@&RNPD?P\]33M+\*ZK9W'@B63[)MT33)+.Z E;
M+,T<2Y3Y<$#RSU(ZUV]% 'G-YX*U^?3-/@B?3XY;?Q0VM3+]H<+)#YSRA,B(
M$M\P'(/W0<] %OO!>MQR^+8M.:R>'7)8[J&6:5U:*12@*,JK]T@,0X;(X^4U
MZ+10!RNIZ#K%UXFU"_LKJ"VBN='-A#/YA,L$NYV$@3;@X++_ !=OSR;'P=J\
M5]97$L.E0EM&N=/N_L[R$^:[1D2[B!YFXIDY52,G+/Q7H%-DD2*-I)'5$0%F
M9C@ #J2: .*TOP]X@MM)\&6TZ6 DT)BMPJ7+;9%6W>!&7]UDDA]V#@#D<]19
MU'P:UW\1-.\20W&RW2W,5];;L"=D.Z!L!?FVLS$Y/5(\=*ZJ">&ZMXKBWECF
M@E0/')&P974C(((X((YS4E ''G0?$&E:SK4F@S:>MGJSBX+W3N7M;C8$9E0*
M1("%4X++@YZCBNMAC,4*1EWD**%WN<LV.Y]Z22>&%X4EEC1YGV1*S %VVEL+
MZG:K' [ GM4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9VOSK:^'-4N'FN(4
MBM)7:6V ,J (3N0'@L.HSWQ7E-U+'IR7GV%8+:"Y\&W=U)#;3Y6::-E"R.Z$
M;I-N02.?O#<1S7L]9YT+1VLTLVTJQ-JD30)";=-BQL060+C 4E5)'0[1Z4 >
M9:)<OHVJ_#NXM$DGN]<T"6.Z$LSL9VB@BEC&6;"D-O .#@.PQSD,CGTVXTOX
M?7C7$,NMRZO";^20J)_.,4HE5QP1B0;0"., "O2H?"WAZVGM9X-"TR*6T&VW
MD2TC5H1DMA"!\O+,>.[$]ZF&A:.MX]XNE6(NGE6=YA;IO:100KEL9+ ,P!ZC
M<?6@#GOBI?1:;\,M=NI4D;;!LC\MRA61V"(V1_=9@WX5RFKG4=!^(>NV>ASW
MCS/X/DNT1IC(7NEE*++ALC<!Z#'MS7J6H:;8:M:FUU*RMKRW)#&*YB61"1T.
M&!%5[;P]HEE?+>VFCZ?!=K&(EGBMD60(%"A0P&<!0 !Z "@#CX(--3Q%X.N=
M"NU=+Z"9;Q8@K"\MQ 2)93W*R",9ZYD(SS5SX5QVT7@I(XDB29+R[694 # B
MYEP&'7ICKVKJ-/T72M)DGDT[3+.S>X(:9K>!8S*1G!8J!GJ>OJ:FM;"SL?/^
MQVD%OY\K3S>3&$\R1OO.V.K' R3R: /,_'UVOVKQ:$NH3<6VC(T)N;D1&U<"
M1P8%7YF=NN[CE5&6&0(;J;^T?B7*^[[0)_ ;/N,8!DW3=2!GKZ<CGBO3YM+L
M)[I[N6RMWNI(#;-.8QYAB)R8]W7;GG&<9J"+P]HD%]!>PZ/I\=W;QB*"=+9!
M)$@7:%5@,@!>,#MQ0!YKI=Q96?A;X?V\<MI;Z9<VR"]GD^>$W/D*8XY@&&22
MSD!C@%1QG;BT\-N;CPOHQ\0/?07>K7@22.5XU>V$$Q,2?,V]%+K'OW9' '3C
MO8/#.A6VBMHT6D60TQF+-:- K1,=V[)4C!YP?P'I3Y/#VB2R64DFCZ>[V(5;
M1FMD)MPN-HC./DQ@8QC&* /)[^QW7/Q6L&O+UHM*TZSFM6-RVY'6T9LYSSDJ
M,_CTJ_K6I13Z7JC3WS7-W!X:BN%,LWE>0S1R-YEN>2\A*%B>V$&[J!Z*WA;P
M\YO"^A:8QO3NNLVD9\\[MV7X^;YN><\\TY/#6@QS03)HFFK+;Q&"%Q:H&BC.
M044XX7YFX''S'UH XW2SITWQ#T.\F>![JY\.[EE?#&5Q)&-P8]6[=<X^G&7/
MHUQJ'@?5[^TO+AM0T;7KZ]MAYI8NL4[9@<MDLK*O0]]N<C(/IG]C:8)K"86%
MLLFG(R696,#[.I4*0F/NC: ,#L*=INDZ;HUNUOI>GVEC SEVCM85B4M@#)"@
M#. !GV% 'FVK2%M&OO&@O+FWL]9O+)!(0P%M8!T4OA2K#S,;F.<[&4=170:)
M>:3HUQK.J2>);!])D2W<"(B.TMF._P"XQ=EW/E25&/X>/F%=8NGV2Z8--%K#
M]A$/V?[,4!C\O&W9MZ;<<8]*I'PQH1T6311I%FNF2/O>T2$+$QW!LE1QU /X
M4 :U>1>%5B/P6\4M/&KI%/J,NUB0"4+,,D<]0*];DC26-HY$5T<%65AD$'J"
M*S8_#6@PZ7-I<6B::FGS/OEM%M4$3MQRR8P3\J\D=AZ4 ,\+V=O8^%],AMHQ
M'']FC; ).25!)R:\RL-:,FIZ+?P:F]Q-<>)Y+5[FX=4F>+9*OE>4"P$8^7!R
M#D*=H)!KUZUM+:PM8[6SMXK>WB&V.*% B(/0 <"L]/#&A1W$]Q'I%FDUQ<I=
MS.L(!DF0Y5R>Y!)(]R3U)- 'F\NZU\,ZWKT=U>RWUCXI9;9YKJ0B-/MD<;1@
M!AE"NX$'.0?IC0U[3[W2O%&IZ7:W,YB\76Y@LW8M)]AE!/G[.>!LD>8#(&Y"
M!U%=U-X;T.XLKFSFTBQDMKJ=KF>)[=2LDK=9&&.6_P!KK5.RTK5YM?;4=9NK
M.2*U>9=/AM8F4JCMPTK$G<P4 < #ELYX( -FRM8[&PM[.(NT<$2Q*7.6(48&
M3W/%>5:+#-#X6\%:W#>ZC+J4^I);NK7\K*\,DDGF1E"Y5MJC).,_N@2>#7K4
MA<1L8U5G .T,V 3VR<''Y&N3\$>"K;PWH]B;RRL6UJ&-TFO(!N,A+'+[B =S
M#;N.,\8R0!0!S-U!<6^A^+O$VFZAJ,VH:?<ZBEI&MRYCC)"!OD)PVPHQ / )
MZ<+C6>RM[+Q;H-CI-Y<W%GJ=G='4(Q>N_FQ;%*W).[@[L+O7!/F=<#%=E8Z5
M8Z8]TUC;1P&[G:XG\L8$DK?><CU.!D]ZKZ3X;T70FD;2M+M+-I,AC#$%."<[
M1Z+DD[1P"3QS0!Q'A>VNYM0M?"NH375Q-X;OIKNYN9G8M<J^XVS%NC;A*Y(R
M<-#S[LLI+V[\.:G;178DN'\37D,4%S=/']J1)';[.)!DKE$(';CTKTB.U@AN
M9KB.)5FGV^:XZMM&!GZ"J#>&](>U:V-DGE-=?;" S ^?G/F @Y#9&<COSUH
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MM^\S@;.N2!UXJJ;N:\^)FE.VGZG:[=&NI2D\J^6_[R$ *JNR[QN;)^4X9>2
M ,^[^']_JL&L0RS6^DQZG;1RS1V$[RH;]9!)Y^UT 7E%!QRPZX(!K>M;#Q%-
MKVE:KJ,.EH]O8W-K<16]Q(PWR-"P="R#()BP5.-N>K=* ,KP?XDT:+P9H?\
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M"[#+1L02I],CBL'Q1!KT\VE?V1MDLUN";^!;@P22)M.W;(!E0&P2!@D<=":
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MPMHFM0ZI<O?V]]JBQDVTK_ZR-_E+,F[YE"CN02#S7I] !1110 4444 %%%%
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MQ,I4.44&*1ESG:RE3D'!Y(..@!V]%>9^%]0U[7M7TNXT_4M0.E-I"S:DUPB
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M7+C25%OK&I6DL)GDF<HTA3:C.O(.W  .TE1D#@D&QI/BG2-:U74-,LKAVN[
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M9K8YAF>-4@7[J(JD!,9."H!&>M11^$M$BATB)+1\:.?] 8W$A>$8QMW%LE<
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MI]O%>RVMC>[Y+F.0!X56WEC0DY!)W.G8C .[WWVUK2E:]5M3LP; !KP&=?\
M1P02#)S\F0"><=*AOM;L((84&HVT4MY!)):2NV8V"IN+YZ;0,'.>E %.?P9H
M]SHMQI<Z3R1W$JSSS&=A++*I!5V<$%B"JX!X^4<8%2:OX9T?Q$\$UVLC75H2
MJ75M.T,RCHR;XR#A@2"O3GL<&LN#QC!I[^&-,O\ 4+/4+W5_,#7EJX6#:D;-
MO!Y')"J!GG)Y^7%'A[Q:C&>#7;^"*[GUN[T^R0KL\P1L=H _W5ZGJ6 SD@$
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M3@9R.*SV\!VQT>XTV/6=5B6?5#JK31M")/-WB3 S'C:' ;&,Y'7'% %*:_\
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MYR,G&?:N1TSQMX@N;F./['97[3:#-J$<5I%(G^E1LH:$2%FCD7+A<H200<@
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M\:DQM@JA=N=_EJ2$/!!.3D@8ZR@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R
M2)%&TDCJB("S,QP !U)-94VNZ==6M]%I^MZ8+N&%FW&99%@.W(9U# [1P3R.
M.]9_Q$@CNOA]K=O*TBK+;%!Y2!V+$@* N1N).!@<GH.<5SPNXM0U?6]5G-VE
M_/HC6L-B-,NHRZ1EF9E,D:F1BTH&U1P,=<T =7HNN6C:=I$-]KNG76HWT DB
M:-UC^T\9+1H3DC_#M6E_:FG^5++]OM?+AE,,K^<N$D'5&.>&'H>:\T70=0C^
M%?A/5(+2[DUOPZD5U':>0T<LH VRV^TKD97*YVDY4$9SSJZIHL^CV_AJ[DM+
MV^BM+N>>_P#L;2-.LDR/F10A#, SE2!SM;@>@!W-E?V>I6J75A=P75N_W98)
M Z-]".*BDUC3(;U;*74;1+IG$:P-.H<N1N"A<YR1SCTK.\*V]I#:7TMCIMW9
M07-X\X-VTGF3DJH:0K)\R9((VG'3./FKDHK&)+K4M&U70=8O;N75I+RWDC>X
M%K*K3>;$YE!V(4&T$''W, '(R :]WXAU#4_$^K:-HNHZ?:RZ9%;R_P"D*'$S
M.S^8K8.0%5,<<@MR:30O$MYK8@UY-3TZ#0_.N(+FVGP'CVRM'"P<' 9MJY!X
M^;CM3]',D/Q&\5W4MI>);RVUFL4IM9-DAC$V\*=N&QD=.N1C-<MIMAJ5OX1\
M.74EEJI@TO5[N:^T^.WDCF>.62=4E48#ML\P-M7J&/<"@#TU-:TJ33SJ$>IV
M;60)7[2LZF/(."-V<<$&L_5O&&C:3;V$SWD$J7UXEG$T<Z;=Q.&))(&%YSW[
M=37&7&GV]I/I_B'1/#>J?8H-:DNKVVDAD\ZY)@:/[2L4AW9#,3@@,Q&<<@G6
MU&1'T^TO[30[NUM/[>BN)-MO()I5[S-$%WC+_+@C.!DC!H [I6#J&4@J1D$'
M@BL!_%^F)XX3PH98_MILS=$F0  [@!'C^\02V.N!GN*T+36+>[UG4=*1)TN;
M 1-)YD15720$JR-T895UR.A4BN<O)I;?Q[JEH%NHY=6TB"*RN$AD,:R1M<;@
M74$(1YB'/'7UZ@'3P:MIMU<?9[?4+2:?YOW<<RLWRG#< YX/!]*J>)/$>G^%
MM';4M1FCCB#K&@>0)O9CT&>IQD_0$]JXNPLKF\\,^!]+AL+RUU32)[5KGS;9
MHQ L2%)CN(VL' 91@G=O!' )&]\2X99O 5\(89)6CFMIF6)"[;$N(W8X')PJ
MD\>E #7\5_8?&][9ZEJ6G0:(FF07L,[D1!3)(R8:1FPV2N01C[P&#C)Z._U;
M3=*5&U'4+2S5]VPW$RQAL#)QN(S@ D^U<1JMN]]XVUB^&G7<MNWA@0PR/928
M+L\A9%ROWB&3*]?4<'&'H8O-"M_"UYK>GZR=/_L-+%OL<-QOLIE?+>:JXD 8
M!!P",H,#&#0!Z['(DL:R1NKHX#*RG((/0@U4DUC3(KG[-)J-HEQG'E-.H;/T
MSGN/SJKX7M+:P\-6-M9Z?-IUJB'R;6=RTD2$D@,220<'."3C..U>6^%?[/AT
MWP_8:I)<P6&E:Q-<P7US:7*-<N7D6,22A!$N6DSGS&#;5!'S$  ]?.I6 ECB
M-[;"23S-B>:N6\LXDP,\[3P?3O3;/5M-U!96LM0M+E8<>:89E<)D9&[!XXYY
M[5YS%X?NM0\"^,H(-.9=4EU/4FMO.A\N1UD?.%+#HZ8'H00#Q5BZNM#U#0=;
MU72O#>LZC>0Z6]G<6UT;B!C&W+P?O",L!DG9DC& <L 0#L[WQ-H]GH5]K']H
M6LUI91&25XIE8#C(&1GDY&!WR,=:?_PD6D1Z1;:G<ZG8V]K.@9)9+J/RSQD@
M/G:V.>A[5Y@IN;BR\<I%%>7+W_AN#[*ZZ;)#&X6.=2J*5!4?, H<ECV+8P-[
M5KVTD\666N7L.J3Z!?Z9]DA:WMKC*2E]Q#QH ^)%*@<8RF* .YNM6TVQ\K[7
MJ%I;^;CR_-F5-^?3)YJC%XHTN;Q9+X<BNH'OH;<3R()EW+DD;=O7.!DCL"">
MHSP>L:/:Z=!:ZCH]K>V<L.C"T71[VVDF@OX',A2U8Y.)?O<9)7<,@C-=587<
ML?Q'OTN[:>%KW2[3[.!"S+^[:=I SKE1@R*,DKG( !ZD Z*_U*PTN#S]0O;:
MTA_YZ7$JQK^9(IXO;5I(8Q<PEYUWQ*)!F1<9RH[C'I7!^,U%AXSL=9U*+4QI
M(L6M4O--1G>TF:0,6<*"P5E 4$ \D@]5(JZEIUN_A72M$T:#4++4HDGO=.N;
MPNDELJN2P=AAD\Q'*!<9"L>,KB@#K]4\8Z)I:6#27\$IOKD6UOY<BD,VX!SN
MS@!!DG)[8ZD Z3ZMIL=[#9/J%HMW,-T4!F4/(/55SD]1TKS2_P!1L;CPWX'U
M73-&O+#2[#54:>T2UD+V@\MQ\T: DY+##8).X?WN:<FG>=KNK:3K%[XG:[GU
M<W]K9V=NOD3QM(C1-YC1';L"(&W.NW8P'N >KMJVFI,(6U"T64S_ &8(9E#&
M7:&\O&?O;2#MZX.:S[?Q5IUUXPN_#44BO>6MLEQ(5<$ L2"A&<A@ K?1A7F7
MCRUAO?!WQ#N+:QW7_P#:]NL#)$3(0JVJDH<9ZI)G'H:ZO3&\GXT:VSK.$O-,
MMO(98G,<@7<6.X*5&.!DL.3@9SP =M>W]GIUN;B^NX+6!>LD\@11QGJ>.@)_
M"B:_L[>U6ZFNX([=MNV5Y $.>F">.>U<IXAU)/#_ (VL=7U*"Z;2C82VRW$$
M,DPMYBZL=R("?F4 ;L<;<=ZPXK.VT;XBZ->/IDUIX;CT"2VL_.A)2VF,H)#9
MSY;-'@?-@GD'G(H ]*:Y@5X4:>,-.<1 N,R'&?E]> 3QV%1?VE8?V?\ VA]M
MMOL6-WVGS5\O&<9W9QUKR;P]IEW;7WA.SO[>5; ZQJ,MK:W2$/%:-#(L0D0\
M+R2 , #<!C-:1M;&;3+J".\;33#XF>6RN+>VS%;2!20TJY :-B'&> 2PY[T
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M!4L?O8 KL:* .<7P_<1>.;7683;K86^F-IZP@G>,NK[AQC V 8]\Y[5T=%%
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MF(M&"8SQ]WTZ#IZ4 <?X3FT_PUIFO)*\-GID&NR0P(BX2$2-&%7 ^Z#)(?0
M-V S7;U5&FV B>(65L(Y'#NOE+AF!R"1CD@@'/J*M4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN\2S>5#+YCM(P8(V. $&<$$Y.?EMMI&ICQ#XVO!82-#?:?;PV9$D>;ATCEW
M#=\O+J/FV\^W-=I10!Y_-H6IVNHZ1JP\/P:KNTJ&PN;.=X5DM'4[MZLV01\[
M!@I_@4C=QC3TRQU*R\3VTCZ-'#:#2O*+631B&*3S2WEA2P;ICD+@D]JZVB@#
MSO1-&UW3]'\%N^BXN+"2:*[M1/$#;K(&4.""5*CCA3NP>!U6NRU^%[C0KN!-
M-CU(2)L>S=P@F0D!U!/&=N[&2!G&2.HTJ* /+Y/#7BB'3K>P2&>\TNRUNRNK
M".YN4>\C@C??*)'+!64$?( 2V#@].-#4]+\2'5?&EWIVEQ2-=6UFMB+QXS'.
MT>_S,#)VMAAM+@#<!G@5Z!10!Y=-X:UL+XVBMM(N_)U?1(+>S>:]CEF>58G4
MI*S.3NS)@G)&%.&Z"NEU.SU*[\<^&-4BTR?[):VUTMRQDB!A:41;01OYQL.=
MN1Z9KK** .<\9:5>:KIVG_8HA+)9ZG:WK1;@K.D4@9@N<#=@<9('O7.>)/">
MJ^)[G5-4^Q+ XCLXK;3[R93'=BWG:9A,%W+M?=M R>F3C.!Z-10!S_AF"7=<
MW<WAJVT)IDB5HU,32R,H.=S1Y4J-V%YS]XD#.*Q_$C7B>.+2YT:QN;F_ATR6
M*Y:W\IC%%+(IC)65T7EHGP0Q^Z<@C%=Q67J'A[3-3OH+ZX@D6\@P$N()Y(),
M#.%+(P++\S?*<CYCQR: .*\/:9+IMYX=U'1-)NKFPL[&XT6ZAFEC6XMV249?
M[^Q\O$RD*W&<C."*GM_!5[)H/B>65?L^HZK?_P!I6L"2@BWECVM#EA@;BZ L
M0>AP#QFN[L[.VT^TCM;2%(8(QA40<#G)/N2223W)S4] 'G6H^$]7U'PAI=U<
MVMK-KD&I1ZU=V&%,<\H4JT 9F(7"L%#$L,H.W(L7>E7MQI%Q-;^$+>QEGO["
M5K6 P">1(;A'<RL&"'Y5(4;CU[9..]HH Y5K'4)/B1:ZQ_9\JV*:-+;M(7CR
M)6EC<)C=GHIYZ9[USNF^']7T_3= NKKPZM[)9O?P7.GDVY<1SS"194)81DCR
MT!!.3O/.1SZ910!P5MH^I:/KVE:W;>'(4B-I<VMQINFO$GV<R2I(LGS%%8X0
M!\'KTW"MOP=IMUIEAJ4=Y;-!-/JMY<X+JP=9)F9&4@G@J5Z@'.>/7HJ* .-U
M*TU6WU#Q,]KHD>H'4K>*.V\WRS Y$;*4F!<,5!R3Q@AL#FLO7_#$VF>&/"AL
M[B-=>TD6^FVUP-P5UE58)<@$<!29 >H*#'?/HU99\.Z4?$(UYK7?J0C\M9GD
M9@@P1E5)VJ<$C< #AB,X)R 7;*S@T^PM[*V0);V\2Q1(.BJHP!^0KS&XT#Q#
M?:WH.H3Z5(LFFZ_,UPD<B)$L$C,5EB0$!U(<,[-^\W%N.H'JM% 'FECH&MVW
M@?0K&329A=VNOBZFB$T>5A-T\F_(;! 5AQG/48QS1K&@:]+X7\:>'HM/FN7O
MYIKJQNO.C"2B1E;RSELJRDD#( PHP>U>ET4 9FOZ;)K?A?5-+1A#)?64MNK.
M,A"Z%<G'IGM7-V<?B'7?#4VD:AI TB]33I;*:\W(4:1D"@VY1B53HQR!C 4
MD$KV]% '")9:IJ\?A.&;2+JR?1YUGNY)'CQN2!D\N,ALN&9QS@#"G)!XK&NO
M#OB._P##?AB.32Y/MUGXK.J7B;HH]D1GFE+ >8PZ2+\H9B.1DXS7JE% '"6F
MF:G9>,?M&E6VHVUM<7LCZA:W<B/:;/WG[^$\LDCL58J,9WG<!C-<]X3T+7M+
M\$^$=.NM N_M&B:S))=+OAP8R)QYB98[@#*O0;C@[>QKURB@#C=9AU-/%.J+
M;Z5/<P:KHR6T5Q&RA(YHC<';)DY4$3+@\]*Q;'2-4TJT\+75UX8DU2.'1HM.
MN[0&%I;:5=N' =@K G(/S<#!]:],HH XFTM=2TGQA;WT7AR-=.O=.CM'%H8P
MUBZ2RNJD9 VL)?FVY&Y?3FMGP;;7=IX3L(;ZU>UN0K&2!V5BA+DX)4D="*W:
M* /,/$F@:S=V7Q'A@TV:1]4%L;(!D_? 1)&<'/&"AR#@XP>]=8D5Q)\0(KS[
M),ML=(*^<R@*',H.S/\ >P,X_GVZ.B@#F/$45^WB'1)(+"2:SQ+'-<VL<9GB
M+;,#<Y!CC8!MS+\W"@8.#7,Z79Z[HUCX;UA=#O+@:?!=V5WIY=&N$6216$L9
M9OG.8@#ELD-D#K7IM% '#Z@-7T_6]+\3)H=W/$MM<VMSIMJ\;2PB61)%D W!
M68E%#X8\G() S4DUOJ5MXDT;Q VE2K9)93VLVGPB-WLWED1_-^7[^[8%8*3@
MX(R-QKM** /+-.\.:CHKV,U[97#+<^*KG6'AMXA-]DA>&1%5L9&=S(?ESU..
M1FMJ\MM4L/$'B9!IUW>V^M6RO:S0%2D+) 4:-PS KD@$$9!+GH1SW-% 'FUC
MI6M+H^A:7+IM[:[/#HM9+BS>*.=)U55V&;)*+D!EV]3UX!4GA72=2LM>\+7%
M[IMU%%:>%192LRJPBG#1_+P2<D(WZ#KD5Z310!YAX>L-;T'0O!>HRZ1<7+6-
MI<66H6R@&XB\UD(D521NPT0!P<X?(!J?Q#HMY/KNAZX_AZ^>TC@FMY[33[\P
M7%EOD4K(#$Z[\C(=5)QG(+8R?2** ,CPQI\>E^'[>UBTT::@:206@E\SRM\C
M/@MDC/S9."0"2 < 5@7GA>XU#7?$FF3P_P#$AUJVCFFFWX*S[?**HH/!PD;E
ML>V#G([:B@#SFYTO69?AMJLVH632>(=4*-<Q6J;LLFR,;<C@;8]^", LW!SS
MM);7*?$U]6^RSFQN-$CA681GY7661RK#J#AQQBNLHH \V\-Z=J6G>&?A[:7&
MGW2RV5R[7:>2281Y$\8+'L-TB_@<]!6]\2-.OM5\!ZA:Z;:&\NM\$J0#&7"3
M1NPY(!^53QGGI75T4 <9=12W.O\ B&Z_LZZ4W&A06\#/ 22X-P[H",C/[R/(
MSR>!G%<]!H%U;V7A&^N])U6>.VT2/3KI-/NI;:YMI $SD(Z%T)4@\GH",BO5
M** ,;PKID6C^&[6QATXZ;&A=EM#.9FBW.S89R3EOFR>2,D@$C%</;Q:Q:V>O
M2II%T_VKQ-]I5VM0\T5NR(JSPHZX+ADX!!*YR00.?4:* /.X/#M]>:#XVTZX
MM;FWFO+TW=I+*D;%W\F(HV 2I(DCY P,],=C6/#6J:_=:5<W=OY)U>S:PUI(
MG_U,.3,@!]B'B)QSYN>PKT2B@#@-6M]6A\1W5[H5I=K=S7MNEU:W$"O:7<:[
M?WX?CRW5>,YR2@&TX4CH/&5C>7_AMTL(!<7$%S;72VY('G"*=)2G/&2$('3G
M'(%;]% ')VT$][XY_P"$B%M<V]E!I#6K":$K))(TBR8"?>.T*1TP2_RYYQ:\
M#+/'X0LH;JVN;:XCWB2*YCVN"6)YQP>".1Q7144 <9<V>H1:]XP;[%-);WNF
M1-;21JI#NJ2JR>N[E<#ISV[YEEINHQV_@:P^S7<+VNCR6US<)"<6TA@1%R>#
M]Y6Z>@)QP:]&HH \Q\%>&Y-/O-'MKKPQJ%O=:/O1KR?59);4 QLGF01F0C+Y
M^[M 0%LG(&?3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ
ME_I\=_$JF6:"2-M\<T#[71O;L1Z@@@]P: +=%8<]_JFC!?M5E/JELTF/M%FB
M^;$I(P7BR"V >3'DG'""M"QU6QU'<+2YCD=/]9%]V2,^C(?F4^Q - %RBBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JWFFV
M6HA!>6L4Q3/ELZ@M&2,$J>JGW&#5JB@#(;3=0M)_,TW4B82&+6UZ&F!.!C:^
M[<G0YSN'/2BW\0VAU)-+OB++4W#&.WE/$R@XW1M@!QR#@<C/(%:]5K^PM]2L
MGM+E"T3E3P2&5E(964CD,& ((Y! - %FBL#P]J%Z;S4=&U6=)KZQ<.DP789X
M'R8W*X R,,I*C;E>#G(&_0 4444 %%%% !4<\\=M;RW$S;8HD+NV,X &2>*D
MKF=?6?7=3C\-PF-;)HUGU-SDLT6X;81CIYFU@V?X-P .<J ;.D7TFIZ3;7TE
MN;<W""18BVXJIY7/ YQ@D=B<<XS5VBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1E
M#*5.<$8X.#^=0V5JEC86]I&\CI!$L2O*Y=V"C +,>2>.3WJ>B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX;K5=0G@D^]'O2+(]-T:JP]>#ST/'%:E% %%+?3="L)Y8H(+.UB1I93'&%&
M,ECCKW/K7&6=]??\(PJ64<EIXB\4//>0 Q;OLZ-M DD[+Y<1A!SU; P2<5N^
M-RDN@K82-&D5_<1V\TDGW$BY>4M[>6C^PSD\ TGA1UUM7\6/$\9U.&,6D<BX
M>*U7)0'_ &F+,YQQAE&3M!(!NV-E!IUC#9VR;(84"*,Y/U)[D]2>YJQ110 4
M444 %%%% !1110 C$A20I8@=!U-&X;BO.0,]./SI:* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFHZ?'J=H;6:69(6
M8&01/M,B@\J3UVGOC&1QT)JW69X@TJ76]#NM-BO7LS<+L:9$#$+GD8/'(X.<
MC!- &%X)TVTL+W6O['W1Z"98X[.!23"KJI\UH\]BQP<<;D/?)/85CZ/H]YIT
M\LMYJTMX#&D4,(B6&*%5S]U%XR>.3G@ #'.=B@ HHHH **** "BBB@ HHHH
MP]<T:XUC4M)5FB_LR"226[B<Y,WR;43;@@KEB3DC@8Y!-;E%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% " DD_*1@]3WI:** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHID,JSPQRH'"NH8!T*, >>5(!!]B,B@!]%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-0.%.]E8
MY/*KCC/'<]L?_6Z4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HIK2(C(K.JESM4$XW'!.!Z\ G\
M*=0 4444 %%%% !1110 4444 %%136Z3O"SM(#$_F+LE9 3@CY@"-PY/!R,X
M.,@5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M13I-(BB&81$.I8E-V5!!*^V1QGMFI:** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &F-#(LA12Z@J&QR
M <9&?? _(4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>ex10-8_003.jpg
<TEXT>
begin 644 ex10-8_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4  X@# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1129.X#:<8Z]A0 M%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112 $$
M_,3D]#VH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **;O'F;#
MP<9'(Y]?RX_,4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBJ]A;R6FG6UM-<R7,L,21O/)]Z4@ %CCN>OXT 6**** "FQAQ&HD96< ;BJX
M!/? R<?F:=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%)M&X-SD#'7C\J6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HIJHJ,[*,%SN;W. /Y 4Z@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHI%8.H92"I&00>"* %HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHI&R5.T@-C@D9&: %HHHH **** "BBB@ HHHH *9%#'!&(X8TC0$D*B@#
M).3P/<T^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FQES&ID55<@;@K9 /?
M!P,_D*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !2-DJ=I ;'!(R,TM% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "*25!*E21T/44M
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1132'\Q2&79@Y&WDGC'.?KV[CICD =1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5&D*)-)*N[?)C<2Q/3I@'I^%244 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%)M&X-SD#'7C\J6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YCQ%X@U7P
MY:WNI3:?:7&GQSV\4 6X9)2)&1"S?(1PSGCT7WXZ>N/^)W/@:X0<NUW:;5'4
MXN8V./HJD_0$]J %US6?$6CF">>/3H[2;4[*W4QLSE(I'V2;BV,G)4@@# ;H
M=O.OJFK1/H>KR:7JFFK=VD<D9FGG7RK:8+QYI&=N#@D'M6/\0Y@="TQ"GG6L
M^KV0G54+[HA,KDX'/&W/'IZ5@:Y-$TWQ0@C(#2Z3&JKL(\V0P2(=IZ.>8UXS
M@X'H* .[&NZ=;)!#J.J:?!>/ DK1F<)D-QN"L<[2P(&?2M2O)+QK>&Z:YT]+
MG[<EE8Q7-C<0,\&J1'8(RI7)5D9VZ=,<@KS7?>,/$1\+>&KG5$LY+R9"J16\
M88EV8@#. 2 .23CH/7% $-EXLCOO%[Z)':DVQMGE@OQ("D[QN$EC48ZH64$Y
MZY':MFZU*PL6*W=[;6[",RD2RJAV @%N3T!91GU(]:X/7M.O?"_A_2=6_MF6
M]31YXI65;<M+=[R4E^8$L=XD9L<C*CH!D)XKUT:1XDENX[:^NX;_ $=82%LW
MF2+,AV'"KN7.YMP8C=\@[< '8WGBC0;""*:ZUBQBCF@-Q$3.O[R(#=O7GYEQ
MW''3UJQ+K.FP:E#ITM] EY,2L<)<;B0-V,>N.<=P#CI7G%G!8W7BGX>K91W&
MH:3:Z9=6:71M7$(<1B,AMWW6(BD!5N>,<]DT/338:W+X?UW2-2U"_?66U2"[
MMVE6SPS^:)6(VHK*=P*X.2 .<T >CG6]+6^2R-_;BY=_+2/>,LX!)4>K *21
MU'?J*K#Q7H!DB1=8LV,KNBE905W)G<"1P.AZ]<<5Q.DVX-['X?U+P[J]QJ%I
MJK7GVEI9ELCF8S+<!]VW/S$[,<OE2 ,D5)PK^$V2+1]31SXL^UW!BTR822Q&
M\:43+M0L1Y07YQ@\!<] 0#TJ#6M,N8;N:&]A>.T<QW!#?ZM@,X/X$'WR,577
MQ1HK17LAU".-;%E6Z$H,9A+?=#!@",Y&*Y+7["]U2X\864%I=DG[#-&#'+$M
MRL15Y$29>I8 I\IR"3^&?J<UGJ&@:S?6_AGQ*CW@@LY!?PW,TDX5@^U8"7(C
M4,^6(49) W$F@#T&[U_3[.VU.9Y78Z9$9;J-(V+JNTL"%QSD XQQQ4^E:E#J
M^E6NH6^[RKB,2*&!!&?K7#>)+&\OO%OB=+>QNI%G\*&UBD\AO+DEWRG8'*E2
MV'7CGKTX-=?X8N#<^%M+E,$\!-L@,<\91Q@8Y4].F: %77].N;I["TO8VO2)
M5C0J2&>,A7"YP&*L0& /'?%9'@WQ;!J^@Z$FH7\!UF^L%N3&%V>;Q\Q4=#CN
M!TYX';G] N]0MM>DD33=7M;4B^GU.PN+621+>3>&+6DXC!D\Q^0BD@@E@ 1@
MP:+!=VVC?#@)I%XES:03I)')9RJ(9!;LF9"5^3+D#)P"&)!Q0!Z#8:_I6J3K
M#97L<S/&TL94';*BD*70XPZ@D#*Y'(]:YG3]=UF?P[HMQ/=1?:9-;ELKIDC!
M$D:3S1X'8?<7D>A]>,/PP]Y>ZMX*O1IVH)':V]WI]TKVNR*T<0PG:G'^JW1N
MJODDGC)[/TZ6>P\+:!:S:5J@F&OSRO''ITQ\J/[3*V]L*0J[9%(YYR<9P< '
MI-^TJZ=<M S+,(F*,J;R&P<$+WY[=ZP/#'BW3=4L=*LI=4AEU>:RCED3<,RM
MY:LY4@!7QNYVC YX&,#>U%9WTRZ6V!,YA<1@-M);!QSD8Y[Y%><Z?IL^OZ5X
M6TV+2;JTFT2T:&ZO+NV\KR6-HT)A3?\ ,P)96)7*X0?,3C !WMGK^EW]TEM;
M7:O+)&98@591-&,?/&2,2+\R_,N1R.:M7E];:?"LMU,L:LXC7/)=CP%4#DD]
M@.:XGP4LET^FK>^&=2L[_2+=[.6ZOIW**WRJWD;F/F!]H.X # ')X%:7CM9#
M;Z')!!)-=1:Q;R0I'LW$@-NP&(!^3>/O+C.<\8(!L0^(]'GTZ>_2_B^SVYVS
M[LJ\+\?(Z'#*_(&T@-D@8J)O%6CIIE]J#W,B0V"[[M&MI1+ O]YHBN\# )SM
MP0,].:X2/3KEYM7DTFPU.36[;78-4N[:[1+<7$9W*!"V2K)M# $M]Y">,@5U
M%A8SZQXJU'5YK>YM]-N=+AL&MKE3&[N&D=C@'H!+MSGKNQQ@D VFU_2T-GYE
MVL?VRW>ZA,BLH,2!2SL2/E #KG=CK5>/Q9HLEK=7)O&ABM8_.E-Q!)"1'_ST
M =063_;&5/K7(VGAK5M4\%7]M>PR+J5I;RZ5I[S2L#-%%)\LA. 4,ICCR>>$
M5AUQ4DUM>^(?#>O(OA2\LM6;2)[ ->W0D=I9%SY43LV'CR02^5!( &<': =8
M/%.B-)"BZA&S3W+6D6U6(>54+E00,?=&1V/ &2126WBK1[RR%W!<R,IF>W\K
M[-*)O,0$LGE%=^X $XV].:S-6BO+N[\'/9Z9=B*"[^TSH@2(6\?V=X\,"W!!
ME'RKG@-UQ7.W&C>)+?6;F]@TF6[2#69K@6ZWH@>6VFB1-T3@@ AE8E68=.VX
M4 =ROB327TU;\71\EI?)"F)Q*9?^>?EXW[^#\N,\=*H>%]3N-0U+Q+')>RW4
M%IJ?DVYEC5#&ODQ.4X1<[6=@"<G &3W.1<6MU;Q:;XBM/#]Q%';WLU[<Z<&$
MEU*'@,?FD;L&49QLRQVY .[Y:V_#T%_#K7B5[RPDMXKG4%GMI3(C+-&((HLC
M!W YB)(8#[PQGG !FZGKTNE_$F*"XN+D::-#EN&@BB:7=()XUW!$!<D*3T'3
MGUK<LM?T:Y_LY+*YC==2C>XM3'&VV51\S'., _-D@X.3ZUSFK6]]IGQ2MO$*
M:1=WEC)I!TXO:*CL)6G#J&!8$+@'YC\HSR0,FL=_"^I>%_!&F31/9OKUIJXN
MX$.?+9[B0QM#O !P5E(W8[ G ' !Z197]OJ$<LELSLD4TD#%HV3YT8JP&X#(
M!!&1P<<&J4OB72(+UK1[O]ZEPEJ^V-V5)7QL1F V@G<N 3W'K5S3;"'2].@L
M8-QCA0*"V,MZDX &2<DX'>O+M2T_Q++/XI^SZ-<_;4UFTGM&MHHHH)H5EAD5
M@3M,LHVG<SY5>F1@T =YJ'C/1--FO8KB:Z+V)7[7Y5E-(( P+!G*H0%V@G<3
MC H\2ZY!9:)JB6]S(+V.P>=#;QEVC!5]CDA2%!*M@MQ\IZX-86KZ-JUU%X^6
M+2Y'?4[(6UBX>(>=^X*8SNR '=C\V.IK+;1==BM/$=O'H[7">(](3R@C+']E
MF6U6$QRAF& 3@C:2>&XXS0!VW@^[GO\ P3H-Y=2M+<3Z=;RRR-U=VC4DGZDU
M)#XETF>\MK6*Z9WNI)(H&$+^7*Z!BP5\;3@*W?L:9X1LKG3?!FAV%Y"8;JUL
M(()HRP;:Z1JI&02#R.QK"\(6>K:99Z9X>OM"B:+1R8EU3*"-U$9"21)DN'*O
MAL@ 9?YCF@#;M/%V@WTEJEMJ"2+=N\=M,$813NA(94D(V,<@X )S@D9P:;<>
M,-%M0&EN)A&+TV,DOV679%,&"XD;;A 690&. =P()'-<=IW@_6I/"6A>$[N"
M2U32[])9-2CF4K)'$Y=#&-Q8,V0.0-N">< %]]X?UN?P7K^G1Z1(+FYUW[9
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MX#E<CD9ZBIZ\XO\ QBNBZC\0KJWT:T^V:-%:.\BR%3=!X\J9/EZJ"0.Y QP
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M"PN/,>1WCN%'\!$I3().,G' !Z?PO#JT>FL^L65C8W$CY^RV7*1@# .[ R2
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MB1(I\PRF4*>#E=[9]<<9%2/X*M1JU]=6VH7MG9Z@XFO=/MF1(;B7NY^7<I8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7/0YZ>G(KLM>\)V>O7UE?_:KRPOK4E1=6,GERO$0<Q,V#E"<'U!&00>:JR^
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M\_V@ZGE0N1Q^N!@8 U]5U36]+\.^,(9]:\V;2H/M$%Y);1*S*T181%<;2<C
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MF1(E5N>O(%9NB:1J-IJ.HZAJVH1WES<N$A$47EI# I8H@&3S\Q))))XY( P
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M\"W'B259+*VE.TK D0V*JDD[BB^8V,8+8QQD];0 4444 %%%(N0HW$%L<D#
MS0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLIYC$1R!@@Y_=R#!SU!('&>/A\4:XGP^L?$ O3<Z@VH_9!:&&/%T!=M#M4
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M*AB3(4XQ\P"KU&"3C=@ $.I?$'0=*OKVSN/[1::Q >Z$6G3NL,9&?,9@F-F
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MG^'S 64'_>/:E\,Z)<Z1?WQ2$66DND:6E@MTTPC8%][@$8C!R@"(=N%S@$D
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MI:* $7)4;@ V.0#D9I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'S<]>@ %:OBC0+_Q!!>6#-83:7=6GDFWNXBWER[O]:".<[3QR,%5((YKI:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY9^ M%2^GMGNYY6*Q6R/M+ =6)P<*"5!..K#UJ77]<\/1:!I%[XDAC^RWMQ
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M)(!M1$CV!5Q@\Y.>?3TR9O"'AU?"?A33]#6\DO!:(5\^08+$L6/'. ,X R<
M 9- %3Q,_BB*ZCDT**"2%;=VVR/UE!# ,NW+;E5E'S* 6).3MQ/X*\2KXO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,8.1D'/"J.@J#XFZ5)>6-A?3ZU9VFDV<ZF]L=0!%M> NFT.PY&"..",D'M0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6+2*[4%[95W9&_/SYR.<#[O>NDHHH AN_/\ L<_V7;]H\MO*W=-^.,_C7/>
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MOT_3(!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!EC8@_4$ CT(KD=%FM;GP'X<\(::J6YO-)MY]4G@V(MM;LB&0M_TTFRRCO\
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M\*Z%=>'=$6PO-9O-7F$KO]JNV+2%2>%))/08'7\NE;= !1110 4444 %%%%
M!1110 4444 %%%% !14:QLL\DAFD96"@1D+M3&<D8&><\Y)Z#&.<R4 %%%%
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M<],X.#T)&1VH XFRU?4O$?B76H+77EM;S1]?@C>V\PK$;'Y04QM(9W;S/<,
M,J,9X&^O[[2]$^)FKZ7JMW9W-IXB4Q^0$B#-YVTAAC+#!/&?FZL.37N$WA'P
M_<>)5\13:3;2:LL:QK<NNX@ Y! /&X=FQNQQG'%2R>&- FCNHY=#TQTNY?.N
M5:TC(FDR3O<8^9LD\GGDT 6FN#/I!N4Q&7@\Q=X;"Y7/.,'\L&O+_@)/#8_"
MN:ZNYH8+=+V:1I9#L55"KDLS''8\],>^:]5^RP&S^QM$LEOY?E&.3YPR8Q@Y
MSGCUZUEKX/\ #"6KVJ^'-(6W<[FB%C&$8\<D;<'H/RH \ZNI[;6/CYX=NX-4
MNA8S:$M]:@3%%?>S8 5L8#*%RN,G'([C&O\ 4WU_X9:?KVH:E=S7ESXAA6[L
MVF4"#;.P$"ICY"%PV<;CD%LC 'LDWAS1[C5[#59-.@-]81M%:S!<&)",$ #C
MZ9Z9.,9-12^$O#D[W+S:#IDING$LX>U1A*X).]@1@MEC\W4YH OP:E97-_=V
M,%U%)=V>S[1"K M%O&5W#MD<BK55H=/L[>^N;V&VCCN;H()Y57!EV A2WJ0#
MC/I@=A5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#D/'$UU>3:)X;M(W;^U;L->,J$[+2+#RG.1MR3&F3D?.1U(KJKFYAL[6:ZN
M'$<$*-)(YZ*H&2?R%<QI<!U/XB:OK!+>3I]LFEV^ 0&8D2S'D<\^4HP>"K<5
M5U"XB\<ZY-X?M+B*31M-E4ZNRYW23*VY+=3C  *@N1GLO&3@ =X8A3Q5J;>,
MKZRQ&P$>BI<)\T5OC)F /W6D))SUV!/4Y[2BB@ HHHH **** "BBB@ HHHH
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M)VHH)8X$F3@ ]*V*YGXA6EW?^ =8L[*TGN[B>#RU@@8*[@L 0">!QGU^AZ4
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M.WYN3D6DT_7M.U5KV]\/0:XVI:=!'>FWDB7R[F-&1@1*R@Q,)&P1D\MD8(!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444U$V*1N9N2<L<]3G% &=J>A6NK
MWEA<74EUMLI?.2".=DBD<%64R*#A]K*K#/0BM.BB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=Y"'']W'F$<\[<US>A>#WOM&U6;P_JRV6NV<C:;!J\$>U;D*JM,)(_N\SM.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#/.GW99V.L7@W.S!5CAPH))"C,9/ XY.>*
MY[4/ UQ>7.H&+Q)?VT&J!1J BBB6:0*FQ=D@4;.  258D9''&.QHH Q;/P^^
MGZ=;V-GK%]!;V\8CC5([<84# _Y9?C4JZ1<BX:9M;OW8C";HK?\ =@XR 1%G
M!(!.2:U:* ./\.^ (?#,5Z+#6]26:\D#RS;+?)"C:BX\K PHQT]3QV9XFTW4
MKG[%HL.MZB_]IOY4[,D $<" M*W$8^9AA,<C+#C&0>SHH Y"W\ Q6WB"36(]
M<U19O*,5O$/),5JIV[_+C,952VP9( SSZU7U#P1J&K:_9OJ&NW5SI=K93Q@N
M(?.DFE(4[E$(3:$'!'S9/89SV]% '*Z1X*;0M,MM.TSQ'JMM:VR!(XTAL_N@
MD\GR,G)))/4GG.229+[PE=:C;K!<^*];>-98IE CLQAXW#J>(/[RJ?PQTR*Z
M:B@#!B\.WD">7%XGU6-,Y"K!9@#+$G@0=\_Y/-5+WP:UV8KK^W+W^UX'5K?4
MGAM_-C49#1_)&H:-LDE6R,D'L*ZFB@#&CT6_0MN\3ZM)DG :*UXSZ8@'2I5T
MJ\&<^(-2;IUCM^,=?^67?O\ IBM2B@#/_LZZ_P"@S??]\0?_ !NK5K#);VR1
M2W,MRZYS-,%#-SWV*H]N .E344 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4U4"LY!;+G)RQ/8#C/3IT'U[TZB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,:;PCX:N+N6[G\/:3+<S%C)
M,]E&SN6&&RQ7)R"<^N:B7P1X23[OA?1%Y#<:?$.1T/W:WJ* ,=?"?AM%VKX?
MTI1O#X%E&/F!R#TZYYS4P\/:( @&CZ> GW1]F3Y>,<<<<5I44 9PT#1@21I%
M@"QR<6R<G\J7^PM'_P"@58_^ Z?X5H44 9_]A:/_ - JQ_\  =/\*/["T?\
MZ!5C_P" Z?X5H44 9_\ 86C_ /0*L?\ P'3_  H_L+1_^@58_P#@.G^%:%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ IJR([.JNK%#M8 YVG .#Z<$'\:=35C1&=E15+G<Q QN. ,GUX 'X4
M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"*Y@%S:S6YDDC$J,F^)MKKD8RI[$=C4M%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% $2PLMU),9Y"KHJ"$XV*0
M6)8<9R=P!R2/E& .<RT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 444V-B\:LR,A(!*-C*^QP2/R- #J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***86<3*@C)0J27R, C&
M!CKSD_E0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "FQES&ID55<@;@K9 /?!P,_
MD*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(<Y&" ,\Y'44M !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 444F3N(VG&.O8T +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1130I$C-O8@@ )Q@8SSTSSGU[#WR .HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **AN[J*QLY[N
MX++#!&TLA5"Q"J,G  )/ Z 9HM+E+VS@NHED6.:-9%$B%& (R,J>0>>AY% $
MU%%% !1110 4444 %%%% "!@20""5.#@]#2T44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%(S!1DYZ@<#-+0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%(V<?*0#D=1GB@!:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHIK!RR;64 'Y@5SD8/3GCG'K_4 #J*** "BBB@
MHHHH **** "BD5@RAAG!&>1@_E2T %%%% !12*P=0RD%2,@@\$4M !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5'Y*_://S)OV;,>8VW&<_=SC/OC-244 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %-21)%+(ZL 2N5.>0<$?@013J* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBFH'"G>RL<GE5QQGCN>V/_K=* '4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %)N 8+D;B,@9YQ_DBEIIC0R+
M(44NH*AL<@'&1GWP/R% #J*** "BBB@ HHJ))F>XEB,$B! I$C8VOGTP<\8Y
MR!0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 44G.X<#;CDYYS_ )S2T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 445%<P"ZM9K=F=%E1D+(<,
M1C(/K0!+12*H10J@!0,  < 4M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %,BE6:)9%#A6&0'0J?Q! (I](JA1A0 ,D\#N: %
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 100H!8L0.IZFEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDHD* 1.BMN4DNI8;<C(QD<
MD9 /8\X/0OHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"* SD2?:$C4AR$\MB
M<IV)R!@^HY^M2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 44C,%&6( R!R>YI: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH 8\4<CQLZ@M&VY"?X3@C/Y$C\
M:?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 (201\I.3U':EHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :I8LX9=H!
MPISG<,#G\\C\*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12*H50HS@#'
M)R?SI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD9@BEF("@9
M))X H 6BHUGB>3RTD5FV!\*<_*>A_'!QZX/I4E !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4BJ%4*,X QR<G\Z6B@ HHHH ***
M* "BBB@ HHHH **:CB120& !(^92.AQW^G7OUIU !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !114<GG;X?*\O9O_ 'N[.=NT_=]]VWKVS0!)1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #2X$BIALD$@[3
MCC'?H.O3Z^AIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-0.-V]E//&
M%Q@?G0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *9#*L\,<J!PKJ& ="C 'GE2 0?8C(I]% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !12-DJ=I ;'!(R,TM !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% #(XS&&&]WRQ;YCTSV'M3Z** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH C@$RP(+B2.28#YWC0HI/L"3C\S4E%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%)D[B-IQCKV- "T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !12,H92IS@C'!P?SI: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1<X^8
M@G)Z#'%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4B@@<
ML3R>32T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% $8F5KAX )-Z(KDF-@N&) PV,$_*<@'
M(XSC(S)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 44R,2 OYCHP+93:I&%]#R<GKS
MQ]*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !117*7NH:M9>,=)LQJ=G.E]++YFG^4$:.!58B4-DDX(12"/F
M+\%0. #JZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IL9<QJ9%57(&X*V0#WP<#/Y"G44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2%02"0"5.1D
M=#0N<?, #D]#GBEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y34]*N
M]>U[1YY=*2S&G7+7'V]I(VEV@D")  3M<'YLD8 QR<$=710 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4F#N!W'&.G8TM% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 44TA_,4AEV8.1MY)XQSGZ]NXZ8Y=0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4T,2[*48 8PQQAOIS_.G44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !135W[GW;<9^7'I@=?QS3J "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBF31B:%X
MBSJ'4KN1MK#/<'L: 'T5''&8HT0/NQ]YF49;U/& "3ST]:DH **** "BBB@
MHHHH **** "BBB@!DB,Y3;*Z;6R0H'S#T.0>/I@\4^BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3G<.
M1MQR,<Y_SFEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHI#G(P0!GG(ZB@!:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI%R5&X -CD Y&:
M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ IJNKLZJ<E#M;V. ?Y$4ZB@ HHHH **** "BFH^]2=K+R1A
MACH<9IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 444UPY4;&53D<LN>,\]QVS_P#7
MZ4 +SN' VXY.><_YS2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 44@4 D@ %CDX'4TM !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1134D212R.K $KE3GD'!'X$$4 .HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ":W>6XMY5NIHEA8LT2;=
MLN5(PV03@9R,$<@9STJ>@ HHHH **** "BBB@ HHHH **9%-'/&)(9$D0D@,
MC C(.#R/<4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I%8.H92"I&00>"*6B@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #L @\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,7GA72KFXT6VDFEM8W=V!RQ*C)ZUT%GX,\-6$BR6NAV$;K]UO)!(_$TO@_\
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M]M*LH5ISABIS@\5ZSIEUXODU")=3TW2X;,Y\QX+AF<<<8!'K71$@=3BC<O\
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MW4.H'Q5=VKB2&XNS)&R_Q PJ10 OA;0=/U[0+?6=:MH]0OKX&9WN!O" DX5
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M>4C/6GZDSCXB^'EW$ V5X6 /!.8JI:WIS^#;"?6]#G>&UM_WEQIKMF&1,\[
M?N-Z8X]JLW\JR?$#PS-]U9;*[V[N.2(SCZX!_*D!9\>,R>!M696*L(>"#@_>
M%5O$[,LWA3#$9U.('!Z_(U3_ ! =4\":MN.,Q #ZEA5?Q3Q/X3!Z_P!J1?\
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M-6GK-F?S')[=J8$)I#3C2&@!A%0W:RK9F14;8S;-^. >N*M11/-,D4:EF<@
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M^(-1U6TM$8KI\HB:7(*R$YR5]@015:#Q-J%]->+8:!+<16UP]L9#<QIN9>N
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MSPAHIL[<WUPN)YA\@/\ "G^)K'\+Z =0G%[<K_HL9RJG_EHW^ KT"@ HHHH
M**** "BBB@!AAB8Y:)"?4J*58T081%4>PQ3J* "BBB@ HHHH **** "BBB@
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M6.) B*,*H' %/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q];TR[U0Q11RQQP+
MR=V<EJV** .;@\(1+S<73O[(-M:EMHFGVO*6ZLW]Y_F/ZUH44 (  ,#@4M%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
B444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>ex23-1_002.jpg
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _! 4# 2(  A$! Q$!_\0
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M>] #&.32444 %%%% !1110 M+244 +1110 4444 %%%% !1FBIXH<89NOI0
M10_Q,/H*GHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH R1XHT%G"#6+$N3M \Y<D],59O]8T
M[3&1;V\B@9P2JL>2!U./3WK"U&[M+GQ;;:?>*T%K;%94+PL$N)S]U0^-N%ZX
MSRQ'I5W2_G\5:^[<LA@C4GLOEYQ],DG\: -J*6.>))8G5XW 974Y# ]P:;<7
M,%K&)+B9(D+! SL "Q. /J3Q6/X4&W3KN)>(XM0N8XU'15$K8 ]JI>+K/^V[
MBUT=6Y$4UV0.S*NV,_\ ?; _\!H Z8W$(N1;&5//*%Q'GYBH.,X],U)6%9.M
MY:Q^)(8VGN)-.54A7 )/+%<^I; _"HDN-;TZYL9=2NK:>&\E$+PQP%#"S E=
MK9.X9&#GUS0!T50VUU#=Q&2!]Z!VC)P1\RDJ1^!!K!T^\UK5]0O@D]O:6EE>
MM ,0[VG5<'G)^7KC-4](CUV:SO'L;JVM8HKVY$4<L)D\[]ZQ)8Y&T9XX],^U
M '85'-/#;H'FE2-2P4%C@$DX ^I-8BZAJ>L66G2:8$M8[J'SIKF1/,$73Y N
M1DDD\GC -%JD^JA[+4I(WN--O49GC3:LH"AT."3CJ,^XH WZ*YN^N?$$%M>:
MJ)+:&WMM[K9/#EI(TSDE\\,0"1@<9&:Z&*19H4E7[KJ&'T- #Z,C..]<PE]K
ME^+V^L)[<1VL\D*V#PY:38<'+Y^5FQD<8Y'6H FLOX^=H[NT2(V,;>6]LQ81
M^8?ESO\ O=>>GM0!UU17%S!:0-/<S)#$N-SNP &3@<GWJ6N<\56L>L-8:%(?
MDO)'DD _N1J3_P"A%* -]KB%)XX&E02R E$)Y8#K@>V14E<[I.Z\TRQUIE,]
MY;64D'E#&6D! 89['='BD%SKFFSV,VHW-K-#=S+#)!'"4,#,#MVMD[@#P<CO
MF@#HZAM[J&Z,PA?<89#$_!&&&,C]16%'>:SJ>MZI9VT]O:6UC,B"4P^8TF45
MBN"0!C)Y]QZ55T^+6KB\UH6-W;V<,>H/M,D/FF5MJYSR-J]N.: .MJ.>>*VA
M::>18XUZNYP!VK$CU#5=4TNP:QCBMYIV=;B9AYB0%"0V!D;B6&!^M-BCNM2^
MV:-JDT<DEM)!,)HX]HECW;AE<G!RA!YH Z&BL"]?Q S7EU;36UM!;%O)MY(=
MYG"C)+-N^4'D# XZUK:?=IJ&FVMZBE4N(EE4'L& ./UH LYHKE=+36$\4ZN\
MU[9M;H\1D1;9@Q79P =_!QUX.?:FG4]<&BGQ$;BV%H(S<_8/)R?)Z_ZS/W]O
M/3&>/>@#K**PH]==+/6II@A:P8L@4$;T*!TS[G./PIJZ[<3:)IERL4<=Y>7"
M6[1G+*C;B)!VS@*_Y4 ;]%<N+W7+ZTN-6L;FU2VC:3R;1X23*J$@[GS\I.TX
MP...M27.L:A>:AI=II@ABCO[-KEII4+F(#9CC(S][&* .DHKG))]7FU1='AU
M&"&:"U6>6Y>VW&8LS !4W8 &WGKU'2MC39;N6R4W\2QW*LR/L^ZV#@,OL1SC
MWH +[5+#3%1KZ\@M@Y(4RN%W8ZXS4=EK>EZE*8K'4+:YD"[BL4@8X]>*N2HK
M1MN4'@]17+6%W/;^&O#UG8>3'>7L*(LLB;EC58]S-@8R<#@9[T =6S!$9F.%
M49)J.VN8KRUBN8'WPS('1L8RI&0>:Q8+K4+>\N=+U&:*Y+6K3PW$<?ED@':R
MLN2,@D<CUJUX9_Y%;2?^O.+_ -!% &A+<P0/$DTR1M,VR,,P!=L$X'J< U+7
M%^*XS>:F\T9);1+47J@?\]"X(_\ '(W'_ JZ"+4I'UU;7]VUI/9BXMW7J2&P
MP/J,,A'U- %^2Y@AFBADFC268D1(S %R!DX'?BI:YF+5)KW6[</;6QB^V7$%
MO(T>754CY8'/&6##CL*D&OW'_"('46CC%^/W!C(.WS]_EXQG.-WOTH Z*L^#
M7-+N;W['!?P27&2 BOR2.H'KCVI=8>2+P_J#JV)5M9"&'&"$/(KG[&]M9]+T
M:WN=)NK6QS ;2Z(4 2 #;P#N4'IDCG..] '6--$DL<32*LDF=BD\MCKBLV7Q
M-H4$KQ2ZO9))&Q5U:905(Z@UDWFH"/5M5UGRS+'I,*VL2YP"[$-)S]-@_ U>
M\5D+H<EM&B^=>R):(0.?WAP3^"[C^% $]YXBT>V98YM4M(V= X#2@94\@_0T
MC:MIR6"WS7L'V1SA9@X*L>G![_A69XGNQI^FPVT$<D8N&$!N(X&D^SQ@<M\H
M..!@>YI%CLEU7P_%9B-K%+>9K?;RN0J $>^"WZT :]MJ%G>6K75O<Q20+G=(
M&X7'7/ICWJ.RUC3M1D:.SO89G4;BJ-SCU]Q[UF?8[>]\0ZU9N/W4UO;/,J'&
MYLOU^H4 ^HJ6Z*WOBK3XK<#=IX>6X<#[BLI58_QSNQZ*/:@9<;6M,2^^Q-?0
M"YW;/++<[O[OIGVZU?KA]-U&";PDL5[I=V=.D+_:;T;0 Y<Y?&=W!_B [9KM
MQPHYSQU]: (KNX%K:R3E=P3'&<9YQ4U4M7_Y!4_T'_H0JZ>M/H3?6P454U+4
M;?2K"2\N6Q&F.X!))Q@9IYO[,&,&Z@S*,Q_O!\X]O6D46**JVUVT]Y>P% !;
MR*@(/WLH&_K5EF51EF"CU)Q0 M44UK3)+[[$E] USN*>6&Y+#J/3/M3;74EU
M"PN)8<*Z/-&JA@22C%<_CC-8,ZPI\-;1P$&R"WD1O23<IR/?)_6D!M2^)-#@
ME>.75K)'0D.K3 %2.H-+=ZYIEFR?:;Z&,N@==S=5_O>P]ZK^*L'2&M(@JS7T
MJ6JG'/SGYC_WSN-/F6PT2WO;Z0';)MW@_,6PH544=_0#U)I@:2LKJ&5@RD9!
M!R"*J7FKZ=ITBQWM];V[N-RK+(%)'KS4.@6<UAH-G;3\2I'\R_W,DG;^&<?A
M3?$-\^FZ3)<0V[33DB.,+$9-I8XW$ $X'4_2D!<L[ZTU"$S6=S%<1!BI>)@P
MSZ<4^YNH+.!I[F9(8E^\[G %4]"CLH]'@6PF$\/),O=WS\Q;_:)SD5#JRJ^J
MZ(D@!C-RYPW3<(G*_CGI0!;@U;3[FUENH;R%H(<^:^[ 3 S\WIQZU%;Z_I%W
M<)!;ZG:2S/\ =C24$GOP*A4(/&$JJ%W2:>ID'][$A )_6J&FW=MJ'BBYDN%:
M&:WW0V=O+$4)4??D!(PQ/3C. />@#2'B30RX0:M9;B=H'G#.>F*EN=>TBSN&
MM[G4K6&9?O1R2@$?45D:A=6MQXHMK"[4P6MN5D4O$P2XG/W%W8VX7KC/)(]*
M;!=7EOKFN);:/)>?Z2CLY=8QCRD&%W?>/!XZ>] '1I=V[V@NUGC-L5W^:&^7
M;ZY]*AO-7TW3V1;R^M[<R#<@ED"[AZBLG4[N'6;'2[*WW"/4I07!&"(D^9P1
MVZ!3]:U=/O$U"":9XE013RP\\\(Q&?TH DM-3L+Z&2:TO()XH^'>-P0O&>?3
MBK$<B2QK)&P=' 964Y!!Z$5QZ%KCPT?+0K/K]X0,<$1,<9_"):Z73[E9VNX$
MB$:6DWV=0#U 12/I]['X4 7:@M[C[0\RA"#%*8^O7 !S^M6 I)P!DU#I,862
M_)Y;[4PS_P !6FEH2W9HNQ0A?F;EOY5-2,RHA9F"J!DDG@"LO2]:BO[![Z2>
MV2WWD*1)G:,X&X],GCCWH&:M%11W5O-L\N>-]ZEEVL#N X)'M3XY$FC62-U=
M&&593D$4 .J*XN8+2W>XN94BAC&7=S@ ?6JNL:I%I&G2W;@.8]O[O< 3E@/Z
MU1\0LDLNBIE7A;4D$@Z@X1R,_P# @OXXH NPZ[I4]K-=1W\!@@QYKEL"//3.
M>E-M?$.C7MREO:ZI:33/G;''*"QQSP*I3A!X[M  NZ73IO,']X+)'MS],MCZ
MFDDB2]\91HN%33[1G;8,8DE.T?B%5O\ OJ@#0CUW2I;[[$E_ USN*",-R6'4
M#L3[5H5S.LVEO#I>G^'K,'SY)8_)[M&J,&:4GM@#KW+>]=-0!DR>)]!BD>.3
M6+)'0E65IE!!'4&M4$, 0<@\@URWB"[M9-<L]+O5:"PXGGF:%O+E;=\D1?&
M,\G)[ =ZZJ@"E?:MI^F;!>W<4!?.T,>3CJ<>E%QK&FVMK%=3W]O';S?ZN5I
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M#J:<-0LVL/MXNH3:;-_G[QLV^N:YZ\OY;;QS,D-A/?3C3HS&D94! 9'W$LQ
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M"UO)+'.D'EF-T&=K $@@@\'CH:I+J6OQ:+!K]U-:" QI--8K$?EC.,XDS]X
MYZ8[>] '645DWXUFYU V]A-'96\<8=KB2'S3(Q)^4#(P !R?<8J71+^74-/+
MW"H+B*62";9G:71BI(SV.,_C0!HT5S7VK7=0CNK_ $^YM8X(99(X;5X"QF\M
MBIW/G*DE3C XXZU--?ZCJ-U;6>GNEBSVBW4TDT7F,@8X5 N0,Y!R3Z4 ;]4Y
MM5L8(;B5[J/9;,%FVG<8R<8! Y!Y'YU7T>\NIGO+.^:)[JSD"-)$I59%90RM
M@DX.#@C/45@ZQ<";2O$\8@AC\FZB3=&F&DRL398]S\V,^@% '94444 %%%%
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MQ7;W>H%;5;O3TB4N<+YH<DIGU^8?6N@:V@>99FAC:5>CE 6'XU(5##! (]Z
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MQA!9+D1Z@\-T_'!\C);\_P!T*31;=AXLN+)P2FF---'QP//8,OY#>*Z_ SG
MSZT8&2<#)[TBCCK6T\WQ?<:7*I-O;-->+QQB90H'YF:E\)1/J$=\M]'DVT2Z
M4V1][9NW_GN'Y5V&!G.!GUH  Z #/- 'G]E;SZAH.JW+AO.L(XK:$$<[[8[R
M1]6K?\.7EJ;,.TZ"ZU5YKV.-CAF3. 0/0+LKH< =AS2>6FY6V+N48!QR![4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>formdrs_001.jpg
<TEXT>
begin 644 formdrs_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !, .D# 2(  A$! Q$!_\0
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MA927+SJ678^#UQC&.:S_ /A.KO\ Z%V^_7_XFJGC:YCLO%NBW,Q(BAP[D#)
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@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>img_1.jpg
<TEXT>
begin 644 img_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #I 0$# 2(  A$! Q$!_\0
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M/GCW%8GHJN+N$_QX_K2FZA'60#O1[2/<=F6**0'/2EJQ!1110 4444 %%%%
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M?[@J]7W=!N5*+?9'@35I-#J***W)"BBB@ HHHH **** "BBB@ HHHH ****
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MZI/]T5S?B;_CYM_]T_SKI(O]4GT%>1@_]^K_ ".NM_ I_,DI:**]<Y HHHH
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M]\@X_"H[C2M3%O>"WFEWR7R-'F<G$(QD#GC^+BNFHH :GW!ZXI]%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>img_2.jpg
<TEXT>
begin 644 img_2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "8 CL# 2(  A$! Q$!_\0
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M:"I?S#MQ_=SQ2ZCZ%JBBBF(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MCG/XU9-4K58UN[LI,79F&Y?[AQ4LI;,N4ZHWD2)2SL%4=235%]8MP,H)IO\
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M%_;[OLQ&/,']VBVUDG4$LK@%S*OR/Y14_1AVJSK36]MH]S)(J@&,H,+DECP
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M)JFH6]R9@\Y6:(2@_-A0&() ]JZB:YAMH]TTBHOJ364E9FU.5XW)J*S9=8A
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>img_4.jpg
<TEXT>
begin 644 img_4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #: -H# 2(  A$! Q$!_\0
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MB$S3"-!*ZA&<*-Q4$D GT!9L?4^M/HHH **** "BBB@ HHHH **** "BBB@
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MG[I^E3U&<7JG_(4N/][^@JIWJWJG_(4N/][^@JIWK\MQW^\3]6?1X?\ A1]
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MTN_^_5 %VBJ7V_\ Z=+O_OU1]O\ ^G2[_P"_5 %P]:8W((]JJ_;_ /ITNO\
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M9&8\@NNTX_  =Q5_2=.ATK3TLX"Q1"3EL9))R3QQWH O44"B@ HHHH ****
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>img_7.jpg
<TEXT>
begin 644 img_7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $> C,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $HKR
MVQ\2ZAIGC;4;G4M1E?1I+R:S\N0_+ ZJ)%Q]1D5'X?\ $FL6]QK6H:E>AT:Q
MBOH8+J3;% )&.T<#CC%:>Q9/,>K45YI!\1[Z31-5N38VTMU820(/+,BI*)3C
MHX!!JY/XWU/3K;64U'3[1;W3V@V^5,3$1-P"Q(R,=Z7LY!S([^BO.;3QWK$]
MGM^QZ?<7=QJ'V"S:"5O)D(7+2$GJOTKH?#>O7FKC4K2]MH;?4=/F\F41,6C8
MD9!!ZXYI.#6XTT=+17C^A:MK&CP7^JO9VMW?W^LFQYGDZY(QSP%'&/:NIN/%
MNIV,VMVUS:6IGTO38[P[&;:TA!R/IQ5.FQ*1V^117E6K:]>)_;&IZ?%';ZBN
MAV]R9C*S !CD@*>,CL>_>NVTW4KFV\+0ZCK9C$JPB24VZNPQV.,9SZU+@TK@
MI7-^C-<]>ZN=1\'WNI:,WS^1(8FG1H\$9SD$9%<EX$U*ZTV'0])>VB(U*TEO
M9)A*[,2,8)SW/?'%"IMIL=STZBO.[3QOK.HVVB+8Z=9&[U.*X?$DC*B>4V.O
M7&*BN_B/>#0],NH;2R@GNX9I9#=S$1 Q'!52.22>E/V4A<R/2>**\T_X2=K/
M4!K6I6(6\30/M<BQ3/CF3B/:>.XYZU:U2^U2;3=(EUVPM%>;5+;R1:W,@ #=
MSTR1Z=#1[-CYCT'(HKRK6?$.J:Y]@FCM88=)37HK>*5)CYK%9,$L.F"<U?@^
M(US<^)/L46FB2R^W&SRBR&48./,)QLQGMG-/V4K7%S(]%HZUY_X]BO[[Q'X:
MTZ(0M9SSL7CDEDCWL@SSM[ <CWJ/_A/=2@T34-8GTZW6T@N7LX CL9)91)M!
M(QPN/QI>S;2:#FU/1*6O-%^)%W%HMU<7.G*;E+F.WA94D6&3?W^9=_&#D 5T
MOA#Q'<>(K.Y>ZM/(DMY?+W*KB.48R&7< :'2DE=CYDSIZ*2EJ!A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH4;>O4U,JDK[UX2?,>C:Q'Y0Z8'XT%4[@YIY7&>*C8?-FMU3 BE48Z].]49
M0,\8]<\U;N'PI (S520_NQR<=JI1U*1!%* _RGCN3VJ'4,+;RAN4*$FI=N)W
MQPG?WJAJ]U%8KLFD $H(7/.:].G'8PJ-(X+PP!%K48[!S_.O;M3D \-:6?\
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M/)7 Y-2>:"*@O)4,(YZ4-CZG!^+UN"(WM_\ 6!L'GM7-V6DW5[>1I.^(\Y8
M]J[#79$\U1ZFI=#L@(S,P^]T^E?0T,5[/!IO<XI4/:5R]90^2J111@C&/I6Q
M#;\ MQ26T.9<E,#%:'E=!7BNJZE[G>TD5U5%4GO[U#+;^;&V<DXXJ_Y''(
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MPH[5[-.$8JT3QZLI2E>1K>'L?VB >@->I:U.D?@72I -J;Y< \>E>::+:>7
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M$M;F/YHP#ZBN7^UZ=7W:D="_JCCK%F);>)[8D>?F)O4]#5_^U;67S'2ZCP0
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M5EZI#R<=*N\@>U4[EMRN>PJ*FC5BXG&ZV-A$@Z@@U8M!)>F**(;F;]*K>(&
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M&8_*,DYII(*G%22_.2.1CUJMG"\=*S;=RUL9TY(C?DG&>37.^'HO/\07$O\
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ME)9I#G)KT'PWJ4B+!:2J6B7*[LX*@_TKS,?A[45;H=D:_M*AZ*K9'0Y/'-&
MH/.#5>.=/+0)]WH .U/,N\ 9!]J^;J/L;$A?OGMTJM>3E0$'W^I/I44LW[T1
MKRHY/O5=\MF1B..OOZT*FV4)++B+T&<5G75SM$NW''!-0:G/)F(K(=N"64?Q
M5SE_K21 V\0+2'DXZ UV4<*Y/W2](J['ZAJ0MX\Y^<\ 5C6L'GRF6499CUI8
MHS-)OEY)/-;,,21J,U]!AJ"HH\ZM5]HR+RD\L@BKGAZ;:TENW53Q]*9Y>>0!
M5*X=[*X6X3L>?I58FE[6FXBI2]G.YVC, OI2B?;]*RK;44O+<$D$$<,*MIC
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M\WZC4J.R1URJTXK5G4:IJL-C:22R..!]XUYMJ7B/SY3< J8QQ&@Y-4KV[O\
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M5?\ P%-/DB'UI=RL?!%F?^7F;\A3/^$%LO\ GYF_(5<_X2E/^@5JO_@*:/\
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MATNTN99XC,TN^4#.3CCCZ5TE%%6 4444 %%%% !1110 4444 %%%% !1110
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M*/*6G<6BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD7W'9 2OT/:HTT^SC)*6D"DYR5C SGK^=7*2@!D<:11B.-0J*,!5& !4E%%
C!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>img_8.jpg
<TEXT>
begin 644 img_8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #3 68# 2(  A$! Q$!_\0
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M9BW]_)?R232@*H?"CV]*Y^[N'6<NC_O,\$&F37FV,DEB6)(!?@51MY//G.X
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MN?L-LOF7,D2@],GFL5)HT=CRP7!C.&#!QTI_VZ0D8<CGH*[T3:'<R[,Q,0>
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MQ"R/:F3C/3Z\5(;CRX^>M8&JWANI2D62BC"@=S13CJ72C9GTWJ__ "+^A?\
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MT0V@'=@],\!0?QILLNJR1Q//J5TT&8MSPQX& 4.X<9SR0:[W%&*  4M(*6@
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CR#)]:=110%D%%%%2%D%-R?6BBF@:5B:W4,YR,\4444AL_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>img_9.jpg
<TEXT>
begin 644 img_9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #= ?4# 2(  A$! Q$!_\0
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M&@50%0#  & !4E% !1110 4444 %%%% !1110 4QOOK^-/IC??7\: 'T444
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MX_ZYM_*IQ4%Y_P >=Q_US;^5-;@SYU%.IHIU?5(\0****8'?_"O_ )"&I?\
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MME86^G0&&TC*)G."Y;G\35RB@ HHHH **** $%07G_'G<?\ 7-OY5.*@O/\
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MD#O7JEO<175O'/!()(I!E6'0B@":BBB@ IC??7\:?3&^^OXT /HHHH ****
M"HI_]3)_NFI:BG_U,G^Z:%N!\YGJ?J:6D/4_4U!/<^1)&-F0W<G %?5.2BKL
M\5)MZ%BBH(YRUPT)C((&<YSQ_2EBF\R66/85,>.O>A5$PY62-]T_2OH72_\
MD$67_7!/_017STWW3]*^A=+_ .019?\ 7!/_ $$5Y>:;0.O![LNTAI:*\D[S
MR'Q2AL/"&O\ A(G;%%>6S0#UM9YQP/H=Z_E7K,<211K'&,*H"@#L!7G'QALI
M(O#HUVVC+O9XCN0!R82ZMG\'13^=>C6\RW%M%.IRDJ!@?8C- $U%%% !1110
M 4444 %%%% !1110 @J"\_X\[C_KFW\JG%07G_'G<?\ 7-OY4UN#/G453DL9
M);B:262*59$VJDD>=H].OK5P4ZOJ6DUJ>*G8S1I96SEMEF $I+2';U)Q^F!B
MK-E;?8[?R@X(R2 !@#/8>U6:*%%)W!S;._\ A7_R$-2_ZYI_,UZA7E_PK_Y"
M&I?]<T_F:]0KP,=_O$CT\/\ PT+29Q2U%+$LT;1N,HP*L/4&N0W..TN_M?"U
MQXDLKZ7R;*SE_M")B,[89N3CZ2!_SKLU8.H8<@C(KQ;Q;X8\0:9J6FZ7;*]]
MH=Y*EA]I<EI;>W:5&\I_4 K\K>A(->U@8X% "T444 %%%% !1110 4444 %%
M%% 'BWQ#_P"1RN/^N4?\JYBNG^(?_(Y7'_7*/^5<Q7TN&_@Q]#R:O\1E?[#:
M[&C^S1>6YRPQU^M2JJ1J$4 (. !VI]%;61G<T/#W_(R:7_U]1_SKW[M7@/A[
M_D9-+_Z^H_YU[]VKQLT_B1]#OPGPLX[Q)KM]:^*-/TZWF$-K]EDNKH[%)8 C
M"C=UZ-P.:P+3QMKUK9 S:<;ZX$:E@P\K!Q'D# ZDRA1_N&N_O-%L]1F$MPDI
MD P"L\B8_ $5#_PC&E_W;K_P+F_^+KS3K.2D\<ZH)@4TA<A'1HB3LR&D^??M
MSC;$3C'<5#=?$+4FMKMK31XXIXK5I<3LQ,;*$^^ /NDR8'/8FNS_ .$8TS^Y
M=?\ @7+_ /%4?\(QIG]RY_\  N7_ .*H Y$>.;^WOC;RZ8)RT^P! 5!0.(SY
M7'SX.]N<8 KH?#'B&[UQKD7.G"S$:121X<G(D!(!X'.,?G5W_A&-,_N7/_@7
M-_\ %U;L=-MM.206RR .<D/*S_S)H O4444 %,;[Z_C3Z8WWU_&@!]%%% !1
M110 5%/_ *F3_=-2U%/_ *F3_=-"W ^<SU/U-1S0)-@/NQW /!J0]3]32U]5
M9-69XM[%=;:-2Y!D&XY/STY($25Y 6WMUR:FHH5-(.9C6^Z?I7T+I?\ R"++
M_K@G_H(KYZ;[I^E?0NE_\@BR_P"N"?\ H(KR\TV@=>#W9=HHHKR3O*FI6$&J
M:;=6%RNZ"YB:*0>Q&*Y_X?W$Q\+QZ9=L3>:3(VGSY[^7PI_%-A_&NJKE)B=%
M\>Q2@8M-<B\ISV%S$,K_ -]1Y'_ !0!UE%)2T %%%% !1110 4444 %%%% "
M"H+S_CSN/^N;?RJ<5!>?\>=Q_P!<V_E36X,^=13J:*=7U2/$"BBBF!W_ ,*_
M^0AJ7_7-/YFO4*\O^%?_ "$-2_ZYI_,UZ@*^>QW^\,]3#_PT+1245R&X8HHH
MH 6BDI: "BBB@ HHHH **** "BBB@#Q;XA?\CC<?]<H_Y5S%=/\ $+_D<;C_
M *Y1_P JYBOI<+_!CZ'D5?XC"BBBMC,T/#W_ ",FE_\ 7U'_ #KW[M7@/A[_
M )&32_\ KZC_ )U[]VKQLT_B1]#T,)\+'4445YIUA1110 4444 %%%% !3&^
M^OXT^F-]]?QH ?1110 4444 %13_ .ID_P!TU+44_P#J9/\ =-"W ^<SU/U-
M+2'J?J:6OJUL>(%%%%,!K?=/TKZ%TO\ Y!%E_P!<$_\ 017STWW3]*^A=+_Y
M!%E_UP3_ -!%>5FFT#MP>[+M%%%>0=P5RGC1H+FSBTN*98M7D_TK3=PP&FA(
M< 'U[8]":ZNLC7]!L_$6F-97@9<,)(IHSAX9!T=3V(H R] \6_VWK8M8X5%O
M)IL-ZC _,"S,K*?H1_.NKKR?X>Z/K^C?$/6[?6R)8Q: VUQ''A)%,I)(]#DD
MD=B37K% !1110 4444 %%%% !1110 @J"\_X\[C_ *YM_*IQ4%Y_QYW'_7-O
MY4UN#/G44ZFBG5]4CQ HHHI@=]\+/^/_ %/_ *Y)_,UW^MWKZ?I-Q=1JK.B\
M!NE<!\*_^/\ U+_KFO\ ,UVWBO\ Y%VZ^@_F*^:S5M3DUV_0]C )2Y4^YS7_
M  G.H_\ /O;_ *TG_"=:C_S[V_YFN9I,'&<<5\A]>Q'\Q]=]0PW\IT__  G6
MH_\ /O;_ )FC_A.M1_Y][?\ ,US.**/KV(_F#ZAAOY3U'0-0DU32TNI556W$
M87IQ6J.GX5S_ (-_Y%V+_??^==!V_"OHJ$G*E%L^9KP4*LDNXZBBBMC(****
M "BBB@ HHHH \6^(7_(XW'_7*/\ E7,5T_Q"_P"1QN/^N4?\JYBOI<+_  8^
MAY%7^(PHHHK8S-#P]_R,FE_]?4?\Z]^[5X#X>_Y&32_^OJ/^=>_=J\;-/XD?
M0]#"?"QU%%%>:=84444 %%%% !1110 4QOOK^-/IC??7\: 'T444 %%%% !4
M4_\ J9/]TU+44_\ J9/]TT+<#YS/4_4TM(>I^II:^K6QX@4444P&M]T_2OH7
M2_\ D$67_7!/_017STWW3]*^A=+_ .019?\ 7!/_ $$5Y6:;0.W![LNT445Y
M!W!1110 4444 %%%% !1110 4444 %%%% ""H+S_ (\[C_KFW\JG%07G_'G<
M?]<V_E36X,^=13J:*=7U2/$"BBBF!WWPK_X_]2_ZYI_,UV_BK_D7+OZ#^8KB
M/A7_ ,?^I?\ 7-/YFNW\5?\ (N7?T'\Q7S.;;S]/T/9R[>'K^IYE6'=VKR>)
M+>9%N5B@C,\\BNVV0]%C S@^M;E%?%4ZC@[GVU2'.K'-F62?Q7:R1Q7\,0CW
M2,RMLE)'"XZ#'4GUKI*,G^]13J5.>WD*G3Y;^9Z/X-_Y%V+_ 'V_G6_VK \&
M_P#(NQ?[[?SK?[5]-AOX,?0^3Q7\:?J.HHHKH, HHHH **** "BBB@#Q;XA?
M\CC<?]<H_P"5<Q73_$+_ )'&X_ZY1_RKF*^EPO\ !CZ'D5?XC"BBBMC,T/#W
M_(R:7_U]1_SKW[M7@/A[_D9-+_Z^H_YU[]VKQLT_B1]#T,)\+'4445YIUC Z
MEBH()'49Z4^O-?#'AO6+'QL]_=63P[9+LW5Z901>K(X,( SGY .X&*]*H **
M** "BBB@ IC??7\:?3&^^OXT /HHHH **** "HI_]3)_NFI:BG_U$G^Z?Y4+
M<#YS/4_4TM(>I^II:^K6QX@4444P&M]T_2OH72_^019?]<$_]!%?/3?=/TKZ
M%TO_ )!%E_UP3^0KR<TV@=F#W9C>(_$-QHL\$<,,;B1226)XK%_X3J]_Y\[<
M?\"-/\=_\?MG[(?YURE?%XS%UJ=9QB]#Z_!8*A4H1E*.IU/_  G5]G/V*#\S
M1_PG5[G_ (\[?_OHUYXT-VNNM<>4TD0/!QP$V]N>N>U.$,S:]%<K!*L6P^83
MQU'UY^E1[>O_ ,_.A?U;#_\ /OK;J>@#QW??\^<'_?1K;\.>(;C6IYXYH(T$
M:J04)YS7GE=9X$(%Y>9_YYK_ #-7@\76J5E&3T(QV"H4Z#G".IWE%%%>\?/A
M1110 4444 -^;U%'S>HIU% #?F]14<T9EA>,D ,",XJ:DH \\_X53:_]!2?_
M +]BE_X55:_]!2?_ +]BN^F?RH7DZ[5)KAM/^(&-#L+_ %.SD!NK6:[/V>(@
M111@%C\QRWWA@CK73]<Q'\YC["GV(O\ A55K_P!!2?\ []BC_A55K_T%)_\
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MTOQ7=Z8]@TUI:1++/+%DR(AC9B^,8P-F.N>:FU/Q_8Z=;7$GV&]>6&/<4*
M2&,RB,G/!*C/I6=6O4J_&[E0I1C\)J:[X=.LS0R?:?*\M2,!<YK(_P"$"/\
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M7Z* *D6G6,!8PVD"%I/-.V,#+_WOK[T^WM;>TB\NV@2&/).R-0HR>IXJQ10
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MXK2HH R%\.:,JR*-,ML/"(''EC#(. I_(5+#HFF01S1Q6,*+.@BE"KCS% P
M?7BM*B@#&7POH:6BVBZ7:B!4\L1B/@+G./IFIY=$TN= DMA;LH*'!C&,I]W\
7NU:5% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>img_10.jpg
<TEXT>
begin 644 img_10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #N 8,# 2(  A$! Q$!_\0
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MB-W;K$96GB" ;BQ<8QZY]*2*^M9DWQW,+KG&4<$9H"Y-MD_O+^5&V3^\OY5
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M"_WCC?1<Z'/:W"3?9;AXH]1D$>;43>7!Y9( 7TWL:[2X\0Z?!;QS>9(ZR3-
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MT+1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6E5?31!4<\\5M$99Y4BC'5W.!4E5=1MI;NR>&"2.)F_CD3/'?\:D]![%H$,
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M1AZBN*\*MY>I7,1ZE/Y&N*O_ !J9UO='6444'H>,_6NP97N;2*Z\LREL1G.
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M@O24)Y)D.:2/3=6541;K: .<29K=HJ_9(=C-L+6]BNI9;N4,""$ .<<USOQ
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4
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M4/:,'+'Z"N%U+4;KQ%<(TL;0Z>K_ +J ?>E;U/J:N6/A.YDDWI9%">LMT_\
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M(]0%+2"EK<\T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ*H?9;__ *"/_D$4?9;_ /Z"(_[\BCVC_E86\R_15#[+?_\ 01_\@BC[+?\
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M* ,%O"NFM#Y.)@"6+$2<N2023^(%/NO#MM?2PM=RS3+%$(]I;[V#G)]:VZ*
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00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>logo_001.jpg
<TEXT>
begin 644 logo_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M%=EH,^HW.F1S:FD4=PXW;(QC:.P/O6M+%4ZLK0=S2%:$W:)JT445TFH4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUMHX(5"1H,*HZ 5/7UF%P\:%-16_4]NC25.-D%%%%=)J%%%% !1110 4444
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M?P6WAC5OM-G$?[,N3F/'2)NZ$_J/;Z4[X:^,3X;UH6EW*1IEVP63)XB?L_\
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M:PGTOPY965R )HDPX4Y /7%;=)BEK4]2$5&*BN@4444%"'H:\<^*?_(S0?\
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M-PHHHH **** "BBD)H 9+*L49=C@ 5R]_<^=.68D @X /7VJ_JU\I'EAB!G
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MH6^J11$).OES,.F\="?<C_T&J7PUUC^S_$)L)6Q%>#:!Z..1_4?C7/'W)V/
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M=7#=BV?3/?WS7156MX8UB0B-0=HYQ@U9KZ2E%QC9GBU)*4FT%%%%:$!1110
M4444 %%%% !1110 4444 %(12T4 12013*5E174]0PR*SW\.:)(V6TFR)]3
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MJ1V\=X0?,6W8LG7C!/MBJ<;;@G<OT445(PHHHH **** "BBB@ HHHH ****
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M(.3WZUT9Z5<VF]"8JR/.++P[:^)&\5V<[-'(NK%X9XSAXG"+A@:H:]KES<^
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M^,>X4444Q!1110 4444 %%%% !1110 4444 %%%% "<T4M% !1110 44446
M**** "DI:* "BBB@ HHHH 2EHHH *2EHH *#110 F#12T4 %)BEHH **** "
MBBB@ HHHH **** "BBB@ Q28I:* "DQ2T4 %%%% !1110 4444 %%%% !111
M0 4E+10 4444 %%%% !1110 E%+10 4444 %%%% !1110 4444 %%%% !111
M0 4444 &!1BBB@ P/2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*/&V$#\*T:*GV<>Q7M)]R".VCC^ZN*G Q115));$MM[A1113$%%%% !1110
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MI:,4K@)12T4"$HI:* $HI:*0Q**6FNZQQL[D*JC))["BX&;K=Z;2TV(V)9>
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MORY_I56M+0TW7S-_=0UK0C>I%>8XZR1T5%&*6O>.H2BC%+0 E%+12 2BEHH
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MB@04$TA-)FJL 9I***=@"BBBF E+113%<**3-&: %I,TE)3 6BBBF(**2B@
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MJ *3-%&/6F(*6CI29H 7.*3-%)FF N129I*6F(2EI,TF:8"YI**2@0M%%%,
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MHI**=@.LI,T9I*^5L>J*32449IB"C-)FDS3L N:3-)FEH **2B@0M)129IV
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M=.M4IRYXO5A?6YU-SXBTM;:2*STM 9!AM\:J/TZUFZ!JL&E7DDTZ2,K)M C
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M(R<D4HTD!+;0#C' JPD<A3;@XSS5Y+;Y<U/'$!4.O)&3:,Y8)%&%&15ZWMF
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M?5!8>*KJ.4_Z/,55P>@.T8-);:8=-\60A!^XE#-&?3@\?A6-XD_Y#]S]5_\
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M #I=*T_Q#'J<+WD\XMU;+;[G<&]L FN_#TW'V;7,[ZZ;(26ERC=1)!XX1$&
M9T;'N<$U<\3ZW?66I"WM9?*4(&)"@EB?7-5]0_Y'N/\ ZZQ_R%5_&'_(=/\
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M%(]?2LG[6T9Y.7_E5BRB>YND3J6:L)TB+):LZ/2]-N+N6.5UQ 3DD]Z[)2%
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MJW<1*I.V2.F:SDO)C*KESD'-4YKHE@,$[?S-(]QN&,8)H4$B956V=58ZG<3
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MBX*5W= [+F=]_P#,U=9R?A_IQ3[H*9Q]#_6N*KI=#\40V>GMINI6QN+0YVX
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M^9/<ZCHSI,D>@^7(00LGVQSM/KC'-3V7_(BZE_U\)_2H3XF)ZZ+HV3_TZ_\
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M:K^E:[/I5M/;I;6L\4Y!=;B,N#CIQD4J=35N79]!N:Y[]!-0O-+N;<)9:/\
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MF/XIO2FG-'UI@.HI#SS3<^],!U%-!QQ2@BF(7(-!Z4W-)DT!<=13<XI2>*+
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M>N,CU%0DC%:&NZFVL:O/=GA"=L:_W4'05FXYK)I=")63LA<T!J:3246)'YI
M:;F@$=Z=@'\'BDX%-R: 2: %8CM33Q2TAIB#/-&:,4<9IB%'(I,4HQV%-)P:
M+ +D =*#R!3<TO)'%.P'+:SI$=E(U[;QG#MEL?P$]\5#I#&:ZFG=1N5<9Q76
M.@="C@%6&"#6.FFC3HG56+!V)#'T]*M:[GI8;$.4>1F?-N+MQD52DC#\'OVK
M2D&":@DC!'2M3>YCBTE%VH!RK,,'TJ[=S))<%1'N .,D>E6=NWI6=<1SV\@>
M,[H\Y([BMHSOH%RV_EF\RN5V1]CC%9 N)3,2)FY/?FI#?%FN)&7MBLV-]SCB
MJU&FCH(IV?A_*;CN*0;'OF.$&Q<#!JC;C)Y)%36B([3/O(&[ IZFBMH3S1J<
MG*_SJ324;[;'M=5&>R57N)88XS\_)J&VNV0O(F<@86EL/0WKFZ\J&?=.QWR8
M '%8SW(:0+'\S^I[574R3/C)9O>KUK9+",@;F/5C64Y6+B^Q9@+D#><GN:U]
MY33)7 !9?F&:SD4#BK+G?93IDXV5QU%S;F\)NYBF^>6YS)M"^BBI)+O>-I.
MO05%%*57RT2-N>I'-,GC=Y-BKR#BJ4?(',E4NN&5MW<<U91MZ[F3(Z$J:HDM
M' \1 #CISUJW9),B;>"[GH3TI3@DKE0J-Z(&VO&1L+-U'-0"1QNDC7[OWN>E
M37,1BW OM(_A!JC#<PI(3,C$GT-$%=70INSL76=2$\P*"PSD'K3YH88[7<OS
M*.HSS4-WY;'8K[$/(&*K1MY+YPKKTY/4544MR'+H6HY/,#[D&!C'J*;;R%;H
MLX(<]#BHLG8\B-MYX%1.7:8,I*J>F:+:C<WU-%?W1+KG<36@;A$M )7+.#@
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M.E(: :=@#\*3DG%.H''UI@-([&CH*<2/2D&.XI@-XI<T'Z4VF(=UI#129XH
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M: < =*V+WPY=)\T.)0/[IP?RK)GCFA)$L;QD=F4BH<6=<*D)J\60F9X3M4X
MYJ>2[::(!5"GO[U6)W#)'T)I47/+9 '7%.Q1+!(T;^S<&I"(]YW9Z\57\Y@<
MC'MQ2F0E@QZX[5+0QS@O\H) ';%/C1$CW*W[U><4"6:9OW8)9N"%%2M9-;_Z
M^1$+=1G)IH3&+.S1LJY'.2.Q-1!F+9SP>JGI4[066T%+ERW8%<5!<R1*1' 2
M0.K'^(T6 T;,P+E(Y/*D8@ GD?C[59OM'N[*%KLJ&C&"6!S^-82\8YK1LYKJ
M0-%YAEA Y4MP!]*F2MJ4M="NJ"?.$ ]QQBG1QL"%D.0#Q[UJ6-U9PQR">%"
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M&:3'-+P*,YIC#BFYI,4[-,!.E)FG;L\4VF(2BBCK3 ,TE%% A<XZ"EWY["D
M[&D(P:8"DTW/:CI29I@+WI<TRES0*XX].*;3B>!32:8$B=#3/XC2H::2=QQ3
M$*<"F$T$TG>F H%.%)10 K]*CI[?=J.F(?VHI 12YI@&>:&I!2,>: #%/&W'
M2HJ6F(..]'%%)GB@!>W2FD<4N2*3<:8KB4H;L:2CZ55@'>_:FYI0#F@J>PH
M::.M&,=>*7BF(::4<\"G'IFF@X!(ZF@ . ?4TF:,TF>],!P!QF@YI-PQZFFD
M\T[")53UIK>U-W,>]!-.P"&CM24E,0N:2EHQ0 =!S29X^M%%, HI*,TQ"T49
MIR\<F@!F<<&EP<4C#+_6E)Q0 W(HI,T4Q'5T4!3WIW4X KY8]4;S0#S3RP'
MZTW&>: #/%(>:#TQ2 TQ"49I>#]::<TP#/-%)13L(***4#/7BF   TG2G@#V
MIK@=:8A,\^U!.:3%)18 S1FEIM.P"YI>HIM'2F 49S13<TP%I=W%)U%&*!"=
M31F@BC IB 'VH)HI*+ +G(I.*3(I*JP#CC%-!HS2\4 &,\TF>II2>PH.,4Q!
MNXIM%(3ZTP#/%'6D-)3 4FBDHIBN&:3-%% @I0<"F\FEQ3 #R:7'%-'6@FF
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M:RH2J3YKRU[&%:#:]U6L;$,@7)NF"\9&P< 9QDGGBNB^P^'_ "HW%]/(K_\
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M_P#K4F;C_GBG_??_ -:E]7I?RCY4<[_P@FE_\][S_OM?_B:/^$#TS_GO>?\
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M\#6DFF_:+>-;>[D8.9"[;$!.2<9]#FN?UOPA9Z9IC7ZZU#(00%C,9!=B>G7
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MUJ/2]+GF<?VAN4%5)2%#N5B>02W' ]/6MB1M-N-19I=*O(V6;S4RZ@;R  2
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M3Z'GBL%=9LK>&X1K=X[F+AD"$[2.XI'"^&OB+K&J:C>V4UM-*^ \N63<V<;
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ML5DNHK>V>YBD0"&1E(92,<YZ>U5&LW']ZM3*M+[*7S&Z*FIV0:"YL)#;C@2
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MK@W301V[RFU$[#"1X0A#[9*DY]R:L3VMC!X>@CEU.*6X6=_W, SL7IECCG)
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M>WF7F@4[E13WQVR:\PN]>O;J)X6DS&V#C: ?TJ?61%>ZIYEO;O%"4"@,VX\
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M&TM$N+A8;8[%W&([ASS@\D#K[5CZ*MI87=CNALI9B/,$T,F0PST*C)8^V*[
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M'3;]"!U]:\_$2]JI4T[]UV+LEN9VIZI%9ZI_9U@WV@.GWY."[$G@ =!C^=8
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MEGCZD_=YQT'YUI6]E]MUF2[U%F6T$@@:XC _=G^$LO4C P<8ZYS70ZMX.O\
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M$'I47A[X@BXO(;;7],LIK>1@#.L>QD'J<5:^(7AW3)+6'Q%I\4<5O*%=DB&
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M\D] 1CM5;PQ=0R6SP6T3+'&YRS-D\\UZ2JQNH]RKZV.AHHHK484444 %%%%
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M$?*(+EC@L>?H,U. KTZD6K:+]3KQ.%J0J14EHT)IL$6LWRP3_9XIV<*DLC%
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M;Y4^68R ;E+'!Z+Z<5APZDEZVR"T9I6.$3/^ KKC3J<MXO3O_P .3."CN=A
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M24VRB/:'=,;G/;([53?/MK_70TA.VK-1=4217=6N"=Y0L< %?:DTJ[87<_D
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M(W1;"^O;>&[O[E(K!)LB&1?EG!.T[??Y0,CFNYFUK2=2TV:SM+"1C8P/^\C
M:1<D*N?7&3W]ZX2ZM(K>Z2R=I)HU&U\,0J<@_+SP,\U=TBSET7Q#;3PS3OIK
MM^_B5\'&#C.,;AD_I7/4<)[NW;0M49VE+=([+PI>:/9ZDZ17;&YFF0V[2*0I
M8P\ENQ&1Q[K56P\0177BBY.IV*@[BN[+*&/N-V/_ -5<Q?$2Z/+.8+J#[-(5
M2Y10"K ?*H&1C).2?0#'6MSX;V^GZW;W/]N:@$NXBQ,4S89AU+DGKCIBN>>#
M]I3;6[,).+LDNI<U^P\/PM=ZDQ>Y=B%:' ,:DC )P !CZU)X</A-= EO[F]\
MC5KA74K'(<Y&?G4#IVZUI:J=5G\+W$5CI5M::7+&Y9GSYCCH&(]^WTKD_"6F
MZ9#-$\Y>[@>-WE@CA#F)A[DC&<CCVK*A!PIN$VV_/^K(TO&6D%HB23PZ->L;
MC48G6.82,BJ2N9B,\XXVDXSBN&FT]I9&CC#>8IP5*D'/I]:]<LHM-ALKI6GC
M=K1VEV)F*53G) SP?PKE+EX[1M2NPY(9SY>[J6;.#^1-;0K3@[6WV(G[JNSA
M[>P:&Z5\!VZ;<9!K8D\Z.4N)$B9OOQ0?(N/0BEM0\<9D2-FE8X4 =!ZUU_AG
M2=/U'PKJMI,D?]J/,KP28^8$#D9^G6NF=3=S=DAT]E)E>_\ !=^EK;7.GL;M
M9@"P,1Q&3C&X>G/IQBL"1M4U& V,-O;)#$,-,(\-NZ'DC.>/:NWTO7[OP[JL
M>DWK9D(&':16 ] =HR/S_"K-S;I)+*Z1JA=V<J.Q)S^/6N2OBHTHJ45OL>CA
M,&J\_(X&U34--5XCEXRV>#C!QU_E3K9H=2CO%8I UK^\DD;+.R8P !Z#^M;6
MJR6UJV)GPW]T<G\JYJZL([V9I8VD0NFQ@@ZCWHHU%53E)6OU-<71I4I)7OY&
M+J2K)I6X!P9)MR[N?D Q_4_E6=I-W+I]]#/$N]@V0OK7>7^@Q7L*,F] J!%C
MQC 'M659:,NFM*TFUY"<*P'05VPQ=)TW%Z^1Y^,ISI>]):'2VVKK/;"2,$9'
MS1M]Y3]*F_M!O(F\@ .X"EMH+8Z ?3FN.N)88;A=\H\\<A <8]S_ (5<A\1F
M'3K=8HEENIBS2%N HW$#\<5Q/"-).".*";U-2VN0EQME60=69V/!..@_ 5VJ
M6"-;D([HQX#KC('M^5</"DU^@,#-LD3YC)C"MR#BNST.ZE?38HKG_7PJ(Y#C
M@D =_I7GXZ+4>:.ZW/H,H5-2<7NQT>DP*BJ%; .06)R3ZG/>DEL@G.!]2*U
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MJ1YBA.,9/5O>K=KIDDMI)>-&PMXN#(R\;L@8^O-;-16I6Q5%M(4$IPJ$XRS
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M%)$5)N<W)]2>TA)1I0VW!Z^E;6NZ_J/B"YM9[R(*8+=+<,2?G"]ZHF2)X!!
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M?H3N8#CGV%<%.L6E/()E2>25]_EG!V]>_45KZ3<W<TL/V>\\B5CN?RG.0/\
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M4N%"QPN2L>#N]\#BJHX>,&I-MLO%9@ZJ5.,;(Z[PE9P\17FP3,@>(>J^H/\
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M'$Z-ITFJZ@MK ?W8RSY/ P.U=)?^!X!:,8XEW#G)-<?'=3VE_#>V#E)(F^3
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M:QI13;[F]YRBHRZ%=YY89"2A4@G"YK8L)%-J"V(U)W-SWJ'3[#=<"SN"0[2
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MH<<E6*2%FR0Q[U'J\RZ)I7DVL;)%"FR.) 7<Y'\)-<58W=SX>@76UL);J"Y
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MKJT,K$!8V'4[NO8<5AS01Z19M,T,;F9LJI/*KV_&JMOJMUY;(5)B<$)'* V
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MXB3$\,BB(+SN(#!B1VW(HR:Y,%BG&3A?0WQ,+151'(PWU_>6T<-S<R^6"#&
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MI^HM;NAS^_PVX#^ <=>O-7O%.D")8-3M/+:&4C=Y?*GT88Z5Q>K:5J/AR^)
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MQ6==K]LV2VJND<HW%9B"Q)[Y'7-9^RITHVCIJ/'59U6I3?HD9>GP16\,XB3
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MG)2B]&1ND;)&#E"PRQQG ]>*Z#3[==&1HKU URP#K"IW9) P/3I^6:Q;@K%
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M=U%G1Z%J(E2>WDMY)VFGWQW4;E"F#\JMQS@8KK+HQWMW(7O&M"HQY21DR'(
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MAGG=KBYNE$C$@Y)Z=NW&*9+-9:/:%K+9+J3.!),HRL (Y$?^UZMVZ#N:BO\
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MRTB],$=:YW7M534X(UMYI'8\2;A@"DM6M;/1YD*S+,ZC</4TW'J-.SU.KO\
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MRN,@^G2I9?BCHMBICL=.D=S@,9 %XKGKOX82V>)3=6ZHO+ECMP?I4]QX$8H
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M]4LK*8K=-.85.59,XQ[CKQ5@>'1>"$6-]^XB8[ T97;@\D>G-6=1\'S7MO\
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M4>9#IT.5^ZH7 7Z5YY;>.M5N[X26UE! UPK$,/FW,!P#6;9^-_%UU=[\,G.
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M-J6WRJNT>W2D:WBDD\PCYB,&DY/H-174\I3P7<AID=@X1=VYK;)P3@#&W _
M5B'PM;S7KVKZ7<_:?+!,P;;$'&2>-M>WRD*@5'9&R />G$NJ8D7 Z@]:EMO2
MX."9X])X<OFNH?LFGNJIM65YT&%7CYL;<&I%GOK26Y6WT23R9)"OG/;GS"IX
M)  '?GVKUS $1P6W>H[T/Y@ ;*XQR2>E/F[BY-3RG[7K\FD-;PV6I208V_,
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M^M57F6ZB8$E]WR\*S >^0*<&MXF,HCBBC!YD^[^!/>GW.O0R[;9)+=MRGY>
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MLT+H;64GYA+@_KTJPC@%"2I7T )/YTKA8<T:2APS/A\$9X ^F*5R 8_G WG
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M>J(M$^T;,/N&&)5>O7K^59R@KNQK%KE1;@NEE0%MJDCMG%0R0I+*Q,TD8QC
M *_EBGK&C3"-F";AA><$FFW49@?:DBEEP) K!F ^F>#0UU8-J]BK%#9Z7?Q7
M<<<LL@RG'H?;H.E)J<HOW$$I(1B3Y2Q#D?7K5I(WN&?S)EA1P/+C8 2#'7N<
MTR]6WCC>.42B,(69XPV?3J*SM%W:&E%OS(ELK)8HXFA5@A!1<XQCI5J)C@JD
M(4D'[W)^N:9I\:RPNT?F*J, A?&YAZT]K/*-M;:[$\G)Z]:J-FKH=TR/S]TA
M#(I&<+CO3(%6*/RHWDVYZ,<X]@35I;?RD5(P@ /.%_6E-K&8U"*.#D<55@T*
MLB++,KN'W*>#GI4T1\I/W:)&IY(4=ZL"+(&YB6IVU<8YX[$<46"Z*;2QS$;T
M#KD]1D\=::6D>1?OE%'RXJ9K.070F2X95!/R8&#GK5@(N#C@BBPM"GND#'.\
M(#C"CG\.]1R307$C1I.K,IP8^,Y]P:MGRPH)#MSV%2Q0Q[=ZQ*F[D_*.3[T6
M!M%,1M(0 0ZAN,D\4JF;.T1\*3]]NOTQ[U=,89DXP5.X'/%.));&<$Y. *=A
M7*C0M GF\-D [1_#3(YFE;RF*AA[\D5;WJ7:-74D#D&H@89\"0-&XQG@K18$
MR4 JN,XP.#ZU#(JS#:ZJWN32/]HC3;%&LJ+W)()_2H#=1S2X^PF1\<,HR/Q(
MH&3+&;=#T+$\@-42RNZ93:#O(9<[B0/3WZ5*KQ2CY4"+UR.AINU'(R =I_BI
M#*]YI-CJ<7^D(Y1CGY"00>G;O26FG65G(PM[9HMIQN=\DGUJ>Y<M 8X97B=B
M-CJ ^?;%,5-\:O(TK%NGS%-WU ^M2XQ;NT-2E:U]"QF0(&<*S]<*<9%,N$+K
MM)!'INP0._-+%-"%(F4@J,\ D&EAO5E1W\HJ%."&XSZ?SJ]"=1EE"L*>0SSJ
MZCY=Y+9_X$:?L>4,HF&1UP2"*=MMV1C%(ISR!P:2*4I\LFT-C.5'!H$AILG>
M/#RAMI!R_/%0F&*,N?-*A0!N+<'TZ&K;C[1&-LG!_N]*9-:A[?9@=B N,\<]
MQ1:XR,F-HE#%68+U' :F,C%6CVJYS\JE@,>U26M@%1A(S.&S]]N0/059CL;>
M)0%7OGYB6_4YHLQ72*NQQ&9 I)/0Y'7UQ20)* CG9EC\PYP..U7BL8 4G.3P
M *JS+*'(W*$R"/E)_6BP)DKDEAUQTVBD9B25(8+CICK5>VB8$*96*'IO;D<8
MXXS^=:(;RTPIW=O7%"$]"KY8D)_A'&<J.:DVL%"HV,>U->=RIB9U&3@D*/E_
M6HUA5#E"A .2>:8$JB1%PQ!8^M1)+*LI5P2I/W@.*:(F0F::<;BNTA7^7&>O
MU]Z>LMM);K,'8A@?X3GCVZT!<G"H'+8&:<[+C!"X/%4U4LZ2+N"@?=)_^O3T
MW D*KC;W/(-%P)3$-X8(I8# .,X%0A)$.TD#)[L2,?3M5B/S-P8A>1C..:<P
M^?).#Z9H @953Y2K9)Z@GBI@I(^51TYZ<T,RX[Y[>]-8;F#+\LBG (/\Z ()
M<[E4R*KJ>,<<?3O3I9D>1(VWD]<@9'XTPVKF9I/.!7'^J"#K]34@C9<XC3KR
MV>?RI:CT$DA1T !'7H.,FF/&($,DD\@0=5."/Y4XP.S':-I/)9!@_K3O,1(G
M,NYF'' W'/\ *G85QIC4R!@[G*[>"<<9[#I4SH&0'< 5Z<=*RKO439,-EG+,
M#]Y]X55^N:HR^(9$D=#:P-$N<R+=+C'8^M &_P#()%.[YC]XC'/UXHGB6>&1
M1,57(^93@C'OBL"XUC5T8J5L<[24+2A<?Y_"JDFJ:I';>2T]LQB!+2"X7!&.
MG//<=J .J0XD5<'D<D\[N/TI%:5MRMMR"0I!/->?7/BO^S]JW-\);A0&"0*T
M@8'H#T[8YI^AZTVN:BT4UY>Y<;ML<>Q5'ID'..?6GR]0NMCNU1O^6A&X'E@<
M "J=S=6-GGSY(U:,9#9QST^E9-[X;N+V8M]NN%@Z*B.1D>Y-8VO>!KZ20RZ?
M*3N(S$YP!QR?>IT&[]#<F\1Z1#=>:7G<[0!*@R,=^:LQ^*M'=&V:DCNO\!)X
M],X&:\R?0]4T6]22>"-R3@@N/F'&1C\*;?Z7JMY-'*-/CM4<8PI7'L?>K4$1
MS,]/'BK3@8WFN%MED^56<Y!^AI[>*-'3@ZG$X8@^ZYZ?RKQ>Y26UOC!(VR2/
M)48+Y['IP#]:MV-O%-/,UY*\( R& () ]AUZ53@3[2^AZK)XQT528XY3<2 X
MQ'V:J<GBR=E4VMM$$W\K+(-P'H*\G-Q<V.H/)IT"-;;N'G4 ,W)R01FD6&_U
M.>29KZZD.[$B1Y5 <9QCCBK5*Z(=5WV/0F^(X>Y("P[%R&"$NP8=OO8JK>?$
M":6PD\I0<?Q ] ?QKB$CD(,"%?W2\HJAN#ZD<C\:B#31DEGCC?;\N&RI'J.M
M/V2%[1G3Z=XFU".8W5I,[F1<LF Z*!U/)Z_2K,WC#4I 9/,D&Y64_,".<>G'
M&/2N):6>XND>V/EQB/'[M@P/OR.#]*?!;RH%#,7&<;I6 )_4?I3]D@]I([#_
M (2_4+:SECN(%NGP!NE;DGZ@@?I69/K<UW'Y4L$0#?QB,$J?SS^5<^_VC+%<
MR1H<;$3Y1CMN]:DB8.TA6.':#P'&2I]F-'LD)U)!!:7<%SYD-Y*!NW-$Q(7(
M.>!N'-;Z^(Y[15:WC6W<*5:0 DO[$D5BI!<SWVQ;J&=L;MI(!4>_O1-<&/S(
M6CFRC?-\I!/?'-4X)B4FNIT,/CO680!]JB!R#L,F&) Z<BNC3Q1>WJQN9X;1
M74@REU9A[87_ !KRK6+D6L<=W%]EB64!_)"D2GL<CMQWJ>SNG,*.2-KG*G &
M14NBBE5?4[Z%[;6C);PZI);WF0K7#^6&<<$@'KCDXP:YC58Y(+AX;J>2<H<*
M[OD@>G4]/K5#S?,7$-RL>.I*Y'UXJQ!J$'GK)+':RXQB4*I.?Q'&<4E3Y0E4
MYAUM'// 0C2+$&"Y8D!N"1Q^%-MM"NKJ7[3%&KP(=TNUEXSD?YYI=2U6WOU@
M>*S4(K .//)W'H21@'J>WI45YJJR7$6G(SPQ\-)';@*&.,_4#I5<K)NB9],N
M?LOVL%=H8C:6!;BJ46JKIUL\/EQ&4X;8Y!VCJ1@\'KVK1N+L6;$7>EX7RMX:
MYF=AM'HJX'4@<YZUA7NIRR7@E-C90H1D P)D#ZXY-5&%]R7.VQ)-)-J$'[TE
M$A0%0.%Y8'(%-BNKZS>W%I'<EF)8F/(('RGM[U+I-]Y^86^4S!MIM@JD'.>P
M]!4-Y/<3B%1(8G1""9"W/S$CGZ8_*FX]!*;W-SQ4_B'4=/262UFC(8*4<D!5
MQU.2#GWK$MM+$H:6ZOEAG(W#*%U/'3<#UX]*UCJ*2-*C:9"TZQ@;XF.#W^ZP
M/(]16-]JBDF\PVOEAB0QZLA'MVJ(QM&R13E=W;N;6@2VVE^9]K6&],I 6(,<
M#KR>.*=J&NZ9J=V&M]-"JHVD<Y.>.#5 G1KG32(;B=;K;O9)UXW#C ;I3;*#
M+1%6#2LRLP9@K;3QC&<GUI<JWZC<G:RV)98&-@'LBZ!66/&,;LGKZ@@#\<U6
M2*--US#>)./F4 #W[Y/]*CTN^N'O9K>(O$LC?OECD)]<'K@]:L:9I=YNG+QJ
M@<%EFW #;D8)'?G'/O0[):B5V64C&I642PHT$V0964;N.O3\:B-NUFD4WVZ3
M"#/F0YRW)X[8'S5/_8US:V0@>6..6; <[B OS<<_2J=[:R6Y%L<W4D9&T[OE
M(./?VI*Q3NB::VEN;@6TTC[R/.._YLG"X/'KSS[T]H2]M.(N(XF^:4#.W@#'
M'3 '>JNJS-&!!;RH4(!D<L%R1C@8[<?C4.CWUI9F*)/+B&\F9UD=FF';*XP"
M.O'7-'30EMW)]-N(K.=OE-S'M(DAE)VL#Z,>5^H K:@O+R71I9M/</:1,P\J
M1A))"/\ :QVY^]T^E<Q'I,XNYHKFZW$L0Y'4\]1D<BK%I="RNFFT]VBEME.)
M(V;([<]CGGCG-4^5K0E2DC3W:?O+WLD:7)SMRI.X]OU__74=KJ\$BM/%"94:
M+9M;;&$)[\G'T^M4VV7D\,S*P+N=Q5"%)'H!T!_R*?J!(D6WCC18E7'F1K]T
M@<\@<<YZU'*B^=V*DB&.^@?R&3'S,()0<')^\1QFKTD\ =(8YI!#(1YWF'(W
M;L' YXX-16EM:V^UIPWDE?\ 6KR&?/' YR<8^E4[B5)794!$@;Y P].H)^@%
M-JX(Z??%HMW!;W&V6SR)8<?=YQPR\E<^]95]*9+M9(+9496W/$@)SSZ=N*99
M:^Y0Z?>PLUL<;"6VO'C((!/_ .KBFW&][1G0.,.(\L>0 >#4N-AIWT*-^)FN
M$3,,04^9&I&.">0<]>_\JT+:*6RD!N;2*>4',('/RXX9<<<\^O2GW-XL_AZ*
MV^RP>;N"B1"?,8C(YYQU]JNJT=[8VMG>QKY,J Q.I"O')T(XSD=#TP#^-2Y-
M65AM>[=="UK%N+J-HS<,JM*6\I\*<.B/M'(Z9/ZTW5-,N%N(4%H)UAM8HT#!
MBK':"P^7!+;W/ SWJU>)92:+9K>2WDR6K")V@B4C(R,<MP"".<G[H-::ZO97
MFE/<W$$LMOETE,C;3M+MW )'0=CQUX%0ZC2LB;=CEK;4H90]K,MC+$QVE"8X
MP3D8^\%(/N.:E;3;.[5#%9FSD*XE)D\^+@C),BY*=QR#]:V9_"6E7>E7MQHU
MS)*C[2/W($BL#]WD@$G=U&/:LC4]%N+"XAGLY+B%[J/S,E"C*_\ &..1\PSC
MT(J[J^@G&8V^N9=!L(WM]):-I1\TQD,D<N#C((XYW=O2H+.[1898;F)([:XB
M9Y44@%"02"N<\KG^8[UI6L>L6$>!>64GGEF:*Z=0) >5^]@'CWJY+H5O?0K)
M.O\ 9$SJ% D<-;RGC[C<D?RI<Z6Y*<T_>1Q;6C00$)( 48JI'3ID$=^?\*T-
M,8Q6"&XCD^R[&BD*H%8YQ[]CCG'%:=WX6U"/=9WD3!\;TE0;EDCP3\ON,\#_
M  KG8Y9(;>9%&V.)U"+_ '1NSU[YQS6B<9#OU-+4)%M;9)(X5<*P)<_,Z YQ
M_/T JM+<1S;41) Q_BWY!]\8%.N!YD;1QJOE,PP#S@-D\#\/6G0P"+3RJMEN
MF&&3M]<]>?Z4AEZ!TBN@'V!6&&W D$'G/!Z@@'BJUZ+997"1;U4XC.=VY3U7
MCTZ U1+HXC4$X"?>)QSR.OY=:&EF#P[B'4,!^[8,PQWP*$#(&FGM (H57;C/
M"@ ?I14=[;3FZ8M%.Q(!RO3D9'';@BBF]R;,^I;IF%U)AAC><\>]0"2106)S
MGLHHHK%[L[(_"BM<V-E=S12W5N)'0_)N'2I5MEC=_+C15?EBJX)/UHHJ;(NX
ML-K"DN\1J7'\;#)_.EN[075LT,F=C=U."***2BK6!O6XR(R6L,5HGF2(!R[=
M?Q-2B4\A8RQ'KQ112C%15D@'O+"2RA^0.1BE&0 ,=J**IDB?*%.3]34(2%E8
MB1V'7[YHHHN4D.+QB,@_>SD MS4,L\*Q9GF9!D<,>OIC%%%(+$BSHR @[U'.
MT]?UI3<Q/U<8/4>E%%%PL@>=B%VJK(3C.:8+DE=YPH!Z^W>BBBY5D!>&Z4!B
MLD3'Y6'M[U+&T3H-C(Z#@K111<EH9(\2947#Q,1P,9Q547:[/(%_M<@XD11P
M:**3=BHJY+:QPP1E(BIW<D@=3WIT;2+(2\2[#D9S110M1,D:=%C0VX4H 3A0
M.?\ "H3+'+;*[S+G[V6.=OXT44R;$@,BPGRP&8 X4G&?2H!+,Z?O(U4G&55^
M0?2BB@H>+8&19D?8X&"5XSWP:<LLH!<JV 2"#U_#UHHIV$)%*DJEU=PJG&.1
MS]*D$C,&^\O! /!S110@9&&G?Y5<,O<]"/\ Z].B$D2 33,Q'0MC/Z#FBBA@
M*C6ZS2&-T\XX+KD;C4K.[%3@;3U#<444(EE9_(EF$,,L*S]=I;<<=^,BIQ$L
M0,>]L#G@D=\^M%%"!MCHI[>Y!,<BOD=5.1FI"!RAC!&.!V/M113!F3?W-U9L
M@M+=-C9+EAE5P.^#G\J%N9_LT*26R%YB-WD+O4?7../J:**AWN5I8MIBVAW(
MBY8Y^7:-Q_IS5:YO;V.Y6-;1B2 696^5?Q[_ (444Q=283.B,?XL=,GK7/ZM
MXI?3T<"!/-;HQG!_3%%%%]1O8Q%\8:Y*RLD2ECT49 ;]:UM/U#6;R<.\$\9'
M/[X H/P&#115$QUW+.KZU?Z? K^; 64Y8)_]>LN7Q^]N \D"[!_$' &/<=?I
M11515Q2=MBLGCZ[EED>V6)H>@#-\P].<5FZIXAU'5%96N9(4(P5#\-^0%%%:
M**,W)G/N;]5)\]Y2?1^M0K=3H2D\<K1;\LBS,JGV-%%79&=[,LS^(89K=K:*
MQBAEZG:"[$?\")J,ZC%-9F%HE21?N2(FT^X(HHHY4',RQ9:Z;32V@>U$TAR!
M)O (S[<_K6=INMWUI<EK3;!+R"[*H!'N #^8%%%'*@<GW+L_B[7I;\+)JC*_
M5(TD"+TSZ $_E4L7B;6)H9+==0N$5B&.&).[N<\]Z**KE0N9]S'O7EO[[SKS
M4KPW"N,9)Y^A; '2H[L1R++:/=&#+Y.^8^9QZ=@***I)$MLKP0K L*>=(Q4<
M$D$X]_\ /XU//]ON+:-K'<YB7#.3]?7/%%%#T!"V\=Z/#LUU++YUU%(> "1L
M'WL>I!-5?M<($J^?#()%YPP49(Y8'K110G<-@L%L+&-Y(IU?S&^9B20WMFK)
ME47;A_+&.4;#<@CW&:** $VQM!M=#-,TH2+:_P H/&<\9[CI5RZ\.R%6>S5V
MB!!=A&J,,]^3G'_U_2BBIDVF5!7W,O"6$AD8'*D@!,D_SY-4IITNK<I(920V
M[ &TD^ISFBBM$036;QVK?:Q"\3/]YV/ J6XW31QL9E<ORBYY [=***+#)B+:
MWM&>XN[=F'&Q069%QZD?I]:K3RV5G;Q%-E[YI)91&04  Z].N?THHID,;')<
M21*B*(XLYZ[< ]SCUV]ZN0I;)&^[4;=0,?NU<G],<T45#;9#DQIO;?3)M]NR
MRR,.8T3 QUP?<G%9:M))--<2I'Y\F<?*6//7.>,444XHN+;W+#W#K;&U$C-N
M WY(YQT ]![4PS1+;LCPQ%7^^^WD>^:**I:"D6=.GLH+M98XU;RQEN 0OR]S
MGZ53LKGS[J-9!B,N,C.<@_RHHJ&R8MIFIK30V-TN74RJJ[TSZCFLBT8RSB++
MN/F 8# !P>***4?A-GN3>;^\*_(_/W!G/Z&K<M_;)<PJ]N1.D@<R(Y&2#W4Y
MHHH$0!W;4#);Q1 -F3.T\<?IS5^RO+N01_O7*;& 900"<#('\^:**4AQ*5W=
MS17$Z2RRM*74MGH.H QW'%3V\UO:D22HB2N=H*J<#TR#T//THHJ6KBOJ:4:2
MW MOE@9)9O*PC G\@<UE7-I:S.LMO;M$R-EMC J?;I].YHHK-149:#LF:FJ1
MJRAH%A29XA$V)   ORCJ1_#MIMCX>O+2W:YE\N-9B$'[T.7'/ VG'%%%2ZC6
MB+E%7)+&T@^R9:X,<ZOE8V7(.>@]NY_"M>P\-RWNJ^2)(2YB,B3(V<@DYR<<
M?_7Z444.3L5&*T*&K:7<6E]<6M_+$T:*#$(LG.<9(XQ@#Z&N7;39K&3S-K39
M8\E<+V[#WSTHHJXR=@DC1> 6ZQS3R-(K^7N38<KQP%/0C!QVQ3YPHB$COY60
M6)/;C/3OQC\J**3;)BM62:6;>WN'CRIR=T?&<MTQUXX/4<_G5@1(]W?VL+3*
M\$OVA2!N=1D!\>X-%%1(T2OH=-J*1V^@1*)3-;7\+RR21?>W>6C\9XZ(_P"=
M9VGPVUDLT4TJ2P7"! BJ0W .?HPR3^/<&BBLY+5HSVD7=*231KN2R$R?8[N/
M,+2\ MD8Z8R#R".V16A87]GJEI=:7<G,T)P(L O$IX&TM]X<=#T[8P***:U5
MS:UF9-SIUW9PP0W"K>VX#1S$DX9,$IWR&&&'.>@K!N;N:UNI(-,N7=)<2K#,
M =P89 P>#D$>AXZ445I#7<QGH=_9^+X[!;6WO8EC@N(PT#]MQPK <<8?('KQ
MTZUSNJ^'K>1W,4D,+MM9YHU+1OR025'*GC/3J","BBE-<KT)6YB26GE7++(X
M)16R8P N/4>V#Q5*[>+<DT!\S><-N;@ #[O!X.#116RU![&=)=$+$[1(?+)4
MH7?U^O\ G-:,L<*LD=]I<051P0SY')ZMD[1QTQW[=:**8B=9$89AD=(L#:L;
0A0!CZ?J>:***S:U*6Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>logo_002.jpg
<TEXT>
begin 644 logo_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSU#_ +\K_P#%5TGC;_D2-;_Z\Y/_ $&O"/AWH=AXA\61V&HQ-);F%W*JY4Y
MXY% 'J?_  N7PQ_SSU#_ +\K_P#%5W\,JSPQRIG:ZAAGT(S7&?\ "I_"'_/A
M+_X$O_C6KXE\5:;X+T^UDO8;F2*1O*C$"JQ&!WW,.U '0T5PT7Q8\.2:-+J3
M+>1(DOE+"\:^9(V,_* Q& .I)%;_ (7\2VOBK2#J-I#-%$)6CVRXSD8]"?6@
M#:HKA-<^+/A[1[Y[.,7%]+&<.UN%* ^FXD9_#-3>'OBCX?U^]2R!GL[F0[8U
MN5 5SZ!@2,_7% ':T54U+4[+1["6^U"X2"VC&6=OY =2?85Y]-\;-"24K%I^
MH2(#C>0BY_#=0!Z97D]G\7[JZ\16^EG2(566[6W,@F.0"^W.,5W7A7Q98^+K
M"6[L8IXUBD\MUF4 YP#Q@GCFOGK2F"^/;)F("C4T))Z#]Z* /J.BO.]0^,GA
MZSNV@MX+R[5#@RQ*H0_3)R?RKK/#GB?3/%.GF\TV5B%.V2.08>,^A']1Q0!L
M45E:_P"(M,\-:>;S4[@1H>$0<O(?11WKB%^-FA&;:VG:B(\_>VH3^6Z@#TRB
ML_1M;T_7]/6^TVX6>!C@D<%3W!!Y!KE=9^*VA:)J]SIES::B\UN^QVCC0J3C
M/&7!_2@#NJ*XK5?B?H6EZQ'I86XN;@NJ.857;&QQP22.1GG%=K0!1UG5K;0M
M(N-3NQ(8( "XC&6Y(' _&N+_ .%R^&/^>>H?]^5_^*K8^)/_ "3W5_\ KFG_
M *&M>._#+P]IOB7Q)<6>J0M+ EFTJJKE?F#H,Y'LQH ]+7XQ^&&8*(]0R3C_
M %*__%5Z#7%+\*/"*L"+"7(.?^/A_P#&NONKNWL;62ZNIDA@B&YY)&P%'UH
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MS@>IR0!^)H Z:BO-[3XT^'YIUCN+2^MT)QYA16"^YP<_D#7H*W<$ED+R)Q+
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M_P#0UKP+PU;Z_<ZC(GAQKH7@A)?[-+L;R\C.3D<9VU[[\2?^2>ZO_P!<T_\
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MM*#Y<TTT;?0@ UY%]GE\&>,!%JFGPW8M)2)()T#),A&,@$$<@Y![''I0!O\
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MDW^-'_"4W_\ <A_)O\:/[5P_F!N'PGX<)R?#^E9_Z\X_\*V    !@#M7%_\
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M8CU"QMKI1T$T0?'TSTKF&\57Y/\ JX!^#?XTG_"4W_\ <A_)O\:Y'FN'\_N
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M2:B@>0>7&<D9ZUP?B76O[<U5[H# P /H*^FRJA.C>ZW,<1*+5D9:1EBH'5B
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MB<<J/O+GJ*V/$:I+:VUPI!!. ?4$9_I7)W-Q'"A!;GU-;\EP+KPCIDRMN#8
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M9YGB%'#**W8HIJ[.A48K1B_U2?2L]:T(O]4GTJ.'E[\O3]3*J<GXM_X_X/\
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M_%/_ ""!_P!=1_(U>*=\-/T-8E#PS_Q[S_[X_E7C5TKJF0.1\O'0FO9?#/\
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MJB1O_!JPO+?Q?<SW*@*=/=!CU\R/_"O5O%/_ ""!_P!=1_(UQGPY0KX@N#@
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MAZ>&Y&H/WCFQ,G)>[L>W? M\Z-J*=U>//_C]=+>?\AN7_KM_6N0^ <ZS66M
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M:P2UMTP%'+'J:U H]* ,4HKY"<Y59<T]V9MMB;:YGQ;X/TWQ-:%;F("8#"2
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M7"?"TJVM3$LID^R,&'?[Z5W?BG_D$#_KJ/Y&M*BM@Y^C.F@K0*'AG_CVN/\
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M2K7_ *YBJWQ7<+XBOO;R_P#T6M;/AZ.SOO"5G,AS*(P&Q]*YZZO([5\*&L<
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M,KU)''55D<YXM_X_X/\ KE_4UJ:-_P @FW^A_F:R_%O_ !_P?]<OZFM31O\
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MQD[1BLY9RARI[\UH17(6/ /)&:<DS!GTMXE_X_8O^N?]374:3_R"+3_KDO\
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MUY\DT['2K-&O\/K&WM=<F>*)48VK D#MN6NM\4_\@@?]=1_(US?@=<:S,?\
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M[5K0PY 9<  [@/4"N:4S)RL=_P#".*./Q%<LH^=[-R2.GWTKT?Q3_P @@?\
M74?R-<!\+1_Q45P0H0&S;"C_ 'TKO_%/_(('_74?R-*L[X2?H_T-:3O$H>&?
M^/:?_?'\J^;9Y)O+VD;5_P!GO7TEX8_X]I_]\?RKY>N+A@G#<(?TK'!1O1B%
M57L12QF:^C@!RH&3_.NDT^,.Z8&"IYY[5SVFJ9+AI#U?@5U=E$(I@<AF4@$C
M]:Z*KZ&-1Z6-J$1LBE,;>Y Z5IVT1\G)/F=<$''-9ENT961ES\WW?8_2KR7<
M5NJ#+$[<8]#7')'-8N+"%*.1B7:.#W'K49F.-D<B[N6?CI]#5"74@[^7$0!C
M&\TL.J[V8&)1SM&1R?K4N.H6.EM8EE,9B.W*@MNXIRS12QF-3@*V=N>E<[#J
MK2*S1[EG4;<YX'O1)J4@& BACGYSTZ=J:30RW=723.T"Y55QG/IGM7 ^*[O?
M&5 Q\WYUOWNI$1%5(RPP3WQWKBM<N-X"@YP:VH0]XTIQ]XT]&N!+#Y;OM&.&
MQT-=&97D@0)AOE&YN,FO.[&Z>$\,1G^5=+87Y,>TL WKZBKJT^IO*.IUD4X@
MRH8.I4#)JZDNQMLF0W&<XYS7,P7"3*H\S:_<-_2M!)55_FR<CD$_K7+*!A*)
MTME(9'"*X4AC@GH16X;:"YB"#N.N<"N*BF*2H4)VKT4G//I6A'JH\DHJLAZE
M5Z9J%%)ZD'=>)?\ C]A_ZY_U-=1I/_((M/\ KDO\JY?Q+_Q^P_\ 7/\ J:ZC
M2?\ D$6G_7)?Y5M@?][J_P!=CTBY7A-[K%G_ ,)5K$8EVRQWTZE&[D2,.*]V
MKX\\;WFSQQX@4'!&I7 _\BM7?BJ$:\.21U8/$RP\^:)[9:WBO$K9'/7FM:*X
M!08-?,UMK&JQMBVO;A?8.2/RKK-)\0>()U*)K#MMZX13C]*^4Q&15*?O*HK?
M,]>&+C7=N6Q[@TR#EL<>]96HZ[86*LT]S''CG;G)_+K7"1_VG<)ONK^XD&.<
MMM'Y"G2VD(M'!C5FQG=CFN!8*"E:<K^G_!.E4VM;&?XG^(\]R6LM&@D!88\X
MCG\!6)H/AK4M:S?799RYX\W.6]S[>U+I%L[^)05P(T&'XSP>U>OZ/;0M:!$4
M*1V%>_*=/!TE&C&U^O4Y51E4DYU7HNG0Y^RT9[*&)%8!@?F"KQCTYK46W.W(
M%:[VV&.[G'&*:+8%P1P0*\+%5)-G>IQL9BPGZ^YJ0V;$\ 8Q^M:/V7G--?(R
M,$8KD;=KLKGOL9C60Q\R+GVJC=:-;SHP>)2#UXK=VLP[4W85;VHIU))Z,KF[
MGFVI>$S"Q>PFD@8<[58A3^%83S:G9R^3<S2D#ISP?I7KMS9"8Y48]17-:SH@
MGC88P>H('0U[F!S)W4*NIQXC#\RYJ;LSF;6]! #9S3?[-AUZ]ELYR5S'N1P.
M48'&?UJA+OM+@QR JR_K5_P]=AM=4^L9'ZBOI:=FTT>)4OKS;GT1IMJUC\.[
M&T=@S0:9%$6'0E8P,_I6;X:_X_9O^N?]16VISX-C/K8K_P"@"L3PU_Q^S?\
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MK3@A +!SFJQD9&!SFIA(K#YG.3Z4[ 1R1%B20#D=J8@"-PI) J03;6&.E!N
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MU)=3Z>@)/@>W)&#]@3/_ 'P*Q_#7_'[-_P!<_P"HKI=1C2'0KB*,81("JCT
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MN!A9E^61?HPYQ[=*XB7X):096:WU6^C0_P +!6/YX%=;:9BZ?8\HBNXU4E&
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M?L/_ %S_ *FNHTG_ )!%I_UR7^5<OXE_X_8?^N?]374:3_R"+3_KDO\ *N;
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MKJTUL<D\;"-9N#O%ER.X2.+<[ +C)+<8^M3;QG@_D:LQ>&2B8>\+-@\A"/\
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MM]5L[:":R\J[D=5+V[DIM0MSAQGICM5M]5BM+B&QN7,M\Z!]D$+'()QNQS@
M]<GC\:6^LI;C5-,N4*^7;22-)D\X,;*,?B:!92_\)$;_ .7R3:"'K\V[>3^6
M*1C::;MW_ 1=;LFN1"#+M,ODB;RF\LOG&W?C&<\?7CK3EUBU-\EH5G1W9D1I
M('5'9020&(P3@$^^.*R+'0);1TMI;43P1S^8DQOI ,!]ZDQ]-P...A(SQ21:
M-J<FHV<]V(W>WO'F><W#,70JX4*F,*,,O ]/QI79*G5TT+5MXGM98[^6XBGM
MX;2787DA<#'R]<C@Y;IZ<U,?$EAODCV7AFC 8PBTDW[3T;;C.W@\GZ=:I7.C
MW\D.K6B)"8KNX6XBE,A!!_=Y4KC_ &3SGTK4CLI5U^ZO25\J6UBB7GG<K.3_
M .A"C4$ZNWZ>O_ "36K-(;:1&EG^TQ^;$L$3.S)@'=@#@<CKZ@4V77K",6Q5
MY)3<Q&6%8HF=G48S@ ?[0Z_TK&A\/7EK:Z4VQ9Y;>S%K-&ET\/3!#*R]><\'
MU]JT[32GM]1L)TBCAA@M)8FC60OM9W1N"1DCY6Y-%V.,JKW5MAD_B6V1]-,$
M4\\-Z6PT<+L5 4GH!G.1@CMSZ5M*=R@X(R,\C%<W#H^H6=KI;Q)#-/9W,\CQ
MF0J&60OT..HW#MZUTBDE06&&QR,YQ315-S=^;^M!:***9J%%%% '*^+HR)K6
M7'!4K^7_ .NK6@2"32D4'E&*G\\_UJ[KUB;_ $QU09EC^=/?U'Y5S&AZ@+2Y
M,<K8BEQD_P!T]C7B8A>PQG.]I#.MHHHKL *@NDN7BQ:S1Q29^])&7&/H"/YU
M/10)JZ,+3=1O6T^XU'4+B!K> S!DBMRK?NV89SN/9>F.]61K=L;9;@0W&V1Q
M'"/*^:8D9&T=QC/)QT-0II%POAR_TXO%YUQ]HVG)VCS&8KGC_:&:74](DN[2
MQV>6TMHP;8[LJO\ *5(W#D=<@X[4',O:QCIV]=;E@:Q"UL)H[>ZD;>8S$D)+
MJPZ@]A^)[BJEUXAC2UM)[>WGD$UQY#IY?S(02""/7BH)-'NQ# (+:W1/-9[B
MV%TX63( !+[<G&.F,?E21Z%>6^FJD8MO/CO_ +6D88A,9^[G&1P3VH%*=9[+
M\"[<>(K.W:X5HKIC;@&;9"2(P5#9)Z=#]>#4MMK5I<SO"!+&5B\X-+&5#Q@\
ML">W3\ZK_P!E7+Q:WO,*R7Z 1@,2%/E!#DX]1^5$VC23S1!Y$$0TZ2S?:3NR
MQ3D<=,*?TH*YJR=[?AYO_@$T&OV=P056=8W1GBD>,A95 R=OX<]LBFVWB&RN
MI[>)$N%-RA>!GB*B4 9(4^N/_K50L- N+:%8)K:U9XH6C2Y$[DL2NT'81A>#
MSR?:ITT2Y5O#YWQ8TY"LW)^;]WM^7CGGUQ02IUK?\#S7Z7+6BZJVJV\LC6TL
M.R5T&]< @.RC'O@<^AK4K,T>TNK%+BWF6(P^=))%(CDL0[LV",<8SCJ:TZ#>
MES<BYMPHHHH- KC8A]NU]=N=LEQGC^[G_"M[6M16TM6B1OW\@P .JCUJGX5L
M2]P]ZX^6/Y4]V/7]/YUPUOWU>%*/1W8'6T445[H@HHHH *9+$LT+Q/G8ZE6V
ML5.#Z$<CZBGT4 <EH^G0GQ;K,+2731636[0(UU*0I9"QZMSDCOFK3>(Y[?2[
MW5+JWB6UMY9(41&)>1UE**<]%!_'UK6MM,AM=3OK]&D,M[Y?F!B-HV+@8X]/
MK3!HMF=+GTZ56EMYY))'#GG+N7.",8P3QW&!4V?0YU3G%6CIO_P"A;Z[,_VE
M)6LRT4(E$V]DB7G!#$CC'!SW]JHR>([NXT_7H(Q$MU8VOG1SH&564J3D \@C
M!]0:V)-%,]C+:7.I7DZN4*._E[HRC!E(PHR<@=<YQ38O#UNLU]-/<7-S)>P"
M"<RLO*@$<!0 .#VHU$XU7HG_ %K_ , @74=3$FGV2QVK7%Q;/,TK,VU0I0#C
MJ<[O:HK?7M0=+::>UMEA>\-E*$D);>&*;AQTW#IUQWK2M-(6VGMIWNKBXEMH
M7A1I=O*L5/.U1DC8/UI!HML+=(=\NU+PW@.1G>7+XZ=,D^^.]%F/EJ=_ZT_X
M)F/XFD,\SQ+ 8(;@PF'#&5PK;688X&"#@=P.HS4DNNWR">X6V@^R6]Z+9\N=
M[ LJ[AQ@8W ^_/2KZ:1Y%T\MM?74$4DOG/;IL*,Q.2>5)&3U /<T/HML]I<V
MQ>79<7(N7.1D,&5L#CIE119ARU7U*UG<ZA)XJU&W=XC:11PD+DY&0_([9.!G
MZ5MU1&FJNKMJ,=Q-&TB*DL0VE) N[:3D9!&X]".U7J:-8)I._=A1113+"LOQ
M#"9M%FVC)3#_ )'G],UJ4UT62-D<95@01ZBLZL/:0<.Z X[PU.$N982?OKD?
M4?\ ZZZ:N+N8)]'U3 SF-MR-V9?\\5U=E>Q7UN)8SS_$O=3Z5XV"FXIT9[H9
M9HHHKN *YS7M-M'U#3961M]Q>K'*1(PW+Y;G'!_V1^5='5:ZLHKN2V>0MFWE
M\Y,'^+:5Y_!C09U8<\;?UNOT,V2XO(-5CTG3DMTB2V$N^;<VT;B,8SS^8JM'
MXAN);W,:(UN+K[/Y8AD+X#["^[[H .3C'0=<\5MBRB&HF^^;S3%Y6,\;<Y_G
M4$>DQPW;30W%Q$CR&1X%<>6S'J<8R,]3@XH,G"I?1]?PZ&:^NSQ:G#$);6:"
M2Y\AEAC<E,YP3)]W.1R,#]*J_P!J:I8Z=KM]++!,MK,XC0HW! 7C.[[O/3UK
M4B\.VT31 7%T8H9A-%"9!L1LY],D<]R:=/X?MKA;^-IIUAO>98E8;=W W#C(
M/RCOCVH(=.LU>_X^7^95:_UO[?)9*M@)#!]H5R'(49(*D9^8YQSQ]*C?Q&\M
MMI?D!(IKVW^T,SQO(L:X'&U<$\MZCH:VC8Q&^^U_-YGD^3UXVYS5;^P[9;2S
M@BEGA:S39#-&PWA< $'(P0<#J.U!3A52=G_6G_!*$&L:E>SVEM!%!#+-#*[M
M,KX4HX7(7@D'.0#C@]:KS:EJEU%IABE@AF-_);3#:Q1B@D'3(.T[<X]<>E;L
M6FQQW<%RTLLDT,+0AG;.X,03GCK\HJ"30[9[<1+)-&RW+722(PW)(Q))&1C^
M(CD=#3!TZK6K_'T_X)IKG:-Q!..<4M(HVJ!DG QD]32TCJ"BBJ&IZG%80D9!
MF8?(G]3[5,YQ@N:0&!K\PFU-E7GRU"?CU/\ .NTLX3;V4$)ZI&JG\!7'Z#8O
MJ&IB>3)CC;>['NW8?G7;UGEL')SKO[6P,****]404444 %<YXCLE$EI<)=7T
M3SWL,4@BO)44J2 0%#8''H*Z.JM]8QWZP+(S*(9TG&WN5.0/I2:N9U8<T;%"
M:YN+"]L])L(1,9(9)?,N9V8J%9<Y)RQ^_P#R[56N/%*17LZ+]F,5O.(71IL3
M.<@,RKCH,]^N#T[[+V2/J<-\6;S(H7A"]B&*DGZ_(*KKI317LD]M>SP1S2"6
M6%0A5FX!/*DC( S@_D>:6I$HU/LOK^!0O_$$UAJ*1,EG)";A(76.<M*@<@!F
M&W Y(XS^-0'6-2M)_$=Q*D#VUA\R)O.>(E8#IT.<GW-7'\-HXDC-]<BW:Y^U
M"$!  _F"0Y.,D;O?O]*DNM!CN7U+_2IDBU"/9/&H7&=FS<"1D' 'Y469+C5?
M]>3_ . 0OJFKKJ,=B;*T$MQ$TL1\]L(%*@AOEY/S#I_]>HF\4 V>GL$MX+B[
M1V;[1-M2/80K<X^8Y( '&>3QBMA[%'U*"^+,)(8GB"]B&*DY_P"^!^=4ET".
M*WM5M[J>&:U+^7,NTG#G+*0000>.W8468W&JKV?]:?\ !*L/B*XNC:16UM \
MT[S1D^<?+!CQ\P8#)!!ST_QJ"[UG4IM*M9;>*&*X_M 6LP,AVY67:<''W3CZ
MX-;*Z9FXL[B:YEFFM1)AF"C=OZY  '';^M0R:%"]C);+/*C-=F[208RDA??P
M",$9XP>U%F)PJM;_ -:?\$TX]_E)YH428&X*<C/?'M3J;&K)$BNY=@ "Y !8
M^O'%.JCI"BBB@"O?1F;3[F->KQ,!]<5QF@3B+4PI_P"6BE/QZ_TKNZX'5K1]
M,U5M@VKN\R(^V<_H:\G,XN+A670#L:*JV%ZE]:K*GWNCK_=-6JUC)27-'884
M4450'.Z]I\'VJRE#7"M<7B1R;;F105(.1@-@=!TJQ--=6M_!I.G1Q;3 TOF3
MNS;0& QUR>OK6C=V,=ZUN9&<>1,LR[3U89Z^W-!LHSJ2WVYO-6(P@9^7!(/Y
M\"@P=-J3<=+M?\$Q'\2/]MD5%A:&*Y^SM'\WFM\P5F'; .>/0=13[C7IK;4H
MXB;66%[E;=EBWLR;C@$MC:#DC*UH)I(AO))[>[N(8Y)/-D@3:49NYY4D9[X(
MJL/#D("H;R[,"7 N4AW*%5P^_P#NY(SZDTS-QK=RBNJZG:+KUU+Y$L5K-A(\
MMD'9'@#T&#GZDU::_P!9&H_8/)L?-DA,R/O?:@! (/&2<D<C'>K%QH,-P]]F
MYN$BO1F6)2NW=@#<,C(.%'?'M5PV,9U%+[<_FI"80,\8)!_/Y10-4ZO=_?YO
M]+&(WB5Y+;3S&D,4UU"9G:8DI&!@$  9)R>.G J2+7+V[>SAMH(!+.)@S.S;
M08V4;AQD@YSCCK5L:!!';VD<%Q<PRVBE(ID8;MIZALC!' X([58335%S:W,M
MQ-+-;HZ*S[?FWD$YP!_=&,8I HUGN_ZT_P""8EQJVHW6GZ;-;^3#,]\;>92S
M%2RLR\8_A.T_I73H&V+OQOQSCIFLQ]"@-BMLD\\92X:Y212-R.6+<9&,?,1@
MCI6FBE(U4N7( !9L9/N<4&E*,TVYOL.HHHH-@K \3RCRH(NY8M^7_P"NMR66
M.&)I)&"HHR2>U<A=32:QJ@$2D[B$C'H/\\UQXVI:'LUNP.G\,QF/1D8_QNS?
MT_I16G;0+;6T4"?=C4*/?%%>M1I^SIQAV0B6BBBM0"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *YG7]":1VO+1,L>9(P.3[BNFHK&O0A7AR3 X
M:PUV:S413+YL8X&3AEK<AUNPF _?;#Z.,?\ UJNWFBV-\Y>6'$AZNAP3]?6L
MF?PBAYM[IAZ"1<_J*\SZOBZ.D;27X_U\QW+_ /:5E_S]1?\ ?0H_M*R_Y^HO
M^^A63_PB-Q_S]1?D:/\ A$;C_GYB_(TN?&?\^P-;^TK+_GZB_P"^A1_:5E_S
M]1?]]"LG_A$;C_GYB_(T?\(C<?\ /S%^1HY\9_S[ U?[2L?^?J+_ +Z%+_:5
ME_S]1?\ ?0K)_P"$1N/^?F+\C1_PB-Q_S\Q?D:.?&?\ /L#6_M*R_P"?J+_O
MH4?VE8_\_47_ 'T*R?\ A$;C_GYB_(T?\(C<?\_,7Y&CGQG_ #[ UO[3LO\
MGZB_[Z%']I67_/U%_P!]"LG_ (1&X_Y^8OR-'_"(W'_/S%^1HY\9_P ^P-;^
MTK'_ )^HO^^A1_:5E_S]1?\ ?0K)_P"$1N/^?F+\C1_PB-Q_S\Q?D:.?&?\
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M?F+\C1_PB-Q_S\Q?D:.?&?\ /L#6_M*R_P"?J+_OH4?VE9?\_47_ 'T*R?\
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M2BH\L5.#S6->2:FG^JO0GMY2FG"',[7%.JH:LW:*\HU?Q7XDL+G8NI?*2?\
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MGBZ:"QZ317G83QXTR1G7[)2YQQ"IQ_Y#J-_$'B&TO[NVFU(2M",#; @YP/\
M9IPQ-.>P6/2**\?_ .$V\1F'<+_!Y_Y8Q_\ Q-86H_$GQ5;+\FKJIZ\P1?\
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M^'K6>-MRMNP1[,1_2N?'-."9>#C)5&WV+U]_R#[G_KDW\C7S)$\AD4%7#9/
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M[3SVR.N:B7+NRHM]#F9/"?B/2/"/AF/2%MI=8TAG#H9,1LKJP8 G&>HJS?\
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MC&JJLFXV8HT^65T;FH';IMTQZ"%S^AKY9.K2C #-A.G-?4FJ G2;T#KY#_\
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M4J17LH.R"=A_LQL<?I7K374DUS';AAF0XSWQ7?6UI;Z?9JD"@!1@GN?K6?\
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M1GD+^&];CY:S"^JD@$5=L/ OB74T:2VLTV*<'+JN#79/'=3DM';S.F/X4/\
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MVO0C!;OYCW*#CFI7^UJ<J(W4=L\GCFEKYC%21&A;S(3&JX!#+P:A$MDTI/\
M&I[J>.]+#/=O#OEM0IQRF[GZ4W[3*8RSV+C(&5X)Z=ZEL$A)5M [R/<,C2*"
M,MC'IBG 1&V6**[*@-C>",GDU::"*8 R1*?9ATI&M(&.3&*?*PN5$M;G=E+Y
MC&0,' )-/$5XBJ%G5@J@#=U)[Y_2I'L87CC3#JL9RH1RO\J:+$IOQ<SY;IEL
M@4<K[?B%QX:\2W<E(WE&=B@D _4U&EQ>\;[50=N25?(SG&/RYIL=I=J]P3=E
ME?'E C[@&,_GS4J0W*PHIG#,&!9BO)7TIV;[AH(;JXBM$DDM6>7@,D?...M1
MMJ4B%LV-P0N!\JYR3CI],G\J>RW@D<JT>S^$&@+?&/DQ!R1QC@#N/>DV_,+(
ME:[6.#S9%=!G&"O/7TI1=Q%4;=@.VU<CJ:@2:[(.^S P< !P<C/6EBFFD*B2
MT\LY!P3G'7]>/UHYG<+$L[SK(OEQJZ[3N]<Y&/ZU$TTP)_T7)P._6IGC9YHW
M\PA4R2OKQCFHY8[IF8P2H,E<!AT'>F[L2(&N+C/_ !XDD]>?:E1UC3RUL6"*
M2<!1BGR)>B.+9+&9 ?GR.#3]UVJ@;$=MHR=V!NY_^M4V>^OW#$9HY5CWP%A*
MO(*9P/>D\RW8>7Y9PORCY< ?2@/>=3%'G!X#<$]AFE:6X"9\@,03D!NHQG^?
M%%_ZL!76YL)$V,NTN@+(1R!SU_6E=["15\SY<[@ 01WP?Y5*KSO(PDMDV9QG
M/48_^N::\A!#"RW$C)..1U./SJ7J.Q5@LK!DD'FO+EFD))Y&3G%/^QV31;C<
M2A68_-NP<DY]*G,_E?*MBQ8J"^Q1CGJ,]ZC,J>6C&Q;823C;T(. 3^M"2#4U
M:\1^,L8D\56@)P?L*XST_P!8]>W5XM\7Q_Q55H<?\N*_^AO76]B8;GCV6M+T
M$Y'S5KLZS;67G-0ZA;;X\E1['N#4&G2DDQYZ?PGK6\'ST^5F4UR5.8N[.*-A
MJ4+FEV&N6UM#KZ%?8?2D9/:K)7':@CCI0(HF/%.5:GV#TIRQ GI^E!!$JG/\
MJF1-^%D7/^T.HJ>.V)P:N+ H'%6D)NQ NG#&X<KZ@4_[.J<8JXJD'(-2 (W#
M+SZ]*TC$F[*.Q5&<4X;?2IGB _B'X\5$D,TTPAAC:1V. J#)-4E80NY5]*L:
M?H.K>)+E;73872,G$ET00D8^O<^PKM?#WPZ9F%SK# IC(@4G.?<_TKTBPLH+
M&W2"U@CBA7HJ# %4UH83J=$8'AOX>Z-HT6^Y@COKQL%YIHP1G'85?USP-H.N
MVOE3644+X^66! C+^7!K;+B,=:6.Z1\\CCWK-WW'&:V9\M:[H]QH.LW-E)N#
MPN5##C(['\JV_#'B+6([:Z1M3N'6WCWQ+).3M([ 9Z59^)%]%JGC"X%HF_RP
M$)7G<17/Z)I&H_;I+@P,ELN5<MP"".U%2K&G'FGHBHQ<W:)R>HW<][JDUS<N
M7FD<LQ/<UZ;X0O%;2E6(<CJ!7-OX;M%O&>1BP+9P*[32DLK"SVVL"HQ[]S7S
M&;XVE6I<D5?S/1PU&=.5V>H^'')M8PTH8XZ>E7M9UFVTJ-3,_P S?=0=37E=
MI<7DTZ/%=21;6R0K<$5JZE')=E)7DWLH[G)KHR7*G+!OGG9-]+W_ ,C'%55&
MH0ZI=KJ-]+.$VACP*J)&%J:.'L:G,0/I7UE*FH14%T/.<KNY6QBF;AFIW55'
M6H%4%LUH!)G XJ)Y#BI=HI"@JK BH22>AI'R1TJWL7%1/CVHL4BF,]UQ0V"N
M":GD VU5:I+L5?LT4<OF(@5SW%13(7Y).:N,1W%5IVXXS6<K%)&<T1,AYKW+
MX?KM\#Z</^NO_HQJ\2#$OQ7M_@'GP5I__;3_ -&-7-5V+-K4^-*O/^N#_P#H
M)KY0%PV*^KM4_P"03>?]<'_]!-?*0LYEC#R(RH>G&*XJTXQW @:1AEB<^U,#
M2.I\M2?<\"K!6$\.H_%JM16ZSP;;=E7;SM]:YG670#$GM9W8$L@]MV:OVLDR
MLD7()'-4Y9B)2C*0P.,5:MUF\T/R,]!WJ9SO'4#2@@\VX Y))KTKPSI%O/;J
MICC) RQ< _SKSJ*WO(W63;M![XQ70V&O2VA\@E@P_N]Z\G%J4_A M>*O#D2[
M-0L1L:/AHU  /O\ 6KV@:)J&J(D@"Q1X!#2'^E075[>31A40%&'()HCUW5(
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ML4 <A3UY[#I7I4,0N7V<HW73U,M+Z'0V.B6EA9HZ1[I&&6>0_P!*K&]DB<J
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MWU?X!8NAE(Z@_C0\4<N-Z*V/[PS6:\5F7W-;S1DMR=I&2/6K LL,&BN9D'/
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M]G9U\R&[;^ZI8Y Y&?Y4X07! 'V[MV4$FFJUK,H@,+*H;A2N!GFJD>GZ9#=
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MU3:#G"BN9U**2PU0*A)2?Y8QDX//2NC@U.,1LB2G8^-^1CD5S'BB[#7FG!7
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M/@'Q')?V\]MIEU& 06DNE$6T]^,Y(K*6)IT]W\BW#F.JDE#("> >]9\]SM)
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M[!AD%WS@=.*G'D.[( I; +#'.*0VD#1JAB0JN,#'3%5RLFY#'!+&(PMTSJH
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M1F16^ZEO@>H%1@(6(:UM^.<E016M'!>R@XJ8<C. \):)::- D]PX>;9D[SD
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M*G@X!./^^JB(L#^\,$RDD] ><'^IJXIO2[Y6$+@[<$YSSC]-OZU$'U0(W[B
ML/NC>0#2:?7\ABK/9F2)@KY^ZI.>*:OV,H'CCD97<J3SUJ0/J!#EH81@#: Q
MY..?U_E2E[XRRCR8U0#Y#NR6-'];"(1'82LH",Q<A@>?I_2H;>2PD+;3*%F5
M0(V!'OD?GS5Q'O?,VM!'LR<$-VQQQ]:BDGU",9%DK\\!7Z=/_KTG88P3V<MK
M%(_FH, A6R&YP<$?E^=*18'AF?+@-M9CTX(X_ 58\RY^SJWV<><>"N[@?C2Q
M/=F7:\,:Q\_,&YIH"]7-ZO>*FI20F0*0 <9]JZ2O#OB)=ZR/B'=0:<I:-8(B
M?3)%>E0^,Y:ZO$[PRQGHZFHS.%R,CBO*(]>UJVN?*N8RK+U K:M_%62L<P*G
MOQ7=J<+CV.PN;H>N:SV?>>3Q5"+4XK@C#YS4D]R(UXY)KGJUE Z*5%O4GEF2
M&(DD#%<?KOB;R=T%ODN1U':M"\D6?Y)9MH[@572RTE8R6Y/K7GSK.3UV/1A#
MD6AQ#W=Q(Y9F<D]3FD$\K?WOQKKY?[(C) %56FTWGI0I+L#5UN<PTTAXP:9Y
MCY^Z<UT#3Z=DXQ4;7%@M.Z$DUJ:2.9[6"XSMD9 21QSCFDBLC=0D^8V\-R<U
MG+JMND?EAB%!R*=!K45LQV$[6/(QUKP99;6;DX/T.Y8B%DF>@6?@FW>VLKII
MY9(W ,B,YVY_.N[T[2[.SMO)MX$C4K@X'6O&1\1;^QL&2W5)((V!VL,,!]?_
M *U:6A?$C7=8E5(H;:WA! 9G!=C].@_G7DK(LUQ5912YEVO8*E2%M&>L'48=
M.TN:2<-Y<"G=@=J\S@^(EU]OED;3LPEB457PP';/O4?C35;[[#;O<3O)$9-K
M+P!T] !Z5Q2:KELA>:]J/#WLX*EC;2:6ENB.?VK3;CU-OQ#>S^)=9:^\CR5V
M*BIG. /4]S44&FRC&:JPZHWI5]-2=L<5ZM*G&E35.&RT,GJ[LT8+)E4=.*O1
MVQQVK/BO7*U;2Y?'45HF"B6Q;\8)H^S#_)JN+AB>U.\Y_6JYAJ"+"V:D\M3C
M;(A'-5A.P/6D:9F/6INR^5HMF*(=A2;8AV%5MY--+'UIJ0<I;_=#H!07B]*J
M \TUADT^8E4T6FDC'85')+$%Z"JC!L\4TJ2*.8M0'O-$,Y J(W42C(45!)&3
MQBF>22.E2Y!RBR7Z _=%5WU)<$!32/:DFECT_<>:AR2!4S.GU ALA:A.L.G1
M<BK=SIYR0*SVT]LD]*7.BN1C)-8D)R!7OWPVF-Q\/],E;JWF_P#HUZ\ .GC'
M).:]_P#AK'Y7P_TQ/3S?_1KU=.:;,ZL+1N=1+_JG_P!TUARY55VAF4'G YK9
MO)&ALIY57<R1LP'J0*XY-<U3&9[/"M]T*N2/RK1R2,X,VDM9)Y,!QM[8%6AI
MK%>7&:Q(?$#*P#PRK]$(J['XIM@N'24?5#6:<1ROT+3:4^.&6H/['G)QE<=J
MF3Q'8OT9ORIP\0Z>QP)J5H]&2G(I#2KI6)_D:&L;P+QO_ UH#7+,DC?^E/76
M;-AGS1CL:5H]QWD8C07PX(D IC1WQ8C#G\*Z$:I:'_ELM"ZE:/TD'Y4VEW'S
M/L<T8;P#[C#\*8?M*#&TD_2NI_M&UVY,@_*A[VT"!F9=IYZ5/*NX<S['(HEX
M$,Y=CO.PJ1_6GM-)C!CX'H*ZQ9K20  I@\CBE\JU?!*I@&CD\PYO(Y$2<?,E
M/!A;[R?G74_8K1B?D4D^],;2;-S_ *O'T-+V;#G1SB):/]Y3GVQ3O*M&Z;@!
M[5MMH5J>5W*:C;04Q\LIS[BE[-AS(RC96S9(8FG+86S'&]?J15]M#EQ\LP)I
M@T2X_P">BXHY&A\R9372;:4X B^I%2C082?E$1QW(J<Z5=H?EP?^!4];6^CX
MV\=\'-'*^P716&AH%W*J9'I0VCL.PJZ%NP,&,X[<42F4[<H44=S183*#:6^"
M #CZU&=+)4?>([&M3SV7C!"CH,BF-=MLVX;CFE9 F9@TQU[-2/I[!.8QC/4Y
M-:BW3%CRX'OVI3=Y&-[$>^*5D48WV##!HXPK'ODFFRV3M@$*Q'J,ULFX4KL4
MD'KGN*47**A!&?<\TO9P[ S%6SF1?EV=.G2G&*\Z&,;?:2M8SQ*/EC7<3R:!
M-&,L8@3^/-0\/1>\4*R.?N=)CN48SP(Y(Z;B:S+GP?H<[9DTI6(Y^^?Y5V0N
M857YHN">0*=Y]I(6^5@"<4+#TD_=5A61FP7]U!$(D5%10%5=F  .U*;^X/WH
MT/\ P$_XU=5X 29$*CH%% ^R'DY%95<%0JJTXW*6FQ0-[(1_JAD^@-9U[:F]
M3YF,;=00.:Z-8K0@D')]Q3=MCOV;PSCK7-')\'%\R@#UW/-;[X>6&H737-Q,
MS2MU.SK17I@LK4C/FJ,]J*[E1BE9"LATXO"=T^F6]SCH4(R/SJTEI'<V*(\'
ME<Y"GDJ:O"EK?D74SYBA#ISP12QQW,F'!P6Y*]>0?QJ%+/4X6D*Z@)@SY421
M@;1QP,?C^=:M%'(N@7,R\N]0@MV>"Q%PXDP$#@93UHM-1N9E<SV$L+*P &=V
M[)QD8_.M+%&/K1ROHPNNQ4L]1AO"P0.K*2"KC!X)'Y<&K9Y!ZXHP :1NAXS[
M>M4KVU$S-DAA0JXNY8=Y)^8GG&1WZ5*(F**(KPGOS@D\8_PI7F+J%FLY,,""
M" 1C\#1%;V]QLE\F2,J, 'Y:BUWH5ZDJ+<*'_>))\ORC&.?<T@>X_=B2)6W,
M0Q4\*,9_'GBJS1V5BZQ&=T8@8RW4?Y-6-QD+/'=#:R_*IQ@=>: &RW$T4;8M
M"W) "]Q[TQ(;:0E#9;,#(.P8].*D,=VH&)%8^9GYACY<=/Y4U'U'"!XH3_>*
ML?3M1Z@,2:RM]Q\TH#\AW9'2D06L4RN+QEP<["^ >O;\:G)D9(Q+;AV8DD#H
MOYU%(8/,5I+-B?[VS.*3=MPL2L#(QDCN0$/  QC-)LNP05G1ASD%/;USZU#Y
MMH["'RGVR'?G&!G@?AU%-S8P2SH)W5R ' 8G;SQCTZT775@6MUTL$AV1-*#\
M@S@'ZU"EQJ.X![-.G)63(S[5-$L-L<><2>GSMZ\U*L\;MA9%)QG@YX_R:K?J
M(BEN9XK=7%LTLA."B$?GS41OY07S9387C@<GZ5=R,=1BE'/2F[O9@0K= JY:
M.1-@!.Y?;-1K?*T,THAE*Q?[/+< \>O6K5&W QCBG[PBNU_;IP[X.=N,'.?\
MBG37<$! ED5"<8!/7)Q_,@5(8D+;BH)]<?Y]::]O%*P9XU8CH2/?/\Z7O!H$
M4\4X8Q.' ."1ZUA2ZE9H9;F6VN8T'RE\C!.XC YZ\'].];JQ+"A$2JO<#WK'
M<:^( (_LHDY&7&1TX)Z=_3J*B?-V*B5EUC2&;8TETAR4W.C+T ;\,]OQJ]8B
MSOFD>VGG(0[3\QQG.[C^5,)UD,N^"VF7S/W@ QN7GID_3K[U8TO[65D%Y90V
M[?* 8F!#?*,G_OK/X8J8_P!:#>Q76*U,KG[?,"?E*E\<YS_4"M%+VUVQJLZ'
M</EYZ]JK1FY4YDL$W!L J1SZGK["I(3*7&^S"A255@1P,\?R%.+M_3!JY,U_
M:IG=.@QUYH%];, 1,AW' P>IJK/!'<*89]/+QY'((YQWII=H$\QM/XBY79@D
M<=AZ]:;FQ61<-_:ABIGC#;MN-W?TIR74$BLRR*0IPWL:I+&)#YG]GJ4X=2<;
MLD<Y_.I,2B([;)06/*[ASU.?SHYF%D3_ &ZU)XG0_C2"_M"H;SX\'H<]:A5%
M,.#8XY*A,CH.!WH:-O(4162!_N@-C"CW_,TU)A9&E7$7[6)\97L<^WS"D9S_
M ,!%=O7S?\6/$%]H_P 3;W[)*4_<PGIG^ 5Z%%VD858\T;'M_P#PC&DWCB>2
M!7R..*\P^(VDZ?I,["!E3<,[>XKE],^,&O6T/EF=&XXS&.*YG7_$M]KEZ]U=
MS%W;VP!6JFXN[>AS\ETE8NV.K-;3??.T'J35G4/$<\^$A)5?45RUH6EE /.:
MZ9-/\V ,$YKAQ$[NYZ-""43)DOYRQ_>,?QJ/[7<,,;F-:ATB0D82G_V-*HSM
MK#G1MR&+F4\DDTTF0=S71#1I?+R% HCT)Y.3_.G[4.5'.C>>>:E".W8UT/\
M8+ __7IRZ&VX?7UH]H'*CG?)D]*3RG]*ZV71 J\?SJ(:1Q]VG[0.5'.V]O-(
MWEQ@DR_)M]<UV>FZ VB)&?.8R/AG'& ?2I-"T=%OHYG7B,[ASWK<O5+G<WK6
ME.O.#O!V8G%;,CUSP]%K$,+_ &B4$#ALY /H1_6N(NM!O-/F*2H2H. XZ&O0
M[*ZVQ[">/>K<D45W!Y;KD=J<Y\[O<23/-K>QD('RFM2+3Y,<*:ZG^RDC^Z@Q
M5B&Q5>JBH<@NCG[>QD[J?RJ[':D=0?RK;$2)R0!43A<\5#;*6IGK;9YQ08L=
MJT%  Z5&Z@M5)CN4Q"3VI?)[8JX !1M^;--L+E3R".U'D5=*\9- 7GI1<5RF
M(/>GFV..:M%1Z5)CBE<=S.^ST"VS5TJ*01U-QHHO9@Y--2S&#FM)HSMJ(*12
M;&4OL*YJ2+3E9NN*MC:.33XY!GBLI,J)5.GPQ@Y&?PK/O;.(@;5Q6O*V>]4Y
MURHJ6RS"%BGF>M>S>"HQ%X1L448 \S_T8U>3%<35ZYX/X\*V7_ __0VK3#.\
MF88A>Z7=;<QZ#J,@X*VLI'X*:^>?^$BOQPMQ*O-?07B0E?"VKD=193$?]\&O
ME5M0N@/NN0?SKHJ-*USD3L=>OB?44'_'RQ ]>M3P>,]2A^[,<9S@L:XK^U'4
M ,C9]U%']I[6PT9&?5<5G?L/F/1(/'VH _?7'?)S5@^.+F5?+<1A<YX49..V
M:\_LG2\?A<<X'-7"AA4D!F.#QBF4F=FGC$[N8ESZ \5+_P )JBLQ:T3)&.!7
MGIO55\;?R-*]VCNI ('0\U-A\QWL7C"W^]Y&/QZU9_X2R!HQ@%1Z>E><M/&2
MJHV!33>[6*EC^%%@YCT@>*H1& KG&.<GI4;>*HS"P7,C8X )/->>1W3.K?O-
MWX4V*Z?+;)""#V[46#G/1I/&9B2!UC;>P52 ^-OKFM./Q9;J1F\E!/OFO*FN
MP[*Q;&._K2O=*W/F#/Y46#F/6AXJC++Y=\QYY+#M4W_"5'Y0+T, ?3%>/+<N
M4)5U].M.^U%\98KCN*5@YCVF+QI<(.)H)/8J15Y?&<YCSY%ONQ_?->$_VA<!
MS^\;V(.,U.FKWD(RL\@_&FF^XM.Q[>/&TH8*UK"Q/]V2IQXR))'V+(]5D%>&
MKXFO@?\ 7MQZ@583Q1? \NC'M\@I\T@T/;E\40-.LDEM<I@%?E.5_&IQXKM/
M,*M'*B^K+UKPU?&%XI*OY)8_],S_ $J;_A++G;\ZQ@^@W4G*7<$DSV^'Q3IK
MN$:<ACVV'BI5\2:83\]U&H[$UX/_ ,)3+E?E1><D@GFM&+QA!'N!@:13Z,.#
M^(H4I#Y4>WG6--*@FZAYZ;CBG+J.G.?^/BW/_ A7BX\6V$HS-#.'_O#:<4X>
M)=**_O9+B(Y^7,8.1^!JN=AR(]J$EF_0PGZ$4OEVK?PQG'TKQA?$NF@96^E3
MGO&U3_\ "26RK\FKHI_VMW^%'/Y#4%W/7OL=JW.WKZ&FG3K8D'G\Z\PA\12\
M&/6K?&.AEY/YXJ_!XDU!\HE_;O\ 5E_QHYEV#D\SOFTV%A@.PIO]DIVD/Y5R
M<6OZS@X2*4_[+#_&GGQ/JJ];-B1U"C-%X]@Y9=&=,=(Q]V09]Q41TF0#Y77\
M*YY/%]\@_?6<H/\ N'^52#QHS$;X9%]ME2W$.61LG2[@$E<'TYJ-M.N>3L.:
MHQ^-K=VV;6# \@C%3_\ "66X0N01SSCTI7CT"TB1K*[W$B(@?2JEU:SJOF31
M2*J\_(IR:L1^+()'+*"T?KCD5;3Q#9R("9![BC1CO(R88C/$LJ+)M89&[(/Y
M45JG4[9R661<?[M%3H5<VQ2T@I:V.<**** "BBB@ IK\H<G QU]*=4<Y @D)
MC:0!2=B]6]A1T JJMS@[+J-N/E!3_P"O2G[:H5@T3'/S+@CMVY]:A9[0+;B2
MWDC:11M&.4]C@\>E+&]K*0!<.K;3E"^.OJ*RUON63.96(+6ZN-PP3U ]?Y4U
MHXANDDM5P4RQ"Y/TQ226TJR1^7>F-!QL(!S^)H(O58,DL<@Q]UAC/O5>J_(!
M[7,,L3*6>/(ZX((J#; I=C?N-^  S\#GM5@M<[F'D1E>QW]>/IZU6D;:JO+I
M^^0#("*#@Y_R:3;ZB+<L@D@<PW"*5_CX8#'7(J)([HR+(+Q'3:,KL&"?6JRS
MP);S>;8RQ!1AP$R&W=<8ZT-<V$2M,!*F$]&X'TH<AI&A<-(D1:*,2/D87.*J
MF6Z$>YK!&<N!M5@>/4TV)K7&R.[=27QR_).<8H0%9Y0-05E*[55F&5;)YH<G
M_5A"232R3.)--W1J,;\@[N.PQ5A;6V,#'[/Y8=<,H&#CTX^@J!(KO>S#4 P*
M@8(''O\ K4Q^U>9N62-D )"CJQQQ23[@5Q+9&RP$=(>F,$'C@?RHE6QA<B6X
M=. 0"Y QP*F1[_YB\,)XX 8\^U1S27;+G^SXW?;D;G!P>PZ>M#LT! JV<8=!
MJ$A^8';O)QD\#_/8U=\DQ /+=O@,<DX Y.<?TJ'?MB#G3SN,@&Q0,_[WX5'-
M>>=M6;3YB@.XY&<87/X^E)<J_ICL6S(H:207J;6&%!(PIJ'9>(%1M0C+=R8P
M">_3/I5-KFR;YI--N -H/$9SS[4AOM-:)I7@N$C()9G1QCJ#UZ?_ %Z5QV-*
MX*QZ>R75PRAAL,B\'DX&,5C+-I0"^7K3QQI\Q7S ,A<J>O.,N/TK7N))6L(W
MM5#DE" WID>O?O5%_MC.2=&MV4'&3("=N><#'TIR:$@$UB?)D&KL%F3]V/,^
M_GN*;+>Z7;7<"S:M^]0@+&7[[6&2!]&//I0EQ>81SH,:LH^0"5<KQGT]:DNT
M<-#+'H\4TL@/F9QE/QQ[G\Z5^WZCL*M[9B))/[4(65"Z.YXQD<\_YYIHU&P@
M,@.LQMN V@R D9-5#=FX55?PS(5B;:%95^7KG Q["I[**">61O[!6W$8RK2(
MH+'KQQQS1S7_ *8[+^K$T5_97:Q"#5 X5OF*'.\]<''3BE6\MWCFF75,J-Y)
MV\(!][C_ &?ZU';+$B[DT0PL2=P 4>W;V%*%54<1:/A6W[EX&XGKV[T7?]7$
MTB5#Y6/-U8;>!\P"G./?IVIIN;=RI76DQV 9>>,_R(J-PDLY9M&9LL#N8#KT
MS^@I[V%E%)B+1XFVC:"$ X_+THO_ %J \R1,PCCU<#">7M!4G(ZGUSP?UJTM
MJ^6;[5(0PZ'I5.&)(Y&:/2$0Y+[@ ,DDY[=>3^=:4$KR1[I(O+/]TG)JHV?]
M,3+-?+'QO_Y*?>_]<(?_ $ 5]3U\L?&YA_PL^^'<0PC_ ,<%=L3,\_AW;AUJ
MU@D55ADPU7D(9:IR0M"SIZ_OT^M>EV,8^S $5YG;-Y<Z'T->E:9(9+8<=JYZ
MVNIO29>CA5AVI)HE"TL;$'FG2$$8K-01=R!4^7 IT2"E3GBI$0YI.([L0PYY
MH5 O&W\ZEY II)]*7*BE<1T!7I42Q>U2DGI2(?FJ9+49;M (D.*=<'<OK3(E
M)Z5;%HS+S2;L@2U*%FI\PBMVV3@9]*K06ZQ-DBK?F!5&*49ME2T1;")LY_E4
M$KJO2H#<,>]1NV[O6Z7<Q8DDI;I3.<4F,FI$7CFFT4U80=:",&I G%(X I("
M.G*,FFCBI%4G'%# 4#BEQ^%2+$6H:)A4<R*41FWWI#U]J=@@4T DX%-,JS&X
MYJ1%SVJ>*V9NHJ]!I$T[ )Q^%8SK0B[-ARM&8P 'K565N>E:E_I\UF2'''K6
M4RDDU49J6P[$?/;FGH#FI$BS5NWLS(V!43=M6.)5,+.A(&:JM&3D8KJ(K Q*
M<C.:I7-ND+[B!S4*2>QI;2YSJ6;-/R#7J?A=/+\.VB>F_P#]#-<(YC!W#&:[
MWPTV[P_:G_?_ /0S6^&BU-W.?$_ BWJ2"32[M#C#0N#G_=-<E#ICV4AC6QMY
M4'\14%3Q76ZF"=)O .I@?_T$UYW9R3S 11NQ&/FY/'UKCS6?*XKU.(MWEM8"
M(P+9VDP+!BQA7KZ"HM,\->'Y+A_.T>VD,P(8;.GT';\*T!8!-NXMS_$W%3(J
M6I8*<L.-ZDUX+Q,X2YK@>0^,?#<7A[Q#LT_/D./-B5C]WDAE_0?G4]E,+6Z2
M9XMT><%3W%=+XTTXR11ZEYA?R6VLIYX8BN:D53 4494C*^IKZ7 XCV]%3*6Y
MFZ]I BO#*L?EQR_.A'0J?2L233R%)#';FNF;49KNS2SG&XVP*HQZ[2<XJFT0
MVNG?&1FM[E6.:$%R25+;0. >N143VLP;Y9@?7(Q6I=1LLP93\N*AE48SZU1#
M('L;F%$D,J['7<& /KBI+>'=((OM(4N>I!K7@C$_AMW/S-;2@X[[6Q_4"H+'
M1KS5I/+LK225\@94<#ZGM6$ZJBG=V$)+I#PX+S\9[ 5!)9A5YF)'N/\ Z]>F
MZ5\-Y3:;=2O4#\$XR<#TS716?A/P_91A8[&*:4#!DE ?/YUY%?-U0^)W&DSP
MAE13M$\?T(P:?':W,B,\<1D7IN5217O=WX/T&]MV2?2K7YA]Y8PI'T(KS?5-
M&O/!4Y-JSRZ;,V0O.4]JO#YS3KKEC\0--'#>7,C<Q'/U(J-KATX='!_WZ[1M
M9B.,\@CI@&LRXN(YF)$49[\J.:[(8BH])Q"Y@"<D?+O+4>>0W+-GW6M$A7?F
M)5/^RN*7[!&P"@%5SG KH53R!LSS<*0#YO.>FVI?.0C[\?OG-=-9Z/HMT@22
MW>-]N"5<BK%KX'T^0/YUS(YSE"@Q@>AS6<L5&/Q($['&[\@D"/\ !A2JKMG]
MV>/[K UZ)'\++*[C#PW[QD_WD!_D:IWWPCO(86EMM1@N&!_U+*4W#ZGBLUCZ
M#=F[#N[7.'5V)V[7)[XJ17..#(/SKIY?A3K$<(F@GM_,ZF+S""OJ,]#BHW^'
M'B4(-I0$C.!.*T^MTNX79SXEV#+.?QH:X!7(E3'UJX?!?BU;DP-IERY'(<<K
M^=03^'_$MJK&?3[E<'O#G^E:>VI]QD/VABHQ@CU%2?:'!!VU2^PZI&V7MF8Y
M_BBP:8Z7D3?O+-B/]TBJYX]Q7-07LA8'+@>U..JW49R+F52/[KD5C--*.3:R
M*/8FH6ODY^1L^YJE)/8=SI$\1ZBI&V]N!@YSYIZU;B\4:E&V?MLA..I<FN,:
M8*!OE+Y[JI&*L1W2-_RT/'4L*=T'M&=LOC;5)#\\R.!V*#/\JL#QQ=#!:.V8
MCLR=:X0319!^T(":>SIT66-L^]&@U-G>3>.#=,':QM8MN,K$"JM]>:5_&L4N
M2NG1Q#=D^7(QR/3DUP0DR,9''H:<)65>A'XT#YCT%O&UBIVI:. !S^^[T5Y_
MYY'I12L'.?7@HIBR(Q(5U)'4 ]*?FM=#,**** "BBB@ J.4D(2&"^YJ2HI]G
MEG>NY>,C&>])[ 5MUZLJCRXWCZ%@<'KU_*GS2-%)E;8R9P,C&:INL#)'MNY8
MFR#@DY(';%3 *T:K#J R. 20<UE=_P!6+$D:*95>XM95;Y<X[<],@T6J6;%D
MMV=6*;>,@@ X_.K5N7V#=*D@(&&48S32UP&.(D9><8/-5Y_H(JQ);-)M6\FW
MI\GSOR2<'\>@J2X:=)<_;(HT. %91GU/]::99MR%M/R0W)X...HIT:VMY+('
MMB)4(+;U[XQU^AQ0O(?J/_TX.<&)DV\9X.[_  I83=[@)DBP<Y*?A_\ 7J%D
MMD89FE01D\9./Q/?I2I) 83#]L;<6)W$X/7^7-&SLV(?*N^0!K3<J,"K9&<C
M&"/UJNTD:19GT_:KAF;:H.,'C..Y'-31H$MQ#;7F7+EM[MN/7)'X4I%ZH2-9
MX6D'+;DQQ] :3 I-)I;[U,,B;3EOD([#_$4DBZ7*L19I8S*@=0&(.UN1G%73
M_: !(%NQR<+STSZ_2G3^:C1F.V21CP[9 VBEK_2&5XIM/CO@5N7\U@PPS$CG
M!_I5Z.[@E;:DH)ZXJO$));ETELHUB&2K'!).?\*@::<RN@TL_(V$<$ $9/(]
M.,4[M(&DS1$\3.R;QN7[PH>6*/EW5?\ >-452WO9=TUC*K$XS(N/ZU"\&E1$
MH;8G!(QL)Y/%-S=A6-8.A'WE/'8T%4=2KA2I'(/0UE1QZ?%#<2@LD49PQ(.
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MK YW!N3]3WHLPT$W7P7:T-N^>I#'&<^E$ N#<?Z1#$$(^4KU'I3CIV&W+<3
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MFZIYY>QMQ+(V_P Y<A]WUSC'X5YY/\+;G[0VV3;&.A.#7T[L7!'-7NL0*!M
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MSC=,5F0ZK#J6N6@ALH"Z$Y9S@#\ZQ'\&>( ,BVC(_P!B8$UZ>J^6@\Q"I(R
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M4IK9#YCL=:U79I<V& 8K@55\-ZLATF--_P RD@UP^HZL]TI3^$^]-TR^-NV
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MIUI8(9-C))IT2 %BN'&/0?B1BAEN% V:?"<=]PX_SS1K_5P&H)/,_P"0L'Y
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MUQC=P:]FO3C5H>Z;M<T6AGQ.M2+&.Z0<JP&1[UY6MVVX FO:?&RQW7AYP>>
M17BBP%I0H7)S@5]!P[4YL+RRZ,Y)S<6D>C^&6'V$$=:[[26SCZ=JX;PGIMP;
M<"1< FO4],T]((EXY(K63YJKC'5G36JQA2L]R["3L'!J.XU#[,.5XJ\J  55
MOX$D@8,!TKT)4JM&GSW/)@XN>J.=U/5C= 8&U5'0'K7+W<^=V35K47:TD()^
M4USE]?*L9.:Y(WK/GO>Y["C&G&T=CG-8E)O6 Z50&6-.NIO.N6-7=-T^2^E
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MC]%R#^0KT"BK4[;JY+C?8\OMOBVB?+?Z7(C \^6V,?@U:\'Q3\.2#,AO(?\
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MF<5I?PLU.\5)M0N5M$<<H/F?'\A6X?A!H.S$EU=N_P#>RH'Y8KTB1#M.>M0
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MM/Q!K)EO9'+>?'!*3_L[?Y8IBW$  S8Q<]U9A_6H]K?L:>RD;_\ :>E,0IA
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M7GE#$"1A6Y)H6M3;0-/N-@&?]6:Q[NRN;9V6>WDB8\?.I%>A&I2F]&OO1.Q
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MVY]117U*J0:NF2?9%%%%=P!1110 4444 %%%% !1110 4444 %%%% !1110
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MO#<+MFB21?1ES7FXG+XU=G9G33Q+CH]4<"B@]/TJ=$STKI;GP_:2C,.83G)
M^8'\#_3%9UQHMW;KNC E7OLZ_E_A7D5,KK0>JNO([*>)IRTO8HK%GIDU<CB
MA.5IL>8L++&58=CP:DOY4BA!20?,.@->?5PDD]"Y2N[(X[Q#;B0%U^\,UQWV
MME.,UVFJRJ4->?W#8G<]LFO8P.M.S"I+E+PO21UI?M1/>LI7._BK$9R.:[^1
M&'.V6))R>,U:TFS^U72EQE1R:S7Z5T^@J$MU8CDUSXF?LZ>A=-<S.A@5(T"#
M@5*WM5=9!VI_F?+7B0O)ZG8E8?NS7;:#_P @6W_X%_Z$:X-6%=WX?.=#MO\
M@7_H1KV<MC:JWY?Y')COX:]1OB;_ )%75_\ KRF_] -?,$9YKZ?\3?\ (J:Q
M_P!>,W_H!KY=CX->V>462,BJ5PG6KJG-13ID'B@# G&#4 DQ5V[0C-9;DJ:8
MBV)>.M*K@]35,,:E0DD4 :, R:U8ATK-M%[UJH,"ID[#2"4X2LR498FKUP_R
MFLR>941B?2O-JN\K(ZHZ(JA?,N=O85MK;!(E*CM6-IREI#*W2N@\U#$ .N*B
MM[J2*AJ5,D'&*R-=DVQJ@[UM, 6S7-:Y)ONE4= *G"J]0*KM$S@H YINP4]!
MO8*3@>M:44]A;@1M#YK$?>KV4CBN,T?6-4T.Z^U:5?W-I*.2T,A7..Q'0CV/
M%>F:)\>_$EE(O]K6UKJ4/1L+Y,GU!''X8_&O-Q;Y4RHN(SVJNZA5)%-H#ZHT
M+XN^#M;C0G4A8SL/FBO%,>/^!_=/YUV\%S!=P+-;31S1.,J\;!E/T(KX4$Y0
MD9X)Y%;&D>+=<\/$?V/K%W:J6W&..4["?4J?E/XBI&?9EYIUG?C%S DA P&(
MPP^A'(KG;WP-;O&38W#Q.>JR'<I_J/UKQWP[^T%K&G((=?L(]20D;9XF$,@^
MHQM/Z5ZEX:^,'A'Q(3&+W^SIP,^5J!6+/T;)4_3.?:HE3A+=#4FMC+NO#FL6
MDCDVKLJG"O <AA]!T_*JT5_J-L1&+F0 'YD(!Q]:]5@FAN8DE@D22-AE71@P
M(]B*KW>DV%[N-Q:QNS#!;&"1]1S7'4R^E/=)_(M5.YYA-J5ZV2);=C_MJ1_*
MH5U"ZD8'R<@=61@<5V-[X#@9B]E<M'G^"3)Q]#7.7WA;4K.8EX,6X'^LCS)D
M_3&17G3R>A_(6K2,>^FDD5\1OGW7O7+:D[-;R;E8?*>HKO/+N+=#"DA)&&Y'
M&??_  ISZ>M[& Z1R2J?F4@8Q6=/+84W>+$Z1X3).2<$X]*T_!]ZMKXHM)G9
M5"L>3TZ5ZI>^'-"N;AL:9;HG9%).*H/X!T1W\^%'MRO(V/D_E7?."E3<.Z)=
M,[VRUJ!F4(P;/<5M7,ZM;;@WS=J\_M=+FL]H2[! Z!Q@UK'5)DA$<BL3CJO-
M?%U\LQ-&ZA&\7_5RDVE8DFD8SG;G.*Q+I"TC,W!S6I:W<#L6>55)XPWRG]:H
MZN\8!:-PP[XKFI4YPERN+(<7:YGRXV8'6LXJQEP 23T&*?)<8!.:ZCP1IPNI
M)-0F3=&ORQ;AGGN:[H1<%=DQ5W8I+\-?[4C2ZO)!%*RCY<<X]_>BO3 !CFBN
MJ-:HE:YMR1-&BBBONC **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *S]3T/3-83;?6<<IQ@.1AA]&'-:%%-2<7=":3
M5F<!JOPPM95+Z5>/;R8/R3#>I/U'(_6N(U;P7XCTA/-:R-Q&#R]O^\'Y#D#W
MQBO=J*[:>85H;N_J<M3!4I]+'R])=,'^88(ZBHFO20><_2OI34_#VD:S$\>H
M:=;S[Q@NR ./HPY'X&O/]5^"UC.7?3-4GMVQ\J3H)%SZ9&"/U_&NZ&:0?Q*Q
MS2P#7PGDTEWD8STJ%KS(P#6UJ_PY\7:23G2I+M,XWVG[T'Z ?-^8%<9).RLR
MNI#*<%3U!K7ZW%K1F?U9K=&B;DALY-1O> =ZRVN,D^HICW!VUG+$^9:HF@UW
MD]<5 ]R>@_.J!DS3"V>]<\L0S:-)(^W:^>?BG/=1_$"_$8!0+%CC_IFM?0U>
M;^+5L'\17 N&AWA4X903]T5Y5F]CT$TMSQVWU*8C]XG)]1Q3I-5:-6'EY)XX
M%>@MIVE2#K;$'_9%,.@Z7+QB#\*7LY Y0['FLMX\I^4$KCH15!D^8DC!->K2
M>$-+E7*.5;T5ABJDO@BWD'!D_ BFZ<T.,X'F8 #9(JQ:9$RR_P!T]J[B3P'C
MD32>P*@U!'X,N8VW>9@=ODI<E0OG@UN9L,Q495B>:O6UXL;.TC@#%+/X4OMF
M%?D=,#%!\*:KL5"$D/MUJU[1+4YY4Z?<M+?*RAE8;2.M1F^4$EC^E9MWH.KV
MQ"O;.OIMJK_9NIIUMYR/7;FAU&MR/8I_";,]\#A5."?6HH=BS?*PP!6'(EQY
MNTA]P/(VFG%IT(7#!L\C'-+V\0]@^QTRW8#8)%9]_>PQY+'GM6/+<2H'X.1T
MK->_F9?+DC+C/&30JJ>PU1?4OSZRLLJX4XZ<UIZ??,EE='S0-R#RUX_&N=1L
MABD0R1U8=*D4;R#+\O..> *QQ$%4@XLZ*+4))H[37YL^$U8GE@O/Y5FIKJ)H
M8@R3)G: /3UJ;6I(?["L[8L#O8< YXK+N=,L8F*JZ[.H<&OFJ-*')RS3W9ZT
MY/=,I71,C+O?=(>":U[?0+"[MT-U'ODQ@G<:R;*S@-T_S^8N.!GI6Q8W$D8V
M;&*CH16V)J24;0=F91C?=%H>$M*M)%NK8R),F< ON!X]ZTX68*N7Y/0U3^WQ
ML-N\ GUJ"\N2WEK&PRIYYKIRC$XB53DJ.Z./&T8*-UN;*-C&#BM[3_%FLZ>B
MHMSYT2]$E&_\,]1^=<6+PQ]1G-78KP&/#_*WH*^CT9Y3<EL>EZ=\0K:0;-1M
MGB?L\/S*?J#R/UKJ+#5K'4U)M+E)"!DKT8?4'FO#Q*Q^;%2K<;#N5B&Z@@]*
METUT+C6DMSW66*.9"DB*ZGL165=>'+2=3Y320MCC!R!^!_QKSG3/%^I:?+LC
MNC,H_P"6<Y+#_$?A73V/Q%MW<)?VK1#H9(CN /N.N/SKGJX:$_CBF=%/$6V=
MC.UCPCK(0M!''<* 3B-\$?@<9_"O,+^&>WNGBN(GBD!P4=<$?A7T/9:YIFHL
M%M+V&1ST3.&_(\U9NK*UO8_+N[:&=/[LL8<?D:P6%C#X=#J^LRDK2U/FB,8J
MPC#%>OZG\+]%O)'EM))K)VZ*F&C!]=IY_6N,U;X;:YI\A-FJZA!UWQD*P^JD
M_P LU+I212JQ9R+.2<5TFES 6Z#VKF[NUO+"X,-Y;36\G99D*G]:T;"?;$IS
MP.]<6+IN4+'32DDSK(9JLELBL2";*]:NQS<<FO)4'%G;<L&0KTKT+PRV_P /
M6K'OO_\ 0S7G.58?>KT3POQX<M/^!_\ H;5ZN7.]1^ARXY_NEZC_ !-_R*FL
M?]>,W_H!KY:0\U]2^)_^13UG_KQG_P#0#7RPIP:]D\DN1GI3W&Y35:-N15I6
M!'- &;=1=?I6'<Q;6KJ+B/(_"L6[B[T7 RAUJQ",L*KMD2&KEJN2*8C6M4P!
M5X<+4%NN%J9^%K&K*R-((J7+\$5BWSYVJ._%:<S9)K+(\^^1!T!KBIKFF;2T
M-"UB\N!5 YJXH('(Q38U"2]:L'!%8XB5Y%TT1,=L98]JXZ_E\V\=O?%=1J$G
ME6<K>V!7'-DL3ZFM\%'>1%=]"Q BE"S'I38BHFWL,C-1@D#&<4S)!XKTKG*;
M*ZH'C*%,>@Q6?)<%U.!BJI8DBGX8^M%QD9Z9[TT<?6I'0XR1Q3 M("25]T2@
MCI3(F(?BG/T%18.>.M '1:'XIUWPS>?:-)U":U?!RJME&_WE((/XBO2-"_:%
MURTE6/6["VOX<C=)"/)E'\U/TP/K7CT<FTX<$FI^#C:GZ4P/JK1?C-X,UJ18
M1J1L9FX"WR>4/Q;E1^+5WT;JZ*ZL&5AD%3D$>HKX491N^9<&M/2/$&N:#*DN
MDZM=VA0_=CD.W\5Z$?44@/L^[TNROAF>!68<AQPP_$<UAW_A&.5"UE.8WZXD
M&X'\>H_6O&='_:$UJT6&+5]+M;Y5P))828I&]\<J3] !7I^@_&+P7K<:[]4&
MGSDX,-[^[(/^]RN/QJ)4XRW0U)H@O] O[-5D:V:1 >?).['O]*HJ7*OYD<87
MJ"1\P%>H1S13Q)+#(DD;C*NIR"/8U7NM.L[L$36\;$_Q8PWY]:Q=#^5EJIW/
M.UV' B0X/.?2J=P62;Y& ..0H KN;KPK'(O^C7#1X'",,C\ZY74?#>JQ,^;5
MI%/1XOF_^O6<J<EN:*:9DR7HMX_-DE( .!DTAEBG;S'@CDW<[BM-EMQM\N10
MP'4$=Z15V+M7  Z 5SN">Z+20[['IL_,ELZGTC;_ !K:T_4WT^U2TL)56&/H
MDT>?U%8P9@.U*&)Z]*SEAZ4E9Q'RQ.R37I]@\V* MZAR**Y)6PO#45D\OP_8
M+(]>HHHKWCC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "L;6/">@:_DZII-K<N>/,9,/_ -]#
M!_6MFBB]@/']=^ ]A<RO-H>I/9YY%O.ID0'T#9R!]=U>:^(_A;XJ\.ON>P:^
M@//G6(:51]1C(_$8]Z^JJ*T562(=-,^(I%:-RC*58<$$8/Y4S..:^Q]>\*:'
MXGA6+6-.AN=OW7.5=?HPP1^=>;>(O@)IUQ \GA^_EM;CJ(;IM\1]MP&Y?_'J
MOVJ>Y'L['L5>7^,DA_X2:Y,D88E4Y_X"*]0KSCQ?9"X\03-OVG:O_H(K.%KZ
MFK;6QROV6(G@#'UIZV28X8Y]J?*%MQM*L_N!TJ$7JJ>4D ]=N:O2XN:;)TMF
M7.&?\ZL+&_\ SU8?\"J"/58%X.2/=2*E&H6;L K%3Z]1518KM=!\\4\<>Y+M
MF/IG.*@CEOE.?M#5:C4W$I$1#9]/2IWL+A%W>1)CV%5<ES12%U>CDR@_45:F
MOKB)(I JG(YXJ&2-U4Y5A]13I/GTX,.=K8Q3!R789-J<\J!VA5P/45'%J0)
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MP!]Q3TD@88+Q_C1>VZ)Y9/J($M6P3'(/HU#1PL1M>5?KS5E%C(X9/SJ18U/
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M?:K=M([HT*<ENU4YH)8)"DJ,C#L10P)0V>I-%0 -CBBE<#[PHHHJ1A111F@
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M]$SO?^%W:A_T!K7_ +^M1_PN[4/^@-:_]_6KD/\ A7_BO_H"7/Z?XT?\*_\
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M[^M7(?\ "O\ Q7_T!+G]/\:/^%?^*_\ H"7/Z?XT>PP?E]X<]4Z__A=VH?\
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M_P#/SIW_ '\?_P")H_X4SXC_ .?G3O\ OX__ ,31?!>06K^97/Q>\4_W[/\
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MR?\ 6-65:W+H72;YM1_C'_D2->_[!UQ_Z*:OC4M]P9^ZF*^R_&'_ ")6N_\
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MK>9U[[&?L(&[1117T!R!69XA_P"1;U3_ *])?_0#6G69XA_Y%O5/^O27_P!
M-5#XD*6S/E6O9?AE_P DUUW_ 'YO_10KQJO9?AE_R377?]^;_P!%"O=QW\'Y
MHX:/QGC5=[X&^'MOXNTF>\EU"6W,4QBVI&&SP#GK[UP5>Y?!?_D5[S_K[/\
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M ,!8?\:/^%E^"_\ H63_ . L/^->7_V%K'_0*OO_  '?_"C^PM8_Z!5]_P"
M[_X5[?U6AW?W_P#!.+VL^WX'J'_"R_!?_0LG_P !8?\ &C_A9?@O_H63_P"
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M6_\ 'II?_85M/_1JT =!1110 5FW2J;ML]>*TJQM0+"];'3 J*FQK1^(L*%
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M(K'3I5@$UG=HJQJ/+;E79 RY;Y1G/%1C:&^4Y%4=W2IDDXJ92N-(U+=JTX)
M,#/!K!AFQSBK\5STKGEHRCH/N)\R_*>F.U,CD2&<.I&#U%16[K' )KE]B9X
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MLPS@WJ<\TT(V-QSE?:BGDACEA^E%=3IJY!K4445](<@=JXKXH?\ (J1?]?\
M;_\ H8KM>U<5\4/^14B_Z_[?_P!#%14^%^@I?"S$^'H!\02GO]G;_P!"6MOX
MD?\ ()L_^OC_ -E-<UX&N!!XHA4_\MHWC_'&?Z5UWC^U:X\/"5?^6$RN1['*
M_P!:X:>N&DCFCK29YG;H)+J&-ONO(JGZ$UZA_P ('H1ZPS?]_FKRV*3RIHY
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M5L070"D-&#D]37)6-TQ51G&*V;>XXX/)KS'H:6-M)T1" 23CIFHFE)^;:<=
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MS4,C\YSUH;NBU$A>7:3Q59V+'-2.-Y/--"!1ZTE*Q7*1*,$YJ*[OOLCP2%L
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M;SA!GK43JNY*AT1']G<#A@*#:RKC#*?H:3[0SM\U2K(".34>W9HJ9$\=VR;
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MJY;[%;3#+P)N[$#%=EH42P:-!&O1=V/^^C75A*BG)V.;%*T%ZBZ[_P B_J7
M/^BR\'_=->!I'$5+R2"-2<*%]:]\UX@>'M2+#(%K+D?\ -> M<V\@(, 51T
M/W:SQZ7,KF%'9C6)4\@T!C33,ACP>23D'OBF!LFO+E;H=*+2N=N.U3PR@/@C
MBJ(? ZU(L@Z]*AE&S&5\I<'J>E8]R1!J!&<!N15N"0[1@UF:P^PI+G)4U&[L
M4D=+I]SD9SQ706UR>/3UKAK"]!0'/ZUT%I>=.>U8R7*]0:N=;'/'LR3R:?YG
M'('-9,$H.#FK1E)%92D)(L^9DCGFD=A^-0Y]Z"<BLV[%J-QKN*IW#$&KWE-*
MP51DU*=#GF ^=%/OS3BY/8=DMRG::@(74.P ;BNC@NE:-2",5S\_@ZXND54U
M'RRK;MPCK8L]'EM(@DET92.^S%:^RFM41*<'H:'VL!<<9J'[5U.!D^E->W["
M3GZ57>)TZ'/TI2J5-F0HQ'O<$Y[5 )0<DG-1/(0,'J:A9\#BL92?4U44:MOL
M> A@"#P0:EMHK:TC,4$4<0Z_(N*S;24YVD_+5[:6&<TXU9+1$R@@ED:1BHYQ
MWI$@_><#DU8AC4IG&6[U/Y8CC#8^;UKIA1<US&3E;0J%-HP.::ZC;S4K90<B
MHI&_=U#TT&M3/GC#9/0BLBZDDMCEURI_B'2M:X9L<'&35"XP1L(!!/(-+EN,
MS#=KUZ"MO3]/:)5GEC5Y7&51NBCU^M<_<6(^TQ&%CY9D =>Z#U^E=JLJD C'
MH*AVB]2K%D82-4P!GH13EB.#GMZTR-P0-ZYQTJW(1Y7R#+,< UUTH*HKHRG)
MQ*K*I./Y4QE X'6G%MA([]#4+R;<UE)I M2%_E)&:K2?,,'CW%2R-R35>1A4
M)IE)M%-TD#<'(HJ8^QHI^S1?.)FC--S1FL;'FW%S6IIFM266(I<R0>G=?I_A
M63FC-;4:LZ,N>F[,5ST"&:.XB$D3AT/0BI*X6QU&>PEWQ-E3]Y#T-=?8:C!J
M$6Z,X<?>0GD5]1@\?#$+E>DNW^0BW1117> 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YAXX
MN_+\4>69&11&AX/UKT^O'?B4<>+-H<!FMT/7'J/Z4TTGJ3-71''K;*JJ&R0/
MO$T3^)3;0C=&920?NCO7*B5@V #CUSQ4RRY4,>G?T-:2=T1%RCLSMH?$T)B6
M21  5!/;%63XMLX9(T*L2_' R!7G\E\K HR!5!QG=UIT%Y$^=DF&4XP:YI4H
M2W1HL1574]4@\2Z:NHM:-,!C/[TC"G'IFMR#5K%NEQ&0.O->-K>JZ ,V['3/
M:A=2=6P)  >/QIQP\.A3KM_$CVF9+/5+0R0R*PYPXKFS"5;:W3UKCK?7KJ"/
M:L[!<\ 'BKZ^*9%'[Q!)]1T^E3/#MOW2J>*4'J=*& X7]:F0FN>A\2P.P5K8
MY"\D-5M-=M&"\NI/9JPEAI]$=L<;1EN=%$21P,U/M(..AK&M=2@D8B.=6?TS
M_2KT5\FY7\Q22>F:R4&M&@<XO5,T1;LR'*G&.M5'=HGVGK4IU)GRH( ]JJ3R
MK(A8.I*]2#45H)[;BIIMZDWVDD$=16+-:NUTY0JJ9R#4DET<<'%1I.7[US.3
MB="A;8LQ6A !$S ^U6UA!Y,C&JB.0.N15J/#%5&3N.![5A[2JW9"DK$)T>TD
M<M@AN^*KW.@L\;&"9E(Z*PX/XUM%'A4,VT\XX-3P 38VG!^M:0E44N5HR]JX
MZH\ZNK:>SEV3(1[]JB$VWV%=]JUO$\9BE16R.*X'4+*2RF"EMR'[K5K?6S.R
MC4YXW+=O."1R*V5G2*T+K<,&'\ .*Y*.4@]<5<CN5*D$@GWYK:G)1N7*',:E
MR;>_3]YP1T;^*N<NE:"8QR=!T/J*NB4HQ(/%0ZAB>U+#EDYS6-]16T*:3 'C
MI5F.?!%8 N2'(_*K$-PS$  L<]JKE9.G4Z>*^"*04!/K5@ZDQ4K'\H/49K#"
MW# 'RWX]J?O8?>5A]10XNQ+C$W(;W.!FI!=$G;U)K"AEPPYZ&KT<Z@Y/6L'"
MS*C&Y:N;66Y4;6"D'O3H].E2(?."?8TS[:J '-6$O@R#/?WJD79I:%:57AX<
M$?K3HYPH.>]:]O!!=+AF"XZY/!/I6?J&GPPL# Y.[^$]C6CA>-V1[1-\K+:7
M<(A10K;_ .(D]*ZW1W$FE0L#D'=_Z$:\W$NT\GIQ7H/AMQ)H%LPZ'?\ ^AFN
MG"/W[>1Q8N*4-.X[Q%_R+.J_]><W_H!KYQ#5](:^H;P[J:GH;64?^.&OGUM,
M4*"&*UCF/QQ,*#T94!IX;BE:SE49#!A55V,1(<%3[UYIT7+6[WI5D]ZHFX [
MTQKL#O2<6QFU'<!<<]*KO'-J%QLAB+C&#Z5!81F\D^;(3^==IIEO'#&JHH"U
ME)\C+YM# T;PGJ[,_FB*&,'@D[C77VWA-D )OFSC_GG6M8(< 8SFM6,J#@XX
M]:F4N?5HCF,/^R+BW'$H<?3%,*S19\Q2!Z]:Z;:&3!YJG-&,<C@]JYVD5&7<
MQTE#'@\5*'R0.^>GK3;JR*JTEN.>I2LNRU R7T<(!WD_,/2L91=S>,DSJ!%+
M# @@ ::3AB?X16I:V[V\&9',CGOZ54@!,RM[5J)(0 "*[*#BU9G/5NB2&)L9
M-$@QD$BIPP(&/2JLC9&/XJ]"I",8JQRIW9#(O4\5493R2>?2K+-M'-5)9!S7
MFS:-T5945P1G!]16-?O-9@N 7B'5O2M=V S@U5:12&# ,C<$'O6=DS5,KZ+=
M&\$KH 41@":Z*/I[5A:5:0Z89U@XAF<2!?[IK>5Q@$=*R:LRGJB>)MC9JS*5
M,=43)QP::9G((!XKKI8CDCRF$H7))7W#L2.U5)FP.OX5+YW/055E;JV.:B4E
M+5#2L59LE6/0#I6'Y\\LS&6+RU7H<YS6Q.S-QQ5"8C&.!3190\\QR%AW[UNZ
M?>"8#G\*YRZ;D<<9Z5-8W+1-D=ZF:NBHG<1ME<CI5N*3Y=O&.M<WIVIB4^66
M&<XZUJB3'(I4JGLV1.%R>;[QJG(<$]Z>TO\ %N):H'F 0C )HG-2=R%&Q$^2
M.M5W8<X-/9_E;)Y["J;R8![4DQCO-QP2**IL^6SFBKN%B]FC--S1FHL><+FC
M--S1FG8!<U)#/);S++$Y1U.0146:2FKIW0'8Z7KT5YB&?$<__CK?3W]JV*\V
MK=TSQ%);[8;O,D70/_$O^->[@\S^Q7^__/\ S"YUE%,BECFC$D3JZ'H5.13Z
M]E-/5 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<%U#Y&=IQ4NC2GT']9K1=N8[ZUO@\0,C!3^E71<$#AO;(-<'<:G'(D6%\IE
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M!/8$U7D^%RM@1:@JCW4GG\Z[@.%I5G&[ )J55E<B5)/H>4ZC\-M8MG)@/VI
MN<QC&?PK"NO#&MV2$RV$NT<_<-?0<;F2V&W!YYIZ?=VM@Y%;.<M+'.XK4^8R
MLH<Y!7!P0?Y4AN&"G!R?2O>=?\$6^J8FMX$&X'>.F:Y"T\ :8LA-P7(' 4-B
MM'-QW)5-2^%GF:W'S<\U,MR5[D#V-=[JGP\LY$+Z>SH_]QFR*PT^'6L3%A&T
M0 Z;FZ_I2]O'N#H,P6OA(@#KD<\CK45K<"V<F, 9Z_2MF[\!Z_;1G%F)>?\
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M3$28O)D8(7<XV^F<5A+!V>C.B.-2U:-EIF)SVI!<%363;ZB]_(;>VC,DAR"
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M8;D'\0_K4-A.;Z^2)7!7JV/2NHNM-.T@'>IX(/<5SMGI:Z5KWG*"L,J8(/\
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MJW.*TEF<@ L !Z55,03@BE 7'2NA55+8ZH3C/8N_;#",JWTS4UO?^9(JRO\
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MK+T_[ZZ?GBNV&(A+R-HU8LWJ*165U#(P92,@@Y!I:V- HHHH **** "BBB@
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M-,)+WM34A<U?B<@=<UE1N,8[U<CDP,9KSY(]).YH>;GWKUCP8<^$[(_]=/\
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MES3,T9JT2/S13,T50'?9I,T45\H>H&:3-%%.P!FDS113$&:3-%%, S29HHH
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?*8!1110 E%%%580E%%% "4444Q!1115(04444P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>62
<FILENAME>safo-20201231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SAFO 20201231 S%2D1 DFN.xfr; Date: 2021%2D03%2D16T18:23:22Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:SAFO="http://save-food.org/20201231">
    <link:schemaRef xlink:href="safo-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ProceedsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:ProceedsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ProceedsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:ProceedsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ProceedsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:ProceedsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TotalCompanysStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:TotalCompanysStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TotalCompanysStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:TotalCompanysStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TotalCompanysStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:TotalCompanysStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-31_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-01to2019-02-28_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-01to2019-03-31_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-28to2019-01-03_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-28</xbrli:startDate>
        <xbrli:endDate>2019-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:MrDanSztubelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-29to2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:MrDanSztubelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-29</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_SalariesAndFeesToOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:SalariesAndFeesToOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ResearchAndDevelopmentExpenseMember_custom_SalariesAndFeesToOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:SalariesAndFeesToOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-01to2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PrepaidExpensesAndAdvancesToVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:PrepaidExpensesAndAdvancesToVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrepaidExpensesAndAdvancesToVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:PrepaidExpensesAndAdvancesToVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_GovernmentInstitutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:GovernmentInstitutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_GovernmentInstitutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:GovernmentInstitutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_RightOfUseLiabilityArisingFromOperatingLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:RightOfUseLiabilityArisingFromOperatingLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RightOfUseLiabilityArisingFromOperatingLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:RightOfUseLiabilityArisingFromOperatingLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ReceivablesFromSaleOfSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:ReceivablesFromSaleOfSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ReceivablesFromSaleOfSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:ReceivablesFromSaleOfSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_MachinesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:MachinesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_MachinesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:MachinesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_FurnitureAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:MachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FurnitureAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SAFO:MachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EmployeesAndRelatedInstitutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:EmployeesAndRelatedInstitutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccruedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:AccruedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AffiliatedCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:AffiliatedCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EmployeesAndRelatedInstitutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:EmployeesAndRelatedInstitutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccruedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:AccruedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AffiliatedCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">SAFO:AffiliatedCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-02_custom_SavescannSolutionsIncMember_custom_CADMember_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SavescannSolutionsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:CADMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-02_custom_SavescannSolutionsIncMember_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SavescannSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_IsraeliInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ShortTermOperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ShortTermOperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ShortTermOperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ShortTermOperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-30to2019-05-31_custom_ShortTermOperatingLeaseAgreementMember_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ShortTermOperatingLeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-30</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-30to2019-05-31_custom_ShortTermOperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ShortTermOperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-30</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-01to2019-05-02_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-01to2019-05-02_custom_LeaseAgreementMember_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:LeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-31_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SaveFoodsLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:XedaInternationalSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-31_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SaveFoodsLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:XedaInternationalSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-01to2019-05-31_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SaveFoodsLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:XedaInternationalSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-28_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-01to2019-03-31_custom_AccreditedInvestorsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_AccreditedInvestorsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-17to2018-10-18_custom_TwoThousandEighteenEquityIncentivePlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-17</xbrli:startDate>
        <xbrli:endDate>2018-10-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-29to2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-29</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-11to2019-11-12_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-11</xbrli:startDate>
        <xbrli:endDate>2019-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-18_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SalariesAndRelatedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:SalariesAndRelatedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SalariesAndRelatedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:SalariesAndRelatedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ShareBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:ShareBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ShareBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:ShareBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_MaterialsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:MaterialsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_MaterialsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:MaterialsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_VehicleMaintenanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:VehicleMaintenanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_VehicleMaintenanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:VehicleMaintenanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TravelExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:TravelExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TravelExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:TravelExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TransportationAndStorageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:TransportationAndStorageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TransportationAndStorageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:TransportationAndStorageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ProfessionalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:ProfessionalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RentAndAssetManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:RentAndAssetManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_LaboratoryAndFieldTestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:LaboratoryAndFieldTestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ProfessionalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:ProfessionalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ProfessionalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:ProfessionalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_LegalExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:LegalExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LegalExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:LegalExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_InsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:InsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_InsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:InsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RentAndOfficeMaintenanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:RentAndOfficeMaintenanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_RentAndOfficeMaintenanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:RentAndOfficeMaintenanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LeviesAndTollsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:LeviesAndTollsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_LeviesAndTollsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:LeviesAndTollsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CommunicationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:CommunicationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CommunicationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:CommunicationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_DirectorsCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:DirectorsCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputExpectedTermMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputExercisePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-08-29to2017-09-01_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-08-29</xbrli:startDate>
        <xbrli:endDate>2017-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-11-04to2017-11-05_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-11-04</xbrli:startDate>
        <xbrli:endDate>2017-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_TwoAdditionalConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoAdditionalConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_ConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_DirectorsCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:DirectorsCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_SalariesAndFeesToOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:SalariesAndFeesToOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember_custom_SalariesAndFeesToOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:SalariesAndFeesToOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-22to2020-06-24_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-22</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-24_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-22to2020-06-24_custom_SecuritiesPurchaseAgreementMember_custom_LendersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:LendersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-22</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-24_custom_SecuritiesPurchaseAgreementMember_custom_LendersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:LendersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_TwoAdditionalConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoAdditionalConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-08to2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-08</xbrli:startDate>
        <xbrli:endDate>2019-05-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-20to2020-04-21_custom_SavescannSolutionsIncMember_custom_CADMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SavescannSolutionsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:CADMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-20</xbrli:startDate>
        <xbrli:endDate>2020-04-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-07-02_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-20to2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:MedigusLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:MedigusLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:MedigusLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-24_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-20to2020-09-22_custom_EmployeesAndDirectorsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:EmployeesAndDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:CommissionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:EarthboundTechnologiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:IntroducedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_ExceedsInNetRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:CommissionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:EarthboundTechnologiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:IntroducedPartiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SAFO:ExceedsInNetRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_ExceedsInNetRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:CommissionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:EarthboundTechnologiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:IntroducedPartiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SAFO:ExceedsInNetRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_OccuranceOfAdditionalEventsInAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:CommissionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:EarthboundTechnologiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:IntroducedPartiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SAFO:OccuranceOfAdditionalEventsInAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_OccuranceOfAdditionalEventsInAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:CommissionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:EarthboundTechnologiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:IntroducedPartiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SAFO:OccuranceOfAdditionalEventsInAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-20to2020-09-22_custom_DistributionAgreementMember_custom_SafePackProductsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:DistributionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:SafePackProductsLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-07-31_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-01to2020-08-31_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-22_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-04to2020-11-05_custom_CoChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:CoChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-04</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:TotalCompanysStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TotalCompanysStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SAFO:TotalCompanysStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-06-01to2018-06-30_custom_SaveFoodsLtdMember_custom_NISMember_custom_XedaInternationalSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SaveFoodsLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:XedaInternationalSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-06-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-06-01to2018-06-30_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SaveFoodsLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:XedaInternationalSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-06-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_AccreditedInvestorsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-01to2019-03-31_custom_AccreditedInvestorsTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_AccreditedInvestorsTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-01to2019-06-30_custom_AccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-01to2019-06-30_custom_AccreditedInvestorsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:AccreditedInvestorsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ProfessionalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:ProfessionalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_RentAndAssetManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:RentAndAssetManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LaboratoryAndFieldTestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SAFO:LaboratoryAndFieldTestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-22to2019-04-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-22</xbrli:startDate>
        <xbrli:endDate>2019-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-22to2021-02-23_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-22</xbrli:startDate>
        <xbrli:endDate>2021-02-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_IsraeliInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-20to2020-04-21_custom_SavescannSolutionsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SavescannSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-20</xbrli:startDate>
        <xbrli:endDate>2020-04-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-21_custom_SavescannSolutionsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">SAFO:SavescannSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-30_custom_TwoThousandTwentyConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_custom_CurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">SAFO:CurrentLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_custom_LongTermLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">SAFO:LongTermLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_custom_TwoThousandTwentyConvertibleLoanAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:TwoThousandTwentyConvertibleLoanAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputExpectedTermMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExpectedTermMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputExercisePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExercisePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputAppraisedValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputAppraisedValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputAppraisedValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-21_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputAppraisedValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputAppraisedValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputAppraisedValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">SAFO:ValuationTechniqueBinomialOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_IsraeliInnovationAuthorityMember_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_IsraeliInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-08to2020-08-09_custom_LeaseAgreementMember_custom_NISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:LeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SAFO:NISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-08</xbrli:startDate>
        <xbrli:endDate>2020-08-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-08to2020-08-09_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-08</xbrli:startDate>
        <xbrli:endDate>2020-08-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-01to2020-12-31_custom_TwoDirectorsMember_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:TwoDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-01to2020-12-31_custom_TwoDirectorsMember_us-gaap_CommonStockMember_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:TwoDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-22to2020-01-23_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-22</xbrli:startDate>
        <xbrli:endDate>2020-01-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-07-02_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandEighteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SAFO:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_ConsultantsAndOtherFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:ConsultantsAndOtherFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_ConsultantsAndOtherFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:ConsultantsAndOtherFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-09to2018-10-10_custom_ConsultingAgreementsMember_custom_AmirUzielEconomicConsultantsLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SAFO:ConsultingAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SAFO:AmirUzielEconomicConsultantsLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-09</xbrli:startDate>
        <xbrli:endDate>2018-10-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-09to2018-10-10_custom_ItzhakShremMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SAFO:ItzhakShremMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-09</xbrli:startDate>
        <xbrli:endDate>2018-10-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-04-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-04-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percentage">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="NIS">
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CAD">
      <xbrli:measure>iso4217:CAD</xbrli:measure>
    </xbrli:unit>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">S-1</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">Save Foods Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001789192</dei:EntityCentralIndexKey>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-402119</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">132</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">146</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">8852461</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">10329571</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-26275</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-26275</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_custom_ProceedsOnAccountOfSharesMember" unitRef="USD" decimals="0">105000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_custom_ProceedsOnAccountOfSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8713091</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-10684508</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-6712</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-21053</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">218227</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">-381066</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-465453</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">211515</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">161</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">11867585</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-26275</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-12277647</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">-436176</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-29277</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">495000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">495000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">1458593</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">1606760</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">1458593</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">1606760</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-01-31_custom_AccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-02-28_custom_AccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-06-30_custom_AccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-06-30_custom_AccreditedInvestorsOneMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31_custom_AccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31_custom_AccreditedInvestorsOneMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31_custom_AccreditedInvestorsTwoMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">417000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_us-gaap_ResearchAndDevelopmentExpenseMember_custom_SalariesAndFeesToOfficersMember" unitRef="USD" decimals="0">116692</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_SalariesAndRelatedExpensesMember" unitRef="USD" decimals="0">177712</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_SalariesAndRelatedExpensesMember" unitRef="USD" decimals="0">39021</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_ShareBasedCompensationMember" unitRef="USD" decimals="0">75998</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_ShareBasedCompensationMember" unitRef="USD" decimals="0">91190</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_VehicleMaintenanceMember" unitRef="USD" decimals="0">26227</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_VehicleMaintenanceMember" unitRef="USD" decimals="0">13657</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_TravelExpensesMember" unitRef="USD" decimals="0">26138</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_TravelExpensesMember" unitRef="USD" decimals="0">7190</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_OtherExpensesMember" unitRef="USD" decimals="0">25600</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_OtherExpensesMember" unitRef="USD" decimals="0">33438</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_ProfessionalFeesMember" unitRef="USD" decimals="0">178854</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_RentAndAssetManagementMember" unitRef="USD" decimals="0">10582</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_LaboratoryAndFieldTestsMember" unitRef="USD" decimals="0">73968</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="USD" decimals="0">29319</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="USD" decimals="0">20544</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember_custom_SalariesAndFeesToOfficersMember" unitRef="USD" decimals="0">25301</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">615623</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_ProfessionalFeesMember" unitRef="USD" decimals="0">130592</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_RentAndAssetManagementMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_LaboratoryAndFieldTestsMember" unitRef="USD" decimals="0">72593</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1070109</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_SalariesAndFeesToOfficersMember" unitRef="USD" decimals="0">358370</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">653458</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_ShareBasedCompensationMember" unitRef="USD" decimals="0">283910</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_ShareBasedCompensationMember" unitRef="USD" decimals="0">416996</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_TravelExpensesMember" unitRef="USD" decimals="0">15310</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_TravelExpensesMember" unitRef="USD" decimals="0">5305</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_OtherExpensesMember" unitRef="USD" decimals="0">12995</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_OtherExpensesMember" unitRef="USD" decimals="0">17848</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_ProfessionalServicesMember" unitRef="USD" decimals="0">461840</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_ProfessionalServicesMember" unitRef="USD" decimals="0">443883</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_LegalExpensesMember" unitRef="USD" decimals="0">125753</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_LegalExpensesMember" unitRef="USD" decimals="0">67492</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_InsuranceMember" unitRef="USD" decimals="0">54367</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_InsuranceMember" unitRef="USD" decimals="0">63380</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_RentAndOfficeMaintenanceMember" unitRef="USD" decimals="0">38080</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_RentAndOfficeMaintenanceMember" unitRef="USD" decimals="0">11135</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_LeviesAndTollsMember" unitRef="USD" decimals="0">28477</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_LeviesAndTollsMember" unitRef="USD" decimals="0">8601</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_CommunicationsMember" unitRef="USD" decimals="0">1910</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_CommunicationsMember" unitRef="USD" decimals="0">1679</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_custom_DepreciationMember" unitRef="USD" decimals="0">2133</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_custom_DepreciationMember" unitRef="USD" decimals="0">13914</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_DirectorsCompensationMember" unitRef="USD" decimals="0">295088</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_DirectorsCompensationMember" unitRef="USD" decimals="0">380756</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_SalariesAndFeesToOfficersMember" unitRef="USD" decimals="0">336433</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">769520</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1004899</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_ConsultantsAndOtherFeesMember" unitRef="USD" decimals="0">52331</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember_custom_ConsultantsAndOtherFeesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1606580</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_custom_ProceedsOnAccountOfSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1971417</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-18986</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">-1971417</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1990403</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1593139</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">-1593139</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-13441</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">140171</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-01-31_custom_AccreditedInvestorsMember" unitRef="Shares" decimals="INF">19050</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-02-01to2019-02-28_custom_AccreditedInvestorsMember" unitRef="Shares" decimals="INF">35717</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-03-01to2019-03-31_custom_AccreditedInvestorsMember" unitRef="Shares" decimals="INF">15874</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-08-01to2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember" unitRef="Shares" decimals="INF">11905</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-03-01to2019-03-31_custom_AccreditedInvestorsOneMember" unitRef="Shares" decimals="INF">7937</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-11-04to2017-11-05_custom_LeaseAgreementMember" unitRef="Shares" decimals="INF">720000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-06-22to2020-06-24_custom_SecuritiesPurchaseAgreementMember_custom_LendersMember" unitRef="Shares" decimals="INF">67369</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-09-20to2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember" unitRef="Shares" decimals="INF">3277</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">45876</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-03-01to2019-03-31_custom_AccreditedInvestorsTwoMember" unitRef="Shares" decimals="INF">7937</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-06-01to2019-06-30_custom_AccreditedInvestorsMember" unitRef="Shares" decimals="INF">31747</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-06-01to2019-06-30_custom_AccreditedInvestorsOneMember" unitRef="Shares" decimals="INF">10004</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-12-01to2020-12-31_custom_TwoDirectorsMember_us-gaap_CommonStockMember_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">6350</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">492619</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">434025</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_custom_ProceedsOnAccountOfSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">4645</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">434025</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">438670</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">487402</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">487402</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">5217</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">492619</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_EmployeesAndDirectorsMember" unitRef="USD" decimals="0">438670</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">272077</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_EmployeesAndDirectorsMember" unitRef="USD" decimals="0">492619</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">394756</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">57793</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">438670</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31" unitRef="Shares" id="Foot-00-0" decimals="INF">92574</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-12-28to2019-01-03_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">80954</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-10-17to2018-10-18_custom_TwoThousandEighteenEquityIncentivePlanMember_srt_MaximumMember" unitRef="Shares" decimals="INF">190477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-11-11to2019-11-12_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember" unitRef="Shares" decimals="INF">45239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31" unitRef="Shares" id="Foot-00-1" decimals="INF">109526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-22to2020-01-23_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">21143</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-07-01to2020-07-02_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">71431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">76730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">8.61</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-12-31_custom_ConsultantMember" unitRef="USDPShares" decimals="INF">6.3</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-06-24_custom_SecuritiesPurchaseAgreementMember" unitRef="USDPShares" decimals="INF">8.4</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember" unitRef="USDPShares" decimals="INF">7.63</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="USDPShares" decimals="INF">8.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-06-30_custom_AccreditedInvestorsOneMember" unitRef="USDPShares" decimals="INF">84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="USDPShares" decimals="INF">8.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-03-31_custom_AccreditedInvestorsTwoMember" unitRef="USDPShares" decimals="INF">84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2019-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">379000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-01-31_custom_TwoAdditionalConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">135000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-03-31_custom_TwoAdditionalConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">135000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">125000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-10-30_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2021-01-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">274000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="Percentage" decimals="INF">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="Percentage" decimals="INF">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2020-06-24_custom_SecuritiesPurchaseAgreementMember" unitRef="USDPShares" decimals="INF">7.63</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="USDPShares" decimals="INF">7.63</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DebtInstrumentMeasurementInput contextRef="AsOf2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputPriceVolatilityMember" unitRef="Percentage" decimals="INF">54.00</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput contextRef="AsOf2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Percentage" decimals="INF">0.00</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput contextRef="AsOf2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" unitRef="Percentage" decimals="INF">1.6</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember" unitRef="Percentage" decimals="INF">0.21</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember" unitRef="Percentage" decimals="INF">51.96</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Percentage" decimals="INF">0</us-gaap:DebtInstrumentMeasurementInput>
    <SAFO:FairValueAssumptionExpectedTerm contextRef="From2020-01-01to2020-12-31_custom_ConvertibleLoanAgreementsMember_us-gaap_MeasurementInputExpectedTermMember">P3Y</SAFO:FairValueAssumptionExpectedTerm>
    <SAFO:FairValueAssumptionExpectedTerm contextRef="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember_srt_MinimumMember">P2Y5M12D</SAFO:FairValueAssumptionExpectedTerm>
    <SAFO:FairValueAssumptionExpectedTerm contextRef="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">P2Y8M16D</SAFO:FairValueAssumptionExpectedTerm>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">4323</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-01-01to2020-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">199709</us-gaap:AmortizationOfDebtDiscountPremium>
    <SAFO:DetachableWarrants contextRef="AsOf2019-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">97406</SAFO:DetachableWarrants>
    <SAFO:DetachableWarrants contextRef="AsOf2020-03-31_custom_ConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">34696</SAFO:DetachableWarrants>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-12-31_custom_ConvertibleLoanAgreementsMember" unitRef="USDPShares" decimals="INF">8.40</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USDPShares" decimals="INF">7.63</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2020-06-22to2020-06-24_custom_SecuritiesPurchaseAgreementMember" unitRef="Shares" decimals="INF">69332</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2019-05-08to2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="Shares" decimals="INF">13107</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2020-09-20to2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember" unitRef="Shares" decimals="INF">13107</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2020-07-01to2020-07-31_custom_SecuritiesPurchaseAgreementMember" unitRef="Shares" decimals="INF">19662</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2020-08-01to2020-08-31_custom_SecuritiesPurchaseAgreementMember" unitRef="Shares" decimals="INF">19662</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-06-30_custom_AccreditedInvestorsOneMember" unitRef="Shares" decimals="INF">10004</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember" unitRef="Shares" decimals="INF">11905</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-06-24_custom_SecuritiesPurchaseAgreementMember_custom_LendersMember" unitRef="Shares" decimals="INF">67369</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-09-24_srt_BoardOfDirectorsChairmanMember" unitRef="Shares" decimals="INF">28572</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-09-22_srt_BoardOfDirectorsChairmanMember" unitRef="Shares" decimals="INF">28572</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-03-31_custom_AccreditedInvestorsTwoMember" unitRef="Shares" decimals="INF">7937</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2020-07-01to2020-07-02_custom_SecuritiesPurchaseAgreementMember" unitRef="Shares" decimals="INF">67369</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">67369</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">14955</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">8115</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">54970</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">27762</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">54970</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2020-10-23_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">27762</us-gaap:LongTermDebtFairValue>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">380732</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">517711</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2019-12-31_custom_RightOfUseLiabilityArisingFromOperatingLeaseMember" unitRef="USD" decimals="0">52093</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2020-12-31_custom_RightOfUseLiabilityArisingFromOperatingLeaseMember" unitRef="USD" decimals="0">15049</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2019-12-31_custom_EmployeesAndRelatedInstitutionsMember" unitRef="USD" decimals="0">135901</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2019-12-31_custom_AccruedExpensesMember" unitRef="USD" decimals="0">184616</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2019-12-31_custom_AffiliatedCompanyMember" unitRef="USD" id="Foot-01-0" decimals="0">8122</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2020-12-31_custom_EmployeesAndRelatedInstitutionsMember" unitRef="USD" decimals="0">110220</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2020-12-31_custom_AccruedExpensesMember" unitRef="USD" decimals="0">392442</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2020-12-31_custom_AffiliatedCompanyMember" unitRef="USD" id="Foot-01-1" xsi:nil="true" />
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">15300</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">65579</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2019-12-31_custom_PrepaidExpensesAndAdvancesToVendorsMember" unitRef="USD" decimals="0">4811</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31_custom_PrepaidExpensesAndAdvancesToVendorsMember" unitRef="USD" decimals="0">51020</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2019-12-31_custom_GovernmentInstitutionsMember" unitRef="USD" decimals="0">10489</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31_custom_GovernmentInstitutionsMember" unitRef="USD" decimals="0">11855</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2019-12-31_custom_ReceivablesFromSaleOfSubsidiaryMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31_custom_ReceivablesFromSaleOfSubsidiaryMember" unitRef="USD" decimals="0">2704</us-gaap:OtherAssetsCurrent>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">350000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">14</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">945679</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_custom_ProceedsOnAccountOfSharesMember" unitRef="USD" decimals="0">-105000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">840693</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-01-31_custom_AccreditedInvestorsMember" unitRef="USD" decimals="0">120000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-02-01to2019-02-28_custom_AccreditedInvestorsMember" unitRef="USD" decimals="0">225000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-03-01to2019-03-31_custom_AccreditedInvestorsMember" unitRef="USD" decimals="0">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-08-01to2019-08-31_custom_SubscriptionAgreementMember_custom_AccreditedInvestorsMember" unitRef="USD" decimals="0">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-03-01to2019-03-31_custom_AccreditedInvestorsOneMember" unitRef="USD" decimals="0">50000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">840693</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">5</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">349995</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">350000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-03-01to2019-03-31_custom_AccreditedInvestorsTwoMember" unitRef="USD" decimals="0">66666</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-06-01to2019-06-30_custom_AccreditedInvestorsMember" unitRef="USD" decimals="0">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-06-01to2019-06-30_custom_AccreditedInvestorsOneMember" unitRef="USD" decimals="0">84034</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">6.3</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2020-12-31_srt_MinimumMember" unitRef="USDPShares" decimals="INF">7.63</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USDPShares" decimals="INF">7.63</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_ExceedsInNetRevenueMember" unitRef="USDPShares" decimals="INF">8.4</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_OccuranceOfAdditionalEventsInAgreementMember" unitRef="USDPShares" decimals="INF">8.4</us-gaap:SharePrice>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-09-21_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USD" decimals="0">15208</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-10-23_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USD" decimals="0">6457</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-12-31_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USD" decimals="0">47499</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-09-21_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="USD" decimals="0">26824</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-10-23_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="USD" decimals="0">15167</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-12-31_us-gaap_MeasurementInputAppraisedValueMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="USD" decimals="0">77381</us-gaap:DerivativeFairValueOfDerivativeNet>
    <SAFO:DebtInstrumentMandatoryConversionProbabilityPercentage contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="Percentage" decimals="INF">0.70</SAFO:DebtInstrumentMandatoryConversionProbabilityPercentage>
    <SAFO:DebtInstrumentMandatoryConversionProbabilityPercentage contextRef="AsOf2020-10-30_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="Percentage" decimals="INF">0.70</SAFO:DebtInstrumentMandatoryConversionProbabilityPercentage>
    <SAFO:DebtInstrumentMandatoryConversionProbabilityPercentage contextRef="AsOf2021-01-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.75</SAFO:DebtInstrumentMandatoryConversionProbabilityPercentage>
    <SAFO:DebtInstrumentOptionalConversionProbabilityPercentage contextRef="AsOf2020-09-21_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="Percentage" decimals="INF">0.30</SAFO:DebtInstrumentOptionalConversionProbabilityPercentage>
    <SAFO:DebtInstrumentOptionalConversionProbabilityPercentage contextRef="AsOf2020-10-30_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="Percentage" decimals="INF">0.30</SAFO:DebtInstrumentOptionalConversionProbabilityPercentage>
    <SAFO:DebtInstrumentOptionalConversionProbabilityPercentage contextRef="AsOf2021-01-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.25</SAFO:DebtInstrumentOptionalConversionProbabilityPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">164289</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember" unitRef="Shares" decimals="INF">28572</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">206862</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember" unitRef="Shares" decimals="INF">14286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">59525</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">6350</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2019-01-01to2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_ExceedsInNetRevenueMember" unitRef="Shares" decimals="INF">7143</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_OccuranceOfAdditionalEventsInAgreementMember" unitRef="Shares" decimals="INF">7143</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">6350</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-12-01to2020-12-31_custom_TwoDirectorsMember_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">6350</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <SAFO:PercentageOfNetRevenues contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember" unitRef="Percentage" decimals="INF">0.125</SAFO:PercentageOfNetRevenues>
    <SAFO:MaximumCompensationPercentageOfGrossProfit contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember" unitRef="Percentage" decimals="INF">0.25</SAFO:MaximumCompensationPercentageOfGrossProfit>
    <us-gaap:Revenues contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember" unitRef="USD" decimals="0">2000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_ExceedsInNetRevenueMember" unitRef="USD" decimals="0">500000</us-gaap:Revenues>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_ExceedsInNetRevenueMember" unitRef="Shares" decimals="INF">7143</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2020-09-20to2020-09-22_custom_CommissionAgreementMember_custom_EarthboundTechnologiesLLCMember_custom_IntroducedPartiesMember_custom_OccuranceOfAdditionalEventsInAgreementMember" unitRef="Shares" decimals="INF">7143</us-gaap:StockRepurchasedDuringPeriodShares>
    <SAFO:PercentageOfPurchaseQuota contextRef="From2020-09-20to2020-09-22_custom_DistributionAgreementMember_custom_SafePackProductsLimitedMember" unitRef="Percentage" decimals="INF">0.03</SAFO:PercentageOfPurchaseQuota>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">199983</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">424515</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2019-04-22to2019-04-23">15 to 1 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2021-02-22to2021-02-23_us-gaap_SubsequentEventMember">7 to 1 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">0.19</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">51.96</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="Percentage" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MinimumMember" unitRef="Percentage" decimals="INF">0.12</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MaximumMember" unitRef="Percentage" decimals="INF">0.16</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-09-21_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="Percentage" decimals="INF">51.96</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">0.11</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">0.09</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">51.96</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="Percentage" decimals="INF">48.06</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="Percentage" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="Percentage" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MinimumMember" unitRef="Percentage" decimals="INF">0.12</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MinimumMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MaximumMember" unitRef="Percentage" decimals="INF">0.2</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember_srt_MaximumMember" unitRef="Percentage" decimals="INF">0.14</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-10-23_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="Percentage" decimals="INF">51.96</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="Percentage" decimals="INF">48.06</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-09-21_us-gaap_MeasurementInputExpectedTermMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">P0Y93M0D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-10-23_us-gaap_MeasurementInputExpectedTermMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">P0Y82M6D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExpectedTermMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">P0Y50M1D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-09-21_us-gaap_MeasurementInputExercisePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USDPShares" decimals="INF">7.63</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-09-21_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USDPShares" decimals="INF">6.72</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-09-21_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="USDPShares" decimals="INF">6.72</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-10-23_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USDPShares" decimals="INF">5.88</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-12-31_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USDPShares" decimals="INF">8.61</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-10-23_us-gaap_MeasurementInputExercisePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USDPShares" decimals="INF">7.63</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExercisePriceMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember" unitRef="USDPShares" decimals="INF">7.63</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-10-23_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="USDPShares" decimals="INF">5.88</SAFO:FairValueOfWarrantPrice>
    <SAFO:FairValueOfWarrantPrice contextRef="AsOf2020-12-31_us-gaap_MeasurementInputSharePriceMember_custom_ValuationTechniqueBinomialOptionPricingModelMember" unitRef="USDPShares" decimals="INF">8.61</SAFO:FairValueOfWarrantPrice>
    <SAFO:MonthlyRetainer contextRef="From2020-11-04to2020-11-05_custom_CoChiefExecutiveOfficerMember" unitRef="USD" decimals="0">8000</SAFO:MonthlyRetainer>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1318422</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1458593</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1606760</us-gaap:SharesOutstanding>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">34696</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">97406</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_custom_ProceedsOnAccountOfSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">97406</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">97406</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">34696</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">34696</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">38194</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">22395</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2019-12-31_custom_NISMember" unitRef="NIS" decimals="0">132000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2020-12-31_custom_NISMember" unitRef="NIS" decimals="0">72000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">24702</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">26553</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:SeveranceCosts1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">7419</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">24000</us-gaap:SeveranceCosts1>
    <SAFO:CumulativeResearchAndDevelopmentGrantsReceived contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">150678</SAFO:CumulativeResearchAndDevelopmentGrantsReceived>
    <SAFO:CumulativeResearchAndDevelopmentGrantsReceived contextRef="From2020-01-01to2020-12-31_custom_NISMember" unitRef="NIS" decimals="0">484429</SAFO:CumulativeResearchAndDevelopmentGrantsReceived>
    <SAFO:RateOfDepreciationPercentage contextRef="From2020-01-01to2020-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MinimumMember" unitRef="Percentage" decimals="INF">0.07</SAFO:RateOfDepreciationPercentage>
    <SAFO:RateOfDepreciationPercentage contextRef="From2020-01-01to2020-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MaximumMember" unitRef="Percentage" decimals="INF">0.15</SAFO:RateOfDepreciationPercentage>
    <SAFO:RateOfDepreciationPercentage contextRef="From2020-01-01to2020-12-31_custom_MachinesMember_srt_MinimumMember" unitRef="Percentage" decimals="INF">0.10</SAFO:RateOfDepreciationPercentage>
    <SAFO:RateOfDepreciationPercentage contextRef="From2020-01-01to2020-12-31_custom_MachinesMember_srt_MaximumMember" unitRef="Percentage" decimals="INF">0.15</SAFO:RateOfDepreciationPercentage>
    <SAFO:RateOfDepreciationPercentage contextRef="From2020-01-01to2020-12-31_us-gaap_ComputerEquipmentMember" unitRef="Percentage" decimals="INF">0.33</SAFO:RateOfDepreciationPercentage>
    <SAFO:RateOfDepreciationPercentage contextRef="From2020-01-01to2020-12-31_us-gaap_VehiclesMember" unitRef="Percentage" decimals="INF">0.15</SAFO:RateOfDepreciationPercentage>
    <us-gaap:Depreciation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">22512</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">27351</us-gaap:Depreciation>
    <us-gaap:EquityMethodInvestments contextRef="AsOf2019-04-02_custom_SavescannSolutionsIncMember_custom_CADMember_custom_SubscriptionAgreementMember" unitRef="CAD" decimals="0">10000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-04-02_custom_SavescannSolutionsIncMember_custom_SubscriptionAgreementMember" unitRef="Percentage" decimals="INF">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2009-04-27" unitRef="Percentage" decimals="INF">0.9894</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" decimals="INF">0.021</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">22185</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">16064</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">7230</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">7949</us-gaap:LongTermDebtCurrent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="Percentage" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2020-01-01to2020-12-31">US resident companies are taxed on their worldwide income for corporate income tax purposes at a statutory rate of 21% this reflect certain effects of the Act which includes a reduction in the corporate tax rate from 35% to 21% as well as other changes</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_srt_MinimumMember" unitRef="USD" decimals="0">1264000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_srt_MaximumMember" unitRef="USD" decimals="0">9412000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1593139</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1971417</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <SAFO:IncomeTaxComputedAtOrdinaryTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">334559</SAFO:IncomeTaxComputedAtOrdinaryTaxRate>
    <SAFO:IncomeTaxComputedAtOrdinaryTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">413998</SAFO:IncomeTaxComputedAtOrdinaryTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-63565</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-2278</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-109772</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-93970</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationDeductions contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">13480</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationDeductions contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">26688</us-gaap:IncomeTaxReconciliationDeductions>
    <SAFO:LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-174702</SAFO:LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated>
    <SAFO:LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-344438</SAFO:LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:ProvisionForEmployeeRelatedObligation contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">29353</SAFO:ProvisionForEmployeeRelatedObligation>
    <SAFO:ProvisionForEmployeeRelatedObligation contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">31627</SAFO:ProvisionForEmployeeRelatedObligation>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2171821</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2350367</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2201174</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2381994</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">290815</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">242900</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">38194</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">22395</us-gaap:RestrictedCashCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">64003</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">147941</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">16302</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">16356</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">424614</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">495171</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">48982</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">14700</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">81119</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">55194</us-gaap:PropertyPlantAndEquipmentNet>
    <SAFO:FundsInRespectOfEmployeeRightsUponRetirement contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">109955</SAFO:FundsInRespectOfEmployeeRightsUponRetirement>
    <SAFO:FundsInRespectOfEmployeeRightsUponRetirement contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">122584</SAFO:FundsInRespectOfEmployeeRightsUponRetirement>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">664670</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">687649</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">7230</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">7949</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">56250</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">235864</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">203323</us-gaap:AccountsPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">623826</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">785233</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">285917</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">146929</us-gaap:ConvertibleDebtNoncurrent>
    <SAFO:LongTermDebtFromBankingInstitutions contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">14955</SAFO:LongTermDebtFromBankingInstitutions>
    <SAFO:LongTermDebtFromBankingInstitutions contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">8115</SAFO:LongTermDebtFromBankingInstitutions>
    <SAFO:LiabilityForEmployeeRightsUponRetirement contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">142091</SAFO:LiabilityForEmployeeRightsUponRetirement>
    <SAFO:LiabilityForEmployeeRightsUponRetirement contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">157855</SAFO:LiabilityForEmployeeRightsUponRetirement>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1066789</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1153102</us-gaap:Liabilities>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">146</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">161</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">10329571</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">11867585</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-26275</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-26275</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-10684508</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-12277647</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-381066</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-436176</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-21053</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-29277</us-gaap:MinorityInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">664670</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">687649</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">232274</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_custom_IsraeliInnovationAuthorityMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">175823</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_custom_IsraeliInnovationAuthorityMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">188869</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">31275</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">51105</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">342058</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1349345</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1931305</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2532</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:ShareInLossesOfAffiliatedCompany contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:ShareInLossesOfAffiliatedCompany contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-15690</SAFO:ShareInLossesOfAffiliatedCompany>
    <SAFO:GainOnDisposalOfAffiliatedCompany contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">15690</SAFO:GainOnDisposalOfAffiliatedCompany>
    <SAFO:GainOnDisposalOfAffiliatedCompany contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-13441</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-18986</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1593139</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1971417</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">-1.05</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-1.38</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">585931</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">7</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">585924</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">585931</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <SAFO:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">28572</SAFO:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">60000</SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2</SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">59998</SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">60000</SAFO:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">19999</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_TotalCompanysStockholdersEquityMember" unitRef="USD" decimals="0">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">45205</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">27351</us-gaap:DepreciationDepletionAndAmortization>
    <SAFO:IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">15764</SAFO:IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement>
    <SAFO:IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">16019</SAFO:IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement>
    <us-gaap:ProvisionForLoanAndLeaseLosses contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">176216</us-gaap:ProvisionForLoanAndLeaseLosses>
    <us-gaap:ProvisionForLoanAndLeaseLosses contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">6147</us-gaap:ProvisionForLoanAndLeaseLosses>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">83938</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-71294</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">54</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-21783</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">47575</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-49739</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-32541</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">39313</us-gaap:IncreaseDecreaseInAccountsPayable>
    <SAFO:IncreaseDecreaseInAccountsPayableOther contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">197659</SAFO:IncreaseDecreaseInAccountsPayableOther>
    <SAFO:IncreaseDecreaseInAccountsPayableOther contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">59625</SAFO:IncreaseDecreaseInAccountsPayableOther>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-798740</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1244772</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-4864</us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">7567</us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates>
    <SAFO:ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">12629</SAFO:ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement>
    <SAFO:ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">12567</SAFO:ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">9065</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-81655</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromSecuredNotesPayable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">135000</us-gaap:ProceedsFromSecuredNotesPayable>
    <us-gaap:ProceedsFromSecuredNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:ProceedsFromConvertibleLoans contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">225000</SAFO:ProceedsFromConvertibleLoans>
    <SAFO:ProceedsFromConvertibleLoans contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">379000</SAFO:ProceedsFromConvertibleLoans>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">7272</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">42257</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">40968</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">350000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">840693</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">60000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">741760</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1177436</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-47915</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-148991</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">290815</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">242900</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">439806</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">408</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">836</us-gaap:InterestPaidNet>
    <SAFO:DisposalOfAffiliatedCompany contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2704</SAFO:DisposalOfAffiliatedCompany>
    <SAFO:DisposalOfAffiliatedCompany contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:TerminationOfLeaseAgreement contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">11590</SAFO:TerminationOfLeaseAgreement>
    <SAFO:TerminationOfLeaseAgreement contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:IssuanceOfWarrantsInConvertibleLoans contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">53388</SAFO:IssuanceOfWarrantsInConvertibleLoans>
    <SAFO:IssuanceOfWarrantsInConvertibleLoans contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">97406</SAFO:IssuanceOfWarrantsInConvertibleLoans>
    <SAFO:ConversionOfConvertibleLoans contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">528138</SAFO:ConversionOfConvertibleLoans>
    <SAFO:ConversionOfConvertibleLoans contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:InitialRecognitionOfOperatingLeaseRightofuseAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:InitialRecognitionOfOperatingLeaseRightofuseAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">48982</SAFO:InitialRecognitionOfOperatingLeaseRightofuseAssets>
    <SAFO:InitialRecognitionOfOperatingLeaseLiability contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:InitialRecognitionOfOperatingLeaseLiability contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-48982</SAFO:InitialRecognitionOfOperatingLeaseLiability>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1031</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">20000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2020-12-01to2020-12-31_custom_TwoDirectorsMember_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="USD" decimals="0">20000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="From2021-02-22to2021-02-23_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.143</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <SAFO:WorkingCapital contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">290062</SAFO:WorkingCapital>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-36700</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-36700</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">54970</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">54970</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">54970</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">54970</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">23327</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">235144</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">231276</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="0">10328</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_custom_FurnitureAndOfficeEquipmentMember" unitRef="USD" decimals="0">5002</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_custom_MachinesMember" unitRef="USD" decimals="0">130797</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" unitRef="USD" decimals="0">85149</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="0">10328</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_custom_FurnitureAndOfficeEquipmentMember" unitRef="USD" decimals="0">5002</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_custom_MachinesMember" unitRef="USD" decimals="0">134665</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_VehiclesMember" unitRef="USD" decimals="0">85149</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">117325</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">139382</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">54970</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">27762</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <SAFO:FairValueMeasurementWithUnobservableInputsChangesInFairValue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">27208</SAFO:FairValueMeasurementWithUnobservableInputsChangesInFairValue>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2382</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:ShareInLossesGainOnDisposalOfAffiliatedCompany contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">15690</SAFO:ShareInLossesGainOnDisposalOfAffiliatedCompany>
    <SAFO:ShareInLossesGainOnDisposalOfAffiliatedCompany contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-15690</SAFO:ShareInLossesGainOnDisposalOfAffiliatedCompany>
    <SAFO:CompensationExpensesInExchangeOfInstruments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-57793</SAFO:CompensationExpensesInExchangeOfInstruments>
    <SAFO:CompensationExpensesInExchangeOfInstruments contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:DecreaseIncreaseInShortTermDepositsInBankingInstitutions contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-15799</SAFO:DecreaseIncreaseInShortTermDepositsInBankingInstitutions>
    <SAFO:DecreaseIncreaseInShortTermDepositsInBankingInstitutions contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">38194</SAFO:DecreaseIncreaseInShortTermDepositsInBankingInstitutions>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="From2020-04-20to2020-04-21_custom_SavescannSolutionsIncMember_custom_CADMember" unitRef="CAD" decimals="0">10000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="From2020-04-20to2020-04-21_custom_SavescannSolutionsIncMember" unitRef="USD" decimals="0">7000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:AccruedInvestmentIncomeReceivable contextRef="AsOf2020-04-21_custom_SavescannSolutionsIncMember" unitRef="USD" decimals="0">2704</us-gaap:AccruedInvestmentIncomeReceivable>
    <us-gaap:ClassOfWarrantOrRightExpenseOrRevenueRecognized contextRef="From2020-06-22to2020-06-24_custom_SecuritiesPurchaseAgreementMember">Each Unit consists of: (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.4 (the "Warrant").</us-gaap:ClassOfWarrantOrRightExpenseOrRevenueRecognized>
    <us-gaap:DebtInstrumentFairValue contextRef="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember" unitRef="USD" decimals="0">203179</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_custom_CurrentLiabilitiesMember" unitRef="USD" decimals="0">56250</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="AsOf2020-12-31_custom_TwoThousandTwentyConvertibleLoanAgreementsMember_custom_LongTermLiabilitiesMember" unitRef="USD" decimals="0">146929</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">7949</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">8115</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <SAFO:RoyaltyDescription contextRef="From2020-01-01to2020-12-31_custom_IsraeliInnovationAuthorityMember">Save Foods Ltd. is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. Save Foods Ltd. was entitled to the grants only upon incurring research and development expenditures. There were no future performance obligations related to the grants received from the IIA.</SAFO:RoyaltyDescription>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability contextRef="AsOf2020-12-31_custom_IsraeliInnovationAuthorityMember_custom_NISMember" unitRef="NIS" decimals="0">484429</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability contextRef="AsOf2020-12-31_custom_IsraeliInnovationAuthorityMember" unitRef="USD" decimals="0">150678</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <SAFO:AgreementTermDescription contextRef="From2020-01-01to2020-12-31_custom_ShortTermOperatingLeaseAgreementMember">Short-term operating lease agreement ends at December 31, 2020 with an option to extend the agreement with additional year ended at December 31, 2021.</SAFO:AgreementTermDescription>
    <us-gaap:PaymentsForRent contextRef="From2019-01-01to2019-12-31_custom_ShortTermOperatingLeaseAgreementMember" unitRef="USD" decimals="0">10605</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2020-01-01to2020-12-31_custom_ShortTermOperatingLeaseAgreementMember" unitRef="USD" decimals="0">14967</us-gaap:PaymentsForRent>
    <SAFO:OfficeAndRelatedServiceFees contextRef="From2019-05-30to2019-05-31_custom_ShortTermOperatingLeaseAgreementMember_custom_NISMember" unitRef="NIS" decimals="0">5000</SAFO:OfficeAndRelatedServiceFees>
    <SAFO:OfficeAndRelatedServiceFees contextRef="From2019-05-30to2019-05-31_custom_ShortTermOperatingLeaseAgreementMember" unitRef="USD" decimals="0">1400</SAFO:OfficeAndRelatedServiceFees>
    <SAFO:OfficeAndRelatedServiceFees contextRef="From2019-05-01to2019-05-02_custom_LeaseAgreementMember" unitRef="USD" decimals="0">3450</SAFO:OfficeAndRelatedServiceFees>
    <SAFO:OfficeAndRelatedServiceFees contextRef="From2019-05-01to2019-05-02_custom_LeaseAgreementMember_custom_NISMember" unitRef="NIS" decimals="0">11214</SAFO:OfficeAndRelatedServiceFees>
    <SAFO:LessorOnetimePaymentAmount contextRef="From2020-08-08to2020-08-09_custom_LeaseAgreementMember_custom_NISMember" unitRef="NIS" decimals="0">10000</SAFO:LessorOnetimePaymentAmount>
    <SAFO:LessorOnetimePaymentAmount contextRef="From2020-08-08to2020-08-09_custom_LeaseAgreementMember" unitRef="USD" decimals="0">3100</SAFO:LessorOnetimePaymentAmount>
    <us-gaap:LeaseExpirationDate1 contextRef="From2017-08-29to2017-09-01_custom_LeaseAgreementMember">2020-09-30</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1 contextRef="From2020-08-08to2020-08-09_custom_LeaseAgreementMember">2020-08-13</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseAndRentalExpense contextRef="From2017-11-04to2017-11-05_custom_LeaseAgreementMember" unitRef="USD" decimals="0">7200</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LegalFees contextRef="From2019-01-01to2019-01-31_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember_custom_NISMember" unitRef="NIS" decimals="0">50000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2019-01-01to2019-01-31_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember" unitRef="USD" decimals="0">13000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2019-05-01to2019-05-31_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember_custom_NISMember" unitRef="NIS" decimals="0">8000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2018-06-01to2018-06-30_custom_SaveFoodsLtdMember_custom_NISMember_custom_XedaInternationalSAMember" unitRef="NIS" decimals="0">165000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2018-06-01to2018-06-30_custom_SaveFoodsLtdMember_custom_XedaInternationalSAMember" unitRef="USD" decimals="0">46000</us-gaap:LegalFees>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2019-05-08to2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="USD" decimals="0">100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2020-09-20to2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember" unitRef="USD" decimals="0">100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2020-07-01to2020-07-31_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">150000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2020-08-01to2020-08-31_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">150000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <SAFO:WarrantsDescription contextRef="From2019-05-08to2019-05-09_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">Unit consists of (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.40 for a period of 36 months following the issuance date. The shares of Common Stock were issued on July 2, 2020.</SAFO:WarrantsDescription>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2020-09-23_custom_SecuritiesPurchaseAgreementMember_custom_MedigusLimitedMember_srt_MaximumMember" unitRef="USD" decimals="0">25000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">97351</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2018-10-18_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">190477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2019-04-29to2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember">The options shall vest quarterly over three years, commencing April 1, 2019, and shall be exercisable for an exercise price of $3.15 per share. In addition, the Board of Directors of the Company approved the issuance of 14,286 options to purchase 14,286 Company's Common Stock 0.0001 par value, to Mr. Dan Sztybel, subject to Save Foods Ltd's obtainment of certain EPA and FDA approvals by the end of the second quarter of 2020.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2019-11-11to2019-11-12_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember">Under the 2018 Equity Incentive Plan of which 28,572 options are vested quarterly over three years commencing January 3, 2019, 9,524 options are vested 1/3 after a year commencing January 3, 2019 and the remaining 2/3 are vested quarterly over additional two years.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2020-01-22to2020-01-23_custom_TwoThousandEighteenEquityIncentivePlanMember">The options shall vest quarterly over two years commencing June 23, 2020, whereby 12.50% of the shares covered by the options will vest on the three month anniversary of June 23, 2020, and 12.50% of the shares covered by the options at the end of each subsequent three month period thereafter over the course of the subsequent twenty-one months.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2020-07-01to2020-07-02_custom_TwoThousandEighteenEquityIncentivePlanMember">The options shall vest quarterly over two years commencing June 1, 2020, whereby 12.50% of the shares covered by the options will vest on the three month anniversary of June 1, 2020, and 12.50% of the shares covered by the options at the end of each subsequent three month period thereafter over the course of the subsequent twenty-one months.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2020-01-01to2020-12-31_custom_TwoThousandEighteenEquityIncentivePlanMember">The Company granted of 80,954 options under the 2018 Equity Incentive Plan of which 9,524 options are vested quarterly over three years commencing May 15, 2018, 35,715 options are vested 1/3 after a year commencing October 1, 2018 and the remaining 2/3 are vested quarterly over additional two years, 14,286 options are vested quarterly over three years commencing October 1, 2018 and 21,429 options are vested 1/3 after a year commencing January 1, 2019 and the remaining 2/3 are vested quarterly over additional two years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <SAFO:OptionToPurchaseOfCommonStock contextRef="From2019-04-29to2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember" unitRef="Shares" decimals="INF">28572</SAFO:OptionToPurchaseOfCommonStock>
    <SAFO:OptionToPurchaseOfCommonStock contextRef="From2019-04-29to2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_BoardOfDirectorsMember" unitRef="Shares" decimals="INF">14286</SAFO:OptionToPurchaseOfCommonStock>
    <us-gaap:StockOptionExercisePriceIncrease contextRef="From2019-04-29to2019-04-30_custom_TwoThousandEighteenEquityIncentivePlanMember_custom_MrDanSztubelMember" unitRef="USDPShares" decimals="INF">3.15</us-gaap:StockOptionExercisePriceIncrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2020-12-31_custom_ConsultantMember" unitRef="Shares" decimals="INF">2858</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1084465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <SAFO:EstimatedFairValueOfNonCashCompensationGranted contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">453976</SAFO:EstimatedFairValueOfNonCashCompensationGranted>
    <SAFO:EstimatedFairValueOfNonCashCompensationGranted contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">440848</SAFO:EstimatedFairValueOfNonCashCompensationGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2020-01-22to2020-01-23_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Percentage" decimals="INF">0.1250</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2020-07-01to2020-07-02_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="USD" decimals="0">344767</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="From2020-07-01to2020-07-02_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">99466</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="From2020-07-01to2020-07-02_custom_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Shares" decimals="INF">289942</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">29365</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">4762</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">14286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">3.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">3.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2019-01-01to2019-12-31" unitRef="Percentage" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" id="Foot-02-0" decimals="INF">0.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2019-01-01to2019-12-31" unitRef="Percentage" id="Foot-02-1" decimals="INF">0.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" id="Foot-03-0" decimals="INF">0.0023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2019-01-01to2019-12-31_srt_MinimumMember" unitRef="Percentage" id="Foot-03-1" decimals="INF">0.0156</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2019-01-01to2019-12-31_srt_MaximumMember" unitRef="Percentage" id="Foot-03-2" decimals="INF">0.0239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-01to2020-12-31" id="Foot-04-0">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-01to2019-12-31" id="Foot-04-1">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2020-12-31_srt_MinimumMember" unitRef="USDPShares" decimals="INF">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2020-12-31_srt_MaximumMember" unitRef="USDPShares" decimals="INF">3.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <SAFO:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">4.19</SAFO:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue>
    <SAFO:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue contextRef="AsOf2020-12-31_srt_MinimumMember" unitRef="USDPShares" decimals="INF">4.83</SAFO:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue>
    <SAFO:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue contextRef="AsOf2020-12-31_srt_MaximumMember" unitRef="USDPShares" decimals="INF">5.17</SAFO:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">43405</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_SalariesAndRelatedExpensesMember" unitRef="USD" decimals="0">35142</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_SalariesAndRelatedExpensesMember" unitRef="USD" decimals="0">8074</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_ShareBasedCompensationMember" unitRef="USD" decimals="0">14531</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_ShareBasedCompensationMember" unitRef="USD" decimals="0">5402</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_MaterialsMember" unitRef="USD" decimals="0">69390</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_MaterialsMember" unitRef="USD" decimals="0">16692</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_VehicleMaintenanceMember" unitRef="USD" decimals="0">8455</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_VehicleMaintenanceMember" unitRef="USD" decimals="0">2063</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_TravelExpensesMember" unitRef="USD" decimals="0">3408</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_TravelExpensesMember" unitRef="USD" decimals="0">978</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_TransportationAndStorageMember" unitRef="USD" decimals="0">13299</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_TransportationAndStorageMember" unitRef="USD" decimals="0">5632</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31_custom_OtherExpensesMember" unitRef="USD" decimals="0">323</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-12-31_custom_OtherExpensesMember" unitRef="USD" decimals="0">4564</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">144548</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestAndDebtExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">202917</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">4323</us-gaap:InterestAndDebtExpense>
    <SAFO:CurrencyExchangeDifferences contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">34037</SAFO:CurrencyExchangeDifferences>
    <SAFO:CurrencyExchangeDifferences contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">28266</SAFO:CurrencyExchangeDifferences>
    <SAFO:ChangesInFairValueOfConvertibleLoans contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">27208</SAFO:ChangesInFairValueOfConvertibleLoans>
    <SAFO:ChangesInFairValueOfConvertibleLoans contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <SAFO:BankChargesAndOtherFinanceExpensesNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">6231</SAFO:BankChargesAndOtherFinanceExpensesNet>
    <SAFO:BankChargesAndOtherFinanceExpensesNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">10819</SAFO:BankChargesAndOtherFinanceExpensesNet>
    <SAFO:FinancingExpensesNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">270393</SAFO:FinancingExpensesNet>
    <SAFO:FinancingExpensesNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">43408</SAFO:FinancingExpensesNet>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31" unitRef="Shares" id="Foot-05-0" decimals="INF">206862</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31" unitRef="Shares" id="Foot-05-1" decimals="INF">164289</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">1519122</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">1424045</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <SAFO:MonthlyConsultancyFee contextRef="From2018-10-09to2018-10-10_custom_ConsultingAgreementsMember_custom_AmirUzielEconomicConsultantsLtdMember" unitRef="USD" decimals="0">1500</SAFO:MonthlyConsultancyFee>
    <SAFO:MonthlyDirectorsFee contextRef="From2018-10-09to2018-10-10_custom_ItzhakShremMember" unitRef="USD" decimals="0">1500</SAFO:MonthlyDirectorsFee>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="From2020-09-20to2020-09-22_custom_EmployeesAndDirectorsMember_srt_MaximumMember" unitRef="USD" decimals="0">1000000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:NatureOfOperations contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;NOTE 1 &amp;#8211;&#13;GENERAL&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Operations&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Save Foods, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated on April 1, 2009, under the laws of the State of Delaware. On April 27, 2009, the Company acquired from its stockholders&#13;98.94% of the issued and outstanding shares of Save Foods Ltd., including preferred and common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Save Foods Ltd. was incorporated&#13;in 2004 and commenced its operations in 2005. Save Foods Ltd. develops, produces, and focuses on delivering innovative solutions&#13;for the food industry aimed at improving food safety and prolonging shelf life of fresh produce.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company&amp;#8217;s common stock&#13;is quoted on the OTC, Pink Tier, under the symbol &amp;#8220;SAFO&amp;#8221;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Reverse stock split&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On April 23, 2019, the Company amended&#13;and restated its Certificate of Incorporation to effect a 15 to 1 reverse stock split of the Company&amp;#8217;s outstanding Common&#13;Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;As a result of the reverse stock&#13;split, which became effective on June 11, 2019, every 15 shares of the Company&amp;#8217;s outstanding Common Stock prior to the effect&#13;of that amendment was combined and reclassified into one share of the Company&amp;#8217;s Common Stock. No fractional shares were issued&#13;in connection with or following the reverse split. The number of outstanding shares of the Company&amp;#8217;s Common Stock and par&#13;value of the shares remained unchanged.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On February 23, 2021, the Company&#13;amended its Certificate of Incorporation to effect a 7 to 1 reverse stock split of the Company&amp;#8217;s outstanding Common Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;As a result of the reverse stock&#13;split, every 7 shares of the Company&amp;#8217;s outstanding Common Stock prior to the effect of that amendment was combined and reclassified&#13;into one share of the Company&amp;#8217;s Common Stock. No fractional shares were issued in connection with or following the reverse&#13;split. The number of authorized capital of the Company&amp;#8217;s Common Stock and par value of the shares remained unchanged.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;All share, stock option and per&#13;share information in these condensed consolidated financial statements have been restated to reflect the stock split on a retroactive&#13;basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Going concern uncertainty&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Since its incorporation (April 1,&#13;2009), the Company has not had any operations other than those carried out by Save Foods Ltd. The development and commercialization&#13;of Save Foods Ltd.&amp;#8217;s products will require substantial expenditures. Save Foods Ltd. and the Company have not yet generated&#13;sufficient revenues from their operations to fund the Group&amp;#8217;s (as defined below) activities and are therefore dependent upon&#13;external sources for financing their operations. There can be no assurance that the Company will succeed in obtaining the necessary&#13;financing to continue its operations. As of December 31, 2020, the Company had $242,900 in cash, a negative working capital of&#13;$290,062 and an accumulated deficit of $12,277,647.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company will need to secure&#13;additional capital in the future in order to meet its anticipated liquidity needs primarily through the sale of additional Common&#13;Stock or other equity securities and/or debt financing. Funds from these sources may not be available to the Company on acceptable&#13;terms, if at all, and the Company cannot give assurance that it will be successful in securing such additional capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company focuses its solutions&#13;towards vegetables and fruits which are considered the largest in terms of worldwide consumption. Among other things, the Company&#13;tries to cooperate with major fruit packing houses in Israel and abroad.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;These factors raise substantial&#13;doubt about Save Foods Ltd. and the Company&amp;#8217;s ability to continue as a going concern. The consolidated financial statements&#13;do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;D&lt;/b&gt;.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;In December 2019, a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. This virus continues to spread globally and, has spread to over 180 countries, including the United States and Israel. The spread of COVID-19 from China to other countries has resulted in the World Health Organization declaring the outbreak of COVID-19 as a &amp;#8220;pandemic,&amp;#8221; or a worldwide spread of a new disease, on March 11, 2020. Many countries around the world have imposed quarantines and restrictions on travel and mass gatherings to slow the spread of the virus, including in the United States and in Israel. Governments may divert spending from other budgeted resources as they seek to reduce and/or stop the spread of an infectious disease, such as COVID-19. Such events may result in a period of business and manufacturing disruption, and in reduced operations, any of which could materially affect the Company&amp;#8217;s business, financial condition and results of operations. The extent to which COVID-19 impacts the Company&amp;#8217;s business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. The Company believes it is taking appropriate actions to mitigate the negative impacts. However, the full impact of COVID-19 is unknown and cannot be reasonably estimated as these events occurred subsequent to year end and are still developing.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Risk factors&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company and Save Foods Ltd.&#13;(collectively, the &amp;#8220;Group&amp;#8221;) face a number of risks, including uncertainties regarding finalization of the development&#13;process, demand and market acceptance of the Group&amp;#8217;s products, the effects of technological changes, competition and the&#13;development of products by competitors. Additionally, other risk factors also exist, such as the ability to manage growth and the&#13;effect of planned expansion of operations on the Group&amp;#8217;s future results. In addition, the Group expects to continue incurring&#13;significant operating costs and losses in connection with the development of its products and increased marketing efforts. As mentioned&#13;above, the Group has not yet generated significant revenues from its operations to fund its activities, and therefore the continuance&#13;of its activities as a going concern depends on the receipt of additional funding from its current stockholders and investors or&#13;from third parties.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;NOTE 2&amp;#8211;&#13;SIGNIFICANT ACCOUNTING POLICIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The financial statements were prepared&#13;in accordance with accounting principles generally accepted in the United States of America (US GAAP).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The preparation of financial statements&#13;in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and&#13;liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported&#13;amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial&#13;statements, the most significant estimates and assumptions relate to the going concern assumptions, share based compensation and&#13;convertible loans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Functional currency&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;A majority of the Group&amp;#8217;s&#13;revenues is generated in U.S. dollars. In addition, most of the Group&amp;#8217;s costs are denominated and determined in U.S. dollars&#13;and in new Israeli shekels. Management believes that the dollar is the currency in the primary economic environment in which the&#13;Group operates. Thus, the functional and reporting currency of the Group is the U.S. dollar.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Accordingly, monetary accounts maintained&#13;in currencies other than the dollar are remeasured into dollars in accordance with Accounting Standards Codification (ASC) 830,&#13;&amp;#8220;Foreign Currency Matters&amp;#8221;. All transaction gains and losses of the remeasured monetary balance sheet items are reflected&#13;in the statements of operations as financial income or expenses, as appropriate.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Principles of consolidation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The consolidated financial statements&#13;include the accounts of the Company and its subsidiary, Save Foods Ltd. All significant intercompany balances and transactions&#13;have been eliminated on consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Cash and cash equivalents, and Restricted cash&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Cash equivalents are short-term&#13;highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted&#13;as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Restricted cash as of December 31,&#13;2020 and 2019 included a NIS 72,000 ($22,395) and NIS 132,000 ($38,194), respectively collateral account for the Company&amp;#8217;s&#13;corporate credit cards and a loan and is classified in current assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Accounts receivables&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Accounts receivables are stated&#13;at their net realizable value. The allowance against gross accounts receivables reflects the best estimate of losses inherent in&#13;the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and&#13;other currently available information. As of December 31, 2020, and 2019, an allowance for doubtful debts in the amount of $26,553&#13;and $24,702, respectively, is reflected in net accounts receivables. Accounts receivables are written off after all reasonable&#13;means to collect the full amount have been exhausted.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Property, plant and equipment, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;1.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the Statements of Operations and Comprehensive Loss.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Rates of depreciation:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Furniture and office equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7-15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Machines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10-15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;Computers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Vehicle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Impairment of long-lived assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Group&amp;#8217;s long-lived assets&#13;are reviewed for impairment in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 360, &amp;#8220;Property,&#13;Plant and Equipment&amp;#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be&#13;recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the&#13;future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment&#13;to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. No impairment expenses&#13;were recorded during the years ended December 31, 2020 or 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Deferred income taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Group accounts for income taxes&#13;in accordance with ASC Topic 740, &amp;#8220;Income Taxes&amp;#8221;. Accordingly, deferred income taxes are determined utilizing the asset&#13;and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases&#13;of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected&#13;to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary,&#13;to reduce deferred tax assets to amounts more likely than not to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Group accounts for uncertain&#13;tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,&#13;measurement and disclosure of uncertain tax positions recognized in an enterprise&amp;#8217;s financial statements. According to ASC&#13;Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&amp;#8217;s accounting policy is to&#13;classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such&#13;items in its fiscal 2020 and 2019 financial statements and did not recognize any liability with respect to an unrecognized tax&#13;position in its balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Liability for employee rights upon retirement&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Save Foods Ltd&amp;#8217;s liability&#13;for employee rights upon retirement with respect to its Israeli employees is calculated, pursuant to Israeli Severance Pay Law,&#13;based on the most recent salary of each employee multiplied by the number of years of employment, as of the balance sheet date.&#13;Employees are entitled to one month&amp;#8217;s salary for each year of employment, or a portion thereof. Save Foods Ltd. makes monthly&#13;deposits to insurance policies and severance pay funds. The liability of the Company is fully provided for.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The deposited funds include profits&#13;accumulated up to the balance sheet date. The deposited funds may be withdrawn upon the fulfillment of the obligation pursuant&#13;to Israeli severance pay laws or labor agreements. The value of the deposited funds is based on the cash surrender value of these&#13;policies, and includes immaterial profits/losses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Severance expenses for the years&#13;ended December 31, 2020 and 2019, amounted to $7,419 and $24,000, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Revenue recognition&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Revenues are recognized when delivery&#13;has occurred and there is persuasive evidence of an agreement, the fee is fixed or determinable and collection of the related receivables&#13;is reasonably assured and no further obligations exist.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Revenues from sales of products&#13;are recognized when title and risk and rewards for the products are transferred to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Research and development expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Research and development expenses&#13;are charged to operations as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Royalty-bearing grants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Royalty-bearing grants from the&#13;Israeli Innovation Authority (the &amp;#8220;IIA&amp;#8221;) for funding approved research and development projects are recognized at the&#13;time Save Foods Ltd. is entitled to such grants (i.e. at the time that there is reasonable assurance that the Company will comply&#13;with the conditions attached to the grant and that there is reasonable assurance that the grant will be received), on the basis&#13;of the costs incurred and reduce research and development costs. The cumulative research and development grants received by the&#13;Company from inception through December 2020 amounted to NIS 484,429 (US$150,678).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;As of December 31, 2020, and 2019,&#13;the Company did not accrue for or pay any royalties to the IIA since no revenues were recognized in respect of the funded projects.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Inventories are valued at the lower&#13;of cost or net realizable value. Cost of raw and packaging materials, purchased products, manufactured finished products and products&#13;in process are determined on the average costs basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company regularly reviews its&#13;inventories for impairment and reserves are established when necessary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Basic and diluted loss per common stock&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Basic loss per common stock is computed&#13;by dividing the loss for the period applicable to shareholders, by the weighted average number of shares of common stock outstanding&#13;during the period. Securities that may participate in dividends with the shares of common stock (such as the convertible preferred)&#13;are considered in the computation of basic loss per share under the two-class method. However, in periods of net loss, only the&#13;convertible preferred shares are considered, since such shares have a contractual obligation to share in the losses of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In computing diluted loss per share,&#13;basic loss per share is adjusted to reflect the potential dilution that could occur upon the exercise of potential shares. Accordingly,&#13;in periods of net loss, no potential shares are considered.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock-based compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company measures and recognizes&#13;the compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC&#13;718, &amp;#8220;Compensation-Stock Compensation&amp;#8221;. Share-based payments including grants of stock options are recognized in the&#13;statement of comprehensive loss as an operating expense based on the fair value of the award at the date of grant. The fair value&#13;of stock options granted is estimated using the Black-Scholes option-pricing model. The Company has expensed compensation costs,&#13;net of estimated forfeitures, applying the accelerated vesting method, over the requisite service period or over the implicit service&#13;period when a performance condition affects the vesting, and it is considered probable that the performance condition will be achieved.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Share-based payments awarded to&#13;consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, &amp;#8220;Equity-Based Payments to Non-Employees&amp;#8221;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Fair value of certain of the Company&amp;#8217;s&#13;financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued&#13;liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with&#13;ASC 820, &amp;#8220;Fair Value Measurements and Disclosure&amp;#8221; defines fair value, establishes a framework for measuring fair value&#13;in accordance with generally accepted accounting principles and expands disclosures about fair value investments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Fair value, as defined in ASC 820,&#13;is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants&#13;at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or&#13;most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the&#13;risk of non-performance, which includes, among other things, the Company&amp;#8217;s credit risk.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Valuation techniques are generally&#13;classified into three categories: the market approach; the income approach; and the cost approach. The selection and application&#13;of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset&#13;or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize&#13;the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs&#13;and resulting measurement as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Level 1: Quoted prices (unadjusted)&#13;in active markets that are accessible at the measurement date for identical assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Level 2: Quoted prices for similar&#13;assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active;&#13;inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or&#13;corroborated by observable market data for substantially the full term of the assets or liabilities; and&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Level 3: Unobservable inputs for&#13;the asset or liability that are supported by little or no market activity, and that are significant to the fair values.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Fair value measurements are required&#13;to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair&#13;value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements&#13;including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to&#13;the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings,&#13;and a description of where those gains or losses included in earning are reported in the statement of income.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company records a debt discount&#13;related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible&#13;instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and&#13;as a reduction to the carrying amount of the convertible instrument equal to the fair value of the conversion features. The debt&#13;discount will be accreted by recording additional non-cash gains and losses related to the change in fair values of derivative&#13;liabilities over the life of the convertible notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company&amp;#8217;s financial assets&#13;and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Balance as of December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 48%; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Fair Value of convertible component in convertible loan&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;The following table presents the&#13;changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Fair value of Convertible component&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 71%"&gt;&lt;font style="font-size: 10pt"&gt;Fair value of issued level 3 liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,762&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Changes in fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Concentrations of credit risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Financial instruments that potentially&#13;subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents as well as certain other current&#13;assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held in Dollars and New Israeli&#13;Shekels, are deposited with major banks in Israel and United States. Management believes that such financial institutions are financially&#13;sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant&#13;off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company records accruals for&#13;loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and&#13;the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information&#13;becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;New Accounting Pronouncements &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In June&#13;2016, the Financial Accounting Standards Board (the &amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;)&#13;No. 2016-13, &amp;#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.&amp;#8221;&#13;In November 2018, FASB issued ASU No. 2018-19, &amp;#8220;Codification Improvements to Topic 326, Financial Instruments-Credit Losses&amp;#8221;,&#13;which amends the scope and transition requirements of ASU 2016-13. Topic 326 requires a financial asset (or a group of financial&#13;assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected&#13;credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable&#13;and supportable forecasts that affect the collectability of the reported amount. Topic 326 will originally become effective for&#13;the Company beginning January 1, 2020, with early adoption permitted, on a modified retrospective approach. As a smaller reporting&#13;company, the effective date for the Company has been delayed until fiscal years beginning after December 15, 2022, in accordance&#13;with ASU 2019-10, although early adoption is still permitted. This standard did not have a material impact to the Company&amp;#8217;s&#13;consolidated financial statements after evaluation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In December&#13;2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this&#13;ASU simplify the accounting for income taxes, eliminates certain exceptions to the general principles in Topic 740 and clarifies&#13;certain aspects of the current guidance to improve consistent application among reporting entities. ASU 2019-12 is effective for&#13;fiscal years beginning after December 15, 2021 and interim periods within annual periods beginning after December 15, 2022, though&#13;early adoption is permitted, including adoption in any interim period for which financial statements have not yet been issued.&#13;This standard is not expected to have a material impact to the Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In August&#13;2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements&#13;for Fair Value Measurement. This standard will require entities to disclose the amount of total gains or losses for the period&#13;recognized in other comprehensive income that is attributable to fair value changes in assets and liabilities held as of the balance&#13;sheet date and categorized within Level 3 of the fair value hierarchy. This ASU will be effective for the Company for annual and&#13;interim periods beginning after December 31, 2020. Early adoption of this standard is permitted. This standard did not have a material&#13;impact to the Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In August&#13;2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#13;Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity s Own Equity.&#13;ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible&#13;debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features&#13;being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject&#13;to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract,&#13;that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible&#13;debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends&#13;the guidance for the derivatives scope exception for contracts in an entity&amp;#8217;s own equity to reduce form-over-substance-based&#13;accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2023,&#13;including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after&#13;December 15, 2020, including interim periods within those fiscal years. Management has not yet evaluated the impact that the adoption&#13;of ASU 2020-06 will have on the Company&amp;#8217;s consolidated financial statement presentation or disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Other new pronouncements issued&#13;but not effective as of December 31, 2020 are not expected to have a material impact on the Company&amp;#8217;s consolidated financial&#13;statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 3 &amp;#8211; OTHER CURRENT&#13;ASSETS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Prepaid expenses and advances to vendors&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,811&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Receivables from sale of subsidiary (Note 5)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,704&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Government Institutions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,855&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,489&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;65,579&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;15,300&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 4 &amp;#8211; PROPERTY AND&#13;EQUIPMENT, NET&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Computers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and office equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Machines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;130,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;134,665&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;85,149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;85,149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;231,276&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;235,144&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less - accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(139,382&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(117,325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less &amp;#8211; Impairment of long lived assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(36,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(36,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total property and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;55,194&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;81,119&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the years ended December 31, 2020 and 2019,&#13;depreciation expenses were US$ 22,512 and US$ 27,351 respectively, and additional property and equipment were purchased in an amount&#13;of US$ 23,327 for the years ended December 31, 2019 (none for the year ended December 31, 2020).&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 5 &amp;#8211; OTHER ACCOUNTS&#13;LIABILITIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Employees and related institutions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;110,220&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;135,901&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;392,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;184,616&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Right Of Use liability arising from operating lease&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,049&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;52,093&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Affiliated company (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;517,711&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;380,732&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On April 2, 2019, the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. (&amp;#8220;Savescann&amp;#8221;) a newly formed company registered in Canada. Savecann intended to market the Company&amp;#8217;s solutions to the Cannabis market.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On April 21, 2020, the Company sold its entire holdings in Savecann for total consideration of 10,000 Canadian Dollars ($7,000), of which $2,704 were not paid yet and are presented as part of other current assets.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;NOTE 6 &amp;#8211; CONVERTIBLE LOANS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;A.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;In December 2019, the Company entered into a series of Convertible Loan Agreements (each a &amp;#8220;CLA&amp;#8221;) with third parties and certain existing shareholders (the &amp;#8220;Lenders&amp;#8221;), pursuant to which the Lenders agreed to provide the Company loans in the aggregate amount of $379,000 and in exchange the Company issued to the Lenders (i) convertible promissory notes (the &amp;#8220;Notes&amp;#8221;) and (ii) warrants with an exercise price of $8.40. In January and March 2020, the Company entered into two additional CLA agreements for an aggregate amount of $135,000, consisting of the same terms.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;According to the terms of the CLA, the Notes bear interest at a rate of 5% per annum and the loan amount represented by the Notes is to be repaid to the Lenders according to the following schedule: (i) the principal amount represented by the Notes to be repaid in twenty four equal monthly installments, commencing on the twenty fifth month following the closing of each CLA, and (ii) the interest accrued on the loan amount to be paid in two bi-annual installments, commencing on the first anniversary of the first payment of the principal amount.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;In addition, according to the terms of the CLA, the outstanding loan amount matures on the earlier of (i) the third anniversary of each CLA or (ii) a deemed liquidation event (as defined therein), and the Lenders may convert all or any portion of the Notes at any time prior to the one-year anniversary of each issuance into shares of the Company&amp;#8217;s Common Stock at a conversion price of $8.40 per share.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;In accordance with ASC 815-15-25, the conversion feature was considered embedded derivative instruments, and is to be recorded at their fair value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component fair value over the face loan amount. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of the above issuances, the Company&#13;        recorded in the periods ended March 31, 2020 and December 31, 2019, a total amount of $34,696 and $97,406, respectively, in respect&#13;        of the detachable warrants, as a credit to stockholders&amp;#8217; equity (additional paid in capital). The fair value of the Warrants&#13;        was determined using the Black-Scholes pricing model, assuming a risk free rate of 1.6%, a volatility factor of 54.00%, dividend&#13;        yields of 0% and an expected life of 3 years.&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On June 24, 2020, the Company entered into a Securities Purchase Agreement (the &amp;#8220;SPA&amp;#8221;) with the Lenders in connection with the sale and issuance of 69,332 units (&amp;#8220;Units&amp;#8221;), at a purchase price of $7.63 per Unit. Each Unit consists of: (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.4 (the &amp;#8220;Warrant&amp;#8221;). In connection with the SPA, the Company issued to the Lenders an aggregate of 67,369 shares of Common Stock and Warrants to purchase an aggregate of 67,369 shares of Common Stock. The shares of Common Stock were issued on July 2, 2020.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Simultaneous with and conditioned upon the execution of the SPA, the Company and each of the Lenders agreed to effectively cancel the CLA and the equity securities issued thereunder. In connection therewith, each of the Lenders voluntarily waived any right to receive interest that accrued thereupon pursuant to the CLA.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;The Company evaluated the transaction as an exchange of instruments and as a result of the above conversion, recorded a compensation expenses in a total amount of $57,793, as of the exchange date, and as a credit to stockholders&amp;#8217; equity (additional paid in capital). The fair value of the additional shares granted in the conversion was calculated based on the Company&amp;#8217;s share price as of the date of the conversion. The fair value of the additional warrants granted in the conversion was determined using the Black-Scholes pricing model, assuming a risk-free rate of 0.21%, a volatility factor of 51.96%, dividend yields of 0% and an expected life of 2.45-2.71 years.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;During the years ended December 31, 2020 and 2019, the Company recorded net interest and amortization expenses in the amount of $199,709 and $4,323, respectively, in respect of the discounts recorded on the CLAs.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;B.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On September 21, 2020, the Company entered into a series of additional convertible loan agreements (each a &amp;#8220;2020 CLA&amp;#8221;) with certain lenders (the &amp;#8220;2020 Lenders&amp;#8221;) to sell convertible promissory notes with an aggregate principal amount of $125,000 (each a &amp;#8220;2020 Note&amp;#8221;). The outstanding loan amount under the 2020 CLA will mature on the earlier of (i) the third anniversary of each 2020 CLA or (ii) a deemed liquidation event (as defined therein), and the 2020 Lenders may convert all or any portion of the 2020 Notes into shares of Common Stock at any time prior to a mandatory conversion event (as defined therein) at a conversion price of $7.63 per share. The 2020 Notes will bear interest at a rate of 5% per annum. The loan amount represented by the 2020 Notes will be repaid to the 2020 Lenders according to the following schedule: (i) the principal amount represented by the 2020 Notes will be repaid in four bi-annual installments, commencing on the first anniversary following the closing of each 2020 CLA, and (ii) the interest accrued on the loan amount will be paid in two bi-annual installments, commencing on the first anniversary of the first payment of that principal amount.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;During October 2020, the Company entered into a series of additional 2020 CLAs with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal amount of $100,000.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;During January 2021, the Company entered into a series of additional 2020 CLAs with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal amount of $274,000. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;As part of the 2020 CLA, the Company entered into a registration rights agreement with each of the 2020 Lenders, whereby each 2020 Lender received piggyback registration rights for the shares issuable upon conversion of the 2020 Notes to shares of Common Stock.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The loans are convertible into common&#13;Stock upon (i) a completion of underwritten public offering (&amp;#8220;Mandatory Conversion&amp;#8221;) convert the outstanding loan amount&#13;at a share price as shall be determined in the offering, or (ii) at the lender&amp;#8217;s discretion (&amp;#8220;Optional Conversion&amp;#8221;)&#13;convert the outstanding loan amount at a share price per share of $7.63.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In accordance with ASC 815-15-25,&#13;the conversion feature was considered embedded derivative instruments, and is to be recorded at their fair value as its fair value&#13;can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded&#13;finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component&#13;fair value over the face loan amount. The conversion liability is then marked to market each reporting period with the resulting&#13;gains or losses shown in the statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The fair value of the convertible&#13;component was estimated by third party appraiser as weighted average of the two possible scenarios of the total loan amount conversion:&#13;as of September 21, 2020 and October 23, 2020, 70% probability for the Mandatory Conversion and 30% probability for the Optional&#13;Conversion and as of December 31, 2020, 75% probability for the Mandatory Conversion and 25% probability for the Optional Conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Mandatory Conversion (scenario&#13;1) was estimated by the appraiser using the Black-Scholes option pricing model, to compute the fair value of the derivative and&#13;to market the fair value of the derivative at each balance sheet date. The following are the data and assumptions used as of issuance&#13;dates and as of the balance sheet date:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 21, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;October 23,&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 43%"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected term (years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.775&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.685&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.417&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,457&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;47,499&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Optional Conversion (scenario&#13;2) was estimated by the appraiser using binomial option pricing model and simulating and waiver of the lender as an exercise price,&#13;to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date.&#13;The following are the data and assumptions used as of the issuance dates and as of balance sheet date:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 21, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;October 23, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 45%"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.12-0.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.12-0.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.10-0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,824&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,167&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;77,381&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The fair value of the convertible&#13;component was estimated by the third-party appraiser after giving effect to the weighted average of the two possible scenarios&#13;as of issuance dates was $27,762 and as of December 31, 2020 was $54,970.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The fair value allocated to the&#13;convertible loan was estimated by third party appraiser as the residual value of the proceeds net of the convertible component&#13;and was estimated at a value of $203,179 as of December 31, 2020 of which $56,250 is presented under current liabilities and $146,929&#13;is presented under long term liabilities.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebtTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-indent: -68.05pt"&gt;&lt;b&gt;NOTE 7 - LONG-TERM LOANS FROM&#13;BANKING INSTITUTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-indent: -68.05pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 38px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Composition&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Interest rate at&lt;br /&gt;&#13;        December 31&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Long-term loans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;16,064&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;22,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less current maturities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(7,949&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(7,230&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,955&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 38px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Maturity dates:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;First year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,949&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Second year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;16,064&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 8 &amp;#8211; COMMITMENT AND&#13;CONTINGENT LIABILITIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;A.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Save Foods Ltd. is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. Save Foods Ltd. was entitled to the grants only upon incurring research and development expenditures. There were no future performance obligations related to the grants received from the IIA. As of December 31, 2020, the contingent liabilities with respect to grants received from the IIA, subject to repayment under these royalty agreements on future sales is NIS 484,429 (US$ 150,678), not including interest.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;B.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;The Company and its subsidiary currently lease office space at Kibbutz Alonim under a short-term operating lease agreement ends at December 31, 2020 with an option to extend the agreement with additional year ended at December 31, 2021. During the years 2020 and 2019, the Company paid an annual rent of $14,967 and $10,605, respectively under the above agreement. The agreement was automatically renewed (option) until December 31, 2021.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In addition, the Company and Save&#13;Foods Ltd. entered into a short term lease agreement for the period ended at May 31, 2019, with a shareholder for the lease of&#13;an office and related services for a monthly fee of NIS 5,000 (approximately $1,400).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On May 1, 2019 the Company and Save&#13;Foods Ltd. entered into a lease agreement for its offices in Tel Aviv for the period ending December 31, 2020, for the lease of&#13;an office and management fees for a monthly fee of NIS 11,214 (approximately $3,450). On August 9, 2020, the Company and the lessor&#13;agreed that the Company would pay the lessor a one-time NIS10,000 ($3,100) and the agreement would be terminate as of August 13,&#13;2020&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On September 1, 2017, the Company&#13;entered into a lease agreement for office space in New York, hereinafter the New York Lease. The New York Lease will expire on&#13;September 30, 2020, unless terminated earlier by either party by providing 30 days prior written notice to the other party. The&#13;New York Lease rent amount, $7,200, was fully paid for through an issuance of 720,000 shares of our Common Stock on November 5,&#13;2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;C.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;In July 2011, Save Foods, Ltd. filed with the Commissioner of Patent of the Israeli Patent Office (the &amp;#8220;Commissioner&amp;#8221;) a claim stating its opposition to a patent application made by Xeda International S.A, (&amp;#8220;Xeda&amp;#8221;), which would have restricted Save Foods Ltd&amp;#8217;s operations.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In June 2018, the Commissioner accepted&#13;Save Foods Ltd&amp;#8217;s claims against Xeda&amp;#8217;s patent application and, accordingly, rejected Xeda&amp;#8217;s application. The&#13;Commissioner awarded Save Foods Ltd. with expenses and legal fees in the aggregate amount of approximately NIS 165,000 (approximately&#13;$46,000)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In September 2018, Xeda filed an&#13;appeal with the District Court in Jerusalem (the &amp;#8220;Court&amp;#8221;), with respect to the Commissioner&amp;#8217;s decision, and in&#13;January 2019, the Court dismissed Xeda&amp;#8217;s appeal and awarded Save Foods Ltd. expenses and legal fees in the aggregate amount&#13;of approximately NIS 50,000 (approximately $13,000).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In February 2019, Xeda filed a request&#13;to appeal the Court&amp;#8217;s decision with the Israeli Supreme Court. In May 2019, the Israeli Supreme Court rejected Xeda&amp;#8217;s&#13;request to appeal and awarded Save Foods Ltd. expenses and legal fees in the aggregate amount of NIS 8,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;D.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On September 22, 2020, the Company entered into a non-exclusive Commission Agreement with Earthbound Technologies, LLC (&amp;#8220;EBT&amp;#8221;) for a period of 12 months, according to which EBT shall introduce the Company to potential clients, pre-approved by the Company (&amp;#8220;Introduced Parties&amp;#8221;) and shall assist the Company in finalizing commercial agreements with the Introduced Parties. In consideration for its services, the Company agreed to pay EBT 12.5% of the net revenues generated from Introduced Parties (during the agreement period and within 18 months following the termination of the agreement) up to a total aggregated amount of $2,000,000, provided that the compensation shall not exceed 25% of the Company&amp;#8217;s gross profit under the given commercial agreement signed with the Introduced Party. In addition, in the event that the aggregated net revenues generated from Introduces Parties exceeds $500,000, and subject to the approval of the Board, the Company shall issue to EBT 7,143 options to purchase 7,143 shares of Common Stock at an exercise price of $8.4 per share. In the event that certain additional events detailed in the agreement occur, the Company will also issue to EBT, subject to the approval of the Board, an additional 7,143 options to purchase 7,143 shares of Common Stock at an exercise price of $8.4 per share.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;E.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On September 22, 2020, the Company entered into a Distribution Agreement (the &amp;#8220;Distribution Agreement&amp;#8221;), with Safe-Pack Products Ltd (&amp;#8220;Safe-Pack&amp;#8221;) according to which the Company granted Safe-Pack an exclusive right to resell, distribute, advertise, and market Company&amp;#8217;s products related to the citrus industry in Israel and other territories, as well as additional products as shall be mutually agreed upon in the future. In addition, the Company agreed to grant Safe-Pack a right of first refusal to be designated as an exclusive distributor of the Company in certain agreed upon territory for additional products of the Company as they relate to the field of post-harvest. In consideration for the above rights granted to Safe-Pack, Safe-Pack will submit to the Company purchase orders of its products at a price specified in the Distribution Agreement. Commencing upon the second calendar year of the agreement, Safe-Pack is required to meet a minimum purchase quota, as shall be mutually agreed upon between the parties. In the event that the parties fail to agree on a quota, the quota shall be equal to last year quota plus 3%.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 9 &amp;#8211; SHAREHOLDERS&amp;#8217;&#13;EQUITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Description of the rights&#13;attached to the Shares in the Company:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;Common stock:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Each share of common stock entitles&#13;the holder to one vote, either in person or by proxy, at meetings of stockholders. The holders are not permitted to vote their&#13;shares cumulatively. Accordingly, the stockholders of the Company&amp;#8217;s common stock who hold, in the aggregate, more than fifty&#13;percent of the total voting rights can elect all of the directors and, in such event, the holders of the remaining minority shares&#13;will not be able to elect any of such directors. The vote of the holders of a majority of the issued and outstanding shares of&#13;common stock entitled to vote thereon is sufficient to authorize, affirm, ratify or consent to such act or action, except as otherwise&#13;provided by law.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;Transactions:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During January 2019 the Company&#13;issued total of 19,050 shares of Common Stock of the Company $0.0001 par value, to accredited investors for total consideration&#13;of $120,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During February 2019 the Company&#13;issued total of 35,717 shares of Common Stock of the Company $0.0001 par value, to accredited investors for total consideration&#13;of $225,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During March 2019 the Company issued&#13;total of 15,874 shares of Common Stock of the Company $0.0001 par value, to accredited investor for total consideration of $100,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In addition, during March 2019 the&#13;Company issued 7,937 shares of Common Stock of the Company $0.0001 par value, to an accredited investor for total consideration&#13;of $50,000 and at the same time issued him 7,937 shares of Common Stock $0.0001 par value for total consideration of $66,666 and&#13;7,937 warrants to purchase the company shares of Common Stock at an exercise price of 84 cents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During June 2019, the Company issued&#13;total of 31,747 shares of Common Stock of the Company $0.0001 par value, to accredited investors for total consideration of $200,000.&#13;In addition, During June 2019 the Company issued 10,004 shares of Common Stock of the Company $0.0001 par value, to an accredited&#13;investor for total consideration of $84,034 and at the same time issued that accredited investor 10,004 warrants to purchase the&#13;company shares of Common Stock at an exercise price of 84 cents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During August 2019, the Company&#13;signed a subscription agreement with an investor according to which the Company will issue total of 11,905 shares of Common Stock&#13;of the Company $0.0001 par value, to accredited investor for total consideration of $100,000. In addition, and at the same time&#13;issued that accredited investor 11,905 warrants to purchase the company shares of Common Stock at an exercise price of 84 cents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On May 9, 2020, the Company entered&#13;into a Securities Purchase Agreement (the &amp;#8220;May Agreement&amp;#8221;) with an existing shareholder (the &amp;#8220;Investor&amp;#8221;),&#13;pursuant to which the Company sold to the Investor for an aggregated amount of $100,000, 13,107 units at a price per unit of $7.63&#13;(the &amp;#8220;2019 Units&amp;#8221;), each 2019 Unit consists of (i) one share of Common Stock and (ii) one warrant to purchase one share&#13;of Common Stock with an exercise price of $8.40 for a period of 36 months following the issuance date. The shares of Common Stock&#13;were issued on July 2, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On July 2, 2020, the Company issued&#13;67,369 shares of Common Stock in respect of the conversion of convertible loans as detailed in Note 3A above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During July and August 2020, the&#13;Company entered into additional Securities Purchase Agreements with existing shareholders (the &amp;#8220;Additional Investors&amp;#8221;),&#13;pursuant to which the Company sold to the Additional Investors for an aggregate amount of $150,000, 19,662 units, based substantially&#13;upon the same terms as in the May Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On September 23, 2020, the Company&#13;entered into a Securities Purchase Agreement (the &amp;#8220;Medigus SPA&amp;#8221;) with Medigus Ltd. (&amp;#8220;Medigus&amp;#8221;) in connection&#13;with the sale and issuance of 13,107 units for total consideration of $100,000, based substantially upon the same terms as in the&#13;May Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Medigus SPA contemplates an&#13;additional investment by Medigus not to exceed $25,000 (the &amp;#8220;Additional Medigus Investment&amp;#8221;), which shall be triggered&#13;following the parties&amp;#8217; initiation of a proof of concept procedure to test the effectiveness of the Company&amp;#8217;s sanitizers&#13;and its residual effects on surfaces against different pathogens including COVID-19. In consideration for the Additional Medigus&#13;Investment, the Company has agreed to issue an additional 3,277 units at a purchase price of $7.63, which units shall contain the&#13;same composition of securities as described in the foregoing description of the Medigus SPA.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On September 22, 2020 and September&#13;24, 2020, the Chairman of the Board of Directors of the Company (the &amp;#8220;Board&amp;#8221;), exercised a warrant to purchase an aggregate&#13;of 28,572 shares of Common Stock, which warrants were granted to him on June 15, 2020 by the Board as a replacement for his recently&#13;expired options, which were previously granted to him in April 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;During December 2020, two directors&#13;on Save Food Ltd exercised 6,350 options under the 2018 Equity Incentive Plan into 6,350 shares of common stock of the Company&#13;total consideration of $20,000.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;b&gt;NOTE 10&#13;&amp;#8211; STOCK OPTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On October 18, 2018, the Company&#13;adopted the 2018 Share Incentive Plan (the &amp;#8220;2018 Equity Incentive Plan&amp;#8221;), pursuant to which the Company&amp;#8217;s Board&#13;of Directors is authorized to grant up to 190,477 options, exercisable into 190,477 shares of Common Stock of the Company. The&#13;purpose of the 2018 Equity Incentive Plan is to offer attract and retain the best available personnel, provide incentive to individuals&#13;who perform services for the Company and promote the success of the Company&amp;#8217;s business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On January 3, 2019, the Company&#13;granted of 80,954 options under the 2018 Equity Incentive Plan of which 9,524 options are vested quarterly over three years commencing&#13;May 15, 2018, 35,715 options are vested 1/3 after a year commencing October 1, 2018 and the remaining 2/3 are vested quarterly&#13;over additional two years, 14,286 options are vested quarterly over three years commencing October 1, 2018 and 21,429 options are&#13;vested 1/3 after a year commencing January 1, 2019 and the remaining 2/3 are vested quarterly over additional two years&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On April, 2019, the Board of Directors&#13;of the Company approved the issuance of 28,572 options to purchase 28,572 Company&amp;#8217;s Common Stock 0.0001 par value, to Mr.&#13;Dan Sztybel, under the Company&amp;#8217;s 2018 Equity Incentive Plan. The options shall vest quarterly over three years, commencing&#13;April 1, 2019, and shall be exercisable for an exercise price of $3.15 per share. In addition, the Board of Directors of the Company&#13;approved the issuance of 14,286 options to purchase 14,286 Company&amp;#8217;s Common Stock 0.0001 par value, to Mr. Dan Sztybel, subject&#13;to Save Foods Ltd&amp;#8217;s obtainment of certain EPA and FDA approvals by the end of the second quarter of 2020. Such conditions&#13;did not met as of June 30, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On November 12, 2019, the Board&#13;of Directors of the Company approved the grant of 45,239 options under the 2018 Equity Incentive Plan of which 28,572 options are&#13;vested quarterly over three years commencing January 3, 2019, 9,524 options are vested 1/3 after a year commencing January 3, 2019&#13;and the remaining 2/3 are vested quarterly over additional two years, and 7,143 options are vested 1/3 after a year commencing&#13;October 1, 2019 and the remaining 2/3 are vested quarterly over additional two years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In addition, the Board of Directors&#13;approved the agreement with a consultant, according to which the consultant would receive 2,858 fully vested options to purchase&#13;Company&amp;#8217;s shares at exercise price of $6.3 per option for certain &amp;#8220;closed&amp;#8221; introduction made by the consultant&#13;in Chile. No options were granted under this agreement as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On June 23, 2020, the Company granted&#13;21,143 options to purchase its Common Stock under the 2018 Equity Incentive Plan (the &amp;#8220;Plan&amp;#8221;). The options shall vest&#13;quarterly over two years commencing June 23, 2020, whereby 12.50% of the shares covered by the options will vest on the three month&#13;anniversary of June 23, 2020, and 12.50% of the shares covered by the options will vest at the end of each subsequent three month&#13;period thereafter over the course of the subsequent 21 months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On July 1, 2020, the Company granted&#13;71,431 options to purchase its Common Stock under the 2018 Equity Incentive Plan. The options shall vest quarterly over two years&#13;commencing June 1, 2020, whereby 12.50% of the shares covered by the options will vest on the three month anniversary of June 1,&#13;2020, and 12.50% of the shares covered by the options will vest at the end of each subsequent three month period thereafter over&#13;the course of the subsequent 21 months. The fair value of the options was estimated at a value of $344,767 at the date of issuance&#13;using the Black-Scholes option pricing model.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In addition, on July 1, 2020, the&#13;Board approved an increase to the share option pool under the Plan by 99,466 shares of Common Stock, such that after the increase&#13;the total number of shares of Common Stock issuable under the Plan is 289,942 shares of Common Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;On September 22, 2020, the Board&#13;approved an amendment of the terms of the outstanding options granted to certain employees and directors of the Company. According&#13;to the new terms, subject to the consummation of equity financing in excess of $1,000,000 and the completion of listing of the&#13;Company&amp;#8217;s Common Stock for trade on the Nasdaq, and in the event that the employment or engagement of such grantee is either&#13;terminated (not for cause) or otherwise changed thereby resulting in the conclusion of such engagement (including voluntary resignation),&#13;all outstanding options of such grantee shall vest immediately and shall be exercisable for a period of three years following the&#13;termination date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The following table presents the&#13;Company&amp;#8217;s stock option activity for employees and directors of the Company for the year ended December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;59,525&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Granted (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;109,526&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,762&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;164,289&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;92,574&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.64&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(29,365&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(14,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;206,862&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Number of options exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;97,351&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -25.65pt"&gt;(*) Options&#13;that were granted on January 3, 2019 with vesting that commences before December 31, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The aggregate intrinsic value of&#13;the awards outstanding as of December 31, 2020 is US$1,084,465. These amounts represent the total intrinsic value, based on the&#13;Company&amp;#8217;s stock price of US$ 8.61 as of December 31, 2020, less the weighted exercise price. This represents the potential&#13;amount received by the option holders had all option holders exercised their options as of that date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The fair value of options granted&#13;was estimated at the dates of grant using the Black-Scholes option pricing model. The following are the data and assumptions used:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility (%) (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate (%) (**)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.56-2.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected term of options (years) (***)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price (US dollars)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15-3.78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Share price (US dollars)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Fair value (US dollars)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.83-5.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 53.85pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 11%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 84%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(**)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;The risk-free interest rate represented the risk-free rate of US$ zero &amp;#8211; coupon US Government Loans.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(***)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the &amp;#8220;simplified method&amp;#8221; in accordance with SEC Staff Accounting Bulletin No. 110.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 120.5pt; text-align: justify; text-indent: -42.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The total fair value estimation&#13;of the non-cash compensation of the grant at 2020 and 2019 was approximately $453,976 and $440,848, respectively. Costs incurred&#13;in respect of stock-based compensation for employees and directors, for the year ended December 31, 2020 and 2019 were $492,619&#13;and $438,670, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52.5pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;As of December 31, 2020, there are&#13;76,730 options available for future grants under the 2018 Equity Incentive Plan.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <SAFO:CostOfSalesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 11 &amp;#8211; COST OF SALES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 71%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Salaries and related expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8,074&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35,142&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,402&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14,531&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16,692&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69,390&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vehicle maintenance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,063&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8,455&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Travel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,408&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Transportation and storage&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,632&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13,299&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,564&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;43,405&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;144,548&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:CostOfSalesTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 12 &amp;#8211; RESEARCH AND&#13;DEVELOPMENT EXPENSES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and related expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;39,021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;177,712&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;91,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;75,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Professional fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;130,592&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;178,854&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,319&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,544&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Travel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,138&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Vehicle maintenance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,657&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Rent and asset management&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,582&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Laboratory and Field tests&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;72,593&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;73,968&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33,438&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;25,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;417,000&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;615,623&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <SAFO:GeneralAndAdministrativeExpensesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 13 &amp;#8211; GENERAL AND&#13;ADMINISTRATIVE EXPENSES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Professional services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;443,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;461,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;416,996&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;283,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;67,492&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Insurance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;63,380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Rent and office maintenance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,080&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Levies and tolls&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,477&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,601&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Communications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,679&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,914&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Travel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,310&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,848&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,995&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;1,070,109&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;1,004,899&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:GeneralAndAdministrativeExpensesTextBlock>
    <SAFO:FinancingExpensesNetDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 14 &amp;#8211; FINANCING EXPENSES,&#13;NET&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Interest and amortization expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;202,917&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Currency exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,037&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,266&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Changes in fair value of convertible loans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Bank charges and other finance expenses, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,819&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;270,393&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;43,408&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:FinancingExpensesNetDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 15 &amp;#8211; INCOME TAX&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 72px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;A.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;US resident companies are taxed on their worldwide&#13;        income for corporate income tax purposes at a statutory rate of 21% this reflect certain effects of the Act which includes a reduction&#13;        in the corporate tax rate from 35% to 21% as well as other changes. No further taxes are payable on this profit unless that profit&#13;        is distributed. If certain conditions are met, income derived from foreign subsidiaries is tax exempt in the US under applicable&#13;        tax treaties to avoid double taxation.&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income of the Israeli company is taxable from&#13;        2018 and onwards, at corporate tax rate of 23%.&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company and Save Foods Ltd. has not received&#13;        final tax assessments since its inception.&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2020, the Company and Save&#13;        Foods Ltd. has estimated carry forward losses for tax purposes of approximately $1,264,000 and $9,412,000, respectively, which&#13;        can be offset against future taxable income, if any.&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 7%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;B.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;The following is reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal tax rate) and the tax expense reported in the financial statements:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Pretax loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,593,139&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,971,417&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Federal tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Income tax computed at the ordinary tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;334,559&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;413,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Non-deductible expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(63,565&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,278&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(109,772&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(93,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Tax in respect of differences in corporate tax rates&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,480&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,688&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Losses and timing differences in respect of which no deferred taxes were generated&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(174,702&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(344,438&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 7%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;C.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Deferred taxes result primarily from temporary differences in the recognition of certain revenue and expense items for financial and income tax reporting purposes. Significant components of the Company&amp;#8217;s future tax assets are as follows:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Composition of deferred tax assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 66%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Provision for employee related obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,627&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,353&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Non capital loss carry forwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,350,367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,171,821&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,381,994&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,201,174&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 17 &amp;#8211; RELATED PARTIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;A. Transactions and balances&#13;with related parties&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;General and administrative expenses:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 66%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Directors compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;380,756&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;295,088&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and fees to officers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;336,433&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;358,370&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Consultants and other fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;52,331&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(*) 769,520&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(*) 653,458&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;(*) share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;394,756&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;272,077&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Research and development expenses:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and fees to officers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;25,301&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;116,692&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;B. Balances with related parties&#13;and officers:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%; padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other accounts payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;424,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;199,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;C. Other information:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 96px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;A.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On November 5, 2020, the board of directors of the Company appointed Mr. David Palach, to serve as co-Chief Executive Officer of the Company, effective as of the same date. In connection with Mr. Palach&amp;#8217;s appointment, the parties entered into a Consulting Agreement pursuant to which the Company and Mr. Palach agreed upon, inter alia, the following engagement terms: (a) a monthly retainer of $8,000, and (b) a grant of options to purchase shares of the Company&amp;#8217;s common stock, which amount shall be determined by the Board on a future date.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 96px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;B.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On October 10, 2018 the Board of directors of Save Foods Ltd. approved to engage in consulting agreements with Amir Uziel Economic Consultant Ltd (a company controlled by Amir Uziel) and with L.A Pure Capital Ltd (a company controlled by Kfir Zilberman) at a monthly fee of $1,500.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 96px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;C.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On October 10, 2018 the Board of directors of Save Foods Ltd. approved a monthly directors fee of $1,500 to Itzhak Shrem.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 17 &amp;#8211; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 96px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;A.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On February 23, 2021, the Company amended its Certificate of Incorporation to effect a 7 to 1 reverse stock split of the Company&amp;#8217;s outstanding Common Stock. As a result of the reverse stock split, which became effective on February 23, 2021, every 7 shares of the Company&amp;#8217;s outstanding Common Stock prior to the effect of that amendment was combined and reclassified into one share of the Company&amp;#8217;s Common Stock. No fractional shares were issued in connection with or following the reverse split. The number of authorized capital of the Company&amp;#8217;s Common Stock and par value of the shares remained unchanged.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"&gt;All share, stock option and per&#13;share information in these condensed consolidated financial statements have been restated to reflect the stock split on a retroactive&#13;basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 96px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;B.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;During January 2021, the Company entered into a series of additional 2020 CLAs (See note 6B above) with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal amount of $274,000.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Functional currency&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;A majority of the Group&amp;#8217;s&#13;revenues is generated in U.S. dollars. In addition, most of the Group&amp;#8217;s costs are denominated and determined in U.S. dollars&#13;and in new Israeli shekels. Management believes that the dollar is the currency in the primary economic environment in which the&#13;Group operates. Thus, the functional and reporting currency of the Group is the U.S. dollar.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Accordingly, monetary accounts maintained&#13;in currencies other than the dollar are remeasured into dollars in accordance with Accounting Standards Codification (ASC) 830,&#13;&amp;#8220;Foreign Currency Matters&amp;#8221;. All transaction gains and losses of the remeasured monetary balance sheet items are reflected&#13;in the statements of operations as financial income or expenses, as appropriate.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Principles of consolidation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The consolidated financial statements&#13;include the accounts of the Company and its subsidiary, Save Foods Ltd. All significant intercompany balances and transactions&#13;have been eliminated on consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Cash and cash equivalents, and Restricted cash&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Cash equivalents are short-term&#13;highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted&#13;as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Restricted cash as of December 31,&#13;2020 and 2019 included a NIS 72,000 ($22,395) and NIS 132,000 ($38,194), respectively collateral account for the Company&amp;#8217;s&#13;corporate credit cards and a loan and is classified in current assets.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Accounts receivables&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Accounts receivables are stated&#13;at their net realizable value. The allowance against gross accounts receivables reflects the best estimate of losses inherent in&#13;the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and&#13;other currently available information. As of December 31, 2020, and 2019, an allowance for doubtful debts in the amount of $26,553&#13;and $24,702, respectively, is reflected in net accounts receivables. Accounts receivables are written off after all reasonable&#13;means to collect the full amount have been exhausted.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Impairment of long-lived assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Group&amp;#8217;s long-lived assets&#13;are reviewed for impairment in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 360, &amp;#8220;Property,&#13;Plant and Equipment&amp;#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be&#13;recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the&#13;future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment&#13;to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. No impairment expenses&#13;were recorded during the years ended December 31, 2020 or 2019.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Deferred income taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Group accounts for income taxes&#13;in accordance with ASC Topic 740, &amp;#8220;Income Taxes&amp;#8221;. Accordingly, deferred income taxes are determined utilizing the asset&#13;and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases&#13;of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected&#13;to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary,&#13;to reduce deferred tax assets to amounts more likely than not to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Group accounts for uncertain&#13;tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,&#13;measurement and disclosure of uncertain tax positions recognized in an enterprise&amp;#8217;s financial statements. According to ASC&#13;Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&amp;#8217;s accounting policy is to&#13;classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such&#13;items in its fiscal 2020 and 2019 financial statements and did not recognize any liability with respect to an unrecognized tax&#13;position in its balance sheets.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <SAFO:LiabilityForEmployeeRightUponRetirement contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Liability for employee rights upon retirement&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Save Foods Ltd&amp;#8217;s liability&#13;for employee rights upon retirement with respect to its Israeli employees is calculated, pursuant to Israeli Severance Pay Law,&#13;based on the most recent salary of each employee multiplied by the number of years of employment, as of the balance sheet date.&#13;Employees are entitled to one month&amp;#8217;s salary for each year of employment, or a portion thereof. Save Foods Ltd. makes monthly&#13;deposits to insurance policies and severance pay funds. The liability of the Company is fully provided for.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The deposited funds include profits&#13;accumulated up to the balance sheet date. The deposited funds may be withdrawn upon the fulfillment of the obligation pursuant&#13;to Israeli severance pay laws or labor agreements. The value of the deposited funds is based on the cash surrender value of these&#13;policies, and includes immaterial profits/losses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Severance expenses for the years&#13;ended December 31, 2020 and 2019, amounted to $7,419 and $24,000, respectively.&lt;/p&gt;</SAFO:LiabilityForEmployeeRightUponRetirement>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Revenue recognition&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Revenues are recognized when delivery&#13;has occurred and there is persuasive evidence of an agreement, the fee is fixed or determinable and collection of the related receivables&#13;is reasonably assured and no further obligations exist.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Revenues from sales of products&#13;are recognized when title and risk and rewards for the products are transferred to the customer.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; padding-right: 0.8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Research and development expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Research and development expenses&#13;are charged to operations as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <SAFO:RoyaltyBearingGrants contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Royalty-bearing grants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Royalty-bearing grants from the&#13;Israeli Innovation Authority (the &amp;#8220;IIA&amp;#8221;) for funding approved research and development projects are recognized at the&#13;time Save Foods Ltd. is entitled to such grants (i.e. at the time that there is reasonable assurance that the Company will comply&#13;with the conditions attached to the grant and that there is reasonable assurance that the grant will be received), on the basis&#13;of the costs incurred and reduce research and development costs. The cumulative research and development grants received by the&#13;Company from inception through December 2020 amounted to NIS 484,429 (US$150,678).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;As of December 31, 2020, and 2019,&#13;the Company did not accrue for or pay any royalties to the IIA since no revenues were recognized in respect of the funded projects.&lt;/p&gt;</SAFO:RoyaltyBearingGrants>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Inventories are valued at the lower&#13;of cost or net realizable value. Cost of raw and packaging materials, purchased products, manufactured finished products and products&#13;in process are determined on the average costs basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company regularly reviews its&#13;inventories for impairment and reserves are established when necessary.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Basic and diluted loss per common stock&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Basic loss per common stock is computed&#13;by dividing the loss for the period applicable to shareholders, by the weighted average number of shares of common stock outstanding&#13;during the period. Securities that may participate in dividends with the shares of common stock (such as the convertible preferred)&#13;are considered in the computation of basic loss per share under the two-class method. However, in periods of net loss, only the&#13;convertible preferred shares are considered, since such shares have a contractual obligation to share in the losses of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;In computing diluted loss per share,&#13;basic loss per share is adjusted to reflect the potential dilution that could occur upon the exercise of potential shares. Accordingly,&#13;in periods of net loss, no potential shares are considered.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock-based compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company measures and recognizes&#13;the compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC&#13;718, &amp;#8220;Compensation-Stock Compensation&amp;#8221;. Share-based payments including grants of stock options are recognized in the&#13;statement of comprehensive loss as an operating expense based on the fair value of the award at the date of grant. The fair value&#13;of stock options granted is estimated using the Black-Scholes option-pricing model. The Company has expensed compensation costs,&#13;net of estimated forfeitures, applying the accelerated vesting method, over the requisite service period or over the implicit service&#13;period when a performance condition affects the vesting, and it is considered probable that the performance condition will be achieved.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Share-based payments awarded to&#13;consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, &amp;#8220;Equity-Based Payments to Non-Employees&amp;#8221;.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Fair value of certain of the Company&amp;#8217;s&#13;financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued&#13;liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with&#13;ASC 820, &amp;#8220;Fair Value Measurements and Disclosure&amp;#8221; defines fair value, establishes a framework for measuring fair value&#13;in accordance with generally accepted accounting principles and expands disclosures about fair value investments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Fair value, as defined in ASC 820,&#13;is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants&#13;at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or&#13;most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the&#13;risk of non-performance, which includes, among other things, the Company&amp;#8217;s credit risk.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Valuation techniques are generally&#13;classified into three categories: the market approach; the income approach; and the cost approach. The selection and application&#13;of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset&#13;or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize&#13;the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs&#13;and resulting measurement as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Level 1: Quoted prices (unadjusted)&#13;in active markets that are accessible at the measurement date for identical assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Level 2: Quoted prices for similar&#13;assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active;&#13;inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or&#13;corroborated by observable market data for substantially the full term of the assets or liabilities; and&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Level 3: Unobservable inputs for&#13;the asset or liability that are supported by little or no market activity, and that are significant to the fair values.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Fair value measurements are required&#13;to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair&#13;value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements&#13;including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to&#13;the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings,&#13;and a description of where those gains or losses included in earning are reported in the statement of income.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company records a debt discount&#13;related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible&#13;instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and&#13;as a reduction to the carrying amount of the convertible instrument equal to the fair value of the conversion features. The debt&#13;discount will be accreted by recording additional non-cash gains and losses related to the change in fair values of derivative&#13;liabilities over the life of the convertible notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company&amp;#8217;s financial assets&#13;and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Balance as of December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 48%; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Fair Value of convertible component in convertible loan&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;The following table presents the&#13;changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Fair value of Convertible component&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 71%"&gt;&lt;font style="font-size: 10pt"&gt;Fair value of issued level 3 liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,762&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Changes in fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Concentrations of credit risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Financial instruments that potentially&#13;subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents as well as certain other current&#13;assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held in Dollars and New Israeli&#13;Shekels, are deposited with major banks in Israel and United States. Management believes that such financial institutions are financially&#13;sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant&#13;off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company records accruals for&#13;loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and&#13;the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information&#13;becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;New Accounting Pronouncements &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In June&#13;2016, the Financial Accounting Standards Board (the &amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;)&#13;No. 2016-13, &amp;#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.&amp;#8221;&#13;In November 2018, FASB issued ASU No. 2018-19, &amp;#8220;Codification Improvements to Topic 326, Financial Instruments-Credit Losses&amp;#8221;,&#13;which amends the scope and transition requirements of ASU 2016-13. Topic 326 requires a financial asset (or a group of financial&#13;assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected&#13;credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable&#13;and supportable forecasts that affect the collectability of the reported amount. Topic 326 will originally become effective for&#13;the Company beginning January 1, 2020, with early adoption permitted, on a modified retrospective approach. As a smaller reporting&#13;company, the effective date for the Company has been delayed until fiscal years beginning after December 15, 2022, in accordance&#13;with ASU 2019-10, although early adoption is still permitted. This standard did not have a material impact to the Company&amp;#8217;s&#13;consolidated financial statements after evaluation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In December&#13;2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this&#13;ASU simplify the accounting for income taxes, eliminates certain exceptions to the general principles in Topic 740 and clarifies&#13;certain aspects of the current guidance to improve consistent application among reporting entities. ASU 2019-12 is effective for&#13;fiscal years beginning after December 15, 2021 and interim periods within annual periods beginning after December 15, 2022, though&#13;early adoption is permitted, including adoption in any interim period for which financial statements have not yet been issued.&#13;This standard is not expected to have a material impact to the Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In August&#13;2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements&#13;for Fair Value Measurement. This standard will require entities to disclose the amount of total gains or losses for the period&#13;recognized in other comprehensive income that is attributable to fair value changes in assets and liabilities held as of the balance&#13;sheet date and categorized within Level 3 of the fair value hierarchy. This ASU will be effective for the Company for annual and&#13;interim periods beginning after December 31, 2020. Early adoption of this standard is permitted. This standard did not have a material&#13;impact to the Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;In August&#13;2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#13;Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity s Own Equity.&#13;ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible&#13;debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features&#13;being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject&#13;to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract,&#13;that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible&#13;debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends&#13;the guidance for the derivatives scope exception for contracts in an entity&amp;#8217;s own equity to reduce form-over-substance-based&#13;accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2023,&#13;including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after&#13;December 15, 2020, including interim periods within those fiscal years. Management has not yet evaluated the impact that the adoption&#13;of ASU 2020-06 will have on the Company&amp;#8217;s consolidated financial statement presentation or disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Other new pronouncements issued&#13;but not effective as of December 31, 2020 are not expected to have a material impact on the Company&amp;#8217;s consolidated financial&#13;statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <SAFO:ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in"&gt;Rates of depreciation:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and office equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7-15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Machines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10-15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 76%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vehicle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company&amp;#8217;s financial assets&#13;and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Balance as of December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Liabilities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 48%; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Fair Value of convertible component in convertible loan&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;The following table presents the&#13;changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Fair value of Convertible component&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 71%"&gt;&lt;font style="font-size: 10pt"&gt;Fair value of issued level 3 liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,762&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Changes in fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Prepaid expenses and advances to vendors&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,811&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Receivables from sale of subsidiary (Note 5)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,704&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Government Institutions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,855&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,489&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;65,579&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;15,300&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Computers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and office equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Machines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;130,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;134,665&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;85,149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;85,149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;231,276&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;235,144&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less - accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(139,382&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(117,325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less &amp;#8211; Impairment of long lived assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(36,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(36,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total property and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;55,194&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;81,119&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Employees and related institutions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;110,220&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;135,901&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;392,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;184,616&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Right Of Use liability arising from operating lease&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,049&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;52,093&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Affiliated company (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;517,711&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;380,732&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On April 2, 2019, the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. (&amp;#8220;Savescann&amp;#8221;) a newly formed company registered in Canada. Savecann intended to market the Company&amp;#8217;s solutions to the Cannabis market.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;On April 21, 2020, the Company sold its entire holdings in Savecann for total consideration of 10,000 Canadian Dollars ($7,000), of which $2,704 were not paid yet and are presented as part of other current assets.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <SAFO:ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember_custom_ValuationTechniqueBlackScholesOptionPricingModelMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Mandatory Conversion (scenario&#13;1) was estimated by the appraiser using the Black-Scholes option pricing model, to compute the fair value of the derivative and&#13;to market the fair value of the derivative at each balance sheet date. The following are the data and assumptions used as of issuance&#13;dates and as of the balance sheet date:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 21, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;October 23,&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 43%"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected term (years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.775&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.685&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.417&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,457&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;47,499&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock>
    <SAFO:ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember_custom_ValuationTechniqueBinomialOptionPricingModelMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Optional Conversion (scenario&#13;2) was estimated by the appraiser using binomial option pricing model and simulating and waiver of the lender as an exercise price,&#13;to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date.&#13;The following are the data and assumptions used as of the issuance dates and as of balance sheet date:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 21, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;October 23, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 45%"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.12-0.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.12-0.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.10-0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,824&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,167&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;77,381&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 38px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Composition&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Interest rate at&lt;br /&gt;&#13;        December 31&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Long-term loans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;16,064&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;22,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less current maturities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(7,949&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(7,230&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,955&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 38px; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Maturity dates:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;First year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,949&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Second year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;16,064&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The following table presents the&#13;Company&amp;#8217;s stock option activity for employees and directors of the Company for the year ended December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;59,525&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Granted (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;109,526&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,762&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at January 1, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;164,289&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;92,574&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.64&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(29,365&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(14,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;206,862&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Number of options exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;97,351&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -25.65pt"&gt;(*) Options&#13;that were granted on January 3, 2019 with vesting that commences before December 31, 2018.&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The fair value of options granted&#13;was estimated at the dates of grant using the Black-Scholes option pricing model. The following are the data and assumptions used:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility (%) (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate (%) (**)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.56-2.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected term of options (years) (***)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price (US dollars)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15-3.78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Share price (US dollars)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Fair value (US dollars)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.83-5.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 53.85pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 11%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 84%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(**)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;The risk-free interest rate represented the risk-free rate of US$ zero &amp;#8211; coupon US Government Loans.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;(***)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the &amp;#8220;simplified method&amp;#8221; in accordance with SEC Staff Accounting Bulletin No. 110.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <SAFO:ScheduleOfCostOfSalesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and related expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,074&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;35,142&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,402&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,531&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;16,692&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;69,390&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Vehicle maintenance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,063&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,455&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Travel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,408&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Transportation and storage&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,632&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,299&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,564&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;43,405&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;144,548&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:ScheduleOfCostOfSalesTableTextBlock>
    <us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and related expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;39,021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;177,712&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;91,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;75,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Professional fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;130,592&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;178,854&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,319&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,544&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Travel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,138&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Vehicle maintenance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,657&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Rent and asset management&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,582&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Laboratory and Field tests&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;72,593&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;73,968&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33,438&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;25,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;417,000&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;615,623&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock>
    <SAFO:ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Professional services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;443,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;461,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;416,996&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;283,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;67,492&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Insurance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;63,380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Rent and office maintenance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,080&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Levies and tolls&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,477&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,601&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Communications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,679&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,914&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Travel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,310&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,848&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,995&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;1,070,109&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;1,004,899&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock>
    <SAFO:ScheduleOfFinancingExpensesNetTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Interest and amortization expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;202,917&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Currency exchange differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,037&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,266&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Changes in fair value of convertible loans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,208&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Bank charges and other finance expenses, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,819&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;270,393&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;43,408&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SAFO:ScheduleOfFinancingExpensesNetTableTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 7%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;B.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;The following is reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal tax rate) and the tax expense reported in the financial statements:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Pretax loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,593,139&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,971,417&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Federal tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Income tax computed at the ordinary tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;334,559&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;413,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Non-deductible expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(63,565&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,278&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(109,772&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(93,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Tax in respect of differences in corporate tax rates&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,480&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,688&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Losses and timing differences in respect of which no deferred taxes were generated&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(174,702&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(344,438&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 7%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;C.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Deferred taxes result primarily from temporary differences in the recognition of certain revenue and expense items for financial and income tax reporting purposes. Significant components of the Company&amp;#8217;s future tax assets are as follows:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Composition of deferred tax assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 66%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Provision for employee related obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,627&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,353&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Non capital loss carry forwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,350,367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,171,821&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,381,994&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,201,174&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;A. Transactions and balances&#13;with related parties&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;General and administrative expenses:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 66%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Directors compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;380,756&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;295,088&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and fees to officers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;336,433&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;358,370&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Consultants and other fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;52,331&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(*) 769,520&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(*) 653,458&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;(*) share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;394,756&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;272,077&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Research and development expenses:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Salaries and fees to officers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;25,301&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;116,692&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;b&gt;B. Balances with related parties&#13;and officers:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%; padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other accounts payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;424,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;199,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 16 &amp;#8211; LOSS PER COMMON&#13;STOCK&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;Basic loss per share is computed&#13;by dividing net loss by the weighted average number of shares outstanding during the year. The weighted average number of shares&#13;of Common Stock used in computing basic and diluted loss per common stock for the years ended December 31, 2020 and 2019, are as&#13;follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 72%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Weighted average number of shares of Common Stock outstanding attributable to shareholders&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,519,122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,424,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;206,862&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;164,289&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;(*) The effect of the inclusion&#13;of option and convertible loans in 2020 and 2019 is anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 72%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Weighted average number of shares of Common Stock outstanding attributable to shareholders&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,519,122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,424,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share (*)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;206,862&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;164,289&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;(*) The effect of the inclusion&#13;of option and convertible loans in 2020 and 2019 is anti-dilutive.&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <SAFO:OtherAccountsLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">380732</SAFO:OtherAccountsLiabilitiesCurrent>
    <SAFO:OtherAccountsLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">517711</SAFO:OtherAccountsLiabilitiesCurrent>
    <SAFO:UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The preparation of financial statements&#13;in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and&#13;liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported&#13;amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial&#13;statements, the most significant estimates and assumptions relate to the going concern assumptions, share based compensation and&#13;convertible loans.&lt;/p&gt;</SAFO:UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 48px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Property, plant and equipment, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px; padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;1.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the Statements of Operations and Comprehensive Loss.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Rates of depreciation:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Furniture and office equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7-15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Machines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10-15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;Computers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Vehicle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-06" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-05" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-1" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-2" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-0" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-1" xlink:label="Foot-04_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-04_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-0" xlink:label="Foot-05_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-1" xlink:label="Foot-05_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-05_loc" xlink:to="Footnote-04" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">The risk-free interest rate represented the risk-free rate of US$ zero-coupon US Government Loans.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with SEC Staff Accounting Bulletin No. 110.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">The effect of the inclusion of option and convertible loans in 2020 and 2019 is anti-dilutive.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-05" xml:lang="en-US">On April 2, 2019, the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. ("Savescann") a newly formed company registered in Canada. Savecann intended to market the Company's solutions to the Cannabis market.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-06" xml:lang="en-US">Options that were granted on January 3, 2019 with vesting that commences before December 31, 2018.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>63
<FILENAME>safo-20201231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SAFO 20201231 S%2D1 DFN.xfr; Date: 2021%2D03%2D16T18:23:22Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaqK2bP9z5Z8mekhvWB9bRmqjywt7CcZKiYyhun2AZgO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:SAFO="http://save-food.org/20201231" elementFormDefault="qualified" targetNamespace="http://save-food.org/20201231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://save-food.org/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StatementsOfComprehensiveLoss" id="StatementsOfComprehensiveLoss">
	  <link:definition>00000004 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" id="StatementsOfChangesInStockholdersDeficit">
	  <link:definition>00000005 - Statement - Statements of Changes in Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/General" id="General">
	  <link:definition>00000007 - Disclosure - General</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherCurrentAssets" id="OtherCurrentAssets">
	  <link:definition>00000009 - Disclosure - Other Current Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
	  <link:definition>00000010 - Disclosure - Property and Equipment, Net</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherAccountsLiabilities" id="OtherAccountsLiabilities">
	  <link:definition>00000011 - Disclosure - Other Accounts Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ConvertibleLoans" id="ConvertibleLoans">
	  <link:definition>00000012 - Disclosure - Convertible Loans</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions" id="Long-termLoansFromBankingInstitutions">
	  <link:definition>00000013 - Disclosure - Long-Term Loans from Banking Institutions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/CommitmentAndContingentLiabilities" id="CommitmentAndContingentLiabilities">
	  <link:definition>00000014 - Disclosure - Commitment and Contingent Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ShareholdersEquity" id="ShareholdersEquity">
	  <link:definition>00000015 - Disclosure - Shareholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StockOptions" id="StockOptions">
	  <link:definition>00000016 - Disclosure - Stock Options</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/CostOfSales" id="CostOfSales">
	  <link:definition>00000017 - Disclosure - Cost of Sales</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ResearchAndDevelopmentExpenses" id="ResearchAndDevelopmentExpenses">
	  <link:definition>00000018 - Disclosure - Research and Development Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/GeneralAndAdministrativeExpenses" id="GeneralAndAdministrativeExpenses">
	  <link:definition>00000019 - Disclosure - General and Administrative Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/FinancingExpensesNet" id="FinancingExpensesNet">
	  <link:definition>00000020 - Disclosure - Financing Expenses, Net</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/IncomeTax" id="IncomeTax">
	  <link:definition>00000021 - Disclosure - Income Tax</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/LossPerCommonStock" id="LossPerCommonStock">
	  <link:definition>00000022 - Disclosure - Loss Per Common Stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/RelatedParties" id="RelatedParties">
	  <link:definition>00000023 - Disclosure - Related Parties</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000024 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000025 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
	  <link:definition>00000026 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherCurrentAssetsTables" id="OtherCurrentAssetsTables">
	  <link:definition>00000027 - Disclosure - Other Current Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
	  <link:definition>00000028 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherAccountsLiabilitiesTables" id="OtherAccountsLiabilitiesTables">
	  <link:definition>00000029 - Disclosure - Other Accounts Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ConvertibleLoansTables" id="ConvertibleLoansTables">
	  <link:definition>00000030 - Disclosure - Convertible Loans (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" id="Long-termLoansFromBankingInstitutionsTables">
	  <link:definition>00000031 - Disclosure - Long-Term Loans from Banking Institutions (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StockOptionsTables" id="StockOptionsTables">
	  <link:definition>00000032 - Disclosure - Stock Options (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/CostOfSalesTables" id="CostOfSalesTables">
	  <link:definition>00000033 - Disclosure - Cost of Sales (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" id="ResearchAndDevelopmentExpensesTables">
	  <link:definition>00000034 - Disclosure - Research and Development Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" id="GeneralAndAdministrativeExpensesTables">
	  <link:definition>00000035 - Disclosure - General and Administrative Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/FinancingExpensesNetTables" id="FinancingExpensesNetTables">
	  <link:definition>00000036 - Disclosure - Financing Expenses, Net (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/IncomeTaxTables" id="IncomeTaxTables">
	  <link:definition>00000037 - Disclosure - Income Tax (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/LossPerCommonStockTables" id="LossPerCommonStockTables">
	  <link:definition>00000038 - Disclosure - Loss Per Common Stock (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/RelatedPartiesTables" id="RelatedPartiesTables">
	  <link:definition>00000039 - Disclosure - Related Parties (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/GeneralDetailsNarrative" id="GeneralDetailsNarrative">
	  <link:definition>00000040 - Disclosure - General (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000041 - Disclosure - Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" id="SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails">
	  <link:definition>00000042 - Disclosure - Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" id="SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails">
	  <link:definition>00000043 - Disclosure - Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" id="SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails">
	  <link:definition>00000044 - Disclosure - Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" id="OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails">
	  <link:definition>00000045 - Disclosure - Other Current Assets - Schedule of Other Current Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
	  <link:definition>00000046 - Disclosure - Property and Equipment, Net (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" id="PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails">
	  <link:definition>00000047 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" id="OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails">
	  <link:definition>00000048 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" id="OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical">
	  <link:definition>00000049 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ConvertibleLoansDetailsNarrative" id="ConvertibleLoansDetailsNarrative">
	  <link:definition>00000050 - Disclosure - Convertible Loans (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" id="ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails">
	  <link:definition>00000051 - Disclosure - Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" id="Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails">
	  <link:definition>00000052 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" id="Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails">
	  <link:definition>00000053 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" id="CommitmentAndContingentLiabilitiesDetailsNarrative">
	  <link:definition>00000054 - Disclosure - Commitment and Contingent Liabilities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
	  <link:definition>00000055 - Disclosure - Shareholders' Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StockOptionsDetailsNarrative" id="StockOptionsDetailsNarrative">
	  <link:definition>00000056 - Disclosure - Stock Options (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" id="StockOptions-ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000057 - Disclosure - Stock Options - Schedule of Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" id="StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails">
	  <link:definition>00000058 - Disclosure - Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/CostOfSalesDetails" id="CostOfSalesDetails">
	  <link:definition>00000059 - Disclosure - Cost of Sales (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" id="ResearchAndDevelopmentExpensesDetails">
	  <link:definition>00000060 - Disclosure - Research and Development Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" id="GeneralAndAdministrativeExpensesDetails">
	  <link:definition>00000061 - Disclosure - General and Administrative Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" id="FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails">
	  <link:definition>00000062 - Disclosure - Financing Expenses, Net - Schedule of Financing Expenses Net (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/IncomeTaxDetailsNarrative" id="IncomeTaxDetailsNarrative">
	  <link:definition>00000063 - Disclosure - Income Tax (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" id="IncomeTax-ScheduleOfIncomeTaxExpensesDetails">
	  <link:definition>00000064 - Disclosure - Income Tax - Schedule of Income Tax Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
	  <link:definition>00000065 - Disclosure - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" id="LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails">
	  <link:definition>00000066 - Disclosure - Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
	  <link:definition>00000067 - Disclosure - Related Parties (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" id="RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails">
	  <link:definition>00000068 - Disclosure - Related Parties - Schedule of Transactions and Balances with Related Parties (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://save-food.org/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000069 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="safo-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="safo-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="safo-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="safo-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="SAFO_FairValueAssumptionExpectedTerm" name="FairValueAssumptionExpectedTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DetachableWarrants" name="DetachableWarrants" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" name="DebtInstrumentMandatoryConversionProbabilityPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" name="DebtInstrumentOptionalConversionProbabilityPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_PercentageOfNetRevenues" name="PercentageOfNetRevenues" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MaximumCompensationPercentageOfGrossProfit" name="MaximumCompensationPercentageOfGrossProfit" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_PercentageOfPurchaseQuota" name="PercentageOfPurchaseQuota" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FairValueOfWarrantPrice" name="FairValueOfWarrantPrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MonthlyRetainer" name="MonthlyRetainer" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CumulativeResearchAndDevelopmentGrantsReceived" name="CumulativeResearchAndDevelopmentGrantsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_RateOfDepreciationPercentage" name="RateOfDepreciationPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IncomeTaxComputedAtOrdinaryTaxRate" name="IncomeTaxComputedAtOrdinaryTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" name="LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ProvisionForEmployeeRelatedObligation" name="ProvisionForEmployeeRelatedObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FundsInRespectOfEmployeeRightsUponRetirement" name="FundsInRespectOfEmployeeRightsUponRetirement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LongTermDebtFromBankingInstitutions" name="LongTermDebtFromBankingInstitutions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LiabilityForEmployeeRightsUponRetirement" name="LiabilityForEmployeeRightsUponRetirement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShareInLossesOfAffiliatedCompany" name="ShareInLossesOfAffiliatedCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_GainOnDisposalOfAffiliatedCompany" name="GainOnDisposalOfAffiliatedCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" name="IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IncreaseDecreaseInAccountsPayableOther" name="IncreaseDecreaseInAccountsPayableOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" name="ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ProceedsFromConvertibleLoans" name="ProceedsFromConvertibleLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DisposalOfAffiliatedCompany" name="DisposalOfAffiliatedCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TerminationOfLeaseAgreement" name="TerminationOfLeaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IssuanceOfWarrantsInConvertibleLoans" name="IssuanceOfWarrantsInConvertibleLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConversionOfConvertibleLoans" name="ConversionOfConvertibleLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets" name="InitialRecognitionOfOperatingLeaseRightofuseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_InitialRecognitionOfOperatingLeaseLiability" name="InitialRecognitionOfOperatingLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue" name="FairValueMeasurementWithUnobservableInputsChangesInFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" name="ShareInLossesGainOnDisposalOfAffiliatedCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CompensationExpensesInExchangeOfInstruments" name="CompensationExpensesInExchangeOfInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" name="DecreaseIncreaseInShortTermDepositsInBankingInstitutions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_RoyaltyDescription" name="RoyaltyDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AgreementTermDescription" name="AgreementTermDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_OfficeAndRelatedServiceFees" name="OfficeAndRelatedServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LessorOnetimePaymentAmount" name="LessorOnetimePaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_WarrantsDescription" name="WarrantsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_OptionToPurchaseOfCommonStock" name="OptionToPurchaseOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_EstimatedFairValueOfNonCashCompensationGranted" name="EstimatedFairValueOfNonCashCompensationGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CurrencyExchangeDifferences" name="CurrencyExchangeDifferences" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ChangesInFairValueOfConvertibleLoans" name="ChangesInFairValueOfConvertibleLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_BankChargesAndOtherFinanceExpensesNet" name="BankChargesAndOtherFinanceExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FinancingExpensesNet" name="FinancingExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MonthlyConsultancyFee" name="MonthlyConsultancyFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MonthlyDirectorsFee" name="MonthlyDirectorsFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CostOfSalesTextBlock" name="CostOfSalesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_GeneralAndAdministrativeExpensesTextBlock" name="GeneralAndAdministrativeExpensesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FinancingExpensesNetDisclosureTextBlock" name="FinancingExpensesNetDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LiabilityForEmployeeRightUponRetirement" name="LiabilityForEmployeeRightUponRetirement" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_RoyaltyBearingGrants" name="RoyaltyBearingGrants" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" name="ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" name="ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ScheduleOfCostOfSalesTableTextBlock" name="ScheduleOfCostOfSalesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" name="ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock" name="ScheduleOfFinancingExpensesNetTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_OtherAccountsLiabilitiesCurrent" name="OtherAccountsLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" name="UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ProceedsOnAccountOfSharesMember" name="ProceedsOnAccountOfSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TotalCompanysStockholdersEquityMember" name="TotalCompanysStockholdersEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CommonStockTwoMember" name="CommonStockTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AccreditedInvestorsMember" name="AccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TwoThousandEighteenEquityIncentivePlanMember" name="TwoThousandEighteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MrDanSztubelMember" name="MrDanSztubelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_EPAndFDAMember" name="EPAndFDAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_EmployeesAndDirectorsMember" name="EmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DirectorsMember" name="DirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SalariesAndFeesToOfficersMember" name="SalariesAndFeesToOfficersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SavescannMember" name="SavescannMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CADMember" name="CADMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SubscriptionAgreementMember" name="SubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CommonStockIssueOneMember" name="CommonStockIssueOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CommonStockIssueTwoMember" name="CommonStockIssueTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_NISMember" name="NISMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IsraeliBankMember" name="IsraeliBankMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_PrepaidExpensesAndAdvancesToVendorsMember" name="PrepaidExpensesAndAdvancesToVendorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_GovernmentInstitutionsMember" name="GovernmentInstitutionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" name="RightOfUseLiabilityArisingFromOperatingLeaseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ReceivablesFromSaleOfSubsidiaryMember" name="ReceivablesFromSaleOfSubsidiaryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FurnitureAndOfficeEquipmentMember" name="FurnitureAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MachinesMember" name="MachinesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TheLoansMember" name="TheLoansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SharePurchaseAgreementMember" name="SharePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConvertibleBridgeLoanAgreementMember" name="ConvertibleBridgeLoanAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_EmployeesAndRelatedInstitutionsMember" name="EmployeesAndRelatedInstitutionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AccruedExpensesMember" name="AccruedExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AffiliatedCompanyMember" name="AffiliatedCompanyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SavescannSolutionsIncMember" name="SavescannSolutionsIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_NonQualifiedOptionMember" name="NonQualifiedOptionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TenPercenatgeOfLoanMember" name="TenPercenatgeOfLoanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_NovemberLoanAgreementMember" name="NovemberLoanAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConvertibleLoanAgreementsMember" name="ConvertibleLoanAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IsraeliInnovationAuthorityMember" name="IsraeliInnovationAuthorityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShortTermOperatingLeaseAgreementMember" name="ShortTermOperatingLeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LeaseAgreementMember" name="LeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SaveFoodsLtdMember" name="SaveFoodsLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_XedaInternationalSAMember" name="XedaInternationalSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_NirEcologyLtdMember" name="NirEcologyLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_OmdanConsultingAndInstructingLtdMember" name="OmdanConsultingAndInstructingLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShareholdersMember" name="ShareholdersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_NineteenAccreditedInvestorsMember" name="NineteenAccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ThirteenInvestorsMember" name="ThirteenInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TwoAccreditedInvestorsMember" name="TwoAccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AccreditedInvestorsOneMember" name="AccreditedInvestorsOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AccreditedInvestorsTwoMember" name="AccreditedInvestorsTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConsultantMember" name="ConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SalariesAndRelatedExpensesMember" name="SalariesAndRelatedExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShareBasedCompensationMember" name="ShareBasedCompensationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MaterialsMember" name="MaterialsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_VehicleMaintenanceMember" name="VehicleMaintenanceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TravelExpensesMember" name="TravelExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TransportationAndStorageMember" name="TransportationAndStorageMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_OtherExpensesMember" name="OtherExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ProfessionalFeesMember" name="ProfessionalFeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DepreciationAndAmortizationMember" name="DepreciationAndAmortizationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_RentAndAssetManagementMember" name="RentAndAssetManagementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LaboratoryAndFieldTestsMember" name="LaboratoryAndFieldTestsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ProfessionalServicesMember" name="ProfessionalServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LegalExpensesMember" name="LegalExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_InsuranceMember" name="InsuranceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_RentAndOfficeMaintenanceMember" name="RentAndOfficeMaintenanceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LeviesAndTollsMember" name="LeviesAndTollsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CommunicationsMember" name="CommunicationsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DepreciationMember" name="DepreciationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DirectorsCompensationMember" name="DirectorsCompensationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" name="ValuationTechniqueBlackScholesOptionPricingModelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LendersMember" name="LendersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TwoAdditionalConvertibleLoanAgreementsMember" name="TwoAdditionalConvertibleLoanAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" name="TwoThousandTwentyConvertibleLoanAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ValuationTechniqueBinomialOptionPricingModelMember" name="ValuationTechniqueBinomialOptionPricingModelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_MedigusLimitedMember" name="MedigusLimitedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CommissionAgreementMember" name="CommissionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_EarthboundTechnologiesLLCMember" name="EarthboundTechnologiesLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_IntroducedPartiesMember" name="IntroducedPartiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ExceedsInNetRevenueMember" name="ExceedsInNetRevenueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_OccuranceOfAdditionalEventsInAgreementMember" name="OccuranceOfAdditionalEventsInAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_DistributionAgreementMember" name="DistributionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_SafePackProductsLimitedMember" name="SafePackProductsLimitedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CoChiefExecutiveOfficerMember" name="CoChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CurrentLiabilitiesMember" name="CurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_LongTermLiabilitiesMember" name="LongTermLiabilitiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_TwoDirectorsMember" name="TwoDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConsultantsAndOtherFeesMember" name="ConsultantsAndOtherFeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ConsultingAgreementsMember" name="ConsultingAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_AmirUzielEconomicConsultantsLtdMember" name="AmirUzielEconomicConsultantsLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ItzhakShremMember" name="ItzhakShremMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CostOfSalesAbstract" name="CostOfSalesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_GeneralAndAdministrativeExpensesAbstract" name="GeneralAndAdministrativeExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_FinancingExpensesNetAbstract" name="FinancingExpensesNetAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CostOfSalesTablesAbstract" name="CostOfSalesTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_GeneralAndAdministrativeExpensesTablesAbstract" name="GeneralAndAdministrativeExpensesTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_ShareholdersEquityAbstract" name="ShareholdersEquityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_CostOfSalesDetailsAbstract" name="CostOfSalesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SAFO_GeneralAndAdministrativeExpensesDetailsAbstract" name="GeneralAndAdministrativeExpensesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>64
<FILENAME>safo-20201231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SAFO 20201231 S%2D1 DFN.xfr; Date: 2021%2D03%2D16T18:23:22Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://save-food.org/role/DocumentAndEntityInformation" xlink:href="safo-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/BalanceSheets" xlink:href="safo-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/BalanceSheetsParenthetical" xlink:href="safo-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfComprehensiveLoss" xlink:href="safo-20201231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" xlink:href="safo-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfCashFlows" xlink:href="safo-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/General" xlink:href="safo-20201231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssets" xlink:href="safo-20201231.xsd#OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNet" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoans" xlink:href="safo-20201231.xsd#ConvertibleLoans" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CommitmentAndContingentLiabilities" xlink:href="safo-20201231.xsd#CommitmentAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ShareholdersEquity" xlink:href="safo-20201231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions" xlink:href="safo-20201231.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSales" xlink:href="safo-20201231.xsd#CostOfSales" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpenses" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpenses" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNet" xlink:href="safo-20201231.xsd#FinancingExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax" xlink:href="safo-20201231.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStock" xlink:href="safo-20201231.xsd#LossPerCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedParties" xlink:href="safo-20201231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SubsequentEvents" xlink:href="safo-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesPolicies" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesTables" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssetsTables" xlink:href="safo-20201231.xsd#OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNetTables" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilitiesTables" xlink:href="safo-20201231.xsd#OtherAccountsLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoansTables" xlink:href="safo-20201231.xsd#ConvertibleLoansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptionsTables" xlink:href="safo-20201231.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSalesTables" xlink:href="safo-20201231.xsd#CostOfSalesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNetTables" xlink:href="safo-20201231.xsd#FinancingExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTaxTables" xlink:href="safo-20201231.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStockTables" xlink:href="safo-20201231.xsd#LossPerCommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedPartiesTables" xlink:href="safo-20201231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralDetailsNarrative" xlink:href="safo-20201231.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:href="safo-20201231.xsd#OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoansDetailsNarrative" xlink:href="safo-20201231.xsd#ConvertibleLoansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:href="safo-20201231.xsd#ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:href="safo-20201231.xsd#CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ShareholdersEquityDetailsNarrative" xlink:href="safo-20201231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptionsDetailsNarrative" xlink:href="safo-20201231.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" xlink:href="safo-20201231.xsd#StockOptions-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:href="safo-20201231.xsd#StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSalesDetails" xlink:href="safo-20201231.xsd#CostOfSalesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:href="safo-20201231.xsd#FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTaxDetailsNarrative" xlink:href="safo-20201231.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:href="safo-20201231.xsd#IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="safo-20201231.xsd#IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:href="safo-20201231.xsd#LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedPartiesDetailsNarrative" xlink:href="safo-20201231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:href="safo-20201231.xsd#RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SubsequentEventsDetailsNarrative" xlink:href="safo-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FundsInRespectOfEmployeeRightsUponRetirement" xlink:label="loc_SAFOFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_SAFOFundsInRespectOfEmployeeRightsUponRetirement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherAccountsLiabilitiesCurrent" xlink:label="loc_SAFOOtherAccountsLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_SAFOOtherAccountsLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LiabilityForEmployeeRightsUponRetirement" xlink:label="loc_SAFOLiabilityForEmployeeRightsUponRetirement" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_SAFOLiabilityForEmployeeRightsUponRetirement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermDebtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LongTermDebtFromBankingInstitutions" xlink:label="loc_SAFOLongTermDebtFromBankingInstitutions" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_SAFOLongTermDebtFromBankingInstitutions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareInLossesOfAffiliatedCompany" xlink:label="loc_SAFOShareInLossesOfAffiliatedCompany" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_SAFOShareInLossesOfAffiliatedCompany" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GainOnDisposalOfAffiliatedCompany" xlink:label="loc_SAFOGainOnDisposalOfAffiliatedCompany" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_SAFOGainOnDisposalOfAffiliatedCompany" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNet" xlink:label="loc_SAFOFinancingExpensesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_SAFOFinancingExpensesNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Statements of Changes in Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_SAFOIncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SAFOIncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses" xlink:label="loc_us-gaapProvisionForLoanAndLeaseLosses" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForLoanAndLeaseLosses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncreaseDecreaseInAccountsPayableOther" xlink:label="loc_SAFOIncreaseDecreaseInAccountsPayableOther" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SAFOIncreaseDecreaseInAccountsPayableOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:label="loc_SAFOShareInLossesGainOnDisposalOfAffiliatedCompany" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SAFOShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CompensationExpensesInExchangeOfInstruments" xlink:label="loc_SAFOCompensationExpensesInExchangeOfInstruments" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SAFOCompensationExpensesInExchangeOfInstruments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="loc_SAFOProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_SAFOProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsForProceedsFromBusinessesAndInterestInAffiliates" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:label="loc_SAFODecreaseIncreaseInShortTermDepositsInBankingInstitutions" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_SAFODecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_us-gaapRepaymentsOfShortTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfShortTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSecuredNotesPayable" xlink:label="loc_us-gaapProceedsFromSecuredNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromSecuredNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsFromConvertibleLoans" xlink:label="loc_SAFOProceedsFromConvertibleLoans" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_SAFOProceedsFromConvertibleLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/General" xlink:title="00000007 - Disclosure - General" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssets" xlink:title="00000009 - Disclosure - Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNet" xlink:title="00000010 - Disclosure - Property and Equipment, Net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities" xlink:title="00000011 - Disclosure - Other Accounts Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoans" xlink:title="00000012 - Disclosure - Convertible Loans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions" xlink:title="00000013 - Disclosure - Long-Term Loans from Banking Institutions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/CommitmentAndContingentLiabilities" xlink:title="00000014 - Disclosure - Commitment and Contingent Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ShareholdersEquity" xlink:title="00000015 - Disclosure - Shareholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions" xlink:title="00000016 - Disclosure - Stock Options" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSales" xlink:title="00000017 - Disclosure - Cost of Sales" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpenses" xlink:title="00000018 - Disclosure - Research and Development Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpenses" xlink:title="00000019 - Disclosure - General and Administrative Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNet" xlink:title="00000020 - Disclosure - Financing Expenses, Net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax" xlink:title="00000021 - Disclosure - Income Tax" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStock" xlink:title="00000022 - Disclosure - Loss Per Common Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedParties" xlink:title="00000023 - Disclosure - Related Parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SubsequentEvents" xlink:title="00000024 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssetsTables" xlink:title="00000027 - Disclosure - Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNetTables" xlink:title="00000028 - Disclosure - Property and Equipment, Net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilitiesTables" xlink:title="00000029 - Disclosure - Other Accounts Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoansTables" xlink:title="00000030 - Disclosure - Convertible Loans (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" xlink:title="00000031 - Disclosure - Long-Term Loans from Banking Institutions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptionsTables" xlink:title="00000032 - Disclosure - Stock Options (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSalesTables" xlink:title="00000033 - Disclosure - Cost of Sales (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000034 - Disclosure - Research and Development Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" xlink:title="00000035 - Disclosure - General and Administrative Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNetTables" xlink:title="00000036 - Disclosure - Financing Expenses, Net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTaxTables" xlink:title="00000037 - Disclosure - Income Tax (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStockTables" xlink:title="00000038 - Disclosure - Loss Per Common Stock (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedPartiesTables" xlink:title="00000039 - Disclosure - Related Parties (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralDetailsNarrative" xlink:title="00000040 - Disclosure - General (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000041 - Disclosure - Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:title="00000042 - Disclosure - Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:title="00000043 - Disclosure - Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:title="00000044 - Disclosure - Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:title="00000045 - Disclosure - Other Current Assets - Schedule of Other Current Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000046 - Disclosure - Property and Equipment, Net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="00000047 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:title="00000048 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:title="00000049 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoansDetailsNarrative" xlink:title="00000050 - Disclosure - Convertible Loans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:title="00000051 - Disclosure - Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:title="00000052 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:title="00000053 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:title="00000054 - Disclosure - Commitment and Contingent Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ShareholdersEquityDetailsNarrative" xlink:title="00000055 - Disclosure - Shareholders&apos; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptionsDetailsNarrative" xlink:title="00000056 - Disclosure - Stock Options (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" xlink:title="00000057 - Disclosure - Stock Options - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:title="00000058 - Disclosure - Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSalesDetails" xlink:title="00000059 - Disclosure - Cost of Sales (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" xlink:title="00000060 - Disclosure - Research and Development Expenses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" xlink:title="00000061 - Disclosure - General and Administrative Expenses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:title="00000062 - Disclosure - Financing Expenses, Net - Schedule of Financing Expenses Net (Details)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNet" xlink:label="loc_SAFOFinancingExpensesNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SAFOFinancingExpensesNet" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CurrencyExchangeDifferences" xlink:label="loc_SAFOCurrencyExchangeDifferences" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SAFOFinancingExpensesNet" xlink:to="loc_SAFOCurrencyExchangeDifferences" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ChangesInFairValueOfConvertibleLoans" xlink:label="loc_SAFOChangesInFairValueOfConvertibleLoans" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SAFOFinancingExpensesNet" xlink:to="loc_SAFOChangesInFairValueOfConvertibleLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_BankChargesAndOtherFinanceExpensesNet" xlink:label="loc_SAFOBankChargesAndOtherFinanceExpensesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SAFOFinancingExpensesNet" xlink:to="loc_SAFOBankChargesAndOtherFinanceExpensesNet" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTaxDetailsNarrative" xlink:title="00000063 - Disclosure - Income Tax (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:title="00000064 - Disclosure - Income Tax - Schedule of Income Tax Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncomeTaxComputedAtOrdinaryTaxRate" xlink:label="loc_SAFOIncomeTaxComputedAtOrdinaryTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_SAFOIncomeTaxComputedAtOrdinaryTaxRate" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="loc_us-gaapIncomeTaxReconciliationDeductions" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationDeductions" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:label="loc_SAFOLossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_SAFOLossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000065 - Disclosure - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProvisionForEmployeeRelatedObligation" xlink:label="loc_SAFOProvisionForEmployeeRelatedObligation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_SAFOProvisionForEmployeeRelatedObligation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:title="00000066 - Disclosure - Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedPartiesDetailsNarrative" xlink:title="00000067 - Disclosure - Related Parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:title="00000068 - Disclosure - Related Parties - Schedule of Transactions and Balances with Related Parties (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://save-food.org/role/SubsequentEventsDetailsNarrative" xlink:title="00000069 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>65
<FILENAME>safo-20201231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SAFO 20201231 S%2D1 DFN.xfr; Date: 2021%2D03%2D16T18:23:22Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://save-food.org/role/DocumentAndEntityInformation" xlink:href="safo-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/BalanceSheets" xlink:href="safo-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/BalanceSheetsParenthetical" xlink:href="safo-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfComprehensiveLoss" xlink:href="safo-20201231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" xlink:href="safo-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfCashFlows" xlink:href="safo-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/General" xlink:href="safo-20201231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssets" xlink:href="safo-20201231.xsd#OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNet" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoans" xlink:href="safo-20201231.xsd#ConvertibleLoans" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CommitmentAndContingentLiabilities" xlink:href="safo-20201231.xsd#CommitmentAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ShareholdersEquity" xlink:href="safo-20201231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions" xlink:href="safo-20201231.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSales" xlink:href="safo-20201231.xsd#CostOfSales" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpenses" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpenses" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNet" xlink:href="safo-20201231.xsd#FinancingExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax" xlink:href="safo-20201231.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStock" xlink:href="safo-20201231.xsd#LossPerCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedParties" xlink:href="safo-20201231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SubsequentEvents" xlink:href="safo-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesPolicies" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesTables" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssetsTables" xlink:href="safo-20201231.xsd#OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNetTables" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilitiesTables" xlink:href="safo-20201231.xsd#OtherAccountsLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoansTables" xlink:href="safo-20201231.xsd#ConvertibleLoansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptionsTables" xlink:href="safo-20201231.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSalesTables" xlink:href="safo-20201231.xsd#CostOfSalesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNetTables" xlink:href="safo-20201231.xsd#FinancingExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTaxTables" xlink:href="safo-20201231.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStockTables" xlink:href="safo-20201231.xsd#LossPerCommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedPartiesTables" xlink:href="safo-20201231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralDetailsNarrative" xlink:href="safo-20201231.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:href="safo-20201231.xsd#OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoansDetailsNarrative" xlink:href="safo-20201231.xsd#ConvertibleLoansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:href="safo-20201231.xsd#ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:href="safo-20201231.xsd#CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ShareholdersEquityDetailsNarrative" xlink:href="safo-20201231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptionsDetailsNarrative" xlink:href="safo-20201231.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" xlink:href="safo-20201231.xsd#StockOptions-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:href="safo-20201231.xsd#StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSalesDetails" xlink:href="safo-20201231.xsd#CostOfSalesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:href="safo-20201231.xsd#FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTaxDetailsNarrative" xlink:href="safo-20201231.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:href="safo-20201231.xsd#IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="safo-20201231.xsd#IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:href="safo-20201231.xsd#LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedPartiesDetailsNarrative" xlink:href="safo-20201231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:href="safo-20201231.xsd#RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SubsequentEventsDetailsNarrative" xlink:href="safo-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsOnAccountOfSharesMember" xlink:label="loc_SAFOProceedsOnAccountOfSharesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SAFOProceedsOnAccountOfSharesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TotalCompanysStockholdersEquityMember" xlink:label="loc_SAFOTotalCompanysStockholdersEquityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SAFOTotalCompanysStockholdersEquityMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="loc_SAFOStockIssuedDuringPeriodValueExerciseOfWarrants_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOStockIssuedDuringPeriodValueExerciseOfWarrants_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="loc_SAFOStockIssuedDuringPeriodSharesExerciseOfWarrants_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOStockIssuedDuringPeriodSharesExerciseOfWarrants_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/General" xlink:title="00000007 - Disclosure - General" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssets" xlink:title="00000009 - Disclosure - Other Current Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNet" xlink:title="00000010 - Disclosure - Property and Equipment, Net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities" xlink:title="00000011 - Disclosure - Other Accounts Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoans" xlink:title="00000012 - Disclosure - Convertible Loans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions" xlink:title="00000013 - Disclosure - Long-Term Loans from Banking Institutions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/CommitmentAndContingentLiabilities" xlink:title="00000014 - Disclosure - Commitment and Contingent Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ShareholdersEquity" xlink:title="00000015 - Disclosure - Shareholders&apos; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions" xlink:title="00000016 - Disclosure - Stock Options" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSales" xlink:title="00000017 - Disclosure - Cost of Sales" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpenses" xlink:title="00000018 - Disclosure - Research and Development Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpenses" xlink:title="00000019 - Disclosure - General and Administrative Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNet" xlink:title="00000020 - Disclosure - Financing Expenses, Net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax" xlink:title="00000021 - Disclosure - Income Tax" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStock" xlink:title="00000022 - Disclosure - Loss Per Common Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedParties" xlink:title="00000023 - Disclosure - Related Parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SubsequentEvents" xlink:title="00000024 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssetsTables" xlink:title="00000027 - Disclosure - Other Current Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNetTables" xlink:title="00000028 - Disclosure - Property and Equipment, Net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilitiesTables" xlink:title="00000029 - Disclosure - Other Accounts Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoansTables" xlink:title="00000030 - Disclosure - Convertible Loans (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" xlink:label="loc_SAFOScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" xlink:title="00000031 - Disclosure - Long-Term Loans from Banking Institutions (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptionsTables" xlink:title="00000032 - Disclosure - Stock Options (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSalesTables" xlink:title="00000033 - Disclosure - Cost of Sales (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000034 - Disclosure - Research and Development Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" xlink:title="00000035 - Disclosure - General and Administrative Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNetTables" xlink:title="00000036 - Disclosure - Financing Expenses, Net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTaxTables" xlink:title="00000037 - Disclosure - Income Tax (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStockTables" xlink:title="00000038 - Disclosure - Loss Per Common Stock (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedPartiesTables" xlink:title="00000039 - Disclosure - Related Parties (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralDetailsNarrative" xlink:title="00000040 - Disclosure - General (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_WorkingCapital" xlink:label="loc_SAFOWorkingCapital_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOWorkingCapital_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000041 - Disclosure - Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NISMember" xlink:label="loc_SAFONISMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SAFONISMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IsraeliInnovationAuthorityMember" xlink:label="loc_SAFOIsraeliInnovationAuthorityMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOIsraeliInnovationAuthorityMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalents_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalents_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaapSeveranceCosts1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSeveranceCosts1_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CumulativeResearchAndDevelopmentGrantsReceived" xlink:label="loc_SAFOCumulativeResearchAndDevelopmentGrantsReceived_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOCumulativeResearchAndDevelopmentGrantsReceived_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_100" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:title="00000042 - Disclosure - Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FurnitureAndOfficeEquipmentMember" xlink:label="loc_SAFOFurnitureAndOfficeEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOFurnitureAndOfficeEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MachinesMember" xlink:label="loc_SAFOMachinesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOMachinesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RateOfDepreciationPercentage" xlink:label="loc_SAFORateOfDepreciationPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFORateOfDepreciationPercentage_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:title="00000043 - Disclosure - Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaapConvertibleDebtFairValueDisclosures_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebtFairValueDisclosures_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:title="00000044 - Disclosure - Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:title="00000045 - Disclosure - Other Current Assets - Schedule of Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PrepaidExpensesAndAdvancesToVendorsMember" xlink:label="loc_SAFOPrepaidExpensesAndAdvancesToVendorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOPrepaidExpensesAndAdvancesToVendorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ReceivablesFromSaleOfSubsidiaryMember" xlink:label="loc_SAFOReceivablesFromSaleOfSubsidiaryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOReceivablesFromSaleOfSubsidiaryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GovernmentInstitutionsMember" xlink:label="loc_SAFOGovernmentInstitutionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOGovernmentInstitutionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherAssetsCurrent_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000046 - Disclosure - Property and Equipment, Net (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="00000047 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FurnitureAndOfficeEquipmentMember" xlink:label="loc_SAFOFurnitureAndOfficeEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOFurnitureAndOfficeEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MachinesMember" xlink:label="loc_SAFOMachinesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOMachinesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:title="00000048 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EmployeesAndRelatedInstitutionsMember" xlink:label="loc_SAFOEmployeesAndRelatedInstitutionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOEmployeesAndRelatedInstitutionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccruedExpensesMember" xlink:label="loc_SAFOAccruedExpensesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOAccruedExpensesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" xlink:label="loc_SAFORightOfUseLiabilityArisingFromOperatingLeaseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFORightOfUseLiabilityArisingFromOperatingLeaseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AffiliatedCompanyMember" xlink:label="loc_SAFOAffiliatedCompanyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOAffiliatedCompanyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableOtherCurrent_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:title="00000049 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SavescannSolutionsIncMember" xlink:label="loc_SAFOSavescannSolutionsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_SAFOSavescannSolutionsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CADMember" xlink:label="loc_SAFOCADMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SAFOCADMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestments_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInvestmentIncomeReceivable" xlink:label="loc_us-gaapAccruedInvestmentIncomeReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedInvestmentIncomeReceivable_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoansDetailsNarrative" xlink:title="00000050 - Disclosure - Convertible Loans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConvertibleLoanAgreementsMember" xlink:label="loc_SAFOConvertibleLoanAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOConvertibleLoanAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoAdditionalConvertibleLoanAgreementsMember" xlink:label="loc_SAFOTwoAdditionalConvertibleLoanAgreementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOTwoAdditionalConvertibleLoanAgreementsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SecuritiesPurchaseAgreementMember" xlink:label="loc_SAFOSecuritiesPurchaseAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOSecuritiesPurchaseAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:label="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LendersMember" xlink:label="loc_SAFOLendersMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOLendersMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CurrentLiabilitiesMember" xlink:label="loc_SAFOCurrentLiabilitiesMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_SAFOCurrentLiabilitiesMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LongTermLiabilitiesMember" xlink:label="loc_SAFOLongTermLiabilitiesMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_SAFOLongTermLiabilitiesMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DetachableWarrants" xlink:label="loc_SAFODetachableWarrants_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFODetachableWarrants_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaapDebtInstrumentMeasurementInput_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMeasurementInput_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueAssumptionExpectedTerm" xlink:label="loc_SAFOFairValueAssumptionExpectedTerm_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOFairValueAssumptionExpectedTerm_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized" xlink:label="loc_us-gaapClassOfWarrantOrRightExpenseOrRevenueRecognized_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExpenseOrRevenueRecognized_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_280" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_280" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_280" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_280" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_280" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_280" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" xlink:label="loc_SAFODebtInstrumentMandatoryConversionProbabilityPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFODebtInstrumentMandatoryConversionProbabilityPercentage_280" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" xlink:label="loc_SAFODebtInstrumentOptionalConversionProbabilityPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFODebtInstrumentOptionalConversionProbabilityPercentage_280" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtFairValue_280" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaapDebtInstrumentFairValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFairValue_280" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_280" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:title="00000051 - Disclosure - Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputAppraisedValueMember" xlink:label="loc_us-gaapMeasurementInputAppraisedValueMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputAppraisedValueMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_220" xlink:type="arc" order="223" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_230" xlink:type="arc" order="233" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_400" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_400" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueOfWarrantPrice" xlink:label="loc_SAFOFairValueOfWarrantPrice_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOFairValueOfWarrantPrice_400" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_400" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:title="00000052 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:title="00000053 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:title="00000054 - Disclosure - Commitment and Contingent Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IsraeliInnovationAuthorityMember" xlink:label="loc_SAFOIsraeliInnovationAuthorityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOIsraeliInnovationAuthorityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_XedaInternationalSAMember" xlink:label="loc_SAFOXedaInternationalSAMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOXedaInternationalSAMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EarthboundTechnologiesLLCMember" xlink:label="loc_SAFOEarthboundTechnologiesLLCMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOEarthboundTechnologiesLLCMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SafePackProductsLimitedMember" xlink:label="loc_SAFOSafePackProductsLimitedMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOSafePackProductsLimitedMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NISMember" xlink:label="loc_SAFONISMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SAFONISMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShortTermOperatingLeaseAgreementMember" xlink:label="loc_SAFOShortTermOperatingLeaseAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOShortTermOperatingLeaseAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LeaseAgreementMember" xlink:label="loc_SAFOLeaseAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOLeaseAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommissionAgreementMember" xlink:label="loc_SAFOCommissionAgreementMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOCommissionAgreementMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DistributionAgreementMember" xlink:label="loc_SAFODistributionAgreementMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFODistributionAgreementMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SaveFoodsLtdMember" xlink:label="loc_SAFOSaveFoodsLtdMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_SAFOSaveFoodsLtdMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IntroducedPartiesMember" xlink:label="loc_SAFOIntroducedPartiesMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOIntroducedPartiesMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ExceedsInNetRevenueMember" xlink:label="loc_SAFOExceedsInNetRevenueMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SAFOExceedsInNetRevenueMember_190" xlink:type="arc" order="194" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OccuranceOfAdditionalEventsInAgreementMember" xlink:label="loc_SAFOOccuranceOfAdditionalEventsInAgreementMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SAFOOccuranceOfAdditionalEventsInAgreementMember_210" xlink:type="arc" order="214" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RoyaltyDescription" xlink:label="loc_SAFORoyaltyDescription_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFORoyaltyDescription_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AgreementTermDescription" xlink:label="loc_SAFOAgreementTermDescription_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOAgreementTermDescription_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OfficeAndRelatedServiceFees" xlink:label="loc_SAFOOfficeAndRelatedServiceFees_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOOfficeAndRelatedServiceFees_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LessorOnetimePaymentAmount" xlink:label="loc_SAFOLessorOnetimePaymentAmount_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOLessorOnetimePaymentAmount_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_250" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_250" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PercentageOfNetRevenues" xlink:label="loc_SAFOPercentageOfNetRevenues_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOPercentageOfNetRevenues_250" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_250" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MaximumCompensationPercentageOfGrossProfit" xlink:label="loc_SAFOMaximumCompensationPercentageOfGrossProfit_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMaximumCompensationPercentageOfGrossProfit_250" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_250" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_250" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_250" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PercentageOfPurchaseQuota" xlink:label="loc_SAFOPercentageOfPurchaseQuota_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOPercentageOfPurchaseQuota_250" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ShareholdersEquityDetailsNarrative" xlink:title="00000055 - Disclosure - Shareholders&apos; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsMember" xlink:label="loc_SAFOAccreditedInvestorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOAccreditedInvestorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsOneMember" xlink:label="loc_SAFOAccreditedInvestorsOneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOAccreditedInvestorsOneMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsTwoMember" xlink:label="loc_SAFOAccreditedInvestorsTwoMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOAccreditedInvestorsTwoMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoDirectorsMember" xlink:label="loc_SAFOTwoDirectorsMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOTwoDirectorsMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SubscriptionAgreementMember" xlink:label="loc_SAFOSubscriptionAgreementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOSubscriptionAgreementMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SecuritiesPurchaseAgreementMember" xlink:label="loc_SAFOSecuritiesPurchaseAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOSecuritiesPurchaseAgreementMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MedigusLimitedMember" xlink:label="loc_SAFOMedigusLimitedMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOMedigusLimitedMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_220" xlink:type="arc" order="223" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_290" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_290" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_290" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_290" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_290" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_WarrantsDescription" xlink:label="loc_SAFOWarrantsDescription_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOWarrantsDescription_290" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_290" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_290" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_290" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_290" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_290" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptionsDetailsNarrative" xlink:title="00000056 - Disclosure - Stock Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MrDanSztubelMember" xlink:label="loc_SAFOMrDanSztubelMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOMrDanSztubelMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_BoardOfDirectorsMember" xlink:label="loc_SAFOBoardOfDirectorsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOBoardOfDirectorsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultantMember" xlink:label="loc_SAFOConsultantMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOConsultantMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EmployeesAndDirectorsMember" xlink:label="loc_SAFOEmployeesAndDirectorsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOEmployeesAndDirectorsMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OptionToPurchaseOfCommonStock" xlink:label="loc_SAFOOptionToPurchaseOfCommonStock_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOOptionToPurchaseOfCommonStock_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionExercisePriceIncrease" xlink:label="loc_us-gaapStockOptionExercisePriceIncrease_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionExercisePriceIncrease_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_190" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EstimatedFairValueOfNonCashCompensationGranted" xlink:label="loc_SAFOEstimatedFairValueOfNonCashCompensationGranted_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOEstimatedFairValueOfNonCashCompensationGranted_190" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_190" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" xlink:title="00000057 - Disclosure - Stock Options - Schedule of Stock Option Activity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:title="00000058 - Disclosure - Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" xlink:label="loc_SAFOShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_80" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSalesDetails" xlink:title="00000059 - Disclosure - Cost of Sales (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndRelatedExpensesMember" xlink:label="loc_SAFOSalariesAndRelatedExpensesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOSalariesAndRelatedExpensesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="loc_SAFOShareBasedCompensationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOShareBasedCompensationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MaterialsMember" xlink:label="loc_SAFOMaterialsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOMaterialsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_VehicleMaintenanceMember" xlink:label="loc_SAFOVehicleMaintenanceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOVehicleMaintenanceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="loc_SAFOTravelExpensesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTravelExpensesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TransportationAndStorageMember" xlink:label="loc_SAFOTransportationAndStorageMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTransportationAndStorageMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="loc_SAFOOtherExpensesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOOtherExpensesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_170" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" xlink:title="00000060 - Disclosure - Research and Development Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndRelatedExpensesMember" xlink:label="loc_SAFOSalariesAndRelatedExpensesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOSalariesAndRelatedExpensesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="loc_SAFOShareBasedCompensationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOShareBasedCompensationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProfessionalFeesMember" xlink:label="loc_SAFOProfessionalFeesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOProfessionalFeesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DepreciationMember" xlink:label="loc_SAFODepreciationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFODepreciationMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="loc_SAFOTravelExpensesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTravelExpensesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_VehicleMaintenanceMember" xlink:label="loc_SAFOVehicleMaintenanceMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOVehicleMaintenanceMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RentAndAssetManagementMember" xlink:label="loc_SAFORentAndAssetManagementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFORentAndAssetManagementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LaboratoryAndFieldTestsMember" xlink:label="loc_SAFOLaboratoryAndFieldTestsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOLaboratoryAndFieldTestsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="loc_SAFOOtherExpensesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOOtherExpensesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" xlink:title="00000061 - Disclosure - General and Administrative Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProfessionalServicesMember" xlink:label="loc_SAFOProfessionalServicesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOProfessionalServicesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="loc_SAFOShareBasedCompensationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOShareBasedCompensationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LegalExpensesMember" xlink:label="loc_SAFOLegalExpensesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOLegalExpensesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InsuranceMember" xlink:label="loc_SAFOInsuranceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOInsuranceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RentAndOfficeMaintenanceMember" xlink:label="loc_SAFORentAndOfficeMaintenanceMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFORentAndOfficeMaintenanceMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LeviesAndTollsMember" xlink:label="loc_SAFOLeviesAndTollsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOLeviesAndTollsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommunicationsMember" xlink:label="loc_SAFOCommunicationsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOCommunicationsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DepreciationMember" xlink:label="loc_SAFODepreciationMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFODepreciationMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="loc_SAFOTravelExpensesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTravelExpensesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="loc_SAFOOtherExpensesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOOtherExpensesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_230" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:title="00000062 - Disclosure - Financing Expenses, Net - Schedule of Financing Expenses Net (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTaxDetailsNarrative" xlink:title="00000063 - Disclosure - Income Tax (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:title="00000064 - Disclosure - Income Tax - Schedule of Income Tax Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000065 - Disclosure - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:title="00000066 - Disclosure - Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedPartiesDetailsNarrative" xlink:title="00000067 - Disclosure - Related Parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CoChiefExecutiveOfficerMember" xlink:label="loc_SAFOCoChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOCoChiefExecutiveOfficerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ItzhakShremMember" xlink:label="loc_SAFOItzhakShremMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOItzhakShremMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultingAgreementsMember" xlink:label="loc_SAFOConsultingAgreementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOConsultingAgreementsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AmirUzielEconomicConsultantsLtdMember" xlink:label="loc_SAFOAmirUzielEconomicConsultantsLtdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOAmirUzielEconomicConsultantsLtdMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyRetainer" xlink:label="loc_SAFOMonthlyRetainer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMonthlyRetainer_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyConsultancyFee" xlink:label="loc_SAFOMonthlyConsultancyFee_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMonthlyConsultancyFee_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyDirectorsFee" xlink:label="loc_SAFOMonthlyDirectorsFee_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMonthlyDirectorsFee_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:title="00000068 - Disclosure - Related Parties - Schedule of Transactions and Balances with Related Parties (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DirectorsCompensationMember" xlink:label="loc_SAFODirectorsCompensationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFODirectorsCompensationMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndFeesToOfficersMember" xlink:label="loc_SAFOSalariesAndFeesToOfficersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOSalariesAndFeesToOfficersMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultantsAndOtherFeesMember" xlink:label="loc_SAFOConsultantsAndOtherFeesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOConsultantsAndOtherFeesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://save-food.org/role/SubsequentEventsDetailsNarrative" xlink:title="00000069 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:label="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_30" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>66
<FILENAME>safo-20201231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SAFO 20201231 S%2D1 DFN.xfr; Date: 2021%2D03%2D16T18:23:22Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsOnAccountOfSharesMember" xlink:label="SAFO_ProceedsOnAccountOfSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsOnAccountOfSharesMember" xlink:to="SAFO_ProceedsOnAccountOfSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ProceedsOnAccountOfSharesMember_lbl" xml:lang="en-US">Proceeds on Account of Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Non-controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TotalCompanysStockholdersEquityMember" xlink:label="SAFO_TotalCompanysStockholdersEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TotalCompanysStockholdersEquityMember" xlink:to="SAFO_TotalCompanysStockholdersEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TotalCompanysStockholdersEquityMember_lbl" xml:lang="en-US">Total Company's Stockholders' Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsMember" xlink:label="SAFO_AccreditedInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccreditedInvestorsMember" xlink:to="SAFO_AccreditedInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AccreditedInvestorsMember_lbl" xml:lang="en-US">Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="SAFO_TwoThousandEighteenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:to="SAFO_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TwoThousandEighteenEquityIncentivePlanMember_lbl" xml:lang="en-US">2018 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MrDanSztubelMember" xlink:label="SAFO_MrDanSztubelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MrDanSztubelMember" xlink:to="SAFO_MrDanSztubelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MrDanSztubelMember_lbl" xml:lang="en-US">Mr. Dan Sztubel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EmployeesAndDirectorsMember" xlink:label="SAFO_EmployeesAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EmployeesAndDirectorsMember" xlink:to="SAFO_EmployeesAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employees and Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndFeesToOfficersMember" xlink:label="SAFO_SalariesAndFeesToOfficersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SalariesAndFeesToOfficersMember" xlink:to="SAFO_SalariesAndFeesToOfficersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SalariesAndFeesToOfficersMember_lbl" xml:lang="en-US">Salaries and Fees to Officers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SubscriptionAgreementMember" xlink:label="SAFO_SubscriptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SubscriptionAgreementMember" xlink:to="SAFO_SubscriptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SubscriptionAgreementMember_lbl" xml:lang="en-US">Subscription Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NISMember" xlink:label="SAFO_NISMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_NISMember" xlink:to="SAFO_NISMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_NISMember_lbl" xml:lang="en-US">NIS [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PrepaidExpensesAndAdvancesToVendorsMember" xlink:label="SAFO_PrepaidExpensesAndAdvancesToVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_PrepaidExpensesAndAdvancesToVendorsMember" xlink:to="SAFO_PrepaidExpensesAndAdvancesToVendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_PrepaidExpensesAndAdvancesToVendorsMember_lbl" xml:lang="en-US">Prepaid Expenses and Advances to Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GovernmentInstitutionsMember" xlink:label="SAFO_GovernmentInstitutionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GovernmentInstitutionsMember" xlink:to="SAFO_GovernmentInstitutionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_GovernmentInstitutionsMember_lbl" xml:lang="en-US">Government Institutions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" xlink:label="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" xlink:to="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember_lbl" xml:lang="en-US">Right of Use Liability Arising from Operating Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ReceivablesFromSaleOfSubsidiaryMember" xlink:label="SAFO_ReceivablesFromSaleOfSubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ReceivablesFromSaleOfSubsidiaryMember" xlink:to="SAFO_ReceivablesFromSaleOfSubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ReceivablesFromSaleOfSubsidiaryMember_lbl" xml:lang="en-US">Receivables From Sale of Subsidiary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FurnitureAndOfficeEquipmentMember" xlink:label="SAFO_FurnitureAndOfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FurnitureAndOfficeEquipmentMember" xlink:to="SAFO_FurnitureAndOfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FurnitureAndOfficeEquipmentMember_lbl" xml:lang="en-US">Furniture and Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MachinesMember" xlink:label="SAFO_MachinesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MachinesMember" xlink:to="SAFO_MachinesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MachinesMember_lbl" xml:lang="en-US">Machines [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EmployeesAndRelatedInstitutionsMember" xlink:label="SAFO_EmployeesAndRelatedInstitutionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EmployeesAndRelatedInstitutionsMember" xlink:to="SAFO_EmployeesAndRelatedInstitutionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_EmployeesAndRelatedInstitutionsMember_lbl" xml:lang="en-US">Employees and Related Institutions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccruedExpensesMember" xlink:label="SAFO_AccruedExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccruedExpensesMember" xlink:to="SAFO_AccruedExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AccruedExpensesMember_lbl" xml:lang="en-US">Accrued Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AffiliatedCompanyMember" xlink:label="SAFO_AffiliatedCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AffiliatedCompanyMember" xlink:to="SAFO_AffiliatedCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AffiliatedCompanyMember_lbl" xml:lang="en-US">Affiliated Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SavescannSolutionsIncMember" xlink:label="SAFO_SavescannSolutionsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SavescannSolutionsIncMember" xlink:to="SAFO_SavescannSolutionsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SavescannSolutionsIncMember_lbl" xml:lang="en-US">Savescann Solutions Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CADMember" xlink:label="SAFO_CADMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CADMember" xlink:to="SAFO_CADMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CADMember_lbl" xml:lang="en-US">Canadian Dollars [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConvertibleLoanAgreementsMember" xlink:label="SAFO_ConvertibleLoanAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConvertibleLoanAgreementsMember" xlink:to="SAFO_ConvertibleLoanAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ConvertibleLoanAgreementsMember_lbl" xml:lang="en-US">Convertible Loan Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Dividend Yields [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Expected Life [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IsraeliInnovationAuthorityMember" xlink:label="SAFO_IsraeliInnovationAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IsraeliInnovationAuthorityMember" xlink:to="SAFO_IsraeliInnovationAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_IsraeliInnovationAuthorityMember_lbl" xml:lang="en-US">Israeli Innovation Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShortTermOperatingLeaseAgreementMember" xlink:label="SAFO_ShortTermOperatingLeaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShortTermOperatingLeaseAgreementMember" xlink:to="SAFO_ShortTermOperatingLeaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ShortTermOperatingLeaseAgreementMember_lbl" xml:lang="en-US">Short-term Operating Lease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LeaseAgreementMember" xlink:label="SAFO_LeaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LeaseAgreementMember" xlink:to="SAFO_LeaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LeaseAgreementMember_lbl" xml:lang="en-US">Lease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SaveFoodsLtdMember" xlink:label="SAFO_SaveFoodsLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SaveFoodsLtdMember" xlink:to="SAFO_SaveFoodsLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SaveFoodsLtdMember_lbl" xml:lang="en-US">Save Foods Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_XedaInternationalSAMember" xlink:label="SAFO_XedaInternationalSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_XedaInternationalSAMember" xlink:to="SAFO_XedaInternationalSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_XedaInternationalSAMember_lbl" xml:lang="en-US">Xeda International S.A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsOneMember" xlink:label="SAFO_AccreditedInvestorsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccreditedInvestorsOneMember" xlink:to="SAFO_AccreditedInvestorsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AccreditedInvestorsOneMember_lbl" xml:lang="en-US">Accredited Investors One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_BoardOfDirectorsMember" xlink:label="SAFO_BoardOfDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_BoardOfDirectorsMember" xlink:to="SAFO_BoardOfDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_BoardOfDirectorsMember_lbl" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultantMember" xlink:label="SAFO_ConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultantMember" xlink:to="SAFO_ConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndRelatedExpensesMember" xlink:label="SAFO_SalariesAndRelatedExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SalariesAndRelatedExpensesMember" xlink:to="SAFO_SalariesAndRelatedExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SalariesAndRelatedExpensesMember_lbl" xml:lang="en-US">Salaries and Related Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="SAFO_ShareBasedCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareBasedCompensationMember" xlink:to="SAFO_ShareBasedCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ShareBasedCompensationMember_lbl" xml:lang="en-US">Share Based Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MaterialsMember" xlink:label="SAFO_MaterialsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MaterialsMember" xlink:to="SAFO_MaterialsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MaterialsMember_lbl" xml:lang="en-US">Materials [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_VehicleMaintenanceMember" xlink:label="SAFO_VehicleMaintenanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_VehicleMaintenanceMember" xlink:to="SAFO_VehicleMaintenanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_VehicleMaintenanceMember_lbl" xml:lang="en-US">Vehicle Maintenance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="SAFO_TravelExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TravelExpensesMember" xlink:to="SAFO_TravelExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TravelExpensesMember_lbl" xml:lang="en-US">Travel Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TransportationAndStorageMember" xlink:label="SAFO_TransportationAndStorageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TransportationAndStorageMember" xlink:to="SAFO_TransportationAndStorageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TransportationAndStorageMember_lbl" xml:lang="en-US">Transportation and Storage [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="SAFO_OtherExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OtherExpensesMember" xlink:to="SAFO_OtherExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_OtherExpensesMember_lbl" xml:lang="en-US">Other Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProfessionalFeesMember" xlink:label="SAFO_ProfessionalFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProfessionalFeesMember" xlink:to="SAFO_ProfessionalFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ProfessionalFeesMember_lbl" xml:lang="en-US">Professional Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RentAndAssetManagementMember" xlink:label="SAFO_RentAndAssetManagementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RentAndAssetManagementMember" xlink:to="SAFO_RentAndAssetManagementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_RentAndAssetManagementMember_lbl" xml:lang="en-US">Rent and asset management [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LaboratoryAndFieldTestsMember" xlink:label="SAFO_LaboratoryAndFieldTestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LaboratoryAndFieldTestsMember" xlink:to="SAFO_LaboratoryAndFieldTestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LaboratoryAndFieldTestsMember_lbl" xml:lang="en-US">Laboratory and Field tests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProfessionalServicesMember" xlink:label="SAFO_ProfessionalServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProfessionalServicesMember" xlink:to="SAFO_ProfessionalServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ProfessionalServicesMember_lbl" xml:lang="en-US">Professional Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LegalExpensesMember" xlink:label="SAFO_LegalExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LegalExpensesMember" xlink:to="SAFO_LegalExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LegalExpensesMember_lbl" xml:lang="en-US">Legal Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InsuranceMember" xlink:label="SAFO_InsuranceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_InsuranceMember" xlink:to="SAFO_InsuranceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_InsuranceMember_lbl" xml:lang="en-US">Insurance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RentAndOfficeMaintenanceMember" xlink:label="SAFO_RentAndOfficeMaintenanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RentAndOfficeMaintenanceMember" xlink:to="SAFO_RentAndOfficeMaintenanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_RentAndOfficeMaintenanceMember_lbl" xml:lang="en-US">Rent and Office Maintenance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LeviesAndTollsMember" xlink:label="SAFO_LeviesAndTollsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LeviesAndTollsMember" xlink:to="SAFO_LeviesAndTollsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LeviesAndTollsMember_lbl" xml:lang="en-US">Levies and Tolls [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommunicationsMember" xlink:label="SAFO_CommunicationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommunicationsMember" xlink:to="SAFO_CommunicationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CommunicationsMember_lbl" xml:lang="en-US">Communications [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DepreciationMember" xlink:label="SAFO_DepreciationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DepreciationMember" xlink:to="SAFO_DepreciationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DepreciationMember_lbl" xml:lang="en-US">Depreciation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DirectorsCompensationMember" xlink:label="SAFO_DirectorsCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DirectorsCompensationMember" xlink:to="SAFO_DirectorsCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DirectorsCompensationMember_lbl" xml:lang="en-US">Directors' Compensation[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:label="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:to="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Black-Scholes Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Share Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoAdditionalConvertibleLoanAgreementsMember" xlink:label="SAFO_TwoAdditionalConvertibleLoanAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoAdditionalConvertibleLoanAgreementsMember" xlink:to="SAFO_TwoAdditionalConvertibleLoanAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TwoAdditionalConvertibleLoanAgreementsMember_lbl" xml:lang="en-US">Two Additional Convertible Loan Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SecuritiesPurchaseAgreementMember" xlink:label="SAFO_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SecuritiesPurchaseAgreementMember" xlink:to="SAFO_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LendersMember" xlink:label="SAFO_LendersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LendersMember" xlink:to="SAFO_LendersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LendersMember_lbl" xml:lang="en-US">Lenders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:label="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:to="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember_lbl" xml:lang="en-US">2020 Convertible Loan Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MedigusLimitedMember" xlink:label="SAFO_MedigusLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MedigusLimitedMember" xlink:to="SAFO_MedigusLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MedigusLimitedMember_lbl" xml:lang="en-US">Medigus [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommissionAgreementMember" xlink:label="SAFO_CommissionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommissionAgreementMember" xlink:to="SAFO_CommissionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CommissionAgreementMember_lbl" xml:lang="en-US">Commission Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EarthboundTechnologiesLLCMember" xlink:label="SAFO_EarthboundTechnologiesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EarthboundTechnologiesLLCMember" xlink:to="SAFO_EarthboundTechnologiesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_EarthboundTechnologiesLLCMember_lbl" xml:lang="en-US">Earthbound Technologies, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IntroducedPartiesMember" xlink:label="SAFO_IntroducedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IntroducedPartiesMember" xlink:to="SAFO_IntroducedPartiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_IntroducedPartiesMember_lbl" xml:lang="en-US">Introduced Parties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ExceedsInNetRevenueMember" xlink:label="SAFO_ExceedsInNetRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ExceedsInNetRevenueMember" xlink:to="SAFO_ExceedsInNetRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ExceedsInNetRevenueMember_lbl" xml:lang="en-US">Exceeds in Net Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OccuranceOfAdditionalEventsInAgreementMember" xlink:label="SAFO_OccuranceOfAdditionalEventsInAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OccuranceOfAdditionalEventsInAgreementMember" xlink:to="SAFO_OccuranceOfAdditionalEventsInAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_OccuranceOfAdditionalEventsInAgreementMember_lbl" xml:lang="en-US">Occurance of Additional Events in Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DistributionAgreementMember" xlink:label="SAFO_DistributionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DistributionAgreementMember" xlink:to="SAFO_DistributionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DistributionAgreementMember_lbl" xml:lang="en-US">Distribution Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SafePackProductsLimitedMember" xlink:label="SAFO_SafePackProductsLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SafePackProductsLimitedMember" xlink:to="SAFO_SafePackProductsLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_SafePackProductsLimitedMember_lbl" xml:lang="en-US">Safe-Pack Products Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:label="SAFO_ValuationTechniqueBinomialOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:to="SAFO_ValuationTechniqueBinomialOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ValuationTechniqueBinomialOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Binomial Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CoChiefExecutiveOfficerMember" xlink:label="SAFO_CoChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CoChiefExecutiveOfficerMember" xlink:to="SAFO_CoChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CoChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Mr. David Palach [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsTwoMember" xlink:label="SAFO_AccreditedInvestorsTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccreditedInvestorsTwoMember" xlink:to="SAFO_AccreditedInvestorsTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AccreditedInvestorsTwoMember_lbl" xml:lang="en-US">Accredited Investors Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CurrentLiabilitiesMember" xlink:label="SAFO_CurrentLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CurrentLiabilitiesMember" xlink:to="SAFO_CurrentLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CurrentLiabilitiesMember_lbl" xml:lang="en-US">Current Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LongTermLiabilitiesMember" xlink:label="SAFO_LongTermLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LongTermLiabilitiesMember" xlink:to="SAFO_LongTermLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LongTermLiabilitiesMember_lbl" xml:lang="en-US">Long Term Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputAppraisedValueMember" xlink:label="us-gaap_MeasurementInputAppraisedValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputAppraisedValueMember" xlink:to="us-gaap_MeasurementInputAppraisedValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputAppraisedValueMember_lbl" xml:lang="en-US">Fair Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoDirectorsMember" xlink:label="SAFO_TwoDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoDirectorsMember" xlink:to="SAFO_TwoDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TwoDirectorsMember_lbl" xml:lang="en-US">Two Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultantsAndOtherFeesMember" xlink:label="SAFO_ConsultantsAndOtherFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultantsAndOtherFeesMember" xlink:to="SAFO_ConsultantsAndOtherFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ConsultantsAndOtherFeesMember_lbl" xml:lang="en-US">Consultants and Other Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultingAgreementsMember" xlink:label="SAFO_ConsultingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultingAgreementsMember" xlink:to="SAFO_ConsultingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ConsultingAgreementsMember_lbl" xml:lang="en-US">Consulting Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AmirUzielEconomicConsultantsLtdMember" xlink:label="SAFO_AmirUzielEconomicConsultantsLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AmirUzielEconomicConsultantsLtdMember" xlink:to="SAFO_AmirUzielEconomicConsultantsLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AmirUzielEconomicConsultantsLtdMember_lbl" xml:lang="en-US">Amir Uziel Economic Consultants Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ItzhakShremMember" xlink:label="SAFO_ItzhakShremMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ItzhakShremMember" xlink:to="SAFO_ItzhakShremMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ItzhakShremMember_lbl" xml:lang="en-US">Itzhak Shrem [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash (Note 2D)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right Of Use asset arising from operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and Equipment, Net (Note 4)</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FundsInRespectOfEmployeeRightsUponRetirement" xlink:label="SAFO_FundsInRespectOfEmployeeRightsUponRetirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FundsInRespectOfEmployeeRightsUponRetirement" xlink:to="SAFO_FundsInRespectOfEmployeeRightsUponRetirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FundsInRespectOfEmployeeRightsUponRetirement_lbl" xml:lang="en-US">Funds in Respect of Employee Rights Upon Retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short-term loan from banking institution (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Current maturities of convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherAccountsLiabilitiesCurrent" xlink:label="SAFO_OtherAccountsLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OtherAccountsLiabilitiesCurrent" xlink:to="SAFO_OtherAccountsLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_OtherAccountsLiabilitiesCurrent_lbl" xml:lang="en-US">Other accounts liabilities (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="us-gaap_LongTermDebtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtFairValue" xlink:to="us-gaap_LongTermDebtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtFairValue_lbl" xml:lang="en-US">Fair Value of Convertible Component in Convertible Loans (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xml:lang="en-US">Convertible Loans (Notes 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LongTermDebtFromBankingInstitutions" xlink:label="SAFO_LongTermDebtFromBankingInstitutions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LongTermDebtFromBankingInstitutions" xlink:to="SAFO_LongTermDebtFromBankingInstitutions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LongTermDebtFromBankingInstitutions_lbl" xml:lang="en-US">Long term from banking institution (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LiabilityForEmployeeRightsUponRetirement" xlink:label="SAFO_LiabilityForEmployeeRightsUponRetirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LiabilityForEmployeeRightsUponRetirement" xlink:to="SAFO_LiabilityForEmployeeRightsUponRetirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LiabilityForEmployeeRightsUponRetirement_lbl" xml:lang="en-US">Liability for employee rights upon retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' Deficit (Note 9)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stocks of US$ 0.0001 par value each ("Common Stocks"): 495,000,000 shares authorized as of December 31, 2020 and 2019; issued and outstanding 1,606,760 and 1,458,593 shares as of December 31, 2020 and 2019, respectively.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stocks of US$ 0.0001 par value ("Preferred stocks"): 5,000,000 shares authorized as of December 31, 2020 and 2019; issued and outstanding 0 shares as of December 31, 2020 and 2019.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stocks, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stocks, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stocks, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stocks, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stocks, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stocks, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stocks, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stocks, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenues from sales of products</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales (Note 11)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses (Note 12)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses (Note 13)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNet" xlink:label="SAFO_FinancingExpensesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNet" xlink:to="SAFO_FinancingExpensesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SAFO_FinancingExpensesNet_lbl" xml:lang="en-US">Financing expenses, net (Note 14)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareInLossesOfAffiliatedCompany" xlink:label="SAFO_ShareInLossesOfAffiliatedCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareInLossesOfAffiliatedCompany" xlink:to="SAFO_ShareInLossesOfAffiliatedCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ShareInLossesOfAffiliatedCompany_lbl" xml:lang="en-US">Shares in losses of affiliated company</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GainOnDisposalOfAffiliatedCompany" xlink:label="SAFO_GainOnDisposalOfAffiliatedCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GainOnDisposalOfAffiliatedCompany" xlink:to="SAFO_GainOnDisposalOfAffiliatedCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_GainOnDisposalOfAffiliatedCompany_lbl" xml:lang="en-US">Gain on disposal of affiliated company</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net loss attributable to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per share (basic and diluted) (Note 16)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of shares for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of shares for cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Value of warrant issued in convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Comprehensive loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of convertible loans, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments required to reconcile net loss for the period to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Loss from sales of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:label="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:to="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany_lbl" xml:lang="en-US">Share in losses (gain on disposal) of affiliated company</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:label="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:to="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement_lbl" xml:lang="en-US">Increase (decrease) in liability for employee rights upon retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses" xlink:label="us-gaap_ProvisionForLoanAndLeaseLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForLoanAndLeaseLosses" xlink:to="us-gaap_ProvisionForLoanAndLeaseLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForLoanAndLeaseLosses_lbl" xml:lang="en-US">Expenses on convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CompensationExpensesInExchangeOfInstruments" xlink:label="SAFO_CompensationExpensesInExchangeOfInstruments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CompensationExpensesInExchangeOfInstruments" xlink:to="SAFO_CompensationExpensesInExchangeOfInstruments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SAFO_CompensationExpensesInExchangeOfInstruments_lbl" xml:lang="en-US">Compensation expenses in exchange of instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Decrease (increase) in accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Decrease (increase) in inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase (decrease) in accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncreaseDecreaseInAccountsPayableOther" xlink:label="SAFO_IncreaseDecreaseInAccountsPayableOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IncreaseDecreaseInAccountsPayableOther" xlink:to="SAFO_IncreaseDecreaseInAccountsPayableOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_IncreaseDecreaseInAccountsPayableOther_lbl" xml:lang="en-US">Increase in other accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:label="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl" xml:lang="en-US">Proceeds from (payments on) investment in unconsolidated entity</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:label="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:to="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions_lbl" xml:lang="en-US">Decrease (increase) in Short term deposits in banking institutions</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement_lbl" xml:lang="en-US">Increase in funds in respect of employee rights upon retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sales of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSecuredNotesPayable" xlink:label="us-gaap_ProceedsFromSecuredNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSecuredNotesPayable" xlink:to="us-gaap_ProceedsFromSecuredNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSecuredNotesPayable_lbl" xml:lang="en-US">Proceeds from Secured promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsFromConvertibleLoans" xlink:label="SAFO_ProceedsFromConvertibleLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsFromConvertibleLoans" xlink:to="SAFO_ProceedsFromConvertibleLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ProceedsFromConvertibleLoans_lbl" xml:lang="en-US">Proceeds from convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayments of long-term loans from banking institutes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="us-gaap_RepaymentsOfShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Repayments of right of use asset arising from operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from stock issued for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid during the year for: Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non cash transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DisposalOfAffiliatedCompany" xlink:label="SAFO_DisposalOfAffiliatedCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DisposalOfAffiliatedCompany" xlink:to="SAFO_DisposalOfAffiliatedCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DisposalOfAffiliatedCompany_lbl" xml:lang="en-US">Disposal of affiliated company</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TerminationOfLeaseAgreement" xlink:label="SAFO_TerminationOfLeaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TerminationOfLeaseAgreement" xlink:to="SAFO_TerminationOfLeaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_TerminationOfLeaseAgreement_lbl" xml:lang="en-US">Termination of lease agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IssuanceOfWarrantsInConvertibleLoans" xlink:label="SAFO_IssuanceOfWarrantsInConvertibleLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IssuanceOfWarrantsInConvertibleLoans" xlink:to="SAFO_IssuanceOfWarrantsInConvertibleLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_IssuanceOfWarrantsInConvertibleLoans_lbl" xml:lang="en-US">Issuance of warrants in convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConversionOfConvertibleLoans" xlink:label="SAFO_ConversionOfConvertibleLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConversionOfConvertibleLoans" xlink:to="SAFO_ConversionOfConvertibleLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SAFO_ConversionOfConvertibleLoans_lbl" xml:lang="en-US">Conversion of convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:label="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:to="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets_lbl" xml:lang="en-US">Initial recognition of operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InitialRecognitionOfOperatingLeaseLiability" xlink:label="SAFO_InitialRecognitionOfOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_InitialRecognitionOfOperatingLeaseLiability" xlink:to="SAFO_InitialRecognitionOfOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_InitialRecognitionOfOperatingLeaseLiability_lbl" xml:lang="en-US">Initial recognition of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">General</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Other Accounts Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Convertible Loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-Term Loans from Banking Institutions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitment and Contingent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Shareholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesAbstract" xlink:label="SAFO_CostOfSalesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CostOfSalesAbstract" xlink:to="SAFO_CostOfSalesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CostOfSalesAbstract_lbl" xml:lang="en-US">Cost Of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesTextBlock" xlink:label="SAFO_CostOfSalesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CostOfSalesTextBlock" xlink:to="SAFO_CostOfSalesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CostOfSalesTextBlock_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xml:lang="en-US">Research and Development [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xml:lang="en-US">Research and Development Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesAbstract" xlink:label="SAFO_GeneralAndAdministrativeExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GeneralAndAdministrativeExpensesAbstract" xlink:to="SAFO_GeneralAndAdministrativeExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_GeneralAndAdministrativeExpensesAbstract_lbl" xml:lang="en-US">General And Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesTextBlock" xlink:label="SAFO_GeneralAndAdministrativeExpensesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GeneralAndAdministrativeExpensesTextBlock" xlink:to="SAFO_GeneralAndAdministrativeExpensesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_GeneralAndAdministrativeExpensesTextBlock_lbl" xml:lang="en-US">General and Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNetAbstract" xlink:label="SAFO_FinancingExpensesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNetAbstract" xlink:to="SAFO_FinancingExpensesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FinancingExpensesNetAbstract_lbl" xml:lang="en-US">Financing Expenses Net</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNetDisclosureTextBlock" xlink:label="SAFO_FinancingExpensesNetDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNetDisclosureTextBlock" xlink:to="SAFO_FinancingExpensesNetDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FinancingExpensesNetDisclosureTextBlock_lbl" xml:lang="en-US">Financing Expenses, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Loss Per Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" xlink:label="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" xlink:to="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock_lbl" xml:lang="en-US">Use of Estimates in the Preparation of Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional Currency</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash and Cash Equivalents, and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Deferred Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LiabilityForEmployeeRightUponRetirement" xlink:label="SAFO_LiabilityForEmployeeRightUponRetirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LiabilityForEmployeeRightUponRetirement" xlink:to="SAFO_LiabilityForEmployeeRightUponRetirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LiabilityForEmployeeRightUponRetirement_lbl" xml:lang="en-US">Liability for Employee Rights Upon Retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RoyaltyBearingGrants" xlink:label="SAFO_RoyaltyBearingGrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RoyaltyBearingGrants" xlink:to="SAFO_RoyaltyBearingGrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_RoyaltyBearingGrants_lbl" xml:lang="en-US">Royalty-Bearing Grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Loss Per Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" xlink:label="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" xlink:to="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment Depreciation Rates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Recurring Basis Financial Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Fair Value Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property Plant and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Account Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" xlink:label="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" xlink:to="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted-average Assumptions Valuation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Schedule of Composition of Long Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturities of Long Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Fair Value of Options Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesTablesAbstract" xlink:label="SAFO_CostOfSalesTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CostOfSalesTablesAbstract" xlink:to="SAFO_CostOfSalesTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SAFO_CostOfSalesTablesAbstract_lbl" xml:lang="en-US">Cost Of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfCostOfSalesTableTextBlock" xlink:label="SAFO_ScheduleOfCostOfSalesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfCostOfSalesTableTextBlock" xlink:to="SAFO_ScheduleOfCostOfSalesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ScheduleOfCostOfSalesTableTextBlock_lbl" xml:lang="en-US">Schedule of Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_lbl" xml:lang="en-US">Schedule of Research and Development Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesTablesAbstract" xlink:label="SAFO_GeneralAndAdministrativeExpensesTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GeneralAndAdministrativeExpensesTablesAbstract" xlink:to="SAFO_GeneralAndAdministrativeExpensesTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SAFO_GeneralAndAdministrativeExpensesTablesAbstract_lbl" xml:lang="en-US">General And Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" xlink:label="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" xlink:to="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock_lbl" xml:lang="en-US">Schedule of General amd Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfFinancingExpensesNetTableTextBlock" xlink:label="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock" xlink:to="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock_lbl" xml:lang="en-US">Schedule of Financing Expenses Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Tax Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Basic and Diluted Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Transactions and Balances with Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_WorkingCapital" xlink:label="SAFO_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_WorkingCapital" xlink:to="SAFO_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Allownace for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xml:lang="en-US">Impaiement expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeveranceCosts1_lbl" xml:lang="en-US">Severance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CumulativeResearchAndDevelopmentGrantsReceived" xlink:label="SAFO_CumulativeResearchAndDevelopmentGrantsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CumulativeResearchAndDevelopmentGrantsReceived" xlink:to="SAFO_CumulativeResearchAndDevelopmentGrantsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CumulativeResearchAndDevelopmentGrantsReceived_lbl" xml:lang="en-US">Cumulative research and development grants received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RateOfDepreciationPercentage" xlink:label="SAFO_RateOfDepreciationPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RateOfDepreciationPercentage" xlink:to="SAFO_RateOfDepreciationPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_RateOfDepreciationPercentage_lbl" xml:lang="en-US">Rate of depreciation, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xml:lang="en-US">Fair Value of convertible component in convertible loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Outstanding beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US">Fair value of issued level 3 liability</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue" xlink:label="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue" xlink:to="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue_lbl" xml:lang="en-US">Changes in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Outstanding ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsCurrent_2_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation of property plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less - accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US">Less - Impairment of long lived assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Other accounts liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Investment amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Ownership pecentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xml:lang="en-US">Proceeds from sale of investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInvestmentIncomeReceivable" xlink:label="us-gaap_AccruedInvestmentIncomeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedInvestmentIncomeReceivable" xlink:to="us-gaap_AccruedInvestmentIncomeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedInvestmentIncomeReceivable_lbl" xml:lang="en-US">Amount receivable on sale of investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DetachableWarrants" xlink:label="SAFO_DetachableWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DetachableWarrants" xlink:to="SAFO_DetachableWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DetachableWarrants_lbl" xml:lang="en-US">Detachable warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US">Measurement input, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueAssumptionExpectedTerm" xlink:label="SAFO_FairValueAssumptionExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FairValueAssumptionExpectedTerm" xlink:to="SAFO_FairValueAssumptionExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FairValueAssumptionExpectedTerm_lbl" xml:lang="en-US">Measurement input, term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock in units</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized" xlink:label="us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized" xlink:to="us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized_lbl" xml:lang="en-US">Warrant description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Common stock exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Issuance of shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to purchase common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Compensation expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" xlink:label="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" xlink:to="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage_lbl" xml:lang="en-US">Mandatory conversion probability percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" xlink:label="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" xlink:to="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage_lbl" xml:lang="en-US">Optional conversion probability percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtFairValue" xlink:to="us-gaap_LongTermDebtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtFairValue_2_lbl" xml:lang="en-US">Fair value of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xml:lang="en-US">Estimated fair value of debt instrument</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Fair value of derivative instrument</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Fair value measurement of derivative instrument percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Fair value measurement of derivative instrument term</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueOfWarrantPrice" xlink:label="SAFO_FairValueOfWarrantPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FairValueOfWarrantPrice" xlink:to="SAFO_FairValueOfWarrantPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FairValueOfWarrantPrice_lbl" xml:lang="en-US">Fair value of derivative instrument price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Long-term loans, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long-term loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Less current maturities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long term from banking institution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">First year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">Second year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Long-term loans</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RoyaltyDescription" xlink:label="SAFO_RoyaltyDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RoyaltyDescription" xlink:to="SAFO_RoyaltyDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_RoyaltyDescription_lbl" xml:lang="en-US">Royalty percentage, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_lbl" xml:lang="en-US">Contingent liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AgreementTermDescription" xlink:label="SAFO_AgreementTermDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AgreementTermDescription" xlink:to="SAFO_AgreementTermDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_AgreementTermDescription_lbl" xml:lang="en-US">Agreement term, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Annual rent expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OfficeAndRelatedServiceFees" xlink:label="SAFO_OfficeAndRelatedServiceFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OfficeAndRelatedServiceFees" xlink:to="SAFO_OfficeAndRelatedServiceFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_OfficeAndRelatedServiceFees_lbl" xml:lang="en-US">Office and related service fees</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LessorOnetimePaymentAmount" xlink:label="SAFO_LessorOnetimePaymentAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LessorOnetimePaymentAmount" xlink:to="SAFO_LessorOnetimePaymentAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LessorOnetimePaymentAmount_lbl" xml:lang="en-US">Lessor one-time payment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease term expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Lease rent amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Issuance of common stock shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PercentageOfNetRevenues" xlink:label="SAFO_PercentageOfNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_PercentageOfNetRevenues" xlink:to="SAFO_PercentageOfNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_PercentageOfNetRevenues_lbl" xml:lang="en-US">Percentage of net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Aggregate amount of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MaximumCompensationPercentageOfGrossProfit" xlink:label="SAFO_MaximumCompensationPercentageOfGrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MaximumCompensationPercentageOfGrossProfit" xlink:to="SAFO_MaximumCompensationPercentageOfGrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MaximumCompensationPercentageOfGrossProfit_lbl" xml:lang="en-US">Maximum compensation percentage of gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Options issued to purchase shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Common stock shares purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PercentageOfPurchaseQuota" xlink:label="SAFO_PercentageOfPurchaseQuota" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_PercentageOfPurchaseQuota" xlink:to="SAFO_PercentageOfPurchaseQuota_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_PercentageOfPurchaseQuota_lbl" xml:lang="en-US">Percentage of purchase quota</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Number of common stock shares issued, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrants to purchase shares of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of stock, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Sale of stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Sale of stock, price</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_WarrantsDescription" xlink:label="SAFO_WarrantsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_WarrantsDescription" xlink:to="SAFO_WarrantsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_WarrantsDescription_lbl" xml:lang="en-US">Warrants description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="us-gaap_InvestmentOwnedAtCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtCost_lbl" xml:lang="en-US">Additional investment amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Stock price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xml:lang="en-US">Proceeds from stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options exercisable shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Share based compensation description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock option issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OptionToPurchaseOfCommonStock" xlink:label="SAFO_OptionToPurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OptionToPurchaseOfCommonStock" xlink:to="SAFO_OptionToPurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_OptionToPurchaseOfCommonStock_lbl" xml:lang="en-US">Option to purchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionExercisePriceIncrease" xlink:label="us-gaap_StockOptionExercisePriceIncrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceIncrease" xlink:to="us-gaap_StockOptionExercisePriceIncrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionExercisePriceIncrease_lbl" xml:lang="en-US">Option exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Options vested to purchase of share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Vesting percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Estimated fair value of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Increase in number of shares approved</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US">Shares issued under equity incentive plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_lbl" xml:lang="en-US">Equity financing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EstimatedFairValueOfNonCashCompensationGranted" xlink:label="SAFO_EstimatedFairValueOfNonCashCompensationGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EstimatedFairValueOfNonCashCompensationGranted" xlink:to="SAFO_EstimatedFairValueOfNonCashCompensationGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_EstimatedFairValueOfNonCashCompensationGranted_lbl" xml:lang="en-US">Estimated fair value of non cash compensation granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_3_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options Outstanding, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Number of Options Outstanding, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Options Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term of options (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price (US dollars)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Share price (US dollars)</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" xlink:label="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" xlink:to="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_lbl" xml:lang="en-US">Fair value (US dollars)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNetAbstract" xlink:to="SAFO_FinancingExpensesNetAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SAFO_FinancingExpensesNetAbstract_2_lbl" xml:lang="en-US">Financing Expenses Net - Schedule Of Financing Expenses Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense" xlink:label="us-gaap_InterestAndDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">Interest and amortization expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CurrencyExchangeDifferences" xlink:label="SAFO_CurrencyExchangeDifferences" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CurrencyExchangeDifferences" xlink:to="SAFO_CurrencyExchangeDifferences_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CurrencyExchangeDifferences_lbl" xml:lang="en-US">Currency exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ChangesInFairValueOfConvertibleLoans" xlink:label="SAFO_ChangesInFairValueOfConvertibleLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ChangesInFairValueOfConvertibleLoans" xlink:to="SAFO_ChangesInFairValueOfConvertibleLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ChangesInFairValueOfConvertibleLoans_lbl" xml:lang="en-US">Changes in fair value of convertible loans</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_BankChargesAndOtherFinanceExpensesNet" xlink:label="SAFO_BankChargesAndOtherFinanceExpensesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_BankChargesAndOtherFinanceExpensesNet" xlink:to="SAFO_BankChargesAndOtherFinanceExpensesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_BankChargesAndOtherFinanceExpensesNet_lbl" xml:lang="en-US">Bank charges and other finance expenses, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNet" xlink:to="SAFO_FinancingExpensesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="SAFO_FinancingExpensesNet_2_lbl" xml:lang="en-US">Financing expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income tax description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Carry forward losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Pretax loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Federal tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncomeTaxComputedAtOrdinaryTaxRate" xlink:label="SAFO_IncomeTaxComputedAtOrdinaryTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IncomeTaxComputedAtOrdinaryTaxRate" xlink:to="SAFO_IncomeTaxComputedAtOrdinaryTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_IncomeTaxComputedAtOrdinaryTaxRate_lbl" xml:lang="en-US">Income tax computed at the ordinary tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Non-deductible expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="us-gaap_IncomeTaxReconciliationDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationDeductions" xlink:to="us-gaap_IncomeTaxReconciliationDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationDeductions_lbl" xml:lang="en-US">Tax in respect of differences in corporate tax rates</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:label="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:to="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated_lbl" xml:lang="en-US">Losses and timing differences in respect of which no deferred taxes were generated</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProvisionForEmployeeRelatedObligation" xlink:label="SAFO_ProvisionForEmployeeRelatedObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProvisionForEmployeeRelatedObligation" xlink:to="SAFO_ProvisionForEmployeeRelatedObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ProvisionForEmployeeRelatedObligation_lbl" xml:lang="en-US">Provision for employee related obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xml:lang="en-US">Non capital loss carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares of Common Stock outstanding attributable to shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyRetainer" xlink:label="SAFO_MonthlyRetainer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MonthlyRetainer" xlink:to="SAFO_MonthlyRetainer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MonthlyRetainer_lbl" xml:lang="en-US">Monthly retainer</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyConsultancyFee" xlink:label="SAFO_MonthlyConsultancyFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MonthlyConsultancyFee" xlink:to="SAFO_MonthlyConsultancyFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MonthlyConsultancyFee_lbl" xml:lang="en-US">Monthly consultancy fee</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyDirectorsFee" xlink:label="SAFO_MonthlyDirectorsFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MonthlyDirectorsFee" xlink:to="SAFO_MonthlyDirectorsFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_MonthlyDirectorsFee_lbl" xml:lang="en-US">Monthly directors fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_3_lbl" xml:lang="en-US">General and administrative expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_3_lbl" xml:lang="en-US">Research and development expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl" xml:lang="en-US">Other accounts payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US">Reverse stock split, ratio</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_2_lbl" xml:lang="en-US">Reverse stock split, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt instrument, aggregate principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccreditedInvestorsMember" xlink:to="SAFO_AccreditedInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AccreditedInvestorsMember_doc" xml:lang="en-US">Accredited Investors [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccreditedInvestorsOneMember" xlink:to="SAFO_AccreditedInvestorsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AccreditedInvestorsOneMember_doc" xml:lang="en-US">Accredited Investors One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccreditedInvestorsTwoMember" xlink:to="SAFO_AccreditedInvestorsTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AccreditedInvestorsTwoMember_doc" xml:lang="en-US">Accredited Investors Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AccruedExpensesMember" xlink:to="SAFO_AccruedExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AccruedExpensesMember_doc" xml:lang="en-US">Accrued Expenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AffiliatedCompanyMember" xlink:to="SAFO_AffiliatedCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AffiliatedCompanyMember_doc" xml:lang="en-US">Affiliated Company [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_BoardOfDirectorsMember" xlink:to="SAFO_BoardOfDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_BoardOfDirectorsMember_doc" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CADMember" xlink:to="SAFO_CADMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CADMember_doc" xml:lang="en-US">Canadian Dollars [Member].</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommonStockIssueOneMember" xlink:label="SAFO_CommonStockIssueOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommonStockIssueOneMember" xlink:to="SAFO_CommonStockIssueOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CommonStockIssueOneMember_doc" xml:lang="en-US">Common Stock Issue One [Member].</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommonStockIssueTwoMember" xlink:label="SAFO_CommonStockIssueTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommonStockIssueTwoMember" xlink:to="SAFO_CommonStockIssueTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CommonStockIssueTwoMember_doc" xml:lang="en-US">Common Stock Issue Two [Member].</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommonStockTwoMember" xlink:label="SAFO_CommonStockTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommonStockTwoMember" xlink:to="SAFO_CommonStockTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CommonStockTwoMember_doc" xml:lang="en-US">Common Stock 2 [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommunicationsMember" xlink:to="SAFO_CommunicationsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CommunicationsMember_doc" xml:lang="en-US">Communications [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultantMember" xlink:to="SAFO_ConsultantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConsultantMember_doc" xml:lang="en-US">Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConvertibleBridgeLoanAgreementMember" xlink:label="SAFO_ConvertibleBridgeLoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConvertibleBridgeLoanAgreementMember" xlink:to="SAFO_ConvertibleBridgeLoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConvertibleBridgeLoanAgreementMember_doc" xml:lang="en-US">Convertible Bridge Loan Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConvertibleLoanAgreementsMember" xlink:to="SAFO_ConvertibleLoanAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConvertibleLoanAgreementsMember_doc" xml:lang="en-US">Convertible Loan Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DepreciationAndAmortizationMember" xlink:label="SAFO_DepreciationAndAmortizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DepreciationAndAmortizationMember" xlink:to="SAFO_DepreciationAndAmortizationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DepreciationAndAmortizationMember_doc" xml:lang="en-US">Depreciation and amortization [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DepreciationMember" xlink:to="SAFO_DepreciationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DepreciationMember_doc" xml:lang="en-US">Depreciation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DetachableWarrants" xlink:to="SAFO_DetachableWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DetachableWarrants_doc" xml:lang="en-US">Detachable warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DirectorsCompensationMember" xlink:to="SAFO_DirectorsCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DirectorsCompensationMember_doc" xml:lang="en-US">Directors Compensation[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DirectorsMember" xlink:label="SAFO_DirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DirectorsMember" xlink:to="SAFO_DirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DirectorsMember_doc" xml:lang="en-US">Directors [Member].</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EPAndFDAMember" xlink:label="SAFO_EPAndFDAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EPAndFDAMember" xlink:to="SAFO_EPAndFDAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_EPAndFDAMember_doc" xml:lang="en-US">EPA and FDA [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EmployeesAndDirectorsMember" xlink:to="SAFO_EmployeesAndDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_EmployeesAndDirectorsMember_doc" xml:lang="en-US">Employees and Directors [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EmployeesAndRelatedInstitutionsMember" xlink:to="SAFO_EmployeesAndRelatedInstitutionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_EmployeesAndRelatedInstitutionsMember_doc" xml:lang="en-US">Employees and Related Institutions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FairValueAssumptionExpectedTerm" xlink:to="SAFO_FairValueAssumptionExpectedTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FairValueAssumptionExpectedTerm_doc" xml:lang="en-US">Measurment input, term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FundsInRespectOfEmployeeRightsUponRetirement" xlink:to="SAFO_FundsInRespectOfEmployeeRightsUponRetirement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FundsInRespectOfEmployeeRightsUponRetirement_doc" xml:lang="en-US">Funds in Respect of Employee Rights Upon Retirement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FurnitureAndOfficeEquipmentMember" xlink:to="SAFO_FurnitureAndOfficeEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FurnitureAndOfficeEquipmentMember_doc" xml:lang="en-US">Furniture and Office Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GovernmentInstitutionsMember" xlink:to="SAFO_GovernmentInstitutionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_GovernmentInstitutionsMember_doc" xml:lang="en-US">Government Institutions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:to="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement_doc" xml:lang="en-US">Increase (decrease) in liability for employee rights upon retirement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_InsuranceMember" xlink:to="SAFO_InsuranceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_InsuranceMember_doc" xml:lang="en-US">Insurance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IsraeliBankMember" xlink:label="SAFO_IsraeliBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IsraeliBankMember" xlink:to="SAFO_IsraeliBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IsraeliBankMember_doc" xml:lang="en-US">Israeli Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IsraeliInnovationAuthorityMember" xlink:to="SAFO_IsraeliInnovationAuthorityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IsraeliInnovationAuthorityMember_doc" xml:lang="en-US">Israeli Innovation Authority [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LaboratoryAndFieldTestsMember" xlink:to="SAFO_LaboratoryAndFieldTestsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LaboratoryAndFieldTestsMember_doc" xml:lang="en-US">Laboratory and Field tests [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LeaseAgreementMember" xlink:to="SAFO_LeaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LeaseAgreementMember_doc" xml:lang="en-US">Lease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LegalExpensesMember" xlink:to="SAFO_LegalExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LegalExpensesMember_doc" xml:lang="en-US">Legal expenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LeviesAndTollsMember" xlink:to="SAFO_LeviesAndTollsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LeviesAndTollsMember_doc" xml:lang="en-US">Levies and tolls [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LiabilityForEmployeeRightsUponRetirement" xlink:to="SAFO_LiabilityForEmployeeRightsUponRetirement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LiabilityForEmployeeRightsUponRetirement_doc" xml:lang="en-US">iability for employee rights upon retirement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MachinesMember" xlink:to="SAFO_MachinesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MachinesMember_doc" xml:lang="en-US">Machines [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MaterialsMember" xlink:to="SAFO_MaterialsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MaterialsMember_doc" xml:lang="en-US">Materials [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MrDanSztubelMember" xlink:to="SAFO_MrDanSztubelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MrDanSztubelMember_doc" xml:lang="en-US">Mr. Dan Sztubel [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_NISMember" xlink:to="SAFO_NISMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_NISMember_doc" xml:lang="en-US">NIS [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NineteenAccreditedInvestorsMember" xlink:label="SAFO_NineteenAccreditedInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_NineteenAccreditedInvestorsMember" xlink:to="SAFO_NineteenAccreditedInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_NineteenAccreditedInvestorsMember_doc" xml:lang="en-US">19 Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NirEcologyLtdMember" xlink:label="SAFO_NirEcologyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_NirEcologyLtdMember" xlink:to="SAFO_NirEcologyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_NirEcologyLtdMember_doc" xml:lang="en-US">Nir Ecology Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NonQualifiedOptionMember" xlink:label="SAFO_NonQualifiedOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_NonQualifiedOptionMember" xlink:to="SAFO_NonQualifiedOptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_NonQualifiedOptionMember_doc" xml:lang="en-US">Non-Qualified Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NovemberLoanAgreementMember" xlink:label="SAFO_NovemberLoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_NovemberLoanAgreementMember" xlink:to="SAFO_NovemberLoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_NovemberLoanAgreementMember_doc" xml:lang="en-US">November Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OmdanConsultingAndInstructingLtdMember" xlink:label="SAFO_OmdanConsultingAndInstructingLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OmdanConsultingAndInstructingLtdMember" xlink:to="SAFO_OmdanConsultingAndInstructingLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_OmdanConsultingAndInstructingLtdMember_doc" xml:lang="en-US">Omdan Consulting and Instructing Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OtherExpensesMember" xlink:to="SAFO_OtherExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_OtherExpensesMember_doc" xml:lang="en-US">Other expenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_PrepaidExpensesAndAdvancesToVendorsMember" xlink:to="SAFO_PrepaidExpensesAndAdvancesToVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_PrepaidExpensesAndAdvancesToVendorsMember_doc" xml:lang="en-US">Prepaid Expenses and Advances to Vendors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement_doc" xml:lang="en-US">Increase in funds in respect of employee rights upon retirement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsOnAccountOfSharesMember" xlink:to="SAFO_ProceedsOnAccountOfSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ProceedsOnAccountOfSharesMember_doc" xml:lang="en-US">Procceds on Accounts of shares [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProfessionalFeesMember" xlink:to="SAFO_ProfessionalFeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ProfessionalFeesMember_doc" xml:lang="en-US">Professional fees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProfessionalServicesMember" xlink:to="SAFO_ProfessionalServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ProfessionalServicesMember_doc" xml:lang="en-US">Professional services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RentAndAssetManagementMember" xlink:to="SAFO_RentAndAssetManagementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_RentAndAssetManagementMember_doc" xml:lang="en-US">Rent and asset management [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RentAndOfficeMaintenanceMember" xlink:to="SAFO_RentAndOfficeMaintenanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_RentAndOfficeMaintenanceMember_doc" xml:lang="en-US">Rent and office maintenance [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" xlink:to="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember_doc" xml:lang="en-US">Right of Use Liability Arising from Operating Lease [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SalariesAndFeesToOfficersMember" xlink:to="SAFO_SalariesAndFeesToOfficersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SalariesAndFeesToOfficersMember_doc" xml:lang="en-US">Salaries and Fees to Officers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SalariesAndRelatedExpensesMember" xlink:to="SAFO_SalariesAndRelatedExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SalariesAndRelatedExpensesMember_doc" xml:lang="en-US">Salaries and related expenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SaveFoodsLtdMember" xlink:to="SAFO_SaveFoodsLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SaveFoodsLtdMember_doc" xml:lang="en-US">Save Foods Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SavescannMember" xlink:label="SAFO_SavescannMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SavescannMember" xlink:to="SAFO_SavescannMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SavescannMember_doc" xml:lang="en-US">Savescann [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SavescannSolutionsIncMember" xlink:to="SAFO_SavescannSolutionsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SavescannSolutionsIncMember_doc" xml:lang="en-US">Savescann Solutions Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareBasedCompensationMember" xlink:to="SAFO_ShareBasedCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ShareBasedCompensationMember_doc" xml:lang="en-US">Share based compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SharePurchaseAgreementMember" xlink:label="SAFO_SharePurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SharePurchaseAgreementMember" xlink:to="SAFO_SharePurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SharePurchaseAgreementMember_doc" xml:lang="en-US">Share Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareholdersMember" xlink:label="SAFO_ShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareholdersMember" xlink:to="SAFO_ShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ShareholdersMember_doc" xml:lang="en-US">Shareholders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShortTermOperatingLeaseAgreementMember" xlink:to="SAFO_ShortTermOperatingLeaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ShortTermOperatingLeaseAgreementMember_doc" xml:lang="en-US">Short-term Operating Lease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SubscriptionAgreementMember" xlink:to="SAFO_SubscriptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SubscriptionAgreementMember_doc" xml:lang="en-US">Subscription Agreement [Member].</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TenPercenatgeOfLoanMember" xlink:label="SAFO_TenPercenatgeOfLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TenPercenatgeOfLoanMember" xlink:to="SAFO_TenPercenatgeOfLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TenPercenatgeOfLoanMember_doc" xml:lang="en-US">10% of Loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TheLoansMember" xlink:label="SAFO_TheLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TheLoansMember" xlink:to="SAFO_TheLoansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TheLoansMember_doc" xml:lang="en-US">The Loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ThirteenInvestorsMember" xlink:label="SAFO_ThirteenInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ThirteenInvestorsMember" xlink:to="SAFO_ThirteenInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ThirteenInvestorsMember_doc" xml:lang="en-US">13 Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TotalCompanysStockholdersEquityMember" xlink:to="SAFO_TotalCompanysStockholdersEquityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TotalCompanysStockholdersEquityMember_doc" xml:lang="en-US">Total Company's Stockholders' Equity [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TransportationAndStorageMember" xlink:to="SAFO_TransportationAndStorageMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TransportationAndStorageMember_doc" xml:lang="en-US">Transportation and storage [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TravelExpensesMember" xlink:to="SAFO_TravelExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TravelExpensesMember_doc" xml:lang="en-US">Travel Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoAccreditedInvestorsMember" xlink:label="SAFO_TwoAccreditedInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoAccreditedInvestorsMember" xlink:to="SAFO_TwoAccreditedInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TwoAccreditedInvestorsMember_doc" xml:lang="en-US">Two Accredited Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:to="SAFO_TwoThousandEighteenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TwoThousandEighteenEquityIncentivePlanMember_doc" xml:lang="en-US">2018 Equity Incentive Plan [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_VehicleMaintenanceMember" xlink:to="SAFO_VehicleMaintenanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_VehicleMaintenanceMember_doc" xml:lang="en-US">Vehicle Maintenance [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_WorkingCapital" xlink:to="SAFO_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_XedaInternationalSAMember" xlink:to="SAFO_XedaInternationalSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_XedaInternationalSAMember_doc" xml:lang="en-US">Xeda International S.A [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LendersMember" xlink:to="SAFO_LendersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LendersMember_doc" xml:lang="en-US">Lenders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoAdditionalConvertibleLoanAgreementsMember" xlink:to="SAFO_TwoAdditionalConvertibleLoanAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TwoAdditionalConvertibleLoanAgreementsMember_doc" xml:lang="en-US">Two Additional Convertible Loan Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SecuritiesPurchaseAgreementMember" xlink:to="SAFO_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareInLossesOfAffiliatedCompany" xlink:to="SAFO_ShareInLossesOfAffiliatedCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ShareInLossesOfAffiliatedCompany_doc" xml:lang="en-US">Share in losses of affiliated company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GainOnDisposalOfAffiliatedCompany" xlink:to="SAFO_GainOnDisposalOfAffiliatedCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_GainOnDisposalOfAffiliatedCompany_doc" xml:lang="en-US">Gain on disposal of affiliated company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DisposalOfAffiliatedCompany" xlink:to="SAFO_DisposalOfAffiliatedCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DisposalOfAffiliatedCompany_doc" xml:lang="en-US">Disposal of affiliated company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IssuanceOfWarrantsInConvertibleLoans" xlink:to="SAFO_IssuanceOfWarrantsInConvertibleLoans_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IssuanceOfWarrantsInConvertibleLoans_doc" xml:lang="en-US">Issuance of warrants in convertible loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConversionOfConvertibleLoans" xlink:to="SAFO_ConversionOfConvertibleLoans_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConversionOfConvertibleLoans_doc" xml:lang="en-US">Conversion of convertible loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_WarrantsDescription" xlink:to="SAFO_WarrantsDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_WarrantsDescription_doc" xml:lang="en-US">Warrants description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TerminationOfLeaseAgreement" xlink:to="SAFO_TerminationOfLeaseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TerminationOfLeaseAgreement_doc" xml:lang="en-US">Termination of lease agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:to="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember_doc" xml:lang="en-US">2020 Convertible Loan Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:to="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember_doc" xml:lang="en-US">Valuation Technique, Black-Scholes Option Pricing Model [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:to="SAFO_ValuationTechniqueBinomialOptionPricingModelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ValuationTechniqueBinomialOptionPricingModelMember_doc" xml:lang="en-US">Valuation Technique, Binomial Option Pricing Model [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" xlink:to="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage_doc" xml:lang="en-US">Mandatory conversion probability percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" xlink:to="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DebtInstrumentOptionalConversionProbabilityPercentage_doc" xml:lang="en-US">Optional conversion probability percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FairValueOfWarrantPrice" xlink:to="SAFO_FairValueOfWarrantPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FairValueOfWarrantPrice_doc" xml:lang="en-US">Fair value of warrant price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MedigusLimitedMember" xlink:to="SAFO_MedigusLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MedigusLimitedMember_doc" xml:lang="en-US">Medigus [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_PercentageOfNetRevenues" xlink:to="SAFO_PercentageOfNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_PercentageOfNetRevenues_doc" xml:lang="en-US">Percentage of net revenues.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CommissionAgreementMember" xlink:to="SAFO_CommissionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CommissionAgreementMember_doc" xml:lang="en-US">Commission Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EarthboundTechnologiesLLCMember" xlink:to="SAFO_EarthboundTechnologiesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_EarthboundTechnologiesLLCMember_doc" xml:lang="en-US">Earthbound Technologies, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MaximumCompensationPercentageOfGrossProfit" xlink:to="SAFO_MaximumCompensationPercentageOfGrossProfit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MaximumCompensationPercentageOfGrossProfit_doc" xml:lang="en-US">Maximum compensation percentage of gross profit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IntroducedPartiesMember" xlink:to="SAFO_IntroducedPartiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IntroducedPartiesMember_doc" xml:lang="en-US">Introduced Parties [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ExceedsInNetRevenueMember" xlink:to="SAFO_ExceedsInNetRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ExceedsInNetRevenueMember_doc" xml:lang="en-US">Exceeds in Net Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OccuranceOfAdditionalEventsInAgreementMember" xlink:to="SAFO_OccuranceOfAdditionalEventsInAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_OccuranceOfAdditionalEventsInAgreementMember_doc" xml:lang="en-US">Occurance of Additional Events in Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DistributionAgreementMember" xlink:to="SAFO_DistributionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DistributionAgreementMember_doc" xml:lang="en-US">Distribution Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_SafePackProductsLimitedMember" xlink:to="SAFO_SafePackProductsLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_SafePackProductsLimitedMember_doc" xml:lang="en-US">Safe-Pack Products Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_PercentageOfPurchaseQuota" xlink:to="SAFO_PercentageOfPurchaseQuota_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_PercentageOfPurchaseQuota_doc" xml:lang="en-US">Percentage of purchase quota.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" xlink:to="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock_doc" xml:lang="en-US">Schedule of Weighted-average Assumptions Valuation Method [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MonthlyRetainer" xlink:to="SAFO_MonthlyRetainer_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MonthlyRetainer_doc" xml:lang="en-US">Monthly retainer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CoChiefExecutiveOfficerMember" xlink:to="SAFO_CoChiefExecutiveOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CoChiefExecutiveOfficerMember_doc" xml:lang="en-US">Co-Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultingAgreementMember" xlink:label="SAFO_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultingAgreementMember" xlink:to="SAFO_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:to="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets_doc" xml:lang="en-US">Initial recognition of operating lease right-of-use assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_InitialRecognitionOfOperatingLeaseLiability" xlink:to="SAFO_InitialRecognitionOfOperatingLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_InitialRecognitionOfOperatingLeaseLiability_doc" xml:lang="en-US">Initial recognition of operating lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CostOfSalesTextBlock" xlink:to="SAFO_CostOfSalesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CostOfSalesTextBlock_doc" xml:lang="en-US">Cost of Sales [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_GeneralAndAdministrativeExpensesTextBlock" xlink:to="SAFO_GeneralAndAdministrativeExpensesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_GeneralAndAdministrativeExpensesTextBlock_doc" xml:lang="en-US">General and Administrative Expenses [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LiabilityForEmployeeRightUponRetirement" xlink:to="SAFO_LiabilityForEmployeeRightUponRetirement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LiabilityForEmployeeRightUponRetirement_doc" xml:lang="en-US">Liability for Employee Rights Upon Retirement [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RoyaltyBearingGrants" xlink:to="SAFO_RoyaltyBearingGrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_RoyaltyBearingGrants_doc" xml:lang="en-US">Royalty-bearing Grants [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" xlink:to="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock_doc" xml:lang="en-US">Schedule of Property, Plant and Equipment Depreciation Rates [ Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfCostOfSalesTableTextBlock" xlink:to="SAFO_ScheduleOfCostOfSalesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ScheduleOfCostOfSalesTableTextBlock_doc" xml:lang="en-US">Schedule of Cost of Sales [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" xlink:to="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock_doc" xml:lang="en-US">Schedule of General amd Administrative Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CumulativeResearchAndDevelopmentGrantsReceived" xlink:to="SAFO_CumulativeResearchAndDevelopmentGrantsReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CumulativeResearchAndDevelopmentGrantsReceived_doc" xml:lang="en-US">Cumulative research and development grants received.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RateOfDepreciationPercentage" xlink:to="SAFO_RateOfDepreciationPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_RateOfDepreciationPercentage_doc" xml:lang="en-US">Rate of depreciation, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IncomeTaxComputedAtOrdinaryTaxRate" xlink:to="SAFO_IncomeTaxComputedAtOrdinaryTaxRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IncomeTaxComputedAtOrdinaryTaxRate_doc" xml:lang="en-US">Income tax computed at the ordinary tax rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:to="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated_doc" xml:lang="en-US">Losses and timing differences in respect of which no deferred taxes were generated.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProvisionForEmployeeRelatedObligation" xlink:to="SAFO_ProvisionForEmployeeRelatedObligation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ProvisionForEmployeeRelatedObligation_doc" xml:lang="en-US">Provision for employee related obligation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LongTermDebtFromBankingInstitutions" xlink:to="SAFO_LongTermDebtFromBankingInstitutions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LongTermDebtFromBankingInstitutions_doc" xml:lang="en-US">Long Term Debt From Banking Institutions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_IncreaseDecreaseInAccountsPayableOther" xlink:to="SAFO_IncreaseDecreaseInAccountsPayableOther_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_IncreaseDecreaseInAccountsPayableOther_doc" xml:lang="en-US">Increase in other accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsFromConvertibleLoans" xlink:to="SAFO_ProceedsFromConvertibleLoans_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ProceedsFromConvertibleLoans_doc" xml:lang="en-US">Convertible loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants_doc" xml:lang="en-US">Stock Issued During Period Shares Exercise Of Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants_doc" xml:lang="en-US">Stock Issued During Period Value Exercise Of Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:to="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany_doc" xml:lang="en-US">Share in losses (gain on disposal) of affiliated company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:to="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions_doc" xml:lang="en-US">Decrease (increase) in Short term deposits in banking institutions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CompensationExpensesInExchangeOfInstruments" xlink:to="SAFO_CompensationExpensesInExchangeOfInstruments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CompensationExpensesInExchangeOfInstruments_doc" xml:lang="en-US">Compensation expenses in exchange of instruments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNetDisclosureTextBlock" xlink:to="SAFO_FinancingExpensesNetDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FinancingExpensesNetDisclosureTextBlock_doc" xml:lang="en-US">Financing Expenses Net [Disclosure Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock" xlink:to="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ScheduleOfFinancingExpensesNetTableTextBlock_doc" xml:lang="en-US">Schedule of Financing Expenses Net [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" xlink:to="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock_doc" xml:lang="en-US">Use of Estimates in the Preparation of Financial Statements [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ReceivablesFromSaleOfSubsidiaryMember" xlink:to="SAFO_ReceivablesFromSaleOfSubsidiaryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ReceivablesFromSaleOfSubsidiaryMember_doc" xml:lang="en-US">Receivables From Sale Of Subsidiary [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue" xlink:to="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue_doc" xml:lang="en-US">Changes in fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CurrentLiabilitiesMember" xlink:to="SAFO_CurrentLiabilitiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CurrentLiabilitiesMember_doc" xml:lang="en-US">Current Liabilities [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LongTermLiabilitiesMember" xlink:to="SAFO_LongTermLiabilitiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LongTermLiabilitiesMember_doc" xml:lang="en-US">Long Term Liabilities [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_RoyaltyDescription" xlink:to="SAFO_RoyaltyDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_RoyaltyDescription_doc" xml:lang="en-US">Royalty percentage, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AgreementTermDescription" xlink:to="SAFO_AgreementTermDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AgreementTermDescription_doc" xml:lang="en-US">Agreement term, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OfficeAndRelatedServiceFees" xlink:to="SAFO_OfficeAndRelatedServiceFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_OfficeAndRelatedServiceFees_doc" xml:lang="en-US">Office and related service fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_LessorOnetimePaymentAmount" xlink:to="SAFO_LessorOnetimePaymentAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_LessorOnetimePaymentAmount_doc" xml:lang="en-US">Lessor one-time payment amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_TwoDirectorsMember" xlink:to="SAFO_TwoDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_TwoDirectorsMember_doc" xml:lang="en-US">Two Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OptionToPurchaseOfCommonStock" xlink:to="SAFO_OptionToPurchaseOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_OptionToPurchaseOfCommonStock_doc" xml:lang="en-US">Option to purchase of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_EstimatedFairValueOfNonCashCompensationGranted" xlink:to="SAFO_EstimatedFairValueOfNonCashCompensationGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_EstimatedFairValueOfNonCashCompensationGranted_doc" xml:lang="en-US">Estimated fair value of non cash compensation granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" xlink:to="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue_doc" xml:lang="en-US">Fair value (US dollars).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CurrencyExchangeDifferences" xlink:to="SAFO_CurrencyExchangeDifferences_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_CurrencyExchangeDifferences_doc" xml:lang="en-US">Currency exchange differences.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ChangesInFairValueOfConvertibleLoans" xlink:to="SAFO_ChangesInFairValueOfConvertibleLoans_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ChangesInFairValueOfConvertibleLoans_doc" xml:lang="en-US">Changes in fair value of convertible loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_BankChargesAndOtherFinanceExpensesNet" xlink:to="SAFO_BankChargesAndOtherFinanceExpensesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_BankChargesAndOtherFinanceExpensesNet_doc" xml:lang="en-US">Bank charges and other finance expenses, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNet" xlink:to="SAFO_FinancingExpensesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_FinancingExpensesNet_doc" xml:lang="en-US">Financing expenses, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultantsAndOtherFeesMember" xlink:to="SAFO_ConsultantsAndOtherFeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConsultantsAndOtherFeesMember_doc" xml:lang="en-US">Consultants and Other Fees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MonthlyConsultancyFee" xlink:to="SAFO_MonthlyConsultancyFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MonthlyConsultancyFee_doc" xml:lang="en-US">Monthly consultancy fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConsultingAgreementsMember" xlink:to="SAFO_ConsultingAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ConsultingAgreementsMember_doc" xml:lang="en-US">Consulting Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_AmirUzielEconomicConsultantsLtdMember" xlink:to="SAFO_AmirUzielEconomicConsultantsLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_AmirUzielEconomicConsultantsLtdMember_doc" xml:lang="en-US">Amir Uziel Economic Consultants Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_MonthlyDirectorsFee" xlink:to="SAFO_MonthlyDirectorsFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_MonthlyDirectorsFee_doc" xml:lang="en-US">Monthly directors fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ItzhakShremMember" xlink:to="SAFO_ItzhakShremMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_ItzhakShremMember_doc" xml:lang="en-US">Itzhak Shrem [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_OtherAccountsLiabilitiesCurrent" xlink:to="SAFO_OtherAccountsLiabilitiesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SAFO_OtherAccountsLiabilitiesCurrent_doc" xml:lang="en-US">Other accounts liabilities (Note 5).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_2_lbl" xml:lang="en-US">Selling and Marketing Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_FinancingExpensesNet" xlink:to="SAFO_FinancingExpensesNet_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_FinancingExpensesNet_4_lbl" xml:lang="en-US">FinancingExpensesNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:to="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany_3_lbl" xml:lang="en-US">ShareInLossesGainOnDisposalOfAffiliatedCompany</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_CompensationExpensesInExchangeOfInstruments" xlink:to="SAFO_CompensationExpensesInExchangeOfInstruments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_CompensationExpensesInExchangeOfInstruments_3_lbl" xml:lang="en-US">CompensationExpensesInExchangeOfInstruments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Businesses and Interest in Affiliates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:to="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions_3_lbl" xml:lang="en-US">DecreaseIncreaseInShortTermDepositsInBankingInstitutions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement_3_lbl" xml:lang="en-US">ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_2_lbl" xml:lang="en-US">Repayments of Short-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_2_lbl" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SAFO_ConversionOfConvertibleLoans" xlink:to="SAFO_ConversionOfConvertibleLoans_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SAFO_ConversionOfConvertibleLoans_3_lbl" xml:lang="en-US">ConversionOfConvertibleLoans</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_2_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>67
<FILENAME>safo-20201231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SAFO 20201231 S%2D1 DFN.xfr; Date: 2021%2D03%2D16T18:23:22Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://save-food.org/role/DocumentAndEntityInformation" xlink:href="safo-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/BalanceSheets" xlink:href="safo-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/BalanceSheetsParenthetical" xlink:href="safo-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfComprehensiveLoss" xlink:href="safo-20201231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" xlink:href="safo-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StatementsOfCashFlows" xlink:href="safo-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/General" xlink:href="safo-20201231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssets" xlink:href="safo-20201231.xsd#OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNet" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoans" xlink:href="safo-20201231.xsd#ConvertibleLoans" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CommitmentAndContingentLiabilities" xlink:href="safo-20201231.xsd#CommitmentAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ShareholdersEquity" xlink:href="safo-20201231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions" xlink:href="safo-20201231.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSales" xlink:href="safo-20201231.xsd#CostOfSales" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpenses" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpenses" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNet" xlink:href="safo-20201231.xsd#FinancingExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax" xlink:href="safo-20201231.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStock" xlink:href="safo-20201231.xsd#LossPerCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedParties" xlink:href="safo-20201231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SubsequentEvents" xlink:href="safo-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesPolicies" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesTables" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssetsTables" xlink:href="safo-20201231.xsd#OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNetTables" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilitiesTables" xlink:href="safo-20201231.xsd#OtherAccountsLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoansTables" xlink:href="safo-20201231.xsd#ConvertibleLoansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptionsTables" xlink:href="safo-20201231.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSalesTables" xlink:href="safo-20201231.xsd#CostOfSalesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNetTables" xlink:href="safo-20201231.xsd#FinancingExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTaxTables" xlink:href="safo-20201231.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStockTables" xlink:href="safo-20201231.xsd#LossPerCommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedPartiesTables" xlink:href="safo-20201231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralDetailsNarrative" xlink:href="safo-20201231.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="safo-20201231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:href="safo-20201231.xsd#SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:href="safo-20201231.xsd#OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:href="safo-20201231.xsd#PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:href="safo-20201231.xsd#OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoansDetailsNarrative" xlink:href="safo-20201231.xsd#ConvertibleLoansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:href="safo-20201231.xsd#ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:href="safo-20201231.xsd#Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:href="safo-20201231.xsd#CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ShareholdersEquityDetailsNarrative" xlink:href="safo-20201231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptionsDetailsNarrative" xlink:href="safo-20201231.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" xlink:href="safo-20201231.xsd#StockOptions-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:href="safo-20201231.xsd#StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/CostOfSalesDetails" xlink:href="safo-20201231.xsd#CostOfSalesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" xlink:href="safo-20201231.xsd#ResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" xlink:href="safo-20201231.xsd#GeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:href="safo-20201231.xsd#FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTaxDetailsNarrative" xlink:href="safo-20201231.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:href="safo-20201231.xsd#IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="safo-20201231.xsd#IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:href="safo-20201231.xsd#LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedPartiesDetailsNarrative" xlink:href="safo-20201231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:href="safo-20201231.xsd#RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://save-food.org/role/SubsequentEventsDetailsNarrative" xlink:href="safo-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FundsInRespectOfEmployeeRightsUponRetirement" xlink:label="loc_SAFOFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_SAFOFundsInRespectOfEmployeeRightsUponRetirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherAccountsLiabilitiesCurrent" xlink:label="loc_SAFOOtherAccountsLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_SAFOOtherAccountsLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LongTermDebtFromBankingInstitutions" xlink:label="loc_SAFOLongTermDebtFromBankingInstitutions" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_SAFOLongTermDebtFromBankingInstitutions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LiabilityForEmployeeRightsUponRetirement" xlink:label="loc_SAFOLiabilityForEmployeeRightsUponRetirement" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_SAFOLiabilityForEmployeeRightsUponRetirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNet" xlink:label="loc_SAFOFinancingExpensesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_SAFOFinancingExpensesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareInLossesOfAffiliatedCompany" xlink:label="loc_SAFOShareInLossesOfAffiliatedCompany" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_SAFOShareInLossesOfAffiliatedCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GainOnDisposalOfAffiliatedCompany" xlink:label="loc_SAFOGainOnDisposalOfAffiliatedCompany" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_SAFOGainOnDisposalOfAffiliatedCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsOnAccountOfSharesMember" xlink:label="loc_SAFOProceedsOnAccountOfSharesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_SAFOProceedsOnAccountOfSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TotalCompanysStockholdersEquityMember" xlink:label="loc_SAFOTotalCompanysStockholdersEquityMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_SAFOTotalCompanysStockholdersEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="loc_SAFOStockIssuedDuringPeriodValueExerciseOfWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOStockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="loc_SAFOStockIssuedDuringPeriodSharesExerciseOfWarrants" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOStockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:label="loc_SAFOShareInLossesGainOnDisposalOfAffiliatedCompany" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SAFOShareInLossesGainOnDisposalOfAffiliatedCompany" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_SAFOIncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SAFOIncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses" xlink:label="loc_us-gaapProvisionForLoanAndLeaseLosses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForLoanAndLeaseLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CompensationExpensesInExchangeOfInstruments" xlink:label="loc_SAFOCompensationExpensesInExchangeOfInstruments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SAFOCompensationExpensesInExchangeOfInstruments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncreaseDecreaseInAccountsPayableOther" xlink:label="loc_SAFOIncreaseDecreaseInAccountsPayableOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SAFOIncreaseDecreaseInAccountsPayableOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsForProceedsFromBusinessesAndInterestInAffiliates" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:label="loc_SAFODecreaseIncreaseInShortTermDepositsInBankingInstitutions" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_SAFODecreaseIncreaseInShortTermDepositsInBankingInstitutions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="loc_SAFOProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_SAFOProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSecuredNotesPayable" xlink:label="loc_us-gaapProceedsFromSecuredNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSecuredNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProceedsFromConvertibleLoans" xlink:label="loc_SAFOProceedsFromConvertibleLoans" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_SAFOProceedsFromConvertibleLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_us-gaapRepaymentsOfShortTermDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfShortTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DisposalOfAffiliatedCompany" xlink:label="loc_SAFODisposalOfAffiliatedCompany" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SAFODisposalOfAffiliatedCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TerminationOfLeaseAgreement" xlink:label="loc_SAFOTerminationOfLeaseAgreement" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SAFOTerminationOfLeaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IssuanceOfWarrantsInConvertibleLoans" xlink:label="loc_SAFOIssuanceOfWarrantsInConvertibleLoans" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SAFOIssuanceOfWarrantsInConvertibleLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConversionOfConvertibleLoans" xlink:label="loc_SAFOConversionOfConvertibleLoans" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SAFOConversionOfConvertibleLoans" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:label="loc_SAFOInitialRecognitionOfOperatingLeaseRightofuseAssets" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SAFOInitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InitialRecognitionOfOperatingLeaseLiability" xlink:label="loc_SAFOInitialRecognitionOfOperatingLeaseLiability" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SAFOInitialRecognitionOfOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/General" xlink:title="00000007 - Disclosure - General">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssets" xlink:title="00000009 - Disclosure - Other Current Assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNet" xlink:title="00000010 - Disclosure - Property and Equipment, Net">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities" xlink:title="00000011 - Disclosure - Other Accounts Liabilities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoans" xlink:title="00000012 - Disclosure - Convertible Loans">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions" xlink:title="00000013 - Disclosure - Long-Term Loans from Banking Institutions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/CommitmentAndContingentLiabilities" xlink:title="00000014 - Disclosure - Commitment and Contingent Liabilities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ShareholdersEquity" xlink:title="00000015 - Disclosure - Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions" xlink:title="00000016 - Disclosure - Stock Options">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSales" xlink:title="00000017 - Disclosure - Cost of Sales">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesAbstract" xlink:label="loc_SAFOCostOfSalesAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesTextBlock" xlink:label="loc_SAFOCostOfSalesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOCostOfSalesAbstract" xlink:to="loc_SAFOCostOfSalesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpenses" xlink:title="00000018 - Disclosure - Research and Development Expenses">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpenses" xlink:title="00000019 - Disclosure - General and Administrative Expenses">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesAbstract" xlink:label="loc_SAFOGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesTextBlock" xlink:label="loc_SAFOGeneralAndAdministrativeExpensesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_SAFOGeneralAndAdministrativeExpensesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNet" xlink:title="00000020 - Disclosure - Financing Expenses, Net">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNetAbstract" xlink:label="loc_SAFOFinancingExpensesNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNetDisclosureTextBlock" xlink:label="loc_SAFOFinancingExpensesNetDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_SAFOFinancingExpensesNetDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax" xlink:title="00000021 - Disclosure - Income Tax">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStock" xlink:title="00000022 - Disclosure - Loss Per Common Stock">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedParties" xlink:title="00000023 - Disclosure - Related Parties">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SubsequentEvents" xlink:title="00000024 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" xlink:label="loc_SAFOUseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SAFOUseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LiabilityForEmployeeRightUponRetirement" xlink:label="loc_SAFOLiabilityForEmployeeRightUponRetirement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SAFOLiabilityForEmployeeRightUponRetirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RoyaltyBearingGrants" xlink:label="loc_SAFORoyaltyBearingGrants" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SAFORoyaltyBearingGrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" xlink:label="loc_SAFOScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SAFOScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssetsTables" xlink:title="00000027 - Disclosure - Other Current Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNetTables" xlink:title="00000028 - Disclosure - Property and Equipment, Net (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilitiesTables" xlink:title="00000029 - Disclosure - Other Accounts Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoansTables" xlink:title="00000030 - Disclosure - Convertible Loans (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" xlink:label="loc_SAFOScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables" xlink:title="00000031 - Disclosure - Long-Term Loans from Banking Institutions (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptionsTables" xlink:title="00000032 - Disclosure - Stock Options (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSalesTables" xlink:title="00000033 - Disclosure - Cost of Sales (Tables)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesTablesAbstract" xlink:label="loc_SAFOCostOfSalesTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfCostOfSalesTableTextBlock" xlink:label="loc_SAFOScheduleOfCostOfSalesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOCostOfSalesTablesAbstract" xlink:to="loc_SAFOScheduleOfCostOfSalesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000034 - Disclosure - Research and Development Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:label="loc_us-gaapScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpensesTables" xlink:title="00000035 - Disclosure - General and Administrative Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesTablesAbstract" xlink:label="loc_SAFOGeneralAndAdministrativeExpensesTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" xlink:label="loc_SAFOScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOGeneralAndAdministrativeExpensesTablesAbstract" xlink:to="loc_SAFOScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNetTables" xlink:title="00000036 - Disclosure - Financing Expenses, Net (Tables)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNetAbstract" xlink:label="loc_SAFOFinancingExpensesNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ScheduleOfFinancingExpensesNetTableTextBlock" xlink:label="loc_SAFOScheduleOfFinancingExpensesNetTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_SAFOScheduleOfFinancingExpensesNetTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTaxTables" xlink:title="00000037 - Disclosure - Income Tax (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStockTables" xlink:title="00000038 - Disclosure - Loss Per Common Stock (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedPartiesTables" xlink:title="00000039 - Disclosure - Related Parties (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralDetailsNarrative" xlink:title="00000040 - Disclosure - General (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_WorkingCapital" xlink:label="loc_SAFOWorkingCapital" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000041 - Disclosure - Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NISMember" xlink:label="loc_SAFONISMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SAFONISMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IsraeliInnovationAuthorityMember" xlink:label="loc_SAFOIsraeliInnovationAuthorityMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOIsraeliInnovationAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaapSeveranceCosts1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSeveranceCosts1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CumulativeResearchAndDevelopmentGrantsReceived" xlink:label="loc_SAFOCumulativeResearchAndDevelopmentGrantsReceived" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOCumulativeResearchAndDevelopmentGrantsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails" xlink:title="00000042 - Disclosure - Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FurnitureAndOfficeEquipmentMember" xlink:label="loc_SAFOFurnitureAndOfficeEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOFurnitureAndOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MachinesMember" xlink:label="loc_SAFOMachinesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOMachinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RateOfDepreciationPercentage" xlink:label="loc_SAFORateOfDepreciationPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFORateOfDepreciationPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails" xlink:title="00000043 - Disclosure - Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaapConvertibleDebtFairValueDisclosures" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebtFairValueDisclosures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails" xlink:title="00000044 - Disclosure - Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue" xlink:label="loc_SAFOFairValueMeasurementWithUnobservableInputsChangesInFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SAFOFairValueMeasurementWithUnobservableInputsChangesInFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails" xlink:title="00000045 - Disclosure - Other Current Assets - Schedule of Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PrepaidExpensesAndAdvancesToVendorsMember" xlink:label="loc_SAFOPrepaidExpensesAndAdvancesToVendorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOPrepaidExpensesAndAdvancesToVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ReceivablesFromSaleOfSubsidiaryMember" xlink:label="loc_SAFOReceivablesFromSaleOfSubsidiaryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOReceivablesFromSaleOfSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GovernmentInstitutionsMember" xlink:label="loc_SAFOGovernmentInstitutionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOGovernmentInstitutionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000046 - Disclosure - Property and Equipment, Net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="00000047 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FurnitureAndOfficeEquipmentMember" xlink:label="loc_SAFOFurnitureAndOfficeEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOFurnitureAndOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MachinesMember" xlink:label="loc_SAFOMachinesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SAFOMachinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails" xlink:title="00000048 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EmployeesAndRelatedInstitutionsMember" xlink:label="loc_SAFOEmployeesAndRelatedInstitutionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOEmployeesAndRelatedInstitutionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccruedExpensesMember" xlink:label="loc_SAFOAccruedExpensesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOAccruedExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember" xlink:label="loc_SAFORightOfUseLiabilityArisingFromOperatingLeaseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFORightOfUseLiabilityArisingFromOperatingLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AffiliatedCompanyMember" xlink:label="loc_SAFOAffiliatedCompanyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_SAFOAffiliatedCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical" xlink:title="00000049 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SavescannSolutionsIncMember" xlink:label="loc_SAFOSavescannSolutionsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_SAFOSavescannSolutionsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CADMember" xlink:label="loc_SAFOCADMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SAFOCADMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInvestmentIncomeReceivable" xlink:label="loc_us-gaapAccruedInvestmentIncomeReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedInvestmentIncomeReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoansDetailsNarrative" xlink:title="00000050 - Disclosure - Convertible Loans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConvertibleLoanAgreementsMember" xlink:label="loc_SAFOConvertibleLoanAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOConvertibleLoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoAdditionalConvertibleLoanAgreementsMember" xlink:label="loc_SAFOTwoAdditionalConvertibleLoanAgreementsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOTwoAdditionalConvertibleLoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SecuritiesPurchaseAgreementMember" xlink:label="loc_SAFOSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:label="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LendersMember" xlink:label="loc_SAFOLendersMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOLendersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CurrentLiabilitiesMember" xlink:label="loc_SAFOCurrentLiabilitiesMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_SAFOCurrentLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LongTermLiabilitiesMember" xlink:label="loc_SAFOLongTermLiabilitiesMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_SAFOLongTermLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DetachableWarrants" xlink:label="loc_SAFODetachableWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFODetachableWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaapDebtInstrumentMeasurementInput" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueAssumptionExpectedTerm" xlink:label="loc_SAFOFairValueAssumptionExpectedTerm" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOFairValueAssumptionExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized" xlink:label="loc_us-gaapClassOfWarrantOrRightExpenseOrRevenueRecognized" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExpenseOrRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage" xlink:label="loc_SAFODebtInstrumentMandatoryConversionProbabilityPercentage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFODebtInstrumentMandatoryConversionProbabilityPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DebtInstrumentOptionalConversionProbabilityPercentage" xlink:label="loc_SAFODebtInstrumentOptionalConversionProbabilityPercentage" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFODebtInstrumentOptionalConversionProbabilityPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaapDebtInstrumentFairValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails" xlink:title="00000051 - Disclosure - Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputAppraisedValueMember" xlink:label="loc_us-gaapMeasurementInputAppraisedValueMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputAppraisedValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBlackScholesOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ValuationTechniqueBinomialOptionPricingModelMember" xlink:label="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_SAFOValuationTechniqueBinomialOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FairValueOfWarrantPrice" xlink:label="loc_SAFOFairValueOfWarrantPrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOFairValueOfWarrantPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails" xlink:title="00000052 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails" xlink:title="00000053 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative" xlink:title="00000054 - Disclosure - Commitment and Contingent Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IsraeliInnovationAuthorityMember" xlink:label="loc_SAFOIsraeliInnovationAuthorityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOIsraeliInnovationAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_XedaInternationalSAMember" xlink:label="loc_SAFOXedaInternationalSAMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOXedaInternationalSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EarthboundTechnologiesLLCMember" xlink:label="loc_SAFOEarthboundTechnologiesLLCMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOEarthboundTechnologiesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SafePackProductsLimitedMember" xlink:label="loc_SAFOSafePackProductsLimitedMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOSafePackProductsLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_NISMember" xlink:label="loc_SAFONISMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SAFONISMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShortTermOperatingLeaseAgreementMember" xlink:label="loc_SAFOShortTermOperatingLeaseAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOShortTermOperatingLeaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LeaseAgreementMember" xlink:label="loc_SAFOLeaseAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOLeaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommissionAgreementMember" xlink:label="loc_SAFOCommissionAgreementMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOCommissionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DistributionAgreementMember" xlink:label="loc_SAFODistributionAgreementMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFODistributionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SaveFoodsLtdMember" xlink:label="loc_SAFOSaveFoodsLtdMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_SAFOSaveFoodsLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IntroducedPartiesMember" xlink:label="loc_SAFOIntroducedPartiesMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOIntroducedPartiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ExceedsInNetRevenueMember" xlink:label="loc_SAFOExceedsInNetRevenueMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SAFOExceedsInNetRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OccuranceOfAdditionalEventsInAgreementMember" xlink:label="loc_SAFOOccuranceOfAdditionalEventsInAgreementMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SAFOOccuranceOfAdditionalEventsInAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RoyaltyDescription" xlink:label="loc_SAFORoyaltyDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFORoyaltyDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AgreementTermDescription" xlink:label="loc_SAFOAgreementTermDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOAgreementTermDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OfficeAndRelatedServiceFees" xlink:label="loc_SAFOOfficeAndRelatedServiceFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOOfficeAndRelatedServiceFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LessorOnetimePaymentAmount" xlink:label="loc_SAFOLessorOnetimePaymentAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOLessorOnetimePaymentAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PercentageOfNetRevenues" xlink:label="loc_SAFOPercentageOfNetRevenues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOPercentageOfNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MaximumCompensationPercentageOfGrossProfit" xlink:label="loc_SAFOMaximumCompensationPercentageOfGrossProfit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMaximumCompensationPercentageOfGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_PercentageOfPurchaseQuota" xlink:label="loc_SAFOPercentageOfPurchaseQuota" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOPercentageOfPurchaseQuota" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ShareholdersEquityDetailsNarrative" xlink:title="00000055 - Disclosure - Shareholders&apos; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareholdersEquityAbstract" xlink:label="loc_SAFOShareholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOShareholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsMember" xlink:label="loc_SAFOAccreditedInvestorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOAccreditedInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsOneMember" xlink:label="loc_SAFOAccreditedInvestorsOneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOAccreditedInvestorsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AccreditedInvestorsTwoMember" xlink:label="loc_SAFOAccreditedInvestorsTwoMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOAccreditedInvestorsTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoDirectorsMember" xlink:label="loc_SAFOTwoDirectorsMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOTwoDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SubscriptionAgreementMember" xlink:label="loc_SAFOSubscriptionAgreementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SecuritiesPurchaseAgreementMember" xlink:label="loc_SAFOSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MedigusLimitedMember" xlink:label="loc_SAFOMedigusLimitedMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOMedigusLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_WarrantsDescription" xlink:label="loc_SAFOWarrantsDescription" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOWarrantsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptionsDetailsNarrative" xlink:title="00000056 - Disclosure - Stock Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SAFOTwoThousandEighteenEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MrDanSztubelMember" xlink:label="loc_SAFOMrDanSztubelMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOMrDanSztubelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_BoardOfDirectorsMember" xlink:label="loc_SAFOBoardOfDirectorsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOBoardOfDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultantMember" xlink:label="loc_SAFOConsultantMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EmployeesAndDirectorsMember" xlink:label="loc_SAFOEmployeesAndDirectorsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOEmployeesAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OptionToPurchaseOfCommonStock" xlink:label="loc_SAFOOptionToPurchaseOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOOptionToPurchaseOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionExercisePriceIncrease" xlink:label="loc_us-gaapStockOptionExercisePriceIncrease" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionExercisePriceIncrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_EstimatedFairValueOfNonCashCompensationGranted" xlink:label="loc_SAFOEstimatedFairValueOfNonCashCompensationGranted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOEstimatedFairValueOfNonCashCompensationGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails" xlink:title="00000057 - Disclosure - Stock Options - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails" xlink:title="00000058 - Disclosure - Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" xlink:label="loc_SAFOShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/CostOfSalesDetails" xlink:title="00000059 - Disclosure - Cost of Sales (Details)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CostOfSalesDetailsAbstract" xlink:label="loc_SAFOCostOfSalesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOCostOfSalesDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndRelatedExpensesMember" xlink:label="loc_SAFOSalariesAndRelatedExpensesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOSalariesAndRelatedExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="loc_SAFOShareBasedCompensationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOShareBasedCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MaterialsMember" xlink:label="loc_SAFOMaterialsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOMaterialsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_VehicleMaintenanceMember" xlink:label="loc_SAFOVehicleMaintenanceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOVehicleMaintenanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="loc_SAFOTravelExpensesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTravelExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TransportationAndStorageMember" xlink:label="loc_SAFOTransportationAndStorageMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTransportationAndStorageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="loc_SAFOOtherExpensesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOOtherExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/ResearchAndDevelopmentExpensesDetails" xlink:title="00000060 - Disclosure - Research and Development Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndRelatedExpensesMember" xlink:label="loc_SAFOSalariesAndRelatedExpensesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOSalariesAndRelatedExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="loc_SAFOShareBasedCompensationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOShareBasedCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProfessionalFeesMember" xlink:label="loc_SAFOProfessionalFeesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOProfessionalFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DepreciationMember" xlink:label="loc_SAFODepreciationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFODepreciationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="loc_SAFOTravelExpensesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTravelExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_VehicleMaintenanceMember" xlink:label="loc_SAFOVehicleMaintenanceMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOVehicleMaintenanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RentAndAssetManagementMember" xlink:label="loc_SAFORentAndAssetManagementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFORentAndAssetManagementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LaboratoryAndFieldTestsMember" xlink:label="loc_SAFOLaboratoryAndFieldTestsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOLaboratoryAndFieldTestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="loc_SAFOOtherExpensesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOOtherExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/GeneralAndAdministrativeExpensesDetails" xlink:title="00000061 - Disclosure - General and Administrative Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_GeneralAndAdministrativeExpensesDetailsAbstract" xlink:label="loc_SAFOGeneralAndAdministrativeExpensesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOGeneralAndAdministrativeExpensesDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProfessionalServicesMember" xlink:label="loc_SAFOProfessionalServicesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOProfessionalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ShareBasedCompensationMember" xlink:label="loc_SAFOShareBasedCompensationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOShareBasedCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LegalExpensesMember" xlink:label="loc_SAFOLegalExpensesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOLegalExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_InsuranceMember" xlink:label="loc_SAFOInsuranceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOInsuranceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_RentAndOfficeMaintenanceMember" xlink:label="loc_SAFORentAndOfficeMaintenanceMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFORentAndOfficeMaintenanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LeviesAndTollsMember" xlink:label="loc_SAFOLeviesAndTollsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOLeviesAndTollsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CommunicationsMember" xlink:label="loc_SAFOCommunicationsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOCommunicationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DepreciationMember" xlink:label="loc_SAFODepreciationMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFODepreciationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TravelExpensesMember" xlink:label="loc_SAFOTravelExpensesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOTravelExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_OtherExpensesMember" xlink:label="loc_SAFOOtherExpensesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SAFOOtherExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails" xlink:title="00000062 - Disclosure - Financing Expenses, Net - Schedule of Financing Expenses Net (Details)">
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNetAbstract" xlink:label="loc_SAFOFinancingExpensesNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CurrencyExchangeDifferences" xlink:label="loc_SAFOCurrencyExchangeDifferences" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_SAFOCurrencyExchangeDifferences" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ChangesInFairValueOfConvertibleLoans" xlink:label="loc_SAFOChangesInFairValueOfConvertibleLoans" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_SAFOChangesInFairValueOfConvertibleLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_BankChargesAndOtherFinanceExpensesNet" xlink:label="loc_SAFOBankChargesAndOtherFinanceExpensesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_SAFOBankChargesAndOtherFinanceExpensesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_FinancingExpensesNet" xlink:label="loc_SAFOFinancingExpensesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SAFOFinancingExpensesNetAbstract" xlink:to="loc_SAFOFinancingExpensesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTaxDetailsNarrative" xlink:title="00000063 - Disclosure - Income Tax (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails" xlink:title="00000064 - Disclosure - Income Tax - Schedule of Income Tax Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_IncomeTaxComputedAtOrdinaryTaxRate" xlink:label="loc_SAFOIncomeTaxComputedAtOrdinaryTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SAFOIncomeTaxComputedAtOrdinaryTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="loc_us-gaapIncomeTaxReconciliationDeductions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:label="loc_SAFOLossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SAFOLossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000065 - Disclosure - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ProvisionForEmployeeRelatedObligation" xlink:label="loc_SAFOProvisionForEmployeeRelatedObligation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SAFOProvisionForEmployeeRelatedObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails" xlink:title="00000066 - Disclosure - Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedPartiesDetailsNarrative" xlink:title="00000067 - Disclosure - Related Parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_CoChiefExecutiveOfficerMember" xlink:label="loc_SAFOCoChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOCoChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ItzhakShremMember" xlink:label="loc_SAFOItzhakShremMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOItzhakShremMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultingAgreementsMember" xlink:label="loc_SAFOConsultingAgreementsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOConsultingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_AmirUzielEconomicConsultantsLtdMember" xlink:label="loc_SAFOAmirUzielEconomicConsultantsLtdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SAFOAmirUzielEconomicConsultantsLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyRetainer" xlink:label="loc_SAFOMonthlyRetainer" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMonthlyRetainer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyConsultancyFee" xlink:label="loc_SAFOMonthlyConsultancyFee" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMonthlyConsultancyFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_MonthlyDirectorsFee" xlink:label="loc_SAFOMonthlyDirectorsFee" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SAFOMonthlyDirectorsFee" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails" xlink:title="00000068 - Disclosure - Related Parties - Schedule of Transactions and Balances with Related Parties (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_DirectorsCompensationMember" xlink:label="loc_SAFODirectorsCompensationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFODirectorsCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_SalariesAndFeesToOfficersMember" xlink:label="loc_SAFOSalariesAndFeesToOfficersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOSalariesAndFeesToOfficersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_ConsultantsAndOtherFeesMember" xlink:label="loc_SAFOConsultantsAndOtherFeesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SAFOConsultantsAndOtherFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://save-food.org/role/SubsequentEventsDetailsNarrative" xlink:title="00000069 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="safo-20201231.xsd#SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember" xlink:label="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SAFOTwoThousandTwentyConvertibleLoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133748689320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Save Foods Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001789192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133740919656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 242,900<span></span>
</td>
<td class="nump">$ 290,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash (Note 2D)</a></td>
<td class="nump">22,395<span></span>
</td>
<td class="nump">38,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">147,941<span></span>
</td>
<td class="nump">64,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">16,356<span></span>
</td>
<td class="nump">16,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets (Note 3)</a></td>
<td class="nump">65,579<span></span>
</td>
<td class="nump">15,300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current assets</a></td>
<td class="nump">495,171<span></span>
</td>
<td class="nump">424,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right Of Use asset arising from operating lease</a></td>
<td class="nump">14,700<span></span>
</td>
<td class="nump">48,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net (Note 4)</a></td>
<td class="nump">55,194<span></span>
</td>
<td class="nump">81,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FundsInRespectOfEmployeeRightsUponRetirement', window );">Funds in Respect of Employee Rights Upon Retirement</a></td>
<td class="nump">122,584<span></span>
</td>
<td class="nump">109,955<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">687,649<span></span>
</td>
<td class="nump">664,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term loan from banking institution (Note 7)</a></td>
<td class="nump">7,949<span></span>
</td>
<td class="nump">7,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Current maturities of convertible loans</a></td>
<td class="nump">56,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">203,323<span></span>
</td>
<td class="nump">235,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OtherAccountsLiabilitiesCurrent', window );">Other accounts liabilities (Note 5)</a></td>
<td class="nump">517,711<span></span>
</td>
<td class="nump">380,732<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">785,233<span></span>
</td>
<td class="nump">623,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair Value of Convertible Component in Convertible Loans (Note 6)</a></td>
<td class="nump">54,970<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible Loans (Notes 6)</a></td>
<td class="nump">146,929<span></span>
</td>
<td class="nump">285,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_LongTermDebtFromBankingInstitutions', window );">Long term from banking institution (Note 7)</a></td>
<td class="nump">8,115<span></span>
</td>
<td class="nump">14,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_LiabilityForEmployeeRightsUponRetirement', window );">Liability for employee rights upon retirement</a></td>
<td class="nump">157,855<span></span>
</td>
<td class="nump">142,091<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,153,102<span></span>
</td>
<td class="nump">1,066,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit (Note 9)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stocks of US$ 0.0001 par value each ("Common Stocks"): 495,000,000 shares authorized as of December 31, 2020 and 2019; issued and outstanding 1,606,760 and 1,458,593 shares as of December 31, 2020 and 2019, respectively.</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stocks of US$ 0.0001 par value ("Preferred stocks"): 5,000,000 shares authorized as of December 31, 2020 and 2019; issued and outstanding 0 shares as of December 31, 2020 and 2019.</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">11,867,585<span></span>
</td>
<td class="nump">10,329,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(26,275)<span></span>
</td>
<td class="num">(26,275)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(12,277,647)<span></span>
</td>
<td class="num">(10,684,508)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity</a></td>
<td class="num">(436,176)<span></span>
</td>
<td class="num">(381,066)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="num">(29,277)<span></span>
</td>
<td class="num">(21,053)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' deficit</a></td>
<td class="num">(465,453)<span></span>
</td>
<td class="num">(402,119)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' deficit</a></td>
<td class="nump">$ 687,649<span></span>
</td>
<td class="nump">$ 664,670<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FundsInRespectOfEmployeeRightsUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds in Respect of Employee Rights Upon Retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FundsInRespectOfEmployeeRightsUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_LiabilityForEmployeeRightsUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>iability for employee rights upon retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_LiabilityForEmployeeRightsUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_LongTermDebtFromBankingInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt From Banking Institutions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_LongTermDebtFromBankingInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_OtherAccountsLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other accounts liabilities (Note 5).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_OtherAccountsLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133747923704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stocks, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stocks, shares authorized</a></td>
<td class="nump">495,000,000<span></span>
</td>
<td class="nump">495,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stocks, shares issued</a></td>
<td class="nump">1,606,760<span></span>
</td>
<td class="nump">1,458,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stocks, shares outstanding</a></td>
<td class="nump">1,606,760<span></span>
</td>
<td class="nump">1,458,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stocks, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stocks, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stocks, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stocks, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133739724984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from sales of products</a></td>
<td class="nump">$ 232,274<span></span>
</td>
<td class="nump">$ 175,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales (Note 11)</a></td>
<td class="num">(43,405)<span></span>
</td>
<td class="num">(144,548)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="nump">188,869<span></span>
</td>
<td class="nump">31,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (Note 12)</a></td>
<td class="num">(417,000)<span></span>
</td>
<td class="num">(615,623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="num">(51,105)<span></span>
</td>
<td class="num">(342,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses (Note 13)</a></td>
<td class="num">(1,070,109)<span></span>
</td>
<td class="num">(1,004,899)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(1,349,345)<span></span>
</td>
<td class="num">(1,931,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FinancingExpensesNet', window );">Financing expenses, net (Note 14)</a></td>
<td class="num">(270,393)<span></span>
</td>
<td class="num">(43,408)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses, net</a></td>
<td class="num">(2,532)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ShareInLossesOfAffiliatedCompany', window );">Shares in losses of affiliated company</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(15,690)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_GainOnDisposalOfAffiliatedCompany', window );">Gain on disposal of affiliated company</a></td>
<td class="nump">15,690<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(1,606,580)<span></span>
</td>
<td class="num">(1,990,403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to non-controlling interests</a></td>
<td class="nump">13,441<span></span>
</td>
<td class="nump">18,986<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to the Company</a></td>
<td class="num">$ (1,593,139)<span></span>
</td>
<td class="num">$ (1,971,417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per share (basic and diluted) (Note 16)</a></td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (1.38)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FinancingExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FinancingExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_GainOnDisposalOfAffiliatedCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on disposal of affiliated company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_GainOnDisposalOfAffiliatedCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ShareInLossesOfAffiliatedCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share in losses of affiliated company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ShareInLossesOfAffiliatedCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133740527800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Changes in Stockholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
<th class="th"><div>Proceeds on Account of Shares [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total Company's Stockholders' Equity [Member]</div></th>
<th class="th"><div>Non-controlling Interests [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 8,852,461<span></span>
</td>
<td class="num">$ (26,275)<span></span>
</td>
<td class="nump">$ 105,000<span></span>
</td>
<td class="num">$ (8,713,091)<span></span>
</td>
<td class="nump">$ 218,227<span></span>
</td>
<td class="num">$ (6,712)<span></span>
</td>
<td class="nump">$ 211,515<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2018</a></td>
<td class="nump">1,318,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares for cash</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">945,679<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(105,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">840,693<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">840,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares for cash, shares</a></td>
<td class="nump">140,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Value of warrant issued in convertible loans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">97,406<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">97,406<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">97,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">434,025<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">434,025<span></span>
</td>
<td class="nump">4,645<span></span>
</td>
<td class="nump">438,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Comprehensive loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,971,417)<span></span>
</td>
<td class="num">(1,971,417)<span></span>
</td>
<td class="num">(18,986)<span></span>
</td>
<td class="num">$ (1,990,403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">10,329,571<span></span>
</td>
<td class="num">(26,275)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,684,508)<span></span>
</td>
<td class="num">(381,066)<span></span>
</td>
<td class="num">(21,053)<span></span>
</td>
<td class="num">$ (402,119)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2019</a></td>
<td class="nump">1,458,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares for cash</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">349,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares for cash, shares</a></td>
<td class="nump">45,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Value of warrant issued in convertible loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487,402<span></span>
</td>
<td class="nump">5,217<span></span>
</td>
<td class="nump">492,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Comprehensive loss for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,593,139)<span></span>
</td>
<td class="num">(1,593,139)<span></span>
</td>
<td class="num">(13,441)<span></span>
</td>
<td class="num">(1,606,580)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible loans</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">585,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible loans, shares</a></td>
<td class="nump">67,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">59,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercise of warrants, shares</a></td>
<td class="nump">28,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">19,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="nump">6,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 11,867,585<span></span>
</td>
<td class="num">$ (26,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,277,647)<span></span>
</td>
<td class="num">$ (436,176)<span></span>
</td>
<td class="num">$ (29,277)<span></span>
</td>
<td class="num">$ (465,453)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="nump">1,606,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Exercise Of Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Exercise Of Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121321822&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121323062&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133741844776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">$ (1,606,580)<span></span>
</td>
<td class="num">$ (1,990,403)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss for the period to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">45,205<span></span>
</td>
<td class="nump">27,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss from sales of Property and Equipment</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany', window );">Share in losses (gain on disposal) of affiliated company</a></td>
<td class="num">(15,690)<span></span>
</td>
<td class="nump">15,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement', window );">Increase (decrease) in liability for employee rights upon retirement</a></td>
<td class="nump">15,764<span></span>
</td>
<td class="nump">16,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">492,619<span></span>
</td>
<td class="nump">438,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanAndLeaseLosses', window );">Expenses on convertible loans</a></td>
<td class="nump">176,216<span></span>
</td>
<td class="nump">6,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CompensationExpensesInExchangeOfInstruments', window );">Compensation expenses in exchange of instruments</a></td>
<td class="nump">57,793<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in accounts receivable</a></td>
<td class="num">(83,938)<span></span>
</td>
<td class="nump">71,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease (increase) in inventory</a></td>
<td class="num">(54)<span></span>
</td>
<td class="nump">21,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="num">(47,575)<span></span>
</td>
<td class="nump">49,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (decrease) in accounts payable</a></td>
<td class="num">(32,541)<span></span>
</td>
<td class="nump">39,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_IncreaseDecreaseInAccountsPayableOther', window );">Increase in other accounts payable</a></td>
<td class="nump">197,659<span></span>
</td>
<td class="nump">59,625<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(798,740)<span></span>
</td>
<td class="num">(1,244,772)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates', window );">Proceeds from (payments on) investment in unconsolidated entity</a></td>
<td class="nump">4,864<span></span>
</td>
<td class="num">(7,567)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions', window );">Decrease (increase) in Short term deposits in banking institutions</a></td>
<td class="nump">15,799<span></span>
</td>
<td class="num">(38,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement', window );">Increase in funds in respect of employee rights upon retirement</a></td>
<td class="num">(12,629)<span></span>
</td>
<td class="num">(12,567)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of Property and Equipment</a></td>
<td class="nump">1,031<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of Property and Equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(23,327)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">9,065<span></span>
</td>
<td class="num">(81,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredNotesPayable', window );">Proceeds from Secured promissory notes</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ProceedsFromConvertibleLoans', window );">Proceeds from convertible loans</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="nump">379,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term loans from banking institutes</a></td>
<td class="num">(7,272)<span></span>
</td>
<td class="num">(42,257)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of right of use asset arising from operating lease</a></td>
<td class="num">(40,968)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from stock issued for cash</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">840,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Exercise of warrants</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">741,760<span></span>
</td>
<td class="nump">1,177,436<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(47,915)<span></span>
</td>
<td class="num">(148,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR</a></td>
<td class="nump">290,815<span></span>
</td>
<td class="nump">439,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS AT END OF YEAR</a></td>
<td class="nump">242,900<span></span>
</td>
<td class="nump">290,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for: Interest</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DisposalOfAffiliatedCompany', window );">Disposal of affiliated company</a></td>
<td class="nump">2,704<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_TerminationOfLeaseAgreement', window );">Termination of lease agreement</a></td>
<td class="nump">11,590<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_IssuanceOfWarrantsInConvertibleLoans', window );">Issuance of warrants in convertible loans</a></td>
<td class="nump">53,388<span></span>
</td>
<td class="nump">97,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ConversionOfConvertibleLoans', window );">Conversion of convertible loans</a></td>
<td class="nump">528,138<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets', window );">Initial recognition of operating lease right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">48,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_InitialRecognitionOfOperatingLeaseLiability', window );">Initial recognition of operating lease liability</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (48,982)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_CompensationExpensesInExchangeOfInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation expenses in exchange of instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_CompensationExpensesInExchangeOfInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ConversionOfConvertibleLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ConversionOfConvertibleLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease (increase) in Short term deposits in banking institutions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_DecreaseIncreaseInShortTermDepositsInBankingInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_DisposalOfAffiliatedCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal of affiliated company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_DisposalOfAffiliatedCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_IncreaseDecreaseInAccountsPayableOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in other accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_IncreaseDecreaseInAccountsPayableOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in liability for employee rights upon retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_IncreaseDecreaseInLiabilityForEmployeeRightsUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_InitialRecognitionOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_InitialRecognitionOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_InitialRecognitionOfOperatingLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_IssuanceOfWarrantsInConvertibleLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of warrants in convertible loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_IssuanceOfWarrantsInConvertibleLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ProceedsFromConvertibleLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ProceedsFromConvertibleLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in funds in respect of employee rights upon retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ProceedsFromRepaymentForIncreaseInFundsInRespectOfEmployeeRightsUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share in losses (gain on disposal) of affiliated company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ShareInLossesGainOnDisposalOfAffiliatedCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_TerminationOfLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_TerminationOfLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow associated with the acquisition or sale of a business segment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSecuredNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSecuredNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanAndLeaseLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to estimated loss from loan and lease transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanAndLeaseLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743314968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">NOTE 1 &#8211;
GENERAL</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><font style="font-size: 10pt"><b>A.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Operations</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Save Foods, Inc. (the &#8220;Company&#8221;)
was incorporated on April 1, 2009, under the laws of the State of Delaware. On April 27, 2009, the Company acquired from its stockholders
98.94% of the issued and outstanding shares of Save Foods Ltd., including preferred and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Save Foods Ltd. was incorporated
in 2004 and commenced its operations in 2005. Save Foods Ltd. develops, produces, and focuses on delivering innovative solutions
for the food industry aimed at improving food safety and prolonging shelf life of fresh produce.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company&#8217;s common stock
is quoted on the OTC, Pink Tier, under the symbol &#8220;SAFO&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt"><b>B.</b></font></td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Reverse stock split</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On April 23, 2019, the Company amended
and restated its Certificate of Incorporation to effect a 15 to 1 reverse stock split of the Company&#8217;s outstanding Common
Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As a result of the reverse stock
split, which became effective on June 11, 2019, every 15 shares of the Company&#8217;s outstanding Common Stock prior to the effect
of that amendment was combined and reclassified into one share of the Company&#8217;s Common Stock. No fractional shares were issued
in connection with or following the reverse split. The number of outstanding shares of the Company&#8217;s Common Stock and par
value of the shares remained unchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On February 23, 2021, the Company
amended its Certificate of Incorporation to effect a 7 to 1 reverse stock split of the Company&#8217;s outstanding Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As a result of the reverse stock
split, every 7 shares of the Company&#8217;s outstanding Common Stock prior to the effect of that amendment was combined and reclassified
into one share of the Company&#8217;s Common Stock. No fractional shares were issued in connection with or following the reverse
split. The number of authorized capital of the Company&#8217;s Common Stock and par value of the shares remained unchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">All share, stock option and per
share information in these condensed consolidated financial statements have been restated to reflect the stock split on a retroactive
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="width: 24px; padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt"><b>C.</b></font></td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt"><b>Going concern uncertainty</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Since its incorporation (April 1,
2009), the Company has not had any operations other than those carried out by Save Foods Ltd. The development and commercialization
of Save Foods Ltd.&#8217;s products will require substantial expenditures. Save Foods Ltd. and the Company have not yet generated
sufficient revenues from their operations to fund the Group&#8217;s (as defined below) activities and are therefore dependent upon
external sources for financing their operations. There can be no assurance that the Company will succeed in obtaining the necessary
financing to continue its operations. As of December 31, 2020, the Company had $242,900 in cash, a negative working capital of
$290,062 and an accumulated deficit of $12,277,647.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company will need to secure
additional capital in the future in order to meet its anticipated liquidity needs primarily through the sale of additional Common
Stock or other equity securities and/or debt financing. Funds from these sources may not be available to the Company on acceptable
terms, if at all, and the Company cannot give assurance that it will be successful in securing such additional capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company focuses its solutions
towards vegetables and fruits which are considered the largest in terms of worldwide consumption. Among other things, the Company
tries to cooperate with major fruit packing houses in Israel and abroad.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">These factors raise substantial
doubt about Save Foods Ltd. and the Company&#8217;s ability to continue as a going concern. The consolidated financial statements
do not include any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>D</b>.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">In December 2019, a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. This virus continues to spread globally and, has spread to over 180 countries, including the United States and Israel. The spread of COVID-19 from China to other countries has resulted in the World Health Organization declaring the outbreak of COVID-19 as a &#8220;pandemic,&#8221; or a worldwide spread of a new disease, on March 11, 2020. Many countries around the world have imposed quarantines and restrictions on travel and mass gatherings to slow the spread of the virus, including in the United States and in Israel. Governments may divert spending from other budgeted resources as they seek to reduce and/or stop the spread of an infectious disease, such as COVID-19. Such events may result in a period of business and manufacturing disruption, and in reduced operations, any of which could materially affect the Company&#8217;s business, financial condition and results of operations. The extent to which COVID-19 impacts the Company&#8217;s business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. The Company believes it is taking appropriate actions to mitigate the negative impacts. However, the full impact of COVID-19 is unknown and cannot be reasonably estimated as these events occurred subsequent to year end and are still developing.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>E.</b></font></td>
    <td><font style="font-size: 10pt"><b>Risk factors</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company and Save Foods Ltd.
(collectively, the &#8220;Group&#8221;) face a number of risks, including uncertainties regarding finalization of the development
process, demand and market acceptance of the Group&#8217;s products, the effects of technological changes, competition and the
development of products by competitors. Additionally, other risk factors also exist, such as the ability to manage growth and the
effect of planned expansion of operations on the Group&#8217;s future results. In addition, the Group expects to continue incurring
significant operating costs and losses in connection with the development of its products and increased marketing efforts. As mentioned
above, the Group has not yet generated significant revenues from its operations to fund its activities, and therefore the continuance
of its activities as a going concern depends on the receipt of additional funding from its current stockholders and investors or
from third parties.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743460728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">NOTE 2&#8211;
SIGNIFICANT ACCOUNTING POLICIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The financial statements were prepared
in accordance with accounting principles generally accepted in the United States of America (US GAAP).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>A.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Use of estimates in the preparation of financial statements</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported
amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial
statements, the most significant estimates and assumptions relate to the going concern assumptions, share based compensation and
convertible loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>B.</b></font></td>
    <td><font style="font-size: 10pt"><b>Functional currency</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">A majority of the Group&#8217;s
revenues is generated in U.S. dollars. In addition, most of the Group&#8217;s costs are denominated and determined in U.S. dollars
and in new Israeli shekels. Management believes that the dollar is the currency in the primary economic environment in which the
Group operates. Thus, the functional and reporting currency of the Group is the U.S. dollar.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Accordingly, monetary accounts maintained
in currencies other than the dollar are remeasured into dollars in accordance with Accounting Standards Codification (ASC) 830,
&#8220;Foreign Currency Matters&#8221;. All transaction gains and losses of the remeasured monetary balance sheet items are reflected
in the statements of operations as financial income or expenses, as appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>C.</b></font></td>
    <td><font style="font-size: 10pt"><b>Principles of consolidation</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The consolidated financial statements
include the accounts of the Company and its subsidiary, Save Foods Ltd. All significant intercompany balances and transactions
have been eliminated on consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>D.</b></font></td>
    <td><font style="font-size: 10pt"><b>Cash and cash equivalents, and Restricted cash</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Cash equivalents are short-term
highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted
as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Restricted cash as of December 31,
2020 and 2019 included a NIS 72,000 ($22,395) and NIS 132,000 ($38,194), respectively collateral account for the Company&#8217;s
corporate credit cards and a loan and is classified in current assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>E.</b></font></td>
    <td><font style="font-size: 10pt"><b>Accounts receivables</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Accounts receivables are stated
at their net realizable value. The allowance against gross accounts receivables reflects the best estimate of losses inherent in
the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and
other currently available information. As of December 31, 2020, and 2019, an allowance for doubtful debts in the amount of $26,553
and $24,702, respectively, is reflected in net accounts receivables. Accounts receivables are written off after all reasonable
means to collect the full amount have been exhausted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>F.</b></font></td>
    <td><font style="font-size: 10pt"><b>Property, plant and equipment, net</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="width: 24px; padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">1.</font></td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the Statements of Operations and Comprehensive Loss.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">2.</font></td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">Rates of depreciation:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Furniture and office equipment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7-15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Machines</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10-15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%"><font style="font-size: 10pt">Computers</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">33</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Vehicle</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; padding-right: 0.8pt">&#160;</td>
    <td style="width: 24px; padding-right: 0.8pt"><font style="font-size: 10pt"><b>G.</b></font></td>
    <td style="padding-right: 0.8pt"><font style="font-size: 10pt"><b>Impairment of long-lived assets</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Group&#8217;s long-lived assets
are reviewed for impairment in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 360, &#8220;Property,
Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the
future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment
to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. No impairment expenses
were recorded during the years ended December 31, 2020 or 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; padding-right: 0.8pt">&#160;</td>
    <td style="width: 24px; padding-right: 0.8pt"><font style="font-size: 10pt"><b>H.</b></font></td>
    <td style="padding-right: 0.8pt"><font style="font-size: 10pt"><b>Deferred income taxes</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Group accounts for income taxes
in accordance with ASC Topic 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are determined utilizing the asset
and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected
to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary,
to reduce deferred tax assets to amounts more likely than not to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Group accounts for uncertain
tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements. According to ASC
Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting policy is to
classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such
items in its fiscal 2020 and 2019 financial statements and did not recognize any liability with respect to an unrecognized tax
position in its balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>I.</b></font></td>
    <td><font style="font-size: 10pt"><b>Liability for employee rights upon retirement</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Save Foods Ltd&#8217;s liability
for employee rights upon retirement with respect to its Israeli employees is calculated, pursuant to Israeli Severance Pay Law,
based on the most recent salary of each employee multiplied by the number of years of employment, as of the balance sheet date.
Employees are entitled to one month&#8217;s salary for each year of employment, or a portion thereof. Save Foods Ltd. makes monthly
deposits to insurance policies and severance pay funds. The liability of the Company is fully provided for.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The deposited funds include profits
accumulated up to the balance sheet date. The deposited funds may be withdrawn upon the fulfillment of the obligation pursuant
to Israeli severance pay laws or labor agreements. The value of the deposited funds is based on the cash surrender value of these
policies, and includes immaterial profits/losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Severance expenses for the years
ended December 31, 2020 and 2019, amounted to $7,419 and $24,000, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>J.</b></font></td>
    <td><font style="font-size: 10pt"><b>Revenue recognition</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Revenues are recognized when delivery
has occurred and there is persuasive evidence of an agreement, the fee is fixed or determinable and collection of the related receivables
is reasonably assured and no further obligations exist.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Revenues from sales of products
are recognized when title and risk and rewards for the products are transferred to the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; padding-right: 0.8pt">&#160;</td>
    <td style="width: 24px; padding-right: 0.8pt"><font style="font-size: 10pt"><b>K.</b></font></td>
    <td style="padding-right: 0.8pt"><font style="font-size: 10pt"><b>Research and development expenses</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Research and development expenses
are charged to operations as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>L.</b></font></td>
    <td><font style="font-size: 10pt"><b>Royalty-bearing grants</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Royalty-bearing grants from the
Israeli Innovation Authority (the &#8220;IIA&#8221;) for funding approved research and development projects are recognized at the
time Save Foods Ltd. is entitled to such grants (i.e. at the time that there is reasonable assurance that the Company will comply
with the conditions attached to the grant and that there is reasonable assurance that the grant will be received), on the basis
of the costs incurred and reduce research and development costs. The cumulative research and development grants received by the
Company from inception through December 2020 amounted to NIS 484,429 (US$150,678).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As of December 31, 2020, and 2019,
the Company did not accrue for or pay any royalties to the IIA since no revenues were recognized in respect of the funded projects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>M.</b></font></td>
    <td><font style="font-size: 10pt"><b>Inventories</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Inventories are valued at the lower
of cost or net realizable value. Cost of raw and packaging materials, purchased products, manufactured finished products and products
in process are determined on the average costs basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company regularly reviews its
inventories for impairment and reserves are established when necessary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>N.</b></font></td>
    <td><font style="font-size: 10pt"><b>Basic and diluted loss per common stock</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Basic loss per common stock is computed
by dividing the loss for the period applicable to shareholders, by the weighted average number of shares of common stock outstanding
during the period. Securities that may participate in dividends with the shares of common stock (such as the convertible preferred)
are considered in the computation of basic loss per share under the two-class method. However, in periods of net loss, only the
convertible preferred shares are considered, since such shares have a contractual obligation to share in the losses of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In computing diluted loss per share,
basic loss per share is adjusted to reflect the potential dilution that could occur upon the exercise of potential shares. Accordingly,
in periods of net loss, no potential shares are considered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>O.</b></font></td>
    <td><font style="font-size: 10pt"><b>Stock-based compensation</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company measures and recognizes
the compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC
718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments including grants of stock options are recognized in the
statement of comprehensive loss as an operating expense based on the fair value of the award at the date of grant. The fair value
of stock options granted is estimated using the Black-Scholes option-pricing model. The Company has expensed compensation costs,
net of estimated forfeitures, applying the accelerated vesting method, over the requisite service period or over the implicit service
period when a performance condition affects the vesting, and it is considered probable that the performance condition will be achieved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Share-based payments awarded to
consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, &#8220;Equity-Based Payments to Non-Employees&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>P.</b></font></td>
    <td><font style="font-size: 10pt"><b>Fair Value Measurements</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Fair value of certain of the Company&#8217;s
financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued
liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with
ASC 820, &#8220;Fair Value Measurements and Disclosure&#8221; defines fair value, establishes a framework for measuring fair value
in accordance with generally accepted accounting principles and expands disclosures about fair value investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Fair value, as defined in ASC 820,
is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or
most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the
risk of non-performance, which includes, among other things, the Company&#8217;s credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Valuation techniques are generally
classified into three categories: the market approach; the income approach; and the cost approach. The selection and application
of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset
or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize
the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs
and resulting measurement as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Level 1: Quoted prices (unadjusted)
in active markets that are accessible at the measurement date for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Level 2: Quoted prices for similar
assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active;
inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or
corroborated by observable market data for substantially the full term of the assets or liabilities; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Level 3: Unobservable inputs for
the asset or liability that are supported by little or no market activity, and that are significant to the fair values.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Fair value measurements are required
to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair
value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements
including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to
the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings,
and a description of where those gains or losses included in earning are reported in the statement of income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company records a debt discount
related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible
instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and
as a reduction to the carrying amount of the convertible instrument equal to the fair value of the conversion features. The debt
discount will be accreted by recording additional non-cash gains and losses related to the change in fair values of derivative
liabilities over the life of the convertible notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company&#8217;s financial assets
and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Balance as of December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 1</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 2</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 3</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Liabilities:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 48%; padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Fair Value of convertible component in convertible loan</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">The following table presents the
changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair value of Convertible component</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at January 1, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 71%"><font style="font-size: 10pt">Fair value of issued level 3 liability</font></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: right"><font style="font-size: 10pt">27,762</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Changes in fair value</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">27,208</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>Q.</b></font></td>
    <td><font style="font-size: 10pt"><b>Concentrations of credit risk</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Financial instruments that potentially
subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents as well as certain other current
assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held in Dollars and New Israeli
Shekels, are deposited with major banks in Israel and United States. Management believes that such financial institutions are financially
sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant
off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>R.</b></font></td>
    <td><font style="font-size: 10pt"><b>Contingencies</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company records accruals for
loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and
the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information
becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt"><b>S.</b></font></td>
    <td><font style="font-size: 10pt"><b>New Accounting Pronouncements </b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In June
2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;)
No. 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.&#8221;
In November 2018, FASB issued ASU No. 2018-19, &#8220;Codification Improvements to Topic 326, Financial Instruments-Credit Losses&#8221;,
which amends the scope and transition requirements of ASU 2016-13. Topic 326 requires a financial asset (or a group of financial
assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected
credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable
and supportable forecasts that affect the collectability of the reported amount. Topic 326 will originally become effective for
the Company beginning January 1, 2020, with early adoption permitted, on a modified retrospective approach. As a smaller reporting
company, the effective date for the Company has been delayed until fiscal years beginning after December 15, 2022, in accordance
with ASU 2019-10, although early adoption is still permitted. This standard did not have a material impact to the Company&#8217;s
consolidated financial statements after evaluation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In December
2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this
ASU simplify the accounting for income taxes, eliminates certain exceptions to the general principles in Topic 740 and clarifies
certain aspects of the current guidance to improve consistent application among reporting entities. ASU 2019-12 is effective for
fiscal years beginning after December 15, 2021 and interim periods within annual periods beginning after December 15, 2022, though
early adoption is permitted, including adoption in any interim period for which financial statements have not yet been issued.
This standard is not expected to have a material impact to the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In August
2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements
for Fair Value Measurement. This standard will require entities to disclose the amount of total gains or losses for the period
recognized in other comprehensive income that is attributable to fair value changes in assets and liabilities held as of the balance
sheet date and categorized within Level 3 of the fair value hierarchy. This ASU will be effective for the Company for annual and
interim periods beginning after December 31, 2020. Early adoption of this standard is permitted. This standard did not have a material
impact to the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In August
2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity s Own Equity.
ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features
being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject
to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract,
that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible
debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends
the guidance for the derivatives scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based
accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2023,
including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after
December 15, 2020, including interim periods within those fiscal years. Management has not yet evaluated the impact that the adoption
of ASU 2020-06 will have on the Company&#8217;s consolidated financial statement presentation or disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Other new pronouncements issued
but not effective as of December 31, 2020 are not expected to have a material impact on the Company&#8217;s consolidated financial
statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743478984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Other Current Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 3 &#8211; OTHER CURRENT
ASSETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Prepaid expenses and advances to vendors</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">51,020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4,811</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Receivables from sale of subsidiary (Note 5)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,704</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Government Institutions</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">11,855</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">10,489</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>65,579</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>15,300</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133822136232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 4 &#8211; PROPERTY AND
EQUIPMENT, NET</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Computers</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,328</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,328</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Furniture and office equipment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,002</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,002</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Machines</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">130,797</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">134,665</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Vehicles</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">85,149</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">85,149</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">231,276</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">235,144</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Less - accumulated depreciation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(139,382</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(117,325</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less &#8211; Impairment of long lived assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(36,700</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(36,700</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Total property and equipment, net</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>55,194</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>81,119</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the years ended December 31, 2020 and 2019,
depreciation expenses were US$ 22,512 and US$ 27,351 respectively, and additional property and equipment were purchased in an amount
of US$ 23,327 for the years ended December 31, 2019 (none for the year ended December 31, 2020).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133748705352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accounts Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Accounts Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 5 &#8211; OTHER ACCOUNTS
LIABILITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Employees and related institutions</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">110,220</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">135,901</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Accrued expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">392,442</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">184,616</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Right Of Use liability arising from operating lease</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,049</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">52,093</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Affiliated company (*)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,122</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>517,711</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>380,732</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">(*)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On April 2, 2019, the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. (&#8220;Savescann&#8221;) a newly formed company registered in Canada. Savecann intended to market the Company&#8217;s solutions to the Cannabis market.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">On April 21, 2020, the Company sold its entire holdings in Savecann for total consideration of 10,000 Canadian Dollars ($7,000), of which $2,704 were not paid yet and are presented as part of other current assets.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133742275880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Loans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Loans</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 6 &#8211; CONVERTIBLE LOANS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt">A.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">In December 2019, the Company entered into a series of Convertible Loan Agreements (each a &#8220;CLA&#8221;) with third parties and certain existing shareholders (the &#8220;Lenders&#8221;), pursuant to which the Lenders agreed to provide the Company loans in the aggregate amount of $379,000 and in exchange the Company issued to the Lenders (i) convertible promissory notes (the &#8220;Notes&#8221;) and (ii) warrants with an exercise price of $8.40. In January and March 2020, the Company entered into two additional CLA agreements for an aggregate amount of $135,000, consisting of the same terms.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">According to the terms of the CLA, the Notes bear interest at a rate of 5% per annum and the loan amount represented by the Notes is to be repaid to the Lenders according to the following schedule: (i) the principal amount represented by the Notes to be repaid in twenty four equal monthly installments, commencing on the twenty fifth month following the closing of each CLA, and (ii) the interest accrued on the loan amount to be paid in two bi-annual installments, commencing on the first anniversary of the first payment of the principal amount.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">In addition, according to the terms of the CLA, the outstanding loan amount matures on the earlier of (i) the third anniversary of each CLA or (ii) a deemed liquidation event (as defined therein), and the Lenders may convert all or any portion of the Notes at any time prior to the one-year anniversary of each issuance into shares of the Company&#8217;s Common Stock at a conversion price of $8.40 per share.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">In accordance with ASC 815-15-25, the conversion feature was considered embedded derivative instruments, and is to be recorded at their fair value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component fair value over the face loan amount. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the above issuances, the Company
        recorded in the periods ended March 31, 2020 and December 31, 2019, a total amount of $34,696 and $97,406, respectively, in respect
        of the detachable warrants, as a credit to stockholders&#8217; equity (additional paid in capital). The fair value of the Warrants
        was determined using the Black-Scholes pricing model, assuming a risk free rate of 1.6%, a volatility factor of 54.00%, dividend
        yields of 0% and an expected life of 3 years.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">On June 24, 2020, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with the Lenders in connection with the sale and issuance of 69,332 units (&#8220;Units&#8221;), at a purchase price of $7.63 per Unit. Each Unit consists of: (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.4 (the &#8220;Warrant&#8221;). In connection with the SPA, the Company issued to the Lenders an aggregate of 67,369 shares of Common Stock and Warrants to purchase an aggregate of 67,369 shares of Common Stock. The shares of Common Stock were issued on July 2, 2020.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Simultaneous with and conditioned upon the execution of the SPA, the Company and each of the Lenders agreed to effectively cancel the CLA and the equity securities issued thereunder. In connection therewith, each of the Lenders voluntarily waived any right to receive interest that accrued thereupon pursuant to the CLA.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">The Company evaluated the transaction as an exchange of instruments and as a result of the above conversion, recorded a compensation expenses in a total amount of $57,793, as of the exchange date, and as a credit to stockholders&#8217; equity (additional paid in capital). The fair value of the additional shares granted in the conversion was calculated based on the Company&#8217;s share price as of the date of the conversion. The fair value of the additional warrants granted in the conversion was determined using the Black-Scholes pricing model, assuming a risk-free rate of 0.21%, a volatility factor of 51.96%, dividend yields of 0% and an expected life of 2.45-2.71 years.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">During the years ended December 31, 2020 and 2019, the Company recorded net interest and amortization expenses in the amount of $199,709 and $4,323, respectively, in respect of the discounts recorded on the CLAs.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><font style="font-size: 10pt">B.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On September 21, 2020, the Company entered into a series of additional convertible loan agreements (each a &#8220;2020 CLA&#8221;) with certain lenders (the &#8220;2020 Lenders&#8221;) to sell convertible promissory notes with an aggregate principal amount of $125,000 (each a &#8220;2020 Note&#8221;). The outstanding loan amount under the 2020 CLA will mature on the earlier of (i) the third anniversary of each 2020 CLA or (ii) a deemed liquidation event (as defined therein), and the 2020 Lenders may convert all or any portion of the 2020 Notes into shares of Common Stock at any time prior to a mandatory conversion event (as defined therein) at a conversion price of $7.63 per share. The 2020 Notes will bear interest at a rate of 5% per annum. The loan amount represented by the 2020 Notes will be repaid to the 2020 Lenders according to the following schedule: (i) the principal amount represented by the 2020 Notes will be repaid in four bi-annual installments, commencing on the first anniversary following the closing of each 2020 CLA, and (ii) the interest accrued on the loan amount will be paid in two bi-annual installments, commencing on the first anniversary of the first payment of that principal amount.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">During October 2020, the Company entered into a series of additional 2020 CLAs with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal amount of $100,000.</font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">During January 2021, the Company entered into a series of additional 2020 CLAs with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal amount of $274,000. </font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">As part of the 2020 CLA, the Company entered into a registration rights agreement with each of the 2020 Lenders, whereby each 2020 Lender received piggyback registration rights for the shares issuable upon conversion of the 2020 Notes to shares of Common Stock.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The loans are convertible into common
Stock upon (i) a completion of underwritten public offering (&#8220;Mandatory Conversion&#8221;) convert the outstanding loan amount
at a share price as shall be determined in the offering, or (ii) at the lender&#8217;s discretion (&#8220;Optional Conversion&#8221;)
convert the outstanding loan amount at a share price per share of $7.63.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In accordance with ASC 815-15-25,
the conversion feature was considered embedded derivative instruments, and is to be recorded at their fair value as its fair value
can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded
finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component
fair value over the face loan amount. The conversion liability is then marked to market each reporting period with the resulting
gains or losses shown in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value of the convertible
component was estimated by third party appraiser as weighted average of the two possible scenarios of the total loan amount conversion:
as of September 21, 2020 and October 23, 2020, 70% probability for the Mandatory Conversion and 30% probability for the Optional
Conversion and as of December 31, 2020, 75% probability for the Mandatory Conversion and 25% probability for the Optional Conversion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Mandatory Conversion (scenario
1) was estimated by the appraiser using the Black-Scholes option pricing model, to compute the fair value of the derivative and
to market the fair value of the derivative at each balance sheet date. The following are the data and assumptions used as of issuance
dates and as of the balance sheet date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 21, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>October 23,</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2020</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 43%"><font style="font-size: 10pt">Dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.19</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.11</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.09</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected term (years)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.775</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.685</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.417</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48.06</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.72</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.88</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.61</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercise price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Fair value</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,208</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,457</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">47,499</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Optional Conversion (scenario
2) was estimated by the appraiser using binomial option pricing model and simulating and waiver of the lender as an exercise price,
to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date.
The following are the data and assumptions used as of the issuance dates and as of balance sheet date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 21, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>October 23, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 45%"><font style="font-size: 10pt">Dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.12-0.16</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.12-0.2</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.10-0.14</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48.06</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.72</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.88</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.61</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Fair value</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,824</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,167</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">77,381</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value of the convertible
component was estimated by the third-party appraiser after giving effect to the weighted average of the two possible scenarios
as of issuance dates was $27,762 and as of December 31, 2020 was $54,970.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value allocated to the
convertible loan was estimated by third party appraiser as the residual value of the proceeds net of the convertible component
and was estimated at a value of $203,179 as of December 31, 2020 of which $56,250 is presented under current liabilities and $146,929
is presented under long term liabilities.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133822024840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Loans from Banking Institutions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Loans from Banking Institutions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-indent: -68.05pt"><b>NOTE 7 - LONG-TERM LOANS FROM
BANKING INSTITUTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-indent: -68.05pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 38px; text-align: justify"><font style="font-size: 10pt"><b>A.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>Composition</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Interest rate at<br />
        December 31</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2020</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify"><font style="font-size: 10pt">Long-term loans</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2.1</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">16,064</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">22,185</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less current maturities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,949</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,230</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,115</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">14,955</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 38px; text-align: justify"><font style="font-size: 10pt"><b>B.</b></font></td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Maturity dates:</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">First year</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">7,949</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Second year</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,115</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>16,064</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133829286904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingent Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 8 &#8211; COMMITMENT AND
CONTINGENT LIABILITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">A.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Save Foods Ltd. is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. Save Foods Ltd. was entitled to the grants only upon incurring research and development expenditures. There were no future performance obligations related to the grants received from the IIA. As of December 31, 2020, the contingent liabilities with respect to grants received from the IIA, subject to repayment under these royalty agreements on future sales is NIS 484,429 (US$ 150,678), not including interest.</font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">B.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">The Company and its subsidiary currently lease office space at Kibbutz Alonim under a short-term operating lease agreement ends at December 31, 2020 with an option to extend the agreement with additional year ended at December 31, 2021. During the years 2020 and 2019, the Company paid an annual rent of $14,967 and $10,605, respectively under the above agreement. The agreement was automatically renewed (option) until December 31, 2021.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In addition, the Company and Save
Foods Ltd. entered into a short term lease agreement for the period ended at May 31, 2019, with a shareholder for the lease of
an office and related services for a monthly fee of NIS 5,000 (approximately $1,400).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On May 1, 2019 the Company and Save
Foods Ltd. entered into a lease agreement for its offices in Tel Aviv for the period ending December 31, 2020, for the lease of
an office and management fees for a monthly fee of NIS 11,214 (approximately $3,450). On August 9, 2020, the Company and the lessor
agreed that the Company would pay the lessor a one-time NIS10,000 ($3,100) and the agreement would be terminate as of August 13,
2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On September 1, 2017, the Company
entered into a lease agreement for office space in New York, hereinafter the New York Lease. The New York Lease will expire on
September 30, 2020, unless terminated earlier by either party by providing 30 days prior written notice to the other party. The
New York Lease rent amount, $7,200, was fully paid for through an issuance of 720,000 shares of our Common Stock on November 5,
2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">C.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">In July 2011, Save Foods, Ltd. filed with the Commissioner of Patent of the Israeli Patent Office (the &#8220;Commissioner&#8221;) a claim stating its opposition to a patent application made by Xeda International S.A, (&#8220;Xeda&#8221;), which would have restricted Save Foods Ltd&#8217;s operations.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In June 2018, the Commissioner accepted
Save Foods Ltd&#8217;s claims against Xeda&#8217;s patent application and, accordingly, rejected Xeda&#8217;s application. The
Commissioner awarded Save Foods Ltd. with expenses and legal fees in the aggregate amount of approximately NIS 165,000 (approximately
$46,000)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In September 2018, Xeda filed an
appeal with the District Court in Jerusalem (the &#8220;Court&#8221;), with respect to the Commissioner&#8217;s decision, and in
January 2019, the Court dismissed Xeda&#8217;s appeal and awarded Save Foods Ltd. expenses and legal fees in the aggregate amount
of approximately NIS 50,000 (approximately $13,000).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In February 2019, Xeda filed a request
to appeal the Court&#8217;s decision with the Israeli Supreme Court. In May 2019, the Israeli Supreme Court rejected Xeda&#8217;s
request to appeal and awarded Save Foods Ltd. expenses and legal fees in the aggregate amount of NIS 8,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">D.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On September 22, 2020, the Company entered into a non-exclusive Commission Agreement with Earthbound Technologies, LLC (&#8220;EBT&#8221;) for a period of 12 months, according to which EBT shall introduce the Company to potential clients, pre-approved by the Company (&#8220;Introduced Parties&#8221;) and shall assist the Company in finalizing commercial agreements with the Introduced Parties. In consideration for its services, the Company agreed to pay EBT 12.5% of the net revenues generated from Introduced Parties (during the agreement period and within 18 months following the termination of the agreement) up to a total aggregated amount of $2,000,000, provided that the compensation shall not exceed 25% of the Company&#8217;s gross profit under the given commercial agreement signed with the Introduced Party. In addition, in the event that the aggregated net revenues generated from Introduces Parties exceeds $500,000, and subject to the approval of the Board, the Company shall issue to EBT 7,143 options to purchase 7,143 shares of Common Stock at an exercise price of $8.4 per share. In the event that certain additional events detailed in the agreement occur, the Company will also issue to EBT, subject to the approval of the Board, an additional 7,143 options to purchase 7,143 shares of Common Stock at an exercise price of $8.4 per share.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">E.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On September 22, 2020, the Company entered into a Distribution Agreement (the &#8220;Distribution Agreement&#8221;), with Safe-Pack Products Ltd (&#8220;Safe-Pack&#8221;) according to which the Company granted Safe-Pack an exclusive right to resell, distribute, advertise, and market Company&#8217;s products related to the citrus industry in Israel and other territories, as well as additional products as shall be mutually agreed upon in the future. In addition, the Company agreed to grant Safe-Pack a right of first refusal to be designated as an exclusive distributor of the Company in certain agreed upon territory for additional products of the Company as they relate to the field of post-harvest. In consideration for the above rights granted to Safe-Pack, Safe-Pack will submit to the Company purchase orders of its products at a price specified in the Distribution Agreement. Commencing upon the second calendar year of the agreement, Safe-Pack is required to meet a minimum purchase quota, as shall be mutually agreed upon between the parties. In the event that the parties fail to agree on a quota, the quota shall be equal to last year quota plus 3%.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743524040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 9 &#8211; SHAREHOLDERS&#8217;
EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b><i>Description of the rights
attached to the Shares in the Company:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Common stock:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each share of common stock entitles
the holder to one vote, either in person or by proxy, at meetings of stockholders. The holders are not permitted to vote their
shares cumulatively. Accordingly, the stockholders of the Company&#8217;s common stock who hold, in the aggregate, more than fifty
percent of the total voting rights can elect all of the directors and, in such event, the holders of the remaining minority shares
will not be able to elect any of such directors. The vote of the holders of a majority of the issued and outstanding shares of
common stock entitled to vote thereon is sufficient to authorize, affirm, ratify or consent to such act or action, except as otherwise
provided by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Transactions:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During January 2019 the Company
issued total of 19,050 shares of Common Stock of the Company $0.0001 par value, to accredited investors for total consideration
of $120,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During February 2019 the Company
issued total of 35,717 shares of Common Stock of the Company $0.0001 par value, to accredited investors for total consideration
of $225,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During March 2019 the Company issued
total of 15,874 shares of Common Stock of the Company $0.0001 par value, to accredited investor for total consideration of $100,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In addition, during March 2019 the
Company issued 7,937 shares of Common Stock of the Company $0.0001 par value, to an accredited investor for total consideration
of $50,000 and at the same time issued him 7,937 shares of Common Stock $0.0001 par value for total consideration of $66,666 and
7,937 warrants to purchase the company shares of Common Stock at an exercise price of 84 cents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During June 2019, the Company issued
total of 31,747 shares of Common Stock of the Company $0.0001 par value, to accredited investors for total consideration of $200,000.
In addition, During June 2019 the Company issued 10,004 shares of Common Stock of the Company $0.0001 par value, to an accredited
investor for total consideration of $84,034 and at the same time issued that accredited investor 10,004 warrants to purchase the
company shares of Common Stock at an exercise price of 84 cents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During August 2019, the Company
signed a subscription agreement with an investor according to which the Company will issue total of 11,905 shares of Common Stock
of the Company $0.0001 par value, to accredited investor for total consideration of $100,000. In addition, and at the same time
issued that accredited investor 11,905 warrants to purchase the company shares of Common Stock at an exercise price of 84 cents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On May 9, 2020, the Company entered
into a Securities Purchase Agreement (the &#8220;May Agreement&#8221;) with an existing shareholder (the &#8220;Investor&#8221;),
pursuant to which the Company sold to the Investor for an aggregated amount of $100,000, 13,107 units at a price per unit of $7.63
(the &#8220;2019 Units&#8221;), each 2019 Unit consists of (i) one share of Common Stock and (ii) one warrant to purchase one share
of Common Stock with an exercise price of $8.40 for a period of 36 months following the issuance date. The shares of Common Stock
were issued on July 2, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On July 2, 2020, the Company issued
67,369 shares of Common Stock in respect of the conversion of convertible loans as detailed in Note 3A above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During July and August 2020, the
Company entered into additional Securities Purchase Agreements with existing shareholders (the &#8220;Additional Investors&#8221;),
pursuant to which the Company sold to the Additional Investors for an aggregate amount of $150,000, 19,662 units, based substantially
upon the same terms as in the May Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On September 23, 2020, the Company
entered into a Securities Purchase Agreement (the &#8220;Medigus SPA&#8221;) with Medigus Ltd. (&#8220;Medigus&#8221;) in connection
with the sale and issuance of 13,107 units for total consideration of $100,000, based substantially upon the same terms as in the
May Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Medigus SPA contemplates an
additional investment by Medigus not to exceed $25,000 (the &#8220;Additional Medigus Investment&#8221;), which shall be triggered
following the parties&#8217; initiation of a proof of concept procedure to test the effectiveness of the Company&#8217;s sanitizers
and its residual effects on surfaces against different pathogens including COVID-19. In consideration for the Additional Medigus
Investment, the Company has agreed to issue an additional 3,277 units at a purchase price of $7.63, which units shall contain the
same composition of securities as described in the foregoing description of the Medigus SPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On September 22, 2020 and September
24, 2020, the Chairman of the Board of Directors of the Company (the &#8220;Board&#8221;), exercised a warrant to purchase an aggregate
of 28,572 shares of Common Stock, which warrants were granted to him on June 15, 2020 by the Board as a replacement for his recently
expired options, which were previously granted to him in April 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During December 2020, two directors
on Save Food Ltd exercised 6,350 options under the 2018 Equity Incentive Plan into 6,350 shares of common stock of the Company
total consideration of $20,000.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743490712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Options</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><b>NOTE 10
&#8211; STOCK OPTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On October 18, 2018, the Company
adopted the 2018 Share Incentive Plan (the &#8220;2018 Equity Incentive Plan&#8221;), pursuant to which the Company&#8217;s Board
of Directors is authorized to grant up to 190,477 options, exercisable into 190,477 shares of Common Stock of the Company. The
purpose of the 2018 Equity Incentive Plan is to offer attract and retain the best available personnel, provide incentive to individuals
who perform services for the Company and promote the success of the Company&#8217;s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On January 3, 2019, the Company
granted of 80,954 options under the 2018 Equity Incentive Plan of which 9,524 options are vested quarterly over three years commencing
May 15, 2018, 35,715 options are vested 1/3 after a year commencing October 1, 2018 and the remaining 2/3 are vested quarterly
over additional two years, 14,286 options are vested quarterly over three years commencing October 1, 2018 and 21,429 options are
vested 1/3 after a year commencing January 1, 2019 and the remaining 2/3 are vested quarterly over additional two years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On April, 2019, the Board of Directors
of the Company approved the issuance of 28,572 options to purchase 28,572 Company&#8217;s Common Stock 0.0001 par value, to Mr.
Dan Sztybel, under the Company&#8217;s 2018 Equity Incentive Plan. The options shall vest quarterly over three years, commencing
April 1, 2019, and shall be exercisable for an exercise price of $3.15 per share. In addition, the Board of Directors of the Company
approved the issuance of 14,286 options to purchase 14,286 Company&#8217;s Common Stock 0.0001 par value, to Mr. Dan Sztybel, subject
to Save Foods Ltd&#8217;s obtainment of certain EPA and FDA approvals by the end of the second quarter of 2020. Such conditions
did not met as of June 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On November 12, 2019, the Board
of Directors of the Company approved the grant of 45,239 options under the 2018 Equity Incentive Plan of which 28,572 options are
vested quarterly over three years commencing January 3, 2019, 9,524 options are vested 1/3 after a year commencing January 3, 2019
and the remaining 2/3 are vested quarterly over additional two years, and 7,143 options are vested 1/3 after a year commencing
October 1, 2019 and the remaining 2/3 are vested quarterly over additional two years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In addition, the Board of Directors
approved the agreement with a consultant, according to which the consultant would receive 2,858 fully vested options to purchase
Company&#8217;s shares at exercise price of $6.3 per option for certain &#8220;closed&#8221; introduction made by the consultant
in Chile. No options were granted under this agreement as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On June 23, 2020, the Company granted
21,143 options to purchase its Common Stock under the 2018 Equity Incentive Plan (the &#8220;Plan&#8221;). The options shall vest
quarterly over two years commencing June 23, 2020, whereby 12.50% of the shares covered by the options will vest on the three month
anniversary of June 23, 2020, and 12.50% of the shares covered by the options will vest at the end of each subsequent three month
period thereafter over the course of the subsequent 21 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On July 1, 2020, the Company granted
71,431 options to purchase its Common Stock under the 2018 Equity Incentive Plan. The options shall vest quarterly over two years
commencing June 1, 2020, whereby 12.50% of the shares covered by the options will vest on the three month anniversary of June 1,
2020, and 12.50% of the shares covered by the options will vest at the end of each subsequent three month period thereafter over
the course of the subsequent 21 months. The fair value of the options was estimated at a value of $344,767 at the date of issuance
using the Black-Scholes option pricing model.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In addition, on July 1, 2020, the
Board approved an increase to the share option pool under the Plan by 99,466 shares of Common Stock, such that after the increase
the total number of shares of Common Stock issuable under the Plan is 289,942 shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On September 22, 2020, the Board
approved an amendment of the terms of the outstanding options granted to certain employees and directors of the Company. According
to the new terms, subject to the consummation of equity financing in excess of $1,000,000 and the completion of listing of the
Company&#8217;s Common Stock for trade on the Nasdaq, and in the event that the employment or engagement of such grantee is either
terminated (not for cause) or otherwise changed thereby resulting in the conclusion of such engagement (including voluntary resignation),
all outstanding options of such grantee shall vest immediately and shall be exercisable for a period of three years following the
termination date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The following table presents the
Company&#8217;s stock option activity for employees and directors of the Company for the year ended December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Options</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Outstanding at January 1, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">59,525</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Granted (*)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">109,526</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,762</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Outstanding at January 1, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">164,289</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">92,574</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.64</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(6,350</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(29,365</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(14,286</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">206,862</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Number of options exercisable at December 31, 2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">97,351</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.27</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -25.65pt">(*) Options
that were granted on January 3, 2019 with vesting that commences before December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The aggregate intrinsic value of
the awards outstanding as of December 31, 2020 is US$1,084,465. These amounts represent the total intrinsic value, based on the
Company&#8217;s stock price of US$ 8.61 as of December 31, 2020, less the weighted exercise price. This represents the potential
amount received by the option holders had all option holders exercised their options as of that date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value of options granted
was estimated at the dates of grant using the Black-Scholes option pricing model. The following are the data and assumptions used:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected volatility (%) (*)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">52</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">54</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Risk-free interest rate (%) (**)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.56-2.39</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected term of options (years) (***)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Exercise price (US dollars)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15-3.78</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Share price (US dollars)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.3</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Fair value (US dollars)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.83-5.17</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.19</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 53.85pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 11%">&#160;</td>
    <td style="width: 5%; text-align: justify"><font style="font-size: 10pt">(*)</font></td>
    <td style="width: 84%; text-align: justify"><font style="font-size: 10pt">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">(**)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">The risk-free interest rate represented the risk-free rate of US$ zero &#8211; coupon US Government Loans.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">(***)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the &#8220;simplified method&#8221; in accordance with SEC Staff Accounting Bulletin No. 110.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 120.5pt; text-align: justify; text-indent: -42.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The total fair value estimation
of the non-cash compensation of the grant at 2020 and 2019 was approximately $453,976 and $440,848, respectively. Costs incurred
in respect of stock-based compensation for employees and directors, for the year ended December 31, 2020 and 2019 were $492,619
and $438,670, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As of December 31, 2020, there are
76,730 options available for future grants under the 2018 Equity Incentive Plan.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743564072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of Sales<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CostOfSalesAbstract', window );"><strong>Cost Of Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CostOfSalesTextBlock', window );">Cost of Sales</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 11 &#8211; COST OF SALES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Year ended December 31</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 71%"><font style="font: 10pt Times New Roman, Times, Serif">Salaries and related expenses</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,074</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35,142</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,402</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,531</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,692</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">69,390</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vehicle maintenance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,063</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,455</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Travel expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">978</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,408</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Transportation and storage</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,632</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,299</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Other expenses</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,564</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>43,405</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>144,548</b></font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_CostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_CostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_CostOfSalesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of Sales [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_CostOfSalesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743580968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 12 &#8211; RESEARCH AND
DEVELOPMENT EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Salaries and related expenses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">39,021</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">177,712</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">91,190</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">75,998</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Professional fees</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">130,592</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">178,854</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Depreciation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">29,319</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">20,544</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Travel expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,190</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,138</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Vehicle maintenance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,657</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,227</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Rent and asset management</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,582</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Laboratory and Field tests</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">72,593</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">73,968</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">33,438</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">25,600</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>417,000</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>615,623</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743509784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_GeneralAndAdministrativeExpensesAbstract', window );"><strong>General And Administrative Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_GeneralAndAdministrativeExpensesTextBlock', window );">General and Administrative Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 13 &#8211; GENERAL AND
ADMINISTRATIVE EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Professional services</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">443,883</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">461,840</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">416,996</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">283,910</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Legal expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">67,492</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">125,753</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Insurance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">63,380</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">54,367</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Rent and office maintenance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">11,135</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">38,080</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Levies and tolls</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">28,477</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,601</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Communications</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,679</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,910</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Depreciation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,914</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,133</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Travel expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,305</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,310</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">17,848</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,995</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>1,070,109</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>1,004,899</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_GeneralAndAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_GeneralAndAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_GeneralAndAdministrativeExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and Administrative Expenses [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_GeneralAndAdministrativeExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133822059848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Expenses, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FinancingExpensesNetAbstract', window );"><strong>Financing Expenses Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FinancingExpensesNetDisclosureTextBlock', window );">Financing Expenses, Net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 14 &#8211; FINANCING EXPENSES,
NET</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Interest and amortization expenses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">202,917</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4,323</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Currency exchange differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,037</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">28,266</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Changes in fair value of convertible loans</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">27,208</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Bank charges and other finance expenses, net</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,231</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">10,819</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">270,393</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">43,408</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FinancingExpensesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FinancingExpensesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FinancingExpensesNetDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Expenses Net [Disclosure Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FinancingExpensesNetDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743497128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 15 &#8211; INCOME TAX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 72px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><font style="font-size: 10pt">A.</font></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">US resident companies are taxed on their worldwide
        income for corporate income tax purposes at a statutory rate of 21% this reflect certain effects of the Act which includes a reduction
        in the corporate tax rate from 35% to 21% as well as other changes. No further taxes are payable on this profit unless that profit
        is distributed. If certain conditions are met, income derived from foreign subsidiaries is tax exempt in the US under applicable
        tax treaties to avoid double taxation.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income of the Israeli company is taxable from
        2018 and onwards, at corporate tax rate of 23%.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and Save Foods Ltd. has not received
        final tax assessments since its inception.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2020, the Company and Save
        Foods Ltd. has estimated carry forward losses for tax purposes of approximately $1,264,000 and $9,412,000, respectively, which
        can be offset against future taxable income, if any.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 7%; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><font style="font-size: 10pt">B.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">The following is reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal tax rate) and the tax expense reported in the financial statements:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Pretax loss</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,593,139</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,971,417</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Federal tax rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Income tax computed at the ordinary tax rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">334,559</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">413,998</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Non-deductible expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(63,565</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(2,278</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Stock-based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(109,772</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(93,970</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Tax in respect of differences in corporate tax rates</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,480</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,688</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Losses and timing differences in respect of which no deferred taxes were generated</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(174,702</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(344,438</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 7%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"><font style="font-size: 10pt">C.</font></td>
    <td style="width: 90%; text-align: justify"><font style="font-size: 10pt">Deferred taxes result primarily from temporary differences in the recognition of certain revenue and expense items for financial and income tax reporting purposes. Significant components of the Company&#8217;s future tax assets are as follows:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Composition of deferred tax assets:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 66%; text-align: justify"><font style="font-size: 10pt">Provision for employee related obligation</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">31,627</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">29,353</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Non capital loss carry forwards</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,350,367</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,171,821</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,381,994</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,201,174</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743279064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 16 &#8211; LOSS PER COMMON
STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Basic loss per share is computed
by dividing net loss by the weighted average number of shares outstanding during the year. The weighted average number of shares
of Common Stock used in computing basic and diluted loss per common stock for the years ended December 31, 2020 and 2019, are as
follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 72%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Weighted average number of shares of Common Stock outstanding attributable to shareholders</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,519,122</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,424,045</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share (*)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">206,862</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">164,289</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">(*) The effect of the inclusion
of option and convertible loans in 2020 and 2019 is anti-dilutive.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743306392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 17 &#8211; RELATED PARTIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>A. Transactions and balances
with related parties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>General and administrative expenses:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 66%; padding-left: 10pt"><font style="font-size: 10pt">Directors compensation</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">380,756</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">295,088</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Salaries and fees to officers</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">336,433</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">358,370</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Consultants and other fees</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">52,331</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(*) 769,520</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(*) 653,458</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">(*) share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">394,756</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">272,077</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Research and development expenses:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Salaries and fees to officers</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">25,301</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">116,692</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>B. Balances with related parties
and officers:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Other accounts payables</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"><font style="font-size: 10pt">424,515</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"><font style="font-size: 10pt">199,983</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>C. Other information:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 96px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt">A.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On November 5, 2020, the board of directors of the Company appointed Mr. David Palach, to serve as co-Chief Executive Officer of the Company, effective as of the same date. In connection with Mr. Palach&#8217;s appointment, the parties entered into a Consulting Agreement pursuant to which the Company and Mr. Palach agreed upon, inter alia, the following engagement terms: (a) a monthly retainer of $8,000, and (b) a grant of options to purchase shares of the Company&#8217;s common stock, which amount shall be determined by the Board on a future date.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 96px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt">B.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On October 10, 2018 the Board of directors of Save Foods Ltd. approved to engage in consulting agreements with Amir Uziel Economic Consultant Ltd (a company controlled by Amir Uziel) and with L.A Pure Capital Ltd (a company controlled by Kfir Zilberman) at a monthly fee of $1,500.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 96px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt">C.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On October 10, 2018 the Board of directors of Save Foods Ltd. approved a monthly directors fee of $1,500 to Itzhak Shrem.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743521800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-indent: -63.8pt"><b>NOTE 17 &#8211; SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 96px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">A.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">On February 23, 2021, the Company amended its Certificate of Incorporation to effect a 7 to 1 reverse stock split of the Company&#8217;s outstanding Common Stock. As a result of the reverse stock split, which became effective on February 23, 2021, every 7 shares of the Company&#8217;s outstanding Common Stock prior to the effect of that amendment was combined and reclassified into one share of the Company&#8217;s Common Stock. No fractional shares were issued in connection with or following the reverse split. The number of authorized capital of the Company&#8217;s Common Stock and par value of the shares remained unchanged.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify">All share, stock option and per
share information in these condensed consolidated financial statements have been restated to reflect the stock split on a retroactive
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 96px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">B.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">During January 2021, the Company entered into a series of additional 2020 CLAs (See note 6B above) with additional 2020 Lenders to sell additional 2020 Notes with an aggregate principal amount of $274,000.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738773096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock', window );">Use of Estimates in the Preparation of Financial Statements</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>A.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Use of estimates in the preparation of financial statements</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported
amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial
statements, the most significant estimates and assumptions relate to the going concern assumptions, share based compensation and
convertible loans.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional Currency</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>B.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Functional currency</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">A majority of the Group&#8217;s
revenues is generated in U.S. dollars. In addition, most of the Group&#8217;s costs are denominated and determined in U.S. dollars
and in new Israeli shekels. Management believes that the dollar is the currency in the primary economic environment in which the
Group operates. Thus, the functional and reporting currency of the Group is the U.S. dollar.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Accordingly, monetary accounts maintained
in currencies other than the dollar are remeasured into dollars in accordance with Accounting Standards Codification (ASC) 830,
&#8220;Foreign Currency Matters&#8221;. All transaction gains and losses of the remeasured monetary balance sheet items are reflected
in the statements of operations as financial income or expenses, as appropriate.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>C.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Principles of consolidation</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The consolidated financial statements
include the accounts of the Company and its subsidiary, Save Foods Ltd. All significant intercompany balances and transactions
have been eliminated on consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>D.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Cash and cash equivalents, and Restricted cash</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Cash equivalents are short-term
highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted
as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Restricted cash as of December 31,
2020 and 2019 included a NIS 72,000 ($22,395) and NIS 132,000 ($38,194), respectively collateral account for the Company&#8217;s
corporate credit cards and a loan and is classified in current assets.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivables</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>E.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Accounts receivables</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Accounts receivables are stated
at their net realizable value. The allowance against gross accounts receivables reflects the best estimate of losses inherent in
the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and
other currently available information. As of December 31, 2020, and 2019, an allowance for doubtful debts in the amount of $26,553
and $24,702, respectively, is reflected in net accounts receivables. Accounts receivables are written off after all reasonable
means to collect the full amount have been exhausted.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>F.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Property, plant and equipment, net</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="width: 24px; padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">1.</font></td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the Statements of Operations and Comprehensive Loss.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: justify">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">2.</font></td>
    <td style="padding-right: 0.8pt; text-align: justify"><font style="font-size: 10pt">Rates of depreciation:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Furniture and office equipment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7-15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Machines</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10-15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%"><font style="font-size: 10pt">Computers</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">33</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Vehicle</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; padding-right: 0.8pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"><font style="font-size: 10pt"><b>G.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt"><font style="font-size: 10pt"><b>Impairment of long-lived assets</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Group&#8217;s long-lived assets
are reviewed for impairment in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 360, &#8220;Property,
Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the
future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment
to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. No impairment expenses
were recorded during the years ended December 31, 2020 or 2019.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Deferred Income Taxes</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; padding-right: 0.8pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"><font style="font-size: 10pt"><b>H.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt"><font style="font-size: 10pt"><b>Deferred income taxes</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Group accounts for income taxes
in accordance with ASC Topic 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are determined utilizing the asset
and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected
to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary,
to reduce deferred tax assets to amounts more likely than not to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Group accounts for uncertain
tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements. According to ASC
Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting policy is to
classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such
items in its fiscal 2020 and 2019 financial statements and did not recognize any liability with respect to an unrecognized tax
position in its balance sheets.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_LiabilityForEmployeeRightUponRetirement', window );">Liability for Employee Rights Upon Retirement</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>I.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Liability for employee rights upon retirement</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Save Foods Ltd&#8217;s liability
for employee rights upon retirement with respect to its Israeli employees is calculated, pursuant to Israeli Severance Pay Law,
based on the most recent salary of each employee multiplied by the number of years of employment, as of the balance sheet date.
Employees are entitled to one month&#8217;s salary for each year of employment, or a portion thereof. Save Foods Ltd. makes monthly
deposits to insurance policies and severance pay funds. The liability of the Company is fully provided for.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The deposited funds include profits
accumulated up to the balance sheet date. The deposited funds may be withdrawn upon the fulfillment of the obligation pursuant
to Israeli severance pay laws or labor agreements. The value of the deposited funds is based on the cash surrender value of these
policies, and includes immaterial profits/losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Severance expenses for the years
ended December 31, 2020 and 2019, amounted to $7,419 and $24,000, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>J.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Revenue recognition</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Revenues are recognized when delivery
has occurred and there is persuasive evidence of an agreement, the fee is fixed or determinable and collection of the related receivables
is reasonably assured and no further obligations exist.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Revenues from sales of products
are recognized when title and risk and rewards for the products are transferred to the customer.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; padding-right: 0.8pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"><font style="font-size: 10pt"><b>K.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt"><font style="font-size: 10pt"><b>Research and development expenses</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Research and development expenses
are charged to operations as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RoyaltyBearingGrants', window );">Royalty-Bearing Grants</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>L.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Royalty-bearing grants</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Royalty-bearing grants from the
Israeli Innovation Authority (the &#8220;IIA&#8221;) for funding approved research and development projects are recognized at the
time Save Foods Ltd. is entitled to such grants (i.e. at the time that there is reasonable assurance that the Company will comply
with the conditions attached to the grant and that there is reasonable assurance that the grant will be received), on the basis
of the costs incurred and reduce research and development costs. The cumulative research and development grants received by the
Company from inception through December 2020 amounted to NIS 484,429 (US$150,678).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As of December 31, 2020, and 2019,
the Company did not accrue for or pay any royalties to the IIA since no revenues were recognized in respect of the funded projects.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>M.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Inventories</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Inventories are valued at the lower
of cost or net realizable value. Cost of raw and packaging materials, purchased products, manufactured finished products and products
in process are determined on the average costs basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company regularly reviews its
inventories for impairment and reserves are established when necessary.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Loss Per Common Stock</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>N.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Basic and diluted loss per common stock</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Basic loss per common stock is computed
by dividing the loss for the period applicable to shareholders, by the weighted average number of shares of common stock outstanding
during the period. Securities that may participate in dividends with the shares of common stock (such as the convertible preferred)
are considered in the computation of basic loss per share under the two-class method. However, in periods of net loss, only the
convertible preferred shares are considered, since such shares have a contractual obligation to share in the losses of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In computing diluted loss per share,
basic loss per share is adjusted to reflect the potential dilution that could occur upon the exercise of potential shares. Accordingly,
in periods of net loss, no potential shares are considered.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based Compensation</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>O.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Stock-based compensation</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company measures and recognizes
the compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC
718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments including grants of stock options are recognized in the
statement of comprehensive loss as an operating expense based on the fair value of the award at the date of grant. The fair value
of stock options granted is estimated using the Black-Scholes option-pricing model. The Company has expensed compensation costs,
net of estimated forfeitures, applying the accelerated vesting method, over the requisite service period or over the implicit service
period when a performance condition affects the vesting, and it is considered probable that the performance condition will be achieved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Share-based payments awarded to
consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, &#8220;Equity-Based Payments to Non-Employees&#8221;.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>P.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Fair Value Measurements</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Fair value of certain of the Company&#8217;s
financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued
liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with
ASC 820, &#8220;Fair Value Measurements and Disclosure&#8221; defines fair value, establishes a framework for measuring fair value
in accordance with generally accepted accounting principles and expands disclosures about fair value investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Fair value, as defined in ASC 820,
is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or
most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the
risk of non-performance, which includes, among other things, the Company&#8217;s credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Valuation techniques are generally
classified into three categories: the market approach; the income approach; and the cost approach. The selection and application
of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset
or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize
the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs
and resulting measurement as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Level 1: Quoted prices (unadjusted)
in active markets that are accessible at the measurement date for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Level 2: Quoted prices for similar
assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active;
inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or
corroborated by observable market data for substantially the full term of the assets or liabilities; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Level 3: Unobservable inputs for
the asset or liability that are supported by little or no market activity, and that are significant to the fair values.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Fair value measurements are required
to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair
value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements
including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to
the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings,
and a description of where those gains or losses included in earning are reported in the statement of income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company records a debt discount
related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible
instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and
as a reduction to the carrying amount of the convertible instrument equal to the fair value of the conversion features. The debt
discount will be accreted by recording additional non-cash gains and losses related to the change in fair values of derivative
liabilities over the life of the convertible notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company&#8217;s financial assets
and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Balance as of December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 1</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 2</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 3</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Liabilities:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 48%; padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Fair Value of convertible component in convertible loan</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">The following table presents the
changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair value of Convertible component</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at January 1, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 71%"><font style="font-size: 10pt">Fair value of issued level 3 liability</font></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: right"><font style="font-size: 10pt">27,762</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Changes in fair value</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">27,208</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>Q.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Concentrations of credit risk</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Financial instruments that potentially
subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents as well as certain other current
assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held in Dollars and New Israeli
Shekels, are deposited with major banks in Israel and United States. Management believes that such financial institutions are financially
sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant
off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>R.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Contingencies</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company records accruals for
loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and
the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information
becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>S.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>New Accounting Pronouncements </b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.65pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In June
2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;)
No. 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.&#8221;
In November 2018, FASB issued ASU No. 2018-19, &#8220;Codification Improvements to Topic 326, Financial Instruments-Credit Losses&#8221;,
which amends the scope and transition requirements of ASU 2016-13. Topic 326 requires a financial asset (or a group of financial
assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected
credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable
and supportable forecasts that affect the collectability of the reported amount. Topic 326 will originally become effective for
the Company beginning January 1, 2020, with early adoption permitted, on a modified retrospective approach. As a smaller reporting
company, the effective date for the Company has been delayed until fiscal years beginning after December 15, 2022, in accordance
with ASU 2019-10, although early adoption is still permitted. This standard did not have a material impact to the Company&#8217;s
consolidated financial statements after evaluation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In December
2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this
ASU simplify the accounting for income taxes, eliminates certain exceptions to the general principles in Topic 740 and clarifies
certain aspects of the current guidance to improve consistent application among reporting entities. ASU 2019-12 is effective for
fiscal years beginning after December 15, 2021 and interim periods within annual periods beginning after December 15, 2022, though
early adoption is permitted, including adoption in any interim period for which financial statements have not yet been issued.
This standard is not expected to have a material impact to the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In August
2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements
for Fair Value Measurement. This standard will require entities to disclose the amount of total gains or losses for the period
recognized in other comprehensive income that is attributable to fair value changes in assets and liabilities held as of the balance
sheet date and categorized within Level 3 of the fair value hierarchy. This ASU will be effective for the Company for annual and
interim periods beginning after December 31, 2020. Early adoption of this standard is permitted. This standard did not have a material
impact to the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">In August
2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity s Own Equity.
ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features
being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject
to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract,
that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible
debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends
the guidance for the derivatives scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based
accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2023,
including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after
December 15, 2020, including interim periods within those fiscal years. Management has not yet evaluated the impact that the adoption
of ASU 2020-06 will have on the Company&#8217;s consolidated financial statement presentation or disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Other new pronouncements issued
but not effective as of December 31, 2020 are not expected to have a material impact on the Company&#8217;s consolidated financial
statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_LiabilityForEmployeeRightUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability for Employee Rights Upon Retirement [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_LiabilityForEmployeeRightUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_RoyaltyBearingGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty-bearing Grants [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_RoyaltyBearingGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Use of Estimates in the Preparation of Financial Statements [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_UseOfEstimatesInPreparationOfFinancialStatementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133747749816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock', window );">Schedule of Property, Plant and Equipment Depreciation Rates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in">Rates of depreciation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>%</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Furniture and office equipment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7-15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Machines</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10-15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 76%"><font style="font: 10pt Times New Roman, Times, Serif">Computers</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vehicle</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Recurring Basis Financial Assets and Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company&#8217;s financial assets
and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Balance as of December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 1</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 2</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 3</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Liabilities:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 48%; padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Fair Value of convertible component in convertible loan</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Fair Value Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">The following table presents the
changes in fair value of the level 3 liabilities for the Year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 67.6pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair value of Convertible component</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at January 1, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 71%"><font style="font-size: 10pt">Fair value of issued level 3 liability</font></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: right"><font style="font-size: 10pt">27,762</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Changes in fair value</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">27,208</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">54,970</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Property, Plant and Equipment Depreciation Rates [ Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ScheduleOfPropertyPlantAndEquipmentDepreciationRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743242472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Prepaid expenses and advances to vendors</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">51,020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4,811</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Receivables from sale of subsidiary (Note 5)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,704</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Government Institutions</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">11,855</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">10,489</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>65,579</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>15,300</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133818948040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Computers</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,328</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,328</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Furniture and office equipment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,002</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,002</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Machines</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">130,797</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">134,665</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Vehicles</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">85,149</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">85,149</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">231,276</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">235,144</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Less - accumulated depreciation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(139,382</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(117,325</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less &#8211; Impairment of long lived assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(36,700</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(36,700</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Total property and equipment, net</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>55,194</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>81,119</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133745306248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accounts Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Account Liabilities</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Employees and related institutions</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">110,220</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">135,901</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Accrued expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">392,442</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">184,616</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Right Of Use liability arising from operating lease</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,049</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">52,093</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Affiliated company (*)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,122</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>517,711</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>380,732</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">(*)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">On April 2, 2019, the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. (&#8220;Savescann&#8221;) a newly formed company registered in Canada. Savecann intended to market the Company&#8217;s solutions to the Cannabis market.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">On April 21, 2020, the Company sold its entire holdings in Savecann for total consideration of 10,000 Canadian Dollars ($7,000), of which $2,704 were not paid yet and are presented as part of other current assets.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743503352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Loans (Tables) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock', window );">Schedule of Weighted-average Assumptions Valuation Method</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Mandatory Conversion (scenario
1) was estimated by the appraiser using the Black-Scholes option pricing model, to compute the fair value of the derivative and
to market the fair value of the derivative at each balance sheet date. The following are the data and assumptions used as of issuance
dates and as of the balance sheet date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 21, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>October 23,</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2020</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 43%"><font style="font-size: 10pt">Dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.19</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.11</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.09</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected term (years)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.775</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.685</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.417</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48.06</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.72</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.88</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.61</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercise price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Fair value</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,208</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,457</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">47,499</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Valuation Technique, Binomial Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock', window );">Schedule of Weighted-average Assumptions Valuation Method</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Optional Conversion (scenario
2) was estimated by the appraiser using binomial option pricing model and simulating and waiver of the lender as an exercise price,
to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date.
The following are the data and assumptions used as of the issuance dates and as of balance sheet date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 21, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>October 23, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 45%"><font style="font-size: 10pt">Dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.12-0.16</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.12-0.2</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.10-0.14</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51.96</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48.06</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.72</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.88</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.61</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Fair value</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,824</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,167</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">77,381</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Weighted-average Assumptions Valuation Method [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ScheduleOfWeightedaverageAssumptionsValuationMethodTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBinomialOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBinomialOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133829813864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Loans from Banking Institutions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Composition of Long Term Debt</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 38px; text-align: justify"><font style="font-size: 10pt"><b>A.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>Composition</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Interest rate at<br />
        December 31</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2020</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify"><font style="font-size: 10pt">Long-term loans</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2.1</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">16,064</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">22,185</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less current maturities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,949</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,230</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,115</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">14,955</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long Term Debt</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 48px; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 38px; text-align: justify"><font style="font-size: 10pt"><b>B.</b></font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>Maturity dates:</b></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90.75pt; text-indent: -22.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">First year</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">7,949</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Second year</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,115</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>16,064</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133748705352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The following table presents the
Company&#8217;s stock option activity for employees and directors of the Company for the year ended December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Options</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Outstanding at January 1, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">59,525</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Granted (*)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">109,526</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,762</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Outstanding at January 1, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">164,289</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">92,574</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.64</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(6,350</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(29,365</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(14,286</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">206,862</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Number of options exercisable at December 31, 2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">97,351</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.27</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -25.65pt">(*) Options
that were granted on January 3, 2019 with vesting that commences before December 31, 2018.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Estimated Fair Value of Options Granted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value of options granted
was estimated at the dates of grant using the Black-Scholes option pricing model. The following are the data and assumptions used:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%; text-align: justify"><font style="font-size: 10pt">Dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected volatility (%) (*)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">52</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">54</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Risk-free interest rate (%) (**)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.56-2.39</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected term of options (years) (***)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Exercise price (US dollars)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15-3.78</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Share price (US dollars)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.63</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.3</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Fair value (US dollars)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.83-5.17</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.19</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 53.85pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 11%">&#160;</td>
    <td style="width: 5%; text-align: justify"><font style="font-size: 10pt">(*)</font></td>
    <td style="width: 84%; text-align: justify"><font style="font-size: 10pt">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">(**)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">The risk-free interest rate represented the risk-free rate of US$ zero &#8211; coupon US Government Loans.</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">(***)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the &#8220;simplified method&#8221; in accordance with SEC Staff Accounting Bulletin No. 110.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743270200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of Sales (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CostOfSalesTablesAbstract', window );"><strong>Cost Of Sales Tables Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ScheduleOfCostOfSalesTableTextBlock', window );">Schedule of Cost of Sales</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Salaries and related expenses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8,074</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">35,142</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,402</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">14,531</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">16,692</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">69,390</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Vehicle maintenance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,063</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,455</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Travel expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">978</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,408</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Transportation and storage</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,632</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,299</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,564</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">323</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>43,405</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>144,548</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_CostOfSalesTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_CostOfSalesTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ScheduleOfCostOfSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Cost of Sales [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ScheduleOfCostOfSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133818401304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock', window );">Schedule of Research and Development Expenses</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Salaries and related expenses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">39,021</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">177,712</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">91,190</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">75,998</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Professional fees</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">130,592</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">178,854</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Depreciation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">29,319</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">20,544</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Travel expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,190</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,138</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Vehicle maintenance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,657</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,227</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Rent and asset management</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,582</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Laboratory and Field tests</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">72,593</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">73,968</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">33,438</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">25,600</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>417,000</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>615,623</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature and amounts of capitalized costs of a research and development nature that were acquired in a transaction other than a business combination, the amount of such assets charged to expense during the period, and identification of the income statement caption in which the charges are included.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133904315480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_GeneralAndAdministrativeExpensesTablesAbstract', window );"><strong>General And Administrative Expenses Tables Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock', window );">Schedule of General amd Administrative Expenses</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Professional services</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">443,883</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">461,840</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">416,996</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">283,910</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Legal expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">67,492</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">125,753</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Insurance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">63,380</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">54,367</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Rent and office maintenance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">11,135</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">38,080</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Levies and tolls</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">28,477</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,601</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Communications</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,679</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,910</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Depreciation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,914</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,133</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Travel expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,305</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,310</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">17,848</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,995</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>1,070,109</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>1,004,899</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_GeneralAndAdministrativeExpensesTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_GeneralAndAdministrativeExpensesTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of General amd Administrative Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ScheduleOfGeneralAmdAdministrativeExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743497128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Expenses, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FinancingExpensesNetAbstract', window );"><strong>Financing Expenses Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ScheduleOfFinancingExpensesNetTableTextBlock', window );">Schedule of Financing Expenses Net</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">Interest and amortization expenses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">202,917</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4,323</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Currency exchange differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,037</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">28,266</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Changes in fair value of convertible loans</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">27,208</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Bank charges and other finance expenses, net</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,231</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">10,819</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">270,393</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">43,408</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FinancingExpensesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FinancingExpensesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ScheduleOfFinancingExpensesNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Financing Expenses Net [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ScheduleOfFinancingExpensesNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133822024840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Expenses</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 7%; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><font style="font-size: 10pt">B.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">The following is reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal tax rate) and the tax expense reported in the financial statements:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Pretax loss</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,593,139</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,971,417</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Federal tax rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Income tax computed at the ordinary tax rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">334,559</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">413,998</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Non-deductible expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(63,565</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(2,278</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Stock-based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(109,772</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(93,970</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Tax in respect of differences in corporate tax rates</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,480</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">26,688</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Losses and timing differences in respect of which no deferred taxes were generated</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(174,702</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(344,438</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 7%; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><font style="font-size: 10pt">C.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">Deferred taxes result primarily from temporary differences in the recognition of certain revenue and expense items for financial and income tax reporting purposes. Significant components of the Company&#8217;s future tax assets are as follows:</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 78pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Composition of deferred tax assets:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 66%; text-align: justify"><font style="font-size: 10pt">Provision for employee related obligation</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">31,627</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">29,353</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Non capital loss carry forwards</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,350,367</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,171,821</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,381,994</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,201,174</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743296824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Loss Per Share</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 72%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Weighted average number of shares of Common Stock outstanding attributable to shareholders</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,519,122</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,424,045</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share (*)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">206,862</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">164,289</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">(*) The effect of the inclusion
of option and convertible loans in 2020 and 2019 is anti-dilutive.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133818929000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Transactions and Balances with Related Parties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>A. Transactions and balances
with related parties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>General and administrative expenses:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 66%; padding-left: 10pt"><font style="font-size: 10pt">Directors compensation</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">380,756</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">295,088</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Salaries and fees to officers</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">336,433</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">358,370</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Consultants and other fees</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">52,331</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(*) 769,520</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(*) 653,458</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">(*) share based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">394,756</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">272,077</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Research and development expenses:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Salaries and fees to officers</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">25,301</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">116,692</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>B. Balances with related parties
and officers:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Other accounts payables</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"><font style="font-size: 10pt">424,515</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 14%; text-align: right"><font style="font-size: 10pt">199,983</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738857592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 23, 2021</div></th>
<th class="th"><div>Apr. 23, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 27, 2009</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.94%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 to 1 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,900<span></span>
</td>
<td class="nump">$ 290,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,277,647)<span></span>
</td>
<td class="num">$ (10,684,508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">7 to 1 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738651720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">$ 22,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allownace for doubtful accounts</a></td>
<td class="nump">26,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impaiement expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance expenses</a></td>
<td class="nump">7,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CumulativeResearchAndDevelopmentGrantsReceived', window );">Cumulative research and development grants received</a></td>
<td class="nump">150,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">232,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SAFO_NISMember', window );">NIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 72,000<span></span>
</td>
<td class="nump">&#8362; 132,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CumulativeResearchAndDevelopmentGrantsReceived', window );">Cumulative research and development grants received | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 484,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_CumulativeResearchAndDevelopmentGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative research and development grants received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_CumulativeResearchAndDevelopmentGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SAFO_NISMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SAFO_NISMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738634728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RateOfDepreciationPercentage', window );">Rate of depreciation, percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RateOfDepreciationPercentage', window );">Rate of depreciation, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember', window );">Machines [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RateOfDepreciationPercentage', window );">Rate of depreciation, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember', window );">Machines [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RateOfDepreciationPercentage', window );">Rate of depreciation, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RateOfDepreciationPercentage', window );">Rate of depreciation, percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RateOfDepreciationPercentage', window );">Rate of depreciation, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_RateOfDepreciationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of depreciation, percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_RateOfDepreciationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133740787384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair Value of convertible component in convertible loan</a></td>
<td class="nump">$ 54,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">54,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair Value of convertible component in convertible loan</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair Value of convertible component in convertible loan</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair Value of convertible component in convertible loan</a></td>
<td class="nump">54,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 54,970<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743409096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Outstanding beginning balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value of issued level 3 liability</a></td>
<td class="nump">27,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue', window );">Changes in fair value</a></td>
<td class="nump">27,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Outstanding ending balance</a></td>
<td class="nump">$ 54,970<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FairValueMeasurementWithUnobservableInputsChangesInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133741866920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Assets - Schedule of Other Current Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 65,579<span></span>
</td>
<td class="nump">$ 15,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_PrepaidExpensesAndAdvancesToVendorsMember', window );">Prepaid Expenses and Advances to Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">51,020<span></span>
</td>
<td class="nump">4,811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_ReceivablesFromSaleOfSubsidiaryMember', window );">Receivables From Sale of Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,704<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_GovernmentInstitutionsMember', window );">Government Institutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 11,855<span></span>
</td>
<td class="nump">$ 10,489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_PrepaidExpensesAndAdvancesToVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_PrepaidExpensesAndAdvancesToVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_ReceivablesFromSaleOfSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_ReceivablesFromSaleOfSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_GovernmentInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_GovernmentInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133747693528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation of property plant and equipment</a></td>
<td class="nump">$ 22,512<span></span>
</td>
<td class="nump">$ 27,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 23,327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738791816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property Plant and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 231,276<span></span>
</td>
<td class="nump">$ 235,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="num">(139,382)<span></span>
</td>
<td class="num">(117,325)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Less - Impairment of long lived assets</a></td>
<td class="num">(36,700)<span></span>
</td>
<td class="num">(36,700)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">55,194<span></span>
</td>
<td class="nump">81,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">10,328<span></span>
</td>
<td class="nump">10,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,002<span></span>
</td>
<td class="nump">5,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember', window );">Machines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">130,797<span></span>
</td>
<td class="nump">134,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 85,149<span></span>
</td>
<td class="nump">$ 85,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SAFO_MachinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133741911480">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 517,711<span></span>
</td>
<td class="nump">$ 380,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_EmployeesAndRelatedInstitutionsMember', window );">Employees and Related Institutions [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,220<span></span>
</td>
<td class="nump">135,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_AccruedExpensesMember', window );">Accrued Expenses [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">392,442<span></span>
</td>
<td class="nump">184,616<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember', window );">Right of Use Liability Arising from Operating Lease [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,049<span></span>
</td>
<td class="nump">52,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=SAFO_AffiliatedCompanyMember', window );">Affiliated Company [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,122<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On April 2, 2019, the Company invested 10,000 Canadian Dollars for 20% of the outstanding shares of Savecann Solutions Inc. ("Savescann") a newly formed company registered in Canada. Savecann intended to market the Company's solutions to the Cannabis market.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_EmployeesAndRelatedInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_EmployeesAndRelatedInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_RightOfUseLiabilityArisingFromOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=SAFO_AffiliatedCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=SAFO_AffiliatedCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133741899352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th"><div>Apr. 27, 2009</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership pecentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.94%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=SAFO_SavescannSolutionsIncMember', window );">Savescann Solutions Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership pecentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of investments</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInvestmentIncomeReceivable', window );">Amount receivable on sale of investments</a></td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=SAFO_SavescannSolutionsIncMember', window );">Savescann Solutions Inc [Member] | Canadian Dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInvestmentIncomeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInvestmentIncomeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=SAFO_SavescannSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=SAFO_SavescannSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SAFO_CADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SAFO_CADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133733549384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Loans (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 24, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 21, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Compensation expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 492,619<span></span>
</td>
<td class="nump">$ 438,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,970<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yields [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember', window );">Convertible Loan Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 379,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DetachableWarrants', window );">Detachable warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,709<span></span>
</td>
<td class="nump">$ 4,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember', window );">Convertible Loan Agreements [Member] | Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember', window );">Convertible Loan Agreements [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember', window );">Convertible Loan Agreements [Member] | Dividend Yields [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember', window );">Convertible Loan Agreements [Member] | Expected Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueAssumptionExpectedTerm', window );">Measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoAdditionalConvertibleLoanAgreementsMember', window );">Two Additional Convertible Loan Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock in units | shares</a></td>
<td class="nump">69,332<span></span>
</td>
<td class="nump">19,662<span></span>
</td>
<td class="nump">19,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per unit | $ / shares</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized', window );">Warrant description</a></td>
<td class="text">Each Unit consists of: (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.4 (the "Warrant").<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock exercise price | $ / shares</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Compensation expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueAssumptionExpectedTerm', window );">Measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueAssumptionExpectedTerm', window );">Measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 16 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Lenders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock | shares</a></td>
<td class="nump">67,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="nump">67,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember', window );">2020 Convertible Loan Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage', window );">Mandatory conversion probability percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DebtInstrumentOptionalConversionProbabilityPercentage', window );">Optional conversion probability percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,762<span></span>
</td>
<td class="nump">$ 27,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember', window );">2020 Convertible Loan Agreements [Member] | Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember', window );">2020 Convertible Loan Agreements [Member] | Long Term Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember', window );">2020 Convertible Loan Agreements [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage', window );">Mandatory conversion probability percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_DebtInstrumentOptionalConversionProbabilityPercentage', window );">Optional conversion probability percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mandatory conversion probability percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_DebtInstrumentMandatoryConversionProbabilityPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_DebtInstrumentOptionalConversionProbabilityPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Optional conversion probability percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_DebtInstrumentOptionalConversionProbabilityPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_DetachableWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detachable warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_DetachableWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FairValueAssumptionExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measurment input, term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FairValueAssumptionExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of expense or revenue offset related to the warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_ConvertibleLoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoAdditionalConvertibleLoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_TwoAdditionalConvertibleLoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_LendersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_LendersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=SAFO_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=SAFO_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=SAFO_LongTermLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=SAFO_LongTermLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133740698536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 21, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yields [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yields [Member] | Valuation Technique, Binomial Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">0.11<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">0.10<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Life [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Fair value measurement of derivative instrument term</a></td>
<td class="text">50 months 1 day<span></span>
</td>
<td class="text">82 months 6 days<span></span>
</td>
<td class="text">93 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">48.06<span></span>
</td>
<td class="nump">51.96<span></span>
</td>
<td class="nump">51.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member] | Valuation Technique, Binomial Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement of derivative instrument percentage</a></td>
<td class="nump">48.06<span></span>
</td>
<td class="nump">51.96<span></span>
</td>
<td class="nump">51.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Share Price [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueOfWarrantPrice', window );">Fair value of derivative instrument price</a></td>
<td class="nump">$ 8.61<span></span>
</td>
<td class="nump">$ 5.88<span></span>
</td>
<td class="nump">$ 6.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Share Price [Member] | Valuation Technique, Binomial Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueOfWarrantPrice', window );">Fair value of derivative instrument price</a></td>
<td class="nump">8.61<span></span>
</td>
<td class="nump">5.88<span></span>
</td>
<td class="nump">6.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Exercise Price [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FairValueOfWarrantPrice', window );">Fair value of derivative instrument price</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputAppraisedValueMember', window );">Fair Value [Member] | Valuation Technique, Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of derivative instrument | $</a></td>
<td class="nump">$ 47,499<span></span>
</td>
<td class="nump">$ 6,457<span></span>
</td>
<td class="nump">$ 15,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputAppraisedValueMember', window );">Fair Value [Member] | Valuation Technique, Binomial Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of derivative instrument | $</a></td>
<td class="nump">$ 77,381<span></span>
</td>
<td class="nump">$ 15,167<span></span>
</td>
<td class="nump">$ 26,824<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FairValueOfWarrantPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrant price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FairValueOfWarrantPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBlackScholesOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBinomialOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=SAFO_ValuationTechniqueBinomialOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputAppraisedValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputAppraisedValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133747759528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Long-term loans, interest rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term loans</a></td>
<td class="nump">$ 16,064<span></span>
</td>
<td class="nump">$ 22,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current maturities</a></td>
<td class="num">(7,949)<span></span>
</td>
<td class="num">(7,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term from banking institution</a></td>
<td class="nump">$ 8,115<span></span>
</td>
<td class="nump">$ 14,955<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133747841368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">First year</a></td>
<td class="nump">$ 7,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Second year</a></td>
<td class="nump">8,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term loans</a></td>
<td class="nump">$ 16,064<span></span>
</td>
<td class="nump">$ 22,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133733851784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingent Liabilities (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 22, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 09, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 02, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Nov. 05, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Sep. 01, 2017</div></th>
<th class="th">
<div>May 31, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jan. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options issued to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ShortTermOperatingLeaseAgreementMember', window );">Short-term Operating Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_AgreementTermDescription', window );">Agreement term, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Short-term operating lease agreement ends at December 31, 2020 with an option to extend the agreement with additional year ended at December 31, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Annual rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,967<span></span>
</td>
<td class="nump">$ 10,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OfficeAndRelatedServiceFees', window );">Office and related service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_LeaseAgreementMember', window );">Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OfficeAndRelatedServiceFees', window );">Office and related service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_LessorOnetimePaymentAmount', window );">Lessor one-time payment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease term expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 13,  2020<span></span>
</td>
<td class="text">Aug. 13,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Lease rent amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SAFO_NISMember', window );">NIS [Member] | Short-term Operating Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OfficeAndRelatedServiceFees', window );">Office and related service fees | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SAFO_NISMember', window );">NIS [Member] | Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OfficeAndRelatedServiceFees', window );">Office and related service fees | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 11,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_LessorOnetimePaymentAmount', window );">Lessor one-time payment amount | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_RoyaltyDescription', window );">Royalty percentage, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Save Foods Ltd. is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. Save Foods Ltd. was entitled to the grants only upon incurring research and development expenditures. There were no future performance obligations related to the grants received from the IIA.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member] | NIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent liabilities | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 484,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_XedaInternationalSAMember', window );">Xeda International S.A [Member] | Save Foods Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_XedaInternationalSAMember', window );">Xeda International S.A [Member] | NIS [Member] | Save Foods Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_EarthboundTechnologiesLLCMember', window );">Earthbound Technologies, LLC [Member] | Commission Agreement [Member] | Introduced Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_PercentageOfNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate amount of revenues</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_MaximumCompensationPercentageOfGrossProfit', window );">Maximum compensation percentage of gross profit</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_EarthboundTechnologiesLLCMember', window );">Earthbound Technologies, LLC [Member] | Commission Agreement [Member] | Introduced Parties [Member] | Exceeds in Net Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate amount of revenues</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options issued to purchase shares of common stock | shares</a></td>
<td class="nump">7,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Common stock shares purchased | shares</a></td>
<td class="nump">7,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share | $ / shares</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_EarthboundTechnologiesLLCMember', window );">Earthbound Technologies, LLC [Member] | Commission Agreement [Member] | Introduced Parties [Member] | Occurance of Additional Events in Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options issued to purchase shares of common stock | shares</a></td>
<td class="nump">7,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Common stock shares purchased | shares</a></td>
<td class="nump">7,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share | $ / shares</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SAFO_SafePackProductsLimitedMember', window );">Safe-Pack Products Ltd [Member] | Distribution Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_PercentageOfPurchaseQuota', window );">Percentage of purchase quota</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_AgreementTermDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement term, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_AgreementTermDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_LessorOnetimePaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor one-time payment amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_LessorOnetimePaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_MaximumCompensationPercentageOfGrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum compensation percentage of gross profit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_MaximumCompensationPercentageOfGrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_OfficeAndRelatedServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Office and related service fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_OfficeAndRelatedServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_PercentageOfNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of net revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_PercentageOfNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_PercentageOfPurchaseQuota">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of purchase quota.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_PercentageOfPurchaseQuota</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_RoyaltyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty percentage, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_RoyaltyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_ShortTermOperatingLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_ShortTermOperatingLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_LeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_LeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SAFO_NISMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SAFO_NISMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_IsraeliInnovationAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_XedaInternationalSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_XedaInternationalSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=SAFO_SaveFoodsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=SAFO_SaveFoodsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_EarthboundTechnologiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_EarthboundTechnologiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_CommissionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_CommissionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_IntroducedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_IntroducedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SAFO_ExceedsInNetRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SAFO_ExceedsInNetRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SAFO_OccuranceOfAdditionalEventsInAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SAFO_OccuranceOfAdditionalEventsInAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_SafePackProductsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_SafePackProductsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_DistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_DistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133732322520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 23, 2020</div></th>
<th class="th"><div>Jul. 02, 2020</div></th>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>May 09, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 24, 2020</div></th>
<th class="th"><div>Sep. 22, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="nump">$ 840,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,876<span></span>
</td>
<td class="nump">140,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible loans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,662<span></span>
</td>
<td class="nump">19,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible loans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Medigus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="nump">3,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, value</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="nump">13,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock price</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Medigus [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Additional investment amount</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsMember', window );">Accredited Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,747<span></span>
</td>
<td class="nump">15,874<span></span>
</td>
<td class="nump">35,717<span></span>
</td>
<td class="nump">19,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsMember', window );">Accredited Investors [Member] | Subscription Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsOneMember', window );">Accredited Investors One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,004<span></span>
</td>
<td class="nump">7,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,034<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsTwoMember', window );">Accredited Investors Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_WarrantsDescription', window );">Warrants description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Unit consists of (i) one share of Common Stock and (ii) one warrant to purchase one share of Common Stock with an exercise price of $8.40 for a period of 36 months following the issuance date. The shares of Common Stock were issued on July 2, 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,572<span></span>
</td>
<td class="nump">28,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_TwoDirectorsMember', window );">Two Directors [Member] | 2018 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_TwoDirectorsMember', window );">Two Directors [Member] | 2018 Equity Incentive Plan [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_WarrantsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_WarrantsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_MedigusLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_MedigusLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_SubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_SubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_AccreditedInvestorsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_TwoDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_TwoDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133733047048">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stock Options (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 22, 2020</div></th>
<th class="th"><div>Jul. 02, 2020</div></th>
<th class="th"><div>Jan. 23, 2020</div></th>
<th class="th"><div>Nov. 12, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Jan. 03, 2019</div></th>
<th class="th"><div>Oct. 18, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,574<span></span>
</td>
<td class="nump">109,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable shares of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,862<span></span>
</td>
<td class="nump">164,289<span></span>
</td>
<td class="nump">59,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,084,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_EstimatedFairValueOfNonCashCompensationGranted', window );">Estimated fair value of non cash compensation granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,976<span></span>
</td>
<td class="nump">$ 440,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 492,619<span></span>
</td>
<td class="nump">438,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested to purchase of share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_EmployeesAndDirectorsMember', window );">Employees and Directors [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 492,619<span></span>
</td>
<td class="nump">$ 438,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Employees and Directors [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Equity financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,431<span></span>
</td>
<td class="nump">21,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable shares of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share based compensation description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The options shall vest quarterly over two years commencing June 1, 2020, whereby 12.50% of the shares covered by the options will vest on the three month anniversary of June 1, 2020, and 12.50% of the shares covered by the options at the end of each subsequent three month period thereafter over the course of the subsequent twenty-one months.<span></span>
</td>
<td class="text">The options shall vest quarterly over two years commencing June 23, 2020, whereby 12.50% of the shares covered by the options will vest on the three month anniversary of June 23, 2020, and 12.50% of the shares covered by the options at the end of each subsequent three month period thereafter over the course of the subsequent twenty-one months.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company granted of 80,954 options under the 2018 Equity Incentive Plan of which 9,524 options are vested quarterly over three years commencing May 15, 2018, 35,715 options are vested 1/3 after a year commencing October 1, 2018 and the remaining 2/3 are vested quarterly over additional two years, 14,286 options are vested quarterly over three years commencing October 1, 2018 and 21,429 options are vested 1/3 after a year commencing January 1, 2019 and the remaining 2/3 are vested quarterly over additional two years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Estimated fair value of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in number of shares approved</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under equity incentive plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan [Member] | Mr. Dan Sztubel [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share based compensation description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The options shall vest quarterly over three years, commencing April 1, 2019, and shall be exercisable for an exercise price of $3.15 per share. In addition, the Board of Directors of the Company approved the issuance of 14,286 options to purchase 14,286 Company's Common Stock 0.0001 par value, to Mr. Dan Sztybel, subject to Save Foods Ltd's obtainment of certain EPA and FDA approvals by the end of the second quarter of 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OptionToPurchaseOfCommonStock', window );">Option to purchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionExercisePriceIncrease', window );">Option exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan [Member] | Board of Directors [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share based compensation description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Under the 2018 Equity Incentive Plan of which 28,572 options are vested quarterly over three years commencing January 3, 2019, 9,524 options are vested 1/3 after a year commencing January 3, 2019 and the remaining 2/3 are vested quarterly over additional two years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_OptionToPurchaseOfCommonStock', window );">Option to purchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Options that were granted on January 3, 2019 with vesting that commences before December 31, 2018.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_EstimatedFairValueOfNonCashCompensationGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated fair value of non cash compensation granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_EstimatedFairValueOfNonCashCompensationGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_OptionToPurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Option to purchase of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_OptionToPurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SAFO_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_MrDanSztubelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_MrDanSztubelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133732978120">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stock Options - Schedule of Stock Option Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Beginning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">164,289<span></span>
</td>
<td class="nump">59,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">92,574<span></span>
</td>
<td class="nump">109,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,350)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(29,365)<span></span>
</td>
<td class="num">(4,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Ending</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">206,862<span></span>
</td>
<td class="nump">164,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">97,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="nump">$ 3.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.64<span></span>
</td>
<td class="nump">3.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.15<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.15<span></span>
</td>
<td class="nump">3.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.15<span></span>
</td>
<td class="nump">$ 3.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Options that were granted on January 3, 2019 with vesting that commences before December 31, 2018.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133740683400">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">52.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue', window );">Fair value (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.56%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue', window );">Fair value (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue', window );">Fair value (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The risk-free interest rate represented the risk-free rate of US$ zero-coupon US Government Loans.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with SEC Staff Accounting Bulletin No. 110.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value (US dollars).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738865288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of Sales (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 43,405<span></span>
</td>
<td class="nump">$ 144,548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_SalariesAndRelatedExpensesMember', window );">Salaries and Related Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">8,074<span></span>
</td>
<td class="nump">35,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember', window );">Share Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">5,402<span></span>
</td>
<td class="nump">14,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_MaterialsMember', window );">Materials [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">16,692<span></span>
</td>
<td class="nump">69,390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_VehicleMaintenanceMember', window );">Vehicle Maintenance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">8,455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_TravelExpensesMember', window );">Travel Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_TransportationAndStorageMember', window );">Transportation and Storage [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">5,632<span></span>
</td>
<td class="nump">13,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_OtherExpensesMember', window );">Other Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 4,564<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_SalariesAndRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_SalariesAndRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_MaterialsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_MaterialsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_VehicleMaintenanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_VehicleMaintenanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_TravelExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_TravelExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_TransportationAndStorageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_TransportationAndStorageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_OtherExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_OtherExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738842680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 417,000<span></span>
</td>
<td class="nump">$ 615,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_SalariesAndRelatedExpensesMember', window );">Salaries and Related Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">39,021<span></span>
</td>
<td class="nump">177,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember', window );">Share Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">91,190<span></span>
</td>
<td class="nump">75,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_ProfessionalFeesMember', window );">Professional Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">130,592<span></span>
</td>
<td class="nump">178,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_DepreciationMember', window );">Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">20,544<span></span>
</td>
<td class="nump">29,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_TravelExpensesMember', window );">Travel Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">7,190<span></span>
</td>
<td class="nump">26,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_VehicleMaintenanceMember', window );">Vehicle Maintenance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">13,657<span></span>
</td>
<td class="nump">26,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_RentAndAssetManagementMember', window );">Rent and asset management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_LaboratoryAndFieldTestsMember', window );">Laboratory and Field tests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">72,593<span></span>
</td>
<td class="nump">73,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_OtherExpensesMember', window );">Other Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 33,438<span></span>
</td>
<td class="nump">$ 25,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_SalariesAndRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_SalariesAndRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_ProfessionalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_ProfessionalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_DepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_DepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_TravelExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_TravelExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_VehicleMaintenanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_VehicleMaintenanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_RentAndAssetManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_RentAndAssetManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_LaboratoryAndFieldTestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_LaboratoryAndFieldTestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_OtherExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_OtherExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133732259416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 1,070,109<span></span>
</td>
<td class="nump">$ 1,004,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_ProfessionalServicesMember', window );">Professional Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">443,883<span></span>
</td>
<td class="nump">461,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember', window );">Share Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">416,996<span></span>
</td>
<td class="nump">283,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_LegalExpensesMember', window );">Legal Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">67,492<span></span>
</td>
<td class="nump">125,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_InsuranceMember', window );">Insurance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">63,380<span></span>
</td>
<td class="nump">54,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_RentAndOfficeMaintenanceMember', window );">Rent and Office Maintenance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">11,135<span></span>
</td>
<td class="nump">38,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_LeviesAndTollsMember', window );">Levies and Tolls [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">28,477<span></span>
</td>
<td class="nump">8,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_CommunicationsMember', window );">Communications [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_DepreciationMember', window );">Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">13,914<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_TravelExpensesMember', window );">Travel Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">5,305<span></span>
</td>
<td class="nump">15,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SAFO_OtherExpensesMember', window );">Other Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 17,848<span></span>
</td>
<td class="nump">$ 12,995<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_ProfessionalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_ProfessionalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_ShareBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_LegalExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_LegalExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_InsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_InsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_RentAndOfficeMaintenanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_RentAndOfficeMaintenanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_LeviesAndTollsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_LeviesAndTollsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_CommunicationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_CommunicationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_DepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_DepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_TravelExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_TravelExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SAFO_OtherExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SAFO_OtherExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133743264552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Expenses, Net - Schedule of Financing Expenses Net (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FinancingExpensesNetAbstract', window );"><strong>Financing Expenses Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest and amortization expenses</a></td>
<td class="nump">$ 202,917<span></span>
</td>
<td class="nump">$ 4,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_CurrencyExchangeDifferences', window );">Currency exchange differences</a></td>
<td class="nump">34,037<span></span>
</td>
<td class="nump">28,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ChangesInFairValueOfConvertibleLoans', window );">Changes in fair value of convertible loans</a></td>
<td class="nump">27,208<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_BankChargesAndOtherFinanceExpensesNet', window );">Bank charges and other finance expenses, net</a></td>
<td class="nump">6,231<span></span>
</td>
<td class="nump">10,819<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_FinancingExpensesNet', window );">Financing expenses, net</a></td>
<td class="nump">$ 270,393<span></span>
</td>
<td class="nump">$ 43,408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_BankChargesAndOtherFinanceExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank charges and other finance expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_BankChargesAndOtherFinanceExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ChangesInFairValueOfConvertibleLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in fair value of convertible loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ChangesInFairValueOfConvertibleLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_CurrencyExchangeDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Currency exchange differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_CurrencyExchangeDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FinancingExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FinancingExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_FinancingExpensesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_FinancingExpensesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133739658264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax description</a></td>
<td class="text">US resident companies are taxed on their worldwide income for corporate income tax purposes at a statutory rate of 21% this reflect certain effects of the Act which includes a reduction in the corporate tax rate from 35% to 21% as well as other changes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry forward losses</a></td>
<td class="nump">$ 1,264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry forward losses</a></td>
<td class="nump">$ 9,412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738791624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Schedule of Income Tax Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Pretax loss</a></td>
<td class="nump">$ 1,593,139<span></span>
</td>
<td class="nump">$ 1,971,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_IncomeTaxComputedAtOrdinaryTaxRate', window );">Income tax computed at the ordinary tax rate</a></td>
<td class="nump">$ 334,559<span></span>
</td>
<td class="nump">$ 413,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="num">(63,565)<span></span>
</td>
<td class="num">(2,278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Stock-based compensation</a></td>
<td class="num">(109,772)<span></span>
</td>
<td class="num">(93,970)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDeductions', window );">Tax in respect of differences in corporate tax rates</a></td>
<td class="nump">13,480<span></span>
</td>
<td class="nump">26,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated', window );">Losses and timing differences in respect of which no deferred taxes were generated</a></td>
<td class="num">(174,702)<span></span>
</td>
<td class="num">(344,438)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total Income tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_IncomeTaxComputedAtOrdinaryTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax computed at the ordinary tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_IncomeTaxComputedAtOrdinaryTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Losses and timing differences in respect of which no deferred taxes were generated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_LossesAndTimingDifferencesInRespectOfWhichNoDeferredTaxesWereGenerated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133747010280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_ProvisionForEmployeeRelatedObligation', window );">Provision for employee related obligation</a></td>
<td class="nump">$ 31,627<span></span>
</td>
<td class="nump">$ 29,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards', window );">Non capital loss carry forwards</a></td>
<td class="nump">2,350,367<span></span>
</td>
<td class="nump">2,171,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(2,381,994)<span></span>
</td>
<td class="num">(2,201,174)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_ProvisionForEmployeeRelatedObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for employee related obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_ProvisionForEmployeeRelatedObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133746987704">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares of Common Stock outstanding attributable to shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,519,122<span></span>
</td>
<td class="nump">1,424,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total weighted average number of shares of Common Stock related to outstanding options, excluded from the calculations of diluted loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">206,862<span></span>
</td>
<td class="nump">164,289<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The effect of the inclusion of option and convertible loans in 2020 and 2019 is anti-dilutive.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133827860760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Parties (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
<th class="th"><div>Oct. 10, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_ConsultingAgreementsMember', window );">Consulting Agreements [Member] | Amir Uziel Economic Consultants Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_MonthlyConsultancyFee', window );">Monthly consultancy fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_CoChiefExecutiveOfficerMember', window );">Mr. David Palach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_MonthlyRetainer', window );">Monthly retainer</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SAFO_ItzhakShremMember', window );">Itzhak Shrem [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SAFO_MonthlyDirectorsFee', window );">Monthly directors fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_MonthlyConsultancyFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly consultancy fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_MonthlyConsultancyFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_MonthlyDirectorsFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly directors fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_MonthlyDirectorsFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SAFO_MonthlyRetainer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly retainer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SAFO_MonthlyRetainer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SAFO_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_ConsultingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_ConsultingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SAFO_AmirUzielEconomicConsultantsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SAFO_AmirUzielEconomicConsultantsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_CoChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_CoChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_ItzhakShremMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_ItzhakShremMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133740663592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties - Schedule of Transactions and Balances with Related Parties (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">$ 1,070,109<span></span>
</td>
<td class="nump">$ 1,004,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">492,619<span></span>
</td>
<td class="nump">438,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">417,000<span></span>
</td>
<td class="nump">615,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent', window );">Other accounts payables</a></td>
<td class="nump">424,515<span></span>
</td>
<td class="nump">199,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">769,520<span></span>
</td>
<td class="nump">653,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">394,756<span></span>
</td>
<td class="nump">272,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member] | Directors' Compensation[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">380,756<span></span>
</td>
<td class="nump">295,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member] | Salaries and Fees to Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">336,433<span></span>
</td>
<td class="nump">358,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member] | Consultants and Other Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">52,331<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Salaries and Fees to Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 25,301<span></span>
</td>
<td class="nump">$ 116,692<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred and payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_DirectorsCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_DirectorsCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_SalariesAndFeesToOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_SalariesAndFeesToOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SAFO_ConsultantsAndOtherFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SAFO_ConsultantsAndOtherFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140133738814888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative)<br></strong></div></th>
<th class="th"><div>Feb. 23, 2021</div></th>
<th class="th"><div>Apr. 23, 2019</div></th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 21, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 to 1 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember', window );">2020 Convertible Loan Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split, ratio</a></td>
<td class="nump">0.143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, description</a></td>
<td class="text">7 to 1 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | 2020 Convertible Loan Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SAFO_TwoThousandTwentyConvertibleLoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>137
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&O4&^(]3S;/15(RLW%6]E@8O?E<L\*D%90=@_T9*<ZC8";K'>_H74$L#!!0
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M??K93II!&R"%"V(GY__/=YR3...=D(\J!]#HJ6!<3;Q<Z_+:]U6:0T%43Y3
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MPB@,LWCB[\ZC="F&LR0/HT[L#=ZDPYN,XIT+I0W %NG55Z$IPMB9-ZVA] S
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MX@F:5_ /YJ@J4;% 8U:NT!W,<XG.T??Y+3K[SZ?+806#RJ;#>#? 33T Z1D
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M#ZQ*3M_<N 4CIN_DV+=MD>9[VX+%<;&MZ1#S])G!/!G=H_J.#FE$PZY_NEV
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M:)Z(>HKO5/*#WQ(TE@#(]F*7Q$!J2<A\@J0F")L4(A(K3A=)$."43MZD4FA
M'0+\ON(Q..8)C3 2Y. ??4LXV*8CA>MV1H9B(YV#C)H(5B+!DN;M ,LJJF#.
M3DQ*WI4@%,7>)MJ4A'!%S*NNH]"BL;EG7TBM=L]/2;J.)SZ4_3:>D>W\D"6(
M#KI"LB'YE:I'DV(#I6C+YO+.4PQ]BI3IB"HB@<*VZ]KX'"N=.7I7CAKO)(JQ
M*K$BTE>3'?"?CA40E?Z7:*3?>C+B!5*J>I"UT67FT3V-(4B80*0@8G'C 9T
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M\:,#P)M?LL4O:,G\8BNW(=B&/Z[0FY6C&_![96WHO] &PYO.T_\!4$L#!!0
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M;QDR]17K*:36AY)$=NE)C4S8ETU*^1[IEGD-VPSCWA*9NQ(6$?N 0=K!S$Q
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MY<Y74"!<+G!N1YQ;D90[T:U>OO; (3H.9$/W P,K8W0]=EX5P@+%5.C-58%
M- K_/9HRRKW1V1#/+6V 3RH1)\W.5D59^B@97]7+LEB+Y_ "8R*!&6Z;7)S
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M."X)L (  &4%   8    >&PO=V]R:W-H965T<R]S:&5E=#DN>&ULI51-;]I
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M./=!]7K:&T:V3L,VTI BNFE%GR!4UH'VMU*:HV$3#!^UQ;]02P,$%     @
MVW1P4AW3:D6A P  40<  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
MK55-;^,V$+WK5PS4;9$L5.O#<FQO; ..XV(-9-=!G+2'H@=:HBPB%*F2=!S_
M^PXI1?$"&Y]ZL47-S.-[3YSAY"#5LRXI-?!:<:&G?FE,_24,=5;2BNB>K*G
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M].SVS35=#9\] 2>LU\! JI15'+8#,5ZD+ %2$.A,?)&ZEL6*Z3578EUFJ5!
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ML$M#L"%<I&P)..L)9L#7. FRJ;4OL43T3T6%9NN<M$$C9EOT+H1JPVG /GE
MVDH)GD#J$5^ B!:43< 4%12'CIPO",1/!78%7C;K]*2T]R'3"*T]T#U.R=-&
M"8]-\/%D)\2-]-[),\D7,I/UEC2_%@7XK/ILTAA=U<;/ ,70:4$5X!FR3%T&
M1T-IJ%#QR0I2MT8?!S!"%>AUN6D/ H%:VY0"IX"B7U$X87K0B/%$Q1V0+TIT
M#NO;>B=Y!:W.+64CD&9H/)?R7'%'QF[K&G,7:QL.YZL["*<4/PZG\REM>#2?
MA>-H&CH+@J=FV] S:6#E3$4-RN%H!Y>C0W1.B"SP>$F(JC'<; EC0Q'1'U5^
M[J5=A[H)KR1(]L18RK>I8?F'Y1-L"($0& F$&NURP4W&D\\7=PGP!"-@7..3
MO$Q%AL)!>X2_0>52?X8P$:)-L,/!]#'JYK[,P#CD%>! =4G0.1D/H@@>IQ+K
MIR(-ME)D*5DS>DQJH\($U4.(N222(X;0!59^#Y5)4P@6C\.O%22<W8FD49+*
MP@\-V!/:HJZPW*F8[C[TBLH.?E&=95'8!JU]K#G8RX"-!4\0=#H/1Z,88AZA
MX=Q2_PU_=34F86;E!.H0<S:8C@@Q<?V O<: P4M7%Z&23 $!D6I@U=3./AZ[
M9(U+K#-1O>K8'=]ZNBK<49?U'G<D*A@/J0C4NFN@P\7M3F&(2IR%H^G<2T.]
M(SKWW3G:-Y$Q@7&$Q0:\R,E:HL=!<14;AQL$=S('C.&%*)NVE$[Q^"8(,8@J
M5S)\ 0_T<W1/(;B5D-$NZ'<:8KETV('I*1&9JU[:.L'B@.[<W>D92PK*/_LF
MHB<H?'B0/80N !I7$IAN.#!/J:I0.#Q H0 \A4F\MARLU[RK"0U;5(+?3EFI
M!X&?^02B$F5:JJ? J)K;08@VSFA;)!#0R_(&*(XA?I>80J\ H!P'6=767UZ&
M/0#CDUDXFX\(A2WI5A(HX$38"? _@VAOBW73%?I\E[&\_$LU$L^2)B-=X@"H
M+<WWZS<3_2:XN^.E-FAV"3] MK:K/"W=#^>8BYT<$PWBX8DD,QS,IUZ280]*
M,O%@#(7H8#9TR>85A).5E.[8VF"O$+#E07_:T;I>(6JO<4+N.59!_^E[(NG6
MZXSG\W 6S4TU,0Y'\>AX,=$:4NH$">B.OW.$-]=PJ)L!@R1Z)ZK:3FF&#\BD
MW:3&LWR_)#XZM"$M]28W;DZ3N2&'EV)HQ]YXAH),9-GI28C+8UTNZ/7:I-N8
MI@X')<56JDMNGT[TB 2NI#EW1. /$IK>\;M:QY;0#_>/O@X?V$2VQ]?[K6"O
M[>MUF1QX%" >FL*+_N.2GN@>VUK(=(]D T\VTO$#9SQF\U<&/'W:>T.>'5W^
MY9.>X^PA/&C2\R,CE--#'N=OWS'I<;+^[V<]8-W^L,?B\WN ?3-O_AX4<\=W
MP+'WQ)G<0<_^\W??A#E1A)C32NZ&K$!I^/\M>3P;&\F!&X[:=_"BG:0=D1X(
M2_Q+!@$-U9"ZRQ5& K\(]:4/V0;! L*D\U7SR-6@*:OD:K5=0"5QD!%.GNNN
MU*=F#?,&U:<>]O0!\"C\=8@"YU"[@Q0Z<D*+ X.5Q.B<<!PKT$PXO*7<L8&*
MO198*2\RF<#MI2#7<+WCVQ92;UM9VWSH\/S$%#,@7-RK^>"G"5RO*K/5AQ,@
M[-*/H6^2=%M%8IFAS%&<J.\K-_OO21H\0%+6D[3%_S8E4!MS>HP8_/PQ8O"3
MQXC!SQ\C!C][C!A\WQCQ2+_CG3'HM(4N!1E2YKQ-Y>Y/D=#95Y7B4F,5 BA+
M?W9'_P$R?-72Q819@7RD/)V( EKNLNW)3%?JATBGJZ>!Z=WZA3RY5)L31ZZZ
MGT'G [7RPFG8X>(A@"$2HR,;7)@'>^N-/+WF"#A/OI%S?&3# 8 Q!CM(Z=SI
M,Q@^.60JX9GH6$M:$L?]SM0@?-74PKKUOKMXF *2!9WW?GVY]? %SRB"S2LO
MV)Q;UVQ+.81%V[ASJW_HETE>#><1SB!N.AD@$>U9"C?WV3P-^AX5['M3W\K!
MJYU6FT7X+_C8]NUM-4D5>C08SMEC_!K2%[2XCX/7KA_'E,3.J>-^ @]GLPE\
M3J_P<SR<!;]W'3_U^4#!?8^O!A%\!W=>$ID.9C&;#*ZNV-5@.@0N.]--ZC/:
MC^"7SC;#21A'5VP:CB<S-IZ%X_F<+'# "3U7BQ_H:@M90-L*5 YY&!E)XYB1
M$\CA3YK"*6<WDXS;&9E_I##X1O=TX,K^&C<-OL]-J>5P@_1]5WV8F_9 [R]P
MT_@"/J;&5_$Z-I<1WAZ#I_V8,WKN%D_#JWB,7C><SMAL%HZNAC^:C.R4X:*7
MD)9P2K8"58"!S'S9-;+?EJB"78BQ=D-)H&$(9]/X5&(PZR;C<#Z+>GD7ZM,R
M,7-A$BSHE20/3[ZV+I I-J4[FH0DDPB1:IK0G2QG3 CZ'*E:;:D]BJ-1.)S-
MCQX6;IKWB1Y-IF$\B;#"Z<8 9HR4-$JA*5T9Y-YG>C0<3\-Y/ \.[,E*3%R(
MF-ZNP:$7QBZ]U^]RH5;TDB$6GE!8F#?QVKOM>XS7YO6];KEY"?(M5RNLKC*Q
MA*T T9,STVZY'W59T<M\B[*NRYPNUX*#O+@ GB]+*&'M#V30OMWY\K]02P,$
M%     @ VW1P4G<R[=BU @  B@4  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&ULM53;CMHP$'W/5XPB5>I*++D0=@$!$NRMJ%Q6"]L^5'TPR0#6QG9J
M.\ONW]=V(*52E[>^Q./QG#-G)A[W]T*^J!VBAC>6<S7P=UH7O2!0Z0X944U1
M(#<G&R$9T68KMX$J))+,@5@>Q&%X%3!"N3_L.]^C'/9%J7/*\5&"*ADC\GV,
MN=@/_,@_.I[H=J>M(QCV"[+%)>KGXE&:75"S9)0A5U1PD+@9^*.H-TYLO OX
M1G&O3FRPE:R%>+&;23;P0RL(<TRU92!F><4;S'-+9&3\.G#Z=4H+/+6/[/>N
M=E/+FBB\$?EWFNG=P._XD.&&E+E^$OLO>*BG;?E2D2OWA7T5F\0^I*72@AW
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M%MK,KC-WYK%$:0/,^48(?=S8!/7S._P-4$L#!!0    ( -MT<%+5W_A+#@L
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M99IP@F\7 X[)U0N/IIF P*?9 C@9B?]Y([GCMRQDH=B%= Z@0G*2K ".I]&
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MO-3/_ /U;KE_YL=U?(&09IF88VMT.AF=^'>T^L.JE7NN?E#6JMS]7 H.I+0
M\W.%^E]]T '-_U]<_0=02P,$%     @ VW1P4HF'IJ"$"P  T"   !D   !X
M;"]W;W)K<VAE971S+W-H965T,38N>&ULO5I;<]NX%7[GK\"X3L?NT#))W7.;
M<6QGN]M-[%EGNP^=/D D)*$A"04@K7A_?;\#@!0E2UXGL^U#$HH #L[U.Q_
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MS!6]6PGJ1%?QM:F *L9V%<K3;E,YP?E7INC7M<;N])73JM&L.NT%-H:46/I
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M)G&5L!]E:12=5H0ST[G4!N0:EKQ&/0X-4=J#,-_#9QV<?0"/&=Q*84H-UZ+
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M1<)A<12,<DY 69"-$F^!5%39#,$\#V*6$YU@E"3>O1*DWPN%U"'S<<#BS'O
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ME<;CV30 W8WJ;F%5X\?C3ED:MOZUHML-M4N@>*F4?5FX#8;[<OT_4$L#!!0
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MLC!'Z%M$T)P)0Y(B+$I*BC),RWCR!"VO4:CSO 7)9 V$AG&18I$LSR>/FKV
M>"M=3F<D1>"9.Y&F5]H.U1Q1O.$:W8^5BQ0KIR$MR\F=;5'="(!T"N1.TTGF
M<'(DB%O9C'STVZ(3,W2@M][R!F7NI!U\,>Z.K\K58*:W\.%)NF5ZRZ4A C:8
M&E],\X#HP>;#PJK>6VNM+!K53UM\&4&[ #S?*&6/"U=@?&NK_U!+ P04
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MII6RY$T_;.@Q1.T M%\K90\3EV!X7HL_4$L#!!0    ( -MT<%($H<Q28 0
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M,=#O-YRKUX%9H/GLF/X+4$L#!!0    ( -MT<%*".YK>P0(  -()   9
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MO<" <AOL^EI*\S1Q9VI[)<K^ E!+ P04    " #;='!2!V_(FI$"  !#!@
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M7;GU52F!I Y4,#_ >.07A')O%KNQE9S%8J<9Y;"22.V*@LA?5\!$-?7ZWM/
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MI.0UBM\D;T&1*US++UI/AT@>"PMELE)KKTD'9M=5PA?"?V>E2K/?Q#KTP)/
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M970V,"YX;6RU5UV/HS84_2L6ZL.NU [8?(51$FF3[*B5=M11IKM]J/K@P$U
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MR:CL OJ>2FFV QN@O>6G?P%02P,$%     @ VW1P4@LT4UR& P  @ H  !D
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MSL#AJ9Y M6'U*CSBN;9N)(1EY88VDG=PYPNM[<[P<Z']&\C_ E!+ P04
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MPNVJY:_F>/ZH3%A_,89_ 5!+ P04    " #;='!2EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( -MT<%)N%.G2- 4
M )PM   /    >&PO=V]R:V)O;VLN>&ULQ9I=3^,X%$#_BM679:5EV^:+&421
M6#K,(B&H*)K7E4G<UB*Q.[;+P/SZL1,Z7--PM2^7/I4XP3FYCGVN[9S\T.;A
M7NL']M34RDX&*^?6Q\.A+5>BX?9OO1;*GUEHTW#G#\UR:-=&\,JNA'!-/4Q&
MHV+8<*D&IR?;NF9F" ^T$Z636OG"4/!-BA_V]7PX9(_2RGM92_<\&;1_UV+
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M*+(:%%D-BJP&15:#(JM!D=6@R&I09#7_*>N]<^L_CA^?96>;_BV?C?\17+P
M4$L! A0#%     @ VW1P4@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #;='!2F 326^X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" #;='!2F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( -MT<%+O%4'SG0(  ,@'   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" #;='!2N%&'B],&   _&@  &               @('@"@  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ VW1P4N9I7K6_ @  30D  !@
M             ("!Z1$  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( -MT<%(N]B9DBP0  %D/   8              " @=X4  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #;='!2CQ7B<W@&   -
M(   &               @(&?&0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ VW1P4F%G99Z-"   920  !@              ("!32
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( -MT<%*+7A&>
M< L  /4<   8              " @1 I  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " #;='!2I4MEHW8=  #=5   &
M@(&V-   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ VW1P
M4F@X+@FP @  904  !@              ("!8E(  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( -MT<%+J$W,D/ ,  . &   9
M      " @4A5  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ VW1P4AW3:D6A P  40<  !D              ("!NU@  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #;='!2/%MT4WT,  #I*0
M&0              @(&37   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( -MT<%)W,NW8M0(  (H%   9              " @4=I  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ VW1P4M7?^$L.
M"P  /1T  !D              ("!,VP  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " #;='!23YCD^H0(  #+&   &0
M@(%X=P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( -MT
M<%*)AZ:@A L  - @   9              " @3.   !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ VW1P4KJ6TK^E @  < 4  !D
M         ("![HL  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " #;='!2&"**ZPD#   8!@  &0              @('*C@  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( -MT<%)TZJUU!@,  "4&
M   9              " @0J2  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ VW1P4N1..K^I @  ?@4  !D              ("!1Y4
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #;='!21</
M*=T%   O#   &0              @($GF   >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( -MT<%)&=;;7/0,  $,'   9
M  " @3N>  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
MVW1P4GF@IL:[!   'PH  !D              ("!KZ$  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " #;='!2"QLZ0<@#  !:"   &0
M            @(&AI@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( -MT<%+YQH+W\QX  *E>   9              " @:"J  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ VW1P4KFU&^*O P
M!@D  !D              ("!RLD  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " #;='!2RJ:SQ)P"  !6!0  &0              @(&P
MS0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( -MT<%((
MK_> SP(  ,P%   9              " @8/0  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ VW1P4F5<?]"/ P  .P<  !D
M     ("!B=,  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M" #;='!2!64R]@D$  #:"@  &0              @(%/UP  >&PO=V]R:W-H
M965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( -MT<%(]#;PVM0(  !(&   9
M              " @8_;  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L!
M A0#%     @ VW1P4CGP^KHZ!0  O L  !D              ("!>]X  'AL
M+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #;='!2]OSP5J("
M  !W!0  &0              @('LXP  >&PO=V]R:W-H965T<R]S:&5E=#,S
M+GAM;%!+ 0(4 Q0    ( -MT<%*UN6,5[ (  /L%   9              "
M@<7F  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ VW1P
M4@8!/NGR @  %@8  !D              ("!Z.D  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " #;='!2V)JMSY0"  !J!0  &0
M        @($1[0  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( -MT<%($H<Q28 0  &<)   9              " @=SO  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ VW1P4D<1NK38 @  $08
M !D              ("!<_0  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " #;='!2/70JH08#  !K!@  &0              @(&"]P
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( -MT<%*+Q@1(
MR@(  )$(   9              " @;_Z  !X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ VW1P4F$-4S:= P  @@P  !D
M ("!P/T  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #;
M='!2@CN:WL$"  #2"0  &0              @(&4 0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( -MT<%+IS((IH@(  !X)   9
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M970T-RYX;6Q02P$"% ,4    " #;='!2Q?@]H:P#   ("P  &0
M    @($T$P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M -MT<%+1H!'%Q@(  )D(   9              " @1<7 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ VW1P4MHGE7W@!P  KRD  !D
M             ("!%!H! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " #;='!2'!!6RYH$  "'&   &0              @($K(@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( -MT<%+D6%OJMP(
M  P'   9              " @?PF 0!X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ VW1P4F6,<_=/ @  =@4  !D              ("!
MZBD! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " #;='!2
M(>Z"IZT(  "#)@  &0              @(%P+ $ >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( -MT<%+.K-4'# @  (@L   9
M      " @50U 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ VW1P4H=^AB!D"   &B4  !D              ("!EST! 'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " #;='!2([L)!2$$  "E#P
M&0              @($R1@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( -MT<%+7P=47"04  %P2   9              " @8I* 0!X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ VW1P4A(Q"O(_
M P  ?@L  !D              ("!RD\! 'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " #;='!2^JQ F<(#  "3#@  &0
M@(% 4P$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( -MT
M<%+ZCVGWP ,  'P/   9              " @3E7 0!X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ VW1P4N)-.N;S @  % @  !D
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M=#8V+GAM;%!+ 0(4 Q0    ( -MT<%)47 +T8P(  !(&   9
M  " @85K 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
MVW1P4D;O1>;= P  !0X  !D              ("!'VX! 'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " #;='!2<@CV;-("   ["0  &0
M            @($S<@$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( -MT<%)8@,<[>P(  #X.   -              "  3QU 0!X;"]S
M='EL97,N>&UL4$L! A0#%     @ VW1P4I>*NQS     $P(   L
M     ( !XG<! %]R96QS+RYR96QS4$L! A0#%     @ VW1P4FX4Z=(T!0
MG"T   \              ( !RW@! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( -MT<%*7=W+D+ (  /8H   :              "  2Q^ 0!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -MT<%+62",N]P$  "LH
M   3              "  9"  0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !- $T $A4  +B" 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>266</ContextCount>
  <ElementCount>373</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>95</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherCurrentAssets</Role>
      <ShortName>Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Other Accounts Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherAccountsLiabilities</Role>
      <ShortName>Other Accounts Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Convertible Loans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ConvertibleLoans</Role>
      <ShortName>Convertible Loans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Long-Term Loans from Banking Institutions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/Long-termLoansFromBankingInstitutions</Role>
      <ShortName>Long-Term Loans from Banking Institutions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Commitment and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/CommitmentAndContingentLiabilities</Role>
      <ShortName>Commitment and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Stock Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StockOptions</Role>
      <ShortName>Stock Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Cost of Sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/CostOfSales</Role>
      <ShortName>Cost of Sales</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Research and Development Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ResearchAndDevelopmentExpenses</Role>
      <ShortName>Research and Development Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - General and Administrative Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/GeneralAndAdministrativeExpenses</Role>
      <ShortName>General and Administrative Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Financing Expenses, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/FinancingExpensesNet</Role>
      <ShortName>Financing Expenses, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Loss Per Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/LossPerCommonStock</Role>
      <ShortName>Loss Per Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://save-food.org/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherCurrentAssetsTables</Role>
      <ShortName>Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/OtherCurrentAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/PropertyAndEquipmentNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Other Accounts Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherAccountsLiabilitiesTables</Role>
      <ShortName>Other Accounts Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/OtherAccountsLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Convertible Loans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ConvertibleLoansTables</Role>
      <ShortName>Convertible Loans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/ConvertibleLoans</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Long-Term Loans from Banking Institutions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/Long-termLoansFromBankingInstitutionsTables</Role>
      <ShortName>Long-Term Loans from Banking Institutions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/Long-termLoansFromBankingInstitutions</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Stock Options (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StockOptionsTables</Role>
      <ShortName>Stock Options (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/StockOptions</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Cost of Sales (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/CostOfSalesTables</Role>
      <ShortName>Cost of Sales (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/CostOfSales</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Research and Development Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ResearchAndDevelopmentExpensesTables</Role>
      <ShortName>Research and Development Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/ResearchAndDevelopmentExpenses</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - General and Administrative Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/GeneralAndAdministrativeExpensesTables</Role>
      <ShortName>General and Administrative Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/GeneralAndAdministrativeExpenses</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Financing Expenses, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/FinancingExpensesNetTables</Role>
      <ShortName>Financing Expenses, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/FinancingExpensesNet</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/IncomeTax</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Loss Per Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/LossPerCommonStockTables</Role>
      <ShortName>Loss Per Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/LossPerCommonStock</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Related Parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/RelatedPartiesTables</Role>
      <ShortName>Related Parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://save-food.org/role/RelatedParties</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - General (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/GeneralDetailsNarrative</Role>
      <ShortName>General (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/GeneralAndAdministrativeExpensesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentDepreciationRatesDetails</Role>
      <ShortName>Significant Accounting Policies - Schedule of Property, Plant and Equipment Depreciation Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfRecurringBasisFinancialAssetsAndLiabilitiesDetails</Role>
      <ShortName>Significant Accounting Policies - Schedule of Recurring Basis Financial Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SignificantAccountingPolicies-ScheduleOfChangesInFairValueLiabilitiesDetails</Role>
      <ShortName>Significant Accounting Policies - Schedule of Changes in Fair Value Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Other Current Assets - Schedule of Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherCurrentAssets-ScheduleOfOtherCurrentAssetsDetails</Role>
      <ShortName>Other Current Assets - Schedule of Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Property and Equipment, Net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/PropertyAndEquipmentNetDetailsNarrative</Role>
      <ShortName>Property and Equipment, Net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/PropertyAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetails</Role>
      <ShortName>Other Accounts Liabilities - Schedule of Other Account Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/OtherAccountsLiabilities-ScheduleOfOtherAccountLiabilitiesDetailsParenthetical</Role>
      <ShortName>Other Accounts Liabilities - Schedule of Other Account Liabilities (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Convertible Loans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ConvertibleLoansDetailsNarrative</Role>
      <ShortName>Convertible Loans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/ConvertibleLoansTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ConvertibleLoans-ScheduleOfWeighted-averageAssumptionsUsedInBlack-scholesValuationMethodDetails</Role>
      <ShortName>Convertible Loans - Schedule of Weighted-average Assumptions Valuation Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfCompositionOfLongTermDebtDetails</Role>
      <ShortName>Long-Term Loans from Banking Institutions - Schedule of Composition of Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/Long-termLoansFromBankingInstitutions-ScheduleOfMaturititesOfLongTermDebtDetails</Role>
      <ShortName>Long-Term Loans from Banking Institutions - Schedule of Maturitites of Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Commitment and Contingent Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/CommitmentAndContingentLiabilitiesDetailsNarrative</Role>
      <ShortName>Commitment and Contingent Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/CommitmentAndContingentLiabilities</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Shareholders' Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ShareholdersEquityDetailsNarrative</Role>
      <ShortName>Shareholders' Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/ShareholdersEquity</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Stock Options (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StockOptionsDetailsNarrative</Role>
      <ShortName>Stock Options (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/StockOptionsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Stock Options - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StockOptions-ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Stock Options - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/StockOptions-ScheduleOfFairValueMeasurementOfPricingModelDetails</Role>
      <ShortName>Stock Options - Schedule of Fair Value Measurement of Pricing Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Cost of Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/CostOfSalesDetails</Role>
      <ShortName>Cost of Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/CostOfSalesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Research and Development Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/ResearchAndDevelopmentExpensesDetails</Role>
      <ShortName>Research and Development Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/ResearchAndDevelopmentExpensesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - General and Administrative Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/GeneralAndAdministrativeExpensesDetails</Role>
      <ShortName>General and Administrative Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/GeneralAndAdministrativeExpensesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Financing Expenses, Net - Schedule of Financing Expenses Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/FinancingExpensesNet-ScheduleOfFinancingExpensesNetDetails</Role>
      <ShortName>Financing Expenses, Net - Schedule of Financing Expenses Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Income Tax (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/IncomeTaxDetailsNarrative</Role>
      <ShortName>Income Tax (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/IncomeTaxTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Income Tax - Schedule of Income Tax Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/IncomeTax-ScheduleOfIncomeTaxExpensesDetails</Role>
      <ShortName>Income Tax - Schedule of Income Tax Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/IncomeTax-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/LossPerCommonStock-ScheduleOfBasicAndDilutedLossPerShareDetails</Role>
      <ShortName>Loss Per Common Stock - Schedule of Basic and Diluted Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Related Parties (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>Related Parties (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/RelatedPartiesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Related Parties - Schedule of Transactions and Balances with Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/RelatedParties-ScheduleOfTransactionsAndBalancesWithRelatedPartiesDetails</Role>
      <ShortName>Related Parties - Schedule of Transactions and Balances with Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="safo-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://save-food.org/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://save-food.org/role/SubsequentEvents</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>safo-20201231.xml</File>
    <File>safo-20201231.xsd</File>
    <File>safo-20201231_cal.xml</File>
    <File>safo-20201231_def.xml</File>
    <File>safo-20201231_lab.xml</File>
    <File>safo-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>142
<FILENAME>0001493152-21-006096-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-006096-xbrl.zip
M4$L#!!0    ( -MT<%*KTA=!3OH  '0##  1    <V%F;RTR,#(P,3(S,2YX
M;6SLO>MWHTB2./K]GG/_!V[MS-[N<VR7>.A5/=._X[++/=YUE;UE=\_._=('
M0\IB"H&:AUWNO_Y&9":0((0 @81D=N?,N&P@(R(CXY7Q^-O_^;ZPI6?B^9;K
M_/V=?#9X)Q''<$W+>?K[NU_O3\_O+ZZOWTG_Y^?_^_^2X/_^]O^<GDI7%K'-
M#]*E:YQ>.S/W)^F+OB ?I%^(0SP]<+V?I-]T.\3?N%>633SIPETL;1(0^ -;
MZ8,T/!L9TNEIB<_^1AS3]7[]>AU_=AX$RP_OW[^\O)PY[K/^XGK?_#/#793[
MWKT;>@:)/W9_?G4K*0-E("NJ+-W_5;F4I<NK+V??9X#'I1[ (_!7&7X_4/&/
MHP=Y\D%1/RC*_U=RO4 /0C]>;_!]P/^/O?ZW[X^>;7W _Y9@+QS_PW??^OL[
M <<7]<SUGMXK@X'\_G\_W]P;<[+03RW'#W3'(.^BMVS+^9;WGCR=3M_3OT:/
MKCR)BT=KJ._QSX^ZGWP9 2QX?@42^*L9Q"^(#P_?LS^F'K5R'QVQ1ZWH49-D
MGO.)<?;D/K^'/[S'_3L=R*>J'#WND=E:D$?OX:_1@Y;O:HH\+L*//1&]$/JG
M3[J^C%^8Z?XC?9C_(0<8^(OGVL3/?8?^)><EQW6<<)$/EQEX[X/7)7D/#YW"
M4\2SC/B]S2^E7P 8\-?YT-&_Y$!GN*$3>*_Y6\+_F/.:[P6KR\ O<Q[%@QD_
MZ^O/Y'3FNB;?%G9<WT7'#UGV@T\/QE<RDRBW?YA3'O#UF7L:O7#VW3??\3\C
M9O!G"T73.^E]]"EV' W7"<CW0++,O[^[\MQ%!-Y #ESZLZR<)NO'KQ$GL(+7
M^+?Q[RT3_S*S0!92*$EJAR*R75S_][N?03#(X\E4GBI_>Y]].5GN?>YZ?+4E
M[*YKKD(!Q]0+4*3]G* 3?2GYV\IK('^3ERC>R?)FZI7H]RD HE]RDJZG\[E_
M.X-MFAXD;9D0#'Y.$(B7X']IADB,&6&-F!FC]7[G\N=WT+8+U[D/7./;9[)X
M)-[>2)EP'GE:$($&\9], .;[TK8,*V"P2J8%3S)KA"/T 34HP?<__1$"W&A-
MN [\TS__;OGO?HX>6\'[;^]SEQ#!>Y\/W_;G*]JA2N<KRSJMG*])SR[=8!=!
M9$S:%!EIN=KO>X?V?=^JXMPTK0"(J-MWNF5>.Q?ZT@IT^TWQ0R$->A521H7T
M;-0Q-MJS:NGYH;O\L'>58QCA(K2!AN9M,"<>TL\C<Z3R,[EV#'=!WA:?E*5'
MKXI*J:*>O0Z#O?:MHGH^.3@^V9?J,D(_<!>_WWFN08CIWSI +(QPW\[NY[I'
M_#?!*!B._["!!+V**E)1/1MUE(WVI(IZ?N@^/^S;6_I* MURB/E)]QS+>7H;
M/!$]EH]\KV3*^$$]X^R=<?;LX?0<T"4.V+<B^>(Z^(;GVC;0XQK>!?4:O"F>
M*")!KU3**)6>B3K%1'M6,#TW=)4;]APH>W #W4:2Z<ZK3Q,MYJYM$L]GQ'P3
M'$+]VE*$Z%5/B:!9SU)=9JG]!M!ZWC@0WMB]6J(%!1&?G!N&1TPK(.:U\PQJ
MVO4.W"?VO>##@Q78Y'9V[9C6LV6&NBWPPUJ$#U'ET*UL1^4DK*,(K*.<*I.>
M=;K&.DH=UL&M;)MU5(%UU%[J=)!UU#JLH[8M=:C!I$P2A3508\/FQ7V8NZ&O
M.^8GZVD>$.(P37[M&$B*9W)GZ\YA<U-DWR F6"\KFC,5T-\K;_$MK*'1!FJK
M3A2LH9VJ@SK\%+WSV;O4G?L_@_"1'$G^;NN<UH00727[7NUVRD9MV^W:J3*-
MQ&#/MCW;-J+TD:DJ"V:1V]NR%]<%3S\MEK;[2HA_#@M;'C&.WV(L0'G?[-.Q
MX&B)BU[6A<4&4IZ;"\NQ_,#3411\^KZ$_2!I,7FOV[IG4<)? ?T?W-O9S#+(
MH3-<)#-9WG(<.KMQ#1U+<M)W.*4(MAOQN6$[^L/0RF'HN;P\E_<,EDVR\HGN
M&7/47.29V.Z2QNA[69O/A27(U4O:+A^$B1#EG A6ZWWXZ!N>M:1;_N01R@-I
M_C^Z0&C$U ^O2V"S<\_3G2>*M\AGZ^FR&T;O;#1V4B<:.VDY[>! &WLEL9IL
MAZY=W+]_N;X_CH-\_J)[)IYFX?S$R!WKO?FZHB2RU"V3:V:?FHW/V.015"5K
MR'DDPOO*<@ M2[>O@:I>F!'?I<EPW-P1296>.PZ-._:A#WYQGXGG(!I(-2L(
MT?AY$PQ1A/G;DA ]#W2+!_8A![[BG=3M[%>?W%CZHV4#X.>>Y5O.$_J3MTML
M%@[_N"'ZL43BBCFC.CW>ELSH^>5P^64O\H48Q'K6'VWB(T'N=0R"8,#%,BW=
M.Y*\[PTL4H8$;TR*]%S1<:YH5U:L[]8?<<A5Z#E@EWD$'#86]L>LF:40L?:]
MX/?/EF,MPL5Q\,N=YP(U@U?,!PH [1CACZ^9>-=&XC07MOZ*\7*V-/XS1?!]
M1J<[.!JA,:;6O_=,O5.F%@G>,W5%IOZL&W/+B=I O66QG*9$+X,/AEW?IL#=
M%;OVTK4.NPH30)9A0+R,,GP3;"I, \FC0<],59GI-S*W#/M8NE96XJ$TZCWK
M%$5I>MG3.=FSWRCN1M_L3;!$4V[J,45RTT;DVV&#JL;S(4N#WHSHBAFQ)RW0
MVP,=M@?V(?5[>^ 0[(%]6(J]/7#\TF!%+_3VP-O:]YPN"%\)'4OUUA))2Y'@
M;7$%%K.%)$ZX?PM<D(OR&]MU,'UL"_F?]S9]$_N>C_1Q[WS6%^BU0->UP$YC
M1+T6Z(@6V,NN]UJ@ UI@1W[_0#L=*$GCE&?B&[KCW+LVDWK7CL%S;/@C%^>7
MZ5\4]%TX5([!A)<+0-ZU+1,YXA."C2U,Q*XF:RG53 Y.4:5\O =[M5$HYW2,
M.WMFK,R,!\XA*<T%='HF7F ]VN3&U1,..!++I:C]S0;4WY8WLX$8<<CS,]']
MT*-_NG:687#G60;YS07;G]8 ]ES3J"K+4GLU#EMJ/X[;)&N*E=&!,4!=7&*C
M*@(>+>B.GI_WS,_K-Z5GZC),_=7ROUW!L]'XOYZI.\#4ZS?E6)EZ<WW*ME+[
M@7A'4LERP(R]NAF[9NB.)YQO;K'?.V1=<<@.HN]MD4B]]CV=V-:UX[C/K-]Q
M&,Q=[^#=-)-8'V[(DV[3P,ZKP$&;,.ZE445I= _4"U":ISOZ'$F@L%23Y%(4
MZ&531=G4,U;W&:O3$FMXJ@ZB9N_#RHQU=.VA=\%I5>#I5+OJK+0<"B.T2K=W
M'W:>J7L>[AEK+6,EHS&&P@7Q6V.C;C)-C6$30^&>N M,\Z84ZIM7GQUE6,&+
MA9\%]:D_DRO7-?V;P$RSZ_\24Z=1>(>&"W3[_OS(^+ED,DR:/,TP\_HXS5JR
MOZ%35,=EIUQ]0*>H/S3=.#1OE)/3!DRO#XZ1M8]&']2TJMIMC975 4<W)_%@
M1A2FTX3E'90Y**?*I-_W;NT[[DG;^SXZ50?]OG=KWT="8+&-S"Q<0Q6L);58
MYM\Z!YY$6(,-8ISW;2BH=0P%=0>&P@;!T3/-$8J/9/?[B=O]Q.VZ_#EI.?%8
MGIS*@U-Y3-4;^SDV;1]>W(>Y&_JZ8W["H6:$.-CY*'B]=@S$Z9E@0R3.O,?7
M-A]P^Z(O1(^X"D&:X]JN=L^/6*>:QN4\UK;&U02-6XF/^3L?7=TS;V>7ED>,
MXY' G>'I(DF<3_K]BF%M!UZ&=JI,(R^C9]^>?1MUC9"Y*KM&(M>W=!,AR_"?
M*+\:?E9ZKN^YOBFNI\Q5E>LI%[9IGN34]_FAC2KEL/EU$XMD\=R?1M]).Z0M
MG*E#Y8"=2:S63+V,=]*6J;=25'0T,Q*[/)VPL^5 ZUGB& (JG8YA'!1+Q$DZ
MMNY98F_1XVBJB9QQY[EF: 2WWCWQGBV#I))OBM'N^:AJI6'/1UWCHTX7%JXO
MA=8]\E'W6;M3H"1-53MN'BI N9=#E2N>>_[I"/\<I/SY#(MYEFX?M]K*8-E+
MF<ICWGLNZ67))EG"IS=]UBUX"WN\'T%F5@&[K$.WERX5I4O/-WOGFX.4-P^>
M_DSL-^%WYZ':RYF*<J;GEUZ^5)0OCK]TO8 U_7/,^\#U]*?CUD[%2/<RI[K,
MZ7FH.SQTD'+H-I@3[TVHK1Q,>XE34>+TW-++EO*R!<@[([Y/VR-<D2-GF'QD
M>PE3D6>^$CK)_=SW2?!9=_2G(VCSMX%SBE#N^:<B_]SHCV .@DGX"B2]LHAM
M/A#_T$<1;&"@0IQ[#MI":W%:'S?[K$>XYYV*]G'/.YW@G8.TEEF?L;?@6^5@
MVDN:BI*FYY9>MI27+=>.'WI'?_F=P;*7*56G;_5<TLN2LA&:V]D,Z/I6\FJ*
MD>XE345)T_-0IWBHLW*HV )^9L5"#ZY]Y,G#>:CV_%+9O^[YI==15<8:+Q:A
M8QDTS^2X^24/U9Y?*H^#[_FEUT?EY<LE67K$L(Z_IG(5T5ZV5)0M/:_T<B6W
M55G?GZ@E-MAM4[+T?O;-A0YW/POT/N_"]OLOQ"&>;F/*E[D 'O<#' _\3/@=
M%R-$+/FCQHW'TX(AZD9W[1CN@MP'(!SQ*S<NLR<9PT0/E2+69F8JR[)%?1(+
MMJ(W:/*%VF!ZJB2,_YGH?NC1S;YVEF'PU?*_77F$T#EJQ ^^ @1I[O]-MT-*
MY@=BS!WKCY!\M'7CV[TQ=VWBW]*I!'<>$-QY^NR:Q#Z.@Y&E4S+_;=T3ZRG9
MS-&(UEW=#['VN-9F[5414/YL6;$7GP&48T9 S$N4-W *^S-0]PRLIV1_!@[C
M##P0;]'S_C:\GU"PY_EN\SP2A/SFVD X&[#HV;X.V^<2L>?\;G/^I^_$,RR?
MT,WK^;Z>N%\A8<_UW>9ZVEBR9_G:+)^E7\_O>^)W'N <XPA$/A=KC.L-A$0;
MW2>969&'SK!%(S+S\-UK0)#O3;6 (-_$5F_#QSC$9Z!QIL&?ASW3=(9IZ-Y4
M91JZB6U&D7'T"T:J]\8,VXKC"(&VS0]9[ SUXIZ;IA70NLP+UWDF7F ]VN3&
MU9,IO@>>HU3FE%6APWX5MKP##E'3P\W>*E-TF@_4EF^FBS,8>Y[H!D]T/ EI
M,RM]6BQM]Y70)/0C&?NY*3V@ .6>?<JR3Y\CT^?(](>@SB$0IF=A^[D'E]49
M'KK4/=2#L&$[^L/0RF'HN;P\E_<,EF:PK\0GNF?,T7PCS\1VETB67M:NX<(2
MY.HE;9</PNA44?A!P)^UF+F)$7I6 !2]"V%_WU98?B/R^V8GW+6J[$2WM\T8
M?<]"76:A=(!1Y(6V HRU14MR&^B81Z-.6V:6)G1HBMZ]B&M"Q/6L_ 99>?>B
M=NWLYEX%=T@%=]PIR!0A5Z_7.W1FVFW%78LR9W>5ZI4*&]X>?]0L33AJUEA?
MH??V^&.;:L7#9)(&;);C:7?2,8.Z2YU7.FXK-<;&Q]#EI>-LO,^&,QUGX_RL
MT#YO^-#RAMO.%\WK9'1@J?@=;Y:3T'EX.IAP.N//T_(*);*XKX%3X17O^$_H
M_J.-R6VY2/-]JIF(AZHR-V6V-M5,S] ]0U=7;UG.;,L=U4Z5071;J6$-=YSE
M W0P=,>Y=^V0=CJ^=HSTY<[%^>5A<R:R ]@WOFM;)IQZ\Q."C<DT8G[-6C(T
MPY(1WYV_Z)Z91$Y8749$X'V;[\@DE2\E-:$*N]4.>XGY_C!W0U]WS(<7P/?U
M;9OPE6BQ7S.^[7I]7&.<Q"OP9Z6_*CR$J\)QC;@!W=ZVPU]306W"SVKES(C/
MQ+2>0O_&6EB@>7I6:TB=FL3B,S,IZ00 \@B^;_:>UM&KR&X[T*O-L'0?[3T
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M,PR__OJL%.GWRO*<LZJQ/&?!?;'\=?#G7/]V/_?(@1?F;9*4*XCVK))S2S\
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MP)//ZY5@*4^AQF!IZNAM *@BAS=U])J"ZD[W;CV:3<PZ(-T1CWZA]'7OW3H
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M9.?WI+708(NPM]BKOEUBEXL*=0#0VN$7;:0=S!%H+"1V4"=_ R:3T3BK%+N
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M>I8O.(,@]W\]NS^33&1D+^L)4ZFS-JK O5P:Y<:6) X+MSJ8.H39 31'*[,
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M@#V>2&+15?&H=D?Z$FB-3^7AUL#OA+-+(/-9-^98HWRPNX%SI3JS'06')N/
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M%[Q)MJ>_L%0%W?BF/Z'BCL+P/KU] ZO?9[* S^)*1F2R9I^6/Q?^SKXEQBI
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M?#7S290/C_ 0VO[S$!,*880IK-:]]T0A9,?SIMQ^%VX%4VQ*C^> I8IZTYW
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M9S+ZJNH&[J4=O!DIV6IWS8$]($H*WO,"+,+'#'[M38VKT@;A2[I]YYN"7\*
MMS >/K[[EN#,NG!UZ"2\ZQ+(RV_&B?PY&V:XPJ[A/>/$N+R^^N/D]OS[5^X4
M;GSY?OV5%NW3Z=5_7%S]85Q<W=Q>W/ZXO;C>31_Q$I/8;%AVIXB9*\> $5NS
MM#1Z5E^O_.G6\Y\NH>@3=I/=-EX3QBI/]D8H1<BC("(0Q!(D[\@$&:!*6#P4
MMMWH;>=,'$:JPFM/POM 8+C0HR&@>^D/H?&7!5(TS;M4P.^.[+<"U=#=8^+
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M?!)&F\J,*4QZ&KU@:P[GD8OV:%6<SWMS=LF,G9:Y)$RBU#8Z[)OFH-->3<W
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MWS1[G;*]1ZHPW_V%6CIFLW2=1C5C+6N<DQNXAA'^+8KDB6 8VV R<4<B/-Q
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M_$F$=CYX[[.3+X++A3MV0:Z9"_$ <D)H[7<HNJW"6PJ*C9LW:I*'2$B="F
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M%25?@O!<-C#_CJ;%CUG@?Q>Q*]GQ'9NF58TG7%0QGI#P$TD^(3F*JY,C E[
M@A3)5;7!N;YNR^8!93TX:B_8-_#R?BQ((Y0T*F-8O4L)S7#D1G.J C8S"!SJ
MX1L4KR2@OCE/QJ7S:*K:H]2@I&1G])(C:R&<(_E)!.)T)'1.$2  #+[4;Y#6
MP/$E'E^AIQD^) V^9S,_&0T#:3A/YH$V&+SDQAZ[-;#2CV+YF564I-'R(6WX
MV?Q7X6\.14Y8YX&J"B:-A12MJ?-31*I:FVA)$AQPK7U0]$0QJ4&%;1DE*SF#
ME9R -HM8EZ8Z))<M!MN#$8.GC'WY[NT_N=1T??'1C21S3F"1)JYR;HY&\RFS
MM:$R3@H9R2@:$?V!0Y&DE_A\NF0 9^)ZGG)BXT_!$,CD>X,Z/\KF3U+T,SL/
M%QU.,7&&R&T)8 ;3DBGF7)AJE+W)D4<PHF@;FD;ZNY&0U@9S((?6Y%+!0%.\
M (9HYLAE^PM'%=\U=Z6R3CD?$ZN?1!11LLS7J(4NI])A"RSPH6>VP:I4 4D"
M&-(#DAE[;Q4[;C&#A(I4T*([@^7!HN7_ OX]@^F![1C6#LK*6X%_JZ(5*-E*
MOPK6MMXFLNAD29D39L(KY*,:"PS6A4\RI1N4Q8@R*L;*V4;P UB0#MHFHH:<
M:!V@W)+1)*539%66H.<G[B_4'&'B1*1C32FVG*+@IE$JA:ZKYQ+1_3E*\QR>
MT'\U5V3Y >BHD-(_4HV('CDWBM^U4DFVFM)<P0;EA%-0N^/Y*!.+S7(!6;-<
M1N=&/V4]W2.%79524F,0%U$Q@'(N!K+,CX7_DKR2513&HKKA1@&G_OASVB;@
MG-5FG>K_%H)@_W$X0; 7VU;4.FLCF=\O++(29:-[&%C>Q#.EEW#_($6V1""]
M*%(R#L_OP9/CQ4^?X"7@H#]"ZBOYCF5.5>W:RTK:M<P\)T/F'H9ZK<7$)L1$
MX<JR]:.RFY1CY,+W@P?VG9PR#E;\9!RAZ:+'S"].,[ED:/V@.X2BSPH[,5PF
MG.#O_Q#*1M)L+$X+8T\-S';!Q>=&&8\BI5')J1RY#=&0 QCTLLHR8\,\S01F
M"YD\"DDBFG+N/;J>1U%MZ4$DCVW,U:9C&?%RXM@9W:<&'0,2\RV@_!?Y+?K>
M4*6(B_&QF4D&5V%[IB"*4V$M34\*7R]=9GJ%/5C2\X;WDJ6/RY54M$B7,-&@
MUH<8!F@0,Q5_#.9W]ZGCA9TNFJL%"XC:_;;9M@?&T8^;#U:G:79[_>-W??MX
M.=,^J1W(AT^=T2B<<]P;_@<]E_C7D(ZWRVV:\#4XGD:$^X17P 0J)4G82^/9
M6AZ%Q I!1YHZGXN.L"+]OIB A[F@0?A4^[<J;P=\K:(=H!C(K>\(FQ WVG*2
MPJ6(A%*VAA<\2A!%0JI A*1E)5-G$C\I=!XESN7HIW.'*E\%+B(SP>(?)YX0
M$_[LSR?.*";'U,3UW>A>^SN/I;M>0##!OT=4[IM-L)/:T<&8P)U2BEO&7#P
MC:)E_\"^W8&J#ZF1 E824$ZW7-:4$7+%!6Q.4)\*&;F-\ SQ1I'K*\F>6Y(-
M4RSS\[KAW E]8)CHFPAO$+.S5A&55Q%75501G^#(CV0*F$<IJ!@J1?=[IL-'
MK3[6ERV\U(7+2[DJ,@>8,U#04GUPQRH;F-Y*/./P]6"<23$.&-D74QA%" 3*
M+)1'@9Y'U%%2SJ=I*2EF=880#:B:4S_2:A3^; ,F/U+8$G0+PX0":H6#:*4Q
M)243[0*#^LG%;\GWCF0)C[H<)G 6LU F$Q^GGK>TND<6R/*:.2JX,\RN,(,9
MISG9\6-P0JF:,G&\8?R5$RRQR8Z<'E&(6AM'P4NDEU[>"LE3$\L2:,I; \U.
M/D$UL0[W\$ =CF#8:7J%VD(UM2QFG-1)[UHW4Z<FW&]DR 5IQ<C6*GUKD0W@
MA#GC?U E<AZ+>A;$Z V!_:!1^4+NX+5_[HTY/IDFR8A?(ARY$44CTQ=YB[.5
M#HD%5L18<)W,OYUCH4+SX 6UOXC!-T4',W&8;(>!MF==)UU]:^&ZBM8"0?.?
M<);62..MVCS8[-5#5EA$JM<#.YJBQ)NEK[V*4)%Y@%@-B'*%+FJ^.SI/G.6/
MS362E%(]S\X-]9JII&)U66T)T="S^IG*+UW.G'#_!OVG3#$8R:T\=9R[IWG4
MT4+1FA0L>+A92Q(Q::4*&Q>@FN&>1:DCI ,0]-17L3ILFR?7*Y-LF$X\*>?%
M= 1UN5< 7D0=>X+3-]2E/TLP/<I%Q>GZIO5=G["EZLG-"$PV5//TTLDL=$?D
M!@C&PLO4HAB8*B,ISYX]OKNSMD']@CF_Z7X&X42XZ"_ )$DP&)^2FKH1B&Q9
M5XU 9_19,HO ZE%%)R'R$N9H4N=%=Y38GN@V50_![1?3,&/U#*=F\G-TXW7P
M+0)(049*(@"&(ZOR<!!)@LSDC-D@3LR]61@,V=!5;O_B$548P!G=(T3T^RXG
M*SQHQ-5D BF35G:KBXPC'S@PD1''=.)DU9,"47BNVJS3[)QTL@6AYRR)/A$)
MWS1)= 5?2A+<=>E09/.4-&(6.A? ^<2J1_$U+5?C5VKKI_+6S[<J6C_(451(
M*PR-IVK7^@9DU9>,^E45DLM[17&ID(9U'L7A/&]*8 &!681_E?R(<C'Y(41G
M?HJ5[E-?%OF +#%@!##Y+-&@5W]3O/X7(YE1  #;B,TC95&XH40.3<$YLRH^
M9_5AH8Z.(5(@?HD$%,%].RMYE[ JC9SV/]0D+]9NN[[0OV=JOFOLGC8)G:EX
M#,*?I N86%SFG"%4H"08P05K?=#JF,4IN!J5TZ88WT@>[("#GJ.TJCC"_CKS
M.+L4"3CKN];Q7[3=<B*YB60=*ZY0F<VR$X9*G7@DWX:6,9'V)U* /107=SD]
M0Z;?(JIH4L_%5=RDU=!)IG4^4+@*,)>?(DZ=@PI,7-IP>AUY6J^4M<03:N#H
M(,7*;X/5:(C7JXJM"4<0S]KPJ>BSIM9.Z2C@,!T5]CGC!_B[<R>".9@\_*8\
M[ Y6,9_0^0WE/\0O!F4B^F19%$S C8IIUQ8K1[ZZNU#V,SJ&T/A/35HSBS@<
M4=D-'!75" -=0.8RV:BP8''L=WTX4LR+6(SN??>?JB8AD4=L ^<Z*3):,@)L
MW5&([S=F5F8JDO%PO?B=KSY<KI_^J !#2/RKGYDWX'#),@1B+G;>T^U87A^Q
MKA,%:Y#V<-3H1B\[7<<0G%,#T/_'?'R71!X9K@/;W2 Z]%C,!*G[U'N)R:N(
M*P*\ 6<C<2\["< *ENXIIC63Z?QS[A 7TS<8]3*IZ73]V1RSHPI7FX##8$WE
M4=</"/OEI9B2< T.:$\POA(_AU2>P1"OEA)I$[]&A$Q=GYXVM"?G_L*SC>0;
MCA<%JMHTHUCALAAB)M>3O.7@:RRH.)HKVW]G<"\BV0<S^NT]'[%+3'LSK-^,
M_YP',5W47026.9K[RME^G!H%E#4G16R*98XF 9P_2N\KU@N\*\C(!.7J,+",
MQJGN.R_MY%VP\[N RQ;!$?$<5GB%"V<L;,WO<-SSPZ2KGXY9O!$XWL(><\8=
M?N1WR0YTBK6^3ME/)B]JIUE%/Q/C))%3O\OR7QHS>16D"]DUB>+W9-JE5/]@
MHH;!,$B0!;5/25D/O.?P(LZ'&!3%6 V' QGKECH Z!(TOQ9$6,V8K=^,'XMR
M&5<V$?2+FYIN9#2?X56(=PG^A)5CF%H5)#H9.4O35^H]34O*=$[-O?VN!89V
MW9YFKH>A4$:&#C,FKV(IN@7O*][MW 7W>:I,]=YZ^A.93[I)$,+'ZF]$9(%3
MUC"01"*AX!WVHNO[6Z#WC2,86C)@YO5CR57#?TCX$+YQB@R0E5R%? ,D2LNG
M. 3(%.!5O:QT*& '? 4;)SB'7\&\F6#_P84$A TA7HA(\.57@;PNY%E@>GSH
M#N>Q3/!(CDK2?AL]@MA1F_O,X=GAE(%<FLB1PE9C)%=?_?,82>)FL_QEV."%
ML9+>%H@T)V//9F(:.2!D$5-LII;AD7+V2P\E^4V>[GQW.S8NT<!^UV<UFY*(
MCI6(%GX8&PH^EZ^2LJI9BCILX>[(JFD]<84!YDE(4D(*_RW"#9P()V9W2RQS
M)8CWDD:8(OO5A-&TX>51T;QQ&> W,MMU#&%@Y1'S7PI,(X\3):XBDB['[X 3
ML!"$O6!I"V7T4)P@0K)L+Z^P^O$EKNM0V37/(/?JZY,2CX%4&'%!=63?RJQ<
MNDJ</*56*HU+P22D)N.])&+2Z: ?@'!/%II'YK97^B%@YGK(EE <P>QQDC;J
MNF661.P\=R**YDXNS_JP%;A4-'10#60\A_Z96!X)BSL9IZ7L<X^%1ZP:L$T%
MVC2EM"G=E79PZ\0@PI(80LE=6BE&MG) :4/1M&$0Q\&T**"V:DA,57GSB$!@
MH[-*-3P0#LOD__N_6.UD4>3LU(A#S!7@<0UJ9)C=G1$A:;XF]Y<1HQ:[7%$9
MU:LC<*LN2$%T[)#VS=[QMDF?R\ZVYRVNGEVOWAJKUZI7[U6K=XOWM2J+5="K
M,/&[$(S6,>K6(/P-K_"Q*)*W:JB2AD+AW#;]7!%-A+ZR-XIJRM\GY1LZ??_?
MV=GY^9<OKSI_)43397I]^:VD.#JD3:@IKRG?^9%]46$F^9<?4XBPC%)/?_;$
M),Y9$B\=:2WU*^?ZPZSQP)<MT/0_8*?@%8T1=1E?-H65;;J7+;#DDUL<&UT+
M2UBKQ-*?['L1ZUVI=^5 =J73-@>]9KTU]=;LT%0NK6V?<7^76$"ZY^NA@2W?
M]%_'+EO@O]T)Z4HXDNJ%KA=ZLU*T7NTJKW:!HMI&&5>WMVX$=NLDW.J)2 8'
M?&564Y3BI:0-K!>S)SR9F:4'T%5"R?]@[Z(EK4BV%_A>?]D///!=Y%O10QUO
M-T*3+3\\*_*9[%ZT;-@&+KL6URD"%.:O_,WQY]A83$\*J)R3>(-V3V7<@SUU
M0UR9?S'U#Z&1<A+VZ94WNN;J-]77WW'5F[VU;K!VS^QU[=?>8*M[52V] &=%
MJK>^A9;@&[O9/PQ1_Z(<R=-EK\1!.350G!WV^D6R-\=,=L/&S1\'<U#86QAR
M[]>2E];JV6M)BJ-2&A!E$47.1WN*6YU\=Z.?9U1@C/]58Z=4#SOE/ZN(G9+A
M(88!3:O42]"[HZOW 2.H%(*A4$IZ C0I"]Z3TB>MLB0.\"@OWR)&XXIBK;P<
M'\!2!6JRA_^!)5-@:' E&79)0#2)*$5SH6I/:KLA2U8<+IHD(L<!5XER80:V
MF,\4>/'O#>-LV1<59$*V!/Y>>%18]!GE1<@%%;C@LD<+47%S+WX*1%SGJE'5
ME):02Z;./X(0E*__DVPI?HU&^>'34S<Q5\=\=7SGCLN6AC"P>%#U (0 FT6J
M<>-YBFF7_$EM#NIX_((I85083)2KW6$ ?4^H_V"TT Z;&N0:A>@X6<"9<0!4
MXJHS-"W\HBTY41-,)B>RA.V$&PMGN"3')*:AT'PG02A@*",!S%"HMXBI.Y.P
M=?(7 I,CWE!OW8OQ'9>'A?AR'N9%AP9;JID*H%"G+B/&G/IC; H(7Q ^M@^N
M\< JK].^5U2GI4Q4"1UV*+55:2$C0FDY7EH,3HB=(WUA00JX5.]+Q?LCSW&G
M0 %ZC"5R=@K,!;(S1/@ 0IUD$,DL<J2.R(. FD-$*=);01$-5)#.>@@$(8,D
M)6UA$VQ-$J612*= !5H*8IJ+;_&X4BM9*AN+(E;*4B0BJE!:^>?Z!/Z3 ,(,
M!5:^1@INQ1,-XU+<H0+(]J_B5"Y?0LN0*BA<0Y&BA[[4J["\J,P+6>"4TP38
MZUL8^/"?(Y;?-?3B@8C:FRJ*6APHY2PCRUI&)63O6O<'-<\</Z1SVK' ?M[A
M=.$;?YO['.2SFU:7H<C2&XBV4S?H0Z*^SI\"Q%/.]S_\<GKS*=, 43JO"X?X
M,2,XH"/M_=.;'_KK1-)5T,#N;]T3JY4%14P(O-"N2"<&&XW&)1=:'S&<;<ON
M'O^F@R=29"CS),C;PB$;&D5$$*S75?"@.OLA=C9..YGJS0]#DMP_L08Y8.TQ
MF>,DW"^FU \R0=%-"#6+Z3C)D*L1Q0@.\KXTI3X=A+PP"F;<E)O _!A260?"
MP"5 :N7B-E(*U&.$$YFME4:\/?@5>6F& R1_UJZ QYF2:="]('[_))QK1-&D
M.FE&(I$QYK3K%B)>2UV-^FTD2^2'0O5]EXHZ RJ%$-GR80Y4\SHIH H-'ST4
MGD" 0%T]2S3*F0.T84= O-.DZ"#W<"4+0H)*PF^$KB \/WGMS?2_)' QU=N2
M5P-^DG W"O-(P$4W@34BP&Q9MD^STW#8&*];8FFHZW*Z001! (3!^2>;A.T+
M0]"0B/ZDP_$H,RV%-,F% 4VV- 2UQW+&\DHWP^YB<8SM3ZC6?4K<2PU,XS"@
M^RE^*<7%.T5^B>!:Z\')8.)5XYD1D\"B):4RP0/3R4Q,N;'PG">$60?)X0&G
M1;@-3P)O_AHZRR2&KR4.;:M#4[+-++XJ'Q&&N":.'YQ8V%G2B^^I56=NZL T
M(#AAB9,U0+:C7UEZ)9TG91L8U>F-FH<E]_:E6+?H?L'H!J.Z)R<L 4N)Y+1$
M@DRY%QR'%P(5>[V$O*C3%$LHO3:0>BTGJYD7@%\N&/WQUOF5JHU>NPEJXX8P
M\2<)V+ZFS9!W]1=9.I$4U@"19,M:_%PDQU*H_?I $G\RQH%,0WCN%#@#88N5
MSTW\DBUFDXZF$OM21]V%YQ+BV;?FP9UKXLJ&$VHLAPYP@AFI)-K=W&6H7_B
MRQI*.0L)*#$%NI0@ILDYYQ[$!(.LK2LU3%B02BN=94L"PN$)FR;]=R3 AN/[
M".NB?BTA%_C$$QF+IUZ3>1I$5/* 3VZU+"FT=:Q]"T\R20@4%4\BEE=4XKX&
MD9"5*BX[\'3=M[* ,5X4+K4L6566G,[OX$DE2?I+)4F?C-1BN&XE4_HVRI04
MMMOXDB!Q@_$J(_UR>[6GON<AS)#MBK^4UU5D+"BT675*\1,*"<[0?"0H#TH
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M^]_?_O;S"GY=/GZY>#][6'W[Y^8I^NG2_^VOZ.^;98Q/SG];C)-'?F#^$JZ
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M623.V5'Y1>M;GFN!B-!-<LJ7<6KWE,R2 MCF'E)?A(L+N!5U1^SFZDCDYO.
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M1+*#.)=@ N;PG@>.]W(01.8IM@[(N127Y'*)X/SJF0<JXOW4]*VX\GQK!^J
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M/K*5QDY(>I/C<AFEN5L'(8D9"']T4#@>0U\F9P'>-#?U8@*DKZUVIA&B-]\
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MC+__=5BTJVN"&&4E%DEE)R0CK<4B2>^(9L#56'5\&KY&\K,]YKY7<[O:TU;
MO@E4Q%-^UG$4;8)K0#9.R9PP1D+X=(NUK.TQ#[86KU D%M "87BB> 6!?]Y6
M1A#H"+$7](.L['>=/#CH04A5A';'(-3V ^EV07;Y47?^+4H71@*[<=5#1P,=
MG>D<.B+A;>0&?ARL8IG%?H&_*Q#D)25)2,("CR!ZV]L?\+% DE_4V?=F7@&E
M_NHGH9>A\"HXAJ/=?,NC0NP!4%@>N(??(3GB-(Y",4Z\'-[+$>1T%I3&-*A0
M%XL;/)15%9P3)Z_IS'U^+XE;\=F#[S_N"L7ODCCEQ2=R*,SV]O,K.W_*/_X]
MLZOY G'10>S?DUAV^WO>KM9L=SJ"Q;T%D6K"#Y&L/4&P"F/Y./T$P_@50@T9
M:3<S@@2O,ZB,G6,6>)1!LOAQ9[_H!\+1RHC1[T_E+7;Y:IF-SAGD_,L"?L[H
MTB;O7+9T$U94O0 5.]ZS7+62U$^H1XCB4TB!8#((!EH'8$-SG)X.)M63E5/G
M]%(L6M^0@,"8NH\)!.WM]L$*A=/2X:1:PO#MG++.$^')*7M5SE'KRJFVPBGC
M[:3*,/'EG/"S#1R<_S2UQ2GBW:2*:.;1.754+\4UA3"NN/8F*_1#B+IQK]IJ
MANQ0;GCR!K5@&.Y12X;<[?CLZO>S51+R\P3BB4<2I%?SSY"AT5=";D1O_.LC
MA:_2*%M@-JA!X.B&P@V_7==)=SX<G497CZ),!T3J7XC/,]*OYE\YD6Q;?(D=
MS W_WN1/,"P[IRAES;'5TYO:3DCZ[8*R5&PJGU#&Z#-(WN(BC8VG]I?-PJ^-
M+0NKSHVH(MNX]E]%JH'.K^KMI_:::.78&79./\JA'W$:HU4_3>VG]J!H_=@9
M'CZV:3HPURQY =8*-;4S;)<_B@U'9XFAJH+5(3KE3!HFPBCB;Y@$1=^O9Y1M
M$-SCP1UR&Z;YT%4.SDV,FC6]I$G0T8.H( XY$9SWT/EU3D/J6<OR@);%B)F;
M.^1>FLR9C<\1+)K:O;V$4-V882"G7D)MLV-X[IV;(&H)NVJ5(D/>:&@[J?4M
MS]:T[09K+:<.4)K%KIE<,Y/.#:1KEI_BPBC$V'CJ: 6M$PNKSJGE. SE+0P_
MOO:C\#SYY#]&Z?JJD6$)H@E@ZO $K9X6EMU341"LEBMYL"R[QJF61,W.2XH3
M@A D [E)EJT$K_*46B[^\%\KGN;[%%=SI=:5<86I_\ZFCH_P0V,X43LWK&[$
MN;^$A)]]EHA%4H7W6JU:TS&<=MBI@S*TTO&"<$Z'.H\P2.-5**^Z,RGJ-&71
M_2H5JZUW5&1D-$E!C+$,0%/""+?HN2_\[H53V\BION'0/-!<&R\744*9Y+Y-
M\WI+]\*O'G78)!CG-*BDFL=)V"4[:X><>I9B>6M>JNVFM@F7.[OPU_/ MXKF
MU]VZ9+[ W^.<GS?7.J@<IC_$'Z;W?JK@^^\AKP'@'BRH</+6QLD:GT?G7@6C
M)U%.9W]^8^(R$J-S6WA8:31IB/M$DA41:V[B3CKS@U3<TOD$(3I$\NSS2SZ-
MQ+$3^"^T9D8;(9O:I!K4I46_&\O(.>>875S^#>:F-+"$/44!X;=@.FUK?\TP
M4SN,=NVU<VQ0TLR1\V[KA+I9/<;&4\\J"P<U_9@TZ-JLL5ZDM]E#*]C4<P>O
M(Q3_[DVC6R+C.Z#ZPF??2;J^7V_)YRTP4Z_?XA76SKE[VFHI^6")I=H IUY<
M[6 ,<3)P3WF9 ;<[*K7-U/Y)I[?I_+5!9X,?!I!U#,X3T:DH=W4\GT-2+/(>
MD>CXB6D)0\"U@TWM<IK%CJ-_+ 7\YD?)57(:\4?*_1BO 03<U$[$K@(TX\[%
M:'(WZI(FM#IQ6[U'&]S4SJ/=4J$8'^'2E>7)HOKE*F/3J;?#[#.C_44FE_PQ
M$(?)'6O-IO;*1JKU&X9U+;EFBBIL;+>]N &JJ7T\1HD;2ZAEIHV\.-_Y2=O*
M O>[V@)W;4T[P^=%B:=B_"\?//,OGG:&8&#FM#=P*YR\[[!4#YB\#-6D$U30
M :;D*0*)G+QF18C+F#^OKFF]K=$%Q_\G9EVL1T?5_'C^07UN WZ/B90NY/Q+
ML5GYOY6Z7KJV<- .>('M]-A%2,,'M^"MF+B(?4JRGY"E;G<%:1N$4Z>0F^MV
M6\X=G=!RX>($>)%9,F0'+5.XJ?W4N>;6D]8N".?T)AGE0"$,/%&'7E1-%4,R
M6X&R.DPKW-29;!].%"$8Y_2IFQ:]6%FS5G'0.-V^=U>W783DWL*&3GU1 LT:
MK;> X93ZEQ])J0:Q_ C:U)_AZJ)4$S1.MS__2+IM%M*/H.):A9--#'()BE/N
MAQ])N0WBF2+'J9$BAQTZGS$#(]<7]AS46!<V'0V0Q/:>B.&N$O%V2>TMO;)6
MG^6H!1(>J66'EY&Z2:I/LXLY$[#I_G17)$@]NKB,M F[HRE3S8Z+_<1S^"V0
MB_[BD1*>,EFROZGJ0R<,2#6ZNF*T@;3<BX,:1"#"=+[EGH,11Y_#%3H," GE
M,WTWY-%_%;(^HZSPAN=)#Q57^^[$T9T,B\+5,3^,R-V;%M<99^+"N,KRR8I'
MB;A-(0[M%YO $&P5-MNV.+<Q1D?W3! C9FO671\>=_0X@*"+D<8"T^T# H/#
MT:V5[D, +[ 1PIUUME3\+$O0GA+YRBT8,GS%J\W1.;K!@O0)VXK1P>FM6"E#
MGH6<WUV0.+HUTV&"=Q>9<\L0#4(HCUAN$0L;<4QZ=2R/W?C57)FM]];2,8T@
MCL:T%L5I-\E:Q.&>C5))5NL4XA18A7 TPMQ,?R9AN*<^U5Z><[X2!1!D#8*B
M*"#.L32 .AHOXA6*%H]S3J3B"$FP8B2\I)#,M&XKM0(Z&B5NIE2+:)Q6Z3?Q
MVJJX9$Q8$+6=QK% .1KP;:;,)J$,OSFH4J$4L1:'@YK2-#N(H^=H$'IIY^T'
MF%[2ME\]RORP&$Z6&B (4$?/T&QH-6WB<4ZQ\KG4ZNNVU;=4(2NL?J"TO"8L
MHJ&^L9U7M2FV66[\E'R>STE@*\T_,AU3IT/3R%V_2]5U;\W)VF\N"].V/+.%
M,(?+"UP6ILTBNU1Z+R_&4=)6N?+V%V_FG48\B"F'\!K^*%L/>",O>DBB>12(
M9;[LU)$L<!A'@2K""ID_U\E4<'AK)-X:RW#D6TXM5FC^4*=9 GHYI%<_U]D_
MH<6":M/[I2JU^WMU:@MHST]"KX3_LU>YXSZ0= U/8YFIWC?+N(#WC&]1]4]T
M8^A<(?:@3JP"YM72B?YI%,M<LY2PI>RI[762"N&'=<(E+K%FEI'M";OMY>@\
M\U;5$$)?+B-9@1T&N*AH")W#'ZUCYJVNA@*1'.MK5&,-'WF^RUP@MD+Y.\T*
M*H#YC>IZB=\A+E2O<PHSG>\U.@6(5\(,.29$E42QG]1 FN;O!(2XT)W##$>:
MM?A< [6:VRN0R(&JH/'6>(;CH*6J5P,/FAO,T4@6JHA&X<): $6E_$!SB25H
M2>C@[C K+Z&68JV0J/F_K+U7*4D[A"_A(KHV+:]7R-,\G@#TKD44)$&]VO;#
M$+-./N]P[;-&AW"@N;<<R"NA!C2FJWM._E@)2_!4.?A9H5!S66LPKX";*%ZW
MQNT'NL>RQ^W>3\5OPY;QMG%T)_86&OC1/5L;/QFV0;G1$Q(;"YH'-*4EH]#=
MD)_8B-<<HB5+&4_VAG3%QD1#8FA*6D;AH9Z]6&@_U'RBEL.,0C(JF;'QH3E.
M=$HS"G]JC&UC0W.PE4A[I-%3AMPV2C4G6PF\1Z'4'H';B-?\;VL</@I#;0&Y
MC27-,R/"\E&8,L7G-D8TE]P0I8]"?!FNVRC6// Z:!_)>-:C=QNUFLLUQO C
M36 UF+<1K;G86D@_YO0\%:_.Q?Q2G'D0T\E(\5O-L1;S\:<<WBL13!<:XUC1
M?&MKD.P0B[/;8$'"E?5 LEK32^P>%7(QBT/WT2WB@!8Y#<(_%E3\V9-T5 -=
M3R7%D[24TG1"AC?BV!:#[TY\'O'<-(/+DEF&*,>SCG6M0M3"AVY"+,GP)!U>
M24B1[PBI5N)NEX18UN0L'W3'BDU?..@D-J5XI^C:DWV/+R<]P56$HW]IE8@6
M]QC3WZH8S!GR&)PWI,@X.ZQ%1M9D>5P;W, 8SOI:U*O%5C:>S8;6:&?7VI[T
MW)M9(N8*Y>OC8!:H:8_QF0F33REMP% .-_5I*HR:]"-["%$X=UZO\GYR>YG3
M#>[$]=?#U,?"-A@5?8O7K:+C32NG==>>-\%&/%JZ:EE<-7GYO.%$0<XV\FA_
M5?5MEY7GSL(9\QW6^I(U*B!ZAUF\'C<,JO.A*/N;G*(DG $4\Q\(A)VK9;:N
MFYT_/(G]X/N,!PM Q$5D+DFZ(.F"AK8I\D[+SW4Q5)5?)\53:/'*GKVLZW%F
M"VH#0$VAZ%+>+(>/JS?^K)(R[%]C=PEJB=2Z>_&G0.-)-(($-R5VX:<K!A2G
MA'>0V.9'Q6H24[JW2FRZZ =WB=9^<78B<@OA$JY>A+UF41)$CWY\GES"Z+I[
M)O$3N:!@T2W1^)9HIP[6C9=_:9\<.AJ[=^+JG\1G=\^TIU%08ILZ)N];^34Q
M.74+H/VT+"Z&VNST[.A+_-J)6AQW^!.VHW.DG C \6(_A3LE_4J4H7R<7Z-Y
MM<87VOI>E:EJ#*%^YQ7H1UK:-[-;+N!?$%\P(*:--"%BO_J"AB2V<J]?@[%P
MKZS8*[UE*YVR/T]V.(X\E%,B5@ZU#+5V3&0,6NWG1&SDO]<R3,1!D3%8:CLI
M8F5*RQ=11T7&8,MT5D2=;8:OK9QJ^5[369+:3--:5;94-DM2QGJ>=,28LZC9
M*"?6?=KZIFU3^\F2AM8'5.M%\6W\#E_L(MNQ#%Z+FZZGT7Q.Q"?&,B2R1+$-
M8K)P'2OV5@Y&$[RV82]6H%#51G"@D]W+[J2*#E(87B=BS0DH8@^R?*Q<S\X8
M(>V6% D[6<&E+EKI) >G4MCR<"4J_WFO+46JQRS'37Y*RI7@I/P,%8-I:;?"
M3#484;XP!&.3/J!3X?<$@LAY9%DY;03H^;&8K!.Q0K]*27B<7K$0Y@-[A0_%
M@;H&DX !G'IQLT7DM0=AD')PKS1B2?L-"2B8P#C;)[^D8HJN NEL$+%F!R13
M+UPB%;L):XXN5V<%6L!.KYF!,5EER/QJ)P2"A', R(5TO!1;V,T#H?^>IBZB
MTVVT#"5IYX94P[0XS>:$N6R[?4:IH%,7W^S%1.BR&*'*?O;,$<2F=]$2PEDE
M@5->"?FVB(+%)3TE\!TC(5!.^#=HEBU-I<8:@ )[7\BG+L?9P;7W*T^W#I&9
M FN%AZ[7#-YK^S^-87;1B_RJ]1+!=%9.DX9"H/7<<"M@SV59RX>:RP> LBM;
M5_=Q]"!'2\.41L).'8PC%5&KSHJ7BG/^56-8KC4(:_0)DN[7.67//@LM7A:-
M8.IPO*-JN[+WH^BW/ EX',?T6:PH=="M"7CJP+DGO3;+Q2UGJM\+5KRJN#<7
MB(V,*!;+ WE;F0A8/:IV"L%\?;CJ7&5GV99IUMT:2O8XUCZP>MT8M^BHG4_0
M+AZ/N_)8Y4'1YQWS(6W+@GM0ZXD?BX')OT7IPLBWF5U#@;(JNU6]JIU*]1;=
M>L_0;Z.LACVI4:O A-.S=DY!J\C4K.E\6HO_W4,.#9_\'U!+ P04    " #;
M='!2+5J,&7DS  !890, %0   '-A9F\M,C R,#$R,S%?9&5F+GAM;.U]ZV_D
M.)+G]P/N?]#5XA:SP+BK['K73-\B_>HU8#N]MKMK[[XD9(GIU)52=(N2'_W7
M+TE)F5)*05)*B62Z-!C,N&P&%1$_/H(1P> ___UY&3J/*"8!CGY]L__+NS<.
MBCSL!]']KV]^O]F;W!R=G;UQ2.)&OAOB"/WZ)L)O_OW__,__X=#__/-_[>TY
MIP$*_6_.,?;VSJ(Y_H=SZ2[1-^<W%*'837#\#^</-TS9;_!I$*+8.<++AQ E
MB/XA^_ WY^,OGSQG;T^AVS]0Y./X]^NS5;>+)'GX]O;MT]/3+Q%^=)]P_(/\
MXN&E6G\W.(T]M.KL9G(Z=0[>';S;/WB_[]S\[X/C?>?X]/*7YSF5X]A-:!/Z
MUWWZ^W?OV1\_W>Y_^7;P_MO!P?]3_%[B)BE9?>_=\[O\/QGY/\,@^O&-_<^=
M2Y!#T8G(MV<2_/JF).;3^U]P?/_VX-V[_;?_=7%^XRW0TMT+(H:2A]X45*R7
M)KK]KU^_ON5_+9K66C[?Q6'QC?=O"W96/=._^LF*H-SXX]OLC^6F@:#K$M,D
M^$:X).?8<Q,^'J4<.6 +]J^]HMD>^]7>_L'>^_U?GHG_IL")*SO&(;I&<X?]
M/QU7JZ\2]Q'MS3'V>:?LKV\IF.D21<DD\D^B)$A>&++QDG-+)>#=+6(T__4-
M<>=XKQA'[)O_HD*;O#S0"48"-C_>.&^[LGGHADRG-PN$$B+CJ['Q$(Q<N3$5
M?X&2P'/#5EPU4O;$(IN/B.%"IG.V,,5H@2(2/*)S3*2Z4R(>@M&%&]TC<A;=
M)-C[L<"A3Q?28S0/O"!IQ;-"/T.P[Y+%:8B?VNEWDZ@GQK)]2CH@-YKUI97@
M/@JHNEVZ+G@>3NG"$-U?X9 "@.3:42'NB=$IG7[Q41JSB3@A1&%=@2EZ8NDJ
MQ@\H3E[8@OIG&CRP<7*)I.-?0M:GOG)4R'G@W@5AD"A@*J/KB;TC'%&C+PGN
M0KI4N9&4+:A]3^R<X^A^+T'QDG=^&N/EH1O]H*/YC)H'09*R/5+*8ZM.>M/C
M<ADD^;9.E<1F(/U'"\#5>^AKR5G0W31?ZMD$2%ZDZPQ(T=O>0'>?Z8,2RDUM
M>P.3)-/YC1NJH%9KVA,3UX@@-_86=#0<HT<48KY G3P_4,-"SI<:=;\[)_W6
MQ%\&44 2>MZCQH\JLZKT/;%[&D34I*33J^A?8;,0T?3$UAD];B_1K?LLXZ76
ML+?%EY KNE73A0AGAJ!\I84H>IL$(37\?&KWJRRAS:W[6IO2.X+^3-DL>F2&
MJ'1] MKK,!A[,1P',B"%W[QU[Q06W19=#&;UJG$JHQO6 E;C48EX8&NXA3:E
MU -9QFHLBJET6LEJ_';H:@!;3W':@Q3]VWVJ: ,$6FQ -1[;]*')'E1CO%TO
M ]J&:NS**?NV$]7X IH/9C.JKCMBND'L1]4) ]/T.T&.4>(&(;ETXVQD*\X(
MB$R'@=:6Y4Z=Z1!DCP7+_#1$TWEA %V%;A:5*:R@8_00(R_@D9EK.B8*AK<2
MNH\/:U;0-?*H"4O_=NB2@.0+'5V9N4%+^2Z98CUKJ/N7-:MH%4 Y=8.8AW2'
M4TJ;;PUV_BGQ4_^CHL#;]3KLV:GM0M>RFV&95UMCE##J[PL#'R$WAT[>I/TT
M[.T#M@C<*MX^S-<&.I.WG:2J] .Q6]+A=Q3<+ZB5N4>I8O<>T14N769'V]\)
M\L^BP]#U?NP1;T$[(FR1Y\; !4H6V%<<R)H^K].I4=X%\?(!DX#]>CIGQ+>4
M]AC=J2YL0WW/D#HNW"2-*7?46-2B#M7O:8NOME\+NO8X6/RU]>%*N8<!?':M
MF56@'8#-TI M_7KBT<^N]=6&]U8=#BO0ROZ_0"Y)8YX@Q>RQ@+FA+K"/PNWD
M:]U__WY8Y:T.HM#BB57DLE4GFGRQBJRW[&9 ;VQY?#;\65&>[7ONVYO;=CV5
M$O;-8$D]J]^U'$5=^AI0C&,T1W&,?/K;+7Q9V_<\F"^^Q!%SH'ELX0G"E!K^
M>5MN02A;B+UT/XAGO^WD4:,>A-62TFYC:FJ['M]VJ>[R5'?R/4@6C0RVDZJ'
M#PV4.M/:=%2D%[%+]]V"XZ;&90: JR3%C19VA^0CYVM!NXB]] [M^<&2Y?NS
M"QSYA\HJ6?421,E;VO1MWN9M8P?#\[WZV)Z/EV[0DNDZM0:.^9?VEFAYA^*6
M[%9)A^?5#<-V''*"X?F*<#)IRUI!HW5,HKF;ADGG05F05WFFOZ9F*UL!S^D_
M*WRCYP1%/O(+SEF'VU[^HK]FG>17^O:=/:>@*O_H1KZ3=>%4^AB,]>8[7A5>
M#RB#J^LV].<CNF?@,/#9+N'D]$[1@1Y&FUW*%:[?JW/M_*W2W[\-*(7:M;"*
M(!]$@JS[<_#<J?3H9%WJ$47EMEA%JH\;4FT(DO7G!)%3[O%?W0=,_N$4'>>2
M%;*%V*L(%+++HCAN7'[XLC%WR1V7)R5[]Z[[\);9&&]1F)#B-]SJV'NWG]\.
M_9?\U[,5MU2+Z(S^N,(N=.]0R+\]RQLWM7UK >L\CT6![;S=)LOKD32)"^;S
MM5=Q@\L6_&\>CA(Z]DY"_C6Z::![]D/!V3S&2ZD^<]UAH01E!5-&WC@XIH/J
MUS?[[]:\A)@@_]<W29PVB&P"I<R+RT,-$9L=D^= 9:PUD_6*8:.I*L.L"@6
METCF!OB, K7!ZW%N $,  <U[!:9NCLM0$2H<JP@ @7/P;N?1F>TWR- 70(5I
MNNU:N"V"7$@(Q/=F02SYER[R,QL$8*WIK'?LJH=' !?Q+,%RGNU<[":^S_7F
MAE=NX)]%1^Y#D+BA#!4AV0#3JW>(Y * >!D&S*/GRI3[\[+LN?(!(7-32\%3
M[6+6M-;;!F0K8<!-K2NH#8[,R>ET=A5C#R&?3*,\AVHZYWYR F+#R"14LZ95
MVQ8X5/D'=R2ST^J:N9LCY)^X<11$]S!..4%S^]D'BQ&2<PYA\Z'GV7&+Z5++
MN'6C%U+V!F1R".>($NWLH\4XM),"PN2CV?ERB2-FV5+=A#Q_+$%TFB>R62.B
MFGVR&#-5_B&T/IE%JS["Z,X8ICZ_>Q!S]29)'-RE"3O,W^)F.45.BC[ZGWTU
M,P):N)]Z$]/.TT"V6T_3A)> I#P+(-]L:C]ZC1R#%J'Y"7M&2(K\XY3=C;I"
M<8!]GJAWB9[X7X1.0P5R^P%3E@(T*FT$,1N'W5'<H-]5&)O$  U0PSZ2_Y\2
MGD5.;C'@./C.\E2B)!-3Y#=IV97UZ':3"+1JS4_8WQBK#2L.'Z^LOJS/;$44
MD4HN #![VW5F/=A=90+-8J-P7\5X'B3E,'T=Q74;Z\'98!72^6?S4PS8T[.[
M;(1?OBK=:[MA]\,KQ1';&3S2;JU'=GOIH,'PQ<;!D%D&_8\&Q7YW=3BT$0\:
M#U_[=?2)!N[),XJ]@+"+JIEYT 0HZZ5=)_:BUU$6T%/0-83;#JML5&T+%M3+
M3J(E%,;2L*%HX)5O!A92"<XPK;NR%^2M) *1MM)UE W:?J 6]+6K6,M$ L$N
MN9C^^79#6LK+#RVYNK77$BJ)N9]:I!O3GIR\J\'2C#=?5Z@P^YGES@>$I6VF
M,:+_6+4>+NU9Z6F%"I=?-KDL]>&L.W'6O0S&O>#IA0K+7S=9YH1.3ND4I(/Q
M*7N*H<SL_KM-9@OJ[#I%0?]WA_<PK&Y%#S14F-YOUG!![U0Z&(QG\/6&"J\'
MF[R6R)R<;C 6VSW>4.'[_2;?O"]6ER3CVF$[@Y-WYU3[&U#ERL\Z5(3Y4 >A
MZ(B/\W57FL:.X/&'"N,?:\M?B3"_TE'0#WA;I>%QB J;GVIL,A)G13/@@*B_
M&%'AK+;+,0JV ><T@W&F^&9$A=G:9E=TP@=IJ1MGW<_0QH/\'8F*"+7-+^^&
M2U#M2(<0PI<FRHP?U#;"%>F*SZ$WP?I3%!4.:[M>UM[A! -N(>"K%!7N:OL<
M(W2NLH<I*:F3TPXXX1K?JZ@P6=O4<B)G137<(@J]8%%AL+91K<F<@LZ,>2XT
MTP_J^Y383'?^5OPTZ(W1%D];5,2I[V<R<;+>AA1&^OI%18+:OM=T"-'!MMJ#
M&!7>:]N@X$RB3?/RES(J,@"'P*8CB@X1)"]IE%E_7]L):R>6-<<6W/(\'Z\1
MC]>(AT1IO$8\7B-NZTH?KQ&/UXA?T37B// JNW52:;8#UX=K_-JYP*TJAM\B
M;Q$%]#0HWH*@]G;O/6(I;;LW4.=6MK+!%&:V'HF^9>!8ONWTAX_-FT\O& ZS
M\0#)3W4F^.,(-]G;"%G H%P36WA%M5MGAC8FZ13"?0C6]VJI#F,0X67@AMM#
M*.G(5-&++?%3D0HT/WI&K_YT2?WEDHUG2OC.?4O7IL.P% +8S$G<ME]3A1<4
MLQ1[$0\"N22YUORF+H_65OR%M;B4<J: #L^GX)W;BA2U^%4EA*W'1PN]?UMA
MM!;#JD2T=3#:ZA'<"N^U\)8TP*U#GI9OXU8DJ@6^%.+=.F12>$"W(D<MX@6$
MOW7P#CVR6V&X%N!:1\-U\"A]<K?";"VBU1@<US-W!>_Q5GBN1; V8N4:9R98
MHK[,\(=:W*J8BG_+Z9U5!V/@:@Q<O=[ 5373Y)9^3Q*R@@CL=AA*Y+3-B]O
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M=7P58P\AOU3)HO7L4^[">D#;26+GXIG',-?,TB,:7J)UT1)A%$),:CV :A*
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MR7S6*U-M.K_$T9%+%F6Y>#)#HS7#LVA:=6(QMEV% =$R7">J<8RVG<X6XZ7
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MO95HE'8<RD@'>1#02";JG39V^"3!C9@T- []BM=QF"AF$Y602\;( 7:)TI<
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M( G/]VGA<P'/>\&'FXRIMY0@]0T/S6:JO+7(!CDHUM=)]J4P)E_7J7AQJM.
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MLV%E=X EU_1XN*BKBN8@4:;FG6;CL2J)UDQVQ^:8:\^V@QVFH'JR'>;!!BZ
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MM(V;*5=IY-Y(49W0=<T47%DK9AME1D*Q:W1^25G%19>Q092"=W"JP2CT HN
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MANZ?;LB_R)_K/Y'_CTZWY"__!U!+ P04    " #;='!2NK)H\?))  #RZ 0
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M9C-"]QTYG!'[$:HP8IAA%>0"91X.TULO*20;J!$BL&,8:+I+[C79,1!Y0U_
M@CQ$\T5E -V%7O$J4UE!%VB3(!^SEYE[(A/5@@]">H@/'YE ]\@G)BSYVYF7
MXK3<Z,C.S Q:LNZ&*38PA?I_^<@DJA]0KCR<L'=:<T31^9:Q^T]C/=T_ A$^
M;%:S=R?=C4YS&K.+A^TQ(!X-]P7#5\BVZ)1#]-5PL ^X@K#6>[N9KQFZD^LJ
M*13>T'(;-/R"\')%K,PW!"KQEHCL</FZN-I^3E$PB\Y"S__Z)O579**4;O+,
M&+A!V2H.@()\I,\?TZG1/ 7C]29.,?WU?$&!'PGL!7J";FRFOF>)'#=>EB=D
M=<18/ HYH-\[VONJ_E[0=T9C[Z_:EROP# 9\=MJ+!< :6&9#9!N_GOKDLSMZ
MZ:Q=:T*S"-7V_PWRTCQA 5+4'L/4#743!R@\##_M^8?WPX*/.A'$43RQP%5J
M37(D7RQPZ9K3&/3&-N63\V<@/H?//+0W5W<_50(.O< &>>K?:4I1G[D,HG&!
M%BA)4$!^>X OZ_"9C?GB&RNB#C2?;CPXS(GA7XYE%@380AQD>B.>?5WE@4$;
M66J#:(\),;4]GQV[A'9EJ'OZ!6<K[@+UL!K@0X9"9[1-1R"\;+F;A!R^4<:N
ML=?D%WL@Z%N&H@ %U41TU8>F?Y!?TTG*3)UWDS>3"JKYHQ<%DV**27..<NG5
MXL/8WUMO2!-CXF2?;G2Y*5DO2W])D?_],GY^&R#\EM*2_L"(^N:'=V7RR[^0
M7_UZ'C^C9/I$CW._#F@+O2<4LJ_\2L:TAKP]VMH*NMRC);,VHHPF0_&7R!_9
M7FE3!*:)/XD3<G$B'*KF)*;9'N.[N43EB+<;YN-ZXZ]P6,O,@ER9130KZ1,K
M%MPD(_G4\6E]3K B5MZ,Z,*W_XVV,F)WA@*I_<X>N0786:%WM0$\DGGY9-X?
M :3N>QO4Y>%BA:A3LHJ KN0J])9\JK:& ,GZP099N=A8W!Q8(NXY,1:6<2+=
M&EH#@33^B[V-@8N914H_K+TP/,M3'*%=]B"/TJV!0$K_:(_27,PL4OIRC9(E
MN>9_2N*7;$5=_%XDE6T! )#R/]FCO!13#@?^\99K-INSJ?GIQWM&]'MB.=>9
MH.3G<W*=B4,<T O,I(2?E!/T%:1*CA9>^L06EZ=OEIZW*80)A5E:_:8M5>6O
M?ZU76+N1O/"N?#F26-HE. RZMYX<CE[ISU BTAYGRQK7HNN^\@@P&6[7&HH;
M59@,D"F=X=9L=SF%>6P0H.H&-VAJ.GU-)/]#W^.>O9"Z*Z;9N9<D6[+YLL<4
M,7> X-;N B!&Q'U0<HF)]XA@A'URIM!5EVB*F288;NUFT8-)4HS=8$H5D72/
M?$2DZ"E$MRA3\D8.9>UBTH-%$/S=X-0LHCY:<I%J9,AV.;,_RMK%I0<G>/BY
M0?DB+J^)BIC^O+'6+C$]N"#&U0U> -G0CP-_=8$#*N*3M1=OH-<%UL(5LN5E
M<>:%;*1=%=K0^G/$+KE&7HKN:9#D?/$Y10Q9B3;)P8!L_9M5\QJ$NAO*)8PX
MEQXY<B@@CSY:Y1$$\4-9Q'E^G5[-?[W*HR"=1<14W""?2,;E>A/&6U0(2OIY
M$Y,_9;B($>/P@,ZA-P7X3FJ'(_H(N:1!^W6X1.<2G DN> 9>RQG4B!,B*MXL
MR%?$^*J]// 9H/PUYDLXP"VG2R<W-*^Q:K#73@8#Y: Q1X,V&X1<=-JU]["*
MDXSF.)S%21*_$#M)LGUR!T,Y9<S? "!UK$;#):8T,IQHZHGRNB4:#V6-,0>$
M-FODF+O!G<IG=>=MJ<,*[*UKCX=RQYAC0IL[<LP-6>BBS$TQW2F8$@I*?6-.
M"3CU0?BXI"$@+@G) .>-,<^"MF: .#).L[V1 UDG3DG8R1\.Y:@Q/X0^1V5X
MNZ%FK</R-HY\34NA"0)^?G74XE92P]#YM"<H\J+,K3,*! EEBS%715^V@#$T
MRYUR]=NK..GAVX.#0_EDS.5P$)\TJ>3&_L>I(2ZU+^!,&H%7X;78%WT<@0.X
M_MX?PQW1A\5C<?@U\B55X5^=D5 >&?-+]# N^-BZP8N[2O$A[. .AG+$F"]"
MFR,2G-U@RC0(F+O?"^\\',RB<V^#LUWI*(Z?2 0 98XQ5X4V<Q2X.\(@W\_7
M.4L3+HKR-1M<%=GO--^;F$0(+Z/BUNAO6<YQ6- ^^']YFI7OU/-%HW,!UPDX
M_,>@@F',3Z(O&.9H[H90W=,<[@@%EUX2T8>%!L*MOF.\D%LU+)3EQAPIVBR'
M4\0-#G81U#%$-2*DG>&0&..Q7RYN<!0GK(Y!A@@;)+K7'0GEHS''BS8?1=BZ
MJE=DOP_S@!4#3AA5LRS!3WE&WY8>8^K BZ.,T"MD+B,5!X>:'\IW@[$C!^OO
M(90=N\ZK[M_]XXO@LC$"_Y&4-H/*@-V46W[=WKW\VP_P_-O)G_?F^]=3/NX1
M_$N$Y/.$+3A@]_RJ A?(Y20&'F_FK@9MW#C[&PMFJTNG>;8BMLKO.Z66,K$+
M9#NU=QCNB8CA*-=F:9IK<:P"L)W:.R2W]HG@**?F>99F7D1-0 UV[4'9SO0=
MDF<<<KC!N'TOMOY!!X6WG1-\ #/U2.0B6^%'G@K.=D+Q8&QT^^#CK55U]LE@
M;&<@#\PV%T] WCI!AZ 2T';R\L#,@QV%1[^SUUBF14N2^E&(/@?QK^U_D5W;
M=_--XL5D;\8)F])F)0GZS%4O4'U7%P)8?>=Z1E&.:% ?;3)"UT/++I_G:4;6
MFEQ^*QV0-(>1_">0/H[VFLSR]5W!Q<XC6&]RN;&_%ITH/A&=99Y#E#QC'Z4/
M<2B]#HIA;-_?]=BGQE[?8_JQV/@BM*0;EGV_^:>$%K=/XH7LB7IOD.U;O1X/
M.?B-_:E#VGA%MMU*P6Q?_'5W5@ -QJ^=#X@]UA$L;[SD*\IV/5PD/GX)C&V'
M@!Z3U=B/G\.*5D22/5D%:-MKH+E/P^@P?H;7E8EV<6]B)G,'V_8KZ#%6@J^]
M@UA4%HC3*(O#'%8MASO4MM< R!HQ J]&RVB8Z6T<Q?O2I]Q557"VBY]IZAZ(
M"H9R\)CC:191A:==5:>+!0XQE0YQ87H*IP:S7=Q,0\F@-##$@D\>CN;1!4XW
M<>J%<!X X*P7--/@ I@,;CA=BMNJW#!HCK%>UDQO4^JB-_8+.3DY=\;-8>&L
M/::R7O5,C_V]B35^HV0/=: ,.% 3[0#^OA8-K[)8JKB#5H-0,2^5@-;KJ.EQ
M%T@(Y]X65UZT1.DL:@8_M_.0]IX9?VP],[9>%HOY)CB:-&?\DT<LC+]/JHF=
MB!+NEVD/ K>:5E*N\)$>'0!,RG$J=>N(K^G'_1YI'_L8-0UM%QA"]!;-R(^R
M@I*<L8XQ9D^L1!QH++]9)LD%+A2B1*\W<40WK>DW#&$('VR,O.%CTGA?MFE-
M[*_M(EZ3"ZK$AN /=XPK,HEK&Q%\A!J^,S>"JF_0^@DE8L9PAMH.<.C##B'&
M;KA#!%4E5,Q1@-F.8NC#*! E'&&:NN*#DH'P*6S'+O1BIBZ%#/F([Y+81RA(
MYU%99Y;8I"QD5,@?"J:$LAUIH,42$$8NJ5>[NH9*ET3C;<<(]%$<.>Z&M.21
M^J'*UX*T>V>3Z@H0UO:SOK;&:-'$#;WA>YA5VB.'LOWFWT>'('1P@V.OK'Z(
M><._XW]QLVS(!B4X#LBJD\R^>U\C<:A_JI#YJX22]8!4H#%SD4IVD:5VD2=4
MGMGJ6,+H+7IA?Y$ZP4#@SMPU0(H.)8=#FWUWR87<]F=A!]Z9RTE/'@H(X@83
M=[4:T\=8X++XXB6)%V6J[-H>4SESHU&QMC>9W. RD\Q/='6<[87)YY.7%@%6
M*$H9^15ZJSN9,_<ED!+W(Y4;O#84D&;^1J3BC#04S;9R"8[NHN%)2DA)4Z;K
MYB</R"<CY4T1#IS6=NSS()8/F'Q.2T)A  PO"N!Y;<=@#V-!'4T81"'R$D&]
M_(82'Z=HOBBM %$_(=U)K$=NJWG7!RT;C"JDZ%!.B6>Q'ME]$*M4U'%ZARV,
M,_JW^89UK*KPD%Q7>DQE/7A[D$-52B>GV5S(Z#!\ELYE/8I[F!-S+)QV_L7@
MU_<.Q'X?^=& XCR(P_DR<B";XY!' QWNVW=5<9=OB)%VTP2\='45QB^"TF,_
M:90>(S--BJD<B 9N8*85_,^!LIL^11=TE\3/F##X;/N9G#VSJ"XP,/4S_%Q4
MN5<BV6<N=RJ'"[G9S<7J23$WCG)3F;"F6'0 O8WER#ZCY"E.D?WS<N_!XQX1
M^\#'(=I+%WR,!U-P,U^S_=0_F("99(8;>\<%(LSQ,6,-^3E$C$=1,%U3@_5W
MQ8L4#-IV+(!1+L8]".*2 -"J#Y0"\^C!"]%\06A L,ZV=Z%7Q,IM!!W RPF@
M\+:#"8XH!'HDM9FP#ZE)T[<ZBNXDMD,2CB$@?>CBK)00NB3(2]$%*OZ7X%1V
MT-I>Q<GE>A/&6X3N\7*5I9\W<71/-L,$"783.N,A$]H.<SB6]!Q.=#>.G:HL
M CCV13#>=A#%$8\5.<G&?_-A%**OS$20KV./FDW75,2+G5)ZM97"V0[(.**(
MP$AHZ/6W*955M<09^<EG54#FBUE$UIXS.@@. *T9;,=6'&O'[T'6\=> ZAYS
M9;IA2BB-\+.\G D,VGJ$QQ$W!AUZOD;IF47/A,QQ(HWV4H!9#S.Q*B\<"KY&
M02F2S/.$LH/V&^&>54(B\:"MQZY8%1LQ/5^C]%2;ZIVW[7M"U:#60V&<.)Y:
ME#1DNBJ_S\08[+;@ UN/8['GHY!1TPU_!/S):(C7<@?"6@9[(].GW-C+G HP
MIA92.E"$A70NJ.P<HV7F@3$6 )JYL3^0G8MMG%=Q4I7 H?WJSO(41[0I'6U]
M5@7PD?VN<N/+W%:]9X3RWYC3\P!FQ@/1P+X-*3 E=H=>];\/JSC)'E&ROD ;
MVIHTG45G7O2517P2<F4Y"Q,6&!?]IX-*B3&_Y^%2<A@!G!61IJC?HTVA T0%
M=BA>Y5% T+I'Z0;Y9)?M\9@V]$>@XF3,WSJ,.)FA_?COLDVZ<*(6R#X,B 71
MF@0<).:N0/5!VT6CYC&>^F2%">K#<XTYH"P_=N1I?\,%3KGQ;Q%PX@UQW8%+
MR['#2/6E19]RK_2*7'?3&^"*+)T+*COF\P@/OB(#:.;(:=(\!FEM !3<QN2R
MIG2&*P&AW#3F.3V -1)304PCPT6,Z=<;A1QHI(CH_BD'@3+FV%Y,#<:HD71)
MQ^HK2SI?7,?1LK@&/TEV3S$$E'G&W(B#:96**N.WO9H8-OP?4,:W0*"</[8#
M\3#.<^DR?M8W-R=:;X!0"-$Z/'4W"MC!*@"%BL*QO82'':U2.KFQD^]9 GJ%
M-0"@4+8>VUMWH,4$+*LQW@#H&M6R"E"%I3S\60(%SKT;E2"(J#-^&8"3:X@+
M,UP^CNV2TY</?<J-W<E"T:7_3WV-SUZ(6#0OH1'V:?X8^<,T"O9_T1A9E"OJ
MANJ4]6JJ^/)[8@1=+A9(YJ Y]CJ@,FN^&AC<N6.'5W]H":_I4Z57?DKB?,.Z
M\*:T[!*.<A2484K\!_@A>*>]"JATN^2ZM,&GU]&-X8\GX1I%O3Z8+^GFIHR_
MLA)P^683,FI[847M6;2(DW7!<'6M+>@$4+DR7RP.+E>:U''#>U$%Y=$^#,3P
M%K.N,Q#*(G/!JYKT;F<J<!%W@RNTGB3!:/>N' 7U]8=5+@0\ML*G@'+2? ,#
MC3=670H9>HG3+Z<R1.V4#^:\N-ITC8&H&64#?2T@R\Q8:7N6*3]=)D@65BF%
M@++!G-?U$#8 B&$J_:IVUU?%SV<1\'T:!@HN/N4D8W3(8ZRV [<%A(PS<A H
M1\SY'0_A"(0<-GW1PC1'G&$OI*E_RP@7BE[G:3&-9T'.\2(GNB]*?BXR_/0G
M@G+<7#C?03K8FW3&4E95"ZH+0_5F8F,&*/>,>:4,<Z]#+ [;CEYT^Q.*R!K#
M>DE[9;;_.GDSH=Z#,$[S!)%_5*/MW3_FR=*+RBJ7NZK?107,NP9AYHN2=5ZX
MJP>NOIL,-+W-"YJ7$5[5LB?UR?'&6JZM/2A_VS<S(6E<T,0'3/:-!?9I<'^1
MR\YZ.H38;[XG[NGGW]KZV9ACLIMD4L]BL>9T!R5 Y6@)C$U?HXQ1CX3M9Z$T
M9 H*;UD3U1QK>QFUZ.*"RDDJQ^SIV<>VGC' 20DY*4%M5M@N;/_S.,W2LF,M
M_AW1#7/CX8!LG6S!Q3IWB*@U\.")+:IIE[D W90"65;(@;C<TEH F5Q0U2KY
MK9GWUG2.-_7UW0]M?:V@)UX43&KX?YO0&:P&X_$3^M2*"0"U&V7(7]V.*0!=
MU)O%LG*">=D-.=0FE0OZ6&PU9<VEZF8K,E3?O>,?H!7\I#F!Y1.CL12=DQ("
M:_LPY"X/>BBJ@&W?&\&\XYU_,,JXH'="5_">OKUOZUL#;%+ V;16GS(](Y0_
MWFI+FR>]LTP(8-VFE/&BTWE&BK4+ZD%3\]YD*%DS(6>%GB1U>_9TYD-;9]A<
M],6RT)@))=ZDG&ZR-Y\K@CA*76IF4P(T23!\3'HDQ=@%+:(9;9A5\206Z3F+
M'5PBVIU48>;]I7OL5!.QF]=N*D<LOMWZTB:FOJ;QISF-S5A@R$H!6J@[CV7U
M[,7G=G!N+]*YH,ZLJ\M>SVB^^O[8>4YH /[)V\3IWR<EO#T)+A:@ULGV.*?Z
MH-."'%KZIC&%957C\T?9Q5Q!$2?4J)$:S%>@GSH*1$$F%8Q%,[%>%$M7KYN]
MW*.PB(1,LY0I^Q/M_515'@.8DP?.:_,*!UWZ67/ID*O>H1/;-F4'D97VU7$8
M:KNP#="USA>T"*-@%^A$S5 (VHJ^@!DT9+)>BD17BVA"SLAAHS?K#\ATI+46
M!Z1>2)U].18OW!W)O"=SD170++$+](S"F#TD5 V]^,+:"2&I)F$7ML8TDWH>
MFR6*> BJCRD5G-6J2\72FNN*6&I"GJ'D(5YD+T1\M6S% Z:T?/3 ^-NISW0@
M!5U0W3*PDK;Q#M8XPA3C##\CN?)VXE+*:9CN[D]TF/H*-GW5JA6'$AQ\R)-*
M]575\:4!;_-,T^5-\Z#3)I$+*E2':E>K%(6'O.^$A]2@M9;T#PT12!UO=0KU
MD(,,J1*\+\&.'-$ZG3I=U,3LJH F25Q0@*+%UJ/WC2_UG1B,8OR$ MC,\BX7
MK>-OEP+9[=;77A? 7I-#63;) /SI-MI3$L$%=:&]Z.Y0PJO>N*<WG5@*"CBY
MH_&_#+1P\MGTB'M)1#8JB@QSH0!\XT((B\K37A1 <R0@MKW@"IZT=$:)NPL*
M4_KJ[KQ$^ +\OA-$40)-*BB;-^UZ^=O'Q(M2P@[JEH>X#U205AT(_,5IN@PT
M)K'N)(#QL>,FT*:3"TKWD#^EZ+><^O%H<VR!VG4"+W9@DQ+.9FVF?10@Q9A$
M$%9+3.TO"O)J*P:QK$0JGG0*2"EP=T)59/EGTD3*]]W(!WDBY>3/U4__^D?/
MJ12X%#ZG:+ZX3#.\ILTT9Q%+4DK$J;ML-5N5J^'@64>34SD(MD+=M""L5W&"
MB%(5F6;^_LD=!>R?89&4K1:%<LX#IH2VFK0O"(?CZI(4[*7T@QDMAP)W>72%
MEQ B.,*NHN:HJB9INY8T0TG"SH-F!;<;<(;= Q#1#7&X1SXBZWL*$7R3EL&
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M,,H8BHEY?(FG08#I&KVP'Y/TIK!]'QJ 8WUH9HA]#[10/WMSN,L3?^6EJ%Z
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M@[M?WD0/G]?"_?/02]/YX@M[/\CFR3TUP&]S>CS-%[LW@G,O#%%PMBW'I>5
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M'8U;6(;IB!_H[#M^7^T#G7U_KX4'NN.XT@VT97EUOG2%PTSL8%("CL6?#J2
M"Q[U*TP-(APM*XFZ15FS>#;GSU(G^_NVD[V>H?:I_]N$3-(NG-T9Q089\;[S
M<%*XVN4@%G6M*JO%7FZ>U ]6HO&V-$M-7*Z"R=$V97+F"4'%WUY^\U>TX,@%
M7BP0_0WB.6Z9Z2:#L.;8TJ6Y$A.S5&??2V=17:^%5C>/GE&2X:<07<=>)"0_
M"-2:MZL7'S2H88@A9U[TE2PC6;(;'[-&"BQ0 P<!1X"PUKQC?5BB10]#/.&M
M6>,HL^@]ZT-Q&;:]"X1E<>:%MEN8S"(_7J-'[UMI]]QZ26$Y\HVM#VUCJX"?
MD EJTVE2SV$S^VV'6+U<=>J;%,B%1_-Q!3- J,JUMDZQ"Z?8A5,/D%,/D%,/
MD%,/D%,/D*.><9?DFNU3XZT^M6D!]7ODQ\0 #HNWBVEVA0+J;Z3;7$X#V?<&
MBP_%028?BT]V0$JZ(1KUTBZ_>6MR(Z((7*#43S"K;PLPJT6 H^F0 22!&_R:
M;Q"]AT7+ZSA-S\FE;+N($UJ<6&*VRF!&TT]"C;@+#R&U+#5>/QKR!<@O^(OD
M-K[_VM'X@U,U:E[5+7VW=>_M\<2.BA.<;:LGA&(8X.&DSVR6#T?]J_XA1'-C
MFWTU%I.QXU5?*LS83JXT<*C728.(<]HF.YLG 3$GDJU8((I(3C6@[5-:@]E0
ME%S2=L%^=1O3HS_WV:-8W[V=/XFU:^S0>[J,1FXP%[+M\%, +K_Y*$T)P!F*
MT )GTW6<1Q(;9O@O67M0,[K)]Z&V&[(D4(*+0@-B;@R!7'^:H-8"XH?>%+KT
M,!4<3^Z"1<@X)C?W92.>9!;=HY0V<YLOOJRPO[J-+TH[@:P6I5_(L"*^+MM=
M[MKA] --;BT O]_A/2Q-'=/;\H0JMQB0=VL?P%K _^$ZRL?]E80Z-/PM#:%D
M57"H+%]C[XGVJ\4*[\N/8.]+]17VI^([K 1$XTLG;XQR []+XF=,LUVOXN1R
MO0GC+4)ED<3Y4XB7GL )7:;*0F#'XSW10,JES;6C;RQZ3<,_#9Y@?#X/3=HX
MRE :(EH0.0SC%QJ4J,%,'O"(_!DZ:/4]43\6AUF$EE3/#W%.&1* QJ'&CPD5
M4:D-.#Z_!Y 6XS:CZ(9TAQ*:)$JNYUGL?VW84^2FCGV:(X%#ZLLKQ[)+O-26
M^JEM2U'("0&=%-^9L ^US"KVL:('0_&Y'13[HA,VU:671.1J5)-!;5")(2RJ
M^1>$EROJG7U&M+/-;4XC5^8+ML!TGF=I1OA 5LUX(L9-<QK+]IB*=RWU[T4C
M-X[Q:93A@"H1?D8/R,\3MF==?O/#G&P-5X0PA7N>47Z^Z!!&X>T<:'K;-IVF
M/ Q*5!<B%LK+Q9V7-"['BHR!OW:;Y[!))N4LCJ4--%#<LK9>7N&<A+3-44&Z
M$+D^R@0"*%-.602N1+B[F47P2'<F&F05X&<<Y%XHSB@0#!T#[<6KMY=IT%G0
M%YRMF%I3/5[AS6-\24[+;"LKC:@]B?V,!:G$R1BF0LU,'<7S^'R%T>+R&[%6
MZ$E<E+%*%,6.I# VJRGVE+K]6D@ BIBJ2Y?]OO*^/I QXJP'%D+3'6<S]6$
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MA?[7DY<B\IO_#U!+ 0(4 Q0    ( -MT<%*KTA=!3OH  '0##  1
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M '-A9F\M,C R,#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( -MT<%*ZLFCQ\DD
M /+H!  5              "  0W( 0!S869O+3(P,C Q,C,Q7W!R92YX;6Q0
52P4&      8 !@"* 0  ,A("

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
